Citrus Sinensis ID: 006677

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-----
Protein Sequence
MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccEEEEEEccccccccccccccccccccccEEEccccccccccccccccccccccEEcccccccccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccEEEEccccccccHHHHHHHHcccccccccccEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccccEEEEEcccEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHccccccccccccccccHHHHHHHHHHHccccEEEccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccEEEEEcccccEEEEEEcccccccccccHHHHHccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHHHcccEEEcccccccccccHHHccccccEEEEEcccccccccccccccccEEEEEccccccccccHHHcccccccHcccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHcccEEEEccccccccHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHcHEEEccccccEEccccHHHHccccccccccccHccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mkfssaaplffplCVIVSLLPLAFADLNSDRQALLDFAdavphlrklnwsstnpicqswvginctqdrtrvfglrlpgiglvgpipnntlgkldALEVLSLRsnvltgglpseitslpsLRYLYLQHnnfsgkipssfspqlVVLDLsfnsftgnipqSIQNLTQltglslqsnnlsgsipnfdipklrhlnlsynglkgsipsslqkfpnssfvgnsllcgpplkacfpvapspsptyspppfiprkqsskqkLGLGAIIAIAVGGSAVLLLVALVILCYCLkkkdngsngvskgkassggrsekpkeefgsgvqepeknklvffegcsynfdlEDLLRASAEVlgkgsygtAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGrvgqhpnvvplrayyyskdekLLVYDYFAsgslstllhgnrgagrtpldWETRVKILLGTARGVahihsmggpkfthgnikasnVLINQdldgcisdfgltplmnvpatpsrsagyrapevietrkhshksdvySFGVLLLEMLtgkaplqsptrddmvdlprwvQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACvakvpdmrpnMDEVVRMIEEVRqsdsenrpsseenkskdsnvqtp
Flexible Loop (DISEMBL)
mkfssaaplfFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNwsstnpicqswVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYClkkkdngsngvskgkassggrsekpkeefgsgvqepeknKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMeivgrvgqhpnvvPLRAYYYSKDEKLLVYDYFASGSLSTllhgnrgagrtpldWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVietrkhshksdVYSFGVLLLEMLTGKaplqsptrddmvdlPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEvrqsdsenrpsseenkskdsnvqtp
Low Complexity Region (SEG)
MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTqltglslqsnnlsgsIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFpvapspsptyspppfipRKQSSKQKlglgaiiaiavggsavlllvalvilCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTvvvkrlkevvvgkRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP
Disordered region (IsUnstruct)
******APLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI*****KFPNSSFVGNSLLCGPPLKACFPV***********************LGLGAIIAIAVGGSAVLLLVALVILCYCLK*************************************KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV************************SDVYSFGVLLLEMLTGKAPL****RDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP****************************************
Disordered Region (DISOPRED)
****SAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGP***********************************AIIAIAVGGSAVLLLVALVILCYCLKK*************************************LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV****RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ****DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM****************************
Disordered Region (DISEMBL)
MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDN***************************QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV************************
Disordered Region (DISPRO)
**FSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACF************************KLGLGAIIAIAVGGSAVLLLVALVILCYCLKKK*********************************KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR***********************
Transmembrane Helix (TMHMM)
ooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	635	2.2.26 [Sep-21-2011]
Q9LVM0	654	Probable inactive recepto	yes	no	0.971	0.943	0.709	0.0
Q9C9Y8	640	Probable inactive recepto	no	no	0.981	0.973	0.619	0.0
Q9FHK7	640	Probable leucine-rich rep	no	no	0.959	0.951	0.576	0.0
O48788	658	Probable inactive recepto	no	no	0.943	0.910	0.551	1e-179
Q9SUQ3	638	Probable inactive recepto	no	no	0.938	0.934	0.503	1e-166
Q9LP77	655	Probable inactive recepto	no	no	0.907	0.879	0.468	1e-146
Q9SH71	587	Putative inactive recepto	no	no	0.897	0.971	0.443	1e-141
Q9FK10	601	Probable inactive recepto	no	no	0.880	0.930	0.459	1e-140
Q9FL63	614	Inactive leucine-rich rep	no	no	0.892	0.923	0.444	1e-138
Q9M9C5	670	Probable leucine-rich rep	no	no	0.929	0.880	0.465	1e-136

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  887 bits (2291), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/627 (70%), Positives = 519/627 (82%), Gaps = 10/627 (1%)

Query: 13  LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 72
           L V  +    A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+ CT D T V 
Sbjct: 31  LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVH 90

Query: 73  GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 132
            LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y+YLQHNNFSG
Sbjct: 91  ALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSG 150

Query: 133 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 192
           ++PS  S QL +LDLSFNSFTG IP + QNL QLTGLSLQ+N LSG +PN D   LR LN
Sbjct: 151 EVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLN 210

Query: 193 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPS--PTYSPPPF--IPRK 248
           LS N L GSIPS+L  FP+SSF GN+LLCG PL+ C   +P PS  P  S PP    P K
Sbjct: 211 LSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHK 270

Query: 249 QSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPK 308
           + SK+KL +  II IA GG+A+LLL+ ++ILC C+KKKD   + + K K      +EK K
Sbjct: 271 EGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT----LTEKAK 326

Query: 309 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 368
           +EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK
Sbjct: 327 QEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 386

Query: 369 RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN 428
           RLKEV  GKR+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +G+LS+LLHGN
Sbjct: 387 RLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGN 446

Query: 429 RGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 488
           RG+ +TPLDW++RVKI L  A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+ D CISDFGL
Sbjct: 447 RGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGL 506

Query: 489 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           TPLM VP  P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+QSP+RDDMVD
Sbjct: 507 TPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVD 566

Query: 549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
           LPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++RP MD+VVRMI
Sbjct: 567 LPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMI 626

Query: 609 EEVRQSDSE-NRPSSEEN-KSKDSNVQ 633
           EE+R SDSE  RPSS++N K KDSNVQ
Sbjct: 627 EEIRVSDSETTRPSSDDNSKPKDSNVQ 653

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  759 bits (1959), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/639 (61%), Positives = 469/639 (73%), Gaps = 16/639 (2%)

Query: 6   AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 65
           AA LF  +   VS      AD+ SD+QALL+FA  VPH RKLNW+ST PIC SW GI C+
Sbjct: 6   AAFLFLLVTTFVSRC--LSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCS 63

Query: 66  QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYL 125
           ++  RV  LRLPG GL GP+P  T  KLDAL ++SLRSN L G +PS I SLP +R LY 
Sbjct: 64  KNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYF 123

Query: 126 QHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI 185
             NNFSG IP   S +LV LDLS NS +GNIP S+QNLTQLT LSLQ+N+LSG IPN   
Sbjct: 124 HENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP- 182

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFI 245
           P+L++LNLS+N L GS+PSS++ FP SSF GNSLLCG PL  C     +PSP+ + P   
Sbjct: 183 PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEG 242

Query: 246 PR-----KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 300
           P      + ++K+ L  GAI+ IAVGGS +L ++  +I   C KK+D G +  +  KA  
Sbjct: 243 PGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKP 302

Query: 301 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 360
           G RS+   EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT YKA+LE
Sbjct: 303 G-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 361

Query: 361 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 420
           E TTVVVKRLKEV  GKR+FEQQME VGR+  H NV PLRAYY+SKDEKLLVYDY+  G+
Sbjct: 362 EGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGN 421

Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
            S LLHGN   GR  LDWETR++I L  ARG++HIHS  G K  HGNIK+ NVL+ Q+L 
Sbjct: 422 FSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELH 481

Query: 481 GCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
            C+SDFG+ PLM+     PSRS GYRAPE IETRKH+ KSDVYSFGVLLLEMLTGKA  +
Sbjct: 482 VCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGK 541

Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEEMVQMLQIGMACVAKVPDMR 598
           +   +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEEMVQMLQI MACV+K PD R
Sbjct: 542 TTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSR 601

Query: 599 PNMDEVVRMIEEVRQS----DSENRPSSEEN-KSKDSNV 632
           P+M+EVV M+EE+R S     S NR SS E  +S DS V
Sbjct: 602 PSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/633 (57%), Positives = 457/633 (72%), Gaps = 24/633 (3%)

Query: 6   AAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCT 65
           AA  FF L    ++L    ADL SD QALL+FA +VPH  KLNW+    +C SW+GI C 
Sbjct: 10  AASFFFLLLAATAVL--VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCD 67

Query: 66  QDR--TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYL 123
           +    +RV  +RLPG+GL G IP  TLGKLDAL+VLSLRSN L G LPS+I SLPSL YL
Sbjct: 68  ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127

Query: 124 YLQHNNFSGKIPS----SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 179
           YLQHNNFSG++ +    S S QLVVLDLS+NS +GNIP  ++NL+Q+T L LQ+N+  G 
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187

Query: 180 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTY 239
           I + D+P ++ +NLSYN L G IP  L+K P  SF+GNSLLCGPPL AC   A SPS   
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNL 247

Query: 240 SPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKG-KA 298
            P P        +++     IIAI VG S  +L + +V L  CL KK     G  +G + 
Sbjct: 248 -PRPLTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLV-CLVKKTKKEEGGGEGVRT 305

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
             GG + K  ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+ASAEVLGKGS+GTAYKAV
Sbjct: 306 QMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAV 365

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LE++T VVVKRL+EVV  K++FEQQMEIVG++ QH N VPL AYYYSKDEKLLVY Y   
Sbjct: 366 LEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTK 425

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSL  ++HGNRG     +DWETR+KI  GT++ ++++HS+   KF HG+IK+SN+L+ +D
Sbjct: 426 GSLFGIMHGNRG--DRGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTED 480

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           L+ C+SD  L  L N+P    R+ GY APEVIETR+ S +SDVYSFGV++LEMLTGK PL
Sbjct: 481 LEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540

Query: 539 QSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
             P  +D   ++DLPRWV+SVVREEWTAEVFDVEL++FQNIEEEMVQMLQ+ +ACVA+ P
Sbjct: 541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600

Query: 596 DMRPNMDEVVRMIEEVRQSD-----SENRPSSE 623
           + RP M+EV RMIE+VR+ D      +NR SSE
Sbjct: 601 ESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  627 bits (1617), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 346/627 (55%), Positives = 448/627 (71%), Gaps = 28/627 (4%)

Query: 29  SDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN 88
           +++QALL F   +PH  +L W+ ++  C +WVG+ C  +++ +  LRLPG GLVG IP+ 
Sbjct: 27  AEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQIPSG 85

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLD 146
           +LG+L  L VLSLRSN L+G +PS+ ++L  LR LYLQHN FSG+ P+SF+    L+ LD
Sbjct: 86  SLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLD 145

Query: 147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
           +S N+FTG+IP S+ NLT LTGL L +N  SG++P+  +  L   N+S N L GSIPSSL
Sbjct: 146 ISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVDFNVSNNNLNGSIPSSL 204

Query: 207 QKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIA 264
            +F   SF GN  LCG PLK C  F V+PSPSP+   P    R  S K KL   AI+AI 
Sbjct: 205 SRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPS--NRLSSKKSKLSKAAIVAII 262

Query: 265 VGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG-- 312
           V  + V LL+  ++L  CL+K+   +   +K    +G          G S   +E  G  
Sbjct: 263 VASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTS 322

Query: 313 SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 371
           SG+  E E+NKLVF EG  Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TTVVVKRLK
Sbjct: 323 SGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 382

Query: 372 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 431
           +V+  K++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+  +GSLS LLHG+RG+
Sbjct: 383 DVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGS 441

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
           GRTPLDW+ R++I +  ARG+AH+H     K  HGNIKASN+L++ + D C+SD+GL  L
Sbjct: 442 GRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQL 499

Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 551
            +  + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+   ++ +DLPR
Sbjct: 500 FSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPR 559

Query: 552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           WV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE+V
Sbjct: 560 WVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619

Query: 612 RQSDSEN---RPSSEENKSKDSNVQTP 635
            +S++ +   R SS++  SK S  QTP
Sbjct: 620 NRSETTDDGLRQSSDD-PSKGSEGQTP 645

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  584 bits (1505), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 314/624 (50%), Positives = 416/624 (66%), Gaps = 28/624 (4%)

Query: 23  AFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLV 82
           A +D   D++ALL+F   +   R LNW+ T+ +C  W G+ C QD +R+  +RLPG+GL 
Sbjct: 22  ANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLN 81

Query: 83  GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--P 140
           G IP NT+ +L AL VLSLRSN+++G  P +   L  L +LYLQ NN SG +P  FS   
Sbjct: 82  GQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWK 141

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYN-GL 198
            L  ++LS N F G IP S+  L ++  L+L +N LSG IP+  +   L+H++LS N  L
Sbjct: 142 NLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDL 201

Query: 199 KGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG 258
            G IP  L++FP SS+ G  ++  PP      V P P     P     +K S  + LGL 
Sbjct: 202 AGPIPDWLRRFPFSSYTGIDII--PPGGNYTLVTPPP-----PSEQTHQKPSKARFLGLS 254

Query: 259 AIIAI----AVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK-ASSGGRSEKPKEEFGS 313
             + +    AV    +  L  ++ +CY  +K   G   +S  K    GG S    E+F S
Sbjct: 255 ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMS---PEKFVS 311

Query: 314 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV 373
            +++   N+L FFEGC+Y+FDLEDLLRASAEVLGKG++GT YKAVLE++T+V VKRLK+V
Sbjct: 312 RMEDV-NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV 370

Query: 374 VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 433
             GKRDFEQQMEI+G + +H NVV L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG  R
Sbjct: 371 AAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENR 429

Query: 434 TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 493
            PLDWETR+KI +G A+G+A IH     K  HGNIK+SN+ +N + +GC+SD GLT +M+
Sbjct: 430 IPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMS 489

Query: 494 VPATP-SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 552
             A P SR AGYRAPEV +TRK S  SDVYSFGV+LLE+LTGK+P+ +   D+++ L RW
Sbjct: 490 PLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRW 549

Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV- 611
           V SVVREEWTAEVFD+EL+R+ NIEEEMV+MLQI M+CV K  D RP M ++VR+IE V 
Sbjct: 550 VHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVG 609

Query: 612 --RQS---DSENRPSSEENKSKDS 630
             R S   + E +P SE   S+ S
Sbjct: 610 NRRTSIEPEPELKPKSENGASETS 633

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  520 bits (1339), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 292/623 (46%), Positives = 388/623 (62%), Gaps = 47/623 (7%)

Query: 26  DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 85
           DLN+DR ALL    AV   R   W+       +W G+ C  +  RV  LRLPG+ L G I
Sbjct: 32  DLNADRTALLSLRSAVGG-RTFRWNIKQTSPCNWAGVKC--ESNRVTALRLPGVALSGDI 88

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS-PQLV 143
           P    G L  L  LSLR N L+G LP ++++  +LR+LYLQ N FSG+IP   FS   LV
Sbjct: 89  PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLV 148

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
            L+L+ NSFTG I     NLT+L  L L++N LSGSIP+ D+P L   N+S N L GSIP
Sbjct: 149 RLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSIP 207

Query: 204 SSLQKFPNSSFVGNSLLCGPPLKAC-----FPVAPSPSPTYSPPPFI-PRKQSSKQKLGL 257
            +LQ+F + SF+  SL CG PLK C      P  P+     +PP      ++  K KL  
Sbjct: 208 KNLQRFESDSFLQTSL-CGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266

Query: 258 GAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP-----KEEFG 312
           GAI  I +G      L+ L+++  C KK    SN  S+    S  + ++P     KE   
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKK----SNKRSRAVDISTIKQQEPEIPGDKEAVD 322

Query: 313 SGV---------------------QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSY 351
           +G                        P   KLVFF   +  FDLEDLLRASAEVLGKG++
Sbjct: 323 NGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTF 382

Query: 352 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 411
           GTAYKAVL+  T V VKRLK+V++  ++F++++E+VG +  H N+VPLRAYY+S+DEKLL
Sbjct: 383 GTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSRDEKLL 441

Query: 412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 471
           VYD+   GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G    +HGNIK+S
Sbjct: 442 VYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHGNIKSS 500

Query: 472 NVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 530
           N+L+ +  D  +SDFGL  L+   AT P+R+ GYRAPEV + ++ S K DVYSFGV+LLE
Sbjct: 501 NILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLE 560

Query: 531 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QMLQIGMA 589
           ++TGKAP  S   ++ VDLPRWV+SV R+EW  EVFD EL+     EEEM+ +M+Q+G+ 
Sbjct: 561 LITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLE 620

Query: 590 CVAKVPDMRPNMDEVVRMIEEVR 612
           C ++ PD RP M EVVR +E +R
Sbjct: 621 CTSQHPDQRPEMSEVVRKMENLR 643

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  503 bits (1296), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 276/622 (44%), Positives = 389/622 (62%), Gaps = 52/622 (8%)

Query: 9   LFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR 68
           LFF   +I+  + ++   L  D++ALL F  +    R L+W+ ++ +C SW G+ C ++ 
Sbjct: 5   LFF-FSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNENG 62

Query: 69  TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 128
            R+  +RLP +G  G IP  T+ +L +L+ LSLR N  TG  PS+ T+L SL +LYLQHN
Sbjct: 63  DRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHN 122

Query: 129 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP 186
           + SG + + FS    L VLDLS N F G+IP S+  LT L  L+L +N+ SG IPN  +P
Sbjct: 123 HLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHLP 182

Query: 187 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIP 246
           KL  +NLS N L G+IP SLQ+F +S+F GN+L                           
Sbjct: 183 KLSQINLSNNKLIGTIPKSLQRFQSSAFSGNNL-------------------------TE 217

Query: 247 RKQSSKQKLGLGAIIAIAVGGSAVLLLVA----LVILCYCLKKKDNGSNGVSKGKASSGG 302
           RK+  K   GL  +  + +  +A +L V+    ++I C+       G   +S GK     
Sbjct: 218 RKKQRKTPFGLSQLAFLLILSAACVLCVSGLSFIMITCF-------GKTRIS-GKLRKRD 269

Query: 303 RSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES 362
            S  P           E  K++FF G ++ FDL+DLL +SAEVLGKG++GT YK  +E+ 
Sbjct: 270 SSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDM 329

Query: 363 TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 422
           +TVVVKRLKEVVVG+R+FEQQMEI+G + +H NV  L+AYYYSKD+KL VY Y+  GSL 
Sbjct: 330 STVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYSYYNHGSLF 388

Query: 423 TLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 481
            +LHGNRG   R PLDW+ R++I  G ARG+A IH     KF HGNIK+SN+ ++    G
Sbjct: 389 EILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYG 445

Query: 482 CISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           CI D GLT +M ++P T   ++GY APE+ +TR+ +  SDVYSFGV+LLE+LTGK+P+  
Sbjct: 446 CIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQ 505

Query: 541 ----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVP 595
               PT  + +DL  W++SVV +EWT EVFD+E++ +    EEEMV+MLQIG+ACVA   
Sbjct: 506 AELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQ 565

Query: 596 DMRPNMDEVVRMIEEVRQSDSE 617
             RP++ +V+++IE++R  D+E
Sbjct: 566 QERPHIAQVLKLIEDIRSVDAE 587

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1

 Score =  499 bits (1286), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 277/603 (45%), Positives = 369/603 (61%), Gaps = 44/603 (7%)

Query: 13  LCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF 72
           L V++  + +    +  D+  LL F + + H   LNWS +  IC  W G+ C  D + V 
Sbjct: 9   LIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTCNSDHSSVD 68

Query: 73  GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 132
            L L   GL G I  + + +L  L  L L SN ++G  P+ + +L +L  L L  N FSG
Sbjct: 69  ALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELKLDFNEFSG 128

Query: 133 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH 190
            +PS  S   +L VLDLS N F G+IP SI  LT L  L+L  N  SG IP+  IP L+ 
Sbjct: 129 PLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPDLHIPGLKL 188

Query: 191 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQS 250
           LNL++N L G++P SLQ+FP S+FVGN +L               +P +S      RK +
Sbjct: 189 LNLAHNNLTGTVPQSLQRFPLSAFVGNKVL---------------APVHSSL----RKHT 229

Query: 251 SKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEE 310
                    ++ IA       L V   IL           +   + + SS  +  K +++
Sbjct: 230 KHHN---HVVLGIA-------LSVCFAILALLAILLVIIIHNREEQRRSSKDKPSKRRKD 279

Query: 311 FGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL 370
               V E + NK+VFFEG +  FDLEDLLRASAEVLGKG +GT YK  LE+S T+VVKR+
Sbjct: 280 SDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRI 338

Query: 371 KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG 430
           KEV V +R+FEQQ+E +G + +H NV  LR Y+YSKDEKL+VYDY+  GSLSTLLHG +G
Sbjct: 339 KEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQKG 397

Query: 431 -AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
              R  L+WETR+ ++ GTARGVAHIHS  G K  HGNIK+SN+ +N    GCIS  G+ 
Sbjct: 398 LRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCISGTGMA 457

Query: 490 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
            LM+  + P  + GYRAPE+ +TRK +  SDVYSFG+L+ E+LTGK+        ++ +L
Sbjct: 458 TLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--------EVANL 507

Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
            RWV SVVREEWT EVFD EL+R   +EEEMV+MLQ+GM C A++P+ RPNM EVVRM+E
Sbjct: 508 VRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVE 567

Query: 610 EVR 612
           E+R
Sbjct: 568 EIR 570

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1

 Score =  493 bits (1268), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 270/608 (44%), Positives = 378/608 (62%), Gaps = 41/608 (6%)

Query: 25  ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 84
            DL  DRQALLDF + + H R L W++++P+C +W G+ C  D TRV  L LPG  L+G 
Sbjct: 28  GDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDGTRVTALHLPGASLLGV 87

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           IP  T+ +L  L++LSLRSN L G  P +   L  L+ + L +N FSG +PS ++    L
Sbjct: 88  IPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNNRFSGPLPSDYATWTNL 147

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
            VLDL  N F G+IP    NLT L  L+L  N+ SG IP+ ++P LR LN S N L GSI
Sbjct: 148 TVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLPGLRRLNFSNNNLTGSI 207

Query: 203 PSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLG--AI 260
           P+SL++F NS+F GN+L+        F  AP       PP  +  K+  K  + +   AI
Sbjct: 208 PNSLKRFGNSAFSGNNLV--------FENAP-------PPAVVSFKEQKKNGIYISEPAI 252

Query: 261 IAIAVGGSAVLLLVALVILCYCLKKKDNGSNGV---SKGKASSGGRSEKPKEEFGSGVQ- 316
           + IA+    V+  V  V++  C  K+   S       K K +    SEK   + G     
Sbjct: 253 LGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVSKLGKEKNI 312

Query: 317 -----EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 371
                + E NK++FFEG +  F+LEDLL ASAE LGKG +G  YKAVLE+S  + VKRLK
Sbjct: 313 EDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSKVIAVKRLK 372

Query: 372 EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG-NRG 430
           ++VV ++DF+ QMEIVG + +H NV PLRAY  SK+EKL+VYDY ++GSLS  LHG N  
Sbjct: 373 DIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLRLHGKNAD 431

Query: 431 AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP 490
            G  PL+WETR++ ++G A+G+ HIH+       HGNIK+SNV +N +  GCIS+ GL P
Sbjct: 432 EGHVPLNWETRLRFMIGVAKGLGHIHTQ---NLAHGNIKSSNVFMNSEGYGCISEAGL-P 487

Query: 491 LMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           L+  P   + S+      YRAPEV +TR+ + +SD+YSFG+L+LE LTG++ +    R +
Sbjct: 488 LLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMDD--RKE 545

Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
            +DL  WV  V+ ++WT EVFD+EL++  N+E +++QMLQ+G +C A VP  RP+M +VV
Sbjct: 546 GIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPDMVKVV 605

Query: 606 RMIEEVRQ 613
             +EE+ +
Sbjct: 606 ETLEEIER 613

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  485 bits (1248), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 300/645 (46%), Positives = 406/645 (62%), Gaps = 55/645 (8%)

Query: 29  SDRQALLDFADAVPHLRKLN-WSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPN 87
           +D + LL+F        KLN W++T   CQ W G++C  +R RV  L L  I L G I +
Sbjct: 30  TDSETLLNFKLTADSTGKLNSWNTTTNPCQ-WTGVSC--NRNRVTRLVLEDINLTGSISS 86

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
            T   L +L VLSL+ N L+G +P+ +++L +L+ L+L +N FSG  P+S +   +L  L
Sbjct: 87  LT--SLTSLRVLSLKHNNLSGPIPN-LSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRL 143

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 205
           DLSFN+F+G IP  + +LT L  L L+SN  SG IPN ++  L+  N+S N   G IP+S
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203

Query: 206 LQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYSP----------PPFIPR-------- 247
           L +FP S F  N  LCG PL  C  ++  P+    P          P  +P         
Sbjct: 204 LSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGG 263

Query: 248 -KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEK 306
            K ++  ++   ++IAI +G   +L  V+L +L YC  ++      V+K K S     EK
Sbjct: 264 DKSNNTSRISTISLIAIILGDFIILSFVSL-LLYYCFWRQ----YAVNKKKHSKILEGEK 318

Query: 307 --------PKEEFGSGVQEP---EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAY 355
                   P     +  Q     +K K+VFFEG +  F+LEDLLRASAE+LGKG +GTAY
Sbjct: 319 IVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAY 377

Query: 356 KAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 413
           KAVLE+   V VKRLK+ V   GK++FEQQME++GR+ +H N+V L+AYY++++EKLLVY
Sbjct: 378 KAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVY 436

Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASN 472
           DY  +GSL  LLHGNRG GRTPLDW TR+KI  G ARG+A IH S    K THG+IK++N
Sbjct: 437 DYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTN 496

Query: 473 VLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML 532
           VL+++  +  +SDFGL+ +     T ++S GYRAPE+I+ RKH+ KSDVYSFGVLLLE+L
Sbjct: 497 VLLDRSGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEIL 555

Query: 533 TGKAP--LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 590
           TGK P  +++      VDLPRWVQSVVREEWTAEVFD+ELMR+++IEEEMV +LQI MAC
Sbjct: 556 TGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMAC 615

Query: 591 VAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
            A   D RP M  VV++IE++R   SE  P    N   +S V +P
Sbjct: 616 TAVAADHRPKMGHVVKLIEDIRGGGSEASPC---NDGINSAVDSP 657

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	635
224145409	636	predicted protein [Populus trichocarpa]	0.998	0.996	0.803	0.0
359478866	637	PREDICTED: probable inactive receptor ki	1.0	0.996	0.802	0.0
297745748	656	unnamed protein product [Vitis vinifera]	1.0	0.967	0.802	0.0
255586379	635	Nodulation receptor kinase precursor, pu	0.996	0.996	0.802	0.0
224126989	635	predicted protein [Populus trichocarpa]	0.995	0.995	0.788	0.0
356537708	664	PREDICTED: probable inactive receptor ki	0.998	0.954	0.766	0.0
449444334	630	PREDICTED: probable inactive receptor ki	0.988	0.996	0.773	0.0
356500954	654	PREDICTED: probable inactive receptor ki	0.995	0.966	0.764	0.0
356570023	631	PREDICTED: probable inactive receptor ki	0.993	1.0	0.770	0.0
357460531	660	Leucine-rich repeat receptor-like protei	0.996	0.959	0.751	0.0

>gi|224145409|ref|XP_002325632.1| predicted protein [Populus trichocarpa] gi|222862507|gb|EEF00014.1| predicted protein [Populus trichocarpa]

 Score = 1050 bits (2714), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 512/637 (80%), Positives = 560/637 (87%), Gaps = 3/637 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MK    + ++F   ++  + P AFADL SD+QALLDFA AVPHLRKLNW+  + +C SWV
Sbjct: 1   MKIFLGSVIYF-FIILTIIFPFAFADLKSDKQALLDFATAVPHLRKLNWNPASSVCNSWV 59

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           G+ C  +RTRV  LRLPG+GLVG IP NTLGKLDAL VLSLRSNVL G LPS+ITSLPSL
Sbjct: 60  GVTCNSNRTRVSQLRLPGVGLVGHIPPNTLGKLDALRVLSLRSNVLEGDLPSDITSLPSL 119

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
             L+LQHNNFSG IP+SFS QL VLDLSFNSFTGNIPQ++ NLTQL GLSLQ+N LSG I
Sbjct: 120 TNLFLQHNNFSGGIPTSFSLQLNVLDLSFNSFTGNIPQTLANLTQLIGLSLQNNTLSGPI 179

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVA--PSPSPT 238
           P+ +  +++ LNLSYN L GSIP SLQ FPNSSF+GNSLLCGPPL  C PV   PSPSP 
Sbjct: 180 PDLNHTRIKRLNLSYNHLNGSIPVSLQNFPNSSFIGNSLLCGPPLNPCSPVIRPPSPSPA 239

Query: 239 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 298
           Y PPP +PRK+SSK KL +GAIIAIAVGGSAVL LV L ILC CLKKKDNG + V KGKA
Sbjct: 240 YIPPPTVPRKRSSKVKLTMGAIIAIAVGGSAVLFLVVLTILCCCLKKKDNGGSSVLKGKA 299

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
            S GR EKPKEEFGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 300 VSSGRGEKPKEEFGSGVQEHEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 359

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LEESTTVVVKRL+EVV+GKRDFEQQME VGRVGQHPN+VPLRAYYYSKDEKLLVYDY   
Sbjct: 360 LEESTTVVVKRLREVVMGKRDFEQQMENVGRVGQHPNIVPLRAYYYSKDEKLLVYDYIPG 419

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS+GGPKFTHGNIK++NVL++QD
Sbjct: 420 GSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSVGGPKFTHGNIKSTNVLLSQD 479

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            DGCISDFGLTPLMNVPAT SRSAGYRAPEVIETRKH+HKSDVYSFGV+LLEMLTGKAP+
Sbjct: 480 HDGCISDFGLTPLMNVPATSSRSAGYRAPEVIETRKHTHKSDVYSFGVVLLEMLTGKAPI 539

Query: 539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
           QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDMR
Sbjct: 540 QSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMR 599

Query: 599 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           PNM+EVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 600 PNMEEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 636

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478866|ref|XP_002276162.2| PREDICTED: probable inactive receptor kinase At5g58300 [Vitis vinifera]

 Score = 1032 bits (2669), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/637 (80%), Positives = 565/637 (88%), Gaps = 2/637 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MK  S + +   L VI  LLPLA ADL++D+QALLDFADAVPH RKLNW+S+ P+C SWV
Sbjct: 1   MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 60

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GINCT D +RV  LRLPGIGL G IP  TLGKLDALE+LSLRSN+LTG LPS+I SLPSL
Sbjct: 61  GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 120

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I NLTQLTGL+LQ+N+LSG+I
Sbjct: 121 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 180

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPT 238
           P+ +  KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCGPPL  C   P++PSP+P+
Sbjct: 181 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 240

Query: 239 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 298
           +  PP    KQ SK+KL +G IIAIAVGG+ VL LV L+I   CL+KKD+  +GV+KGKA
Sbjct: 241 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 300

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
           S GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 301 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 360

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY + 
Sbjct: 361 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 420

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSLS LLHGNR  GR+PLDW  RVKI LG ARG+ HIHS+GG KFTHGNIK+SNVL+NQD
Sbjct: 421 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 480

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 481 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 540

Query: 539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
           QSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEMVQMLQ+ MACVAKVPDMR
Sbjct: 541 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 600

Query: 599 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           P+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 601 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745748|emb|CBI15804.3| unnamed protein product [Vitis vinifera]

 Score = 1031 bits (2665), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/637 (80%), Positives = 565/637 (88%), Gaps = 2/637 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MK  S + +   L VI  LLPLA ADL++D+QALLDFADAVPH RKLNW+S+ P+C SWV
Sbjct: 20  MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 79

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GINCT D +RV  LRLPGIGL G IP  TLGKLDALE+LSLRSN+LTG LPS+I SLPSL
Sbjct: 80  GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 139

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YL+LQHNNFSG IP+SFSPQL VLDLSFNSFTGNIP +I NLTQLTGL+LQ+N+LSG+I
Sbjct: 140 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 199

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC--FPVAPSPSPT 238
           P+ +  KL+HLNLSYN L GSIPSSLQ+FPNSSFVGNSLLCGPPL  C   P++PSP+P+
Sbjct: 200 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 259

Query: 239 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 298
           +  PP    KQ SK+KL +G IIAIAVGG+ VL LV L+I   CL+KKD+  +GV+KGKA
Sbjct: 260 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 319

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
           S GGRSEKPKEEFGSGVQEP+KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 320 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 379

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LEESTTVVVKRLKEVVVGKRDFEQQM+IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY + 
Sbjct: 380 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 439

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSLS LLHGNR  GR+PLDW  RVKI LG ARG+ HIHS+GG KFTHGNIK+SNVL+NQD
Sbjct: 440 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 499

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +GCISDFGLTPLMN PAT SR+AGYRAPEVIE+RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 500 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 559

Query: 539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
           QSP RDDMVDLPRWVQSVVREEWTAEVFD+ELMR+QNIEEEMVQMLQ+ MACVAKVPDMR
Sbjct: 560 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 619

Query: 599 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           P+MDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 620 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 656

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586379|ref|XP_002533837.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223526229|gb|EEF28551.1| Nodulation receptor kinase precursor, putative [Ricinus communis]

 Score = 1025 bits (2650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 511/637 (80%), Positives = 556/637 (87%), Gaps = 4/637 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MKF  A+   F L V+ +L  LA ADLNSD+QALL+F+ A+PH R LNW+  + IC+SWV
Sbjct: 1   MKFFPASS--FRLIVLFTLFSLAIADLNSDKQALLNFSAAIPHYRLLNWNPASSICKSWV 58

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           G+ C   +TRV  LRLPG+G +G IP NTLGKLDAL VLSLRSN+L G LPS++TSLPSL
Sbjct: 59  GVTCNPSQTRVLELRLPGVGFIGQIPANTLGKLDALRVLSLRSNLLYGNLPSDVTSLPSL 118

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           R LYLQHNNFS  IP+SFS QL VLDLSFNSF+G+IPQ+I NLTQLTGLSLQ+N LSG+I
Sbjct: 119 RNLYLQHNNFSSTIPTSFSSQLNVLDLSFNSFSGSIPQTIANLTQLTGLSLQNNTLSGAI 178

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 240
           P+ +  +LRHLNLSYN L GS+P SLQKFPNSSF GNSLLCG PL  C P+   PSP+ +
Sbjct: 179 PDLNQSRLRHLNLSYNHLNGSVPFSLQKFPNSSFTGNSLLCGLPLNPCSPILSPPSPSPA 238

Query: 241 PPPFIP--RKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 298
             P      K+ SK KL LGAIIAIAVGG AVL L+ ++ILC CLKKKDNG + V KGKA
Sbjct: 239 SSPPPEMPHKKGSKAKLTLGAIIAIAVGGFAVLFLIVVIILCCCLKKKDNGGSSVLKGKA 298

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
            S GR EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 299 VSSGRGEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LEESTTVVVKRLKEVVVGKR+FEQQMEIVGRVGQH NVVPLRAYYYSKDEKLLVYDY   
Sbjct: 359 LEESTTVVVKRLKEVVVGKREFEQQMEIVGRVGQHQNVVPLRAYYYSKDEKLLVYDYIQG 418

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSLSTLLHGNR AGRTPLDW+ RVKI LGTARG+AH+HS GGPKFTHGNIK+SNVL+NQD
Sbjct: 419 GSLSTLLHGNRQAGRTPLDWDNRVKIALGTARGIAHLHSAGGPKFTHGNIKSSNVLLNQD 478

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 479 HDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHTHKSDVYSFGVLLLEMLTGKAPL 538

Query: 539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
           QSP+RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGMACVAKVPDMR
Sbjct: 539 QSPSRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMACVAKVPDMR 598

Query: 599 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 599 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 635

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126989|ref|XP_002319979.1| predicted protein [Populus trichocarpa] gi|222858355|gb|EEE95902.1| predicted protein [Populus trichocarpa]

 Score = 1004 bits (2596), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 503/638 (78%), Positives = 552/638 (86%), Gaps = 6/638 (0%)

Query: 1   MKF--SSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 58
           MKF  +S   LF  L +I    P A +DL SD+QALLDFA  VPH RKLNW+  + +C+S
Sbjct: 1   MKFFRASVIHLFIILTII---FPFAISDLKSDKQALLDFAAVVPHSRKLNWNPASLVCKS 57

Query: 59  WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 118
           WVG+ C  + TRV  LRLPG+GL+G +P NTLGKLDAL  LSLRSNVL G LPS++TSLP
Sbjct: 58  WVGVTCNSNDTRVVELRLPGVGLLGHVPPNTLGKLDALNTLSLRSNVLEGDLPSDVTSLP 117

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           SL+ L+LQHNNFSG +P+SFS +L VLDLSFNSFTGNIPQ+I NLTQLTGLSLQ+N LSG
Sbjct: 118 SLQNLFLQHNNFSGGVPTSFSLKLNVLDLSFNSFTGNIPQTIANLTQLTGLSLQNNALSG 177

Query: 179 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPV-APSPSP 237
            IP+ +  +++HLNLSYN L GSIP SLQKFPNSSF+GNSLLCGPPL  C  V  P PSP
Sbjct: 178 PIPDLNHTRIKHLNLSYNHLNGSIPVSLQKFPNSSFIGNSLLCGPPLNPCSIVLPPPPSP 237

Query: 238 TYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGK 297
            Y+PPP    K+SSK KL +GAIIAIAVGGSAVL LV L++ C CLKKKDN   GV KGK
Sbjct: 238 AYTPPPATSHKRSSKLKLTMGAIIAIAVGGSAVLFLVVLIVFCCCLKKKDNEGPGVLKGK 297

Query: 298 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 357
           A S GR EKPKE+FGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA
Sbjct: 298 AVSSGRGEKPKEDFGSGVQESEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 357

Query: 358 VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA 417
           VLEESTTVVVKRLKEVVVGKRDFEQQMEI GRVGQHPNVVPLRAYYYSKDE+LLVYDY  
Sbjct: 358 VLEESTTVVVKRLKEVVVGKRDFEQQMEIAGRVGQHPNVVPLRAYYYSKDERLLVYDYIP 417

Query: 418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 477
            GSLSTLLH NRGAGRTPLDW++RVKI LGTARG++H+HS GGPKFTHGNIK+SNVL++Q
Sbjct: 418 GGSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSAGGPKFTHGNIKSSNVLLSQ 477

Query: 478 DLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           D DGCISDFGLTPLMNVPA+ SRSAGYRAPEVIET KHSHKSDVYSFGV+LLEMLTGKAP
Sbjct: 478 DHDGCISDFGLTPLMNVPASSSRSAGYRAPEVIETSKHSHKSDVYSFGVILLEMLTGKAP 537

Query: 538 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 597
           +QSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQIGM CVAKVPDM
Sbjct: 538 IQSPRRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDM 597

Query: 598 RPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           RPNM+EVVRMIEE+RQSDSENRPSSE NKSKDSNV TP
Sbjct: 598 RPNMEEVVRMIEEIRQSDSENRPSSEGNKSKDSNVHTP 635

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max]

 Score =  987 bits (2551), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/635 (76%), Positives = 549/635 (86%), Gaps = 1/635 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MKF S +   F L VIV   PLA ADL+SD+QALL+FA+AVPH R L W+ +  +C SWV
Sbjct: 31  MKFCSTSVASF-LFVIVIFFPLAIADLSSDKQALLNFANAVPHRRNLMWNPSTSVCSSWV 89

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GI C ++RTRV  +RLPG+GLVG IP+NTLGKLDA++++SLRSN+L+G LP++I SLPSL
Sbjct: 90  GITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLLSGNLPADIGSLPSL 149

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YLYLQHNN SG IP+S SPQL+VLDLS+NSFTG IP++ QN++ LT L+LQ+N+LSG I
Sbjct: 150 QYLYLQHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVLTSLNLQNNSLSGQI 209

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 240
           PN ++  L+ LNLSYN L GSIP +L+ FPNSSF GNSLLCGPPLK C  V P+PSP  +
Sbjct: 210 PNLNVTLLKLLNLSYNHLNGSIPKALEIFPNSSFEGNSLLCGPPLKPCSAVPPTPSPAST 269

Query: 241 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 300
           PPP    +QSSK KL   AII IAVGG+ VL  +ALV +  CLKK+DN  + V KGK  S
Sbjct: 270 PPPSTTGRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKEDNRGSNVIKGKGPS 329

Query: 301 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 360
           GGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTAYKA+LE
Sbjct: 330 GGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILE 389

Query: 361 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 420
           ES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSKDEKLLVYDY   G+
Sbjct: 390 ESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGN 449

Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           L TLLHG R  GRTPLDW++R+KI LGTA+G+AHIHS+GGPKFTHGNIK+SNVL+NQD D
Sbjct: 450 LHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHIHSVGGPKFTHGNIKSSNVLLNQDND 509

Query: 481 GCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           GCISDFGL PLMNVPATPSR+AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS
Sbjct: 510 GCISDFGLAPLMNVPATPSRAAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 569

Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
           P RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAK+PDMRP+
Sbjct: 570 PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPS 629

Query: 601 MDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           MDE VRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 630 MDEAVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 664

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449444334|ref|XP_004139930.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] gi|449475802|ref|XP_004154555.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus]

 Score =  975 bits (2521), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 493/637 (77%), Positives = 551/637 (86%), Gaps = 9/637 (1%)

Query: 1   MKFSSAA--PLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQS 58
           MKF SA+  PLFF   VI++LL LA ADL SD+QALLDFA +VPH R LNW+ T PIC S
Sbjct: 1   MKFCSASVLPLFF---VIINLLHLAIADLESDKQALLDFASSVPHRRSLNWNDTTPICTS 57

Query: 59  WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP 118
           WVG+ C+ D T V  LRLPGIGLVG IP++TLGKLD L++LSLRSN+L+G +PS+ITSLP
Sbjct: 58  WVGVTCSADGTHVLTLRLPGIGLVGSIPSDTLGKLDGLKILSLRSNLLSGIIPSDITSLP 117

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           SL+YLYLQHNN SG +PSS SP LVVL+LSFN   G IP+++QNLTQLTGL+LQ+NNLSG
Sbjct: 118 SLQYLYLQHNNLSGDVPSSLSPTLVVLNLSFNLLEGKIPKTVQNLTQLTGLNLQNNNLSG 177

Query: 179 SIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPT 238
           SIP+ ++PKL+HLN+SYN L GSIP+    FPNSSF+GN  LCG PLKAC  +  SP+P 
Sbjct: 178 SIPDINLPKLKHLNISYNHLNGSIPTFFNTFPNSSFIGNPSLCGSPLKAC-SIVLSPAPH 236

Query: 239 YSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKA 298
             P P I +KQSSK KL +G IIAIAVGG  VL LV L ++  CLKKK+ G  G  KGK 
Sbjct: 237 APPSPAISQKQSSK-KLKMGVIIAIAVGGFFVLFLVVLFVVLCCLKKKEGGDAGTRKGKV 295

Query: 299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
           S GGRSEKPKEEFGSGVQEPEKNKLVFFEGCS+NFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct: 296 SGGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSFNFDLEDLLRASAEVLGKGSYGTAYKAV 355

Query: 359 LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
           LEE TTVVVKRLKEVVVGKR+FEQQM+IVGRVGQHPNV+PLRAYYYSKDEKLLVYDY   
Sbjct: 356 LEEPTTVVVKRLKEVVVGKREFEQQMDIVGRVGQHPNVMPLRAYYYSKDEKLLVYDYVPG 415

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
           GSLS+LLHGNRG  RTPLDW++RVKI L TA+G+AHIH+MGGPKFTHGNIKASNVL+ QD
Sbjct: 416 GSLSSLLHGNRGGERTPLDWDSRVKIALATAKGIAHIHAMGGPKFTHGNIKASNVLLIQD 475

Query: 479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++ C+SDFGLTPLMNVP   SR+AGYRAPEVIE RKH+HKSDVYSFGVLLLEMLTGKAPL
Sbjct: 476 VNACVSDFGLTPLMNVPT--SRTAGYRAPEVIEARKHTHKSDVYSFGVLLLEMLTGKAPL 533

Query: 539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
           QSP RD+MVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI M CVAK+PDMR
Sbjct: 534 QSPGRDEMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMTCVAKLPDMR 593

Query: 599 PNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           PNMDEVVRMIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 594 PNMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 630

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500954|ref|XP_003519295.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max]

 Score =  964 bits (2491), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/636 (76%), Positives = 546/636 (85%), Gaps = 4/636 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MKF S+    F L +IV L PLA ADL+SD+QALLDFA AVPH R L W+   PIC SWV
Sbjct: 22  MKFYSSQVHRF-LFIIVILFPLAIADLSSDKQALLDFAAAVPHRRNLKWNPATPICSSWV 80

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GI C  + TRV  +RLPGIGLVG IP NTLGK+D+L  +SLR+N+L+G LP +ITSLPSL
Sbjct: 81  GITCNPNGTRVVSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLSGSLPPDITSLPSL 140

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YLYLQHNN SG +P+S S +L VLDLS+NSF+G IP+++QN+TQL  L+LQ+N+LSG I
Sbjct: 141 QYLYLQHNNLSGSVPTSLSTRLNVLDLSYNSFSGAIPKTLQNITQLIKLNLQNNSLSGQI 200

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 240
           PN ++ KLRHLNLSYN L GSIP +LQ FPNSSF GNSL CG PLK+C  V+ +P P+  
Sbjct: 201 PNLNVTKLRHLNLSYNHLNGSIPDALQIFPNSSFEGNSL-CGLPLKSCSVVSSTP-PSTP 258

Query: 241 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 300
             P  P + SSK KL   AIIAIAVGG  +LLLVAL+I+  CLKKKD+ S  V+KGK  S
Sbjct: 259 VSPSTPARHSSKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCLKKKDDRSPSVTKGKGPS 318

Query: 301 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 360
           GGRSEKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTAYKA+LE
Sbjct: 319 GGRSEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILE 378

Query: 361 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 420
           ESTTVVVKRLKEVVVGKR+FEQQMEIVGRVG HPNVVPLRAYYYSKDEKLLVYDY  SG+
Sbjct: 379 ESTTVVVKRLKEVVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSKDEKLLVYDYIPSGN 438

Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           LSTLLHGNR +GRTPLDW +R+KI +G ARG+AHIHS+GGPKFTHGN+K+SNVL+N D D
Sbjct: 439 LSTLLHGNRASGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFTHGNVKSSNVLLNHDND 498

Query: 481 GCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           GCISDFGLTPLMNVPATPSR+AGYRAPEVIETRKH+HKSDVYSFG+LLLEMLTGKAP QS
Sbjct: 499 GCISDFGLTPLMNVPATPSRAAGYRAPEVIETRKHTHKSDVYSFGILLLEMLTGKAPQQS 558

Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
           P RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAKVPDMRP+
Sbjct: 559 PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKVPDMRPS 618

Query: 601 MDEVVRMIEEVRQSDSENRPSSEENKSK-DSNVQTP 635
           MDEVVRMIEE+R SDSENRPSSEEN+SK +S  QTP
Sbjct: 619 MDEVVRMIEEIRLSDSENRPSSEENRSKEESAAQTP 654

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356570023|ref|XP_003553192.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max]

 Score =  962 bits (2486), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/632 (77%), Positives = 546/632 (86%), Gaps = 1/632 (0%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MKF S +   F L VIV L PLA ADL+SD+QALLDFA+AVPH R L W+ +  +C SWV
Sbjct: 1   MKFHSTSVASF-LFVIVILFPLAIADLSSDKQALLDFANAVPHRRNLMWNPSTSVCTSWV 59

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GI C ++RTRV  +RLPG+GLVG IP+NTLGKL A++++SLRSN+L+G LP++I SLPSL
Sbjct: 60  GITCNENRTRVVKVRLPGVGLVGTIPSNTLGKLGAVKIISLRSNLLSGNLPADIGSLPSL 119

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YLYLQHNN SG IP+S S QLVVLDLS+NSFTG IP + QNL++LT L+LQ+N+LSG I
Sbjct: 120 QYLYLQHNNLSGDIPASLSLQLVVLDLSYNSFTGVIPTTFQNLSELTSLNLQNNSLSGQI 179

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 240
           PN ++  L+ LNLSYN L GSIP +LQ FPNSSF GNSLLCGPPLK C  V P+PSP+ +
Sbjct: 180 PNLNVNLLKLLNLSYNQLNGSIPKALQIFPNSSFEGNSLLCGPPLKPCSVVPPTPSPSST 239

Query: 241 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASS 300
           PP   P +QSSK KL   AIIAIAVGG+ VL  VALV    CLKK+D+  + V KGK  S
Sbjct: 240 PPQSTPGRQSSKNKLSKIAIIAIAVGGAVVLFFVALVFFICCLKKEDDRGSNVIKGKGPS 299

Query: 301 GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 360
           GGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTAYKA+LE
Sbjct: 300 GGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILE 359

Query: 361 ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS 420
           ES TVVVKRLKEVVVGK+DFEQQMEI+GRVGQH NVVPLRAYYYSKDEKLLVYDY   G+
Sbjct: 360 ESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGN 419

Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           L TLLHG R  GRTPLDW++R+KI LGTA+G+AH+HS+GGPKFTHGNIK+SNVL+NQD D
Sbjct: 420 LHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHVHSVGGPKFTHGNIKSSNVLLNQDND 479

Query: 481 GCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           GCISDFGL PLMNVPATPSR+AGYRAPEVIE RKHSHKSDVYSFGVLLLEMLTGKAPLQS
Sbjct: 480 GCISDFGLAPLMNVPATPSRTAGYRAPEVIEARKHSHKSDVYSFGVLLLEMLTGKAPLQS 539

Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
           P RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAK+PDMRP+
Sbjct: 540 PGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPS 599

Query: 601 MDEVVRMIEEVRQSDSENRPSSEENKSKDSNV 632
           MDEVVRMIEE+RQSDSENRPSSEENKSKDSNV
Sbjct: 600 MDEVVRMIEEIRQSDSENRPSSEENKSKDSNV 631

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357460531|ref|XP_003600547.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355489595|gb|AES70798.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula]

 Score =  943 bits (2437), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 481/640 (75%), Positives = 545/640 (85%), Gaps = 7/640 (1%)

Query: 1   MKFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWV 60
           MKF SA+   F L VI  + PLA ADLNSD+QALLDF + VPH + L W+ +  IC SWV
Sbjct: 23  MKFYSASAASF-LLVIAIIFPLAIADLNSDKQALLDFINVVPHRKNLMWNPSTSICTSWV 81

Query: 61  GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL 120
           GI C QD TRV  +RLPG+GL+G IP+NTLGKLDA++++SLRSN+L G LP++I SLPSL
Sbjct: 82  GITCNQDGTRVVNVRLPGVGLIGSIPSNTLGKLDAVKIISLRSNLLGGNLPADIASLPSL 141

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +YLYLQHNNFSG IP+S SPQL+VLDLS+NSF G IP+++QNLT+L  L+LQ+N+LSGSI
Sbjct: 142 QYLYLQHNNFSGDIPTSLSPQLIVLDLSYNSFAGRIPKTLQNLTELNSLNLQNNSLSGSI 201

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFPVAPSPSPTYS 240
           PN ++ KL HLNLSYN L G IPS+LQ +PNSSF GN  LCGPPLK C  + P P+ T +
Sbjct: 202 PNLNVTKLGHLNLSYNNLSGPIPSALQVYPNSSFEGNYHLCGPPLKPCSTIPPPPALTPT 261

Query: 241 PPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSN-----GVSK 295
           P    P KQSSK KL   AIIAIAVGG+ +L  + LVI+  CLKK+D+G +         
Sbjct: 262 PSS-APGKQSSKSKLSKVAIIAIAVGGAVLLFFIVLVIVLCCLKKEDDGGSREVKRKGPS 320

Query: 296 GKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAY 355
           G    GGR EKPKEEFGSGVQEPEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT+Y
Sbjct: 321 GGGGGGGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTSY 380

Query: 356 KAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 415
           KA+LEE+ TVVVKRLKEVVVGK++F+QQMEI+GRVGQH NV+PLRAYYYSKDEKLLVYDY
Sbjct: 381 KAILEEAMTVVVKRLKEVVVGKKEFDQQMEIMGRVGQHANVLPLRAYYYSKDEKLLVYDY 440

Query: 416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 475
             +G+LSTLLHGNR  GRTPLDW++RVKI LGTARG+AHIHS+GGPKFTHGNIK+SNVL+
Sbjct: 441 VPAGNLSTLLHGNRTGGRTPLDWDSRVKISLGTARGMAHIHSVGGPKFTHGNIKSSNVLL 500

Query: 476 NQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           NQD DGCISDFGL  LMNVPA PSR+AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK
Sbjct: 501 NQDNDGCISDFGLASLMNVPANPSRAAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 560

Query: 536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
           APLQSP RDDMVDLPRWVQSVVREEWTAEVFDVELMR+QNIEEEMVQMLQI MACVAK+P
Sbjct: 561 APLQSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMP 620

Query: 596 DMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQTP 635
           DMRPNMDEVV+MIEE+RQSDSENRPSSEENKSKDSNVQTP
Sbjct: 621 DMRPNMDEVVKMIEEIRQSDSENRPSSEENKSKDSNVQTP 660

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	635
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.985	0.957	0.634	8e-211
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.551	0.546	0.648	3.5e-178
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.530	0.526	0.589	3e-168
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.952	0.919	0.494	2.3e-151
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.544	0.542	0.568	7.8e-144
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.503	0.488	0.518	5e-125
TAIR|locus:2154227	601	AT5G53320 [Arabidopsis thalian	0.478	0.505	0.542	4.5e-122
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.491	0.465	0.563	7.4e-122
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.462	0.454	0.556	5.9e-120
TAIR|locus:2024517	587	AT1G64210 [Arabidopsis thalian	0.510	0.551	0.476	5.9e-120

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 2038 (722.5 bits), Expect = 8.0e-211, P = 8.0e-211
 Identities = 404/637 (63%), Positives = 471/637 (73%)

Query:     3 FSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGI 62
             F S   + F L V  +    A ADLNSDRQALL FA +VPHLR+LNW+STN IC+SWVG+
Sbjct:    22 FLSTCLVSF-LFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGV 80

Query:    63 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 122
              CT D T V  LRLPGIGL+GPIP NTLGKL++L +LSLRSN+L+G LP +I SLPSL Y
Sbjct:    81 TCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDY 140

Query:   123 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPN 182
             +YLQHNNFSG++PS  S QL +LDLSFNSFTG IP + QNL                +PN
Sbjct:   141 IYLQHNNFSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPN 200

Query:   183 FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXX 242
              D   LR LNLS N L GSIPS+L  FP+SSF GN+LLCG PL+ C              
Sbjct:   201 LDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHIS 260

Query:   243 XXXX----RKQSSKQKXXXXXXXXXXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKA 298
                      K+ SK+K                         C C+KKKD   + + K K 
Sbjct:   261 TPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT 320

Query:   299 SSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 358
              +    EK K+EFGSGVQEPEKNKLVFF GCSYNFDLEDLLRASAEVLGKGSYGTAYKAV
Sbjct:   321 LT----EKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 376

Query:   359 LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
             LEESTT             R+FEQQMEI+ RVG HP+VVPLRAYYYSKDEKL+V DY+ +
Sbjct:   377 LEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPA 436

Query:   419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD 478
             G+LS+LLHGNRG+ +TPLDW++RVKI L  A+G+AH+H+ GGPKF+HGNIK+SNV++ Q+
Sbjct:   437 GNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQE 496

Query:   479 LDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
              D CISDFGLTPLM VP  P R AGYRAPEV+ETRKH+HKSDVYSFGVL+LEMLTGK+P+
Sbjct:   497 SDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV 556

Query:   539 QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR 598
             QSP+RDDMVDLPRWVQSVVREEWT+EVFD+ELMRFQNIEEEMVQMLQI MACVA+VP++R
Sbjct:   557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVR 616

Query:   599 PNMDEVVRMIEEVRQSDSEN-RPSSEEN-KSKDSNVQ 633
             P MD+VVRMIEE+R SDSE  RPSS++N K KDSNVQ
Sbjct:   617 PTMDDVVRMIEEIRVSDSETTRPSSDDNSKPKDSNVQ 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 1151 (410.2 bits), Expect = 3.5e-178, Sum P(2) = 3.5e-178
 Identities = 232/358 (64%), Positives = 268/358 (74%)

Query:   282 CLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRA 341
             C KK+D G +  +  KA  G RS+   EEFGSGVQE EKNKLVFFEG SYNFDLEDLLRA
Sbjct:   284 CAKKRDGGQDSTAVPKAKPG-RSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRA 342

Query:   342 SAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRA 401
             SAEVLGKGSYGT YKA+LEE TT             R+FEQQME VGR+  H NV PLRA
Sbjct:   343 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRA 402

Query:   402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
             YY+SKDEKLLVYDY+  G+ S LLHGN   GR  LDWETR++I L  ARG++HIHS  G 
Sbjct:   403 YYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGA 462

Query:   462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSD 520
             K  HGNIK+ NVL+ Q+L  C+SDFG+ PLM+     PSRS GYRAPE IETRKH+ KSD
Sbjct:   463 KLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSD 522

Query:   521 VYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-NIEEE 579
             VYSFGVLLLEMLTGKA  ++   +++VDLP+WVQSVVREEWT EVFDVEL++ Q N+EEE
Sbjct:   523 VYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEE 582

Query:   580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE----NRPSSEEN-KSKDSNV 632
             MVQMLQI MACV+K PD RP+M+EVV M+EE+R S S     NR SS E  +S DS V
Sbjct:   583 MVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDSPV 640

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1058 (377.5 bits), Expect = 3.0e-168, Sum P(2) = 3.0e-168
 Identities = 207/351 (58%), Positives = 261/351 (74%)

Query:   282 CLKKKDNGSNGVSKG-KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLR 340
             CL KK     G  +G +   GG + K  ++FGSGVQ+PEKNKL FFE C++NFDLEDLL+
Sbjct:   288 CLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLK 347

Query:   341 ASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
             ASAEVLGKGS+GTAYKAVLE++T              ++FEQQMEIVG++ QH N VPL 
Sbjct:   348 ASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLL 407

Query:   401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             AYYYSKDEKLLVY Y   GSL  ++HGNRG     +DWETR+KI  GT++ ++++HS+  
Sbjct:   408 AYYYSKDEKLLVYKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL-- 463

Query:   461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSD 520
              KF HG+IK+SN+L+ +DL+ C+SD  L  L N+P    R+ GY APEVIETR+ S +SD
Sbjct:   464 -KFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSD 522

Query:   521 VYSFGVLLLEMLTGKAPLQSPTRDD---MVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
             VYSFGV++LEMLTGK PL  P  +D   ++DLPRWV+SVVREEWTAEVFDVEL++FQNIE
Sbjct:   523 VYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIE 582

Query:   578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS-----ENRPSSE 623
             EEMVQMLQ+ +ACVA+ P+ RP M+EV RMIE+VR+ D      +NR SSE
Sbjct:   583 EEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSE 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
 Identities = 311/629 (49%), Positives = 404/629 (64%)

Query:    25 ADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP 84
             ++  +++QALL F   +PH  +L W+ ++  C +WVG+ C  +++ +  LRLPG GLVG 
Sbjct:    23 SESTAEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQSSIHSLRLPGTGLVGQ 81

Query:    85 IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 142
             IP+ +LG+L  L VLSLRSN L+G +PS+ ++L  LR LYLQHN FSG+ P+SF+    L
Sbjct:    82 IPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNL 141

Query:   143 VVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPNFDIPKLRHLNLSYNGLKGSI 202
             + LD+S N+FTG+IP S+ NLT               +P+  +  L   N+S N L GSI
Sbjct:   142 IRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNGSI 200

Query:   203 PSSLQKFPNSSFVGNSLLCGPPLKACFXXXXXXXXXXXXXXXXXRKQSSKQKXXXXXXXX 262
             PSSL +F   SF GN  LCG PLK C                  R  S K K        
Sbjct:   201 PSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVA 260

Query:   263 XXXXXXXXXXXXXXXXXCYCLKKKDNGSNGVSKGKASSG----------GRSEKPKEEFG 312
                                CL+K+   +   +K    +G          G S   +E  G
Sbjct:   261 IIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTG 320

Query:   313 --SGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXX 369
               SG+  E E+NKLVF EG  Y+FDLEDLLRASAEVLGKGS GT+YKAVLEE TT     
Sbjct:   321 TSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 380

Query:   370 XXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR 429
                     ++FE QME+VG++ +HPNV+PLRAYYYSKDEKLLV+D+  +GSLS LLHG+R
Sbjct:   381 LKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSR 439

Query:   430 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
             G+GRTPLDW+ R++I +  ARG+AH+H     K  HGNIKASN+L++ + D C+SD+GL 
Sbjct:   440 GSGRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLN 497

Query:   490 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
              L +  + P+R AGY APEV+ETRK + KSDVYSFGVLLLE+LTGK+P Q+   ++ +DL
Sbjct:   498 QLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDL 557

Query:   550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
             PRWV SVVREEWTAEVFDVELMR+ NIEEEMVQ+LQI MACV+ VPD RP M EV+RMIE
Sbjct:   558 PRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIE 617

Query:   610 EVRQSDSEN---RPSSEENKSKDSNVQTP 635
             +V +S++ +   R SS++  SK S  QTP
Sbjct:   618 DVNRSETTDDGLRQSSDD-PSKGSEGQTP 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1019 (363.8 bits), Expect = 7.8e-144, Sum P(2) = 7.8e-144
 Identities = 204/359 (56%), Positives = 259/359 (72%)

Query:   280 CYCLKKKDNGSNGVSKGKASS-GGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDL 338
             CY  +K   G   +S  K    GG S  P E+F S +++   N+L FFEGC+Y+FDLEDL
Sbjct:   280 CYVRRKLRRGDGVISDNKLQKKGGMS--P-EKFVSRMEDVN-NRLSFFEGCNYSFDLEDL 335

Query:   339 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 398
             LRASAEVLGKG++GT YKAVLE++T+             RDFEQQMEI+G + +H NVV 
Sbjct:   336 LRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGI-KHENVVE 394

Query:   399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
             L+AYYYSKDEKL+VYDYF+ GS+++LLHGNRG  R PLDWETR+KI +G A+G+A IH  
Sbjct:   395 LKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKE 454

Query:   459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIETRKHSH 517
                K  HGNIK+SN+ +N + +GC+SD GLT +M+  A P SR AGYRAPEV +TRK S 
Sbjct:   455 NNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQ 514

Query:   518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
              SDVYSFGV+LLE+LTGK+P+ +   D+++ L RWV SVVREEWTAEVFD+EL+R+ NIE
Sbjct:   515 LSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIE 574

Query:   578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV---RQS---DSENRPSSEENKSKDS 630
             EEMV+MLQI M+CV K  D RP M ++VR+IE V   R S   + E +P SE   S+ S
Sbjct:   575 EEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGASETS 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 843 (301.8 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
 Identities = 170/328 (51%), Positives = 227/328 (69%)

Query:   287 DNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVL 346
             DNG N  S   A++   +   K   G+G   P   KLVFF   +  FDLEDLLRASAEVL
Sbjct:   322 DNG-NVYSVSAAAAAAMTGNGKASEGNG---PATKKLVFFGNATKVFDLEDLLRASAEVL 377

Query:   347 GKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSK 406
             GKG++GTAYKAVL+  T              ++F++++E+VG +  H N+VPLRAYY+S+
Sbjct:   378 GKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSR 436

Query:   407 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG 466
             DEKLLVYD+   GSLS LLHGNRGAGR+PL+W+ R +I +G ARG+ ++HS G    +HG
Sbjct:   437 DEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQG-TSTSHG 495

Query:   467 NIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFG 525
             NIK+SN+L+ +  D  +SDFGL  L+   AT P+R+ GYRAPEV + ++ S K DVYSFG
Sbjct:   496 NIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFG 555

Query:   526 VLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV-QML 584
             V+LLE++TGKAP  S   ++ VDLPRWV+SV R+EW  EVFD EL+     EEEM+ +M+
Sbjct:   556 VVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMV 615

Query:   585 QIGMACVAKVPDMRPNMDEVVRMIEEVR 612
             Q+G+ C ++ PD RP M EVVR +E +R
Sbjct:   616 QLGLECTSQHPDQRPEMSEVVRKMENLR 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)]

 Score = 851 (304.6 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
 Identities = 172/317 (54%), Positives = 221/317 (69%)

Query:   297 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 356
             + SS  +  K +++    V E + NK+VFFEG +  FDLEDLLRASAEVLGKG +GT YK
Sbjct:   266 RRSSKDKPSKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYK 324

Query:   357 AVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 416
               LE+S T             R+FEQQ+E +G + +H NV  LR Y+YSKDEKL+VYDY+
Sbjct:   325 VDLEDSATIVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYY 383

Query:   417 ASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI 475
               GSLSTLLHG +G   R  L+WETR+ ++ GTARGVAHIHS  G K  HGNIK+SN+ +
Sbjct:   384 EHGSLSTLLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFL 443

Query:   476 NQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
             N    GCIS  G+  LM+  + P  + GYRAPE+ +TRK +  SDVYSFG+L+ E+LTGK
Sbjct:   444 NGKGYGCISGTGMATLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGK 501

Query:   536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
             +        ++ +L RWV SVVREEWT EVFD EL+R   +EEEMV+MLQ+GM C A++P
Sbjct:   502 S--------EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLP 553

Query:   596 DMRPNMDEVVRMIEEVR 612
             + RPNM EVVRM+EE+R
Sbjct:   554 EKRPNMIEVVRMVEEIR 570

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 875 (313.1 bits), Expect = 7.4e-122, Sum P(2) = 7.4e-122
 Identities = 181/321 (56%), Positives = 234/321 (72%)

Query:   316 QEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXX 375
             Q  +K K+VFFEG +  F+LEDLLRASAE+LGKG +GTAYKAVLE+              
Sbjct:   339 QVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVT 397

Query:   376 XX--RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 433
                 ++FEQQME++GR+ +H N+V L+AYY++++EKLLVYDY  +GSL  LLHGNRG GR
Sbjct:   398 VAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGR 456

Query:   434 TPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
             TPLDW TR+KI  G ARG+A IH S    K THG+IK++NVL+++  +  +SDFGL+ + 
Sbjct:   457 TPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS-IF 515

Query:   493 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDLP 550
                 T ++S GYRAPE+I+ RKH+ KSDVYSFGVLLLE+LTGK P  +++      VDLP
Sbjct:   516 APSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLP 575

Query:   551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             RWVQSVVREEWTAEVFD+ELMR+++IEEEMV +LQI MAC A   D RP M  VV++IE+
Sbjct:   576 RWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIED 635

Query:   611 VRQSDSENRPSSEE-NKSKDS 630
             +R   SE  P ++  N + DS
Sbjct:   636 IRGGGSEASPCNDGINSAVDS 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 832 (297.9 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
 Identities = 167/300 (55%), Positives = 215/300 (71%)

Query:   322 KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE 381
             KLVFF   +  FDLEDLLRASAEVLGKG++GTAYKAVL+  T              R+F+
Sbjct:   347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFK 406

Query:   382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 441
             +++E+VG +  H N+VPLRAYYYS DEKLLVYD+   GSLS LLHGN+GAGR PL+WE R
Sbjct:   407 EKIEVVGAM-DHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVR 465

Query:   442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSR 500
               I LG ARG+ ++HS   P  +HGN+K+SN+L+    D  +SDFGL  L++  +T P+R
Sbjct:   466 SGIALGAARGLDYLHSQD-PLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNR 524

Query:   501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + GYRAPEV + R+ S K+DVYSFGV+LLE+LTGKAP  S   ++ +DL RWV SV REE
Sbjct:   525 ATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREE 584

Query:   561 WTAEVFDVELMRFQ---NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
             W  EVFD ELM  +   ++EEEM +MLQ+G+ C  + PD RP M EVVR I+E+RQS ++
Sbjct:   585 WRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)]

 Score = 781 (280.0 bits), Expect = 5.9e-120, Sum P(2) = 5.9e-120
 Identities = 160/336 (47%), Positives = 221/336 (65%)

Query:   289 GSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGK 348
             G   +S GK      S  P           E  K++FF G ++ FDL+DLL +SAEVLGK
Sbjct:   257 GKTRIS-GKLRKRDSSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGK 315

Query:   349 GSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE 408
             G++GT YK  +E+ +T             R+FEQQMEI+G + +H NV  L+AYYYSKD+
Sbjct:   316 GAFGTTYKVTMEDMSTVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDD 374

Query:   409 KLLVYDYFASGSLSTLLHGNRGA-GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 467
             KL VY Y+  GSL  +LHGNRG   R PLDW+ R++I  G ARG+A IH  G  KF HGN
Sbjct:   375 KLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE-G--KFIHGN 431

Query:   468 IKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGV 526
             IK+SN+ ++    GCI D GLT +M ++P T   ++GY APE+ +TR+ +  SDVYSFGV
Sbjct:   432 IKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGV 491

Query:   527 LLLEMLTGKAPLQS----PTRDDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMV 581
             +LLE+LTGK+P+      PT  + +DL  W++SVV +EWT EVFD+E++ +    EEEMV
Sbjct:   492 VLLELLTGKSPVSQAELVPTGGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMV 551

Query:   582 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
             +MLQIG+ACVA     RP++ +V+++IE++R  D+E
Sbjct:   552 EMLQIGLACVALKQQERPHIAQVLKLIEDIRSVDAE 587

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LVM0	Y5830_ARATH	No assigned EC number	0.7097	0.9716	0.9434	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	635
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-43
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-16
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.001
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	0.002
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  156 bits (397), Expect = 1e-43
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 16/211 (7%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ-MEI-VGRVGQHPNVVPLR 400
             LG GS+GT YKA        V VK LK+     +  +    EI + R   HPN+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +  KD   LV +Y   G L   L         PL  +   KI L   RG+ ++HS G 
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI-ETRKH 515
               H ++K  N+L++++    I+DFGL   +   ++       +  Y APEV+     +
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
             K DV+S GV+L E+LTGK P       D 
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQ 207

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  164 bits (417), Expect = 1e-42
 Identities = 161/608 (26%), Positives = 251/608 (41%), Gaps = 125/608 (20%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           +RL      G +P+    KL  +  L + +N L G + S    +PSL+ L L  N F G 
Sbjct: 409 VRLQDNSFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467

Query: 134 IPSSF-SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 190
           +P SF S +L  LDLS N F+G +P+ + +L++L  L L  N LSG IP+      KL  
Sbjct: 468 LPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527

Query: 191 LNLSYNGLKGSIPSSLQKFP---------------------------------------- 210
           L+LS+N L G IP+S  + P                                        
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587

Query: 211 ---------NSSFV-GNSLLCG----PPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKLG 256
                    N+S V GN  LCG      L  C  V  +PS  +                 
Sbjct: 588 PSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF----------------- 630

Query: 257 LGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQ 316
               I   +G   VL LVA   +   ++ ++N                E  + E   G  
Sbjct: 631 ---YITCTLGAFLVLALVAFGFV--FIRGRNN---------------LELKRVENEDGTW 670

Query: 317 EPEKNKLVFFEG-CSYNFDLEDLLRASAE--VLGKGSYGTAYKA-VLEESTTVVVKRLKE 372
           E     L FF+   S +  + D+L +  E  V+ +G  G +YK   ++     VVK + +
Sbjct: 671 E-----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725

Query: 373 VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
           V          M       QHPN+V L     S+    L+++Y    +LS +L       
Sbjct: 726 VNSIPSSEIADM----GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776

Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL 491
              L WE R KI +G A+ +  +H    P    GN+    ++I+ +D         L  L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--LSLPGL 831

Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDL 549
           +        S+ Y APE  ET+  + KSD+Y FG++L+E+LTGK+P   +      +V+ 
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 550 PRWVQSVVR-EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
            R+  S    + W       ++   QN   E+V+++ + + C A  P  RP  ++V++ +
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 609 EEVRQSDS 616
           E   +S S
Sbjct: 949 ESASRSSS 956

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (364), Expect = 2e-39
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 17/195 (8%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           LG+G +GT Y A   +    V +K +K  +      +  +++EI+ ++  HPN+V L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           +  ++   LV +Y   GSL  LL  N G     L  +  ++ILL    G+ ++HS G   
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNG--- 112

Query: 463 FTHGNIKASNVLINQDLDGC-ISDFGL----TPLMNVPATPSRSAGYRAPEVIETR-KHS 516
             H ++K  N+L++ D     ++DFGL    T   ++  T   +  Y APEV+  +  +S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 517 HKSDVYSFGVLLLEM 531
            KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (366), Expect = 3e-39
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 46/287 (16%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 397
           + LG+G++G  YK  L     ++T V VK LKE      ++DF ++  ++ ++G HPNVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVA 453
            L      ++   LV +Y   G L   L  +R       ++ L  +  +   +  A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 507
           ++ S    KF H ++ A N L+ +DL   ISDFGL+  +       +  G +      AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 562
           E ++    + KSDV+SFGVLL E+ T G  P   P   +  ++  +++   R    E   
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSN-EEVLEYLRKGYRLPKPEYCP 233

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
            E++++              ML     C    P+ RP   E+V  +E
Sbjct: 234 DELYEL--------------MLS----CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (350), Expect = 4e-37
 Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 29/270 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E LG+GS+G  Y A   +    V +K +K  ++   +    ++++I+ ++ +HPN+V L 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNIVRLY 63

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +  +D+  LV +Y   G L  LL          L  +     L      + ++HS G 
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG- 117

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 517
               H ++K  N+L+++D    ++DFGL   ++     +   G   Y APEV+  + +  
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
             D++S GV+L E+LTGK P           L    + + + +              +I 
Sbjct: 176 AVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPP------FPPPEWDIS 224

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
            E   +++     + K P+ R   +E ++ 
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (350), Expect = 5e-37
 Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 53/286 (18%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 396
           + LG+G++G  YK  L        T V VK LKE      + +F ++  I+ ++  HPN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L       +   +V +Y   G L   L  +       L  +  +++ L  A+G+ ++ 
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYR-----APEVI 510
           S     F H ++ A N L+ ++L   ISDFGL+  +        R  G       APE +
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 562
           +  K + KSDV+SFGVLL E+ T G+ P    + +++++       LPR       E   
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENCP 230

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
            E++++              MLQ    C A  P+ RP   E+V  +
Sbjct: 231 DELYEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (335), Expect = 6e-35
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 55/287 (19%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 396
           + LG+G++G  YK  L      +   V VK LKE        +F ++  I+ ++  HPN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L      ++  ++V +Y   G L   L  NR      L     +   L  ARG+ ++ 
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 505
           S     F H ++ A N L+ ++L   ISDFGL+               +P         R
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--------IR 169

Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
             APE ++  K + KSDV+SFGVLL E+ T G+ P          ++  +++   R    
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYR---- 222

Query: 563 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 608
                  L +  N   E+ + MLQ    C A+ P+ RP   E+V ++
Sbjct: 223 -------LPKPPNCPPELYKLMLQ----CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  129 bits (328), Expect = 6e-34
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 56/287 (19%)

Query: 344 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 396
           + LG+G++G  YK  L+     +   V VK LKE    +   +F ++  I+ ++  HPNV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L      ++   +V +Y   G L + L  NR      L     +   L  ARG+ ++ 
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLE 119

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-----------PLMNVPATPSRSAGYR 505
           S     F H ++ A N L+ ++L   ISDFGL+               +P         R
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP--------IR 168

Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
             APE ++  K + KSDV+SFGVLL E+ T G+ P          ++  ++++  R    
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYR---- 221

Query: 563 AEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 608
                  L +  N   E+   MLQ    C A+ P+ RP   E+V ++
Sbjct: 222 -------LPQPPNCPPELYDLMLQ----CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (300), Expect = 6e-28
 Identities = 72/201 (35%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 19  LLPLAFADLNSDR-QALLDFA----DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFG 73
            L L F+ L+++  + LL F     D + +L   NW+S+  +C  W GI C  + +RV  
Sbjct: 18  FLFLNFSMLHAEELELLLSFKSSINDPLKYLS--NWNSSADVCL-WQGITCN-NSSRVVS 73

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 132
           + L G  + G I +     L  ++ ++L +N L+G +P +I T+  SLRYL L +NNF+G
Sbjct: 74  IDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132

Query: 133 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 190
            IP    P L  LDLS N  +G IP  I + + L  L L  N L G IPN   ++  L  
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEF 192

Query: 191 LNLSYNGLKGSIPSSLQKFPN 211
           L L+ N L G IP  L +  +
Sbjct: 193 LTLASNQLVGQIPRELGQMKS 213

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  111 bits (279), Expect = 2e-27
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 43/217 (19%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 398
           E+LG+GS+G+ Y A+ +++  ++   +K V +     E+   +   +      QHPN+V 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMA--VKSVELSGDSEEELEALEREIRILSSLQHPNIV- 62

Query: 399 LRAYYYSKDEK----LLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 448
              YY S+ ++    L ++ +Y + GSLS+LL      G+ P   E  ++     IL   
Sbjct: 63  --RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLP---EPVIRKYTRQIL--- 111

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGL------TPLMNVPATPSR 500
             G+A++HS G     H +IK +N+L+  D DG   ++DFG               +   
Sbjct: 112 -EGLAYLHSNG---IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APEVI   ++   +D++S G  ++EM TGK P
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (276), Expect = 5e-27
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 344 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  YKA        V +K +K     K++       + +  +HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y  KDE  +V ++ + GSL  LL          L       +     +G+ ++HS G   
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNG--- 118

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSH 517
             H +IKA+N+L+  D +  + DFGL+  ++   T +R     +  + APEVI  + + +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 518 KSDVYSFGVLLLEMLTGKAPL 538
           K+D++S G+  +E+  GK P 
Sbjct: 177 KADIWSLGITAIELAEGKPPY 197

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (280), Expect = 9e-27
 Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 30/280 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPL 399
             LG+GS+G  Y A   +   V +K L + +  K      F ++++I+  +   PN+V L
Sbjct: 6   RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             ++  +    LV +Y   GSL  LL      G         + IL      + ++HS G
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121

Query: 460 GPKFTHGNIKASNVLINQDLDGC-ISDFGL----------TPLMNVPATPSRSAGYRAPE 508
                H +IK  N+L+++D     + DFGL          + +  +P+T   + GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 509 VIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 565
           V+        S  SD++S G+ L E+LTG  P +                ++ E  T  +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSL 235

Query: 566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
                +   N E        +    +AK P  R +    +
Sbjct: 236 A--SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  109 bits (274), Expect = 9e-25
 Identities = 64/142 (45%), Positives = 82/142 (57%), Gaps = 5/142 (3%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           L L G  LVG IPN +L  L +LE L+L SN L G +P E+  + SL+++YL +NN SG+
Sbjct: 169 LDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Query: 134 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 189
           IP        L  LDL +N+ TG IP S+ NL  L  L L  N LSG IP   F + KL 
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287

Query: 190 HLNLSYNGLKGSIPSSLQKFPN 211
            L+LS N L G IP  + +  N
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQN 309

Length = 968

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (253), Expect = 6e-24
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 22/204 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 402
           E LG+GSYG+ YKA+ +E+  VV   +K V V +   E   EI + +    P +V     
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVA--IKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y+   +  +V +Y  +GS+S ++   +   +T L  E    IL  T +G+ ++HS    K
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGLEYLHSN---K 119

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAPEVIETRK 514
             H +IKA N+L+N++    ++DFG++  +         V  TP     + APEVI+   
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF----WMAPEVIQEIG 175

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPL 538
           +++K+D++S G+  +EM  GK P 
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 1e-23
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 398
           +++G+G++G  YK +  E+   V   +K++ + K   E    I+  +      +HPN+V 
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVA--IKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
                 + D   ++ +Y  +GSL  ++      G  P   E+ V + +    +G+A++H 
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKF---GPFP---ESLVAVYVYQVLQGLAYLHE 117

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAG---YRAPEVIETR 513
            G     H +IKA+N+L  +D    ++DFG+ T L +V    +   G   + APEVIE  
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAP 537
             S  SD++S G  ++E+LTG  P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.9 bits (250), Expect = 2e-23
 Identities = 59/284 (20%), Positives = 127/284 (44%), Gaps = 52/284 (18%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-------KEVVVGKRDFEQQMEIVGRVGQHPN 395
           + +GKGS+G  Y      +    V+K +       KE    + D   +++I+ ++  HPN
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKL-NHPN 60

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           ++     +  K +  +V +Y   G LS  +   +     P   E  +   +     + ++
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRAP 507
           HS    K  H +IK  N+ +  +    + DFG++ +++        V  TP     Y +P
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY----YLSP 172

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EV 565
           E+ + + +++KSD++S G +L E+ T K P +    +++++L      +++ ++      
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLEL---ALKILKGQYPPIPSQ 226

Query: 566 FDVELMRFQNIEEEMV-QMLQIGMACVAKVPDMRPNMDEVVRMI 608
           +  EL         +V  +LQ       K P+ RP++ ++++  
Sbjct: 227 YSSEL-------RNLVSSLLQ-------KDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 2e-23
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 38/279 (13%)

Query: 336 EDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEV-VVGKRDFEQQ----MEIVGRV 390
            DL R    VLG+GS G  YK   + +  +    LK++ V G  +F +Q    ++ + R 
Sbjct: 1   SDLERVK--VLGQGSSGVVYKVRHKPTGKIYA--LKKIHVDGDEEFRKQLLRELKTL-RS 55

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
            + P VV     +Y + E  +V +Y   GSL+ LL          L +  R +IL G   
Sbjct: 56  CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILKG--- 111

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG----LTPLMNVPATPSRSAGY 504
            + ++H+       H +IK SN+LIN    G   I+DFG    L   ++   T   +  Y
Sbjct: 112 -LDYLHTK--RHIIHRDIKPSNLLINSK--GEVKIADFGISKVLENTLDQCNTFVGTVTY 166

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
            +PE I+   +S+ +D++S G+ LLE   GK P   P +    +L + +         AE
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 603
            F  E   F +             AC+ K P  RP+  E
Sbjct: 227 EFSPEFRDFIS-------------ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G   +  L    ++   V +K LK     K   DF  +  I+G+   HPN++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNII 68

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          +++ +Y  +GSL   L  N G           V +L G A G+ ++  
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG-----YRAPEVIE 511
           M    + H ++ A N+L+N +L   +SDFGL+  L +  AT +   G     + APE I 
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 512 TRKHSHKSDVYSFGVLLLEMLT-GKAP 537
            RK +  SDV+SFG+++ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 2e-22
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)

Query: 346 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLR 400
           LGKGS+G       +++  +  +K L K+ ++ +++ E  +    I+ R+  HP +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKL- 58

Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 454
            Y +  +EKL LV +Y   G L + L      GR     E R +     I+L     + +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS---EERARFYAAEIVLA----LEY 108

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA---TPSRSAGYRAPEVI 510
           +HS+G     + ++K  N+L++ D    ++DFGL   L +  +   T   +  Y APEV+
Sbjct: 109 LHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
             + +    D +S GVLL EMLTGK P  +  R ++ + 
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 51/297 (17%)

Query: 346 LGKGSYGTAYKAVLE---ESTT--VVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 398
           LG+G +G       +   ++T   V VK L      +   DFE+++EI+  +  H N+V 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVK 70

Query: 399 LRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            +        +   L+ +Y  SGSL   L  +R      ++ +  +       +G+ ++ 
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG 126

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEV 509
           S    ++ H ++ A N+L+  +    ISDFGL  ++                    APE 
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
           + T K S  SDV+SFGV L E+ T   P QSP  + +                     + 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-------------------MIG 224

Query: 570 LMRFQNIEEEMVQMLQIG--MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
           + + Q I   ++++L+ G  +      P      DEV  +++   +++ ++RPS  +
Sbjct: 225 IAQGQMIVTRLLELLKEGERLPRPPSCP------DEVYDLMKLCWEAEPQDRPSFAD 275

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 32/267 (11%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 400
           LGKGSYG+ YK             LKEV +G    +++ + V  +       HPN++  +
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYA--LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +   ++  +V +Y   G LS  +   R   R  +  +   +I +   RG+  +H    
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-- 122

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 518
            K  H ++K++N+L+  +    I D G++ ++  N+  T   +  Y APEV + R +S+K
Sbjct: 123 -KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYK 181

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
           SD++S G LL EM T   P ++     M DL   VQ                 ++  I  
Sbjct: 182 SDIWSLGCLLYEMATFAPPFEA---RSMQDLRYKVQR---------------GKYPPIPP 223

Query: 579 EMVQ-MLQIGMACVAKVPDMRPNMDEV 604
              Q +     + +   P +RPN D++
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 57/290 (19%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           EV+G+G+YG  YKA  +++  +V +K +  +   + + +++  I+ +   HPN+      
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 403 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           +  K      D+  LV +    GS++ L+ G R  G+  L  E    IL  T RG+A++H
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLH 130

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 506
                K  H +IK  N+L+ ++ +  + DFG      V A    + G R          A
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFG------VSAQLDSTLGRRNTFIGTPYWMA 181

Query: 507 PEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSVVR- 558
           PEVI         +  +SDV+S G+  +E+  GK PL    P R  +  +PR     ++ 
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPPTLKS 240

Query: 559 -EEWTAEVFDVELMRFQN-IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
            E W+ +        F + I E           C+ K  + RP M+E++ 
Sbjct: 241 PENWSKK--------FNDFISE-----------CLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.5 bits (235), Expect = 5e-20
 Identities = 59/151 (39%), Positives = 77/151 (50%), Gaps = 5/151 (3%)

Query: 69  TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN 128
            ++  L L    L G IP   + +L  LE+L L SN  TG +P  +TSLP L+ L L  N
Sbjct: 284 QKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342

Query: 129 NFSGKIPSSFSPQ--LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--D 184
            FSG+IP +      L VLDLS N+ TG IP+ + +   L  L L SN+L G IP     
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402

Query: 185 IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV 215
              LR + L  N   G +PS   K P   F+
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433

Length = 968

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 10/196 (5%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
             +GKG +G            V VK LK+     + F  +  ++  + +HPN+V L    
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV 69

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
              +   +V +Y A GSL   L   R  GR  +    ++   L    G+ ++       F
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKSDVY 522
            H ++ A NVL+++DL   +SDFGL    +      +    + APE +  +K S KSDV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 523 SFGVLLLEMLT-GKAP 537
           SFG+LL E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 52/281 (18%)

Query: 345 VLGKGSYGTA--YKAVLEESTTVVVK-----RLKEVVVGKRDFEQQMEIVGRVGQHPNVV 397
           VLGKG++G A  Y+   E+ + VV K     RL E    +RD   ++ I+  + QHPN++
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLL-QHPNII 62

Query: 398 PLRAYY--YSKDEKLLV-YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
              AYY  +  D  LL+  +Y   G+L   +   +G      + E  +  L      V++
Sbjct: 63  ---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSY 116

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--------VPATPSRSAGYRA 506
           IH  G     H +IK  N+ + +     + DFG++ ++         V  TP     Y +
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY----YMS 169

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 566
           PE+ +  K++ KSD+++ G +L E+LT K         D  +    V  +V+  +T  V 
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV- 222

Query: 567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
                       E++ ++    + + + P+ RP  DEV+  
Sbjct: 223 -------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +     E   V +K ++E  + + DF ++ +++ ++  HP +V L      
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE 70

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++ S       H
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLES---SNVIH 123

Query: 466 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T   ++   T S    +     +PEV    K+S KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           V+SFGVL+ E+ + GK P ++ +  ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 13/198 (6%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +      +T V VK LK   +    F Q+ +I+ ++ +H  +V L A    
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE 72

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V +Y + GSL   L    G G+  L     V +    A G+A++ S     + H
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 466 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGY----RAPEVIETRKHSHKSD 520
            ++ A N+L+ ++L   I+DFGL  L  +   T    A +     APE     + + KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 521 VYSFGVLLLEMLT-GKAP 537
           V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 398
             +GKGS+G  +K V +    V    +K++ + K +  ++ E +             ++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYII- 62

Query: 399 LRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVA 453
              YY S     KL +V +Y  +G L  LL   RG    P D  W   ++ILLG    +A
Sbjct: 63  --RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLG----LA 115

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEV 509
           H+HS    K  H +IK+ N+ ++   +  I D G    L+   N   T   +  Y +PE+
Sbjct: 116 HLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            E + ++ KSDV++ GV+L E  TGK P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 22/245 (8%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +      ST V VK LK   +  + F ++  ++ +  QH  +V L A    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLM-KTLQHDKLVRLYAVVTK 72

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 461
           ++   ++ +Y A GSL   L  + G G+  L    D+  ++      A G+A+I      
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIER---K 122

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+NVL+++ L   I+DFGL  ++      +R        + APE I     +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
            KSDV+SFG+LL E++T GK P    +  D M  L R  +    E    E++D+    ++
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWK 242

Query: 575 NIEEE 579
              EE
Sbjct: 243 EKAEE 247

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 13/198 (6%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  ++ +   +T V VK LK   +  +DF  + +I+ ++ +HP ++ L A    
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL 72

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V +    GSL   L G  GAGR  L     + +    A G+A++ +     + H
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQG--GAGRA-LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            ++ A NVL+ ++    ++DFGL  ++      +R        + APE     + S KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 521 VYSFGVLLLEMLT-GKAP 537
           V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 35/234 (14%)

Query: 348 KGSYGTAYKA------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN 395
           KG++G+ Y A            VL++S  +   ++  V   +     Q       G+ P 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-------GESPY 58

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           V  L   + SKD   LV +Y   G  ++L+   +  G  P DW    + +     GV  +
Sbjct: 59  VAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDL 113

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKH 515
           H  G     H +IK  N+LI+Q     ++DFGL+           +  Y APE I     
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD 170

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--LPRWVQSVVREEWTAEVFD 567
              SD +S G ++ E L G  P  + T D + D  L R +       W  EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKE 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 37/214 (17%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
           + +G G+YG  YKA  +     V +K +K  +    DFE  Q EI + +  +HPN+V   
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIV--- 63

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           AY+  Y + +KL +V +Y   GSL  +    RG    PL       +   T +G+A++H 
Sbjct: 64  AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE 119

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 507
            G     H +IK +N+L+ +D D  ++DFG      V A  + +   R          AP
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFG------VSAQLTATIAKRKSFIGTPYWMAP 170

Query: 508 EVIETRKHS---HKSDVYSFGVLLLEMLTGKAPL 538
           EV    +      K D+++ G+  +E+   + P+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 8e-18
 Identities = 52/144 (36%), Positives = 72/144 (50%), Gaps = 6/144 (4%)

Query: 67  DRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ 126
               +F L L    L G IP  +LG   +L  + L+ N  +G LPSE T LP + +L + 
Sbjct: 378 SSGNLFKLILFSNSLEGEIPK-SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436

Query: 127 HNNFSGKIPSSF--SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 182
           +NN  G+I S     P L +L L+ N F G +P S  +  +L  L L  N  SG++P   
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495

Query: 183 FDIPKLRHLNLSYNGLKGSIPSSL 206
             + +L  L LS N L G IP  L
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDEL 519

Length = 968

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)

Query: 344 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 397
           EV+G G +G   +  L+        V +K LK     K  RDF  +  I+G+   HPN++
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          +++ ++  +G+L + L  N G   T +     V +L G A G+ ++  
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQL---VGMLRGIAAGMKYLSE 124

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG--------YRAPE 508
           M    + H ++ A N+L+N +L   +SDFGL+  L +  + P+ ++         + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
            I  RK +  SDV+S+G+++ E+++ G+ P    +  D+++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 24/219 (10%)

Query: 344 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRD-FEQQME--IVGRVGQHPNV 396
           +VLG+GS+G  +   K    ++  +  +K LK+  +  RD    +ME  I+  V  HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFI 60

Query: 397 VPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAH 454
           V L  Y +  + KL L+ D+   G L T L       +  +  E  VK  L   A  + H
Sbjct: 61  VKLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 113

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS--RSAGYRAPEVI 510
           +HS+G     + ++K  N+L++++    ++DFGL+   + +     S   +  Y APEV+
Sbjct: 114 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
             R H+  +D +SFGVL+ EMLTG  P Q   R + + +
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 22/208 (10%)

Query: 344 EVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 397
           +V+G G +G  ++ +L+    +   V +K LK     K+  DF  +  I+G+   H N++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NII 69

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          +++ +Y  +G+L   L  + G   +       V +L G A G+ ++  
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQL---VGMLRGIAAGMKYLSD 125

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG-----YRAPEVI 510
           M    + H ++ A N+L+N +L+  +SDFGL+ ++  +   T + S G     + APE I
Sbjct: 126 M---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
             RK +  SDV+SFG+++ E+++ G+ P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 395
             LG+G++G  +           +   V VK LKE      ++DFE++ E++    QH N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHEN 69

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HG-------NRGAGRTPLDWETRVKILL 446
           +V         D  ++V++Y   G L+  L  HG       +  +    L     ++I +
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-RSAGYR 505
             A G+ +   +    F H ++   N L+  DL   I DFG++   +V  T   R  G+ 
Sbjct: 130 QIASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMS--RDVYTTDYYRVGGHT 184

Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                   PE I  RK + +SDV+SFGV+L E+ T GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 46/288 (15%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 395
           + LG+G++G   KA         E++TV VK LK+    K   D   +ME++  +G+H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTPLDWETRVKIL-- 445
           ++ L      +    +V +Y A G+L   L   R  G        R P +  T+  ++  
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 446 -LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 503
               ARG+  + S    K  H ++ A NVL+ +D    I+DFGL   + ++      + G
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 504 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 557
                + APE +  R ++H+SDV+SFGVLL E+ T G +P      +++  L       +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-------L 247

Query: 558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
           +E +  E       + QN  +E+  ++     C  +VP  RP   ++V
Sbjct: 248 KEGYRME-------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 70/235 (29%), Positives = 98/235 (41%), Gaps = 70/235 (29%)

Query: 59  WVGINCTQDRTR----VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI 114
           W G +C  D T+    + GL L   GL G IPN  + KL  L+ ++L  N + G +P  +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 115 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 174
            S+ SL                       VLDLS+NSF G+IP+S+  LT L  L+L  N
Sbjct: 463 GSITSL----------------------EVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 175 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG-PPLKACFPVAP 233
           +LSG +P                  G        F   +F  N+ LCG P L+AC P   
Sbjct: 501 SLSGRVP---------------AALGGRLLHRASF---NFTDNAGLCGIPGLRACGP--- 539

Query: 234 SPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDN 288
                                L +GA I IA G S   L + +  +C+  K++ N
Sbjct: 540 --------------------HLSVGAKIGIAFGVSVAFLFLVICAMCWW-KRRQN 573

Length = 623

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 28/217 (12%)

Query: 345 VLGKGSYGTAYKAV---LEESTT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 397
           VLG G++GT YK V     E     V +K L+E       ++   +  ++  V  HP+VV
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 455
            L     S  +  L+      G L   +  ++     +  L+W  ++      A+G++++
Sbjct: 73  RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEV 509
                    H ++ A NVL+       I+DFGL  L++V      + G +      A E 
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 544
           I  R ++HKSDV+S+GV + E++T G  P +  P  +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 40/218 (18%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQ------H 393
           EV+G G+    Y A+ L  +  V +KR+        D E+    ++ + +  Q      H
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI--------DLEKCQTSVDELRKEVQAMSQCNH 58

Query: 394 PNVVPLRAYYYS---KDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTA 449
           PNVV    YY S    DE  LV  Y + GSL  ++       G   LD      +L    
Sbjct: 59  PNVV---KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVL 112

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           +G+ ++HS G     H +IKA N+L+ +D    I+DFG++  +      +R         
Sbjct: 113 KGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 504 --YRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 538
             + APEV+E    +  K+D++SFG+  +E+ TG AP 
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 9e-17
 Identities = 54/130 (41%), Positives = 71/130 (54%), Gaps = 5/130 (3%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 139
           L GPIP +    L  L  L L  N L+G +P  +  L +L  L+L  NNF+GKIP + + 
Sbjct: 272 LSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330

Query: 140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 196
            P+L VL L  N F+G IP+++     LT L L +NNL+G IP        L  L L  N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 197 GLKGSIPSSL 206
            L+G IP SL
Sbjct: 391 SLEGEIPKSL 400

Length = 968

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 9e-17
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)

Query: 345 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 398
           V+G G +G      L+        V +K LK     K  RDF  +  I+G+   HPN++ 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIH 69

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L          ++V +Y  +GSL   L  + G           V +L G A G+ ++  M
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDM 125

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVIE 511
           G   + H ++ A N+L+N +L   +SDFGL+ ++ + P     + G      + APE I 
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 512 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
            RK +  SDV+S+G+++ E+++ G+ P    +  D++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 52/230 (22%), Positives = 103/230 (44%), Gaps = 41/230 (17%)

Query: 344 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 398
           +++G+GS+ T   A   E +    +K L +  + K    + +    E++ R+  HP ++ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 399 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           L  YY  +DE+ L  V +Y  +G L   +    G+    LD +            + ++H
Sbjct: 67  L--YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS----LDEKCTRFYAAEILLALEYLH 119

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--------------- 501
           S G     H ++K  N+L+++D+   I+DFG   +++  ++P  +               
Sbjct: 120 SKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 502 ---------AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
                    A Y +PE++  +     SD+++ G ++ +MLTGK P +   
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 37/218 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQ------- 392
           E++GKG+YG  Y A+    TT  +  +K+V +      R   +Q ++V  +         
Sbjct: 7   ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 393 --HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 449
             H N+V    +  +++   +  +Y   GS+ + L   R  GR     E  V+       
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFE---EQLVRFFTEQVL 118

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDG-C-ISDFGLTP-----LMNVPATPSR-S 501
            G+A++HS G     H ++KA N+L+  D DG C ISDFG++        N      + S
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLV--DADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 502 AGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 537
             + APEVI +  + +S K D++S G ++LEM  G+ P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 54/280 (19%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRA 401
           E +GKG++G  YK VL+ +T V VK  +  +    KR F Q+ EI+ +   HPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
               K    +V +    GSL T L   +         +  +++ L  A G+ ++ S    
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYLESK--- 112

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYR------- 505
              H ++ A N L+ ++    ISDFG+          SR         S G +       
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGM----------SREEEGGIYTVSDGLKQIPIKWT 162

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV 565
           APE +   +++ +SDV+S+G+LL E  +                P       RE      
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGD----------TPYPGMSNQQTRER----- 207

Query: 566 FDVEL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
             +E   R    +    ++ ++ + C A  P+ RP+  E+
Sbjct: 208 --IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 53/262 (20%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 395
           E LG+G++G  YK  L        +T+V +K LKE    K  ++F Q+ E++  + QHPN
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPN 69

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 444
           +V L      +    ++++Y A G L   L     H + GA       ++ LD    + I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRS 501
            +  A G+ ++ S     F H ++ A N L+ + L   ISDFGL+  +   +     S+S
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 502 ---AGYRAPEVIETRKHSHKSDVYSFGVLL-------------------LEMLTGKAPLQ 539
                +  PE I   K + +SD++SFGV+L                   +EM+  +  L 
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246

Query: 540 SPTRDDMVDLPRWVQSVVREEW 561
            P      D P  V +++ E W
Sbjct: 247 CP-----EDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 14/209 (6%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +         V +K ++E  + + DF ++ +++ ++  HPN+V L      
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK 70

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    +V +Y A+G L   L   +G   T    E  + +       + ++ S G   F H
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 466 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 520
            ++ A N L+ +D    +SDFGL   +++   T S+   +      PEV +  + S KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           V+SFGVL+ E+ + GK P +  +  ++V+
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFSNSEVVE 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 34/274 (12%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRV 390
           DLE L       LG G+ G   K +   +  ++  +   + + +   +Q   +++I+ + 
Sbjct: 2   DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC 56

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
              P +V     +Y+  +  +  +Y   GSL  +L      GR P       KI +   +
Sbjct: 57  -NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPER--ILGKIAVAVLK 111

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-TPSRSAGYRAPE 508
           G+ ++H     K  H ++K SN+L+N      + DFG+   L+N  A T   ++ Y APE
Sbjct: 112 GLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE 169

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEV 565
            I+   +S KSD++S G+ L+E+ TG+ P               +Q +V E      +  
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGK 228

Query: 566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           F  +   F N              C+ K P  RP
Sbjct: 229 FSPDFQDFVN-------------LCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T V +K LK   +    F Q+ +++ ++ +H  +V L A   S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 71

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V +Y + GSL   L G  G     L     V +    A G+A++  M    + H
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM---NYVH 125

Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           V+SFG+LL E+ T G+ P       +++D
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLD 214

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 31/210 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 400
           + LG G++G+ Y A  +E+  +V +K++K+      +     E+    ++ +HPN+V L+
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMG 459
             +   DE   V++Y   G+L  L+   +G    P   E+ ++ I+    +G+AHIH  G
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFS-ESVIRSIIYQILQGLAHIHKHG 119

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YRAPEV 509
              F H ++K  N+L++      I+DFGL       A   RS            YRAPE+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGL-------AREIRSRPPYTDYVSTRWYRAPEI 169

Query: 510 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +  +  +S   D+++ G ++ E+ T + PL
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR-PL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 31/273 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG G +G  +       T V +K LK+  +    F  +  ++ ++ QHP +V L A  
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV 70

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            +++   ++ +Y  +GSL   L    G     L     + +    A G+A I       +
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H +++A+N+L+++ L   I+DFGL  L+      +R        + APE I     + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV+SFG+LL E++T G+ P    T       P  +Q++ R           + R  N  
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLER--------GYRMPRPDNCP 229

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           EE+ +++     C  + P+ RP  + +  ++E+
Sbjct: 230 EELYELM---RLCWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 34/242 (14%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLK-EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G +G  ++ + +    V +K LK + ++ ++DF+++++ + R+ +H +++ L A   
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCS 72

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TARGVAHIHSMGG 460
             +   ++ +    GSL   L       R+P      V  L+      A G+A++     
Sbjct: 73  VGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--ATPSRSAGYR--APEVIETRKHS 516
               H ++ A N+L+ +DL   ++DFGL  L+      +  +   Y+  APE       S
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL-------------PRWVQSVVREEWT 562
            KSDV+SFG+LL EM T G+ P       ++ D              P+ +  ++ E W 
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWA 242

Query: 563 AE 564
           AE
Sbjct: 243 AE 244

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 14/198 (7%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +      +T V VK LK   +    F ++ +I+ ++ +H  +V L A   S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVV-S 71

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V +Y + GSL   L    G GR  L     V +    A G+A+I  M    + H
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++++N+L+   L   I+DFGL  L+      +R        + APE     + + KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 521 VYSFGVLLLEMLT-GKAP 537
           V+SFG+LL E++T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 31/271 (11%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T V +K LK   +    F Q+ +I+ ++ +H  +VPL A   S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV-S 71

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V ++   GSL   L    G G+  L     V +    A G+A+I  M    + H
Sbjct: 72  EEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIH 125

Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+N+L+  +L   I+DFGL  L+      +R        + APE     + + KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           V+SFG+LL E++T G+ P            P  V   V E+         +   Q   E 
Sbjct: 186 VWSFGILLTELVTKGRVP-----------YPGMVNREVLEQVER---GYRMPCPQGCPES 231

Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           + +++++   C  K PD RP  + +   +E+
Sbjct: 232 LHELMKL---CWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ------MEI-VGRVGQHPNV 396
           E +G+G+ G  YKA             KEV + K    +Q       EI + +  +HPN+
Sbjct: 25  EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 455
           V     Y   DE  +V +Y   GSL+ ++  N       ++ E ++  +     +G+ ++
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMN-EPQIAYVCREVLQGLEYL 132

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--G---YRAPEVI 510
           HS       H +IK+ N+L+++D    ++DFG    +       R++  G   + APEVI
Sbjct: 133 HSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVVGTPYWMAPEVI 188

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           + + +  K D++S G++ +EM  G+ P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 35/210 (16%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHPNV 396
           +G+G+YG  YKA  + +  +V +K++K        FE +        EI   +   HPN+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 455
           + L   +  K +  LV+++      + L    +   +  L  E+ +K  L    +G+A  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDR-QRGLP-ESLIKSYLYQLLQGLAFC 114

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSAGYRAPEV 509
           HS G     H ++K  N+LIN +    ++DFGL      P  P      +R   YRAPE+
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPEL 169

Query: 510 IET-RKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +   + +S   D++S G +  E+L+ + PL
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR-PL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 23/216 (10%)

Query: 346 LGKGSYGTAYKAV---LEEST--TVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T   V VK+L+       RDFE+++EI+ +  QH N+V  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDNIVKY 70

Query: 400 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS  +    LV +Y   GSL   L  +R             K+LL  ++    +  
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-------KLLLYASQICKGMEY 123

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM------NVPATPSRSAGY-RAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++           P  S  +  APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              K S  SDV+SFGV+L E+ T      SP  + M
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 346 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G YG  Y+ V ++ S TV VK LKE  +   +F ++  ++  + +HPN+V L     
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
            +    ++ ++   G+L   L   R   R  ++    + +    +  + ++       F 
Sbjct: 73  REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126

Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLM-----NVPATPSRSAGYRAPEVIETRKHSHKS 519
           H ++ A N L+ ++    ++DFGL+ LM        A       + APE +   K S KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 520 DVYSFGVLLLEMLT-GKAP 537
           DV++FGVLL E+ T G +P
Sbjct: 187 DVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPNVVP 398
           LG+G++G  + A        ++   V VK LKE     R DF+++ E++  V QH ++V 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL-TVLQHQHIVR 71

Query: 399 LRAYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGT 448
                      L+V++Y   G L          + +L G        L     + I    
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRA-- 506
           A G+ ++ S+    F H ++   N L+ Q L   I DFG++   ++ +T     G R   
Sbjct: 132 ASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTML 186

Query: 507 ------PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                 PE I  RK + +SD++SFGV+L E+ T GK P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 29/228 (12%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           VLGKGS+G    A L+ +     +K LK +VV+   D E  M    ++    +HP +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIHS 457
              + +K+    V +Y   G L   +   + +GR           +I+ G    +  +H 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG----LQFLHK 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 513
            G     + ++K  NVL+++D    I+DFG+    MN     S   G   Y APE+++ +
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 553
           K++   D +SFGVLL EML G++P      D++ D         PRW+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 34/271 (12%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 400
           +GKG +   YKA+ L +   V +K+++  E++  K  +D  ++++++ ++  HPNV+   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYL 68

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
           A +   +E  +V +   +G LS ++   +   R  +   T  K  +     + H+HS   
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMHSK-- 125

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIETRKHS 516
            +  H +IK +NV I       + D GL    +   T + S  G   Y +PE I    ++
Sbjct: 126 -RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---AEVFDVELMRF 573
            KSD++S G LL EM    A LQSP   D ++L    + + + ++    A+ +  EL   
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL--- 237

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
                ++V        C+   P+ RP++  V
Sbjct: 238 ----RDLVSR------CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 4e-15
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 62/236 (26%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------------QQMEIVGRV 390
           E LG+G+YG  YKA  +++  +V   LK++ +   + E             +++      
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVA--LKKIRLDNEE-EGIPSTALREISLLKEL------ 55

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 449
            +HPN+V L    +++ +  LV++Y     L   L    G    PL     +K I+    
Sbjct: 56  -KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLS-PNLIKSIMYQLL 108

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 503
           RG+A+ HS    +  H ++K  N+LIN   DG   ++DFGL          +R+ G    
Sbjct: 109 RGLAYCHSH---RILHRDLKPQNILIN--RDGVLKLADFGL----------ARAFGIPLR 153

Query: 504 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
                     YRAPE++  ++ +S   D++S G +  EM+TGK      +  D + 
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 75.3 bits (186), Expect = 7e-15
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 46/241 (19%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD-FEQQM--EI-VGRVGQHPNVVPLR 400
           +G+G+YG  YKA   +    V +K+++  +  +++ F      EI + +  +HPN+V L+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 401 AYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHS 457
               SK +    +V++Y     L+ LL  +     T    E+++K  +     G+ ++HS
Sbjct: 65  EIVTSKGKGSIYMVFEYM-DHDLTGLLD-SPEVKFT----ESQIKCYMKQLLEGLQYLHS 118

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-- 510
            G     H +IK SN+LIN D    ++DFGL        +   +       YR PE++  
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRDD---MVDLPR 551
            TR +  + D++S G +L E+  GK   Q                SPT ++   +  LP 
Sbjct: 176 ATR-YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234

Query: 552 W 552
           +
Sbjct: 235 F 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---QMEIVG----RVGQHPNV 396
           E++G+G+YG  Y+     +  VV   LK + +   D +    Q E+      R  Q PN+
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVA--LKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 397 VPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
                YY  Y K  +L ++ +Y   GS+ TL+     AG  P+  +    I+      + 
Sbjct: 65  T---KYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AG--PIAEKYISVIIREVLVALK 115

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS--AG---YRAPE 508
           +IH +G     H +IKA+N+L+    +  + DFG+  L+N   +  RS   G   + APE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-NSSKRSTFVGTPYWMAPE 171

Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           VI E + +  K+D++S G+ + EM TG  P 
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY 202

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 346 LGKGSYGTAYKAVLEE----STTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPL 399
           LG G++G+  K V          V VK LK+  +  GK++F ++  ++ ++  HP +V  
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV-- 59

Query: 400 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHS 457
           R     K E L LV +    G L   L   R        +   +V      A G+A++ S
Sbjct: 60  RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEVI 510
                F H ++ A NVL+       ISDFG++  +   +    + +AG     + APE I
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT 533
              K S KSDV+S+GV L E  +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 346 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 395
           LG+G +G    A          +E+ TV VK LK+    K   D   +ME++  +G+H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 444
           ++ L           ++ +Y + G+L   L   R  G              + ++  V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 503
               ARG+ ++ S    K  H ++ A NVL+ ++    I+DFGL   + N+      + G
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 504 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 52/223 (23%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV-VKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPL 399
            +G G+YG    AV + +   V +K++     +++  KR   ++++++  + +H N++ L
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHL-RHENIIGL 64

Query: 400 RAYYYSKD----EKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVA 453
                         + +V +   +  L  ++   +     PL  +  ++  L    RG+ 
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLT-DDHIQYFLYQILRGLK 117

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 503
           ++HS       H ++K SN+L+N + D  I DFGL          +R             
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL----------ARGVDPDEDEKGFLT 164

Query: 504 -------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
                  YRAPE++ +     K+ D++S G +  E+LT K PL
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 39/215 (18%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEI-VGRVGQHP 394
           E +GKGS+G  YKA+ + +  VV   +K +     D E+        Q EI      + P
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVA--IKVI-----DLEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 395 NVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            +     YY  + K  KL ++ +Y   GS   LL          LD      IL     G
Sbjct: 60  YIT---KYYGSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLG 110

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AG---YR 505
           + ++H  G  K  H +IKA+N+L++++ D  ++DFG++  +   +T S+     G   + 
Sbjct: 111 LEYLHEEG--KI-HRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWM 165

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           APEVI+   +  K+D++S G+  +E+  G+ PL  
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 55/301 (18%)

Query: 345 VLGKGSYGTAYKAVLEE------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNV 396
            LG+G +G   KA           TTV VK LKE       RD   +  ++ +V  HP+V
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHV 65

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---------------PLDWETR 441
           + L          LL+ +Y   GSL + L  +R  G +               P +    
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 442 VKILLGTA----RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPA 496
           +  L+  A    RG+ ++  M   K  H ++ A NVL+ +     ISDFGL+  +    +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 497 TPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 550
              RS G     + A E +    ++ +SDV+SFGVLL E++T G  P      + + +L 
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL- 241

Query: 551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             +++  R E           R +N  EEM  ++   + C  + PD RP   ++ + +E+
Sbjct: 242 --LKTGYRME-----------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285

Query: 611 V 611
           +
Sbjct: 286 M 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 35/220 (15%)

Query: 344 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   +A++++        +K LKE       RDF  ++E++ ++G HPN++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 399 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 441
           L      R Y Y      +  +Y   G+L   L  +R     P           L  +  
Sbjct: 68  LLGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 499
           ++     A G   +  +   +F H ++ A NVL+ ++L   I+DFGL+    + V  T  
Sbjct: 122 LQFASDVATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 500 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           R    + A E +    ++ KSDV+SFGVLL E+++ G  P
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 65/245 (26%), Positives = 119/245 (48%), Gaps = 23/245 (9%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  + A   + T V VK +K   +    F  +  ++  + QH  +V L A   +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV-T 71

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 461
           K+   ++ ++ A GSL   L  + G  + PL    D+  ++      A G+A I      
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQI------AEGMAFIEQR--- 121

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  ++      +R        + APE I     +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRFQ 574
            KSDV+SFG+LL+E++T G+ P    +  +++  L R  +    E    E++++ +  ++
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK 241

Query: 575 NIEEE 579
           N  EE
Sbjct: 242 NRPEE 246

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +GKG +G            V VK +K     +  F  +  ++ ++ +H N+V L    
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA-FLAEASVMTQL-RHSNLVQLLGVI 68

Query: 404 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             +   L +V +Y A GSL   L   R  GR+ L  +  +K  L     + ++       
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANN 122

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSHKSDV 521
           F H ++ A NVL+++D    +SDFGLT    +   T      + APE +  +K S KSDV
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 522 YSFGVLLLEMLT-GKAP 537
           +SFG+LL E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 82/319 (25%), Positives = 138/319 (43%), Gaps = 48/319 (15%)

Query: 307 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV 366
           P       +++PE  +L F E      D E L     E+ G GS+G  Y A  +  T  V
Sbjct: 1   PSTSRAGSLKDPEIAELFFKE------DPEKLFTDLREI-GHGSFGAVYFA-RDVRTNEV 52

Query: 367 VKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSL 421
           V   K    GK+  E+  +I+  V      +HPN +  +  Y  +    LV +Y   GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSA 111

Query: 422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 481
           S LL       + PL       I  G  +G+A++HS       H +IKA N+L+ +    
Sbjct: 112 SDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164

Query: 482 CISDFGLTPLMNVPATPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            ++DFG   + +   +   +  + APEVI   +  ++  K DV+S G+  +E+   K PL
Sbjct: 165 KLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Query: 539 QSPTRDDMVDLPRWVQ----SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV 594
            +   + M  L    Q    ++   EW+          F+N  +          +C+ K+
Sbjct: 225 FN--MNAMSALYHIAQNESPTLQSNEWSD--------YFRNFVD----------SCLQKI 264

Query: 595 PDMRPNMDEVVRMIEEVRQ 613
           P  RP  +E+++ +  +R+
Sbjct: 265 PQDRPTSEELLKHMFVLRE 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 30/210 (14%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 396
           E+LG GS+G+ Y+ + L++     VK +     G+      +  EQ++ ++ ++ QHPN+
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNI 64

Query: 397 VPLRAYYYSK--DEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           V    Y  ++  ++ L ++ +    GSL+ LL    G+   P+      +ILLG    + 
Sbjct: 65  V---QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILLG----LE 116

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR---SAGYRAPE 508
           ++H        H +IK +N+L+  D +G +  +DFG+   +   +       S  + APE
Sbjct: 117 YLHDRN---TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171

Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           VI +   +   +D++S G  +LEM TGK P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 346 LGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPL 399
           +G+GS+G   KA+L    E+    V+K +    +  ++ E+  + V  +    HPN+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 456
           +  +       +V DY   G L   ++  RG        LDW   V+I L     + H+H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHVH 118

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET 512
                K  H +IK+ N+ + +D    + DFG+  ++N     +R+      Y +PE+ E 
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           R +++KSD+++ G +L EM T K   ++    ++V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVG-----QHPNVV 397
           E +GKGS+GT  K   +    ++V   KE+  G     E+Q  +V  V      +HPN+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILV--WKEIDYGNMTEKEKQQ-LVSEVNILRELKHPNIV 62

Query: 398 PLRAYYYSKD---EKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
                YY +        +Y   +Y   G L+ L+   +   R  ++ E   +IL      
Sbjct: 63  R----YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLA 117

Query: 452 VAHIH--SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YR 505
           +   H  S  G    H ++K +N+ ++ + +  + DFGL  ++   ++ +++  G   Y 
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           +PE +    +  KSD++S G L+ E+     P  
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 67/277 (24%), Positives = 125/277 (45%), Gaps = 38/277 (13%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLR 400
           LG G+ G+  K     + TV+ K  K V +G +    + +I+  +      + P +V   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAK--KVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFY 69

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             + +++   +  ++   GSL  +    +  G  P+  E   KI +    G+ +++++  
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNV-- 122

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIETRKHSHK 518
            +  H +IK SN+L+N      + DFG++  L+N +  T   ++ Y +PE I+  K++ K
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDD--------MVDLPRWVQSVVREEWTAEVFDVEL 570
           SDV+S G+ ++E+  GK P      DD        ++DL   +Q +V+E           
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSS--- 236

Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
             F     + V       AC+ K P  RP   ++  M
Sbjct: 237 -DFPEDLRDFVD------ACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 74/303 (24%), Positives = 122/303 (40%), Gaps = 77/303 (25%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRA 401
           +G G++G  Y AV L+    + VK ++      +  ++   +M+++  + +HPN+V    
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK--- 63

Query: 402 YYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWE-TRV--KILLGTARGVAH 454
            YY      EK+ ++ +Y + G+L  LL   R      LD    RV    LL    G+A+
Sbjct: 64  -YYGVEVHREKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLL---EGLAY 114

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG--------Y 504
           +HS G     H +IK +N+ +  D +G I   DFG    +    T              Y
Sbjct: 115 LHSHG---IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 505 RAPEVIETRKHSHK---SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 561
            APEVI   K       +D++S G ++LEM TGK P                        
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP------------------------ 205

Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 621
                      +  ++ E   M  +G      +PD      E    ++   +SD + RP+
Sbjct: 206 -----------WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254

Query: 622 SEE 624
           + E
Sbjct: 255 ASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 73/298 (24%), Positives = 135/298 (45%), Gaps = 58/298 (19%)

Query: 344 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++        +KR+KE       RDF  ++E++ ++G HPN++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 399 L------RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETR 441
           L      R Y Y      L  +Y   G+L   L  +R     P           L  +  
Sbjct: 73  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPS 499
           +      ARG+ ++      +F H ++ A N+L+ ++    I+DFGL+    + V  T  
Sbjct: 127 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 500 R-SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSV 556
           R    + A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ + LP+     
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----- 238

Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 610
                        L +  N ++E+  +++    C  + P  RP+  +++    RM+EE
Sbjct: 239 ----------GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 48/300 (16%)

Query: 346 LGKGSYGTAYKAVL--------EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 395
           LG+G +G   +A          +++ TV VK LK+    K   D   +ME++  +G+H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 444
           ++ L      +    ++ +Y A G+L   L   R  G              L ++  V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 503
               ARG+ ++ S    +  H ++ A NVL+ +D    I+DFGL   + ++      S G
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 504 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 557
                + APE +  R ++H+SDV+SFG+L+ E+ T G +P      +++  L       +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL-------L 249

Query: 558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
           RE    +       +  N   E+  +++    C   VP  RP   ++V  +++V  + SE
Sbjct: 250 REGHRMD-------KPSNCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 344 EVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E++G+G +G    AVL+   T   V VK +K  V  +  F ++  ++ ++  H N+V L 
Sbjct: 12  EIIGEGEFG----AVLQGEYTGQKVAVKNIKCDVTAQA-FLEETAVMTKL-HHKNLVRLL 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                     +V +  + G+L   L   R  GR  +     ++  L  A G+ ++ S   
Sbjct: 66  GVILHNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES--- 118

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHKS 519
            K  H ++ A N+L+++D    +SDFGL  + ++    S+    + APE ++ +K S KS
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKS 178

Query: 520 DVYSFGVLLLEMLT-GKAP 537
           DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 346 LGKGSYGTAY--------KAVLEESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPN 395
           LG+G +G           K    +  TV VK LK+    K   D   +ME++  +G+H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETRVKI 444
           ++ L           ++ +Y + G+L   L   R  G        + P   L ++  V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG 503
               ARG+ ++ S    K  H ++ A NVL+ +D    I+DFGL   + N+      + G
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 504 -----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE +  R ++H+SDV+SFGVLL E+ T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 64/288 (22%), Positives = 121/288 (42%), Gaps = 46/288 (15%)

Query: 345 VLGKGSYGTAYKAVLEES------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 396
            LG+G +G  + A  +        T V+VK L++        +F +++++  ++  H NV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNV 70

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT----PLDWETRVKILLGTARGV 452
           V L       +   ++ +Y   G L   L   +         PL  + +V +    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT---------PLMNVPATPSRSAG 503
            H+ +    +F H ++ A N L++   +  +S   L+          L N    P R   
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLR--- 183

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
           + APE ++    S KSDV+SFGVL+ E+ T G+ P    + +++++              
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-------------R 230

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            +   +EL   +     + +++     C A  P  RP+  E+V  + E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)

Query: 344 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 397
           + LG GS+G   +     S      V VK LK   +     DF ++  I+  +  H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLI 59

Query: 398 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLD--WETRVKILLGTARGVAH 454
             R Y       L +V +    GSL   L      G   +    +  V+I    A G+ +
Sbjct: 60  --RLYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQI----ANGMRY 112

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------AP 507
           + S    +F H ++ A N+L+  D    I DFGL   +           +        AP
Sbjct: 113 LES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           E + TR  SH SDV+ FGV L EM T G+ P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 24/214 (11%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 390
           D E+L     E +GKGS+G  +K +   +  VV  +   L+E      D +Q++ ++ + 
Sbjct: 1   DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 391 GQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
              P V     YY  Y KD KL ++ +Y   GS   LL         PLD      IL  
Sbjct: 60  -DSPYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILRE 109

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG--- 503
             +G+ ++HS    K  H +IKA+NVL+++  +  ++DFG+   L +     +   G   
Sbjct: 110 ILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           + APEVI+   +  K+D++S G+  +E+  G+ P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +     V +K++      K++      +V R  ++PN+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS---NQ 135

Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ N+L+  D    ++DFG    +TP  +  +T   +  + APEV+  + +  K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQME-------IVGRVGQHPN 395
           + LG G++ + Y+A  ++  T + VK++  V     + E+ +E       ++ R+  HP+
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           ++ +           L  ++ A GS+S LL    G           +       RG++++
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYG----AFKEAVIINYTEQLLRGLSYL 119

Query: 456 HSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPATPSR--------SAGY 504
           H     +  H ++K +N+LI+   Q L   I+DFG    +    T +         +  +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAF 174

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            APEV+   ++    DV+S G +++EM T K P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 64/250 (25%), Positives = 117/250 (46%), Gaps = 26/250 (10%)

Query: 344 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++        +KR+KE       RDF  ++E++ ++G HPN++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 447
           L      +    L  +Y   G+L   L  +R     P           L  +  +     
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT--PLMNVPATPSR-SAGY 504
            ARG+ ++      +F H ++ A N+L+ ++    I+DFGL+    + V  T  R    +
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 562
            A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ + LP+  +        
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237

Query: 563 AEVFDVELMR 572
            EV+  +LMR
Sbjct: 238 DEVY--DLMR 245

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 27/226 (11%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           VLGKGS+G    A L+ +  +  VK L K+V++   D E  M    ++   G+HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 458
            + + +KD    V +Y   G L  + H  R +GR     E R +        G+  +H  
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFLHER 115

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 514
           G     + ++K  NVL++ +    I+DFG+    +    T S   G   Y APE++  + 
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 552
           +    D ++ GVLL EML G++P +    D++        V  PRW
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 61/212 (28%), Positives = 87/212 (41%), Gaps = 24/212 (11%)

Query: 345 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLRA 401
           VLGKG+YG  Y A  L     + +K + E     R  +   E +       H N+V    
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA--RGVAHIHSMG 459
                    +  +    GSLS LL    G    PL    +  I        G+ ++H   
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDN- 127

Query: 460 GPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSAGYRAPEVIE--T 512
             +  H +IK  NVL+N       ISDFG    L  +     T + +  Y APEVI+   
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAP---LQSP 541
           R +   +D++S G  ++EM TGK P   L  P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 28/206 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 395
           E +G+G+ GT Y A+ + +T       +EV + + + +QQ +        +V R  +HPN
Sbjct: 25  EKIGQGASGTVYTAI-DVATG------QEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +V     Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 131

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 511
           HS       H +IK+ N+L+  D    ++DFG    +TP  +  +T   +  + APEV+ 
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAP 537
            + +  K D++S G++ +EM+ G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 29/229 (12%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           +VLGKGS+G    A L+ +     VK LK +VV+   D E  M    ++    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 456
           L   + +K+    V ++   G L  + H  +  GR  L   T    +I+ G    +  +H
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDLYRATFYAAEIVCG----LQFLH 113

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 512
           S G     + ++K  NV++++D    I+DFG+        N  +T   +  Y APE+++ 
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWV 553
            K++   D +SFGVLL EML G++P      D++ +         PRW+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 62/270 (22%), Positives = 121/270 (44%), Gaps = 31/270 (11%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G            V +K +KE  + + +F ++ +++ ++  H  +V L      
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK 70

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    +V +Y ++G L   L   R  G+     +  +++      G+A++ S    +F H
Sbjct: 71  QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQL-LEMCKDVCEGMAYLES---KQFIH 123

Query: 466 GNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKSD 520
            ++ A N L++      +SDFGL+  +++   T S  + +      PEV+   K S KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           V++FGVL+ E+ + GK P +     + V+    V   +R           L R     E+
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEK---VSQGLR-----------LYRPHLASEK 229

Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
           +  ++    +C  +  + RP   +++  IE
Sbjct: 230 VYAIM---YSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 33/270 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +         V +K + E  + + DF ++ +++ ++  HP +V L      
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ 70

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFT 464
           +    +V ++  +G L   L   +G        +    +LL   + V   +  +    F 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 465 HGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RAPEVIETRKHSHKS 519
           H ++ A N L++      +SDFG+T  +++   T S  A +      PEV    K+S KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
           DV+SFGVL+ E+ T GK P +  +  ++V++      + R +  +               
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASM-------------- 228

Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
               + ++  +C  + P+ RP   E++R I
Sbjct: 229 ---TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 47/293 (16%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVP 398
           LG+G++G  + A        ++   V VK LK+     ++DF ++ E++  + QH ++V 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLL--HG------NRGAGRTPLDWETRVKILLGTAR 450
                   D  ++V++Y   G L+  L  HG        G     L     + I    A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------- 503
           G+ ++ S     F H ++   N L+ ++L   I DFG++   +V +T     G       
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPI 186

Query: 504 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW 561
            +  PE I  RK + +SDV+S GV+L E+ T GK P    + +++++     Q  V    
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--ITQGRV---- 240

Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
                   L R +   +E+  ++   + C  + P MR N+ E+  +++ + ++
Sbjct: 241 --------LQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKA 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLR 400
           +G+G +   Y+A  L +   V +K+++   +     + D  ++++++ ++  HPNV+   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYY 68

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
           A +   +E  +V +   +G LS ++   +   R  +  +T  K  +     + H+HS   
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMHSR-- 125

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 516
            +  H +IK +NV I       + D GL    +   T + S      Y +PE I    ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
            KSD++S G LL EM    A LQSP   D ++L    + +       E  D   +   + 
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHY 233

Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
            EE+ Q++ +   C+   P+ RP++  V  +
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 9e-13
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)

Query: 346 LGKGSYG---TAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVP 398
           +G G++G   +A   +      V +K++       V+ KR + ++++++  + +H N++ 
Sbjct: 18  VGMGAFGLVCSARDQL--TGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHL-RHENIIS 73

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L   + S  E +    YF +  L T LH  R     PL+ +     L    RG+ ++HS 
Sbjct: 74  LSDIFISPLEDI----YFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPEVIET-RKHS 516
           G     H ++K SN+LIN++ D  I DFGL  + +   T   S   YRAPE++ T +K+ 
Sbjct: 128 G---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYD 184

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            + D++S G +  EML GK PL  P +D
Sbjct: 185 VEVDIWSAGCIFAEMLEGK-PL-FPGKD 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 38/219 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 402
           EV+G G+YG  YK    ++  +   ++ +V   + +  + ++ ++ +   H N+      
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 403 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV--KILLGTARGVAH 454
           +  K      D+  LV ++  +GS++ L+   +G      DW   +  +IL    RG+AH
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIAYICREIL----RGLAH 136

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 505
           +H+    K  H +IK  NVL+ ++ +  + DFG      V A   R+ G R         
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYW 187

Query: 506 -APEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
            APEVI   +     + ++SD++S G+  +EM  G  PL
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 34/217 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD-FEQQMEIVGRVGQHPNVVPLRAY 402
           E++G G+YG  YK    ++  +   ++ +V   + +  +Q++ ++ +   H N+      
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 403 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           +  K      D+  LV ++  +GS++ L+   +G     L  E    I     RG++H+H
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 128

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 506
                K  H +IK  NVL+ ++ +  + DFG      V A   R+ G R          A
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 179

Query: 507 PEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
           PEVI   +     +  KSD++S G+  +EM  G  PL
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-------RDFEQQMEIVGRVGQHPNVV 397
           V+GKG++G     ++++  T  +  +K +   K       R+   +  I+  +  HP +V
Sbjct: 7   VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLV 63

Query: 398 PLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 455
            L  Y +  +E + LV D    G L    H ++    +    E +VK  +      + ++
Sbjct: 64  NLW-YSFQDEENMYLVVDLLLGGDLR--YHLSQKVKFS----EEQVKFWICEIVLALEYL 116

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 511
           HS G     H +IK  N+L+++     I+DF     +TP     +T S + GY APEV+ 
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-SGTPGYMAPEVLC 172

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAP 537
            + +S   D +S GV   E L GK P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 52/246 (21%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR-------DFEQQMEI-VGRVGQHPNV 396
           LG+G+Y   YKA  +E+  +V +K++K   +G+R       +F    EI + +  +HPN+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 455
           + L   +  K    LV++ F    L  ++  ++    TP D    +K  +L T RG+ ++
Sbjct: 65  IGLLDVFGHKSNINLVFE-FMETDLEKVIK-DKSIVLTPAD----IKSYMLMTLRGLEYL 118

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPE 508
           HS       H ++K +N+LI  D    ++DFGL        +P+R          YRAPE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF---GSPNRKMTHQVVTRWYRAPE 172

Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ----------------SPTRD---DMVD 548
           ++   R +    D++S G +  E+L     L                 +PT +    +  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 549 LPRWVQ 554
           LP +V+
Sbjct: 233 LPDYVE 238

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-------VGRVGQHPNV 396
           E+LGKG++G  +K  L++ T V VK  KE      D  Q+++I       + +   HPN+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKE------DLPQELKIKFLSEARILKQYDHPNI 54

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L      +    +V +    G   + L   +   +T    +  VK  L  A G+A++ 
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLE 110

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-----------LMNVPATPSRSAGYR 505
           S       H ++ A N L+ ++    ISDFG++            L  +P        + 
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WT 161

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT 533
           APE +   ++S +SDV+S+G+LL E  +
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 53/291 (18%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ +       E  T V +K + E   +  + +F  +  ++     H +VV
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L     +    L+V +  A G L + L   R       G  P   +  +++    A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 505
           A++ +    KF H ++ A N ++ +DL   I DFG+T  +        +  YR       
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY------ETDYYRKGGKGLL 183

Query: 506 -----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVRE 559
                APE ++    + KSDV+SFGV+L EM T  + P Q  + ++++            
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---------- 233

Query: 560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
                V D   +     E    ++L++   C    P MRP   E+V  +++
Sbjct: 234 -----VIDGGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK-----RDFEQQMEIVGRVGQHPNVVPL 399
           V+G+GS+G A       S       +KE+ + K      D  ++  ++ ++ +HPN+V  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYA--MKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAF 63

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIH 456
           +  + +     +V +Y   G L   +   RG      T L W  ++ +      GV HIH
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGYRAPEVIET 512
                +  H +IK+ N+ + Q+    + DFG   L+  P     T   +  Y  PE+ E 
Sbjct: 118 E---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
             +++KSD++S G +L E+ T K P Q+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG+YG  YK    ++ +   VK L  +     + E +  I+  +  HPNVV     
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 403 YYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +Y  D+ +     LV +    GS++ L+ G    G+  LD      IL G   G+ H+H+
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 513
               +  H ++K +N+L+  +    + DFG++  L +     + S G   + APEVI   
Sbjct: 147 ---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 514 K-----HSHKSDVYSFGVLLLEMLTGKAPL 538
           +     +  + DV+S G+  +E+  G  PL
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 30/214 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPN 395
           E +G+G+ GT Y       T + V   +EV + + + +QQ +        +V R  ++PN
Sbjct: 26  EKIGQGASGTVY-------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +V     Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFL 132

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIE 511
           HS    +  H +IK+ N+L+  D    ++DFG    +TP  +  +T   +  + APEV+ 
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR 543
            + +  K D++S G++ +EM+ G+ P   ++P R
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E +GKGS+G  YK +   +  VV  +   L+E      D +Q++ ++ +    P +    
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYY 68

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             Y    +  ++ +Y   GS   LL         PL+      IL    +G+ ++HS   
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS--- 119

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS 516
            +  H +IKA+NVL+++  D  ++DFG    LT       T   +  + APEVI+   + 
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 517 HKSDVYSFGVLLLEMLTGKAP 537
            K+D++S G+  +E+  G+ P
Sbjct: 180 FKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 67/276 (24%), Positives = 130/276 (47%), Gaps = 28/276 (10%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLK--EVVVGK--RDFEQQMEIVGRVGQHPNVVPLR 400
           +G+G +   Y+A  L +   V +K+++  E++  K  +D  ++++++ ++  HPNV+   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYL 68

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +   +E  +V +   +G LS ++   +   R  +   T  K  +     V H+HS   
Sbjct: 69  DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSR-- 125

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 516
            +  H +IK +NV I       + D GL    +   T + S      Y +PE I    ++
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
            KSD++S G LL EM    A LQSP   D ++L    Q +       E  D   +  ++ 
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHY 233

Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
            E++ +++ +   C+   PD RP++  V ++ +++ 
Sbjct: 234 SEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--------QMEIVGRVGQHPN 395
           E LG+G+Y T YK      TT  +  LKE+     D E+        ++ ++  + +H N
Sbjct: 6   EKLGEGTYATVYKG--RNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKEL-KHEN 59

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVA 453
           +V L    +++++ +LV++Y     L   +  HG RGA    LD  T         +G+A
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIA 114

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEV 509
             H     +  H ++K  N+LIN+  +  ++DFGL     +P     +      YRAP+V
Sbjct: 115 FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171

Query: 510 I-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           +  +R +S   D++S G ++ EM+TG+        +D
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           QH N+V         D   +  +Y   GS++ LL+ N GA    L      +IL    +G
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQIL----KG 118

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------ 505
           + ++H+ G     H +IK +N+L++      ISDFG++  +   +  +++ G R      
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
               APEV++   ++ K+D++S G L++EMLTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 39/282 (13%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKR---LKEVVVGKRDFEQQMEIVGRV 390
           D E+L     E +GKGS+G  +K +   +  VV  +   L+E      D +Q++ ++ + 
Sbjct: 1   DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
              P V      Y    +  ++ +Y   GS   LL         P D      +L    +
Sbjct: 60  -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILK 112

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRA 506
           G+ ++HS    K  H +IKA+NVL+++  D  ++DFG    LT       T   +  + A
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVREEWTAE 564
           PEVI+   +  K+D++S G+  +E+  G+ P     P R  +  +P+     +  E++  
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLFLIPKNNPPTLTGEFSKP 228

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                   F+   +          AC+ K P  RP   E+++
Sbjct: 229 --------FKEFID----------ACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 71/279 (25%), Positives = 118/279 (42%), Gaps = 51/279 (18%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 395
           E LG+  +G  YK  L      E++  V +K LK+   G  + +F+ +  +  R+ QHPN
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPN 69

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVKI 444
           +V L      +    +++ Y +   L   L     H + G+       ++ L+    V I
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVP 495
           +   A G+  + S       H ++   NVL+   L+  ISD GL           LM   
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV------- 547
             P R   + +PE I   K S  SD++S+GV+L E+ + G  P    +  D++       
Sbjct: 187 LLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243

Query: 548 ------DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 580
                 D P WV +++ E W    F     RF++I   +
Sbjct: 244 VLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 29/235 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           ++LGKGS+G  + A L+ +     +K LK +VV+   D E  M    ++    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 456
           L   + +K+    V +Y   G L   +   +   +  L   T    +I+ G    +  +H
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 512
           S G     + ++K  N+L++ D    I+DFG+    M   A      G   Y APE++  
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAP--------LQSPTRDDMVDLPRWVQSVVRE 559
           +K++   D +SFGVLL EML G++P        L    R D    PRW+    ++
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 54/297 (18%)

Query: 346 LGKGSYGTAYKAVLEES-----------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQ 392
           LG+G +G   + V+ E+           T V VK LK     K   D   +ME++  +G+
Sbjct: 26  LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RTP---LDWETR 441
           H N++ L           ++ +Y + G+L   L   R  G        + P   L ++  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSR 500
           V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFGL   + ++      
Sbjct: 143 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 501 SAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ 554
           + G     + APE +  R ++H+SDV+SFGVLL E+ T G +P      +++  L +   
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259

Query: 555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            + +                N   E+  M++    C   VP  RP   ++V  ++ +
Sbjct: 260 RMDKP--------------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNV 396
           E LG+ ++G  YK  L     + +  V +K LK++   ++  +F+Q+  ++  +  HPN+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNI 69

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAG-------RTPLDWETRVKI 444
           V L      +    ++++Y   G L   L     H + G         ++ LD    + I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATP 498
            +  A G+ ++ S     F H ++ A N+LI + L   ISD GL+          V    
Sbjct: 130 AIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 551
                +  PE I   K S  SD++SFGV+L E+ + G  P    +  +++++ R
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           + +G+GS+G  Y A  + +S   V+K   L ++ V +++  ++  I+    +HPN+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIHS 457
           A +       +V +Y   G L   ++  RG   +    L W  ++ +      G+ HIH 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119

Query: 458 MGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 512
               K  H +IK+ N+ ++++ +   + DFG+   +N     + +  G   Y +PE+ + 
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           R +++K+D++S G +L E+ T K P + 
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 23/217 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQQM--EI-VGRVGQHPNVVPLR 400
           +G+G++G  +KA   E+   V   LK+V + + +     Q   EI   +  QHP VV L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVA--LKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +      +LV +Y  S  LS +L       R   + + +   +    +GVA++H+ G 
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEE---RPLPEAQVK-SYMRMLLKGVAYMHANG- 119

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI-ETRK 514
               H ++K +N+LI+ D    I+DFGL  L +       S       YRAPE++   RK
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 551
           +    D+++ G +  E+L G +PL  P  +D+  L  
Sbjct: 178 YDPGVDLWAVGCIFAELLNG-SPL-FPGENDIEQLAI 212

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 54/294 (18%)

Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 389
              D E L     E+ G GS+G  Y A  +  +  V +K++     GK+  E+  +I+  
Sbjct: 9   SKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKE 65

Query: 390 VG-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           V      +HPN +  +  Y  +    LV +Y   GS S +L       + PL       I
Sbjct: 66  VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILE----VHKKPLQEVEIAAI 120

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 499
             G  +G+A++HS    +  H +IKA N+L+ +     ++DFG   L++ PA     TP 
Sbjct: 121 CHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFVGTPY 176

Query: 500 RSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-- 554
               + APEVI          K DV+S G+  +E+   K PL +   + M  L    Q  
Sbjct: 177 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQND 230

Query: 555 --SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
             ++   +W+               +     +    +C+ K+P  RP+ +E+++
Sbjct: 231 SPTLSSNDWS---------------DYFRNFVD---SCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 24/243 (9%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG+YG  +K + +++ +   VK L  +     + E +  I+  +  HPNVV     
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 403 YYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           YY KD K      LV +    GS++ L+ G    G   ++      IL     G+ H+H 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG---YRAPEVIETR 513
               K  H ++K +N+L+  +    + DFG++  L +     + S G   + APEVI   
Sbjct: 143 ---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199

Query: 514 K-----HSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR--EEWTAE 564
           +     +  + DV+S G+  +E+  G  PL    P R  +  +PR     +   E W+ E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNPPPTLHQPELWSNE 258

Query: 565 VFD 567
             D
Sbjct: 259 FND 261

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 47/225 (20%)

Query: 346 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPNVV 397
           LG G +G      V  ++ T  +K +K+  + +   ++        +E       HP +V
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC----NHPFIV 56

Query: 398 PLRAYYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARG 451
            L   +  KD+K  +Y   +Y   G L T+L   R  G    ++  R     ++L     
Sbjct: 57  KLYRTF--KDKKY-IYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIACVVLAFE-- 107

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPA-------TPSRSA 502
             ++H+ G     + ++K  N+L+  D +G +   DFG    +           TP    
Sbjct: 108 --YLHNRG---IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP---- 156

Query: 503 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            Y APE+I  + +    D +S G+LL E+LTG+ P      D M 
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)

Query: 344 EVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQME-----IVGRVGQHP 394
            V+GKG +G  Y   L +S        VK L  +     D E+  +     I+ +   HP
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHP 56

Query: 395 NVVPLRAYYYSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG----TA 449
           NV+ L       +   L+V  Y   G L    +  R     P      VK L+G     A
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP-----TVKDLIGFGLQVA 108

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--TPSRSAGYRAP 507
           +G+ ++ S    KF H ++ A N ++++     ++DFGL   +      +     G + P
Sbjct: 109 KGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 508 ------EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREE 560
                 E ++T+K + KSDV+SFGVLL E++T  AP   P  D D  D+  ++    R  
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVDSFDITVYLLQGRR-- 220

Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
                    L++ +   + + +++    +C    P+MRP   E+V  IE++
Sbjct: 221 ---------LLQPEYCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.7 bits (161), Expect = 7e-12
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 44/223 (19%)

Query: 346 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQM---------EIVGRVGQHP 394
           + KG+YG  + A  ++ST     +K     V+ K D  ++          +I+ +  Q P
Sbjct: 1   ISKGAYGRVFLAK-KKSTGDIYAIK-----VIKKADMIRKNQVDQVLTERDILSQA-QSP 53

Query: 395 NVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            VV L   YYS    + L LV +Y   G L++LL  N G+    LD +     +      
Sbjct: 54  YVVKL---YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLA 105

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNVPATPSRSA 502
           + ++HS G     H ++K  N+LI+ +    ++DFGL           L +      R  
Sbjct: 106 LEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 503 G---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           G   Y APEVI  + HS   D +S G +L E L G  P    T
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 48/288 (16%)

Query: 346 LGKGSYGTAYKAVLEE------STTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVV 397
           +G G +G   K +L E         VVVK L+          F Q+++   R   HPNV+
Sbjct: 3   IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY-RELNHPNVL 58

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
                       LLV ++   G L   L  NRG        +   ++    A G+  +H 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------ATPSRSAGYRAP 507
                F H ++   N  +  DL   I D+GL  L   P          A P R   + AP
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLR---WLAP 171

Query: 508 EVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 560
           E++E R         + KS+++S GV + E+ T          D+ V     ++ VVRE+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ 226

Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
                 D++L + Q   +   +  ++   C    P+ RP  +EV  ++
Sbjct: 227 ------DIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 38/223 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRL----KEVVVGKRDFEQQMEIVG--RVGQHPNVV 397
           EVLGKG+YGT Y  +  +   + VK++      V+  ++++E+  E V   +  +H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIH 456
                    +   +  ++   GS+S++L  NR G    P+  +   +IL     GVA++H
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL----DGVAYLH 119

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTP--------------LMNVPATPSR 500
           +       H +IK +NV++  +  G I   DFG                 L ++  TP  
Sbjct: 120 N---NCVVHRDIKGNNVMLMPN--GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY- 173

Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 543
              + APEVI    +  KSD++S G  + EM TGK PL S  R
Sbjct: 174 ---WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 26/220 (11%)

Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV 390
           Y  D E++     E+ G GS+G  Y A     T  VV   K    GK+  E+  +I+  V
Sbjct: 15  YKDDPEEIFVGLHEI-GHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72

Query: 391 G-----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
                 +HPN +  +  Y  +    LV +Y   GS S LL       + PL       I 
Sbjct: 73  KFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAIT 127

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS 501
            G  +G+A++HS       H +IKA N+L+ +     ++DFG     +P  +   TP   
Sbjct: 128 HGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-- 182

Query: 502 AGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             + APEVI   +  ++  K DV+S G+  +E+   K PL
Sbjct: 183 --WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 30/210 (14%)

Query: 344 EVLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI------VGRVGQHPNV 396
            V+G+G+YG   K         V +K+ KE      D E   +       V R  +H N+
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTALREVKVLRQLRHENI 62

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L+  +  K    LV++Y    +L  LL  + G     L  +     +    + +A+ H
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCH 117

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-------SRSAGYRAPEV 509
           S       H +IK  N+L+++     + DFG    +             +R   YRAPE+
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--WYRAPEL 172

Query: 510 -IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +    +    DV++ G ++ E+L G+ PL
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE-PL 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)

Query: 341 ASAEVLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQME--IVGRVGQHPN 395
           A  + LG+G +G+  +  L +  +   V VK +K  +  + + E  +   +  +   HPN
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 396 VVPLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLG 447
           V+ L        E       +++  +   G L + L  +R  G  P  L  +  VK +  
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATP 498
            A G+ ++ S     F H ++ A N ++N++++ C++DFGL+  +          +   P
Sbjct: 121 IASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
            +   + A E +  R ++ KSDV+SFGV + E+ T G+ P
Sbjct: 178 VK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 45/240 (18%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           + LG GS+G       + S     +K L K  +V  +  E  +    I+  + +HP +V 
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLV- 64

Query: 399 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRV---KILLGTARGVA 453
              Y   +D+  L  V +Y   G L + L   R +GR P     R    +++L     + 
Sbjct: 65  -NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVVLA----LE 115

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPL-----MNVPATPSRSAGYRA 506
           ++HS+      + ++K  N+L+  D DG I  +DFG           +  TP     Y A
Sbjct: 116 YLHSLD---IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGRTYTLCGTPE----YLA 166

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 558
           PE+I ++ +    D ++ G+L+ EML G  P        +        V  P +     +
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAK 226

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QH 393
           L +    +G GS+G  Y A    ++ VV  + K    GK+  E+  +I+  V      +H
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           PN +  R  Y  +    LV +Y   GS S LL       + PL       +  G  +G+A
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLA 129

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVI--- 510
           ++HS       H ++KA N+L+++     + DFG   +M        +  + APEVI   
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAM 186

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +  ++  K DV+S G+  +E+   K PL
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/217 (23%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVV 397
           ++LG+G +G+  +  L +       V VK +K  +    + E+ +     +    HPNV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 398 PLRAYYYSKDEK------LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 450
            L    +           +++  +   G L + L  +R G     L  +T +K ++  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRS 501
           G+ ++ +     F H ++ A N ++ +D+  C++DFGL+  +          +   P + 
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 180

Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
             + A E +  R ++ KSDV++FGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)

Query: 350 SYGTAYKAVLEESTTVVV-----KRLKEVVVGKRDFEQQME--------IVGRVGQHPNV 396
           SY   +  + E ST +V         ++V V K D  +Q          ++ R  QHPN+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V + + Y   DE  +V ++   G+L+ ++   R      ++ E    + L   + ++ +H
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLH 132

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-AG---YRAPEVIET 512
           + G     H +IK+ ++L+  D    +SDFG    ++      +S  G   + APEVI  
Sbjct: 133 AQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPL 538
             +  + D++S G++++EM+ G+ P 
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 47/292 (16%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGK--RDFEQQMEIVGRV 390
           DL+DL       +G+G++GT  K + + S T++ VKR++  V  K  +     +++V R 
Sbjct: 5   DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
              P +V      + + +  +  +     SL           ++ +  E   KI + T +
Sbjct: 60  SDCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLT-PLMNVPATPSRSAG---Y 504
            + ++      K  H ++K SN+L+  D +G I   DFG++  L++  A  +R AG   Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPY 173

Query: 505 RAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE- 560
            APE I+      +  +SDV+S G+ L E+ TGK P   P  + + D    +  VV+ + 
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFD---QLTQVVKGDP 228

Query: 561 -----WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
                     F    + F N+             C+ K    RP   E++  
Sbjct: 229 PILSNSEEREFSPSFVNFINL-------------CLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 346 LGKGSYGTAYKA------VLEESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVVP 398
           LG+G++G  + A        ++   V VK LK+  +  ++DF+++ E++  + QH ++V 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 447
                   D  ++V++Y   G L+  L  +       +D + R           + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 503
            A G+ ++ S     F H ++   N L+  +L   I DFG++   +V +T     G    
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS--RDVYSTDYYRVGGHTM 186

Query: 504 ----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
               +  PE I  RK + +SDV+SFGV+L E+ T GK P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 47/227 (20%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG------------- 391
           LG+G+YG   KA        V +K++K ++    D  +  ++VG  G             
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 392 --QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGT 448
             +H N++ L   Y   D   LV D  AS  L  ++       +  L  E++VK ILL  
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDR-----KIRLT-ESQVKCILLQI 128

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT------PLMNVPATPSRSA 502
             G+  +H      F H ++  +N+ IN      I+DFGL       P  +  +      
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 503 G------------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKA 536
                        YRAPE++    K+    D++S G +  E+LTGK 
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 30/205 (14%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHPNVV 397
           +G+GS G    A  + +        K+V V K D  +Q          ++ R   H NVV
Sbjct: 30  IGEGSTGIVCIATEKHTG-------KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            +   Y   DE  +V ++   G+L+ ++   R      ++ E    + L   R ++++H+
Sbjct: 83  DMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHN 136

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIET 512
            G     H +IK+ ++L+  D    +SDFG    ++    P R     +  + APEVI  
Sbjct: 137 QG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISR 192

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAP 537
             +  + D++S G++++EM+ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 30/216 (13%)

Query: 345 VLGKGSYGTA----YKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVP 398
           ++GK           K     +T V VK++      K D +  QQ  I  R  QHPN++P
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
               +    E  +V    A GS   LL  H   G     + +     IL      + +IH
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH 118

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCIS-----------DFGLTPLMNVPATPSRSAGYR 505
           S G   F H ++KAS++L++ D    +S                 + + P +  ++  + 
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 506 APEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQ 539
           +PEV++     +  KSD+YS G+   E+  G  P +
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 46/254 (18%)

Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFE-- 381
           F GCS   D E L       LG+G++G  YKA   ++  VV   LK++++   K  F   
Sbjct: 1   FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVA--LKKILMHNEKDGFPIT 53

Query: 382 --QQMEIVGRVGQHPNVVPL--RAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGA 431
             ++++I+ ++ +HPNVVPL   A       K       +V  Y     LS LL      
Sbjct: 54  ALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-V 110

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
             T    +  +  LL    G+ ++H        H +IKA+N+LI+      I+DFGL   
Sbjct: 111 KLTESQIKCYMLQLL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 492 MNVPATPSRSAG---------------YRAPE-VIETRKHSHKSDVYSFGVLLLEMLTGK 535
            + P    +  G               YR PE ++  R+++   D++  G +  EM T +
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Query: 536 APLQSPTRDDMVDL 549
             LQ  +  D + L
Sbjct: 225 PILQGKSDIDQLHL 238

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 31/204 (15%)

Query: 346 LGKGSYGTAY-----KAVLEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHP 394
           LGKGS+GT Y     KAV EE     +K LKE+ VG+ +        Q+ +++ ++  HP
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKL-DHP 62

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARG 451
            +V   A +  +D   ++ +Y     L   L   +  G+T       E  +++LLG    
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG---- 118

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAP 507
              +H M   +  H ++KA N+ +  +L   I DFG++ L+    ++  T + +  Y +P
Sbjct: 119 ---VHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 508 EVIETRKHSHKSDVYSFGVLLLEM 531
           E ++ + +  KSD++S G +L EM
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 27/229 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV-VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
            VLGKGS+G    A L+ES  +  VK LK +V++   D E  M    I+     HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L   + + D    V ++   G L   +  +R       D E R +         +  +H 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFD-EARARFYAAEITSALMFLHD 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--VPATPSRSAGYRAPEVIETR 513
            G     + ++K  NVL++ +    ++DFG+    + N    +T   +  Y APE+++  
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQ 554
            +    D ++ GVLL EML G AP ++   DD+        V  P W+ 
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 14/197 (7%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G+GS G    A ++ S  +V VK++      +R+      ++ R  QH NVV +   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
             DE  +V ++   G+L+ ++   R      ++ E    + L   + ++ +H+ G     
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG---VI 138

Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR--SAGYRAPEVIETRKHSHKSD 520
           H +IK+ ++L+  D    +SDFG    ++  VP   S   +  + APE+I    +  + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 521 VYSFGVLLLEMLTGKAP 537
           ++S G++++EM+ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.0 bits (155), Expect = 4e-11
 Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT + A+ +     V +K++      K++      +V +  ++PN+V     
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           +   DE  +V +Y A GSL+ ++        T +D      +     + +  +H+    +
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHA---NQ 135

Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ NVL+  D    ++DFG    +TP  +  +T   +  + APEV+  + +  K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 42/218 (19%)

Query: 345 VLGKGSYGTAYKA---------------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 389
           VLG G+YG  +                 VL+++T V   +  E    +R      +++  
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER------QVLEA 60

Query: 390 VGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG- 447
           V + P +V L  Y +  D KL L+ DY   G L T L+  R         E+ V++ +  
Sbjct: 61  VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-----ESEVRVYIAE 113

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---- 503
               + H+H +G     + +IK  N+L++ +    ++DFGL+    +     R+      
Sbjct: 114 IVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGT 169

Query: 504 --YRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAP 537
             Y APEVI      H    D +S GVL  E+LTG +P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 42/226 (18%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-DFEQQMEIVGRVG----------QHP 394
           +G+G+YG  Y+A   ++T+       E+V  K+   + + + +              +HP
Sbjct: 15  IGEGTYGIVYRA--RDTTS------GEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 395 NVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARG 451
           N+V L+     K  D   LV +Y     L++LL        TP   E++VK ++L   RG
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEY-CEQDLASLLDNMP----TPFS-ESQVKCLMLQLLRG 120

Query: 452 VAHIHSMGGPKFT-HGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGY 504
           + ++H      F  H ++K SN+L+     GC  I+DFGL     +PA P      +  Y
Sbjct: 121 LQYLHE----NFIIHRDLKVSNLLLTDK--GCLKIADFGLARTYGLPAKPMTPKVVTLWY 174

Query: 505 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           RAPE++     ++   D+++ G +L E+L  K  L   +  + +DL
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 19/166 (11%)

Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           V ++  HPN+VP RA + + +E  +V  + A GS   L+  +   G + L       IL 
Sbjct: 52  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQ 108

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTP-------LMNVP 495
           G  + + +IH MG   + H ++KAS++LI+ D    L G  S+  +         + + P
Sbjct: 109 GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 496 ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
               +   + +PEV++   + +  KSD+YS G+   E+  G  P +
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 55/206 (26%), Positives = 105/206 (50%), Gaps = 25/206 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 403
           LG G++G  YKA  +E+  +   ++ E    +   D+  ++EI+     HP +V L   +
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAF 78

Query: 404 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGP 461
           Y   +  ++ ++   G++ + +L  +RG        E +++++       + ++HSM   
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVICRQMLEALQYLHSM--- 129

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 514
           K  H ++KA NVL+  D D  ++DFG++   NV     R +      + APEV+  ET K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 515 ---HSHKSDVYSFGVLLLEMLTGKAP 537
              + +K+D++S G+ L+EM   + P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 9e-11
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTV----VVKRLKEVVVGKRDFEQQME-IVGRVGQHPNVV 397
           +VLG G++GT YK + + E  TV     +K L E    K + E   E ++     HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 455
            L     S   +L V      G L   +H ++     +  L+W  ++      A+G+ ++
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 509
                 +  H ++ A NVL+       I+DFGL  L+        + G + P      E 
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 544
           I  RK +H+SDV+S+GV + E++T G  P    PTR+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 341 ASAEVLGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPN 395
            S + +G G+YG+   A+ + +   V +K+L    +  +  KR + +++ ++  + QH N
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHM-QHEN 75

Query: 396 VVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 453
           V+ L   + S        D Y     + T L    G    PL  E +V+ L+     G+ 
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLS-EDKVQYLVYQMLCGLK 131

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP-SRSAGYRAPEVIET 512
           +IHS G     H ++K  N+ +N+D +  I DFGL    +   T    +  YRAPEVI  
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILN 188

Query: 513 RKHSHKS-DVYSFGVLLLEMLTGK 535
             H +++ D++S G ++ EMLTGK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 41/222 (18%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 397
           +G+G++G  ++A        E  T V VK LKE      + DF+++  ++     HPN+V
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIV 71

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----------------GAGRTPLDWET 440
            L           L+++Y A G L+  L                     G    PL    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----- 495
           ++ I    A G+A++      KF H ++   N L+ +++   I+DFGL+  +        
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 496 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
               A P R   +  PE I   +++ +SDV+++GV+L E+ +
Sbjct: 189 SENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 345 VLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVP 398
           +LGKG +G+  +A L+        V VK LK  +    D E+ +     + +  HPNV+ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 399 LRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTAR 450
           L         K      +++  +   G L T L  +R  G  P  L  +T V+ ++  A 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP--- 507
           G+ ++ S     F H ++ A N ++N+++  C++DFGL+  +       +    + P   
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 508 ---EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
              E +    ++  SDV++FGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-------QQMEIVGRVGQHPNV 396
           E +G+G+YG  YKA   +  T  +  LK+  + + D E       +++ ++  + +   +
Sbjct: 7   EKIGEGTYGKVYKA--RDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSESIYI 63

Query: 397 VPLRAYYYSKDEK-----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           V L    + +++       LV++Y  S  L   +  N      PL  +T    +    +G
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGYRA 506
           VAH H  G     H ++K  N+L+++      I+D GL    ++P         +  YRA
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 507 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           PEV + +  +S   D++S G +  EM   K PL
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 345 VLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVV 397
           VLG G++GT YK +           V +K L+E    K + E   +  ++  VG  P V 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVC 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHI 455
            L     +   +L V      G L   +  N+     +  L+W  ++      A+G++++
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EV 509
             +   +  H ++ A NVL+       I+DFGL  L+++  T   + G + P      E 
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 544
           I  R+ +H+SDV+S+GV + E++T G  P    P R+
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 41/213 (19%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKE----VVVGKRDFE-----QQMEIVGRVGQH 393
             +G G+YG    A   ++   V +K+L       +  KR +      + M        H
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DH 73

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTA 449
            NV+ L   + +    L   + F    L T L G   N       L  +  ++ L+    
Sbjct: 74  ENVIGLLDVF-TPASSL---EDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQIL 128

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS G     H ++K SN+ +N+D +  I DFGL    +   T     G      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRW 180

Query: 504 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           YRAPE++    H +++ D++S G ++ E+LTGK
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 41/239 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTT-VVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVV 397
           E LG GS+G    A  + +     +K LK+  + K   +Q   +           HP +V
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIV 81

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHI 455
            +   +  ++    + ++   G L T L   R AGR P D       +++L       ++
Sbjct: 82  NMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA----FEYL 134

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-------ATPSRSAGYRAPE 508
           HS       + ++K  N+L++      ++DFG      VP        TP     Y APE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFTLCGTPE----YLAPE 185

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL--QSPTR------DDMVDLPRWVQSVVRE 559
           VI+++ H    D ++ GVLL E + G  P    +P R         +  P W     R+
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244

Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 57/231 (24%), Positives = 105/231 (45%), Gaps = 18/231 (7%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVPLR 400
           +G+G YG  + A  +++  +V +KR+K+ ++ K +       + +I+    +   +V L 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKL- 66

Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            Y +  DE L L  +Y   G   TLL+ N G      +   R  +       V  +H +G
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLS---EDHARFYMAEMFE-AVDALHELG 121

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
              + H ++K  N LI+      ++DFGL   ++    +   S  Y APEV+  + +   
Sbjct: 122 ---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDD-MVDLPRWVQSVVREEWTAEVFDV 568
            D +S G +L E L G  P    T ++   +L  W +++ R  +    F++
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 45/287 (15%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+         E  T V VK + E    +   +F  +  ++     H +VV
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
            APE ++    +  SD++SFGV+L E+ +            + + P   Q +  E+    
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS------------LAEQP--YQGLSNEQVLKF 233

Query: 565 VFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 5e-10
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)

Query: 347 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--------EI-VGRVGQHPNVV 397
           G+G+YG  YKA  +         +K+    K D EQ          EI + R  +H NVV
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF---KGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 398 PLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
            L   +    +K   L++DY A   L  ++  +R A R  +       +L     GV ++
Sbjct: 66  SLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSAG-------Y 504
           HS       H ++K +N+L+  +        I D GL  L N P  P            Y
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 505 RAPEVIETRKHSHKS-DVYSFGVLLLEMLT 533
           RAPE++   +H  K+ D+++ G +  E+LT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRA 401
           LG G++G  YKA      T +    K + +       DF  +++I+    +HPN+V L  
Sbjct: 13  LGDGAFGKVYKAQ--HKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYE 69

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            Y+ +++  ++ ++   G+L +++          L       +       +  +HS    
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIML----ELERGLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK 514
           K  H ++KA N+L+  D D  ++DFG++   N      R        + APEV+  ET K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 515 ---HSHKSDVYSFGVLLLEMLTGKAPLQ--SPTR 543
              + +K+D++S G+ L+E+   + P    +P R
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 35/211 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 395
           E +G+G+YG  YKA  + +  VV   LK++   + D E +        EI + +   HPN
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVA--LKKI---RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVK-ILLGTARGVA 453
           +V L    +++++  LV+++     L   +  +  +G   PL     +K  L    +G+A
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQGLA 114

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRA 506
             HS    +  H ++K  N+LIN +    ++DFGL     VP    R+         YRA
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRA 168

Query: 507 PEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           PE+ +  + +S   D++S G +  EM+T +A
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 6e-10
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 54/221 (24%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--------QQM--EIV--GRVGQH 393
           LGKG+YG  +KA+         +R KEVV  K+ F+        Q+   EI+    +G H
Sbjct: 15  LGKGAYGIVWKAI--------DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66

Query: 394 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 450
           PN+V L     ++++K   LV++Y     + T LH    A    +  +   + I+    +
Sbjct: 67  PNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRAN---ILEDVHKRYIMYQLLK 118

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL----TPLMNVPATP----- 498
            + +IHS       H ++K SN+L+N D   C   ++DFGL    + L   P  P     
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 499 --SRSAGYRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 536
             +R   YRAPE+ + + +++   D++S G +L EML GK 
Sbjct: 173 VATR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 35/211 (16%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYY 403
           LG G++G  YKA  +E+  +   ++ +    +   D+  +++I+     HPN+V L   +
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAF 71

Query: 404 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSMGGP 461
           Y ++   ++ ++ A G++ + +L   R     PL  E +++++   T   + ++H     
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELER-----PLT-EPQIRVVCKQTLEALNYLHE---N 122

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------APEVI- 510
           K  H ++KA N+L   D D  ++DFG      V A  +R+   R          APEV+ 
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG------VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176

Query: 511 -ET---RKHSHKSDVYSFGVLLLEMLTGKAP 537
            ET   R + +K+DV+S G+ L+EM   + P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 345 VLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVVP 398
           +LG G +G   +  L+        V +  L+     K  R F  +   +G+   H N+V 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVR 70

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L       +  ++V +Y ++G+L + L  + G     L     + +L G A G+ ++  M
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM 126

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 513
           G   + H  + A  VL+N DL   IS F         A  +  +G     + APE I+  
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 514 KHSHKSDVYSFGVLLLEMLT-GKAP 537
             S  SDV+SFG+++ E+++ G+ P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 61/285 (21%), Positives = 120/285 (42%), Gaps = 43/285 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GK---------RDFEQQMEIVGR 389
           E LG G++G  YK V +++    +  LKE+ V     GK          D   ++ I+  
Sbjct: 6   EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD---WETRVKILL 446
             +HPN+V     +   D   +V D      L    +  +   +   +   W   V+++L
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
                + ++H     +  H ++  +N+++ +D    I+DFGL       +  +   G   
Sbjct: 125 A----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
           Y  PE+++   +  K+DV++FG +L +M T + P  S    +M+ L   +   V E    
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS---TNMLSLATKIVEAVYEPLPE 235

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
            ++  E +        ++       +C+    + RP++ +V  MI
Sbjct: 236 GMYS-EDVTD------VIT------SCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 44/280 (15%)

Query: 346 LGKGSYGTAYKAVL-------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 396
           LG G++G  Y+               V VK L++      K++F ++  ++     HPN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTARGVAH 454
           V L       + + ++ +    G L + L   R     P  L  +  + I L  A+G  +
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLT-PLMNVPATPSRSAG----- 503
           +  M    F H ++ A N L+++          I DFGL   +           G     
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
           + APE +   K + +SDV+SFGVL+ E+LT G+ P   P  ++  ++ + V +  R    
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQ-EVLQHVTAGGR---- 231

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 602
                  L + +N  +++ Q++     C A+ P  RP  D
Sbjct: 232 -------LQKPENCPDKIYQLMTN---CWAQDPSERPTFD 261

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 37/227 (16%)

Query: 333 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTT---VVVKRL----KEVVVGKRDFEQQME 385
           FD+    +   E +G G+YG    A+  ++ +   V +K++        + KR      E
Sbjct: 1   FDVGSRYKPI-ENIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLR---E 54

Query: 386 I-VGRVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
           + + R  +H N++ +R              +V D   S  L  ++H ++     PL  E 
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ-----PLTEEH 108

Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPS 499
               L    RG+ +IHS       H ++K SN+L+N+D +  I DFG+   L + P    
Sbjct: 109 IRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 500 R-------SAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL 538
                   +  YRAPE++ +  +++   D++S G +  EML G+  L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 20/203 (9%)

Query: 345 VLGKGSYG-----TAYKAVLEEST-TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNV 396
            LG G++G     TAY     ++   V VK LK       +     +++I+  +G H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L          L++ +Y   G L   L   R    + L  E  +      A+G+A + 
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-----VPATPSRSAGYRAPEVI 510
           S       H ++ A NVL+       I DFGL   +MN     V         + APE I
Sbjct: 159 S---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT 533
               ++ +SDV+S+G+LL E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 52/224 (23%), Positives = 103/224 (45%), Gaps = 31/224 (13%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQ--HPNVV 397
           ++LG G +GT +K + + E  ++ +    + +    G++ F++  + +  +G   H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 455
            L         +L V      GSL   +  +R +   +  L+W  ++      A+G+ ++
Sbjct: 73  RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYRA 506
                    H N+ A N+L+  D    I+DFG+  L+         +   TP +   + A
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK---WMA 179

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
            E I   +++H+SDV+S+GV + EM++ G  P       ++ DL
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 19/215 (8%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           +VLGKGS+G    A L+ +  V  +K L K+V++   D +  M    I+    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L   + +KD    V +Y   G L   +  +R       D E R +         +  +H 
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFD-EPRSRFYAAEVTLALMFLHR 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 513
            G     + ++K  N+L++ +    ++DFG+    +    T +   G   Y APE+++  
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           ++    D ++ GVL+ EM+ G+ P ++   DD+ +
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPL 399
           +G G+ GT YK +   +  +    LK V+ G      +R   +++EI+ R   HPNVV  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYA--LK-VIYGNHEDTVRRQICREIEIL-RDVNHPNVVKC 137

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              +    E  ++ ++   GSL     G   A    L    R +IL     G+A++H   
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVAR-QIL----SGIAYLHRR- 187

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET--- 512
                H +IK SN+LIN   +  I+DFG++ ++     P  S+     Y +PE I T   
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245

Query: 513 --RKHSHKSDVYSFGVLLLEMLTGKAPL 538
                 +  D++S GV +LE   G+ P 
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 40/221 (18%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 363 TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----LVYD 414
             V+++  K+   G        E +++ + R+    N++ +  +     + L    L+ +
Sbjct: 44  KEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102

Query: 415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNV 473
           Y   G L  +L   +      L ++T++ + +   +G+ +++     P   + N+ + + 
Sbjct: 103 YCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSF 154

Query: 474 LINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVIET--RKHSHKSDVYSFGVLLLE 530
           L+ ++    I   GL  +++ P   + +   Y + +++     +++ K D+YS GV+L E
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214

Query: 531 MLTGKAPLQSPTRDDMVDL--------------PRWVQSVV 557
           + TGK P ++ T  ++ DL              P  ++ +V
Sbjct: 215 IFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255

Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 13/153 (8%)

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P +   ++ I     RG+ 
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISI--AVLRGLT 113

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEV 509
           ++      K  H ++K SN+L+N   +  + DFG++  L++  A     +RS  Y +PE 
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPER 169

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           ++   ++ +SD++S G+ L+EM  G+ P+  P 
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 46/201 (22%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRA 401
           V+G+G++G  +    +    +V+ +   V    +D     Q E  V ++  HPN++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63

Query: 402 YYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           YY +  +D+ L +V +Y   G+L+  +        + LD +T +   +     + H+H+ 
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT- 119

Query: 459 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
                 H ++K  N+L+++      I DFG++ +++  +      G   Y +PE+ E + 
Sbjct: 120 --KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177

Query: 515 HSHKSDVYSFGVLLLEMLTGK 535
           ++ KSD+++ G +L E+ + K
Sbjct: 178 YNQKSDIWALGCVLYELASLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 345 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 396
           VLGKGS+G   K +L E         +K LK +VV+   D E  M    ++   G+ P +
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
             L + + + D    V +Y   G L   +    G  + P       +I    A G+  +H
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEI----AIGLFFLH 118

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 512
           S G     + ++K  NV+++ +    I+DFG+          ++    +  Y APE+I  
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           + +    D ++FGVLL EML G+AP +    D++
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 25/215 (11%)

Query: 345 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM---EIVGRVGQHPNV 396
           VLGKGS+G   K +L E         +K LK +V++   D E  M    ++   G+ P +
Sbjct: 7   VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHI 455
             L + + + D    V +Y   G L  + H  + G  + P       +I    A G+  +
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEI----AIGLFFL 117

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE 511
           HS G     + ++K  NV+++ +    I+DFG+          +R    +  Y APE+I 
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
            + +    D ++FGVLL EML G+ P      D++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 73/291 (25%)

Query: 361 ESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
               V VK L+       + DF ++++I+ R+   PN+  L           ++ +Y  +
Sbjct: 45  APVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMEN 103

Query: 419 GSLSTLLH------GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN 472
           G L+  L                L + T + +    A G+ ++ S+    F H ++   N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160

Query: 473 VLINQDLDGCISDFGLTPLMNVPATPSRSAGY---------RAP--------EVIETRKH 515
            L+ ++    I+DFG+          SR+  Y         RAP        E +   K 
Sbjct: 161 CLVGKNYTIKIADFGM----------SRNL-YSSDYYRVQGRAPLPIRWMAWESVLLGKF 209

Query: 516 SHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 573
           + KSDV++FGV L E+LT   + P +  T   ++                          
Sbjct: 210 TTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI-------------------------- 243

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
           +N               + + P   P   ++  ++ E  + D E+RP+  E
Sbjct: 244 ENAGH--FFRDDGRQIYLPR-PPNCP--KDIYELMLECWRRDEEDRPTFRE 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 403
           +G G+YG  YKA    +  +   ++ ++  G  DF   QQ   + +  +H N+V     Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            S+++  +  +Y   GSL  + H        PL       +   T +G+A++HS G    
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGK--- 127

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 516
            H +IK +N+L+  + D  ++DFG+   +       +S      + APEV    K   ++
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
              D+++ G+  +E+    A LQ P  D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 63/245 (25%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVV--KRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVP 398
           V+G+G++G  +  V ++ T  V   K L++  + KR+       + +I+      P +V 
Sbjct: 8   VIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSPWIVK 65

Query: 399 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 453
           L  YY  +DE+ L  V +Y   G L  LL   R     P +   R    +++L     + 
Sbjct: 66  L--YYSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEET-ARFYIAELVLA----LD 115

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL------------------TPLMN 493
            +H +G   F H +IK  N+LI  D DG I  +DFGL                    L  
Sbjct: 116 SVHKLG---FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 494 VPATPSRSA---------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                 R                  Y APEV+    +  + D +S GV+L EML G  P 
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Query: 539 QSPTR 543
            S T 
Sbjct: 231 YSDTL 235

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 346 LGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPL 399
           LGKG +G    A   ++T      K+L +  + KR  EQ    + +I+ +V     +V L
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR---GVAH 454
              + +KD+  LV      G L   +   G  G        E R   +   A+   G+ H
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP------EARA--IFYAAQIICGLEH 110

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIE 511
           +H        + ++K  NVL++   +  ISD GL   +         AG   Y APEV++
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
              +    D ++ G  L EM+ G++P +
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFR 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQ--HPNVVPLR 400
            ++G+GSYG   K   +E+  +V +K+  E    K   +  M  +  + Q  H N+V L 
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +  K    LV+++     L  L     G     LD     K L    RG+   HS   
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH-- 119

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPE-VIE 511
               H +IK  N+L++Q     + DFG    +  P        AT      YRAPE ++ 
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVAT----RWYRAPELLVG 174

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             K+    D+++ G L+ EMLTG+ PL
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE-PL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 64/298 (21%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVV 397
             +G+G +G  Y+ V      E   V VK  K       +  F Q+  I+ R   HP++V
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM-RQFDHPHIV 70

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L     +++   +V +    G L + L  N+      LD  + +      +  +A++ S
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES 125

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 512
               +F H +I A NVL++      + DFGL+  +   +    S G     + APE I  
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 513 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV-------------DLPRWVQSVVR 558
           R+ +  SDV+ FGV + E+L  G  P Q    +D++             + P  + S++ 
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242

Query: 559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           + W  +                              P  RP   E+   + ++ Q + 
Sbjct: 243 KCWAYD------------------------------PSKRPRFTELKAQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 30/177 (16%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+A++HS     + H ++ A NVL++ D    I DFGL       A P     YR     
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVREDG 170

Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWVQSV 556
                  A E ++  K S+ SDV+SFGV L E+LT     QSP +  ++M+   +   +V
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV 230

Query: 557 VREEWTAEVFD--VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           VR     E+ +  + L   +N  +E+  +++    C       RP    ++ +++E+
Sbjct: 231 VR---LIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 37/257 (14%)

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTAR 450
           +HPN++     + +     ++  + A GS ++LL      G +    E  +  IL G  R
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS----EALIGNILFGALR 112

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-------------MNVPAT 497
           G+ ++H  G   + H NIKAS++LI+ D  G +S  GL+ L              + P  
Sbjct: 113 GLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167

Query: 498 PSRSAGYRAPEVIETRKHSH--KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 555
            +    + +PE++    + +  KSD+YS G+   E+ TG+ P Q   R  M  L + ++ 
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKG 225

Query: 556 VVREEWTAEVFDVELMRFQN--------IEEEMV--QMLQIGMACVAKVPDMRPNMDEVV 605
                     F  E  R +N        I E +V   M Q   +   + P  +       
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285

Query: 606 RMIEEVRQSDSENRPSS 622
            ++E   Q D E RPS+
Sbjct: 286 NLVELCLQQDPEKRPSA 302

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 398
           ++G+G +G   + V E++T  +  +K +K+ V+  ++    FE++ +I+      P +  
Sbjct: 8   LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQ 65

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L+  +  KD   LV +Y   G L +LL  NR       D E   +  L  A  V  IHS+
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYL--AELVLAIHSV 118

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPEVIETR 513
               + H +IK  NVLI++     ++DFG    +          P  +  Y APEV+ T 
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 514 KHSHKS------DVYSFGVLLLEMLTGKAPLQSPT 542
               K       D +S GV+  EM+ G++P    T
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNVVPLRAYY 403
           +G G+YG  YKA    +  +   ++ ++  G+ DF   QQ  I+ +  +H N+V     Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +D+  +  ++   GSL  + H        PL       +   T +G+ ++HS G    
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGK--- 127

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK---HS 516
            H +IK +N+L+  +    ++DFG++  +       +S      + APEV    +   ++
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
              D+++ G+  +E+    A LQ P  D
Sbjct: 188 QLCDIWAVGITAIEL----AELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G++G  +   L  ++T V VK  +E +    K  F Q+  I+ +   HPN+V L 
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 59

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                K    +V +    G   T L    G     L  +  ++++   A G+ ++ S   
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGMEYLES--- 112

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 513
               H ++ A N L+ +     ISDFG++         + + G +       APE +   
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 514 KHSHKSDVYSFGVLLLEMLT-GKAP 537
           ++S +SDV+SFG+LL E  + G  P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----FEQQMEI-VGRVGQHPNVVP 398
           E +G+G+YGT +KA   E+  +V   LK V +   D         EI + +  +H N+V 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVA--LKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L    +S  +  LV++Y     L        G     +D E     +    +G+A  HS 
Sbjct: 64  LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH 118

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETR 513
                 H ++K  N+LIN++ +  ++DFGL     +P     SA      YR P+V+   
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGA 174

Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPL 538
           K +S   D++S G +  E+     PL
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 346 LGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           LG G++G   K V +   +   V +K LK     K   ++ M     + Q  N   +R  
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 403 YYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-- 459
              + E L LV +  + G L+  L G +             +I +     + H  SMG  
Sbjct: 62  GVCEAEALMLVMEMASGGPLNKFLSGKKD------------EITVSNVVELMHQVSMGMK 109

Query: 460 ---GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YRAPEV 509
              G  F H ++ A NVL+       ISDFGL+  +    +   +RSAG     + APE 
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           I  RK S +SDV+S+G+ + E  + G+ P
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 346 LGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G+GS G    A  + S   V VK +      +R+      ++ R  QH NVV +   Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
             +E  ++ ++   G+L+ ++   R      L+ E    +     + + ++HS G     
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSR--SAGYRAPEVIETRKHSHKSD 520
           H +IK+ ++L+  D    +SDFG    +  +VP   S   +  + APEVI    +  + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 521 VYSFGVLLLEMLTGKAPLQSPT 542
           ++S G++++EM+ G+ P  S +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDS 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 18/191 (9%)

Query: 346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           L  GS G  + A    +   VV+K      +G++       ++ +   HP+V+ ++    
Sbjct: 74  LTPGSEGRVFVATKPGQPDPVVLK------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           S     +V  +++S  L T L         PL  +  + I      G+ ++H+    +  
Sbjct: 128 SGAITCMVLPHYSS-DLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQ---RII 179

Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY---RAPEVIETRKHSHKSDV 521
           H ++K  N+ IN     CI D G      V       AG     APEV+   K++ K+D+
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239

Query: 522 YSFGVLLLEML 532
           +S G++L EML
Sbjct: 240 WSAGIVLFEML 250

Length = 357

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 45/287 (15%)

Query: 346 LGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ +       E  T V +K + E    +   +F  +  ++     H +VV
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R        + P   +  +++    A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 187

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----------EQVLRFVMEG 237

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 238 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 21/231 (9%)

Query: 345 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 399
           VLGKG +G      V         K+L++  + KR  E     + +I+ +V     VV L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSL 65

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              Y +KD   LV      G L   ++    AG    +    V        G+  +H   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG---FEEGRAVFYAAEICCGLEDLHQ-- 120

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETRK 514
             +  + ++K  N+L++      ISD GL   ++VP   +      + GY APEV++  +
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNER 177

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAE 564
           ++   D ++ G LL EM+ G++P Q   +     ++ R V+  V+EE++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 76/311 (24%), Positives = 127/311 (40%), Gaps = 65/311 (20%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQ-----MEIVGRVGQHPNVV 397
           E LG+G+YG   K     + T++ VKR++  V      EQ+     ++I  R    P  V
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTV 63

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
                 + + +  +  +   + SL          G T +  +   KI +   + + ++HS
Sbjct: 64  TFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT-IPEDILGKIAVSIVKALEYLHS 121

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVI---- 510
                  H ++K SNVLIN++    + DFG++  +      +  AG   Y APE I    
Sbjct: 122 K--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW------VQSVVRE---EW 561
             + +  KSDV+S G+ ++E+ TG+ P  S           W      ++ VV E   + 
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQVVEEPSPQL 228

Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 621
            AE F  E   F N              C+ K    RPN  E+++             P 
Sbjct: 229 PAEKFSPEFQDFVN-------------KCLKKNYKERPNYPELLQH------------PF 263

Query: 622 SEENKSKDSNV 632
            E + SK+++V
Sbjct: 264 FELHLSKNTDV 274

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 51/203 (25%), Positives = 101/203 (49%), Gaps = 17/203 (8%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 402
           LG G+ G  +K   + S  ++ ++L  + +    +    ++++++      P +V     
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ ++      K
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLTYLREKH--K 124

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 518
             H ++K SN+L+N   +  + DFG++  L++  A     +RS  Y +PE ++   +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182

Query: 519 SDVYSFGVLLLEMLTGKAPLQSP 541
           SD++S G+ L+EM  G+ P+  P
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPP 205

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 58.3 bits (141), Expect = 1e-08
 Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 33/200 (16%)

Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDW 438
           F ++  +  R+  HPN+V L     +    L  V++Y    +L  +L     A    L  
Sbjct: 25  FRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-----AADGALPA 78

Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGC--ISDFGLTPLM--- 492
               +++L     +A  H+ G     H ++K  N++++Q  +     + DFG+  L+   
Sbjct: 79  GETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135

Query: 493 --NVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                AT +R      +  Y APE +     +  SD+Y++G++ LE LTG+  +Q  +  
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVA 195

Query: 545 DM---------VDLPRWVQS 555
           ++         V LP W+  
Sbjct: 196 EILYQQLSPVDVSLPPWIAG 215

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 17/208 (8%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAY 402
           LG G+ G   K   + S  ++ ++L  + +    +    ++++++      P +V     
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           +YS  E  +  ++   GSL  +L   + A R P   E   K+ +   RG+A++      +
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLAYLREKH--Q 124

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEVIETRKHSHK 518
             H ++K SN+L+N   +  + DFG++  L++  A     +RS  Y +PE ++   +S +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           SD++S G+ L+E+  G+ P+  P   ++
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E+LG G+ GT YKA    +  ++   V  L   V  ++    ++EI+ +    P ++   
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFY 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             ++ ++   +  ++   GSL           + P     R  I +   +G+ ++ S+  
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSL-- 114

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGL-TPLMN-VPATPSRSAGYRAPEVIETRKHSHK 518
            K  H ++K SN+L+N      + DFG+ T L+N +  T   +  Y APE I   ++   
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 519 SDVYSFGVLLLEMLTGKAP 537
           SDV+S G+  +E+  G+ P
Sbjct: 174 SDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 10/109 (9%)

Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176

Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
            M  P   +R   YRAPEVI    +    D++S G ++ E++ G    Q
Sbjct: 177 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------Q 392
           E +G+G+YG  YKA        V +K+++         E + E V               
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPN+V L    +S+++  LV+++        L      +  T LD       L    +G+
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YR 505
           A+ HS    +  H ++K  N+LI+++    ++DFGL     VP    R+         YR
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTLWYR 166

Query: 506 APEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           APE+ + +R++S   D++S G +  EM+  + PL
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 342 SAEVLGKGSYGTAYKAVLEESTT-----VVVKRLK----EVVVGKRDFEQQMEIVGRVGQ 392
            +++L +G++G  +  +L +        V VK +K    E+ V     ++   + G    
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-TLLLQESCLLYGL--S 66

Query: 393 HPNVVP-LRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGT-- 448
           H N++P L       +   ++Y Y   G+L   L   R G    P    T+  + +    
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-------TPSRS 501
           A G++++H  G     H +I A N +I+++L   I+D  L+  +  P          +R 
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNENRP 182

Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
             + A E +  +++S  SDV+SFGVLL E++T G+ P
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 46/200 (23%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 346 LGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLR 400
           +G G++G  +     + E    + V  + EV+  K++     +  ++  V  HP ++  R
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFII--R 65

Query: 401 AYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
            ++   D++ L  + +Y   G L + L   R +GR      +    L   +  V  +  +
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRF-----SNSTGLFYASEIVCALEYL 117

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGYRAPEVIETRKHSH 517
              +  + ++K  N+L++++    ++DFG    L +   T   +  Y APEVI+++ H+ 
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNK 177

Query: 518 KSDVYSFGVLLLEMLTGKAP 537
             D ++ G+L+ EML G  P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 37/209 (17%)

Query: 346 LGKGSYGTAYKAVLEES-TTVVVKRL----KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           +G G+YGT   A+   +   V +K+L    +  +  KR + +++ ++  + +H NV+ L 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHM-KHENVIGLL 80

Query: 401 AYYYSKDEKLLVY-DY-----FASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVA 453
             + + D  L  + D+     F    L  L+   + +       E R++ L+    +G+ 
Sbjct: 81  DVF-TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-------EDRIQFLVYQMLKGLK 132

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAP 507
           +IH+ G     H ++K  N+ +N+D +  I DFGL        T S   G      YRAP
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA-----RQTDSEMTGYVVTRWYRAP 184

Query: 508 EVIETRKH-SHKSDVYSFGVLLLEMLTGK 535
           EVI    H +   D++S G ++ EMLTGK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 58/223 (26%)

Query: 411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVAHIHSMGGPKFTHGN 467
           LV DY  +G L   +       RT  + E     +++LL     V H+HS       H +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA----VHHVHSK---HMIHRD 168

Query: 468 IKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------YRAPEVIETRKHSHKS 519
           IK++N+L+  +    + DFG + +    AT S   G        Y APE+   + +S K+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA 226

Query: 520 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           D++S GVLL E+LT K P                            FD E     N+EE 
Sbjct: 227 DMFSLGVLLYELLTLKRP----------------------------FDGE-----NMEEV 253

Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
           M + L      +   P + P M E+V  +     SD + RPSS
Sbjct: 254 MHKTLAGRYDPLP--PSISPEMQEIVTAL---LSSDPKRRPSS 291

Length = 496

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 24/218 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM--EIVGRVGQHPNVVPL 399
           ++LGKG++G       + S      ++  KEV++ K +    +    V +  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
           +  + +KD    V +Y   G L    H      R  +  E R +     A  V+ +  + 
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFY--GAEIVSALDYLH 112

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEVIE 511
             K  + ++K  N+++++D    I+DFGL          +     TP     Y APEV+E
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE----YLAPEVLE 168

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
              +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 399
           VLGKG +G      +  +  +   K+L++  + KR  E     + +I+ +V     VV L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 65

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV-----KILLGTARGVAH 454
              Y +KD   LV      G L   ++ N G        E R      +I  G    +  
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFD---EERAVFYAAEITCG----LED 117

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSR----SAGYRAPEV 509
           +H     +  + ++K  N+L++      ISD GL   + +P     R    + GY APEV
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEV 172

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           ++  +++   D +  G L+ EM+ GK+P +
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGKRDFE--QQMEIVGRVGQHPNV 396
           +VLG G++GT YK +           V +K L+E    K + E   +  ++  V  +P+V
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 71

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAH 454
             L     +   +L +      G L   +  H +    +  L+W  ++      A+G+ +
Sbjct: 72  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 124

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------E 508
           +      +  H ++ A NVL+       I+DFGL  L+        + G + P      E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
            I  R ++H+SDV+S+GV + E++T G  P
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 344 EVLGKGSYGTAY---------------KAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG 388
           +VLG G+YG  +                 VL+++T V   +  E    +R      +++ 
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 59

Query: 389 RVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
            + Q P +V L  Y +  D KL L+ DY   G L T L     + R     E  V+I  G
Sbjct: 60  HIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSG 112

Query: 448 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----S 501
                + H+H +G     + +IK  N+L++ +    ++DFGL+   +            +
Sbjct: 113 EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 502 AGYRAPEVIETRKHSHKS--DVYSFGVLLLEMLTGKAPL 538
             Y AP+++      H    D +S GVL+ E+LTG +P 
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFE----QQMEIVGRVGQHPNVVPL 399
           VLGKG +G      +  +  +   KRL++  + KR  E     + +I+ +V     VV L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNL 65

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
              Y +KD   LV      G L   ++  GN G      + E  +        G+  +H 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHR 120

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIET 512
                  + ++K  N+L++      ISD GL   + +P   S      + GY APEV+  
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           ++++   D +  G L+ EM+ G++P + 
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDF-----EQQMEIVGRVGQHPNVVP 398
           +GKG++G  Y+   +++  +  +K L K+ +V K++      E+ + +   + + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 457
           L+  + +  +  LV DY + G L   L      GR     E R K  +      + H+H 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFS---EDRAKFYIAELVLALEHLHK 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVI-ET 512
                  + ++K  N+L++      + DFGL+   +    T +   G   Y APEV+ + 
Sbjct: 115 Y---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           + ++   D +S GVL+ EM  G +P  +     M
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRDFEQ----QMEIVGRVGQHPNVVPLR 400
           LGKG +G      ++ +  +   K+L +  + K+  E+    + EI+ +V   P +V L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
             + SK    LV      G L   ++  G RG     L+ E  +        G+ H+HSM
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLHSM 114

Query: 459 GGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
                 + ++K  NVL++ D   C +SD GL   +    T ++ AG   Y APE+++   
Sbjct: 115 D---IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQ 539
           +S+  D ++ G  + EM+ G+ P +
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 19/212 (8%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           VLGKGS+G    A  + +  +   ++  K+VV+   D E  M    ++    + P +  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSM 458
            + + + D    V +Y   G L  + H  + G  + P       +I    + G+  +H  
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEI----SVGLFFLHRR 120

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRK 514
           G     + ++K  NV+++ +    I+DFG+     V    +R+      Y APE+I  + 
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           +    D +++GVLL EML G+ P      D++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 38/214 (17%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD--FEQ---QMEIVGRVGQHPNVVPLR 400
           LGKG+YG+ YK +     T V   +KE+ +   +  F Q   +++I+ +    P +V   
Sbjct: 9   LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFY 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             ++ +    +  +Y  +GSL  L  G       P D      +L      V       G
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED------VLRRITYAVVK-----G 114

Query: 461 PKF-------THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEV 509
            KF        H ++K +NVL+N +    + DFG++   N+ A+ +++      Y APE 
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPER 172

Query: 510 IETR------KHSHKSDVYSFGVLLLEMLTGKAP 537
           I++        ++ +SDV+S G+ +LEM  G+ P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 346 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 394
           +G G+ G    AY A+LE +  V +K+L       R F+ Q          ++ +   H 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 453
           N++ L   +  +       D +    +  L+  N     +  LD E    +L     G+ 
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYI---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 508
           H+HS G     H ++K SN+++  D    I DFGL     T  M  P   +R   YRAPE
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 195

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
           VI    +    D++S G ++ EM+ G      P  D
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLF--PGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 19/215 (8%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           +V+GKGS+G    A  + +     VK L K++V+ +++ +  M    ++ +  +HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L   + + ++   V D+   G L   L   R         E R +      A  + ++HS
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP------EPRARFYAAEIASALGYLHS 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSAGYRAPEVIETR 513
           +      + ++K  N+L++      ++DFGL        +   T   +  Y APEVI  +
Sbjct: 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
            + +  D +  G +L EML G  P       +M D
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 20/101 (19%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+L+N + D  I DFGL  +    A P           
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI----ADPEHDHTGFLTEY 169

Query: 504 -----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
                YRAPE++   K   K+ D++S G +L EML+ + PL
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 29/213 (13%)

Query: 344 EVLGKGSYGTAY---KAVLEESTTV-VVKRLKEVVVGKRDFEQQ-----MEIVGRVGQHP 394
           +VLG G+YG  +   K    ++  +  +K L++  + ++    +       ++  V Q P
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 395 NVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 452
            +V L  Y +  + KL L+ DY + G + T L+            E  V+   G     +
Sbjct: 66  FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILAL 118

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRA 506
            H+H +G     + +IK  N+L++ +    ++DFGL+    +     R+        Y A
Sbjct: 119 EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMA 174

Query: 507 PEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 538
           PE+I  +  H    D +S G+L+ E+LTG +P 
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 402 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
           +Y  +DE    LV DY+  G L TLL  ++   R P   E   +  +     V  IHS+ 
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYIAEM--VLAIHSIH 119

Query: 460 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIET 512
              + H +IK  NVL+  D++G I  +DFG    MN   T   S       Y +PE+++ 
Sbjct: 120 QLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 513 R-----KHSHKSDVYSFGVLLLEMLTGKAPL 538
                 K+  + D +S GV + EML G+ P 
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 60/244 (24%)

Query: 345 VLGKGSYGTAYKAVLEESTTV----VVKRLK-EVVVGKRDFEQQM------EIVGRVGQH 393
           VLG+G +G   K +L E         +K LK   ++ + + E  M      E      +H
Sbjct: 6   VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RH 61

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGT 448
           P +V L A + ++D    V +Y A G L   +H +  +       E R       ++LG 
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFYAACVVLGL 114

Query: 449 ARGVAHIHSMGGPKFTHGN------IKASNVLINQDLDGC--ISDFGLTPL-MNVPATPS 499
                        ++ H N      +K  N+L+  D +G   I+DFGL    M      S
Sbjct: 115 -------------QYLHENKIVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFGDRTS 159

Query: 500 RSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
              G   + APEV+    ++   D +  GVL+ EML G++P      +++ D      S+
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SI 213

Query: 557 VREE 560
           V +E
Sbjct: 214 VNDE 217

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 10/90 (11%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYR 505
           G+ H+HS G     H ++K SN+++  D    I DFGL     T  M  P   +R   YR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 184

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           APEVI    +    D++S G ++ EM+ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           V+GKGS+G    A  +       VK L K+ ++ K++ +  M    ++ +  +HP +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHSM 458
              + + D+   V DY   G L   L   R     P   E R +      A  + ++HS+
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLHSL 115

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 514
                 + ++K  N+L++      ++DFGL    +    T S   G   Y APEV+  + 
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           +    D +  G +L EML G  P  S    +M D
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 8/110 (7%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 508
           RG+ +IHS G     H ++K SNV +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185

Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 557
           ++    H +++ D++S G ++ E+L GKA       +D +D  + +  VV
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG---NDYIDQLKRIMEVV 232

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)

Query: 346 LGKGSYG---TAYKAVLEESTTVVVKRLKEVVVGKRDFEQQME--------IVGRVGQHP 394
           +G G+ G    AY AVL+ +  V +K+L       R F+ Q          ++ +   H 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLS------RPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVA 453
           N++ L   +  +       D +    +  L+  N     +  LD E    +L     G+ 
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYL---VMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPE 508
           H+HS G     H ++K SN+++  D    I DFGL     T  M  P   +R   YRAPE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 188

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
           VI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 47/214 (21%)

Query: 349 GSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVG---------------Q 392
           G+YG  Y+A  +++  +V +K+LK         E++ E     G               Q
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLK--------MEKEKE-----GFPITSLREINILLKLQ 62

Query: 393 HPNVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTA 449
           HPN+V ++        D+  +V +Y     L +L+   +            VK ++L   
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-----EVKCLMLQLL 116

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYR 505
            GVAH+H        H ++K SN+L+N      I DFGL      P  P         YR
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 506 APEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           APE++   +++S   D++S G +  E+LT K PL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK-PL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVP 398
           +V+GKGS+G    A  + E     VK L++  + K+  E+ +     ++ +  +HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L   + + D+   V DY   G L   L   R         E R +      A  + ++HS
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCF------LEPRARFYAAEIASALGYLHS 114

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-ATPSRSAG---YRAPEVIETR 513
           +      + ++K  N+L++      ++DFGL         T S   G   Y APEV+  +
Sbjct: 115 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
            +    D +  G +L EML G  P  S    +M D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 51/227 (22%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPNV 396
            +G+G+YG  YKA  +++  +V   LK+V   + D E++        EI + R   H N+
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVA--LKKV---RLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 397 VPLRAYYYSKDEKL----------LVYDYFAS---GSL-STLLHGNRGAGRTPLDWETRV 442
           V L+     K + L          LV++Y      G L S L+H +    ++ +      
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM------ 122

Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
           K LL    G+ + H      F H +IK SN+L+N      ++DFGL  L N  +  SR  
Sbjct: 123 KQLL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174

Query: 501 -----SAGYRAPEVI--ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
                +  YR PE++  E R +    DV+S G +L E+ T K   Q+
Sbjct: 175 TNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVV 397
           +V+G+G++G   + V  +S+  V  +K L +  + KR     F ++ +I+        +V
Sbjct: 49  KVIGRGAFG-EVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIV 106

Query: 398 PLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVA 453
            L  +Y  +D+K L  V +Y   G L  L+         P  W      +++L     + 
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLA----LD 156

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPE 508
            IHSMG   F H ++K  N+L+++     ++DFG    M+        T   +  Y +PE
Sbjct: 157 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 509 VIETRKHS----HKSDVYSFGVLLLEMLTGKAP 537
           V++++        + D +S GV L EML G  P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 339 LRASAE------VLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRD----FEQQMEI 386
           LR  AE      V+G+G++G   + V  +ST  V  +K L +  + KR     F ++ +I
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           +      P VV L  +Y  +D++ L  V +Y   G L  L+       +    +   V +
Sbjct: 97  MA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPS 499
            L        IHSMG   F H ++K  N+L+++     ++DFG    MN        T  
Sbjct: 154 ALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 500 RSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPL 538
            +  Y +PEV++++     +  + D +S GV L EML G  P 
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 49/219 (22%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRL----------KEVVVGKRDFEQQMEIVGRVGQHP 394
           LG+G++G  Y    ++    + VK++          KEV       E +++++  + QH 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV----NALECEIQLLKNL-QHE 64

Query: 395 NVVPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            +V    YY     DE L ++ +Y   GS+   L        T     TR +IL     G
Sbjct: 65  RIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QIL----EG 116

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG-----------LTPLMNVPATP 498
           V ++HS       H +IK +N+L  +D  G   + DFG            T + +V  TP
Sbjct: 117 VEYLHS---NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                + +PEVI    +  K+DV+S G  ++EMLT K P
Sbjct: 172 Y----WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 21/216 (9%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVP 398
           +V+GKGS+G    A  + + +   VK L K+ ++ K++    M    ++ +  +HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 399 LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIH 456
           L  Y +   EKL  V DY   G L    H  R   R  L  E R +      A  + ++H
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE--RCFL--EPRARFYAAEVASAIGYLH 113

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIET 512
           S+      + ++K  N+L++      ++DFGL    +    T S   G   Y APEV+  
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
             +    D +  G +L EML G  P  S     M D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 39/215 (18%)

Query: 344 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------- 391
           E +G+G+YG  YKA   V  E  T+ +K+++         EQ+ E V             
Sbjct: 8   EKIGEGTYGVVYKARDRVTNE--TIALKKIR--------LEQEDEGVPSTAIREISLLKE 57

Query: 392 -QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTA 449
            QH N+V L+   +S+    LV++Y     L   +  +    + P      +K  L    
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP----RLIKTYLYQIL 112

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR----SAGY 504
           RG+A+ HS    +  H ++K  N+LI++  +   ++DFGL     +P         +  Y
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169

Query: 505 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
           RAPE++   +H S   D++S G +  EM+  K PL
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL 203

Length = 294

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 11/82 (13%)

Query: 465 HGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATPSRSAG---YRAPEVIE----TRKH 515
           H ++K SN+L+  D  G +   DFG++  +      +RSAG   Y APE I+      K+
Sbjct: 138 HRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195

Query: 516 SHKSDVYSFGVLLLEMLTGKAP 537
             ++DV+S G+ L+E+ TG+ P
Sbjct: 196 DIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 26/219 (11%)

Query: 345 VLGKGSYGTAYKAVLEEST----TVVVKRLKE--VVVGKRDF---EQQMEIVGRVGQHPN 395
           VLGKG YG  ++              +K LK+  +V  ++D    + +  I+  V +HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPF 61

Query: 396 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVA 453
           +V L  Y +    KL L+ +Y + G L   L       R  +  E      L   +  + 
Sbjct: 62  IVDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEISLALE 114

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP----LMNVPATPSRSAGYRAPEV 509
           H+H  G     + ++K  N+L++      ++DFGL         V  T   +  Y APE+
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           +    H    D +S G L+ +MLTG  P  +  R   +D
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 17/135 (12%)

Query: 85  IPNNTLGKLDALEVLSLR--------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 136
           +  + +  LD  E L           +        SE+  L +L  L L +NN +  IP 
Sbjct: 75  LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPP 133

Query: 137 S---FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHL 191
                   L  LDLS N    ++P  ++NL  L  L L  N+LS  +P    ++  L +L
Sbjct: 134 LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191

Query: 192 NLSYNGLKGSIPSSL 206
           +LS N +   +P  +
Sbjct: 192 DLSGNKIS-DLPPEI 205

Length = 394

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 404
           +G+G+YG  YKA  ++        LK++           EI + R  +HPNV+ L+  + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 405 SKDEK--LLVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 459
           S  ++   L++DY A   L  ++  +R   A + P+    + VK LL   + +  IH + 
Sbjct: 69  SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL--YQILDGIHYLH 125

Query: 460 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 508
                H ++K +N+L+  +        I+D G   L N P  P            YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++   +H  K+ D+++ G +  E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-----VGRVGQHPNVVPLR 400
           LG+G+ G+  K  L+ +  +   +    +    + + Q +I     + +  + P +V   
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 401 AYYYSKDEKLL--VYDYFASGSLSTLL-----HGNRGAGRTPLDWETRVKILLGTARGVA 453
             +  +    +    +Y   GSL ++       G R  G   L      KI     +G++
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLG-----KIAESVLKGLS 119

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-VPATPSRSAGYRAPEVIE 511
           ++HS    K  H +IK SN+L+ +     + DFG++  L+N +  T + ++ Y APE I+
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAP 537
            + +S  SDV+S G+ LLE+   + P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 32/211 (15%)

Query: 346 LGKGSYGT---AYKAVLEESTTVVVKRLKEV----VVGKRDFEQQMEIVGRVGQHPNVVP 398
           LG+G+YG    A  A   E  TV +K++  V    ++ KR   ++++++     H N+  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNITC 66

Query: 399 L---RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           L      +     +L +Y+      L  ++   +     PL        +     G+ +I
Sbjct: 67  LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYI 121

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----------YR 505
           HS       H ++K  N+L+N D +  I DFGL    +    P  +AG          YR
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYR 176

Query: 506 APEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           APE++ + +   K+ DV+S G +L E+L  K
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 38/237 (16%)

Query: 338 LLRASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVGKR--DFEQQMEIVGR 389
           LLRA    LG G++G  Y+ +            V VK L E    +   DF  +  I+ +
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
              H N+V L    + +  + ++ +  A G L + L  NR     P      +K LL  A
Sbjct: 66  F-NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS--SLTMKDLLFCA 122

Query: 450 RGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSRSAGYR 505
           R VA     +    F H +I A N L+     G    I+DFG+   +       R++ YR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------YRASYYR 176

Query: 506 ------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
                        PE       + K+DV+SFGVLL E+ + G  P    T  ++++ 
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV--VVKRL-KEVVVGKRDFEQQMEIVGRVGQ---HPNVV 397
           ++LGKG++G     V E++T     +K L KEV++ K +    +    RV Q   HP + 
Sbjct: 1   KLLGKGTFGKVI-LVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFLT 58

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L+  + + D    V +Y   G L    H +R    T    E R +     A  V+ +  
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEIVSALEY 110

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 509
           +      + +IK  N+++++D    I+DFGL          +     TP     Y APEV
Sbjct: 111 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----YLAPEV 166

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           +E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKR--------------LKEVVVGKRDFEQQMEIVGRV 390
           +G+G+YGT YKA  L     V +K+              L+E+ + K+  E         
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-LESF------- 58

Query: 391 GQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVK 443
            +HPN+V L          ++ KL LV+++     L+T L      G     +    R +
Sbjct: 59  -EHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMR-Q 115

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-------PLMNVPA 496
           +L    RGV  +HS    +  H ++K  N+L+  D    I+DFGL         L +V  
Sbjct: 116 LL----RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           T      YRAPEV+    ++   D++S G +  E+   +   +  +  D +D
Sbjct: 169 T----LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEV----VVGKRDF-EQQMEIVGRVGQHPNVVPL 399
           +G+GSYG  +K    E+  +V +K+  E     V+ K    E +M    +  +HPN+V L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML---KQLKHPNLVNL 65

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              +  K +  LV++Y     L+ L    RG     +      KI+  T + V   H   
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH- 119

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--------ATPSRSAGYRAPEVI- 510
                H ++K  N+LI +     + DFG   ++  P        AT      YRAPE++ 
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT----RWYRAPELLV 173

Query: 511 -ETRKHSHKSDVYSFGVLLLEMLTGKA 536
            +T ++    DV++ G +  E+LTG+ 
Sbjct: 174 GDT-QYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.0 bits (110), Expect = 9e-07
 Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 119 SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 176
           +L+ L L +N  +     +F   P L VLDLS N+ T   P++   L  L  L L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 187

Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 1e-06
 Identities = 24/60 (40%), Positives = 32/60 (53%), Gaps = 4/60 (6%)

Query: 96  LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSF 152
           L+ L L +N LT  +P      LP+L+ L L  NN +   P +FS  P L  LDLS N+ 
Sbjct: 2   LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 344 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDF-EQQMEIVGRVGQ-- 392
           E LG+G++   +K +  E         T V++K L +     R++ E   E    + Q  
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS 57

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H ++V         DE ++V +Y   GSL T L  N+      + W+  V   L  A   
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLEVAKQLAWA--- 112

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGY 504
             +H +     THGN+ A NVL+ ++ D          +SD G++  +           +
Sbjct: 113 --LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW 170

Query: 505 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 534
             PE IE  ++ S  +D +SFG  L E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 45.0 bits (107), Expect = 1e-06
 Identities = 14/42 (33%), Positives = 21/42 (50%), Gaps = 3/42 (7%)

Query: 27 LNSDRQALLDFADAV---PHLRKLNWSSTNPICQSWVGINCT 65
          LN DR ALL F  ++   P     +W+ ++    SW G+ C 
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 17/203 (8%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 399
           V+G+GSY       L+++  +   ++  KE+V    D    + +  +  +   HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            + + ++     V +Y   G L  + H  R   +  L  E         +  + ++H  G
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNYLHERG 116

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 515
                + ++K  NVL++ +    ++D+G+      P  T S   G   Y APE++    +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 516 SHKSDVYSFGVLLLEMLTGKAPL 538
               D ++ GVL+ EM+ G++P 
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 17/225 (7%)

Query: 345 VLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRDF---EQQMEIVGRVGQHPNVVPL 399
           V+G+GSY       L+++  +   ++  KE+V    D    + +  +  +   +P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            + + +     LV +Y   G L  + H  R   +  L  E            +  +H  G
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFLHERG 116

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIETRKH 515
                + ++K  NVL++ D    ++D+G+      P  T S   G   Y APE++   ++
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 560
               D ++ GVL+ EM+ G++P    T +  ++   ++  V+ E+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 70/303 (23%), Positives = 134/303 (44%), Gaps = 54/303 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVP 398
           E LG+G+Y T +K   + +  +V   LKE+ +   +       +++ ++  + +H N+V 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVT 68

Query: 399 LRAYYYSKDEKLLVYDYFAS---------GSLSTLLHGNRGAGRTPLDWETRVKILL-GT 448
           L    ++     LV++Y            G++ ++                 VKI L   
Sbjct: 69  LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------------HNVKIFLYQI 113

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGY 504
            RG+A+ H     K  H ++K  N+LIN+  +  ++DFGL    +VP    +    +  Y
Sbjct: 114 LRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWY 170

Query: 505 RAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWT 562
           R P+V + + ++S + D++  G +  EM +G+      T +D + L  R + +   E W 
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPS 621
             +   +  +  N  +   Q L I  A         P +D E + ++ +  Q +S+ R S
Sbjct: 231 G-ISSNDEFKNYNFPKYKPQPL-INHA---------PRLDTEGIELLTKFLQYESKKRIS 279

Query: 622 SEE 624
           +EE
Sbjct: 280 AEE 282

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLR 400
           EV+GKGSYG    A+       V +K++ +V     D  + +  +   R+ +HP++V ++
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSM 458
                   +     Y     + + LH    A    TP   +  +  LL   R + +IH+ 
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL---RALKYIHTA 122

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-------RSAGYRAPEVIE 511
                 H ++K  N+L N D    I DFGL  +       +        +  YRAPE+  
Sbjct: 123 N---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 512 T--RKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +   K++   D++S G +  E+LTGK PL
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAYYY 404
           +G+G+YG  YKA  ++        LK++           EI + R  +HPNV+ L+  + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 405 SK-DEKL-LVYDYFASGSLSTLLHGNRG--AGRTPLDW-ETRVKILLGTARGVAHIHSMG 459
           S  D K+ L++DY A   L  ++  +R   A + P+      VK LL   + +  IH + 
Sbjct: 69  SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL--YQILDGIHYLH 125

Query: 460 GPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG-------YRAPE 508
                H ++K +N+L+  +        I+D G   L N P  P            YRAPE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++   +H  K+ D+++ G +  E+LT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 3e-06
 Identities = 23/60 (38%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 198
            L  LDLS N  T     + + L  L  L L  NNL+   P     +P LR L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 48/193 (24%), Positives = 68/193 (35%), Gaps = 64/193 (33%)

Query: 403 YYS---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 458
           YYS   KD    V DY   G + +LL       R  +  E   +  +      +  +H M
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLI------RLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 459 GGPKFTHGNIKASNVLINQDLDGCI--SDFGL---------------------------- 488
           G   F H +IK  N+LI  D DG I  +DFGL                            
Sbjct: 121 G---FIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 489 --TPLMNVPATPSR-----------------SAGYRAPEVIETRKHSHKSDVYSFGVLLL 529
             + +      P                   +  Y APEV+    ++   D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 530 EMLTGKAPLQSPT 542
           EML G+ P  + T
Sbjct: 236 EMLVGQPPFLADT 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 19/180 (10%)

Query: 365 VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGS 420
           V VK LK    G    D ++++EI+ R   H N+V  +            L+ ++  SGS
Sbjct: 36  VAVKSLKPESGGNHIADLKKEIEIL-RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94

Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           L   L  N+      ++ + ++K  +   +G+ +   +G  ++ H ++ A NVL+  +  
Sbjct: 95  LKEYLPRNKNK----INLKQQLKYAVQICKGMDY---LGSRQYVHRDLAARNVLVESEHQ 147

Query: 481 GCISDFGLTPLM-------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
             I DFGLT  +        V         + APE +   K    SDV+SFGV L E+LT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV---VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E LG+GSY T YK   + +  +V   V RL+E         ++  ++  + +H N+V L 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLH 69

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMG 459
              ++K+   LV++Y  +  L   +  + G G  P      VK+ L    RG+++IH   
Sbjct: 70  DIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHP----ENVKLFLFQLLRGLSYIHQR- 122

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETRK 514
                H ++K  N+LI+   +  ++DFGL    +VP+ T S    +  YR P+V + + +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           +S   D++  G + +EM+ G A    P   D+ D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQD 212

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 25/202 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 400
           LG+G+Y T +K   + +  +V   LKE+ +   +       +++ ++  + +H N+V L 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLH 69

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLH-GNRGAGRTPLDWETRVKILL-GTARGVAHIHSM 458
              +++    LV++Y  S     L + GN       L     VKI +    RG+++ H  
Sbjct: 70  DIIHTERCLTLVFEYLDSDLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEV-IETR 513
              K  H ++K  N+LIN+  +  ++DFGL    +VP  T S    +  YR P+V + + 
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 514 KHSHKSDVYSFGVLLLEMLTGK 535
           ++S   D++  G +L EM TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 28/221 (12%)

Query: 346 LGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVV 397
           LG+G++   YK VL  +S   +V   +EV V         RD     E    + Q  +  
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 398 PLRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            ++ Y    +DE ++V +Y   G L   LH  +      L W  ++ +    A  + ++ 
Sbjct: 63  LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASALHYLE 118

Query: 457 SMGGPKFTHGNIKASNVLINQD-------LDGCISDFGL-TPLMNVPATPSRSAGYRAPE 508
                K  HGN+   N+L+ +            +SD G+   +++      R   + APE
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-WIAPE 174

Query: 509 VIE--TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 546
            I       +  +D +SFG  LLE+ + G+ PL + +  + 
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTT--VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNVVP 398
           ++LGKG++G     V E++T     +K LK+ V+  +D         RV Q   HP +  
Sbjct: 1   KLLGKGTFGKVI-LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L+  + + D    V +Y   G L   L   R      +  E R +         + ++HS
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHS 113

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSAGYRAPEV 509
                  + ++K  N+++++D    I+DFGL          +     TP     Y APEV
Sbjct: 114 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE----YLAPEV 167

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           +E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLR 400
           AE LG+G+     + VL     V VK L+  V    + DF ++++I+ R+ ++PN++ L 
Sbjct: 30  AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83

Query: 401 AYYYSKDEKLLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGTAR 450
               S D   ++ +Y  +G L          ST  H N       +   +   +L    +
Sbjct: 84  GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN------IPSVSIANLLYMAVQ 137

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP---------LMNVPATPSRS 501
             + +  +    F H ++   N L+       I+DFG++          +      P R 
Sbjct: 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR- 196

Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
             + A E I   K +  SDV++FGV L EM T
Sbjct: 197 --WMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 33/212 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QH 393
           E +G+G+YG  YK   +++  +V  +       K   E + E V              QH
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMK-------KIRLESEEEGVPSTAIREISLLKELQH 58

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           PN+V L+     +    L+++ F S  L   L          +D E     L    +G+ 
Sbjct: 59  PNIVCLQDVLMQESRLYLIFE-FLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGIL 115

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAP 507
             HS    +  H ++K  N+LI+    G I  +DFGL     +P         +  YRAP
Sbjct: 116 FCHSR---RVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170

Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           EV+  + ++S   D++S G +  EM T K PL
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)

Query: 344 EVLGKGSYGTAYKAVL-EESTT---VVVKRLKEVVVGKRDFEQQMEIVGRVGQ---HPNV 396
           ++LGKG++G   K +L  E  T     +K LK+ V+  +D         RV Q   HP +
Sbjct: 1   KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---VKILLGTARGVA 453
             L+  + + D    V +Y   G L    H +R   R   +   R    +I+      + 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIVSA----LG 109

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEV 509
           ++HS       + ++K  N+++++D    I+DFGL    ++  AT     G   Y APEV
Sbjct: 110 YLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           +E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 48/215 (22%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 345 VLGKGSYG-TAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLR 400
           V+GKGSYG  +      +    V+K+L      +R+    EQ+ +++ ++ +HPN+V  R
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYR 65

Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIH 456
             +  +D  L +V  +   G L   L   +G        ++W  ++      A  + ++H
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLH 119

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSAGYRAPEVIET 512
                   H ++K  NV + +     + D G+  ++    ++ +T   +  Y +PE+   
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           + +++KSDV++ G  + EM T K    +   + +V
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 4e-06
 Identities = 20/46 (43%), Positives = 23/46 (50%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 130
           IP+     L  L+VL L  N LT   P   + LPSLR L L  NN 
Sbjct: 15  IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 21/206 (10%)

Query: 345 VLGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN---VVPLR 400
           VLGKG +G      V         K+L++  + KR  E       R+ +  N   VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
             Y +KD   LV      G L   ++  GN G      D +  +        G+  +   
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAIFYAAELCCGLEDLQR- 120

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVIETR 513
              +  + ++K  N+L++      ISD GL   + +P   +      + GY APEVI   
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNE 176

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           K++   D +  G L+ EM+ G++P +
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 12/201 (5%)

Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 398
           LRAS E         +      +   ++ KR+K         E ++  +GR+  H N++ 
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILK 227

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           +     S+    ++   +     S +          PL  +TR  I+      V +IH  
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHD- 285

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------RAPEVIET 512
              K  H +IK  N+ +N D    + DFG               G+       +PE++  
Sbjct: 286 --KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAG 342

Query: 513 RKHSHKSDVYSFGVLLLEMLT 533
             +   +D++S G++LL+ML+
Sbjct: 343 DGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 41/245 (16%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNV 396
           +G+G+YG  +KA  L+     V   LK V V   +    +  +  V         +HPNV
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 397 VPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           V L          ++ KL LV+++     L+T L      G      ET   ++    RG
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRG 122

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGYRAPE 508
           +  +HS    +  H ++K  N+L+       ++DFGL  + +     +    +  YRAPE
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVDLPRWVQSVVREE 560
           V+    ++   D++S G +  EM   K PL   + D        D++ LP        E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG------EED 232

Query: 561 WTAEV 565
           W  +V
Sbjct: 233 WPRDV 237

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHIHSMGGPKF 463
           S D+ LL+ +Y + G L+  +   R     P   E  V +L       +  +HS    K 
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQ-EYEVGLLFYQIVLALDEVHSR---KM 190

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPL------MNVPATPSRSAGYRAPEVIETRKHSH 517
            H ++K++N+ +       + DFG +        ++V ++   +  Y APE+ E +++S 
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           K+D++S GV+L E+LT   P + P++ +++
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIM 280

Length = 478

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV-VVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G      L+ +  V  +K L +  + KR     F ++ +++   G +  +  
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITT 65

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L   +  ++   LV DY+  G L TLL  ++   R P   E   +  L  A  V  I S+
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVIAIDSV 118

Query: 459 GGPKFTHGNIKASNVLINQDLDGCI--SDFG--LTPLMNVPATPSRSAG---YRAPEVIE 511
               + H +IK  N+L+  D++G I  +DFG  L  + +     S + G   Y +PE+++
Sbjct: 119 HQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 512 TR-----KHSHKSDVYSFGVLLLEMLTGKAPL 538
                  K+  + D +S GV + EML G+ P 
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 7e-06
 Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 10/158 (6%)

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           +PN + L     +    +L+ DY   G L  LL          L      KI+      +
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEAL 122

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAPEVIE 511
             +H        H +IK  NVL ++  D   + D+GL  ++  P+    +  Y +PE I+
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK 179

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
              +    D ++ GVL  E+LTGK P +    D+ +DL
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKE-DEDEELDL 216

Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 8e-06
 Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 63/248 (25%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ---------QMEIVGRVGQHP 394
           ++LGKG  G  +  ++    T  +  LK  V+ K++  +         + EI+  +  HP
Sbjct: 7   KLLGKGDVGRVF--LVRLKGTGKLFALK--VLDKKEMIKRNKVKRVLTEQEILATL-DHP 61

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTA 449
            +  L A + ++    LV DY   G L  LL    G        E   +     +LL   
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-KCLS---EEVARFYAAEVLLA-- 115

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-PATPSRSAG----- 503
             + ++H +G     + ++K  N+L+++     +SDF L+   +V P   S++       
Sbjct: 116 --LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 504 ---------------------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 536
                                      Y APEVI    H    D ++ G+LL EML G  
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230

Query: 537 PLQSPTRD 544
           P +   RD
Sbjct: 231 PFKGSNRD 238

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 8/83 (9%)

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YRAPEVIETRKH 515
           F H ++ A NVL+       ISDFGL+  +       ++         + APE +   K 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 516 SHKSDVYSFGVLLLEMLT-GKAP 537
           S KSDV+SFGVL+ E  + G+ P
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.8 bits (114), Expect = 9e-06
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 23/101 (22%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+L+N + D  I DFGL       A  +   G      
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL-------ARTTSEKGDFMTEY 168

Query: 504 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                YRAPE++    +++   DV+S G +  E+L  K PL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
            + PL  E  +      ARG+  + S    K  H ++ A N+L++++    I DFGL   
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARD 222

Query: 492 MNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           +       R    R      APE I  + ++ +SDV+SFGVLL E+ +  A   SP    
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA---SPYPGV 279

Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
            +D          EE+   + +   MR    E    ++  I + C    P+ RP   E+V
Sbjct: 280 QID----------EEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDRPTFSELV 327

Query: 606 RMIEEVRQSD 615
            ++ ++ Q +
Sbjct: 328 EILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 32/204 (15%)

Query: 346 LGKGSYGTAYKA-VLEESTTVVVKRLKEVVVGKRDFEQQMEI--VGRVGQHPNVVPLRAY 402
           +G+G++    KA   +      +K +K+            EI  + R+  HPN++ L   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 403 YYSKDEKLLVYDYFASGSLS---TLLHGN-----RGAGRTPLDWETRVK-ILLGTARGVA 453
            +  D K        +G L+    L+  N     +G  + PL  E RVK  +    + + 
Sbjct: 67  LF--DRK--------TGRLALVFELMDMNLYELIKGR-KRPLP-EKRVKSYMYQLLKSLD 114

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG-YRAPEVI 510
           H+H  G     H +IK  N+LI  D+   ++DFG    +    P T   S   YRAPE +
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 511 ETR-KHSHKSDVYSFGVLLLEMLT 533
            T   +  K D+++ G +  E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 25/205 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEI-VGRVGQHPNVVPL 399
           + LG+GSY T YK   + +  +V   LKE+ +   +   F    E  + +  +H N+V L
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVA--LKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILL-GTARGVAHIH 456
               ++K    LV++Y  +  L   +   G    G +       V++ L    RG+A+ H
Sbjct: 69  HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSM----HNVRLFLFQLLRGLAYCH 120

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR---SAGYRAPEVI-E 511
                +  H ++K  N+LI++  +  ++DFGL    +VP+ T S    +  YR P+V+  
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKA 536
           + ++S   D++  G +  EM TG+ 
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 26/188 (13%)

Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
           ++PL  E  +      ARG+  + S    K  H ++ A N+L++++    I DFGL   +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 493 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 545
                  R    R      APE I  + ++ +SDV+SFGVLL E+ + G +P        
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----- 279

Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
                  VQ  + EE+   + D   MR    E    ++ +I +AC    P  RP    +V
Sbjct: 280 -------VQ--INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALV 328

Query: 606 RMIEEVRQ 613
            ++ ++ Q
Sbjct: 329 EILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 35/210 (16%)

Query: 345 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           ++G GS+G  Y+A+ ++ S  V +K+    V+    ++ +  ++ +   H N++ L+ YY
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128

Query: 404 YS----KDEKLL----VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTARGVAH 454
           Y+    K+EK +    V ++        + H  R     PL     VK+      R +A+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---FLVKLYSYQLCRALAY 185

Query: 455 IHSMGGPKFT-HGNIKASNVLIN---QDLDGCISDFG-----LTPLMNVPATPSRSAGYR 505
           IHS    KF  H ++K  N+LI+     L  C  DFG     L    +V    SR   YR
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLC--DFGSAKNLLAGQRSVSYICSRF--YR 237

Query: 506 APEV-IETRKHSHKSDVYSFGVLLLEMLTG 534
           APE+ +    ++   D++S G ++ EM+ G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 34/220 (15%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFE----QQMEIVGRVGQHPNVVPL 399
           +G+G++G  +KA  +++  +V   LK+V++   K  F     ++++I+  + +H NVV L
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVA--LKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 76

Query: 400 RAYYYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
                +K            LV++ F    L+ LL  N+    T  + +  +K+LL    G
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFE-FCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLN---G 131

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAG 503
           + +IH     K  H ++KA+N+LI +D    ++DFGL    ++              +  
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 504 YRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           YR PE+ +  R +    D++  G ++ EM T    +Q  T
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 37/225 (16%)

Query: 346 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLR 400
           +GKG  G  Y A     S  V +K+++E +      K+ F ++ +I   +  HP +VP+ 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVY 68

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE--TRVKILLG----TARGVAH 454
           +     D       Y    +L +LL           +    T V   L         + +
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL----------------------M 492
           +HS G     H ++K  N+L+    +  I D+G                          M
Sbjct: 129 VHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 493 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            +P     +  Y APE +     S  +D+Y+ GV+L +MLT   P
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPS-------RS 501
           RG+ +IHS       H ++K +NV IN  DL   I DFGL  +++   +          +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 502 AGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
             YR+P ++ +  +  K+ D+++ G +  EMLTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 23/150 (15%)

Query: 402 YYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
           +Y  +DE    LV DY+  G L TLL  ++   R P   E   +  L  A  V  I S+ 
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYL--AEMVLAIDSVH 119

Query: 460 GPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRSAG-----YRAPEVIE- 511
              + H +IK  NVL+  D +G I  +DFG    +    T   +       Y +PE+++ 
Sbjct: 120 QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177

Query: 512 ----TRKHSHKSDVYSFGVLLLEMLTGKAP 537
                 ++  + D +S GV + EML G+ P
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 28/211 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRL--KEVVVGKRD---FEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G       + S  V   +L  K  ++ + D   F ++ +I+      P VV 
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQ 107

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET--RVKILLGTARGVAHIH 456
           L   +       +V +Y   G L  L+         P  W      +++L     +  IH
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLA----LDAIH 159

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----TPSRSAGYRAPEVIE 511
           SMG     H ++K  N+L+++     ++DFG    M+        T   +  Y +PEV++
Sbjct: 160 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 512 TRK----HSHKSDVYSFGVLLLEMLTGKAPL 538
           ++     +  + D +S GV L EML G  P 
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFE-----QQMEIVGRVGQHPNVVPLR 400
           LG+G+Y T YK   + +  +V   LKE+ +   +       +++ ++  + +H N+V L 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVA--LKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLH 70

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
              +++    LV++Y     L   L   GN       ++       L    RG+ + H  
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS------INMHNVKLFLFQLLRGLNYCHRR 123

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEV-IETR 513
              K  H ++K  N+LIN+  +  ++DFGL    ++P    +    +  YR P++ + + 
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPL 538
            +S + D++  G +  EM TG+ PL
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR-PL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 24/94 (25%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 506
           G+ H+H     +  + ++K  NVL++ D +  ISD GL   +    + ++    + G+ A
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           PE+++  ++    D ++ GV L EM+  + P ++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----Y 504
           RG+ ++HS G     H +IK  N+L+N +    I DFGL  +     +   +       Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 505 RAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQS 540
           RAPE++   +H +   D++S G +  E+L  +   Q+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 32/197 (16%)

Query: 377 KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL----------H 426
           + DF ++++I+ R+ + PN++ L      +D   ++ +Y  +G L+  L          +
Sbjct: 63  RNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 427 GNRGAGRT----PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC 482
           GN           + + + + + L  A G+ ++ S+    F H ++   N L+ ++L   
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIK 178

Query: 483 ISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           I+DFG++          +      P R   + A E I   K +  SDV++FGV L E+L 
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASDVWAFGVTLWEILM 235

Query: 534 --GKAPLQSPTRDDMVD 548
              + P    T + +++
Sbjct: 236 LCKEQPYGELTDEQVIE 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 11/116 (9%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY----- 504
           R + ++H     +  H +IKA N+ IN   D C+ DFG      V    ++  G+     
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248

Query: 505 -RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVR 558
             APE++    +    D++S G++L EM T    L +    D   D  R ++ ++R
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304

Length = 391

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 46/139 (33%), Positives = 64/139 (46%), Gaps = 5/139 (3%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           L  L  L  L L  N ++  LP EI  L +L  L L  NN   ++ SS S    L  L+L
Sbjct: 182 LSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLEL 239

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 207
           S N    ++P+SI NL+ L  L L +N +S       +  LR L+LS N L  ++P    
Sbjct: 240 SNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Query: 208 KFPNSSFVGNSLLCGPPLK 226
                  + N LL    L+
Sbjct: 299 LLLLLELLLNLLLTLKALE 317

Length = 394

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 18/98 (18%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 499
           GV+++HS       H +IK +N+L +   +  + DFG            T + +V  TP 
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
               + +PEVI    +  K+D++S G  ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 346 LGKGSYGTAYKAVLEESTTV-VVKRLKEV-VVGKRDFEQQME---IVGRVGQHPNVVPLR 400
           +GKGS+G   +    ++  +  +K +++  +V + +    +    ++ +V   P +VPL+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIHSMG 459
             + S ++  LV  +   G L    H  +  GR      +R +         + ++H   
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFD---LSRARFYTAELLCALENLHKF- 112

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKH 515
                + ++K  N+L++      + DFGL  L M      +   G   Y APE++    +
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           +   D ++ GVLL EMLTG  P      ++M
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVG-QHPNVVPL 399
           E LG+GSY T YK +   +  +V   LK + +   +   F    E     G +H N+V L
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVA--LKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
               ++K+    V++Y  +  L+  +  + G G  P +    +  LL   RG+A+IH   
Sbjct: 69  HDIIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVRLFMFQLL---RGLAYIH--- 120

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVI-ETRK 514
           G    H ++K  N+LI+   +  ++DFGL    ++P+    S      YR P+V+     
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 515 HSHKSDVYSFGVLLLEMLTGK 535
           +S   D++  G + +EML G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 44.6 bits (105), Expect = 9e-05
 Identities = 52/242 (21%), Positives = 105/242 (43%), Gaps = 36/242 (14%)

Query: 308 KEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL--EESTTV 365
           K++  S  +   KNK+ + +   +NF            LG GS+G    A    E+   V
Sbjct: 12  KKDSDSTKEPKRKNKMKYED---FNF---------IRTLGTGSFGRVILATYKNEDFPPV 59

Query: 366 VVKRL-KEVVVGKRDFEQ---QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 421
            +KR  K  ++ ++  +    + +I+  +  HP  V L   +  +    LV ++   G  
Sbjct: 60  AIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 422 STLLHGNRGAGRTPLD----WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ 477
            T L  N+   R P D    +  ++ ++        ++ S+      + ++K  N+L+++
Sbjct: 119 FTFLRRNK---RFPNDVGCFYAAQIVLIF------EYLQSL---NIVYRDLKPENLLLDK 166

Query: 478 DLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 536
           D    ++DFG   +++    T   +  Y APE++    H   +D ++ G+ + E+L G  
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226

Query: 537 PL 538
           P 
Sbjct: 227 PF 228

Length = 340

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 53/290 (18%)

Query: 346 LGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKR--DFEQQMEIVGRVGQHPNVV 397
           +G G +G   K +L E  T      VVVK LK     K   +F QQ +   R+ QHPN++
Sbjct: 3   IGNGWFG---KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPY-RILQHPNIL 58

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 454
                       LLV++Y   G L + L      R   +  L      +I    A GV H
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTH 114

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYR 505
           +H      F H ++   N  +  DL   + D+G+ P           +    P R   + 
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---WL 168

Query: 506 APEVIETR-------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 558
           APE++          + +  S+V++ GV L E+    A   S   D  V     +  V++
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----LNHVIK 223

Query: 559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
           ++   ++F  +L       E   ++LQ    C    P+ R   +EV R++
Sbjct: 224 DQQV-KLFKPQLE--LPYSERWYEVLQF---CWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 18/98 (18%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATPS 499
           G++++H        H +IK +N+L +   +  + DFG            T + +V  TP 
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
               + +PEVI    +  K+DV+S G  ++EMLT K P
Sbjct: 175 ----WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 49/189 (25%), Positives = 80/189 (42%), Gaps = 24/189 (12%)

Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
           +  L  E  +      A+G+  + S    K  H ++ A N+L++++    I DFGL   +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 493 NVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
                  R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   SP     
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVK 286

Query: 547 VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           +D          EE+   +   E  R +  +    +M Q  + C    P  RP   E+V 
Sbjct: 287 ID----------EEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334

Query: 607 MIEEVRQSD 615
            +  + Q++
Sbjct: 335 HLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 37/170 (21%)

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 450
           ++P VV +   + +K    +V +Y   G  +TLL   +  G  P+D     ++    T  
Sbjct: 59  ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVD---MARMYFAETVL 112

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--------------- 493
            + ++H+ G     H ++K  N+LI       ++DFGL+   LM+               
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 494 ------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                 V  TP     Y APEVI  + +    D ++ G++L E L G  P
Sbjct: 170 EFLDKQVCGTPE----YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 47/186 (25%), Positives = 88/186 (47%), Gaps = 24/186 (12%)

Query: 365 VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS 422
           V VK L+E      + DF ++++I+ R+ + PN++ L A   + D   ++ +Y  +G L+
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 423 TLL--HGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN 476
             L  H  + A        + + T + +    A G+ ++ S+    F H ++   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164

Query: 477 QDLDGCISDFGLTP---------LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 527
           ++    I+DFG++          +      P R   + + E I   K +  SDV++FGV 
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVT 221

Query: 528 LLEMLT 533
           L E+LT
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 18/99 (18%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNVPATP 498
           +GV+++HS       H +IK +N+L +   +  + DFG            T + +V  TP
Sbjct: 117 QGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                + +PEVI    +  K+DV+S    ++EMLT K P
Sbjct: 174 Y----WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 62/291 (21%)

Query: 346 LGKGSYGTAYKAVLEE------STTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPNVV 397
           +G G +G   K +L E         VVVK L+    V  +  F ++ +   R  QH N++
Sbjct: 3   IGNGWFG---KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPY-RSLQHSNLL 58

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
                       LLV ++   G L   L   R A     D  T  ++    A G+ H+H 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSR---SAGYRAPEVIE 511
                F H ++   N L+  DL   I D+GL+      +   TP +      + APE+++
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 512 -------TRKHSHKSDVYSFGVLLLEMLT-GKAP---------LQSPTRDDMVDLPR-WV 553
                      + +S+V+S GV + E+   G  P         L    R+  + LP+  +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235

Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
           +  + + W       E+M+F  ++                 P+ RP+ +EV
Sbjct: 236 KLPLSDRW------YEVMQFCWLQ-----------------PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 14/169 (8%)

Query: 381 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
           E+ M  +   G  P +V +   +++ D+   + D    G L   L  +       + +  
Sbjct: 44  ERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA 103

Query: 441 RVKILLGTARGVAHIHSMGGPKFT-HGNIKASNVLINQDLDGCISDFGLTPLMN--VPAT 497
              IL     G+ H+H+    +F  + ++K +N+L+++     ISD GL    +   P  
Sbjct: 104 TEIIL-----GLEHMHN----RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154

Query: 498 PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPL-QSPTRD 544
              + GY APEV++    +   +D +S G +L ++L G +P  Q  T+D
Sbjct: 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 55/197 (27%), Positives = 76/197 (38%), Gaps = 60/197 (30%)

Query: 393 HPNVVPLRAYYYS-KDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +P VV L   YYS +DE    L+ +Y   G + TLL        T  + ETR  I    A
Sbjct: 60  NPWVVKL---YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYI----A 108

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFGL-TPL--------------- 491
             +  I S+    + H +IK  N+L+  D  G I  SDFGL T L               
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 492 -----MNVPATPSRSAG---------------------YRAPEVIETRKHSHKSDVYSFG 525
                ++  + P  S                       Y APEV     ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 526 VLLLEMLTGKAPLQSPT 542
           V++ EML G  P  S  
Sbjct: 227 VIMYEMLVGYPPFCSDN 243

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 23/202 (11%)

Query: 346 LGKGSYGTAYKAVL---EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           L  GS G  +       E+   V+VK     V G +   ++++I+  +  H  ++ L   
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVK----AVTGGKTPGREIDILKTI-SHRAIINLIHA 154

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y  K    +V   +    L T +         PL  E  + I       +A++H  G   
Sbjct: 155 YRWKSTVCMVMPKYKC-DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG--- 205

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP-----SRSAGYRAPEVIETRKHS 516
             H ++K  N+ +++  +  + DFG    L   P TP     S +    +PE++    + 
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 517 HKSDVYSFGVLLLEMLTGKAPL 538
            K+D++S G++L EM      L
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 55/214 (25%), Positives = 76/214 (35%), Gaps = 62/214 (28%)

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           VV L   +  KD    V DY   G + +LL      G  P D        L  A  V  +
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFPEDLARFYIAELTCA--VESV 117

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------------------------- 487
           H MG   F H +IK  N+LI++D    ++DFG                            
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174

Query: 488 --------------LTPLMNVPATPSR---------SAGYRAPEVIETRKHSHKSDVYSF 524
                         L PL    A   +         +  Y APEV+    ++   D +S 
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234

Query: 525 GVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSV 556
           GV+L EML G+ P   Q+P    M  +  W  S+
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQM-KVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 345 VLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDF---EQQMEIVGRVGQHPNVV 397
           V+G+GSY       L+++  +    V+K  KE+V    D    + +  +      HP +V
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK--KELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
            L + + ++     V ++ + G L  + H  R   + P   E   +          + +H
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDL--MFHMQR-QRKLP---EEHARFYSAEISLALNFLH 113

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAPEVIET 512
             G     + ++K  NVL++ +    ++D+G+      P  T S   G   Y APE++  
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAP 537
             +    D ++ GVL+ EM+ G++P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 10/110 (9%)

Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN 493
           PLD +  ++     A+G+  + S       H ++ A NVL+       I DFGL   +MN
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 494 -----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                V         + APE I    ++ +SDV+S+G+LL E+ + GK+P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 17/104 (16%)

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY------- 504
           + +IH  G     H +IK  NVL+N   D C+ DFG        A  S S  +       
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF----ARGSWSTPFHYGIAGT 325

Query: 505 ---RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
               APEV+    ++   D++S G+++ E     A L S +R D
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369

Length = 461

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 38/132 (28%), Positives = 51/132 (38%), Gaps = 24/132 (18%)

Query: 92  KLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSF--------- 138
           KL  L+VL L  N L       L S +   PSL+ L L   N +G+IP            
Sbjct: 21  KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCL-SLNETGRIPRGLQSLLQGLTK 79

Query: 139 SPQLVVLDLSFNSFTGNIPQSIQNLTQ---LTGLSLQSNNLSGSIPNFDI-------PKL 188
              L  LDLS N+   +    +++L +   L  L L +N L                P L
Sbjct: 80  GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139

Query: 189 RHLNLSYNGLKG 200
             L L  N L+G
Sbjct: 140 EKLVLGRNRLEG 151

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 346 LGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------QHPNVV 397
           +G G+YGT YKA    S   V   LK V V   +    +  V  V          HPN+V
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVA--LKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 398 PLRAYYYS----KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
            L     +    ++ K+ LV+++     L T L      G   L  ET   ++    RG+
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGL 121

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--VPATPSR-SAGYRAPEV 509
             +H+       H ++K  N+L+       ++DFGL  + +  +  TP   +  YRAPEV
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +    ++   D++S G +  EM   K PL
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK-PL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 27/109 (24%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAGYRAPE 508
           G+ H+H+       + ++K +N+L+++     ISD GL    +   P     + GY APE
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165

Query: 509 VIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
           V++    +   +D +S G +L ++L G +P +     D  ++ R   ++
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 61/249 (24%)

Query: 342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP--- 398
           S +V+G+G++G     ++++  T  V  +K  ++ K D  ++ E VG +    +++    
Sbjct: 5   SLKVIGRGAFGEV--RLVQKKDTGHVYAMK--ILRKADMLEK-EQVGHIRAERDILVEAD 59

Query: 399 ---LRAYYYSKDEKL---LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
              +   +YS  +KL   L+ ++   G + TLL       +  L  E     +  T   +
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLAI 114

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPAT----------PS-- 499
             IH +G   F H +IK  N+L++      +SDFGL T L     T          PS  
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 500 --------RSA------------------GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
                   R A                   Y APEV     ++   D +S GV++ EML 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 534 GKAPLQSPT 542
           G  P  S T
Sbjct: 232 GYPPFCSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 17/39 (43%), Positives = 25/39 (64%)

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           Y APEV+  + ++   D +S GV+L EML G+ P  +PT
Sbjct: 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT 252

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	635
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PLN03150	623	hypothetical protein; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
smart00090	237	RIO RIO-like kinase.	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.53
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.45
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.39
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.36
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.32
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.31
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.29
PLN03150	623	hypothetical protein; Provisional	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.23
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.17
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.17
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.16
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.14
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.11
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.09
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.05
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.02
KOG1243	690	consensus Protein kinase [General function predict	99.02
KOG3087	229	consensus Serine/threonine protein kinase [General	98.96
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.93
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.86
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.86
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.77
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.77
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.77
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.73
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.71
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.71
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.7
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.6
PRK09902	216	hypothetical protein; Provisional	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.4
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.39
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.36
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.36
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.32
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.19
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.18
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.18
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.17
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.15
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.12

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.8e-61  Score=567.83  Aligned_cols=493  Identities=28%  Similarity=0.464  Sum_probs=316.6

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeecc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS  148 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls  148 (635)
                      +..|+|++|.+.|.+|. .+ .+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|..+.  ++|++|+|+
T Consensus       454 L~~L~L~~n~~~~~~p~-~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  531 (968)
T PLN00113        454 LQMLSLARNKFFGGLPD-SF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS  531 (968)
T ss_pred             CcEEECcCceeeeecCc-cc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence            44445555555544443 22 335555666666666666666666666666666666666666666554  556666666


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcc--cCCCCCCCccCCCCCCCCC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPP  224 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~l~~~~  224 (635)
                      +|+++|.+|..|.++++|+.|+|++|+++|.+|..  .+++|+.|++++|+++|.+|..  +..+....+.+|+.+||.+
T Consensus       532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  611 (968)
T PLN00113        532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD  611 (968)
T ss_pred             CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence            66666666666666666666666666666666653  5566666666666666666632  3344445566666666532


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCcccccccccCcceeeeeehhhHHHHHHHHHHHhhhhccccCCCCCCCccCCCCCCCCC
Q 006677          225 LKACFPVAPSPSPTYSPPPFIPRKQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRS  304 (635)
Q Consensus       225 l~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~ivvg~~~~~llv~~~i~~~~~~r~~~~~~~~~~~~~~~~~~~  304 (635)
                      .+.-          .++.     . ...+...+..+++++++++++ +++++++++++++|+..+....           
T Consensus       612 ~~~~----------~~~c-----~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------  663 (968)
T PLN00113        612 TTSG----------LPPC-----K-RVRKTPSWWFYITCTLGAFLV-LALVAFGFVFIRGRNNLELKRV-----------  663 (968)
T ss_pred             cccC----------CCCC-----c-cccccceeeeehhHHHHHHHH-HHHHHHHHHHHHhhhccccccc-----------
Confidence            1100          0000     0 000111122222222222222 2222222222222221111100           


Q ss_pred             CCCccccCCCCCCcccCceeeeccCCcCCChHHHHHHh--hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHH
Q 006677          305 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRAS--AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFE  381 (635)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~  381 (635)
                      +....     ..+..    .+.......++.+++....  .++||+|+||.||+|.. .++..||||+++....   ...
T Consensus       664 ~~~~~-----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~  731 (968)
T PLN00113        664 ENEDG-----TWELQ----FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPS  731 (968)
T ss_pred             ccccc-----ccccc----ccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccH
Confidence            00000     00000    0000001123444443333  45899999999999997 4688999999865432   223


Q ss_pred             HHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006677          382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP  461 (635)
Q Consensus       382 ~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  461 (635)
                      .|+++++++ +|||||+++++|.+++..++||||+++|+|.++++.        ++|..+.+++.|+|+||+|||+.+.+
T Consensus       732 ~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~  802 (968)
T PLN00113        732 SEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSP  802 (968)
T ss_pred             HHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCC
Confidence            467888898 999999999999999999999999999999999962        88999999999999999999976556


Q ss_pred             CceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       462 ~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                      +|+||||||+||+++.++.+++. ||.+..........++..|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus       803 ~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            69999999999999999988875 67665544444456788999999999999999999999999999999999999643


Q ss_pred             CCCCCCChhHHHHHHhhhccccccchhhhhcc-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          542 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      . .....+..|.+...........+|+.+... ....++..++.+++.+||+.+|++||||+|+++.|+++.+..+
T Consensus       882 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        882 F-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             c-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            2 233457777776554444444455444221 2234667788999999999999999999999999999876443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-52  Score=435.92  Aligned_cols=281  Identities=38%  Similarity=0.679  Sum_probs=250.2

Q ss_pred             CcCCChHHHHHHh-----hccccccCceEEEEEEecCCCeEEEEEeecccCC-hHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          330 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       330 ~~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      ...|+++++..+|     .++||+|+||.||+|.+.+++.||||++...... .++|..|++++.++ +|||+|+++|||
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYC  140 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEE
Confidence            3468999999998     4689999999999999999999999988776554 67799999999999 799999999999


Q ss_pred             EeCC-eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          404 YSKD-EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       404 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      .+.+ +.+||||||++|+|.++|+.....   +++|..|++||.++|+||+|||+...|+|||||||++|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998 599999999999999999975432   699999999999999999999999988999999999999999999999


Q ss_pred             EeecCCCCCCCC-CCC---C-CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006677          483 ISDFGLTPLMNV-PAT---P-SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV  557 (635)
Q Consensus       483 i~DfGla~~~~~-~~~---~-~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  557 (635)
                      |+|||+|+.... ...   . .||.+|+|||++..+..+.|+|||||||+|+|++||+.|.+.....+...+..|....+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999977654 322   1 68999999999999999999999999999999999999988665555556999999999


Q ss_pred             hhccccccchhhhhcccChH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          558 REEWTAEVFDVELMRFQNIE-EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       558 ~~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      .+....+++|+.+....... .++..+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            99899999999986434333 6888999999999999999999999999999766644

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-47  Score=389.20  Aligned_cols=262  Identities=31%  Similarity=0.480  Sum_probs=213.8

Q ss_pred             CCChHHHHHHhhccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC-
Q 006677          332 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-  407 (635)
Q Consensus       332 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-  407 (635)
                      ..+..++.  ..+.||+|+||+||+|.+.+...||||++.....+   .++|.+|+.++.++ +|||||+++|+|.+.. 
T Consensus        37 ~i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   37 EIDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG  113 (362)
T ss_pred             ecChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC
Confidence            34455553  34569999999999999986556999999876443   45899999999999 9999999999999887 


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeec
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDF  486 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Df  486 (635)
                      ..++||||+++|+|.++++..   ....+++..++.++.|||+||.|||+++ + |||||||++|||++.++ ++||+||
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCC
Confidence            789999999999999999864   2345999999999999999999999986 2 99999999999999998 9999999


Q ss_pred             CCCCCCCC---CCC-CCCCCcccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          487 GLTPLMNV---PAT-PSRSAGYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       487 Gla~~~~~---~~~-~~~~~~y~aPE~~~--~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                      |+++....   ..+ ..||..|||||++.  ...|+.|+||||||+++|||+||+.||......+      .........
T Consensus       189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~  262 (362)
T KOG0192|consen  189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGG  262 (362)
T ss_pred             ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC
Confidence            99977653   223 46899999999999  5689999999999999999999999998664311      111111111


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..          ......+...+..++.+||..||+.||++.|++..|+.+......
T Consensus       263 ~R----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  263 LR----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             CC----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            11          111122556677888899999999999999999999998875554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-47  Score=387.85  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=219.0

Q ss_pred             cCCChHHHHHHhhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeE
Q 006677          331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL  410 (635)
Q Consensus       331 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~  410 (635)
                      +.++.+++  ...+.||+|.||+||.|.++....||+|.++......++|.+|+++|++| +|+|||+++|+|..++..|
T Consensus       201 wei~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  201 WEIPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             eeecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceE
Confidence            34555555  34678999999999999999888999999998888889999999999999 9999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      ||||||+.|+|.++|+...   +..+...+.+.++.|||+||+||++++   +|||||.++|||++++..+||+|||+|+
T Consensus       278 IVtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence            9999999999999998632   345889999999999999999999998   9999999999999999999999999999


Q ss_pred             CCCCCCCCC-----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          491 LMNVPATPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       491 ~~~~~~~~~-----~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      .........     -...|.|||.+....++.|||||||||+||||+| |+.||..+...+..       ..+..++   
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-------~~le~Gy---  421 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-------ELLERGY---  421 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-------HHHhccC---
Confidence            544332211     1235999999999999999999999999999999 89999876644321       1222222   


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                             +.+.++.+...+.++|..||+.+|++|||++.+...|+++....
T Consensus       422 -------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  422 -------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence                   23334556677888999999999999999999999999887644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=361.74  Aligned_cols=253  Identities=27%  Similarity=0.415  Sum_probs=206.3

Q ss_pred             CChHHHHHHhhccccccCceEEEEEEecC-CCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-e
Q 006677          333 FDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-E  408 (635)
Q Consensus       333 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~  408 (635)
                      ....++++  .+.||+|..|+|||+.++. ++.+|+|++....  ..++++.+|++++++. +||+||.++|.|+.+. .
T Consensus        76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence            44556633  5789999999999999874 6678999984332  2367899999999999 9999999999999999 5


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      ..++||||++|+|.+++...     ..+++....+|+.+|++||.|||+ .+   ||||||||+|||++..|++||+|||
T Consensus       153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence            99999999999999999743     349999999999999999999996 54   9999999999999999999999999


Q ss_pred             CCCCCCCC--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          488 LTPLMNVP--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       488 la~~~~~~--~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      .++.+...  .+..||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ....+..+.+..++.+...   
T Consensus       225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~ppP---  300 (364)
T KOG0581|consen  225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEPPP---  300 (364)
T ss_pred             ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCCCC---
Confidence            99876543  46679999999999999999999999999999999999999998652 2223333334444432211   


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            ..+. .....++..++..|+++||.+||++.|++++
T Consensus       301 ------~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  301 ------RLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ------CCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  1110 0234456667779999999999999999984

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-45  Score=395.35  Aligned_cols=253  Identities=26%  Similarity=0.445  Sum_probs=214.0

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|+..      +...||||.+++....  ..+|++|++++..+ +|||||+++|+|..++.+++|+|
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFE  569 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFE  569 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEE
Confidence            467999999999999853      3567999999987554  67899999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          415 YFASGSLSTLLHGNRGA-----G----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      ||..|||.+||......     .    ..+++..+.+.||.|||.||+||-++.   +|||||..+|+||+++..|||+|
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecc
Confidence            99999999999755321     1    334899999999999999999999987   99999999999999999999999


Q ss_pred             cCCCCCCCCCCCCC------CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          486 FGLTPLMNVPATPS------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       486 fGla~~~~~~~~~~------~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      ||+++.....+.+.      -..+|||||.+..++++++||||||||+|||+++ |+.||.+...++.++.       ++
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-------i~  719 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-------IR  719 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-------HH
Confidence            99998765443322      2357999999999999999999999999999999 9999988776553322       11


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .+.          -.+-++.+..++..||..||+.+|++||+++||-..|+..-+..+
T Consensus       720 ~g~----------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  720 AGQ----------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             cCC----------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            211          123446777889999999999999999999999999998876554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-44  Score=374.72  Aligned_cols=238  Identities=25%  Similarity=0.462  Sum_probs=203.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +++||+|||+.||.++. ..|..||+|++.+..    ...+...+|+++.+.+ +|||||+++++|++.+..|+|.|+|.
T Consensus        23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~  101 (592)
T KOG0575|consen   23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCH  101 (592)
T ss_pred             eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecC
Confidence            57899999999999997 789999999998742    2356788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.++++.     ++++++.++..++.||+.||.|||+.+   |+|||||..|++++++.++||+|||+|.....+  
T Consensus       102 ~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen  102 RGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             CccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999973     456999999999999999999999998   999999999999999999999999999887643  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        .+.+|||.|.|||++....++..+||||+||+||-|+.|++||+..+..+.      ..++...++.           
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~Y~-----------  236 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNEYS-----------  236 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcCcc-----------
Confidence              466899999999999999999999999999999999999999986543322      2222222221           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .+.....+..+||.++++.+|.+|||+++|+.+
T Consensus       237 -~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 -MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             112233445667779999999999999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=353.03  Aligned_cols=193  Identities=27%  Similarity=0.430  Sum_probs=173.1

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      +.||+|+||+||+|+++ ++..||||.+......   .+-...|+++|+.+ +|||||++++++..++..|+|||||++|
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGG   94 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence            34999999999999976 4789999999776433   34567899999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC------CCeEEeecCCCCCCC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD------LDGCISDFGLTPLMN  493 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~ki~DfGla~~~~  493 (635)
                      ||.++++...     .+++..+..++.|+|.||++||+++   ||||||||.||||+.+      -.+||+|||+|+.+.
T Consensus        95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999998543     4999999999999999999999998   9999999999999865      468999999999987


Q ss_pred             CCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 006677          494 VPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD  545 (635)
Q Consensus       494 ~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~  545 (635)
                      ...   +.+|++-|||||++..++|+.|+|+||+|+++|+|++|+.||+..+..+
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            643   5679999999999999999999999999999999999999999765444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-44  Score=354.86  Aligned_cols=243  Identities=24%  Similarity=0.399  Sum_probs=195.8

Q ss_pred             hhccccccCceEEEEEEe-cCCCeEEEEEeecccC--------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          342 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      +.+.||+|+||.|-+|.. ++|+.||||++.+...        ...+..+|+++|++| +|||||++.+++...+..|+|
T Consensus       176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmV  254 (475)
T KOG0615|consen  176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMV  254 (475)
T ss_pred             eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEE
Confidence            357899999999999985 4689999999976532        123457999999999 999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC---CCeEEeecCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~DfGla  489 (635)
                      |||++||+|.+.+-.+.     .+.+...+.+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||+|
T Consensus       255 lE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999997543     3777888999999999999999999   9999999999999766   78999999999


Q ss_pred             CCCCCC---CCCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          490 PLMNVP---ATPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       490 ~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      +.....   .+.+||+.|.|||++.+..   +..|+|+||+||+||-+++|.+||.+......     ....+....+..
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~G~y~f  401 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILKGRYAF  401 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhcCcccc
Confidence            987643   4678999999999997654   33488999999999999999999986543321     111222221110


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .        .....+...+.++++.+++..||++|||+.|+++
T Consensus       402 ~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  402 G--------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             c--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            0        0111233445667777999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-43  Score=329.71  Aligned_cols=249  Identities=23%  Similarity=0.406  Sum_probs=203.7

Q ss_pred             hhccccccCceEEEEEE-ecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeE-EEEeCCe-eEEEEEe
Q 006677          342 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRA-YYYSKDE-KLLVYDY  415 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~-~~lv~e~  415 (635)
                      ..++||+|.||+||++. ..+|..+|.|.+.-...+   .++...|+.+|+.| +|||||++++ .+.++.+ .++||||
T Consensus        23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~  101 (375)
T KOG0591|consen   23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMEL  101 (375)
T ss_pred             HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHh
Confidence            35789999999999998 567899999998744333   45678899999999 9999999998 4555555 7899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK--FTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      +..|||...++..+. .++.+++..+++++.|++.||.++|++- ++  |+||||||.||+++.+|.+|++|||+++++.
T Consensus       102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999987664 3556999999999999999999999943 44  9999999999999999999999999999887


Q ss_pred             CCC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          494 VPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       494 ~~~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      ...    ...|||.||+||.+.+..|+.||||||+||++|||+.-.+||.+.      ++.....++...+.. .+    
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~~-~~----  248 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDYP-PL----  248 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCCC-CC----
Confidence            643    457999999999999999999999999999999999999999864      344444444333221 00    


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                           ..+.....+..|+..|+..||+.||+...++..+.
T Consensus       249 -----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  249 -----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                 11455667888889999999999999655555444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=337.54  Aligned_cols=237  Identities=23%  Similarity=0.372  Sum_probs=195.8

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||.++.++ ++.+|+|++++...    ..+...+|..++.++ +||+||.+...|++.+..|+|+||+.
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccC
Confidence            4789999999999999654 78899999987643    234577899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      ||.|...|++..     .+++..+.-++..|+.||.|||+++   ||||||||+|||||++|+++|+|||+++.....  
T Consensus       109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999997432     4899999999999999999999999   999999999999999999999999999854332  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        .+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+.      ..+.+++..+...         ..
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k~~---------~~  245 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGKLP---------LP  245 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCcCC---------CC
Confidence              345799999999999999999999999999999999999999986543      3344454444311         11


Q ss_pred             cC-hHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 006677          574 QN-IEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR  606 (635)
Q Consensus       574 ~~-~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~  606 (635)
                      +. .+.   ...+++...++.||++|.    .+.++.+
T Consensus       246 p~~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  246 PGYLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             CccCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            11 233   345556699999999996    4555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=369.38  Aligned_cols=249  Identities=26%  Similarity=0.514  Sum_probs=215.4

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .++||.|.||+||+|+++-    ...||||.++....  .+.+|..|+.||.+. .||||++|-|+.......+||+|||
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyM  712 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYM  712 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhh
Confidence            6899999999999999763    34699999987643  357899999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|+.||+.+.+    .+++-+...|+.+||.||+||-+++   +|||||.++|||++.+..+||+|||+++...++.
T Consensus       713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999987654    3999999999999999999999998   9999999999999999999999999999875543


Q ss_pred             -CCCC------CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 -TPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 -~~~~------~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                       ....      ..+|.|||.+..++++.++|||||||+|||.++ |..||+++...+..       +.+.+++       
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-------kaIe~gy-------  851 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------KAIEQGY-------  851 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-------HHHHhcc-------
Confidence             2222      246999999999999999999999999999877 99999987765432       2222222       


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                         +.+.+.++...|.+||..||++|-.+||++.||+..|+++.....
T Consensus       852 ---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  852 ---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             ---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence               445566788899999999999999999999999999999986543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=348.60  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=204.1

Q ss_pred             HhhccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          341 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ...+.||+|.||+||+|++.  ..||||+++-....   .+.|+.|+.++++- +|.||+-+.|+|..+.. .||+.+|+
T Consensus       395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-eeeehhcc
Confidence            45789999999999999986  46999999765433   46799999999998 99999999999998877 99999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      |-+|+.++|-.+    ..++..+.+.|+.|||+||.|||.++   |||||||..||++.++++|||+|||++..-..-  
T Consensus       471 GsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  471 GSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             Cchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            999999999654    34889999999999999999999998   999999999999999999999999998653221  


Q ss_pred             ----CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ----ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                          ....+...|||||+++.   .+|++++||||||+|+|||+||..||.....+.++-.       +..++..  .|.
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------VGrG~l~--pd~  614 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------VGRGYLM--PDL  614 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------ecccccC--ccc
Confidence                12345667999999964   3589999999999999999999999995444433211       1111110  111


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      .    .....+.+++.+|+..||..++++||.+.+|+..|+++....+.
T Consensus       615 s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  615 S----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             h----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            1    11234455667777799999999999999999999999985443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.3e-42  Score=324.47  Aligned_cols=255  Identities=22%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ..++|+|+||.|||++.++ |+.||||++.....+   ++-..+|+++++.+ +|+|+|.++.+|......++|+|||+.
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dh   85 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDH   85 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecch
Confidence            3579999999999999765 788999999876543   45678999999999 999999999999999999999999988


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                       ++.+-|+....    .++...+.+++.|++.|+.|+|+++   +|||||||+|||++.++.+|++|||+|+.+..+.  
T Consensus        86 -TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   86 -TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             -HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence             55555554432    3889999999999999999999998   9999999999999999999999999999887443  


Q ss_pred             --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--------ChhHHHHHHhhhc-cccc
Q 006677          497 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--------DLPRWVQSVVREE-WTAE  564 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~  564 (635)
                        .+..|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-+..        +++.--++++..+ ....
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence              2346889999999987 67999999999999999999999999876532221        1111112222211 1111


Q ss_pred             cchhhhhccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          565 VFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       565 ~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +.-+.....+    .++.....+++++..|++.||.+|++-+|++.
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111110001    11223346788999999999999999999886

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=380.53  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=213.3

Q ss_pred             hccccccCceEEEEEEecC--CC----eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE--ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|.||.||.|...+  +.    .||||.++....  ...+|.+|..+|+.+ +|||||+++|+|.+....++++|
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEeh
Confidence            6789999999999999754  32    489999987633  467899999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAG--RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ||++|||..+|++.+...  ...++..+.+.++.|||+|+.||++++   +|||||.++|+||+....+||+|||+|+..
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhh
Confidence            999999999998764322  345889999999999999999999998   999999999999999999999999999844


Q ss_pred             CCCC-CCC-----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          493 NVPA-TPS-----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       493 ~~~~-~~~-----~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      .... ...     -...|||||.+..+.++.|+|||||||+|||++| |..||.+.+..+...      .....+     
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg-----  921 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG-----  921 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-----
Confidence            3222 111     1246999999999999999999999999999999 899998765443211      011111     


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS  621 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~  621 (635)
                            +.+.++.+...+.++|.+||+.+|++||++..+++.+.++.+......+.
T Consensus       922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~  971 (1025)
T KOG1095|consen  922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYG  971 (1025)
T ss_pred             ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccc
Confidence                  33445567778889999999999999999999999999998776654433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=348.04  Aligned_cols=239  Identities=23%  Similarity=0.376  Sum_probs=199.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCCh-HHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      -++||+|+.|.||.|.. ..++.||||++......+ +-...|+.+|+.. +|+|||.++..|...++.|+|||||++|+
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggs  356 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGS  356 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCc
Confidence            45799999999999984 567889999998776654 4577899999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----CC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----~~  496 (635)
                      |.+.+....      +++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++.....    ..
T Consensus       357 LTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  357 LTDVVTKTR------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             hhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            999997543      899999999999999999999999   99999999999999999999999999876643    34


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      +..||+.|||||+.....|++|+||||||++++||+.|.+||-..+.-      ..+.. +...-.        ......
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyL-Ia~ng~--------P~lk~~  492 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYL-IATNGT--------PKLKNP  492 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHH-HhhcCC--------CCcCCc
Confidence            567999999999999999999999999999999999999999753321      11111 111111        112222


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +.....|.++..+|++.|+++|+++.|+++
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            333445556666999999999999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=332.95  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=198.4

Q ss_pred             HhhccccccCceEEEEEEecC-CCeEEEEEeecccCC-hHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEec
Q 006677          341 ASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF  416 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~  416 (635)
                      ...+.||+|+||+||++...+ |...|||.+...... .+.+++|+.++.++ +|||||+++|.....+  .+++.|||+
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeeeecc
Confidence            346789999999999999765 888999998765322 45689999999999 6999999999865555  588999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCC-
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV-  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~-  494 (635)
                      ++|+|.+++.+..+    .+++..+..+..||++||+|||+++   ||||||||+|||++. ++.+||+|||+++.... 
T Consensus        99 ~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999986543    4999999999999999999999998   999999999999999 79999999999876652 


Q ss_pred             ------CCCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          495 ------PATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       495 ------~~~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                            .....||+.|||||++..+. ...++||||+||++.||+||+.||...     .....+.-.+........+  
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i--  244 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI--  244 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC--
Confidence                  12346899999999998633 345999999999999999999999753     1222333333333211111  


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                           ....++   ...+++.+|++.+|++||||+|++++--.....
T Consensus       245 -----p~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  245 -----PDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             -----CcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                 111233   344556699999999999999999976654433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=341.30  Aligned_cols=239  Identities=20%  Similarity=0.340  Sum_probs=197.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ++.||+|+|++|++|+.. .++++|||++.+...    ..+-..+|-++|.+|.+||.|++|+..|.++..+|.|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            467999999999999954 578999999976532    223466788899999899999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.++|++.     ..+++.....++.+|+.||+|||+.|   ||||||||+|||||.|+++||+|||.|+.+...  
T Consensus       158 nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  158 NGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             CCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999854     34999999999999999999999999   999999999999999999999999999876421  


Q ss_pred             ---------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          496 ---------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       496 ---------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                                     ...+||..|.+||++.....+..+|+|+|||++|+|+.|++||.+.++.-.      .+++    
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------FqkI----  299 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQKI----  299 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHHH----
Confidence                           124578889999999999999999999999999999999999987653211      1121    


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ++....-.+++++   ...+|+.+.+..||.+|+|.+||.++
T Consensus       300 -----~~l~y~fp~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  300 -----QALDYEFPEGFPE---DARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----HHhcccCCCCCCH---HHHHHHHHHHccCccccccHHHHhhC
Confidence                 1222222233333   44566669999999999999999885

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=338.46  Aligned_cols=257  Identities=21%  Similarity=0.364  Sum_probs=202.6

Q ss_pred             HhhccccccCceEEEEEEe-cCCCeEEEEEeecccCChHH--HHHHHHHHHhhcCCCceeceeEEEEeCC-eeEEEEEec
Q 006677          341 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRD--FEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYF  416 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~--~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~e~~  416 (635)
                      .+.++||.|+||+||+|+. ..+..||||+++......++  -.+|++.|+++..||||+++..++.+.+ ..++|||||
T Consensus        13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M   92 (538)
T KOG0661|consen   13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM   92 (538)
T ss_pred             HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence            3456799999999999994 45888999999987655444  4579999999955999999999999888 899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      +. +|+++++.+    ...+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+......
T Consensus        93 d~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   93 DC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             hh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence            76 999999864    346999999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ---CCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccc-----
Q 006677          497 ---TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAE-----  564 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~-~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  564 (635)
                         .+..|..|+|||++. ..-|+.+.||||+|||++|+.+-++-|.+.++-|  ++.+.+.-+...   .|...     
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHHHhCCCccccchhHHHHHH
Confidence               345688899999875 5678999999999999999999999998765433  332222222111   11110     


Q ss_pred             cchhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+...+...      .-.+....+.++++.+|++.||.+||||+|++++
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            000001000      0112355678888999999999999999999984

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.5e-41  Score=311.55  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=202.5

Q ss_pred             hhccccccCceEEEEEEe-cCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          342 SAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ..++||+|.||.||+|+. +.|+.||||+++.....   .....+|++.++.+ +|+||+.++++|...+...+|+|||+
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm~   84 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFMP   84 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEecc
Confidence            457899999999999995 56899999999876443   45688999999999 89999999999999999999999998


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      . ||...++..    ...++..+++.++.++++|++|||++.   |+||||||.|+|++++|.+||+|||+|+....+..
T Consensus        85 t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   85 T-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             c-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            7 999999754    345899999999999999999999998   99999999999999999999999999998876543


Q ss_pred             C----CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcccccc--ch
Q 006677          498 P----SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEV--FD  567 (635)
Q Consensus       498 ~----~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~d  567 (635)
                      .    ..|..|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.+.  ..++....+..-   .+.|..-.  -|
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCcccCcccccccc
Confidence            2    35788999998865 5699999999999999999999988876542  222222222211   12232111  11


Q ss_pred             hhh-h------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VEL-M------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~-~------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ... .      ...-++......++++..++..||.+|+|+.|++++
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            110 0      011223444567899999999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=337.09  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=207.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .++||+|-||+|.++....+..||||+++....  ..++|.+|+++|.++ +|||||+++|+|..++..++|+|||++|+
T Consensus       543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGD  621 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGD  621 (807)
T ss_pred             hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence            689999999999999999889999999987644  357899999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCC-
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-  499 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~-  499 (635)
                      |.+++..+...   .+......+|+.|||.||+||.+.+   +|||||.++|+|++.++++||+|||.++-+.....+. 
T Consensus       622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999866422   1455667889999999999999987   9999999999999999999999999998665444332 


Q ss_pred             -----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          500 -----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       500 -----~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                           -..+|||+|.+.-++++.++|||+||+++||+++  ...||...+.++.   ++-....+...-....       
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~-------  765 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV-------  765 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee-------
Confidence                 2367999999999999999999999999999887  7789987654432   2222222222211111       


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ...+..+...+.+++.+||+.+.++||+++++...|.+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            112345566788999999999999999999999998864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.2e-40  Score=341.90  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=198.1

Q ss_pred             hhccccccCceEEEEEEe------cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-eeEEE
Q 006677          342 SAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLV  412 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv  412 (635)
                      ..++||+|+||.||+|..      .++..||+|+++....  ..+.+.+|++++.++.+||||+++++++...+ ..++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI   90 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence            357899999999999974      2246799999875432  23568889999999988999999999987654 57899


Q ss_pred             EEeccCCChhhhccCCCCC---------------------------------------------------------CCCC
Q 006677          413 YDYFASGSLSTLLHGNRGA---------------------------------------------------------GRTP  435 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~  435 (635)
                      |||+++|+|.+++......                                                         ...+
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            9999999999998753210                                                         0234


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC------CCCCCCcccCccc
Q 006677          436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEV  509 (635)
Q Consensus       436 l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~  509 (635)
                      +++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......      ...++..|+|||+
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence            888999999999999999999998   9999999999999999999999999997653221      1224567999999


Q ss_pred             ccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHH
Q 006677          510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGM  588 (635)
Q Consensus       510 ~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  588 (635)
                      +.+..++.++|||||||++|||++ |..||......+     .... .........          ........+.+++.
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~-~~~~~~~~~----------~~~~~~~~l~~li~  311 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQ-RLKDGTRMR----------APENATPEIYRIML  311 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHH-HHhcCCCCC----------CCCCCCHHHHHHHH
Confidence            999999999999999999999997 999997643221     1111 111111100          01122345778888


Q ss_pred             HcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          589 ACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       589 ~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      +||+.||++|||+.|+++.|+++.+.
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.4e-40  Score=334.58  Aligned_cols=255  Identities=17%  Similarity=0.334  Sum_probs=204.1

Q ss_pred             CChHHHHHHhhccccccCceEEEEEEecCCCeEEEEEeecccCCh----HHHHHHHHHHHhhcCCCceeceeEEEEe---
Q 006677          333 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYS---  405 (635)
Q Consensus       333 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~---  405 (635)
                      ++.+++.......||+|++|.||+|.+ +++.||||+++......    +.+.+|+.++.++ +||||+++++++.+   
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD   92 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEeccc
Confidence            455666555557899999999999998 48899999997654332    5677999999999 99999999999877   


Q ss_pred             -CCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEE
Q 006677          406 -KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       406 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                       ....++||||+++|+|.+++...     ..+++.....++.|++.||+|||+. +   ++||||||+||++++++.+||
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence             34678999999999999999743     3488999999999999999999985 5   889999999999999999999


Q ss_pred             eecCCCCCCCCCC-CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          484 SDFGLTPLMNVPA-TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       484 ~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                      +|||+++...... ...++..|+|||++.+  ..++.++|||||||++|||++|+.||...+..      ..........
T Consensus       165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~  238 (283)
T PHA02988        165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKN  238 (283)
T ss_pred             cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcC
Confidence            9999988654432 3457788999999976  67999999999999999999999999854322      1222222111


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ....          ........+.+++.+||+.||++|||++|+++.|+.++.
T Consensus       239 ~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 NSLK----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCC----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            1100          001223456778889999999999999999999998763

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=339.53  Aligned_cols=239  Identities=25%  Similarity=0.416  Sum_probs=200.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+-||.|+-|.||+|+++ +..||||+++.      .-+.+++-|++| +||||+.+.|+|...-.++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhh------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            356999999999999997 68899998854      234567889999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---CCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---TPS  499 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---~~~  499 (635)
                      .+|+..     .++.......+..+||.||.|||.+.   |||||||.-||||+.+..+||+|||-++......   ...
T Consensus       201 ~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  201 EVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence            999853     35788888999999999999999987   9999999999999999999999999987765443   456


Q ss_pred             CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHH
Q 006677          500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE  579 (635)
Q Consensus       500 ~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  579 (635)
                      ||..|||||++...+.++|+||||||||||||+||..||...+...++    |         .   +-.+....+-++.+
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w---------G---VGsNsL~LpvPstc  336 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W---------G---VGSNSLHLPVPSTC  336 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E---------e---ccCCcccccCcccC
Confidence            899999999999999999999999999999999999999754322111    0         0   01111233444566


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       580 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ...|.-|+++||+..|.+||++.+++.+|+-+..
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            6677778889999999999999999999986553

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=345.87  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             hccccccCceEEEEEEecCC----Ce-EEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TT-VVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~-vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .++||+|+||+||+|.+..+    .. ||||..+...    ....++.+|+++++.+ +|||||+++|++..++..|+||
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivm  240 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVM  240 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEE
Confidence            47899999999999997542    23 8999988522    2356899999999998 9999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |+|+||+|.++|+...+    .++..++..++.+.|.||+|||+++   +|||||.++|+|++.++.+||+|||+++...
T Consensus       241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999986543    4999999999999999999999998   9999999999999999999999999987764


Q ss_pred             CCCC----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          494 VPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       494 ~~~~----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .-..    ..-...|+|||.+....|+.++|||||||++||+++ |..||.+....+      ....+...++.....+ 
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~~r~~~~~-  386 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNGYRMPIPS-  386 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcCccCCCCC-
Confidence            2111    113457999999999999999999999999999999 889998765332      2223324443332211 


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                               .....+..++.+||..+|++||+|.++.+.++.+......
T Consensus       387 ---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  387 ---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                     2234455666799999999999999999999999876553

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-40  Score=331.44  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=195.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .++||+|+||.||+|+. .+|+.||+|++.-....   .....+|+.+|+++ +||||+++.+...+.  ...|+|+|||
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYM  200 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYM  200 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecc
Confidence            36799999999999994 56889999999765422   34577899999999 999999999999887  6899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      +. ||..++...    .-.+++.+++.++.|++.||+|||.++   |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus       201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            88 999888742    234999999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC-----CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHHHHHhhhcccc------
Q 006677          497 TP-----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-PRWVQSVVREEWTA------  563 (635)
Q Consensus       497 ~~-----~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~------  563 (635)
                      ..     +-|..|+|||.+.+. .|+.++|+||.||||.||++|++.|++.++-+.... .+.+..-..+.|..      
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            22     347789999999775 599999999999999999999999998654332211 11111111122220      


Q ss_pred             ccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..+.+.-.-...+    .......++|+..++..||.+|.|+.++++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0010000000001    111233566777999999999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=320.36  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhc-CCCceeceeEEEEeCC----eeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKD----EKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lv~e~~~  417 (635)
                      .++||+|+||.||||.+. ++.||||++...  .++.|..|-+++.... +|+||++++++-...+    +++||+||.+
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            467999999999999987 589999999753  3567888887776543 8999999999987665    8899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------GPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      .|+|.++|..+      .++|....+|+..+++||+|||+..      +|+|+|||||++|||+..|+++.|+|||+|..
T Consensus       292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999999754      4999999999999999999999743      57899999999999999999999999999977


Q ss_pred             CCCCC------CCCCCCcccCcccccCCCC------CCccchhhHHHHHHHHHhCCCCCCC--------CCCCCCC--Ch
Q 006677          492 MNVPA------TPSRSAGYRAPEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQS--------PTRDDMV--DL  549 (635)
Q Consensus       492 ~~~~~------~~~~~~~y~aPE~~~~~~~------~~k~Dvws~Gvvl~el~tg~~p~~~--------~~~~~~~--~~  549 (635)
                      +....      ...||.+|||||++.+..-      -.+.||||+|.|||||++...-++.        ..+.+..  ..
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            65322      3568999999999976532      2368999999999999996544431        1111111  01


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      .+-.+..+-.+..+..+...+..    ...+..+.+.+..||..||+.|.|+.-+.+.+.++....+.
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            11222222222222222222211    24566788889999999999999999999999999877765

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=332.94  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=196.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc------CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|.||.|+.|... ++..||+|++....      ...+...+|+.+++++..||||++++.++......++||||
T Consensus        22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy  101 (370)
T KOG0583|consen   22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY  101 (370)
T ss_pred             eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence            467999999999999854 57999999765531      12445678999999995599999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCC-
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMN-  493 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~-  493 (635)
                      +.+|+|.+++.. .    ..+.+..+..++.|++.|++|||+.+   |+||||||+|||++.+ +++||+|||++.... 
T Consensus       102 ~~gGdL~~~i~~-~----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen  102 CSGGDLFDYIVN-K----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             cCCccHHHHHHH-c----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999985 2    34888999999999999999999999   9999999999999999 999999999998772 


Q ss_pred             ---CCCCCCCCCcccCcccccCCC-CC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          494 ---VPATPSRSAGYRAPEVIETRK-HS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       494 ---~~~~~~~~~~y~aPE~~~~~~-~~-~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                         ...+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+      ...-...+......      
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~~~~------  241 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKGEFK------  241 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcCCcc------
Confidence               234678999999999999987 86 77999999999999999999998632      22222222222111      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                         -.....  ..++.+++.+|+..+|.+|+|+.|++.
T Consensus       242 ---~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  242 ---IPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ---CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence               001110  445677778999999999999999994

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=306.17  Aligned_cols=237  Identities=19%  Similarity=0.265  Sum_probs=192.2

Q ss_pred             CChHHHHHHhhccccccCceEEEEEEec-CCCeEEEEEeecccC-C---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC
Q 006677          333 FDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-G---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD  407 (635)
Q Consensus       333 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~  407 (635)
                      +.+++..  +.+.||.|+||.|.+++.+ +|..+|+|++.+... .   .+....|..+++.+ .||+++++.+.+.+.+
T Consensus        41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNS  117 (355)
T ss_pred             cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCC
Confidence            4445542  3568999999999999975 477899999976533 2   23456688899999 8999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      ..|+||||++||.|++++++..     .+++..+..++.||+.|++|||+.+   |++|||||+|||+|.+|.+||+|||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence            9999999999999999998543     4999999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          488 LTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       488 la~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      +|+..... -+.+|||.|+|||++.+..|..++|+|||||++|||+.|.+||...+..      ....+++..+..    
T Consensus       190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v~----  259 (355)
T KOG0616|consen  190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKVK----  259 (355)
T ss_pred             ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCccc----
Confidence            99887654 3568999999999999999999999999999999999999999866542      223333332211    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMR  598 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  598 (635)
                              .++.....+.+|+...++.|-.+|
T Consensus       260 --------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 --------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                    111122234455557777777777

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-39  Score=335.72  Aligned_cols=240  Identities=25%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ++.||+|+.|.|-+|++ .+|+.+|||++.+..    .....+++|+-+|+.+ .||||++++++|++..++|+|.||++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEecC
Confidence            57799999999999995 568999999997662    1245688999888888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|.|++++-.     +.++++.++++++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|..-..+  
T Consensus        96 gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   96 GGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             CchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence            9999999963     446999999999999999999999998   999999999999999999999999999776544  


Q ss_pred             -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .+.+|++.|.|||++.+..| +.++||||+|||||-|+||+.||++.+      +...+.++.+..+-           
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G~f~-----------  230 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRGVFE-----------  230 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCccc-----------
Confidence             47789999999999999998 578999999999999999999998432      33333333222221           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                       -+.....+..+|+++|+..||+.|.|++||+++--
T Consensus       231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             -CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence             11223345567777999999999999999999643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=318.10  Aligned_cols=254  Identities=21%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||.|..++||+|+. ..+..||||++......  -+.+.+|+..+..+ +||||++++..|..+...|+||.||.+|
T Consensus        31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~G  109 (516)
T KOG0582|consen   31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGG  109 (516)
T ss_pred             EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCC
Confidence            46799999999999994 56789999999866443  46788899999888 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      ++.++++.....   .+++..+..|..++++||.|||++|   .||||||+.||||+.+|.+||+|||.+..+...    
T Consensus       110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            999999865533   3999999999999999999999999   999999999999999999999999976443222    


Q ss_pred             ----CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc--cch
Q 006677          496 ----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE--VFD  567 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~d  567 (635)
                          .+..+++.|||||++..  ..|+.|+||||||++..||.+|..||....+.++.     ...+-.......  ..+
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcccccCC
Confidence                34468999999999654  45999999999999999999999999854332211     111111111111  111


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhc
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQ  613 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~  613 (635)
                      ..     ........+.+++..|++.||++|||++++++  +++..+.
T Consensus       259 ~d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  259 KD-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hH-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            11     11122346788888999999999999999997  4554443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=329.95  Aligned_cols=239  Identities=25%  Similarity=0.381  Sum_probs=193.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|+-+ +|..+|+|++++...-    -+....|-.+|... .+|+||+++..|++.+.+||||||++
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecC
Confidence            468999999999999965 4788999999877542    24466788888886 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      |||+..+|..     ...|++..+...+.+++.|+..||+.|   +|||||||+|+|||..|++||+||||+.-...   
T Consensus       225 GGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  225 GGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             CccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            9999999974     446999999999999999999999999   99999999999999999999999999732100   


Q ss_pred             ----------------------C--------------------------CCCCCCCcccCcccccCCCCCCccchhhHHH
Q 006677          495 ----------------------P--------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV  526 (635)
Q Consensus       495 ----------------------~--------------------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gv  526 (635)
                                            .                          ....|||.|||||++.+..|+..+|+||+||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                                  0                          0123688899999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 006677          527 LLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MD  602 (635)
Q Consensus       527 vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~  602 (635)
                      |+|||+.|.+||.+.+..+. ..+..|.........               .....+..++|.+|+. ||++|.-   ++
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------VDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------CcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            99999999999998776553 334445443222111               1122455667779999 9999976   55


Q ss_pred             HHHH
Q 006677          603 EVVR  606 (635)
Q Consensus       603 evl~  606 (635)
                      ||.+
T Consensus       441 EIK~  444 (550)
T KOG0605|consen  441 EIKK  444 (550)
T ss_pred             HHhc
Confidence            5554

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=337.16  Aligned_cols=232  Identities=25%  Similarity=0.351  Sum_probs=195.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|.||.|+++..+. ++.+|||++++...    +-+....|..|+....+||.+++++..|+..++.|.||||+.
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            5789999999999999764 67899999998743    234567788888888789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----  493 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----  493 (635)
                      |||+..+.+.      ..+++..+..++..|+.||+|||+++   |||||||.+|||||.+|++||+|||+++..-    
T Consensus       453 Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  453 GGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             CCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9997666653      24999999999999999999999999   9999999999999999999999999997643    


Q ss_pred             CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       494 ~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      ...+.+||+.|||||++.+..|+..+|+|||||+||||+.|..||.+.++++..+      +++.++..           
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------sI~~d~~~-----------  586 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------SIVNDEVR-----------  586 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHhcCCCC-----------
Confidence            2346689999999999999999999999999999999999999999877665432      22222211           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM  601 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~  601 (635)
                       .+.....+.+.++++.+..+|++|.-+
T Consensus       587 -yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 -YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCcccHHHHHHHHHHhccCcccccCC
Confidence             122334566777889999999999877

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=330.45  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=215.2

Q ss_pred             hhccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          342 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ...+||-|.||.||.|.|+. .-.||||.++.....-++|..|..+|+.+ +|||+|+++|+|..+-..|||+|||..|+
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            36789999999999999875 56799999999888889999999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCC-
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-  499 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~-  499 (635)
                      |.++|++..   +..++.-..+.|+.||+.||+||..++   +|||||.++|+|+.++..+||+|||+++++..+..+. 
T Consensus       350 LLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  350 LLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             HHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence            999998764   345777788999999999999999988   9999999999999999999999999999987554221 


Q ss_pred             ----CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          500 ----RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       500 ----~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                          -...|.|||.+....++.|+|||+|||+|||+.| |..||.+.+..       .+...+..++.+          .
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEkgyRM----------~  486 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEKGYRM----------D  486 (1157)
T ss_pred             cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhccccc----------c
Confidence                2345999999999999999999999999999999 88999865422       233333333322          2


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .++.+...+.+||+.||+..|.+||+++|+-+.++.|....+
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            334566778899999999999999999999999999986554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=315.32  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=200.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhc-CCCceeceeEEEEeCC----eeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKD----EKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lv~e~~~  417 (635)
                      .+.||+|.||+||+|.++ |..||||++...  +++.+.+|.++++-+. +|+||+.+++.-..++    ++|||++|.+
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            578999999999999998 789999999753  3567888888887433 9999999998865443    6799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-----MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      .|+|+|+|..      ..++....++++..+|.||+|||-     +|+|.|+|||||+.|||+..++.+.|+|+|+|-..
T Consensus       293 ~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  293 HGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             CCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            9999999974      359999999999999999999995     67899999999999999999999999999998654


Q ss_pred             CCC--------CCCCCCCcccCcccccCCCC-----C-CccchhhHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006677          493 NVP--------ATPSRSAGYRAPEVIETRKH-----S-HKSDVYSFGVLLLEMLTG----------KAPLQSPTRDDMVD  548 (635)
Q Consensus       493 ~~~--------~~~~~~~~y~aPE~~~~~~~-----~-~k~Dvws~Gvvl~el~tg----------~~p~~~~~~~~~~~  548 (635)
                      ...        ....||-+|||||++.....     + ..+||||||.|+||+...          +.||.+....+-  
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--  444 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP--  444 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--
Confidence            332        34568999999999965321     2 358999999999998873          556654332221  


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      -.+-.++.+-....+..+    ...-...+.+..+.++|+.||..+|..|.|+=.+.+.|.++.+..
T Consensus       445 s~eeMrkVVCv~~~RP~i----pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNI----PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             CHHHHhcceeecccCCCC----CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            011122222222222122    222234678889999999999999999999999999999998643

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=344.26  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=207.4

Q ss_pred             HHhhccccccCceEEEEEEecCC-CeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEE-EEe------CCeeE
Q 006677          340 RASAEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAY-YYS------KDEKL  410 (635)
Q Consensus       340 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~------~~~~~  410 (635)
                      ....+.|.+|||+.||.|....+ ..+|+|++-... ..-+...+|+++|++|..|+|||.+++. ...      .-+.+
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl  118 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL  118 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence            34467899999999999998776 999999987652 2346788999999999889999999993 221      13678


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      |.||||.+|.|-+++......   .|++.++++|+.|+++|+++||... |+|||||||-+||||+.+++.||||||.|.
T Consensus       119 lLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  119 LLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            999999999999999754422   2999999999999999999999985 889999999999999999999999999886


Q ss_pred             CCCCCC-------------CCCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          491 LMNVPA-------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       491 ~~~~~~-------------~~~~~~~y~aPE~~---~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ..-...             ....|+.|+|||.+   .+..+++|+|||||||+||-|+....||+....-.         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            432221             12357889999987   56789999999999999999999999998542211         


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                                +....+ .++..+.+...+.+||+.||+++|.+||++.+|+..+-+|......
T Consensus       266 ----------Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  266 ----------ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             ----------EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                      122222 2334457778888999999999999999999999999999876654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.9e-38  Score=323.79  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=194.7

Q ss_pred             hccccccCceEEEEEEecC-----------------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      .+.||+|+||.||+|.+++                 +..||+|.+.....  ...++.+|++++.++ +||||+++++++
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~   88 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC   88 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence            4679999999999998542                 23699999875432  245788999999999 999999999999


Q ss_pred             EeCCeeEEEEEeccCCChhhhccCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006677          404 YSKDEKLLVYDYFASGSLSTLLHGNRG--------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK  469 (635)
Q Consensus       404 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  469 (635)
                      ...+..++||||+++|+|.+++.....              .....+++..+..++.||+.||+|||+.+   |+|||||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlk  165 (304)
T cd05096          89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA  165 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcc
Confidence            999999999999999999998854321              11234788999999999999999999998   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCC
Q 006677          470 ASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSP  541 (635)
Q Consensus       470 ~~NIll~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t--g~~p~~~~  541 (635)
                      |+||++++++.+||+|||+++......      ...++..|+|||++.+..++.++||||||+++|||++  +..||...
T Consensus       166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            999999999999999999987653322      2234667999999988899999999999999999997  56777654


Q ss_pred             CCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          542 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ...+   .............. ...      ..........+.+++.+||+.+|++|||+.||.+.|+
T Consensus       246 ~~~~---~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         246 TDEQ---VIENAGEFFRDQGR-QVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CHHH---HHHHHHHHhhhccc-ccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            3221   22222221111100 000      0001123346788889999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.8e-38  Score=320.13  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=193.5

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|.. .+++.||+|.+.....    ....+.+|++++.++ +|+||+++++++..++..++||||++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecC
Confidence            36799999999999996 4688999999865432    234577899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++....... 
T Consensus        84 ~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          84 GGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             CCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            999988875322   234899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||++.+..++.++|||||||++|||++|+.||.........   .-.........        .   .
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~---~  223 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------E---E  223 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc--------c---c
Confidence              335788999999999999999999999999999999999999865432211   11111111100        0   0


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ........+.+++.+||+.||++||+     ++|++++
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            01112335667888999999999997     7888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-39  Score=325.58  Aligned_cols=237  Identities=22%  Similarity=0.384  Sum_probs=198.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCCh---HHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|.||.||||+-+. .+.||+|.+.+....+   +...+|+++++++ +|||||.++++|+...+.++|+||+.|
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhhh
Confidence            4569999999999999664 5778999987765544   3477899999999 999999999999999999999999987


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                       +|..++....     .++++.+..|+.++..||.|||+.+   |+|||+||.|||++..+.+|++|||+|+.+....  
T Consensus        86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence             9999997543     4999999999999999999999998   9999999999999999999999999999886543  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...|||-|||||+..++.|+..+|+||+||++|||++|++||....      +...+..+..+...            
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v~------------  218 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPVK------------  218 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCCC------------
Confidence              2358999999999999999999999999999999999999997432      22334444433211            


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+......+..++...+..||..|.+..+++.+
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            112334456666679999999999999999873

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.1e-38  Score=331.22  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=197.2

Q ss_pred             hhccccccCceEEEEEEe------cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||+|..      ..+..||||+++....  ..+.+.+|+.++..+.+||||+++++++...+..++||
T Consensus        39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~  118 (375)
T cd05104          39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT  118 (375)
T ss_pred             hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence            367899999999999973      2356799999875432  24568889999999988999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCC--------------------------------------------------------------
Q 006677          414 DYFASGSLSTLLHGNRGA--------------------------------------------------------------  431 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~--------------------------------------------------------------  431 (635)
                      ||+++|+|.++++.....                                                              
T Consensus       119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (375)
T cd05104         119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD  198 (375)
T ss_pred             hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence            999999999998653210                                                              


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC------
Q 006677          432 --------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT------  497 (635)
Q Consensus       432 --------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~------  497 (635)
                              ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......      
T Consensus       199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence                    0124789999999999999999999998   99999999999999999999999999876543221      


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++|||||||++|||++ |..||.......  ...    ..+.......       .   .
T Consensus       276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~~~~~~~-------~---~  339 (375)
T cd05104         276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIKEGYRML-------S---P  339 (375)
T ss_pred             CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHHhCccCC-------C---C
Confidence            123456999999999999999999999999999998 889987543211  111    1111111110       0   0


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      .....++.+++.+||+.||++||++.|+++.|++.
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            11124577888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-37  Score=312.29  Aligned_cols=241  Identities=24%  Similarity=0.401  Sum_probs=197.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||++.++++..+|+|.+........++.+|+++++++ +||||+++++++..++..++||||+++|+|.
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   87 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLL   87 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            467999999999999998888999999876666677899999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-----
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-----  497 (635)
                      ++++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||.++.......     
T Consensus        88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence            9987433    24889999999999999999999998   99999999999999999999999999876533221     


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||.....      ......+......   ..        .
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~---~~--------~  223 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL---YR--------P  223 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC---CC--------C
Confidence            123456999999998889999999999999999999 8999975432      1112222211110   00        0


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ......+.+++.+||+.+|++||+++|+++.|
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            11234578888999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=324.92  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=213.5

Q ss_pred             CCChHHHHHHhhccccccCceEEEEEEecC---C--CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEE
Q 006677          332 NFDLEDLLRASAEVLGKGSYGTAYKAVLEE---S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY  404 (635)
Q Consensus       332 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~  404 (635)
                      +|.++.-.....++||.|.||.||+|.+.+   |  -.||||.-+....  +.+.|.+|..+++.+ +||||++++|+|.
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCV  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeee
Confidence            344333333457899999999999999643   3  3488998876533  466799999999999 9999999999996


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       405 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                      + ...|+|||.++-|.|..+|+.++.    .++......++.||+.||+|||+..   +|||||.++|||+....-+|++
T Consensus       462 e-~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  462 E-QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             c-cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeec
Confidence            5 588999999999999999987654    3888999999999999999999987   9999999999999999999999


Q ss_pred             ecCCCCCCCCCCCCCCC-----CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          485 DFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       485 DfGla~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      |||+++.+.....+..+     ..|||||.+.-++++.++|||.|||.+||++. |..||.+-...+.....        
T Consensus       534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------  605 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------  605 (974)
T ss_pred             ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--------
Confidence            99999998776544433     34999999999999999999999999999887 99999987655532110        


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                               .+-.+.+-++.+.-.+..++.+||.++|.+||++.|+...|.++.+.+
T Consensus       606 ---------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  606 ---------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             ---------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence                     011234455667778889999999999999999999999999998743

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=322.08  Aligned_cols=238  Identities=25%  Similarity=0.412  Sum_probs=197.3

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ++||+|.||.||+|... .++.||+|++.....  ...+.++|+.++..+ +++||.++++.+..+..++++||||.+|+
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            67999999999999965 467899999976543  356889999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----CC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----~~  496 (635)
                      +.+.++..     ..+++.....|+.++..|+.|||.++   .+|||||+.|||+..+|.+|++|||++..+..    ..
T Consensus        98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            99999743     33588888889999999999999998   99999999999999999999999999876643    35


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      +..||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+....-+       +.+.     .-+.+   .+ 
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~-----~PP~L---~~-  233 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKS-----APPRL---DG-  233 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCC-----CCCcc---cc-
Confidence            67799999999999988999999999999999999999999986654322111       0000     00111   11 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .....+.+++..|++.+|+.||+|.+++++
T Consensus       234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence             233446667779999999999999999873

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.6e-38  Score=332.84  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=197.4

Q ss_pred             HhhccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          341 ASAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      ...+.||+|+||.||+|...      ++..||+|+++.....  ...+.+|+++++.+.+|+||+++++++......++|
T Consensus        41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv  120 (374)
T cd05106          41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI  120 (374)
T ss_pred             eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence            34678999999999998742      2357999999754322  346788999999987899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCC--------------------------------------------------------------
Q 006677          413 YDYFASGSLSTLLHGNRG--------------------------------------------------------------  430 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~--------------------------------------------------------------  430 (635)
                      |||+++|+|.++++....                                                              
T Consensus       121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (374)
T cd05106         121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE  200 (374)
T ss_pred             HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence            999999999998854211                                                              


Q ss_pred             ---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC------CCCC
Q 006677          431 ---AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT------PSRS  501 (635)
Q Consensus       431 ---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~------~~~~  501 (635)
                         .....+++..+.+++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......      ..++
T Consensus       201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  277 (374)
T cd05106         201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP  277 (374)
T ss_pred             hccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence               01134788999999999999999999998   99999999999999999999999999876543221      1234


Q ss_pred             CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHH
Q 006677          502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM  580 (635)
Q Consensus       502 ~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  580 (635)
                      ..|+|||++.+..++.++|||||||++|||++ |+.||.......  .    .............       .   ....
T Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~~-------~---~~~~  341 (374)
T cd05106         278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMSR-------P---DFAP  341 (374)
T ss_pred             cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCccC-------C---CCCC
Confidence            56999999998899999999999999999997 999997543221  0    1111111111000       0   0112


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          581 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       581 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            45677888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-38  Score=315.37  Aligned_cols=245  Identities=26%  Similarity=0.442  Sum_probs=200.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .++||+|+||.||+|...++..|++|.+.......+.+.+|+.+++++ +|+||+++++++...+..+++|||+++|+|.
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLL   89 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence            568999999999999988888999999876555567889999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-----
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-----  497 (635)
                      ++++...   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........     
T Consensus        90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05072          90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG  163 (261)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence            9997543   234888999999999999999999988   99999999999999999999999999976543221     


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++....++.++|||||||++|||+| |+.||......+   .    .......+..          +..
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~----------~~~  226 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---V----MSALQRGYRM----------PRM  226 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCCC----------CCC
Confidence            123457999999998889999999999999999998 999997543211   1    1111111110          001


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ......+.+++.+|+..+|++||+++++++.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11234567888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-38  Score=326.07  Aligned_cols=237  Identities=20%  Similarity=0.289  Sum_probs=191.5

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||++... +++.||+|+++....    ....+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999864 578899999976422    124567789999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            9999998643     34899999999999999999999998   999999999999999999999999998753221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+.....       .     
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~-------~-----  213 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-------R-----  213 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC-------C-----
Confidence             2335789999999999999999999999999999999999999754321      11111111110       0     


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ........+.+++.+|++.||++||     ++.|++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            0011233566778899999999999     79998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.2e-37  Score=321.37  Aligned_cols=238  Identities=22%  Similarity=0.344  Sum_probs=187.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|++.....  ....+.+|+++++++ +|+||+++++++...+..++||||+++|
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            568999999999999965 578999999865432  245688999999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+..         ..++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....    
T Consensus       158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            986543         2567788899999999999999998   999999999999999999999999998765432    


Q ss_pred             CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          496 ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      ....++..|+|||++..     ...+.++|||||||++|||++|+.||......+.   ............         
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~---------  293 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQP---------  293 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccCC---------
Confidence            23457889999998843     2345689999999999999999999974332221   111111110000         


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..........+.+++.+||+.||++||++.|++++
T Consensus       294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00011223457788889999999999999999985

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-37  Score=312.62  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=195.7

Q ss_pred             hhccccccCceEEEEEEec----CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          342 SAEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      ..+.||+|+||.||+|.+.    .+..||+|.++.....  ...+.+|+.++.++ +||||+++++++...+..++||||
T Consensus         9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~   87 (266)
T cd05064           9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEY   87 (266)
T ss_pred             EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEe
Confidence            3568999999999999854    3567999998765332  34688899999998 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+......
T Consensus        88 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          88 MSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999997432    34899999999999999999999998   999999999999999999999999987553222


Q ss_pred             C-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          496 A-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       496 ~-----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      .     ...++..|+|||++.+..++.++|||||||++||+++ |..||......+      ....+ .+...       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~-~~~~~-------  226 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAV-EDGFR-------  226 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHH-HCCCC-------
Confidence            1     1123467999999999999999999999999999875 999997543221      11111 11111       


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                         .+........+.+++.+||+.+|++||+++|+.+.|+++
T Consensus       227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               011122344677788899999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-37  Score=317.10  Aligned_cols=247  Identities=27%  Similarity=0.478  Sum_probs=197.2

Q ss_pred             hccccccCceEEEEEEecCC------CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|.....      ..|++|.+.....  ...++.+|++++.++ +||||+++++++...+..+++||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e   88 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFE   88 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEe
Confidence            46799999999999986532      4689998875432  245688999999999 99999999999999899999999


Q ss_pred             eccCCChhhhccCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEE
Q 006677          415 YFASGSLSTLLHGNRGAG-----------RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                      |+++|+|.+++.......           ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L  165 (283)
T cd05048          89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence            999999999997543211           145889999999999999999999998   999999999999999999999


Q ss_pred             eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006677          484 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       484 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  556 (635)
                      +|||+++......      ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+   +   ... 
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---~~~-  238 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---IEM-  238 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHH-
Confidence            9999987543221      2234667999999988899999999999999999998 999997643221   1   111 


Q ss_pred             hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       557 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      +......          .........+.+++.+||+.+|.+||++.||+++|+.
T Consensus       239 i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 IRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1111110          0112334567788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-38  Score=301.48  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~  416 (635)
                      .+.|++|+||.||+|+.+. +..||+|+++-....   .-...+|+.++.++ +|||||.+-.+...  -+..|+|||||
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeeeeHHHH
Confidence            4679999999999999764 677999999754321   12467899999999 89999999888764  35799999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      +. ||..+++...    +++...+++.++.|+++|++|||...   |+|||||++|+|++..|.+||+|||+|+.+..+.
T Consensus       160 Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  160 EH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             Hh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            88 9999998644    45899999999999999999999998   9999999999999999999999999999988763


Q ss_pred             CC----CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccchhh
Q 006677          497 TP----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFDVE  569 (635)
Q Consensus       497 ~~----~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d~~  569 (635)
                      ..    ..|..|+|||.+.+. .|++..|+||+|||+.||+++++-|.+..+-+.  +....+-.-  .+..........
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccCCCccccc
Confidence            32    357889999998765 599999999999999999999999987654332  222221111  011111110000


Q ss_pred             ----hh-----------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          570 ----LM-----------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       570 ----~~-----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ..           .+.... ....-++++...+..||.+|.|++|.+++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence                00           011111 11345667779999999999999999874

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-37  Score=323.52  Aligned_cols=245  Identities=19%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||++... +++.||+|+++....    ..+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999975 478899999986432    2345778888988887899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----  494 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....    
T Consensus        81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            9999888632     24899999999999999999999998   99999999999999999999999999865321    


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD--MVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||+.....+  ......+...........        .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--------I  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--------C
Confidence            123457889999999999999999999999999999999999997533222  111222322222221100        0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  607 (635)
                      .   ......+.+++.+|++.||.+||+      ++|++++
T Consensus       225 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 P---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             C---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            0   112234667888999999999997      6777653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=312.16  Aligned_cols=245  Identities=26%  Similarity=0.439  Sum_probs=200.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||+|...+++.||+|.++......+++.+|+++++++ +|+||+++++++...+..++||||+++++|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   89 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL   89 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence            478999999999999988888899999976665677899999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC--CCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSR  500 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~--~~~  500 (635)
                      +++....   ...+++..+..++.|++.|+.|||+.+   ++||||||+||++++++.++|+|||+++.......  ..+
T Consensus        90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  163 (261)
T cd05068          90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG  163 (261)
T ss_pred             HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence            9997533   234899999999999999999999998   99999999999999999999999999876543211  112


Q ss_pred             ---CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          501 ---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       501 ---~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                         ...|+|||++.+..++.++||||||+++|||+| |+.||.+....+       ..........          ....
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~----------~~~~  226 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR----------MPCP  226 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----------CCCC
Confidence               246999999999899999999999999999999 999997543211       1111111110          0011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ......+.+++.+|++.+|++||++.++++.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            12335677888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-38  Score=315.86  Aligned_cols=242  Identities=29%  Similarity=0.520  Sum_probs=188.3

Q ss_pred             hccccccCceEEEEEEec-----CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|.||.||+|.+.     .+..|+||.++....  ..+++.+|++.+.++ +||||++++|++...+..++|+||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccc
Confidence            367999999999999987     256799999965432  257899999999999 999999999999988889999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...   ...+++..+..|+.||+.||+|||+.+   ++|+||+++||+++.++.+||+|||++......
T Consensus        83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999998652   235899999999999999999999988   999999999999999999999999998766321


Q ss_pred             ------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                            ........|+|||.+.+..++.++||||||+++|||++ |+.||....      ...+...+...... .    
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~~~~~~~-~----  225 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKLKQGQRL-P----  225 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHHHTTEET-T----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccc-e----
Confidence                  11224557999999999889999999999999999999 678886432      22223333222111 1    


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                            ........+.+++.+||+.+|++||++.|+++.|
T Consensus       226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  1112234567888899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-38  Score=292.97  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=205.3

Q ss_pred             CCChHHHHHHhhccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeC
Q 006677          332 NFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK  406 (635)
Q Consensus       332 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~  406 (635)
                      .+.+++.  ..++.||+|-||.||.|+.+. +-.||+|++.+.+.    -..++.+|+++-..| +||||.+++++|.+.
T Consensus        18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS   94 (281)
T ss_pred             ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc
Confidence            3555555  347889999999999999654 66799999987643    256788999999999 999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          407 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       407 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      ...|+++||...|++...|...+.   ..+++.....++.|+|.|+.|+|..+   ||||||||+|+|++.++..||+||
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            999999999999999999985443   34888889999999999999999987   999999999999999999999999


Q ss_pred             CCCCCCC--CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          487 GLTPLMN--VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       487 Gla~~~~--~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      |-+....  ...+.+||..|.+||...+..++.++|+|++|+++||++.|.+||......+..      +++..-    +
T Consensus       169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY------krI~k~----~  238 (281)
T KOG0580|consen  169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY------KRIRKV----D  238 (281)
T ss_pred             CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH------HHHHHc----c
Confidence            9875543  344678999999999999999999999999999999999999999876533221      111111    1


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      +.+        ++.......+++.+|+..+|.+|.+..|++++-
T Consensus       239 ~~~--------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  239 LKF--------PSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ccC--------CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            111        122334556777899999999999999998864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-37  Score=322.93  Aligned_cols=192  Identities=22%  Similarity=0.368  Sum_probs=166.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... ++..+|+|.+.....  ....+.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG   88 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence            467999999999999976 467788888865422  245688999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--CC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--~~  497 (635)
                      +|.+++...     ..+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++......  ..
T Consensus        89 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  161 (331)
T cd06649          89 SLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  161 (331)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence            999999743     24889999999999999999999853  3999999999999999999999999998765432  23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            357889999999999899999999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-38  Score=306.27  Aligned_cols=241  Identities=22%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             HhhccccccCceEEEEEEe-cCCCeEEEEEeecccCC-hH---HHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          341 ASAEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG-KR---DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      ...+.||+|.||.|-+|.. ..|+.||||.+++.... ++   .+.+|+++|..| +||||+.++.+|++.+...+||||
T Consensus        56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEY  134 (668)
T KOG0611|consen   56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEY  134 (668)
T ss_pred             HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEe
Confidence            4457899999999999985 67999999999876442 33   478899999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      ..+|.|++++...     ..+++.++..++.||..|+.|+|.++   ++|||||.+|||+|+++++||+|||++..+...
T Consensus       135 aS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  135 ASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             cCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999753     34999999999999999999999998   999999999999999999999999999877654


Q ss_pred             C---CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 A---TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .   +.+|++-|.+||++.+.+| ++.+|.||+||+||-|+.|..||++.+      .-..++.+-...+.    .+   
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYr----EP---  273 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYR----EP---  273 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhccccc----CC---
Confidence            3   6789999999999999998 578999999999999999999998643      22233333333222    11   


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                            +......-||+.|+..+|++|-|..+|..+..
T Consensus       274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  274 ------ETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                  11123345677999999999999999999876

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-37  Score=321.42  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=191.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||+|... +++.||+|+++....    ....+.+|+.++.++.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999975 467899999976432    2234667888888777899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence            9999888643     24899999999999999999999998   999999999999999999999999998753221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhccccccchhhhhc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--VDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||......+.  .....+..........          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence             233578899999999999999999999999999999999999964322211  1122222222211110          


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPN------MDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  607 (635)
                       ..+......+.+++.+|++.||++||+      +.+++++
T Consensus       223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             001112345667888999999999998      4676654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=290.36  Aligned_cols=254  Identities=19%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             hhccccccCceEEEEEE-ecCCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEEE
Q 006677          342 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD  414 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e  414 (635)
                      ..+.+|+|||+-||.++ ..++..+|+|++.-.. .+.+...+|++..+++ +||||++++++...+     ...|++++
T Consensus        25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~P  103 (302)
T KOG2345|consen   25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLP  103 (302)
T ss_pred             EeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEee
Confidence            35679999999999999 5667889999987554 4567788999999999 999999998887543     35899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+..|+|.+.+..... ++..+++.+.+.|+.+|++||++||+.. |+++||||||.|||+.+.+.+++.|||.++...-
T Consensus       104 yy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i  181 (302)
T KOG2345|consen  104 YYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI  181 (302)
T ss_pred             hhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccce
Confidence            9999999999986553 3556999999999999999999999986 6899999999999999999999999999876542


Q ss_pred             CC-------------CCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          495 PA-------------TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       495 ~~-------------~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      .-             ...-|..|+|||.+.   +...++++|||||||++|+|+.|..||+..-.. +..+         
T Consensus       182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl---------  251 (302)
T KOG2345|consen  182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL---------  251 (302)
T ss_pred             EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE---------
Confidence            11             112367799999985   445789999999999999999999999754321 1110         


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                         ...+....+ ..+.-......+.+++.+|++.||.+||+..|++..++++.
T Consensus       252 ---aLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ---ALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---EEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence               011111111 11111224556777888999999999999999999998764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.2e-37  Score=308.72  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|... .++.|++|+++.......++.+|++++.++ +|+||+++++++..++..++||||+++++|
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL   89 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence            467999999999999965 477899999876555567789999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........    
T Consensus        90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence            99986532   234899999999999999999999998   99999999999999999999999999876644321    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+..|+|||.+.+..++.++|||||||++|||++ |..||......      ....... .....          ..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~  226 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLE-KGYRM----------ER  226 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-CCCCC----------CC
Confidence             123457999999999999999999999999999998 99998754321      1111111 11110          00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      .......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111234577788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=320.42  Aligned_cols=235  Identities=20%  Similarity=0.301  Sum_probs=189.0

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||.||+|... +++.||+|+++...    .....+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999975 47789999987542    1234577899999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....    .
T Consensus        80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  151 (312)
T cd05585          80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN  151 (312)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence            99999642     24899999999999999999999998   999999999999999999999999998754221    2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||....      ..............         ..   
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~~---------~~---  213 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPLR---------FP---  213 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCCC---------CC---
Confidence            2357889999999999999999999999999999999999997543      22222222221110         01   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  607 (635)
                      ......+.+++.+||+.||++||+   +.|++.+
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            112234567778999999999985   5666553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3e-37  Score=321.07  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=193.5

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||+||+|... +++.||+|+++....    ..+.+.+|+.++.++.+|+||+.+++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999975 467899999986532    1245778888888887899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----  494 (635)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence            9999888632     24899999999999999999999998   99999999999999999999999999875322    


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      .....+++.|+|||++.+..++.++|||||||++|||++|+.||.............+...........        .. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~p-  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--------IP-  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--------CC-
Confidence            123457889999999999999999999999999999999999997544333333333333322221100        00 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  607 (635)
                        ......+.+++.+|++.||++|+++      ++++++
T Consensus       224 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 --RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence              1112345677789999999999985      466553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-37  Score=316.82  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=190.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... ++..||+|+++....  ....+.+|+.+++++ +||||+++++++...+..++||||+++ 
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~-   87 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS-   87 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence            467999999999999865 578899999875432  244677899999999 999999999999999999999999975 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++......   
T Consensus        88 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          88 DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            9998886432    24788999999999999999999998   9999999999999999999999999987543221   


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccccchhhh
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVEL  570 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~d~~~  570 (635)
                       ...+++.|+|||++.+ ..++.++||||+||++|||+||+.||...+..+...   .......    +.|.........
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccchhh
Confidence             2346788999999865 568999999999999999999999997654322111   0111000    001000000000


Q ss_pred             h-----cc--cC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 M-----RF--QN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~-----~~--~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .     ..  ..    .........+++.+|++.||.+|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0     00  00    00112346678889999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=318.76  Aligned_cols=238  Identities=17%  Similarity=0.246  Sum_probs=193.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|++.....    ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   84 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVP   84 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCC
Confidence            467999999999999975 578899999865421    235678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  156 (291)
T cd05612          85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW  156 (291)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence            99999999643     24889999999999999999999998   9999999999999999999999999987664332 


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+......       +  .   
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~-------~--~---  218 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKLE-------F--P---  218 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcC-------C--C---
Confidence            345788999999999988999999999999999999999999754321      112222211100       0  0   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ......+.+++.+|++.||.+||+     ++|++++
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            111234667888999999999995     8888875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4e-37  Score=327.09  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=198.6

Q ss_pred             hhccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..++||+|+||.||+|....      +..||||+++....  ..+.+.+|++++.++..||||+++++++......++||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT  120 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence            35789999999999998532      23699999975432  24568899999999956999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCC--------------------------------------------------------------
Q 006677          414 DYFASGSLSTLLHGNRGA--------------------------------------------------------------  431 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~--------------------------------------------------------------  431 (635)
                      ||+++|+|.++++.....                                                              
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (400)
T cd05105         121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY  200 (400)
T ss_pred             EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence            999999999988653210                                                              


Q ss_pred             -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          432 -----------------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       432 -----------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                                                   ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k  277 (400)
T cd05105         201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK  277 (400)
T ss_pred             hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence                                         0124788889999999999999999998   99999999999999999999


Q ss_pred             EeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006677          483 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS  555 (635)
Q Consensus       483 i~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  555 (635)
                      |+|||+++......      ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+.      ...
T Consensus       278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------~~~  351 (400)
T cd05105         278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------FYN  351 (400)
T ss_pred             EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------HHH
Confidence            99999987653221      1234567999999998899999999999999999997 9999975432211      111


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ........          .........+.+++.+||+.+|++||++.++.++|+++..
T Consensus       352 ~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 KIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111100          0111233567788899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-37  Score=322.78  Aligned_cols=238  Identities=20%  Similarity=0.264  Sum_probs=193.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|++.....    ..+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~  101 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVV  101 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence            568999999999999976 478899999875421    235678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       102 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  173 (329)
T PTZ00263        102 GGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF  173 (329)
T ss_pred             CChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence            99999998743     24788999999999999999999998   9999999999999999999999999997664432 


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+......         .... 
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~---------~p~~-  237 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRLK---------FPNW-  237 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCcC---------CCCC-
Confidence            345788999999999999999999999999999999999999754311      111121111100         0001 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                        ....+.+++.+||+.||++||+     +++++++
T Consensus       238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1234567888999999999997     6888765

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=324.53  Aligned_cols=246  Identities=20%  Similarity=0.306  Sum_probs=195.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|+++....    ....+.+|++++..+ +||||+++++++...+..++||||++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVP   84 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCC
Confidence            467999999999999976 478899999976432    234677899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-C
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-~  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... .
T Consensus        85 g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~  156 (333)
T cd05600          85 GGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN  156 (333)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence            99999999642     34889999999999999999999998   999999999999999999999999999765442 3


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|..||...+..+.      ...+..  +......+.. . ...
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~--~~~~~~~~~~-~-~~~  226 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKY--WKETLQRPVY-D-DPR  226 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHh--ccccccCCCC-C-ccc
Confidence            44688999999999999999999999999999999999999976432221      111110  0000000000 0 000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+|+..+|++||+++|++++
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1223456677789999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-37  Score=321.14  Aligned_cols=237  Identities=21%  Similarity=0.306  Sum_probs=191.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||++... +++.||+|++.....    ....+.+|+++++.+ +||||+++.+++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999965 578999999976422    234677888999998 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence            9999888642     24899999999999999999999998   999999999999999999999999998754221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+.....       .+  . 
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~~-------~~--p-  215 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEDI-------KF--P-  215 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCCc-------cC--C-
Confidence             2335788999999999989999999999999999999999999754321      11111111110       00  0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                        ......+.+++.+|++.||++||     ++.|++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 --RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              11223466777899999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.6e-37  Score=320.96  Aligned_cols=237  Identities=21%  Similarity=0.290  Sum_probs=190.7

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||++... ++..||+|+++....    ....+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            36999999999999964 578999999976422    234566788999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|..++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          80 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            9999888643     24899999999999999999999998   999999999999999999999999998753221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..+      ...........       .  . 
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~~~-------~--p-  215 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIR-------F--P-  215 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCCC-------C--C-
Confidence             22357889999999999999999999999999999999999997543211      11111111110       0  0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                        ......+.+++.+|++.||++||     ++.+++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              11223456777899999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-37  Score=316.43  Aligned_cols=256  Identities=17%  Similarity=0.222  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.||+|+++....   ..+.+.+|++++..+ +|+||+++++++..++..++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEK   84 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCC
Confidence            467999999999999976 467899999876432   245678899999999 999999999999999999999999998


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +.+..+...     ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            777655432     234889999999999999999999998   9999999999999999999999999997654321  


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh---------HHHHHHhhhccccc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP---------RWVQSVVREEWTAE  564 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~  564 (635)
                         ...++..|+|||++.+..++.++|||||||++|||++|+.||......+.....         .+............
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence               234678899999999888999999999999999999999999865422110000         00000000000000


Q ss_pred             cchhhhhcccC-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDVELMRFQN-----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+.......     .......+.+++.+|++.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000     01123457889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.8e-37  Score=319.51  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             hhccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV  412 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv  412 (635)
                      ..+.||+|+||.||+|...      .++.||+|+++.....  .+.+.+|++++.++.+|+||++++++|... ...+++
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v   90 (337)
T cd05054          11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (337)
T ss_pred             hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence            3578999999999999742      2467999998754322  345778999999998899999999988754 467899


Q ss_pred             EEeccCCChhhhccCCCCC--------------------------------------------------------CCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGA--------------------------------------------------------GRTPL  436 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l  436 (635)
                      |||+++|+|.+++......                                                        ....+
T Consensus        91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (337)
T cd05054          91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL  170 (337)
T ss_pred             EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence            9999999999998643210                                                        01258


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccc
Q 006677          437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVI  510 (635)
Q Consensus       437 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~  510 (635)
                      ++..+..++.||+.||+|||+.+   |+||||||+|||+++++.++|+|||++.......      ...++..|+|||++
T Consensus       171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  247 (337)
T cd05054         171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI  247 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence            99999999999999999999998   9999999999999999999999999997653221      12235679999999


Q ss_pred             cCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHH
Q 006677          511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA  589 (635)
Q Consensus       511 ~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  589 (635)
                      .+..++.++|||||||++|||++ |..||......+.      ...........          .........+.+++.+
T Consensus       248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~l~~~  311 (337)
T cd05054         248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM----------RAPEYATPEIYSIMLD  311 (337)
T ss_pred             cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC----------CCCccCCHHHHHHHHH
Confidence            99999999999999999999998 9999975432211      11111111110          0011223467888899


Q ss_pred             cccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          590 CVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       590 cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ||+.+|++||++.|++++|+++.+.
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-37  Score=308.81  Aligned_cols=242  Identities=25%  Similarity=0.422  Sum_probs=197.1

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..+.||+|+||.||+|..+++..+|+|.+........++.+|+++++++ +|+||+++++++...+..++||||+++++|
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            3567999999999999988778899999876555667888999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....    ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++.......    
T Consensus        87 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          87 LNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             HHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99997433    24899999999999999999999998   99999999999999999999999999876543221    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+..|+|||.+.+..++.++||||||+++|||++ |+.||......+   .   ... ......          ...
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~-~~~~~~----------~~~  222 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VES-VSAGYR----------LYR  222 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHH-HHcCCc----------CCC
Confidence             112346999999998899999999999999999999 899997543221   1   111 111100          000


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      .......+.+++.+||+.+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            112344677888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.3e-37  Score=306.19  Aligned_cols=242  Identities=23%  Similarity=0.353  Sum_probs=197.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|...++..+|+|.++.......++.+|+.++.++ +||||+++++++...+..++||||+.+|+|.
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL   87 (256)
T ss_pred             eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence            457999999999999988777899999886655677899999999999 8999999999999888999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-----
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-----  497 (635)
                      +++....    ..+++..+..++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||.++.......     
T Consensus        88 ~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          88 NYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence            9987532    24899999999999999999999998   99999999999999999999999999875533221     


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||......      ............           ...
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~-----------~~~  223 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLRL-----------YRP  223 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCCC-----------CCC
Confidence            123456999999988889999999999999999999 99998754321      111122111110           000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ......+.+++.+||+.+|++||++.++++.|+
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            112356788888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=318.33  Aligned_cols=241  Identities=22%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-eEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~e~~~  417 (635)
                      .+.+|+|+||.++.++.+ ++..+++|.+.-....   ++...+|+.++.++ +|||||.+.+.|..++. .+|||+|++
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecC
Confidence            467999999999999865 4678999998766443   34678899999998 99999999999999988 899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      ||++.+.+...+   +..++++.+..++.|++.|+.|||++.   |+|||||+.||+++.+..+||+|||+|+.+.... 
T Consensus        88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999998665   345899999999999999999999887   9999999999999999999999999999987654 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         +..||+.||.||++.+.+|..|+||||+||++|||++-+++|.+.+.      ...+.++.....           .
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki~~~~~-----------~  224 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKINRGLY-----------S  224 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHHhhccC-----------C
Confidence               45689999999999999999999999999999999999999986542      222333332221           1


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +....+..++..++..|++.+|+.||++.+++.+
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2224455677788889999999999999999985

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-37  Score=309.18  Aligned_cols=245  Identities=25%  Similarity=0.438  Sum_probs=198.5

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..++||+|+||+||+|...++..||+|+++......+.+.+|++++.++ +|+||+++++++. .+..++||||+++|+|
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L   87 (262)
T cd05071          10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSL   87 (262)
T ss_pred             EeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence            3567999999999999988777899999987655667899999999999 8999999999874 4567999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||.+........    
T Consensus        88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          88 LDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             HHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence            99997532   234789999999999999999999998   99999999999999999999999999876543321    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ..++..|+|||+..+..++.++||||||+++|||+| |..||......+.      ..... ....          ...
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~~-~~~~----------~~~  224 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVE-RGYR----------MPC  224 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHHh-cCCC----------CCC
Confidence             223457999999988889999999999999999999 8888875432111      11111 1100          011


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ..+....+.+++.+|++.+|++||+++++++.|++.
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            123345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-37  Score=320.31  Aligned_cols=237  Identities=24%  Similarity=0.359  Sum_probs=188.3

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||+||+|...+ ++.||+|+++...    .....+..|..++....+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            369999999999999764 6789999997642    12345666777887766999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence            9999998642     24889999999999999999999998   999999999999999999999999998653221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||......+      ....+......   +        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~~---~--------  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSIRMDNPC---Y--------  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC---C--------
Confidence             23347889999999999899999999999999999999999997543211      11111111100   0        


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  606 (635)
                       .......+.+++.+|++.+|++||++. ++.+
T Consensus       216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             011223456778899999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.4e-37  Score=317.18  Aligned_cols=237  Identities=24%  Similarity=0.342  Sum_probs=190.0

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||+||+|... +++.||+|+++...    .....+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 47889999987542    12345667888888776899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----  494 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....    
T Consensus        81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence            9999988643     24889999999999999999999998   99999999999999999999999999875322    


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      .....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+......         .. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~---------~~-  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEVV---------YP-  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCCC---------CC-
Confidence            12345788999999999989999999999999999999999999754321      122222211110         00 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~  606 (635)
                        ......+.+++.+|++.||++||++      +++++
T Consensus       217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         217 --TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             --CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence              1122356678889999999999998      66655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=329.77  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=210.7

Q ss_pred             HHHHHhhccccccCceEEEEEEe-cCC----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCee
Q 006677          337 DLLRASAEVLGKGSYGTAYKAVL-EES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK  409 (635)
Q Consensus       337 ~l~~~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~  409 (635)
                      |.+....++||+|+||+||+|.+ .+|    -+||+|++.....  ...++.+|+.+|.++ +|||+++++|+|.... .
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence            33344468999999999999985 333    4588998876643  357899999999999 9999999999998776 8


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      .||++||+.|+|.++++.+++    .+-....+.+..|||+||.|||.+.   +|||||.++|||+..-..+||+|||++
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            899999999999999987654    3778899999999999999999987   999999999999999999999999999


Q ss_pred             CCCCCCCCCCC------CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~~~~~------~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +..........      .+.|||-|.+..+.|+.++|||||||++||++| |..||++...+++.++.+       .+  
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g--  916 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG--  916 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc--
Confidence            98876554332      245999999999999999999999999999999 999999887666443221       11  


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                              .+...++-+..++..++.+||..|+..||+++++...+.++...
T Consensus       917 --------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  917 --------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             --------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                    12334456677888999999999999999999999998887643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.4e-37  Score=319.11  Aligned_cols=238  Identities=22%  Similarity=0.344  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||+|...+ ++.||+|+++....    ....+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999999764 67899999876422    2345667888888776899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            9999988643     24889999999999999999999998   999999999999999999999999998753221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+......         .. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~~---------~p-  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDVL---------YP-  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC---------CC-
Confidence             2234788999999999989999999999999999999999999754322      112222221110         00 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-------NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~~  607 (635)
                        ......+.+++.+|++.+|++||       ++++++++
T Consensus       217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              01123566788899999999999       78888764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.5e-37  Score=321.75  Aligned_cols=238  Identities=18%  Similarity=0.273  Sum_probs=192.4

Q ss_pred             hccccccCceEEEEEEecC--CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|...+  +..||+|++.....    ..+.+.+|++++..+ +||||+++++++...+..++||||+
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~  113 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFV  113 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCC
Confidence            5689999999999998653  35799999865421    235677899999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-  495 (635)
                      ++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...... 
T Consensus       114 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        114 IGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            999999999743     24889999999999999999999998   999999999999999999999999999766432 


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+......   +      ...
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~~---~------p~~  250 (340)
T PTZ00426        186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGIIY---F------PKF  250 (340)
T ss_pred             ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCC---C------CCC
Confidence            2345788999999999888999999999999999999999999754321      111111111100   0      111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ..   ..+.+++.+|++.+|++|+     +++|++++
T Consensus       251 ~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        251 LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            12   2356777899999999995     89988875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.7e-36  Score=305.05  Aligned_cols=246  Identities=23%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ..+.||+|+||.||+|...++..+++|.+..... ...++.+|+.+++.+ +|+||+++++++...+..++||||+++|+
T Consensus        10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (261)
T cd05148          10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGS   88 (261)
T ss_pred             HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCC
Confidence            3577999999999999988889999999876544 456788999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.++++...   ...+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||.+.......    
T Consensus        89 L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          89 LLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence            999997543   234899999999999999999999998   9999999999999999999999999987654322    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ...++..|+|||.+....++.++||||||+++|+|++ |+.||......+      ...... ....          .+.
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~~~~~-~~~~----------~~~  225 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VYDQIT-AGYR----------MPC  225 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHH-hCCc----------CCC
Confidence            1223557999999998889999999999999999998 899997543211      111111 1110          011


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      .......+.+++.+||+.+|++|||++++++.|+.+
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            122334677888999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-37  Score=320.12  Aligned_cols=236  Identities=24%  Similarity=0.329  Sum_probs=187.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||+|... ++..||+|+++...    ........|..++....+||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999976 47889999997642    12345666777777666899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----  494 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....    
T Consensus        81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            9999988642     24889999999999999999999998   99999999999999999999999999864321    


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      .....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+....       ...   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~-------~~~---~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDT-------PHY---P  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCC---C
Confidence            12345788999999999999999999999999999999999999754321      1111111110       000   0


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVV  605 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl  605 (635)
                        ......+.+++.+|++.||++||++. +++
T Consensus       217 --~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 --RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              01223456777899999999999985 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.4e-37  Score=311.98  Aligned_cols=246  Identities=25%  Similarity=0.440  Sum_probs=197.4

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...+      +..||+|.++.....  .+.+.+|++++.++ +|+||+++++++......++|||
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   88 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFE   88 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEEe
Confidence            4679999999999998643      467999998765433  46789999999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          415 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      |+++++|.++++....         .....+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence            9999999999975421         12345889999999999999999999998   99999999999999999999999


Q ss_pred             cCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          486 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       486 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      ||++......      .....+..|+|||++.+..++.++|||||||++|||++ |..||......+      ....+. 
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~~~~-  238 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECIT-  238 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHH-
Confidence            9998754321      12223567999999999999999999999999999999 999987543221      111111 


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ......          ........+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111000          01122345778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=305.09  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEe-----CCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~  413 (635)
                      .+.||+|+||.|+.+... +|..||||++.....   ..++..+|+++++.+ +|+||+.+..++..     -+..|+|+
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~  105 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVF  105 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEeh
Confidence            367999999999999965 578999999985533   457788999999999 79999999999865     35789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |+|+. ||...++..     +.++..+...+++|+++||+|+|+.+   |+||||||+|++++.+..+||+|||+|+...
T Consensus       106 elMet-DL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  106 ELMET-DLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             hHHhh-HHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence            99954 999999743     34999999999999999999999998   9999999999999999999999999999885


Q ss_pred             CC------CCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHH---------HHHHh
Q 006677          494 VP------ATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW---------VQSVV  557 (635)
Q Consensus       494 ~~------~~~~~~~~y~aPE~~~-~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~  557 (635)
                      ..      ..+..|..|+|||++. ...|+.+.||||.||++.||++|+.-|.+.+.-+...++-.         ...+.
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            32      2334688899999875 46799999999999999999999999987654332211100         00000


Q ss_pred             hhccccccchhh--------hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          558 REEWTAEVFDVE--------LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       558 ~~~~~~~~~d~~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      .+.- ...+...        ...++...   ...+++..+|+..||.+|+|++|++++  |....
T Consensus       257 s~~a-r~yi~slp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  257 SEKA-RPYIKSLPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             cHHH-HHHHHhCCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            0000 0000000        00122222   345666779999999999999999984  44444

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-36  Score=314.63  Aligned_cols=237  Identities=25%  Similarity=0.355  Sum_probs=187.1

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||+|... +++.||+|+++....    ..+.+..|.+++....+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999975 467899999976432    2334556677777666899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   
T Consensus        81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence            9999998642     24889999999999999999999998   999999999999999999999999998754321   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..+      ....+......   +      . 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~---~------~-  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILNDRPH---F------P-  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---C------C-
Confidence             23357889999999999899999999999999999999999997543211      11111111100   0      0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  606 (635)
                        ......+.+++.+||+.+|++||++. ++++
T Consensus       217 --~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 --RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              11223456777899999999999975 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-36  Score=306.73  Aligned_cols=238  Identities=21%  Similarity=0.326  Sum_probs=187.0

Q ss_pred             ccccccCceEEEEEEecC-------------CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCee
Q 006677          344 EVLGKGSYGTAYKAVLEE-------------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK  409 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~  409 (635)
                      +.||+|+||.||+|....             ...|++|.+..... ....+.+|+.++..+ +||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence            368999999999998532             22478888765432 234677788888888 999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC-------eE
Q 006677          410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-------GC  482 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~k  482 (635)
                      ++||||+++|+|..+++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.       ++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999998886432    34899999999999999999999998   999999999999987664       89


Q ss_pred             EeecCCCCCCCCCCCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          483 ISDFGLTPLMNVPATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       483 i~DfGla~~~~~~~~~~~~~~y~aPE~~~-~~~~~~k~Dvws~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                      ++|||++..........++..|+|||++. +..++.++|||||||++|||+ +|..||......+.       .......
T Consensus       153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~~~~  225 (262)
T cd05077         153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFYEGQ  225 (262)
T ss_pred             eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHHhcC
Confidence            99999987765555556788899999986 466899999999999999998 58888864322110       0000000


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ..            ........+.+++.+||+.||++||++.++++.+
T Consensus       226 ~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 CM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00            0011224567888899999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-36  Score=309.96  Aligned_cols=243  Identities=20%  Similarity=0.273  Sum_probs=191.0

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||+||++... +++.||+|++......    .+.+..|+++++++ +|+||+++.+++..+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999865 5788999998754321    24567799999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++..... ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++.......    
T Consensus        80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            9988754322 2345899999999999999999999998   9999999999999999999999999987654322    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||........  ............         .   ...
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~---------~---~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILNDS---------V---TYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcccC---------C---CCc
Confidence            23578889999999999999999999999999999999999975432211  111111111100         0   001


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ......+.+++.+|++.||++||     +++|++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            12234567788899999999999     67777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=304.65  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=195.7

Q ss_pred             ccccccCceEEEEEEecC-CC--eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-ST--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||+|...+ +.  .+++|.++....  ..+.+.+|++++.++.+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999764 33  468888764322  2457888999999998899999999999999999999999999


Q ss_pred             CChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          419 GSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       419 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      |+|.++++.....           ....+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            9999999754311           1234789999999999999999999988   9999999999999999999999999


Q ss_pred             CCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          488 LTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       488 la~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      ++......   .....+..|+|||++....++.++|||||||++|||++ |..||......      ....... ..+..
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~-~~~~~  230 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP-QGYRL  230 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh-CCCCC
Confidence            98543211   11123456999999988889999999999999999997 99999654321      1122111 11111


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      +.          .......+.+++.+||+.+|.+|||+.|+++.|+++.+
T Consensus       231 ~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         231 EK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             CC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence            10          01122456788899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-37  Score=318.07  Aligned_cols=237  Identities=22%  Similarity=0.350  Sum_probs=190.3

Q ss_pred             ccccccCceEEEEEEe----cCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      +.||+|+||.||++..    ..++.||+|+++....     ....+..|++++..+ +||||+++++++..++..++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence            5799999999999985    3478899999875421     234567899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++...     ..+.+..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          81 YLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            99999999998642     34788889999999999999999998   99999999999999999999999999864322


Q ss_pred             C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          495 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       495 ~----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      .    ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+.....         
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~---------  217 (323)
T cd05584         153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL---------  217 (323)
T ss_pred             CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------
Confidence            1    1235788999999999888999999999999999999999999754321      11222221110         


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ....   .....+.+++.+|++.+|++||     ++++++++
T Consensus       218 ~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPP---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCC---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            0011   1123566788899999999999     78888773

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=305.60  Aligned_cols=244  Identities=26%  Similarity=0.485  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|.+..    ...|++|.++.....  ..++.+|+.++.++ +|+||+++++++...+..++||||+
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~   87 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYM   87 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcC
Confidence            4679999999999999753    357899988754332  45688899999999 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++++|.+++....    ..+++..+..++.|++.|++|||+.+   |+|+||||+||++++++.++|+|||++.......
T Consensus        88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999997543    24899999999999999999999988   9999999999999999999999999998764211


Q ss_pred             C------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          497 T------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       497 ~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      .      ...+..|+|||.+.+..++.++||||||+++|||++ |..||......+      ....+ ...+..      
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~-~~~~~~------  227 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAV-EDGYRL------  227 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHHH-HcCCCC------
Confidence            1      123457999999998899999999999999999998 999996433211      11111 111110      


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                          +........+.+++.+||+.+|++||++.|++++|+++
T Consensus       228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                00112334677888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.7e-36  Score=302.47  Aligned_cols=244  Identities=26%  Similarity=0.453  Sum_probs=197.8

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.+++++ +|+|++++++++. .+..+++|||+++++|
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L   87 (260)
T cd05070          10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSL   87 (260)
T ss_pred             hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence            3567999999999999988888999999987666677899999999999 9999999999875 4568999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .++++...   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........    
T Consensus        88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            99997532   234899999999999999999999998   99999999999999999999999999876543221    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ..++..|+|||++.+..++.++||||||+++|||++ |..||......      .....+.. ....          +.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~-~~~~----------~~  224 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVER-GYRM----------PC  224 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCCC----------CC
Confidence             123456999999988889999999999999999999 88999754321      11111111 1100          00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      .......+.+++.+|++.+|++|||++++.+.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11223467788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-37  Score=317.12  Aligned_cols=247  Identities=22%  Similarity=0.370  Sum_probs=195.4

Q ss_pred             hccccccCceEEEEEEecC-CC----eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|.+.. +.    .||+|+++....  ..+++.+|+.++..+ +||||+++++++... ..++|+||
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~   89 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL   89 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cceeeeec
Confidence            4679999999999998642 33    389999865432  245788899999999 999999999999764 57799999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999997543    24889999999999999999999998   999999999999999999999999999876533


Q ss_pred             CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ..      ...+..|+|||++.+..++.++|||||||++|||++ |+.||.+....+      + .........      
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~-~~~~~~~~~------  229 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------I-SSILEKGER------  229 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHhCCCC------
Confidence            22      122457999999999999999999999999999998 999997542211      1 111111110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                          .+........+.+++.+||..+|++||++.+++..+..+....
T Consensus       230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                0011122345778889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.6e-37  Score=299.11  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCc-eeceeEEEEeCC------eeEEE
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~------~~~lv  412 (635)
                      ++||+|+||+||+|+.. +|+.||+|++.....   ......+|+.++.++ +|+| ||++++++...+      ..++|
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEEE
Confidence            56999999999999954 578999999986644   234578999999999 8999 999999999887      78899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +||++. +|..++....... ..++...++.++.||+.||+|||+++   |+||||||.|||++++|.+||+|||+|+..
T Consensus        96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence            999977 9999998654321 34777889999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCC----CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccc
Q 006677          493 NVPAT----PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAE  564 (635)
Q Consensus       493 ~~~~~----~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  564 (635)
                      ..+..    ...|..|+|||++.+. .|+...||||+||+++||++++.-|.+....+  ++....+..-   .+.|...
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCccCCCCc
Confidence            64432    3467889999999876 69999999999999999999999998765421  1111111111   1233322


Q ss_pred             cchhh----hhcc---cChHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 006677          565 VFDVE----LMRF---QNIEEE----MVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV  611 (635)
Q Consensus       565 ~~d~~----~~~~---~~~~~~----~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~  611 (635)
                      ..-+.    ....   ......    .....+++.+|++++|.+|.|++.++.+  +..+
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            21111    1111   111111    1356788889999999999999999986  5443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-36  Score=315.07  Aligned_cols=191  Identities=21%  Similarity=0.376  Sum_probs=165.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .++||+|+||.||++... ++..+|+|.+.....  ....+.+|+++++++ +|+||+++++++..++..++||||+++|
T Consensus        10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650          10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCC
Confidence            467999999999999976 467788888765432  235688999999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--CC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--~~  497 (635)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+  .|+||||||+|||++.++.+||+|||++......  ..
T Consensus        89 ~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  161 (333)
T cd06650          89 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  161 (333)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence            999999642     24888999999999999999999852  3999999999999999999999999998755332  23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            35788899999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-36  Score=317.68  Aligned_cols=243  Identities=20%  Similarity=0.317  Sum_probs=190.5

Q ss_pred             hccccccCceEEEEEEe----cCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||.||+++.    .+++.||+|++.....     ..+.+..|++++.++.+|+||+++++++..++..++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            46799999999999985    3578899999875421     23457789999999977999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999998642     34889999999999999999999998   9999999999999999999999999987643


Q ss_pred             CCC-----CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          494 VPA-----TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       494 ~~~-----~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      ...     ...+++.|+|||++.+.. ++.++|||||||++|||+||+.||........  .......+....       
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~-------  227 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKCD-------  227 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcCC-------
Confidence            221     234788999999998654 78899999999999999999999975432221  111111111110       


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ...  .   ......+.+++.+|++.||++||     ++++++++
T Consensus       228 ~~~--~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PPF--P---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC--C---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            000  0   11223456778899999999999     67788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-38  Score=318.94  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=202.1

Q ss_pred             ChHHHHHHhhccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe
Q 006677          334 DLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE  408 (635)
Q Consensus       334 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~  408 (635)
                      |.+.+..... -||.|+||-||-|+.. +...||||++.-.-    ....++..|+.+++.+ +|||++.+.|+|..+..
T Consensus        23 DPEklf~dLr-EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   23 DPEKLFSDLR-EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHT  100 (948)
T ss_pred             CHHHHHHHHH-HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccch
Confidence            5555555443 4999999999999964 46779999986432    1246788999999999 99999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .|+|||||-| +-.|++.-.    ++++-+..+..|+.+.+.||+|||+.+   .||||||+.|||+++.|.||++|||.
T Consensus       101 aWLVMEYClG-SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  101 AWLVMEYCLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             HHHHHHHHhc-cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccc
Confidence            9999999955 777777543    356889999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          489 TPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       489 a~~~~~~~~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      |..+.......|||.|||||++.   .+.|+-|+||||+|+++.|+...++|+..++...      .+..+. .+.....
T Consensus       173 Asi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIA-QNesPtL  245 (948)
T KOG0577|consen  173 ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNESPTL  245 (948)
T ss_pred             hhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHH-hcCCCCC
Confidence            99999999999999999999984   5789999999999999999999999987654221      111111 1111111


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                            .   -.+....|..++..|++.-|.+|||.++++++-
T Consensus       246 ------q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  246 ------Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             ------C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                  1   123445566677799999999999999998753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=308.37  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=196.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---------------ChHHHHHHHHHHHhhcCCCceeceeEEEEeC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~  406 (635)
                      .+.||+|.||.|-+|+.. +++.||||++.+...               ..+...+|+.+++++ +|||||+|+.+..+.
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP  180 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDP  180 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCc
Confidence            456999999999999954 688999999965421               124688999999999 999999999999864


Q ss_pred             --CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          407 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       407 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                        +..|||+|||..|.+...=.     ....+++.++.+++.++..||+|||.++   ||||||||+|+||+++|++||+
T Consensus       181 ~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  181 ESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             ccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence              57899999999888754432     1233999999999999999999999999   9999999999999999999999


Q ss_pred             ecCCCCCCCCC---------CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 006677          485 DFGLTPLMNVP---------ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR  551 (635)
Q Consensus       485 DfGla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~  551 (635)
                      |||.+......         ....|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+....+      
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------  326 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------  326 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH------
Confidence            99998765221         1356899999999997743    3567899999999999999999997543221      


Q ss_pred             HHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       552 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...+++.+.         + .++..++....+.+|+.+++++||+.|.+..+|..+..-.....
T Consensus       327 l~~KIvn~p---------L-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  327 LFDKIVNDP---------L-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHHHHhcCc---------c-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            112222111         1 22333355667788889999999999999999999887665533

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.9e-36  Score=303.27  Aligned_cols=243  Identities=25%  Similarity=0.455  Sum_probs=198.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .++||+|+||.||+|..++++.||+|.+........++.+|+++++++ +|+|++++++++. .+..+++|||+++++|.
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   88 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIITEYMENGSLV   88 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence            468999999999999998899999999987666678899999999999 8999999999864 56789999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......     .
T Consensus        89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05067          89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG  162 (260)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence            9986533   235899999999999999999999998   9999999999999999999999999987654222     1


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++....++.++||||||+++|||++ |+.||......+      ..... .......          ..
T Consensus       163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~~~~~----------~~  225 (260)
T cd05067         163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNL-ERGYRMP----------RP  225 (260)
T ss_pred             CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHH-HcCCCCC----------CC
Confidence            223457999999998889999999999999999999 999997543211      11111 1111100          01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ......+.+++.+|++.+|++||++++++..|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1123457788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.2e-37  Score=305.33  Aligned_cols=241  Identities=24%  Similarity=0.376  Sum_probs=192.5

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      +.||+|+||.||+|... +++.+|+|.+.....  ....+.+|+++++++ +||||+++++++...+..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            36999999999999975 688899998765432  245688999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP--  498 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~--  498 (635)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.........  
T Consensus        80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99998642    234889999999999999999999998   999999999999999999999999998754322111  


Q ss_pred             ----CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          499 ----SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       499 ----~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                          ..+..|+|||.+.+..++.++||||||+++|||++ |..||......+       ...........          
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~----------  215 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL----------  215 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC----------
Confidence                12345999999998899999999999999999998 888886433211       11111111000          


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .........+.+++.+|++.+|++|||+.|+.+.|+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            011122346778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=309.57  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||+||++..     .++..||+|.++....  ....+.+|+++++++ +||||+++++++...  ...++||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~   87 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIM   87 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEe
Confidence            46799999999988653     3467899999876432  356788999999999 999999999988754  3578999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...      .+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++....
T Consensus        88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999642      3899999999999999999999998   9999999999999999999999999987664


Q ss_pred             CCCC-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~~-------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ....       ..++..|+|||.+.+..++.++||||||+++|||+||..||......- .....+..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            3221       123456999999988889999999999999999999999986543210 00000000000000000000


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      +... ..+........+.+++.+||+.+|++|||++++++.|+++.
T Consensus       238 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000 00111223356778888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=299.86  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|.-|+||++++.+ +..+|+|++.+....    -.+.+.|.+||+.+ +||.++.|++.++.++..|+|||||+
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEEecCC
Confidence            4679999999999999876 478999999876432    23566788899999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      ||+|..++++..+   ..+++..+..++..|+.||+|||-.|   ||+|||||+||||-++|++.++||.++.....   
T Consensus       161 GGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  161 GGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            9999999987653   45999999999999999999999999   99999999999999999999999998632110   


Q ss_pred             ------------------------------C-C--------------------------CCCCCCcccCcccccCCCCCC
Q 006677          495 ------------------------------P-A--------------------------TPSRSAGYRAPEVIETRKHSH  517 (635)
Q Consensus       495 ------------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~~~  517 (635)
                                                    . .                          ..+||-.|+|||++.+..++.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                          012455699999999999999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCC
Q 006677          518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM  597 (635)
Q Consensus       518 k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~  597 (635)
                      ++|+|+|||++|||+.|..||.+.+.++..      ..++.+.         + .++..++......+||++.+.+||++
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NIv~~~---------l-~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNIVGQP---------L-KFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHHhcCC---------C-cCCCCCcchhHHHHHHHHHhccChhh
Confidence            999999999999999999999988766542      1122111         1 22233345567788889999999999


Q ss_pred             CCC----HHHHHHH
Q 006677          598 RPN----MDEVVRM  607 (635)
Q Consensus       598 RPs----~~evl~~  607 (635)
                      |.-    ++||-++
T Consensus       379 Rlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRH  392 (459)
T ss_pred             hhccccchHHhhcC
Confidence            999    8888763

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-36  Score=312.43  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=188.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|++.....  ....+.+|+++++++ +||||+++++++..++..++||||+. +
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVH-T   87 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence            467999999999999976 578899999875432  234677899999999 99999999999999999999999996 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......    
T Consensus        88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            8888776432    34888999999999999999999998   999999999999999999999999998654322    


Q ss_pred             CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccc----cc
Q 006677          496 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE----VF  566 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~----~~  566 (635)
                      ....+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+...  .............    ..|...    .+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            22346788999999865 4578899999999999999999999975421  1011111111100    000000    00


Q ss_pred             hhh-h--hcccChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 DVE-L--MRFQNIEE------EMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 d~~-~--~~~~~~~~------~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ++. .  ........      ....+.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000 0  00000000      1134667888999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-36  Score=319.74  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=198.6

Q ss_pred             HhhccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          341 ASAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      ...++||+|+||.||+|.+.      .+..||+|+++.....  .+.+.+|++++.++.+||||+++++++...+..++|
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv  119 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII  119 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence            34678999999999999864      2457999999765322  346888999999995599999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCC-------------------------------------------------------------
Q 006677          413 YDYFASGSLSTLLHGNRGA-------------------------------------------------------------  431 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~-------------------------------------------------------------  431 (635)
                      |||+++|+|.++++..+..                                                             
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            9999999999999754310                                                             


Q ss_pred             --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC
Q 006677          432 --------------------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL  479 (635)
Q Consensus       432 --------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  479 (635)
                                                      ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCC
Confidence                                            1124678889999999999999999987   99999999999999999


Q ss_pred             CeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006677          480 DGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW  552 (635)
Q Consensus       480 ~~ki~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  552 (635)
                      .+||+|||+++.....      ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+      .
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~  350 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------Q  350 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------H
Confidence            9999999998754321      12234667999999998889999999999999999998 889987543211      1


Q ss_pred             HHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       553 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ....+...+...          ........+.+++.+||..+|++||+++|+++.|+++.
T Consensus       351 ~~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 FYNAIKRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111111111100          01112346677888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.6e-37  Score=323.59  Aligned_cols=197  Identities=27%  Similarity=0.391  Sum_probs=171.7

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-----CceeceeEEEEeCCeeEEEEEe
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-----PNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-----~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      ..++||+|+||.|-+|... +++.||||+++....-..+...|+.+|..+.+|     -|+|+++++|...++.|||+|.
T Consensus       190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL  269 (586)
T KOG0667|consen  190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL  269 (586)
T ss_pred             EEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence            3578999999999999965 488999999988765556677789999998534     4799999999999999999998


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC--CCeEEeecCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMN  493 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~DfGla~~~~  493 (635)
                      +.. +|+++++.++   ...++...+..|+.||+.||.+||+.+   |||+||||+||||.+.  ..+||+|||.|.+..
T Consensus       270 L~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  270 LST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             hhh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence            865 9999998775   345999999999999999999999998   9999999999999754  479999999998765


Q ss_pred             CC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 006677          494 VP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD  545 (635)
Q Consensus       494 ~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~  545 (635)
                      .. .++..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+
T Consensus       343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            43 35567788999999999999999999999999999999999898766544

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.1e-37  Score=314.81  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             HhhccccccCceEEEEEEecC--------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeE
Q 006677          341 ASAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL  410 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~  410 (635)
                      ...+.||+|+||.||++...+        ...+|+|.++....  ...++.+|++++.++.+|+||+++++++...+..+
T Consensus        21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (307)
T cd05098          21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  100 (307)
T ss_pred             EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            346789999999999998532        34699999875432  23567789999999978999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL  479 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  479 (635)
                      +||||+++|+|.+++......           ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++
T Consensus       101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~  177 (307)
T cd05098         101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN  177 (307)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCC
Confidence            999999999999999754321           1234899999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCCCCCCCCC----CC--CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006677          480 DGCISDFGLTPLMNVPA----TP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW  552 (635)
Q Consensus       480 ~~ki~DfGla~~~~~~~----~~--~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  552 (635)
                      .+||+|||+++......    ..  ..+..|+|||++.+..++.++|||||||++|||++ |..||.....      ...
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------~~~  251 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EEL  251 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHH
Confidence            99999999987654321    11  12357999999998889999999999999999998 8888864321      111


Q ss_pred             HHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       553 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ... +......+          ........+.+++.+|+..+|++||++.|+++.|+++.....
T Consensus       252 ~~~-~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         252 FKL-LKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HHH-HHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            111 11111111          111223466778889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-36  Score=313.46  Aligned_cols=238  Identities=25%  Similarity=0.348  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||+||+|.... +..||+|+++...    .....+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999764 6789999997642    12345677888888887899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....   
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            9999988643     24899999999999999999999998   999999999999999999999999998653221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+......            
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~~~------------  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDEVR------------  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC------------
Confidence             1234788899999999999999999999999999999999999754311      111221111110            


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  607 (635)
                      ........+.+++.+||+.||++||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            001123456778889999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-37  Score=288.60  Aligned_cols=242  Identities=21%  Similarity=0.356  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|..++|-++.++ +|.+.|+|++......         .+...+|+.+++++..||+|+.+.++|+.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            456999999999888765 5788999998654221         234567899999999999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +|.|+.|.|+++|..     ...++++...+|+.|+..|++|||...   ||||||||+|||++++.++||+|||+|+..
T Consensus       102 Fdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence            999999999999973     456999999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCC---CCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          493 NVPA---TPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       493 ~~~~---~~~~~~~y~aPE~~~~------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      ..+.   ..+|||+|+|||.+..      ..|+..+|+||+||+||-++.|.+||......-      .++.+...+   
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------MLR~ImeGk---  244 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------MLRMIMEGK---  244 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH------HHHHHHhcc---
Confidence            7765   3579999999999853      357888999999999999999999997432100      011111111   


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                        +......+   .+......+++.+|++.||++|.|++|+++
T Consensus       245 --yqF~speW---adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 --YQFRSPEW---ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --cccCCcch---hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence              11111112   233344556777999999999999999998

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-36  Score=309.00  Aligned_cols=237  Identities=21%  Similarity=0.322  Sum_probs=185.1

Q ss_pred             cccccCceEEEEEEecC-------------------------CCeEEEEEeecccCC-hHHHHHHHHHHHhhcCCCceec
Q 006677          345 VLGKGSYGTAYKAVLEE-------------------------STTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVP  398 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~  398 (635)
                      .||+|+||.||+|.+..                         ...|++|++...... ...+.+|+.+++++ +||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            59999999999997521                         134788888654322 34677788888888 9999999


Q ss_pred             eeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC
Q 006677          399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD  478 (635)
Q Consensus       399 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  478 (635)
                      +++++......++||||+++|+|..++....    ..+++..+..++.||++||+|||+++   |+||||||+||+++.+
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~  153 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence            9999999999999999999999999986432    34889999999999999999999988   9999999999999865


Q ss_pred             C-------CeEEeecCCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHH-hCCCCCCCCCCCCCCCh
Q 006677          479 L-------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEML-TGKAPLQSPTRDDMVDL  549 (635)
Q Consensus       479 ~-------~~ki~DfGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~-tg~~p~~~~~~~~~~~~  549 (635)
                      +       .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.   
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---  230 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---  230 (274)
T ss_pred             CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence            4       379999998865544444456788999998865 56899999999999999985 69999975433221   


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ..+    ......          .+  ......+.+++.+||+.+|++||++.++++.|
T Consensus       231 ~~~----~~~~~~----------~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ERF----YEKKHR----------LP--EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHH----HHhccC----------CC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            111    111100          00  01123577888899999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-36  Score=319.59  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||++... .++.||+|+..     ...+.+|+++++++ +||||+++++++......++|+|++. ++|
T Consensus        97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L  169 (391)
T PHA03212         97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDL  169 (391)
T ss_pred             EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence            467999999999999965 57789998653     34578899999999 99999999999999999999999995 688


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----C
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----A  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~  496 (635)
                      ..++...     ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       170 ~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        170 YCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence            8888642     24889999999999999999999998   999999999999999999999999998754321     1


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhh------ccccc---cc
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVRE------EWTAE---VF  566 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~------~~~~~---~~  566 (635)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+.......++..      .+...   ..
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            23578999999999999999999999999999999999988754322111 0111111111100      00000   00


Q ss_pred             hhhh--------------hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 DVEL--------------MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 d~~~--------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +...              ............+.+++.+|++.||++|||++|+++
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000              000011123346778899999999999999999997

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-36  Score=309.40  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=201.7

Q ss_pred             HhhccccccCceEEEEEEec--------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeE
Q 006677          341 ASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL  410 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~  410 (635)
                      ...+.||+|+||.||+|...        ++..||+|.+.....  ..+++.+|+.++..+.+||||+++++++......+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY   97 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence            34678999999999999742        234689998875432  24578899999999878999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL  479 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  479 (635)
                      +||||+++|+|.+++......           ....+++..+..++.||+.||+|||+.+   ++||||||+||++++++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~  174 (304)
T cd05101          98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENN  174 (304)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCC
Confidence            999999999999999754321           1235789999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006677          480 DGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW  552 (635)
Q Consensus       480 ~~ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  552 (635)
                      .+||+|||+++.......      ..++..|+|||++.+..++.++||||||+++|||++ |..||.....      ..+
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~  248 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EEL  248 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHH
Confidence            999999999976643221      123457999999998889999999999999999998 7888864432      222


Q ss_pred             HHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       553 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ...+. ......          ........+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus       249 ~~~~~-~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         249 FKLLK-EGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHH-cCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            22221 111100          011233567778889999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.3e-37  Score=319.10  Aligned_cols=237  Identities=20%  Similarity=0.286  Sum_probs=189.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||++... ++..||+|+++....    ....+..|++++..+ +||||+++.+++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999864 578899999976432    234566788888888 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      |+|..++...     ..+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            9999988642     348999999999999999999997 66   999999999999999999999999998653221  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||......+      ....+......       .  .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~~~~-------~--p  216 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEIR-------F--P  216 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcCCCC-------C--C
Confidence              22357889999999999999999999999999999999999997543211      11111111100       0  0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                         ......+.+++.+|++.||++|+     ++.|++++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 ---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence               11223466777899999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.5e-36  Score=301.33  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|.+.....    ...++.+|+++++++ +||||+++++++...+..++|+||++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELAD   85 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecC
Confidence            467999999999999964 678999998764322    234678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            9999998864322 2345889999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...++..|+|||.+.+..++.++||||||+++|||++|+.||.....    +...+...........          
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~----------  227 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYPP----------  227 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCCC----------
Confidence               23467789999999888899999999999999999999999964321    1222222221111100          


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      .........+.+++.+||+.+|++||+++|+++.++.++
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            001223356778888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-36  Score=311.30  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=198.6

Q ss_pred             hhccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||++...+      ...+|+|.+......  ..++.+|++++.++.+|+||+++++++..+...+++|
T Consensus        16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~   95 (293)
T cd05053          16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV   95 (293)
T ss_pred             EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence            35789999999999998643      357899988754322  3457889999999878999999999999999999999


Q ss_pred             EeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          414 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      ||+++|+|.++++....           .....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+|
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEE
Confidence            99999999999964320           12345899999999999999999999988   99999999999999999999


Q ss_pred             EeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006677          483 ISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS  555 (635)
Q Consensus       483 i~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  555 (635)
                      |+|||+++.......      ..++..|+|||++.+..++.++|||||||++|||++ |..||......+.      .. 
T Consensus       173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~-  245 (293)
T cd05053         173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------FK-  245 (293)
T ss_pred             eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH------HH-
Confidence            999999976543221      123457999999988899999999999999999998 9999875432111      11 


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ........          .........+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus       246 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11111100          011122346778889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-36  Score=306.98  Aligned_cols=251  Identities=24%  Similarity=0.435  Sum_probs=198.8

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||++...      ++..+|+|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   88 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY   88 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEc
Confidence            467999999999999842      235588888865432 345788999999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          416 FASGSLSTLLHGNRG--------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      +++++|.+++.....        .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg  165 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG  165 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCC
Confidence            999999999864321        12234899999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          488 LTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       488 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                      ++.......      ...++..|+|||++.+..++.++|||||||++|||++ |..||......+      ....+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~i~~~~  239 (288)
T cd05093         166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQGR  239 (288)
T ss_pred             ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC
Confidence            987553221      1223567999999998899999999999999999999 899987543221      111111111


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                       ...       ..   ......+.+++.+||+.+|.+|||+.|+.+.|+++...
T Consensus       240 -~~~-------~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         240 -VLQ-------RP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -cCC-------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             000       00   11223578888899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-36  Score=304.92  Aligned_cols=238  Identities=22%  Similarity=0.350  Sum_probs=190.9

Q ss_pred             ccccccCceEEEEEEecCCC-----------eEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          344 EVLGKGSYGTAYKAVLEEST-----------TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      +.||+|+||.||+|...+..           .+++|.+.........+.+|+.+++++ +|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEE
Confidence            46999999999999976533           477787765443367888999999999 89999999999988 778999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-------CeEEee
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-------DGCISD  485 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~ki~D  485 (635)
                      |||+++|+|.+++.....    .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++       .+||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999975332    4899999999999999999999988   99999999999999888       799999


Q ss_pred             cCCCCCCCCCCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          486 FGLTPLMNVPATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       486 fGla~~~~~~~~~~~~~~y~aPE~~~~~--~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ||++..........++..|+|||++...  .++.++|||||||++|||++ |..||......+      +..........
T Consensus       152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~~~~~~  225 (259)
T cd05037         152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQDQHRL  225 (259)
T ss_pred             CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHhcCCCC
Confidence            9999876654455567789999999876  78999999999999999999 577776543221      11111100000


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                               ..+    ....+.+++.+||..+|++|||+.|+++.|+
T Consensus       226 ---------~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         226 ---------PMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---------CCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     000    1156778889999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-38  Score=306.66  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=194.3

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-----eEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~e~~  416 (635)
                      .+++|+|+||.||+|...+ +..||||+.-...   +.-.+|+++|+++ .|||||++..+|....+     ..+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            4789999999999999654 5889999986542   2334688999988 99999999999875432     24899999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~  495 (635)
                      +. +|.++++.... .+..++.-.++-+..||++||+|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.....
T Consensus       105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            88 99999975321 2334777888899999999999999988   9999999999999976 99999999999987655


Q ss_pred             CCC---CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc------
Q 006677          496 ATP---SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV------  565 (635)
Q Consensus       496 ~~~---~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  565 (635)
                      ...   .-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+  ++...++- +.-....++      
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~-lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKV-LGTPTREDIKSMNPN  256 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHH-hCCCCHHHHhhcCcc
Confidence            433   346779999998765 59999999999999999999999998754332  22222221 111100110      


Q ss_pred             ----chhhhhccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhcc
Q 006677          566 ----FDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQS  614 (635)
Q Consensus       566 ----~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~~  614 (635)
                          -.+.+....    .......+.++++.++++++|.+|.++.|++.  ..++++..
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                001111111    11223346778888999999999999999997  56666655

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.2e-36  Score=307.08  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=199.0

Q ss_pred             hccccccCceEEEEEEecC-CC--eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|...+ +.  .+++|.++....  ..+.+.+|++++.++.+||||+++++++......++|+||++
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            4579999999999998754 32  468888764322  245788899999999789999999999999999999999999


Q ss_pred             CCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          418 SGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       418 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +|+|.++++.....           ....+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df  163 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF  163 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence            99999999653211           1234889999999999999999999988   999999999999999999999999


Q ss_pred             CCCCCCCCCC-C--CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          487 GLTPLMNVPA-T--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       487 Gla~~~~~~~-~--~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      |++....... .  ...+..|+|||++.+..++.++|||||||++|||++ |..||......      ........ ...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~~~~-~~~  236 (297)
T cd05089         164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQ-GYR  236 (297)
T ss_pred             CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhc-CCC
Confidence            9986433211 1  112346999999998889999999999999999998 99999754321      11222111 110


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..          ........+.+++.+||+.+|.+||+++++++.|+.+.+....
T Consensus       237 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         237 ME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            00          0011234567888899999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5e-36  Score=306.83  Aligned_cols=251  Identities=24%  Similarity=0.437  Sum_probs=199.5

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|...      ++..+++|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   88 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEY   88 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEec
Confidence            467999999999999843      245688888865433 245788999999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          416 FASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                      +++++|.+++.....           .....+++..++.++.||+.|++|||+++   |+||||||+||+++.++.++|+
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEEC
Confidence            999999999965321           11234899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHh
Q 006677          485 DFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV  557 (635)
Q Consensus       485 DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  557 (635)
                      |||++.......      ...++..|+|||++.+..++.++|||||||++|||+| |+.||......+      ......
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~  239 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIECIT  239 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHh
Confidence            999987653321      2234567999999999999999999999999999999 999987543221      111111


Q ss_pred             hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       558 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                       ......          ........+.+++.+||+.+|++||++.++++.|+++...
T Consensus       240 -~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 -QGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -CCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111100          0112234577888899999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.6e-36  Score=303.80  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEecCCC---eEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeE
Q 006677          343 AEVLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~  410 (635)
                      .+.||+|+||.||+|...++.   .+|+|.++....   ..+.+.+|+++++++ +|+||+++++++...      ...+
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence            467999999999999976543   588998865432   235678899999999 999999999987532      2468


Q ss_pred             EEEEeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      ++|||+++|+|.+++...+. .....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence            99999999999988743221 12345899999999999999999999988   999999999999999999999999999


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +......      ....++.|+|||+..+..++.++||||||+++|||++ |+.||......      ..... +.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~-~~~~~~  232 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDY-LRQGNR  232 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHcCCC
Confidence            8764322      1224567999999999899999999999999999999 78998753221      11111 111111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      .          .........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       233 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0          00112234567888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-36  Score=306.09  Aligned_cols=241  Identities=23%  Similarity=0.330  Sum_probs=189.6

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||+||++... +++.||+|++.....    ....+..|++++.++ +||||+++++++..+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999865 478999999864322    233456789999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T  497 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---~  497 (635)
                      |.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.......   .
T Consensus        80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  153 (277)
T cd05607          80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ  153 (277)
T ss_pred             HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence            998886432   234889999999999999999999998   9999999999999999999999999987654322   2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||++.+..++.++||||+||++|||++|+.||.......  ................        ...   
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~--------~~~---  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDEVKF--------EHQ---  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcccccc--------ccc---
Confidence            357889999999998889999999999999999999999997533211  1111111111111100        001   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ....++.+++.+||+.||++||+++|+++
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            12334677888999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-36  Score=318.11  Aligned_cols=191  Identities=25%  Similarity=0.379  Sum_probs=166.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||++... +++.||+|++.....    ....+.+|++++.++ +|+||+++++.+.+....++||||++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCC
Confidence            467999999999999865 478899999975422    234577889999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999742     34899999999999999999999998   999999999999999999999999998654211  


Q ss_pred             -------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 006677          496 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL  538 (635)
Q Consensus       496 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~  538 (635)
                                                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                                 1235788999999999999999999999999999999999999


Q ss_pred             CCCC
Q 006677          539 QSPT  542 (635)
Q Consensus       539 ~~~~  542 (635)
                      ....
T Consensus       237 ~~~~  240 (363)
T cd05628         237 CSET  240 (363)
T ss_pred             CCCC
Confidence            7543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-36  Score=309.39  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=193.8

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|..     ..+..|++|.++.....  ..++.+|+++++++ +||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~   88 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEY   88 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEc
Confidence            46799999999999984     24578999998754332  35688899999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEE
Q 006677          416 FASGSLSTLLHGNRG------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                      +++|+|.+++.....            .....+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEe
Confidence            999999999853221            11234889999999999999999999998   999999999999999999999


Q ss_pred             eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006677          484 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       484 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  556 (635)
                      +|||+++......      ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+      .... 
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------~~~~-  238 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------VIEM-  238 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-
Confidence            9999987653221      2224557999999988889999999999999999999 999987543211      1111 


Q ss_pred             hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       557 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ........          ........+.+++.+||+.+|++||++.++.++|..
T Consensus       239 ~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111100          001122356677889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-36  Score=303.75  Aligned_cols=243  Identities=26%  Similarity=0.438  Sum_probs=196.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||+|....+..+++|++.......+.+.+|+++++++ +|+|++++++++. .+..++||||+++|+|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   88 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL   88 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence            467999999999999988777899998876555567889999999999 8999999998875 45688999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      ++++...   ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......     .
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  162 (260)
T cd05069          89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG  162 (260)
T ss_pred             HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence            9997532   234889999999999999999999998   9999999999999999999999999987654322     1


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||...+..++.++||||||+++|||+| |..||......+      ...... .....          ...
T Consensus       163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~-~~~~~----------~~~  225 (260)
T cd05069         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVE-RGYRM----------PCP  225 (260)
T ss_pred             CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-cCCCC----------CCC
Confidence            223557999999998899999999999999999999 899997543211      111111 11110          011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ......+.+++.+||+.+|++||+++++++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1233567788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-36  Score=300.15  Aligned_cols=241  Identities=26%  Similarity=0.421  Sum_probs=194.7

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ++||+|+||.||+|...+++.+|+|.+......  ...+.+|++++..+ +||||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            369999999999999888899999998754322  34688899999998 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----  496 (635)
                      .+++....    ..+++..+..++.|++.||.|+|+.+   ++||||||+||++++++.+||+|||++.......     
T Consensus        80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            99986432    24889999999999999999999998   9999999999999999999999999986543321     


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+..|+|||++.+..++.++||||||+++||+++ |..||......+       ............          .
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~----------~  215 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMS----------C  215 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCC----------C
Confidence            1123456999999998889999999999999999998 999997543211       111111111110          0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .......+.+++.+|++.+|++||++.|+++.|.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1122356778888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.5e-37  Score=320.85  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=190.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-----eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~  413 (635)
                      .++||+|+||.||+|... ++..||+|++.....   ....+.+|+++++++ +||||+++++++....     ..++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~   83 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF   83 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEE
Confidence            467999999999999965 578999999875322   234678899999999 9999999999886432     479999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+. ++|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9995 6899888642     24899999999999999999999998   9999999999999999999999999987543


Q ss_pred             CC-------CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHH
Q 006677          494 VP-------ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWVQS  555 (635)
Q Consensus       494 ~~-------~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~---------~~~~~~  555 (635)
                      ..       ....+++.|+|||++.+  ..++.++|||||||++|||+||+.||...........         ..+...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21       12347888999999875  6789999999999999999999999976432111000         000000


Q ss_pred             Hhhhccccccchhhhhcc-cC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhc
Q 006677          556 VVREEWTAEVFDVELMRF-QN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ  613 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~-~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~  613 (635)
                      +.... ....++...... ..    .......+.+++.+||+.+|++|||++|++++  ++.+..
T Consensus       235 i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEK-ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhh-HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            00000 000000000000 00    00112346788889999999999999999984  544443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-36  Score=311.87  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=198.6

Q ss_pred             hccccccCceEEEEEEecC-CC--eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|...+ +.  .+++|.++....  ....+.+|++++.++.+|+||+++++++..++..++||||++
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            4679999999999999653 43  357777654322  245688899999999889999999999999999999999999


Q ss_pred             CCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          418 SGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       418 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +|+|.++++....           .....+++..++.++.|++.|++|||+.+   ++||||||+|||+++++.+||+||
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df  168 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  168 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence            9999999975431           11235889999999999999999999998   999999999999999999999999


Q ss_pred             CCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          487 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       487 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      |++.......   ....+..|+|||++.+..++.++|||||||++|||+| |..||......+      ..... .....
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~-~~~~~  241 (303)
T cd05088         169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL-PQGYR  241 (303)
T ss_pred             ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHHH-hcCCc
Confidence            9986432111   1123456999999988889999999999999999998 999997543221      11111 11100


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..       ..   ......+.+++.+||+.+|++||+++++++.|+.+.+....
T Consensus       242 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         242 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence            00       00   11223567888899999999999999999999998876653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.4e-36  Score=304.68  Aligned_cols=247  Identities=23%  Similarity=0.380  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...+      +..||+|+++.....  ...+.+|+.++..+ +||||+++++++...+..++++|
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~e   88 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIFS   88 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEEE
Confidence            5679999999999998642      467999998755332  35678889898988 89999999999999999999999


Q ss_pred             eccCCChhhhccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEE
Q 006677          415 YFASGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                      |+.+++|.+++....           ......+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl  165 (283)
T cd05091          89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence            999999999985321           011234888999999999999999999998   999999999999999999999


Q ss_pred             eecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006677          484 SDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       484 ~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  556 (635)
                      +|||+++......      ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...      ..+...+
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~i  239 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVIEMI  239 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Confidence            9999987653322      2224567999999988889999999999999999998 8888865322      1222222


Q ss_pred             hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       557 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ......           .........+.+++.+||+.+|++||+++|+++.|+.
T Consensus       240 ~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 RNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            221110           0011233456788889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=303.89  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=193.7

Q ss_pred             ccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ++||+|+||.||+|.+..    +..+|+|.+.....  ..+++.+|+++++++ .|+||+++++++. .+..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            469999999999998543    25799999876654  356788999999999 8999999999876 456899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +|+|.+++....     .+++..+..++.|++.|++|||..+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999997432     4899999999999999999999998   99999999999999999999999999876543322


Q ss_pred             CC-------CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          498 PS-------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       498 ~~-------~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      ..       ++..|+|||.+.+..++.++||||||+++|||++ |..||...+..   ++..+.    ......      
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~~------  217 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESGERL------  217 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcCCcC------
Confidence            11       2346999999998899999999999999999998 99999754321   111111    111110      


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                          .........+.+++.+||+.+|++||++.++++.|+++.
T Consensus       218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                011122346778888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=307.86  Aligned_cols=244  Identities=24%  Similarity=0.311  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||++... +++.||+|++.....    ....+.+|+.+++++ +|+||+++++++..++..++||||++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccC
Confidence            367999999999999965 578899999875422    234567899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999998886432   234899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||++.+..++.++||||+||++|||++|..||........   ...+...+....           ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------~~  223 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ-----------EE  223 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc-----------cc
Confidence              23567889999999988899999999999999999999999985432211   111111111100           00


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ........+.+++.+||+.||++||     ++++++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            0112234567788899999999999     78888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-36  Score=308.34  Aligned_cols=246  Identities=22%  Similarity=0.384  Sum_probs=193.1

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...      .+..||+|++.....  ...++.+|+.+++.+ +|+||+++++++......++|||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e   89 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME   89 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEe
Confidence            567999999999999854      245799998864322  245688899999998 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      |+++|+|.++++.....     ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence            99999999998653211     1234678899999999999999999988   999999999999999999999999998


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +......      ...++..|+|||++.+..++.++|||||||++|||++ |..||......      .......... .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~  239 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVMEGG-L  239 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC-c
Confidence            7543221      1223567999999998899999999999999999999 78898754322      1111111111 0


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ...          .......+.+++.+|++.+|++|||+.|+++.|+
T Consensus       240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         240 LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            000          0122345778888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=328.72  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=192.6

Q ss_pred             hccccccCceEEEEEEecC--CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|....  +..||+|.+..... ....+.+|+.+++++ +||||+++++++...+..++||||+++|
T Consensus        72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg  150 (478)
T PTZ00267         72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGG  150 (478)
T ss_pred             EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence            5679999999999998543  46688887644322 234577899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.++++.... ...++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus       151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            99998864321 2345889999999999999999999998   999999999999999999999999999765432    


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .............           
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~-----------  289 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYD-----------  289 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----------
Confidence              233478899999999999999999999999999999999999975432      1122222211110           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +........+.+++.+||+.+|++||++++++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            000112245677888999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.9e-36  Score=304.15  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=191.0

Q ss_pred             cccccCceEEEEEEec---CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          345 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .||+|+||.||+|.++   ++..+|+|+++.....   .+++..|+.+++++ +|+||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            5899999999999753   4678999998654332   45688899999999 9999999999875 4567899999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-  497 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-  497 (635)
                      |+|.+++...     ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||++........ 
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            9999999642     24899999999999999999999998   99999999999999999999999999876643321 


Q ss_pred             ------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          498 ------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       498 ------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                            ..++..|+|||.+....++.++|||||||++|||++ |+.||......+      +...+ .......      
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~i-~~~~~~~------  218 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE------VTQMI-ESGERME------  218 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-HCCCCCC------
Confidence                  112467999999988889999999999999999998 999997543221      11111 1111110      


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                          ........+.+++.+||+.+|++||++++|++.|++.
T Consensus       219 ----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 ----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                0011234567888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-36  Score=322.67  Aligned_cols=242  Identities=24%  Similarity=0.369  Sum_probs=187.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++.....    ....+.+|++++.++ +|+||+++++++.+.+..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence            467999999999999865 468899999976432    234578899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus        85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          85 GGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999998643     24888999999999999999999998   99999999999999999999999998753210   


Q ss_pred             ------------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHH
Q 006677          495 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV  526 (635)
Q Consensus       495 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gv  526 (635)
                                                                      .....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                            01235788999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 006677          527 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMA--CVAKVPDMRPNMDEV  604 (635)
Q Consensus       527 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPs~~ev  604 (635)
                      ++|||+||+.||......+.      ...+..  +....   ..........   ++.+++.+  |+..+|..||+++|+
T Consensus       237 il~elltG~~Pf~~~~~~~~------~~~i~~--~~~~~---~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTET------QLKVIN--WENTL---HIPPQVKLSP---EAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHH------HHHHHc--ccccc---CCCCCCCCCH---HHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999976432211      111110  00000   0001111223   33444445  666777779999999


Q ss_pred             HHH
Q 006677          605 VRM  607 (635)
Q Consensus       605 l~~  607 (635)
                      +++
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-36  Score=304.34  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEecC---CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .||+|+||.||+|...+   +..+++|.++....  ....+.+|+.+++++ +||||+++++++.+....++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            58999999999998653   35689998865433  234688899999999 9999999999999989999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.++++..+.......++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997544322334677888899999999999999998   9999999999999999999999999986543221   


Q ss_pred             ---CCCCCCcccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          497 ---TPSRSAGYRAPEVIETR-------KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~-------~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                         ...++..|+|||++...       .++.++||||||+++|||++ |..||......+.   ...   ..... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~~-~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVREQ-QLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhhcc-cCCC
Confidence               22346679999998642       35789999999999999996 9999975432211   000   01110 0011


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .++...     ......+.+++..|| .+|++|||++||++.|+
T Consensus       231 ~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111110     011234566778999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-36  Score=310.83  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=187.3

Q ss_pred             hccccccCceEEEEEEec--CCCeEEEEEeecccC---ChHHHHHHHHHHHhhc--CCCceeceeEEEEe-----CCeeE
Q 006677          343 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~  410 (635)
                      .+.||+|+||+||+|...  ++..||+|+++....   ....+.+|++++..+.  +||||+++++++..     ....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            357999999999999863  367899999875432   2345667887777664  69999999999853     34678


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            9999996 59999886433   234899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhcccc
Q 006677          491 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----REEWTA  563 (635)
Q Consensus       491 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~  563 (635)
                      ......   ...+++.|+|||.+.+..++.++|||||||++|||++|+.||......+.   ........    .+.|..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhchh
Confidence            654322   23468889999999888999999999999999999999999986543211   11111000    011111


Q ss_pred             ccc--hhhhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVF--DVELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~--d~~~~--~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ...  ...+.  .....    ......+.+++.+|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000  00000  00000    112234567888999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9e-36  Score=299.18  Aligned_cols=245  Identities=29%  Similarity=0.482  Sum_probs=199.3

Q ss_pred             ccccccCceEEEEEEecC----CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||.||+|....    +..|++|.+......  .+.+.+|++.+.++ +|+|++++++++......++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence            469999999999999764    778999999766443  57788999999999 79999999999999999999999999


Q ss_pred             CCChhhhccCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          418 SGSLSTLLHGNRGA----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       418 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      +++|.+++......    ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999764211    0245899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...      ...++..|+|||.+....++.++||||+|+++|||++ |..||......      ........ ...    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-~~~----  225 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK-GYR----  225 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC----
Confidence            432      2335678999999988889999999999999999999 69999765221      11222111 110    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                            ..........+.+++.+|++.+|++||++.|++++|+
T Consensus       226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0111222456778888999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-36  Score=315.86  Aligned_cols=233  Identities=25%  Similarity=0.389  Sum_probs=187.9

Q ss_pred             ccccccCceEEEEEEe----cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      +.||+|+||.||++..    .+++.||+|++.....   ....+..|++++.++ +||||+++++++...+..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence            4699999999999875    3578899999976432   234567789999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999998642     34899999999999999999999998   9999999999999999999999999987654331


Q ss_pred             ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          497 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                          ...+++.|+|||.+.+..++.++|||||||++|||++|+.||......      .....+......         .
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~~---------~  217 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKLG---------M  217 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCCC---------C
Confidence                234788899999999888999999999999999999999999754321      111111111110         0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE  603 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  603 (635)
                      .   ......+.+++.+||+.||++||++.+
T Consensus       218 p---~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 P---QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C---CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0   112234567778999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=303.61  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=200.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||+|..+++..+++|.+.......+++.+|+++++++ +|+|++++++++......++||||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   89 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL   89 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence            567999999999999988888899999987666778899999999999 8999999999999888999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....   ...+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.++++|||++.......     .
T Consensus        90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  163 (261)
T cd05034          90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG  163 (261)
T ss_pred             HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence            9997543   234899999999999999999999998   9999999999999999999999999987654321     1


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |+.||.+....      ........ ...          ....
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~-~~~----------~~~~  226 (261)
T cd05034         164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVER-GYR----------MPRP  226 (261)
T ss_pred             cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHc-CCC----------CCCC
Confidence            223457999999998889999999999999999999 99999654311      11111111 100          0000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ......+.+++.+|++.+|++||+++|+++.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1123457788889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.9e-36  Score=306.59  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=190.0

Q ss_pred             hccccccCceEEEEEEecC-CC----eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|.+.. +.    .+++|.+.....  ...++..|+..+.++ +||||+++++++. ....++++||
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~   89 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQL   89 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEe
Confidence            4679999999999999643 43    367777654322  124566677778888 8999999999875 4557889999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...    ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999997432    34899999999999999999999998   999999999999999999999999999765322


Q ss_pred             C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .      ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+   +.    ..+......  .. 
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~--~~-  232 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VP----DLLEKGERL--AQ-  232 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcC--CC-
Confidence            1      1224567999999998899999999999999999998 999997543221   11    111111100  00 


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                             .......+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus       233 -------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         233 -------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                   011223566788899999999999999999999987753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.8e-36  Score=311.22  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=200.3

Q ss_pred             HhhccccccCceEEEEEEec--------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeE
Q 006677          341 ASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL  410 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~  410 (635)
                      ...+.||+|+||.||++...        ....+|+|.++.....  ..++.+|++++.++.+||||+++++++......+
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY   94 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence            34678999999999999742        2346889988754332  3467889999999867999999999999988999


Q ss_pred             EEEEeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL  479 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  479 (635)
                      +||||+++|+|.+++.....           .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++
T Consensus        95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~  171 (314)
T cd05099          95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDN  171 (314)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCC
Confidence            99999999999999965321           11235899999999999999999999998   99999999999999999


Q ss_pred             CeEEeecCCCCCCCCCCC----C--CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006677          480 DGCISDFGLTPLMNVPAT----P--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW  552 (635)
Q Consensus       480 ~~ki~DfGla~~~~~~~~----~--~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~  552 (635)
                      .+||+|||+++.......    .  .++..|+|||++.+..++.++|||||||++|||++ |..||......+      .
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~  245 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------L  245 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence            999999999976543211    1  12356999999998889999999999999999999 889986543211      1


Q ss_pred             HHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       553 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .. ..........          .......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus       246 ~~-~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         246 FK-LLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             HH-HHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence            11 1111111100          11223456678889999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-36  Score=308.72  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEec-----CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e  414 (635)
                      .+.||+|+||+||++...     ++..|++|++..... ..+.+.+|++++.++ +||||+++++++...  ...++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e   87 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVME   87 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEE
Confidence            467999999999999753     477899999875432 245788999999999 999999999987543  46789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999996432    24899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCC-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC---------CChhHHHHHHhh
Q 006677          495 PATP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM---------VDLPRWVQSVVR  558 (635)
Q Consensus       495 ~~~~-------~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~---------~~~~~~~~~~~~  558 (635)
                      ....       .++..|+|||++.+..++.++|||||||++|||++|..|+......-.         ............
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3211       123359999999988899999999999999999998877643321100         000000001111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ...          ..+........+.+++.+||+.+|++|||+.|+++.|++++
T Consensus       241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            100          01111122346778888999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4e-36  Score=312.21  Aligned_cols=232  Identities=22%  Similarity=0.302  Sum_probs=183.3

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHH-HHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||+||+|... +++.||+|++.....    ...++..|... ++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            36999999999999975 578899999875422    12344455544 4556 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            99999998642     24889999999999999999999998   999999999999999999999999998754222  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+.....         ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~---------~~~  216 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKPL---------RLK  216 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCCC---------CCC
Confidence              1234788999999999999999999999999999999999999754321      12222221110         001


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMD  602 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~  602 (635)
                      +.   ....+.+++.+|++.+|++||++.
T Consensus       217 ~~---~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PN---ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            11   133566778899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=301.04  Aligned_cols=248  Identities=22%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe------e
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------K  409 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~  409 (635)
                      .+.||+|+||.||+|....    +..||+|+++.....   ...+.+|++.+..+ +|+||+++++++...+.      .
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCccc
Confidence            4679999999999998643    367999998764332   34678899999998 99999999999876554      6


Q ss_pred             EEEEEeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ++|+||+++|+|..++...+. .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence            899999999999998854332 12345899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      ++.......      ...+..|+|||++.+..++.++|||||||++|||++ |..||......      ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~  233 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHGNR  233 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC
Confidence            876543321      123457999999988889999999999999999999 88998654321      11221111111


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      .           .........+.+++.+||+.||++||++.|+++.|+++
T Consensus       234 ~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 L-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C-----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0           01122345678888899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-35  Score=298.86  Aligned_cols=240  Identities=23%  Similarity=0.389  Sum_probs=190.2

Q ss_pred             ccccCceEEEEEEec---CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||.||+|.+.   ++..||+|++......  .+.+.+|+.+++++ +|+||+++++++. .+..++||||+++|+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            899999999999764   3456899988765322  45688999999999 9999999999875 457899999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC---
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---  497 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~---  497 (635)
                      |.+++....    ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........   
T Consensus        81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999986432    34899999999999999999999998   99999999999999999999999999875543221   


Q ss_pred             ----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          498 ----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       498 ----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                          ..++..|+|||.+....++.++|||||||++||+++ |..||......+      +.. .+......         
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~-~~~~~~~~---------  217 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMS-FIEQGKRL---------  217 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCCCCC---------
Confidence                112457999999988889999999999999999996 999997543211      111 11111110         


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                       ........++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 -~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 -DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             01112234667788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-36  Score=308.07  Aligned_cols=251  Identities=27%  Similarity=0.421  Sum_probs=197.3

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|....      ...+++|.+......  ..++.+|+.++..+ +||||+++++.+..++..++|+|
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEE
Confidence            4679999999999998532      246888887654322  35688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          415 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      |+.+|+|.+++...+.                   .....+++..+..++.|++.||+|||+.+   ++||||||+||++
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence            9999999999864321                   11235889999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD  548 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~  548 (635)
                      ++++.+||+|||+++......      ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---  237 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER---  237 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            999999999999987543221      1223567999999988889999999999999999999 999997543211   


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                          +.......+...          ........+.+++.+|++.+|++||+++|+++.|+++...
T Consensus       238 ----~~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 ----LFNLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             ----HHHHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence                111111111100          0112234677888899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-36  Score=315.34  Aligned_cols=237  Identities=23%  Similarity=0.306  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHH---hhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVG---RVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~---~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... +++.||+|+++....    ..+.+.+|.+++.   ++ +||||+++++++...+..|+|||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEEEEc
Confidence            367999999999999865 578899999975421    2244566666554   44 79999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|..+++.      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          83 YAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             CCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999988863      24899999999999999999999998   99999999999999999999999999865322


Q ss_pred             C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          495 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       495 ~----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      .    ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+......        
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~--------  219 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR--------  219 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC--------
Confidence            1    2345788999999999999999999999999999999999999754322      112222211110        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                          ........+.+++.+|++.||.+||     ++.+++++
T Consensus       220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                0011234566788899999999999     56676663

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-36  Score=314.99  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEe------cCCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEE
Q 006677          341 ASAEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLL  411 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~l  411 (635)
                      ...+.||+|+||.||+|..      .+++.||||+++.....  ...+.+|++++.++.+|+||+++++++... ...++
T Consensus        10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l   89 (343)
T cd05103          10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (343)
T ss_pred             cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence            4467899999999999973      34678999999754322  346788999999998899999999988654 45789


Q ss_pred             EEEeccCCChhhhccCCCCC------------------------------------------------------------
Q 006677          412 VYDYFASGSLSTLLHGNRGA------------------------------------------------------------  431 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------  431 (635)
                      ||||+++|+|.++++.....                                                            
T Consensus        90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T cd05103          90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE  169 (343)
T ss_pred             EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence            99999999999998643210                                                            


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC------CCCCCCc
Q 006677          432 --GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAG  503 (635)
Q Consensus       432 --~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~------~~~~~~~  503 (635)
                        ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||++.......      ...++..
T Consensus       170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd05103         170 DLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  246 (343)
T ss_pred             hhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence              0124788899999999999999999998   9999999999999999999999999987643221      1223456


Q ss_pred             ccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHH
Q 006677          504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ  582 (635)
Q Consensus       504 y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  582 (635)
                      |+|||.+.+..++.++||||||+++|||++ |..||......+      ..............       .   ......
T Consensus       247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~---~~~~~~  310 (343)
T cd05103         247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------P---DYTTPE  310 (343)
T ss_pred             eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC-------C---CCCCHH
Confidence            999999988899999999999999999997 999997542211      01111111111000       0   011235


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          583 MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       583 l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      +.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            77888899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=321.31  Aligned_cols=241  Identities=23%  Similarity=0.370  Sum_probs=194.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|+++...    .....+.+|++++..+ +|+||+++++++.+++..++||||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMP   84 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCC
Confidence            467999999999999976 57899999997643    2245678899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999743     34899999999999999999999988   9999999999999999999999999987654322 


Q ss_pred             --------------------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          497 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       497 --------------------------------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                                                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                            234788899999999999999999999999999999999999754321


Q ss_pred             CCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 006677          545 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRM  607 (635)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~  607 (635)
                            .....+..  +....   ......   .....+.+++.+|++ +|.+||+ ++|++++
T Consensus       237 ------~~~~~i~~--~~~~~---~~p~~~---~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ------ETYNKIIN--WKESL---RFPPDP---PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ------HHHHHHhc--cCCcc---cCCCCC---CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                  11111111  00000   000011   123456677779997 9999999 9999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=290.05  Aligned_cols=242  Identities=22%  Similarity=0.348  Sum_probs=195.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecc---cCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEV---VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|.|+.||++.. ..|+.+|+|++...   ..+.++.++|+.+.+.+ +||||+++...+.+....|+|+|+|.|
T Consensus        16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G   94 (355)
T KOG0033|consen   16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG   94 (355)
T ss_pred             HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccc
Confidence            46799999999999875 45788888887543   23567889999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~~  495 (635)
                      ++|..-+-.     +...++..+-..+.||+.+|.|+|..+   |||||+||+|+++..   ...+|++|||+|......
T Consensus        95 ~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   95 GELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             hHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            999655532     234788888899999999999999998   999999999999953   356899999999887744


Q ss_pred             C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .   ...|||+|||||++...+|+..+|||+.||+||-++.|..||.+.+....      .+.+     ....+|.....
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I-----~~g~yd~~~~~  235 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQI-----KAGAYDYPSPE  235 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHH-----hccccCCCCcc
Confidence            3   34589999999999999999999999999999999999999997543321      1222     22223333333


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+.+.++.+.   |+++|+..||.+|.|+.|++++
T Consensus       236 w~~is~~Ak~---LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  236 WDTVTPEAKS---LIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cCcCCHHHHH---HHHHHhccChhhhccHHHHhCC
Confidence            4455555554   5559999999999999998764

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-36  Score=312.65  Aligned_cols=238  Identities=25%  Similarity=0.338  Sum_probs=189.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.... +..||+|++.....    ....+..|..++..+.+|++|+.+++++...+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            4679999999999999764 67899999876432    123456677788777689999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....  
T Consensus        85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999988643     24889999999999999999999998   999999999999999999999999998754321  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||+||+.||......+      ....+......           
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~~~-----------  219 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNVA-----------  219 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-----------
Confidence              23357889999999999999999999999999999999999997543211      11222111100           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~  606 (635)
                       ........+.+++.+|++.+|++|++.     .++.+
T Consensus       220 -~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         220 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence             001123456678889999999999985     56654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.4e-36  Score=312.09  Aligned_cols=239  Identities=24%  Similarity=0.326  Sum_probs=188.5

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|...+ ++.||+|++.....    ..+.+..|.+++..+.+|++|+.+++++...+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence            4679999999999999764 67899999975421    234567788888888556779999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......  
T Consensus        85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          85 GGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            99999998642     24889999999999999999999998   999999999999999999999999998643221  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||+||+.||......+      ....+.....       .  ..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~~-------~--~~  221 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHNV-------S--YP  221 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC-------C--CC
Confidence              12347889999999999999999999999999999999999997543211      1111111110       0  00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  607 (635)
                      .   .....+.+++.+|+..+|.+|++.     +++.++
T Consensus       222 ~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         222 K---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1   122356678889999999999986     566543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-36  Score=301.61  Aligned_cols=242  Identities=26%  Similarity=0.363  Sum_probs=194.7

Q ss_pred             ccccccCceEEEEEEecC--C--CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||.||+|.+.+  +  ..||+|.+.....  ..+.+.+|+.++.++ +|+||+++++++.. ...++|+||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998653  2  2589999877654  356788999999999 99999999999988 88899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++.....   ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence            9999999975432   35899999999999999999999998   9999999999999999999999999987664321 


Q ss_pred             ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          497 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       497 ------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                            ...++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+      ...........       
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~-------  219 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGER-------  219 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCc-------
Confidence                  1234567999999998899999999999999999999 999997543221      11111111100       


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                         ..........+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               0011122346778888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=293.65  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             hHHHHHHhhccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          335 LEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       335 ~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+++.. ..++||+|+||+||+|.+++ |..+|+|.+.- ..+-+++..|+.+++.. +.++||+++|.|......|+||
T Consensus        31 PEEVFD-i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   31 PEEVFD-IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             hHHHHH-HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeeh
Confidence            444433 34679999999999999764 78889998754 34567888999999999 9999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |||..|++.+.++..    ++++++.++..++...++||+|||...   -||||||+.|||++.+|.+|++|||.|..+.
T Consensus       108 EYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  108 EYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             hhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence            999999999999753    457999999999999999999999987   8999999999999999999999999997765


Q ss_pred             C----CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          494 V----PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       494 ~----~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      .    ..+-.||+.|||||++..-.|+.++||||+|++..||..|++||....+..-.-               .+-...
T Consensus       181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------MIPT~P  245 (502)
T KOG0574|consen  181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------MIPTKP  245 (502)
T ss_pred             hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------------eccCCC
Confidence            4    345568999999999999999999999999999999999999998543221100               000011


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+..+++...++-+++++|+-..|++|-|+.+++++
T Consensus       246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            12344566777889999999999999999999998764

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7e-36  Score=326.22  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC--------eeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~  410 (635)
                      .+.||+|+||+||+|... +++.||||++......   ...+.+|+..+..+ +|+|++++...+...+        ..+
T Consensus        37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~  115 (496)
T PTZ00283         37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA  115 (496)
T ss_pred             EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence            467999999999999854 6889999998765433   34577788888888 9999999987775432        357


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||+++|+|.++++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCe
Confidence            99999999999999875432 2345899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          491 LMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       491 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      .....      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....      ............... 
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~~~~-  264 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGRYDP-  264 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCCCCC-
Confidence            65321      23457889999999999999999999999999999999999997543      222233222211100 


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                                ........+.+++.+||+.+|++||++.+++++
T Consensus       265 ----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        265 ----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                      011223456778889999999999999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.1e-36  Score=305.21  Aligned_cols=246  Identities=24%  Similarity=0.384  Sum_probs=193.5

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|.+.+      +..|++|.+.....  ....+.+|+.+++++ +|+||+++++++.+.+..++|||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   89 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLE   89 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEe
Confidence            4679999999999999754      45688888764432  245688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla  489 (635)
                      |+++++|.++++..+..  ....+++..+..++.||+.|++|||+.+   ++||||||+||+++.++   .+||+|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccc
Confidence            99999999999754321  1235899999999999999999999998   99999999999998765   5999999999


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +......      ....+..|+|||++.+..++.++|||||||++|||++ |..||......+      ...........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~  240 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGGRL  240 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCCcC
Confidence            7653221      1122456999999998899999999999999999997 999997543221      11111111100


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                                 .........+.+++.+|++.+|++||++.+++++|+
T Consensus       241 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 -----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                       001122346778888999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-36  Score=304.38  Aligned_cols=247  Identities=23%  Similarity=0.401  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEec-CCC----eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-EST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|.+. ++.    .||+|+++....  ...++.+|+.++.++ +|+||+++++++.. ...++++||
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~l~~~~   89 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STVQLVTQL   89 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCcEEEEEc
Confidence            468999999999999854 343    378998865432  245678888899988 89999999999875 457899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...    ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            99999999997532    24899999999999999999999998   999999999999999999999999998766432


Q ss_pred             CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ..      ..++..|+|||...+..++.++|||||||++|||++ |..||......+   +..+..    ....      
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~------  229 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGER------  229 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCc------
Confidence            21      123457999999998899999999999999999998 899987543211   111111    1100      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                          ..........+.+++.+||+.||++||++.|+++.|+++....
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                0001122345778888999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-35  Score=301.79  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=195.0

Q ss_pred             HhhccccccCceEEEEEEe-----cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEE
Q 006677          341 ASAEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLL  411 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~l  411 (635)
                      ...+.||+|+||.||++..     .++..||+|.++....  ....+.+|+++++++ +|+|++++.+++...  ...++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEE
Confidence            3456799999999999984     2467899999875432  235788999999999 999999999998875  56789


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||+++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.
T Consensus        86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            999999999999986432    24899999999999999999999998   99999999999999999999999999876


Q ss_pred             CCCCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC---------CCCChhHHHHH
Q 006677          492 MNVPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD---------DMVDLPRWVQS  555 (635)
Q Consensus       492 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~---------~~~~~~~~~~~  555 (635)
                      .....       ...++..|+|||++.+..++.++|||||||++|||+|+..|+......         .......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            54322       223455699999998888999999999999999999988765432110         00011111111


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                       .....          ..+........+.+++.+|++.+|++||+++++++.|+++
T Consensus       239 -~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 -LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             11110          0011112345678888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-35  Score=299.40  Aligned_cols=251  Identities=21%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++.. .++..++||.+.....    ...++.+|+.+++.+ +|+||+++++++..++..+++|||++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~   85 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD   85 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecC
Confidence            45799999999999995 4688999998865322    235688899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            9999998864322 2345899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...++..|+|||.+.+..++.++||||||+++|||++|..||......    ...+..........      ..   
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~------~~---  228 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCDYP------PL---  228 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCCCC------CC---
Confidence               234677899999999888999999999999999999999999753321    11111111111100      00   


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                       ........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             01123346777888999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-35  Score=306.42  Aligned_cols=194  Identities=22%  Similarity=0.406  Sum_probs=158.9

Q ss_pred             hccccccCceEEEEEEec---CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~  417 (635)
                      +++||+|+||+||+|...   +++.||+|.+..... ...+.+|+++++++ +||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            357999999999999864   457899999865432 35578899999999 99999999999864  346789999986


Q ss_pred             CCChhhhccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE----cCCCCeEEeecCCC
Q 006677          418 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT  489 (635)
Q Consensus       418 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~DfGla  489 (635)
                      + +|.+++.....    .....+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 88887753321    11235889999999999999999999998   9999999999999    45688999999999


Q ss_pred             CCCCCCC-------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          490 PLMNVPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       490 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      +......       ...+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            7654321       23468889999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-36  Score=304.93  Aligned_cols=239  Identities=25%  Similarity=0.394  Sum_probs=187.2

Q ss_pred             ccccccCceEEEEEEecC--------CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      +.||+|+||+||+|....        ...+++|.+..... ..+.+.+|+.++..+ +||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999998642        23477777754332 235677888888888 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC--------eEEeec
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISDF  486 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~ki~Df  486 (635)
                      |+++|+|.++++...    ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++||
T Consensus        80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999997543    24899999999999999999999998   999999999999987765        599999


Q ss_pred             CCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          487 GLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       487 Gla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      |++..........++..|+|||++.+ ..++.++|||||||++|||++|. .||.......      ... ......   
T Consensus       153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~-~~~~~~---  222 (258)
T cd05078         153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQ-FYEDRH---  222 (258)
T ss_pred             ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHH-HHHccc---
Confidence            99877665555667888999999986 45789999999999999999995 5554322111      111 000000   


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                               .........+.+++.+||+.+|++|||++++++.|+
T Consensus       223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 ---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     000111245678888999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-35  Score=295.94  Aligned_cols=251  Identities=22%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.|++|.++....    ..+.+.+|+++++++ +|+|++++++++...+..++||||++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELAD   85 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCC
Confidence            357999999999999976 688999998864321    245788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++..... ....+++..+..++.+++.|++|||+.+   ++||||+|+||+++.++.++|+|||++....... 
T Consensus        86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            9999999865332 2345899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...++..|+|||.+.+..++.++|||||||++|||++|+.||....    .+............. ..        .
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~-~~--------~  228 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY-PP--------L  228 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC-CC--------C
Confidence               2346778999999998889999999999999999999999996432    122222221111110 00        0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                       ..+.....+.+++.+||..+|++||++.++++.|+++.
T Consensus       229 -~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 -PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             01123346778888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-35  Score=300.95  Aligned_cols=242  Identities=21%  Similarity=0.358  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .++||+|+||.||+|.. .+++.||+|++.....  ..+.+.+|++++.++ +||||+++++++..++..++||||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            36799999999999986 4578899999865422  235688899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--CC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--AT  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--~~  497 (635)
                      +|..+.         .+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++......  ..
T Consensus        85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~  152 (279)
T cd06619          85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT  152 (279)
T ss_pred             ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence            996553         2788889999999999999999998   999999999999999999999999998765432  23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ....+..........      .. ..   
T Consensus       153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~-~~---  222 (279)
T cd06619         153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP------VL-PV---  222 (279)
T ss_pred             CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC------CC-CC---
Confidence            45788899999999989999999999999999999999999754322211 111111111111100      00 00   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+|++.+|++||+++|++++
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1122356778889999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=317.42  Aligned_cols=241  Identities=24%  Similarity=0.348  Sum_probs=201.6

Q ss_pred             hhccccccCceEEEEEEecC--C--CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          342 SAEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      ..++||+|.||.|++|.|..  |  -.||||.++....  ...+|.+|+.+|.++ +|+|+++|+|+..+ ....+|||+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhhh
Confidence            36789999999999999863  3  3589999987654  357899999999999 99999999999887 788899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      ++.|+|.+.|++.   .+..+-....-.++.|||.||+||..++   +|||||.++|+|+-....+||+|||+.+.+...
T Consensus       192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999862   2445788888999999999999999998   999999999999999999999999999887655


Q ss_pred             CCCC-------CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 ATPS-------RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ~~~~-------~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      ....       -...|+|||.+..+.++.++|||+|||++|||+| |..||.+-...++..                .+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hcc
Confidence            4332       2345999999999999999999999999999999 788987654322111                122


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .-.+....+.+.+.+.+++..||..+|.+|||+..+.+.
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             222445556778899999999999999999999999843

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-36  Score=318.98  Aligned_cols=241  Identities=21%  Similarity=0.306  Sum_probs=190.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||++... ++..||+|++....    .....+.+|+++++.+ +||||+++++++.+++..++||||++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCC
Confidence            568999999999999975 47889999987532    1234577899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......  
T Consensus       127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999998642      3788889999999999999999998   999999999999999999999999998765432  


Q ss_pred             ---CCCCCCCcccCcccccCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ---ATPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~----~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                         ....+++.|+|||++.+.    .++.++|||||||++|||++|+.||.....      ......+.......     
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~-----  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL-----  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC-----
Confidence               234578899999998653    478999999999999999999999975432      11112222111000     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  607 (635)
                         ..+........+.+++.+|++.+|++  ||+++|++++
T Consensus       267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               01111112345667778999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-35  Score=301.04  Aligned_cols=243  Identities=22%  Similarity=0.385  Sum_probs=191.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.||+|++.........+.+|+.++.++.+|+||+++++++...      ...++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            457999999999999865 4778999998766556678889999999987899999999998753      457899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....   ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus        91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            99999999987532   234889999999999999999999998   999999999999999999999999998765322


Q ss_pred             ----CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                          ....++..|+|||++.     ...++.++|||||||++|||++|+.||.......     .+. . ......... 
T Consensus       165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~-~-~~~~~~~~~-  236 (272)
T cd06637         165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-L-IPRNPAPRL-  236 (272)
T ss_pred             cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH-H-HhcCCCCCC-
Confidence                2334677899999986     3457889999999999999999999996432111     110 0 000000000 


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ..   ......+.+++.+||..+|++|||+.|++++
T Consensus       237 -----~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         237 -----KS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -----CC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                 00   1122456788889999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=297.83  Aligned_cols=244  Identities=26%  Similarity=0.440  Sum_probs=199.4

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||+|... ++.|++|.++......+.+.+|+.++.++ +|+||+++++++...+..++||||+++++|.
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   88 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence            567999999999999876 78899999987655567888999999999 8999999999999989999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-CCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-PSRS  501 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-~~~~  501 (635)
                      +++....   ...+++..+..++.|++.|+.|||+.+   ++|+||||+||++++++.++|+|||.++....... ...+
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  162 (256)
T cd05039          89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP  162 (256)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence            9997432   225899999999999999999999998   99999999999999999999999999987643322 2234


Q ss_pred             CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHH
Q 006677          502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM  580 (635)
Q Consensus       502 ~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  580 (635)
                      ..|+|||.+....++.++||||||+++|||++ |..||......+       ....+...+....          .....
T Consensus       163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~----------~~~~~  225 (256)
T cd05039         163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRMEA----------PEGCP  225 (256)
T ss_pred             ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCCC----------ccCCC
Confidence            56999999988889999999999999999997 999987443211       1111111111100          11223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          581 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       581 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ..+.+++.+|+..+|++||++.|++++|+.+
T Consensus       226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            5677888899999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-35  Score=308.79  Aligned_cols=263  Identities=26%  Similarity=0.367  Sum_probs=204.0

Q ss_pred             ChHHHHHHhhccccccCceEEEEEEecC--------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          334 DLEDLLRASAEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       334 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      .+........+.||+|+||.||+|....        ...||+|.++....  ..+++.+|++++.++.+|+||+++++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            3333333456789999999999997421        23689998875432  2457888999999997899999999999


Q ss_pred             EeCCeeEEEEEeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 006677          404 YSKDEKLLVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN  472 (635)
Q Consensus       404 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  472 (635)
                      ...+..++++||+++|+|.+++.....           .....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence            999999999999999999999875321           11235889999999999999999999998   9999999999


Q ss_pred             eEEcCCCCeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 006677          473 VLINQDLDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD  545 (635)
Q Consensus       473 Ill~~~~~~ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~  545 (635)
                      |++++++.+||+|||+++.......      ..++..|+|||++.+..++.++||||||+++|||++ |..||.....  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999876543221      112356999999999999999999999999999999 8888875432  


Q ss_pred             CCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                          ..+...+... ....          ........+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus       243 ----~~~~~~~~~~-~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         243 ----EELFKLLKEG-HRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ----HHHHHHHHcC-CCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence                2222222111 1111          011223467788899999999999999999999999985543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-35  Score=300.43  Aligned_cols=247  Identities=23%  Similarity=0.362  Sum_probs=183.9

Q ss_pred             cccccCceEEEEEEecC---CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .||+|+||+||+|...+   ...+++|.+......  ...+.+|+++++.+ +|+||+++++++......++||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999997543   345778876543322  34678899999988 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++...+.......++.....++.||+.|++|||+.+   |+||||||+||++++++.+||+|||++......    
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999997655333334578888999999999999999998   999999999999999999999999998654221    


Q ss_pred             --CCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          496 --ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~-------~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                        ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+      .......... ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence              12234567999998743       356789999999999999999 788886543211      1111111111 001


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      .++..     .......+.+++..|| .||++|||++||++.|
T Consensus       231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11110     1122234455667888 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.8e-35  Score=296.65  Aligned_cols=241  Identities=24%  Similarity=0.454  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||++...++..+++|.+........++.+|+++++++ +|||++++++++......++||||+++++|.
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLS   87 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence            467999999999999987788999999887666677899999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....    ..++++.+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++.......     .
T Consensus        88 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          88 DYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence            9987433    24789999999999999999999998   9999999999999999999999999986543221     1


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+.+|+|||++.+..++.++||||||+++|||++ |..||......      ...... .....  ...+        
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~~~--~~~~--------  223 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI-NAGFR--LYKP--------  223 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH-hCCCC--CCCC--------
Confidence            223457999999998889999999999999999998 99999753321      111111 11100  0000        


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ......+.+++.+||+.+|++||++.|++++|
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11234678889999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-36  Score=312.96  Aligned_cols=235  Identities=22%  Similarity=0.287  Sum_probs=183.2

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHH-HHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||+||+|... +++.||+|++.....    ....+..|... ++.+ +|+||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36999999999999976 467799999875422    12334444444 4555 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          80 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            99999998742     23778888899999999999999998   999999999999999999999999998754221  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+.....         ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~---------~~~  216 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL---------QLK  216 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCc---------CCC
Confidence              2335788999999999999999999999999999999999999754321      11122211110         001


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV  605 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl  605 (635)
                      +.   ....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~---~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PN---ITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CC---CCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            11   223456777799999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.6e-36  Score=306.69  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             hhccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||++...      .+..||+|+++....  ..+.+.+|+++++++.+|+||+++++++...+..++||
T Consensus        39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  118 (302)
T cd05055          39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT  118 (302)
T ss_pred             EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence            3678999999999999742      234689998875432  23568899999999977999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.++++....   ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++++|||+++...
T Consensus       119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccccc
Confidence            99999999999975332   23899999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...      ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+      -........+...  
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~--  264 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA--  264 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC--
Confidence            322      1224567999999999899999999999999999998 999997543221      0111111111100  


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                              ........+.+++.+|+..+|++|||+.|+++.|+++
T Consensus       265 --------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 --------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                    0011224577888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-35  Score=297.17  Aligned_cols=243  Identities=26%  Similarity=0.411  Sum_probs=194.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEE-eCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-SKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||++... +..|++|.++... ..+.+.+|+.+++++ +|+|++++++++. .++..++|+||+++++|
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            468999999999999875 7789999886432 356788999999999 9999999999765 44578999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR  500 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~  500 (635)
                      .++++...   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+|++|||++....... ....
T Consensus        88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  161 (256)
T cd05082          88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  161 (256)
T ss_pred             HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence            99987533   234889999999999999999999998   9999999999999999999999999987654322 2234


Q ss_pred             CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHH
Q 006677          501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE  579 (635)
Q Consensus       501 ~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  579 (635)
                      +..|+|||++.+..++.++|||||||++|||++ |+.||....      .......+ ...+....          ....
T Consensus       162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~  224 (256)
T cd05082         162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMDA----------PDGC  224 (256)
T ss_pred             ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCCC----------CCCC
Confidence            567999999998889999999999999999998 999986432      11112111 11111110          1122


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       580 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ...+.+++.+|++.+|++|||+.++++.|+++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            34567788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=319.31  Aligned_cols=241  Identities=21%  Similarity=0.363  Sum_probs=189.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||||++.....    ....+.+|++++..+ +|+||+++++++.+.+..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCC
Confidence            467999999999999975 578899999975421    234577899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++....... 
T Consensus        85 ~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          85 GGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999998742     24899999999999999999999998   9999999999999999999999999986532110 


Q ss_pred             -----------------------------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC
Q 006677          497 -----------------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK  535 (635)
Q Consensus       497 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~  535 (635)
                                                               ...||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                     124788999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006677          536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM  607 (635)
Q Consensus       536 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  607 (635)
                      .||......+      ....+..  +....   .........+   .+.+++.+|+. +|.+|++   ++|++++
T Consensus       237 ~Pf~~~~~~~------~~~~i~~--~~~~~---~~~~~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQE------TYRKIIN--WKETL---QFPDEVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHH------HHHHHHc--CCCcc---CCCCCCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9997543211      1111111  10000   0000111222   44566668886 8999998   9998874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-35  Score=299.57  Aligned_cols=244  Identities=24%  Similarity=0.474  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEecC-C---CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|.... +   ..+++|+++....  ..+++..|++++.++ +|+|++++.+++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~   88 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYM   88 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcC
Confidence            4689999999999999753 2   2688998865432  245688899999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++++|.+++....    ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999996432    34899999999999999999999998   9999999999999999999999999987654322


Q ss_pred             CC-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 TP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 ~~-------~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ..       ..+..|+|||++....++.++|||||||++|||++ |+.||......      .+...+....        
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~--------  227 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGF--------  227 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCC--------
Confidence            11       12346999999998889999999999999999998 99999754321      1222221110        


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                         ..+........+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0111112335678888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-35  Score=332.43  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=200.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||+|... .++.||+|++.....    ..+++.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~e   85 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIE   85 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence            467999999999999965 478899999875422    145688999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          418 SGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       418 ~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      +|+|.+++......      .....++..++.++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||+++.
T Consensus        86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCccee
Confidence            99999998642211      1233667888999999999999999998   99999999999999999999999999876


Q ss_pred             CCC----------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006677          492 MNV----------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL  549 (635)
Q Consensus       492 ~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~  549 (635)
                      ...                      .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+... 
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~-  241 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY-  241 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh-
Confidence            511                      011347889999999999999999999999999999999999997533221100 


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhccCCCCC
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENR  619 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~~~~~~~~~  619 (635)
                         ...         ..++.  ......+....+.+++.+|++.||++|| +++++.+.|+...+...+..
T Consensus       242 ---~~~---------i~~P~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~  298 (932)
T PRK13184        242 ---RDV---------ILSPI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT  298 (932)
T ss_pred             ---hhh---------ccChh--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcccc
Confidence               000         00000  0000112234566788899999999996 57788888988877655443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-36  Score=316.09  Aligned_cols=242  Identities=22%  Similarity=0.348  Sum_probs=191.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||++... +++.||+|+++....    ..+.+.+|++++..+ +|+||+++++++.+.+..++||||++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQP   84 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCC
Confidence            467999999999999965 578899999986533    234577888888887 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999997542    34899999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ----CCCCCCcccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          497 ----TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~------~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                          ...+++.|+|||++.      ...++.++|||||||++|||++|+.||......      .....+.......   
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~---  228 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFL---  228 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCcc---
Confidence                235788999999986      456789999999999999999999999754321      1122221111000   


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ..+........+.+++..|++ +|.+||++++++++
T Consensus       229 -----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         229 -----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                 011111122345667778997 99999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-35  Score=298.32  Aligned_cols=243  Identities=24%  Similarity=0.452  Sum_probs=196.5

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||++...++..+++|.+.........+.+|+++++++ +|+||+++++++.. ...+++|||+++|+|.
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~   88 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLL   88 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence            467999999999999988888899998876554567788999999999 89999999999877 7789999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-----
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-----  497 (635)
                      +++....   ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||.+........     
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  162 (260)
T cd05073          89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  162 (260)
T ss_pred             HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence            9997543   234788999999999999999999988   99999999999999999999999999875543221     


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++....++.++|+|||||++||++| |+.||......+   .   .. .....+..          +..
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~---~~-~~~~~~~~----------~~~  225 (260)
T cd05073         163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---IR-ALERGYRM----------PRP  225 (260)
T ss_pred             CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H---HH-HHhCCCCC----------CCc
Confidence            123456999999998889999999999999999999 899997543211   1   11 11111110          011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1233467788889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=310.45  Aligned_cols=241  Identities=23%  Similarity=0.375  Sum_probs=201.0

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|.||.||++..+. |+.+|+|++.+...    ......+|+.+|+++..|||||.+.+.|++.+..++|||++.|
T Consensus        41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G  120 (382)
T KOG0032|consen   41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG  120 (382)
T ss_pred             hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence            679999999999999775 89999999987644    2368999999999996699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC----CCeEEeecCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMNV  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~DfGla~~~~~  494 (635)
                      |.|.+.+...      .+++..+..++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++|||++.....
T Consensus       121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            9999999754      2899999999999999999999998   9999999999999643    5799999999988776


Q ss_pred             C---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          495 P---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 ~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .   ....||+.|+|||++....|+..+||||+||++|.|++|..||.+.+..+...      .+....+     +....
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-----~f~~~  260 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-----DFTSE  260 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-----CCCCC
Confidence            3   24569999999999999999999999999999999999999999776443211      2222222     11111


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+....+   ..-+++..|+..||..|+|+.+++++
T Consensus       261 ~w~~is~---~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  261 PWDDISE---SAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CccccCH---HHHHHHHHhcccCcccCCCHHHHhcC
Confidence            2333334   44556669999999999999999995

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.5e-36  Score=314.08  Aligned_cols=234  Identities=21%  Similarity=0.297  Sum_probs=183.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||+||+|... +++.+|+|++.....    ....+..|..++.+..+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999965 578999999975422    2234555555444333999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|..++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....   
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            9999888642     34899999999999999999999998   999999999999999999999999998753221   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+..      ...........         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~~---------~~~~  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKPL---------VLRP  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCCc---------cCCC
Confidence             2334788999999999999999999999999999999999999754321      11222221110         0011


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDE  603 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  603 (635)
                      .   ....+.+++.+|++.+|++||++.+
T Consensus       218 ~---~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 G---ASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             C---CCHHHHHHHHHHhccCHHhcCCCCC
Confidence            1   2234567778999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-35  Score=303.01  Aligned_cols=243  Identities=23%  Similarity=0.305  Sum_probs=191.8

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||+||++... +++.||+|.+......    ...+.+|+.+++++ +|+|++.+.+.+..++..++||||+++
T Consensus         6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            57999999999999965 5788999998754321    23467799999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+++....   ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......  
T Consensus        85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            99999885432   234899999999999999999999988   9999999999999999999999999987654322  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||.........   ........ .....          .
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~-~~~~~----------~  224 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVK-EVQEE----------Y  224 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhh-hhhhh----------c
Confidence             235788899999999989999999999999999999999999754321110   00111100 00000          0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      .......+.+++.+||+.||++|||     ++|++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            0112234667888999999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-35  Score=297.02  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=188.4

Q ss_pred             ccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEEec
Q 006677          344 EVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYF  416 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~  416 (635)
                      +.||+|+||.||+|...+    ...+|+|++.....  ..+.+.+|+.+++.+ +||||+++++++.. +...++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998642    34689998754322  235677898989888 99999999998764 45678999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      .+|+|.++++...    ...++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            9999999997432    23677888999999999999999988   9999999999999999999999999987543211


Q ss_pred             --------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 --------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                              ...++..|+|||.+.+..++.++|||||||++|||++| ..||....      ..............     
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~-----  221 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRL-----  221 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCC-----
Confidence                    12235579999999888899999999999999999995 55565322      11122221111100     


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                            .........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       222 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 ------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                  0001122457788889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-35  Score=304.07  Aligned_cols=253  Identities=21%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEecC-----------------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      .+.||+|+||.||+|...+                 +..||+|.+.....  ..+++.+|++++.++ +|+||+++++++
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   88 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVC   88 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence            4679999999999998643                 24578998875432  245788899999999 999999999999


Q ss_pred             EeCCeeEEEEEeccCCChhhhccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC
Q 006677          404 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       404 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  477 (635)
                      ..++..++|+||+++++|.+++......      ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~  165 (296)
T cd05051          89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK  165 (296)
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence            9999999999999999999999754421      1235899999999999999999999998   999999999999999


Q ss_pred             CCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 006677          478 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL  549 (635)
Q Consensus       478 ~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t--g~~p~~~~~~~~~~~~  549 (635)
                      ++.++|+|||+++......      ...++..|+|||++.+..++.++|||||||++|||++  +..||......+   .
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~  242 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---V  242 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---H
Confidence            9999999999987543221      2234567999999988889999999999999999998  677876433211   1


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ................       .........++.+++.+|++.+|++|||+.|+++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         243 IENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1111111111000000       0011122356888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-35  Score=300.12  Aligned_cols=244  Identities=21%  Similarity=0.322  Sum_probs=191.3

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.++ +||||+++++++..++..++||||+++++
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~   92 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGS   92 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence            46799999999999996 4578899999875432 345677899999998 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.++++..     ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++......    .
T Consensus        93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99998632     34889999999999999999999998   999999999999999999999999998765322    2


Q ss_pred             CCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      ...++..|+|||.+.   ...++.++|||||||++|||++|+.||......+...      ........    .+   ..
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~----~~---~~  231 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNFQ----PP---KL  231 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCCC----CC---CC
Confidence            234677899999884   3457889999999999999999999996443221100      00000000    00   00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      .........+.+++.+||+.+|++||+++++++++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11112234677888899999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=320.16  Aligned_cols=241  Identities=20%  Similarity=0.334  Sum_probs=187.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||++... +++.||+|++.....    ..+.+.+|++++.++ +||||+++++++.+.+..|+||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCC
Confidence            467999999999999864 578899999865422    134577899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        85 gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          85 GGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999998643     34888999999999999999999998   999999999999999999999999998632110  


Q ss_pred             -------------------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHH
Q 006677          496 -------------------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGV  526 (635)
Q Consensus       496 -------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gv  526 (635)
                                                                       ....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                             0124788899999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC---CCHHH
Q 006677          527 LLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR---PNMDE  603 (635)
Q Consensus       527 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~e  603 (635)
                      ++|||++|..||......+      ....+..  +....      ..+........+.+++.+|++ +|.+|   +++.|
T Consensus       237 il~elltG~~Pf~~~~~~~------~~~~i~~--~~~~~------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE------TYRKIIN--WRETL------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH------HHHHHHc--cCCcc------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999997543211      1111111  00000      001101112345667778887 66665   69999


Q ss_pred             HHHH
Q 006677          604 VVRM  607 (635)
Q Consensus       604 vl~~  607 (635)
                      ++++
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            9885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-36  Score=309.11  Aligned_cols=252  Identities=21%  Similarity=0.362  Sum_probs=189.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|+++....  ....+.+|+++++++ +|+||+++++++..++..++||||+++ 
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-   88 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK-   88 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence            467999999999999865 467899999875432  234677899999999 999999999999999999999999975 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   
T Consensus        89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            8888876432    34788999999999999999999998   9999999999999999999999999987543322   


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc-----cc
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA-----EV  565 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~-----~~  565 (635)
                       ...++..|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+....   ......    +.|..     ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhhh
Confidence             2346788999998865 4588999999999999999999999976543221110   111000    00000     00


Q ss_pred             chhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          566 FDVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       566 ~d~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .+......      .........+.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000      000112234667888999999999999999988

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.5e-36  Score=316.33  Aligned_cols=241  Identities=21%  Similarity=0.307  Sum_probs=187.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++.... ++.+|+|++.+...    ....+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence            4679999999999999764 67899999865321    234577888888888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......  
T Consensus       127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999999632      3788999999999999999999998   999999999999999999999999999765432  


Q ss_pred             ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                         ....+|+.|+|||++.+..    ++.++||||+||++|||++|+.||...+..      .....+.......     
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~-----  266 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL-----  266 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc-----
Confidence               2345889999999986543    788999999999999999999999754321      1112222111000     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  607 (635)
                         ..+........+.+++..|+..++.+  |+++.|++++
T Consensus       267 ---~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 ---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               00110112234456666888755543  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-35  Score=299.61  Aligned_cols=250  Identities=22%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             hccccccCceEEEEEEecC-----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e  414 (635)
                      .++||+|+||.||+|...+     +..|++|+++....  ....+.+|+.++.++ +|+||+++++++.. ....++++|
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~   89 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYP   89 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEE
Confidence            4679999999999999765     67889998875432  245678899999999 99999999998876 467899999


Q ss_pred             eccCCChhhhccCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          415 YFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      |+++|+|.+++......   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            99999999998654321   1245899999999999999999999988   99999999999999999999999999976


Q ss_pred             CCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          492 MNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       492 ~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      +....      ...++..|+|||++.+..++.++||||||+++||+++ |+.||......      .+..... ....  
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~-~~~~--  237 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMAAYLK-DGYR--  237 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHHHHHH-cCCC--
Confidence            53321      1234567999999998889999999999999999999 99999754321      1111111 1110  


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                              ..........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         238 --------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    00011123456788889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.4e-36  Score=327.38  Aligned_cols=255  Identities=18%  Similarity=0.272  Sum_probs=184.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhc-----CCCceeceeEEEEeC-CeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSK-DEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~-~~~~lv~e~  415 (635)
                      .++||+|+||+||+|... .++.||||+++.......++..|++++..+.     +|.+++.+++++... ...++|||+
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~  213 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK  213 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence            467999999999999865 4678999999754333455677887777762     345688898888765 467899998


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCC---------------
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDL---------------  479 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~---------------  479 (635)
                      + +++|.+++...     ..+++..+..++.||+.||+|||++ +   ||||||||+|||++.++               
T Consensus       214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            7 67888888642     3489999999999999999999984 7   99999999999998765               


Q ss_pred             -CeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006677          480 -DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV  557 (635)
Q Consensus       480 -~~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  557 (635)
                       .+||+|||.+...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+...........+
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence             4999999987654332 23467899999999999999999999999999999999999998654322111100000000


Q ss_pred             hhcccc--------ccc----------hhh-hh---cccChH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          558 REEWTA--------EVF----------DVE-LM---RFQNIE--EEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       558 ~~~~~~--------~~~----------d~~-~~---~~~~~~--~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ...|..        ..+          ++. +.   ......  .....+.+|+.+||+.||++|||++|+++
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            000000        000          000 00   000000  11245778999999999999999999998

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.1e-36  Score=319.55  Aligned_cols=191  Identities=27%  Similarity=0.392  Sum_probs=164.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|... +++.||+|++.....    ....+.+|+++++++ +|+||+++++.+.+++..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            467999999999999964 577899999875422    234677899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....   
T Consensus        85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999998643     24788899999999999999999998   99999999999999999999999999743210   


Q ss_pred             ------------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHH
Q 006677          495 ------------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGV  526 (635)
Q Consensus       495 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gv  526 (635)
                                                                      .....||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                            01124788899999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 006677          527 LLLEMLTGKAPLQSPT  542 (635)
Q Consensus       527 vl~el~tg~~p~~~~~  542 (635)
                      ++|||++|+.||...+
T Consensus       237 il~elltG~~Pf~~~~  252 (382)
T cd05625         237 ILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-35  Score=303.69  Aligned_cols=254  Identities=22%  Similarity=0.364  Sum_probs=194.7

Q ss_pred             hccccccCceEEEEEEecC-----------------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----------------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      .+.||+|+||.||++...+                 ...+|+|++.....  ...++.+|+++++++ +|+||+++++++
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   88 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVC   88 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence            4679999999999986432                 33588998875432  245788999999999 999999999999


Q ss_pred             EeCCeeEEEEEeccCCChhhhccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC
Q 006677          404 YSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       404 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  477 (635)
                      ...+..++||||+++|+|.+++......      ....+++..+..++.|++.|++|||+.+   ++||||||+||++++
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~  165 (296)
T cd05095          89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK  165 (296)
T ss_pred             ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcC
Confidence            9999999999999999999998754321      1234788899999999999999999998   999999999999999


Q ss_pred             CCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 006677          478 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDL  549 (635)
Q Consensus       478 ~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t--g~~p~~~~~~~~~~~~  549 (635)
                      ++.++|+|||+++......      ....+..|+|||...++.++.++|||||||++|||++  |..||......+.   
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---  242 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---  242 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---
Confidence            9999999999987653322      1223467999999888889999999999999999998  7788865433221   


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      .................       +....+...+.+++.+||+.+|++||++.|+++.|++
T Consensus       243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 IENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111111100000       0111223567788899999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=297.37  Aligned_cols=241  Identities=27%  Similarity=0.437  Sum_probs=194.9

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ++||+|+||.||++...+++.|++|.+......  ...+.+|+++++++ +|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            369999999999999877899999988765432  45788999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....    ..+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.++|+|||++........    
T Consensus        80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99986432    24789999999999999999999998   99999999999999999999999999876542211    


Q ss_pred             --CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 --PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 --~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...+..|+|||.+.+..++.++|||||||++|||+| |..||.......      .... ......          ..
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~-~~~~~~----------~~  215 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRER-IESGYR----------MP  215 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHH-HhcCCC----------CC
Confidence              112446999999998899999999999999999999 888886543211      1111 111110          00


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ........+.+++.+|++.+|++||++.|+++.|+
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11122346788889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-36  Score=319.76  Aligned_cols=241  Identities=22%  Similarity=0.342  Sum_probs=187.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++.....    ....+.+|++++.++ +|+||+++++.+..++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP   84 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCC
Confidence            467999999999999965 478899999865321    245678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....   
T Consensus        85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999642     34788899999999999999999998   99999999999999999999999999743210   


Q ss_pred             --------------------------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHH
Q 006677          495 --------------------------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE  530 (635)
Q Consensus       495 --------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~e  530 (635)
                                                                  .....||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                        011247889999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 006677          531 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP---NMDEVVRM  607 (635)
Q Consensus       531 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~evl~~  607 (635)
                      |++|+.||......+      ....+..  +.....   ........   ..+.+++.+|+ .+|++|+   ++.|++++
T Consensus       237 ll~G~~Pf~~~~~~~------~~~~i~~--~~~~~~---~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAE------TQLKVIN--WETTLH---IPSQAKLS---REASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHH------HHHHHhc--cCcccc---CCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999997654221      1111111  100000   00011122   23445555665 4999999   89999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.1e-35  Score=298.53  Aligned_cols=244  Identities=25%  Similarity=0.491  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEecC-C---CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|.... +   ..|++|.++....  ...++..|+.+++.+ +||||+++++++..+...++||||+
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~   87 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFM   87 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecC
Confidence            5689999999999999753 2   3599999875422  245788999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++....    ..+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.+|++|||++.......
T Consensus        88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999987432    34899999999999999999999998   9999999999999999999999999987654321


Q ss_pred             CC------CC---CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          497 TP------SR---SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       497 ~~------~~---~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..      .+   +..|+|||++.+..++.++|||||||++|||++ |..||......+   ...++    ...+.    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~~~----  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQDYR----  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCCc----
Confidence            11      11   236999999999999999999999999999987 999997543211   11111    11110    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                            .+...+....+.+++.+||+.+|.+||++++++..|+++
T Consensus       230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  011112334567888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-35  Score=300.41  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=198.7

Q ss_pred             hccccccCceEEEEEEec-----CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~  413 (635)
                      .+.||+|+||.||+|.+.     .+..+|+|+++.....  .+++.+|+++++++ +|+||+++++++..  ....++||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIM   87 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEE
Confidence            367999999999999864     3578999999866553  56899999999999 99999999999887  55789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+....
T Consensus        88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999997543    24899999999999999999999998   9999999999999999999999999997765


Q ss_pred             CCCC-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHh
Q 006677          494 VPAT-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQSVV  557 (635)
Q Consensus       494 ~~~~-------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~---------~~~~~~~~~~  557 (635)
                      ....       ...+..|+|||.+.+..++.++||||||+++|||+||+.|+.........         ....+.. ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HH
Confidence            3221       12344599999998889999999999999999999999998654322110         0111111 11


Q ss_pred             hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       558 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ....          ...........+.+++.+||+.+|++|||+.|++++|+.++
T Consensus       240 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         240 KEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1100          01111122356888999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.9e-36  Score=310.24  Aligned_cols=232  Identities=21%  Similarity=0.304  Sum_probs=182.2

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHH-HHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQME-IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ++||+|+||.||+|+.. +++.||+|++.....    ....+..|.. +++.+ +||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999975 478899999875432    1234455554 45555 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|...+...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            99999888632     34788899999999999999999998   999999999999999999999999998753222  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+.....         ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~---------~~~  216 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKPL---------QLP  216 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCCC---------CCC
Confidence              123478899999999998999999999999999999999999975431      112222221110         000


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMD  602 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~  602 (635)
                         ......+.+++.+|++.+|.+||++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 ---GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence               11233567788899999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-35  Score=302.92  Aligned_cols=240  Identities=22%  Similarity=0.343  Sum_probs=193.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|++++..+ +|+||+++++++......++||||+++++
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~  103 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence            357999999999999854 578899998875433 346688899999988 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++...      .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......    
T Consensus       104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654         104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            99998632      3789999999999999999999998   9999999999999999999999999987653321    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||......+     .+.. ..... ..        .....
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~-~~~~~-~~--------~~~~~  239 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYL-IATNG-TP--------ELQNP  239 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHH-HhcCC-CC--------CCCCc
Confidence            2346778999999998889999999999999999999999997543211     1111 00000 00        00111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||..+|++||++.|++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            2233456788889999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-35  Score=293.08  Aligned_cols=241  Identities=23%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... ++..|++|.+.....   ...++.+|+++++++ +|||++++++++..++..++||||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCC
Confidence            357999999999999975 578899999865422   345688899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.++++...   ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++......  
T Consensus        84 ~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          84 GDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999997542   235899999999999999999999988   9999999999999999999999999987654432  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||++.+..++.++||||||+++|||++|+.||......      .......... ...          
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~----------  220 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRGV-FPP----------  220 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-CCC----------
Confidence              224677899999999988999999999999999999999999754311      1111111111 000          


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........+.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            011233567888889999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=300.05  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...+      +..|++|.+.....  ....+.+|+.++..+ +|+||+++++++......++|||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e   89 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVME   89 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEe
Confidence            5679999999999998653      36799999865432  234678899999998 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRGA-----GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      |+++|+|.+++......     ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence            99999999998653321     1234788999999999999999999988   999999999999999999999999998


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +......      ...++..|+|||.+.+..++.++|||||||++||+++ |..||......+   .   .. .......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---~~-~~~~~~~  239 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V---LK-FVIDGGH  239 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H---HH-HHhcCCC
Confidence            7543321      2234667999999988889999999999999999998 999997543221   1   11 1111111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ..          ........+.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         240 LD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            00          01112456778889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.6e-36  Score=304.68  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||++...      ++..+++|.+..... ...++.+|++++.++ +|+||+++++++......++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   88 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEY   88 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEec
Confidence            467999999999999742      355788888765432 346789999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          416 FASGSLSTLLHGNRG----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      +++|+|.+++.....          .....+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECC
Confidence            999999999875431          11134889999999999999999999998   99999999999999999999999


Q ss_pred             cCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          486 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       486 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      ||++.......      ...+++.|+|||.+.+..++.++|||||||++|||++ |..||......+      .......
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~  239 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIECITQ  239 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHHHHHc
Confidence            99986543221      1223567999999999999999999999999999998 899986543211      1111111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .. ...          ........+.+++.+||+.+|++||+++|+++.|+
T Consensus       240 ~~-~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 GR-ELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             Cc-cCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            10 000          00112235668888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=304.51  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEecCC---------------CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS  405 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~---------------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~  405 (635)
                      .+.||+|+||.||++...+.               ..||+|.+.....  ....+.+|++++.++ +|+|++++++++..
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~   88 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS   88 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence            46799999999999876431               2488998875422  235688999999999 99999999999999


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC
Q 006677          406 KDEKLLVYDYFASGSLSTLLHGNRGA-------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD  478 (635)
Q Consensus       406 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  478 (635)
                      .+..++||||+++++|.+++......       ....+++..++.++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~  165 (295)
T cd05097          89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH  165 (295)
T ss_pred             CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence            99999999999999999998643210       1124788999999999999999999998   9999999999999999


Q ss_pred             CCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 006677          479 LDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRDDMVDLP  550 (635)
Q Consensus       479 ~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t--g~~p~~~~~~~~~~~~~  550 (635)
                      +.+||+|||++.......      ...++..|+|||++.+..++.++|||||||++|||++  |..||......+   ..
T Consensus       166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~  242 (295)
T cd05097         166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI  242 (295)
T ss_pred             CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence            999999999987543221      1123557999999998889999999999999999998  667776543222   11


Q ss_pred             HHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       551 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .................    ..   ......+.+++.+||+.+|++||++++|++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~----~~---~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         243 ENTGEFFRNQGRQIYLS----QT---PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHhhhhccccccCC----CC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            11111111100000000    00   112246788889999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-35  Score=299.02  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=195.0

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|..++      +..||+|.+......  ...+.+|+.+++++ +|+||+++++++...+..++|||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e   89 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVME   89 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence            5689999999999997542      457999987654322  34577889999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      |+++|+|.++++....     .+....++..+..++.|++.||+|||+.+   |+||||||+||++++++.++++|||++
T Consensus        90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~  166 (288)
T cd05061          90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT  166 (288)
T ss_pred             CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence            9999999999965321     12344677888999999999999999998   999999999999999999999999998


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +......      ...++..|+|||.+.+..++.++|||||||++|||++ |..||......      ............
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~  240 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMDGGYL  240 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence            7543221      1123557999999998899999999999999999999 78898754322      122222111110


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      .           ........+.+++.+|++.+|++|||+.|+++.|++..
T Consensus       241 ~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         241 D-----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             C-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0           01122346788888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-35  Score=300.97  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=191.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.+|+|.+......    ...+.+|++++.++ +|+|++.+.+++..++..++||||++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEecc
Confidence            357999999999999965 5788999998754321    23467899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++....   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          84 GGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             CccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999998886432   235899999999999999999999998   9999999999999999999999999986543322 


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||++.+..++.++|+|||||++|||++|..||........  ...+... .....  ..+      . 
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~-~~~~~--~~~------~-  225 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRR-VLETE--EVY------S-  225 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh-hhccc--ccc------C-
Confidence              23468889999999988999999999999999999999999975432111  0011111 11000  000      0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                        ......+.+++..|++.+|++||+     +.|++.+
T Consensus       226 --~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         226 --AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              112234567788999999999999     6676664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-35  Score=308.08  Aligned_cols=233  Identities=24%  Similarity=0.325  Sum_probs=186.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++.....    ..+.+..|.+++..+.+|++|+++.+++...+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~   84 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN   84 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence            367999999999999965 578899999875421    234567788888888677889999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999998642     34899999999999999999999998   999999999999999999999999998754322  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||......      .....+......           
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~~-----------  219 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNVS-----------  219 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-----------
Confidence              2234788999999999989999999999999999999999999754321      112222211110           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM  601 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~  601 (635)
                       ........+.+++.+|++.+|.+|++.
T Consensus       220 -~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 -YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             001122356778889999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=299.30  Aligned_cols=244  Identities=26%  Similarity=0.518  Sum_probs=194.7

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|....    +..+|+|.++....  ..+.+..|+.++.++ +||||+++++++..++..++||||+
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~   87 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYM   87 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcC
Confidence            5689999999999998642    33689998865432  245788899999999 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++++|.+++....    ..+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||++.......
T Consensus        88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999997432    34899999999999999999999998   9999999999999999999999999987654322


Q ss_pred             CC-------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 TP-------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 ~~-------~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ..       ..+..|+|||.+.+..++.++||||||+++||+++ |..||......+   .   ...+ .+.+.      
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~-~~~~~------  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKAI-EEGYR------  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHHH-hCCCc------
Confidence            11       12346999999998889999999999999999887 999997543221   1   1111 11110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                          .+........+.+++.+|++.+|++||++.++++.|+++
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                001112234567888899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-35  Score=297.25  Aligned_cols=245  Identities=27%  Similarity=0.451  Sum_probs=193.0

Q ss_pred             cccccCceEEEEEEecC-------CCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          345 VLGKGSYGTAYKAVLEE-------STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .||+|+||.||+|...+       +..+++|.+....  .....+.+|+.+++++ +||||+++++++...+..++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEec
Confidence            68999999999998653       2468899876543  2356788999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-----CeEEeecCC
Q 006677          416 FASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-----DGCISDFGL  488 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~ki~DfGl  488 (635)
                      +++++|.+++......  ....+++..++.++.|++.|++|||+.+   ++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753221  1234789999999999999999999988   99999999999999887     899999999


Q ss_pred             CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      +.......      ....+..|+|||++.+..++.++|||||||++|||+| |+.||......      .....+. ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~~-~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHVT-AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHHh-cCC
Confidence            87543221      1234567999999999999999999999999999998 99999744321      1111111 110


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      .          ..........+.+++.+||+.+|++||+++++++.|++
T Consensus       231 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 R----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0          01111223456788889999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.1e-35  Score=294.70  Aligned_cols=241  Identities=25%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|...+ +..+++|.+..... .+++.+|+++++++ +|+||+++++++..+...++++||+++++|
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   85 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSV   85 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence            4569999999999999765 78899999875433 67899999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----C
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----~  497 (635)
                      .+++....    ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++.......    .
T Consensus        86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            99986432    35899999999999999999999998   9999999999999999999999999987654332    2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||......+..      .. ......        .......
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~--------~~~~~~~  223 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKPP--------PTLSDPE  223 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCCC--------CCCCchh
Confidence            23577899999999889999999999999999999999999754322110      00 000000        0011111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.+++.+||+.+|++|||+.|++++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            223457788889999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-35  Score=298.10  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=197.8

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ..+.||+|+||+||++... +++.||+|++.....  ..+.+.+|++++..+ +||||+++++++......++||||+++
T Consensus         9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (284)
T cd06620           9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDC   87 (284)
T ss_pred             HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCC
Confidence            3578999999999999965 478899998765432  346788999999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      ++|.+++...     ..+++..+..++.+++.||.|||+. +   ++||||||+||++++++.++|+|||++......  
T Consensus        88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            9999988642     3489999999999999999999974 5   999999999999999999999999998654322  


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-----CChhHHHHHHhhhccccccchhhh
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-----VDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      ....++..|+|||++.+..++.++|||||||++|||+||..||......+.     ..+..+......+...        
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  231 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--------  231 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--------
Confidence            223577889999999888899999999999999999999999986543211     1122222222221110        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                       .. ...+....+.+++.+|++.||++|||+.|++++..
T Consensus       232 -~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         232 -RL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             -CC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence             00 00123345778888999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=295.97  Aligned_cols=240  Identities=20%  Similarity=0.278  Sum_probs=191.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||++... ++..+++|.+.....      ..+.+.+|++++.++ +||||+++++++..++..++|+||
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEE
Confidence            467999999999999864 578899998864422      124678899999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++.....
T Consensus        86 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          86 MPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             CCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            9999999998642     34888999999999999999999998   999999999999999999999999998654322


Q ss_pred             -------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 -------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 -------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                             ....++..|+|||.+.+..++.++||||||+++|||++|+.||......      .-...........     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~-----  226 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNP-----  226 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCC-----
Confidence                   1233567899999999988999999999999999999999999753211      1011111111100     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           .........+.+++.+||..+|++|||+.|++++
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 0111223456778889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-35  Score=313.22  Aligned_cols=251  Identities=18%  Similarity=0.259  Sum_probs=189.4

Q ss_pred             hccccccCceEEEEEEec---CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++...   .+..|++|.+...    ....+|+++++++ +||||+++++++......++|||++. +
T Consensus        97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~  170 (392)
T PHA03207         97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-C  170 (392)
T ss_pred             EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-C
Confidence            567999999999999754   3467888887542    3457899999999 99999999999999999999999986 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++..     ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++.......   
T Consensus       171 ~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        171 DLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            88888842     235899999999999999999999998   9999999999999999999999999987654322   


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---cc---cch
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---AE---VFD  567 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~d  567 (635)
                         ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.+...........-+.........   ..   .+.
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence               234788999999999999999999999999999999999999765433211111111111100000   00   000


Q ss_pred             hhhh------cc-cChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELM------RF-QNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~------~~-~~~~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+.      +. ...+      .....+.+++.+|+..||++|||+.|++.+
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000      00 0000      112356678889999999999999999985

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.5e-36  Score=322.55  Aligned_cols=259  Identities=21%  Similarity=0.302  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeC--------CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~lv~  413 (635)
                      .++||+|+||.||+|... .++.||||++...   .....+|+.+++.+ +|+||+++++++...        ...++||
T Consensus        71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            578999999999999975 5788999988543   23345799999999 999999999887542        1356899


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLM  492 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~  492 (635)
                      ||+++ +|.+++..... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+++..
T Consensus       147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            99985 77776643221 2345899999999999999999999998   99999999999999665 7999999999865


Q ss_pred             CCCC---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----------h
Q 006677          493 NVPA---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV----------R  558 (635)
Q Consensus       493 ~~~~---~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~  558 (635)
                      ....   ...+++.|+|||++.+. .++.++|||||||++|||++|..||.+....+.  +....+...          .
T Consensus       222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhc
Confidence            4322   34568889999998654 689999999999999999999999986542211  111111000          0


Q ss_pred             hcccc----ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhc
Q 006677          559 EEWTA----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQ  613 (635)
Q Consensus       559 ~~~~~----~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~  613 (635)
                      ..+..    .+....+.. ........++.+++.+||+.||++|||+.|+++  .++.+..
T Consensus       300 ~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            00000    000000000 000112245778888999999999999999997  5555544

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-35  Score=308.54  Aligned_cols=183  Identities=25%  Similarity=0.354  Sum_probs=156.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.... +..||+|+...     .....|+.+++++ +|+||+++++++......++|+||+. ++|
T Consensus        71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l  143 (357)
T PHA03209         71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYS-SDL  143 (357)
T ss_pred             EEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence            5789999999999999764 56788887433     2335688899999 99999999999999999999999995 588


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---CCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATP  498 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---~~~  498 (635)
                      .+++...    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ...
T Consensus       144 ~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        144 YTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence            8888642    235899999999999999999999998   999999999999999999999999998754322   233


Q ss_pred             CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006677          499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ  539 (635)
Q Consensus       499 ~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~  539 (635)
                      .++..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            57889999999999999999999999999999999665553

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.2e-35  Score=301.22  Aligned_cols=194  Identities=23%  Similarity=0.415  Sum_probs=158.2

Q ss_pred             hccccccCceEEEEEEecC---CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~  417 (635)
                      +.+||+|+||+||+|...+   +..||+|.+..... ...+.+|+++++++ +||||+++++++..  +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3579999999999999653   46799998865432 34678899999999 99999999999854  456789999987


Q ss_pred             CCChhhhccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE----cCCCCeEEeecCCC
Q 006677          418 SGSLSTLLHGNRG----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLT  489 (635)
Q Consensus       418 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~DfGla  489 (635)
                      + +|.+++.....    .....+++..+..++.|++.||+|||+.+   |+||||||+||++    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 78777643221    12235889999999999999999999998   9999999999999    56689999999999


Q ss_pred             CCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          490 PLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       490 ~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      +......       ...+++.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            7654322       2245788999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-35  Score=313.26  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=187.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.... ++.||||...     ...+.+|+++++++ +|+|||++++++...+..++|||++. ++|
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L  246 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDL  246 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence            4679999999999999764 6789998632     23467899999999 99999999999999999999999995 689


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----  496 (635)
                      .+++....    ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......     
T Consensus       247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            88886432    25999999999999999999999998   9999999999999999999999999987653221     


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhhc------ccccc---
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREE------WTAEV---  565 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~---  565 (635)
                       ...||..|+|||++.+..++.++|||||||++|||++|..|+........ ......+..++...      +....   
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence             23478899999999999999999999999999999998876543322111 11111111111110      00000   


Q ss_pred             chhhh------------h--cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 FDVEL------------M--RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~------------~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....+            .  .+.........+.+++.+|++.||.+|||+.|++++
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000            0  000000111256678889999999999999999975

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.4e-35  Score=312.48  Aligned_cols=252  Identities=18%  Similarity=0.281  Sum_probs=189.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-----eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~  413 (635)
                      .+.||+|+||.||++... +++.||+|++.....   ..+.+.+|++++..+ +|+||+++++++...+     ..++|+
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEe
Confidence            467999999999999964 688999999865422   235678899999999 9999999999998776     789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+. ++|.+++..     ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          84 ELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             eccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9997 588887753     234899999999999999999999998   9999999999999999999999999987643


Q ss_pred             CCC-----CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc---
Q 006677          494 VPA-----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE---  564 (635)
Q Consensus       494 ~~~-----~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  564 (635)
                      ...     ...++..|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...   .+..........+   
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~~~  231 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAMRS  231 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHHH
Confidence            221     23457789999998774 47899999999999999999999998654322110   0000000000000   


Q ss_pred             -------cchhhhhcc-------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 -------VFDVELMRF-------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 -------~~d~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                             .+.......       .........+.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                   000000000       0001113456788889999999999999999984

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.9e-35  Score=299.11  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=195.1

Q ss_pred             hccccccCceEEEEEEecCC----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|...+.    ..|++|.......  ..+.+.+|+.+++++ +|+||+++++++.. +..++||||+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~   88 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELA   88 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcC
Confidence            56899999999999986432    4688888765432  245788899999999 89999999998865 5678999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999997532    24899999999999999999999988   9999999999999999999999999987654332


Q ss_pred             C-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 ~-----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      .     ..++..|+|||.+....++.++||||||+++|||++ |..||......+.      ..........        
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~--------  227 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL--------  227 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC--------
Confidence            1     112356999999988889999999999999999996 9999975542211      1111111100        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                         .........+.+++.+|+..+|++|||+.|+++.|+++....
T Consensus       228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence               011122346777888999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.4e-35  Score=298.67  Aligned_cols=247  Identities=23%  Similarity=0.409  Sum_probs=195.0

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...      ++..||+|.+.....  ...++.+|+.++.++ +||||+++++++..++..++|||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   88 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFE   88 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEe
Confidence            357999999999999864      357899999875432  245688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC
Q 006677          415 YFASGSLSTLLHGNRG-----------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  477 (635)
                      |+++|+|.+++.....                 .....+++..++.++.|++.||+|||+.+   ++||||||+||++++
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~  165 (288)
T cd05050          89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGE  165 (288)
T ss_pred             cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecC
Confidence            9999999999964321                 11234788999999999999999999998   999999999999999


Q ss_pred             CCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 006677          478 DLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP  550 (635)
Q Consensus       478 ~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~  550 (635)
                      ++.++|+|||++.......      ....+..|+|||.+.+..++.++|||||||++|||++ |..||......      
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------  239 (288)
T cd05050         166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------  239 (288)
T ss_pred             CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence            9999999999987543221      1223456999999998899999999999999999998 88888654321      


Q ss_pred             HHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       551 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      .+...+...... .          ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus       240 ~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 EVIYYVRDGNVL-S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHhcCCCC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            222222111110 0          011223467788889999999999999999998873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-35  Score=297.85  Aligned_cols=245  Identities=27%  Similarity=0.486  Sum_probs=192.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHH---HHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||++.... ++.+|+|++.........   ..+|+.++.++ +||||+++++++......++||||+++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccccccccccccc
Confidence            4689999999999999775 457999999876543332   34589999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----C
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----V  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----~  494 (635)
                      ++|.+++..     ...+++..+..++.|++.||++||+.+   ++|+||||+||++++++.++|+|||.+....    .
T Consensus        83 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   83 GSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             ccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999972     234899999999999999999999998   9999999999999999999999999986531    1


Q ss_pred             CCCCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          495 PATPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~-~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      .....++..|+|||++. +..++.++||||+|+++|+|++|..||......+   ............     ....   .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~---~  223 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRP-----LPSS---S  223 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTH-----HHHH---T
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhccccc-----cccc---c
Confidence            22345678899999998 8889999999999999999999999998551111   011111111000     0000   0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .........+.+++.+|++.+|++||++.|++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000112678888889999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.7e-35  Score=301.52  Aligned_cols=253  Identities=20%  Similarity=0.320  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... ++..+++|.+.....  ...++.+|++++.++ +||||+++++++..++..++||||++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            467999999999999965 466788888764322  234678899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--C
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--~  496 (635)
                      +|.++++..     ..+++..+..++.|++.||.|||+. +   ++||||||+||++++++.+||+|||++......  .
T Consensus        85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (308)
T cd06615          85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  156 (308)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence            999999743     3488999999999999999999984 5   999999999999999999999999998765332  2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc-------------
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA-------------  563 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  563 (635)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||...+....   ..+...........             
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCCCCCc
Confidence            34567889999999888899999999999999999999999975432211   11110000000000             


Q ss_pred             -------ccchhhh----hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          564 -------EVFDVEL----MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       564 -------~~~d~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                             +..+...    ...+ .......+.+++.+|+..+|++||++.|++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                   0000000    0000 001223577888899999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8e-35  Score=294.24  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=183.3

Q ss_pred             cccccCceEEEEEEecCCC---eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLEEST---TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .||+|+||+||+|...++.   .+++|.++....  ..+.+.+|+.++..+ +||||+++++.+......++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence            5999999999999855433   355666554322  346788899999988 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----  494 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-----  494 (635)
                      +|.++++..... ....++.....++.||+.||+|||+.+   ++||||||+|||++.++.++|+|||++.....     
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999754321 234677788899999999999999988   99999999999999999999999999864321     


Q ss_pred             -CCCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          495 -PATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~-------~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                       .....++..|+|||++..       ..++.++|||||||++|||++ |..||.....      .........+.. ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~  229 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQ-VKL  229 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhcc-ccc
Confidence             123346778999999853       245789999999999999997 5668764321      122222222211 111


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .++.+..  .   ....+.+++..|| .+|++||+++|+++.|.
T Consensus       230 ~~~~~~~--~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLEL--P---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCC--C---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222111  1   2234556777899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.9e-35  Score=298.58  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=190.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEE-----eCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYY-----SKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-----~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||++... +++.+++|++........++..|+.++.++.+|+||+++++++.     .++..++||||+
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  102 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC  102 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence            357999999999999865 46789999886544445678889999999867999999999885     335689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-  495 (635)
                      ++++|.++++.... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++...... 
T Consensus       103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  178 (286)
T cd06638         103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  178 (286)
T ss_pred             CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence            99999998864322 1235889999999999999999999988   999999999999999999999999998765432 


Q ss_pred             ---CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 ---ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                         ....++..|+|||++..     ..++.++|||||||++|||++|+.||........  +    .... ........ 
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~----~~~~-~~~~~~~~-  250 (286)
T cd06638         179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L----FKIP-RNPPPTLH-  250 (286)
T ss_pred             CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H----hhcc-ccCCCccc-
Confidence               22346788999999853     4478899999999999999999999975432110  0    0000 00000000 


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                             ........+.+++.+||+.+|++|||+.|++++.
T Consensus       251 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         251 -------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                   0111223577888899999999999999998763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.2e-35  Score=306.98  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=186.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||++... .+..||+|++.....   ....+.+|+.++..+ +||||+++++++...+      ..++|
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv  104 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV  104 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEE
Confidence            468999999999999864 478899999875422   245677899999999 9999999999986543      46899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++ +|.+.++.       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            999976 66666542       2788899999999999999999998   999999999999999999999999998764


Q ss_pred             CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC------------ChhHH----H
Q 006677          493 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV------------DLPRW----V  553 (635)
Q Consensus       493 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~------------~~~~~----~  553 (635)
                      ...   ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+..            .....    +
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            332   2235688899999999999999999999999999999999999865321100            00000    0


Q ss_pred             HHHhhhc--cccccchhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          554 QSVVREE--WTAEVFDVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       554 ~~~~~~~--~~~~~~d~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......  .....+.......      .........+.+++.+|++.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000  0000000000000      0000112456788889999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=308.59  Aligned_cols=236  Identities=20%  Similarity=0.282  Sum_probs=182.1

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhc--CCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ||+|+||+||+|... +++.||+|++......    ...+..|..++.+..  +||||+.+++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 4789999998654221    123445666666654  799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            9999988642     34899999999999999999999998   999999999999999999999999998754221   


Q ss_pred             -CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       ....++..|+|||++.+. .++.++|||||||++|||++|+.||......      .....+.....       .+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~-------~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV-------RFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC-------CCCC-
Confidence             234578899999998754 4799999999999999999999999754321      11111111110       0000 


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRP----NMDEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~  606 (635)
                      .   .....+.+++.+|++.+|.+||    ++.|+++
T Consensus       219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0   1123456777899999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.5e-35  Score=296.28  Aligned_cols=243  Identities=21%  Similarity=0.322  Sum_probs=189.8

Q ss_pred             hhccccccCceEEEEEEecC-CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          342 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      ..+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|+++++.+ +|+|++++++++..++..++|+||++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            45679999999999999764 56778888754322 245688899999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|..++...    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        88 ~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          88 AVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999887642    235899999999999999999999998   999999999999999999999999998654322    


Q ss_pred             CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          496 ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      ....++..|+|||++.     ...++.++|||||||++|||++|+.||......+      ............ .     
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~~-~-----  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPPT-L-----  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCCC-C-----
Confidence            2234678899999984     3457789999999999999999999997543111      111111111100 0     


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...   ......+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 AQP---SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   1122456778889999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-35  Score=311.45  Aligned_cols=242  Identities=21%  Similarity=0.320  Sum_probs=186.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++... +++.+|+|++.....    ....+.+|+.+++.+ +||||+++++.+..++..++||||++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP  126 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            568999999999999976 467899999865321    234567788888888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            99999998632      3788889999999999999999998   999999999999999999999999998765432  


Q ss_pred             ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                         ....+|+.|+|||++....    ++.++|||||||++|||++|+.||...+.      ......+........    
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~----  267 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT----  267 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc----
Confidence               2345889999999986543    78999999999999999999999975432      111222221110000    


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRMI  608 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L  608 (635)
                          .+........+.+++..|+...+.+  |++++|++++.
T Consensus       268 ----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 ----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                1111122334556667899744433  78999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-34  Score=301.44  Aligned_cols=192  Identities=26%  Similarity=0.393  Sum_probs=160.5

Q ss_pred             hcccccc--CceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .++||+|  +|++||++... +++.||+|++......   .+.+.+|+++++.+ +||||+++++++..++..++||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence            3579999  78999999864 5788999998765332   24567788888888 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC--
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~--  494 (635)
                      ++|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.......  
T Consensus        82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999986432   224899999999999999999999998   99999999999999999999999986433211  


Q ss_pred             ---------CCCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          495 ---------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       495 ---------~~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                               .....++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                     111234567999999976  45889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.3e-35  Score=298.69  Aligned_cols=239  Identities=23%  Similarity=0.352  Sum_probs=192.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.+ +|+||+++++++...+..++||||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS  102 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence            46799999999999996 4688999999875433 345678899999888 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++..      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......    
T Consensus       103 L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656         103 LTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            9999863      23788999999999999999999998   9999999999999999999999999987654322    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++|+.||..........      ...... .     +   .....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~-----~---~~~~~  238 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-T-----P---ELQNP  238 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-C-----C---CCCCc
Confidence            2346778999999998889999999999999999999999997544321110      000000 0     0   00111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ......+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222344667888999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.4e-35  Score=298.85  Aligned_cols=239  Identities=22%  Similarity=0.349  Sum_probs=192.8

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||.|+||.||+|.. .+++.|++|.+..... ..+.+.+|+++++.+ +|+|++++++++...+..++|+||+++++
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  102 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGS  102 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCc
Confidence            35799999999999985 4688999999875433 356778899999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++..      ..+++.++..++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||++.......    
T Consensus       103 L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655         103 LTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            9998863      23899999999999999999999998   9999999999999999999999999987654322    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||......+      ...... .....        .....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~-~~~~~--------~~~~~  238 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIA-TNGTP--------ELQNP  238 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCc--------ccCCc
Confidence            2346778999999998889999999999999999999999997543211      111110 00000        00111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ......+.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            122335667888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-34  Score=290.07  Aligned_cols=241  Identities=22%  Similarity=0.373  Sum_probs=193.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... ++..+++|.++...  ...+.+.+|+.+++++ +|+||+++++.+..++..++||||+++|
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGG   83 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence            467999999999999965 57889999886432  2346778899999998 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....   ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++++|||.+.......   
T Consensus        84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  157 (255)
T cd08219          84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA  157 (255)
T ss_pred             cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence            9999886432   234789999999999999999999998   9999999999999999999999999987654322   


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||++.+..++.++||||||+++|+|++|+.||...+.      ............ ...          
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~----------  220 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGSY-KPL----------  220 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCCC-CCC----------
Confidence             23467789999999988899999999999999999999999975321      111111111110 000          


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+||+.+|++||++.|++..
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            01122356788889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-35  Score=312.14  Aligned_cols=191  Identities=25%  Similarity=0.388  Sum_probs=166.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||++... +++.||+|++.....    ....+.+|++++..+ +|+||+++++.+.+++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            367999999999999975 478899999975421    234577889999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......  
T Consensus        85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          85 GGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             CccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999998643     34889999999999999999999998   999999999999999999999999998643211  


Q ss_pred             -------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCC
Q 006677          496 -------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL  538 (635)
Q Consensus       496 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~  538 (635)
                                                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                                 1234788999999999999999999999999999999999999


Q ss_pred             CCCC
Q 006677          539 QSPT  542 (635)
Q Consensus       539 ~~~~  542 (635)
                      ....
T Consensus       237 ~~~~  240 (360)
T cd05627         237 CSET  240 (360)
T ss_pred             CCCC
Confidence            7544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-35  Score=299.69  Aligned_cols=256  Identities=22%  Similarity=0.316  Sum_probs=188.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhc--CCCceeceeEEEEeC-----CeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSK-----DEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~l  411 (635)
                      .+.||+|+||+||+|... +++.||+|.++....   ....+.+|++++.++.  +||||+++++++...     ...++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            357999999999999975 578899998875422   2345667888777664  699999999988642     35789


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||+++ +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence            9999985 8988886432   234899999999999999999999998   99999999999999999999999999976


Q ss_pred             CCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhcccccc
Q 006677          492 MNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEWTAEV  565 (635)
Q Consensus       492 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  565 (635)
                      .....   ...++..|+|||++.+..++.++||||+||++|||++|+.||......+.  +.......   ....|....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhCcccc
Confidence            64332   23467889999999988999999999999999999999999975432211  11111000   001111100


Q ss_pred             ------chhhhhc-c-cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 ------FDVELMR-F-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ------~d~~~~~-~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            +...... . .........+.+++.+|++.||++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  0000000 0 0001123456788889999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-34  Score=296.81  Aligned_cols=246  Identities=25%  Similarity=0.393  Sum_probs=191.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-----eeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~e~~  416 (635)
                      .+.||+|+||.||++... +++.+|+|++.........+.+|+.++.++.+|||++++++++...+     ..++||||+
T Consensus        27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~  106 (291)
T cd06639          27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC  106 (291)
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence            357999999999999974 57889999987654445678889999999878999999999987543     579999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-  495 (635)
                      ++|+|.++++.... ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++...... 
T Consensus       107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  182 (291)
T cd06639         107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  182 (291)
T ss_pred             CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence            99999998864321 2335899999999999999999999998   999999999999999999999999998765432 


Q ss_pred             ---CCCCCCCcccCcccccCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 ---ATPSRSAGYRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~-----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                         ....++..|+|||++....     ++.++|||||||++|||++|+.||......+      -+..... ......  
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~--  253 (291)
T cd06639         183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------TLFKIPR-NPPPTL--  253 (291)
T ss_pred             ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------HHHHHhc-CCCCCC--
Confidence               2234677899999986433     6889999999999999999999997543211      0111110 000001  


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            ...+.....+.+++.+||+.+|++||++.|++++
T Consensus       254 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         254 ------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                  1112233457788899999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=298.59  Aligned_cols=249  Identities=19%  Similarity=0.342  Sum_probs=195.1

Q ss_pred             hHHHHHHhhccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          335 LEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       335 ~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      +..-++...+.||+||.+.||++...+.+.+|+|++.....+   ...|..|++.|.++..|.+||++++|-..++..|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            333344556789999999999999988899999988765543   35699999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||= ..||..+|+....   ....| .++.+..|++.++.++|++|   |||.||||.|+|+- .|.+||+|||+|..
T Consensus       438 vmE~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             Eeecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            99965 4599999975432   22334 78889999999999999999   99999999999985 57899999999988


Q ss_pred             CCCCC------CCCCCCcccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          492 MNVPA------TPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       492 ~~~~~------~~~~~~~y~aPE~~~~~-----------~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ...+.      ...||+.||+||.+...           +.++++||||+||+||+|+.|+.||..        +.....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~a  580 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIA  580 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHH
Confidence            76654      45699999999998532           256899999999999999999999973        221111


Q ss_pred             HHhhhccccccchhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 SVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +      ...+.|+.-. .++..++ ..+++++|+.|++.||.+||+..|++++
T Consensus       581 K------l~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 K------LHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             H------HHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1      1222232110 1121111 1238899999999999999999999873

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=293.01  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=195.3

Q ss_pred             hccccccCceEEEEEEecC-CC----eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|...+ +.    .+++|.+.....  ....+.+|++++.++ +|+|++++++++.. ...++||||
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~   89 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQL   89 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEec
Confidence            4789999999999998643 22    588888765533  235688899999999 99999999999987 788999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...    ..+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999997543    23899999999999999999999987   999999999999999999999999999766433


Q ss_pred             CCC------CCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ATP------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~~~------~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ...      ..+..|+|||.+....++.++|+||||+++||+++ |+.||......      .+...+.....       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~-------  229 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKGER-------  229 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCCCC-------
Confidence            221      12356999999988889999999999999999999 99999754322      11221111110       


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                          ..........+.+++.+||..+|.+||++.++++.|+++..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                00011122456778889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.9e-35  Score=293.59  Aligned_cols=244  Identities=19%  Similarity=0.302  Sum_probs=190.3

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      ..+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.++..+ +||||+++++++...+..++||||++++
T Consensus        13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~   91 (267)
T cd06645          13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGG   91 (267)
T ss_pred             HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence            3567999999999999864 578899999875432 234577899999998 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++...     ..+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.++|+|||++......    
T Consensus        92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            999998642     24899999999999999999999998   999999999999999999999999998654322    


Q ss_pred             CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      ....++..|+|||++.   ...++.++|||||||++|||++|..||........      ...............    .
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~~----~  233 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQPPKLK----D  233 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCCCccc----c
Confidence            2335778899999974   45588999999999999999999999864432111      000011111000000    0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   .....+.+++.+|++.+|++||++++++++
T Consensus       234 ~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 KM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00   112346678889999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.5e-35  Score=301.55  Aligned_cols=247  Identities=24%  Similarity=0.400  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEec-CCC----eEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-EST----TVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... ++.    .||+|.+......  ..++.+|+.++.++ +||||+++++++... ..++++||
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cceeeehh
Confidence            467999999999999864 333    4688887654322  33678899999998 999999999998754 46799999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999987432    24889999999999999999999998   999999999999999999999999999765432


Q ss_pred             CC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 AT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ..      ..++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ...+    ......      
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~------  229 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----LEKGER------  229 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCC------
Confidence            21      123557999999998899999999999999999998 899997543211   1111    111100      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                          ..........+.+++.+||..+|++||+++|+++.|+++....
T Consensus       230 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         230 ----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                0001112345778888999999999999999999999986554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.5e-35  Score=293.02  Aligned_cols=240  Identities=24%  Similarity=0.359  Sum_probs=191.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC-------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|...+++.+|+|.++.....       ...+.+|+++++++ +|+||+++++++...+..++|+||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEec
Confidence            4679999999999999888899999988654221       24578899999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999642     24789999999999999999999998   999999999999999999999999988654211


Q ss_pred             ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          496 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       496 ----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                                ....++..|+|||++.+..++.++||||||+++|||++|+.||.......     .............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~-  229 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLMPR-  229 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCCCC-
Confidence                      12346778999999998889999999999999999999999997532111     00000000000000 


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                          .     .......+.+++.+||+.+|++||++.|+++
T Consensus       230 ----~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 ----L-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----C-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                0     0112345677788999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.9e-35  Score=301.04  Aligned_cols=252  Identities=19%  Similarity=0.337  Sum_probs=189.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... ++..||+|.++....  ....+.+|+.+++++ +|+||+++++++..++..++||||++ +
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~-~   88 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K   88 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc-c
Confidence            367999999999999875 478899999865432  244677899999999 99999999999999999999999997 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++.......   
T Consensus        89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            8988886432    24889999999999999999999998   9999999999999999999999999987643322   


Q ss_pred             -CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccccc----
Q 006677          497 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF----  566 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----  566 (635)
                       ...+++.|+|||.+.+. .++.++|||||||++|||+||+.||...+..+.   .........    ..|.....    
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccccc
Confidence             23357789999998654 478899999999999999999999976543211   111111110    00100000    


Q ss_pred             -hhhhhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 -DVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 -d~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       ........      ........+.+++.+|++.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00000000      00011234567888999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.5e-34  Score=293.19  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=189.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... ++..||+|+++....   ..+.+.+|+.++.++ +||||+++++++..++..++||||++ 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            357999999999999975 578899999865432   235678899999999 89999999999999999999999997 


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          83 MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            589888864332  245899999999999999999999998   9999999999999999999999999987553321  


Q ss_pred             --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc--cccch-
Q 006677          497 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWT--AEVFD-  567 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~d-  567 (635)
                        ...+++.|+|||++.+. .++.++|||||||++|||+||+.||......+  ..........   ...|.  ....+ 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHH
Confidence              22357789999988654 47889999999999999999999997543211  0000000000   00000  00000 


Q ss_pred             -hhhhcc--c----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 -VELMRF--Q----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 -~~~~~~--~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ......  .    .......++.+++.+|++.||++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             000000  0    000122355678889999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8e-35  Score=295.67  Aligned_cols=238  Identities=24%  Similarity=0.379  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... ++..||+|.+.....  ..+.+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCC
Confidence            456999999999999865 467899998864432  245688999999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++..      ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++.......   
T Consensus        88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          88 SALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            99999863      24889999999999999999999988   9999999999999999999999999987654322   


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||++.+..++.++|||||||++|||++|+.||........      ... ......     ..     .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~~~~-----~~-----~  221 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL-IPKNSP-----PT-----L  221 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-hhcCCC-----CC-----C
Confidence             12356789999999988899999999999999999999999875432211      110 111100     00     0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+||+.+|++||++.|++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11233457788889999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=323.08  Aligned_cols=262  Identities=27%  Similarity=0.402  Sum_probs=210.3

Q ss_pred             cCCChHHHHHHhhccccccCceEEEEEEec--------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceecee
Q 006677          331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLR  400 (635)
Q Consensus       331 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~  400 (635)
                      +.++.+.+  ...+.||+|.||.|++|...        ....||||.++.....  .+.+..|++++..+++|+||+.++
T Consensus       291 ~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  291 WEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            44555555  34559999999999999843        1456999999876543  678999999999999999999999


Q ss_pred             EEEEeCCeeEEEEEeccCCChhhhccCCC---CC------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006677          401 AYYYSKDEKLLVYDYFASGSLSTLLHGNR---GA------GR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK  469 (635)
Q Consensus       401 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~------~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  469 (635)
                      |+|..+...++|+||+..|+|.++++..+   ..      ..  ..++....+.++.|||.|++||++..   +|||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence            99999999999999999999999998776   11      11  23889999999999999999999987   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCCCCCCCCCCC--C---C--CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 006677          470 ASNVLINQDLDGCISDFGLTPLMNVPATP--S---R--SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSP  541 (635)
Q Consensus       470 ~~NIll~~~~~~ki~DfGla~~~~~~~~~--~---~--~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~  541 (635)
                      ++|||++++..+||+|||+|+.......+  .   +  ...|||||.+....|+.|+|||||||+|||++| |..||.+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999865443222  1   1  234999999999999999999999999999999 88999752


Q ss_pred             CCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          542 TRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ..     .... ...+.++.          +...+..+..++.++|+.||+.+|++||++.|+.+.++....
T Consensus       526 ~~-----~~~l-~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  526 PP-----TEEL-LEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             Cc-----HHHH-HHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            21     1111 11222322          122334556678899999999999999999999999998644

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-34  Score=295.66  Aligned_cols=243  Identities=22%  Similarity=0.380  Sum_probs=190.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe------CCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.+|+|.+........++..|+.++.++.+|+||+++++++..      .+..+++|||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            467999999999999974 478899998866544556788899999998789999999999853      4577999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++...+   ...+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus       101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            99999999987543   234788889999999999999999998   999999999999999999999999998754322


Q ss_pred             ----CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                          ....++..|+|||.+.     ...++.++|||||||++|||++|+.||......+...       .........  
T Consensus       175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~--  245 (282)
T cd06636         175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPRNPPPK--  245 (282)
T ss_pred             ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------hHhhCCCCC--
Confidence                2334678899999985     3457889999999999999999999996543211100       000000000  


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         .    ........+.+++.+||+.+|++||++.|++++
T Consensus       246 ---~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         246 ---L----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ---C----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence               0    001223467788889999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-34  Score=300.65  Aligned_cols=244  Identities=18%  Similarity=0.302  Sum_probs=186.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||++..+. ++.+|+|++.+...    ....+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~   84 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYV   84 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccC
Confidence            4679999999999999764 67799999865321    233477788888887 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.++++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999997532    24889999999999999999999998   9999999999999999999999999986543221 


Q ss_pred             ----CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 ----TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                          ...|++.|+|||++.     ...++.++|||||||++|||++|+.||....      .......+........ +.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~-~p  230 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ-FP  230 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc-CC
Confidence                235788999999986     3457899999999999999999999997543      2222222222111000 00


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVP--DMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P--~~RPs~~evl~~  607 (635)
                            .........+.+++.+|+..++  ..|++++|++++
T Consensus       231 ------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 ------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                  0011122345556667775544  447899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-35  Score=308.11  Aligned_cols=240  Identities=23%  Similarity=0.393  Sum_probs=188.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEE---EEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe--eEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVV---VKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE--KLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~va---vK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--~~lv~e  414 (635)
                      .++||+|+|-+||+|... +|.+||   ||.-+.....  .+.|..|+++|+.| +|+||++++.+|.+...  .-+|+|
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence            357999999999999965 366666   3322222222  36789999999999 99999999999998766  668999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMN  493 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~  493 (635)
                      .+..|+|..|+++.+     .++....+.|+.||++||.|||++. |||||||||.+||+|+. .|.|||+|.|+|+.+.
T Consensus       124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999998655     3788899999999999999999986 89999999999999975 5999999999998876


Q ss_pred             CCCC--CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          494 VPAT--PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       494 ~~~~--~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      ....  -.|||.|||||.+. ..|++.+||||||+.++||+|+..||..     -.+-....+++... .....+.    
T Consensus       198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SG-iKP~sl~----  266 (632)
T KOG0584|consen  198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSG-IKPAALS----  266 (632)
T ss_pred             ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcC-CCHHHhh----
Confidence            6543  35999999999997 6899999999999999999999999963     22222223332222 1111111    


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ...  ..   ++.++|.+|+.. .++|||+.|+++
T Consensus       267 kV~--dP---evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 KVK--DP---EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ccC--CH---HHHHHHHHHhcC-chhccCHHHHhh
Confidence            111  12   355667799999 999999999997

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-34  Score=295.58  Aligned_cols=242  Identities=21%  Similarity=0.328  Sum_probs=189.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|+++++.+ +|+||+++++++..+...++||||+++++
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            4679999999999999764 78899999865432 245678899999998 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |..++....    ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++......    .
T Consensus        96 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          96 VDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            988875432    24899999999999999999999998   999999999999999999999999988654322    2


Q ss_pred             CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      ...++..|+|||++.     ...++.++|||||||++|||++|..||......      ............         
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~---------  233 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP---------  233 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCCc---------
Confidence            234677899999985     344678999999999999999999999653311      111111111100         


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...........+.+++.+||+.+|++||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000111223456788889999999999999999873

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=281.75  Aligned_cols=262  Identities=21%  Similarity=0.351  Sum_probs=203.7

Q ss_pred             ChHHHHHHhhccccccCceEEEEEE-ecCCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          334 DLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       334 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      .++++.+-+.+.||+|+|+.|-.+. +.++.++|||++.+.. -.+....+|++++.....|+||++++.+|++++..|+
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            4788888999999999999998887 6779999999997652 2467888999999999899999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGL  488 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGl  488 (635)
                      |||-|.||.|...+++.     ..+++.++.++..+|+.||.|||.+|   |.||||||+|||-....   -+||+||.+
T Consensus       154 VfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999853     35999999999999999999999999   99999999999997654   479999988


Q ss_pred             CCCCCC-----------CCCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC----CC
Q 006677          489 TPLMNV-----------PATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VD  548 (635)
Q Consensus       489 a~~~~~-----------~~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~----~~  548 (635)
                      +.-...           -.+++|+..|||||+..     ...|+.++|.||+|||+|-|+.|..||.+....+-    ..
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            643211           12445777899999863     33588999999999999999999999987654332    12


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .-+-.+..+.+......+...-..+..++.+.+   +++...+..++.+|.++.+++.
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eak---dlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAK---DLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHH---HHHHHHHhccHHhhhhhhhccC
Confidence            222333333333222222111112223344444   4555777899999999999887

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-34  Score=291.48  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=191.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||+|++.....   ..+.+.+|++++.++ +|+|++++++++......++||||+++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~   84 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH   84 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence            357999999999999976 478899999865432   235678899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +.|..++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        85 ~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          85 TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            8888876532     24899999999999999999999988   9999999999999999999999999987664433  


Q ss_pred             --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hcc
Q 006677          497 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------------EEW  561 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~  561 (635)
                        ...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+..   ........            ..+
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcccccc
Confidence              2335678999999876 45789999999999999999999999765432110   00111000            000


Q ss_pred             ccccchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.......    .......+.+++.+||+.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000000    01123457788889999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-34  Score=301.19  Aligned_cols=244  Identities=19%  Similarity=0.301  Sum_probs=186.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+++.. +++.||+|++.....    ....+.+|..++..+ +|+||+++++++...+..|+||||++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~   84 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYV   84 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            467999999999999975 467899999875321    233467788888887 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999997532    24889999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ----CCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                          ...+++.|+|||++.+     ..++.++|||||||++|||++|+.||.....      ......+........ + 
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-~-  229 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ-F-  229 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc-C-
Confidence                2347889999999875     4678899999999999999999999975432      111222221110000 0 


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  607 (635)
                           ..........+.+++.+|+..++.+  |+++++++++
T Consensus       230 -----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 -----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 0111112345566677888765544  5688888875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.3e-34  Score=290.33  Aligned_cols=238  Identities=24%  Similarity=0.374  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... ++..||+|.+.....  ....+.+|++++.++ +|+||+++++++.++...++||||+++|
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            356999999999999975 478899998875432  245688899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++..      ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        88 ~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          88 SALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            99999863      23888999999999999999999988   9999999999999999999999999986654322   


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||++.+..++.++|||||||++|||++|..||.........      .. ......          ...
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~~~----------~~~  221 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL-IPKNNP----------PTL  221 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh-hhcCCC----------CCC
Confidence             223567799999998888999999999999999999999999754322111      00 000000          111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12344567788899999999999999999886

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=294.30  Aligned_cols=237  Identities=20%  Similarity=0.319  Sum_probs=199.8

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      +.||+|.|+.|-+|++- .|..||||++.+...   ....+.+|+.-|+.+ +|||||++|.+.......|+|+|+=++|
T Consensus        24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~G  102 (864)
T KOG4717|consen   24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDGG  102 (864)
T ss_pred             hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCCc
Confidence            46999999999999853 689999999987654   356788899999888 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE-cCCCCeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +|++|+.++..    .+.+....+++.||+.|+.|+|+.+   +|||||||+||.+ ..-|-+|++|||++-.+..+.  
T Consensus       103 Dl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen  103 DLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             hHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            99999976543    3899999999999999999999998   9999999999877 456899999999997776543  


Q ss_pred             -CCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 -TPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~-~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       +.+|+..|-|||++.+..|+ +++||||+||+||-|+.|+.||+..+..+...               .++|-.+   .
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY---t  237 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY---T  237 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc---c
Confidence             56788899999999999986 57899999999999999999999776555432               1223222   2


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      -+.....+..+||.+|+..||.+|.+.+||+.
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            23445566677778999999999999999986

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-34  Score=305.68  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=187.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||++... .++.||+|++......   ...+.+|+.+++.+ +||||+++++++....      ..++|
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv  100 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV  100 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEE
Confidence            467999999999999864 5788999998754322   35677899999988 9999999999886443      46899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++ ++.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874         101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            999975 67666642       3788999999999999999999998   999999999999999999999999999765


Q ss_pred             CCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-C--------hhH-------HH
Q 006677          493 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-D--------LPR-------WV  553 (635)
Q Consensus       493 ~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~-~--------~~~-------~~  553 (635)
                      ....   ...++..|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .        ...       .+
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            4432   235788899999999989999999999999999999999999754321100 0        000       00


Q ss_pred             HHHhhhccc--cccchhhhh-----c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          554 QSVVREEWT--AEVFDVELM-----R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       554 ~~~~~~~~~--~~~~d~~~~-----~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .........  ...+.....     . ..........+.+++.+|++.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000  000000000     0 00001123456788899999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=307.35  Aligned_cols=238  Identities=26%  Similarity=0.367  Sum_probs=191.8

Q ss_pred             ccccccCceEEEEEEecCC-CeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      -+||+|.||+||.|+..++ ..+|||-+..... ..+....|+...+.+ +|.|||+++|.+..+...-+.||.++||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            3799999999999997654 5689998876533 345577888888888 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla~~~~~----  494 (635)
                      .++++..    ..++  ++.......+||++||.|||+..   |||||||-.|||++ -.|.+||+|||-++.+..    
T Consensus       660 SsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  660 SSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             HHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            9999743    3456  67788889999999999999997   99999999999996 579999999998776543    


Q ss_pred             CCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh-h
Q 006677          495 PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-M  571 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~--~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~  571 (635)
                      ..+..||..|||||++..+  .|+.++|||||||++.||.||++||.......-                 .+|...+ +
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----------------AMFkVGmyK  795 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----------------AMFKVGMYK  795 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----------------hhhhhccee
Confidence            3455689999999999765  489999999999999999999999976542211                 1111111 0


Q ss_pred             -cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 -RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 -~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       ..+-+++...+...++.+|+.++|..||+++++++
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             12233445566677888999999999999999987

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-34  Score=286.63  Aligned_cols=241  Identities=24%  Similarity=0.380  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||.++.. ++..+++|.+.....   ..+++.+|+++++++ +|+||+++++++.+.+..+++|||+++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANG   83 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCC
Confidence            467999999999999854 478899998865432   345688999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+++....   ...+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            99999997543   234899999999999999999999998   9999999999999999999999999987654332  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...+++.|+|||.+.+..++.++||||||+++|||++|..||.....      ......+....+..           
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~-----------  220 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQGNYTP-----------  220 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC-----------
Confidence              33467889999999888899999999999999999999999975321      12222222211110           


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........+.+++.+||+.+|++||+++|++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            001223456778889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=299.94  Aligned_cols=244  Identities=18%  Similarity=0.302  Sum_probs=185.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||++... +++.||+|++....    ...+.+.+|..++..+ +|+||+++++++.+++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCC
Confidence            467999999999999965 47889999987532    1234577888888888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....... 
T Consensus        85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999996422    24889999999999999999999998   9999999999999999999999999986543322 


Q ss_pred             ----CCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 ----TPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                          ...+++.|+|||++..     ..++.++|||||||++|||++|+.||.....      ......+......... .
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-~  230 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF-P  230 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC-C
Confidence                1347889999999863     4578899999999999999999999975432      1222222211100000 0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPs~~evl~~  607 (635)
                      .   .....++   .+.+++.+|+..  ++..||++++++++
T Consensus       231 ~---~~~~~~~---~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 P---DVTDVSE---EAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C---ccCCCCH---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0   0111233   344455565544  44458899999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-34  Score=293.12  Aligned_cols=247  Identities=20%  Similarity=0.352  Sum_probs=193.1

Q ss_pred             hccccccCceEEEEEEecC--CCeEEEEEeecccC-----------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCee
Q 006677          343 AEVLGKGSYGTAYKAVLEE--STTVVVKRLKEVVV-----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK  409 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~  409 (635)
                      .+.||+|+||.||+|....  ++.+|+|.+.....           ...++.+|+.++.+..+|+||+++++++..++..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            3569999999999999765  67899998753311           1234667777777655999999999999999999


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||.
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence            999999999999998854321 23458999999999999999999996 55   99999999999999999999999999


Q ss_pred             CCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          489 TPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       489 a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      +.......   ...++..|+|||.+.+..++.++||||||+++|||++|+.||....      ............+. ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~  233 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEAVYE-PL  233 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhhccCC-cC
Confidence            87654432   2346778999999998889999999999999999999999996432      11222222111111 00


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                               ........+.+++.+||+.||++||++.|+..+++
T Consensus       234 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 ---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                     00112345778888999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-34  Score=294.21  Aligned_cols=245  Identities=22%  Similarity=0.388  Sum_probs=192.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... .+..||+|.++.....  ...+.+|++++.++ +|+||+++++++...+..++||||++++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAG   84 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCC
Confidence            467999999999999976 6789999988754222  35688899999998 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--C
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--A  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--~  496 (635)
                      +|.++++...  ....+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.++|+|||++......  .
T Consensus        85 ~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (286)
T cd06622          85 SLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK  159 (286)
T ss_pred             CHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence            9999987532  123589999999999999999999974 5   999999999999999999999999998765332  2


Q ss_pred             CCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 TPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~------~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      ...++..|+|||.+.+..      ++.++|||||||++|||++|+.||.......   ............ .        
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~-~--------  227 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDGD-P--------  227 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhcC-C--------
Confidence            334677899999985543      4789999999999999999999997532211   111111111110 0        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..........+.+++.+|++.+|++||++++++.+
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 --PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence              00112234556778889999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=293.92  Aligned_cols=243  Identities=22%  Similarity=0.350  Sum_probs=191.6

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      ..+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|+++++++ +|+||+++++++..+...++||||++++
T Consensus         9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (280)
T cd06611           9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGG   87 (280)
T ss_pred             HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCC
Confidence            3467999999999999975 578899999865432 245688899999999 7999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.......   
T Consensus        88 ~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          88 ALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999986432    34899999999999999999999998   9999999999999999999999999886543221   


Q ss_pred             -CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 -TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                       ...+++.|+|||.+.     ...++.++||||||+++|||++|+.||......      ............      . 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~------~-  227 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEPP------T-  227 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCCC------C-
Confidence             234678899999974     344678999999999999999999999754321      111111111100      0 


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..........+.+++.+||+.+|++||++.+++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 --LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              00011123356678889999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=288.43  Aligned_cols=244  Identities=23%  Similarity=0.379  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+++++++ +||||+++++++...+..+++|||+++++
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~   86 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGS   86 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence            367999999999999975 467899999875432 356788999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++....    ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++......    .
T Consensus        87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999987532    34889999999999999999999998   999999999999999999999999998765432    2


Q ss_pred             CCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~---~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      ...++..|+|||.+...   .++.++||||||+++|||+||+.||......+.      ............       ..
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~~~~-------~~  226 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNFPPP-------KL  226 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCCCc-------cc
Confidence            23467789999999776   789999999999999999999999975432110      000001100000       00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .........+.+++.+||+.+|.+|||+.+++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1112234567888899999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=294.15  Aligned_cols=237  Identities=22%  Similarity=0.326  Sum_probs=189.0

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||-+... +|+.+|.|++.+.+.    ++.-...|-.++.++ +.+.||.+-..|++.+..++|+..|+|
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecC
Confidence            58999999999999865 478899998876543    344566788899999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |||.-+|.+..   ...+++..+...+.+|+.||++||+.+   ||+|||||+|||+|++|+++|+|.|+|..+....  
T Consensus       270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            99999887543   345999999999999999999999998   9999999999999999999999999998776543  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...||.+|||||++..+.|+...|+||+||++|||+.|+.||.......-.   +-+.+..        ......-...
T Consensus       344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~--------~~~~~ey~~k  412 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRT--------LEDPEEYSDK  412 (591)
T ss_pred             ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHH--------hcchhhcccc
Confidence             336899999999999999999999999999999999999999743321110   0011111        0000011123


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNM  601 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~  601 (635)
                      ++++.+.+.+   ..++.||++|.-.
T Consensus       413 FS~eakslc~---~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  413 FSEEAKSLCE---GLLTKDPEKRLGC  435 (591)
T ss_pred             cCHHHHHHHH---HHHccCHHHhccC
Confidence            4555555555   7788999998643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-35  Score=306.79  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=186.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||.||+|... ++..||||++.....   ....+.+|+++++++ +|+||+++++++...      ...+++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~   98 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLV   98 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEE
Confidence            467999999999999864 577899999875432   234577899999999 999999999887543      356899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +|++ +++|.+++..      ..+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        99 ~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          99 TNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             eecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence            9987 7799888753      23899999999999999999999998   999999999999999999999999999776


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---cccccc-
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEVF-  566 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  566 (635)
                      .... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.  +..+. ......   ....+. 
T Consensus       169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~  245 (343)
T cd07878         169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIM-EVVGTPSPEVLKKISS  245 (343)
T ss_pred             CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCCHHHHHhcch
Confidence            5432 3457888999999876 5688999999999999999999999975432110  00000 000000   000000 


Q ss_pred             ---h---hhhhcccC--h----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 ---D---VELMRFQN--I----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 ---d---~~~~~~~~--~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         .   ..+...+.  .    ......+.+++.+|++.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0   00000000  0    0011236788889999999999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-34  Score=304.74  Aligned_cols=253  Identities=21%  Similarity=0.322  Sum_probs=187.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||.||++... .++.||||++.....   ....+.+|+.+++.+ +||||+++++++...      ...++|
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv  107 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV  107 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence            467999999999999864 478899999875432   245677899999998 999999999987543      356999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++ +|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            999975 77777642       3788999999999999999999998   999999999999999999999999999765


Q ss_pred             CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHH------
Q 006677          493 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQ------  554 (635)
Q Consensus       493 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~~~~------  554 (635)
                      ...   ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+...         ...+..      
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            443   23357888999999999999999999999999999999999997643211100         000000      


Q ss_pred             -HHhhhcc--ccccchhhhhc--c----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 -SVVREEW--TAEVFDVELMR--F----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 -~~~~~~~--~~~~~d~~~~~--~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .......  ....++.....  .    .........+.+++.+|++.||++|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0000000  00000000000  0    0000112456788899999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-34  Score=291.28  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=187.7

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++|+||+++++|
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            47999999999999965 467899998865533 345788999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPL--DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~~---  495 (635)
                      .+++....    ..+  ++..+..++.||+.|++|||+.+   |+||||||+||+++. ++.++|+|||++......   
T Consensus        93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            99997432    124  78888999999999999999998   999999999999976 679999999998654321   


Q ss_pred             -CCCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 -ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~--~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                       ....++..|+|||++....  ++.++||||||+++|||++|+.||........   ..+........       +.   
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~-------~~---  232 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKIH-------PE---  232 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhccC-------CC---
Confidence             1234677899999986543  78899999999999999999999975322110   01110000000       00   


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ........+.+++.+||+.+|++|||+.|++++
T Consensus       233 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         233 --IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              011223456677889999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=291.58  Aligned_cols=239  Identities=22%  Similarity=0.373  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      .+.||+|+||.||+|... +++.+++|.+......          .+.+.+|++++.++ +||||+++++++...+..++
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEE
Confidence            467999999999999864 5788999988654321          14577899999999 99999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.++.
T Consensus        84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999643     34888999999999999999999998   99999999999999999999999999876


Q ss_pred             CCCCC----------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          492 MNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       492 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      .....          ...++..|+|||.+.+..++.++|||||||++|||++|+.||.......      -..... .. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~-  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG-EN-  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh-cc-
Confidence            54211          1235678999999998889999999999999999999999997542110      011100 00 


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .    .+     .........+.+++.+||+.+|.+||++.|++++
T Consensus       228 ~----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 A----SP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             C----CC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0    00     0011223456677889999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=290.93  Aligned_cols=239  Identities=23%  Similarity=0.371  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||.|+||.||+|... +++.|++|.+.....  ....+.+|+++++.+ +|+|++++++++..+...++|+||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGG   84 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence            357999999999999965 578899999875432  235688899999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.++++..      .+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||+++.....    
T Consensus        85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            999999743      4899999999999999999999998   999999999999999999999999998776543    


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....++..|+|||++.+..++.++||||||+++|||+||+.||......+      .... ..........     ..  
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~-~~~~~~~~~~-----~~--  221 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFL-IPKNNPPSLE-----GN--  221 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHH-hhhcCCCCCc-----cc--
Confidence            22346778999999998889999999999999999999999997543211      1111 1111111100     00  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .....+.+++.+|+..+|++|||+++++++
T Consensus       222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              023356778889999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-34  Score=297.32  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=191.4

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..+ +|||++++++++..++..++|+||+++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            36999999999999864 57899999986543 2355688899999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----CC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~~  497 (635)
                      .+++..      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......    ..
T Consensus       106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            988753      23889999999999999999999998   999999999999999999999999998654322    22


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......+      ..... ......     .....   .
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~~-----~~~~~---~  241 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRL-RDSPPP-----KLKNA---H  241 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hccCCC-----Ccccc---C
Confidence            346788999999998889999999999999999999999997433211      11111 111000     00001   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.+++.+|++.+|++||+++|++++
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            112346678889999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.1e-34  Score=292.18  Aligned_cols=247  Identities=23%  Similarity=0.409  Sum_probs=193.4

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|+.+.      ...|++|.+......  .+++.+|+++++++ +|+||+++++++...+..++|||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEE
Confidence            3569999999999999642      456888887654332  35789999999999 99999999999998889999999


Q ss_pred             eccCCChhhhccCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          415 YFASGSLSTLLHGNRGAG----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      |+++|+|.++++......    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999997544211    125899999999999999999999998   9999999999999999999999999986


Q ss_pred             CCCCCC-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          491 LMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       491 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      ......     ...++..|+|||.+.+..++.++||||||+++|||++ |..||......+      .+...........
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~~~~~~~  239 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQAGKLELP  239 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHcCCcCCC
Confidence            543221     1223556999999988888999999999999999999 788986433211      1111111111000


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                                ........+.+++.+|++.+|++||++.|+++.|.
T Consensus       240 ----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         240 ----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                      00112246778888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.4e-34  Score=286.36  Aligned_cols=240  Identities=25%  Similarity=0.431  Sum_probs=191.4

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++.++ +|||++++++++.. +..++||||+++++|.
T Consensus        11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~   86 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKL-HHKNLVRLLGVILH-NGLYIVMELMSKGNLV   86 (254)
T ss_pred             eeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhC-CCCCcCeEEEEEcC-CCcEEEEECCCCCCHH
Confidence            57899999999999985 47789999986532 346788999999999 99999999999865 4579999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRS  501 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~~  501 (635)
                      +++....   ...+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++....... ....+
T Consensus        87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (254)
T cd05083          87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP  160 (254)
T ss_pred             HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence            9997532   234889999999999999999999988   9999999999999999999999999987644322 22234


Q ss_pred             CcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHH
Q 006677          502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM  580 (635)
Q Consensus       502 ~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  580 (635)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||......      ...... ...+...          ......
T Consensus       161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-~~~~~~~----------~~~~~~  223 (254)
T cd05083         161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKECV-EKGYRME----------PPEGCP  223 (254)
T ss_pred             ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHHH-hCCCCCC----------CCCcCC
Confidence            57999999998899999999999999999998 99999754321      111111 1111110          011223


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          581 VQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       581 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      ..+.+++.+||+.+|++||++++++..|+
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            45678888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.9e-34  Score=293.82  Aligned_cols=241  Identities=24%  Similarity=0.369  Sum_probs=191.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++.....    ..+++.+|+++++++ +||||+++.+++..++..++|+||++
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCL   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence            467999999999999965 578899998864422    124678899999999 89999999999999999999999997


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                       |++.+++....    ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~  170 (307)
T cd06607          99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS  170 (307)
T ss_pred             -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence             57777765322    24899999999999999999999998   99999999999999999999999999987665555


Q ss_pred             CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..++..|+|||++.   ...++.++||||||+++|||+||+.||......      ........ .....         .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~-~~~~~---------~  234 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NDSPT---------L  234 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhc-CCCCC---------C
Confidence            66788899999884   456889999999999999999999999754211      11111110 00000         0


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ........+.+++.+||+.+|++||++.+++.+.
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0122345678888999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.8e-34  Score=284.84  Aligned_cols=241  Identities=21%  Similarity=0.340  Sum_probs=192.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++... +++.|++|++.....   ..+.+.+|+++++++ +|+|++++++.+... ...++||||++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCE   83 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccC
Confidence            467999999999999965 467899999875432   245678899999999 899999999887644 45789999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.+++....   ...+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++......  
T Consensus        84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999997532   234899999999999999999999998   999999999999999999999999998765432  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++||||||++++||++|+.||...+      ...+....... ....         
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~~---------  221 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-KLPP---------  221 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-CCCC---------
Confidence              22346778999999999999999999999999999999999997432      12222222111 1100         


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ........+.+++.+|++.+|++||++.|++++
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             011233467788889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-34  Score=291.79  Aligned_cols=248  Identities=23%  Similarity=0.438  Sum_probs=192.1

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC------ee
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EK  409 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~  409 (635)
                      .+.||+|+||+||+|.+.    .+..||+|++......   .+++.+|+++++++ +||||+++++++...+      ..
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccce
Confidence            457999999999999854    3578999998765332   34678899999999 8999999999886543      23


Q ss_pred             EEEEEeccCCChhhhccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ++++||+++|+|.+++...+ ......+++.....++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence            78999999999988875332 112234789999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      ++......      ...+++.|++||.+....++.++||||||+++|||++ |+.||......+   +   .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~~  233 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I---YNYLIKGNR  233 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H---HHHHHcCCc
Confidence            87654322      1223467999999998889999999999999999999 888887543211   1   111111110


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ..           ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       234 ~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 LK-----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00           0012234678888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.5e-34  Score=285.34  Aligned_cols=241  Identities=20%  Similarity=0.389  Sum_probs=195.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++... +++.|++|++.....   ..+++.+|+++++++ +|+||+++++++...+..++|+||+++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEG   83 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCC
Confidence            467999999999999864 578899999875422   245788899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++....   ...+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        84 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          84 GDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999987533   224789999999999999999999998   9999999999999999999999999987654322  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||++.+..++.++|||||||+++||++|+.||....      ....+..........           
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~-----------  220 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSYPP-----------  220 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCCCC-----------
Confidence              2236778999999998889999999999999999999999997432      222222222221110           


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........+.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            011223457788889999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=290.81  Aligned_cols=246  Identities=26%  Similarity=0.408  Sum_probs=192.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.+++|++.......+++.+|+++++++.+|+||+++++++....      ..++||||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            467999999999999975 46789999987665556789999999999977999999999997654      47999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.++++.... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            999999999865331 1245899999999999999999999998   999999999999999999999999998654322


Q ss_pred             ----CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ----ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                          ....++..|+|||++..     ..++.++|||||||++|||++|+.||.......      -....... ...   
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~---  236 (275)
T cd06608         167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPRN-PPP---  236 (275)
T ss_pred             hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhcc-CCC---
Confidence                23346778999998753     346789999999999999999999996432111      01111110 000   


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ...........+.+++.+|+..||++|||+.|++++
T Consensus       237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 111112234567788889999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-33  Score=288.93  Aligned_cols=254  Identities=21%  Similarity=0.268  Sum_probs=193.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~  417 (635)
                      .+.||.|++|.||++... +++.+|+|.+.....  ...++.+|+++++++ +||||+++++++...  ...++||||++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            357999999999999975 478899998875432  345788999999999 899999999998654  36799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          85 GGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             CCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            9999988754322 2334888999999999999999999998   9999999999999999999999999987554322 


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||.+.+..++.++||||||+++|||++|+.||...... .................  ......   ..
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~---~~  234 (287)
T cd06621         161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMPNP--ELKDEP---GN  234 (287)
T ss_pred             ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCCch--hhccCC---CC
Confidence             234567899999999989999999999999999999999999865331 11111111111110100  000000   00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            01123457788899999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.7e-34  Score=285.66  Aligned_cols=242  Identities=29%  Similarity=0.481  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEecC-----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||++...+     +..||+|++.....  ..+.+.+|++++.++ +|+||+++++++...+..+++|||
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence            4679999999999999764     37799999976544  356788999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.+++.....   ..+++..+..++.|++.|++|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999975331   12899999999999999999999998   999999999999999999999999998765433


Q ss_pred             CC-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          496 AT-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       496 ~~-----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      ..     ..++..|+|||.+.+..++.++||||+|++++||++ |..||.....      .............       
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-------  223 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGYRL-------  223 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCCCC-------
Confidence            11     224578999999988889999999999999999999 7888865321      1112211111110       


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                          .........+.+++.+|++.+|++|||+.|+++.|
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                00111344677788899999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-34  Score=296.29  Aligned_cols=240  Identities=21%  Similarity=0.337  Sum_probs=190.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ...||+|+||.||++... ++..||+|.+..... ..+.+.+|+.++..+ +|+||+++++.+...+..++||||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            356999999999999864 578899998865432 345688899999998 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++..      ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.++|+|||++......    .
T Consensus       106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            9998853      23889999999999999999999998   999999999999999999999999998654322    1


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+      .... .....     .....   ..
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~-~~~~~-----~~~~~---~~  241 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AMRR-IRDNL-----PPRVK---DS  241 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhcC-----CCccc---cc
Confidence            2346778999999988889999999999999999999999997533211      0111 11100     00000   01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+|+..+|++|||++|++++
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1122345667789999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6e-34  Score=290.00  Aligned_cols=244  Identities=24%  Similarity=0.359  Sum_probs=187.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... ++..||+|+++....  ...++..|+.++.+..+||||+++++++..++..++||||++ |
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T   84 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence            357999999999999975 588999999876533  234566677766666699999999999999999999999997 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +|.+++...... ...+++..+..++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++.......  
T Consensus        85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (283)
T cd06617          85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK  160 (283)
T ss_pred             cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            888887653322 24589999999999999999999986 6   9999999999999999999999999987654322  


Q ss_pred             -CCCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 -TPSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       ...++..|+|||.+.+    ..++.++|+|||||++|||++|+.||......    . ........... ...      
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~-~~~------  228 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVEEPS-PQL------  228 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHhcCC-CCC------
Confidence             2346778999998865    45688999999999999999999999643211    1 11111111100 000      


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                        + .......+.+++.+||..+|++||+++++++
T Consensus       229 --~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 --P-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --C-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 0112345677888999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.4e-34  Score=290.46  Aligned_cols=240  Identities=24%  Similarity=0.404  Sum_probs=195.0

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      +.||+|+||.||+|... ++..+++|++.........+.+|++++.++ +|+|++++++++...+..++|+||+++++|.
T Consensus        25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (286)
T cd06614          25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLT  103 (286)
T ss_pred             HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence            56999999999999976 578899999976544466788999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----CCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATP  498 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~~~  498 (635)
                      +++....    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......    ...
T Consensus       104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614         104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence            9997532    25899999999999999999999988   999999999999999999999999987654332    223


Q ss_pred             CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHH
Q 006677          499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE  578 (635)
Q Consensus       499 ~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  578 (635)
                      .++..|+|||++.+..++.++|||||||++|+|++|+.||......      ........... .        .......
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~--------~~~~~~~  241 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKGI-P--------PLKNPEK  241 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC-C--------CCcchhh
Confidence            4667899999998888999999999999999999999999643211      11111111110 0        0111111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          579 EMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       579 ~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ....+.+++.+|++.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2345677888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-34  Score=292.70  Aligned_cols=254  Identities=22%  Similarity=0.324  Sum_probs=187.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +|..+++|+++....   ....+.+|++++.++ +|+||+++++++.+.+..++|+||+++
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCDQ   83 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCCC
Confidence            357999999999999975 578899999865422   234677899999999 999999999999999999999999974


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                       +|.+++....    ..+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        84 -~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          84 -DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             -CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence             8888776432    34899999999999999999999998   9999999999999999999999999987654322  


Q ss_pred             --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----ccc--cccch
Q 006677          497 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWT--AEVFD  567 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~d  567 (635)
                        ...++..|+|||++.+. .++.++|||||||++|||+||+.|+......+  ............    .|.  ....+
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccc
Confidence              23457789999998764 47899999999999999999999864322110  000000000000    000  00000


Q ss_pred             h-hhhcc-------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 V-ELMRF-------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~-~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      . .....       +........+.+++.+|++.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0 00000       0001123456678889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-33  Score=285.46  Aligned_cols=235  Identities=21%  Similarity=0.313  Sum_probs=185.6

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhh
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL  424 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  424 (635)
                      ||+|+||.||++..+ ++..+|+|.+.......    .|......+.+|+|++++++++...+..++||||+++|+|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            699999999999965 46778888876543221    1222333333799999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCCCCCCCCCc
Q 006677          425 LHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPATPSRSAG  503 (635)
Q Consensus       425 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~~~~~~~~~  503 (635)
                      +....     .+++..+..++.|+++|++|||+.+   ++||||||+||+++.++ .++|+|||++..........++..
T Consensus       100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  171 (267)
T PHA03390        100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD  171 (267)
T ss_pred             HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCc
Confidence            97432     5899999999999999999999998   99999999999999998 999999999987766666678889


Q ss_pred             ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHH
Q 006677          504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM  583 (635)
Q Consensus       504 y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  583 (635)
                      |+|||++.+..++.++||||||+++|||++|+.||......+ .+...+.... ...            ..........+
T Consensus       172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~------------~~~~~~~~~~~  237 (267)
T PHA03390        172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QKK------------LPFIKNVSKNA  237 (267)
T ss_pred             ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-ccc------------CCcccccCHHH
Confidence            999999999899999999999999999999999998543322 2222222221 100            00111233456


Q ss_pred             HHHHHHcccCCCCCCCC-HHHHHH
Q 006677          584 LQIGMACVAKVPDMRPN-MDEVVR  606 (635)
Q Consensus       584 ~~l~~~cl~~~P~~RPs-~~evl~  606 (635)
                      .+++.+|++.+|++||+ ++|+++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhc
Confidence            77778999999999996 588875

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.2e-34  Score=320.33  Aligned_cols=250  Identities=16%  Similarity=0.307  Sum_probs=190.2

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|.... +..+|+|.+......   ...+.+|+.++..+ +|||||+++++|...  ...|+||||+
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~   96 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFC   96 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence            4679999999999999764 567888888654322   45688899999999 999999999988654  4689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCceecCCCCCCeEEcC---------------
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG----PKFTHGNIKASNVLINQ---------------  477 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dlk~~NIll~~---------------  477 (635)
                      ++|+|.+++...... ...+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.               
T Consensus        97 ~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~  175 (1021)
T PTZ00266         97 DAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL  175 (1021)
T ss_pred             CCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence            999999999753321 2358999999999999999999998542    34999999999999964               


Q ss_pred             --CCCeEEeecCCCCCCCCC---CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 006677          478 --DLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP  550 (635)
Q Consensus       478 --~~~~ki~DfGla~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~  550 (635)
                        .+.+||+|||++......   ....+++.|+|||++.+  ..++.++|||||||++|||+||+.||.....     ..
T Consensus       176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~  250 (1021)
T PTZ00266        176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FS  250 (1021)
T ss_pred             CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HH
Confidence              345899999999765432   23357889999999854  4588999999999999999999999974321     11


Q ss_pred             HHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 006677          551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV  611 (635)
Q Consensus       551 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~  611 (635)
                      .... .+.....       + .   .......+.+++..||+.+|.+||++.|++.  .+..+
T Consensus       251 qli~-~lk~~p~-------l-p---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        251 QLIS-ELKRGPD-------L-P---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHH-HHhcCCC-------C-C---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            1111 1111100       0 0   0112345778888999999999999999995  45444

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.2e-34  Score=289.45  Aligned_cols=240  Identities=19%  Similarity=0.279  Sum_probs=183.3

Q ss_pred             cccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhh--cCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          345 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +||+|+||.||++... +++.+|+|.+......    ...+.+|..++..+  .+|+|++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 4788999988654321    22334444433333  279999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++++|||++....... 
T Consensus        81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            99999988632     34899999999999999999999998   9999999999999999999999999986543322 


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ...++..|+|||.+.. ..++.++|||||||++|||++|..||........    ......... .     ...     
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~-~-----~~~-----  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT-V-----NVE-----  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc-C-----CcC-----
Confidence             3357889999999864 5689999999999999999999999975432211    111111100 0     000     


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      ........+.+++.+|++.||++||     +++|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0112234566777899999999999     58888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5e-34  Score=293.00  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=190.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.|++|++......      ...+..|++++.++ +|+||+++++++.+.+..++||||
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEcc
Confidence            357999999999999965 5789999999765332      34567789999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      + +|+|.+++....    ..+++..+..++.||++||+|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9 889999997432    25899999999999999999999998   999999999999999999999999998766443


Q ss_pred             C----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc-----
Q 006677          496 A----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWT-----  562 (635)
Q Consensus       496 ~----~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-----  562 (635)
                      .    ...++..|+|||.+.+ ..++.++|||||||++|||++|..||......+  .+........   ...+.     
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhcccc
Confidence            2    1234667999998854 457899999999999999999988876543211  0111110000   00000     


Q ss_pred             cccchhhhhcc----cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 AEVFDVELMRF----QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ~~~~d~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...........    .........+.+++.+||+.+|++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000    0011224567788899999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.4e-34  Score=287.36  Aligned_cols=246  Identities=22%  Similarity=0.355  Sum_probs=196.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... +++.+++|++.....  ...++.+|+++++++ +||||+++++++..+...++|+||++++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCC
Confidence            357999999999999976 578899998876532  345688899999999 7999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +|.+++....    ..+++..+..++.|++.|++|||+ .+   ++|+||||+||++++++.++|+|||.+.......  
T Consensus        85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999997532    358899999999999999999999 77   9999999999999999999999999986553221  


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........+......... .         ..
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-~---------~~  226 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPPR-L---------PS  226 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCCC-C---------Ch
Confidence            245677899999999989999999999999999999999999754321 112222222222211100 0         00


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||..+|++|||+.|++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1133457788889999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-33  Score=293.13  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++... ++..+|+|++.....    ...++.+|+++++++ +|+|++++++++..++..++||||++
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  108 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCL  108 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence            467999999999999964 578899999864322    124677899999999 89999999999999999999999997


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      + +|.+.+...    ...+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus       109 g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (317)
T cd06635         109 G-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS  180 (317)
T ss_pred             C-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence            4 787777533    234899999999999999999999998   99999999999999999999999999887665556


Q ss_pred             CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..++..|+|||++.   .+.++.++|||||||++|||++|+.||......      ............          ..
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~----------~~  244 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP----------TL  244 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCC----------CC
Confidence            66788899999974   456889999999999999999999998753211      111111111110          00


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ........+.+++.+|++.+|++||++.++++++.....
T Consensus       245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            111223456788889999999999999999997765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=302.49  Aligned_cols=241  Identities=22%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             ccccccCceEEEEEEecCCCeE-EEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTV-VVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~v-avK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .-||-|+||.||+|..++.... |.|++.... ..-++|.-|++||..+ .||+||.+++.|+.++.++++.|||.||-+
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGGAV  116 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCchH
Confidence            3489999999999998765544 456664432 2346788999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----CCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPAT  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----~~~~  497 (635)
                      ..++-...    .++++.++..+++|++.||.|||++.   |||||||+.|||++-+|.++++|||.+....    ..+.
T Consensus       117 DaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  117 DAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             hHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            88875432    35999999999999999999999997   9999999999999999999999999875432    3456


Q ss_pred             CCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          498 PSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       498 ~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      ..|||.|||||+..     ..+|+.++||||||++|.||..+.+|....+..      +.+-++-..+.         ..
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSeP---------PT  254 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP---------PT  254 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcCC---------Cc
Confidence            78999999999874     567999999999999999999999998754321      11111111110         11


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .-.++.....|.++..+|+..+|..||++++++++
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            22334556677888889999999999999998763

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.4e-34  Score=290.26  Aligned_cols=249  Identities=21%  Similarity=0.318  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.++.++..|+||+++++++..+...+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            357999999999999965 478899999875432  2456788999999996699999999999999999999999864 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      ++.++...........+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++......   
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            554433211111123589999999999999999999975 5   999999999999999999999999998654332   


Q ss_pred             CCCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ATPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~---~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      ....++..|+|||++.+.   .++.++|||||||++|||++|+.||....     ...............      .+. 
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~------~~~-  232 (288)
T cd06616         165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDPP------ILS-  232 (288)
T ss_pred             ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCCC------cCC-
Confidence            223467789999999766   68899999999999999999999997432     111111111111100      000 


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..........+.+++.+||+.+|++|||++|++++
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00001233467788889999999999999999884

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-33  Score=286.64  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=189.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---C--------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---G--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~  410 (635)
                      .+.||+|+||.||+|... +++.+|+|.++....   .        .+.+..|++++.++ +|+|++++++++...+..+
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceE
Confidence            467999999999999864 578899998864211   0        13567889999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||+++|+|.++++..     ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++++|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999743     34889999999999999999999988   9999999999999999999999999987


Q ss_pred             CCCCCC------CCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          491 LMNVPA------TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       491 ~~~~~~------~~~~~~~y~aPE~~~~~~--~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ......      ...++..|+|||.+....  ++.++||||||+++||+++|..||......     .... ...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-~~~~~~-~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-KLGNKR-S  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-Hhhccc-c
Confidence            654321      224677899999987654  789999999999999999999999643211     1111 111000 0


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+....     .......+.+++.+|+..+|++||+++|++++
T Consensus       230 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00111100     01223567778889999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.7e-34  Score=286.38  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||.|+||+||+|... ++..+++|++.....  ..+.+.+|++.++.+ +|+|++++++.+..++..++|+||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGG   84 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence            467999999999999964 577899999865432  356788999999998 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~--  497 (635)
                      +|.++++....  ...+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++........  
T Consensus        85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999975321  234899999999999999999999998   99999999999999999999999999866543322  


Q ss_pred             ------CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          498 ------PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       498 ------~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                            ..++..|+|||++... .++.++|||||||++|||++|+.||......+.  +    .........      ..
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~------~~  227 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L----MLTLQNDPP------SL  227 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H----HHHhcCCCC------Cc
Confidence                  2367789999998776 789999999999999999999999975432211  1    111111100      00


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ............+.+++.+|++.+|++||+++|++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000011233556788889999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=287.51  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||+|... +++.||+|.+......    ...+..|..++....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 4789999998654321    123445555555555899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP  498 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~  498 (635)
                      ++|.+++...     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  153 (260)
T cd05611          82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF  153 (260)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence            9999999643     24889999999999999999999998   999999999999999999999999998776554455


Q ss_pred             CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHH
Q 006677          499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE  578 (635)
Q Consensus       499 ~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  578 (635)
                      .++..|+|||.+.+..++.++||||||+++|||++|..||...+..+      ...........   ...     .....
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---~~~-----~~~~~  219 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRIN---WPE-----EVKEF  219 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcccC---CCC-----ccccc
Confidence            67888999999988889999999999999999999999997543211      11111111000   000     00012


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          579 EMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       579 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....+.+++.+||+.+|++||++.++.+.
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            23457788889999999999987655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.8e-34  Score=285.95  Aligned_cols=241  Identities=24%  Similarity=0.383  Sum_probs=191.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.|++|.++....   ..+.+..|+++++++ +|+||+++++++...+..++|+||+++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSG   83 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCC
Confidence            467999999999999865 578899999876544   345788899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-  497 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-  497 (635)
                      ++|.+++...     ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999742     23788999999999999999999998   99999999999999999999999999876543322 


Q ss_pred             -------CCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          498 -------PSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       498 -------~~~~~~y~aPE~~~~~~---~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                             ..++..|+|||++.+..   ++.++||||||+++|||++|+.||......     ......... ..     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----C
Confidence                   23567899999998766   889999999999999999999999754211     011111111 00     0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..   .+........+.+++.+||+.+|++||++.|++.
T Consensus       225 ~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PP---IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CC---CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00   0111112345567888999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=280.43  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=199.4

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~  413 (635)
                      .-++-+|.||.||.|.+.      +.+.|.||.++.....  -..+.+|--.+..+ .|||+..+.+++..+ +..+.+|
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y  367 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLY  367 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEE
Confidence            346889999999999654      3456788888765432  23455666566666 799999999998654 5678999


Q ss_pred             EeccCCChhhhccCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          414 DYFASGSLSTLLHGNRG---AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      .++.-|+|..|+.-.++   ...+.++..+...++.|++.|++|||..+   |||.||.++|++||+..++||+|=.+++
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence            99999999999974332   23455778888999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          491 LMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       491 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      .+-..      +...+...||+||.+....|+.++|||||||+||||+| |+.||...++.|+       ..++.+++  
T Consensus       445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ylkdGy--  515 (563)
T KOG1024|consen  445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYLKDGY--  515 (563)
T ss_pred             ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHHhccc--
Confidence            76433      33445667999999999999999999999999999999 9999987655443       22233332  


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                              +...+-.+..+++.+|.-||...|++||+++|++..|.++.
T Consensus       516 --------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  516 --------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             --------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                    23334466778899999999999999999999999998875

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=272.39  Aligned_cols=257  Identities=21%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             cCCcCCChHHHHHHhhccccccCceEEEEEEecC-CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEE
Q 006677          328 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY  404 (635)
Q Consensus       328 ~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~  404 (635)
                      |..+..++.++..  ...||.|..|.|++++... |..+|||.+....-  ..+++...+.++..-...|+||+.+|||.
T Consensus        84 g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   84 GQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             CcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            4556677777743  4569999999999999764 67899999976532  23455666666666546899999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       405 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                      .+...++.||.|.. -+..++..-    ..++++.-+-++...+.+||.||.+++  .|+|||+||+|||+|+.|++|++
T Consensus       162 ~n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  162 TNTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             eCchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            99999999999855 455555533    345888888899999999999998876  69999999999999999999999


Q ss_pred             ecCCCCCCCCCCC---CCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          485 DFGLTPLMNVPAT---PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       485 DfGla~~~~~~~~---~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      |||++..+.....   ..|-+.|||||.+.-   ..|+.++||||||++++||.||..||.+-+.+  .+   -+.+++.
T Consensus       235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe---~ltkvln  309 (391)
T KOG0983|consen  235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE---VLTKVLN  309 (391)
T ss_pred             cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH---HHHHHHh
Confidence            9999987765443   345677999999953   46899999999999999999999999864322  11   1122222


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ++.      +.+....+   ....+.+++..|++.|+.+||...+++++
T Consensus       310 ~eP------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 EEP------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCC------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            111      11111111   33456777779999999999999988764

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.9e-34  Score=293.03  Aligned_cols=244  Identities=20%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++.... ++.|++|.+.....    ....+.+|++++..+ +||||+++++.+..++..++||||++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence            3679999999999999754 67899998875432    234677889999988 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.+++...     ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||+++.....  
T Consensus        85 g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          85 GGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999643     24899999999999999999999998   999999999999999999999999988642110  


Q ss_pred             -----------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          496 -----------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       496 -----------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                                       ....++..|+|||.+....++.++|+|||||++|||++|..||.+....      .+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~  230 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS  230 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence                             0123566799999998888999999999999999999999999754321      12222111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                      ....    .+.     ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 ~~~~----~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DDIE----WPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cccC----CCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1100    000     001123456788889999999999997666666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-34  Score=292.71  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=190.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||+|++.....   ..+.+.+|+++++++ +||||+++++++..++..++|+||+++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDH   84 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCc
Confidence            367999999999999976 478899998865432   245688899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.++....     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          85 TVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            9998876532     23899999999999999999999998   9999999999999999999999999987653322  


Q ss_pred             --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHH-------HHhhhc-cccc
Q 006677          497 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQ-------SVVREE-WTAE  564 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~-------~~~~~~-~~~~  564 (635)
                        ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..+..+..       ...... ....
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence              2235678999999875 4478899999999999999999999975432110 00000000       000000 0000


Q ss_pred             cchhhhhccc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDVELMRFQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+......    ........+.+++.+||+.+|++||++.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000000    001223557788889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.1e-34  Score=286.21  Aligned_cols=242  Identities=21%  Similarity=0.350  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||++.. .+++.||+|++.....       ..+.+.+|+++++++ +|+||+++++++.+.+..++|+|
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEe
Confidence            46799999999999985 4578899999875432       135688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMN  493 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~  493 (635)
                      |+++++|.+++...     .++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++ .++|+|||.+....
T Consensus        84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999998642     34889999999999999999999998   99999999999998776 59999999987654


Q ss_pred             CCC--------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          494 VPA--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       494 ~~~--------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      ...        ...++..|+|||.+.+..++.++||||+|+++|||++|..||........   .............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~---  229 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTA---  229 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCC---
Confidence            321        12356789999999888899999999999999999999999964332211   1111111100000   


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                             ..........+.+++.+|+..+|++||++.|+++
T Consensus       230 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 -------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   0111223356778888999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.3e-34  Score=290.66  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||++... ++..|++|.+.... ...+.+.+|+.+++++ +||||+++++++...+..++|+||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGS  102 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence            467999999999999854 57889999986433 2345688899999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++...      .+++..+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||++.......    
T Consensus       103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647         103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            99998632      3788999999999999999999998   9999999999999999999999999876554322    


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||.+....++.++||||||+++||+++|+.||......+....      ..... .        ......
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~-~--------~~~~~~  238 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-T--------PELQNP  238 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC-C--------CCCCCc
Confidence            22466779999999888899999999999999999999999976543221100      00000 0        001111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||..+|++||++.+++.+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223456778889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-33  Score=282.19  Aligned_cols=241  Identities=18%  Similarity=0.388  Sum_probs=193.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++... ++..+++|.+.....   ....+.+|+++++++ +|||++++++.+..++..++||||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPG   83 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCC
Confidence            467999999999999864 578899999865432   245688899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~~-  496 (635)
                      ++|.+++....   ...+++..+..++.+++.|++|||+.+   ++|+||+|+||+++++ +.+|++|||.+....... 
T Consensus        84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999997533   234899999999999999999999998   9999999999999865 457999999987664332 


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..      ............ ..         
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~-~~---------  221 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGTFA-PI---------  221 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcCCC-CC---------
Confidence              234677899999999888999999999999999999999999754321      122222111100 00         


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .......+.+++.+||+.+|++|||+.|++++
T Consensus       222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             01123456788889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-34  Score=294.27  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|...+ +..+|+|.+......    .+.+..|++++.++ +|+||+++++.+...+..++||||+.
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecC
Confidence            3579999999999999764 789999999765332    34678899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999987432   235899999999999999999999998   9999999999999999999999999876542211 


Q ss_pred             --------------------------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          497 --------------------------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       497 --------------------------------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                                                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                            123567799999999888999999999999999999999999754322


Q ss_pred             CCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 006677          545 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN----MDEVVR  606 (635)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~  606 (635)
                      +.      .........          ...........+.+++.+|++.+|++||+    ++|+++
T Consensus       239 ~~------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 ET------FSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH------HHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            10      111111110          01111113456778888999999999999    666666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-33  Score=283.09  Aligned_cols=238  Identities=20%  Similarity=0.305  Sum_probs=191.8

Q ss_pred             ccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||.||++.... ++.+++|++.....    ..+.+.+|+++++++ +|+||+++++++.+++..++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            6999999999999764 78899999875432    245688899999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T  497 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---~  497 (635)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        80 L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~  151 (262)
T cd05572          80 LWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT  151 (262)
T ss_pred             HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence            99999743     23889999999999999999999988   9999999999999999999999999988765432   2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..||.....    +..............          .....
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~~~~~  217 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK----------LEFPN  217 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC----------CCCCc
Confidence            3467789999999888899999999999999999999999975542    112222222210000          00011


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPN-----MDEVVR  606 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~  606 (635)
                      .....+.+++.+||+.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11346778888999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-33  Score=283.58  Aligned_cols=240  Identities=23%  Similarity=0.344  Sum_probs=191.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... ++..|++|.+.....      ..+.+.+|+++++++ +|+||+++++++......++|+||
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEe
Confidence            367999999999999976 688999998865431      235688899999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.+++...     ..+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          84 VPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999643     24889999999999999999999998   999999999999999999999999998765432


Q ss_pred             C---CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 A---TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .   ...++..|+|||.+.... ++.++|+||||+++|+|++|+.||......      .............. +     
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~-~-----  223 (258)
T cd06632         156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP-I-----  223 (258)
T ss_pred             ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC-c-----
Confidence            2   334677899999987766 899999999999999999999999754311      11111111000000 0     


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          .......+.+++.+||+.+|.+||++.+++++
T Consensus       224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                01122455677889999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=291.83  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.|++|+++....   ..+.+.+|+++++++ +|+||+++++++..++..++||||+++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCC
Confidence            467999999999999976 477899998875432   246788999999999 899999999999999999999999998


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +.+..+...     ...+++..+..++.||+.|++|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          85 TLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            777666542     233889999999999999999999998   9999999999999999999999999987765433  


Q ss_pred             ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hc
Q 006677          497 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------------EE  560 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~~  560 (635)
                         ...++..|+|||++.+. .++.++||||||+++|||++|+.||......+.   .........            ..
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence               23356779999999888 789999999999999999999999975432110   000000000            00


Q ss_pred             ccc-----ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          561 WTA-----EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       561 ~~~-----~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...     ...+...............+.+++.+||..+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000     00000000000011124667888899999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-33  Score=283.54  Aligned_cols=242  Identities=25%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|++|.||+|...+ ++.|++|++.....  ....+..|++.+.++ +|+|++++++++...+..++||||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            3679999999999999775 88999999876543  356788999999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-  497 (635)
                      +|.+++...     ..+++..+..++.|++.|++|||+ .+   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            999999743     348999999999999999999999 88   99999999999999999999999999876644332 


Q ss_pred             ---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ---~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                         ..++..|+|||.+.+..++.++||||||+++|||+||+.||......+..+.   ...+..... .     .     
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~~-~-----~-----  222 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGPP-P-----S-----  222 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhcCCC-C-----C-----
Confidence               2356789999999998899999999999999999999999976543111111   111111100 0     0     


Q ss_pred             ChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .... ....+.+++.+|+..+|++||++.|++++
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0011 33567778889999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-33  Score=288.99  Aligned_cols=255  Identities=21%  Similarity=0.298  Sum_probs=189.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-----eEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~  413 (635)
                      .+.||+|+||.||+|... +++.||+|++.....   ....+.+|++++.++.+|+||+++++++...+.     .++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            467999999999999965 578899998765432   235688899999999778999999999987665     79999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLM  492 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~  492 (635)
                      ||+++ +|.+++..........+++..+..++.||+.||+|||+.+   ++||||||+||+++. ++.+||+|||++...
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99986 8988886543322346899999999999999999999998   999999999999998 899999999998755


Q ss_pred             CCCC----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc--ccccc
Q 006677          493 NVPA----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE--WTAEV  565 (635)
Q Consensus       493 ~~~~----~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  565 (635)
                      ....    ...+++.|+|||++.+ ..++.++||||||+++|||++|..||......      .....+....  .....
T Consensus       162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHhCCCChhh
Confidence            3321    2235678999998865 45789999999999999999999999754321      1111111000  00000


Q ss_pred             c----h-hh---hhc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 F----D-VE---LMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~----d-~~---~~~--~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +    + ..   ...  ..    ..+.....+.+++.+|+..+|.+||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0    0 00   000  00    001223457788889999999999999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=286.63  Aligned_cols=240  Identities=23%  Similarity=0.391  Sum_probs=190.9

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhc--CCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.. .++..|++|.+.....  ...++.+|+.+++++.  .|||++++++++..+...++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            35799999999999996 4578899998865422  3456888999999984  49999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.++++..      .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999998632      4899999999999999999999998   9999999999999999999999999987654332 


Q ss_pred             ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          497 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                         ...++..|+|||.+.+. .++.++|||||||++|+|++|..||........      ... ......     +.+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~~~~~~-----~~~~~  224 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-IPKSKP-----PRLED  224 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-cccCCC-----CCCCc
Confidence               23467789999998654 468999999999999999999999975432111      110 000000     00000


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ......+.+++.+||+.+|++||++.|++++
T Consensus       225 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                0123467788889999999999999999873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.6e-34  Score=289.40  Aligned_cols=239  Identities=21%  Similarity=0.361  Sum_probs=192.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .++||+|++|.||++... +++.+++|++..... ..+.+.+|+.++..+ +|+||+++++++...+..++|+||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~  102 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGA  102 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence            368999999999999864 578899998864432 345678899999998 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++..      ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.++|+|||.+......    .
T Consensus       103 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648         103 LTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            9999864      23889999999999999999999998   999999999999999999999999987654322    1


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||...+.      .......... ...     ...   ..
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~~-----~~~---~~  238 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LPP-----KLK---NL  238 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CCC-----CCc---cc
Confidence            23467789999999988899999999999999999999999965321      1122211111 100     000   01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ......+.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            112346778888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-33  Score=286.95  Aligned_cols=238  Identities=24%  Similarity=0.393  Sum_probs=191.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... ++..||+|.+.....  ..+.+.+|++++.++ +|+||+++++++..++..++||||++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG   87 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence            457999999999999864 578899998764432  235688899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++..      ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        88 ~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          88 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            99999863      23889999999999999999999998   9999999999999999999999999986554321   


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...++..|+|||.+.+..++.++|||||||++|||++|..||......      .+......... . .+         
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~-~~---------  221 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKNNP-P-TL---------  221 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcCCC-C-CC---------
Confidence             224677899999998888899999999999999999999999743211      11111111110 0 00         


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+|++.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            01223456778889999999999999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.4e-34  Score=289.56  Aligned_cols=253  Identities=20%  Similarity=0.283  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|+++.....  .....+|+.++.++.+|+|++++++++.+.  +..++|+||++
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD   83 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence            357999999999999964 5788999998764322  234456888888886799999999999987  88999999997


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                       |+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++....... 
T Consensus        84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence             58888876432    35899999999999999999999998   999999999999999 999999999987654322 


Q ss_pred             --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-----------ccc
Q 006677          497 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-----------EWT  562 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~  562 (635)
                        ...++..|+|||++.. ..++.++|||||||++|||++|+.||...+..+   ...+.......           ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccccc
Confidence              2336778999997644 557889999999999999999999997654221   11111111100           000


Q ss_pred             ccc-chhhhh-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 AEV-FDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ~~~-~d~~~~-~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ... +..... . ..........+.+++.+|++.+|++||+++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000 000000 0 00011234678888999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.4e-33  Score=283.10  Aligned_cols=239  Identities=20%  Similarity=0.306  Sum_probs=184.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC------ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||.||+|... .+..|++|++.....      ....+.+|+.+++++ +|+||+++++++...  ...++++
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEE
Confidence            467999999999999865 478899998864321      124577899999999 899999999998753  5678999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        86 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          86 EYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            999999999998642     24889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..       ....++..|+|||.+.+..++.++|||||||++|||++|+.||......      ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~-----  226 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT-----  226 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence            21       1123677899999999888999999999999999999999999743211      11111111110     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+..     .......+.+++ +||..+|++||+++|++++
T Consensus       227 ~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         227 NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            0000     011122334444 6888999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-34  Score=293.74  Aligned_cols=260  Identities=21%  Similarity=0.308  Sum_probs=191.3

Q ss_pred             hccccccCceEEEEEEecC---CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||.||+|....   +..||+|.+....    .....+.+|++++.++ +||||+++++++...  +..++||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEE
Confidence            3579999999999999754   6889999997633    1235677899999999 999999999999988  7899999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC----CCCeEEeecCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDFGLT  489 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~DfGla  489 (635)
                      ||+++ +|.+++..........+++..+..++.|++.||+|||+.+   |+||||||+||+++.    ++.+||+|||++
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99975 7777765443333346899999999999999999999998   999999999999999    999999999998


Q ss_pred             CCCCCCC-------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-------HHHH
Q 006677          490 PLMNVPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-------RWVQ  554 (635)
Q Consensus       490 ~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~-------~~~~  554 (635)
                      .......       ...++..|+|||++.+. .++.++|||||||++|||++|+.||............       ..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            7654322       12356789999988664 5789999999999999999999999866543311110       0000


Q ss_pred             HHh------------hhccccccchhhhhccc--ChH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 SVV------------REEWTAEVFDVELMRFQ--NIE-------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 ~~~------------~~~~~~~~~d~~~~~~~--~~~-------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...            ...+.............  ...       .....+.+++.+|++.||++|||+.|++++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000            00000000000000000  000       223457889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=289.13  Aligned_cols=253  Identities=22%  Similarity=0.361  Sum_probs=188.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... +++.||+|.+.....  ....+.+|+++++++ +|+||+++++++..++..++||||+.+ 
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~-   87 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDT-   87 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCC-
Confidence            467999999999999975 578899999875432  234567899999999 999999999999999999999999985 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   
T Consensus        88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            9999886432    24889999999999999999999998   9999999999999999999999999986543221   


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccc--------
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT--------  562 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~--------  562 (635)
                       ...++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......  +..........    +.+.        
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccc
Confidence             2235677999999865 457899999999999999999999997543100  00000000000    0000        


Q ss_pred             ----cccc-hhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 ----AEVF-DVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ----~~~~-d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          .... ..... ..... .....+.+++.+|++.+|++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                0000 00000 00000 012456788889999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-33  Score=283.61  Aligned_cols=239  Identities=19%  Similarity=0.253  Sum_probs=185.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---C---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---G---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .++||+|+||.||+|... ++..|++|.+.....   .   .+.+.+|+.++.++ +|+||+++++++.+.  ...++||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEE
Confidence            467999999999999965 478899998853321   1   24677899999999 999999999988764  4578999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++...     ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          86 EHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            999999999998632     23788899999999999999999998   9999999999999999999999999987543


Q ss_pred             C-------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 V-------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~-------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .       .....++..|+|||.+.+..++.++|||||||++|||++|+.||......      ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-----  226 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT-----  226 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCCC-----
Confidence            2       11234677899999998888999999999999999999999999643211      11111111110     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ...........+.+++.+|+. +|++||+++|++++
T Consensus       227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                 001112233456667778885 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.2e-33  Score=285.08  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.|++|++.....   ....+.+|+.+++++ +|+|++++++++......++||||+ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~-~   82 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-P   82 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEeccc-C
Confidence            467999999999999965 578999999876542   245788999999999 8999999999999999999999999 9


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++....    ..+++..+..++.||+.||+|||+.+   ++|+||||+||++++++.++|+|||++.......  
T Consensus        83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99999986433    34899999999999999999999998   9999999999999999999999999987664432  


Q ss_pred             ---CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------------
Q 006677          497 ---TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-------------  559 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------  559 (635)
                         ...++..|+|||.+.+. .++.++||||+|+++|||++|..||......+   ...+.......             
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence               23467789999998654 46899999999999999999988886543211   11111111000             


Q ss_pred             ccccccchhhhh-c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          560 EWTAEVFDVELM-R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       560 ~~~~~~~d~~~~-~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .+....+..... . ....++....+.+++.+|++.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000 0 00001223667788889999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-33  Score=286.51  Aligned_cols=253  Identities=22%  Similarity=0.350  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.|++|++.....   ....+.+|++++.++ +||||+++++++.+.+..++||||+. 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccc-
Confidence            357999999999999875 578899998865432   235688899999999 99999999999999999999999996 


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            58988886433   234899999999999999999999998   9999999999999999999999999987654322  


Q ss_pred             --CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---c---------
Q 006677          497 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---W---------  561 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---------  561 (635)
                        ...++..|+|||++.+.. ++.++||||||+++|||+||+.||......+  .............   +         
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHH
Confidence              223567899999887644 6889999999999999999999997543211  1111110000000   0         


Q ss_pred             cc---ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TA---EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~---~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   ..........  .......+.+++.+|++.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00   0000000000  00112345678889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-33  Score=281.50  Aligned_cols=242  Identities=21%  Similarity=0.346  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~  417 (635)
                      +.||.|+||.||++... ++..+++|.+......   .+.+..|+++++++ +|+||+++++++..  ....+++|||++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~   84 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCE   84 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhcc
Confidence            57999999999999864 5788999988754332   34577899999999 99999999998764  345789999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +++|.+++..... ....+++..+..++.|++.||+|||     +.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999975432 2345899999999999999999999     555   999999999999999999999999998876


Q ss_pred             CCCC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          493 NVPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       493 ~~~~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ....    ...++..|+|||++.+..++.++||||||+++|+|++|+.||......      ....... .....     
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~-----  228 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKIK-EGKFR-----  228 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHHh-cCCCC-----
Confidence            5433    234678899999999888999999999999999999999999754311      1111111 11100     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           .........+.+++.+|++.+|++||++.||+++
T Consensus       229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 0111233567788889999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-33  Score=280.39  Aligned_cols=242  Identities=26%  Similarity=0.439  Sum_probs=196.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.++++ +|+|++++++++..+...++++||+++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            357999999999999976 578899999976544 457788999999999 79999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---T  497 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---~  497 (635)
                      |.+++....    ..+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||.+.......   .
T Consensus        84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence            999987532    35899999999999999999999988   9999999999999999999999999987765442   3


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||......      .......... ...        .....
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~--------~~~~~  221 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIATNG-PPG--------LRNPE  221 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhcC-CCC--------cCccc
Confidence            44677899999998888999999999999999999999999754311      1111111100 000        00011


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.+++.+|++.+|++|||+.|++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            113467788889999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-33  Score=287.30  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=186.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... ++..|++|++.....  ....+.+|+++++.+ +|+||+++.+++..++..++|+||+. +
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~-~   87 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence            367999999999999864 578999999865432  234677899999999 89999999999999999999999996 6


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      ++.+++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++.....    
T Consensus        88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          88 DLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            7777765322    23788889999999999999999998   999999999999999999999999998754322    


Q ss_pred             CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---h-------------
Q 006677          496 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---R-------------  558 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~-------------  558 (635)
                      ....++..|+|||.+.+. .++.++|||||||++|||++|..||......     .+......   .             
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhc
Confidence            122357789999998754 4788999999999999999999999754321     00000000   0             


Q ss_pred             hccccccc----hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVF----DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~----d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+.....    ................+.+++.+|+..||++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            00000000    00000000000112456678889999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-33  Score=285.13  Aligned_cols=240  Identities=21%  Similarity=0.301  Sum_probs=187.3

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||+||++... +++.+++|.+.....    ....+..|+++++++ +||||+++++++...+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999855 578899999865321    234567899999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---CC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---AT  497 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---~~  497 (635)
                      |.+++.....   ..+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||.+......   ..
T Consensus        80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  153 (277)
T cd05577          80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG  153 (277)
T ss_pred             HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence            9999875432   35899999999999999999999998   999999999999999999999999998765432   12


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||++.+..++.++|||||||++|+|++|+.||........  ... ..    ......    ..   ....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~----~~~~~~----~~---~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LK----RRTLEM----AV---EYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HH----hccccc----cc---cCCc
Confidence            3456789999999888899999999999999999999999975443111  000 00    000000    00   0001


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRP-----NMDEVVR  606 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  606 (635)
                      .....+.+++.+||+.+|++||     ++.+++.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1233566778899999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-33  Score=289.82  Aligned_cols=254  Identities=21%  Similarity=0.375  Sum_probs=191.6

Q ss_pred             cCCChHHHHHHhhccccccCceEEEEEEecC-CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC
Q 006677          331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD  407 (635)
Q Consensus       331 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~  407 (635)
                      +.++.++.  ...+.||+|+||.||+|..++ ++.||||.++....  ....+..|++++.+...|+||+++++++..+.
T Consensus        10 ~~~~~~~~--~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          10 YPADLNDL--ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             ccCCcchh--eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            33444443  346789999999999999875 88899999975432  23456667777777756999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      ..++||||+.+ ++.+++....    ..+++..+..++.|++.||+|||+. +   |+||||+|+||++++++.+||+||
T Consensus        88 ~~~~v~e~~~~-~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          88 DVFICMELMST-CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             eEEEEeeccCc-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence            99999999854 7777765422    2589999999999999999999974 5   999999999999999999999999


Q ss_pred             CCCCCCCCCC---CCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006677          487 GLTPLMNVPA---TPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE  559 (635)
Q Consensus       487 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  559 (635)
                      |++.......   ...++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     ..........
T Consensus       160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~  234 (296)
T cd06618         160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE  234 (296)
T ss_pred             ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC
Confidence            9987654322   223567899999987654    788999999999999999999999643211     1111111111


Q ss_pred             ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       560 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ...         ...........+.+++.+||+.+|++||++++++++-
T Consensus       235 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         235 EPP---------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCC---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            100         0000011234577888899999999999999998763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-34  Score=312.44  Aligned_cols=260  Identities=18%  Similarity=0.245  Sum_probs=178.9

Q ss_pred             hccccccCceEEEEEEecCC--CeEEEE------------------EeecccCChHHHHHHHHHHHhhcCCCceeceeEE
Q 006677          343 AEVLGKGSYGTAYKAVLEES--TTVVVK------------------RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY  402 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~--~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~  402 (635)
                      .+.||+|+||+||++..+..  ..++.|                  ++.........+++|++++.++ +|+||++++++
T Consensus       153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~  231 (501)
T PHA03210        153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEI  231 (501)
T ss_pred             EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEE
Confidence            56899999999999875421  111111                  1111111234678899999999 99999999999


Q ss_pred             EEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       403 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      +...+..|+|+|++. ++|.+++....-..........+..++.||+.||+|||+.+   |+||||||+|||++.++.+|
T Consensus       232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999985 47777765332111122345667889999999999999998   99999999999999999999


Q ss_pred             EeecCCCCCCCCCC-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCCCCCChhHHHHHH
Q 006677          483 ISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP-LQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       483 i~DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~  556 (635)
                      |+|||+++......     ...|+..|+|||++.+..++.++|||||||++|||++|..+ +..........+.......
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~  387 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL  387 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence            99999997664322     23578899999999999999999999999999999998754 4332221111111111110


Q ss_pred             h--hhcccc---ccchh----hhh-cccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          557 V--REEWTA---EVFDV----ELM-RFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       557 ~--~~~~~~---~~~d~----~~~-~~~~~~~~------~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .  .+++..   ..++.    ... ........      ...+.+++.+|++.||++|||+.|++++
T Consensus       388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0  000000   00000    000 00000111      1245667889999999999999999874

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.8e-33  Score=285.40  Aligned_cols=238  Identities=18%  Similarity=0.241  Sum_probs=191.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++... +++.+|+|++.....    ..+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVP   84 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCC
Confidence            467999999999999975 478899999875422    245678899999999 79999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....... 
T Consensus        85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  156 (290)
T cd05580          85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY  156 (290)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence            99999998743     34899999999999999999999988   9999999999999999999999999987765432 


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||.+.+..++.++||||||+++|||++|+.||......      .-.........         ....  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~--  219 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEGKV---------RFPS--  219 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc---------cCCc--
Confidence            334678899999998888899999999999999999999999754311      11111111110         0001  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                       .....+.+++.+||..+|.+|+     +++|++++
T Consensus       220 -~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         220 -FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence             1124556777899999999999     77777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-33  Score=287.76  Aligned_cols=239  Identities=21%  Similarity=0.363  Sum_probs=190.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+||+|+||.||++... ++..||+|++..... ....+.+|+.+++++ +|+|++++++++...+..++||||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            57999999999999874 578899998854332 345688899999998 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----C
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----T  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----~  497 (635)
                      .+++...      .+++.....++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||++.......    .
T Consensus       105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            9987532      3789999999999999999999998   9999999999999999999999999876543321    2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..||......      ..... .......     ..   ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~-~~~~~~~-----~~---~~~~  240 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNLPP-----KL---KNLH  240 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhhCCc-----cc---CCcc
Confidence            34677899999998888999999999999999999999999753221      11111 1111100     00   0111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.+++.+||+.+|.+||++.+++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            122345677889999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-33  Score=283.46  Aligned_cols=239  Identities=21%  Similarity=0.303  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..|++|.+.....    ..+.+.+|+++++++ +||||+++++++...+..++|+||+.
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLL   83 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCC
Confidence            467999999999999976 488899999975432    246788899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......  
T Consensus        84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999643     35889999999999999999999998   999999999999999999999999998765443  


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ...+.......  .         ...
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~---------~~~  220 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--A---------DVL  220 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--c---------ccc
Confidence             2234667899999998888999999999999999999999999865432    11111111111  0         001


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNM--DEVV  605 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl  605 (635)
                      ........+.+++.+||+.+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            111223567788889999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-33  Score=280.62  Aligned_cols=241  Identities=21%  Similarity=0.391  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|..+ ++..+|+|.+....   ...+.+.+|+++++++ +|+||+++++.+......++|+||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDG   83 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCC
Confidence            467999999999999976 47889999986542   2345678899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~~-  496 (635)
                      ++|.+++....   ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++ .+||+|||.+....... 
T Consensus        84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999987533   234799999999999999999999998   99999999999999886 46999999987654332 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...+++.|+|||++.+..++.++||||||+++|||++|..||...+      ...+.......... ..       .
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~-------~  223 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGYFA-PI-------S  223 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcccCC-CC-------C
Confidence               2246778999999988889999999999999999999999997432      22222222221110 00       0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ......+.+++.+|+..+|++|||+.|++++
T Consensus       224 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 ---PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               1122457778889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-33  Score=287.68  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|... +++.+++|.++.....   ...+.+|+++++++ +||||+++++++...  ...++||||+
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~   88 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV   88 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhc
Confidence            467999999999999976 4788999998754322   23567899999999 899999999999877  7899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++ +|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        89 ~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          89 EH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             Cc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            75 9998886432    25899999999999999999999998   9999999999999999999999999987665432


Q ss_pred             ----CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcc------
Q 006677          497 ----TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEW------  561 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~------  561 (635)
                          ...++..|+|||.+.+.. ++.++|+||||+++|||++|..||......+..  .. ......    ..|      
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL--NK-IFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHhCCCchHHHHHhhcc
Confidence                233567899999987544 689999999999999999999999754321110  00 000000    000      


Q ss_pred             -------ccccchhhh-hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 -------TAEVFDVEL-MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 -------~~~~~d~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                             ........+ ...+.. .....+.+++.+|++.+|++|||+.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   000000000 001100 023456778889999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.6e-33  Score=282.97  Aligned_cols=239  Identities=19%  Similarity=0.298  Sum_probs=183.1

Q ss_pred             cccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhh--cCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          345 VLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRV--GQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +||+|+||.||+|... +++.||+|.+......    ...+..|..++..+  ..||||+.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 4789999998754321    12233444333332  379999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++......  
T Consensus        81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            99999988632     34899999999999999999999988   999999999999999999999999998755322  


Q ss_pred             CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ....++..|+|||.+.++ .++.++||||+||++|||++|+.||..........    .......      ....+    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~----  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVEL----  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCC----
Confidence            234578889999999754 58999999999999999999999997653222111    0000000      00000    


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  606 (635)
                       .......+.+++.+|+..+|.+||     ++.|+++
T Consensus       219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             011234667778899999999999     8999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-33  Score=290.29  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=191.1

Q ss_pred             ccccc--CceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          345 VLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       345 ~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .||+|  +||+||++... .++.||+|++......   .+.+.+|+.+++.+ +||||+++++++...+..++|+||+.+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccC
Confidence            46666  99999999964 6899999998754332   35677888888888 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----  494 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----  494 (635)
                      |+|.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+.....    
T Consensus        84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999999875432   24889999999999999999999988   99999999999999999999999975432211    


Q ss_pred             -------CCCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----------
Q 006677          495 -------PATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ-----------  554 (635)
Q Consensus       495 -------~~~~~~~~~y~aPE~~~~~--~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~-----------  554 (635)
                             .....++..|+|||++.+.  .++.++|||||||++|||++|+.||......+.  +.....           
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence                   0111234569999999764  478999999999999999999999975432110  000000           


Q ss_pred             -----H----------------HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 006677          555 -----S----------------VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV  611 (635)
Q Consensus       555 -----~----------------~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~  611 (635)
                           .                .....+.....+..+ ...........+.+++.+||+.||++|||++|+++  .++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                 0                000000000000000 11112234567889999999999999999999987  56666


Q ss_pred             hcc
Q 006677          612 RQS  614 (635)
Q Consensus       612 ~~~  614 (635)
                      ++.
T Consensus       315 ~~~  317 (328)
T cd08226         315 KEQ  317 (328)
T ss_pred             HHh
Confidence            554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=285.23  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=190.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|...+ ++.+++|++....   .....+.+|++++.++ +|+|++++++++...  +..++|+||+
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEeccc
Confidence            3579999999999999764 7889999998653   1235688899999999 899999999999988  7899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++ +|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            75 8988886432    35899999999999999999999998   9999999999999999999999999987665432


Q ss_pred             -----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc--c
Q 006677          497 -----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA--E  564 (635)
Q Consensus       497 -----~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~--~  564 (635)
                           ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   .........    ..|..  .
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence                 2234667999998764 4578999999999999999999999975442211   011111000    00000  0


Q ss_pred             -----------cchhhhhcccChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 -----------VFDVELMRFQNIEE-EMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 -----------~~d~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                                 .....+.  ..... +...+.+++.+|++.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         232 LPWFENLKPKKPYKRRLR--EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhhhhccccccchhHHH--HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                       0000000  00011 24567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-33  Score=289.50  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=184.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC--------eeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~  410 (635)
                      .+.||+|+||.||+|... +++.||+|++......   ...+.+|+++++++ +||||+++++++....        ..+
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~   95 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFY   95 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEE
Confidence            467999999999999975 5788999988654321   33566799999999 9999999999987654        349


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||+.+ +|.+++....    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        96 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          96 LVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             EEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence            99999975 8888875422    24899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCC--------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          491 LMNVPA--------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       491 ~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      ......        ...++..|+|||.+.+. .++.++||||||+++|||++|..||.......................
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            653322        12346679999988664 478899999999999999999999976442211111110000000000


Q ss_pred             ccc-----cchh-hhhc--ccChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAE-----VFDV-ELMR--FQNIE------EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~-----~~d~-~~~~--~~~~~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...     ..+. ....  .....      .....+.+++.+|+..+|++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000     0000 0000  00000      012345688999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.7e-33  Score=288.64  Aligned_cols=263  Identities=22%  Similarity=0.365  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|... +++.+|+|++....   .....+.+|+.++.++.+|+||+++++++...+  ..++||||+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            467999999999999975 47889999886432   223457789999999978999999999986543  679999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      + ++|..++...      .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            7 5999888632      4889999999999999999999998   9999999999999999999999999987553322


Q ss_pred             ---------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHH-------HHHhh
Q 006677          497 ---------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWV-------QSVVR  558 (635)
Q Consensus       497 ---------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~-~~~~~-------~~~~~  558 (635)
                               ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... +....       .....
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                     1236778999998755 457889999999999999999999997543221100 00000       00000


Q ss_pred             hccccccch----hhhhc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhccC
Q 006677          559 EEWTAEVFD----VELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSD  615 (635)
Q Consensus       559 ~~~~~~~~d----~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~~  615 (635)
                      ......+.+    ..... ..........+.+++.+||+.+|++|||+.+++++  +..+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~  305 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS  305 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence            000000000    00000 00001123567888899999999999999999985  66654433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.8e-33  Score=287.35  Aligned_cols=260  Identities=21%  Similarity=0.262  Sum_probs=188.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.+|.|+++.||++.. +++.||+|++....   ...+.+.+|+++++++ +|+||+++++++..++..+++|||+++|
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCC
Confidence            44456666666666655 58899999987542   2345788999999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.++++....   ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+......    
T Consensus        85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999975432   24888999999999999999999998   999999999999999999999999987544221    


Q ss_pred             -------CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccc
Q 006677          496 -------ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT  562 (635)
Q Consensus       496 -------~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  562 (635)
                             ....++..|+|||++..  ..++.++|||||||++|||++|+.||.......  .+.........    ....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence                   11234567999999876  358899999999999999999999997543211  00000000000    0000


Q ss_pred             -c---c-------cchhhh---hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 006677          563 -A---E-------VFDVEL---MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR  612 (635)
Q Consensus       563 -~---~-------~~d~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~  612 (635)
                       .   .       ..+...   ............+.+++.+||+.+|++|||++|+++  .++.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence             0   0       000000   001111222346778899999999999999999998  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3e-33  Score=286.69  Aligned_cols=246  Identities=13%  Similarity=0.215  Sum_probs=171.3

Q ss_pred             hccccccCceEEEEEEecCC----CeEEEEEeecccCC---hH---------HHHHHHHHHHhhcCCCceeceeEEEEeC
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVVG---KR---------DFEQQMEIVGRVGQHPNVVPLRAYYYSK  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~---~~---------~~~~e~~~l~~l~~h~niv~l~~~~~~~  406 (635)
                      .++||+|+||+||+|...++    ..+++|+.......   +.         ....+...+..+ .|+|++++++++...
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~   95 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFK   95 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEe
Confidence            46799999999999997654    34555543222111   00         011112223344 799999999987654


Q ss_pred             C----eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          407 D----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       407 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      .    ..++++|++.. ++.+.+...     ...++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++
T Consensus        96 ~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         96 RCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             cCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence            4    34677777643 666665422     12577888999999999999999998   99999999999999999999


Q ss_pred             EeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 006677          483 ISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR  551 (635)
Q Consensus       483 i~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~  551 (635)
                      |+|||+++.....           ....+|+.|+|||++.+..++.++|||||||++|||++|+.||........  ...
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~  244 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIH  244 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHH
Confidence            9999998765321           122478889999999999999999999999999999999999986532211  111


Q ss_pred             HHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       552 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ....    +....+..... ..   ......+.+++..|++.+|++||+++++++.+
T Consensus       245 ~~~~----~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKC----DFIKRLHEGKI-KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHH----HHHHHhhhhhh-cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0000    00000000000 01   12235677888899999999999999999876

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=271.21  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             HHHhhccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEE
Q 006677          339 LRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVY  413 (635)
Q Consensus       339 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~  413 (635)
                      ...+.++||-|-.|.|-.+..+ .++.+|+|++.+.    ...++|++..-+...|||||.++++|.+    ....++||
T Consensus        63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm  138 (400)
T KOG0604|consen   63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM  138 (400)
T ss_pred             heehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence            3344678999999999988865 4677999998763    4456788877777789999999999864    34678999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTP  490 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~  490 (635)
                      |.|+||.|++.++...   ...+++.++..|+.||+.|+.|||+.+   |.||||||+|+|.+.   +..+|++|||+|+
T Consensus       139 E~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  139 ECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             ecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccc
Confidence            9999999999998643   456999999999999999999999998   999999999999964   5679999999998


Q ss_pred             CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          491 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       491 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .....   .+++-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||....-.   .+..-.+..+..+.. +.-+
T Consensus       213 ~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy-~FP~  288 (400)
T KOG0604|consen  213 ETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY-EFPE  288 (400)
T ss_pred             ccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc-cCCC
Confidence            76533   3567799999999999999999999999999999999999999765421   111111111111100 0001


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +      ..+...+...++++..++.+|++|.|..|++.+
T Consensus       289 p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  289 P------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             h------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            1      113344556677789999999999999999875

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.8e-33  Score=287.17  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..+++|.+.....    ...++.+|+++++.+ +|+|++++.+++......++||||+.
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccC
Confidence            467999999999999965 467899998864321    134577899999999 99999999999999999999999996


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                       |++.+++....    ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  170 (308)
T cd06634          99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX  170 (308)
T ss_pred             -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence             58877775322    34889999999999999999999998   99999999999999999999999999887665555


Q ss_pred             CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+      ......... ...         .
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~---------~  234 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPA---------L  234 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC-CCC---------c
Confidence            66788999999974   3567889999999999999999999986532111      111111111 000         0


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ........+.+++.+||+.+|++||++.+++++-..+.
T Consensus       235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            01123345677888999999999999999998755444

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.3e-34  Score=271.32  Aligned_cols=194  Identities=27%  Similarity=0.448  Sum_probs=166.3

Q ss_pred             hccccccCceEEEEEEecC-----CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~  413 (635)
                      ...||+|.||.||+|.-.+     +..+|+|+++.....   .....+|+..++.+ +||||+.+..++.. +...++++
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~f  107 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLF  107 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEe
Confidence            4679999999999996432     336899999865332   34578899999999 99999999999877 77889999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC----CCeEEeecCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLT  489 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~DfGla  489 (635)
                      ||.+. ||.+.++-++......++...++.|+.||+.|+.|||++-   |+||||||.|||+..+    |.+||+|||++
T Consensus       108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            99988 9999998777666678999999999999999999999998   9999999999999877    99999999999


Q ss_pred             CCCCCCCCC-------CCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          490 PLMNVPATP-------SRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       490 ~~~~~~~~~-------~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                      +.+..+-.+       ..|..|+|||.+.+.. |+.+.||||.||++.||+|-++-|.+.
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            987665432       2477899999998765 888999999999999999998888754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4e-33  Score=284.07  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=191.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|++|.||+|... ++..||+|+++....  ....+.+|+++++++ +|+||+++++++...+..++||||+++ 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~-   82 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDK-   82 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence            367999999999999975 578899999875432  245677899999999 999999999999999999999999985 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++++|||++......    
T Consensus        83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            88888764331  235899999999999999999999998   999999999999999999999999998755332    


Q ss_pred             CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-hhH---------HHHHHhhhccccc
Q 006677          496 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPR---------WVQSVVREEWTAE  564 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~  564 (635)
                      ....++..|++||++.+. .++.++|||||||++|||++|+.||...+..+... +..         |-.-.....+...
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            123457789999988654 57889999999999999999999997654321100 000         0000000000000


Q ss_pred             cchhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....... .....+.....+.+++.+|++.+|.+||+++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000 000011223457788889999999999999999853

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=280.99  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=190.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||.|++|.||+|... ++..|++|++.....   ....+.+|+++++++ +|+|++++++++.+.+..+++|||++ 
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccC-
Confidence            467999999999999865 688999999875432   235688899999999 89999999999999999999999995 


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++.......  
T Consensus        82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            689999875432   35899999999999999999999988   9999999999999999999999999987654321  


Q ss_pred             --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccccchh--
Q 006677          497 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEVFDV--  568 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~--  568 (635)
                        ...++..|+|||++.+. .++.++||||||+++|||++|+.||......+  .+....+...   ...|......+  
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence              22346789999988664 57889999999999999999999997543211  1111111000   00000000000  


Q ss_pred             --hhhc--ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 --ELMR--FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 --~~~~--~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ....  ...    .......+.+++.+|++.+|++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0000  000    01112456788889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.6e-33  Score=282.00  Aligned_cols=239  Identities=24%  Similarity=0.370  Sum_probs=189.8

Q ss_pred             ccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||.||++...+ ++.+++|++.....    ..+.+.+|++++.++ +|+||+++++.+......++|+||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            6899999999999874 88999999875432    245678889999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......    
T Consensus        80 L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          80 LASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            99999743     24899999999999999999999998   9999999999999999999999999986543321    


Q ss_pred             --------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 --------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 --------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                              ...++..|+|||......++.++||||||+++||+++|+.||......      ...........       
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~-------  218 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKI-------  218 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCc-------
Confidence                    123566799999998888999999999999999999999999754321      11111111100       


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                         ..+........+.+++.+|++.+|++|||+.++.+.|+
T Consensus       219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence               00000011356678888999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-32  Score=274.87  Aligned_cols=241  Identities=25%  Similarity=0.357  Sum_probs=195.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .+.||+|++|.||+|... +++.|++|++.....   ..+.+.+|+++++++ +|+||+++++.+...  +..++|+||+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            367999999999999976 588899999876542   356788899999999 899999999999988  8899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++++|.+++....     .+++..+..++.|++.|++|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          84 SGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999987432     5899999999999999999999988   9999999999999999999999999987665432


Q ss_pred             ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 ------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                            ...++..|+|||.+.+..++.++||||||+++++|++|..||....     +..............        
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------  222 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP--------  222 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC--------
Confidence                  2346778999999998889999999999999999999999997543     111111111100000        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..........+.+++.+|++.+|++||++.|++++
T Consensus       223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence              00111224567788889999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.6e-32  Score=282.36  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=192.8

Q ss_pred             ChHHHHHHhhccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe
Q 006677          334 DLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE  408 (635)
Q Consensus       334 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~  408 (635)
                      +.+++. ...+.||+|+||+||+|... ++..|++|++......    ...+.+|+++++++ +|+|++++++++.+.+.
T Consensus        18 ~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          18 DPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             CHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence            444442 23466999999999999864 5788999998654221    24577899999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .++||||+. |++.+++...    ...+++.++..++.|++.|++|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCC
Confidence            999999996 5787777532    234899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          489 TPLMNVPATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       489 a~~~~~~~~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      +..........++..|+|||++.   ...++.++|||||||++|||++|..||......      ............. .
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~~-~  240 (313)
T cd06633         168 ASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDSPT-L  240 (313)
T ss_pred             CcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCCC-C
Confidence            87665555556788899999984   456888999999999999999999999754321      1111111111100 0


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .      .   ......+.+++.+|++.+|++||++.+++++
T Consensus       241 ~------~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 Q------S---NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C------c---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0      0   1112346678889999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=276.00  Aligned_cols=259  Identities=22%  Similarity=0.331  Sum_probs=195.5

Q ss_pred             CCChHHHHHHhhccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe
Q 006677          332 NFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE  408 (635)
Q Consensus       332 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~  408 (635)
                      .|+-++|+.  ...||.|+||+|+|-.++ .|+..|||++.....  +.+++..|.+...+-.+.||||+++|.+..+..
T Consensus        60 ~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd  137 (361)
T KOG1006|consen   60 TFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD  137 (361)
T ss_pred             ccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence            444444432  256999999999999875 588899999987644  356788888888877799999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .|+.||.|+- +|..+-+.-....+..+++.-.-.|......||.||.+..  +|||||+||+|||++..|.+|++|||+
T Consensus       138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence            9999999965 6655443222222345888888888888999999998765  699999999999999999999999999


Q ss_pred             CCCCCCCC---CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          489 TPLMNVPA---TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       489 a~~~~~~~---~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      +..+..+-   ...|-..|||||.+..  ..|+.+|||||+|++|||+.||..||...+     ++.+.+..++......
T Consensus       215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPI  289 (361)
T ss_pred             hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCe
Confidence            87765432   2235567999999953  348999999999999999999999997543     2333333333332222


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      -..+..      .-+....+.+++-.|+..|-..||...++.+
T Consensus       290 l~~~~~------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  290 LLFDKE------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ecCccc------ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            112211      1234456777788999999999999999876

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4e-33  Score=291.29  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=188.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCCh---------------HHHHHHHHHHHhhcCCCceeceeEEEEeC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---------------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~l~~~~~~~  406 (635)
                      .+.||+|+||+||+|... +++.||+|+++......               ..+.+|++++.++ +|+||+++++++...
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG   92 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence            567999999999999965 58899999986543221               2467899999999 999999999999999


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          407 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       407 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +..++||||+. |+|.+++...     ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence            99999999997 5999988632     34889999999999999999999998   999999999999999999999999


Q ss_pred             CCCCCCCCC------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 006677          487 GLTPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV  547 (635)
Q Consensus       487 Gla~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~  547 (635)
                      |++......                  ....++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+. 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-  242 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-  242 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            998655411                  011246679999998764 468999999999999999999999976543211 


Q ss_pred             ChhHHHHHHhh----hccccccchhhh-----hcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          548 DLPRWVQSVVR----EEWTAEVFDVEL-----MRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       548 ~~~~~~~~~~~----~~~~~~~~d~~~-----~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ...+.....    ..|.........     .....    .......+.+++.+|++.+|++||+++|++.+
T Consensus       243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence              111111110    001100000000     00000    01123457788899999999999999999873

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.3e-33  Score=288.56  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|... ++..||+|+++.....   ...+.+|+.+++++ +|+|++++++++...  +..++||||+
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecC
Confidence            467999999999999975 4788999998754322   23466799999999 999999999998765  4679999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      .+ +|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        91 ~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          91 EQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             CC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            75 8888886432    34899999999999999999999998   9999999999999999999999999987664332


Q ss_pred             ----CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccc-----
Q 006677          497 ----TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTA-----  563 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-----  563 (635)
                          ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.   ..........   .+..     
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhhcc
Confidence                1224667999999865 4578999999999999999999999975432211   0001110000   0000     


Q ss_pred             ---ccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 ---EVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ---~~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ..+..........    ......+.+++.+|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0000000000000    1123456778889999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.6e-33  Score=292.51  Aligned_cols=260  Identities=20%  Similarity=0.331  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... ++..|++|++.....   ..+.+.+|+.++.++ +||||+++++++..    ....++|||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e   88 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMD   88 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEe
Confidence            457999999999999965 588999999875422   245677899999999 89999999988763    346799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+. |+|.+++...     ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        89 ~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          89 LME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             hhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            996 5899988632     34899999999999999999999998   99999999999999999999999999865432


Q ss_pred             CC--------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------
Q 006677          495 PA--------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------  559 (635)
Q Consensus       495 ~~--------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  559 (635)
                      ..        ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ..........      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~  236 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVL  236 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhh
Confidence            21        2246778999999865 4588999999999999999999999975432111   1111110000      


Q ss_pred             -----ccccccchhhh-hcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhccC
Q 006677          560 -----EWTAEVFDVEL-MRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSD  615 (635)
Q Consensus       560 -----~~~~~~~d~~~-~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~~  615 (635)
                           .......+... .....    .......+.+++.+|++.+|++||++++++.+  ++......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                 00000000000 00000    01224567888889999999999999999984  44444333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-33  Score=284.42  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|++|.||+|... +++.+++|++......   ...+.+|+++++++ +|+||+++++++...+..++|+||+++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCC
Confidence            357999999999999975 5788999998765332   45788899999999 899999999999999999999999975


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                       +|.+++....    ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||.+.......  
T Consensus        83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence             8888886432    35899999999999999999999998   9999999999999999999999999987664432  


Q ss_pred             --CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccccch---
Q 006677          497 --TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEVFD---  567 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d---  567 (635)
                        ...++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+..+.  + .-....+..   .......+   
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--L-FKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHcCCCchHhcccchhhhh
Confidence              23356679999998776 789999999999999999999999975432111  0 000000000   00000000   


Q ss_pred             ---hhhh--c----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 ---VELM--R----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ---~~~~--~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ....  .    ....+.....+.+++.+||+.||.+||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               0000  0    00112234567889999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=269.24  Aligned_cols=237  Identities=23%  Similarity=0.341  Sum_probs=189.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHH---HHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRD---FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|.||.|.+++-+ .++.+|+|++++... .+.+   -..|-.+++.. +||.+..+-..|+..+..+.||||..
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEcc
Confidence            367999999999999965 478899999987743 3333   34467788888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----  493 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----  493 (635)
                      ||.|+-+|.+.     ..++++.....-..|..||.|||+.+   ||.||||.+|.|+|.+|++||+|||+++.--    
T Consensus       252 GGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  252 GGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             CceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99999988753     34888888888999999999999988   9999999999999999999999999986532    


Q ss_pred             CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       494 ~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      ...+.+|||.|+|||++....|+.++|+|.+||++|||+.|+.||...+.+....++      +         -..+.-.
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l---------~ed~kFP  388 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------L---------MEDLKFP  388 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------H---------hhhccCC
Confidence            234678999999999999999999999999999999999999999865433322211      1         1111112


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~  606 (635)
                      .....+++.++.   ..+..||.+|.-     +.||.+
T Consensus       389 r~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  389 RTLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ccCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHh
Confidence            233445555444   778899999953     666655

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-32  Score=277.36  Aligned_cols=256  Identities=24%  Similarity=0.342  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhc--CCCceeceeEEEEeCCe-----eEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDE-----KLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~-----~~l  411 (635)
                      .+.||+|+||.||+|..+. ++.+|+|+++.....   ...+.+|++++.++.  +|+|++++++++...+.     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            3579999999999999864 789999999754322   235667887777764  59999999999988776     899


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      +|||+.+ +|.+++.....   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++..
T Consensus        84 ~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          84 VFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             Eehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999975 89888865332   24899999999999999999999998   99999999999999999999999999877


Q ss_pred             CCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcccccc
Q 006677          492 MNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAEV  565 (635)
Q Consensus       492 ~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  565 (635)
                      .....   ...++..|+|||++.+..++.++|||||||++|||++|..||......+  .+.++.....   ...+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCCc
Confidence            64332   2235677999999999899999999999999999999999997544221  1111111110   00010000


Q ss_pred             ------chhhhhc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 ------FDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ------~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            +......  ..........+.+++.+||+.||++||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                  0000000  00112234566788899999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=319.91  Aligned_cols=239  Identities=25%  Similarity=0.368  Sum_probs=188.5

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecc---cCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEV---VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.+||.|.||.||.|.. ++|...|+|-++..   ...-+...+|+.++..+ +|||+|+++|+-.+++..+|.||||.+
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhcc
Confidence            56899999999999985 45777888877543   22345688899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+.+...+     -.++.....+..|++.|++|||++|   ||||||||.||+++.+|.+|++|||.|.......  
T Consensus      1319 GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             CcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            99999997433     2566667778899999999999999   9999999999999999999999999997765442  


Q ss_pred             ------CCCCCCcccCcccccCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH-HHHhhhccccccc
Q 006677          497 ------TPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV-QSVVREEWTAEVF  566 (635)
Q Consensus       497 ------~~~~~~~y~aPE~~~~~---~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  566 (635)
                            ...||+.|||||++.+.   ....+.||||+|||+.||+||+.||...+.+       |. ...+..+-     
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh----- 1458 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGH----- 1458 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccC-----
Confidence                  23589999999999754   3667899999999999999999999854321       11 11111111     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ..+.++....+-.+++.+|+..||+.|+++.|++++
T Consensus      1459 -----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 011112223334556669999999999999877664

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=291.12  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-----eeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~e  414 (635)
                      .+.||+|+||.||+|... +++.||+|++....  .....+.+|+.++.++ +|+||+++++++....     ..++|+|
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEeh
Confidence            467999999999999864 57899999986432  2245677899999999 8999999998876543     5799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+.+ +|.+.+..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          89 LMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             hccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            9975 88887753      24899999999999999999999998   99999999999999999999999999876533


Q ss_pred             CC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc---
Q 006677          495 PA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA---  563 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  563 (635)
                      ..       ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+...   ...............   
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence            21       1245778999998754 568899999999999999999999997543211   111111111100000   


Q ss_pred             ccchhh-------hhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          564 EVFDVE-------LMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       564 ~~~d~~-------~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      .+.+..       .....      ........+.+++.+||+.+|++|||+.|++++  ++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000       00000      001123457789999999999999999999996  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=293.56  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=197.6

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~  413 (635)
                      .+.||+|+||.||+|+. +.|+.||||.+.....  ..+...+|+++++++ +|+|||+++++-+...      ...+||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEE
Confidence            45699999999999995 4689999999987533  456788999999999 7999999999876544      567999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc--CCC--CeEEeecCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDL--DGCISDFGLT  489 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~ki~DfGla  489 (635)
                      |||.+|||+..++...+  ...+++.+.+.++.+++.||.|||+++   |+||||||.||++-  .+|  .-||+|||.|
T Consensus        97 EyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999986654  456999999999999999999999998   99999999999983  334  4699999999


Q ss_pred             CCCCCCC---CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          490 PLMNVPA---TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       490 ~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      +......   ...||..|.+||.+.. +.|+..+|.|||||++||++||..||..........-.-|..  ........+
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~--~tkkp~~v~  249 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI--ITKKPSGVA  249 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh--hccCCCcee
Confidence            9887665   3458999999999984 788999999999999999999999997433221110011111  111111000


Q ss_pred             ------------chhhhhcc-cChHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHhhccC
Q 006677          566 ------------FDVELMRF-QNIEEEMVQMLQIGMACVAKVPDMRP--NMDEVVRMIEEVRQSD  615 (635)
Q Consensus       566 ------------~d~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evl~~L~~~~~~~  615 (635)
                                  +...+... .-.......+.+....++..+|++|.  ...+....+..|.+..
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                        00011000 01123334455566677788888888  7777777777776544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-33  Score=291.25  Aligned_cols=259  Identities=19%  Similarity=0.309  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~  413 (635)
                      .+.||+|+||+||+|... ++..||+|.+....   .....+.+|+.++..+ +|+||+++++++...     ...++|+
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEE
Confidence            457999999999999964 57899999987532   2345677899999998 899999999987644     3479999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+. ++|.+++...     ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        89 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          89 ELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             eCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            9996 6898888632     34899999999999999999999998   9999999999999999999999999987654


Q ss_pred             CC----CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccc
Q 006677          494 VP----ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE---EWTAEV  565 (635)
Q Consensus       494 ~~----~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  565 (635)
                      ..    ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+..+.   ..........   .....+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhc
Confidence            33    12346778999998865 4688999999999999999999999975431110   0000000000   000000


Q ss_pred             chhh-------hhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhcc
Q 006677          566 FDVE-------LMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS  614 (635)
Q Consensus       566 ~d~~-------~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~  614 (635)
                      .+..       ....      .........+.+++.+|++.+|++|||++|++++  ++.+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            0000       0000      0001233556788899999999999999999996  7665433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-33  Score=288.46  Aligned_cols=238  Identities=21%  Similarity=0.357  Sum_probs=195.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|.|+.|.+|.+. .+..||+|.+.+....   ...+.+|++++..+ +|||||+++.+.......|+||||+.+
T Consensus        61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccC
Confidence            467999999999999964 5889999999876543   23478899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |.+++++.++..     ..+..+..++.|+..|++|||+++   |+|||||++||||+.+.++||+|||++.++...   
T Consensus       140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccc
Confidence            999999986542     445788889999999999999998   999999999999999999999999999887653   


Q ss_pred             CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      .+.+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++.+-.+...      +.+...         +....
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~gk---------~rIp~  276 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLRGK---------YRIPF  276 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hheeee---------ecccc
Confidence            46789999999999999887 578999999999999999999999765443221      111111         11111


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....+.   -+++++++-.+|.+|++++++.+.
T Consensus       277 ~ms~dc---e~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  277 YMSCDC---EDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeechh---HHHHHHhhccCccccCCHHHhhhh
Confidence            122223   345568899999999999999874

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.7e-33  Score=283.24  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=185.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.|++|++.....   ..+.+.+|+++++++ +|+||+++++++...+..++||||++ 
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~-   84 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLD-   84 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEeccc-
Confidence            357999999999999975 578899998865432   235678899999999 99999999999999999999999996 


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~~--  495 (635)
                      ++|.+++....   ...+++..+..++.||+.||+|||+++   ++||||+|+||+++. ++.+||+|||++......  
T Consensus        85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            48887775432   223678888899999999999999998   999999999999985 567999999998754322  


Q ss_pred             --CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc--ccc
Q 006677          496 --ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA--EVF  566 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~  566 (635)
                        ....++..|+|||++.+ ..++.++|||||||++|+|+||+.||......+.  +.... ....    ..|..  ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGVTSLP  235 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhccccccch
Confidence              12345678999998866 4578999999999999999999999975432110  00000 0000    00000  000


Q ss_pred             hhh--hhc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 DVE--LMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 d~~--~~~--~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +..  ...  ..    ........+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000  000  00    00112234677888999999999999999987

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-32  Score=279.71  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||.||++...    ++..||||.++....     ..+.+.+|++++.++.+|+||+++.+.+..+...++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            467999999999999843    467899999875321     23567889999999977999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...     ..+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999998642     24889999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCC-----CCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPA-----TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~-----~~~~~~~y~aPE~~~~~~--~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...     ...++..|+|||.+.+..  ++.++||||||+++|||++|..||......  .......+.......     
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~-----  229 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSKP-----  229 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccCC-----
Confidence            322     123677899999987665  788999999999999999999999643211  111111222111110     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                             .........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       230 -------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         230 -------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                   00011223456778899999999999998887776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.6e-33  Score=291.32  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=187.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||+|++.....   ....+.+|++++.++ +|+||+++++++...      ...++|
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv   99 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLV   99 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEE
Confidence            467999999999999965 588999999865422   234677899999999 999999999998644      346999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+.+ +|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850         100 MELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             EeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            999964 88887752       1788899999999999999999998   999999999999999999999999999765


Q ss_pred             CCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHH------
Q 006677          493 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQ------  554 (635)
Q Consensus       493 ~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~---------~~~~~~~------  554 (635)
                      ....   ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..         ....+..      
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            4332   234677899999999999999999999999999999999999754321100         0000000      


Q ss_pred             -HHhhhccc--cccchhhhhc-------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 -SVVREEWT--AEVFDVELMR-------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 -~~~~~~~~--~~~~d~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ........  ...+......       ..........+.+++.+|++.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000000  0000000000       00011234456788899999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-32  Score=279.07  Aligned_cols=243  Identities=22%  Similarity=0.346  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEe----cCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||.||++..    .++..||+|++.....     ..+.+.+|+.++.++.+|+||+.+++++..+...++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            46799999999999986    3678899999875321     24567889999999977999999999999988999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++...     ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999998642     34888999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCC-----CCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPA-----TPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~-----~~~~~~~y~aPE~~~~~--~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...     ...++..|+|||.+...  .++.++||||||+++|+|++|..||......  .....+.........     
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~-----  229 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP-----  229 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-----
Confidence            322     23367789999998753  4678999999999999999999999743221  111222221111110     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                             +........+.+++.+|++.+|++||     ++++++.+
T Consensus       230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                   00011223556788899999999997     66666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-33  Score=290.67  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=191.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||+|... ++..||+|++.....   ....+.+|+++++++ +|+||+++++++....      ..++|
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEE
Confidence            467999999999999964 588999999875422   234678899999999 9999999999987543      46899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +||+.. +|..+..       ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            999964 7766652       23889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccccccch
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWTAEVFD  567 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d  567 (635)
                      .... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.   .........   ........+
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhcc
Confidence            4322 2345678999999876 4688999999999999999999999975432110   000000000   000000000


Q ss_pred             -------hhhhccc--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhccCCCCC
Q 006677          568 -------VELMRFQ--N----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENR  619 (635)
Q Consensus       568 -------~~~~~~~--~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~~~~~~  619 (635)
                             .......  .    .+.....+.+++.+|++.||++||+++|++.+  ++.+++....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~  311 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE  311 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCC
Confidence                   0000000  0    01122356788889999999999999999975  888776544443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=279.45  Aligned_cols=258  Identities=22%  Similarity=0.388  Sum_probs=190.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|...+ ++.|++|++......  .....+|+..+.++.+|+|++++++++..++..++||||+ +|
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            4679999999999999764 678999998765332  3345568888999944999999999999999999999999 78


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....   ...+++..++.++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++.......   
T Consensus        83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence            9999887543   235899999999999999999999998   9999999999999999999999999987664322   


Q ss_pred             CCCCCCcccCccccc-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC-Ch---------hHHHHHHhhhcccccc
Q 006677          497 TPSRSAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-DL---------PRWVQSVVREEWTAEV  565 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~-~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~  565 (635)
                      ...++..|+|||++. ...++.++|+||||+++|||++|+.||......+.. ..         ..|.............
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            234577899999885 445789999999999999999999999755322110 00         0011110000000000


Q ss_pred             chhhhhc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 FDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +......  ..........+.+++.+||+.+|++|||++|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000  00001113567888999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.1e-32  Score=271.92  Aligned_cols=243  Identities=20%  Similarity=0.374  Sum_probs=196.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++... ++..+++|++.....   ..+.+.+|+++++.+ +|+|++++.+.+...+..++|+||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCC
Confidence            357999999999999975 578899999876533   345688899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++..... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            999999975431 1245899999999999999999999998   9999999999999999999999999987654432  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...+++.|+|||...+..++.++||||+|+++++|++|+.||.....      ............. .        . 
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~--------~-  223 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKGQYP-P--------I-  223 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcCCCC-C--------C-
Confidence              23467789999999888899999999999999999999999975431      1222222111100 0        0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .......+.+++.+||..+|++||++.|++++
T Consensus       224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             01223456778889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-32  Score=270.99  Aligned_cols=238  Identities=24%  Similarity=0.444  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|++|.||++... +++.|++|.+.....   ....+.+|++++.++ +|+|++++++++......++||||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAEN   83 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCC
Confidence            467999999999999865 577899999977653   345688899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-  497 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-  497 (635)
                      ++|.+++...     ..+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999998643     34899999999999999999999998   99999999999999999999999999876654332 


Q ss_pred             ---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 ---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ---~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                         ..++..|+|||...+..++.++||||+|+++|+|++|..||.....     .... .......  ...+        
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~--~~~~--------  219 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAAL-FRIVQDD--HPPL--------  219 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHH-HHHhccC--CCCC--------
Confidence               3467789999999888889999999999999999999999975431     1111 1111000  0000        


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       .......+.+++.+|+..+|++||++.|++.
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             0112345667888999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=273.42  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-----ceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-----NVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      ..++|+|.||.|..+.... +..||+|+++....-.+...-|+++++++..+.     -+|.+.++|+-.++.++|+|.+
T Consensus        94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell  173 (415)
T KOG0671|consen   94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL  173 (415)
T ss_pred             hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence            4579999999999998654 588999999876655667778999999995433     3788888899999999999987


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-------------------
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------------------  477 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------------------  477 (635)
                       |-++.+++..+.   ..+++..++..|+.|++.+++|||+.+   ++|-||||+|||+.+                   
T Consensus       174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence             459999998654   446899999999999999999999998   999999999999942                   


Q ss_pred             -CCCeEEeecCCCCCCCCCCC-CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC-------
Q 006677          478 -DLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-------  548 (635)
Q Consensus       478 -~~~~ki~DfGla~~~~~~~~-~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~-------  548 (635)
                       +..++|+|||.|++...... -..|..|+|||++.+-..+.++||||+||||.|+.||..-|+.....|...       
T Consensus       247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG  326 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG  326 (415)
T ss_pred             CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence             34588999999988766553 356888999999999999999999999999999999999998765333111       


Q ss_pred             -hhHH------HHHHhhhc---cccccchh-----------hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          549 -LPRW------VQSVVREE---WTAEVFDV-----------ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       549 -~~~~------~~~~~~~~---~~~~~~d~-----------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ++..      .++....+   |.....+.           .-......+++..+|++|+++++..||.+|+|+.|++.+
T Consensus       327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence             1111      01111110   00000000           000112235667789999999999999999999999863

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.5e-32  Score=272.52  Aligned_cols=243  Identities=24%  Similarity=0.376  Sum_probs=195.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++... ++..+++|++......   ...+.+|+++++++ +|+||+++.+++......++|+||+++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCC
Confidence            467999999999999855 5778999998764322   34677889999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++..... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+|++|||++.......  
T Consensus        84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            999999865322 2345899999999999999999999998   9999999999999999999999999987664432  


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|+.||...+..      .......... ..          ...
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~----------~~~  222 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQRGK-YP----------PIP  222 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC-CC----------CCc
Confidence            234677899999999988999999999999999999999999754321      1111111111 00          011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+|++.+|++||++.|++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            2334567888899999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-32  Score=281.25  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=187.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..||+|++.....   ..+.+.+|++++.++ +||||+++.+++.. .+..++|+||+ 
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            467999999999999855 688899998864322   245678899999999 89999999999875 45788999998 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.++++.      ..+++.....++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||.+....... 
T Consensus        93 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~  163 (328)
T cd07856          93 GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT  163 (328)
T ss_pred             ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence            5689888863      23788888899999999999999998   9999999999999999999999999987654332 


Q ss_pred             CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHhhhccccccc
Q 006677          497 TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---------DLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|+.||.........         ...++..............
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            2345778999998866 56899999999999999999999999754321100         0011111111110000000


Q ss_pred             hhhhhcccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...........    .....+.+++.+|++.+|++||+++|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000001    123567788889999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-32  Score=287.70  Aligned_cols=259  Identities=20%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-----eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-----EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~  413 (635)
                      .+.||+|+||.||+|...+ +..+++|++.....   ..+.+.+|+++++.+ +|+||+++.+++...+     ..++||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~   83 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVT   83 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEe
Confidence            4679999999999999754 78899999876532   346788899999999 8999999999988775     789999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++ +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++....
T Consensus        84 e~~~~-~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          84 ELMET-DLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             cchhh-hHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99984 898888642     25899999999999999999999998   9999999999999999999999999987664


Q ss_pred             CCC-------CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc----
Q 006677          494 VPA-------TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW----  561 (635)
Q Consensus       494 ~~~-------~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  561 (635)
                      ...       ...++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..   ...........    
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence            432       22356779999999887 7899999999999999999999999765432110   00000000000    


Q ss_pred             -------ccccchhhhhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhccC
Q 006677          562 -------TAEVFDVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSD  615 (635)
Q Consensus       562 -------~~~~~d~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~~  615 (635)
                             ....... .....      ........+.+++.+||+.+|++||++++++++  ++.+....
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~  299 (330)
T cd07834         232 KFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE  299 (330)
T ss_pred             hhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence                   0000000 00000      001123457788889999999999999999994  77766543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2e-32  Score=281.61  Aligned_cols=253  Identities=22%  Similarity=0.284  Sum_probs=186.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC----------e
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----------E  408 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----------~  408 (635)
                      .+.||+|+||.||+|... +++.|++|+++....   ....+.+|+++++++ +||||+++++++....          .
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~   90 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGA   90 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCc
Confidence            467999999999999976 478899999875422   235677899999999 8999999999987654          7


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .++|+||+++ ++...+...    ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+
T Consensus        91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence            8999999986 777776543    234899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCC-----CCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc-
Q 006677          489 TPLMNVPAT-----PSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW-  561 (635)
Q Consensus       489 a~~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  561 (635)
                      +........     ...+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+   ....+........ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~  239 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRLCGSPCP  239 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence            876543221     124567999998864 457889999999999999999999997543211   1111111111000 


Q ss_pred             --ccccc--------hhhhhc----ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 --TAEVF--------DVELMR----FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 --~~~~~--------d~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ...+.        +.....    ..........+.+++.+||+.+|++||++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              00000        000000    00001113457788889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5e-33  Score=306.13  Aligned_cols=246  Identities=22%  Similarity=0.363  Sum_probs=179.4

Q ss_pred             cCCChHHHHHHhhccccccCceEEEEEEec-CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeC-
Q 006677          331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-  406 (635)
Q Consensus       331 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-  406 (635)
                      +.-+++++     ++||+||||.||+++.+ ||+.||||++....  .....+.+|+..++++ +|||||+++..|.+. 
T Consensus       477 Y~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~  550 (1351)
T KOG1035|consen  477 YLNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVEST  550 (1351)
T ss_pred             HhhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccC
Confidence            44466666     57999999999999965 79999999998764  2235678899999999 999999987654100 


Q ss_pred             --------------------------------------------------------------------------------
Q 006677          407 --------------------------------------------------------------------------------  406 (635)
Q Consensus       407 --------------------------------------------------------------------------------  406 (635)
                                                                                                      
T Consensus       551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~  630 (1351)
T KOG1035|consen  551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL  630 (1351)
T ss_pred             CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHH
Q 006677          407 --------------------------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT  448 (635)
Q Consensus       407 --------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i  448 (635)
                                                            ...||-||||+...+.++++.+.-.    -.....++++.+|
T Consensus       631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI  706 (1351)
T KOG1035|consen  631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI  706 (1351)
T ss_pred             ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence                                                  0136778888887777777644310    1356778999999


Q ss_pred             HHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----------------------CCCCCCCCCcccC
Q 006677          449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----------------------VPATPSRSAGYRA  506 (635)
Q Consensus       449 a~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----------------------~~~~~~~~~~y~a  506 (635)
                      +.||+|+|++|   ||||||||.||+++++..|||+|||+|+...                      ......||.-|+|
T Consensus       707 lEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  707 LEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999999   9999999999999999999999999997621                      0012346777999


Q ss_pred             cccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc-cChHHHHHH
Q 006677          507 PEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF-QNIEEEMVQ  582 (635)
Q Consensus       507 PE~~~~~~---~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~  582 (635)
                      ||++.+..   |+.|+|+||+|||++||+.   ||....  |...   .+.... ..        .+... ....+.+..
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~---iL~~LR-~g--------~iP~~~~f~~~~~~~  846 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS---ILTNLR-KG--------SIPEPADFFDPEHPE  846 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHH---HHHhcc-cC--------CCCCCcccccccchH
Confidence            99997654   9999999999999999996   454321  1111   111111 11        11100 011233344


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 006677          583 MLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       583 l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      -.++++++++.||.+||||.|++.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            456778999999999999999986

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-32  Score=268.95  Aligned_cols=231  Identities=25%  Similarity=0.340  Sum_probs=187.5

Q ss_pred             ccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          346 LGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ||+|+||.||++... +++.+++|.+.....    ....+..|+++++++ +|+||+++++.+..++..++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999976 478899999876533    234788899999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++...     ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++......    .
T Consensus        80 L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (250)
T cd05123          80 LFSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN  151 (250)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence            99999743     24899999999999999999999988   999999999999999999999999998765432    2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...++..|+|||...+...+.++|+||||+++|||++|..||.....      ....+.......            ...
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~~  213 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL------------RFP  213 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC------------CCC
Confidence            23467789999999888889999999999999999999999975432      111222221110            000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDE  603 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~e  603 (635)
                      ......+.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            111345677888999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.8e-32  Score=282.77  Aligned_cols=255  Identities=21%  Similarity=0.275  Sum_probs=184.5

Q ss_pred             hccccccCceEEEEEEecC---CCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC----CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK----DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~~~~lv  412 (635)
                      .+.||+|+||.||++....   +..||+|++.....   ..+.+.+|+++++++.+|+||+++++.+...    ...+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            4679999999999999653   67899999875322   2456788999999996799999999875432    356788


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +||+. ++|.+++...     ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            88886 5899888632     34899999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCC--------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHH
Q 006677          493 NVPA--------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQ  554 (635)
Q Consensus       493 ~~~~--------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~~~~  554 (635)
                      ....        ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+...         ...+..
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            3211        2246778999998765 468999999999999999999999997543211000         000111


Q ss_pred             HHhhhccccccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          555 SVVREEWTAEVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ....+.................    ......+.+++.+|++.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1100000000000000000000    011346778888999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.8e-31  Score=269.05  Aligned_cols=239  Identities=18%  Similarity=0.259  Sum_probs=185.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc------CChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||.||+|... ++..|++|.+....      .....+.+|+++++++ +|+||+++++++.+.  ...++|+
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEE
Confidence            467999999999999964 47889999875321      1134678899999999 899999999998764  3578999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++...     ..+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++...
T Consensus        86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            999999999998632     23788999999999999999999998   9999999999999999999999999987643


Q ss_pred             CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..       ....++..|+|||++.+..++.++|||||||++|||++|+.||......      .-........... . 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-~-  229 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTKP-M-  229 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCCC-C-
Confidence            21       1224677899999999888999999999999999999999999743211      1111111111100 0 


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                              ........+.+++.+|++ +|..||++.+++.+
T Consensus       230 --------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         230 --------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             --------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                    111223456667779999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.8e-32  Score=284.98  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=184.4

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||.||+|.. .+++.||+|+++....   ..+.+.+|++++.++ +|+||+++++++...      ...+++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEE
Confidence            35799999999999985 4678899999875432   235677899999999 999999999988643      346788


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ++++ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus       101 ~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         101 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence            8876 7799888753      23899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccch-
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV--REEWTAEVFD-  567 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d-  567 (635)
                      .... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||........  +........  .......+.+ 
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHhhcccH
Confidence            4332 2346778999999866 4678899999999999999999999965432110  000000000  0000000000 


Q ss_pred             ------hhhhccc--ChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 ------VELMRFQ--NIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ------~~~~~~~--~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            ..+...+  ...    .....+.+++.+|++.+|++||++.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                  0000000  000    112346788889999999999999999984

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=2.6e-32  Score=281.85  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=183.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--------eeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--------EKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~  410 (635)
                      .+.||+|+||.||+|... +++.+++|++.....   ....+.+|+++++++ +|+||+++++++....        ..+
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~   91 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVY   91 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEE
Confidence            467999999999999965 578899999865432   134677899999999 9999999998875433        468


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +|+||+.. ++...+...    ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++.
T Consensus        92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence            99999975 777776542    234899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCCCC---------------CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          491 LMNVPAT---------------PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       491 ~~~~~~~---------------~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                      .......               ..++..|+|||.+.+. .++.++|||||||++|||++|+.||...+......  . ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~--~-~~  240 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH--L-IF  240 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HH
Confidence            5432211               1235679999987654 57899999999999999999999997543211100  0 00


Q ss_pred             HHhh----hccc-----cc----cchhhhhc--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 SVVR----EEWT-----AE----VFDVELMR--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 ~~~~----~~~~-----~~----~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....    ..+.     ..    ........  ..........+.+++.+|++.+|++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000    0000     00    00000000  00001112457788899999999999999998763

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=5.1e-32  Score=275.52  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=191.7

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      +.||+|+||.||+|...+ ++.+++|++....   ...+.+..|+++++++ +|+|++++++++...+..++|+||++ +
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            569999999999999764 8899999987653   2245677899999999 89999999999999999999999998 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||++.......   
T Consensus        83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9999997532    34899999999999999999999998   9999999999999999999999999987664432   


Q ss_pred             -CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccc--ccc--c
Q 006677          497 -TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWT--AEV--F  566 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~--~  566 (635)
                       ....+..|+|||.+.+. .++.++|||||||++|||++|..||......+.   .........    ..|.  ...  .
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccccc
Confidence             12245679999998776 789999999999999999999999976432111   011111000    0000  000  0


Q ss_pred             hhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +......      .........+.+++.+|++.+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000      0001123467888999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=1.6e-32  Score=278.73  Aligned_cols=239  Identities=21%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..|++|++....    ...+.+.+|.+++.++.+|+||+++++++..++..++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            357999999999999975 58899999986532    1245678889999999349999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||++........
T Consensus        86 ~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          86 NGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999743     25999999999999999999999998   99999999999999999999999999875533221


Q ss_pred             ------------------------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 006677          498 ------------------------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV  553 (635)
Q Consensus       498 ------------------------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  553 (635)
                                              ..++..|+|||......++.++||||||++++++++|..||.......      -.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~  231 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TF  231 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HH
Confidence                                    124667999999988889999999999999999999999998553111      01


Q ss_pred             HHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 006677          554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM----DEVVRM  607 (635)
Q Consensus       554 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~~  607 (635)
                      +......+            .........+.+++.+||+.+|++||++    +|++++
T Consensus       232 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 QKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11111111            0111123456788889999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=7.4e-32  Score=271.12  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=187.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||++.... +..+++|.++....      ...++.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   83 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY   83 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence            4679999999999998654 34455666553221      223566788889998 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++++|.+++..... ....+++..++.++.|++.|+.|||+.+   ++|+||+|+||++++ +.++|+|||++......
T Consensus        84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            999999998865332 2345899999999999999999999998   999999999999975 56999999998765332


Q ss_pred             C----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .    ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....      ............ ..        
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~--------  223 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-TP--------  223 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-CC--------
Confidence            2    2346778999999988888999999999999999999999996422      111122111110 00        


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .........+.+++.+||+.+|++||++.|++++
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0112333567788889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=285.05  Aligned_cols=235  Identities=22%  Similarity=0.314  Sum_probs=188.4

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      ..+|.|+|+.|-.+... +++..+||++.+.   ..+-.+|+.++.+..+||||+++.+.+.+..+.|+|||++.++-+.
T Consensus       328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell  404 (612)
T KOG0603|consen  328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL  404 (612)
T ss_pred             cccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence            45999999999888854 5778899998765   3445667788888889999999999999999999999999999888


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE-cCCCCeEEeecCCCCCCCCC-CCCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVP-ATPSR  500 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~DfGla~~~~~~-~~~~~  500 (635)
                      +.+...+      .....+..|+.+|+.|+.|||++|   ||||||||+|||+ ++.++++|+|||.++..... .++.-
T Consensus       405 ~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~  475 (612)
T KOG0603|consen  405 RRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL  475 (612)
T ss_pred             HHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence            8776432      233677789999999999999998   9999999999999 68999999999999887655 34456


Q ss_pred             CCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHH
Q 006677          501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM  580 (635)
Q Consensus       501 ~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  580 (635)
                      |..|.|||++....|++++||||||++||+|++|+.||.....+  .+   ....+......           ..+++.+
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e---i~~~i~~~~~s-----------~~vS~~A  539 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE---IHTRIQMPKFS-----------ECVSDEA  539 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH---HHHhhcCCccc-----------cccCHHH
Confidence            78899999999999999999999999999999999999865433  11   11111111110           1223444


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          581 VQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       581 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      +   +|+..|++.||.+||+|.|+..+=.
T Consensus       540 K---dLl~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  540 K---DLLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             H---HHHHHhccCChhhCcChhhhccCcc
Confidence            4   5556999999999999999988543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.6e-32  Score=282.88  Aligned_cols=257  Identities=21%  Similarity=0.340  Sum_probs=191.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||++... ++..||+|++.....   ....+.+|+++++++ +|+||+++++++..+.      ..++|
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEE
Confidence            467999999999999854 588899999865322   234677899999999 9999999999987553      35899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||++...
T Consensus        99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence            9998 6799888753      24899999999999999999999998   999999999999999999999999998766


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------cccc
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE------WTAE  564 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~  564 (635)
                      .... ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......      ..........      +...
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL------DQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHh
Confidence            4432 2346778999999876 45889999999999999999999999754321      1111111000      0000


Q ss_pred             cch-------hhhhccc--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhccCC
Q 006677          565 VFD-------VELMRFQ--N----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSDS  616 (635)
Q Consensus       565 ~~d-------~~~~~~~--~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~~~~  616 (635)
                      +..       ..+....  .    .......+.+++.+|++.||++|||+.++++  .++.+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence            000       0000000  0    0112234678889999999999999999995  6666654433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.3e-32  Score=287.98  Aligned_cols=243  Identities=24%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe-----CCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-----KDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~e~~  416 (635)
                      .+.||.|.+|.||+++. ++++.+|+|++......+++.+.|.++++.+..|||++.++|++..     ++.+|+|||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC  103 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC  103 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence            46899999999999995 4578899999887777788899999999999999999999999974     56899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC--
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~--  494 (635)
                      .+|+..+++++..   ...+.|+.+..|+..++.|+++||...   ++|||+|-.|||++.++.+|+.|||++..+..  
T Consensus       104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            9999999998776   334999999999999999999999987   99999999999999999999999999876643  


Q ss_pred             --CCCCCCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          495 --PATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       495 --~~~~~~~~~y~aPE~~~~~-----~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                        ..+..||+.|||||++...     .|+..+|+||+|++..||--|.+|+.++.+....      -.+.+..       
T Consensus       178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~IpRNP-------  244 (953)
T KOG0587|consen  178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPRNP-------  244 (953)
T ss_pred             ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccCCCCC-------
Confidence              3456789999999999543     4778899999999999999999999865432110      0000000       


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                        .......+.-.+++.++|..|+..|-++||++.++++
T Consensus       245 --PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  245 --PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              0112234566778899999999999999999988765

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.3e-32  Score=283.11  Aligned_cols=254  Identities=21%  Similarity=0.310  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe------eEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv  412 (635)
                      .+.||+|+||.||+|... ++..||+|++.....   ..+.+.+|+.+++++ +|+|++++.+++...+.      .++|
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEE
Confidence            467999999999999975 478899999865322   234567899999998 99999999988776554      8999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +||+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++...
T Consensus        99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence            9998 5699998863      24899999999999999999999998   999999999999999999999999998766


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHhhhcc
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------LPRWVQSVVREEW  561 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~  561 (635)
                      .... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...         ...+......+..
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence            4432 3346778999999865 367899999999999999999999997543211000         0000000000000


Q ss_pred             ccccchhhhhcccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+.+.........    ......+.+++.+|++.+|++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000000000000000    1124567888999999999999999999873

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=7.6e-32  Score=282.36  Aligned_cols=255  Identities=23%  Similarity=0.286  Sum_probs=183.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--------------
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------------  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------------  406 (635)
                      .+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+++++++ +||||+++++++...              
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTEL   88 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccccccccc
Confidence            467999999999999965 478899999865533 345688899999999 999999999776543              


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEee
Q 006677          407 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISD  485 (635)
Q Consensus       407 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~D  485 (635)
                      ...++||||++ ++|.+++..      ..+++..+..++.||+.||+|||+.+   ++||||||+||+++. ++.+|++|
T Consensus        89 ~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          89 NSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence            35789999997 589888753      23889999999999999999999998   999999999999974 56789999


Q ss_pred             cCCCCCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-
Q 006677          486 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV-  556 (635)
Q Consensus       486 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-  556 (635)
                      ||++.......       ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  ........ 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~  236 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVP  236 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcC
Confidence            99987543221       1235677999998754 5578899999999999999999999975432110  00000000 


Q ss_pred             ---------hhhccccccchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHH
Q 006677          557 ---------VREEWTAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEE  610 (635)
Q Consensus       557 ---------~~~~~~~~~~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~  610 (635)
                               ...................    ......++.+++.+|++.||++|||+.|+++  .++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                     0000000000000000000    0112245678888999999999999999996  4543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.3e-31  Score=265.62  Aligned_cols=220  Identities=17%  Similarity=0.182  Sum_probs=172.5

Q ss_pred             cCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhhccC
Q 006677          349 GSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHG  427 (635)
Q Consensus       349 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  427 (635)
                      |.||.||++... +++.+|+|++....    .+.+|...+... .|||++++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999965 57889999987542    233444444444 699999999999999999999999999999999864


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCCCCcccC
Q 006677          428 NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRA  506 (635)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~~~~y~a  506 (635)
                      .     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||.+....... ...++..|+|
T Consensus        79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a  150 (237)
T cd05576          79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA  150 (237)
T ss_pred             h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence            3     24899999999999999999999998   9999999999999999999999999876554322 2335667999


Q ss_pred             cccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHH
Q 006677          507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI  586 (635)
Q Consensus       507 PE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l  586 (635)
                      ||.+.+..++.++||||+|+++|||++|+.|+....... .           ...     ....  .   ......+.++
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~-----------~~~-----~~~~--~---~~~~~~~~~l  208 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-N-----------THT-----TLNI--P---EWVSEEARSL  208 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c-----------ccc-----ccCC--c---ccCCHHHHHH
Confidence            999988889999999999999999999998875321100 0           000     0000  0   1122356678


Q ss_pred             HHHcccCCCCCCCCHHH
Q 006677          587 GMACVAKVPDMRPNMDE  603 (635)
Q Consensus       587 ~~~cl~~~P~~RPs~~e  603 (635)
                      +.+|++.||++||++.+
T Consensus       209 i~~~l~~dp~~R~~~~~  225 (237)
T cd05576         209 LQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHccCCHHHhcCCCc
Confidence            88999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.4e-31  Score=300.35  Aligned_cols=139  Identities=24%  Similarity=0.371  Sum_probs=123.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|... +++.||+|+++.....    ...+.+|+.++..+ +|+||+++++++...+..|+||||+.
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~   87 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLI   87 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCC
Confidence            467999999999999976 5789999999754321    25677888888888 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +++|.++++..     ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        88 g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          88 GGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999643     24788999999999999999999998   9999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-33  Score=260.00  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecc--cCC-hHHHHHHHHHHHhhcCCCceeceeEEEEeC--------CeeE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEV--VVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~  410 (635)
                      ..+||+|.||+||+|+.++ ++.||+|+.--.  ..+ .....+|++++..+ +|+|++.++..|...        ...|
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceee
Confidence            3579999999999999654 667787765321  222 34567899999999 999999999888543        2479


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||++|+. ||..++....    ..++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+++
T Consensus       101 lVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen  101 LVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence            99999987 9999887532    34888999999999999999999987   9999999999999999999999999997


Q ss_pred             CCCCCCCC--------CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHH-HHHHhhhc
Q 006677          491 LMNVPATP--------SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW-VQSVVREE  560 (635)
Q Consensus       491 ~~~~~~~~--------~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~  560 (635)
                      .+..+...        ..|..|++||.+.+ +.|+++.|||+-||++.||+||.+-+++.++.....+++. +.++-.+-
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            66443221        23778999998876 4689999999999999999999999988765544433322 22222222


Q ss_pred             ccccc-------chhh-hh--cccChHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          561 WTAEV-------FDVE-LM--RFQNIEEEMV------QMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       561 ~~~~~-------~d~~-~~--~~~~~~~~~~------~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      |..-.       +..+ +.  ....+++..+      ...+++..++..||.+|+++.+++.+-
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            32110       0000 00  0111223333      566778899999999999999987653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=270.46  Aligned_cols=232  Identities=25%  Similarity=0.348  Sum_probs=184.4

Q ss_pred             hccccccCceEEEEEEecCC-CeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ..+||+|+||.|-+|.-+++ ..+|||++++...-    -+.-..|-++|....+-|.++++..+|+.-+.+|.||||+.
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn  433 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN  433 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence            36899999999999987653 55899999876432    22344566777777789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      ||+|--.++...     .+.+..+...|..||-||-+||+++   ||+||||..|||+|.+|++||+|||+++.--..  
T Consensus       434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence            999988887432     3778889999999999999999999   999999999999999999999999998754322  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        .+.+||+.|+|||++...+|+..+|+|||||+||||+.|+.||++.++++..      +.+...         +.   
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------~aI~eh---------nv---  567 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QAIMEH---------NV---  567 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHHc---------cC---
Confidence              3557999999999999999999999999999999999999999987655432      111111         11   


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCC
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPN  600 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs  600 (635)
                      ..+.....+...+....+...|.+|.-
T Consensus       568 syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cCcccccHHHHHHHHHHhhcCCccccC
Confidence            111222334445555777888988843

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=298.87  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecc----cCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEV----VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.|..++++. ++.||+|++.+.    +.....|..|-.+|..- +.+-|+.+...|.++.+.|+|||||+
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~p  158 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYMP  158 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEeccc
Confidence            4689999999999999865 677899999874    23456688888888776 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      ||||..++.+..     .+++..+..++..|..||.-||+.|   +|||||||+|||||..|++|++|||.+-.+...  
T Consensus       159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            999999997543     4899999999999999999999999   999999999999999999999999988776643  


Q ss_pred             ---CCCCCCCcccCccccc----C-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 ---ATPSRSAGYRAPEVIE----T-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~----~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                         ...+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||....      ++.=..++......   +.
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~---l~  301 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKES---LS  301 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhh---cC
Confidence               3567999999999984    3 579999999999999999999999997543      22212222221100   00


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH-------HHHhhccCCCC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN---MDEVVRM-------IEEVRQSDSEN  618 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~-------L~~~~~~~~~~  618 (635)
                        ++....+++++..+++   +.+. +|+.|..   .+++..|       ...|++..+.-
T Consensus       302 --FP~~~~VSeeakdLI~---~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~  356 (1317)
T KOG0612|consen  302 --FPDETDVSEEAKDLIE---ALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV  356 (1317)
T ss_pred             --CCcccccCHHHHHHHH---HHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence              0011123455555444   4333 6778877   8888764       35666555543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=267.49  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=187.1

Q ss_pred             hccccccCceEEEEEE-ecCCCeEEEEEeecccCCh--------HHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK--------RDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv  412 (635)
                      ..+||+|||++||+|. +.+.+.||||+-.....++        +...+|..+.+.| .||.||++++|+.-+ +..|-|
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccccceee
Confidence            3579999999999998 4557788898764333221        2355688888888 999999999999754 567899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla  489 (635)
                      +|||+|-+|.-+|+.++     .+++.++..|+.||+.||.||.+.. |+|||-||||.|||+..   -|.+||+|||++
T Consensus       547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            99999999999998654     4889999999999999999999885 88999999999999954   488999999999


Q ss_pred             CCCCCCCC-----------CCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          490 PLMNVPAT-----------PSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       490 ~~~~~~~~-----------~~~~~~y~aPE~~~~----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                      +.+.....           ..||.+|++||.+--    ...+.|+||||.||++|.++.|+.||......         +
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------Q  691 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------Q  691 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---------H
Confidence            99865432           136788999998843    34788999999999999999999999864322         1


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .++.++.........+..-+.+..+.   ..+|++|+++.-++|....++..
T Consensus       692 dILqeNTIlkAtEVqFP~KPvVsseA---kaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 DILQENTILKATEVQFPPKPVVSSEA---KAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHhhhchhcceeccCCCCCccCHHH---HHHHHHHHHhhhhhhhhHHHHcc
Confidence            22222222222222222222333344   45566999999999999888765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-32  Score=271.62  Aligned_cols=249  Identities=19%  Similarity=0.334  Sum_probs=192.1

Q ss_pred             ChHHHHHHh-hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe
Q 006677          334 DLEDLLRAS-AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE  408 (635)
Q Consensus       334 ~~~~l~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~  408 (635)
                      ++..+.+.. .++||.|.||+||-|.++ +|+.||||++.+.+.   .+...+.|+.+++.+ +||.||.+-..|+..+.
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPER  637 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCce
Confidence            344444433 789999999999999965 589999999987754   345688999999999 99999999999999999


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC---CCeEEee
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISD  485 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~D  485 (635)
                      .++|||-+.|.=|.-.|...+    ..+++...+.++.||+.||.|||.++   |+|+||||+|||+...   -++||+|
T Consensus       638 vFVVMEKl~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  638 VFVVMEKLHGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             EEEEehhhcchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecc
Confidence            999999996644455554333    34899999999999999999999998   9999999999999754   4799999


Q ss_pred             cCCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          486 FGLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       486 fGla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ||+|+......   .-.||+.|+|||++..+.|...-|+||.||++|--++|..||....     ++.+.++...     
T Consensus       711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNAa-----  780 (888)
T KOG4236|consen  711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNAA-----  780 (888)
T ss_pred             ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhccc-----
Confidence            99999987643   4469999999999999999999999999999999999999997421     2211111110     


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       -++.     .....+.....+++|...++..=++|-+.++.+.
T Consensus       781 -FMyP-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  781 -FMYP-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -cccC-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             0000     0111233344556666777777777877776554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=235.16  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=188.9

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      ++||+|.||+||+|+..+ +..||+|+++....+   .....+|+-+++.+ +|.|||++++....+...-+|+|||.. 
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhH-
Confidence            679999999999999654 677999998755332   35678899999999 999999999999999999999999965 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|..+.....+    .++.+.+..++.|+++|+.|+|+++   +.|||+||.|.||+.+|+.|++|||+++.+..+.   
T Consensus        86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            89888876554    3888999999999999999999998   9999999999999999999999999998876543   


Q ss_pred             -CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH-HHhhhcccccc--chhhh
Q 006677          497 -TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ-SVVREEWTAEV--FDVEL  570 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~d~~~  570 (635)
                       ....|..|++|.++.+.. |+...|+||-||++.|+.. |.+-|.+.+.++...-+-|.- ....+.|....  -|...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence             334688899999987754 8899999999999999998 555566554333211111111 11123332211  11111


Q ss_pred             h-cccC-------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 M-RFQN-------IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~-~~~~-------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      . .++.       .+..-..-.++..+.+.-+|.+|.++++.+++
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            0 0000       01111122455557777799999999988764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-31  Score=236.40  Aligned_cols=197  Identities=25%  Similarity=0.359  Sum_probs=163.6

Q ss_pred             HhhccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          341 ASAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .....||+|+||.|-+.++. +|+..|+|++....-.  .+....|+.+.++...+|.+|.++|.+.+....++.||.|.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            34567999999999888854 5888999999765433  45567788888888799999999999999999999999996


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      . +|..+-.+--. ....+++.-.-+|+..+..||.|||++-  .+||||+||+|||++.+|++|++|||.+..+..+..
T Consensus       129 t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  129 T-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             h-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            6 77666543322 2345889999999999999999999975  799999999999999999999999999987765432


Q ss_pred             ---CCCCCcccCcccccC----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          498 ---PSRSAGYRAPEVIET----RKHSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       498 ---~~~~~~y~aPE~~~~----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                         ..|-..|||||.+..    ..|+-|+||||+|+++.||.+++.||+..
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence               235556999999853    36899999999999999999999999854

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.6e-30  Score=284.90  Aligned_cols=252  Identities=19%  Similarity=0.217  Sum_probs=161.2

Q ss_pred             hccccccCceEEEEEEecC-----CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEE------EEeCCeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-----STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY------YYSKDEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~------~~~~~~~~l  411 (635)
                      .+.||+|+||.||+|.+.+     +..||+|++...... +.+..+  .+.+. .+.+++.++..      ...+...++
T Consensus       137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L  212 (566)
T PLN03225        137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWL  212 (566)
T ss_pred             eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEE
Confidence            5789999999999999754     578999987643211 111111  11111 22222222211      235567899


Q ss_pred             EEEeccCCChhhhccCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc
Q 006677          412 VYDYFASGSLSTLLHGNRGA---------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN  476 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~  476 (635)
                      ||||+.+++|.++++.....               .........+..++.|++.||+|||+.+   |+||||||+|||++
T Consensus       213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~  289 (566)
T PLN03225        213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS  289 (566)
T ss_pred             EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence            99999999999998643210               0001123445679999999999999998   99999999999998


Q ss_pred             C-CCCeEEeecCCCCCCCCC-----CCCCCCCcccCcccccCC----------------------CCCCccchhhHHHHH
Q 006677          477 Q-DLDGCISDFGLTPLMNVP-----ATPSRSAGYRAPEVIETR----------------------KHSHKSDVYSFGVLL  528 (635)
Q Consensus       477 ~-~~~~ki~DfGla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~k~Dvws~Gvvl  528 (635)
                      + ++.+||+|||+|+.....     ....+++.|+|||.+...                      .++.++|||||||++
T Consensus       290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL  369 (566)
T PLN03225        290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF  369 (566)
T ss_pred             CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence            6 589999999999765432     234578899999965322                      234567999999999


Q ss_pred             HHHHhCCCCCCCCCC-------CCCCChhHHHHHHhhhccccccchhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCC
Q 006677          529 LEMLTGKAPLQSPTR-------DDMVDLPRWVQSVVREEWTAEVFDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPN  600 (635)
Q Consensus       529 ~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  600 (635)
                      |||+++..|++....       ....+...|.......      ...... .............+++.+|++.||++|||
T Consensus       370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            999998776542100       0011122222111100      000000 00000111223457888999999999999


Q ss_pred             HHHHHHH
Q 006677          601 MDEVVRM  607 (635)
Q Consensus       601 ~~evl~~  607 (635)
                      ++|++++
T Consensus       444 a~e~L~H  450 (566)
T PLN03225        444 AKAALAH  450 (566)
T ss_pred             HHHHhCC
Confidence            9999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1e-29  Score=251.63  Aligned_cols=234  Identities=24%  Similarity=0.369  Sum_probs=189.2

Q ss_pred             CceEEEEEEecC-CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhhcc
Q 006677          350 SYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLH  426 (635)
Q Consensus       350 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  426 (635)
                      +||.||+|...+ +..+++|++......  .+.+.+|++.++++ +|+|++++++++......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999874 789999998765432  57899999999999 99999999999999999999999999999999987


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---CCCCCCCc
Q 006677          427 GNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPSRSAG  503 (635)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---~~~~~~~~  503 (635)
                      ...     .+++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++++|||.+......   ....++..
T Consensus        80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       80 KRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             hcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            432     2889999999999999999999998   999999999999999999999999998776543   23446778


Q ss_pred             ccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHH
Q 006677          504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM  583 (635)
Q Consensus       504 y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  583 (635)
                      |++||.+....++.++||||||+++++|++|..||....     +................         .........+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKPPFP---------PPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCCCc---------cccccCCHHH
Confidence            999999988889999999999999999999999997531     11111111111111000         0000033467


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 006677          584 LQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       584 ~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            78888999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-31  Score=280.02  Aligned_cols=239  Identities=26%  Similarity=0.435  Sum_probs=184.5

Q ss_pred             hccccccCceE-EEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+++|.|+-|+ ||+|..+ ++.||||++-...  ..-..+|+..++.-.+|||||++++.-.+++..|+..|.|.. +|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence            56799999875 7999987 7899999986543  345678999999888999999999999999999999999965 99


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---C--CCeEEeecCCCCCCCCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---D--LDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~ki~DfGla~~~~~~~  496 (635)
                      .+++... ..............+..|++.||++||+.+   ||||||||.||||+.   +  ..++|+|||+++.+....
T Consensus       590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999864 111111111345678899999999999988   999999999999976   3  568999999998876543


Q ss_pred             -------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 -------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 -------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                             +..||-||+|||++....-+.++||||+||++|+.++| .+||...-..+.        .++........   
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~---  734 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH---  734 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee---
Confidence                   33478899999999998888899999999999999996 899985432221        11112211111   


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                          .....++  +..+||.+|+.++|..||++.+|+.
T Consensus       735 ----L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 ----LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ----eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                1111122  5667888999999999999999975

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-30  Score=245.08  Aligned_cols=239  Identities=19%  Similarity=0.305  Sum_probs=185.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+|+.|..+++.. .+.+|+|++++.-..    ....+.|-.+.....+||.+|-+..+|..+...+.|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            4689999999999999765 567899998876332    23456666777777799999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|--.++..+     .++++.+...-..|..||.|||+.|   ||.||||..|||+|..|++|++|||.++.--.   
T Consensus       335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            999987776433     4999999999999999999999999   99999999999999999999999999875432   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC-CCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                       ..+.+||+.|.|||++.+..|+..+|+|++||+++||+.|+.||+--..+ ...+...++-.++-+...+        .
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------i  478 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------I  478 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------c
Confidence             24567999999999999999999999999999999999999999843211 1122333333333222111        1


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCC
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPN  600 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs  600 (635)
                      ....+..   ...+.+.-++.||.+|.-
T Consensus       479 prslsvk---as~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  479 PRSLSVK---ASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cceeehh---hHHHHHHhhcCCcHHhcC
Confidence            1111222   223445778899999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2e-29  Score=270.85  Aligned_cols=250  Identities=21%  Similarity=0.339  Sum_probs=170.6

Q ss_pred             hccccccCceEEEEEEe-----------------cCCCeEEEEEeecccCC-hH--------------HHHHHHHHHHhh
Q 006677          343 AEVLGKGSYGTAYKAVL-----------------EESTTVVVKRLKEVVVG-KR--------------DFEQQMEIVGRV  390 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~~--------------~~~~e~~~l~~l  390 (635)
                      .++||+|+||+||+|..                 .+++.||||++...... .+              .+..|+.++.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            46899999999999964                 23567999998653221 12              233466677777


Q ss_pred             cCCCc-----eeceeEEEEe--------CCeeEEEEEeccCCChhhhccCCCCC-------------------CCCCCCH
Q 006677          391 GQHPN-----VVPLRAYYYS--------KDEKLLVYDYFASGSLSTLLHGNRGA-------------------GRTPLDW  438 (635)
Q Consensus       391 ~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~  438 (635)
                       +|.+     +++++++|..        +...++||||+++|+|.++++...+.                   ....+++
T Consensus       230 -~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        230 -KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             -hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence             4444     4677777753        35679999999999999999753211                   1123577


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-----CCCCCcccCcccccCC
Q 006677          439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-----PSRSAGYRAPEVIETR  513 (635)
Q Consensus       439 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-----~~~~~~y~aPE~~~~~  513 (635)
                      ..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........     ...++.|+|||.+...
T Consensus       309 ~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            889999999999999999998   99999999999999999999999999876543221     1236789999987542


Q ss_pred             C--------------------C--CCccchhhHHHHHHHHHhCCC-CCCCCCCCC------CCChhHHHHHHhhhccccc
Q 006677          514 K--------------------H--SHKSDVYSFGVLLLEMLTGKA-PLQSPTRDD------MVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       514 ~--------------------~--~~k~Dvws~Gvvl~el~tg~~-p~~~~~~~~------~~~~~~~~~~~~~~~~~~~  564 (635)
                      .                    +  ..+.||||+||+++||++|.. ||.......      ..++..|... ....    
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~~~----  460 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KGQK----  460 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-cccC----
Confidence            2                    1  134799999999999999875 775321110      0111222211 0011    


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVP---DMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~~  607 (635)
                       .+     ............+++.+++..+|   .+|+|++|+++|
T Consensus       461 -~~-----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 -YD-----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -CC-----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence             11     11111222345566668888765   689999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-31  Score=267.37  Aligned_cols=249  Identities=19%  Similarity=0.273  Sum_probs=198.0

Q ss_pred             CChHHHHHHhhccccccCceEEEEEEecCCC-eEEEEEeecccC-C---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC
Q 006677          333 FDLEDLLRASAEVLGKGSYGTAYKAVLEEST-TVVVKRLKEVVV-G---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD  407 (635)
Q Consensus       333 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~-~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~  407 (635)
                      ..+.++.+  ...||-|+||.|=++..+... .+|+|++++... +   .+....|-.+|... +.|.||+++-.|.+..
T Consensus       417 v~l~dl~~--iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  417 VKLSDLKR--IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSK  493 (732)
T ss_pred             cchhhhhh--hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccch
Confidence            34455533  346999999999999876443 388898877633 2   23455677889988 8999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      ..|+.||-|-||.|...++.     +..++......++..+..|++|||+++   ||+|||||+|.+++.+|-+||.|||
T Consensus       494 yvYmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence            99999999999999999974     334888889999999999999999999   9999999999999999999999999


Q ss_pred             CCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          488 LTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       488 la~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      +|+......   +.+||+.|.|||++....++.++|.||+|+++|||++|.+||.+.++....++      ++ .+..  
T Consensus       566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------IL-kGid--  636 (732)
T KOG0614|consen  566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------IL-KGID--  636 (732)
T ss_pred             hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------HH-hhhh--
Confidence            999887765   45699999999999999999999999999999999999999997654332211      11 1100  


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRMI  608 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~L  608 (635)
                      .       ...+....+...+++++.++.+|.+|.-     ..+|.++-
T Consensus       637 ~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  637 K-------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             h-------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            0       0111233345667788999999999976     66666653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.8e-30  Score=263.06  Aligned_cols=201  Identities=25%  Similarity=0.398  Sum_probs=167.0

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||-|+||+|++++-.+ ...+|.|.+.+...-    ....+.|-.||... ..+-||+|+..|.+++.+|+||||++|
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCC
Confidence            469999999999998544 456889988765331    23466788899988 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC-----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----  493 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~-----  493 (635)
                      ||+-.+|-+     ...+.+..+..++..+..|+++.|..|   +|||||||+|||||.+|++||+|||+++-+.     
T Consensus       714 GDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  714 GDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999998863     234778888888999999999999999   9999999999999999999999999974321     


Q ss_pred             ----CC-------------------------------------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHH
Q 006677          494 ----VP-------------------------------------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML  532 (635)
Q Consensus       494 ----~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~  532 (635)
                          ..                                     ....||+.|+|||++....|+..+|+||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                00                                     0113577899999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCCC-ChhHHH
Q 006677          533 TGKAPLQSPTRDDMV-DLPRWV  553 (635)
Q Consensus       533 tg~~p~~~~~~~~~~-~~~~~~  553 (635)
                      .|+.||...+..+.. .+..|-
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~  887 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWR  887 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehh
Confidence            999999987766543 334443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.8e-29  Score=230.81  Aligned_cols=251  Identities=19%  Similarity=0.307  Sum_probs=187.0

Q ss_pred             hccccccCceEEEEEE-ecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~~g  419 (635)
                      .+++|+|.|++||.|. ..++..++||+++...  ++.+.+|+.++..+..||||+.++++..+..  ...+|+||+++.
T Consensus        43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~  120 (338)
T KOG0668|consen   43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT  120 (338)
T ss_pred             HHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence            4679999999999998 4567889999998653  6789999999999988999999999988765  456999999998


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCCCCC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVPATP  498 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~~~~  498 (635)
                      +...+-.        .++...+...+.++++||.|+|++|   |.|||+||.|+|+|.. -.++++|||+|.++......
T Consensus       121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY  189 (338)
T KOG0668|consen  121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  189 (338)
T ss_pred             cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence            8776653        3777889999999999999999999   9999999999999865 57999999999988765543


Q ss_pred             ---CCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc------ccchh
Q 006677          499 ---SRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA------EVFDV  568 (635)
Q Consensus       499 ---~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~d~  568 (635)
                         ..+..|-.||.+-. ..|+..-|+|||||++..|+..+.||..... ...++++.+.-...++...      ...|+
T Consensus       190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence               24566889999865 4578889999999999999999999864321 1222332222111111000      00111


Q ss_pred             hh------------hcccCh---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 EL------------MRFQNI---EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ~~------------~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..            .++-..   .-...+.++++.+.+..|-.+|+|++|++++
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            11            110000   0011345666778999999999999999873

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=243.62  Aligned_cols=255  Identities=18%  Similarity=0.283  Sum_probs=190.0

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e  414 (635)
                      +.||.|+||.||.+... +|+.|+.|++.....   ..+.+.+|++++... +|.|++..+++..-.     ++.|+++|
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            57999999999999864 689999999976543   357788899999998 999999998886543     35688999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      .|.. ||...+-     +.+.++.+.++-+++||++||+|||+.+   |.||||||.|.|++.+...||+|||+++....
T Consensus       138 LmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  138 LMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            8865 8888875     3456899999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCC-----CCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHH---------HHHHhhh
Q 006677          495 PATP-----SRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW---------VQSVVRE  559 (635)
Q Consensus       495 ~~~~-----~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~  559 (635)
                      ....     ..|..|+|||++.+. .|+.+.||||.||++.|++..+.-|+..+.-+..+++.-         .+... +
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-E  287 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-E  287 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-h
Confidence            4332     236679999999875 589999999999999999999999987655443322211         11111 1


Q ss_pred             ccccccc-----hhhh---hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          560 EWTAEVF-----DVEL---MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       560 ~~~~~~~-----d~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      +-...+.     .+.+   .........-.+.+.+...++..||..|.+.++.+.++.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1000000     0010   011111122233445556889999999999999887653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=241.10  Aligned_cols=129  Identities=19%  Similarity=0.222  Sum_probs=109.8

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-------CceeceeEEEEe----CCee
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-------PNVVPLRAYYYS----KDEK  409 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-------~niv~l~~~~~~----~~~~  409 (635)
                      ..++||-|.|++||++... ..+.||+|+.+....-.+....|+++++++..+       .+||+|++.|..    ..+.
T Consensus        82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV  161 (590)
T KOG1290|consen   82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV  161 (590)
T ss_pred             EEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence            3578999999999999954 467899999988766667788899999988643       379999999974    4588


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc
Q 006677          410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN  476 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~  476 (635)
                      ++|+|++ |.+|..+|....   .+.++...+++|+.||+.||.|||.++  .|||.||||+|||+.
T Consensus       162 CMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  162 CMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             EEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            9999988 568999887544   334899999999999999999999988  799999999999994

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.6e-27  Score=228.60  Aligned_cols=205  Identities=31%  Similarity=0.527  Sum_probs=180.2

Q ss_pred             ccccCceEEEEEEecC-CCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          346 LGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      ||+|.+|.||++...+ +..+++|++......  ...+.+|++.++++ +|++++++++++......++++||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999999765 888999998766442  56799999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCCC----CC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP----AT  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~~----~~  497 (635)
                      +++....    ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+......    ..
T Consensus        80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            9987432    34889999999999999999999998   999999999999999 899999999998766543    22


Q ss_pred             CCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+...|++||..... .++.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            3456779999999887 788999999999999999                                             


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                356678889999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=250.81  Aligned_cols=190  Identities=22%  Similarity=0.362  Sum_probs=163.0

Q ss_pred             hhccccccCceEEEEEEecC-CCeEEEEEeecccCChH---------HHHHHHHHHHhhc--CCCceeceeEEEEeCCee
Q 006677          342 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKR---------DFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEK  409 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~---------~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~  409 (635)
                      +.+.+|+|+||.|+.|.++. ...|+||.+.+.+.-.+         ..-.|+.||..+.  .|+||++++.+|++++.+
T Consensus       565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y  644 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY  644 (772)
T ss_pred             eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence            35679999999999999865 56688898877643211         2445899999993  299999999999999999


Q ss_pred             EEEEEec-cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYF-ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      |++||-. ++.+|++++...     +.+++.++..|+.||+.|+++||+++   |||||||-+||.++.+|-+||+|||.
T Consensus       645 yl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  645 YLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             EEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence            9999976 456999999743     34899999999999999999999999   99999999999999999999999999


Q ss_pred             CCCCCCC--CCCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q 006677          489 TPLMNVP--ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQ  539 (635)
Q Consensus       489 a~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~k~Dvws~Gvvl~el~tg~~p~~  539 (635)
                      |.....+  ....||.+|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus       717 aa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8776543  456799999999999999985 45799999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-28  Score=226.00  Aligned_cols=249  Identities=20%  Similarity=0.308  Sum_probs=184.0

Q ss_pred             hhccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEE-EEeCCeeEEEEEeccCC
Q 006677          342 SAEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY-YYSKDEKLLVYDYFASG  419 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~~~lv~e~~~~g  419 (635)
                      +.+.+|+|.||.+-+++++. .+.+++|.+.......++|.+|...--.|..|.||+.-++. |+..+.+..++||++.|
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g  107 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG  107 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence            45679999999999999875 57799999988888899999998776667789999987765 45566777999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc--CCCCeEEeecCCCCCCCCCCC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~DfGla~~~~~~~~  497 (635)
                      ||.+.+..      ..+-+...++++.|++.|+.|||+++   +||||||.+||||-  +...+|++|||+++..+.--.
T Consensus       108 dL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  108 DLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             hhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            99988864      33788899999999999999999998   99999999999993  335799999999876543322


Q ss_pred             C-CCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          498 P-SRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       498 ~-~~~~~y~aPE~~~~~-----~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      . .....|.|||.....     ...+.+|||.||++++.++||+.||+.....+ ..+.+|.+-.-+..  ...    ..
T Consensus       179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~~rk~--~~~----P~  251 (378)
T KOG1345|consen  179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWLKRKN--PAL----PK  251 (378)
T ss_pred             hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHhcccC--ccC----ch
Confidence            2 235569999987543     24677899999999999999999998433222 23344433221111  110    01


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .+.   .....++++.++-+..+|++|-...++.++..
T Consensus       252 ~F~---~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  252 KFN---PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             hhc---ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            111   22234455566889999999955555555443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=5.2e-28  Score=244.47  Aligned_cols=259  Identities=20%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhc-----CCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      ....|+|-|++|.+|... .|..||||++.....-.+.=..|+++|.+|.     .--|+++++-.|...+++|||+|-+
T Consensus       437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L  516 (752)
T KOG0670|consen  437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL  516 (752)
T ss_pred             EeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence            345899999999999964 4789999999987766777788999999985     2357899999999999999999977


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~  495 (635)
                      .. +|.++|+....  ...|....+..++.|+..||..|...+   |+|.||||.|||+++. ..+||||||.|......
T Consensus       517 sl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en  590 (752)
T KOG0670|consen  517 SL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASEN  590 (752)
T ss_pred             hc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccc
Confidence            54 99999986532  334788899999999999999999998   9999999999999876 56899999999876544


Q ss_pred             CCC--CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH-----HHHhhh-ccccccch
Q 006677          496 ATP--SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV-----QSVVRE-EWTAEVFD  567 (635)
Q Consensus       496 ~~~--~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~d  567 (635)
                      ..+  ..+..|.|||++.+-.|+...|+||.||+|||+.||+.-|.+.+..++..+.--+     .+++.. .+....||
T Consensus       591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD  670 (752)
T KOG0670|consen  591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFD  670 (752)
T ss_pred             cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcc
Confidence            321  2345599999999999999999999999999999999999987665553221111     011111 01111111


Q ss_pred             hhh--------------------------------hcc---c-ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VEL--------------------------------MRF---Q-NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~--------------------------------~~~---~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+                                ...   + .-......|.+|...|+..||++|.|..+++++
T Consensus       671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            111                                111   1 112334567888999999999999999999874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=228.72  Aligned_cols=251  Identities=23%  Similarity=0.326  Sum_probs=184.8

Q ss_pred             ccccccCceEEEEEEe-cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEEE
Q 006677          344 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLVY  413 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~  413 (635)
                      ..+|.|.- .|..+.. -.++.||+|++.....   ..+...+|...+..+ +|+|+++++.++.-.      .+.|+||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHH
Confidence            46788876 5555553 3478999999876532   356778898888888 999999999998644      3579999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |||.. +|...++.       .++-.....|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+...
T Consensus       101 e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen  101 ELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             Hhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence            99965 89888862       2777889999999999999999999   9999999999999999999999999997655


Q ss_pred             CC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC----------------ChhHHHH
Q 006677          494 VP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------------DLPRWVQ  554 (635)
Q Consensus       494 ~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~----------------~~~~~~~  554 (635)
                      ..   .....+..|.|||++-+..|.+.+||||.||++.||++|+.-|.+.+.-+..                ++...++
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            43   2334677899999999988999999999999999999999999854321110                1111111


Q ss_pred             HHhh--hccccccchhhhhc------ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 SVVR--EEWTAEVFDVELMR------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 ~~~~--~~~~~~~~d~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+.  +++....+...+..      ..+..-......+++.+|+..+|++|.++++++++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1111  01111111111100      00111233456778889999999999999999984

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=5.7e-26  Score=222.40  Aligned_cols=190  Identities=29%  Similarity=0.478  Sum_probs=166.8

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|++|+||++...+ +..+++|.+.....  ..+.+.+|++.+.++ +|+|++++++++...+..++++||++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCC
Confidence            3579999999999999875 78899999976543  356888999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++.....    .+++.....++.+++.++.+||+.+   ++|+|++++||+++.++.++|+|||.+......    
T Consensus        83 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       83 DLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999975331    1789999999999999999999998   999999999999999999999999998776544    


Q ss_pred             -CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 006677          496 -ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS  540 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~-~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~  540 (635)
                       ....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             233456779999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-28  Score=250.52  Aligned_cols=241  Identities=22%  Similarity=0.340  Sum_probs=190.5

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..+|.|.||.|||++.. .+...|+|+++.... .....++|+-+++.. +|+|||.++|.|..++..+++||||.+|+|
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggsl   99 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGSL   99 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence            56999999999999964 577889999986643 345677788888887 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----CCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPAT  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----~~~~  497 (635)
                      ++.-+.     ..++++.++..++....+|++|||+++   -+|||||-.||++++.|.+|++|||.+....    ....
T Consensus       100 Qdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen  100 QDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             cceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            998873     346999999999999999999999998   8999999999999999999999999876553    2345


Q ss_pred             CCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~---~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..||+.|||||+.   ..+.|..++|||+.|++..|+-.-+.|..........-    +       .....+++.  ...
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~----L-------mTkS~~qpp--~lk  238 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF----L-------MTKSGFQPP--TLK  238 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH----H-------hhccCCCCC--ccc
Confidence            6799999999987   35568999999999999999998888865432211100    0       001111111  111


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      +.......|.++++.|+..+|++||+++.++.
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            22233445667778999999999999987654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.4e-25  Score=208.12  Aligned_cols=170  Identities=20%  Similarity=0.260  Sum_probs=127.7

Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP  498 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~  498 (635)
                      |+|.++++..    ...+++..+..++.||+.||+|||+.+         ||+||+++.++.+|+  ||++....... .
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~   64 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-S   64 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-C
Confidence            6889998743    234999999999999999999999975         999999999999999  99987765433 3


Q ss_pred             CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHH
Q 006677          499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE  578 (635)
Q Consensus       499 ~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  578 (635)
                      .+++.|+|||++.+..++.++|||||||++|||+||+.||.....     ..................     .......
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~  134 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADDPR-----DRSNLES  134 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCCcc-----ccccHHH
Confidence            578999999999999999999999999999999999999964321     111111111111000000     0011111


Q ss_pred             HH--HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          579 EM--VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       579 ~~--~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ..  ..+.+++.+||+.+|++||++.|+++++..+...
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            22  2578899999999999999999999999877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=8.2e-26  Score=261.60  Aligned_cols=189  Identities=20%  Similarity=0.225  Sum_probs=135.8

Q ss_pred             CC-CceeceeEEE-------EeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 006677          392 QH-PNVVPLRAYY-------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF  463 (635)
Q Consensus       392 ~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  463 (635)
                      +| +||++++++|       ...+..+.++||+ +++|.++++..    ...+++.+++.++.||++||+|||+++   |
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            44 6777888877       2234567788887 55999999742    234899999999999999999999998   9


Q ss_pred             eecCCCCCCeEEcC-------------------CCCeEEeecCCCCCCCCC--------------------CCCCCCCcc
Q 006677          464 THGNIKASNVLINQ-------------------DLDGCISDFGLTPLMNVP--------------------ATPSRSAGY  504 (635)
Q Consensus       464 vH~Dlk~~NIll~~-------------------~~~~ki~DfGla~~~~~~--------------------~~~~~~~~y  504 (635)
                      +||||||+||||+.                   ++.+|++|||+++.....                    ....+|+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   445667777766532110                    012357779


Q ss_pred             cCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHH
Q 006677          505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQML  584 (635)
Q Consensus       505 ~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  584 (635)
                      ||||++.+..++.++|||||||+||||++|..|+....     .   ..... ...    .....      .........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~---~~~~~-~~~----~~~~~------~~~~~~~~~  242 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----R---TMSSL-RHR----VLPPQ------ILLNWPKEA  242 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----H---HHHHH-HHh----hcChh------hhhcCHHHH
Confidence            99999999999999999999999999999988865211     0   01110 000    00000      011122345


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHH
Q 006677          585 QIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       585 ~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +++.+||+.+|.+||+|.|++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            67789999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=1.8e-25  Score=222.60  Aligned_cols=187  Identities=28%  Similarity=0.495  Sum_probs=158.7

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .++||+|.|++||++...    ....||+|.+.... .......|++++.+++.+.||+.+.+++...+...+|+||++.
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            578999999999999854    35779999886543 3466889999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCC-----
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLM-----  492 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~-----  492 (635)
                      ....++...        ++...+...+..+..||+++|.+|   ||||||||.|+|.+. .+.-.|.|||+|...     
T Consensus       120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            998888753        778899999999999999999999   999999999999985 467789999998511     


Q ss_pred             ------------CC----------------C---------------CCCCCCCcccCcccccC-CCCCCccchhhHHHHH
Q 006677          493 ------------NV----------------P---------------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLL  528 (635)
Q Consensus       493 ------------~~----------------~---------------~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl  528 (635)
                                  ..                +               ....||+||+|||++.. ...++++||||.||++
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                        00                0               00126889999999865 4578899999999999


Q ss_pred             HHHHhCCCCCCCC
Q 006677          529 LEMLTGKAPLQSP  541 (635)
Q Consensus       529 ~el~tg~~p~~~~  541 (635)
                      ..+++++.||...
T Consensus       269 Lslls~~~PFf~a  281 (418)
T KOG1167|consen  269 LSLLSRRYPFFKA  281 (418)
T ss_pred             ehhhccccccccC
Confidence            9999999998643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.92  E-value=1.5e-24  Score=257.76  Aligned_cols=186  Identities=35%  Similarity=0.638  Sum_probs=152.6

Q ss_pred             ChhHHHHHHHHHHhCCC--CCCCCCCCCCCCCCCcceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecC
Q 006677           27 LNSDRQALLDFADAVPH--LRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN  104 (635)
Q Consensus        27 ~~~~~~al~~~~~~~~~--~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n  104 (635)
                      .+.|+.||++||+++..  ....+|+..+++| .|.||+|++ .++|+.|+|++++++|.+|+ .+..+++|++|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCC
Confidence            56899999999999843  3345898666655 899999985 46899999999999999987 7999999999999999


Q ss_pred             CCCCCCCCCCC-CCCcccEEeeccCccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC
Q 006677          105 VLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF  183 (635)
Q Consensus       105 ~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  183 (635)
                      +++|.+|..+. ++++|++|+|++|+++|.+|....++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  183 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS  183 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence            99999998766 89999999999999999888766678888888888888888888888888888888888887777764


Q ss_pred             --CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          184 --DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       184 --~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                        .+++|++|+|++|++++.+|..++++++|+.+
T Consensus       184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  217 (968)
T PLN00113        184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI  217 (968)
T ss_pred             hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence              67777777777777777777666666655543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=203.04  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=184.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+|.+...|+.|+|+++ |..+++|++.-...   -.++|..|.-.++-. .||||..++|.|....+..++..||+.|+
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccchH
Confidence            36788889999999998 55667777764432   246788887777666 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcee-cCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH-GNIKASNVLINQDLDGCISDFGLTPLMNVPATPS  499 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH-~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~  499 (635)
                      |+..+|+..   ....+..++.+++.+||+|++|||+..  +++- --|.+..+++|++.+++|+ .+-+++.-......
T Consensus       274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~  347 (448)
T KOG0195|consen  274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRA  347 (448)
T ss_pred             HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeeccccc
Confidence            999999654   335778899999999999999999986  4444 4689999999999998874 11122211112233


Q ss_pred             CCCcccCcccccCCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          500 RSAGYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       500 ~~~~y~aPE~~~~~~~---~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+.||+||.++..+.   -+++|+|||.+++||+.|...||......+..      .++.-++...       ...++ 
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialeglrv-------~ippg-  413 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEGLRV-------HIPPG-  413 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhccccc-------cCCCC-
Confidence            4678999999987654   35789999999999999999999876554421      1111111110       11222 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                        ....+.+++.-|+..||.+||.+..++-.|++|+
T Consensus       414 --is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  414 --ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              3345566777999999999999999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.4e-21  Score=201.73  Aligned_cols=152  Identities=19%  Similarity=0.260  Sum_probs=117.6

Q ss_pred             hccccccCceEEEEEEec--CCCeEEEEEeecccC------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|...  +++.||||++.....      ....+.+|++++.++ +|+|++..+..   ....++|||
T Consensus        23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---~~~~~LVmE   98 (365)
T PRK09188         23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---TGKDGLVRG   98 (365)
T ss_pred             ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---cCCcEEEEE
Confidence            467999999999999865  467789998753311      145689999999999 89998853322   246799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |+++++|... ..        ..   ...++.++++||+|||+.+   |+|||| ||+|||++.++.+||+|||+|+...
T Consensus        99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            9999999632 10        11   1467889999999999998   999999 9999999999999999999998654


Q ss_pred             CCC------------CCCCCCcccCcccccCC
Q 006677          494 VPA------------TPSRSAGYRAPEVIETR  513 (635)
Q Consensus       494 ~~~------------~~~~~~~y~aPE~~~~~  513 (635)
                      ...            +..+++.|+|||.+...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            322            12246679999998643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-21  Score=185.16  Aligned_cols=255  Identities=19%  Similarity=0.220  Sum_probs=195.6

Q ss_pred             hhccccccCceEEEEEE-ecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          342 SAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+++||+|.||..+.|+ +-++..||||.- .......+...|...++.|...++|...+.+.....+-.||+|.+ |.+
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            46789999999999998 456899999864 334456778889999999988999999998888888888999987 668


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-----CCeEEeecCCCCCCCCC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLTPLMNVP  495 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~ki~DfGla~~~~~~  495 (635)
                      |.|++.-..    ..++..+++.+|.|++.-++|+|++.   +|.|||||+|+||...     ..+.|+|||+|+.+..+
T Consensus       110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            888876433    23899999999999999999999998   9999999999999753     45789999999988665


Q ss_pred             CC-----------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          496 AT-----------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       496 ~~-----------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      .+           ..||.+||+-.-..++..+.+.|+=|+|-+++..+-|..||++........   -.++ +.+.....
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---kYeK-IGe~Kr~T  258 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---KYEK-IGETKRST  258 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---HHHH-hccccccC
Confidence            43           247889999998899999999999999999999999999999876543221   1111 12211111


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      -++..   -.++++++...++.+++   .+-.+-|..+-+...+.++.+..
T Consensus       259 ~i~~L---c~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  259 PIEVL---CEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             CHHHH---HhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhc
Confidence            11111   12345666666666554   67778888888888777766543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-20  Score=194.59  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=186.1

Q ss_pred             hhccccccCceEEEEEEecCC--CeEEEEEeecccCC-hHHHHHHHHHHHhhcC---CCceeceeEEE-EeCCeeEEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEES--TTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQ---HPNVVPLRAYY-YSKDEKLLVYD  414 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~---h~niv~l~~~~-~~~~~~~lv~e  414 (635)
                      ..+.||+|+||.||++...+.  ..+|+|........ ...+..|..++..+..   -.++..++... ......++||+
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~  101 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMS  101 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEe
Confidence            356899999999999997654  36777776654322 2278889999988852   36888888888 47778899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-----CCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-----LDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~ki~DfGla  489 (635)
                      .+ |.+|.++.....   ...++..+...|+.|++.+|++||+.|   ++||||||.|++++..     ..+.+.|||++
T Consensus       102 l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen  102 LL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             cc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            77 669999886543   234899999999999999999999999   9999999999999865     46899999999


Q ss_pred             CCCC---CC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH
Q 006677          490 PLMN---VP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS  555 (635)
Q Consensus       490 ~~~~---~~-----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  555 (635)
                      +...   ..           ....||..|.++....+...+.+.|+||++.++.|++.|..||.........   .-+..
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~~~  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKFEK  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHHHH
Confidence            8221   11           1123788999999999999999999999999999999999999755432211   00111


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .....    ....   .....+.+.   .++...+-..+..++|....+...++++....
T Consensus       252 ~~~~~----~~~~---~~~~~~~~~---~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRKL----LTDR---FGDLKPEEF---AKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             Hhhhh----cccc---ccCCChHHH---HHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11000    0000   011122333   34444455589999999999999988877654

>PLN03150 hypothetical protein; Provisional

Probab=99.86  E-value=3e-21  Score=215.50  Aligned_cols=135  Identities=32%  Similarity=0.580  Sum_probs=96.8

Q ss_pred             ccCCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCC----CcceeEecCC--C--CeEEEEEeCCCCccCcCCcccccCCC
Q 006677           23 AFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQ----SWVGINCTQD--R--TRVFGLRLPGIGLVGPIPNNTLGKLD   94 (635)
Q Consensus        23 ~~~~~~~~~~al~~~~~~~~~~~~~~w~~~~~~c~----~w~gv~C~~~--~--~~v~~l~l~~~~l~g~l~~~~l~~l~   94 (635)
                      ...+...|..||+.+|.++.....++|+.  ++|+    .|.||.|...  .  .+|+.|+|++|++.|.+|+ .+++|+
T Consensus       366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~  442 (623)
T PLN03150        366 ESKTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLR  442 (623)
T ss_pred             ccccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCC
Confidence            34556789999999999986554568964  3452    7999999632  1  3588889999999888887 688888


Q ss_pred             CCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchh
Q 006677           95 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSI  160 (635)
Q Consensus        95 ~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~  160 (635)
                      +|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++  ++|+.|+|++|+|+|.+|..+
T Consensus       443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l  510 (623)
T PLN03150        443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL  510 (623)
T ss_pred             CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence            888888888888888888888888887777777777765554443  344444444444444444433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=1.2e-19  Score=187.56  Aligned_cols=252  Identities=28%  Similarity=0.391  Sum_probs=188.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCC-ceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||.|+||.||++...  ..+++|.+......    ...+.+|+.++..+ .|+ +++++...+......+++++|+.
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEEecCC
Confidence            356899999999999987  78899998766432    56788999999999 555 89999999977777899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP-  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~-  495 (635)
                      ++++.+++......  ..+.......++.|++.+++|+|+.+   ++|||+||+||+++..+ .++++|||.+...... 
T Consensus        82 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          82 GGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999777643211  24888999999999999999999998   99999999999999998 7999999998755432 


Q ss_pred             ---------CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          496 ---------ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       496 ---------~~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                               ....++..|+|||.+.+   ..+....|+||+|++++++++|..||......   .........+......
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence                     33457888999999987   57889999999999999999999997654321   0011111111111110


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ........... ......+.+++..|+..+|..|.++.+....
T Consensus       234 -~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             00000000000 1223456677789999999999999988775

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.3e-20  Score=171.67  Aligned_cols=193  Identities=20%  Similarity=0.261  Sum_probs=160.2

Q ss_pred             hccccccCceEEEEEE-ecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .++||.|+||.+|.|. +.+|.+||+|.-.. .....+...|..++..+..-..|..+..+..+...-.+|||.. |.+|
T Consensus        20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL   97 (341)
T KOG1163|consen   20 VRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL   97 (341)
T ss_pred             EEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence            4689999999999998 56799999997544 3345667788899999977788888999998888889999987 6699


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC---CCeEEeecCCCCCCCCCC--
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~DfGla~~~~~~~--  496 (635)
                      .+++.-...    .++..+++-++-|++.-++|+|.++   +|||||||+|+|..-+   ..+.++|||+|+.+....  
T Consensus        98 EdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   98 EDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             HHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            888864432    3888999999999999999999999   9999999999999754   467899999998764432  


Q ss_pred             ---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          497 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       497 ---------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                               ...||..|.+-....+...+.+.|+-|+|.+|...--|..||++....
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence                     223677888777777777788999999999999999999999986543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.9e-20  Score=176.60  Aligned_cols=138  Identities=14%  Similarity=0.185  Sum_probs=106.7

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCC----------hHH-----------------HHHHHHHHHhhcCCCce
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG----------KRD-----------------FEQQMEIVGRVGQHPNV  396 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------~~~-----------------~~~e~~~l~~l~~h~ni  396 (635)
                      +.||+|+||.||+|...+|+.||||+++.....          ...                 ...|++.+.++ .++++
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~v   81 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAGI   81 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCCC
Confidence            579999999999999888999999999754221          112                 23488889998 67766


Q ss_pred             eceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCCCCeEE
Q 006677          397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       397 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlk~~NIll  475 (635)
                      .....+..  ...++||||++++++......     ...++......++.|++.+|.|+ |+.+   |+||||||+|||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli  151 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY  151 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence            43333222  234899999998877654321     12488899999999999999999 6887   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~  493 (635)
                      + ++.++|+|||+|....
T Consensus       152 ~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             E-CCcEEEEEccccccCC
Confidence            8 5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.6e-21  Score=214.48  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=177.2

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeec---ccCChHH----HHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKE---VVVGKRD----FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~----~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+++|.|++|.|+.+... .....+.|....   ......+    +..|..+-..+ .|+|++..+..+.+....+-+|
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhh
Confidence            3578999999977777633 223333333221   1111111    23344444455 8999988877777666666669


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++ ||+.++...     ..+...++-.++.|+..|++|+|+.|   |.|||+|++|++++.++.+||+|||.+....
T Consensus       401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence            99999 999999743     24778888999999999999999999   9999999999999999999999999986654


Q ss_pred             CCC--------CCCCCCcccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          494 VPA--------TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       494 ~~~--------~~~~~~~y~aPE~~~~~~~~~k-~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      .+.        ...|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||......+...     .......+...
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~  546 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNI  546 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccc
Confidence            332        3346778999999999999765 799999999999999999998765443211     00000000000


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV  611 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~  611 (635)
                      .    .....-..........++.++++.+|.+|.|+++|++  .++.+
T Consensus       547 ~----~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  547 F----EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             c----cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            0    0001112333455667888999999999999999987  44443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=6.5e-20  Score=172.16  Aligned_cols=182  Identities=16%  Similarity=0.151  Sum_probs=139.4

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChH-----HHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ...|++|+||+||.+.- .+..++.+.+........     .+.+|++++.++.+|+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            35799999999997775 567788777765543222     578999999999777889999886    45799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI-KASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      |.+|...+..            ....++.|++.+|+++|+.|   |+|||| ||+|||++.++.++|+|||+|.......
T Consensus        82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9888654320            11357789999999999999   999999 7999999999999999999998554332


Q ss_pred             CC-----------------CCCCcccCcccccCC-CCC-CccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          497 TP-----------------SRSAGYRAPEVIETR-KHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       497 ~~-----------------~~~~~y~aPE~~~~~-~~~-~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                      ..                 ..++.|+.|+...-. ..+ ...++++-|.-+|.++|+..+..+.++.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~  213 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG  213 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence            10                 125567777654322 223 5679999999999999999998765543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=6.1e-21  Score=209.05  Aligned_cols=236  Identities=23%  Similarity=0.337  Sum_probs=174.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeeccc--CChHHHHHHHHHHH-hhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV--VGKRDFEQQMEIVG-RVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~e~~~l~-~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+-||.+.|=.|.+|+.++|. |+||++.+..  ..-+.|.++++-++ .+.+|||++++.-.-..+...|+|-+|+.+ 
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-  105 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-  105 (1431)
T ss_pred             ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence            456999999999999988776 8899986543  34455666554333 444899999988777777778899999876 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|+|.+.     .+..+...+.+.|+.|++.|+..+|..+   |+|+|||.+||||+.-.-+.|+||..-+...-+.   
T Consensus       106 nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  106 NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            9999986     4566888899999999999999999999   9999999999999999999999998654332111   


Q ss_pred             --------CCCCCCcccCcccccCC-----------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006677          497 --------TPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       497 --------~~~~~~~y~aPE~~~~~-----------~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  556 (635)
                              +..+...|.|||.+...           ..+++.||||+||+++|+++ |.+||.-.      ++..+.   
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr---  248 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR---  248 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh---
Confidence                    22234569999988541           14678899999999999999 57777521      111100   


Q ss_pred             hhhccccccchhh--hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          557 VREEWTAEVFDVE--LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       557 ~~~~~~~~~~d~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           .....+.+  +...++     ..+..++..|++.||++|.++++.++.
T Consensus       249 -----~~~~~~~e~~Le~Ied-----~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  249 -----SGNADDPEQLLEKIED-----VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -----ccCccCHHHHHHhCcC-----ccHHHHHHHHHccCchhccCHHHHHHh
Confidence                 00011111  001110     146778889999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4.2e-20  Score=177.39  Aligned_cols=163  Identities=13%  Similarity=0.180  Sum_probs=127.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHH----------HHHHHHHHHhhcCCCceeceeEEEEeC------
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD----------FEQQMEIVGRVGQHPNVVPLRAYYYSK------  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~~h~niv~l~~~~~~~------  406 (635)
                      .+++|.|+||.||.+.. ++..+|+|.+.......+.          +++|+..+.++ .|++|.....++...      
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeeccccccc
Confidence            57899999999999766 5778999999765433222          57888899999 999999998886643      


Q ss_pred             --CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          407 --DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       407 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                        ...++||||++|.+|.++..         ++.    ....+++.++..+|+.+   ++|||++|+||++++++ ++++
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEE
Confidence              35789999999999987742         332    24568999999999998   99999999999999988 9999


Q ss_pred             ecCCCCCCCCCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHH
Q 006677          485 DFGLTPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEML  532 (635)
Q Consensus       485 DfGla~~~~~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~  532 (635)
                      |||...........        ..+...+.+..++|+|+||+++.-..
T Consensus       177 Dfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence            99987655322111        11344556778999999999876654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4.2e-21  Score=201.05  Aligned_cols=186  Identities=29%  Similarity=0.425  Sum_probs=159.5

Q ss_pred             cccccCceEEEEEE----ecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          345 VLGKGSYGTAYKAV----LEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      ++|+|.||.|++++    ...+..++.|++++....   +.....|..++..+.+||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998875    234667888888765331   22455677888888679999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +|+|...+...     ..+++.........++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-....
T Consensus        81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99999888643     23677777778888999999999998   99999999999999999999999999988776666


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS  540 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~  540 (635)
                      .+||..|||||++.  .+...+|.||||++++||+||..||..
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            68999999999998  567889999999999999999999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=2.4e-19  Score=170.94  Aligned_cols=138  Identities=17%  Similarity=0.245  Sum_probs=109.0

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCC---------------------------hHHHHHHHHHHHhhcCCCce
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------------------KRDFEQQMEIVGRVGQHPNV  396 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~~h~ni  396 (635)
                      +.||+|+||.||+|...+|+.||||++......                           ...+++|.+.+.++ .|+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i   81 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAGV   81 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCCC
Confidence            579999999999999878999999998754211                           11235678888888 78887


Q ss_pred             eceeEEEEeCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeE
Q 006677          397 VPLRAYYYSKDEKLLVYDYFASGSLSTL-LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVL  474 (635)
Q Consensus       397 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIl  474 (635)
                      .....+...  ..++||||++++++... +..      ..++......++.|++.++.++|+ .+   |+||||||+||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl  150 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL  150 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence            544444332  34899999998855433 321      237788899999999999999999 88   999999999999


Q ss_pred             EcCCCCeEEeecCCCCCCCC
Q 006677          475 INQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       475 l~~~~~~ki~DfGla~~~~~  494 (635)
                      ++ ++.++|+|||++.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            99 89999999999977643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.5e-19  Score=189.81  Aligned_cols=210  Identities=21%  Similarity=0.389  Sum_probs=159.9

Q ss_pred             CCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 006677          392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS  471 (635)
Q Consensus       392 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~  471 (635)
                      .|.|+.+++|.+.++...++|.+|+..|+|.+.+...    ...++|.....+..+|+.||+|+|...  -..|+.++++
T Consensus         5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~   78 (484)
T KOG1023|consen    5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS   78 (484)
T ss_pred             chhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence            8999999999999999999999999999999999752    345899999999999999999999865  2299999999


Q ss_pred             CeEEcCCCCeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCC-------CCCccchhhHHHHHHHHHhCCCCC
Q 006677          472 NVLINQDLDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRK-------HSHKSDVYSFGVLLLEMLTGKAPL  538 (635)
Q Consensus       472 NIll~~~~~~ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~-------~~~k~Dvws~Gvvl~el~tg~~p~  538 (635)
                      |+++|..+.+|++|||+.........      .....-|.|||.+....       .+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            99999999999999999877643110      11123499999997642       356799999999999999999999


Q ss_pred             CCCCCCCC-CChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          539 QSPTRDDM-VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       539 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      +.....+. ..+..++.+    . ....+-+.+...   .+....+..++.+||..+|++||+++++...++.+....
T Consensus       159 ~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK----G-GSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCChHHHHHHHHh----c-CCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            86543322 122222222    0 111111111110   122236888899999999999999999999998887654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.1e-18  Score=172.43  Aligned_cols=193  Identities=20%  Similarity=0.307  Sum_probs=135.5

Q ss_pred             cCCCceeceeEEEEeC---------------------------CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHH
Q 006677          391 GQHPNVVPLRAYYYSK---------------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK  443 (635)
Q Consensus       391 ~~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~  443 (635)
                      .+|||||++.++|.+.                           ...|+||.-++. +|..++..+.      .+.....-
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~  345 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRV  345 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHH
Confidence            3899999998887431                           245899998865 9999986432      56667778


Q ss_pred             HHHHHHHHHHHHHhcCCCCceecCCCCCCeEE--cCCC--CeEEeecCCCCCCCC----------CCCCCCCCcccCccc
Q 006677          444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLI--NQDL--DGCISDFGLTPLMNV----------PATPSRSAGYRAPEV  509 (635)
Q Consensus       444 i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~ki~DfGla~~~~~----------~~~~~~~~~y~aPE~  509 (635)
                      |+.|+++|+.|||++|   |.|||+|++|||+  |+|+  ...|+|||.+---..          .-...|...-||||+
T Consensus       346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            9999999999999999   9999999999999  3444  357899997532211          112234556899999


Q ss_pred             ccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHH
Q 006677          510 IETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM  583 (635)
Q Consensus       510 ~~~~~------~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l  583 (635)
                      ....+      .-.|+|.|+.|-+.||+++...||....+. ..+...+-+..+             .  .-.+...-.+
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yqe~qL-------------P--alp~~vpp~~  486 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQESQL-------------P--ALPSRVPPVA  486 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhhhhhC-------------C--CCcccCChHH
Confidence            86543      246899999999999999999999753211 122222111111             0  0112233456


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          584 LQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       584 ~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                      .+++...++.||++|++..-....|.
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHH
Confidence            67788999999999999877666554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=8.4e-19  Score=173.47  Aligned_cols=230  Identities=17%  Similarity=0.287  Sum_probs=139.3

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcC---------CCceeceeEEEE----
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQ---------HPNVVPLRAYYY----  404 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~---------h~niv~l~~~~~----  404 (635)
                      ++.||.|+|+.||.+...+ ++.+|+|+.......    .+.+++|.-.+..+..         |-.++-.++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            4689999999999999865 788999998654321    2345555433333211         211222222211    


Q ss_pred             -----eC--C------eeEEEEEeccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006677          405 -----SK--D------EKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK  469 (635)
Q Consensus       405 -----~~--~------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  469 (635)
                           ..  .      ..+++|+-+ .+||.+++..-..  .....+....++.+..|+++.+++||+.|   ++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence                 11  1      235677766 4588777542110  01122445566778899999999999999   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCCCCCCCCCC-CCCCCcccCcccccCC--------CCCCccchhhHHHHHHHHHhCCCCCCC
Q 006677          470 ASNVLINQDLDGCISDFGLTPLMNVPAT-PSRSAGYRAPEVIETR--------KHSHKSDVYSFGVLLLEMLTGKAPLQS  540 (635)
Q Consensus       470 ~~NIll~~~~~~ki~DfGla~~~~~~~~-~~~~~~y~aPE~~~~~--------~~~~k~Dvws~Gvvl~el~tg~~p~~~  540 (635)
                      |+|++++++|.++++||+.....+.... ...+..|.+||.....        .++.+.|.|++|+++|.|++|..||..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999987654433222 2344679999977442        478899999999999999999999986


Q ss_pred             CCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC
Q 006677          541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR  598 (635)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  598 (635)
                      .......+.                      .+....+....+.+|+..+++.+|++|
T Consensus       253 ~~~~~~~~~----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEW----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGG----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccc----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            532221110                      111112334455667779999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.9e-17  Score=158.70  Aligned_cols=134  Identities=12%  Similarity=0.125  Sum_probs=103.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeeccc-CChHHHHHHHHHHHhhc----CCCceeceeEEEEeCC---eeE-EEE
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKD---EKL-LVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~---~~~-lv~  413 (635)
                      .+.||+|+||.||.  +.+....+||++.... ...+.+.+|+.++..+.    .||||+++++++.++.   ..+ +|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            46799999999996  4444444788876542 24567999999999984    4799999999998874   333 789


Q ss_pred             Ee--ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCCeEEcC----CCCeEEeec
Q 006677          414 DY--FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV-AHIHSMGGPKFTHGNIKASNVLINQ----DLDGCISDF  486 (635)
Q Consensus       414 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~Df  486 (635)
                      ||  +.+|+|.+++...      .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            99  5579999999642      25544  35677888777 9999998   999999999999974    347999995


Q ss_pred             CCC
Q 006677          487 GLT  489 (635)
Q Consensus       487 Gla  489 (635)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=1.2e-16  Score=155.33  Aligned_cols=133  Identities=20%  Similarity=0.367  Sum_probs=112.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCC---------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      +.||+|++|.||+|.. .+..+++|+.......         ...+.+|++++..+ +|+++.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEE
Confidence            4699999999999987 5678899986543221         23567888999998 88888887778777888899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      |+++++|.+++...        .+ .+..++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998531        12 78899999999999999998   99999999999999 78999999998765

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.7e-16  Score=155.93  Aligned_cols=139  Identities=15%  Similarity=0.202  Sum_probs=106.7

Q ss_pred             hhccccccCceEEEEEE--ecCCCeEEEEEeecccCC-------------------------hHHHHHHHHHHHhhcCC-
Q 006677          342 SAEVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQH-  393 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h-  393 (635)
                      ..+.||+|+||.||+|.  ..+|+.||+|+++.....                         ...+++|++.+.++ .+ 
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~~  110 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YEA  110 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-Hhc
Confidence            35789999999999998  567999999998754210                         12356789999998 44 


Q ss_pred             -CceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 006677          394 -PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN  472 (635)
Q Consensus       394 -~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  472 (635)
                       ..+.+.+++    ...++||||+++++|......     ...........++.|++.++++||+.+  .|+||||||+|
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence             223344432    245899999999888765422     123555667889999999999999986  59999999999


Q ss_pred             eEEcCCCCeEEeecCCCCCCC
Q 006677          473 VLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       473 Ill~~~~~~ki~DfGla~~~~  493 (635)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=2.4e-16  Score=151.62  Aligned_cols=130  Identities=21%  Similarity=0.353  Sum_probs=105.5

Q ss_pred             cccccCceEEEEEEecCCCeEEEEEeecccC---------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .||+|+||.||+|.+ ++..+++|+......         ....+.+|++++..+ +|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999995 467899998654321         124567899999998 777766555566667778999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +++++|.+++....      .      .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999998875311      0      78999999999999998   99999999999999 899999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=5.2e-17  Score=182.19  Aligned_cols=184  Identities=24%  Similarity=0.342  Sum_probs=145.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhc--CCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|...+|+.||+|+-+....++  |.--.+++.||.  --+-|+.+...+.-.+..++|+||.+.|+
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            45799999999999998889999999987765442  222223444441  12344455555556677889999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-------CCCeEEeecCCCCCCC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------DLDGCISDFGLTPLMN  493 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~ki~DfGla~~~~  493 (635)
                      |.+++...     +..+|.-+..+..|+++-+++||..+   |||+||||+|+||..       ...++|+|||.+-.+.
T Consensus       781 lld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  781 LLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             HHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            99999843     34899999999999999999999998   999999999999942       3458999999986553


Q ss_pred             C---CC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCC
Q 006677          494 V---PA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA  536 (635)
Q Consensus       494 ~---~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~  536 (635)
                      .   ..   ..++|-.+-.+|...++..+.++|.|.+.-+++-|+.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            2   21   1235667899999999999999999999999999999874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=3.7e-16  Score=150.12  Aligned_cols=132  Identities=15%  Similarity=0.174  Sum_probs=104.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC-----------------------hHHHHHHHHHHHhhcCCC--cee
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-----------------------KRDFEQQMEIVGRVGQHP--NVV  397 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------~~~~~~e~~~l~~l~~h~--niv  397 (635)
                      .+.||+|+||.||++...+|+.||||++......                       .....+|..++..+ .|+  .++
T Consensus        20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~v~   98 (198)
T cd05144          20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEGFPVP   98 (198)
T ss_pred             CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcCCCCC
Confidence            5789999999999999888999999987643210                       12356778888888 666  344


Q ss_pred             ceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC
Q 006677          398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       398 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  477 (635)
                      ..++    ....++||||+++++|......           .....++.+++.++.++|+.+   |+||||||+||++++
T Consensus        99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~  160 (198)
T cd05144          99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD  160 (198)
T ss_pred             ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence            4443    2456899999999998765421           234678899999999999988   999999999999999


Q ss_pred             CCCeEEeecCCCCCCC
Q 006677          478 DLDGCISDFGLTPLMN  493 (635)
Q Consensus       478 ~~~~ki~DfGla~~~~  493 (635)
                      ++.++|+|||.+....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.8e-16  Score=173.79  Aligned_cols=131  Identities=21%  Similarity=0.334  Sum_probs=107.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEE-eecccC--------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVV--------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||+||+|.+.+.. +++|+ ..+...        ..+.+.+|++++.++ +|++++....++......++||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEE
Confidence            568999999999999976544 34443 222111        124578899999999 8999988888888777889999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ||+++++|.+++.             ....++.+++.+|.|||+.+   ++||||||+||++ +++.++|+|||+++..
T Consensus       416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999998874             35678999999999999998   9999999999999 6789999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=9.6e-17  Score=176.49  Aligned_cols=196  Identities=26%  Similarity=0.392  Sum_probs=134.5

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .++|-.|+||.||.++++. .+++|+|+-++.     .+.+.  ++... ..|.+|                     ||-
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~-----lilRn--ilt~a-~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILRN--ILTFA-GNPFVV---------------------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccc-----hhhhc--ccccc-CCccee---------------------chh
Confidence            4789999999999999875 456777432221     11111  22222 444444                     565


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-------
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-------  494 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-------  494 (635)
                      ...++..     .+++..        ++.+++|+|+.+   |+|||+||+|.+|+.-|++|++|||+.+....       
T Consensus       139 ~tllk~~-----g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  139 ATLLKNI-----GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhhcccC-----CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            5555431     123322        267899999998   99999999999999999999999998754211       


Q ss_pred             ------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc--
Q 006677          495 ------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE--  560 (635)
Q Consensus       495 ------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  560 (635)
                                  +..-++|+.|+|||++....|+..+|+|++|+++||.+-|+.||.+.+.++...      ..+.+.  
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~  276 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIE  276 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcc
Confidence                        112257999999999999999999999999999999999999999887665432      122211  


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCC
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN  600 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs  600 (635)
                      |.+.  |         +....+..+++.+.++.+|.+|--
T Consensus       277 wpE~--d---------ea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  277 WPEE--D---------EALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cccc--C---------cCCCHHHHHHHHHHHHhChHhhcc
Confidence            1111  1         122234455666888899988843

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.63  E-value=9.3e-17  Score=165.56  Aligned_cols=118  Identities=25%  Similarity=0.353  Sum_probs=103.4

Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      ..|+.|+++.-.+|.+|+.+.+.  ....++...+.++.|++.|+.|   ++   .+|||+||.||+...+..+||+|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence            46899999999999999975543  3346788899999999999999   65   9999999999999999999999999


Q ss_pred             CCCCCCCCC----------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh
Q 006677          488 LTPLMNVPA----------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT  533 (635)
Q Consensus       488 la~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t  533 (635)
                      +........          ...+|..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            987664433          2347888999999999999999999999999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=1.4e-15  Score=138.88  Aligned_cols=135  Identities=18%  Similarity=0.168  Sum_probs=113.0

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-CceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      +.||+|.++.||++...+ ..+++|....... ...+.+|+.++..+.++ .++++++++....+..++++||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            569999999999999865 7899998865433 56789999999999444 68899998888778899999999887665


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      .+            +......++.+++.+++++|....+.++|+|++|+||++++++.++++|||.+...
T Consensus        82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            43            44667788999999999999864445999999999999999999999999988653

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.63  E-value=8.6e-18  Score=147.91  Aligned_cols=143  Identities=31%  Similarity=0.511  Sum_probs=127.9

Q ss_pred             CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           68 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        68 ~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      ..+++.|.|++|.++ .+|+ .++.|.+|++|++++|+++ .+|.+++.|++|+.|+++-|++. .+|..|+  +.|+.|
T Consensus        32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            357999999999999 7888 6999999999999999999 89999999999999999999999 8999998  899999


Q ss_pred             eccCccCc-ccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ||++|+++ ..+|..|..++.|+-|+|++|.+.-.+|+. .+++|+.|.+..|.+- .+|.+++.++.|+-+
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrel  178 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLREL  178 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHH
Confidence            99999986 458889999999999999999998666665 8999999999999988 789888887776654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=1.3e-14  Score=138.16  Aligned_cols=136  Identities=18%  Similarity=0.227  Sum_probs=97.8

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCCh---HH----------------------HHHHHHHHHhhcCC-Ccee
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RD----------------------FEQQMEIVGRVGQH-PNVV  397 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~----------------------~~~e~~~l~~l~~h-~niv  397 (635)
                      +.||+|+||+||+|...+++.||||++.......   ..                      ...|.+.+.++..+ -.+.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            5799999999999998889999999987542211   11                      13455556665222 2244


Q ss_pred             ceeEEEEeCCeeEEEEEeccCCChhhh-ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEE
Q 006677          398 PLRAYYYSKDEKLLVYDYFASGSLSTL-LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       398 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll  475 (635)
                      +.+++    ...++||||++++++... +....      .. .....++.+++.++.++|. .+   |+|+||||+||++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            44443    346899999999654321 11100      11 5678899999999999999 77   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~  494 (635)
                      + ++.++++|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 99999999999866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.9e-14  Score=140.48  Aligned_cols=137  Identities=18%  Similarity=0.233  Sum_probs=106.0

Q ss_pred             Hhhcccc-ccCceEEEEEEecCCCeEEEEEeeccc--------------CChHHHHHHHHHHHhhcCCCce--eceeEEE
Q 006677          341 ASAEVLG-KGSYGTAYKAVLEESTTVVVKRLKEVV--------------VGKRDFEQQMEIVGRVGQHPNV--VPLRAYY  403 (635)
Q Consensus       341 ~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~  403 (635)
                      .....|| .|+.|+||.+... +..+++|++....              .....+.+|++++.++ +|+++  +..+++.
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~  111 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAAR  111 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeee
Confidence            3467798 8999999999886 6788888875321              1234578899999999 77774  6677665


Q ss_pred             EeCCe----eEEEEEeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC
Q 006677          404 YSKDE----KLLVYDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD  478 (635)
Q Consensus       404 ~~~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  478 (635)
                      ..+..    .++||||+++ .+|.+++...      .++..    .+.+++.++.+||+.|   |+||||||+|||++.+
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~  178 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD  178 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence            43322    2599999997 6898887532      24443    3578999999999999   9999999999999999


Q ss_pred             CCeEEeecCCCCCC
Q 006677          479 LDGCISDFGLTPLM  492 (635)
Q Consensus       479 ~~~ki~DfGla~~~  492 (635)
                      +.++|+|||.+...
T Consensus       179 ~~v~LIDfg~~~~~  192 (239)
T PRK01723        179 GKFWLIDFDRGELR  192 (239)
T ss_pred             CCEEEEECCCcccC
Confidence            99999999988764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.53  E-value=3e-16  Score=138.24  Aligned_cols=135  Identities=32%  Similarity=0.485  Sum_probs=122.7

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCC-cCCCCcc--CCcceee
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVLD  146 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~--~~L~~L~  146 (635)
                      .+..|++.+|++. .+|. .++.|+.|+.|+++-|++. .+|..|+.++.|+.|||++|+++. .+|..|.  ..|+-|+
T Consensus        57 nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly  133 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY  133 (264)
T ss_pred             hhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence            4677899999998 8998 7999999999999999999 899999999999999999999984 6888887  7899999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFP  210 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~  210 (635)
                      |++|.|. .+|..+++|++|+.|.+..|.+- ++|..  .++.|+.|.+.+|+++ .+|++++++.
T Consensus       134 l~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~  196 (264)
T KOG0617|consen  134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD  196 (264)
T ss_pred             hcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence            9999999 99999999999999999999998 45543  8999999999999999 7888877653

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.49  E-value=1.9e-15  Score=156.99  Aligned_cols=138  Identities=30%  Similarity=0.400  Sum_probs=104.0

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCC-----------------
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-----------------  132 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-----------------  132 (635)
                      ....|+|++|++. +||...+-+|+.|-.||||+|+|. .+|+.+.+|.+|++|+|++|.|.-                 
T Consensus       127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm  204 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM  204 (1255)
T ss_pred             CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence            4667888888887 788878888999999999999998 788889999999999999987751                 


Q ss_pred             --------cCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCC
Q 006677          133 --------KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGS  201 (635)
Q Consensus       133 --------~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~  201 (635)
                              .+|.++.  .+|..+|||.|+|. .+|..+-++.+|+.|+||+|+|+..--.. ...+|+.|+||+|+|+ .
T Consensus       205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~  282 (1255)
T KOG0444|consen  205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V  282 (1255)
T ss_pred             ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence                    2333333  56888899999998 88888889999999999999888422211 4556666777777666 5


Q ss_pred             CCcccCCCCC
Q 006677          202 IPSSLQKFPN  211 (635)
Q Consensus       202 ~p~~~~~l~~  211 (635)
                      +|..+.+|++
T Consensus       283 LP~avcKL~k  292 (1255)
T KOG0444|consen  283 LPDAVCKLTK  292 (1255)
T ss_pred             chHHHhhhHH
Confidence            5555555543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=6.8e-15  Score=162.29  Aligned_cols=243  Identities=25%  Similarity=0.356  Sum_probs=175.8

Q ss_pred             ccccccCceEEEEEEecCC--CeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEES--TTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|.|+.|-.......  ..+++|.+......   ......|..+-..+.+|+|++.+++...+.+..+++++|..+
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g  105 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG  105 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence            3489999999988775433  34556555443221   223333555555664599999999999999999999999999


Q ss_pred             CChhhhc-cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCC-
Q 006677          419 GSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV-  494 (635)
Q Consensus       419 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~-  494 (635)
                      +++.+.+ +...    ...+.......+.|+..++.|+| ..+   +.|||+||+|.+++..+ ..+++|||+|..+.. 
T Consensus       106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9999988 4322    12555677788999999999999 777   99999999999999999 999999999977655 


Q ss_pred             CC------CCCC-CCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          495 PA------TPSR-SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       495 ~~------~~~~-~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..      ...| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++.....+. ....|........      
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~------  251 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKGRFT------  251 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccccccc------
Confidence            22      2347 88899999998854 46778999999999999999999986654432 1122222110000      


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                         ...+....   ....++..+++..+|+.|.+.+++..
T Consensus       252 ---~~~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  252 ---QLPWNSIS---DQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cCccccCC---hhhhhcccccccCCchhccccccccc
Confidence               00111112   23445556888899999999988765

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.45  E-value=1.3e-14  Score=150.13  Aligned_cols=143  Identities=30%  Similarity=0.303  Sum_probs=100.8

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      ....|+|+.|+++ .+..+.+.+|+.|+.||||+|.|...-++.+.-..+|++|+|++|+++..-+.+|.  ..|++|+|
T Consensus       270 kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL  348 (873)
T KOG4194|consen  270 KMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL  348 (873)
T ss_pred             ccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence            4677888888888 56666888899999999999999877788888889999999999999855555554  56677777


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC-----CCCCCcEEEeecccCcCCCC-cccCCCCCCCc
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSF  214 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~  214 (635)
                      ++|+++..--..|..+++|++|||++|.|++.|.+.     .|++|+.|+|.+|++. .|| ..|.++.+|..
T Consensus       349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~  420 (873)
T KOG4194|consen  349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEH  420 (873)
T ss_pred             cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccce
Confidence            777766555556666777777777777776655442     5666666666666665 333 34544444443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.44  E-value=2.4e-15  Score=149.11  Aligned_cols=138  Identities=32%  Similarity=0.507  Sum_probs=118.1

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      +.+.+++.+|.+. .+|++.+. ++.|+.||.-+|-++ ++|++++.|.+|.-|||.+|++. .+| +|+  ..|++|++
T Consensus       161 ~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~  235 (565)
T KOG0472|consen  161 KLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHV  235 (565)
T ss_pred             HHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHh
Confidence            3556777888887 67765554 899999999999988 89999999999999999999998 778 665  78999999


Q ss_pred             cCccCcccCCchhh-ccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          148 SFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       148 s~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      +.|+|+ .+|.+.. +|.+|.+|||.+|+++ ++|+.  .+.+|.+||||+|.++ .+|.+++++ .|.|+.
T Consensus       236 g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~  303 (565)
T KOG0472|consen  236 GENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLA  303 (565)
T ss_pred             cccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehh
Confidence            999999 8888776 9999999999999999 56654  7899999999999999 688899998 777763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1.6e-12  Score=139.22  Aligned_cols=141  Identities=21%  Similarity=0.310  Sum_probs=99.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC-----------------------------------------hHHHH
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-----------------------------------------KRDFE  381 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~  381 (635)
                      .+.||.|++|.||+|++.+|+.||||+.+.....                                         +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3579999999999999999999999998643110                                         00234


Q ss_pred             HHHHHHHhhc----CCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 006677          382 QQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR-GVAHIH  456 (635)
Q Consensus       382 ~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH  456 (635)
                      +|...+.++.    +++++.-..-+.......++||||++|++|.++......    ..   .+..++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence            4444444442    234433222223334567999999999999887643211    12   23456666665 467889


Q ss_pred             hcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       457 ~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ..|   ++|+|++|.||++++++.++++|||++....
T Consensus       275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            888   9999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.39  E-value=8.4e-14  Score=138.12  Aligned_cols=162  Identities=24%  Similarity=0.329  Sum_probs=121.6

Q ss_pred             eeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc-Ccc
Q 006677           61 GINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH-NNF  130 (635)
Q Consensus        61 gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~-N~l  130 (635)
                      -|.|+..         ....+.|+|..|+|+ .||+++|+.+.+|+.||||+|+|+-+-|..|.+|++|..|-+-+ |+|
T Consensus        50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI  128 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI  128 (498)
T ss_pred             eEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence            4778753         245789999999999 89999999999999999999999988899999988887766655 777


Q ss_pred             CCcCCCCcc-----------------------------------------------------------------------
Q 006677          131 SGKIPSSFS-----------------------------------------------------------------------  139 (635)
Q Consensus       131 ~g~~p~~~~-----------------------------------------------------------------------  139 (635)
                      + .+|....                                                                       
T Consensus       129 ~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~  207 (498)
T KOG4237|consen  129 T-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP  207 (498)
T ss_pred             h-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence            6 3332100                                                                       


Q ss_pred             ------------------------------------------------------------------CCcceeeccCccCc
Q 006677          140 ------------------------------------------------------------------PQLVVLDLSFNSFT  153 (635)
Q Consensus       140 ------------------------------------------------------------------~~L~~L~ls~N~l~  153 (635)
                                                                                        ++|+.|+|++|+|+
T Consensus       208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~  287 (498)
T KOG4237|consen  208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT  287 (498)
T ss_pred             hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence                                                                              23566666666666


Q ss_pred             ccCCchhhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCcCCCCcccCCC---CCCCccCCCCCCCCCC
Q 006677          154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF---PNSSFVGNSLLCGPPL  225 (635)
Q Consensus       154 g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~~~n~~l~~~~l  225 (635)
                      +.-+.+|..+..|+.|+|..|+|.. +...   ++..|+.|+|.+|+++-.-|..|..+   +.|..++|+..|.+.+
T Consensus       288 ~i~~~aFe~~a~l~eL~L~~N~l~~-v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l  364 (498)
T KOG4237|consen  288 RIEDGAFEGAAELQELYLTRNKLEF-VSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL  364 (498)
T ss_pred             hhhhhhhcchhhhhhhhcCcchHHH-HHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence            6666666666666666666666652 2221   68899999999999998888887755   4556779999997654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.36  E-value=4.4e-14  Score=146.97  Aligned_cols=126  Identities=33%  Similarity=0.530  Sum_probs=71.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCC-cCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~--~~L~~L  145 (635)
                      .+++.|.|...+|. .+|+ .++.|.+|++|.+++|+|. .+-.+++.|+.|+.+++.+|+|.. -||..+.  ..|+.|
T Consensus        32 t~~~WLkLnrt~L~-~vPe-EL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~l  108 (1255)
T KOG0444|consen   32 TQMTWLKLNRTKLE-QVPE-ELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTIL  108 (1255)
T ss_pred             hheeEEEechhhhh-hChH-HHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceee
Confidence            45666666666665 5665 5666666666666666665 444455555555555555555532 2444443  455555


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~  199 (635)
                      |||+|+|. ..|..+.+-+++-.|+||+|+|. .||..   +|+.|-+||||+|+|.
T Consensus       109 DLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen  109 DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             ecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence            66666555 55555555555555555555555 34432   5555555555555555

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=1.1e-11  Score=115.74  Aligned_cols=131  Identities=15%  Similarity=0.114  Sum_probs=96.8

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST  423 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  423 (635)
                      +.|+.|.++.||++... +..+++|...........++.|++++..+.+...+.+++.+.  .+..++||||+++.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            46889999999999876 778999987654433445788999999884333344454443  344689999999987754


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          424 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       424 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      .-          .   ....++.+++++++.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            30          1   11245678999999999986  12359999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.4e-12  Score=125.08  Aligned_cols=194  Identities=21%  Similarity=0.308  Sum_probs=136.1

Q ss_pred             CCCceeceeEEEEeCC-----eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 006677          392 QHPNVVPLRAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHG  466 (635)
Q Consensus       392 ~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  466 (635)
                      .|.|+|++..|+.+.+     ...++.|||..|++..+|++.+. ....+......+++.||..||.|||+.. |+|+|+
T Consensus       125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppiihg  202 (458)
T KOG1266|consen  125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCD-PPIIHG  202 (458)
T ss_pred             HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccC-CccccC
Confidence            5999999999987654     45789999999999999986553 2345778888999999999999999975 899999


Q ss_pred             CCCCCCeEEcCCCCeEEeecCCCCCCC------C--CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC-
Q 006677          467 NIKASNVLINQDLDGCISDFGLTPLMN------V--PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP-  537 (635)
Q Consensus       467 Dlk~~NIll~~~~~~ki~DfGla~~~~------~--~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p-  537 (635)
                      ++..+-|++..++-+||+--.-.....      .  .....+-++|.+||+=.....+.++|||+||....||..+..- 
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~  282 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS  282 (458)
T ss_pred             CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence            999999999999988875321111100      0  0112245789999988777778899999999999999987653 


Q ss_pred             CCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          538 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      -......+.           .+.....++..+-.          .-..++..|++..|..||+|.+++.+.
T Consensus       283 tnseS~~~~-----------ee~ia~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  283 TNSESKVEV-----------EENIANVIIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             CCCcceeeh-----------hhhhhhheeeccCc----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            221111100           00000000000000          002345699999999999999988754

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.31  E-value=1.8e-11  Score=138.00  Aligned_cols=123  Identities=28%  Similarity=0.518  Sum_probs=97.0

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN  150 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N  150 (635)
                      .+.|+|.+++++ .+|. .+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+..+|+.|+|++|
T Consensus       180 ~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N  251 (754)
T PRK15370        180 KTELRLKILGLT-TIPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSIN  251 (754)
T ss_pred             ceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCC
Confidence            566888888888 5776 343  57999999999999 6887664  58999999999998 678877788999999999


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCccc
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL  206 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~  206 (635)
                      ++. .+|..+.  ++|+.|+|++|+|+ .+|..-..+|+.|+|++|+|++ +|..+
T Consensus       252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l  302 (754)
T PRK15370        252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYDNSIRT-LPAHL  302 (754)
T ss_pred             ccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCCCcccc-Ccccc
Confidence            988 7787764  57899999999988 4565444688889999888884 55433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.29  E-value=1.8e-12  Score=134.38  Aligned_cols=144  Identities=26%  Similarity=0.247  Sum_probs=80.8

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .+..|+|++|.|+ .+....|-+|++|+.++|.+|.|+ .||...+...+|+.|+|.+|.++..-..++.  +.|+.|||
T Consensus        79 ~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   79 QTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL  156 (873)
T ss_pred             ceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence            3566888888887 344446778888888888888887 7776555555577777777766633333332  45555555


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |.|.|+...-++|-.-.+|++|+|++|.|+..-...  .+.+|..|.|+.|+++...+..|.+|++|.++
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~L  226 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESL  226 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhh
Confidence            555555332234444445555555555555322211  34455555555555553333444444444433

>PLN03150 hypothetical protein; Provisional

Probab=99.25  E-value=5.5e-12  Score=141.29  Aligned_cols=89  Identities=42%  Similarity=0.665  Sum_probs=76.7

Q ss_pred             CCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcC
Q 006677           95 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ  172 (635)
Q Consensus        95 ~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  172 (635)
                      .++.|+|++|.++|.+|..|++|++|+.|+|++|.|+|.+|..+.  ++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            578899999999999999999999999999999999988888776  678888888888888888888888888888888


Q ss_pred             CCcccccCCCC
Q 006677          173 SNNLSGSIPNF  183 (635)
Q Consensus       173 ~N~l~~~~p~~  183 (635)
                      +|+++|.+|..
T Consensus       499 ~N~l~g~iP~~  509 (623)
T PLN03150        499 GNSLSGRVPAA  509 (623)
T ss_pred             CCcccccCChH
Confidence            88888777753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=8.5e-12  Score=131.73  Aligned_cols=239  Identities=18%  Similarity=0.228  Sum_probs=173.2

Q ss_pred             hhccccc--cCceEEEEEEe---cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGK--GSYGTAYKAVL---EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ....+|.  |.+|.||.+..   .++..+|+|+-+....   ....-.+|....+.+..|+|.++....+...+..++-+
T Consensus       118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt  197 (524)
T KOG0601|consen  118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT  197 (524)
T ss_pred             cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence            3567899  99999999986   3467788888654432   23344566777777778999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR----GVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGL  488 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGl  488 (635)
                      |++. .+|..+.+....    .++.........+..+    |+.++|...   ++|-|+||.||+...+ ...+++|||+
T Consensus       198 E~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  198 ELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             cccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence            9885 688888875432    2566667777777777    999999987   9999999999999999 8889999998


Q ss_pred             CCCCCCCC---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006677          489 TPLMNVPA---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE  559 (635)
Q Consensus       489 a~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  559 (635)
                      ........         ...+...|++||...+ .++.+.|+|++|.+..|..++..+...........+..|.      
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------  342 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------  342 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence            76654432         1135566999999865 6788999999999999999987766533211111111100      


Q ss_pred             ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       560 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                            +.     ....+.....+...+..+++.+|..|++.+.+..
T Consensus       343 ------ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  343 ------IP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------Cc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  00     0011111223333667899999999999988876

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.23  E-value=1.7e-13  Score=136.19  Aligned_cols=138  Identities=30%  Similarity=0.456  Sum_probs=120.3

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      -.+.|++.+|.++ ++|+ +++.+..++.|+.++|+++ .+|++++.+.+|+.|++++|.+. .+|+.++  ..|..|+.
T Consensus        69 ~l~vl~~~~n~l~-~lp~-aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~  144 (565)
T KOG0472|consen   69 CLTVLNVHDNKLS-QLPA-AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA  144 (565)
T ss_pred             ceeEEEeccchhh-hCCH-HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence            4778899999998 7888 7999999999999999999 89999999999999999999998 7777777  67889999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      .+|+++ +.|+.++++.+|..|++.+|++....|.. +++.|++||...|.++ .+|+.++.+.+|.
T Consensus       145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~  209 (565)
T KOG0472|consen  145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLE  209 (565)
T ss_pred             cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhH
Confidence            999999 88999999999999999999999766654 7888999999988887 7888888877664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.17  E-value=2.9e-11  Score=136.24  Aligned_cols=120  Identities=26%  Similarity=0.428  Sum_probs=90.7

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      ..++.|+|++|+|+ .+|.. +.  .+|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+..+|+.|+|+
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~-l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls  270 (754)
T PRK15370        199 EQITTLILDNNELK-SLPEN-LQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLF  270 (754)
T ss_pred             cCCcEEEecCCCCC-cCChh-hc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECc
Confidence            35888999999999 68873 33  58999999999998 6786554  47888888888888 7787777788888888


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g  200 (635)
                      +|+|+ .+|..+.  ++|+.|+|++|+|++ +|....++|+.|+|++|+|++
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTA  318 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCcccc
Confidence            88888 5776654  478888888888884 443323456677777777763

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.17  E-value=1e-10  Score=126.85  Aligned_cols=140  Identities=18%  Similarity=0.265  Sum_probs=89.2

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccC---------------------------C--------------hHHHH
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV---------------------------G--------------KRDFE  381 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------------------------~--------------~~~~~  381 (635)
                      +.||.|++|.||+|++++ |+.||||+......                           .              +-++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 99999999964310                           0              01233


Q ss_pred             HHHHHHHhhc---CCCceeceeEEEEe-CCeeEEEEEeccCCChhhhccCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006677          382 QQMEIVGRVG---QHPNVVPLRAYYYS-KDEKLLVYDYFASGSLSTLLHGN-RGAGRTPLDWETRVKILLGTARGVAHIH  456 (635)
Q Consensus       382 ~e~~~l~~l~---~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH  456 (635)
                      +|+.-+.++.   .+.+.+.+-.++.+ ....++||||++|+.+.++-.-. .+.....+.......++       ..++
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-------~Qif  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-------TQVF  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-------HHHH
Confidence            4444343332   23333333333332 45678999999999997742111 11000112222222222       3344


Q ss_pred             hcCCCCceecCCCCCCeEEcCCC----CeEEeecCCCCCCC
Q 006677          457 SMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTPLMN  493 (635)
Q Consensus       457 ~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla~~~~  493 (635)
                      ..|   ++|+|+||.||+++.++    .++++|||++....
T Consensus       278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            566   99999999999999988    99999999987664

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.16  E-value=2e-11  Score=112.77  Aligned_cols=126  Identities=27%  Similarity=0.328  Sum_probs=48.2

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCCCCC-CCCcccEEeeccCccCCcCCCCccCCcceeeccCccCcccCCchh-hccccCC
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLT  167 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~-~~l~~L~  167 (635)
                      +.+..+++.|+|++|.|+ .|. .++ .|.+|+.|||++|.++..-.-...+.|++|+|++|+|+ .++..+ ..+++|+
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ   91 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence            566677888888888888 453 566 57888888888888884322112278889999999988 555555 4689999


Q ss_pred             cEEcCCCcccccCCC---CCCCCCcEEEeecccCcCCCCc----ccCCCCCCCccCCCC
Q 006677          168 GLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVGNSL  219 (635)
Q Consensus       168 ~L~l~~N~l~~~~p~---~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~~~n~~  219 (635)
                      .|+|++|+|...-.-   ..+++|+.|+|.+|.++.. +.    .+..+|+|.+++...
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~~  149 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQD  149 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTEE
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCEE
Confidence            999999999742211   2788999999999998843 32    356788888887543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.16  E-value=1.1e-12  Score=135.98  Aligned_cols=148  Identities=30%  Similarity=0.492  Sum_probs=94.6

Q ss_pred             EEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCcc
Q 006677           74 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS  151 (635)
Q Consensus        74 l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~  151 (635)
                      +.|.+|-+. +||. .+++|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++  ..|..||.+.|+
T Consensus       103 liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne  177 (722)
T KOG0532|consen  103 LILYHNCIR-TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE  177 (722)
T ss_pred             HHHHhccce-ecch-hhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhh
Confidence            334444444 4555 4666666666666666666 5555555553 566666666665 5555555  556666777777


Q ss_pred             CcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc--CCCCCCCCCCCCC
Q 006677          152 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV--GNSLLCGPPLKAC  228 (635)
Q Consensus       152 l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~--~n~~l~~~~l~~c  228 (635)
                      +. .+|..+++|.+|+.|.+..|++...++...--.|..||+|.|+++ .||-.|.+++.|.++  .|+.|-.+|-..|
T Consensus       178 i~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC  254 (722)
T KOG0532|consen  178 IQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQIC  254 (722)
T ss_pred             hh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHH
Confidence            66 666677777777777777777765544444446889999999999 899999999988775  4444443443333

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=6.5e-10  Score=104.79  Aligned_cols=136  Identities=13%  Similarity=0.159  Sum_probs=97.6

Q ss_pred             ccccccCceEEEEEEecC-------CCeEEEEEeecccC----------------------C-hHH----HHHHHHHHHh
Q 006677          344 EVLGKGSYGTAYKAVLEE-------STTVVVKRLKEVVV----------------------G-KRD----FEQQMEIVGR  389 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~----------------------~-~~~----~~~e~~~l~~  389 (635)
                      ..||.|--+.||.|.-.+       +..+|||+.+....                      + .+.    .++|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       47899998853210                      0 111    2368888888


Q ss_pred             hcCC-CceeceeEEEEeCCeeEEEEEeccCCChhh-hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceec
Q 006677          390 VGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLST-LLHGNRGAGRTPLDWETRVKILLGTARGVAHI-HSMGGPKFTHG  466 (635)
Q Consensus       390 l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~  466 (635)
                      +... -++...+++    ...++||||+.+..+.. .++.      ..++......+..+++.+|..| |+.+   +||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            8533 456666654    56789999997754422 2221      1245556677889999999999 7887   9999


Q ss_pred             CCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          467 NIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       467 Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||++.||+++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999997 4689999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=6e-10  Score=108.82  Aligned_cols=142  Identities=19%  Similarity=0.236  Sum_probs=109.6

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcC-CCceeceeEEEEeCC---eeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD---EKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~---~~~lv~e~~~  417 (635)
                      +.|+.|.++.||++...+|..+++|.......  ....+.+|.+++..+.+ +.++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999987778899998765433  35678899999999843 234667777766532   5689999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------  459 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  459 (635)
                      +.++.+.+..      ..++......++.+++++|.+||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888776531      13677788888889999999988531                                      


Q ss_pred             ---------------CCCceecCCCCCCeEEcC--CCCeEEeecCCCCC
Q 006677          460 ---------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPL  491 (635)
Q Consensus       460 ---------------~~~ivH~Dlk~~NIll~~--~~~~ki~DfGla~~  491 (635)
                                     ...++|+|+.+.||++++  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           134699999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.14  E-value=2.6e-11  Score=111.94  Aligned_cols=118  Identities=35%  Similarity=0.494  Sum_probs=51.3

Q ss_pred             eEEEEEeCCCCccCcCCccccc-CCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc---cCCccee
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SPQLVVL  145 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~-~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---~~~L~~L  145 (635)
                      +...|+|.+|+++ .|..  ++ .|.+|+.|||++|.|+ .++ .+..|++|+.|+|++|+++ .++..+   .++|++|
T Consensus        20 ~~~~L~L~~n~I~-~Ie~--L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TIEN--LGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -----------------S----TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             ccccccccccccc-cccc--hhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            5788999999998 5653  66 6899999999999999 565 5889999999999999999 454433   2899999


Q ss_pred             eccCccCcccCC-chhhccccCCcEEcCCCcccccCCCC------CCCCCcEEEee
Q 006677          146 DLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------DIPKLRHLNLS  194 (635)
Q Consensus       146 ~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~------~l~~L~~l~l~  194 (635)
                      +|++|+|...-- ..+..+++|+.|+|.+|.++.. +..      .+|+|+.||-.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence            999999974322 4678899999999999999854 442      68999999843

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.11  E-value=2.2e-10  Score=128.64  Aligned_cols=94  Identities=28%  Similarity=0.375  Sum_probs=55.1

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF  149 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~  149 (635)
                      +++.|+|.+|+|+ .||.    .+++|++|+|++|+|+ .+|..   .++|+.|+|++|.|+ .+|. +..+|+.|+|++
T Consensus       223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~-lp~~L~~L~Ls~  291 (788)
T PRK15387        223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPA-LPSGLCKLWIFG  291 (788)
T ss_pred             CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhh-chhhcCEEECcC
Confidence            3555666666665 3553    1355666666666666 44532   345566666666665 3443 225566677777


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccc
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      |+|+ .+|..   +++|+.|+|++|+|++
T Consensus       292 N~Lt-~LP~~---p~~L~~LdLS~N~L~~  316 (788)
T PRK15387        292 NQLT-SLPVL---PPGLQELSVSDNQLAS  316 (788)
T ss_pred             Cccc-ccccc---ccccceeECCCCcccc
Confidence            7766 44542   3567777777777775

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.09  E-value=1e-11  Score=135.52  Aligned_cols=146  Identities=32%  Similarity=0.455  Sum_probs=108.1

Q ss_pred             eEEEEEeCCCCccCcCCccccc-------------------------CCCCCcEEEeecCCCCCCCCCCCCCCCcccEEe
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLG-------------------------KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLY  124 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~-------------------------~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~  124 (635)
                      .+..|+|..|+|. .+|+..+.                         .+..|+.|+|.+|.|+...-+.|.+.++|+.|+
T Consensus       311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            4677888888776 55543222                         234467788888888876666788889999999


Q ss_pred             eccCccCCcCCCCcc---CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcC
Q 006677          125 LQHNNFSGKIPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       125 l~~N~l~g~~p~~~~---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g  200 (635)
                      |++|+|. .+|+...   ..|++|+||+|+|+ .+|..+.++..|++|...+|+|. .+|.. .++.|+.+|||.|+|+-
T Consensus       390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccchhhh
Confidence            9999988 7777665   56888999999998 88889999999999999999988 55554 88889999999998863


Q ss_pred             -CCCccc--CCCCCCCccCCCC
Q 006677          201 -SIPSSL--QKFPNSSFVGNSL  219 (635)
Q Consensus       201 -~~p~~~--~~l~~l~~~~n~~  219 (635)
                       .+|...  .+|..|.+.||..
T Consensus       467 ~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  467 VTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhhCCCcccceeeccCCcc
Confidence             334333  2455555556653

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.06  E-value=1.7e-11  Score=133.82  Aligned_cols=124  Identities=31%  Similarity=0.412  Sum_probs=108.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      ..+..|.|.+|.|+...=+ .|-+..+|++|+|++|+|. .+| ..+.+|..|+.|+||+|+|+ .+|.++.  ..|++|
T Consensus       359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL  435 (1081)
T KOG0618|consen  359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL  435 (1081)
T ss_pred             HHHHHHHHhcCcccccchh-hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence            4677889999999876655 6999999999999999999 777 55889999999999999999 8888776  789999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccc-cCCCC-CCCCCcEEEeeccc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF-DIPKLRHLNLSYNG  197 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~-~l~~L~~l~l~~N~  197 (635)
                      ...+|+|. ..| .+.++++|+.+||+.|+|+. .+|.. ..++|++|||++|.
T Consensus       436 ~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  436 RAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            99999999 788 89999999999999999995 34443 33899999999997

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.1e-10  Score=123.51  Aligned_cols=240  Identities=18%  Similarity=0.206  Sum_probs=171.7

Q ss_pred             ccccccCceEEEEEEec--CCCeEEEEEeecccCCh-H--HHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVVGK-R--DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~-~--~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ..||.|.|+.|+....+  ++..+++|.+....... .  .-..|+.+...+..|.+++..+..|......|+--||+++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            56999999999998743  56778888877654332 2  2334666667777899999999888888888999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCC-C
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP-A  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~-~  496 (635)
                      +++...+.     ....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..+++|||.+..+... .
T Consensus       351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence            98876652     2334788889999999999999999988   9999999999999886 78899999998643322 2


Q ss_pred             CCCCCCccc--CcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 TPSRSAGYR--APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 ~~~~~~~y~--aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ......+++  +++......+..+.|+||||..+.|.+++..--.....                 | ..+.........
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------------~-~~i~~~~~p~~~  484 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------------S-LTIRSGDTPNLP  484 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------------c-eeeecccccCCC
Confidence            222333444  45555666788999999999999999998753321110                 0 011111111222


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ...   .++..+...+...++..||.+.++..+.+-..
T Consensus       485 ~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  485 GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             chH---HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            222   44555666778899999999998877665443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.05  E-value=3.3e-10  Score=127.22  Aligned_cols=110  Identities=31%  Similarity=0.471  Sum_probs=50.9

Q ss_pred             EEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCccCc
Q 006677           74 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFT  153 (635)
Q Consensus        74 l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~  153 (635)
                      |+|++++|+ ++|+ .+.  .+|+.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|. +.++|+.|+|++|+|+
T Consensus       206 LdLs~~~Lt-sLP~-~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~-lp~sL~~L~Ls~N~L~  275 (788)
T PRK15387        206 LNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLT  275 (788)
T ss_pred             EEcCCCCCC-cCCc-chh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccC-cccccceeeccCCchh
Confidence            455555555 4554 232  24555555555555 34431   345555555555555 3332 2245555555555554


Q ss_pred             ccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCc
Q 006677          154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       154 g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~  199 (635)
                       .+|..+   ++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+
T Consensus       276 -~Lp~lp---~~L~~L~Ls~N~Lt~-LP~-~p~~L~~LdLS~N~L~  315 (788)
T PRK15387        276 -HLPALP---SGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLA  315 (788)
T ss_pred             -hhhhch---hhcCEEECcCCcccc-ccc-cccccceeECCCCccc
Confidence             333321   334455555555552 222 2344555555555554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=3.6e-09  Score=96.25  Aligned_cols=130  Identities=22%  Similarity=0.331  Sum_probs=98.3

Q ss_pred             cccccCceEEEEEEecCCCeEEEEEeecccC---------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+++|+-+.+|.+.+.+ ..+++|.-..+..         ......+|+.++.++ +--.|..-.-+..+.+...++|||
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEEE
Confidence            58899999999998764 3455554332221         123466788888887 444555555566677888999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ++|-.|.+.+...            ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++|||++...
T Consensus        81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999998888632            2456777777888999999   99999999999998766 999999998754

>PLN03210 Resistant to P

Probab=99.02  E-value=8.3e-10  Score=132.73  Aligned_cols=73  Identities=27%  Similarity=0.356  Sum_probs=41.1

Q ss_pred             cceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCC
Q 006677           59 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS  136 (635)
Q Consensus        59 w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~  136 (635)
                      |.|+.+-   .++..|+|+++...+.+|.  ++.+++|+.|+|++|.....+|..+++|++|+.|+|++|...+.+|.
T Consensus       627 ~~~~~~l---~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~  699 (1153)
T PLN03210        627 WDGVHSL---TGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT  699 (1153)
T ss_pred             ccccccC---CCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence            5555332   3456666666554445553  66666666666666554446666666666666666665433334443

syringae 6; Provisional

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.02  E-value=2.1e-09  Score=114.80  Aligned_cols=161  Identities=18%  Similarity=0.249  Sum_probs=119.6

Q ss_pred             cCCCeEEEEEeecccCC-hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCH
Q 006677          360 EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW  438 (635)
Q Consensus       360 ~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~  438 (635)
                      .++.+|.|+..+..... .....+.++.++.+ +||||++++..+..+...|+|+|-+.  -|..++..        +..
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~  103 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK  103 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence            35777888777654331 23456667778888 99999999999999999999999774  35555542        345


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCC----CCCcccCcccccCCC
Q 006677          439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----RSAGYRAPEVIETRK  514 (635)
Q Consensus       439 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~----~~~~y~aPE~~~~~~  514 (635)
                      ......+.||+.||.|||+.+  .++|++|.-..|++++.|..||++|-++..........    --..|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            666778899999999999776  69999999999999999999999998765433222111    112366666553322


Q ss_pred             CCCccchhhHHHHHHHHHhCC
Q 006677          515 HSHKSDVYSFGVLLLEMLTGK  535 (635)
Q Consensus       515 ~~~k~Dvws~Gvvl~el~tg~  535 (635)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.96  E-value=8.9e-09  Score=93.16  Aligned_cols=141  Identities=12%  Similarity=0.275  Sum_probs=100.6

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEe-ec----cc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRL-KE----VV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l-~~----~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+|-||+-+.|+++.+. |+...||.- .+    ..    ..++...+|++.+.++ +--.|..-.-++.+...-.++||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEE
Confidence            57889999999999987 555455432 22    11    1345678899999888 44455544555556667789999


Q ss_pred             eccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCCC
Q 006677          415 YFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTP  490 (635)
Q Consensus       415 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla~  490 (635)
                      |+++ -++.+++...-..   +........++..|-+.+.-||..+   ++|+||..+||++..++   .+.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            9977 3777777543211   1222333678889999999999998   99999999999997654   35799999986


Q ss_pred             CC
Q 006677          491 LM  492 (635)
Q Consensus       491 ~~  492 (635)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            54

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.93  E-value=1.2e-10  Score=120.53  Aligned_cols=167  Identities=23%  Similarity=0.226  Sum_probs=113.7

Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCC--CCCcceeEec-CCCCeEEEEEeCCCCccCcCCcccccCCCC---CcEEEeecCCC
Q 006677           33 ALLDFADAVPHLRKLNWSSTNPI--CQSWVGINCT-QDRTRVFGLRLPGIGLVGPIPNNTLGKLDA---LEVLSLRSNVL  106 (635)
Q Consensus        33 al~~~~~~~~~~~~~~w~~~~~~--c~~w~gv~C~-~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~---L~~L~L~~n~l  106 (635)
                      ++.+.....+....+.|....-.  +..|..+.+. ....+++.|+|+++.+.+..+. .+..+.+   |++|+|++|.+
T Consensus        42 ~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~  120 (319)
T cd00116          42 ALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGL  120 (319)
T ss_pred             HHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCcc
Confidence            33333334344555566544322  3234433221 1245799999999999865555 5666665   99999999999


Q ss_pred             CC----CCCCCCCCC-CcccEEeeccCccCCcCCCCc----c--CCcceeeccCccCccc----CCchhhccccCCcEEc
Q 006677          107 TG----GLPSEITSL-PSLRYLYLQHNNFSGKIPSSF----S--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSL  171 (635)
Q Consensus       107 ~g----~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~----~--~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l  171 (635)
                      ++    .+...+..+ ++|+.|+|++|.+++..+..+    .  .+|++|+|++|.+++.    ++..+..+++|+.|+|
T Consensus       121 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L  200 (319)
T cd00116         121 GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL  200 (319)
T ss_pred             chHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEec
Confidence            83    334456677 899999999999996433322    2  5799999999999853    4445666779999999


Q ss_pred             CCCcccccCCC------CCCCCCcEEEeecccCcC
Q 006677          172 QSNNLSGSIPN------FDIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       172 ~~N~l~~~~p~------~~l~~L~~l~l~~N~l~g  200 (635)
                      ++|.+++....      ..+++|++|++++|.+++
T Consensus       201 ~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             cCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            99998743321      157889999999999885

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.92  E-value=1.7e-11  Score=127.27  Aligned_cols=143  Identities=27%  Similarity=0.413  Sum_probs=127.4

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc-CCcceeeccC
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSF  149 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~L~~L~ls~  149 (635)
                      .+..+|+.|.+. .+|. .++.+..|+.|.|.+|.+. .||..+.+|..|++|||+.|+++ .+|..++ --|+.|-+++
T Consensus        77 t~~aDlsrNR~~-elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEec
Confidence            456789999998 8998 7999999999999999999 89999999999999999999999 7787776 6799999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCC--CCCccCCCC
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP--NSSFVGNSL  219 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~--~l~~~~n~~  219 (635)
                      |+++ .+|..++.+..|..||.+.|+|...++.. .+.+|+.|.+..|++. .+|+++..|+  .|.|..|+.
T Consensus       153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNki  223 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKI  223 (722)
T ss_pred             Cccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCce
Confidence            9999 89999999999999999999999666655 8999999999999999 6788877665  566777664

>PLN03210 Resistant to P

Probab=98.89  E-value=7.5e-09  Score=124.57  Aligned_cols=143  Identities=25%  Similarity=0.256  Sum_probs=98.9

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .+..|++.++.+. .+|. .+ .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. +.  ++|+.|+|
T Consensus       590 ~Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L  664 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL  664 (1153)
T ss_pred             ccEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence            3555666666655 6665 34 5678888888888887 6777788888888888887765556665 33  67888888


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCccCC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN  217 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  217 (635)
                      ++|.....+|..++++++|+.|++++|..-+.+|.. ++++|+.|+|++|...+.+|....++..|...+|
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n  735 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET  735 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence            887766678888888888888888876544455553 6777777777777665566655445544443333

syringae 6; Provisional

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.88  E-value=4e-10  Score=125.11  Aligned_cols=192  Identities=24%  Similarity=0.305  Sum_probs=134.0

Q ss_pred             cccccCceEEEEEEecC-CCeEEEEEeeccc---C-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLEE-STTVVVKRLKEVV---V-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      -+-+|.++.++.+.-.. +...+.|......   . ..+....+-.++... +||.++.....+......+++++|..++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhhHHhccC
Confidence            67788899888776332 2122222222110   0 011111222222222 5677777666666678889999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC------
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN------  493 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~------  493 (635)
                      +|...++...     ..+.+-.......+.++.+|||...   +.|||++|.|.+...++..+++|||......      
T Consensus       890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             CchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            9999998543     2444444455566778999999976   8999999999999999999999998432110      


Q ss_pred             -C----------------------------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          494 -V----------------------------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       494 -~----------------------------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                       .                            .....+|+.|.+||...+......+|+|++|++++|.++|..||......
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence             0                            00112577899999999999999999999999999999999999876654


Q ss_pred             C
Q 006677          545 D  545 (635)
Q Consensus       545 ~  545 (635)
                      .
T Consensus      1042 ~ 1042 (1205)
T KOG0606|consen 1042 Q 1042 (1205)
T ss_pred             h
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.86  E-value=5.7e-08  Score=98.26  Aligned_cols=262  Identities=15%  Similarity=0.160  Sum_probs=155.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEE------EeCCe-eEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY------YSKDE-KLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~------~~~~~-~~lv~e~  415 (635)
                      +.-||+|+-+.+|..-.-  ..-+.|+....-...+  .+.++.|.....||-+-.-+.+-      -+... .-+.|..
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecchh--hchhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            567999999999965322  2234566654432222  22344555555676554422221      11222 4566776


Q ss_pred             ccCC-ChhhhccC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          416 FASG-SLSTLLHG-NRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       416 ~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      +.+. -...+... .+..+....+|...++.+..+|.+.+.||..|   .+-+|+.++|+|+++++.+.+.|=..-....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence            6553 22222221 12234456899999999999999999999999   8899999999999999999998754322222


Q ss_pred             CC---CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCC--CChhHHHHHHhhhccc
Q 006677          494 VP---ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDM--VDLPRWVQSVVREEWT  562 (635)
Q Consensus       494 ~~---~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg-~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  562 (635)
                      .+   .-..+...|.+||.-.     +-.-+...|-|.+||++++++.| ++||.+......  ..+..-    +..+..
T Consensus       169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~----Ia~g~f  244 (637)
T COG4248         169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD----IAHGRF  244 (637)
T ss_pred             CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh----hhccee
Confidence            22   2345777899999754     33456778999999999999886 999986432111  000000    000000


Q ss_pred             cccchhhh-----hcccChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHhhccC
Q 006677          563 AEVFDVEL-----MRFQNIEEEMVQMLQIGMACVAK--VPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       563 ~~~~d~~~-----~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ....|...     .+....+-..-.+..+..+|+..  .+.-|||++-.+..|.++.+..
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            00000000     00011111122333444578865  4678999999999888777654

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.86  E-value=2.1e-10  Score=110.24  Aligned_cols=121  Identities=24%  Similarity=0.289  Sum_probs=83.7

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcE
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGL  169 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L  169 (635)
                      +..-..|+.||||+|.|+ .|.++..-+++++.|++|+|.+...-.-.+.++|+.||||+|.|+ .+-.+=..|-+.+.|
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            445567788888888888 677777778888888888888873322223378888888888887 555666677778888


Q ss_pred             EcCCCcccccCCCC-CCCCCcEEEeecccCcCCC-CcccCCCCCCC
Q 006677          170 SLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSI-PSSLQKFPNSS  213 (635)
Q Consensus       170 ~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~-p~~~~~l~~l~  213 (635)
                      .|+.|.|.. +... .+-+|.+||+++|++...- -..|++++.|.
T Consensus       358 ~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE  402 (490)
T KOG1259|consen  358 KLAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE  402 (490)
T ss_pred             ehhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHH
Confidence            888888763 3322 6677888888888876211 13566666554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=7e-08  Score=96.26  Aligned_cols=142  Identities=14%  Similarity=0.143  Sum_probs=99.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC------------ChHHHHHHHHHHHhhcC-CCceeceeEEEEe----
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYS----  405 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~----  405 (635)
                      .+.+-.-....|++..+. |+.++||+......            ....+.+|...+.++.. .-.++..+++...    
T Consensus        27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            344444444557777664 67899997743321            11247788888877731 2223444555543    


Q ss_pred             -CCeeEEEEEeccCC-ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC------
Q 006677          406 -KDEKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ------  477 (635)
Q Consensus       406 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~------  477 (635)
                       ....++|+|++++. +|.+++....   ..+.+...+..++.+++..+.-||+.|   |+|+|++++|||++.      
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCC
Confidence             23468999999986 8988875321   122456677889999999999999999   999999999999975      


Q ss_pred             -CCCeEEeecCCCCC
Q 006677          478 -DLDGCISDFGLTPL  491 (635)
Q Consensus       478 -~~~~ki~DfGla~~  491 (635)
                       +..+.++||+.+..
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46789999998754

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.85  E-value=2.5e-10  Score=109.75  Aligned_cols=123  Identities=24%  Similarity=0.321  Sum_probs=79.5

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeecc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS  148 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls  148 (635)
                      ++.+||++|.++ .|.+ +..-++.++.|+||+|++. .+- .+..|++|+.||||+|.++. +-..-.  -+++.|.|+
T Consensus       286 LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhccccccchh-hhhh-hhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence            456777777776 5665 5677777777777777776 443 37777777777777777762 221111  466777777


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccC--CCC-CCCCCcEEEeecccCcC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~-~l~~L~~l~l~~N~l~g  200 (635)
                      .|.|. .+ ..++.|-+|..||+++|+|...-  -.. +++-|+.|.|.+|.+.+
T Consensus       361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            77765 22 34666777777777777776321  111 66777777777777774

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=4e-08  Score=92.39  Aligned_cols=126  Identities=20%  Similarity=0.289  Sum_probs=81.6

Q ss_pred             EEEEEEecCCCeEEEEEeecccC-----------------------C----hHHHHHHHHHHHhhcCC-CceeceeEEEE
Q 006677          353 TAYKAVLEESTTVVVKRLKEVVV-----------------------G----KRDFEQQMEIVGRVGQH-PNVVPLRAYYY  404 (635)
Q Consensus       353 ~Vy~~~~~~~~~vavK~l~~~~~-----------------------~----~~~~~~e~~~l~~l~~h-~niv~l~~~~~  404 (635)
                      .||.|...++..+|+|+.+....                       .    ....++|.+.|.++... -++.+.+.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988899999999853210                       0    12366788999998433 256666644  


Q ss_pred             eCCeeEEEEEecc--CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          405 SKDEKLLVYDYFA--SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       405 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                        ....+||||++  +..+..+....       ++......++.+++..+.. +|..|   |+|+||.+.||+++++ .+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence              24579999998  55554443311       1133456677788876665 57887   9999999999999988 99


Q ss_pred             EEeecCCCCCCC
Q 006677          482 CISDFGLTPLMN  493 (635)
Q Consensus       482 ki~DfGla~~~~  493 (635)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.77  E-value=7e-10  Score=114.90  Aligned_cols=146  Identities=27%  Similarity=0.308  Sum_probs=106.0

Q ss_pred             CeEEEEEeCCCCccC----cCCcccccCC-CCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcC----C
Q 006677           69 TRVFGLRLPGIGLVG----PIPNNTLGKL-DALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKI----P  135 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g----~l~~~~l~~l-~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~----p  135 (635)
                      .+++.|++++|.+++    .+.. .+..+ ++|+.|+|++|.+++.    ++..+..+.+|+.|+|++|.+++..    +
T Consensus       108 ~~L~~L~ls~~~~~~~~~~~l~~-~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~  186 (319)
T cd00116         108 SSLQELKLNNNGLGDRGLRLLAK-GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA  186 (319)
T ss_pred             CcccEEEeeCCccchHHHHHHHH-HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence            459999999998873    2332 45667 8999999999999953    3445777889999999999998532    2


Q ss_pred             CCcc--CCcceeeccCccCccc----CCchhhccccCCcEEcCCCcccccCCCC-------CCCCCcEEEeecccCcC--
Q 006677          136 SSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNF-------DIPKLRHLNLSYNGLKG--  200 (635)
Q Consensus       136 ~~~~--~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------~l~~L~~l~l~~N~l~g--  200 (635)
                      ..+.  ++|++|+|++|.+++.    ++..+..+++|+.|++++|.+++.....       ..+.|+.|++++|.++.  
T Consensus       187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~  266 (319)
T cd00116         187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDG  266 (319)
T ss_pred             HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHH
Confidence            2222  5899999999999744    3455667889999999999998522110       34799999999999972  


Q ss_pred             --CCCcccCCCCCCCcc
Q 006677          201 --SIPSSLQKFPNSSFV  215 (635)
Q Consensus       201 --~~p~~~~~l~~l~~~  215 (635)
                        .+...+..+++|.++
T Consensus       267 ~~~l~~~~~~~~~L~~l  283 (319)
T cd00116         267 AKDLAEVLAEKESLLEL  283 (319)
T ss_pred             HHHHHHHHhcCCCccEE
Confidence              233344444555444

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.77  E-value=2.7e-09  Score=114.03  Aligned_cols=141  Identities=31%  Similarity=0.479  Sum_probs=109.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCC-CCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc--cCCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~-~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~~~L~~L  145 (635)
                      ..++.|++.+++++ .||+ ..+.+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...  .+.|+.|
T Consensus       116 ~~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             cceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            35889999999998 7887 677775 9999999999999 78888999999999999999999 666654  3889999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCC-CCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ++++|+++ .+|..+..+..|++|.+++|.+...+. ...+.++..|.+++|++. .++..+++++++..+
T Consensus       192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L  260 (394)
T COG4886         192 DLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETL  260 (394)
T ss_pred             eccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhcccccccee
Confidence            99999999 788877777789999999995332333 236667777777777766 335555555555444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.77  E-value=3.8e-09  Score=112.94  Aligned_cols=137  Identities=34%  Similarity=0.459  Sum_probs=107.6

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCC-cccEEeeccCccCCcCCCC--ccCCcceeeccC
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSS--FSPQLVVLDLSF  149 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~--~~~~L~~L~ls~  149 (635)
                      .+++..+.+...+.  .+..++.++.|++.+|+++ .||.....++ +|+.|++++|++. .+|..  ..+.|+.|++++
T Consensus        97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            47777777754444  3777788999999999999 7888888885 9999999999998 55433  348999999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |+++ .+|...+.+++|+.|++++|+++ .+|..  .+..|+.|++++|++. .++..+.++.++..++
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~  238 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE  238 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc
Confidence            9999 78887778999999999999999 45543  5556999999999754 4666677776666554

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.73  E-value=8.7e-09  Score=78.21  Aligned_cols=59  Identities=39%  Similarity=0.578  Sum_probs=36.0

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCcc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF  130 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l  130 (635)
                      +..|+|++|+++ .+|++.|.++++|++|+|++|+++...|..|.+|++|++|+|++|+|
T Consensus         3 L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    3 LESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455666666666 55555666666666666666666644445566666666666666653

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.71  E-value=1e-08  Score=77.83  Aligned_cols=57  Identities=44%  Similarity=0.588  Sum_probs=28.3

Q ss_pred             CcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeeccc
Q 006677          141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNG  197 (635)
Q Consensus       141 ~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~  197 (635)
                      +|++|+|++|+|+...+..|.++++|++|++++|+|+...|..  .+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3445555555555333344555555555555555555433332  45555555555554

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.71  E-value=1.5e-07  Score=90.86  Aligned_cols=136  Identities=23%  Similarity=0.261  Sum_probs=97.6

Q ss_pred             HHhhccccccCceEEEEEEecCCCeEEEEEeecccC-----------------------ChHHHHHHHHHHHhhcCC-Cc
Q 006677          340 RASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----------------------GKRDFEQQMEIVGRVGQH-PN  395 (635)
Q Consensus       340 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~~h-~n  395 (635)
                      .+.++.||-|--+.||.|...+|.+++||.=+....                       +....++|.++|.+|..+ -.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345789999999999999999999999996532111                       123467788999998333 24


Q ss_pred             eeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       396 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      |...+++    +...+||||+++--|...-          ++......++..|+.-+..+-..|   +||+|+++-||++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence            5555554    5678999999986654332          223334445555555555555677   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLM  492 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~  492 (635)
                      +++|.+.++||--+...
T Consensus       236 ~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ecCCCEEEEeCcccccC
Confidence            99999999999765443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.70  E-value=5.7e-07  Score=93.59  Aligned_cols=169  Identities=25%  Similarity=0.350  Sum_probs=125.6

Q ss_pred             eEEEEEEe-cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEeccC-CChhhh
Q 006677          352 GTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS-GSLSTL  424 (635)
Q Consensus       352 g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  424 (635)
                      .+.||+.. .+|..|+.|++...+. .....-.-++.++++ .|.|+|++..++..    +...++||+|+++ ++|.+.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            57899984 4789999999943322 122233456788888 89999999988863    4467899999987 477665


Q ss_pred             ccCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          425 LHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       425 l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      -......          .....++...+.++.|+..||.++|+.|   +.-+-|.+++|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5433211          1234678899999999999999999999   99999999999999999999998887665543


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP  537 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p  537 (635)
                      ..+          |-+.+   -.+-|.=.||.+++-|.||..-
T Consensus       446 d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            321          11111   1356888999999999999643

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.60  E-value=1.1e-08  Score=102.41  Aligned_cols=159  Identities=25%  Similarity=0.318  Sum_probs=118.6

Q ss_pred             ceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc
Q 006677           60 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS  139 (635)
Q Consensus        60 ~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  139 (635)
                      .+.+|++..+  ..++-++.+|+ .+|.+ +  -..-..|+|..|+|+..-|..|+.+++|+.||||+|.|+-+-|+.|.
T Consensus        39 ~pC~Cs~~~g--~~VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~  112 (498)
T KOG4237|consen   39 APCTCSDVEG--GIVDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFK  112 (498)
T ss_pred             CCcccCCCCC--ceEEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhh
Confidence            4557776333  33455667777 66652 2  13457899999999955557899999999999999999988888886


Q ss_pred             --CCc-ceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCc-ccCCCCCCC
Q 006677          140 --PQL-VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS-SLQKFPNSS  213 (635)
Q Consensus       140 --~~L-~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~  213 (635)
                        ++| +-+++++|+|+...-..|++|.+|+.|.+.-|++.-.....  .+++|..|.|-.|.+. .++. +|..+.+++
T Consensus       113 GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~  191 (498)
T KOG4237|consen  113 GLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIK  191 (498)
T ss_pred             hhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccc
Confidence              444 45566669999555578999999999999999999544443  8999999999999998 5665 677776665


Q ss_pred             cc---CCCCCCCCCC
Q 006677          214 FV---GNSLLCGPPL  225 (635)
Q Consensus       214 ~~---~n~~l~~~~l  225 (635)
                      .+   .|+..|.+.+
T Consensus       192 tlhlA~np~icdCnL  206 (498)
T KOG4237|consen  192 TLHLAQNPFICDCNL  206 (498)
T ss_pred             hHhhhcCcccccccc
Confidence            54   5565655433

>PRK09902 hypothetical protein; Provisional

Probab=98.52  E-value=2.8e-06  Score=80.46  Aligned_cols=138  Identities=15%  Similarity=0.167  Sum_probs=101.3

Q ss_pred             ccccCceEEEEEEecCCCeEEEEEeecc-------cCChHHHHHHHHHHHhhcC-CCceeceeEEEE-eC----CeeEEE
Q 006677          346 LGKGSYGTAYKAVLEESTTVVVKRLKEV-------VVGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYY-SK----DEKLLV  412 (635)
Q Consensus       346 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~-~~----~~~~lv  412 (635)
                      -|+||.+-|++....+ ..+.+|+-...       -.+...|.+|...+.++.. .-.+.+.+ ++. ..    -..+||
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            3678889999988764 46889987622       1256789999999888842 22244444 332 21    135799


Q ss_pred             EEeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC--eEEeecCCC
Q 006677          413 YDYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~DfGla  489 (635)
                      +|-+++ -+|.+++....   ..+.+...+..+..+++..++-||+.|   +.|+|+-+.||+++.++.  ++++||--+
T Consensus       104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            997764 48888875322   223577778899999999999999999   999999999999987667  999999765


Q ss_pred             CC
Q 006677          490 PL  491 (635)
Q Consensus       490 ~~  491 (635)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            43

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=1.8e-06  Score=83.21  Aligned_cols=108  Identities=21%  Similarity=0.289  Sum_probs=83.4

Q ss_pred             hHHHHHHHHHHHhhcC-CCceeceeEEEEeCC----eeEEEEEeccCC-ChhhhccCCCCCCCCCCCHHHHHHHHHHHHH
Q 006677          377 KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKD----EKLLVYDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTAR  450 (635)
Q Consensus       377 ~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  450 (635)
                      .....+|...+.++.+ .-.++..+++.....    ..++|+|++++. +|.+++....     ..+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            4567778877776632 334556667666533    348999999884 8999886422     1555677889999999


Q ss_pred             HHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCCCCC
Q 006677          451 GVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLM  492 (635)
Q Consensus       451 ~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla~~~  492 (635)
                      .++-||+.|   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999   99999999999999887   8999999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.44  E-value=4.1e-06  Score=81.81  Aligned_cols=140  Identities=14%  Similarity=0.173  Sum_probs=85.8

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCc-eeceeEEEEeCCeeEEEEEeccCCC-h
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASGS-L  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~-L  421 (635)
                      ..||+|..+.||+..   +..+++|.... .....+..+|.+++..+....- +.+.+++....+...+|||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEec---CCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            468999999999842   45677777654 3345667899999998843322 5677888777777889999999863 2


Q ss_pred             hhhc---------------------cCCCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCceecC
Q 006677          422 STLL---------------------HGNRGAGRTPLDWETRV-KILL----------GTAR-GVAHIHSM-GGPKFTHGN  467 (635)
Q Consensus       422 ~~~l---------------------~~~~~~~~~~l~~~~~~-~i~~----------~ia~-~l~~LH~~-~~~~ivH~D  467 (635)
                      ...+                     |.... ..  ....... .+-.          .+.. ...+|... ..+.++|+|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            2111                     21100 00  1111100 0000          0001 12222211 123578999


Q ss_pred             CCCCCeEEcCCCCeEEeecCCCCC
Q 006677          468 IKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       468 lk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999987653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=7.5e-08  Score=103.59  Aligned_cols=145  Identities=21%  Similarity=0.263  Sum_probs=95.2

Q ss_pred             HHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC-------------CCCCCcccCcccccC
Q 006677          446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT-------------PSRSAGYRAPEVIET  512 (635)
Q Consensus       446 ~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~-------------~~~~~~y~aPE~~~~  512 (635)
                      .+++.|+.|+|...  ++||++|.|++|.++..+..||+.|+++.....+..             ......|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34558999999864  799999999999999999999999997644332111             012345999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcc
Q 006677          513 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACV  591 (635)
Q Consensus       513 ~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl  591 (635)
                      ...+.++|+||+||++|-+.. |+.-+..........     ......+..         ..........++.+=+.+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~~~~~---------~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNLLNAG---------AFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhcccccc---------cccccccCcHHHHHHHHHHh
Confidence            888999999999999999994 554444332211111     000000000         00001122234444455788


Q ss_pred             cCCCCCCCCHHHHHH
Q 006677          592 AKVPDMRPNMDEVVR  606 (635)
Q Consensus       592 ~~~P~~RPs~~evl~  606 (635)
                      ..++.-||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            899999997776643

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.39  E-value=6.7e-08  Score=98.07  Aligned_cols=130  Identities=28%  Similarity=0.334  Sum_probs=73.8

Q ss_pred             CeEEEEEeCCCCccCcCCc-ccccCCCCCcEEEeecCCCCCCCCCCC-CCCCcccEEeeccCccCC--------------
Q 006677           69 TRVFGLRLPGIGLVGPIPN-NTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG--------------  132 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~-~~l~~l~~L~~L~L~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g--------------  132 (635)
                      .+|+.|||++|=+..--|- .....|++|+.|+|+.|.+.-.+-+.. ..+++|+.|.|+.+.|+-              
T Consensus       146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~  225 (505)
T KOG3207|consen  146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE  225 (505)
T ss_pred             CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence            4677888887755421110 134567778888888887763332221 234555555555555541              


Q ss_pred             -------------cCCCCccCCcceeeccCccCcccCC--chhhccccCCcEEcCCCcccc-cCCCC-------CCCCCc
Q 006677          133 -------------KIPSSFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSG-SIPNF-------DIPKLR  189 (635)
Q Consensus       133 -------------~~p~~~~~~L~~L~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~-~~p~~-------~l~~L~  189 (635)
                                   ..+..+...|++|||++|++- ..+  ...+.|+.|+.|+++.+.+.. .+|+.       .+++|+
T Consensus       226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~  304 (505)
T KOG3207|consen  226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE  304 (505)
T ss_pred             HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence                         111112245677777777665 334  455666777777777776663 12221       466777


Q ss_pred             EEEeecccCc
Q 006677          190 HLNLSYNGLK  199 (635)
Q Consensus       190 ~l~l~~N~l~  199 (635)
                      +|+++.|++.
T Consensus       305 ~L~i~~N~I~  314 (505)
T KOG3207|consen  305 YLNISENNIR  314 (505)
T ss_pred             eeecccCccc
Confidence            7777777775

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.36  E-value=5.1e-09  Score=111.81  Aligned_cols=122  Identities=32%  Similarity=0.352  Sum_probs=98.1

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc--cCCcceeecc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLS  148 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~~~L~~L~ls  148 (635)
                      +...+.+.|.|+ .+.. ++.-|+.|+.|||++|+++.. . .+-.|++|++|||++|.|. .+|.--  +-.|+.|.|+
T Consensus       166 L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr  240 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR  240 (1096)
T ss_pred             HhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence            445566667776 4444 788999999999999999943 3 7889999999999999998 666432  2569999999


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCccccc---CCCCCCCCCcEEEeecccCc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS---IPNFDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~---~p~~~l~~L~~l~l~~N~l~  199 (635)
                      +|.++. + ..+.+|.+|+.|||+.|-|++.   .|-+.|..|+.|+|.+|.+.
T Consensus       241 nN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            999983 3 4688999999999999999863   34447888999999999886

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=2.1e-06  Score=92.88  Aligned_cols=150  Identities=19%  Similarity=0.310  Sum_probs=96.3

Q ss_pred             hHHHHHHhh-ccccccCceEEEEEEecCCCeEEEEEeecccC---------------------------C----------
Q 006677          335 LEDLLRASA-EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------------------------G----------  376 (635)
Q Consensus       335 ~~~l~~~~~-~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------------------~----------  376 (635)
                      .+++..... +.|+.++-|.||+|++++|+.||||+......                           .          
T Consensus       121 iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         121 IEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             HHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            334433333 67889999999999999999999999853210                           0          


Q ss_pred             ----hHHHHHHHHHHHhhc----CCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHH
Q 006677          377 ----KRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT  448 (635)
Q Consensus       377 ----~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i  448 (635)
                          +-++.+|..-+.++.    +.+++.----|++-.....++|||++|-.+.+......    ...+...   ++..+
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~---ia~~~  273 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKE---LAELL  273 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHH---HHHHH
Confidence                012333433333332    34444333334444567889999999998888743211    1244333   33333


Q ss_pred             HHH-HHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          449 ARG-VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       449 a~~-l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      +++ +..+-..|   +.|.|..|.||+++.++.+.+.|||+......
T Consensus       274 ~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         274 VRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            322 33333455   99999999999999999999999999866543

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.32  E-value=7e-07  Score=62.13  Aligned_cols=37  Identities=38%  Similarity=0.811  Sum_probs=26.5

Q ss_pred             hhHHHHHHHHHHhCCC---CCCCCCCCC--CCCCCCcceeEec
Q 006677           28 NSDRQALLDFADAVPH---LRKLNWSST--NPICQSWVGINCT   65 (635)
Q Consensus        28 ~~~~~al~~~~~~~~~---~~~~~w~~~--~~~c~~w~gv~C~   65 (635)
                      ++|++||++||+++..   ....+|+.+  .++| +|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence            5799999999999964   335599987  4555 89999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.26  E-value=3.5e-08  Score=84.65  Aligned_cols=23  Identities=26%  Similarity=0.265  Sum_probs=11.4

Q ss_pred             cCCchhhccccCCcEEcCCCccc
Q 006677          155 NIPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       155 ~~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                      ..|.-+..|.+|..|+..+|.+.
T Consensus       114 ~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  114 AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cchHHHHHHHhHHHhcCCCCccc
Confidence            44444444555555555555544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.3e-05  Score=79.65  Aligned_cols=142  Identities=15%  Similarity=0.151  Sum_probs=87.0

Q ss_pred             ccccCc-eEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhh
Q 006677          346 LGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTL  424 (635)
Q Consensus       346 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  424 (635)
                      |-.|.. ..||+.... +..+++|+.....  ..+..+|++++..+..+--+.+++++....+..++|||+++|.++...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            445555 789999865 4678888875543  446778999998886665566777777666678999999998777643


Q ss_pred             c-------------------cCCCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 006677          425 L-------------------HGNRGAGRTPLDW--ETRVKILL--------------------GTARGVAHIHS----MG  459 (635)
Q Consensus       425 l-------------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~~l~~LH~----~~  459 (635)
                      .                   |.... ...+...  ........                    .+...+..|-.    ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            2                   11110 0001110  00000000                    01111222211    11


Q ss_pred             CCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       460 ~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      .+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            24589999999999999987788999987653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.19  E-value=2.2e-08  Score=107.07  Aligned_cols=125  Identities=34%  Similarity=0.449  Sum_probs=95.6

Q ss_pred             CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCc-hhhccccCCcEE
Q 006677           94 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLS  170 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~  170 (635)
                      ..|.+.+.+.|.|. .+..++.-++.|+.|||++|+|+..-  .+.  +.|++|||++|.|. .+|. ....+. |+.|.
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            35677888999998 67788888999999999999999432  332  78999999999999 5664 334454 99999


Q ss_pred             cCCCcccccCCCCCCCCCcEEEeecccCcCCC---C-cccCCCCCCCccCCCCCCCC
Q 006677          171 LQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI---P-SSLQKFPNSSFVGNSLLCGP  223 (635)
Q Consensus       171 l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~---p-~~~~~l~~l~~~~n~~l~~~  223 (635)
                      |+||.++..--..+|.+|+.|||++|-|++--   | ..+..|..|..-||+..|.+
T Consensus       239 lrnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  239 LRNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ecccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99999995554458999999999999887532   1 22344455556688877754

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.18  E-value=1.8e-07  Score=80.33  Aligned_cols=110  Identities=21%  Similarity=0.291  Sum_probs=87.0

Q ss_pred             CCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcce
Q 006677           67 DRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV  144 (635)
Q Consensus        67 ~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~  144 (635)
                      ...+++.++|++|++. .+|+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+.  .+|-.
T Consensus        51 ~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~  127 (177)
T KOG4579|consen   51 KGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDM  127 (177)
T ss_pred             CCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence            3468999999999999 788855556679999999999999 89999999999999999999999 6676666  57788


Q ss_pred             eeccCccCcccCCchhhccccCCcEEcCCCcccccC
Q 006677          145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI  180 (635)
Q Consensus       145 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~  180 (635)
                      ||.-+|.+. .||..+---+++-..++.+|.+.+.-
T Consensus       128 Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~  162 (177)
T KOG4579|consen  128 LDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDET  162 (177)
T ss_pred             hcCCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence            999999988 77766443333444455666665443

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.18  E-value=9.1e-07  Score=61.69  Aligned_cols=37  Identities=43%  Similarity=0.655  Sum_probs=31.1

Q ss_pred             CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccC
Q 006677           94 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS  131 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~  131 (635)
                      ++|++|+|++|+|+ .+|+.|++|++|+.|+|++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            47899999999999 68877999999999999999988

...

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.17  E-value=2.9e-07  Score=98.84  Aligned_cols=124  Identities=27%  Similarity=0.274  Sum_probs=80.9

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN  150 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N  150 (635)
                      +..+++..|.+. .+-. .+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+...+-.....|+.|++++|
T Consensus        74 l~~l~l~~n~i~-~~~~-~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N  150 (414)
T KOG0531|consen   74 LKELNLRQNLIA-KILN-HLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGN  150 (414)
T ss_pred             HHhhccchhhhh-hhhc-ccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchhhccchhhheeccC
Confidence            334445555555 2221 4677777777777777777 344346777777777777777776555544456777777777


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCC--CCCCCCCcEEEeecccCc
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP--NFDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~l~~L~~l~l~~N~l~  199 (635)
                      .|+. + ..+..+.+|+.+++++|.+...-+  ...+.+|+.+++++|.+.
T Consensus       151 ~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  151 LISD-I-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR  199 (414)
T ss_pred             cchh-c-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence            7772 2 345557777777777777775444  256777777777777665

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.15  E-value=6.8e-07  Score=95.20  Aligned_cols=179  Identities=21%  Similarity=0.210  Sum_probs=129.4

Q ss_pred             cccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCc-eeceeEEEEeCCeeEEEEEeccCC-Chh
Q 006677          345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASG-SLS  422 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~L~  422 (635)
                      -.++|+++.+||.+-...+....+.+...    ....-++++|.++ +||| .+..++-++.++..+++++++..+ +..
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            36889999999988554444445554332    4455678899999 9999 777777777777889999999877 222


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---CCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---ATPS  499 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---~~~~  499 (635)
                      ....    ...-.+...+...+...-.++++|+|+..   -+|||    ||+..+ +..+..||+....+...   .+..
T Consensus       324 ~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  324 LEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             ccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence            1111    01111333344455566678899999864   58999    777655 67899999988776554   3445


Q ss_pred             CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 006677          500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS  540 (635)
Q Consensus       500 ~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~  540 (635)
                      +++.|+|||+.....+..+.|+|+.|+-..+|--|..|-..
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            78889999999999999999999999988888888777543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.12  E-value=6.3e-05  Score=72.36  Aligned_cols=136  Identities=18%  Similarity=0.245  Sum_probs=90.9

Q ss_pred             cccccCceEEEEEEecCCCeEEEEEeecccCCh----------H---------------HHHHHHHHHHhhc-CCCceec
Q 006677          345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK----------R---------------DFEQQMEIVGRVG-QHPNVVP  398 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----------~---------------~~~~e~~~l~~l~-~h~niv~  398 (635)
                      .|.+|--+.||+|.-.++..+|||+++......          .               ....|..-|.++. .+-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            577888889999998889999999996432211          0               1233444455543 2334444


Q ss_pred             eeEEEEeCCeeEEEEEeccCCCh-hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEc
Q 006677          399 LRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLIN  476 (635)
Q Consensus       399 l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~  476 (635)
                      -+++.    +-.|||||+..... .-.|.      ..++.......+..++++.+.-|-. .+   +||+||+.-|||+.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE
Confidence            44443    34699999965311 11111      1223333566778888888888876 54   99999999999999


Q ss_pred             CCCCeEEeecCCCCCCCC
Q 006677          477 QDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       477 ~~~~~ki~DfGla~~~~~  494 (635)
                       ++.+.|+|||-|.....
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             88999999998866553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	635
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-11
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-11
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  169 bits (428), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 113/347 (32%), Positives = 183/347 (52%), Gaps = 22/347 (6%)
Query: 303 RSEKPKEEFGS--GVQEPEKNKLVFFEGCSYNFDLEDLLRAS-----AEVLGKGSYGTAY 355
           R +KP++ F      ++PE +      G    F L +L  AS       +LG+G +G  Y
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHL-----GQLKRFSLRELQVASDNFSNKNILGRGGFGKVY 55
Query: 356 KAVLEESTTXXXXXXXXXXXXXRDFEQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYD 414
           K  L + T               + + Q E+ +  +  H N++ LR +  +  E+LLVY 
Sbjct: 56  KGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 115
Query: 415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL 474
           Y A+GS+++ L   R   + PLDW  R +I LG+ARG+A++H    PK  H ++KA+N+L
Sbjct: 116 YMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 174
Query: 475 INQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLL 529
           ++++ +  + DFGL  LM+     V      + G+ APE + T K S K+DV+ +GV+LL
Sbjct: 175 LDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 234
Query: 530 EMLTGKAP--LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIG 587
           E++TG+    L     DD V L  WV+ +++E+    + DV+L +    +EE+ Q++Q+ 
Sbjct: 235 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVA 293
Query: 588 MACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSNVQT 634
           + C    P  RP M EVVRM+E    ++       EE   +D N  T
Sbjct: 294 LLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQDFNYPT 340

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  166 bits (419), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 153/273 (56%), Gaps = 10/273 (3%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI-VGRVGQHPNVVPLRAYY 403
           +LG+G +G  YK  L +                 + + Q E+ +  +  H N++ LR + 
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            +  E+LLVY Y A+GS+++ L   R   + PLDW  R +I LG+ARG+A++H    PK 
Sbjct: 97  MTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAGYRAPEVIETRKHSHK 518
            H ++KA+N+L++++ +  + DFGL  LM+     V        G+ APE + T K S K
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK 215
Query: 519 SDVYSFGVLLLEMLTGKAP--LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
           +DV+ +GV+LLE++TG+    L     DD V L  WV+ +++E+    + DV+L +    
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-QGNYK 274
Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
           +EE+ Q++Q+ + C    P  RP M EVVRM+E
Sbjct: 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 20/294 (6%)
Query: 323 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ 382
           LV  E  + NFD + L+       G G +G  YK VL +                 +  +
Sbjct: 31  LVDLEEATNNFDHKFLI-------GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
                    +HP++V L  +   ++E +L+Y Y  +G+L   L+G+       + WE R+
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRL 142
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP------LMNVPA 496
           +I +G ARG+ ++H+       H ++K+ N+L++++    I+DFG++         ++  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
               + GY  PE     + + KSDVYSFGV+L E+L  ++ +      +MV+L  W    
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQML-QIGMACVAKVPDMRPNMDEVVRMIE 609
                  ++ D  L     I  E ++      + C+A   + RP+M +V+  +E
Sbjct: 260 HNNGQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 20/294 (6%)
Query: 323 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ 382
           LV  E  + NFD + L+       G G +G  YK VL +                 +  +
Sbjct: 31  LVDLEEATNNFDHKFLI-------GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
                    +HP++V L  +   ++E +L+Y Y  +G+L   L+G+       + WE R+
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRL 142
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP------LMNVPA 496
           +I +G ARG+ ++H+       H ++K+ N+L++++    I+DFG++         ++  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
               + GY  PE     + + KSDVYSFGV+L E+L  ++ +      +MV+L  W    
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQML-QIGMACVAKVPDMRPNMDEVVRMIE 609
                  ++ D  L     I  E ++      + C+A   + RP+M +V+  +E
Sbjct: 260 HNNGQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 139/302 (46%), Gaps = 23/302 (7%)
Query: 325 FFE--GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD--- 379
           F+E    + NFD E  +      +G+G +G  YK  +  +T               +   
Sbjct: 17  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 75
Query: 380 -FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
            F+Q+++++ +  QH N+V L  +    D+  LVY Y  +GSL   L    G    PL W
Sbjct: 76  QFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSW 132
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 498
             R KI  G A G+  +H        H +IK++N+L+++     ISDFGL       A  
Sbjct: 133 HMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 499 ---SRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 552
              SR  G   Y APE +     + KSD+YSFGV+LLE++TG  P     R+  + L   
Sbjct: 190 VMXSRIVGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 247
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
            +    E+   +  D ++    +   E   M  +   C+ +  + RP++ +V ++++E+ 
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 613 QS 614
            S
Sbjct: 306 AS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 23/302 (7%)
Query: 325 FFE--GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD--- 379
           F+E    + NFD E  +      +G+G +G  YK  +  +T               +   
Sbjct: 17  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 75
Query: 380 -FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
            F+Q+++++ +  QH N+V L  +    D+  LVY Y  +GSL   L    G    PL W
Sbjct: 76  QFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSW 132
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 498
             R KI  G A G+  +H        H +IK++N+L+++     ISDFGL       A  
Sbjct: 133 HMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 499 SR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 552
                   +  Y APE +     + KSD+YSFGV+LLE++TG  P     R+  + L   
Sbjct: 190 VMXXRIVGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 247
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
            +    E+   +  D ++    +   E   M  +   C+ +  + RP++ +V ++++E+ 
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 613 QS 614
            S
Sbjct: 306 AS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 137/302 (45%), Gaps = 23/302 (7%)
Query: 325 FFE--GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD--- 379
           F+E    + NFD E  +      +G+G +G  YK  +  +T               +   
Sbjct: 11  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 69
Query: 380 -FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
            F+Q+++++ +  QH N+V L  +    D+  LVY Y  +GSL   L    G    PL W
Sbjct: 70  QFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSW 126
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 498
             R KI  G A G+  +H        H +IK++N+L+++     ISDFGL       A  
Sbjct: 127 HMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 499 SR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 552
                   +  Y APE +     + KSD+YSFGV+LLE++TG  P     R+  + L   
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 241
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
            +    E+   +  D ++    +   E   M  +   C+ +  + RP++ +V ++++E+ 
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 299
Query: 613 QS 614
            S
Sbjct: 300 AS 301

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR--DFEQQMEIVGRVGQHPNVVPLRA 401
           E +G GS+GT ++A    S               R  +F +++ I+ R+ +HPN+V    
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMG 101
Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
                    +V +Y + GSL  LLH  +   R  LD   R+ +    A+G+ ++H+   P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----YRAPEVIETRKHSH 517
              H N+K+ N+L+++     + DFGL+ L       S+SA     + APEV+     + 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 518 KSDVYSFGVLLLEMLTGKAP 537
           KSDVYSFGV+L E+ T + P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 132/301 (43%), Gaps = 21/301 (6%)
Query: 325 FFE--GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ 382
           F+E    + NFD E  +       G+G +G  YK  +  +T               + +Q
Sbjct: 8   FYELKNVTNNFD-ERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ 66
Query: 383 QMEIVGRVG---QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           Q +   +V    QH N+V L  +    D+  LVY Y  +GSL   L    G    PL W 
Sbjct: 67  QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT--PPLSWH 124
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--- 496
            R KI  G A G+  +H        H +IK++N+L+++     ISDFGL       A   
Sbjct: 125 XRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 497 TPSRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 553
             SR  G   Y APE +     + KSD+YSFGV+LLE++TG  P     R+  + L    
Sbjct: 182 XXSRIVGTTAYXAPEALRGEI-TPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKE 239
Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
           +    E+   +  D +     +   E      +   C+ +  + RP++ +V ++++E   
Sbjct: 240 EIEDEEKTIEDYIDKKXNDADSTSVEA--XYSVASQCLHEKKNKRPDIKKVQQLLQEXTA 297
Query: 614 S 614
           S
Sbjct: 298 S 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR--DFEQQMEIVGRVGQHPNVVPLRA 401
           E +G GS+GT ++A    S               R  +F +++ I+ R+ +HPN+V    
Sbjct: 43  EKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMG 101
Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
                    +V +Y + GSL  LLH  +   R  LD   R+ +    A+G+ ++H+   P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----YRAPEVIETRKHSH 517
              H ++K+ N+L+++     + DFGL+ L       S+ A     + APEV+     + 
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 518 KSDVYSFGVLLLEMLTGKAP 537
           KSDVYSFGV+L E+ T + P
Sbjct: 219 KSDVYSFGVILWELATLQQP 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 33/242 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          ++V +Y  +GSL T L  N G       
Sbjct: 68  RDFLGEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI-- 124
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPA 496
               V +L G + G+ ++  MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P 
Sbjct: 125 --QLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 497 TPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
               + G      + APE I  RK +  SDV+S+G+++ E+++ G+ P    T  D++  
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI-- 237
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                  V E +          R  +  +    + Q+ + C  K  + RP  DE+V M++
Sbjct: 238 -----KAVEEGY----------RLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLD 282
Query: 610 EV 611
           ++
Sbjct: 283 KL 284

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ------HPNVV 397
           E++G G +G  Y+A                     D  Q +E V +  +      HPN++
Sbjct: 13  EIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            LR     +    LV ++   G L+ +L G R      ++W  ++      ARG+ ++H 
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHD 123
Query: 458 MGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGY--RAP 507
                  H ++K+SN+LI Q ++          I+DFGL    +     S +  Y   AP
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAP 183
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           EVI     S  SDV+S+GVLL E+LTG+ P +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           EV+G+G++G   KA  +                 + F  ++  + RV  HPN+V L  Y 
Sbjct: 15  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKL--YG 69
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL---LGTARGVAHIHSMGG 460
              +   LV +Y   GSL  +LHG       PL + T    +   L  ++GVA++HSM  
Sbjct: 70  ACLNPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHS 516
               H ++K  N+L+      L  C  DFG    +    T ++ SA + APEV E   +S
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKIC--DFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
            K DV+S+G++L E++T + P       D +  P       R  W         +  +N+
Sbjct: 183 EKCDVFSWGIILWEVITRRKPF------DEIGGP-----AFRIMWAVHNGTRPPL-IKNL 230
Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
            + +  ++     C +K P  RP+M+E+V+++
Sbjct: 231 PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           EV+G+G++G   KA  +                 + F  ++  + RV  HPN+V L  Y 
Sbjct: 14  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKL--YG 68
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL---LGTARGVAHIHSMGG 460
              +   LV +Y   GSL  +LHG       PL + T    +   L  ++GVA++HSM  
Sbjct: 69  ACLNPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 461 PKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR-SAGYRAPEVIETRKHSHK 518
               H ++K  N+L+        I DFG    +    T ++ SA + APEV E   +S K
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
            DV+S+G++L E++T + P       D +  P       R  W         +  +N+ +
Sbjct: 184 CDVFSWGIILWEVITRRKPF------DEIGGP-----AFRIMWAVHNGTRPPL-IKNLPK 231
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
            +  ++     C +K P  RP+M+E+V+++
Sbjct: 232 PIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 20/182 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPNV+ L          +++ ++  +GSL + L  N G       
Sbjct: 79  RDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG------- 130
Query: 438 WETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---- 492
            +  V  L+G  RG+A  +  +    + H ++ A N+L+N +L   +SDFGL+  +    
Sbjct: 131 -QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 493 NVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 546
           + P   S   G     + APE I+ RK +  SDV+S+G+++ E+++ G+ P    T  D+
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 249
Query: 547 VD 548
           ++
Sbjct: 250 IN 251

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQ-MEIVGRVG-----QHPNVV 397
           +V+G G +G  YK +L+ S+                 E+Q ++ +G  G      H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
            L          +++ +Y  +G+L   L    G        E  V  L+G  RG+A  + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMK 161
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG-----YRAPEV 509
            +    + H ++ A N+L+N +L   +SDFGL+ ++  +  AT + S G     + APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           I  RK +  SDV+SFG+++ E++T G+ P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E LG+GSYG+ YKA+ +E+               ++  +++ I+ +    P+VV     Y
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSY 93
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
           +   +  +V +Y  +GS+S ++   R   +T L  +    IL  T +G+ ++H M   + 
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKT-LTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 464 THGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVIETRKHSHKS 519
            H +IKA N+L+N +    ++DFG+   L +  A  +   G   + APEVI+   ++  +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 520 DVYSFGVLLLEMLTGKAP 537
           D++S G+  +EM  GK P
Sbjct: 207 DIWSLGITAIEMAEGKPP 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 343 AEVLGKGSYGTAYKAVLEES--TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
            EVLGKG +G A K    E+                 R F ++++++ R  +HPNV+   
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM-RCLEHPNVLKFI 73
Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              Y KD++L  + +Y   G+L  ++     +  +   W  RV      A G+A++HSM 
Sbjct: 74  GVLY-KDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----------PSRSAGYR---- 505
                H ++ + N L+ ++ +  ++DFGL  LM    T          P R   Y     
Sbjct: 129 ---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEML 532
               APE+I  R +  K DV+SFG++L E++
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 20/182 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPNV+ L          +++ ++  +GSL + L  N G       
Sbjct: 53  RDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG------- 104
Query: 438 WETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---- 492
            +  V  L+G  RG+A  +  +    + H  + A N+L+N +L   +SDFGL+  +    
Sbjct: 105 -QFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDT 163
Query: 493 NVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 546
           + P   S   G     + APE I+ RK +  SDV+S+G+++ E+++ G+ P    T  D+
Sbjct: 164 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 223
Query: 547 VD 548
           ++
Sbjct: 224 IN 225

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   F H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 97
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 153
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 154 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 248

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 80
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 137 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 231

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 107
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 163
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 164 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 258

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL  ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 14/162 (8%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARG 451
           HP VV L   + ++ +  L+ D+   G L T L       +  +  E  VK  L   A G
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALG 142
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAP 507
           + H+HS+G     + ++K  N+L++++    ++DFGL+         + S      Y AP
Sbjct: 143 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAP 199
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+  + HSH +D +S+GVL+ EMLTG  P Q   R + + L
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTL 241

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 18/179 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          ++V +Y  +GSL T L  + G       
Sbjct: 95  RDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------- 146
Query: 438 WETRVKILLGTARGV-AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVP 495
            +  +  L+G  RGV A +  +    + H ++ A NVL++ +L   +SDFGL+ ++ + P
Sbjct: 147 -QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 496 ATPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
                + G      + APE I  R  S  SDV+SFGV++ E+L  G+ P  + T  D++
Sbjct: 206 DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL  ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 18/179 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          ++V +Y  +GSL T L  + G       
Sbjct: 95  RDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------- 146
Query: 438 WETRVKILLGTARGV-AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVP 495
            +  +  L+G  RGV A +  +    + H ++ A NVL++ +L   +SDFGL+ ++ + P
Sbjct: 147 -QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 496 ATPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
                + G      + APE I  R  S  SDV+SFGV++ E+L  G+ P  + T  D++
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 117/255 (45%), Gaps = 34/255 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          +++ +Y  +GSL   L  N G       
Sbjct: 60  RDFLSEASIMGQF-DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 116
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPA 496
               V +L G   G+ ++  M    + H ++ A N+L+N +L   +SDFG++ ++ + P 
Sbjct: 117 --QLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 171
Query: 497 TPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
               + G      + APE I  RK +  SDV+S+G+++ E+++ G+ P    +  D++  
Sbjct: 172 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-- 229
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                  + E +          R     +  + + Q+ + C  K    RP   ++V M++
Sbjct: 230 -----KAIEEGY----------RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 274
Query: 610 E-VRQSDSENRPSSE 623
           + +R  +S  R  SE
Sbjct: 275 KLIRNPNSLKRTGSE 289

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 117/255 (45%), Gaps = 34/255 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          +++ +Y  +GSL   L  N G       
Sbjct: 54  RDFLSEASIMGQF-DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 110
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPA 496
               V +L G   G+ ++  M    + H ++ A N+L+N +L   +SDFG++ ++ + P 
Sbjct: 111 --QLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 165
Query: 497 TPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
               + G      + APE I  RK +  SDV+S+G+++ E+++ G+ P    +  D++  
Sbjct: 166 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-- 223
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                  + E +          R     +  + + Q+ + C  K    RP   ++V M++
Sbjct: 224 -----KAIEEGY----------RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 268
Query: 610 E-VRQSDSENRPSSE 623
           + +R  +S  R  SE
Sbjct: 269 KLIRNPNSLKRTGSE 283

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPNVV L          ++V ++  +G+L   L  + G       
Sbjct: 89  RDFLCEASIMGQF-DHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI-- 145
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPA 496
               V +L G A G+ ++  MG   + H ++ A N+L+N +L   +SDFGL+ ++ + P 
Sbjct: 146 --QLVGMLRGIAAGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 497 TPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
               + G      + APE I+ RK +  SDV+S+G+++ E+++ G+ P    +  D++
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 258

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           EV+G G +G   +  L      E                 R+F  +  I+G+  +HPN++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF-EHPNII 78
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
            L     +    +++ ++  +G+L + L  N G        +  V  L+G  RG+A  + 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--------QFTVIQLVGMLRGIASGMR 130
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PATPSRSAG-----YRAP 507
            +    + H ++ A N+L+N +L   +SDFGL+  +      P   S   G     + AP
Sbjct: 131 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           E I  RK +  SD +S+G+++ E+++ G+ P    +  D+++
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 137/292 (46%), Gaps = 31/292 (10%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 4   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 62
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH    A  T  + +  + I   T
Sbjct: 63  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQT 117
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSA 502
           ARG+ ++H+       H ++K++N+ +++D    I DFGL  + +  +        S S 
Sbjct: 118 ARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSI 174
Query: 503 GYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 559
            + APEVI   ++  +S +SDVY+FG++L E++TG+ P  +    D +     ++ V R 
Sbjct: 175 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRG 229
Query: 560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
             + ++  V      N  + M +++     C+ K  D RP+   ++  IEE+
Sbjct: 230 SLSPDLSKVR----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 274

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           EV+G G +G   +  L      E                 R+F  +  I+G+  +HPN++
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF-EHPNII 80
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
            L     +    +++ ++  +G+L + L  N G        +  V  L+G  RG+A  + 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--------QFTVIQLVGMLRGIASGMR 132
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PATPSRSAG-----YRAP 507
            +    + H ++ A N+L+N +L   +SDFGL+  +      P   S   G     + AP
Sbjct: 133 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           E I  RK +  SD +S+G+++ E+++ G+ P    +  D+++
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVIN 234

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 80
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +   +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 136
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 137 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 231

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 34/233 (14%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP---LDWETRVKILLGT 448
            HPN+V     +  KDE  LV    + GS+  ++      G      LD  T   IL   
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------- 500
             G+ ++H  G     H ++KA N+L+ +D    I+DFG++  +      +R        
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 501 -SAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDL---PRWV 553
            +  + APEV+E  R +  K+D++SFG+  +E+ TG AP     P +  M+ L   P  +
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           ++ V+++         L ++     +M+ +      C+ K P+ RP   E++R
Sbjct: 248 ETGVQDKEM-------LKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 116/255 (45%), Gaps = 34/255 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           RDF  +  I+G+   HPN++ L          +++ +Y  +GSL   L  N G       
Sbjct: 75  RDFLSEASIMGQF-DHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI-- 131
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPA 496
               V +L G   G+ ++  M      H ++ A N+L+N +L   +SDFG++ ++ + P 
Sbjct: 132 --QLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 497 TPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
               + G      + APE I  RK +  SDV+S+G+++ E+++ G+ P    +  D++  
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-- 244
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                  + E +          R     +  + + Q+ + C  K    RP   ++V M++
Sbjct: 245 -----KAIEEGY----------RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 289
Query: 610 E-VRQSDSENRPSSE 623
           + +R  +S  R  SE
Sbjct: 290 KLIRNPNSLKRTGSE 304

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 34/233 (14%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP---LDWETRVKILLGT 448
            HPN+V     +  KDE  LV    + GS+  ++      G      LD  T   IL   
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------- 500
             G+ ++H  G     H ++KA N+L+ +D    I+DFG++  +      +R        
Sbjct: 126 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 501 -SAGYRAPEVIE-TRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDL---PRWV 553
            +  + APEV+E  R +  K+D++SFG+  +E+ TG AP     P +  M+ L   P  +
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           ++ V+++         L ++     +M+ +      C+ K P+ RP   E++R
Sbjct: 243 ETGVQDKEM-------LKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 282

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 16  SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 74
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH    A  T  + +  + I   T
Sbjct: 75  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQT 129
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 503
           ARG+ ++H+       H ++K++N+ +++D    I DFGL          SR +G     
Sbjct: 130 ARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLA------TEKSRWSGSHQFE 180
Query: 504 -------YRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 553
                  + APEVI   ++  +S +SDVY+FG++L E++TG+ P  +    D +     +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----I 235
Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           + V R   + ++  V      N  + M +++     C+ K  D RP+   ++  IEE+
Sbjct: 236 EMVGRGSLSPDLSKVR----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +   +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV 390
           Y+ DL+D      + LG+GS+    K V ++S                + ++++  +   
Sbjct: 10  YDLDLKD------KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-NTQKEITALKLC 62
Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
             HPN+V L   ++ +    LV +    G L   +   +    T   +     I+     
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IMRKLVS 117
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFG---LTPLMNVP-ATPSRSAG 503
            V+H+H +G     H ++K  N+L    N +L+  I DFG   L P  N P  TP  +  
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR 543
           Y APE++    +    D++S GV+L  ML+G+ P QS  R
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 30/271 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +      ST              + F ++  ++ +  QH  +V L A    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLM-KTLQHDKLVRLYAVVTR 79
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   ++ +Y A GSL   L  + G G+  L     +      A G+A+I       + H
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEG-GKVLL--PKLIDFSAQIAEGMAYIER---KNYIH 133
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+NVL+++ L   I+DFGL  ++      +R        + APE I     + KSD
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           V+SFG+LL E++T GK P    T  D++              TA      + R +N  +E
Sbjct: 194 VWSFGILLYEIVTYGKIPYPGRTNADVM--------------TALSQGYRMPRVENCPDE 239
Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           +  ++++   C  +  + RP  D +  ++++
Sbjct: 240 LYDIMKM---CWKEKAEERPTFDYLQSVLDD 267

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 137/310 (44%), Gaps = 37/310 (11%)
Query: 318 PEKNKLVFFEGCSYNFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXX 373
           P++NK   + G S N+D  ++ R    +   LG G YG  Y+ V ++ S T         
Sbjct: 198 PKRNKPTIY-GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 256
Query: 374 XXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 433
                +F ++  ++  + +HPN+V L      +    ++ ++   G+L   L   R   R
Sbjct: 257 TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNR 312
Query: 434 TPLDWETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
                E    +LL  A  ++  +  +    F H N+ A N L+ ++    ++DFGL+ LM
Sbjct: 313 Q----EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368
Query: 493 NVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 546
                 + +       + APE +   K S KSDV++FGVLL E+ T G +P         
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------ 422
Query: 547 VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           +DL +  + + +        D  + R +   E++ ++++   AC    P  RP+  E+ +
Sbjct: 423 IDLSQVYELLEK--------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 471
Query: 607 MIEEVRQSDS 616
             E + Q  S
Sbjct: 472 AFETMFQESS 481

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 137/310 (44%), Gaps = 37/310 (11%)
Query: 318 PEKNKLVFFEGCSYNFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXX 373
           P++NK   + G S N+D  ++ R    +   LG G YG  Y+ V ++ S T         
Sbjct: 237 PKRNKPTVY-GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED 295
Query: 374 XXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR 433
                +F ++  ++  + +HPN+V L      +    ++ ++   G+L   L   R   R
Sbjct: 296 TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNR 351
Query: 434 TPLDWETRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
                E    +LL  A  ++  +  +    F H N+ A N L+ ++    ++DFGL+ LM
Sbjct: 352 Q----EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 407
Query: 493 NVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDM 546
                 + +       + APE +   K S KSDV++FGVLL E+ T G +P         
Sbjct: 408 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------ 461
Query: 547 VDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           +DL +  + + +        D  + R +   E++ ++++   AC    P  RP+  E+ +
Sbjct: 462 IDLSQVYELLEK--------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 510
Query: 607 MIEEVRQSDS 616
             E + Q  S
Sbjct: 511 AFETMFQESS 520

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 344 EVLGKGSYGTAYKA-------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNV 396
           E +G+G+YG  YKA       V  +                R+     E+      HPN+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNI 81
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHI 455
           V L    +S+    LV++ F    L  +L  N+   +     ++++KI L    RGVAH 
Sbjct: 82  VSLIDVIHSERCLTLVFE-FMEKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHC 135
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE 511
           H     +  H ++K  N+LIN D    ++DFGL     +P         +  YRAP+V+ 
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 512 -TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            ++K+S   D++S G +  EM+TGK      T DD +
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 344 EVLGKGSYGTAYKA-------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNV 396
           E +G+G+YG  YKA       V  +                R+     E+      HPN+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNI 81
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL-GTARGVAHI 455
           V L    +S+    LV++ F    L  +L  N+   +     ++++KI L    RGVAH 
Sbjct: 82  VSLIDVIHSERCLTLVFE-FMEKDLKKVLDENKTGLQ-----DSQIKIYLYQLLRGVAHC 135
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE 511
           H     +  H ++K  N+LIN D    ++DFGL     +P         +  YRAP+V+ 
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 512 -TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            ++K+S   D++S G +  EM+TGK      T DD +
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 344 EVLGKGSYGTAYKAVL------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L      E S               RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +   +GSL + L     A  T +     V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQ---LVGMLRGIASGMKYLSD 165
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAG------YRAPEVI 510
           MG     H ++ A N+LIN +L   +SDFGL+ ++ + P     + G      + +PE I
Sbjct: 166 MGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
             RK +  SDV+S+G++L E+++ G+ P    +  D++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARG 451
           HP +V L   + ++ +  L+ D+   G L T L       +  +  E  VK  L   A  
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 139
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAP 507
           + H+HS+G     + ++K  N+L++++    ++DFGL+         + S      Y AP
Sbjct: 140 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 196
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+  R H+  +D +SFGVL+ EMLTG  P Q   R + + +
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARG 451
           HP +V L   + ++ +  L+ D+   G L T L       +  +  E  VK  L   A  
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 138
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAP 507
           + H+HS+G     + ++K  N+L++++    ++DFGL+         + S      Y AP
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+  R H+  +D +SFGVL+ EMLTG  P Q   R + + +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARG 451
           HP +V L   + ++ +  L+ D+   G L T L       +  +  E  VK  L   A  
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALA 138
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAP 507
           + H+HS+G     + ++K  N+L++++    ++DFGL+         + S      Y AP
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+  R H+  +D +SFGVL+ EMLTG  P Q   R + + +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/311 (23%), Positives = 139/311 (44%), Gaps = 31/311 (9%)
Query: 314 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXX 372
           G QE  K +       SY +++E      +  +G GS+GT YK     +           
Sbjct: 12  GTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDP 71
Query: 373 XXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
                + F  ++ ++ R  +H N++    Y  +KD   +V  +    SL   LH      
Sbjct: 72  TPEQFQAFRNEVAVL-RKTRHVNILLFMGYM-TKDNLAIVTQWCEGSSLYKHLH----VQ 125
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
            T       + I   TA+G+ ++H+       H ++K++N+ +++ L   I DFGL  + 
Sbjct: 126 ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182
Query: 493 NVPA------TPSRSAGYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTR 543
           +  +       P+ S  + APEVI  + +   S +SDVYS+G++L E++TG+ P      
Sbjct: 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242
Query: 544 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 603
            D +     +  V R   + ++  +    ++N  + M +++     CV KV + RP   +
Sbjct: 243 RDQI-----IFMVGRGYASPDLSKL----YKNCPKAMKRLV---ADCVKKVKEERPLFPQ 290
Query: 604 VVRMIEEVRQS 614
           ++  IE ++ S
Sbjct: 291 ILSSIELLQHS 301

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKI-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 73
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 126
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLD 216

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 72
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 73  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H N++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 230
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 231 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 262

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 72
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 125
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVNREVLD 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 74
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 127
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVNREVLD 217

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 76
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 129
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVNREVLD 219

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 30  DRQALLDFADAVPHLRKLN-WSSTNPIC-QSWVGINCTQDRT--RVFGLRLPGIGLVGPI 85
           D+QALL     + +   L+ W  T   C ++W+G+ C  D    RV  L L G+ L  P 
Sbjct: 7   DKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 86  P-NNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           P  ++L  L  L  L +   N L G +P  I  L  L YLY+ H N SG IP   S    
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 142 LVVLDLSFNSFTGNIPQSIQNLTXXXXXXXXXXXXXXXIPNF--DIPKL-RHLNLSYNGL 198
           LV LD S+N+ +G +P SI +L                IP+      KL   + +S N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 199 KGSIPSSLQKFPNSSFV 215
            G IP +     N +FV
Sbjct: 187 TGKIPPTFANL-NLAFV 202

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 313 SGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXX 372
           S VQ+  +N + F +G     D+           G GSY    + +     T        
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDI-----------GVGSYSVCKRCI--HKATNMEFAVKI 54
Query: 373 XXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGA 431
                RD  +++EI+ R GQHPN++ L+  Y       +V +    G L   +L     +
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDF 486
            R          +L    + V ++H+ G     H ++K SN+L   D  G      I DF
Sbjct: 115 EREA------SAVLFTITKTVEYLHAQG---VVHRDLKPSNILY-VDESGNPESIRICDF 164
Query: 487 GLTPLMNVP----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           G    +        TP  +A + APEV+E + +    D++S GVLL  MLTG  P 
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 121/274 (44%), Gaps = 43/274 (15%)
Query: 348 KGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD 407
           KG Y  A K + E S +              +F Q+ + + ++  HP +V        + 
Sbjct: 30  KGQYDVAVKMIKEGSMSED------------EFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76
Query: 408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 467
              +V +Y ++G L   L  + G G  P      +++      G+A + S    +F H +
Sbjct: 77  PIYIVTEYISNGCLLNYLRSH-GKGLEP---SQLLEMCYDVCEGMAFLES---HQFIHRD 129
Query: 468 IKASNVLINQDLDGCISDFGLTPLM----NVPATPSR-SAGYRAPEVIETRKHSHKSDVY 522
           + A N L+++DL   +SDFG+T  +     V +  ++    + APEV    K+S KSDV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 523 SFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 581
           +FG+L+ E+ + GK P    T  ++V        + R    ++                 
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT---------------- 233
Query: 582 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 615
            + QI  +C  ++P+ RP   +++  IE +R+ D
Sbjct: 234 -IYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 43/282 (15%)
Query: 346 LGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G GS+GT YK     +                + F+ ++ ++ R  +H N++ L   Y 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNIL-LFMGYS 89
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +  +  +V  +    SL   LH    A  T  + +  + I   TARG+ ++H+       
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------YRAPEVI-- 510
           H ++K++N+ +++D    I DFGL          SR +G            + APEVI  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA------TEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 511 -ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
            ++  +S +SDVY+FG++L E++TG+ P  +    D +     ++ V R   + ++  V 
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKVR 251
Query: 570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
                N  + M +++     C+ K  D RP+   ++  IEE+
Sbjct: 252 ----SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV------GQHPNVVPL 399
           +G+GS+G   KA+L +ST              R   ++ E   R        +HPN+V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA---GRTPLDWETRVKILLGTARGVAHIH 456
           R  +       +V DY   G L   ++  +G        LDW  ++ + L       H+H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL------KHVH 142
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIET 512
                K  H +IK+ N+ + +D    + DFG+  ++N     +R+      Y +PE+ E 
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           + +++KSD+++ G +L E+ T K   ++ +  ++V
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 33/276 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 76
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ACVIH 129
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-MRFQNIEE 578
           V+SFGVL+ E+ + GK P ++ +  ++V+                  D+    R      
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVE------------------DISTGFRLYKPRL 231
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
               + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 33/276 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 73
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ACVIH 126
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-MRFQNIEE 578
           V+SFGVL+ E+ + GK P ++ +  ++V+                  D+    R      
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVE------------------DISTGFRLYKPRL 228
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
               + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 229 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E +G GSY    + V     T             RD  +++EI+ R GQHPN++ L+  Y
Sbjct: 33  ETIGVGSYSECKRCV--HKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSMGGPK 462
                  LV +    G L   +       R     E     +L T  + V ++HS G   
Sbjct: 91  DDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKTVEYLHSQG--- 141
Query: 463 FTHGNIKASNVLINQDLDG--C--ISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK 514
             H ++K SN+L   +     C  I DFG    +        TP  +A + APEV++ + 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
           +    D++S G+LL  ML G  P  +   D
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSD 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 249
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 302
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 33/276 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 71
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ACVIH 124
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-MRFQNIEE 578
           V+SFGVL+ E+ + GK P ++ +  ++V+                  D+    R      
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVE------------------DISTGFRLYKPRL 226
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
               + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 249
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 302
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR A       Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 237
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 238 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 281

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E +G GSY    + V     T             RD  +++EI+ R GQHPN++ L+  Y
Sbjct: 33  ETIGVGSYSECKRCV--HKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSMGGPK 462
                  LV +    G L   +       R     E     +L T  + V ++HS G   
Sbjct: 91  DDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKTVEYLHSQG--- 141
Query: 463 FTHGNIKASNVLINQDLDG--C--ISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK 514
             H ++K SN+L   +     C  I DFG    +        TP  +A + APEV++ + 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
           +    D++S G+LL  ML G  P  +   D
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSD 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  + S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDSTRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVIETRK 514
            K  H +IK  N+L+    +  I+DFG +    V A  SR A       Y  PE+IE R 
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQD 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGR-----VGQHPNVVP 398
           ++LGKGS+G  + A  +++                D + +  +V +       +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           +   + +K+    V +Y   G L   +        +   +     IL     G+  +HS 
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-----GLQFLHSK 138
Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 514
           G     + ++K  N+L+++D    I+DFG+    M   A  +   G   Y APE++  +K
Sbjct: 139 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWVQSVVRE 559
           ++H  D +SFGVLL EML G++P      +++           PRW++   ++
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 248

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 392 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
           +H N+V L      +   L +V +Y A GSL   L   R  GR+ L  +  +K  L    
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 128
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
            + ++    G  F H ++ A NVL+++D    +SDFGLT      A+ ++  G     + 
Sbjct: 129 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT 181
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPL-QSPTRD 544
           APE +  +K S KSDV+SFG+LL E+ + G+ P  + P +D
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 80
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y   GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLP----QLVDMSAQIASGMAYVERMN---YV 133
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 78
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 79  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 236
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 237 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 268

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + G L   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 84
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 85  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 242
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 243 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 274

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H ++ A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 76
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 234
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 235 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 82
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 83  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 240
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 241 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 77
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 78  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 235
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 236 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 267

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 392 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
           +H N+V L      +   L +V +Y A GSL   L   R  GR+ L  +  +K  L    
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 113
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
            + ++    G  F H ++ A NVL+++D    +SDFGLT      A+ ++  G     + 
Sbjct: 114 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT 166
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPL-QSPTRD 544
           APE +  +K S KSDV+SFG+LL E+ + G+ P  + P +D
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 249
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVERMN---YV 302
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLD 392

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 85
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 86  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 243
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 244 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGR-----VGQHPNVVP 398
           ++LGKGS+G  + A  +++                D + +  +V +       +HP +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           +   + +K+    V +Y   G L   +        +   +     IL     G+  +HS 
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-----GLQFLHSK 137
Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRK 514
           G     + ++K  N+L+++D    I+DFG+    M   A  +   G   Y APE++  +K
Sbjct: 138 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD--------LPRWVQSVVRE 559
           ++H  D +SFGVLL EML G++P      +++           PRW++   ++
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 80
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y   GSL   L G  G   R P   +   +I    A G+A++  M    + 
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI----ASGMAYVERMN---YV 133
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLD 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 76
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 234
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 235 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  + A   + T                F  +  ++ +  QH  +V L A   +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVKLHAVV-T 80
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           K+   ++ ++ A GSL   L  + G+ + PL     +      A G+A I       + H
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+N+L++  L   I+DFGL  ++      +R        + APE I     + KSD
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 194
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           V+SFG+LL+E++T G+ P    +       P  ++++ R           + R +N  EE
Sbjct: 195 VWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEE 240
Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           +  ++   M C    P+ RP  + +  ++++
Sbjct: 241 LYNIM---MRCWKNRPEERPTFEYIQSVLDD 268

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 71
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 72  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 229
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 230 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 33/276 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKL-SHPKLVQLYGVCLE 93
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ACVIH 146
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-MRFQNIEE 578
           V+SFGVL+ E+ + GK P ++ +  ++V+                  D+    R      
Sbjct: 207 VWSFGVLMWEVFSEGKIPYENRSNSEVVE------------------DISTGFRLYKPRL 248
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
               + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 249 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 83
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + G L   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 136
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLD 226

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 332
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   +V +Y + GSL   L G  G     L     V +    A G+A++  M    + H
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           V+SFG+LL E+ T G+ P       +++D
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLD 475

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 41/295 (13%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 75
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 127
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGYRAPEVIETRKHS 516
            +  H +IK  N+L+    +  I+DFG +   + P+    T S +  Y  PE+IE R H 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
            K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R    
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR---- 235
Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
             +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 236 --DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNSQNKESASK 279

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               ++       +++EI   +  HPN++ L 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL-HHPNILRLY 89
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y+Y +    L+ +Y   G L   L  +        D +    I+   A  + + H   G
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKS-----CTFDEQRTATIMEELADALMYCH---G 141
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIETRKHS 516
            K  H +IK  N+L+    +  I+DFG +  ++ P+   ++      Y  PE+IE R H+
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
            K D++  GVL  E+L G  P +S + ++
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 76
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 234
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 235 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 81
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 82  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 239
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 240 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 271

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG+G +G  +      +T                F Q+ +++ ++ +H  +V L A   S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 250
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAG-RTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           ++   +V +Y + GSL   L G  G   R P      V +    A G+A++  M    + 
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVERM---NYV 303
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + KS
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           DV+SFG+LL E+ T G+ P       +++D
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVNREVLD 393

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  +      ST              + F ++  ++ +  QH  +V L A    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLM-KTLQHDKLVRLYAVVTK 78
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPL----DWETRVKILLGTARGVAHIHSMGGP 461
           ++   ++ ++ A GSL   L  + G G+  L    D+  ++      A G+A+I      
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIER---K 128
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+NVL+++ L   I+DFGL  ++      +R        + APE I     +
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KS+V+SFG+LL E++T GK P    T  D       V S + + +        + R +N
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGRTNAD-------VMSALSQGY-------RMPRMEN 234
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             +E+  ++++   C  +  + RP  D +  ++++
Sbjct: 235 CPDELYDIMKM---CWKEKAEERPTFDYLQSVLDD 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 82
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 83  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 240
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 241 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            E LG G +G  +       T                F  +  ++ ++ QH  +V L A 
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV 86
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGP 461
             +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  +A  +  +   
Sbjct: 87  V-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHS 516
            + H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     +
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            KSDV+SFG+LL E++T G+ P    T       P  +Q++ R           ++R  N
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER--------GYRMVRPDN 244
Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
             EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 245 CPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 276

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 77
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 130
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H N+   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 131 LGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 221

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  + A   + T                F  +  ++ +  QH  +V L A   +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVKLHAVV-T 253
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           K+   ++ ++ A GSL   L  + G+ + PL     +      A G+A I       + H
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +++A+N+L++  L   I+DFGL  ++      +R        + APE I     + KSD
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE 579
           V+SFG+LL+E++T G+ P    +       P  ++++ R           + R +N  EE
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEE 413
Query: 580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           +  ++   M C    P+ RP  + +  ++++
Sbjct: 414 LYNIM---MRCWKNRPEERPTFEYIQSVLDD 441

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 131/300 (43%), Gaps = 36/300 (12%)
Query: 328 GCSYNFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQ 383
           G S N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++
Sbjct: 1   GMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 60
Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 443
             ++  + +HPN+V L      +    ++ ++   G+L   L   R   R     E    
Sbjct: 61  AAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAV 112
Query: 444 ILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPAT 497
           +LL  A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM       PA 
Sbjct: 113 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG 172
Query: 498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 556
                 + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + +
Sbjct: 173 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELL 226
Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
            +        D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 227 EK--------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 275

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 73
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV+++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           V+SFGVL+ E+ + GK P ++ +  ++V+
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVE 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 32/226 (14%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           QH  +V L A   +++   ++ +Y  +GSL   L       +TP   +  +  LL  A  
Sbjct: 66  QHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL-------KTPSGIKLTINKLLDMAAQ 117
Query: 452 VAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
           +A  +  +    + H +++A+N+L++  L   I+DFGL  L+      +R        + 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWT 177
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
           APE I     + KSDV+SFG+LL E++T G+ P    T       P  +Q++ R      
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLER------ 225
Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
                ++R  N  EE+ Q++++   C  + P+ RP  D +  ++E+
Sbjct: 226 --GYRMVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLED 266

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 392 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
           +H N+V L      +   L +V +Y A GSL   L   R  GR+ L  +  +K  L    
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 300
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
            + ++    G  F H ++ A NVL+++D    +SDFGLT      A+ ++  G     + 
Sbjct: 301 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT 353
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPL-QSPTRD 544
           APE +  +K S KSDV+SFG+LL E+ + G+ P  + P +D
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 82/336 (24%), Positives = 137/336 (40%), Gaps = 55/336 (16%)
Query: 307 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXX 366
           P+EE  S  +  E  K          + LED        LGKG +G  Y A  ++S    
Sbjct: 13  PEEELASKQKNEESKK--------RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 367 XXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 421
                      +        +++EI   + +HPN++ L  Y++      L+ +Y   G++
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 481
              L        +  D +     +   A  +++ HS    +  H +IK  N+L+    + 
Sbjct: 122 YRELQK-----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 173
Query: 482 CISDFGLTPLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
            I+DFG +    V A  SR      +  Y  PE+IE R H  K D++S GVL  E L GK
Sbjct: 174 KIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229
Query: 536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
            P ++ T  +        + + R E+T   F  E  R      +++  L      +   P
Sbjct: 230 PPFEANTYQET------YKRISRVEFTFPDFVTEGAR------DLISRL------LKHNP 271
Query: 596 DMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
             RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 272 SQRPMLREV---LEHPWITANSSKPSNCQNKESASK 304

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 82/336 (24%), Positives = 137/336 (40%), Gaps = 55/336 (16%)
Query: 307 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXX 366
           P+EE  S  +  E  K          + LED        LGKG +G  Y A  ++S    
Sbjct: 13  PEEELASKQKNEESKK--------RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFIL 62
Query: 367 XXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 421
                      +        +++EI   + +HPN++ L  Y++      L+ +Y   G++
Sbjct: 63  ALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTV 121
Query: 422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 481
              L        +  D +     +   A  +++ HS    +  H +IK  N+L+    + 
Sbjct: 122 YRELQK-----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 173
Query: 482 CISDFGLTPLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
            I+DFG +    V A  SR      +  Y  PE+IE R H  K D++S GVL  E L GK
Sbjct: 174 KIADFGWS----VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229
Query: 536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
            P ++ T  +        + + R E+T   F  E  R      +++  L      +   P
Sbjct: 230 PPFEANTYQET------YKRISRVEFTFPDFVTEGAR------DLISRL------LKHNP 271
Query: 596 DMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
             RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 272 SQRPMLREV---LEHPWITANSSKPSNCQNKESASK 304

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 35/278 (12%)
Query: 298 ASSGGRSEKPKEEFGSGVQ-EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 356
           A   G S  P E  GSG+Q    +N   F + C ++    D++      LG+G++G  + 
Sbjct: 2   AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWE--LGEGAFGKVFL 59
Query: 357 AVL-------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 409
           A         ++                +DF+++ E++  + QH ++V            
Sbjct: 60  AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPL 118
Query: 410 LLVYDYFASGSL----------STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
           L+V++Y   G L          + LL G       PL     + +    A G+ +   + 
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY---LA 175
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRA--------PEVIE 511
           G  F H ++   N L+ Q L   I DFG++   ++ +T     G R         PE I 
Sbjct: 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTMLPIRWMPPESIL 233
Query: 512 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
            RK + +SDV+SFGV+L E+ T GK P    +  + +D
Sbjct: 234 YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 79
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  +  A R        +K+L  T++    +  
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--AERI-----DHIKLLQYTSQICKGMEY 132
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 137/335 (40%), Gaps = 55/335 (16%)
Query: 307 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXX 366
           P+EE  S  +  E  K          + LED        LGKG +G  Y A  ++S    
Sbjct: 4   PEEELASKQKNEESKK--------RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFIL 53
Query: 367 XXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL 421
                      +        +++EI   + +HPN++ L  Y++      L+ +Y   G++
Sbjct: 54  ALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTV 112
Query: 422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG 481
              L        +  D +     +   A  +++ HS    +  H +IK  N+L+    + 
Sbjct: 113 YRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGEL 164
Query: 482 CISDFGLTPLMNVPATPSR------SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
            I+DFG +    V A  SR      +  Y  PE+IE R H  K D++S GVL  E L GK
Sbjct: 165 KIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220
Query: 536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
            P ++ T  +        + + R E+T   F  E  R      +++  L      +   P
Sbjct: 221 PPFEANTYQET------YKRISRVEFTFPDFVTEGAR------DLISRL------LKHNP 262
Query: 596 DMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDS 630
             RP + EV   +E    + + ++PS+ +NK   S
Sbjct: 263 SQRPMLREV---LEHPWITANSSKPSNCQNKESAS 294

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 234
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 235 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 278

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 234
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 235 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 278

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 79
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 131
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 239
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 240 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 283

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 33/276 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           +G G +G  +                       DF ++ E++ ++  HP +V L      
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 74
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           +    LV ++   G LS  L   RG        ET + + L    G+A++         H
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLEE---ACVIH 127
Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSHKSD 520
            ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S KSD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL-MRFQNIEE 578
           V+SFGVL+ E+ + GK P ++ +  ++V+                  D+    R      
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVE------------------DISTGFRLYKPRL 229
Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
               + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 76
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 128
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 236
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 237 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 280

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR A       Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +                  ++      +V R  ++PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQ 137
Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H NIK+ N+L+  D    ++DFG    +TP  +  +T   +  + APEV+  + +  K
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 79
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSK-- 132
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE IE R 
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 239
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 240 ----DLISRL------LKHNPSQRPXLREV---LEHPWITANSSKPSNCQNKESASK 283

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 79
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G +   L        +  D +     +   A  +++ HS   
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQK-----LSKFDEQRTATYITELANALSYCHS--- 131
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 239
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 240 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 283

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 237
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 238 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 79
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G +   L        +  D +     +   A  +++ HS   
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQK-----LSKFDEQRTATYITELANALSYCHS--- 131
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 239
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 240 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 283

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 75
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 128
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 129 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 189 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 219

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 75
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 127
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDTLCGTLDYLPPEMIEGRM 183
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 235
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 236 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 279

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 75
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 127
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 235
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 236 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 279

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 79
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 131
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 239
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 240 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 283

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 81
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 134
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 135 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 195 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 225

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 82
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 135
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 136 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 196 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 226

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 79
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 132
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 76
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 129
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 74
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 127
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 128 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 188 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 76
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 129
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 80
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 133
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 134 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 107
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 160
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 251

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 76
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 129
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 83
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 136
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 137 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 197 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 227

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 94
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 147
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 313 SGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXX 372
           S VQ+  +N + F +G     D+           G GSY    + +     T        
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDI-----------GVGSYSVCKRCI--HKATNXEFAVKI 54
Query: 373 XXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGA 431
                RD  +++EI+ R GQHPN++ L+  Y       +V +    G L   +L     +
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFS 114
Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDF 486
            R          +L    + V ++H+ G     H ++K SN+L   D  G      I DF
Sbjct: 115 EREA------SAVLFTITKTVEYLHAQG---VVHRDLKPSNILY-VDESGNPESIRICDF 164
Query: 487 GLTPLMNVP----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           G    +        TP  +A + APEV+E + +    D++S GVLL   LTG  P 
Sbjct: 165 GFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 117
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRS 501
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM       PA     
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 177
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 229
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 230 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 234
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENK 626
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK
Sbjct: 235 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNK 273

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 94
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ +Y   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERID---HIKLLQYTSQICKGMEY 147
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 334 DLEDLLRASAEV---LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV 390
           D+ ++ R S ++   LG G +G  +      +T                F ++ +I+ ++
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
            +H  +V L A   S++   +V +Y   GSL   L    G GR  L     V +    A 
Sbjct: 62  -KHDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKD--GEGRA-LKLPNLVDMAAQVAA 116
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
           G+A+I  M    + H +++++N+L+   L   I+DFGL  L+      +R        + 
Sbjct: 117 GMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT 173
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           APE     + + KSDV+SFG+LL E++T G+ P
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 234
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENK 626
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK
Sbjct: 235 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNK 273

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY  +       H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 135/304 (44%), Gaps = 37/304 (12%)
Query: 324 VFFEGCSYNFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRD 379
           ++F+G S N+D  ++ R    +   LG G YG  Y+ V ++ S T              +
Sbjct: 10  LYFQG-SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 68
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           F ++  ++  + +HPN+V L      +    ++ ++   G+L   L   R   R     E
Sbjct: 69  FLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----E 120
Query: 440 TRVKILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 498
               +LL  A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      
Sbjct: 121 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 180
Query: 499 SRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 552
           + +       + APE +   K S KSDV++FGVLL E+ T G +P         +DL + 
Sbjct: 181 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQV 234
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
            + + +        D  + R +   E++ ++++   AC    P  RP+  E+ +  E + 
Sbjct: 235 YELLEK--------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMF 283
Query: 613 QSDS 616
           Q  S
Sbjct: 284 QESS 287

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 134
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 191
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 192 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E++G G+YG  YK   ++                  + +Q++ ++ +   H N+      
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 403 YYSK------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           +  K      D+  LV ++  +GS++ L+   +G     L  E    I     RG++H+H
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 146
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 506
                K  H +IK  NVL+ ++ +  + DFG      V A   R+ G R          A
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 197
Query: 507 PEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
           PEVI   +     +  KSD++S G+  +EM  G  PL
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+    + + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 82
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 139
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 192
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 247

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 132
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFG 189
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 190 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 137
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 138 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 194
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 195 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 94
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 151
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAPE 204
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 89
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 146
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 199
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 93
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 150
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 203
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 248
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T
Sbjct: 249 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 346 LGKGSYGTAYKAV---LEEST---TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           LGKG++G+        L+++T                 RDFE+++EI+  + QH N+V  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKY 79
Query: 400 RAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
           +   YS   +   L+ ++   GSL   L  ++      +D    +K+L  T++    +  
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHK----ERID---HIKLLQYTSQICKGMEY 132
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-------NVPATPSRSAGYRAPEVI 510
           +G  ++ H ++   N+L+  +    I DFGLT ++        V         + APE +
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
              K S  SDV+SFGV+L E+ T     +SP
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 100
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 157
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 210
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 85
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 142
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAP 195
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 250

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 19/244 (7%)
Query: 314 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXX 372
           G ++  + K +     S ++++ D      + +G GS+GT YK     +           
Sbjct: 12  GSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 373 XXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
                + F+ ++ ++ R  +H N++ L   Y +K +  +V  +    SL   LH      
Sbjct: 72  TPQQLQAFKNEVGVL-RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----II 125
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
            T  +    + I   TA+G+ ++H+       H ++K++N+ +++DL   I DFGL  + 
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 182
Query: 493 NVPATP------SRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTR 543
           +  +        S S  + APEVI  +    +S +SDVY+FG++L E++TG+ P  +   
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242
Query: 544 DDMV 547
            D +
Sbjct: 243 RDQI 246

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 116
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 173
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSXICSRY--YRAPE 226
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 36/300 (12%)
Query: 328 GCSYNFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQ 383
           G S N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++
Sbjct: 1   GPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 60
Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 443
             ++  + +HPN+V L      +    ++ ++   G+L   L   R   R     E    
Sbjct: 61  AAVMKEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ----EVNAV 112
Query: 444 ILLGTARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
           +LL  A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + + 
Sbjct: 113 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG 172
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 556
                 + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + +
Sbjct: 173 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELL 226
Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
            +        D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 227 EK--------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 275

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +                  ++      +V R  ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ N+L+  D    ++DFG    +TP  +  +T   +  + APEV+  + +  K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 26/229 (11%)
Query: 328 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQ 382
           G    + LED        LGKG +G  Y A  ++S               +        +
Sbjct: 4   GSKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           ++EI   + +HPN++ L  Y++      L+ +Y   G++   L        +  D +   
Sbjct: 62  EVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTA 115
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
             +   A  +++ HS    +  H +IK  N+L+    +  I+DFG +    V A  SR  
Sbjct: 116 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRT 168
Query: 501 ----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
               +  Y  PE+IE R H  K D++S GVL  E L GK P ++ T  +
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---IMRKLDHCNIVRLRYF 81
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 138
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAP 191
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 76
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 128
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I++FG +    V A  SR      +  Y  PE+IE R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           H  K D++S GVL  E L GK P ++ T  +        + + R E+T   F  E  R  
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR-- 236
Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDSN 631
               +++  L      +   P  RP + EV   +E    + + ++PS+ +NK   S 
Sbjct: 237 ----DLISRL------LKHNPSQRPMLREV---LEHPWITANSSKPSNCQNKESASK 280

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T G +P
Sbjct: 196 LARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 392 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
           +H N+V L      +   L +V +Y A GSL   L   R  GR+ L  +  +K  L    
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCE 119
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YR 505
            + ++    G  F H ++ A NVL+++D    +SDFGLT      A+ ++  G     + 
Sbjct: 120 AMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT 172
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPL-QSPTRD 544
           APE +     S KSDV+SFG+LL E+ + G+ P  + P +D
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 213

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
           +++     +V+G GS+G  Y+A L +S               ++ E Q   + R   H N
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ---IMRKLDHCN 74
Query: 396 VVPLRAYYYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +V LR ++YS  EK       LV DY          H +R     P+ +   VK+ +   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQL 131
Query: 450 -RGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSR 500
            R +A+IHS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSR 186
Query: 501 SAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVR 558
              YRAPE+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  R
Sbjct: 187 Y--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 559 EE 560
           E+
Sbjct: 245 EQ 246

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 118/267 (44%), Gaps = 33/267 (12%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           LG G +G  + A   + T                F  +  ++ +  QH  +V L A   +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVKLHAVV-T 247
Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           K+   ++ ++ A GSL   L  + G+ + PL     +      A G+A I       + H
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 301
Query: 466 GNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSF 524
            +++A+N+L++  L   I+DFGL  +    P        + APE I     + KSDV+SF
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVGAKFPIK------WTAPEAINFGSFTIKSDVWSF 355
Query: 525 GVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQM 583
           G+LL+E++T G+ P    +       P  ++++ R           + R +N  EE+  +
Sbjct: 356 GILLMEIVTYGRIPYPGMSN------PEVIRALER--------GYRMPRPENCPEELYNI 401
Query: 584 LQIGMACVAKVPDMRPNMDEVVRMIEE 610
           +   M C    P+ RP  + +  ++++
Sbjct: 402 M---MRCWKNRPEERPTFEYIQSVLDD 425

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 74
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 126
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 213

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           H  K D++S GVL  E L GK P ++ T
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 73
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 74  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 125
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R 
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 212

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
            +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR +
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYF 94
Query: 403 YYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHI 455
           +YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+I
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYI 151
Query: 456 HSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAP 507
           HS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAP
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAP 204
Query: 508 EVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           E+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 259

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 5   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 63
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH       T  +    + I   T
Sbjct: 64  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQT 118
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSA 502
           A+G+ ++H+       H ++K++N+ +++DL   I DFGL  + +  +        S S 
Sbjct: 119 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 503 GYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            + APEVI  +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 60
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH       T  +    + I   T
Sbjct: 61  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQT 115
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSA 502
           A+G+ ++H+       H ++K++N+ +++DL   I DFGL  + +  +        S S 
Sbjct: 116 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 172
Query: 503 GYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            + APEVI  +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 173 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 116
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 173
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPE 226
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 5   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 63
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH       T  +    + I   T
Sbjct: 64  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQT 118
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSA 502
           A+G+ ++H+       H ++K++N+ +++DL   I DFGL  + +  +        S S 
Sbjct: 119 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 175
Query: 503 GYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            + APEVI  +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 176 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 87
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 144
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPE 197
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 251

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 346 LGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G GS+GT YK     +                + F+ ++ ++ R  +H N++ L   Y 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNIL-LFMGYS 73
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +K +  +V  +    SL   LH       T  +    + I   TA+G+ ++H+       
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHA---KSII 126
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSAGYRAPEVIETRK---H 515
           H ++K++N+ +++DL   I DFGL  + +  +        S S  + APEVI  +    +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 110
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 167
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPE 220
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 274

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 64/138 (46%), Gaps = 26/138 (18%)
Query: 95  ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSF 152
           ++  L +  N+L+G +P EI S+P L  L L HN+ SG IP        L +LDLS N  
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 153 TGNIPQSIQNLTXXXXXXXXXXXXXXXIPNFDIPKLRHLNLSYNGLKGSIP--SSLQKFP 210
            G IPQ++  LT                       L  ++LS N L G IP     + FP
Sbjct: 693 DGRIPQAMSALTM----------------------LTEIDLSNNNLSGPIPEMGQFETFP 730
Query: 211 NSSFVGNSLLCGPPLKAC 228
            + F+ N  LCG PL  C
Sbjct: 731 PAKFLNNPGLCGYPLPRC 748

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 118
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 175
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPE 228
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 282

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 64/138 (46%), Gaps = 26/138 (18%)
Query: 95  ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSF 152
           ++  L +  N+L+G +P EI S+P L  L L HN+ SG IP        L +LDLS N  
Sbjct: 630 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 689
Query: 153 TGNIPQSIQNLTXXXXXXXXXXXXXXXIPNFDIPKLRHLNLSYNGLKGSIP--SSLQKFP 210
            G IPQ++  LT                       L  ++LS N L G IP     + FP
Sbjct: 690 DGRIPQAMSALTM----------------------LTEIDLSNNNLSGPIPEMGQFETFP 727
Query: 211 NSSFVGNSLLCGPPLKAC 228
            + F+ N  LCG PL  C
Sbjct: 728 PAKFLNNPGLCGYPLPRC 745

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 27  SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 85
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH       T  +    + I   T
Sbjct: 86  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQT 140
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSA 502
           A+G+ ++H+       H ++K++N+ +++DL   I DFGL  + +  +        S S 
Sbjct: 141 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 197
Query: 503 GYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            + APEVI  +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 38/251 (15%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 236
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS 540
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T G +P   
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
              +++  L +    + +                N   E+  M++    C   VP  RP 
Sbjct: 297 VPVEELFKLLKEGHRMDKP--------------SNCTNELYMMMR---DCWHAVPSQRPT 339
Query: 601 MDEVVRMIEEV 611
             ++V  ++ +
Sbjct: 340 FKQLVEDLDRI 350

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXX--XXXXXXXRDFEQQ 383
           +E  + + + ED      E LG G++G  YKA  +E++                 D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRV 442
           ++I+     HPN+V L   +Y ++   ++ ++ A G++ + +L   R     PL   T  
Sbjct: 85  IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TES 135
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
           +I +   + +  ++ +   K  H ++KA N+L   D D  ++DFG++   N      R +
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDS 194
Query: 503 -----GYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                 + APEV+     + R + +K+DV+S G+ L+EM   + P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
           +++     +V+G GS+G  Y+A L +S               ++ E Q   + R   H N
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCN 153
Query: 396 VVPLRAYYYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +V LR ++YS  EK       LV DY          H +R     P+ +   VK+ +   
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQL 210
Query: 450 -RGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSR 500
            R +A+IHS G     H +IK  N+L++ D   L  C  DFG    +     NV    SR
Sbjct: 211 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSR 265
Query: 501 SAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVR 558
              YRAPE+I     ++   DV+S G +L E+L G+      +  D +V++ + + +  R
Sbjct: 266 Y--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 323
Query: 559 EE 560
           E+
Sbjct: 324 EQ 325

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXX--XXXXXXXRDFEQQ 383
           +E  + + + ED      E LG G++G  YKA  +E++                 D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRV 442
           ++I+     HPN+V L   +Y ++   ++ ++ A G++ + +L   R     PL   T  
Sbjct: 85  IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TES 135
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
           +I +   + +  ++ +   K  H ++KA N+L   D D  ++DFG++   N      R +
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDS 194
Query: 503 -----GYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                 + APEV+     + R + +K+DV+S G+ L+EM   + P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S               ++ E Q   + R   H N+V LR ++
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ---IMRKLDHCNIVRLRYFF 120
Query: 404 YSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIH 456
           YS  EK       LV DY          H +R     P+ +   VK+ +    R +A+IH
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 177
Query: 457 SMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLM-----NVPATPSRSAGYRAPE 508
           S G     H +IK  N+L++ D   L  C  DFG    +     NV    SR   YRAPE
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPE 230
Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-RDDMVDLPRWVQSVVREE 560
           +I     ++   DV+S G +L E+L G+      +  D +V++ + + +  RE+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 284

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++  Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T G +P
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 113/250 (45%), Gaps = 31/250 (12%)
Query: 314 GVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXX 372
           G ++  + K +     S ++++ D      + +G GS+GT YK     +           
Sbjct: 12  GSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 373 XXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
                + F+ ++ ++ R  +H N++ L   Y +K +  +V  +    SL   LH      
Sbjct: 72  TPQQLQAFKNEVGVL-RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----II 125
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
            T  +    + I   TA+G+ ++H+       H ++K++N+ +++DL   I DFGL    
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--- 179
Query: 493 NVPATPSRSAG------------YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAP 537
                 SR +G            + APEVI  +    +S +SDVY+FG++L E++TG+ P
Sbjct: 180 ---TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236
Query: 538 LQSPTRDDMV 547
             +    D +
Sbjct: 237 YSNINNRDQI 246

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T G +P
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++  Y + G+L   L   R  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD 145
Query: 433 --RTP---LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
             R P   + ++  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFG
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 202
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + N+      + G     + APE +  R ++H+SDV+SFGVL+ E+ T
Sbjct: 203 LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXX--XXXXXXXRDFEQQ 383
           +E  + + + ED      E LG G++G  YKA  +E++                 D+  +
Sbjct: 26  YEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 84
Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRV 442
           ++I+     HPN+V L   +Y ++   ++ ++ A G++ + +L   R     PL   T  
Sbjct: 85  IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PL---TES 135
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
           +I +   + +  ++ +   K  H ++KA N+L   D D  ++DFG++   N      R  
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDX 194
Query: 501 ---SAGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
              +  + APEV+     + R + +K+DV+S G+ L+EM   + P
Sbjct: 195 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/292 (22%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 344 EVLGKGSYGTAYKAVLEES-----TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++                     RDF  ++E++ ++G HPN++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 447
           L      +    L  +Y   G+L   L  +R     P           L  +  +     
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AGY 504
            ARG+ ++      +F H N+ A N+L+ ++    I+DFGL+    V    +       +
Sbjct: 148 VARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 562
            A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ + LP+           
Sbjct: 205 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----------- 253
Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 610
                  L +  N ++E+  +++    C  + P  RP+  +++    RM+EE
Sbjct: 254 ----GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 298

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 184
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 185 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 120
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 232
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 233 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 188
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 189 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L   R  G      
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 187
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 188 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ----EVSAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 346 LGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G GS+GT YK     +                + F+ ++ ++ R  +H N++ L   Y 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNIL-LFMGYS 73
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +K +  +V  +    SL   LH       T  +    + I   TA+G+ ++H+       
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHA---KSII 126
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------YRAPEVIET 512
           H ++K++N+ +++DL   I DFGL          SR +G            + APEVI  
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLA------TEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 513 RK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 117
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 229
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 230 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 65
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 66  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 117
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 177
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 229
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 230 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 276

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVSAVVLLY 120
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 232
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 233 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 279

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 31/234 (13%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S ++++ D      + +G GS+GT YK     +                + F+ ++ ++ 
Sbjct: 20  SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL- 78
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R  +H N++ L   Y +K +  +V  +    SL   LH       T  +    + I   T
Sbjct: 79  RKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQT 133
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 503
           A+G+ ++H+       H ++K++N+ +++DL   I DFGL          SR +G     
Sbjct: 134 AQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLA------TEKSRWSGSHQFE 184
Query: 504 -------YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
                  + APEVI  +    +S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 185 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ----EVSAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVSAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 346 LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G YG  Y+ V ++ S T              +F ++  ++  + +HPN+V L     
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 77
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKF 463
            +    ++ ++   G+L   L   R   R     E    +LL  A  ++  +  +    F
Sbjct: 78  REPPFYIIIEFMTYGNLLDYL---RECNRQ----EVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV++FGVLL E+ T G +P   P  D     P  V  ++ +       D  + R +   
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY--PGID-----PSQVYELLEK-------DYRMERPEGCP 236
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 237 EKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVSAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 274

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           V ++  HPN+VP RA + + +E  +V  + A GS   L+  +   G   L       IL 
Sbjct: 63  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---AIAYILQ 119
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTP-------LMNVP 495
           G  + + +IH MG   + H ++KAS++LI+ D    L G  S+  +         + + P
Sbjct: 120 GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 176
Query: 496 ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
               +   + +PEV++   + +  KSD+YS G+   E+  G  P +
Sbjct: 177 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 222

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++S               +        +++EI   + +HPN++ L 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 77
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 129
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I++FG +    V A  SR      +  Y  PE+IE R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 216

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 346 LGKGSYGTAYKAVLEE-----STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  ++     +                   +++EI   + +HPN++ L 
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLY 71
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++      L+ +Y   G++   L        +  D +     +   A  +++ HS   
Sbjct: 72  GYFHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS--- 123
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
            +  H +IK  N+L+    +  I+DFG     +V A  SR      +  Y  PE+IE R 
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           H  K D++S GVL  E L GK P ++ T  +
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 210

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           V ++  HPN+VP RA + + +E  +V  + A GS   L+  +   G   L       IL 
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---AIAYILQ 135
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTP-------LMNVP 495
           G  + + +IH MG   + H ++KAS++LI+ D    L G  S+  +         + + P
Sbjct: 136 GVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 496 ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
               +   + +PEV++   + +  KSD+YS G+   E+  G  P +
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 146
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 245
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 246 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 120
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 232
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q
Sbjct: 233 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +                  ++      +V R  ++PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQ 137
Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ N+L+  D    ++DFG    +TP  +  +    +  + APEV+  + +  K
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 120
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 232
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q
Sbjct: 233 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +                  ++      +V R  ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ N+L+  D    ++DFG    +TP  +  +    +  + APEV+  + +  K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 344 EVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +G+G+ GT Y A+ +                  ++      +V R  ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 463 FTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
             H +IK+ N+L+  D    ++DFG    +TP  +  +    +  + APEV+  + +  K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 519 SDVYSFGVLLLEMLTGKAPL--QSPTR 543
            D++S G++ +EM+ G+ P   ++P R
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 26/226 (11%)
Query: 328 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQ 382
           G    + LED        LGKG +G  Y A   +S               +        +
Sbjct: 4   GSKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           ++EI   + +HPN++ L  Y++      L+ +Y   G++   L        +  D +   
Sbjct: 62  EVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSRFDEQRTA 115
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
             +   A  +++ HS    +  H +IK  N+L+  + +  I+DFG     +V A  SR  
Sbjct: 116 TYITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRT 168
Query: 501 ----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
               +  Y  PE+IE R H  K D++S GVL  E L G  P ++ T
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 26/226 (11%)
Query: 328 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXR-----DFEQ 382
           G    + LED        LGKG +G  Y A   +S               +        +
Sbjct: 4   GSKRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRR 61
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           ++EI   + +HPN++ L  Y++      L+ +Y   G++   L        +  D +   
Sbjct: 62  EVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-----LSRFDEQRTA 115
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
             +   A  +++ HS    +  H +IK  N+L+  + +  I+DFG     +V A  SR  
Sbjct: 116 TYITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRD 168
Query: 501 ----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
               +  Y  PE+IE R H  K D++S GVL  E L G  P ++ T
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 346 LGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +G GS+GT YK     +                + F+ ++ ++ R  +H N++    Y  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNILLFMGY-- 72
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           S   +L +   +  GS  +L H +     T  +    + I   TA+G+ ++H+       
Sbjct: 73  STAPQLAIVTQWCEGS--SLYH-HLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSII 126
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------SRSAGYRAPEVIETRK---H 515
           H ++K++N+ +++DL   I DFGL  + +  +        S S  + APEVI  +    +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           S +SDVY+FG++L E++TG+ P  +    D +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 68  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 119
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 231
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q
Sbjct: 232 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 68
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 69  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 120
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 232
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q
Sbjct: 233 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 166
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 167 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 265
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 266 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 148
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 149 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 247
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 248 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 139
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 140 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 238
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 239 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 148
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 149 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 247
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 248 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E + Q
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 165
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 166 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 264
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 265 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 145
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 146 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 244
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 245 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 147
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 148 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 246
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 247 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 206
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 305
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 306 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 147
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 148 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 246
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 247 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 152
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 153 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 251
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 252 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 147
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
            +   KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 148 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 246
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 247 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNV 396
           ++   + +V+G GS+G  ++A L ES               + F+ +   + R+ +HPNV
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNV 94
Query: 397 VPLRAYYYS----KDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI-LLGTA 449
           V L+A++YS    KDE    LV +Y          H  +     P+     +K+ +    
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM---LLIKLYMYQLL 151
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLM-----NVPATPSRSA 502
           R +A+IHS+G     H +IK  N+L++    G +   DFG   ++     NV    SR  
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAGEPNVSXICSRY- 206
Query: 503 GYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGK 535
            YRAPE+I     ++   D++S G ++ E++ G+
Sbjct: 207 -YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R   H NVV + + Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 94  VIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVC 147
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   R ++++H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 148 LSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVG 203
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APEVI    +  + D++S G++++EM+ G+ P
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/292 (21%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 344 EVLGKGSYGTAYKAVLEES-----TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++                     RDF  ++E++ ++G HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 447
           L      +    L  +Y   G+L   L  +R     P           L  +  +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AGY 504
            ARG+ ++      +F H ++ A N+L+ ++    I+DFGL+    V    +       +
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 562
            A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ + LP+           
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----------- 256
Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 610
                  L +  N ++E+  +++    C  + P  RP+  +++    RM+EE
Sbjct: 257 ----GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 301

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 142
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 241
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 242 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 145
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 146 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 244
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 245 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 146
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 245
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 246 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 346 LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G YG  Y+ V ++ S T              +F ++  ++  + +HPN+V L     
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 77
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKF 463
            +    ++ ++   G+L   L   R   R     E    +LL  A  ++  +  +    F
Sbjct: 78  REPPFYIITEFMTYGNLLDYL---RECNRQ----EVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV++FGVLL E+ T G +P   P  D     P  V  ++ +       D  + R +   
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY--PGID-----PSQVYELLEK-------DYRMERPEGCP 236
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 237 EKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQM 384
            +  D  D++R     LGKG +G  Y A  +++               ++       +++
Sbjct: 10  KFTIDDFDIVRP----LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 385 EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           EI   + +HPN++ +  Y++ +    L+ ++   G L   L  +   GR   D +     
Sbjct: 66  EIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GR--FDEQRSATF 119
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---- 500
           +   A  + + H     K  H +IK  N+L+    +  I+DFG +  ++ P+   R    
Sbjct: 120 MEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCG 174
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           +  Y  PE+IE + H  K D++  GVL  E L G  P  SP+  +
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 147
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 148 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 246
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 247 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQME-----IVGRVGQHPNVVP 398
           EV+G+G +G  Y   L ++                D  +  +     I+ +   HPNV+ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 399 LRAY-YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IH 456
           L      S+   L+V  Y   G L   +   R     P      VK L+G    VA  + 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKGMK 144
Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS--RSAGYRAP------E 508
            +   KF H ++ A N ++++     ++DFGL   M      S     G + P      E
Sbjct: 145 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D                     FD+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPD------------------VNTFDI 243
Query: 569 ELMRFQNIEEEMVQ-------MLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            +   Q     ++Q       + ++ + C     +MRP+  E+V  I  +
Sbjct: 244 TVYLLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVGQHPNVVPLR 400
           LGKG +G  Y A  +++               ++       +++EI   + +HPN++ + 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMY 81
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y++ +    L+ ++   G L   L  +   GR   D +     +   A  + + H    
Sbjct: 82  NYFHDRKRIYLMLEFAPRGELYKELQKH---GR--FDEQRSATFMEELADALHYCHER-- 134
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHS 516
            K  H +IK  N+L+    +  I+DFG +  ++ P+   R    +  Y  PE+IE + H 
Sbjct: 135 -KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
            K D++  GVL  E L G  P  SP+  +
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/292 (21%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 344 EVLGKGSYGTAYKAVLEES-----TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++                     RDF  ++E++ ++G HPN++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTP-----------LDWETRVKILLG 447
           L      +    L  +Y   G+L   L  +R     P           L  +  +     
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS---AGY 504
            ARG+ ++      +F H ++ A N+L+ ++    I+DFGL+    V    +       +
Sbjct: 141 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-LPRWVQSVVREEWT 562
            A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ + LP+           
Sbjct: 198 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----------- 246
Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV----RMIEE 610
                  L +  N ++E+  +++    C  + P  RP+  +++    RM+EE
Sbjct: 247 ----GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 291

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG------ 432
           D   +ME++  +G+H N++ L           ++ +Y + G+L   L      G      
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 433 -----RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG 487
                   L  +  V      ARG+ ++ S    K  H ++ A NVL+ +D    I+DFG
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 195
Query: 488 LT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
           L   + ++      + G     + APE +  R ++H+SDV+SFGVLL E+ T
Sbjct: 196 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++ I  ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 126/289 (43%), Gaps = 36/289 (12%)
Query: 332 NFDLEDLLRASAEV---LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIV 387
           N+D  ++ R    +   LG G YG  Y+ V ++ S T              +F ++  ++
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
             + +HPN+V L      +    ++ ++   G+L   L   R   R     E    +LL 
Sbjct: 64  KEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ----EVNAVVLLY 115
Query: 448 TARGVAH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
            A  ++  +  +    F H ++ A N L+ ++    ++DFGL+ LM      + +     
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
             + APE +   K S KSDV++FGVLL E+ T G +P         +DL +  + + +  
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYELLEK-- 227
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                 D  + R +   E++ ++++   AC    P  RP+  E+ +  E
Sbjct: 228 ------DYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 267

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 51/258 (19%)
Query: 296 GKASSGGRSE--KPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 353
           G  S+ G  E  +PKE  G GV    +        C +    ++      +V G GS+  
Sbjct: 8   GSHSTHGFYENYEPKEILGRGVSSVVRR-------CIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 354 AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 413
                L E+T                  ++++I+ +V  HPN++ L+  Y +     LV+
Sbjct: 61  EEVQELREATL-----------------KEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           D    G L   L        T  + ETR KI+      +  +H +      H ++K  N+
Sbjct: 104 DLMKKGELFDYL----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHRDLKPENI 155
Query: 474 LINQDLDGCISDFGLT-------PLMNVPATPSRSAGYRAPEVIETRK------HSHKSD 520
           L++ D++  ++DFG +        L +V  TPS    Y APE+IE         +  + D
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPS----YLAPEIIECSMNDNHPGYGKEVD 211
Query: 521 VYSFGVLLLEMLTGKAPL 538
           ++S GV++  +L G  P 
Sbjct: 212 MWSTGVIMYTLLAGSPPF 229

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 51/258 (19%)
Query: 296 GKASSGGRSE--KPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 353
           G  S+ G  E  +PKE  G GV    +        C +    ++      +V G GS+  
Sbjct: 8   GSHSTHGFYENYEPKEILGRGVSSVVRR-------CIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 354 AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY 413
                L E+T                  ++++I+ +V  HPN++ L+  Y +     LV+
Sbjct: 61  EEVQELREATL-----------------KEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           D    G L   L        T  + ETR KI+      +  +H +      H ++K  N+
Sbjct: 104 DLMKKGELFDYL----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHRDLKPENI 155
Query: 474 LINQDLDGCISDFGLT-------PLMNVPATPSRSAGYRAPEVIETRK------HSHKSD 520
           L++ D++  ++DFG +        L  V  TPS    Y APE+IE         +  + D
Sbjct: 156 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS----YLAPEIIECSMNDNHPGYGKEVD 211
Query: 521 VYSFGVLLLEMLTGKAPL 538
           ++S GV++  +L G  P 
Sbjct: 212 MWSTGVIMYTLLAGSPPF 229

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 33/279 (11%)
Query: 346 LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G +G  Y+ V ++ S T              +F ++  ++  + +HPN+V L     
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 77
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH-IHSMGGPKF 463
            +    ++ ++   G+L   L   R   R     E    +LL  A  ++  +  +    F
Sbjct: 78  REPPFYIITEFMTYGNLLDYL---RECNRQ----EVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S K
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV++FGVLL E+ T G +P   P  D     P  V  ++ +       D  + R +   
Sbjct: 191 SDVWAFGVLLWEIATYGMSPY--PGID-----PSQVYELLEK-------DYRMERPEGCP 236
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           E++ ++++   AC    P  RP+  E+ +  E + Q  S
Sbjct: 237 EKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQESS 272

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG YG  ++   + E+               R+ E    ++ R   H N++   A 
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 70
Query: 403 ----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-- 456
                +S  +  L+  Y   GSL   L        T LD  + ++I+L  A G+AH+H  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 457 ---SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------Y 504
              + G P   H ++K+ N+L+ ++   CI+D GL  +M+  +T     G         Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 505 RAPEVIETRKH-----SHKS-DVYSFGVLLLEM 531
            APEV++         S+K  D+++FG++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG YG  ++   + E+               R+ E    ++ R   H N++   A 
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 99
Query: 403 ----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-- 456
                +S  +  L+  Y   GSL   L        T LD  + ++I+L  A G+AH+H  
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 457 ---SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------Y 504
              + G P   H ++K+ N+L+ ++   CI+D GL  +M+  +T     G         Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-AVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 505 RAPEV------IETRKHSHKSDVYSFGVLLLEM 531
            APEV      ++      + D+++FG++L E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 68
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 123
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG YG  ++   + E+               R+ E    ++ R   H N++   A 
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 70
Query: 403 ----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-- 456
                +S  +  L+  Y   GSL   L        T LD  + ++I+L  A G+AH+H  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 457 ---SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------Y 504
              + G P   H ++K+ N+L+ ++   CI+D GL  +M+  +T     G         Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 505 RAPEVIETRKH-----SHKS-DVYSFGVLLLEM 531
            APEV++         S+K  D+++FG++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++ I  ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++ I  ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI-NKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQH-----PNVVPLR 400
           LGKG +   Y+ + +  T                  Q+ ++   +  H     P+VV   
Sbjct: 34  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++   D   +V +     SL  L H  R A   P   E R   +  T +GV ++H+   
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEP---EARY-FMRQTIQGVQYLHNN-- 145
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHS 516
            +  H ++K  N+ +N D+D  I DFGL   +       +    +  Y APEV+  + HS
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQS 540
            + D++S G +L  +L GK P ++
Sbjct: 205 FEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPNV+   A +   +E  +V +   +G LS ++   +   R  +   T  K  +     +
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSAL 149
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPE 508
            H+HS    +  H +IK +NV I       + D GL    +   T + S      Y +PE
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            I    ++ KSD++S G LL EM    A LQSP   D ++L    + +       E  D 
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDY 255
Query: 569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
             +   +  EE+ Q++ +   C+   P+ RP++  V
Sbjct: 256 PPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQH-----PNVVPLR 400
           LGKG +   Y+ + +  T                  Q+ ++   +  H     P+VV   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++   D   +V +     SL  L H  R A   P   E R   +  T +GV ++H+   
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEP---EARY-FMRQTIQGVQYLHNN-- 161
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHS 516
            +  H ++K  N+ +N D+D  I DFGL   +       +    +  Y APEV+  + HS
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQS 540
            + D++S G +L  +L GK P ++
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFET 244

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 332 NFDLEDLLRASAEVLGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           + D E+L     E +GKGS+G  +K +    ++                 D +Q++ ++ 
Sbjct: 2   SLDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 389 RVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           +    P V     YY  Y KD KL ++ +Y   GS   LL         PLD      IL
Sbjct: 61  QCDS-PYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATIL 110
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG- 503
               +G+ ++HS    K  H +IKA+NVL+++  +  ++DFG+   L +     +   G 
Sbjct: 111 REILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGT 167
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
             + APEVI+   +  K+D++S G+  +E+  G+ P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 49/246 (19%)
Query: 306 KPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTX 365
           +PKE  G GV    +        C +    ++      +V G GS+       L E+T  
Sbjct: 7   EPKEILGRGVSSVVRR-------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL- 58
Query: 366 XXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 425
                           ++++I+ +V  HPN++ L+  Y +     LV+D    G L   L
Sbjct: 59  ----------------KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL 102
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                   T  + ETR KI+      +  +H +      H ++K  N+L++ D++  ++D
Sbjct: 103 ----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 154
Query: 486 FGLT-------PLMNVPATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEML 532
           FG +        L  V  TPS    Y APE+IE         +  + D++S GV++  +L
Sbjct: 155 FGFSCQLDPGEKLREVCGTPS----YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 210
Query: 533 TGKAPL 538
            G  P 
Sbjct: 211 AGSPPF 216

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQH-----PNVVPLR 400
           LGKG +   Y+ + +  T                  Q+ ++   +  H     P+VV   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++   D   +V +     SL  L H  R A   P   E R   +  T +GV ++H+   
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEP---EARY-FMRQTIQGVQYLHNN-- 161
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHS 516
            +  H ++K  N+ +N D+D  I DFGL   +       +    +  Y APEV+  + HS
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQS 540
            + D++S G +L  +L GK P ++
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQH-----PNVVPLR 400
           LGKG +   Y+ + +  T                  Q+ ++   +  H     P+VV   
Sbjct: 50  LGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++   D   +V +     SL  L H  R A   P   E R   +  T +GV ++H+   
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEP---EARY-FMRQTIQGVQYLHNN-- 161
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIETRKHS 516
            +  H ++K  N+ +N D+D  I DFGL   +       ++      Y APEV+  + HS
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQS 540
            + D++S G +L  +L GK P ++
Sbjct: 221 FEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 332 NFDLEDLLRASAEVLGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           + D E+L     E +GKGS+G  +K +    ++                 D +Q++ ++ 
Sbjct: 2   SLDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 389 RVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           +    P V     YY  Y KD KL ++ +Y   GS   LL         PLD      IL
Sbjct: 61  QCDS-PYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATIL 110
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG- 503
               +G+ ++HS    K  H +IKA+NVL+++  +  ++DFG+   L +     +   G 
Sbjct: 111 REILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 167
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
             + APEVI+   +  K+D++S G+  +E+  G+ P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYY----SKDEKLLVYDYFASGSLSTLLHGNRGAGR 433
           R+  Q+   + R+  HPN++ L AY      +K E  L+  +F  G+L   +   +  G 
Sbjct: 70  REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 434 TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 493
             L  +  + +LLG  RG+  IH+ G   + H ++K +N+L+  +    + D G      
Sbjct: 130 F-LTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 494 VPATPSRSA-------------GYRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAP 537
           +    SR A              YRAPE+   + H     ++DV+S G +L  M+ G+ P
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 332 NFDLEDLLRASAEVLGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           + D E+L     E +GKGS+G  +K +    ++                 D +Q++ ++ 
Sbjct: 22  SMDPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 80
Query: 389 RVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           +    P V     YY  Y KD KL ++ +Y   GS   LL         PLD      IL
Sbjct: 81  QC-DSPYVT---KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATIL 130
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG- 503
               +G+ ++HS    K  H +IKA+NVL+++  +  ++DFG+   L +     +   G 
Sbjct: 131 REILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 187
Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
             + APEVI+   +  K+D++S G+  +E+  G+ P
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXX---RDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G+YG  YKA      T                    +++ I+  + +H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              ++K   +LV+++     L  LL    G     L+  T    LL    G+A+ H    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE-TRKH 515
            +  H ++K  N+LIN++ +  I+DFGL     +P         +  YRAP+V+  ++K+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 516 SHKSDVYSFGVLLLEMLTGKAPL 538
           S   D++S G +  EM+ G APL
Sbjct: 179 STTIDIWSVGCIFAEMVNG-APL 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 344 EVLGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           E +GKGS+G  +K +    ++                 D +Q++ ++ +    P V    
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVT--- 83
Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            YY  Y KD KL ++ +Y   GS   LL         PLD      IL    +G+ ++HS
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVIETR 513
               K  H +IKA+NVL+++  +  ++DFG+   L +     +   G   + APEVI+  
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 514 KHSHKSDVYSFGVLLLEMLTGKAP 537
            +  K+D++S G+  +E+  G+ P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+YG    A   V EE+                + ++++  +  +  H NVV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINAMLNHENVVKF 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 78  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 131
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 132 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 187
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 188 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 80  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 133
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 134 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 189
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 190 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 200 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 253
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 254 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 309
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 310 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++     
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILG---- 64
Query: 403 YYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           + + D K         LV DY   GSL   L+      R  +  E  +K+ L TA G+AH
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 118
Query: 455 IH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG- 503
           +H     + G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G 
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 504 --YRAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
             Y APEV++     KH     ++D+Y+ G++  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++     
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILG---- 61
Query: 403 YYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           + + D K         LV DY   GSL   L+      R  +  E  +K+ L TA G+AH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 115
Query: 455 IH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-----VPATPSRSAG- 503
           +H     + G P   H ++K+ N+L+ ++   CI+D GL    +     +   P+   G 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 504 --YRAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
             Y APEV++     KH     ++D+Y+ G++  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 345 VLGKGSYGTAYKAV-----LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           +LGKGS+   Y+A      LE +               +  + +++I  ++ +HP+++ L
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILEL 76
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             Y+   +   LV +   +G ++  L  NR     P         +     G+ ++HS G
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYL-KNR---VKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGYRAPEVIETRKH 515
                H ++  SN+L+ ++++  I+DFGL   + +P     T   +  Y +PE+     H
Sbjct: 133 ---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPT 542
             +SDV+S G +   +L G+ P  + T
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 69  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 122
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 123 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 178
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP+    + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPA----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++     
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILG---- 62
Query: 403 YYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           + + D K         LV DY   GSL   L+      R  +  E  +K+ L TA G+AH
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 116
Query: 455 IH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG- 503
           +H     + G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G 
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 504 --YRAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
             Y APEV++     KH     ++D+Y+ G++  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++     
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILG---- 67
Query: 403 YYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           + + D K         LV DY   GSL   L+      R  +  E  +K+ L TA G+AH
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 121
Query: 455 IH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG- 503
           +H     + G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G 
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 504 --YRAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
             Y APEV++     KH     ++D+Y+ G++  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 341 ASAEVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           A  E +GKG YG  ++ +   ES               R+ E    ++ R   H N++  
Sbjct: 11  ALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLR---HDNILGF 67
Query: 400 RAYYY----SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
            A       S  +  L+  Y   GSL   L       R  L+    +++ +  A G+AH+
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQ------RQTLEPHLALRLAVSAACGLAHL 121
Query: 456 H-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-------MNVPATPSR-SA 502
           H     + G P   H + K+ NVL+  +L  CI+D GL  +       +++   P   + 
Sbjct: 122 HVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTK 181
Query: 503 GYRAPEVIETRK-----HSHK-SDVYSFGVLLLEM 531
            Y APEV++ +       S+K +D+++FG++L E+
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 109/228 (47%), Gaps = 26/228 (11%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 137
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 138 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 195
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD-DMVDLPRWVQSVVREEWTAEVFDVEL 570
              +S +SD++S G+ L+EM  G+ P+ S +    + +L  ++ +    +  + VF +E 
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEF 255
Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSE 617
             F N              C+ K P  R ++ ++  M+   +++SD+E
Sbjct: 256 QDFVN-------------KCLIKNPAERADLKQL--MVHAFIKRSDAE 288

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 34/248 (13%)
Query: 327 EGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL-------EESTTXXXXXXXXXXXXXRD 379
           + C ++    D++      LG+G++G  + A         ++                +D
Sbjct: 9   DACVHHIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 66
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL----------STLLHGNR 429
           F+++ E++  + QH ++V            L+V++Y   G L          + LL G  
Sbjct: 67  FQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 125
Query: 430 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
                PL     + +    A G+ +   + G  F H ++   N L+ Q L   I DFG++
Sbjct: 126 DVAPGPLGLGQLLAVASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 182
Query: 490 PLMNVPATPSRSAGYRA--------PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS 540
              ++ +T     G R         PE I  RK + +SDV+SFGV+L E+ T GK P   
Sbjct: 183 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 240
Query: 541 PTRDDMVD 548
            +  + +D
Sbjct: 241 LSNTEAID 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++     
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILG---- 87
Query: 403 YYSKDEK--------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           + + D K         LV DY   GSL   L+      R  +  E  +K+ L TA G+AH
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 141
Query: 455 IH-----SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG- 503
           +H     + G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G 
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 504 --YRAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
             Y APEV++     KH     ++D+Y+ G++  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 344 EVLGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E +GKG +G  ++     E                R+ E    ++ R   H N++   A 
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 104
Query: 403 YYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH- 456
             +KD     +  LV DY   GSL   L+      R  +  E  +K+ L TA G+AH+H 
Sbjct: 105 D-NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 457 ----SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---Y 504
               + G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G   Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 505 RAPEVIE---TRKHSH---KSDVYSFGVLLLEM 531
            APEV++     KH     ++D+Y+ G++  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 123 VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 176
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 177 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 232
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 233 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   DE  +V ++   G+L+ ++   R      ++ E    + 
Sbjct: 73  VIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVC 126
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
           L   + ++ +H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 127 LAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVG 182
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APE+I    +  + D++S G++++EM+ G+ P
Sbjct: 183 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 34/248 (13%)
Query: 327 EGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL-------EESTTXXXXXXXXXXXXXRD 379
           + C ++    D++      LG+G++G  + A         ++                +D
Sbjct: 3   DACVHHIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD 60
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL----------STLLHGNR 429
           F+++ E++  + QH ++V            L+V++Y   G L          + LL G  
Sbjct: 61  FQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 119
Query: 430 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
                PL     + +    A G+ +   + G  F H ++   N L+ Q L   I DFG++
Sbjct: 120 DVAPGPLGLGQLLAVASQVAAGMVY---LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 176
Query: 490 PLMNVPATPSRSAGYRA--------PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS 540
              ++ +T     G R         PE I  RK + +SDV+SFGV+L E+ T GK P   
Sbjct: 177 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 234
Query: 541 PTRDDMVD 548
            +  + +D
Sbjct: 235 LSNTEAID 242

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 114/254 (44%), Gaps = 40/254 (15%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HG------NR 429
           +DF ++ E++  + QH ++V         D  ++V++Y   G L+  L  HG        
Sbjct: 60  KDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 118
Query: 430 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
           G   T L     + I    A G+ ++ S     F H ++   N L+ ++L   I DFG++
Sbjct: 119 GNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMS 175
Query: 490 PLMNVPATPSRSAG--------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS 540
              +V +T     G        +  PE I  RK + +SDV+S GV+L E+ T GK P   
Sbjct: 176 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233
Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
            + +++++     Q  V            L R +   +E+ +++   + C  + P MR N
Sbjct: 234 LSNNEVIECI--TQGRV------------LQRPRTCPQEVYELM---LGCWQREPHMRKN 276
Query: 601 MDEVVRMIEEVRQS 614
           +  +  +++ + ++
Sbjct: 277 IKGIHTLLQNLAKA 290

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 59  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 112
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 113 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 166
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 167 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 545 DMV 547
           + +
Sbjct: 223 ETL 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 59  DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTE 112
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 113 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 166
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 167 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 545 DMV 547
           + +
Sbjct: 223 ETL 225

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 111/234 (47%), Gaps = 32/234 (13%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSP-TRDD------MVDLPRWVQSVVREEWTAE 564
              +S +SD++S G+ L+EM  G+ P+  P  ++D      + +L  ++ +    +  + 
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSG 236
Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSE 617
           VF +E   F N              C+ K P  R ++ ++  M+   +++SD+E
Sbjct: 237 VFSLEFQDFVN-------------KCLIKNPAERADLKQL--MVHAFIKRSDAE 275

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTP 435
           RDF+++++I+ +      +V  R   Y   + E  LV +Y  SG L   L  +R      
Sbjct: 53  RDFQREIQIL-KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---- 107
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--- 492
           LD     ++LL +++    +  +G  +  H ++ A N+L+  +    I+DFGL  L+   
Sbjct: 108 LDAS---RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 164
Query: 493 ---NVPATPSRS-AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
               V   P +S   + APE +     S +SDV+SFGV+L E+ T
Sbjct: 165 KDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXX---RDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G+YG  YKA      T                    +++ I+  + +H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              ++K   +LV+++     L  LL    G     L+  T    LL    G+A+ H    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE-TRKH 515
            +  H ++K  N+LIN++ +  I+DFGL     +P         +  YRAP+V+  ++K+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 516 SHKSDVYSFGVLLLEMLTG 534
           S   D++S G +  EM+ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++ R  QH NVV +   Y   +E  ++ ++   G+L+ ++   R      L+ E    + 
Sbjct: 94  VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR------LNEEQIATVC 147
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----- 500
               + +A++H+ G     H +IK+ ++L+  D    +SDFG    ++    P R     
Sbjct: 148 EAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVG 203
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +  + APEVI    ++ + D++S G++++EM+ G+ P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXX---RDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G+YG  YKA      T                    +++ I+  + +H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              ++K   +LV+++     L  LL    G     L+  T    LL    G+A+ H    
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIE-TRKH 515
            +  H ++K  N+LIN++ +  I+DFGL     +P         +  YRAP+V+  ++K+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 516 SHKSDVYSFGVLLLEMLTG 534
           S   D++S G +  EM+ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 381 EQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           +  MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P    
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARY 121
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       
Sbjct: 122 YLRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 500 RS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           ++      Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 384 MEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P       
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR 122
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-- 500
           +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       +  
Sbjct: 123 QIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 501 --SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
             +  Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 381 EQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           +  MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P    
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARY 121
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       
Sbjct: 122 YLRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 500 RS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           ++      Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 145
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 381 EQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           +  MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P    
Sbjct: 87  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARY 145
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       
Sbjct: 146 YLRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 500 R----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           +    +  Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 381 EQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           +  MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P    
Sbjct: 85  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARY 143
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       
Sbjct: 144 YLRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 196
Query: 500 R----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           +    +  Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 197 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 13/165 (7%)
Query: 381 EQQMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           +  MEI + R   H +VV    ++   D   +V +     SL  L H  R A   P    
Sbjct: 67  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARY 125
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              +I+LG      ++H     +  H ++K  N+ +N+DL+  I DFGL   +       
Sbjct: 126 YLRQIVLGCQ----YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 178
Query: 500 RS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           ++      Y APEV+  + HS + DV+S G ++  +L GK P ++
Sbjct: 179 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE-----QQMEIVGRVGQHPNVVPL 399
           VLGKGS+G    A ++E+               +D +      +  I+     HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              + + D    V ++   G L   +  +R         E R +     A  ++ +  + 
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD------EARARFY--AAEIISALMFLH 141
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTP--LMN--VPATPSRSAGYRAPEVIETRKH 515
                + ++K  NVL++ +    ++DFG+    + N    AT   +  Y APE+++   +
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
               D ++ GVLL EML G AP ++   DD+ +
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 111/255 (43%), Gaps = 45/255 (17%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +DF+++ E++  + QH ++V         D  ++V++Y   G L+  L  +       +D
Sbjct: 62  KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 438 WETR-VKILLGTARGVAHIHS--------MGGPKFTHGNIKASNVLINQDLDGCISDFGL 488
            + R  K  LG ++ + HI S        +    F H ++   N L+  +L   I DFG+
Sbjct: 121 GQPRQAKGELGLSQ-MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 489 TPLMNVPATPSRSAG--------YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQ 539
           +   +V +T     G        +  PE I  RK + +SDV+SFGV+L E+ T GK P  
Sbjct: 180 S--RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 540 SPTRDDMVDLPRWVQSVVREE---WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPD 596
             +  ++++     Q  V E       EV+DV L                   C  + P 
Sbjct: 238 QLSNTEVIECI--TQGRVLERPRVCPKEVYDVML------------------GCWQREPQ 277
Query: 597 MRPNMDEVVRMIEEV 611
            R N+ E+ +++  +
Sbjct: 278 QRLNIKEIYKILHAL 292

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R+ +HP+++ L     SKDE ++V +Y  +     ++  ++ +     + E R +     
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMS-----EQEAR-RFFQQI 122
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYR 505
              V + H     K  H ++K  N+L+++ L+  I+DFGL+ +M   N   T   S  Y 
Sbjct: 123 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 179
Query: 506 APEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPLQSPT 542
           APEVI  + ++  + DV+S GV+L  ML  + P    +
Sbjct: 180 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R+ +HP+++ L     SKDE ++V +Y  +     ++  ++ +     + E R +     
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMS-----EQEAR-RFFQQI 112
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYR 505
              V + H     K  H ++K  N+L+++ L+  I+DFGL+ +M   N   T   S  Y 
Sbjct: 113 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 169
Query: 506 APEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           APEVI  + ++  + DV+S GV+L  ML  + P 
Sbjct: 170 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R+ +HP+++ L     SKDE ++V +Y  +     ++  ++ +     + E R +     
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMS-----EQEAR-RFFQQI 116
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYR 505
              V + H     K  H ++K  N+L+++ L+  I+DFGL+ +M   N   T   S  Y 
Sbjct: 117 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 173
Query: 506 APEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           APEVI  + ++  + DV+S GV+L  ML  + P 
Sbjct: 174 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 346 LGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +GKGS+G  YK +    +E                 D +Q++ ++ +    P +      
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYFGS 85
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y    +  ++ +Y   GS   LL         PL+      IL    +G+ ++HS    +
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS---ER 136
Query: 463 FTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVIETRKHSHK 518
             H +IKA+NVL+++  D  ++DFG+   L +     +   G   + APEVI+   +  K
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 519 SDVYSFGVLLLEMLTGKAP 537
           +D++S G+  +E+  G+ P
Sbjct: 197 ADIWSLGITAIELAKGEPP 215

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           R+ +HP+++ L     SKDE ++V +Y  +     ++  ++ +     + E R +     
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMS-----EQEAR-RFFQQI 121
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYR 505
              V + H     K  H ++K  N+L+++ L+  I+DFGL+ +M   N   T   S  Y 
Sbjct: 122 ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 178
Query: 506 APEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPLQSPT 542
           APEVI  + ++  + DV+S GV+L  ML  + P    +
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           D E+++ I+  + QHPNV+ L   Y +K + +L+ +  A G L   L     A +  L  
Sbjct: 60  DIEREVSILKEI-QHPNVITLHEVYENKTDVILIGELVAGGELFDFL-----AEKESLTE 113
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-------ISDFGLT-- 489
           E   + L     GV ++HS+   +  H ++K  N+++   LD         I DFGL   
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIML---LDRNVPKPRIKIIDFGLAHK 167
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 168 IDFGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 545 DMV 547
           + +
Sbjct: 224 ETL 226

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 346 LGKGSYGTAYKAVLEE-STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           LG G YG  Y  V ++ S T              +F ++  ++  + +HPN+V L     
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 98
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
            +    +V +Y   G+L   L   R   R  +   T V +L    +  + +  +    F 
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYL---RECNREEV---TAVVLLYMATQISSAMEYLEKKNFI 152
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKS 519
           H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +     S KS
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 520 DVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
           DV++FGVLL E+ T G +P        + DL
Sbjct: 213 DVWAFGVLLWEIATYGMSPYPGIDLSQVYDL 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 24/155 (15%)
Query: 411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-------MGGPKF 463
           L+  +   GSLS  L  N       + W     I    ARG+A++H           P  
Sbjct: 99  LITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVIE-----T 512
           +H +IK+ NVL+  +L  CI+DFGL        +   + G      Y APEV+E      
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           R    + D+Y+ G++L E+ +       P  + M+
Sbjct: 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      K  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 13/157 (8%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 180
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATP---SRSAGYRAPEV 509
           ++      K  H ++K SN+L+N   +  + DFG++  L++  A     +RS  Y +PE 
Sbjct: 181 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPER 236
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           ++   +S +SD++S G+ L+EM  G+ P+  P   ++
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 273

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI----VGRVGQHPNVVPL 399
           E LG G+Y T YK +    TT              +      I    + +  +H N+V L
Sbjct: 11  EKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-VKIL-LGTARGVAHIHS 457
               +++++  LV++ F    L   +  +R  G TP   E   VK       +G+A  H 
Sbjct: 69  YDVIHTENKLTLVFE-FMDNDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIE-T 512
               K  H ++K  N+LIN+     + DFGL     +P     S      YRAP+V+  +
Sbjct: 127 ---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           R +S   D++S G +L EM+TGK PL   T D+
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK-PLFPGTNDE 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 343 AEVLGKGSYGT---AYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
            + LG+G+ G    A   V EE+                + ++++  + ++  H NVV  
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKF 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             +    + + L  +Y + G L   +  + G            +       GV ++H +G
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ-----RFFHQLMAGVVYLHGIG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG---YRAPEVIETR 513
               TH +IK  N+L+++  +  ISDFGL  +    N     ++  G   Y APE+++ R
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           + H+   DV+S G++L  ML G+ P   P+
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 324 VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXX------ 377
           VF E    NFD  ++LRA    +GKGS+G     +++++ T                   
Sbjct: 5   VFDENEDVNFDHFEILRA----IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNE 58
Query: 378 -RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL 436
            R+  ++++I+  + +HP +V L   +  +++  +V D    G L   L  N        
Sbjct: 59  VRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---- 113
Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 496
             E  VK+ +     V  +  +   +  H ++K  N+L+++     I+DF +  ++    
Sbjct: 114 --EETVKLFI--CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 497 TPSRSAG---YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAP 537
             +  AG   Y APE+  +RK   +S   D +S GV   E+L G+ P
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 344 EVLGKGSYGTAYKAV---LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           E +GKGS+G  +K +    ++                 D +Q++ ++ +     +   + 
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC----DSSYVT 84
Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            YY  Y K  KL ++ +Y   GS   LL         P D      +L    +G+ ++HS
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS 138
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG---YRAPEVIETR 513
               K  H +IKA+NVL+++  D  ++DFG+   L +     +   G   + APEVI+  
Sbjct: 139 ---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 514 KHSHKSDVYSFGVLLLEMLTGKAP 537
            +  K+D++S G+  +E+  G+ P
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPP 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S GV++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S GV++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 293 VSKGKASSGGRSEKP--KEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEV-LGKG 349
           ++K  A+ G RS +P  K E   GV   EK K V +E   Y    E++  A+ ++ LG+G
Sbjct: 32  LAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYE---YR---EEVHWATHQLRLGRG 85
Query: 350 SYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 409
           S+G  ++  +E+  T                E+ M   G     P +VPL          
Sbjct: 86  SFGEVHR--MEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS--PRIVPLYGAVREGPWV 141
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGPKFTHGNI 468
            +  +    GSL  L+   +  G  P   E R    LG A  G+ ++HS    +  HG++
Sbjct: 142 NIFMELLEGGSLGQLV---KEQGCLP---EDRALYYLGQALEGLEYLHSR---RILHGDV 192
Query: 469 KASNVLINQD-LDGCISDFGLTPLMN-------------VPATPSRSAGYRAPEVIETRK 514
           KA NVL++ D     + DFG    +              +P T +    + APEV+  R 
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET----HMAPEVVLGRS 248
Query: 515 HSHKSDVYSFGVLLLEMLTGKAP 537
              K DV+S   ++L ML G  P
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 79/155 (50%), Gaps = 9/155 (5%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + A R P   E   K+ +   RG+A
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLA 128
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIE 511
           ++      +  H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y APE ++
Sbjct: 129 YLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQ 186
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
              +S +SD++S G+ L+E+  G+ P+  P   ++
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 293 VSKGKASSGGRSEKP--KEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEV-LGKG 349
           ++K  A+ G RS +P  K E   GV   EK K V +E   Y    E++  A+ ++ LG+G
Sbjct: 51  LAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYE---YR---EEVHWATHQLRLGRG 104
Query: 350 SYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK 409
           S+G  ++  +E+  T                E+ M   G     P +VPL          
Sbjct: 105 SFGEVHR--MEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS--PRIVPLYGAVREGPWV 160
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGPKFTHGNI 468
            +  +    GSL  L+   +  G  P   E R    LG A  G+ ++HS    +  HG++
Sbjct: 161 NIFMELLEGGSLGQLV---KEQGCLP---EDRALYYLGQALEGLEYLHSR---RILHGDV 211
Query: 469 KASNVLINQD-LDGCISDFGLTPLMN-------------VPATPSRSAGYRAPEVIETRK 514
           KA NVL++ D     + DFG    +              +P T +    + APEV+  R 
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET----HMAPEVVLGRS 267
Query: 515 HSHKSDVYSFGVLLLEMLTGKAP 537
              K DV+S   ++L ML G  P
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 346 LGKGSYGTAYKAVLEES--TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           LG G++G  YKA  +E+                  D+  ++EI+     HP +V L   Y
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY 77
Query: 404 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   +  ++ ++   G++ + +L  +RG         T  +I +   + +  ++ +   +
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGL--------TEPQIQVVCRQMLEALNFLHSKR 129
Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK- 514
             H ++KA NVL+  + D  ++DFG++   N+     R +      + APEV+  ET K 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 515 --HSHKSDVYSFGVLLLEMLTGKAP 537
             + +K+D++S G+ L+EM   + P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           P +V     +YS  E  +  ++   GSL  +L   + AGR P     +V I     +G+ 
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSI--AVIKGLT 121
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEV 509
           ++      K  H ++K SN+L+N   +  + DFG    L   M      +RS  Y +PE 
Sbjct: 122 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS--YMSPER 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
           ++   +S +SD++S G+ L+EM  G+ P       +++D   ++ +    +  + VF +E
Sbjct: 178 LQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLD---YIVNEPPPKLPSAVFSLE 234
Query: 570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSE 617
              F N              C+ K P  R ++ ++  M+   +++SD+E
Sbjct: 235 FQDFVN-------------KCLIKNPAERADLKQL--MVHAFIKRSDAE 268

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 346 LGKGSYGTAYKAVLE-ESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYY 404
           +GKG YG  +      E                R+ E    ++ R   H N++   A   
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMR---HENILGFIAADI 101
Query: 405 ----SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS--- 457
               S  +  L+ DY  +GSL   L        T LD ++ +K+   +  G+ H+H+   
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 458 --MGGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSRSAG---YR 505
              G P   H ++K+ N+L+ ++   CI+D GL       T  +++P  P+   G   Y 
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP--PNTRVGTKRYM 213
Query: 506 APEVIE---TRKHSHK---SDVYSFGVLLLEM 531
            PEV++    R H      +D+YSFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 181
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M VP   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 182 FMMVPFVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 346 LGKGSYGTAYKAVLEES--TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           LG G++G  YKA  +E+                  D+  ++EI+     HP +V L   Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY 85
Query: 404 YSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           Y   +  ++ ++   G++ + +L  +RG         T  +I +   + +  ++ +   +
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGL--------TEPQIQVVCRQMLEALNFLHSKR 137
Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVI--ETRK- 514
             H ++KA NVL+  + D  ++DFG++   N+     R +      + APEV+  ET K 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 515 --HSHKSDVYSFGVLLLEMLTGKAP 537
             + +K+D++S G+ L+EM   + P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           ++   G+L   +   RG     LD    +++     +GV +IHS    K  H ++K SN+
Sbjct: 114 EFCDKGTLEQWIEKRRGE---KLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNI 167
Query: 474 LINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLE 530
            +       I DFGL   +      +RS G   Y +PE I ++ +  + D+Y+ G++L E
Sbjct: 168 FLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
Query: 531 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 590
           +L           D   +  ++    +R+   +++FD +       E+ ++Q L      
Sbjct: 228 LL--------HVCDTAFETSKFFTD-LRDGIISDIFDKK-------EKTLLQKL------ 265
Query: 591 VAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
           ++K P+ RPN  E++R +   ++S  +N
Sbjct: 266 LSKKPEDRPNTSEILRTLTVWKKSPEKN 293

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 53/280 (18%)
Query: 344 EVLGKGSYGTAYKAVL--------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
           E LG+  +G  YK  L         ++                +F  +  +  R+ QHPN
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPN 90
Query: 396 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVK 443
           VV L     +KD+ L +++ Y + G L   L     H + G+       ++ L+    V 
Sbjct: 91  VVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNV 494
           ++   A G+ ++ S       H ++   NVL+   L+  ISD GL           L+  
Sbjct: 150 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV------ 547
              P R   + APE I   K S  SD++S+GV+L E+ + G  P    +  D+V      
Sbjct: 207 SLLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263
Query: 548 -------DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 580
                  D P WV +++ E W    F     RF++I   +
Sbjct: 264 QVLPCPDDCPAWVYALMIECWNE--FPSRRPRFKDIHSRL 301

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 114/280 (40%), Gaps = 53/280 (18%)
Query: 344 EVLGKGSYGTAYKAVL--------EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
           E LG+  +G  YK  L         ++                +F  +  +  R+ QHPN
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPN 73
Query: 396 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLL-----HGNRGAG------RTPLDWETRVK 443
           VV L     +KD+ L +++ Y + G L   L     H + G+       ++ L+    V 
Sbjct: 74  VVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL---------TPLMNV 494
           ++   A G+ ++ S       H ++   NVL+   L+  ISD GL           L+  
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV------ 547
              P R   + APE I   K S  SD++S+GV+L E+ + G  P    +  D+V      
Sbjct: 190 SLLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 246
Query: 548 -------DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 580
                  D P WV +++ E W    F     RF++I   +
Sbjct: 247 QVLPCPDDCPAWVYALMIECWNE--FPSRRPRFKDIHSRL 284

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 343 AEVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV-----GQHPNV 396
            +VLG G++GT YK + + E  T                +  +E +          HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAH 454
           V L     S   +L V      G L   +H ++     +  L+W  ++      A+G+ +
Sbjct: 80  VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 132
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------E 508
           +      +  H ++ A NVL+       I+DFGL  L+        + G + P      E
Sbjct: 133 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRD 544
            I  RK +H+SDV+S+GV + E++T  GK     PTR+
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 227

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 378 RDFEQQMEIVGRVGQHPN-VVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRT 434
           RDF+++++I+  +  H + +V  R   Y   +    LV +Y  SG L   L  +R     
Sbjct: 69  RDFQREIQILKAL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--- 123
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-- 492
            LD     ++LL +++    +  +G  +  H ++ A N+L+  +    I+DFGL  L+  
Sbjct: 124 -LDAS---RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
Query: 493 ----NVPATPSRS-AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
                V   P +S   + APE +     S +SDV+SFGV+L E+ T
Sbjct: 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 378 RDFEQQMEIVGRVGQHPN-VVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRT 434
           RDF+++++I+  +  H + +V  R   Y   +    LV +Y  SG L   L  +R     
Sbjct: 56  RDFQREIQILKAL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--- 110
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-- 492
            LD     ++LL +++    +  +G  +  H ++ A N+L+  +    I+DFGL  L+  
Sbjct: 111 -LDAS---RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 166
Query: 493 ----NVPATPSRS-AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
                V   P +S   + APE +     S +SDV+SFGV+L E+ T
Sbjct: 167 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 378 RDFEQQMEIVGRVGQHPN-VVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRT 434
           RDF+++++I+  +  H + +V  R   Y   +    LV +Y  SG L   L  +R     
Sbjct: 57  RDFQREIQILKAL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--- 111
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-- 492
            LD     ++LL +++    +  +G  +  H ++ A N+L+  +    I+DFGL  L+  
Sbjct: 112 -LDAS---RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 167
Query: 493 ----NVPATPSRS-AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
                V   P +S   + APE +     S +SDV+SFGV+L E+ T
Sbjct: 168 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXX---------XXXXXXXRDFEQQMEIVGRVGQHPNV 396
           +GKG +G  +K  L +  +                      ++F++++ I+  +  HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNI 85
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L  Y    +   +V ++   G L   L         P+ W  +++++L  A G+ ++ 
Sbjct: 86  VKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ 139
Query: 457 SMGGPKFTHGNIKASNVLINQDLD------GCISDFGLTPLMNVPATPSRSAGYR--APE 508
           +   P   H ++++ N+ + Q LD        ++DFGL+   +V +       ++  APE
Sbjct: 140 NQN-PPIVHRDLRSPNIFL-QSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPE 196
Query: 509 VI--ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            I  E   ++ K+D YSF ++L  +LTG+ P 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG-----QHPNVVPLR 400
           +G GS+G  Y A  +   +             +  E+  +I+  V      +HPN +  R
Sbjct: 62  IGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             Y  +    LV +Y   GS S LL       + PL       +  G  +G+A++HS   
Sbjct: 121 GCYLREHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSHN- 174
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVI---ETRKHSH 517
               H ++KA N+L+++     + DFG   +M        +  + APEVI   +  ++  
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 232
Query: 518 KSDVYSFGVLLLEMLTGKAPL 538
           K DV+S G+  +E+   K PL
Sbjct: 233 KVDVWSLGITCIELAERKPPL 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG-----QHPNVVPLR 400
           +G GS+G  Y A  +   +             +  E+  +I+  V      +HPN +  R
Sbjct: 23  IGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             Y  +    LV +Y   GS S LL       + PL       +  G  +G+A++HS   
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVI---ETRKHSH 517
               H ++KA N+L+++     + DFG   +M        +  + APEVI   +  ++  
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 518 KSDVYSFGVLLLEMLTGKAPL 538
           K DV+S G+  +E+   K PL
Sbjct: 194 KVDVWSLGITCIELAERKPPL 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ---QMEIV 387
           ++F  EDL +   E+ G+G+YG+  K V + S               ++ +Q    +++V
Sbjct: 17  WDFTAEDL-KDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
            R    P +V      + + +  +  +   S S               +  E   KI L 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 504
           T + + H+      K  H +IK SN+L+++  +  + DFG++  +      +R AG   Y
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 505 RAPEVIE----TRKHSHKSDVYSFGVLLLEMLTGKAP 537
            APE I+     + +  +SDV+S G+ L E+ TG+ P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 343 AEVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV-----GQHPNV 396
            +VLG G++GT YK + + E  T                +  +E +          HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAH 454
           V L     S   +L V      G L   +H ++     +  L+W  ++      A+G+ +
Sbjct: 103 VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 155
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------E 508
           +      +  H ++ A NVL+       I+DFGL  L+        + G + P      E
Sbjct: 156 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT--GKAPLQSPTRD 544
            I  RK +H+SDV+S+GV + E++T  GK     PTR+
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 343 AEVLGKGSYGTAYKAV-------LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
            +VLG G++GT YK +       ++                 ++   +  ++  VG  P 
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PY 80
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVA 453
           V  L     +   +L V      G L   +  NRG    +  L+W  ++      A+G++
Sbjct: 81  VSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMS 133
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------ 507
           ++  +   +  H ++ A NVL+       I+DFGL  L+++  T   + G + P      
Sbjct: 134 YLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQS-PTRD 544
           E I  R+ +H+SDV+S+GV + E++T G  P    P R+
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 229

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 21/170 (12%)
Query: 382 QQMEIVGRVGQ---------HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
           + +++VG++ +         HP+++ L     +  +  +V +Y + G L   +  N   G
Sbjct: 55  RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---G 111
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
           R  LD +   ++      GV + H        H ++K  NVL++  ++  I+DFGL+ +M
Sbjct: 112 R--LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
Query: 493 NVPATPSRSAG---YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           +       S G   Y APEVI  R ++  + D++S GV+L  +L G  P 
Sbjct: 167 SDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAGRT 434
            E ++ ++ ++ +HPN+V L   Y S     L+    + G L   +     +  R A R 
Sbjct: 63  MENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR- 120
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL---INQDLDGCISDFGLTPL 491
                    ++      V ++H +G     H ++K  N+L   +++D    ISDFGL+ +
Sbjct: 121 ---------LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 492 MN---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +   V +T   + GY APEV+  + +S   D +S GV+   +L G  P 
Sbjct: 169 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-RSAGYRAPE 508
           +G+ +IHS G     H ++K  N+ +N+D +  I DFGL    +   T    +  YRAPE
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPE 193
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           VI +  H +++ D++S G ++ EMLTGK 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAGRT 434
            E ++ ++ ++ +HPN+V L   Y S     L+    + G L   +     +  R A R 
Sbjct: 63  MENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR- 120
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL---INQDLDGCISDFGLTPL 491
                    ++      V ++H +G     H ++K  N+L   +++D    ISDFGL+ +
Sbjct: 121 ---------LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 492 MN---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +   V +T   + GY APEV+  + +S   D +S GV+   +L G  P 
Sbjct: 169 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 25/169 (14%)
Query: 381 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAGRTP 435
           E ++ ++ ++ +HPN+V L   Y S     L+    + G L   +     +  R A R  
Sbjct: 64  ENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR-- 120
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL---INQDLDGCISDFGLTPLM 492
                   ++      V ++H +G     H ++K  N+L   +++D    ISDFGL+ + 
Sbjct: 121 --------LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169
Query: 493 N---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +   V +T   + GY APEV+  + +S   D +S GV+   +L G  P 
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS G     H ++K SNV +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPE 190
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
           ++    H +++ D++S G ++ E+L GKA    P  D +  L R ++ V
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLKRIMEVV 237

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV--GQHPNVVPL-- 399
           E++G+G YG  YK  L+E                ++F  +  I  RV   +H N+     
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIY-RVPLMEHDNIARFIV 74
Query: 400 ---RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
              R     + E LLV +Y+ +GSL   L  +        DW +  ++     RG+A++H
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLH 128
Query: 457 S------MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM------------NVPATP 498
           +         P  +H ++ + NVL+  D    ISDFGL+  +            N   + 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 499 SRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEML 532
             +  Y APEV+E             + D+Y+ G++  E+ 
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-RSAGYRAPE 508
           +G+ +IHS G     H ++K  N+ +N+D +  I DFGL    +   T    +  YRAPE
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPE 211
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           VI +  H +++ D++S G ++ EMLTGK 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPEVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 181 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL-----HGNRGAGRT 434
            E ++ ++ ++ +HPN+V L   Y S     L+    + G L   +     +  R A R 
Sbjct: 63  MENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR- 120
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL---INQDLDGCISDFGLTPL 491
                    ++      V ++H +G     H ++K  N+L   +++D    ISDFGL+ +
Sbjct: 121 ---------LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 492 MN---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            +   V +T   + GY APEV+  + +S   D +S GV+   +L G  P 
Sbjct: 169 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 344 EVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVP 398
           E LG+GS+G     T YK   + +                  E+++  + ++ +HP+++ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHPHIIK 73
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L     +  + ++V +Y A G L   +   +   R   D   R    +  A    H H  
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH-- 127
Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETRKH 515
              K  H ++K  N+L++ +L+  I+DFGL+ +M   N   T   S  Y APEVI  + +
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 516 SH-KSDVYSFGVLLLEMLTGKAPL 538
           +  + DV+S G++L  ML G+ P 
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L T +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-FLHQDLKTFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 172
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 173 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 81/334 (24%), Positives = 143/334 (42%), Gaps = 65/334 (19%)
Query: 305 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA-EVLGKGSYGTAYKAVLEEST 363
           E PK EF      P KN LV  +      +   +++A+A  + G+  Y T    +L+E+ 
Sbjct: 14  EDPKWEF------PRKN-LVLGKTLGEG-EFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 364 TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST 423
           +             RD   +  ++ +V  HP+V+ L          LL+ +Y   GSL  
Sbjct: 66  SPSEL---------RDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 424 LLHGNRGAG-----------RTPLDWETRVKILLG--------TARGVAHIHSMGGPKFT 464
            L  +R  G            + LD      + +G         ++G+ ++  M   K  
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 465 HGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
           H ++ A N+L+ +     ISDFGL+  +    +   RS G     + A E +    ++ +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV+SFGVLL E++T G  P      + + +L   +++  R E           R  N  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---LKTGHRME-----------RPDNCS 278
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           EEM +++   + C  + PD RP   ++ + +E++
Sbjct: 279 EEMYRLM---LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXX---------XXXXXXXRDFEQQMEIVGRVGQHPNV 396
           +GKG +G  +K  L +  +                      ++F++++ I+  +  HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNI 85
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L  Y    +   +V ++   G L   L         P+ W  +++++L  A G+ ++ 
Sbjct: 86  VKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ 139
Query: 457 SMGGPKFTHGNIKASNVLINQDLD------GCISDFGLTPLMNVPATPSRSAGYR--APE 508
           +   P   H ++++ N+ + Q LD        ++DFG T   +V +       ++  APE
Sbjct: 140 NQN-PPIVHRDLRSPNIFL-QSLDENAPVCAKVADFG-TSQQSVHSVSGLLGNFQWMAPE 196
Query: 509 VI--ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            I  E   ++ K+D YSF ++L  +LTG+ P 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG 534
            M  P   +R   YRAPEVI    +    D++S G ++ EM+ G
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 82/198 (41%), Gaps = 17/198 (8%)
Query: 346 LGKGSYG---TAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +G G+ G    AY A+LE +                    +  ++ +V  H N++ L   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
           +  +       D +    +  L+  N     +  LD E    +L     G+ H+HS G  
Sbjct: 92  FTPQKSLEEFQDVYI---VMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAGYRAPEVIETRKHS 516
              H ++K SN+++  D    I DFGL     T  M  P   +R   YRAPEVI    + 
Sbjct: 147 -IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILGMGYK 203
Query: 517 HKSDVYSFGVLLLEMLTG 534
              D++S G ++ EM+ G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTARG 451
           HPN++ L  ++  K    LV + +  G L   ++H      R   +      I+     G
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH------RMKFNEVDAAVIIKQVLSG 148
Query: 452 VAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCIS--DFGLTPLM-NVPATPSR--SAGYR 505
           V ++H        H ++K  N+L+ +++ D  I   DFGL+ +  N      R  +A Y 
Sbjct: 149 VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           APEV+  +K+  K DV+S GV+L  +L G  P    T  +++          D P W
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPN++ L   +  K    LV +++  G L   +       R   D      I+     G+
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMKQILSGI 159
Query: 453 AHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRA 506
            ++H        H +IK  N+L+   N  L+  I DFGL+   +         G   Y A
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           PEV++ +K++ K DV+S GV++  +L G  P       D++
Sbjct: 217 PEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           ++Q+++I+ R   H +++  +     + EK   LV +Y   GSL   L       R  + 
Sbjct: 63  WKQEIDIL-RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIG 115
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 497
               +        G+A++HS     + H N+ A NVL++ D    I DFGL       A 
Sbjct: 116 LAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-----AV 167
Query: 498 PSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
           P     YR            APE ++  K  + SDV+SFGV L E+LT     QSP
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 63
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F S  L   +  +   G  PL        L    +G+A 
Sbjct: 64  NIVKLLDVIHTENKLYLVFE-FLSMDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 119
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS G     H ++K SNV +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
           ++    H +++ D++S G ++ E+L GKA    P  D +  L R ++ V
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLKRIMEVV 245

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F S  L   +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-FLSMDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 35/258 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA---GR 433
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R      +
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 434 TPLDW-------ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF 486
           TP D        E  +      A+G+  + S    K  H ++ A N+L+++     I DF
Sbjct: 136 TPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF 192
Query: 487 GLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           GL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   S
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---S 249
Query: 541 PTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPN 600
           P     +D          EE+   + +   MR  +      +M Q  + C    P  RP 
Sbjct: 250 PYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPT 297
Query: 601 MDEVVRMIEEVRQSDSEN 618
             E+V  +  + Q++++ 
Sbjct: 298 FSELVEHLGNLLQANAQQ 315

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 81/334 (24%), Positives = 143/334 (42%), Gaps = 65/334 (19%)
Query: 305 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA-EVLGKGSYGTAYKAVLEEST 363
           E PK EF      P KN LV  +      +   +++A+A  + G+  Y T    +L+E+ 
Sbjct: 14  EDPKWEF------PRKN-LVLGKTLGEG-EFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 364 TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST 423
           +             RD   +  ++ +V  HP+V+ L          LL+ +Y   GSL  
Sbjct: 66  SPSEL---------RDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 424 LLHGNRGAG-----------RTPLDWETRVKILLG--------TARGVAHIHSMGGPKFT 464
            L  +R  G            + LD      + +G         ++G+ ++  M   K  
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172
Query: 465 HGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
           H ++ A N+L+ +     ISDFGL+  +    +   RS G     + A E +    ++ +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV+SFGVLL E++T G  P      + + +L   +++  R E           R  N  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---LKTGHRME-----------RPDNCS 278
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           EEM +++   + C  + PD RP   ++ + +E++
Sbjct: 279 EEMYRLM---LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTP 435
           RDF ++   + R+  HPNV+P+     S       L+  +   GSL  +LH   G     
Sbjct: 52  RDFNEECPRL-RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFV- 107
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS------DFGLT 489
           +D    VK  L  ARG+A +H++  P      + + +V+I++D+   IS       F   
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166
Query: 490 PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             M  PA  +  A  + PE  +T + S  +D++SF VLL E++T + P 
Sbjct: 167 GRMYAPAWVAPEALQKKPE--DTNRRS--ADMWSFAVLLWELVTREVPF 211

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 40/232 (17%)
Query: 337 DLLRASAEVLGKGSYGTAYKA---------------VLEESTTXXXXXXXXXXXXXRDFE 381
           +LLR    VLGKG YG  ++                VL+++               R+  
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE-T 440
           +++       +HP +V L   + +  +  L+ +Y + G L   L       R  +  E T
Sbjct: 76  EEV-------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE------REGIFMEDT 122
Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPA 496
               L   +  + H+H  G     + ++K  N+++N      ++DFGL         V  
Sbjct: 123 ACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           T   +  Y APE++    H+   D +S G L+ +MLTG  P     R   +D
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS G     H ++K SNV +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
           ++    H +++ D++S G ++ E+L GKA    P  D +  L R ++ V
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGKALF--PGSDYIDQLKRIMEVV 245

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 218 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 267

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F S  L   +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-FLSMDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 64
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F S  L   +  +   G  PL        L    +G+A 
Sbjct: 65  NIVKLLDVIHTENKLYLVFE-FLSMDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAF 120
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR 450
           H N+V +       D   LV +Y    +LS  +  HG       PL  +T +        
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-------PLSVDTAINFTNQILD 122
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYR 505
           G+ H H M   +  H +IK  N+LI+ +    I DFG+   ++  +         +  Y 
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           +PE  +       +D+YS G++L EML G+ P    T
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 218 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 267

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 181 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 230

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 173 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 174 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 223

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG-RVGQHPNVVPLRAYYY 404
           +G G++G A + + ++ T               D   Q EI+  R  +HPN+V  +    
Sbjct: 28  IGSGNFGVA-RLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +     ++ +Y + G L   +     AGR   D E R         GV++ HSM   +  
Sbjct: 87  TPTHLAIIMEYASGGELYERIC---NAGRFSED-EARF-FFQQLLSGVSYCHSM---QIC 138
Query: 465 HGNIKASNVLINQDLDGC------ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
           H ++K  N L    LDG       I DFG +    + + P  + G   Y APEV+  +++
Sbjct: 139 HRDLKLENTL----LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194
Query: 516 SHK-SDVYSFGVLLLEMLTGKAPLQSP 541
             K +DV+S GV L  ML G  P + P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDP 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 28/242 (11%)
Query: 311 FGSGVQEPE--KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV--LEESTTXX 366
           F S   +PE  K+K +F +        ++LL A  E LG G++G+  + V  + +     
Sbjct: 315 FESPFSDPEELKDKKLFLKR-------DNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDV 366
Query: 367 XXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLL 425
                       D E+ M     + Q  N   +R     + E L LV +    G L   L
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL 426
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
            G R     P+      ++L   + G+ ++       F H N+ A NVL+       ISD
Sbjct: 427 VGKRE--EIPVS--NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISD 479
Query: 486 FGLTPLMNVPAT--PSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           FGL+  +    +   +RSAG     + APE I  RK S +SDV+S+GV + E L+ G+ P
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 538 LQ 539
            +
Sbjct: 540 YK 541

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 178
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 179 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 228

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 174 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 181 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 230

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARG 451
           HP ++ +   +    +  ++ DY   G L +LL   R + R P       K         
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVAKFYAAEVCLA 118
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM-NVPATPSRSAGYRAPEVI 510
           + ++HS       + ++K  N+L++++    I+DFG    + +V      +  Y APEV+
Sbjct: 119 LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVV 175
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            T+ ++   D +SFG+L+ EML G  P 
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 51/304 (16%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG-QHPNVVPLRAY 402
           E+  +G +G  +KA L                  + ++ + EI    G +H N++   A 
Sbjct: 21  EIKARGRFGCVWKAQL---MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAA 77
Query: 403 YYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS- 457
                  + E  L+  +   GSL+  L GN       + W     +    +RG++++H  
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGN------IITWNELCHVAETMSRGLSYLHED 131
Query: 458 -------MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------Y 504
                     P   H + K+ NVL+  DL   ++DFGL         P  + G      Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 505 RAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 559
            APEV+E      R    + D+Y+ G++L E+++       P  + M  LP         
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYM--LP--------- 240
Query: 560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR-PNMDEVVRMIEEVRQSDSEN 618
                 F+ E+ +  ++EE    ++   M    K   ++ P + ++   IEE    D+E 
Sbjct: 241 ------FEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEA 294
Query: 619 RPSS 622
           R S+
Sbjct: 295 RLSA 298

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 10/115 (8%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 121 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN 177
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
            M  P   +R   YRAPEVI    +    D++S G ++ E++ G    Q     D
Sbjct: 178 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 230

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 84
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H N+ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 145 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 199
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 245
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P+MRP   E+V ++++
Sbjct: 246 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 289

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMEPEVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK--ILFPGRD 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPGRD 229

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 42/297 (14%)
Query: 346 LGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           LG+G++G   +A            +               R    +++I+  +G H NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 398 PLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA---------GRTPLDWETRVKILLG 447
            L          L+V   F   G+LST L   R            +  L  E  +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A+G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R  
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 561
               APE I  R ++ +SDV+SFGVLL E+ +  A   SP     +D          EE+
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKID----------EEF 260
Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
              + +   MR  +      +M Q  + C    P  RP   E+V  +  + Q++++ 
Sbjct: 261 CRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H N+ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 144 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 198
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 244
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P+MRP   E+V ++++
Sbjct: 245 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 174 FMMTPYVVTRY--YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK--ILFPGRD 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE------QQMEIVGRVGQHPNVV 397
           E LG G++G  ++ V E +T               D E      Q M ++    +HP +V
Sbjct: 163 EELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL----RHPTLV 217
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L   +   +E +++Y++ + G L   +          +  +  V+ +    +G+ H+H 
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE 273
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCIS--DFGLT----PLMNVPATPSRSAGYRAPEVIE 511
                + H ++K  N++        +   DFGLT    P  +V  T + +A + APEV E
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAE 329
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            +   + +D++S GVL   +L+G +P      D+ +
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 184
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 185 FMMTPYVVTRY--YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK--ILFPGRD 234

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 29/176 (16%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           ++Q+++I+ R   H +++  +     + EK   LV +Y   GSL   L       R  + 
Sbjct: 63  WKQEIDIL-RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIG 115
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 497
               +        G+A++H+     + H N+ A NVL++ D    I DFGL       A 
Sbjct: 116 LAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-----AV 167
Query: 498 PSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
           P     YR            APE ++  K  + SDV+SFGV L E+LT     QSP
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 223

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIXETDXXRKGGKGLLPVRW 198
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 244
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P+MRP   E+V ++++
Sbjct: 245 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 10/115 (8%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
            M  P   +R   YRAPEVI    ++   D++S G ++ E++ G    Q     D
Sbjct: 180 FMMTPYVVTRY--YRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHID 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXX---------XXXXXXXRDFEQQMEIVGRVGQHPNV 396
           +GKG +G  +K  L +  +                      ++F++++ I+  +  HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNI 85
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           V L  Y    +   +V ++   G L   L         P+ W  +++++L  A G+ ++ 
Sbjct: 86  VKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ 139
Query: 457 SMGGPKFTHGNIKASNVLINQDLD------GCISDFGLTPLMNVPATPSRSAGYR--APE 508
           +   P   H ++++ N+ + Q LD        ++DF L+   +V +       ++  APE
Sbjct: 140 NQN-PPIVHRDLRSPNIFL-QSLDENAPVCAKVADFSLSQ-QSVHSVSGLLGNFQWMAPE 196
Query: 509 VI--ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            I  E   ++ K+D YSF ++L  +LTG+ P 
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE------QQMEIVGRVGQHPNVV 397
           E LG G++G  ++ V E +T               D E      Q M ++    +HP +V
Sbjct: 57  EELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL----RHPTLV 111
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L   +   +E +++Y++ + G L   +          +  +  V+ +    +G+ H+H 
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCIS--DFGLT----PLMNVPATPSRSAGYRAPEVIE 511
                + H ++K  N++        +   DFGLT    P  +V  T + +A + APEV E
Sbjct: 168 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAE 223
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            +   + +D++S GVL   +L+G +P      D+ +
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 259

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV+++     L T +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEH-VHQDLKTFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 40/232 (17%)
Query: 337 DLLRASAEVLGKGSYGTAYKA---------------VLEESTTXXXXXXXXXXXXXRDFE 381
           +LLR    VLGKG YG  ++                VL+++               R+  
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE-T 440
           +++       +HP +V L   + +  +  L+ +Y + G L   L       R  +  E T
Sbjct: 76  EEV-------KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE------REGIFMEDT 122
Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR 500
               L   +  + H+H  G     + ++K  N+++N      ++DFGL        T + 
Sbjct: 123 ACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 501 ----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
               +  Y APE++    H+   D +S G L+ +MLTG  P     R   +D
Sbjct: 180 XFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 69
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 70  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 125
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI 510
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE++
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 511 ETRK-HSHKSDVYSFGVLLLEMLTGKA 536
              K +S   D++S G +  EM+T +A
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI 510
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE++
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 511 ETRK-HSHKSDVYSFGVLLLEMLTGKA 536
              K +S   D++S G +  EM+T +A
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAV--LEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQH 393
           ++LL A  E LG G++G+  + V  + +                 D E+ M     + Q 
Sbjct: 9   DNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 394 PNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
            N   +R     + E L LV +    G L   L G R     P+      ++L   + G+
Sbjct: 68  DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVS--NVAELLHQVSMGM 123
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG-----YR 505
            ++       F H ++ A NVL+       ISDFGL+  +    +   +RSAG     + 
Sbjct: 124 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQ 539
           APE I  RK S +SDV+S+GV + E L+ G+ P +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLI 114
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 334 DLEDLLRASAEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQME 385
           D+E+  +   E +G+G+YG  YKA        V  +                R+     E
Sbjct: 5   DMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           +      HPN+V L    +++++  LV++ F    L   +  +   G  PL        L
Sbjct: 63  L-----NHPNIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYL 113
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----S 501
               +G+A  HS    +  H ++K  N+LIN +    ++DFGL     VP         +
Sbjct: 114 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 502 AGYRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGKA 536
             YRAPE+ +  + +S   D++S G +  EM+T +A
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 64
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 65  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 120
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG---- 391
           E ++  S  V+GKG +G  Y     +                 +  QQ+E   R G    
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMR 77
Query: 392 --QHPNVVPLRAYYYSKDE-KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
              HPNV+ L       +    ++  Y   G L   +   R   R P   +  +   L  
Sbjct: 78  GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNP-TVKDLISFGLQV 133
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM----NVPATPSRSA-- 502
           ARG+ +   +   KF H ++ A N ++++     ++DFGL   +           R A  
Sbjct: 134 ARGMEY---LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 503 --GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
              + A E ++T + + KSDV+SFGVLL E+LT  AP
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  HPN+V L     ++    L+ +Y + G +   L  +   GR   + E R K   
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMK-EKEARSK-FR 121
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
                V + H     +  H ++KA N+L++ D++  I+DFG +    V        G   
Sbjct: 122 QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP 178
Query: 504 YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 80/334 (23%), Positives = 142/334 (42%), Gaps = 65/334 (19%)
Query: 305 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA-EVLGKGSYGTAYKAVLEEST 363
           E PK EF      P KN LV  +      +   +++A+A  + G+  Y T    +L+E+ 
Sbjct: 14  EDPKWEF------PRKN-LVLGKTLGEG-EFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 364 TXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST 423
           +             RD   +  ++ +V  HP+V+ L          LL+ +Y   GSL  
Sbjct: 66  SPSEL---------RDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 424 LLHGNRGAG-----------RTPLDWETRVKILLG--------TARGVAHIHSMGGPKFT 464
            L  +R  G            + LD      + +G         ++G+ ++  M      
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LV 172
Query: 465 HGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
           H ++ A N+L+ +     ISDFGL+  +    +   RS G     + A E +    ++ +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV+SFGVLL E++T G  P      + + +L   +++  R E           R  N  
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL---LKTGHRME-----------RPDNCS 278
Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
           EEM +++   + C  + PD RP   ++ + +E++
Sbjct: 279 EEMYRLM---LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----TP 490
           LD E    +L     G+ H+HS G     H ++K SN+++  D    I DFGL     T 
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 491 LMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            M  P   +R   YRAPEVI    +    D++S G ++ EM+  K  +  P RD
Sbjct: 180 FMMEPEVVTRY--YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK--ILFPGRD 229

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 66
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 67  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 122
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 179
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 63
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 64  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 119
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  HPN+V L     ++    L+ +Y + G +   L  +   GR   + E R K   
Sbjct: 64  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMK-EKEARSK-FR 118
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
                V + H     +  H ++KA N+L++ D++  I+DFG +    V        G   
Sbjct: 119 QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPP 175
Query: 504 YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 64
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 65  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 120
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 343 AEVLGKGSYGTAYKAVLEE----STTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNV 396
            ++LG+G +G+  +  L++    S               R+ E+ +     +    HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 397 VPLRAYYYSKDEK-----LLVYDYFASGSLST-LLHGNRGAGRTPLDWETRVKILLGTAR 450
           + L         +     +++  +   G L T LL+     G   +  +T +K ++  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRS 501
           G+ ++ +     F H ++ A N ++  D+  C++DFGL+  +          +   P + 
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
             + A E +  R ++ KSDV++FGV + E+ T G  P       +M D
Sbjct: 215 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 69
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 70  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 125
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 64
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 65  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 120
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 63
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 64  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 119
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIXETDXXRKGGKGLLPVRW 198
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 244
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 245 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 63
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 64  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 119
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI----VGRVGQHPNVVPLR 400
            +G GSYG   K +  +S                + E+QM +    + R  +HPN+V  R
Sbjct: 13  TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--R 69
Query: 401 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAG-RTPLDWE--TRVKILLGTARGVA 453
            Y    D       +V +Y   G L++++   +G   R  LD E   RV   L  A    
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV 509
           H  S GG    H ++K +NV ++   +  + DFGL  ++N   + ++    +  Y +PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 187
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           +    ++ KSD++S G LL E+     P  + ++ ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           ++   G+L   +   RG     LD    +++     +GV +IHS    K  + ++K SN+
Sbjct: 100 EFCDKGTLEQWIEKRRGE---KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNI 153
Query: 474 LINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLE 530
            +       I DFGL   +       RS G   Y +PE I ++ +  + D+Y+ G++L E
Sbjct: 154 FLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
Query: 531 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMAC 590
           +L           D   +  ++    +R+   +++FD +       E+ ++Q L      
Sbjct: 214 LL--------HVCDTAFETSKFFTD-LRDGIISDIFDKK-------EKTLLQKL------ 251
Query: 591 VAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
           ++K P+ RPN  E++R +   ++S  +N
Sbjct: 252 LSKKPEDRPNTSEILRTLTVWKKSPEKN 279

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI----VGRVGQHPNVVPLR 400
            +G GSYG   K +  +S                + E+QM +    + R  +HPN+V  R
Sbjct: 13  TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--R 69
Query: 401 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAG-RTPLDWE--TRVKILLGTARGVA 453
            Y    D       +V +Y   G L++++   +G   R  LD E   RV   L  A    
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV 509
           H  S GG    H ++K +NV ++   +  + DFGL  ++N   + ++    +  Y +PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           +    ++ KSD++S G LL E+     P  + ++ ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 182
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 239
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 240 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 287
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 288 TFSELVEHLGNLLQANAQQ 306

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 63
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 64  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 119
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 80
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 141 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIXETDXXRKGGKGLLPVRW 195
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 241
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 242 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 285

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 34/223 (15%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES-TTXXXXXXXXXXXXXRDFEQQMEIVG 388
           S N+D++       E LGKG++    + V + +                RDF Q++E   
Sbjct: 28  SDNYDVK-------EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREA 79
Query: 389 RVG---QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           R+    QHPN+V L      +    LV+D    G L   +       R           +
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADASHCI 134
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN-------VP 495
                 +A+ HS G     H N+K  N+L+     G    ++DFGL   +N         
Sbjct: 135 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 191
Query: 496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            TP    GY +PEV++   +S   D+++ GV+L  +L G  P 
Sbjct: 192 GTP----GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 346 LGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           LG+G++G   +A            +               R    +++I+  +G H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 398 PLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA-------GRTPLDWETRVKILLGTA 449
            L          L+V   F   G+LST L   R          +  L  E  +      A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---- 505
           +G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R    
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
             APE I  R ++ +SDV+SFGVLL E+ +  A   SP     +D          EE+  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKID----------EEFCR 258
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
            + +   MR  +      +M Q  + C    P  RP   E+V  +  + Q+++
Sbjct: 259 RLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 27/209 (12%)
Query: 344 EVLGKGSYGTAYKAVLEES-TTXXXXXXXXXXXXXRDFEQQMEIVGRVG---QHPNVVPL 399
           E LGKG++    + V + +                RDF Q++E   R+    QHPN+V L
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRL 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    LV+D    G L   +       R           +      +A+ HS G
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN-------VPATPSRSAGYRAPEV 509
                H N+K  N+L+     G    ++DFGL   +N          TP    GY +PEV
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----GYLSPEV 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++   +S   D+++ GV+L  +L G  P 
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 15/165 (9%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
            E ++ ++ ++ +H N+V L   Y S +   LV    + G L   +        T  D  
Sbjct: 67  IENEIAVLRKI-KHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDAS 123
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDG--CISDFGLTPLM---N 493
           T ++ +L     V ++H MG     H ++K  N+L  +QD +    ISDFGL+ +    +
Sbjct: 124 TLIRQVLD---AVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           V +T   + GY APEV+  + +S   D +S GV+   +L G  P 
Sbjct: 178 VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 99/260 (38%), Gaps = 53/260 (20%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPL 436
           +++I+  +GQH N+V L          L++ +Y   G L   L     A      GR PL
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PL 157
Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-- 493
           +    +      A+G+A + S       H ++ A NVL+       I DFGL   +MN  
Sbjct: 158 ELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 214
Query: 494 ---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
              V         + APE I    ++ +SDV+S+G+LL E+ + G  P      +     
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 270
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ----------IGMACVAKVPDMRP 599
                                 +F  + ++  QM Q          I  AC A  P  RP
Sbjct: 271 ----------------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 308
Query: 600 NMDEVVRMIEEVRQSDSENR 619
              ++   ++E  Q D   R
Sbjct: 309 TFQQICSFLQEQAQEDRRER 328

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 346 LGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVV 397
           LG+G++G   +A            +               R    +++I+  +G H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 398 PLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA-------GRTPLDWETRVKILLGTA 449
            L          L+V   F   G+LST L   R          +  L  E  +      A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---- 505
           +G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R    
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
             APE I  R ++ +SDV+SFGVLL E+ +  A   SP     +D          EE+  
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKID----------EEFXR 258
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
            + +   MR  +      +M Q  + C    P  RP   E+V  +  + Q+++
Sbjct: 259 RLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 27/209 (12%)
Query: 344 EVLGKGSYGTAYKAVLEES-TTXXXXXXXXXXXXXRDFEQQMEIVGRVG---QHPNVVPL 399
           E LGKG++    + V + +                RDF Q++E   R+    QHPN+V L
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRL 69
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    LV+D    G L   +       R           +      +A+ HS G
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDI-----VAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN-------VPATPSRSAGYRAPEV 509
                H N+K  N+L+     G    ++DFGL   +N          TP    GY +PEV
Sbjct: 125 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----GYLSPEV 177
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++   +S   D+++ GV+L  +L G  P 
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 114
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG----YRA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T SR +     +  
Sbjct: 115 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP 174
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 344 EVLGKGSYGTAY---------------KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG 388
           +VLG G+YG  +                 VL+++T              R      +++ 
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 113
Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG- 447
            + Q P +V L   + ++ +  L+ DY   G L T L     + R     E  V+I +G 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFT-EHEVQIYVGE 167
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SA 502
               + H+H +G     + +IK  N+L++ +    ++DFGL+       T        + 
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 503 GYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            Y AP+++      H    D +S GVL+ E+LTG +P 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 344 EVLGKGSYGTAYKAVLEES-TTXXXXXXXXXXXXXRDFEQQMEIVGRVG---QHPNVVPL 399
           E LGKG++    + V + +                RDF Q++E   R+    QHPN+V L
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRL 70
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    LV+D    G L   +           D    ++ +L     +A+ HS G
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQIL---ESIAYCHSNG 125
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN-------VPATPSRSAGYRAPEV 509
                H N+K  N+L+     G    ++DFGL   +N          TP    GY +PEV
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----GYLSPEV 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++   +S   D+++ GV+L  +L G  P 
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 19/215 (8%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ-----QMEIVGRVGQHPNVVP 398
           +V+GKGS+G    A  +                 +  E+     +  ++ +  +HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHIHS 457
           L   + + D+   V DY   G L   L   R         E R +      A  + ++HS
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCF------LEPRARFYAAEIASALGYLHS 157
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAPEVIETR 513
           +      + ++K  N+L++      ++DFGL    +   +T S   G   Y APEV+  +
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
            +    D +  G +L EML G  P  S    +M D
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 182
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 239
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 240 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 287
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 288 TFSELVEHLGNLLQANAQQ 306

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 57  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLI 111
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 112 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L       +  LD  + +
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ----VRKYSLDLASLI 117
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 118 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V                   R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V                   R+     E+      HP
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-----NHP 61
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G+A 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 117
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLI 114
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLI 114
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 62  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLI 116
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 117 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 174 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 88  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLI 142
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 143 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 200 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L       +  LD  + +
Sbjct: 65  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ----VRKYSLDLASLI 119
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 120 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-------YR 505
           A++++    KF H ++ A N ++  D    I DFG+T  +   A   R  G       + 
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAY-YRKGGKGLLPVRWM 199
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
           APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                 
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--------------- 244
Query: 565 VFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 245 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 191
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 248
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 249 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 296
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 297 TFSELVEHLGNLLQANAQQ 315

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 182
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 239
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 240 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 287
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 288 TFSELVEHLGNLLQANAQQ 306

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 182
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 239
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 240 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 287
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 288 TFSELVEHLGNLLQANAQQ 306

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI----VGRVGQHPNVVPLR 400
            +G GSYG   K +  +S                + E+QM +    + R  +HPN+V  R
Sbjct: 13  TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--R 69
Query: 401 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAG-RTPLDWE--TRVKILLGTARGVA 453
            Y    D       +V +Y   G L++++   +G   R  LD E   RV   L  A    
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV 509
           H  S GG    H ++K +NV ++   +  + DFGL  ++N     ++    +  Y +PE 
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQ 187
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           +    ++ KSD++S G LL E+     P  + ++ ++
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLT---PLMNVPATPSRSA 502
                V + H     KF  H ++KA N+L++ D++  I+DFG +      N   T   S 
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 503 GYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLT---PLMNVPATPSRSA 502
                V + H     KF  H ++KA N+L++ D++  I+DFG +      N   T   S 
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 503 GYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 191
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 192 FGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 248
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 249 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 296
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 297 TFSELVEHLGNLLQANAQQ 315

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLT---PLMNVPATPSRSA 502
                V + H     KF  H ++KA N+L++ D++  I+DFG +      N   T   S 
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 503 GYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 65
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV+++     L   +  +   G  PL        L    +G+A 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEH-VDQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAF 121
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 343 AEVLGKGSYGTAYKA--------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E +G+G+YG  YKA        V  +                R+     E+      HP
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHP 62
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           N+V L    +++++  LV++ F    L   +  +   G  PL        L    +G++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFE-FLHQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLSF 118
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEV- 509
            HS    +  H ++K  N+LIN +    ++DFGL     VP         +  YRAPE+ 
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKA 536
           +  + +S   D++S G +  EM+T +A
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG-RVGQHPNVVPLRAYYY 404
           +G G++G A + + ++                 D   + EI+  R  +HPN+V  +    
Sbjct: 27  IGAGNFGVA-RLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +     +V +Y + G L   +     AGR   D E R         GV++ H+M   +  
Sbjct: 86  TPTHLAIVMEYASGGELFERIC---NAGRFSED-EARF-FFQQLISGVSYAHAM---QVA 137
Query: 465 HGNIKASNVLINQDLDGC------ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
           H ++K  N L    LDG       I+DFG +    + + P  + G   Y APEV+  +++
Sbjct: 138 HRDLKLENTL----LDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEY 193
Query: 516 SHK-SDVYSFGVLLLEMLTGKAPLQSP 541
             K +DV+S GV L  ML G  P + P
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLI 494
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++ +    + DFGL+  M        S 
Sbjct: 495 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 26/251 (10%)
Query: 341 ASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVP 398
           +  E+LG G +G  +K   E +T              +D E+    +  + Q  H N++ 
Sbjct: 92  SKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L   + SK++ +LV +Y   G L   +  +     T LD    +  +     G+ H+H M
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRI-IDESYNLTELD---TILFMKQICEGIRHMHQM 206
Query: 459 GGPKFTHGNIKASNVL-INQDLDGC-ISDFGLTPLMNVPATPSRSAG---YRAPEVIETR 513
                 H ++K  N+L +N+D     I DFGL            + G   + APEV+   
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD 263
Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 573
             S  +D++S GV+   +L+G +P       + ++      +++   W     D+E   F
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NILACRW-----DLEDEEF 312
Query: 574 QNIEEEMVQML 584
           Q+I EE  + +
Sbjct: 313 QDISEEAKEFI 323

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV-----GQHPNVVPL 399
           VLGKGS+G    +  + +               +D + +  +V +      G+ P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            + + + D    V +Y   G L   +    G  + P      V      A G+  + S G
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP----HAVFYAAEIAIGLFFLQSKG 141
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 515
                + ++K  NV+++ +    I+DFG+          ++    +  Y APE+I  + +
Sbjct: 142 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
               D ++FGVLL EML G+AP +    D++
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 228
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 285
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 286 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 333
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 334 TFSELVEHLGNLLQANAQQ 352

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 83
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 198
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 244
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 245 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPL 436
           D ++++EI+ R   H N+V  +        +   L+ ++  SGSL   L  N+      +
Sbjct: 69  DLKKEIEIL-RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----I 123
Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---- 492
           + + ++K  +   +G+ +   +G  ++ H ++ A NVL+  +    I DFGLT  +    
Sbjct: 124 NLKQQLKYAVQICKGMDY---LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 493 ---NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
               V         + APE +   K    SDV+SFGV L E+LT
Sbjct: 181 EXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 382 QQMEIVGRVGQ---------HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
           + +++VG++ +         HP+++ L     +  +  +V +Y + G L   +  +   G
Sbjct: 50  RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---G 106
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
           R       R+   + +A    H H +      H ++K  NVL++  ++  I+DFGL+ +M
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHMV-----VHRDLKPENVLLDAHMNAKIADFGLSNMM 161
Query: 493 N---VPATPSRSAGYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           +      T   S  Y APEVI  R ++  + D++S GV+L  +L G  P 
Sbjct: 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFASGSLSTLLHGNRGAGRTPL 436
           D ++++EI+ R   H N+V  +        +   L+ ++  SGSL   L  N+      +
Sbjct: 57  DLKKEIEIL-RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----I 111
Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---- 492
           + + ++K  +   +G+ +   +G  ++ H ++ A NVL+  +    I DFGLT  +    
Sbjct: 112 NLKQQLKYAVQICKGMDY---LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 168
Query: 493 ---NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT 533
               V         + APE +   K    SDV+SFGV L E+LT
Sbjct: 169 EXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 193
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 194 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 250
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 251 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 298
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 299 TFSELVEHLGNLLQANAQQ 317

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 36/259 (13%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS-GSLSTLLHGNRGA----- 431
           R    +++I+  +G H NVV L          L+V   F   G+LST L   R       
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 432 ------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
                  +  L  E  +      A+G+  + S    K  H ++ A N+L+++     I D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICD 191
Query: 486 FGLTPLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           FGL   +       R    R      APE I  R ++ +SDV+SFGVLL E+ +  A   
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--- 248
Query: 540 SPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP 599
           SP     +D          EE+   + +   MR  +      +M Q  + C    P  RP
Sbjct: 249 SPYPGVKID----------EEFCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRP 296
Query: 600 NMDEVVRMIEEVRQSDSEN 618
              E+V  +  + Q++++ 
Sbjct: 297 TFSELVEHLGNLLQANAQQ 315

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           VV L   Y +KD   LV      G L   ++    AG          + +   A     +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP------EARAVFYAAEICCGL 299
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVI 510
             +   +  + ++K  N+L++      ISD GL   ++VP   +      + GY APEV+
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           +  +++   D ++ G LL EM+ G++P Q 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 346 LGKGSYGTAYKA-----VLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+      +  E+ T             R+   F  +  ++     H +VV
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 82
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTARGV 452
            L          L+V +  A G L + L   R       GR P   +  +++    A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++  D    I DFG+T   ++  T     G        +
Sbjct: 143 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 197
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            APE ++    +  SD++SFGV+L E+ +  + P Q  + + ++                
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF-------------- 243
Query: 564 EVFD-VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            V D   L +  N  E +  ++++   C    P MRP   E+V ++++
Sbjct: 244 -VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 287

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           VV L   Y +KD   LV      G L   ++    AG          + +   A     +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP------EARAVFYAAEICCGL 299
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-----RSAGYRAPEVI 510
             +   +  + ++K  N+L++      ISD GL   ++VP   +      + GY APEV+
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           +  +++   D ++ G LL EM+ G++P Q 
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV-----GQHPNVVPL 399
           VLGKGS+G    +  + +               +D + +  +V +      G+ P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            + + + D    V +Y   G L   +    G  + P      V      A G+  + S G
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP----HAVFYAAEIAIGLFFLQSKG 462
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 515
                + ++K  NV+++ +    I+DFG+          ++    +  Y APE+I  + +
Sbjct: 463 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
               D ++FGVLL EML G+AP +    D++
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 98/256 (38%), Gaps = 53/256 (20%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA------GRTPL 436
           +++I+  +GQH N+V L          L++ +Y   G L   L     A      GR PL
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR-PL 149
Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN-- 493
           +    +      A+G+A + S       H ++ A NVL+       I DFGL   +MN  
Sbjct: 150 ELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 494 ---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
              V         + APE I    ++ +SDV+S+G+LL E+ + G  P      +     
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 262
Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ----------IGMACVAKVPDMRP 599
                                 +F  + ++  QM Q          I  AC A  P  RP
Sbjct: 263 ----------------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 300
Query: 600 NMDEVVRMIEEVRQSD 615
              ++   ++E  Q D
Sbjct: 301 TFQQICSFLQEQAQED 316

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 60  QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLI 114
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++      + DFGL+  M        S 
Sbjct: 115 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +  S  SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 121
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
                V + H        H ++KA N+L++ D++  I+DFG +    V        G   
Sbjct: 122 QIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPP 178
Query: 504 YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG-RVGQHPNVVPLRAYYY 404
           +G G++G A + + ++ +               D   + EI+  R  +HPN+V  +    
Sbjct: 26  IGSGNFGVA-RLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +     +V +Y + G L   +     AGR   D E R         GV++ H+M   +  
Sbjct: 85  TPTHLAIVMEYASGGELFERI---CNAGRFSED-EARF-FFQQLISGVSYCHAM---QVC 136
Query: 465 HGNIKASNVLINQDLDGC------ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
           H ++K  N L    LDG       I DFG +    + + P  + G   Y APEV+  +++
Sbjct: 137 HRDLKLENTL----LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 192
Query: 516 SHK-SDVYSFGVLLLEMLTGKAPLQSP 541
             K +DV+S GV L  ML G  P + P
Sbjct: 193 DGKVADVWSCGVTLYVMLVGAYPFEDP 219

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE-QQMEIVGRVGQHPNVV 397
           L  S ++LG GS GT    V + S                D    +++++     HPNV+
Sbjct: 34  LVVSEKILGYGSSGTV---VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 90
Query: 398 PLRAYYYSK--DEKLLVYDYFASGSLSTLLHG-NRGAGRTPLDWETR-VKILLGTARGVA 453
               YY S+  D  L +     + +L  L+   N       L  E   + +L   A GVA
Sbjct: 91  ---RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 454 HIHSMGGPKFTHGNIKASNVLIN-------------QDLDGCISDFGLTPLMNVPA---- 496
           H+HS+   K  H ++K  N+L++             ++L   ISDFGL   ++       
Sbjct: 148 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 497 ----TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLT-GKAPL 538
                PS ++G+RAPE++E    R+ +   D++S G +   +L+ GK P 
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 382 QQMEIVGRVGQ---------HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG 432
           + +++VG++ +         HP+++ L     +  +  +V +Y + G L   +  +   G
Sbjct: 50  RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---G 106
Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
           R       R+   + +A    H H +      H ++K  NVL++  ++  I+DFGL+ +M
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHMV-----VHRDLKPENVLLDAHMNAKIADFGLSNMM 161
Query: 493 NVPATPSRSAG---YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           +       S G   Y APEVI  R ++  + D++S GV+L  +L G  P 
Sbjct: 162 SDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 26/185 (14%)
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+A++H+     + H ++ A NVL++ D    I DFGL       A P     YR     
Sbjct: 146 GMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEXYRVREDG 197
Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--DMVDLPRWVQSV 556
                  APE ++  K  + SDV+SFGV L E+LT     QSP     +++ + +   +V
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           +R     E  +  L R      E+  +++    C       RP  + ++ +++ V +   
Sbjct: 258 LRLTELLERGE-RLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVHEKYQ 313
Query: 617 ENRPS 621
              PS
Sbjct: 314 GQAPS 318

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 503
                V + H     KF  H ++KA N+L++ D++  I+DFG +             G  
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSP 176
Query: 504 -YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +  L   +  ++   LV DY+  G L TLL  ++   + P   E   +  +G    V  I
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLP---EDMARFYIGEM--VLAI 188
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI 510
            S+    + H +IK  NVL++ +    ++DFG    MN   T   S       Y +PE++
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 511 ETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           +       K+  + D +S GV + EML G+ P  + +
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 285

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +  L   +  ++   LV DY+  G L TLL  ++   + P   E   +  +G    V  I
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLP---EDMARFYIGEM--VLAI 204
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVI 510
            S+    + H +IK  NVL++ +    ++DFG    MN   T   S       Y +PE++
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 511 ETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           +       K+  + D +S GV + EML G+ P  + +
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 301

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE-QQMEIVGRVGQHPNVV 397
           L  S ++LG GS GT    V + S                D    +++++     HPNV+
Sbjct: 34  LVVSEKILGYGSSGTV---VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 90
Query: 398 PLRAYYYSK--DEKLLVYDYFASGSLSTLLHG-NRGAGRTPLDWETR-VKILLGTARGVA 453
               YY S+  D  L +     + +L  L+   N       L  E   + +L   A GVA
Sbjct: 91  ---RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 454 HIHSMGGPKFTHGNIKASNVLIN-------------QDLDGCISDFGLTPLMNVPA---- 496
           H+HS+   K  H ++K  N+L++             ++L   ISDFGL   ++       
Sbjct: 148 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 204
Query: 497 ----TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLT-GKAPL 538
                PS ++G+RAPE++E    R+ +   D++S G +   +L+ GK P 
Sbjct: 205 XNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/267 (21%), Positives = 108/267 (40%), Gaps = 49/267 (18%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPL-RAYYYSKDE------KLLVYDYFASGSLSTLLHGNRG 430
           R   Q++  + ++  HPN+V    A    K+E      + L+      G L   L   + 
Sbjct: 70  RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKM 127
Query: 431 AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG-LT 489
             R PL  +T +KI   T R V H+H    P   H ++K  N+L++      + DFG  T
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 490 PLMNVP---------------ATPSRSAGYRAPEVIETRKH---SHKSDVYSFGVLLLEM 531
            + + P                T + +  YR PE+I+   +     K D+++ G +L  +
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 532 LTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACV 591
              + P +   +            +V  +++    D +   F ++   M+Q+        
Sbjct: 247 CFRQHPFEDGAK----------LRIVNGKYSIPPHDTQYTVFHSLIRAMLQV-------- 288
Query: 592 AKVPDMRPNMDEVVRMIEEVRQSDSEN 618
              P+ R ++ EVV  ++E+  + + N
Sbjct: 289 --NPEERLSIAEVVHQLQEIAAARNVN 313

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 441
           ++  I+ +V  HP+++ L   Y S     LV+D    G L   L             ETR
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK----ETR 203
Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-------PLMNV 494
             I+      V+ +H+       H ++K  N+L++ ++   +SDFG +        L  +
Sbjct: 204 -SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL 259
Query: 495 PATPSRSAGYRAPEVIE-TRKHSH-----KSDVYSFGVLLLEMLTGKAPL 538
             TP    GY APE+++ +   +H     + D+++ GV+L  +L G  P 
Sbjct: 260 CGTP----GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGR-----VGQHPNVVPL 399
           VLGKGS+G    A  + +               +D + +  +V +     + + P +  L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            + + + D    V +Y   G L   +    G  + P      V      + G+  +H  G
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEP----QAVFYAAEISIGLFFLHKRG 140
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 515
                + ++K  NV+++ +    I+DFG+     +    +R    +  Y APE+I  + +
Sbjct: 141 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY 197
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
               D +++GVLL EML G+ P      D++
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 439 ETRVKILL-GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 497
           E R++ L+    +G+ +IH+ G     H ++K  N+ +N+D +  I DFGL    +    
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMX 183
Query: 498 PS-RSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGK 535
               +  YRAPEVI    +++   D++S G ++ EM+TGK
Sbjct: 184 GXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 35/179 (19%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++++EI+ R   H ++V  +     + EK   LV +Y   GSL   L         P  
Sbjct: 57  WQREIEIL-RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRH 106
Query: 438 WETRVKILL---GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 494
                ++LL       G+A++H+     + H  + A NVL++ D    I DFGL      
Sbjct: 107 CVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK---- 159
Query: 495 PATPSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
            A P     YR            APE ++  K  + SDV+SFGV L E+LT     QSP
Sbjct: 160 -AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 79/179 (44%), Gaps = 35/179 (19%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++++EI+ R   H ++V  +     + EK   LV +Y   GSL   L         P  
Sbjct: 58  WQREIEIL-RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRH 107
Query: 438 WETRVKILL---GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV 494
                ++LL       G+A++H+     + H  + A NVL++ D    I DFGL      
Sbjct: 108 CVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK---- 160
Query: 495 PATPSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
            A P     YR            APE ++  K  + SDV+SFGV L E+LT     QSP
Sbjct: 161 -AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           Q  +  R   HP++V L     +++   ++ +    G L + L   + +    LD  + +
Sbjct: 440 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLI 494
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 +  +A++ S    +F H +I A NVL++      + DFGL+  M        S 
Sbjct: 495 LYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 503 G-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
           G     + APE I  R+ +  SDV+ FGV + E+L  G  P Q    +D++
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 147 RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPE 203
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 430 GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT 489
           G  + P+  E  +      ARG+  + S    K  H ++ A N+L++++    I DFGL 
Sbjct: 190 GFYKEPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLA 246
Query: 490 PLMNVPATPSRSAGYR------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPT 542
             +       R    R      APE I  + +S KSDV+S+GVLL E+ + G +P     
Sbjct: 247 RDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQ 306
Query: 543 RDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMD 602
            D              E++ + +   E MR +  E    ++ QI + C  + P  RP   
Sbjct: 307 MD--------------EDFCSRL--REGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFA 350
Query: 603 EVVRMI 608
           E+V  +
Sbjct: 351 ELVEKL 356

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 141 RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPE 197
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 102/237 (43%), Gaps = 27/237 (11%)
Query: 333 FDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGR 389
           +D  D+L    E LG G++G  ++ V E++T               D    + ++ I+ +
Sbjct: 50  YDYYDIL----EELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104
Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +  HP ++ L   +  K E +L+ ++ + G L   +     A    +     +  +    
Sbjct: 105 L-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQAC 159
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMN---VPATPSRSAGY 504
            G+ H+H        H +IK  N++        +   DFGL   +N   +    + +A +
Sbjct: 160 EGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 561
            APE+++       +D+++ GVL   +L+G +P      DD+  L    Q+V R +W
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETL----QNVKRCDW 267

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 141 RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPE 197
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 138 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 194
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 199
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 141 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 197
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 148 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 204
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 135 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 191
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 148 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 204
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 147 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 203
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 148 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 204
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 345 VLGKGSYGTAYKAVLEES----TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVP 398
           +LGKG +G+  +A L++                     D E+ +     + +  HP+V  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 399 LRAYYYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTP--LDWETRVKILLGTAR 450
           L         K      +++  +   G L   L  +R  G  P  L  +T V+ ++  A 
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR-IGENPFNLPLQTLVRFMVDIAC 148
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP--- 507
           G+ ++ S     F H ++ A N ++ +D+  C++DFGL+  +       +    + P   
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 508 ---EVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
              E +    ++  SDV++FGV + E++T G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 22/218 (10%)
Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXX---XXRDFEQQMEIV 387
           +  + EDL+    E +G+G++G  +   L    T                  F Q+  I+
Sbjct: 109 WVLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL 166
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
            +   HPN+V L      K    +V +    G   T L       R     +T ++++  
Sbjct: 167 KQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV----KTLLQMVGD 221
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A G+ ++ S       H ++ A N L+ +     ISDFG++         + S G R  
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQV 277
Query: 506 -----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                APE +   ++S +SDV+SFG+LL E  + G +P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 138 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 194
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 503
                V + H     KF  H ++KA N+L++ D++  I+DFG +             G  
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP 176
Query: 504 -YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 138 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 194
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 31/231 (13%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYG---TAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI 386
           S++   ED+ +   +VLG+G++    T    +  +                R F +++E+
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-REVEM 63
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +   H NV+ L  ++  +D   LV++    GS+ + +H  R       + E  V ++ 
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASV-VVQ 118
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA------- 496
             A  +  +H+ G     H ++K  N+L    NQ     I DFGL   + +         
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 497 ----TPSRSAGYRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
               TP  SA Y APEV+E        +  + D++S GV+L  +L+G  P 
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 141 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 197
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 43/234 (18%)
Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE-QQMEIVGRVGQHPNVV 397
           L  S ++LG GS GT    V + S                D    +++++     HPNV+
Sbjct: 16  LVVSEKILGYGSSGTV---VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 398 PLRAYYYSK--DEKLLVYDYFASGSLSTLLHG-NRGAGRTPLDWETR-VKILLGTARGVA 453
               YY S+  D  L +     + +L  L+   N       L  E   + +L   A GVA
Sbjct: 73  ---RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 454 HIHSMGGPKFTHGNIKASNVLIN-------------QDLDGCISDFGLTPLMNVPAT--- 497
           H+HS+   K  H ++K  N+L++             ++L   ISDFGL   ++   +   
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 498 -----PSRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLT-GKAPL 538
                PS ++G+RAPE++E        R+ +   D++S G +   +L+ GK P 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 133 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 189
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 159 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 215
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 146 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 202
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 133 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 189
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 134 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 190
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 156 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 212
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 155 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 211
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 378 RDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTP 435
           RDF ++   + R+  HPNV+P+     S       L+  +   GSL  +LH   G     
Sbjct: 52  RDFNEECPRL-RIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLH--EGTNFV- 107
Query: 436 LDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP 495
           +D    VK  L  ARG A +H++  P      + + +V I++D    IS   +      P
Sbjct: 108 VDQSQAVKFALDXARGXAFLHTLE-PLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP 166
Query: 496 ATPSRSAGYRAPEVIETR---KHSHKSDVYSFGVLLLEMLTGKAPL 538
                +  + APE ++ +    +   +D +SF VLL E++T + P 
Sbjct: 167 GR-XYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPF 211

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 26/163 (15%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDW----ET 440
           + +V  HPN+V L     ++    LV +Y + G +   L  HG          W    E 
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG----------WMKEKEA 108
Query: 441 RVKILLGTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLT---PLMNVPA 496
           R K        V + H     KF  H ++KA N+L++ D++  I+DFG +      N   
Sbjct: 109 RAK-FRQIVSAVQYCHQ----KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD 163
Query: 497 TPSRSAGYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
           T   S  Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 164 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 29/251 (11%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--------RT 434
           +++I+  +GQH N+V L          L++ +Y   G L   L   R  G          
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 435 PLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN 493
           P +  +   +L  +++    +  +      H ++ A NVL+       I DFGL   +MN
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 494 -----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
                V         + APE I    ++ +SDV+S+G+LL E+ +             + 
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LG 265
Query: 549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
           L  +   +V  ++   V D   M       +   +  I  AC A  P  RP   ++   +
Sbjct: 266 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFL 323
Query: 609 EEVRQSDSENR 619
           +E  Q D   R
Sbjct: 324 QEQAQEDRRER 334

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 113 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 115 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 116 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 155 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 211
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 156 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 212
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 345 VLGKGSYGTAYKA----VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           +LGKGS+G   K       +E                    +++E++ ++  HPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLF 87
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                     +V + +  G L      +    R         +I+     G+ ++H    
Sbjct: 88  EILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 461 PKFTHGNIKASNVLIN---QDLDGCISDFGL-TPLMNVPATPSR--SAGYRAPEVIETRK 514
               H ++K  N+L+    +D D  I DFGL T          R  +A Y APEV+    
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          DLP+W
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD--FEQQMEIVGRVGQHPNVVPLRA 401
           EVLG G++   +      +               RD   E ++ ++ ++ +H N+V L  
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLED 73
Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            Y S     LV    + G L   +   RG   T  D    ++ +L     V ++H  G  
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-LERGV-YTEKDASLVIQQVLS---AVKYLHENG-- 126
Query: 462 KFTHGNIKASNVLI---NQDLDGCISDFGLTPLMN--VPATPSRSAGYRAPEVIETRKHS 516
              H ++K  N+L     ++    I+DFGL+ +    + +T   + GY APEV+  + +S
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
              D +S GV+   +L G  P    T   + +
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFE 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 24/121 (19%)
Query: 432 GRTPLDWETR---VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL 488
           GR  ++   R   + I L  A  V  +HS G     H ++K SN+    D    + DFGL
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL 164
Query: 489 TPLMN-----------VPATPSRSAG------YRAPEVIETRKHSHKSDVYSFGVLLLEM 531
              M+           +PA  +R  G      Y +PE I    +SHK D++S G++L E+
Sbjct: 165 VTAMDQDEEEQTVLTPMPAY-ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 532 L 532
           L
Sbjct: 224 L 224

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 385 EIVG-RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 443
           EI+  R  +HPN+V  +    +     +V +Y + G L   +     AGR   D E R  
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSED-EARF- 119
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC------ISDFGLTPLMNVPAT 497
                  GV++ H+M   +  H ++K  N L    LDG       I DFG +    + + 
Sbjct: 120 FFQQLISGVSYCHAM---QVCHRDLKLENTL----LDGSPAPRLKICDFGYSKSSVLHSQ 172
Query: 498 PSRSAG---YRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSP 541
           P  + G   Y APEV+  +++  K +DV+S GV L  ML G  P + P
Sbjct: 173 PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 15/94 (15%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T    AG      
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRW 187
Query: 504 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           YRAPE++    H +++ D++S G ++ E+LTG+ 
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 15/93 (16%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T    AG      
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRW 187
Query: 504 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           YRAPE++    H +++ D++S G ++ E+LTG+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVPLR 400
           VLGKGS+G     K  +                   D E  +  V  + Q  HPN++ L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++  K    LV + +  G L      +    R         +I+     G+ ++H    
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMHK--- 150
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
            K  H ++K  N+L+   ++D +  I DFGL+             G   Y APEV+    
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-T 209
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          +LP+W
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 257

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 138 RGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPE 194
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 339 LRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFE-QQMEIVGRVGQHPNVV 397
           L  S ++LG GS GT    V + S                D    +++++     HPNV+
Sbjct: 16  LVVSEKILGYGSSGTV---VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 398 PLRAYYYSK--DEKLLVYDYFASGSLSTLLHG-NRGAGRTPLDWETR-VKILLGTARGVA 453
               YY S+  D  L +     + +L  L+   N       L  E   + +L   A GVA
Sbjct: 73  ---RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 454 HIHSMGGPKFTHGNIKASNVLIN-------------QDLDGCISDFGLTPLMNVPA---- 496
           H+HS+   K  H ++K  N+L++             ++L   ISDFGL   ++       
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFR 186
Query: 497 ----TPSRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLT-GKAPL 538
                PS ++G+RAPE++E        R+ +   D++S G +   +L+ GK P 
Sbjct: 187 XNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 22/218 (10%)
Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXX---XXRDFEQQMEIV 387
           +  + EDL+    E +G+G++G  +   L    T                  F Q+  I+
Sbjct: 109 WVLNHEDLV--LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL 166
Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
            +   HPN+V L      K    +V +    G   T L       R     +T ++++  
Sbjct: 167 KQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV----KTLLQMVGD 221
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A G+ ++ S       H ++ A N L+ +     ISDFG++         + S G R  
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQV 277
Query: 506 -----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                APE +   ++S +SDV+SFG+LL E  + G +P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 345 VLGKGSYGTAYKA----VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           +LGKGS+G   K       +E                    +++E++ ++  HPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLF 87
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                     +V + +  G L      +    R         +I+     G+ ++H    
Sbjct: 88  EILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 461 PKFTHGNIKASNVLIN---QDLDGCISDFGL-TPLMNVPATPSR--SAGYRAPEVIETRK 514
               H ++K  N+L+    +D D  I DFGL T          R  +A Y APEV+    
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          DLP+W
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 142 RGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPE 198
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 345 VLGKGSYGTAYKA----VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           +LGKGS+G   K       +E                    +++E++ ++  HPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLF 87
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                     +V + +  G L      +    R         +I+     G+ ++H    
Sbjct: 88  EILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 461 PKFTHGNIKASNVLIN---QDLDGCISDFGL-TPLMNVPATPSR--SAGYRAPEVIETRK 514
               H ++K  N+L+    +D D  I DFGL T          R  +A Y APEV+    
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          DLP+W
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 143 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 346 LGKGSYGTAYKAVLEESTTXXX----XXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRA 401
           +G+GS+ T YK +  E+T                  + F+++ E +  + QHPN+V    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGL-QHPNIVRFYD 92
Query: 402 YYYS--KDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR----GVA 453
            + S  K +K  +LV +   SG+L T L   +           ++K+L    R    G+ 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVX---------KIKVLRSWCRQILKGLQ 143
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMN------VPATPSRSAGYRA 506
            +H+   P   H ++K  N+ I        I D GL  L        V  TP     + A
Sbjct: 144 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FXA 198
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           PE  E  K+    DVY+FG   LE  T + P
Sbjct: 199 PEXYE-EKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 15/93 (16%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T    AG      
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMAGFVATRW 183
Query: 504 YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           YRAPE++    H +++ D++S G ++ E+LTG+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 78/210 (37%), Gaps = 28/210 (13%)
Query: 344 EVLGKGSYGTAYKAVL----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           E LGKG++    + V     +E                +  E++  I  R+ +HPN+V L
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC-RLLKHPNIVRL 75
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    L++D    G L   +       R           +      V H H MG
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLT--------PLMNVPATPSRSAGYRAPE 508
                H N+K  N+L+   L G    ++DFGL                TP    GY +PE
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP----GYLSPE 183
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           V+    +    D+++ GV+L  +L G  P 
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 62  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 113
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG----YRA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T S  +     +  
Sbjct: 114 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 173
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 216

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVPLR 400
           VLGKGS+G     K  +                   D E  +  V  + Q  HPN++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++  K    LV + +  G L      +    R         +I+     G+ ++H    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMHK--- 144
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
            K  H ++K  N+L+   ++D +  I DFGL+             G   Y APEV+    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-T 203
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          +LP+W
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 109
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAGY----RA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T S  + +      
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 344 EVLGKGSYGTAYKAVL----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG--QHPNVV 397
           +VLG G +GT +K V     E                 + F+   + +  +G   H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 455
            L         +L V  Y   GSL   +  +RGA   +  L+W  ++      A+G+ ++
Sbjct: 97  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYRA 506
              G     H N+ A NVL+       ++DFG+  L+         +   TP +   + A
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---WMA 203
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT 533
            E I   K++H+SDV+S+GV + E++T
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 18/228 (7%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQM--EI-VGRVGQHPNVVPLR 400
           E +G+G+YGT +KA   E+                        EI + +  +H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              +S  +  LV++ F    L        G     LD E     L    +G+   HS   
Sbjct: 68  DVLHSDKKLTLVFE-FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK-H 515
               H ++K  N+LIN++ +  ++DFGL     +P    +    +  YR P+V+   K +
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 516 SHKSDVYSFGVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSVVREEW 561
           S   D++S G +  E+     PL   +   D +  + R + +   E+W
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAY 402
           VLGKG+YG  Y  + +  +                +   +++ +   + +H N+V     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGS 87
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL-DWETRVKILLGTA-RGVAHIHSMGG 460
           +       +  +    GSLS LL    G    PL D E  +         G+ ++H    
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHD--- 140
Query: 461 PKFTHGNIKASNVLINQDLDGC--ISDFG----LTPLMNVPATPSRSAGYRAPEVIET-- 512
            +  H +IK  NVLIN    G   ISDFG    L  +     T + +  Y APE+I+   
Sbjct: 141 NQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPL 538
           R +   +D++S G  ++EM TGK P 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/99 (24%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------S 501
           TA  V+ +  + G    H ++K  N+L+N+D+   I+DFG   +++  +  +R      +
Sbjct: 141 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           A Y +PE++  +     SD+++ G ++ +++ G  P ++
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T   +   YRAPE
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPE 199
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T   +   YRAPE
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPE 199
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 129
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YR 505
              +  +   +F H ++ A N L+N      +SDFGL+  + +    + S G      + 
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEETSSVGSKFPVRWS 188
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
            PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I D+GL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 114
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG----YRA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T S  +     +  
Sbjct: 115 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 174
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 344 EVLGKGSYG---TAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           + +G+G+YG   +AY  V +                 +   ++++I+ R  +H NV+ +R
Sbjct: 49  QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF-RHENVIGIR 107
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
               +   + +   Y     + T L+    + +  L  +     L    RG+ +IHS   
Sbjct: 108 DILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ--LSNDHICYFLYQILRGLKYIHSAN- 164
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS-------RSAGYRAPEVIETR 513
               H ++K SN+LIN   D  I DFGL  + +     +        +  YRAPE++   
Sbjct: 165 --VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 514 KHSHKS-DVYSFGVLLLEMLTGK 535
           K   KS D++S G +L EML+ +
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 30/207 (14%)
Query: 344 EVLGKGSYGTAYKAVL----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG--QHPNVV 397
           +VLG G +GT +K V     E                 + F+   + +  +G   H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHI 455
            L         +L V  Y   GSL   +  +RGA   +  L+W  ++      A+G+ ++
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---------NVPATPSRSAGYRA 506
              G     H N+ A NVL+       ++DFG+  L+         +   TP +   + A
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---WMA 185
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT 533
            E I   K++H+SDV+S+GV + E++T
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL        T   +   YRAPE
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPE 199
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGK 535
           ++    H +++ D++S G ++ E+LTG+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 114
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 346 LGKGSYGTAYKAVLEES-----TTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLR 400
           LGKG+YG  +K++   +                    R F + M I+  +  H N+V L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM-ILTELSGHENIVNLL 75
Query: 401 AYYYSKDEK--LLVYDYFASGSLSTLLHGN-RGAGRTPLDWETRVKILLGTARGVAHIHS 457
               + +++   LV+DY     + T LH   R     P+  +  V  L+   + + ++HS
Sbjct: 76  NVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLI---KVIKYLHS 127
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--------NVPATPSRSA------- 502
            G     H ++K SN+L+N +    ++DFGL+           N+P + + +        
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 503 ----------GYRAPEV-IETRKHSHKSDVYSFGVLLLEMLTGK 535
                      YRAPE+ + + K++   D++S G +L E+L GK
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +   T   +   YRAPE
Sbjct: 165 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 221
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H + + D++S G ++ E+LTG+ 
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVPLR 400
           VLGKGS+G     K  +                   D E  +  V  + Q  HPN++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++  K    LV + +  G L   +       R         +I+     G+ ++H    
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVLSGITYMHK--- 167
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
            K  H ++K  N+L+   ++D +  I DFGL+             G   Y APEV+    
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-T 226
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          +LP+W
Sbjct: 227 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +V  HPN+V L     ++    LV +Y + G +   L  +   GR   + E R K   
Sbjct: 66  IXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH---GRXK-EKEARAK-FR 120
Query: 447 GTARGVAHIHSMGGPKF-THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 503
                V + H     KF  H ++KA N+L++ D +  I+DFG +             G  
Sbjct: 121 QIVSAVQYCHQ----KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP 176
Query: 504 -YRAPEVIETRKHSH-KSDVYSFGVLLLEMLTGKAPL 538
            Y APE+ + +K+   + DV+S GV+L  +++G  P 
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVPLR 400
           VLGKGS+G     K  +                   D E  +  V  + Q  HPN++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++  K    LV + +  G L   +       R         +I+     G+ ++H    
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVLSGITYMHK--- 168
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
            K  H ++K  N+L+   ++D +  I DFGL+             G   Y APEV+    
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-T 227
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          +LP+W
Sbjct: 228 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 119
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 120 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 179
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 221

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 103 MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 154
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 155 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 214
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 215 SFGVLMWEAFSYGQKPYR 232

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 103 MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 154
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 155 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 214
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 215 SFGVLMWEAFSYGQKPYR 232

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 87  MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 138
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 139 ARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 198
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 199 SFGVLMWEAFSYGQKPYR 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 69  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 120
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG----YRA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T S  +     +  
Sbjct: 121 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 180
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 181 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 83/183 (45%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  HPN++ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS-------DFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 21/218 (9%)
Query: 333 FDLEDLLRASAEVLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRV 390
           +D E        VLGKG+YG  Y  + +  +                +   +++ +   +
Sbjct: 3   YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL 62
Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL-DWETRVKILLGTA 449
            +H N+V     +       +  +    GSLS LL    G    PL D E  +       
Sbjct: 63  -KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIGFYTKQI 117
Query: 450 -RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFG----LTPLMNVPATPSRSA 502
             G+ ++H     +  H +IK  NVLIN    G   ISDFG    L  +     T + + 
Sbjct: 118 LEGLKYLHD---NQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTL 173
Query: 503 GYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPL 538
            Y APE+I+   R +   +D++S G  ++EM TGK P 
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 93  MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 144
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 145 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 204
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 205 SFGVLMWEAFSYGQKPYR 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 83  MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 134
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 195 SFGVLMWEAFSYGQKPYR 212

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 91
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R A        P      +++    A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 206
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 256
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 257 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 296

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           H  +V L      +    ++ +Y A+G L   L   R   +T        + LL   + V
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT--------QQLLEMCKDV 129
Query: 453 AH-IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP-LMNVPATPSRSAG----YRA 506
              +  +   +F H ++ A N L+N      +SDFGL+  +++   T S  +     +  
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 189
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD 548
           PEV+   K S KSD+++FGVL+ E+ + GK P +  T  +  +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 81  MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 132
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 133 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 192
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 193 SFGVLMWEAFSYGQKPYR 210

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 101 MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 152
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 153 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 212
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 213 SFGVLMWEAFSYGQKPYR 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK 469
           +LV +    G L+  L  NR      +     ++++   + G+ ++       F H ++ 
Sbjct: 87  MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLA 138
Query: 470 ASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKHSHKSDVY 522
           A NVL+       ISDFGL+  +       ++         + APE I   K S KSDV+
Sbjct: 139 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 198
Query: 523 SFGVLLLEMLT-GKAPLQ 539
           SFGVL+ E  + G+ P +
Sbjct: 199 SFGVLMWEAFSYGQKPYR 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 76
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 137 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIXETDXXRKGGKGLLPVRW 191
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 192 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 241
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + +++++++   C    P MRP+  E++  I+E
Sbjct: 242 GLLD----KPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKE 281

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 114
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 98/264 (37%), Gaps = 57/264 (21%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           +++I+  +GQH N+V L          L++ +Y   G L   L   R   R  L+ +   
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRV-LETDPAF 154
Query: 443 KILLGTA--RGVAHIHS--------MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PL 491
            I   TA  R + H  S        +      H ++ A NVL+       I DFGL   +
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 492 MN-----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 545
           MN     V         + APE I    ++ +SDV+S+G+LL E+ + G  P      + 
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274
Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ----------IGMACVAKVP 595
                                     +F  + ++  QM Q          I  AC A  P
Sbjct: 275 --------------------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308
Query: 596 DMRPNMDEVVRMIEEVRQSDSENR 619
             RP   ++   ++E  Q D   R
Sbjct: 309 THRPTFQQICSFLQEQAQEDRRER 332

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 114
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +       +   YRAPE
Sbjct: 159 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPE 215
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 114
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 25/178 (14%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPN++ L  ++  K    LV + +  G L      +    R          I+     G 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELF-----DEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 453 AHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRA 506
            ++H        H ++K  N+L+   ++D    I DFGL+    V        G   Y A
Sbjct: 118 TYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRWVQ 554
           PEV+  +K+  K DV+S GV+L  +L G  P    T  +++          D P W Q
Sbjct: 175 PEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 117
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 118 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 177
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 25/178 (14%)
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPN++ L  ++  K    LV + +  G L      +    R          I+     G 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELF-----DEIILRQKFSEVDAAVIMKQVLSGT 134
Query: 453 AHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRA 506
            ++H        H ++K  N+L+   ++D    I DFGL+    V        G   Y A
Sbjct: 135 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 191
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRWVQ 554
           PEV+  +K+  K DV+S GV+L  +L G  P    T  +++          D P W Q
Sbjct: 192 PEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +HP +  L+  + + D    V +Y   G L    H +R    T    E R +     A  
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFY--GAEI 114
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRAP 507
           V+ +  +      + +IK  N+++++D    I+DFGL    ++  AT     G   Y AP
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           EV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 81
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R A        P      +++    A G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 142 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 196
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 197 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 246
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 247 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 286

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLD 437
           F ++ +I+      P VV L  +Y  +D++ L  V +Y   G L  L+       +    
Sbjct: 121 FWEERDIMA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 177
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 496
           +   V + L        IHSMG   F H ++K  N+L+++     ++DFG    MN    
Sbjct: 178 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 497 ----TPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
               T   +  Y +PEV++++     +  + D +S GV L EML G  P  + +
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLD 437
           F ++ +I+      P VV L  +Y  +D++ L  V +Y   G L  L+       +    
Sbjct: 116 FWEERDIMA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 172
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 496
           +   V + L        IHSMG   F H ++K  N+L+++     ++DFG    MN    
Sbjct: 173 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 497 ----TPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
               T   +  Y +PEV++++     +  + D +S GV L EML G  P  + +
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DFGL    +       +   YRAPE
Sbjct: 156 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPE 212
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVG 391
           DLLR    V+G+GSY       L+++                D      + +  +  +  
Sbjct: 23  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            HP +V L + + ++     V +Y   G L  + H  R   +  L  E         +  
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 133
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAP 507
           + ++H  G     + ++K  NVL++ +    ++D+G+      P  T S   G   Y AP
Sbjct: 134 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           E++    +    D ++ GVL+ EM+ G++P 
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 85
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIXETDXXRKGGKGLLPVRW 200
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 250
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 251 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 290

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 19/107 (17%)
Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN-------- 493
           + I +  A  V  +HS G     H ++K SN+    D    + DFGL   M+        
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 494 ---VPATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEML 532
              +PA  +         Y +PE I    +SHK D++S G++L E+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 61/250 (24%)
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLV----------YDYFASGSLSTLLHGNRGAGRTPL 436
           VG  G HP V+ L  ++ +++  +LV          +DY           G  G G +  
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-------KGPLGEGPS-- 141
Query: 437 DWETRVKILLG-TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLM- 492
                 +   G     + H HS G     H +IK  N+LI+    GC  + DFG   L+ 
Sbjct: 142 ------RCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR-RGCAKLIDFGSGALLH 191
Query: 493 NVPATP-SRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP 550
           + P T    +  Y  PE I   + H+  + V+S G+LL +M+ G  P +   RD      
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE---RDQ----- 243
Query: 551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
                        E+ + EL    ++  +   +++    C+A  P  RP+++E+  +++ 
Sbjct: 244 -------------EILEAELHFPAHVSPDCCALIR---RCLAPKPSSRPSLEEI--LLDP 285
Query: 611 VRQSDSENRP 620
             Q+ +E+ P
Sbjct: 286 WMQTPAEDVP 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 28/210 (13%)
Query: 344 EVLGKGSYGTAYKAVL----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           E LGKG++    + V     +E                +  E++  I  R+ +HPN+V L
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARIC-RLLKHPNIVRL 86
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    L++D    G L   +       R           +      V H H MG
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLT--------PLMNVPATPSRSAGYRAPE 508
                H ++K  N+L+   L G    ++DFGL                TP    GY +PE
Sbjct: 142 ---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP----GYLSPE 194
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           V+    +    D+++ GV+L  +L G  P 
Sbjct: 195 VLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 380 FEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLD 437
           F ++ +I+      P VV L  +Y  +D++ L  V +Y   G L  L+       +    
Sbjct: 121 FWEERDIMA-FANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 177
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA- 496
           +   V + L        IHSMG   F H ++K  N+L+++     ++DFG    MN    
Sbjct: 178 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 497 ----TPSRSAGYRAPEVIETR----KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
               T   +  Y +PEV++++     +  + D +S GV L EML G  P  + +
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 335 LEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI-VGRVGQH 393
           +EDL       +G+G+YG  YKA  ++                       EI + R  +H
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH 77
Query: 394 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTA 449
           PNV+ L+  + S  ++   L++DY A   L  ++  +R   A + P      V++  G  
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKP------VQLPRGMV 130
Query: 450 RGVAH-----IHSMGGPKFTHGNIKASNVLIN----QDLDGCISDFGLTPLMNVPATPSR 500
           + + +     IH +      H ++K +N+L+     +     I+D G   L N P  P  
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 501 -------SAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
                  +  YRAPE++   +H  K+ D+++ G +  E+LT +
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVG 391
           DLLR    V+G+GSY       L+++                D      + +  +  +  
Sbjct: 8   DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            HP +V L + + ++     V +Y   G L  + H  R   +  L  E         +  
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 118
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAP 507
           + ++H  G     + ++K  NVL++ +    ++D+G+      P  T S   G   Y AP
Sbjct: 119 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           E++    +    D ++ GVL+ EM+ G++P 
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG-RVGQHPNVVPLRAYYY 404
           +G G++G A + + ++ +               D   + EI+  R  +HPN+V  +    
Sbjct: 27  IGSGNFGVA-RLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +     +V +Y + G L   +     AGR   D E R         GV++ H+M   +  
Sbjct: 86  TPTHLAIVMEYASGGELFERI---CNAGRFSED-EARF-FFQQLISGVSYCHAM---QVC 137
Query: 465 HGNIKASNVLINQDLDGC------ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
           H ++K  N L    LDG       I  FG +    + + P  + G   Y APEV+  +++
Sbjct: 138 HRDLKLENTL----LDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 193
Query: 516 SHK-SDVYSFGVLLLEMLTGKAPLQSP 541
             K +DV+S GV L  ML G  P + P
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVG 391
           DLLR    V+G+GSY       L+++                D      + +  +  +  
Sbjct: 55  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            HP +V L + + ++     V +Y   G L  + H  R   +  L  E         +  
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 165
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAP 507
           + ++H  G     + ++K  NVL++ +    ++D+G+      P  T S   G   Y AP
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           E++    +    D ++ GVL+ EM+ G++P 
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVG-RVGQHPNVVPLRAYYY 404
           +G G++G A + + ++ +               D   + EI+  R  +HPN+V  +    
Sbjct: 27  IGSGNFGVA-RLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
           +     +V +Y + G L   +     AGR   D E R         GV++ H+M   +  
Sbjct: 86  TPTHLAIVMEYASGGELFERI---CNAGRFSED-EARF-FFQQLISGVSYCHAM---QVC 137
Query: 465 HGNIKASNVLINQDLDGC------ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
           H ++K  N L    LDG       I  FG +    + + P  + G   Y APEV+  +++
Sbjct: 138 HRDLKLENTL----LDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEY 193
Query: 516 SHK-SDVYSFGVLLLEMLTGKAPLQSP 541
             K +DV+S GV L  ML G  P + P
Sbjct: 194 DGKVADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/183 (21%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+  + +HPN++ L   + +K + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS-------DFGLT-- 489
           +   + L     GV ++HS    +  H ++K  N+++   LD  +        DFG+   
Sbjct: 115 DEATQFLKQILDGVHYLHS---KRIAHFDLKPENIML---LDKNVPNPRIKLIDFGIAHK 168
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEAGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 29/228 (12%)
Query: 345 VLGKGSYGTAY--KAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQ--HPNVVPLR 400
           VLGKGS+G     K  +                   D E  +  V  + Q  HPN+  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            ++  K    LV + +  G L   +       R         +I+     G+ + H    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARIIRQVLSGITYXHK--- 144
Query: 461 PKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK 514
            K  H ++K  N+L+   ++D +  I DFGL+             G   Y APEV+    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHG-T 203
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRW 552
           +  K DV+S GV+L  +L+G  P       D++          +LP+W
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/183 (21%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+  + +HPN++ L   + +K + +L+ +  + G L   L     A +  L  
Sbjct: 75  EIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTE 128
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS-------DFGLT-- 489
           +   + L     GV ++HS    +  H ++K  N+++   LD  +        DFG+   
Sbjct: 129 DEATQFLKQILDGVHYLHS---KRIAHFDLKPENIML---LDKNVPNPRIKLIDFGIAHK 182
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 183 IEAGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 238
Query: 545 DMV 547
           + +
Sbjct: 239 ETL 241

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD-----FEQQMEIVGRVG 391
           DLLR    V+G+GSY       L+++                D      + +  +  +  
Sbjct: 12  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
            HP +V L + + ++     V +Y   G L  + H  R   +  L  E         +  
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLA 122
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAG---YRAP 507
           + ++H  G     + ++K  NVL++ +    ++D+G+      P  T S   G   Y AP
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           E++    +    D ++ GVL+ EM+ G++P 
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/183 (21%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+  + +HPN++ L   + +K + +L+ +  + G L   L     A +  L  
Sbjct: 54  EIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTE 107
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS-------DFGLT-- 489
           +   + L     GV ++HS    +  H ++K  N+++   LD  +        DFG+   
Sbjct: 108 DEATQFLKQILDGVHYLHS---KRIAHFDLKPENIML---LDKNVPNPRIKLIDFGIAHK 161
Query: 490 -----PLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 162 IEAGNEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217
Query: 545 DMV 547
           + +
Sbjct: 218 ETL 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 330 SYNFDLEDLLRASAEVLGKGSYG---TAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEI 386
           S++   ED+ +   +VLG+G++    T    +  +                R F +++E+
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-REVEM 63
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +   H NV+ L  ++  +D   LV++    GS+ + +H  R       + E  V ++ 
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEASV-VVQ 118
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA------- 496
             A  +  +H+ G     H ++K  N+L    NQ     I DF L   + +         
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 497 ----TPSRSAGYRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
               TP  SA Y APEV+E        +  + D++S GV+L  +L+G  P 
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 111/262 (42%), Gaps = 53/262 (20%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL------------H 426
           DF+++  ++     +PN+V L           L+++Y A G L+  L            H
Sbjct: 96  DFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154
Query: 427 GNRGA-------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL 479
            +          G  PL    ++ I    A G+A++      KF H ++   N L+ +++
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 211
Query: 480 DGCISDFGLTPLMNVPATPSRSAG--------YRAPEVIETRKHSHKSDVYSFGVLLLEM 531
              I+DFGL+   N+ +     A         +  PE I   +++ +SDV+++GV+L E+
Sbjct: 212 VVKIADFGLS--RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 532 LT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF-QNIEEEMVQMLQIGMA 589
            + G  P                  +  EE    V D  ++   +N   E+  ++++   
Sbjct: 270 FSYGLQPY---------------YGMAHEEVIYYVRDGNILACPENCPLELYNLMRL--- 311
Query: 590 CVAKVPDMRPNMDEVVRMIEEV 611
           C +K+P  RP+   + R+++ +
Sbjct: 312 CWSKLPADRPSFCSIHRILQRM 333

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 402 YYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
           Y +  D  L LV DY+  G L TLL  ++   R P   E   +  L  A  V  I S+  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLP---EEMARFYL--AEMVIAIDSVHQ 193
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFG-LTPLMNVPATPSRSA----GYRAPEVIETR-- 513
             + H +IK  N+L++ +    ++DFG    LM      S  A     Y +PE+++    
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 514 ---KHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
              ++  + D +S GV + EML G+ P  + +
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 94/262 (35%), Gaps = 53/262 (20%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
           +++I+  +GQH N+V L          L++ +Y   G L   L        T   +    
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 443 KILLGTARGVAHIHS--------MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMN 493
             L  + R + H  S        +      H ++ A NVL+       I DFGL   +MN
Sbjct: 159 STL--STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 494 -----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
                V         + APE I    ++ +SDV+S+G+LL E+ + G  P      +   
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274
Query: 548 DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ----------IGMACVAKVPDM 597
                                   +F  + ++  QM Q          I  AC A  P  
Sbjct: 275 ------------------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTH 310
Query: 598 RPNMDEVVRMIEEVRQSDSENR 619
           RP   ++   ++E  Q D   R
Sbjct: 311 RPTFQQICSFLQEQAQEDRRER 332

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I  FGL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 18/228 (7%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQM--EI-VGRVGQHPNVVPLR 400
           E +G+G+YGT +KA   E+                        EI + +  +H N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              +S  +  LV++ F    L        G     LD E     L    +G+   HS   
Sbjct: 68  DVLHSDKKLTLVFE-FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK-H 515
               H ++K  N+LIN++ +  +++FGL     +P    +    +  YR P+V+   K +
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 516 SHKSDVYSFGVLLLEMLTGKAPL--QSPTRDDMVDLPRWVQSVVREEW 561
           S   D++S G +  E+     PL   +   D +  + R + +   E+W
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I DF L    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 91
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 206
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 256
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 257 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 296

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 78
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 139 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 193
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 243
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 244 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 69/311 (22%), Positives = 127/311 (40%), Gaps = 47/311 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 84
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 199
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 249
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP--S 621
            + D    +  N  + + +++++   C    P MRP+  E++  I+E  +          
Sbjct: 250 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 302
Query: 622 SEENKSKDSNV 632
           SEENK +++ V
Sbjct: 303 SEENKMENNPV 313

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I D GL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 85
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 200
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 250
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 251 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 290

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKH 515
           F H ++ A NVL+       ISDFGL+  +       ++         + APE I   K 
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 516 SHKSDVYSFGVLLLEMLT-GKAPLQ 539
           S KSDV+SFGVL+ E  + G+ P +
Sbjct: 550 SSKSDVWSFGVLMWEAFSYGQKPYR 574

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-------AGYRAPEVIETRKH 515
           F H ++ A NVL+       ISDFGL+  +       ++         + APE I   K 
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 516 SHKSDVYSFGVLLLEMLT-GKAPLQ 539
           S KSDV+SFGVL+ E  + G+ P +
Sbjct: 551 SSKSDVWSFGVLMWEAFSYGQKPYR 575

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 82
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 143 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 197
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 198 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 247
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 248 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 287

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 113
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 174 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 228
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 229 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 278
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 279 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 318

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I D GL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 84
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N ++ +D    I DFG+T   ++  T     G        +
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 199
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 249
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + + +++++   C    P MRP+  E++  I+E
Sbjct: 250 GLLD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 289

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  H NV+ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI-------SDFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  H NV+ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI-------SDFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  H NV+ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI-------SDFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  H NV+ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI-------SDFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 335 LEDLLRASAEVLGKGSYGTAYKAV-LEESTTXXXXXXXXXXXXXRD-FEQQMEIVGRVGQ 392
            ED+ + ++E+LG+G+Y     AV L+                 R    +++E + +   
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           + N++ L  ++       LV++    GS+  L H  +   +   +     +++   A  +
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSI--LAHIQK---QKHFNEREASRVVRDVAAAL 124
Query: 453 AHIHSMGGPKFTHGNIKASNVLIN-----QDLDGCISDFG--------LTPLMNVP-ATP 498
             +H+ G     H ++K  N+L         +  C  D G         TP+      TP
Sbjct: 125 DFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 499 SRSAGYRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKAPL 538
             SA Y APEV+E        +  + D++S GV+L  ML+G  P 
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 62/149 (41%), Gaps = 13/149 (8%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +H N+V L      K    LV+++     L  L     G     LD++   K L     G
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQIING 136
Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----PSRSAGYRAP 507
           +   HS       H +IK  N+L++Q     + DFG    +  P         +  YRAP
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 508 E-VIETRKHSHKSDVYSFGVLLLEMLTGK 535
           E ++   K+    DV++ G L+ EM  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 44/258 (17%)
Query: 383 QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA----------- 431
           +++I+  +GQH N+V L          L++ +Y   G L   L     A           
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 432 --------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI 483
                   GR PL+    +      A+G+A + S       H ++ A NVL+       I
Sbjct: 144 PEGLDKEDGR-PLELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKI 199
Query: 484 SDFGLT-PLMN-----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            DFGL   +MN     V         + APE I    ++ +SDV+S+G+LL E+ +    
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---- 255
Query: 538 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDM 597
                    + L  +   +V  ++   V D   M       +   +  I  AC A  P  
Sbjct: 256 ---------LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK--NIYSIMQACWALEPTH 304
Query: 598 RPNMDEVVRMIEEVRQSD 615
           RP   ++   ++E  Q D
Sbjct: 305 RPTFQQICSFLQEQAQED 322

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPE 508
           RG+ +IHS       H ++K SN+ +N+D +  I D GL    +   T   +   YRAPE
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPE 192
Query: 509 VIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
           ++    H +++ D++S G ++ E+LTG+ 
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 120 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 170
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 171 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 110 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 110 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 135 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 185
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 186 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 117 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 167
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 168 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 230
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 231 THQSDVWSYGVTVWELMT 248

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 111 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 161
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 162 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 30/183 (16%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E+++ I+ +V  H NV+ L   Y ++ + +L+ +  + G L   L     A +  L  
Sbjct: 61  EIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSE 114
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS-------DFGL--- 488
           E     +     GV ++H+    K  H ++K  N+++   LD  I        DFGL   
Sbjct: 115 EEATSFIKQILDGVNYLHT---KKIAHFDLKPENIML---LDKNIPIPHIKLIDFGLAHE 168
Query: 489 ----TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
                   N+  TP     + APE++       ++D++S GV+   +L+G +P    T+ 
Sbjct: 169 IEDGVEFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 545 DMV 547
           + +
Sbjct: 225 ETL 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 110 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 114 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 164
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 165 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 197
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 198 THQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 506
           G+ H+H        + ++K  NVL++ D +  ISD GL   +    T ++    + G+ A
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           PE++   ++    D ++ GV L EM+  + P ++
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 194 THQSDVWSYGVTVWELMT 211

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 199
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 200 THQSDVWSYGVTVWELMT 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 346 LGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVV 397
           LG+GS+G  Y+ V      +E  T             R+   F  +  ++     H +VV
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 78
Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR-----TPLDWETRVKILLGTARGV 452
            L          L++ +    G L + L   R          P      +++    A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------Y 504
           A++++    KF H ++ A N  + +D    I DFG+T   ++  T     G        +
Sbjct: 139 AYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMT--RDIYETDYYRKGGKGLLPVRW 193
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
            +PE ++    +  SDV+SFGV+L E+ T  + P Q  +           + V+R     
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------EQVLRFVMEG 243
Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            + D    +  N  + +++++++   C    P MRP+  E++  I+E
Sbjct: 244 GLLD----KPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIKE 283

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFGL  L+        + G + P      E I  R +
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 202
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 203 THQSDVWSYGVTVWELMT 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 506
           G+ H+H        + ++K  NVL++ D +  ISD GL   +    T ++    + G+ A
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           PE++   ++    D ++ GV L EM+  + P ++
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 104 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FGL  L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 506
           G+ H+H        + ++K  NVL++ D +  ISD GL   +    T ++    + G+ A
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           PE++   ++    D ++ GV L EM+  + P ++
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 105/278 (37%), Gaps = 50/278 (17%)
Query: 288 NGSNGVSKGKASSGGRSEK-------------PKEEFGSGVQEPEKNKLVFFEGCSYNFD 334
            GS  VS G+A S     K             P+ E   GV   EK K V      Y + 
Sbjct: 14  QGSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPV-----DYEYR 68
Query: 335 LEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
            E         LG+GS+G  ++  +++  T                E+ +   G     P
Sbjct: 69  EEVHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEELVACAGL--SSP 124
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVA 453
            +VPL           +  +    GSL  L+   +  G  P   E R    LG A  G+ 
Sbjct: 125 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLE 178
Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMN-------------VPATPS 499
           ++H+    +  HG++KA NVL++ D     + DFG    +              +P T +
Sbjct: 179 YLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
               + APEV+  +    K D++S   ++L ML G  P
Sbjct: 236 ----HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/94 (26%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRA 506
           G+ H+H        + ++K  NVL++ D +  ISD GL   +    T ++    + G+ A
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           PE++   ++    D ++ GV L EM+  + P ++
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 132 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 128 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---- 500
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  +    A P      
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARV----ADPDHDHTG 182
Query: 501 -------SAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
                  +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 128 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 184
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 185 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 132 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 189 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 134 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 135 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 126 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 190
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 191 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 135 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXE 191
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 192 XVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 138 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 195 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 130 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 187 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 190
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----- 499
           L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +     
Sbjct: 150 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 500 --RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
              +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 207 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 21/167 (12%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTAR 450
           +HP +  L+  + + D    V +Y   G L   L   R         E R +        
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAEIVS 262
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSA 502
            + ++HS       + ++K  N+++++D    I+DFGL          +     TP    
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE--- 317
Query: 503 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
            Y APEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 318 -YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 363

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 149 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 21/167 (12%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTAR 450
           +HP +  L+  + + D    V +Y   G L   L   R         E R +        
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAEIVS 259
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL--------TPLMNVPATPSRSA 502
            + ++HS       + ++K  N+++++D    I+DFGL          +     TP    
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE--- 314
Query: 503 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
            Y APEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 315 -YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
           KI +   + + H+HS       H ++K SNVLIN      + DFG++  +      +  A
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 503 G---YRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           G   Y APE I      + +S KSD++S G+ ++E+   + P  S
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 259

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 63  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 119
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 120 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 176
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 177 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 64  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 120
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 121 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 177
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 178 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 226

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 65  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 121
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 122 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 178
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 179 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 227

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 58  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 114
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 115 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 171
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 172 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 57  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 113
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 114 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 171 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 73  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 129
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 130 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 186
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 187 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 235

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 159
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 160 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 115
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 173 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 11/100 (11%)
Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS---- 499
            L    RG+ +IHS       H ++K SN+L+N   D  I DFGL  + +     +    
Sbjct: 131 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 500 ---RSAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGK 535
               +  YRAPE++   K   KS D++S G +L EML+ +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAV---------LEESTTXXXXXXXXXXXXXRDFEQQMEI 386
           EDL+    E LG+G++   +K V         L E+                 F +   +
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  H ++V      +  DE +LV ++   GSL T L  N+      + W+  V   L
Sbjct: 66  MSKLS-HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQL 122
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--------CISDFGLTPLMNVPATP 498
             A     +H +      HGN+ A N+L+ ++ D          +SD G++  +      
Sbjct: 123 AWA-----MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 499 SRSAGYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTG 534
                +  PE IE  K+ +  +D +SFG  L E+ +G
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---- 500
           +  T R V  +H   G    H ++K SN+LIN + D  + DFGL  +++  A  +     
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 501 ----------SAGYRAPEVIETR-KHSHKSDVYSFGVLLLEML 532
                     +  YRAPEV+ T  K+S   DV+S G +L E+ 
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---- 500
           +  T R V  +H   G    H ++K SN+LIN + D  + DFGL  +++  A  +     
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 501 ----------SAGYRAPEVIETR-KHSHKSDVYSFGVLLLEML 532
                     +  YRAPEV+ T  K+S   DV+S G +L E+ 
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---- 500
           +  T R V  +H   G    H ++K SN+LIN + D  + DFGL  +++  A  +     
Sbjct: 118 IYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 501 ----------SAGYRAPEVIETR-KHSHKSDVYSFGVLLLEML 532
                     +  YRAPEV+ T  K+S   DV+S G +L E+ 
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 109 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 165
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 166 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 222
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 223 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 271

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 115
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 173 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 13/163 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTAR 450
           +HP +  L+  + + D    V +Y   G L   L   R         E R +        
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAEIVS 119
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRA 506
            + ++HS       + ++K  N+++++D    I+DFGL    +   AT     G   Y A
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           PEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
           KI +   + + H+HS       H ++K SNVLIN      + DFG++  +         A
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 503 G---YRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
           G   Y APE I      + +S KSD++S G+ ++E+   + P  S
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 18/220 (8%)
Query: 335 LEDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHP 394
           L D     +E LG+G+    Y+   + +               +    ++ ++ R+  HP
Sbjct: 51  LSDFFEVESE-LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HP 108
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSL-STLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           N++ L+  + +  E  LV +    G L   ++     + R   D    VK +L     VA
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD---AVKQIL---EAVA 162
Query: 454 HIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMN---VPATPSRSAGYRAP 507
           ++H  G     H ++K  N+L      D    I+DFGL+ ++    +  T   + GY AP
Sbjct: 163 YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           E++    +  + D++S G++   +L G  P      D  +
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 13/163 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTAR 450
           +HP +  L+  + + D    V +Y   G L   L   R         E R +        
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAEIVS 120
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRA 506
            + ++HS       + ++K  N+++++D    I+DFGL    +   AT     G   Y A
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 178
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           PEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 105/277 (37%), Gaps = 50/277 (18%)
Query: 289 GSNGVSKGKASSGGRSEK-------------PKEEFGSGVQEPEKNKLVFFEGCSYNFDL 335
           GS  VS G+A S     K             P+ E   GV   EK K V      Y +  
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPV-----DYEYRE 55
Query: 336 EDLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPN 395
           E         +G+GS+G  ++  +++  T                E+ +   G     P 
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVEELVACAGL--SSPR 111
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA-RGVAH 454
           +VPL           +  +    GSL  L+   +  G  P   E R    LG A  G+ +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEY 165
Query: 455 IHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMN-------------VPATPSR 500
           +H+    +  HG++KA NVL++ D     + DFG    +              +P T + 
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET- 221
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
              + APEV+  +    K D++S   ++L ML G  P
Sbjct: 222 ---HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 13/163 (7%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL-LGTAR 450
           +HP +  L+  + + D    V +Y   G L   L   R         E R +        
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAEIVS 121
Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL-MNVPATPSRSAG---YRA 506
            + ++HS       + ++K  N+++++D    I+DFGL    +   AT     G   Y A
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLA 179
Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           PEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 200 NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 257
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVP 495
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 258 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 496 ATPSRSAG---YRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +      G   Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/167 (23%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 381 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
           E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+           
Sbjct: 188 ETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NV 494
              +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   ++
Sbjct: 246 YQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 495 PATPSRSAGYRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             T   +  Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVP 495
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 119 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 496 ATPSRSAG---YRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +      G   Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--- 492
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 119 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 493 NVPATPSRSAGYRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++  T   +  Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 75/209 (35%), Gaps = 26/209 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVG---QHPNVVPLR 400
           E LGKG++    + V +  T                  Q++E   R+    +HPN+V L 
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 96
Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                +    LV+D    G L   +       R           +      V HIH    
Sbjct: 97  DSISEEGFHYLVFDLVTGGELFEDI-----VAREYYSEADASHCIHQILESVNHIHQH-- 149
Query: 461 PKFTHGNIKASNVLINQDLDGC---ISDFGLT--------PLMNVPATPSRSAGYRAPEV 509
               H ++K  N+L+     G    ++DFGL                TP    GY +PEV
Sbjct: 150 -DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP----GYLSPEV 204
Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +    +    D+++ GV+L  +L G  P 
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 60  NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 117
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--- 492
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 118 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 493 NVPATPSRSAGYRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++  T   +  Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 61  NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--- 492
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 119 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 493 NVPATPSRSAGYRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           ++  T   +  Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ---QMEIVGRVGQHPNVVPLR 400
           E LG G +G   + + +++               ++ E+   +++I+ ++  HPNVV  R
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAR 79
Query: 401 AY------YYSKDEKLLVYDYFASGSLSTLLHGNR---GAGRTPLDWETRVKILLGTARG 451
                       D  LL  +Y   G L   L+      G    P+       +L   +  
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-----TLLSDISSA 134
Query: 452 VAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPATPSRSAG---YR 505
           + ++H     +  H ++K  N+++    Q L   I D G    ++     +   G   Y 
Sbjct: 135 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           APE++E +K++   D +SFG L  E +TG  P 
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 344 EVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ---QMEIVGRVGQHPNVVPLR 400
           E LG G +G   + + +++               ++ E+   +++I+ ++  HPNVV  R
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAR 78
Query: 401 AY------YYSKDEKLLVYDYFASGSLSTLLHGNR---GAGRTPLDWETRVKILLGTARG 451
                       D  LL  +Y   G L   L+      G    P+       +L   +  
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-----TLLSDISSA 133
Query: 452 VAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPATPSRSAG---YR 505
           + ++H     +  H ++K  N+++    Q L   I D G    ++     +   G   Y 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           APE++E +K++   D +SFG L  E +TG  P 
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 77/169 (45%), Gaps = 19/169 (11%)
Query: 379 DFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW 438
           + E ++EI+ ++  HP ++ ++ ++ ++D   +V +    G L   + GN+         
Sbjct: 67  NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL 124
Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVP 495
                +L      V ++H  G     H ++K  NVL++   + C   I+DFG + ++   
Sbjct: 125 YFYQMLL-----AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 496 ATPSRSAG---YRAPEV---IETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +      G   Y APEV   + T  ++   D +S GV+L   L+G  P 
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 96/246 (39%), Gaps = 37/246 (15%)
Query: 307 PKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTXX 366
           P+ E   GV   EK K V      Y +  E         +G+GS+G  ++  +++  T  
Sbjct: 48  PETEDNEGVLLTEKLKPV-----DYEYREEVHWMTHQPRVGRGSFGEVHR--MKDKQTGF 100
Query: 367 XXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLH 426
                         E+ +   G     P +VPL           +  +    GSL  L+ 
Sbjct: 101 QCAVKKVRLEVFRVEELVACAGL--SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI- 157
Query: 427 GNRGAGRTPLDWETRVKILLGTA-RGVAHIHSMGGPKFTHGNIKASNVLINQDLD-GCIS 484
             +  G  P   E R    LG A  G+ ++H+    +  HG++KA NVL++ D     + 
Sbjct: 158 --KQMGCLP---EDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 209
Query: 485 DFGLTPLMN-------------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEM 531
           DFG    +              +P T +    + APEV+  +    K D++S   ++L M
Sbjct: 210 DFGHALCLQPDGLGKSLLTGDYIPGTET----HMAPEVVMGKPCDAKVDIWSSCCMMLHM 265
Query: 532 LTGKAP 537
           L G  P
Sbjct: 266 LNGCHP 271

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A+G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R  
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 561
               APE I  R ++ +SDV+SFGVLL E+ +  A   SP     +D          EE+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKID----------EEF 305
Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
              + +   MR  +      +M Q  + C    P  RP   E+V  +  + Q++++
Sbjct: 306 CRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 26/178 (14%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A+G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R  
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
               APE I  R ++ +SDV+SFGVLL E+ + G +P      D              EE
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 311
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
           +   + +   MR  +      +M Q  + C    P  RP   E+V  +  + Q++++ 
Sbjct: 312 FCRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 367

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 26/178 (14%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-- 505
            A+G+  + S    K  H ++ A N+L+++     I DFGL   +       R    R  
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 506 ----APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE 560
               APE I  R ++ +SDV+SFGVLL E+ + G +P      D              EE
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EE 309
Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
           +   +   E  R +  +    +M Q  + C    P  RP   E+V  +  + Q++++ 
Sbjct: 310 FCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 365

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 16/228 (7%)
Query: 324 VFFEGCSYNFDLE-DLLRASAEVLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRDFEQ 382
           ++F+G   NF+++ D L    E LG+G+YG   K     S               ++ ++
Sbjct: 20  LYFQGAXENFEVKADDLEPIXE-LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKR 78
Query: 383 ---QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
               ++I  R    P  V      + + +  +  +     SL          G+T +  +
Sbjct: 79  LLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQT-IPED 136
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS 499
              KI +   + + H+HS       H ++K SNVLIN        DFG++  +       
Sbjct: 137 ILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD 194
Query: 500 RSAG---YRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
             AG   Y APE I      + +S KSD++S G+  +E+   + P  S
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFG   L+        + G + P      E I  R +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFG   L+        + G + P      E I  R +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFG   L+        + G + P      E I  R +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 198
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 26/138 (18%)
Query: 414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           +Y  +G+L  L+H      +    W    +IL      +++IHS G     H ++K  N+
Sbjct: 95  EYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNI 147
Query: 474 LINQDLDGCISDFGLTPLM------------NVPATPSR------SAGYRAPEVIE-TRK 514
            I++  +  I DFGL   +            N+P +         +A Y A EV++ T  
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 515 HSHKSDVYSFGVLLLEML 532
           ++ K D+YS G++  EM+
Sbjct: 208 YNEKIDMYSLGIIFFEMI 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFG   L+        + G + P      E I  R +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 203
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 204 THQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKH 515
           +  H ++ A NVL+       I+DFG   L+        + G + P      E I  R +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 516 SHKSDVYSFGVLLLEMLT 533
           +H+SDV+S+GV + E++T
Sbjct: 197 THQSDVWSYGVTVWELMT 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 15/114 (13%)
Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           H +    +  L+W  ++      A+G+ ++      +  H ++ A NVL+       I+D
Sbjct: 114 HKDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 164
Query: 486 FGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLLLEMLT 533
           FG   L+        + G + P      E I  R ++H+SDV+S+GV + E++T
Sbjct: 165 FGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 381 EQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
           E ++E++  +  HPN++ +   +       +V +    G L   +   +  G+  L    
Sbjct: 68  EAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGY 125
Query: 441 RVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPA 496
             +++      +A+ HS       H ++K  N+L  QD        I DFGL  L     
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDE 181
Query: 497 TPSRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
             + +AG   Y APEV + R  + K D++S GV++  +LTG  P    + +++
Sbjct: 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 28/217 (12%)
Query: 336 EDLLRASAEVLGKGSYGTAYKAV---------LEESTTXXXXXXXXXXXXXRDFEQQMEI 386
           EDL+    E LG+G++   +K V         L E+                 F +   +
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  H ++V         DE +LV ++   GSL T L  N+      + W+  V   L
Sbjct: 66  MSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQL 122
Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--------CISDFGLTPLMNVPATP 498
             A     +H +      HGN+ A N+L+ ++ D          +SD G++  +      
Sbjct: 123 AAA-----MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 499 SRSAGYRAPEVIETRKHSH-KSDVYSFGVLLLEMLTG 534
                +  PE IE  K+ +  +D +SFG  L E+ +G
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIE 511
           +   K  H ++ A N+L+++     I DFGL   +       R    R      APE I 
Sbjct: 207 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 266
Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 571
            R ++ +SDV+SFGVLL E+ +  A   SP     +D          EE+   + +   M
Sbjct: 267 DRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKID----------EEFCRRLKEGTRM 313
Query: 572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           R  +      +M Q  + C    P  RP   E+V  +  + Q+++
Sbjct: 314 RAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTP--LMNVPATPSR 500
           +GTA    H H++      H ++K  N+L     +D    ++DFG       N   TP  
Sbjct: 118 IGTAIQFLHSHNIA-----HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 172
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           +  Y APEV+   K+    D++S GV++  +L G  P  S T
Sbjct: 173 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 345 VLGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           +LG+G +G  Y+ V      E+                ++      ++ +   HP++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 ++   ++ + +  G L   L  N+ + +      T V   L   + +A++ S+ 
Sbjct: 75  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLESIN 129
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPATPSR-SAGYRAPEVIETRK 514
                H +I   N+L+       + DFGL+  +       A+ +R    + +PE I  R+
Sbjct: 130 C---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 515 HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
            +  SDV+ F V + E+L+ GK P       D++
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTP--LMNVPATPSR 500
           +GTA    H H++      H ++K  N+L     +D    ++DFG       N   TP  
Sbjct: 137 IGTAIQFLHSHNIA-----HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191
Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
           +  Y APEV+   K+    D++S GV++  +L G  P  S T
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/308 (20%), Positives = 114/308 (37%), Gaps = 54/308 (17%)
Query: 343 AEVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFE---QQMEIVGRVGQHP 394
            + LG G++G     TAY  +  ++                + E    +++++  +G H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL--------- 445
           N+V L          L++ +Y   G L   L   R +       +T   I+         
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDL 167
Query: 446 -------LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----- 493
                     A+G+A + S       H ++ A N+L+       I DFGL   +      
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 494 -VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 551
            V         + APE I    ++ +SDV+S+G+ L E+ + G +P      D       
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 279
Query: 552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
               +++E            R  + E    +M  I   C    P  RP   ++V++IE+ 
Sbjct: 280 -FYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK- 327
Query: 612 RQSDSENR 619
           + S+S N 
Sbjct: 328 QISESTNH 335

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 103/234 (44%), Gaps = 28/234 (11%)
Query: 344 EVLGKGSYGTAYKA-------VLEESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNV 396
           + LG+G + T YKA       ++                  R   ++++++  +  HPN+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 74
Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 455
           + L   +  K    LV+D F    L  ++  N     TP    + +K  +L T +G+ ++
Sbjct: 75  IGLLDAFGHKSNISLVFD-FMETDLEVIIKDNSLV-LTP----SHIKAYMLMTLQGLEYL 128
Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVI- 510
           H        H ++K +N+L++++    ++DFGL      P         +  YRAPE++ 
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV---VREEW 561
             R +    D+++ G +L E+L  + P   P   D+  L R  +++     E+W
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPFL-PGDSDLDQLTRIFETLGTPTEEQW 237

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/307 (20%), Positives = 115/307 (37%), Gaps = 54/307 (17%)
Query: 344 EVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFE---QQMEIVGRVGQHPN 395
           + LG G++G     TAY  +  ++                + E    +++++  +G H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL---------- 445
           +V L          L++ +Y   G L   L   R +       +T   I+          
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDLE 145
Query: 446 ------LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN------ 493
                    A+G+A + S       H ++ A N+L+       I DFGL   +       
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 552
           V         + APE I    ++ +SDV+S+G+ L E+ + G +P      D        
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 256
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
              +++E +          R  + E    +M  I   C    P  RP   ++V++IE+ +
Sbjct: 257 FYKMIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK-Q 305
Query: 613 QSDSENR 619
            S+S N 
Sbjct: 306 ISESTNH 312

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 130 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHXVMQEHR 184
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +      G     
Sbjct: 57  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFT 113
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
                +I+      + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 114 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N    P  +  Y APEV+   K+    D++S GV++  +L G  P  S
Sbjct: 171 HNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHXVMQEHR 174
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 345 VLGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           +LG+G +G  Y+ V      E+                ++      ++ +   HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 ++   ++ + +  G L   L  N+ + +      T V   L   + +A++ S+ 
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLESIN 133
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPATPSR-SAGYRAPEVIETRK 514
                H +I   N+L+       + DFGL+  +       A+ +R    + +PE I  R+
Sbjct: 134 C---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 515 HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
            +  SDV+ F V + E+L+ GK P       D++
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 124 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHYVMQEHR 178
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 345 VLGKGSYGTAYKAVL-----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           +LG+G +G  Y+ V      E+                ++      ++ +   HP++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 ++   ++ + +  G L   L  N+ + +      T V   L   + +A++ S+ 
Sbjct: 91  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAMAYLESIN 145
Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPATPSR-SAGYRAPEVIETRK 514
                H +I   N+L+       + DFGL+  +       A+ +R    + +PE I  R+
Sbjct: 146 C---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 515 HSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV 547
            +  SDV+ F V + E+L+ GK P       D++
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 124 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHYVMQEHR 178
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIE-----TRKHS 516
           H ++K SN+L+++     + DFG++  +       RSAG   Y APE I+        + 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
            ++DV+S G+ L+E+ TG+ P ++   D
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTD 235

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 130 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHYVMQEHR 184
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHYVMQEHR 174
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/308 (20%), Positives = 114/308 (37%), Gaps = 54/308 (17%)
Query: 343 AEVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFE---QQMEIVGRVGQHP 394
            + LG G++G     TAY  +  ++                + E    +++++  +G H 
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 110
Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL--------- 445
           N+V L          L++ +Y   G L   L   R +       +T   I+         
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDL 167
Query: 446 -------LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----- 493
                     A+G+A + S       H ++ A N+L+       I DFGL   +      
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 494 -VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 551
            V         + APE I    ++ +SDV+S+G+ L E+ + G +P      D       
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 279
Query: 552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
               +++E            R  + E    +M  I   C    P  RP   ++V++IE+ 
Sbjct: 280 -FYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK- 327
Query: 612 RQSDSENR 619
           + S+S N 
Sbjct: 328 QISESTNH 335

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----- 502
            A G+ ++ S    +F H ++ A N+L+       I DFGL  +  +P            
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL--MRALPQNDDHYVMQEHR 174
Query: 503 ----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                + APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 79/178 (44%), Gaps = 18/178 (10%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLH--GNRGAGRTPLDWETRVKILLGTA 449
           +H N+V L    +++    LV++Y     L   L   GN       ++       L    
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN------IINMHNVKLFLFQLL 110
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYR 505
           RG+A+ H     K  H ++K  N+LIN+  +  ++DFGL    ++P         +  YR
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 506 APEV-IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-LPRWVQSVVREEW 561
            P++ + +  +S + D++  G +  EM TG+      T ++ +  + R + +   E W
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/307 (20%), Positives = 115/307 (37%), Gaps = 54/307 (17%)
Query: 344 EVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFE---QQMEIVGRVGQHPN 395
           + LG G++G     TAY  +  ++                + E    +++++  +G H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL---------- 445
           +V L          L++ +Y   G L   L   R +       +T   I+          
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDLE 161
Query: 446 ------LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN------ 493
                    A+G+A + S       H ++ A N+L+       I DFGL   +       
Sbjct: 162 DLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 552
           V         + APE I    ++ +SDV+S+G+ L E+ + G +P      D        
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 272
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
              +++E +          R  + E    +M  I   C    P  RP   ++V++IE+ +
Sbjct: 273 FYKMIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK-Q 321
Query: 613 QSDSENR 619
            S+S N 
Sbjct: 322 ISESTNH 328

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 64/307 (20%), Positives = 114/307 (37%), Gaps = 54/307 (17%)
Query: 344 EVLGKGSYG-----TAYKAVLEESTTXXXXXXXXXXXXXRDFE---QQMEIVGRVGQHPN 395
           + LG G++G     TAY  +  ++                + E    +++++  +G H N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL---------- 445
           +V L          L++ +Y   G L   L   R +       +T   I+          
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDLE 163
Query: 446 ------LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN------ 493
                    A+G+A + S       H ++ A N+L+       I DFGL   +       
Sbjct: 164 DLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRW 552
           V         + APE I    ++ +SDV+S+G+ L E+ + G +P      D        
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 274
Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
              +++E            R  + E    +M  I   C    P  RP   ++V++IE+ +
Sbjct: 275 FYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK-Q 323
Query: 613 QSDSENR 619
            S+S N 
Sbjct: 324 ISESTNH 330

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 75/210 (35%), Gaps = 28/210 (13%)
Query: 344 EVLGKGSYGTAYKAVL----EESTTXXXXXXXXXXXXXRDFEQQMEIVGRVGQHPNVVPL 399
           E +GKG++    + V      E                +  E++  I  R+ +H N+V L
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARIC-RLLKHSNIVRL 68
Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
                 +    LV+D    G L   +       R           +      V H H MG
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDI-----VAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 460 GPKFTHGNIKASNVLINQDLDGC---ISDFGLT--------PLMNVPATPSRSAGYRAPE 508
                H ++K  N+L+     G    ++DFGL                TP    GY +PE
Sbjct: 124 ---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP----GYLSPE 176
Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           V+    +    D+++ GV+L  +L G  P 
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 19/151 (12%)
Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGR---TPLDWETRVKILLGT 448
           +HPN+V L   +  K    LV++Y     L  L    RG        + W+T        
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL------Q 113
Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----TPSRSAGY 504
           A    H H+       H ++K  N+LI +     + DFG   L+  P+        +  Y
Sbjct: 114 AVNFCHKHNC-----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 505 RAPE-VIETRKHSHKSDVYSFGVLLLEMLTG 534
           R+PE ++   ++    DV++ G +  E+L+G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           L  ++H ++     PL  E     L    RG+ ++HS    +  H ++K SN+L+N++ +
Sbjct: 146 LHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCE 197
Query: 481 GCISDFGLTP-LMNVPATPS-------RSAGYRAPEV-IETRKHSHKSDVYSFGVLLLEM 531
             I DFG+   L   PA           +  YRAPE+ +   +++   D++S G +  EM
Sbjct: 198 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 257
Query: 532 LTGK 535
           L  +
Sbjct: 258 LARR 261

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 382 QQMEIVGRVGQHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD 437
           +++E+  R  Q P++V +       Y  +   L+V +    G L + +  +RG       
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQ-DRGDQAFTER 161
Query: 438 WETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI---SDFGL---TPL 491
             + +   +G A  + ++HS+      H ++K  N+L        I   +DFG    T  
Sbjct: 162 EASEIXKSIGEA--IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 492 MNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS 540
            N   TP  +  Y APEV+   K+    D +S GV+   +L G  P  S
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYS 265

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
           L  ++H ++     PL  E     L    RG+ ++HS    +  H ++K SN+L+N++ +
Sbjct: 145 LHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCE 196
Query: 481 GCISDFGLTP-LMNVPATPS-------RSAGYRAPEV-IETRKHSHKSDVYSFGVLLLEM 531
             I DFG+   L   PA           +  YRAPE+ +   +++   D++S G +  EM
Sbjct: 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256
Query: 532 LTGK 535
           L  +
Sbjct: 257 LARR 260

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 14/129 (10%)
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVPATPSR-------- 500
           RG+ +IHS       H ++K +N+ IN +DL   I DFGL  +M+ P    +        
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHLSEGLV 186
Query: 501 SAGYRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 559
           +  YR+P ++ +  +  K+ D+++ G +  EMLTGK         + + L      VV E
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 560 EWTAEVFDV 568
           E   E+  V
Sbjct: 247 EDRQELLSV 255

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 33/246 (13%)
Query: 321 NKLVFFEGCSYNFDLE-DLLRASAE---VLGKGSYG-----TAY---KAVLEESTTXXXX 368
           N+  + +   Y +DL+ +  R + E   VLG G++G     TAY   K  +         
Sbjct: 24  NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 83
Query: 369 XXXXXXXXXRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN 428
                         +++++ ++G H N+V L           L+++Y   G L   L   
Sbjct: 84  KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 429 RGA-GRTPLDWETRVKI-------------LLGTARGVAH-IHSMGGPKFTHGNIKASNV 473
           R       +++E + ++             LL  A  VA  +  +      H ++ A NV
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203
Query: 474 LINQDLDGCISDFGLT-PLMN-----VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVL 527
           L+       I DFGL   +M+     V         + APE +    ++ KSDV+S+G+L
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 528 LLEMLT 533
           L E+ +
Sbjct: 264 LWEIFS 269

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 392 QHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
           +HPNVV L          ++ KL +        L+T L      G   +  ET   ++  
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQ 128
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGY 504
             RG+  +HS    +  H ++K  N+L+       ++DFGL  + +     +    +  Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           RAPEV+    ++   D++S G +  EM   K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 392 QHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
           +HPNVV L          ++ KL +        L+T L      G   +  ET   ++  
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQ 128
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGY 504
             RG+  +HS    +  H ++K  N+L+       ++DFGL  + +     +    +  Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           RAPEV+    ++   D++S G +  EM   K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 13/85 (15%)
Query: 464 THGNIKASNVLINQDLDGCISDFG---------LTPLMNVPATPSRSAGYRAPEVIETRK 514
           TH ++K  N+L++ D    + DFG         LT L N   T      Y APE      
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT----LYYXAPERFSESH 211
Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQ 539
            ++++D+Y+   +L E LTG  P Q
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQ 236

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 20/212 (9%)
Query: 345 VLGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVVPLRA 401
            +G+GS+G   K  +++ T               D   F+Q++EI+  +  HPN++ L  
Sbjct: 33  TIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYE 90
Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            +    +  LV +    G L       R   +         +I+      VA+ H +   
Sbjct: 91  TFEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDVLSAVAYCHKLN-- 143
Query: 462 KFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKH 515
              H ++K  N L   D       + DFGL              G   Y +P+V+E   +
Sbjct: 144 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y 201
Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
             + D +S GV++  +L G  P  +PT  +++
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 233

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +GQH +VV   + +   D  L+  +Y   GSL+  +  N        + E +  +LL   
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVG 121
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQ-----------DLDGC--------ISDFGLTP 490
           RG+ +IHSM      H +IK SN+ I++           D D          I D G   
Sbjct: 122 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 178
Query: 491 LMNVPATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            ++ P      + + A EV+ E   H  K+D+++  + ++    G  PL
Sbjct: 179 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXA-AGAEPL 226

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 392 QHPNVVPL----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
           +HPNVV L          ++ KL +        L+T L      G   +  ET   ++  
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQ 128
Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---SAGY 504
             RG+  +HS    +  H ++K  N+L+       ++DFGL  + +     +    +  Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           RAPEV+    ++   D++S G +  EM   K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 20/211 (9%)
Query: 346 LGKGSYGTAYKAVLEESTTXXXXXXXXXXXXXRD---FEQQMEIVGRVGQHPNVVPLRAY 402
           +G+GS+G   K  +++ T               D   F+Q++EI+  +  HPN++ L   
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYET 74
Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           +    +  LV +    G L       R   +         +I+      VA+ H +    
Sbjct: 75  FEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--- 126
Query: 463 FTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHS 516
             H ++K  N L   D       + DFGL              G   Y +P+V+E   + 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 185
Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
            + D +S GV++  +L G  P  +PT  +++
Sbjct: 186 PECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 216

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +GQH +VV   + +   D  L+  +Y   GSL+  +  N        + E +  +LL   
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVG 123
Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQ-----------DLDGC--------ISDFGLTP 490
           RG+ +IHSM      H +IK SN+ I++           D D          I D G   
Sbjct: 124 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 491 LMNVPATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
            ++ P      + + A EV+ E   H  K+D+++  + ++    G  PL
Sbjct: 181 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPL 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 27/170 (15%)
Query: 382 QQMEIVGRVGQHPNVVPLRAYYY--SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWE 439
           Q++ I+ ++  HPNVV L       ++D   +V++    G +  +          PL  +
Sbjct: 85  QEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPLSED 137
Query: 440 TRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP--------L 491
                     +G+ ++H     K  H +IK SN+L+ +D    I+DFG++         L
Sbjct: 138 QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 492 MNVPATPSRSAGYRAPEVI-ETRK-HSHKS-DVYSFGVLLLEMLTGKAPL 538
            N   TP+    + APE + ETRK  S K+ DV++ GV L   + G+ P 
Sbjct: 195 SNTVGTPA----FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	635
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-68
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-52
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-43
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-39
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-30
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-26
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-28
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-26
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-12
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-19
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-09
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-13
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-19
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-08
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-04
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-17
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-04
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-05
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-14
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-12
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  252 bits (646), Expect = 7e-79
 Identities = 106/291 (36%), Positives = 169/291 (58%), Gaps = 17/291 (5%)

Query: 333 FDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQME 385
           F L +L  A     +  +LG+G +G  YK  L + T V VKRLKE     G+  F+ ++E
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           ++     H N++ LR +  +  E+LLVY Y A+GS+++ L   R   + PLDW  R +I 
Sbjct: 80  MISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIA 137

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--PSRSAG 503
           LG+ARG+A++H    PK  H ++KA+N+L++++ +  + DFGL  LM+   T   +   G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMVDLPRWVQSVVR 558
              + APE + T K S K+DV+ +GV+LLE++TG+          DD V L  WV+ +++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
           E+    + DV+L +    +EE+ Q++Q+ + C    P  RP M EVVRM+E
Sbjct: 258 EKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  225 bits (575), Expect = 1e-68
 Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 26/318 (8%)

Query: 312 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRA-----SAEVLGKGSYGTAYKAVLEESTTVV 366
            +       +        SY   L DL  A        ++G G +G  YK VL +   V 
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 367 VKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 425
           +KR       G  +FE ++E +    +HP++V L  +   ++E +L+Y Y  +G+L   L
Sbjct: 68  LKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126

Query: 426 HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD 485
           +G        + WE R++I +G ARG+ ++H+       H ++K+ N+L++++    I+D
Sbjct: 127 YG-SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD 182

Query: 486 FGLTPLM----------NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
           FG++              V  T     GY  PE     + + KSDVYSFGV+L E+L  +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTL----GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 536 APLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
           + +      +MV+L  W           ++ D   +  +   E + +     + C+A   
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLALSS 297

Query: 596 DMRPNMDEVVRMIEEVRQ 613
           + RP+M +V+  +E   +
Sbjct: 298 EDRPSMGDVLWKLEYALR 315

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  220 bits (562), Expect = 6e-67
 Identities = 89/295 (30%), Positives = 144/295 (48%), Gaps = 25/295 (8%)

Query: 332 NFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEI 386
           NFD E  +      +G+G +G  YK  +   TTV VK+L  +V       K+ F+Q++++
Sbjct: 26  NFD-ERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKV 83

Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + +  QH N+V L  +    D+  LVY Y  +GSL   L    G    PL W  R KI  
Sbjct: 84  MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQ 140

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT---PSRSAG 503
           G A G+  +H        H +IK++N+L+++     ISDFGL       A     SR  G
Sbjct: 141 GAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 560
              Y APE +   + + KSD+YSFGV+LLE++TG   +    R+    L    + +  EE
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV-DEHREPQ-LLLDIKEEIEDEE 254

Query: 561 WT-AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
            T  +  D ++         +  M  +   C+ +  + RP++ +V ++++E+  S
Sbjct: 255 KTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  198 bits (504), Expect = 3e-58
 Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 40/319 (12%)

Query: 330 SYNFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM 384
             +   E+L   S      EV  +G +G  +KA L     V VK            E ++
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYEV 69

Query: 385 EIVGRVGQHPNVVPLRAY----YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
             +  + +H N++              +  L+  +   GSLS  L  N       + W  
Sbjct: 70  YSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122

Query: 441 RVKILLGTARGVAHIHSMGG-------PKFTHGNIKASNVLINQDLDGCISDFGLTPLMN 493
              I    ARG+A++H           P  +H +IK+ NVL+  +L  CI+DFGL     
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 494 VPATPSRS------AGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT 542
              +   +        Y APEV+E      R    + D+Y+ G++L E+ +       P 
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 543 RDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ-----NIEEEMVQMLQIGMACVAKVPDM 597
            + M+     +      E   EV   +  R            M  + +    C     + 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 598 RPNMDEVVRMIEEVRQSDS 616
           R +   V   I ++++  +
Sbjct: 303 RLSAGCVGERITQMQRLTN 321

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  180 bits (460), Expect = 5e-52
 Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 13/191 (6%)

Query: 28  NSDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG 83
             D+QALL     + +   L +W  T   C  +W+G+ C  D    RV  L L G+ L  
Sbjct: 5   PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 84  --PIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 139
             PIP++ L  L  L  L +   N L G +P  I  L  L YLY+ H N SG IP   S 
Sbjct: 65  PYPIPSS-LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKL-RHLNLSY 195
              LV LD S+N+ +G +P SI +L  L G++   N +SG+IP+      KL   + +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 196 NGLKGSIPSSL 206
           N L G IP + 
Sbjct: 184 NRLTGKIPPTF 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  144 bits (366), Expect = 8e-39
 Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 27/151 (17%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS 139
           L G IP  T   L+ L  + L  N+L G       S  + + ++L  N+ +  +     S
Sbjct: 186 LTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 199
             L  LDL  N   G +PQ +  L  L                        LN+S+N L 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLH----------------------SLNVSFNNLC 281

Query: 200 GSIPSS--LQKFPNSSFVGNSLLCGPPLKAC 228
           G IP    LQ+F  S++  N  LCG PL AC
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  167 bits (426), Expect = 2e-47
 Identities = 72/297 (24%), Positives = 134/297 (45%), Gaps = 27/297 (9%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH 393
           D +++     EV+G+G++G   KA    +  V +K+++     ++ F  ++  + RV  H
Sbjct: 6   DYKEIEVE--EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRV-NH 60

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           PN+V L       +   LV +Y   GSL  +LHG              +   L  ++GVA
Sbjct: 61  PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVA 116

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR-SAGYRAPEVIE 511
           ++HSM      H ++K  N+L+        I DFG    +    T ++ SA + APEV E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 571
              +S K DV+S+G++L E++T + P      D++      +   V       +      
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPLIK---- 227

Query: 572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSEENKS 627
              N+ + +  ++     C +K P  RP+M+E+V+++  + +     + P     + 
Sbjct: 228 ---NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  156 bits (397), Expect = 1e-43
 Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 49/297 (16%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK-----EVVVGKRDFEQQMEIVG 388
           D  +L     E++G G +G  Y+A       V VK  +     ++     +  Q+ ++  
Sbjct: 5   DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
            + +HPN++ LR     +    LV ++   G L+ +L G R      +  +  V   +  
Sbjct: 62  ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQI 114

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGL------TPLMNV 494
           ARG+ ++H        H ++K+SN+LI Q ++          I+DFGL      T  M+ 
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

Query: 495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 554
                    + APEVI     S  SDV+S+GVLL E+LTG+ P        + D      
Sbjct: 175 AGAY----AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGI-DGLAVAY 224

Query: 555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
            V           + L       E   ++++    C    P  RP+   ++  +  +
Sbjct: 225 GVAMN-------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  156 bits (397), Expect = 4e-43
 Identities = 68/332 (20%), Positives = 117/332 (35%), Gaps = 50/332 (15%)

Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR 389
             + DL++L     E++G+G YG  YK  L+E   V VK        +++F  +  I   
Sbjct: 7   EPSLDLDNL--KLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFA--NRQNFINEKNIYRV 61

Query: 390 VG-QHPNVVPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 443
              +H N+        R     + E LLV +Y+ +GSL   L           DW +  +
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCR 115

Query: 444 ILLGTARGVAHIHSM------GGPKFTHGNIKASNVLINQDLDGCISDFGL--------- 488
           +     RG+A++H+         P  +H ++ + NVL+  D    ISDFGL         
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 489 TPLMNVPATPSRSAG---YRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                         G   Y APEV+E             + D+Y+ G++  E+      L
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 539 QSPTRDDMVDLP--RWVQSVVREEWTAEVFDVELMR------FQNIEEEMVQMLQIGMAC 590
                     +     V +    E    +   E  R      ++     +  + +    C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 591 VAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
             +  + R         + E+      N+  S
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (392), Expect = 1e-42
 Identities = 56/298 (18%), Positives = 127/298 (42%), Gaps = 43/298 (14%)

Query: 331 YNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLK--------EVVVGKRDFE 381
                 ++     + +GKG +G  +K  L +  +VV +K L         E++   ++F+
Sbjct: 14  PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71

Query: 382 QQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR 441
           +++ I+  +  HPN+V L       +   +V ++   G L   L         P+ W  +
Sbjct: 72  REVFIMSNL-NHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVK 124

Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-----ISDFGLTPLMNVPA 496
           ++++L  A G+ ++ +   P   H ++++ N+ +    +       ++DFGL+       
Sbjct: 125 LRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183

Query: 497 TPSR-SAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RW 552
           +    +  + APE I      ++ K+D YSF ++L  +LTG+ P      D+      ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKF 238

Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
           +  +  E     + +       +    +  +++    C +  P  RP+   +V+ + E
Sbjct: 239 INMIREEGLRPTIPE-------DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  155 bits (393), Expect = 1e-42
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 48/288 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 400
           E +G GS+GT ++A     + V VK L E         +F +++ I+ R+ +HPN+V   
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                     +V +Y + GSL  LLH +    R  LD   R+ +    A+G+ ++H+   
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN- 157

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA----GYRAPEVIETRKHS 516
           P   H N+K+ N+L+++     + DFGL+ L       S+SA     + APEV+     +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV----------DLPRWVQSVVREEWTAEVF 566
            KSDVYSFGV+L E+ T + P  +     +V          ++PR +   V         
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA-------- 269

Query: 567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
              ++                  C    P  RP+   ++ ++  + +S
Sbjct: 270 --AIIE----------------GCWTNEPWKRPSFATIMDLLRPLIKS 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  152 bits (387), Expect = 9e-42
 Identities = 69/327 (21%), Positives = 123/327 (37%), Gaps = 55/327 (16%)

Query: 333 FDLEDLLRASAEVLGKGSYGTAYKAVLEEST-TVVVKRLKEV-VVGKRDFEQQMEIVGRV 390
           F   DL+    EVLGKG +G A K    E+   +V+K L       +R F ++++++  +
Sbjct: 7   FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
            +HPNV+      Y       + +Y   G+L  ++            W  RV      A 
Sbjct: 65  -EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIAS 119

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+A++HSM      H ++ + N L+ ++ +  ++DFGL  LM    T             
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 506 -------------APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRW 552
                        APE+I  R +  K DV+SFG++L E++                    
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------- 221

Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQ-----MLQIGMACVAKVPDMRPNMDEVVRM 607
                  ++     D  L     ++             I + C    P+ RP+  ++   
Sbjct: 222 -----DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276

Query: 608 IEEVRQSDSENRPSSEENKSKDSNVQT 634
           +E +R   + + P   + +  D     
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGFWE 303

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (377), Expect = 9e-41
 Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 45/294 (15%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRV 390
           D + L       L +   G  +K   +    +VVK LK         RDF ++   +   
Sbjct: 8   DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 391 GQHPNVVPLRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
             HPNV+P+     S        +  +   GSL  +LH         +D    VK  L  
Sbjct: 65  -SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDM 120

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---TPSRSAGYR 505
           ARG+A +H++  P      + + +V+I++D+   IS   +      P     P     + 
Sbjct: 121 ARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWV 175

Query: 506 APEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
           APE ++ +    +   +D++SF VLL E++T + P       D+         V  E   
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADL-SNMEIGMKVALEG-- 227

Query: 563 AEVFDVELMRF---QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                   +R      I   + ++++I   C+ + P  RP  D +V ++E+++ 
Sbjct: 228 --------LRPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKMQD 270

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  151 bits (384), Expect = 1e-38
 Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 9/145 (6%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           L + G  L G      +     L++L++ SN   G +P     L SL+YL L  N F+G+
Sbjct: 228 LDISGNKLSGDFSRA-ISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGE 284

Query: 134 IPSSFS---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPK 187
           IP   S     L  LDLS N F G +P    + + L  L+L SNN SG +P      +  
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344

Query: 188 LRHLNLSYNGLKGSIPSSLQKFPNS 212
           L+ L+LS+N   G +P SL     S
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (382), Expect = 2e-38
 Identities = 52/168 (30%), Positives = 69/168 (41%), Gaps = 27/168 (16%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
             +      G     T     ++  L +  N+L+G +P EI S+P L  L L HN+ SG 
Sbjct: 613 CNITSRVYGGHTSP-TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS 671

Query: 134 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 191
           IP        L +LDLS N   G IPQ++  LT LT                       +
Sbjct: 672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT----------------------EI 709

Query: 192 NLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFPVAPSPSP 237
           +LS N L G IP     + FP + F+ N  LCG PL  C P       
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYA 757

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (381), Expect = 2e-38
 Identities = 51/135 (37%), Positives = 72/135 (53%), Gaps = 5/135 (3%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 139
           L G IP++ LG L  L  L L  N+L G +P E+  + +L  L L  N+ +G+IPS  S 
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 196
              L  + LS N  TG IP+ I  L  L  L L +N+ SG+IP    D   L  L+L+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548

Query: 197 GLKGSIPSSLQKFPN 211
              G+IP+++ K   
Sbjct: 549 LFNGTIPAAMFKQSG 563

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  149 bits (378), Expect = 6e-38
 Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 42  PHLRKLNWSSTN---PICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNN--TLGKLDAL 96
             L+ LN SS     P   S  G+           L L    + G              L
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSG-GLKLNSLEV----LDLSANSISGANVVGWVLSDGCGEL 180

Query: 97  EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGN 155
           + L++  N ++G +   ++   +L +L +  NNFS  IP       L  LD+S N  +G+
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238

Query: 156 IPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
             ++I   T+L  L++ SN   G IP   +  L++L+L+ N   G IP  L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFL 289

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  148 bits (377), Expect = 8e-38
 Identities = 45/142 (31%), Positives = 60/142 (42%), Gaps = 6/142 (4%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           L +        IP   LG   AL+ L +  N L+G     I++   L+ L +  N F G 
Sbjct: 205 LDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPN--FDIPKLRH 190
           IP      L  L L+ N FTG IP  +      LTGL L  N+  G++P        L  
Sbjct: 263 IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322

Query: 191 LNLSYNGLKGSIP-SSLQKFPN 211
           L LS N   G +P  +L K   
Sbjct: 323 LALSSNNFSGELPMDTLLKMRG 344

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  146 bits (370), Expect = 6e-37
 Identities = 54/138 (39%), Positives = 72/138 (52%), Gaps = 8/138 (5%)

Query: 81  LVGPIPNNTLGKLDA-LEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSS 137
             G +P  +L  L A L  L L SN  +G +   +      +L+ LYLQ+N F+GKIP +
Sbjct: 355 FSGELPE-SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

Query: 138 FS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNL 193
            S   +LV L LSFN  +G IP S+ +L++L  L L  N L G IP     +  L  L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473

Query: 194 SYNGLKGSIPSSLQKFPN 211
            +N L G IPS L    N
Sbjct: 474 DFNDLTGEIPSGLSNCTN 491

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  144 bits (366), Expect = 2e-36
 Identities = 44/203 (21%), Positives = 72/203 (35%), Gaps = 32/203 (15%)

Query: 18  SLLPLAFADLNSDRQALLDFADAVPHLRKL-NWSSTNPICQSWVGINCTQDRTRVFGLRL 76
           S        L  +   L+ F D +P    L +WSS    C ++ G+ C     +V  + L
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTC--RDDKVTSIDL 57

Query: 77  PGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 136
               L                            + S + SL  L  L+L +++ +G +  
Sbjct: 58  SSKPLNVGF----------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG 95

Query: 137 -SFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRH 190
              S  L  LDLS NS +G +    S+ + + L  L++ SN L           +  L  
Sbjct: 96  FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155

Query: 191 LNLSYNGLKGSIPSSLQKFPNSS 213
           L+LS N + G+            
Sbjct: 156 LDLSANSISGANVVGWVLSDGCG 178

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  138 bits (351), Expect = 2e-34
 Identities = 47/147 (31%), Positives = 68/147 (46%), Gaps = 10/147 (6%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSG 132
           L +     VGPIP   L  L   + LSL  N  TG +P  ++ +  +L  L L  N+F G
Sbjct: 252 LNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308

Query: 133 KIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---P 186
            +P  F     L  L LS N+F+G +P  ++  +  L  L L  N  SG +P        
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368

Query: 187 KLRHLNLSYNGLKGSIPSSLQKFPNSS 213
            L  L+LS N   G I  +L + P ++
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNT 395

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  123 bits (312), Expect = 1e-29
 Identities = 31/135 (22%), Positives = 52/135 (38%), Gaps = 7/135 (5%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 140
           L G IP   +G+L+ L +L L +N  +G +P+E+    SL +L L  N F+G IP++   
Sbjct: 502 LTGEIPK-WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN--NLSGSIPN--FDIPKLRHLNLSYN 196
           Q     ++ N   G     I+N           N     G        +      N++  
Sbjct: 561 QS--GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618

Query: 197 GLKGSIPSSLQKFPN 211
              G    +     +
Sbjct: 619 VYGGHTSPTFDNNGS 633

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  143 bits (363), Expect = 2e-38
 Identities = 63/302 (20%), Positives = 113/302 (37%), Gaps = 43/302 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY- 402
           + +GKG YG  +         V VK            E ++     + +H N++   A  
Sbjct: 43  KQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILGFIAAD 100

Query: 403 ---YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 458
                S  +  L+ DY  +GSL   L        T LD ++ +K+   +  G+ H+H+  
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 459 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YRA 506
               G P   H ++K+ N+L+ ++   CI+D GL     +    V   P+   G   Y  
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 507 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQS 555
           PEV++   +         +D+YSFG++L E+                  D+V        
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV----PSDP 270

Query: 556 VVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
              +                  + +E + QM ++   C A  P  R     V + + ++ 
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

Query: 613 QS 614
           +S
Sbjct: 331 ES 332

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (362), Expect = 4e-38
 Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 45/305 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-QHPNVVPLRA- 401
           E +GKG +G  ++        V VK        +R + ++ EI   V  +H N++   A 
Sbjct: 48  ESIGKGRFGEVWRGKWRG-EEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 402 ---YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
                 +  +  LV DY   GSL   L+      R  +  E  +K+ L TA G+AH+H  
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158

Query: 459 -----GGPKFTHGNIKASNVLINQDLDGCISDFGL-----TPLMNVPATPSRSAG---YR 505
                G P   H ++K+ N+L+ ++   CI+D GL     +    +   P+   G   Y 
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 506 APEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-----DDMVDLPRWVQ 554
           APEV++        +   ++D+Y+ G++  E+    +             D+V       
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV----PSD 274

Query: 555 SVVREEWTAEVFD---VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
             V E             +       E +  M +I   C       R     + + + ++
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 612 RQSDS 616
            Q + 
Sbjct: 335 SQQEG 339

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  141 bits (357), Expect = 9e-38
 Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 65/309 (21%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E +GKG YG  ++   +    V VK            E ++     + +H N++   A  
Sbjct: 14  ECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASD 71

Query: 404 YSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM- 458
            +         L+  Y   GSL   L        T LD  + ++I+L  A G+AH+H   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 459 ----GGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSR-SAGYRA 506
               G P   H ++K+ N+L+ ++   CI+D GL       T  ++V   P   +  Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 507 PEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQS---------------PTRDD 545
           PEV++            + D+++FG++L E+                        P+ +D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 546 MVDLPRWVQSVVRE----EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM 601
           M  +      V  +          F    +        + ++++    C  + P  R   
Sbjct: 246 MRKV------VCVDQQRPNIPNRWFSDPTLT------SLAKLMK---ECWYQNPSARLTA 290

Query: 602 DEVVRMIEE 610
             + + + +
Sbjct: 291 LRIKKTLTK 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (353), Expect = 2e-37
 Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 37/280 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKR---DFEQQMEIVGRVGQHPNVVPLR 400
           + +G GS+GT YK        V VK L       +    F+ ++ ++ +  +H N++   
Sbjct: 30  QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 86

Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
            Y  S   +L +V  +    SL   LH +        + +  + I   TARG+ ++H+  
Sbjct: 87  GY--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKS 140

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI--- 510
                H ++K++N+ +++D    I DFGL    +  +   +         + APEVI   
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 570
           ++  +S +SDVY+FG++L E++TG+ P       ++ +  + ++ V R   + ++  V  
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIEMVGRGSLSPDLSKVR- 251

Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
               N  + M +++     C+ K  D RP+   ++  IEE
Sbjct: 252 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  131 bits (332), Expect = 3e-34
 Identities = 53/309 (17%), Positives = 118/309 (38%), Gaps = 52/309 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLR 400
           E++GKG +G  Y         V ++ +      +   + F++++    +  +H NVV   
Sbjct: 39  ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFM 95

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
               S     ++       +L +++   +      LD     +I     +G+ ++H+   
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--- 148

Query: 461 PKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAG---------YRAPEVI 510
               H ++K+ NV    D     I+DFGL  +  V     R            + APE+I
Sbjct: 149 KGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 511 ETRK---------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW 561
                         S  SDV++ G +  E+   + P ++   + ++     + + ++   
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---MGTGMKPN- 262

Query: 562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS 621
                    +    + +E+  +L   + C A   + RP   +++ M+E++ + +   R S
Sbjct: 263 ---------LSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPKRNR--RLS 308

Query: 622 SEENKSKDS 630
              +  K +
Sbjct: 309 HPGHFWKSA 317

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (316), Expect = 3e-32
 Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 34/271 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
             +G+GS+ T YK +  E +  V    L++  + K + ++ + E  + +  QHPN+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 401 AYYYS---KDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
             + S     + +++  +   SG+L T L   +      +  +          +G+  +H
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS--RSAGYRAPEVIET 512
           +   P   H ++K  N+ I     G   I D GL  L       +   +  + APE+ E 
Sbjct: 147 TRT-PPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 203

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
            K+    DVY+FG+ +LEM T + P       +   + R V S V+     +V   E+  
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 603
              IE            C+ +  D R ++ +
Sbjct: 262 I--IEG-----------CIRQNKDERYSIKD 279

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  130 bits (329), Expect = 5e-32
 Identities = 33/155 (21%), Positives = 49/155 (31%), Gaps = 9/155 (5%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-- 138
           L      +    L  L  L +               L SL  L +  N+F          
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 139 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 195
               L  LDLS        P +  +L+ L  L++  NN           +  L+ L+ S 
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527

Query: 196 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 226
           N +  S    LQ FP+S    +   N   C    +
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  124 bits (313), Expect = 4e-30
 Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 5/140 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           + + +      L+VL L    +         SL  L  L L  N        +FS    L
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL-SGSIPNF--DIPKLRHLNLSYNGLK 199
             L     +        I +L  L  L++  N + S  +P +  ++  L HL+LS N ++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 200 GSIPSSLQKFPNSSFVGNSL 219
               + L+       +  SL
Sbjct: 163 SIYCTDLRVLHQMPLLNLSL 182

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  117 bits (294), Expect = 1e-27
 Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
            + L L  N L         S P L+ L L           ++     L  L L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 210
                +   L+ L  L     NL+         +  L+ LN+++N ++   +P       
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 211 N 211
           N
Sbjct: 150 N 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (289), Expect = 4e-27
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 10/156 (6%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           L++ G         +   +L  L  L L    L    P+   SL SL+ L + HNNF   
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509

Query: 134 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNL-TQLTGLSLQSNNLSGSIPNFD----IP 186
               +     L VLD S N    +  Q +Q+  + L  L+L  N+ + +  +      I 
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569

Query: 187 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 222
             R L +    ++ + PS  Q  P  S    ++ C 
Sbjct: 570 DQRQLLVEVERMECATPSDKQGMPVLSL---NITCQ 602

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  113 bits (285), Expect = 2e-26
 Identities = 34/144 (23%), Positives = 50/144 (34%), Gaps = 9/144 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 141
           +       L +L+ L      L       I  L +L+ L + HN   S K+P  FS    
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLT----GLSLQSNNLSGSIPN-FDIPKLRHLNLSYN 196
           L  LDLS N         ++ L Q+      L L  N ++   P  F   +L  L L  N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

Query: 197 GLKGSIPS-SLQKFPNSSFVGNSL 219
               ++    +Q           L
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVL 234

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (283), Expect = 2e-26
 Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 9/132 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I +     L  L  L L  N +        + L SL+ L     N +            L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 143 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR----HLNLSY 195
             L+++ N      +P+   NLT L  L L SN +          + ++      L+LS 
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 196 NGLKGSIPSSLQ 207
           N +    P + +
Sbjct: 187 NPMNFIQPGAFK 198

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (256), Expect = 6e-23
 Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 11/135 (8%)

Query: 87  NNTLGKLDALEVLSLRS---NVLTGGLPSEITSLPSLRYLYLQHN--NFSGKIPSSFS-- 139
           N   G+   L++ SL+        GG       LPSL +L L  N  +F G    S    
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 196
             L  LDLSFN     +  +   L QL  L  Q +NL           +  L +L++S+ 
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 197 GLKGSIPSSLQKFPN 211
             + +         +
Sbjct: 432 HTRVAFNGIFNGLSS 446

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.0 bits (229), Expect = 1e-19
 Identities = 34/157 (21%), Positives = 50/157 (31%), Gaps = 26/157 (16%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
            RL  +        +    L  +   SL S  +      + +     ++L L +  F   
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQF 319

Query: 134 IPSSFS---------------------PQLVVLDLSFN--SFTGNIPQSIQNLTQLTGLS 170
                                      P L  LDLS N  SF G   QS    T L  L 
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 171 LQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 206
           L  N +     NF  + +L HL+  ++ LK     S+
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 28/156 (17%), Positives = 51/156 (32%), Gaps = 27/156 (17%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--- 140
           + N  +G L  L+ L++  N++    LP   ++L +L +L L  N       +       
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 141 ---QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS-----NNLSGSIPNF---DIPKLR 189
                + LDLS N      P + + +       L       N  S ++       +  L 
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI------RLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 190 HLNLSYNGLKGS------IPSSLQKFPNSSFVGNSL 219
              L     +          S+L+   N +     L
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 29/142 (20%), Positives = 46/142 (32%), Gaps = 8/142 (5%)

Query: 75  RLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL---TGGLPSEITSLPSLRYLYLQHNNFS 131
                G +     + L  L  L +   R   L      +      L ++    L      
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

Query: 132 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 191
                S++     L+L    F       +++L +LT  S +  N        D+P L  L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA---FSEVDLPSLEFL 352

Query: 192 NLSYNGL--KGSIPSSLQKFPN 211
           +LS NGL  KG    S     +
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTS 374

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 86.6 bits (215), Expect = 6e-18
 Identities = 30/146 (20%), Positives = 44/146 (30%), Gaps = 18/146 (12%)

Query: 83  GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY----LYLQHNNFSGKIPSSF 138
             +P      L  LE L L SN +     +++  L  +      L L  N  +   P +F
Sbjct: 139 FKLPE-YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 139 S-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-----LRHL 191
              +L  L L  N  + N+ +  IQ L  L    L               K     L +L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 192 NLSYNGLK------GSIPSSLQKFPN 211
            +    L         I        N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTN 283

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 4/100 (4%)

Query: 114 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 173
           +  +P++ Y      NF  KIP +       LDLSFN        S  +  +L  L L  
Sbjct: 4   VEVVPNITYQ-CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61

Query: 174 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
             +          +  L  L L+ N ++     +     +
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.1 bits (198), Expect = 7e-16
 Identities = 27/147 (18%), Positives = 42/147 (28%), Gaps = 13/147 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-----KIPSSF 138
           I      ++  L  L+LR+N  +  +    I  L  L    L    F       K   S 
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 139 SPQLVVLDLSFNS------FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 192
              L  L +          +  +I      LT ++  SL S  +            +HL 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 193 LSYNGLKGSIPSSLQKFPNSSFVGNSL 219
           L            L+     +F  N  
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKG 337

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (309), Expect = 3e-31
 Identities = 63/274 (22%), Positives = 102/274 (37%), Gaps = 41/274 (14%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 399
             LG GSYG  +K    E+     VKR      G +D      ++    +VGQHP  V  
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120

Query: 400 RAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIH 456
                +  +   L +       SL         A    L  E +V   L  T   +AH+H
Sbjct: 121 -RLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLP-EAQVWGYLRDTLLALAHLH 174

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETR 513
           S G     H ++K +N+ +       + DFGL   +          G   Y APE+++  
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-G 230

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 573
            +   +DV+S G+ +LE+         P   +     +  Q  +  E+TA     EL   
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL---PHGGE--GWQQLRQGYLPPEFTAG-LSSELRSV 284

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
                 +V ML+         P +R   + ++ +
Sbjct: 285 ------LVMMLE-------PDPKLRATAEALLAL 305

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (305), Expect = 1e-30
 Identities = 55/302 (18%), Positives = 110/302 (36%), Gaps = 44/302 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLR 400
           + LG+G +                  LK ++  ++   ++   E  + R+  HPN++ L 
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYA--LKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 401 AYYYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           AY   +        L+  +F  G+L   +          L  +  + +LLG  RG+  IH
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------- 503
           +     + H ++K +N+L+  +    + D G      +    SR A              
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 504 YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE 560
           YRAPE+   + H     ++DV+S G +L  M+ G+ P     +         V   V+ +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQNQ 263

Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 620
            +             +   +  M+          P  RP++  ++  +E ++        
Sbjct: 264 LSIPQSPRHSSALWQL---LNSMMT-------VDPHQRPHIPLLLSQLEALQPPAPGQHT 313

Query: 621 SS 622
           + 
Sbjct: 314 TQ 315

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  118 bits (297), Expect = 2e-29
 Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 68/326 (20%)

Query: 344 EVLGKGSYGTAYKAVL---EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +          +KR+KE       RDF  ++E++ ++G HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKILLG 447
           L      +    L  +Y   G+L   L  +R     P                 +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-YR- 505
            ARG+ ++      +F H ++ A N+L+ ++    I+DFGL          SR    Y  
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL----------SRGQEVYVK 197

Query: 506 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 553
                      A E +    ++  SDV+S+GVLL E+++ G  P    T  ++ +    +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---L 254

Query: 554 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
               R         EV+D+              M Q    C  + P  RP+  +++  + 
Sbjct: 255 PQGYRLEKPLNCDDEVYDL--------------MRQ----CWREKPYERPSFAQILVSLN 296

Query: 610 EVRQSDSENRPSSEENKSKDSNVQTP 635
            + +       ++   K   + +   
Sbjct: 297 RMLEERKTYVNTTLYEKFTYAGIDCS 322

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  120 bits (303), Expect = 2e-29
 Identities = 63/285 (22%), Positives = 124/285 (43%), Gaps = 39/285 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG G +G  + A   + T V VK +K   +    F  +  ++  + QH  +V L A  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV 252

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            +K+   ++ ++ A GSL   L  + G   +       +      A G+A I       +
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR---NY 305

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H +++A+N+L++  L   I+DFGL  ++      +R        + APE I     + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 573
           SDV+SFG+LL+E++T G+ P    +  +++     ++   R    E    E++++     
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEELYNI----- 417

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
                    M++    C    P+ RP  + +  ++++   +    
Sbjct: 418 ---------MMR----CWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  120 bits (303), Expect = 2e-29
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
             LG+G +G  +      +T V +K LK   +    F Q+ +++ ++ +H  +V L A  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 248

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            S++   +V +Y + GSL   L G  G     L     V +    A G+A++  M    +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 301

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 573
           SDV+SFG+LL E+ T G+ P       +++D    V+   R     E    + D+     
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 413

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
                    M Q    C  K P+ RP  + +   +E+   S        E 
Sbjct: 414 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  120 bits (304), Expect = 8e-29
 Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 9/138 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----P 140
           I NN   K   L  L L  N L+         L +L+ L L +N                
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-----NFDIPKLRHLNLSY 195
            L  L+LS N      P     + +L GL L +  L  S+            +R+L+LS 
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231

Query: 196 NGLKGSIPSSLQKFPNSS 213
           + L  +  ++      ++
Sbjct: 232 SQLSTTSNTTFLGLKWTN 249

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  119 bits (300), Expect = 3e-28
 Identities = 36/133 (27%), Positives = 49/133 (36%), Gaps = 4/133 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +P     +   L  L +  N ++   P     LP L+ L LQHN  S     +F+    L
Sbjct: 40  LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 200
             L L  NS              L  L L  N LS +       +  L+ L LS N ++ 
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 201 SIPSSLQKFPNSS 213
                L  F NSS
Sbjct: 160 LKSEELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  115 bits (290), Expect = 5e-27
 Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS--------GKIPSSFS 139
           +    L  L +L L +N +       +  L  L  L LQHNN +        G       
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533

Query: 140 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY 195
               L +L+L  N F     +  ++L +L  + L  NNL+    +   +   L+ LNL  
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593

Query: 196 NGLKGSIPSSLQKFPNS----SFVGNSLLCGPP 224
           N +             +        N   C   
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (286), Expect = 2e-26
 Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 6/135 (4%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           + + T      L  L L SN +     +      +L  L L HN  S     +      L
Sbjct: 88  LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147

Query: 143 VVLDLSFNSFTGNIPQSIQ--NLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 198
             L LS N       + +     + L  L L SN +    P     I +L  L L+   L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207

Query: 199 KGSIPSSLQKFPNSS 213
             S+   L     ++
Sbjct: 208 GPSLTEKLCLELANT 222

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (286), Expect = 2e-26
 Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT---SLPSLRYLYLQHNNFSGKIPSSFS-- 139
                   +  L  L L +  L   L  ++    +  S+R L L ++  S    ++F   
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245

Query: 140 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 195
               L +LDLS+N+       S   L QL    L+ NN+     +    +  +R+LNL  
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305

Query: 196 NGLKGSIPS-SLQKFPNSSFVGNSLL 220
           +  K SI   SL K  + SF     L
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (284), Expect = 2e-26
 Identities = 35/152 (23%), Positives = 52/152 (34%), Gaps = 14/152 (9%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 132
           L L    +   +       L+ +  + L  N       +    +PSL+ L L+       
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

Query: 133 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GSIP 181
              PS F     L +LDLS N+        ++ L +L  L LQ NNL+        G   
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

Query: 182 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            F   +  L  LNL  NG         +    
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (284), Expect = 2e-26
 Identities = 33/120 (27%), Positives = 48/120 (40%), Gaps = 4/120 (3%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
           + VL+L  N L     +  T    L  L +  N  S   P      P L VL+L  N  +
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
               ++    T LT L L SN++     N       L  L+LS+NGL  +   +  +  N
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  113 bits (284), Expect = 3e-26
 Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 9/136 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS------F 138
           I + +   L  LE L++  N + G   +  T L +L+YL L ++  S +  ++       
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379

Query: 139 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSY 195
              L +L+L+ N  +     +   L  L  L L  N +   +   +      +  + LSY
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 196 NGLKGSIPSSLQKFPN 211
           N       +S    P+
Sbjct: 440 NKYLQLTRNSFALVPS 455

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (252), Expect = 3e-22
 Identities = 51/227 (22%), Positives = 75/227 (33%), Gaps = 41/227 (18%)

Query: 16  IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDR-TRVFGL 74
           I    P  F  +                L  L  ++   +  S     C +   T +  L
Sbjct: 183 IKEFSPGCFHAI--------------GRLFGLFLNN-VQLGPSLTEKLCLELANTSIRNL 227

Query: 75  RLPGIGLVGPIPNNTLGKLD--ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 132
            L    L     N T   L    L +L L  N L          LP L Y +L++NN   
Sbjct: 228 SLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286

Query: 133 KIPSSFS--PQLVVLDL---------SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 181
               S      +  L+L         S  S       S Q L  L  L+++ N++ G   
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346

Query: 182 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 226
           N    +  L++L+LS +        SL+   N +FV    L   PL 
Sbjct: 347 NMFTGLINLKYLSLSNSFT------SLRTLTNETFVS---LAHSPLH 384

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.4 bits (225), Expect = 5e-19
 Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 3/95 (3%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           S       H   + ++P      + VL+L+ N        +    +QLT L +  N +S 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 179 SIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
             P     +P L+ LNL +N L      +     N
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.7 bits (223), Expect = 7e-19
 Identities = 28/138 (20%), Positives = 47/138 (34%), Gaps = 5/138 (3%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 143
           P   L  L  L +L+L SN            L  L+ + L  NN +    S F+    L 
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 144 VLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
            L+L  N  T    +        LT L ++ N    +  +     +  +N ++  +    
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA-WFVNWINETHTNIPELS 646

Query: 203 PSSLQKFPNSSFVGNSLL 220
              L   P   + G  + 
Sbjct: 647 SHYLCNTP-PHYHGFPVR 663

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.7 bits (192), Expect = 4e-15
 Identities = 30/118 (25%), Positives = 44/118 (37%), Gaps = 8/118 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---Q 141
           IP      L  L+++ L  N L     S   +  SL+ L LQ N  +      F P    
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

Query: 142 LVVLDLSFNSFTGNIP-----QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 194
           L  LD+ FN F           +  N T      L S+ L  + P++    +R  + S
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (289), Expect = 1e-28
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 39/232 (16%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 399
           E +G G +G+ +K V   +     +KR K+ + G  D +   +++     +GQH +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74

Query: 400 RAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHI 455
             Y+  +++D+ +L+  +Y   GSL+  +  N          E  +K +LL   RG+ +I
Sbjct: 75  -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFK-EAELKDLLLQVGRGLRYI 131

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGC-------------------ISDFGLTPLMNVPA 496
           HSM      H +IK SN+ I++                        I D G    ++ P 
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 497 TPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
                + + A EV+ E   H  K+D+++  + ++     +     P   D  
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQW 237

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  114 bits (287), Expect = 1e-28
 Identities = 66/283 (23%), Positives = 122/283 (43%), Gaps = 39/283 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG G +G       +    V VK +KE  + + +F Q+ + + ++  HP +V      
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC 72

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +    +V +Y ++G L   L  +       L+    +++      G+A + S    +F
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESH---QF 125

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 518
            H ++ A N L+++DL   +SDFG+T  +      S        +  APEV    K+S K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 573
           SDV++FG+L+ E+ + GK P    T  ++V     V    R       +  ++ +     
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGHRLYRPHLASDTIYQI----- 237

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                    M      C  ++P+ RP   +++  IE +R+ D 
Sbjct: 238 ---------MYS----CWHELPEKRPTFQQLLSSIEPLREKDK 267

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  119 bits (299), Expect = 1e-28
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 39/284 (13%)

Query: 344 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             LG G YG  Y+ V  + S TV VK LKE  +   +F ++  ++  + +HPN+V L   
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 284

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
              +    ++ ++   G+L   L   R   R  +     + +    +  + ++       
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 517
           F H N+ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 518 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 572
           KSDV++FGVLL E+ T G +P        + +L   ++   R    E    +V+++    
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 451

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                     M      C    P  RP+  E+ +  E + Q  S
Sbjct: 452 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESS 481

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  114 bits (288), Expect = 1e-28
 Identities = 59/284 (20%), Positives = 115/284 (40%), Gaps = 41/284 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG G +G            V +K +KE  + + +F ++ +++  +  H  +V L    
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 88

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +    ++ +Y A+G L   L   R         +  +++       + ++ S    +F
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK---QF 141

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHSH 517
            H ++ A N L+N      +SDFGL+  +      + S G +       PEV+   K S 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 518 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 572
           KSD+++FGVL+ E+ + GK P +  T  +  +    +   +R       + +V+ +    
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRPHLASEKVYTI---- 253

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                     M      C  +  D RP    ++  I +V   +S
Sbjct: 254 ----------MYS----CWHEKADERPTFKILLSNILDVMDEES 283

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (290), Expect = 1e-28
 Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 70/315 (22%)

Query: 344 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 396
             LG+G +G       +         V VK LK     +    ++Q+++I+  +  H ++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHI 95

Query: 397 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           +  +            LV +Y   GSL   L  +       +     +        G+A+
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY 149

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 505
           +H+     + H ++ A NVL++ D    I DFGL   +     P     YR         
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPV 201

Query: 506 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 558
              APE ++  K  + SDV+SFGV L E+LT   +    PT+  +++ + +   +V+R  
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 559 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                       ++  AEV+ +              M      C       RP  + ++ 
Sbjct: 262 ELLERGERLPRPDKCPAEVYHL--------------MKN----CWETEASFRPTFENLIP 303

Query: 607 MIEEVRQSDSENRPS 621
           +++ V +      PS
Sbjct: 304 ILKTVHEKYQGQAPS 318

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  114 bits (288), Expect = 2e-28
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 39/298 (13%)

Query: 344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             LG G YG  Y+ V +  S TV VK LKE  +   +F ++  ++  + +HPN+V L   
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 77

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
              +    ++ ++   G+L   L   R   R  +     + +    +  + ++       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSH 517
           F H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191

Query: 518 KSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMR 572
           KSDV++FGVLL E+ T G +P        + +L   ++   R    E    +V+++    
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 244

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKSKDS 630
                     M      C    P  RP+  E+ +  E + Q  S +    +E   + +
Sbjct: 245 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (292), Expect = 2e-28
 Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 47/287 (16%)

Query: 344 EVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G++G  +   L  ++T V VK  +E +    K  F Q+  I+ +   HPN+V L 
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 178

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                K    +V +    G   T L          L  +T ++++   A G+ ++ S   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK-- 232

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR-------APEVIETR 513
               H ++ A N L+ +     ISDFG++         + S G R       APE +   
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYG 290

Query: 514 KHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE--- 569
           ++S +SDV+SFG+LL E  + G +P            P       RE        VE   
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASP-----------YPNLSNQQTREF-------VEKGG 332

Query: 570 -LMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
            L   +   + + + M Q    C A  P  RP+   + + ++ +R+ 
Sbjct: 333 RLPCPELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIRKR 375

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (290), Expect = 3e-28
 Identities = 58/313 (18%), Positives = 127/313 (40%), Gaps = 48/313 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 398
           + +G+GS+G A      E     V  +KE+ + +   +++ E    V      +HPN+V 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYV--IKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
            R  +       +V DY   G L   ++  +G        +  +   +     + H+H  
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDR 144

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-G---YRAPEVIETRK 514
              K  H +IK+ N+ + +D    + DFG+  ++N     +R+  G   Y +PE+ E + 
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--EVFDVELMR 572
           +++KSD+++ G +L E+ T K   ++     M +L   V  ++   +      +  +L  
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEA---GSMKNL---VLKIISGSFPPVSLHYSYDLRS 255

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR----------MIEEVRQSDSENRPSS 622
                  + Q+ +       + P  RP+++ ++            +     ++     + 
Sbjct: 256 L------VSQLFK-------RNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302

Query: 623 EENKSKDSNVQTP 635
            +  S+    + P
Sbjct: 303 SKFGSQPIPAKRP 315

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (286), Expect = 3e-28
 Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 50/298 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E++G G +G  +KA         V  +K V       E++++ + ++  H N+V     +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKL-DHVNIVHYNGCW 73

Query: 404 YSKDEKL----------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
              D                   +  ++   G+L   +   RG     LD    +++   
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 504
             +GV +IHS    K  + ++K SN+ +       I DFGL   +      +RS G   Y
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
            +PE I ++ +  + D+Y+ G++L E+L         T  +         + +R+   ++
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVC-----DTAFETSKF----FTDLRDGIISD 238

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
           +FD +          + ++L        K P+ RPN  E++R +   ++S  +N   +
Sbjct: 239 IFDKKEKTL------LQKLLS-------KKPEDRPNTSEILRTLTVWKKSPEKNERHT 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  113 bits (284), Expect = 3e-28
 Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 39/281 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +G G +G  +         V +K ++E  + + DF ++ E++ ++  HP +V L    
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 72

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +    LV ++   G LS  L   RG        ET + + L    G+A++        
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEA---CV 125

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H ++ A N L+ ++    +SDFG+T  +      S +       + +PEV    ++S K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 573
           SDV+SFGVL+ E+ + GK P ++ +  ++V+    + +  R       +  V+ +     
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFRLYKPRLASTHVYQI----- 237

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
                    M      C  + P+ RP    ++R + E+ +S
Sbjct: 238 ---------MNH----CWRERPEDRPAFSRLLRQLAEIAES 265

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  118 bits (296), Expect = 4e-28
 Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 39/291 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
             LG+G +G  +      +T V +K LK   +    F Q+ +++ ++ +H  +V L A  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 331

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            S++   +V +Y + GSL   L G  G     L     V +    A G+A++  M    +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHK 518
            H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRF 573
           SDV+SFG+LL E+ T G+ P       +++D    V+   R     E    + D+     
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHDL----- 496

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
                    M Q    C  K P+ RP  + +   +E+   S        E 
Sbjct: 497 ---------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  113 bits (284), Expect = 5e-28
 Identities = 57/283 (20%), Positives = 108/283 (38%), Gaps = 45/283 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVP 398
             +G GSYG   K   +    ++V   KE+  G     ++  +V  V      +HPN+V 
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILV--WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 399 LRAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
                  +    L  V +Y   G L++++       +  LD E  ++++      +   H
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECH 128

Query: 457 SMGGPKFT--HGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRA 506
                  T  H ++K +NV ++   +  + DFGL  ++N           TP     Y +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY----YMS 184

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA--E 564
           PE +    ++ KSD++S G LL E+     P  +       +L      +   ++     
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKEL---AGKIREGKFRRIPY 238

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
            +  EL         + +ML             RP+++E++  
Sbjct: 239 RYSDELNEI------ITRMLN-------LKDYHRPSVEEILEN 268

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  113 bits (284), Expect = 5e-28
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E LG G +G  +       T V VK LK+  +    F  +  ++ ++ QH  +V L A  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV 77

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            +++   ++ +Y  +GSL   L    G     L     + +    A G+A I       +
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YR--APEVIETRKHSHK 518
            H +++A+N+L++  L   I+DFGL  L+      +R       +  APE I     + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 519 SDVYSFGVLLLEMLT-GKAP 537
           SDV+SFG+LL E++T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (286), Expect = 6e-28
 Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 63/319 (19%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
             LG+GS+G  Y+ V       E  T V +K + E   +  + +F  +  ++       +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 89

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-----GAGRTPLDWETRVKILLGTAR 450
           VV L          L++ +    G L + L   R          P      +++    A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+A++++    KF H ++ A N ++ +D    I DFG+T  +        +  YR     
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY------ETDYYRKGGKG 200

Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 557
                  +PE ++    +  SDV+SFGV+L E+ T  + P Q  + + ++     V    
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEGG 257

Query: 558 R----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                +     +F  ELMR                 C    P MRP+  E++  I+E  +
Sbjct: 258 LLDKPDNCPDMLF--ELMR----------------MCWQYNPKMRPSFLEIISSIKEEME 299

Query: 614 SDSENRP--SSEENKSKDS 630
                     SEENK  + 
Sbjct: 300 PGFREVSFYYSEENKLPEP 318

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (284), Expect = 7e-28
 Identities = 58/295 (19%), Positives = 121/295 (41%), Gaps = 36/295 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVGQHPNV 396
           + +G+G +   Y+A        V   LK+V +        + D  ++++++ ++  HPNV
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVA--LKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNV 94

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           +   A +   +E  +V +   +G LS ++  +    +  +   T  K  +     + H+H
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSRS-AG---YRAPEVI 510
           S    +  H +IK +NV I     G +   D GL    +   T + S  G   Y +PE I
Sbjct: 154 SR---RVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 570
               ++ KSD++S G LL EM   ++P       ++  L + ++        ++ +  EL
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDHYSEEL 267

Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEEN 625
            +       +   +          P+ RP++  V  + + +    + +      +
Sbjct: 268 RQL------VNMCIN-------PDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  117 bits (295), Expect = 1e-27
 Identities = 80/461 (17%), Positives = 156/461 (33%), Gaps = 87/461 (18%)

Query: 190 HLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKACF--PVAPSPSPTYSPPPFIPR 247
              +SY   KG+ P+ L  F     +  S       K      +A +P P          
Sbjct: 247 EEGISYLTDKGANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPEP---------- 296

Query: 248 KQSSKQKLGLGAIIAIAVGGSAVLLLVALVILCYCLKKKDNGSNGVSKGKASSGGRSEKP 307
                        + +      +   +A +I  YC        + + + +          
Sbjct: 297 -------------LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSI 343

Query: 308 KEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLRASA--------------EVLGKGSY 351
            +   +  Q    + +   E   Y    D ED     +                +G+G +
Sbjct: 344 PKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQF 403

Query: 352 GTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS 405
           G  ++ +       +  V +K  K       +  F Q+   + +   HP++V L     +
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-T 461

Query: 406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTH 465
           ++   ++ +    G L + L   +      LD  + +      +  +A++ S    +F H
Sbjct: 462 ENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESK---RFVH 514

Query: 466 GNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIETRKHSHKSD 520
            +I A NVL++ +    + DFGL+  M        S G     + APE I  R+ +  SD
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574

Query: 521 VYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQN 575
           V+ FGV + E+L  G  P Q    +D++     +++  R          ++ +       
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYSL------- 624

Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
                  M +    C A  P  RP   E+   +  + + + 
Sbjct: 625 -------MTK----CWAYDPSRRPRFTELKAQLSTILEEEK 654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (283), Expect = 1e-27
 Identities = 64/313 (20%), Positives = 117/313 (37%), Gaps = 54/313 (17%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNV 396
           +VLG G +GT +K V           V +K +++       +     M  +G +  H ++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHI 77

Query: 397 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           V L              LV  Y   GSL   +  +RG     L  +  +   +  A+G+ 
Sbjct: 78  VRL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMY 129

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 507
           ++         H N+ A NVL+       ++DFG+  L+         +  +      A 
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 562
           E I   K++H+SDV+S+GV + E++T G  P       ++ DL   ++   R    +  T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERLAQPQICT 243

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
            +V+ V              M++    C     ++RP   E+      + +         
Sbjct: 244 IDVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIK 285

Query: 623 EENKSKDSNVQTP 635
            E+    +    P
Sbjct: 286 RESGPGIAPGPEP 298

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (282), Expect = 1e-27
 Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 66/311 (21%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
           + LG+G++G   +A            TV VK LKE       R    +++I+  +G H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 396 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 443
           VV L          L ++ ++   G+LST L   R              +  L  E  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG 503
                A+G+  + S    K  H ++ A N+L+++     I DFGL   +       +   
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY------KDPD 203

Query: 504 YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLP 550
           Y             APE I  R ++ +SDV+SFGVLL E+ + G +P   P      +  
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFC 261

Query: 551 RWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           R ++   R    +  T E++                ML     C    P  RP   E+V 
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQT--------------MLD----CWHGEPSQRPTFSELVE 303

Query: 607 MIEEVRQSDSE 617
            +  + Q++++
Sbjct: 304 HLGNLLQANAQ 314

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  112 bits (281), Expect = 2e-27
 Identities = 63/307 (20%), Positives = 110/307 (35%), Gaps = 68/307 (22%)

Query: 344 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 396
             LG+G +G       +         V VK LK    G    D ++++EI+  +  H N+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENI 85

Query: 397 VPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           V  +            L+ ++  SGSL   L  N+      ++ + ++K  +   +G+ +
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY 141

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR--------- 505
           + S    ++ H ++ A NVL+  +    I DFGLT  +      +    Y          
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-----ETDKEYYTVKDDRDSPV 193

Query: 506 ---APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR-DDMVDLPRWVQSVVR-- 558
              APE +   K    SDV+SFGV L E+LT   +          M+       +V R  
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 559 ------------EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                            EV+ +              M +    C    P  R +   ++ 
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQL--------------MRK----CWEFQPSNRTSFQNLIE 295

Query: 607 MIEEVRQ 613
             E + +
Sbjct: 296 GFEALLK 302

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 2e-27
 Identities = 28/217 (12%), Positives = 75/217 (34%), Gaps = 26/217 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVV 397
            +LG+G++   Y+A   +          V+K  K     +     Q+    +       +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
              + +  ++  +LV + ++ G+L   ++  +      +     +   +     +  +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 458 MGGPKFTHGNIKASNVLINQDLDG-----------CISDFGLTPLMNVPATPSR------ 500
                  HG+IK  N ++                  + D G +  M +    +       
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           ++G++  E++  +  +++ D +     +  ML G   
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (280), Expect = 2e-27
 Identities = 66/304 (21%), Positives = 126/304 (41%), Gaps = 60/304 (19%)

Query: 344 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 397
           + LGKG++G+      +         V VK+L+       RDFE+++EI+  + QH N+V
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 74

Query: 398 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
             +   YS   +   L+ +Y   GSL   L  ++      +D    ++      +G+ ++
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 130

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 505
            +    ++ H ++   N+L+  +    I DFGLT ++     P     ++          
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEFFKVKEPGESPIF 182

Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
             APE +   K S  SDV+SFGV+L E+ T     +SP  + M  +    Q         
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 236

Query: 564 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            VF +     + ++             E+   M +    C     + RP+  ++   +++
Sbjct: 237 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 288

Query: 611 VRQS 614
           +R +
Sbjct: 289 IRDN 292

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  112 bits (282), Expect = 2e-27
 Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 54/295 (18%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 396
           +VLG G++GT YK +      +    V +K L+E       ++   +  ++  V  +P+V
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79

Query: 397 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
             L              L+      G L   +  ++      +  +  +   +  A+G+ 
Sbjct: 80  CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMN 131

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 507
           ++      +  H ++ A NVL+       I+DFGL  L+        + G +      A 
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 562
           E I  R ++H+SDV+S+GV + E++T G  P       ++  +   ++   R       T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
            +V+ +              M +    C     D RP   E++    ++ +    
Sbjct: 246 IDVYMI--------------MRK----CWMIDADSRPKFRELIIEFSKMARDPQR 282

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 3e-27
 Identities = 66/327 (20%), Positives = 122/327 (37%), Gaps = 60/327 (18%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 399
            VL +G +   Y+A    S       LK ++  + +  + +      + ++  HPN+V  
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYA--LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 400 RAYYYSKDEK-------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
            +      E+        L+      G L   L   +   R PL  +T +KI   T R V
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--------- 503
            H+H    P   H ++K  N+L++      + DFG    ++     S SA          
Sbjct: 150 QHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 504 -------YRAPEVIETRKH---SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV 553
                  YR PE+I+   +     K D+++ G +L  +   + P +              
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----------K 258

Query: 554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
             +V  +++    D +   F ++   +  MLQ         P+ R ++ EVV  ++E+  
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSL---IRAMLQ-------VNPEERLSIAEVVHQLQEIAA 308

Query: 614 SDSENRPS-----SEENKSKDSNVQTP 635
           + + N  S      E+N    S   + 
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSR 335

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (280), Expect = 3e-27
 Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 67/316 (21%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE-VVVGKRDFEQQMEIVGRVGQHPNVV 397
             LGKG++G+                V VK+L+      +RDF+++++I+  +     +V
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87

Query: 398 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
             R   Y    +   LV +Y  SG L   L  +R      LD    +       +G+ ++
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYL 143

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 505
            S    +  H ++ A N+L+  +    I+DFGL  L+     P     Y           
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL-----PLDKDYYVVREPGQSPIF 195

Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP---------LQSPTRDDMV--DLPR 551
             APE +     S +SDV+SFGV+L E+ T              +    RD      L  
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255

Query: 552 WVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
            ++   R        AEV ++              M      C A  P  RP+   +   
Sbjct: 256 LLEEGQRLPAPPACPAEVHEL--------------MKL----CWAPSPQDRPSFSALGPQ 297

Query: 608 IEEVRQSDSENRPSSE 623
           ++ +          + 
Sbjct: 298 LDMLWSGSRGCETHAF 313

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (277), Expect = 5e-27
 Identities = 60/312 (19%), Positives = 115/312 (36%), Gaps = 76/312 (24%)

Query: 344 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP 394
           E LG+G++   +K V            T V++K L +        F +   ++ ++  H 
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHK 72

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           ++V         DE +LV ++   GSL T L  N+      ++   ++++    A  +  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHF 128

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC--------ISDFGLTPLMNVPATPSRSAGYR- 505
           +         HGN+ A N+L+ ++ D          +SD G++  +            + 
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQE 179

Query: 506 -----APEVIETRKH-SHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL--------- 549
                 PE IE  K+ +  +D +SFG  L E+ + G  PL +      +           
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239

Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
           P+           AE+ ++              +      C+   PD RP+   ++R + 
Sbjct: 240 PKA----------AELANL--------------INN----CMDYEPDHRPSFRAIIRDLN 271

Query: 610 EVRQSDSENRPS 621
            +   D   R S
Sbjct: 272 SLFTPDLVPRGS 283

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  109 bits (275), Expect = 6e-27
 Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 57/289 (19%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +GKG +G            V VK +K      + F  +  ++ ++ +H N+V L    
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 83

Query: 404 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             +   L +V +Y A GSL   L   R  GR+ L  +  +K  L     + ++       
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYR------APEVIE 511
           F H ++ A NVL+++D    +SDFGL          ++         +      APE + 
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGL----------TKEASSTQDTGKLPVKWTAPEALR 187

Query: 512 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF 566
            +K S KSDV+SFG+LL E+ + G+ P       D+V     V+   +    +     V+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVY 244

Query: 567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 615
           +V              M      C      MRP+  ++   +E ++  +
Sbjct: 245 EV--------------MKN----CWHLDAAMRPSFLQLREQLEHIKTHE 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  109 bits (275), Expect = 7e-27
 Identities = 58/290 (20%), Positives = 114/290 (39%), Gaps = 46/290 (15%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 397
             +G+G +G  ++ +       +  V +K  K       +  F Q+   + +   HP++V
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 79

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L     +++   ++ +    G L + L   +      LD  + +      +  +A++ S
Sbjct: 80  KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 134

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 512
               +F H +I A NVL++ +    + DFGL+  M        S G     + APE I  
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191

Query: 513 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFD 567
           R+ +  SDV+ FGV + E+L  G  P Q    +D++     +++  R          ++ 
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLYS 248

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
           +              M +    C A  P  RP   E+   +  + + +  
Sbjct: 249 L--------------MTK----CWAYDPSRRPRFTELKAQLSTILEEEKA 280

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (276), Expect = 7e-27
 Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 43/291 (14%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 397
           EV+G+G +G  Y   L     +     VK L  +  +     F  +  I+     HPNV+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 89

Query: 398 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            L       +   L V  Y   G L   +             +  +   L  A+G+ ++ 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLA 145

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 508
           S    KF H ++ A N ++++     ++DFGL   M      +     G +      A E
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
            ++T+K + KSDV+SFGVLL E++T G  P       D+      +    R         
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR--------- 250

Query: 568 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
             L++ +   + + + ML+    C     +MRP+  E+V  I  +  +   
Sbjct: 251 --LLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTFIG 295

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 8e-27
 Identities = 67/304 (22%), Positives = 125/304 (41%), Gaps = 60/304 (19%)

Query: 344 EVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNVV 397
           + LGKG++G+      +         V VK+L+       RDFE+++EI+  + QH N+V
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 105

Query: 398 PLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
             +   YS   +   L+ +Y   GSL   L  ++      +D    ++      +G+ ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 161

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---------- 505
            +    ++ H ++   N+L+  +    I DFGLT ++     P     Y+          
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-----PQDKEYYKVKEPGESPIF 213

Query: 506 --APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
             APE +   K S  SDV+SFGV+L E+ T     +SP  + M  +    Q         
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQM 267

Query: 564 EVFDVELMRFQNIEE------------EMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEE 610
            VF +     + ++             E+   M +    C     + RP+  ++   +++
Sbjct: 268 IVFHL----IELLKNNGRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQ 319

Query: 611 VRQS 614
           +R  
Sbjct: 320 IRDQ 323

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (277), Expect = 8e-27
 Identities = 63/312 (20%), Positives = 114/312 (36%), Gaps = 67/312 (21%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPN 395
           + LG G++G   +A        + + TV VK LK    +  +     +++++  +G H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 448
           +V L          L++ +Y   G L   L   R +          ++            
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 449 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 A+G+A + S       H ++ A N+L+       I DFGL   +         +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK------NDS 199

Query: 503 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
            Y             APE I    ++ +SDV+S+G+ L E+ + G +P   P        
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKF 257

Query: 550 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
            + ++   R    E   AE++D+              M      C    P  RP   ++V
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDI--------------MKT----CWDADPLKRPTFKQIV 299

Query: 606 RMIEEVRQSDSE 617
           ++IE+     + 
Sbjct: 300 QLIEKQISESTN 311

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (278), Expect = 2e-26
 Identities = 62/309 (20%), Positives = 111/309 (35%), Gaps = 37/309 (11%)

Query: 344 EVLGKG--SYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVP 398
            V+GKG     T   A        V V+R+             Q E+ V ++  HPN+VP
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 399 LRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
              Y   +  D +L +V  + A GS   L+          ++      IL G  + + +I
Sbjct: 91  ---YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAG---Y 504
           H MG   + H ++KAS++LI+ D    +S       +         V   P  S     +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 505 RAPEVIETRKH--SHKSDVYSFGVLLLEMLTGKAPLQS--PTRDDMV----DLPRWVQSV 556
            +PEV++        KSD+YS G+   E+  G  P +    T+  +      +P  + + 
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-MIEEVRQSD 615
                   +     +    + + +           +                +E+  Q +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 616 SENRPSSEE 624
            + RPS+  
Sbjct: 322 PDARPSAST 330

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (277), Expect = 2e-26
 Identities = 75/328 (22%), Positives = 124/328 (37%), Gaps = 71/328 (21%)

Query: 344 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 393
           + LG+G++G    A             T V VK LK         D   +ME++  +G+H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 442
            N++ L           ++ +Y + G+L   L   R  G              L  +  V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 ARG+ ++ S    K  H ++ A NVL+ +D    I+DFGL   ++         
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH------HID 245

Query: 503 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
            Y+            APE +  R ++H+SDV+SFGVLL E+ T G +P      +++  L
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

Query: 550 PRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
              ++   R       T E++   +MR                 C   VP  RP   ++V
Sbjct: 306 ---LKEGHRMDKPSNCTNELY--MMMR----------------DCWHAVPSQRPTFKQLV 344

Query: 606 RMIEEVRQSDSENRPS---SEENKSKDS 630
             ++ +    S           +   D 
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHDYDI 372

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  109 bits (275), Expect = 2e-26
 Identities = 63/314 (20%), Positives = 105/314 (33%), Gaps = 66/314 (21%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
           +VLG G++G    A          S  V VK LKE      +     +++++ ++G H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 448
           +V L           L+++Y   G L   L   R             K L          
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 449 -----------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT 497
                      A+G+  +         H ++ A NVL+       I DFGL   +     
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM---- 223

Query: 498 PSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRD 544
               + Y             APE +    ++ KSDV+S+G+LL E+ + G  P   P   
Sbjct: 224 --SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--YPGIP 279

Query: 545 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDE 603
              +  + +Q+  +           + +     EE+   M      C A     RP+   
Sbjct: 280 VDANFYKLIQNGFK-----------MDQPFYATEEIYIIMQS----CWAFDSRKRPSFPN 324

Query: 604 VVRMIEEVRQSDSE 617
           +   +        E
Sbjct: 325 LTSFLGCQLADAEE 338

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (274), Expect = 2e-26
 Identities = 57/313 (18%), Positives = 117/313 (37%), Gaps = 54/313 (17%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 396
           +VLG G++GT YK +      +    V +K L+E       ++   +  ++  V  +P+V
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79

Query: 397 VPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
             L              L+      G L   +  ++      +  +  +   +  A+G+ 
Sbjct: 80  CRL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMN 131

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------AP 507
           ++      +  H ++ A NVL+       I+DFGL  L+        + G +      A 
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWT 562
           E I  R ++H+SDV+S+GV + E++T G  P       ++  +   ++   R       T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICT 245

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
            +V+ +              M++    C     D RP   E++    ++ +         
Sbjct: 246 IDVYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

Query: 623 EENKSKDSNVQTP 635
            + +    +    
Sbjct: 288 GDERMHLPSPTDS 300

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  112 bits (283), Expect = 3e-26
 Identities = 40/219 (18%), Positives = 69/219 (31%), Gaps = 24/219 (10%)

Query: 16  IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 75
           +      +++DL +              LR L+ S    I  S   +   + +     L 
Sbjct: 362 LSFSGCCSYSDLGT------------NSLRHLDLSFNGAIIMSANFMGLEELQH----LD 405

Query: 76  LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 135
                L      +    L+ L  L +               L SL  L +  N+F     
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 136 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRH 190
           S+    +  L  LDLS              L +L  L++  NNL     +    +  L  
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525

Query: 191 LNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 226
           L+ S+N ++ S         + +F     NS+ C    +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ 564

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  108 bits (271), Expect = 9e-25
 Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 5/140 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           + + +      L+ L L    +          L  L  L L  N      P SFS    L
Sbjct: 47  LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLK 199
             L              I  L  L  L++  N +    +P +  ++  L H++LSYN ++
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166

Query: 200 GSIPSSLQKFPNSSFVGNSL 219
               + LQ    +  V  SL
Sbjct: 167 TITVNDLQFLRENPQVNLSL 186

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 99.7 bits (249), Expect = 4e-22
 Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 5/121 (4%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
            + + L  N L        ++   L++L L           ++     L  L L+ N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG-SIPSSLQKFP 210
              P S   LT L  L      L+         +  L+ LN+++N +    +P+      
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 211 N 211
           N
Sbjct: 154 N 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 31/145 (21%), Positives = 48/145 (33%), Gaps = 19/145 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I +     L  L  L L  N +    P   + L SL  L       +            L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 143 VVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNLS 194
             L+++ N      +P    NLT L  + L  N +  +I   D+  LR        L++S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRENPQVNLSLDMS 189

Query: 195 YNGLKGSIPSSLQKFPNSSFVGNSL 219
            N         +    + +F G  L
Sbjct: 190 LN--------PIDFIQDQAFQGIKL 206

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 32/130 (24%), Positives = 47/130 (36%), Gaps = 8/130 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG-KIPSSFS--PQ 141
               +   L +LE L      L       I  L +L+ L + HN     K+P+ FS    
Sbjct: 95  FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 196
           LV +DLS+N         +Q L +       L +  N +       F   KL  L L  N
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214

Query: 197 GLKGSIPSSL 206
               +I  + 
Sbjct: 215 FNSSNIMKTC 224

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.3 bits (222), Expect = 8e-19
 Identities = 27/145 (18%), Positives = 45/145 (31%), Gaps = 10/145 (6%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK 133
           L++ G        +N       L  L L    L         +L  L+ L + HNN    
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 134 IPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 191
             S ++    L  LD SFN    +          L   +L +N+++  I       L+ +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICE-HQKFLQWV 570

Query: 192 NLSYNGLKG------SIPSSLQKFP 210
                 L        + P  +    
Sbjct: 571 KEQKQFLVNVEQMTCATPVEMNTSL 595

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.0 bits (216), Expect = 4e-18
 Identities = 22/131 (16%), Positives = 39/131 (29%), Gaps = 5/131 (3%)

Query: 85  IPNNTLGKLDAL--EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 142
              + +  L  +  +   L           +   L ++  + L   +           + 
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             L +              +L  L  L+L  N  S S     +P L +L+LS N L  S 
Sbjct: 310 QSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366

Query: 203 PSSLQKFPNSS 213
             S      +S
Sbjct: 367 CCSYSDLGTNS 377

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 4/106 (3%)

Query: 108 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
           G L   I  +P++          S K+P         +DLSFN        S  N ++L 
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59

Query: 168 GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            L L    +          +  L +L L+ N ++   P S     +
Sbjct: 60  WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 81.2 bits (201), Expect = 3e-16
 Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 23/151 (15%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           + K    + LS+    L    P+    LP L+ L L  N  S        P L  LDLS 
Sbjct: 303 VPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359

Query: 150 NSFTGNIPQSIQNL--TQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS- 205
           N+ + +   S  +L    L  L L  N       NF  + +L+HL+  ++ LK     S 
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

Query: 206 ----------------LQKFPNSSFVGNSLL 220
                            +   +  F+G + L
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.1 bits (180), Expect = 9e-14
 Identities = 22/147 (14%), Positives = 36/147 (24%), Gaps = 16/147 (10%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR----YLYLQHNNFSGKIPS 136
           +           L  L  + L  N +     +++  L         L +  N        
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199

Query: 137 SFS-PQLVVLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPNFDIP-------- 186
           +F   +L  L L  N  + NI +  +QNL  L    L                       
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259

Query: 187 --KLRHLNLSYNGLKGSIPSSLQKFPN 211
              +    L+Y               N
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLAN 286

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  108 bits (273), Expect = 4e-26
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 62/309 (20%)

Query: 344 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 393
           + LG+G++G    A          +E+ TV VK LK+        D   +ME++  +G+H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT----- 448
            N++ L           ++ +Y + G+L   L   R  G        RV     T     
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 449 ------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA 502
                 ARG+ ++ S    K  H ++ A NVL+ ++    I+DFGL   +N         
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN------NID 211

Query: 503 GYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
            Y+            APE +  R ++H+SDV+SFGVL+ E+ T G +P      +++  L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271

Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMI 608
              ++   R           + +  N   E+   M      C   VP  RP   ++V  +
Sbjct: 272 ---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 313

Query: 609 EEVRQSDSE 617
           + +    + 
Sbjct: 314 DRILTLTTN 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  110 bits (278), Expect = 4e-26
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 47/286 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +GKG +G            V VK +K      + F  +  ++ ++ +H N+V L    
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 255

Query: 404 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             +   L +V +Y A GSL   L   R  GR+ L  +  +K  L     + ++       
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------APEVIETRKHS 516
           F H ++ A NVL+++D    +SDFGLT   +     S     +      APE +  +K S
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFS 364

Query: 517 HKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELM 571
            KSDV+SFG+LL E+ + G+ P       D+V     V+   +    +     V+DV   
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYDV--- 418

Query: 572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
                      M      C       RP   ++   +E +R  +  
Sbjct: 419 -----------MKN----CWHLDAATRPTFLQLREQLEHIRTHELH 449

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 4e-26
 Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 47/297 (15%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 397
           +++G G  G      L    +    V +K LK       +RDF  +  I+G+   HPN++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNII 113

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL T L  + G           V +L G   G+ ++  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSD 169

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG---YR--APEVI 510
           +G   + H ++ A NVL++ +L   +SDFGL+ ++  +  A  + + G    R  APE I
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 565
             R  S  SDV+SFGV++ E+L  G+ P  + T  D++     V+   R          +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGYRLPAPMGCPHAL 283

Query: 566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSS 622
             +              ML     C  K    RP   ++V +++ + +S    R ++
Sbjct: 284 HQL--------------MLD----CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  107 bits (269), Expect = 4e-26
 Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 52/294 (17%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 397
            +LG+G +G  Y+ V      E   V VK  K+   +  K  F  +  I+  +  HP++V
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIV 76

Query: 398 PLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
            L         ++   ++ + +  G L   L  N+ +    L   T V   L   + +A+
Sbjct: 77  KL----IGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAY 128

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEV 509
           + S+      H +I   N+L+       + DFGL+  +        S       + +PE 
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 564
           I  R+ +  SDV+ F V + E+L+ GK P       D++ +   ++   R    +     
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKPDLCPPV 242

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
           ++ +              M +    C    P  RP   E+V  + +V Q + + 
Sbjct: 243 LYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  108 bits (271), Expect = 5e-26
 Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 55/301 (18%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 396
           ++LG+G +G+  +  L      S  V VK +K          +F  +   +     HPNV
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNV 98

Query: 397 VPL-----RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTAR 450
           + L             + +++  +   G L T L  +R   G   +  +T +K ++  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+ ++ +     F H ++ A N ++  D+  C++DFGL+  +           YR     
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY------SGDYYRQGRIA 209

Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVV 557
                  A E +  R ++ KSDV++FGV + E+ T G  P       +M D    +    
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLHGH 266

Query: 558 REEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           R           L + ++  +E+ + M      C    P  RP    +   +E++ +S  
Sbjct: 267 R-----------LKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLESLP 311

Query: 617 E 617
           +
Sbjct: 312 D 312

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (271), Expect = 5e-26
 Identities = 68/310 (21%), Positives = 108/310 (34%), Gaps = 51/310 (16%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 395
             LG G++G  Y+  +           V VK L EV     + DF  +  I+ +   H N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG--RTPLDWETRVKILLGTARGVA 453
           +V           + ++ +  A G L + L   R      + L     + +    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 505
           ++       F H +I A N L+     G    I DFG+   +                  
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 506 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
             PE       + K+D +SFGVLL E+ + G  P  S +  ++++    V S  R     
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGR----- 263

Query: 564 EVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-------- 614
                 +   +N    + + M Q    C    P+ RPN   ++  IE   Q         
Sbjct: 264 ------MDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313

Query: 615 DSENRPSSEE 624
             E  P  EE
Sbjct: 314 PIEYGPLVEE 323

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  108 bits (272), Expect = 8e-26
 Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 57/313 (18%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
             LG G++G  Y+  +           V VK L EV     + DF  +  I+ +   H N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 135

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVA 453
           +V           + ++ +  A G L + L   R   +  + L     + +    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLT-PLMNVPATPSRSAGYR---- 505
           ++       F H +I A N L+     G    I DFG+   +                  
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 506 -APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----E 559
             PE       + K+D +SFGVLL E+ + G  P  S +  ++++    V S  R    +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGRMDPPK 309

Query: 560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS----- 614
                V+   +M                  C    P+ RPN   ++  IE   Q      
Sbjct: 310 NCPGPVY--RIMT----------------QCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351

Query: 615 ---DSENRPSSEE 624
                E  P  EE
Sbjct: 352 TALPIEYGPLVEE 364

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (271), Expect = 8e-26
 Identities = 61/316 (19%), Positives = 119/316 (37%), Gaps = 28/316 (8%)

Query: 323 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ 382
            +  +        +D  +     LG G+ G  +K   + S  V+ ++L  + +      Q
Sbjct: 20  FLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77

Query: 383 -QMEI-VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWET 440
              E+ V      P +V     +YS  E  +  ++   GSL  +L   + AGR P   E 
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP---EQ 131

Query: 441 RV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPA-- 496
            + K+ +   +G+ ++      K  H ++K SN+L+N   +  + DFG+   L++  A  
Sbjct: 132 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 189

Query: 497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD---MVDLP 550
              T S    Y +PE ++   +S +SD++S G+ L+EM  G+ P+  P   +   M    
Sbjct: 190 FVGTRS----YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245

Query: 551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNM--DEVVRMI 608
               +                   +    M     +        P +   +   E    +
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305

Query: 609 EEVRQSDSENRPSSEE 624
            +    +   R   ++
Sbjct: 306 NKCLIKNPAERADLKQ 321

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (271), Expect = 1e-25
 Identities = 74/309 (23%), Positives = 135/309 (43%), Gaps = 54/309 (17%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L    ++  +V +K LK       +RDF  +  I+G+   HPN++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          ++V +Y  +GSL + L  +             V +L G A G+ ++  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSD 165

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEVI 510
           MG   + H ++ A N+LIN +L   +SDFGL   L + P     + G +      +PE I
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD-------LPRWVQSVVREEWT 562
             RK +  SDV+S+G++L E+++ G+ P    +  D++        LP         +  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCP 276

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPS 621
           A ++ +              ML     C  K  + RP  +++V ++++ +R   S    +
Sbjct: 277 AALYQL--------------MLD----CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318

Query: 622 SEENKSKDS 630
           S   +  + 
Sbjct: 319 SAAARPSNL 327

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  107 bits (269), Expect = 1e-25
 Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 56/308 (18%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNV 396
            +LGKG +G+  +A L         V VK LK  ++      +F ++   +     HP+V
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHV 87

Query: 397 VPL------RAYYYSKDEKLLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTA 449
             L                +++  +   G L   L  +R G     L  +T V+ ++  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR---- 505
            G+ ++ S     F H ++ A N ++ +D+  C++DFGL+  +           YR    
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIY------SGDYYRQGCA 198

Query: 506 --------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV 556
                   A E +    ++  SDV++FGV + E++T G+ P       ++ +    +   
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---LIGG 255

Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 615
            R           L +     EE+   M Q    C +  P  RP+   +   +E +    
Sbjct: 256 NR-----------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGHL 300

Query: 616 SENRPSSE 623
           S    S +
Sbjct: 301 SVLSTSQD 308

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  108 bits (271), Expect = 1e-25
 Identities = 72/313 (23%), Positives = 128/313 (40%), Gaps = 70/313 (22%)

Query: 344 EVLGKGSYGTAYKAVL--------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQH 393
           + LG+G +G    A          +E+ TV VK LK+        D   +ME++  +G+H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 394 PNVVPLRAYYY---SKDEKL-LVYDYFASGSLSTLLHGNR-----------GAGRTPLDW 438
            N++ L        ++D  L ++ +Y + G+L   L   R                 + +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 439 ETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP 498
           +  V      ARG+ ++ S    K  H ++ A NVL+ ++    I+DFGL   +N     
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254

Query: 499 SRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDD 545
                Y+            APE +  R ++H+SDV+SFGVL+ E+ T G +P      ++
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313

Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEV 604
           +  L   ++   R           + +  N   E+   M      C   VP  RP   ++
Sbjct: 314 LFKL---LKEGHR-----------MDKPANCTNELYMMMRD----CWHAVPSQRPTFKQL 355

Query: 605 VRMIEEVRQSDSE 617
           V  ++ +    + 
Sbjct: 356 VEDLDRILTLTTN 368

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (278), Expect = 1e-25
 Identities = 25/149 (16%), Positives = 53/149 (35%), Gaps = 6/149 (4%)

Query: 76  LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKI 134
              +        +     + ++++ +  N L    + + +  +  L  L   +N   GK+
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346

Query: 135 PS-SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 190
           P+     +L  L+L++N  T           Q+  LS   N L      FD      +  
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA 406

Query: 191 LNLSYNGLKGSIPSSLQKFPNSSFVGNSL 219
           ++ SYN +      +      + F G ++
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (277), Expect = 2e-25
 Identities = 24/206 (11%), Positives = 59/206 (28%), Gaps = 20/206 (9%)

Query: 34  LLDFADAVPHLRKLNWS--STNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLG 91
            L     +                 +++V  +  +D + +    +        I  +   
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS-SR 180

Query: 92  KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNS 151
                  +   SN +T  +   +  L  LR  Y+ ++ F  +            +  +  
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA---WENENSEYAQ 236

Query: 152 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG--SIPSSLQ 207
                     NL  LT + + +      +P     +P+++ +N++ N       +    Q
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 208 KFPNSSFV---------GNSLLCGPP 224
              ++             N+L   P 
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPV 322

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (276), Expect = 2e-25
 Identities = 28/147 (19%), Positives = 49/147 (33%), Gaps = 21/147 (14%)

Query: 85  IPNNT-LGKLDALEVLSLRSNVLTG-------GLPSEITSLPSLRYLYLQHNNFSGKIPS 136
           IPN      +  +  +    N +          L        ++  + L +N  S     
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

Query: 137 SFS--PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 185
            FS    L  ++L  N  T        +  ++ +N   LT + L+ N L+    +F    
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511

Query: 186 -PKLRHLNLSYNGLKGSIPSSLQKFPN 211
            P L  ++LSYN      P+       
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSST 537

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (273), Expect = 5e-25
 Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 13/138 (9%)

Query: 87  NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           N        L  + LR N LT  L  +   T+LP L  + L +N+FS   P+       L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538

Query: 143 VVL------DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
                    D   N      P+ I     LT L + SN++   +     P +  L++  N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDN 597

Query: 197 GLKGSIPSSLQKFPNSSF 214
                  S +  +  +  
Sbjct: 598 PNISIDLSYVCPYIEAGM 615

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (272), Expect = 6e-25
 Identities = 34/154 (22%), Positives = 55/154 (35%), Gaps = 19/154 (12%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPSSFS 139
           L G +P    G    L  L+L  N +T  +P+        +  L   HN     IP+ F 
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397

Query: 140 ----PQLVVLDLSFNSFTG-------NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIP 186
                 +  +D S+N            +  +      ++ ++L +N +S           
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 187 KLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
            L  +NL  N L   IP +  K  N +F    LL
Sbjct: 458 PLSSINLMGNMLTE-IPKNSLKDENENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  107 bits (269), Expect = 2e-24
 Identities = 26/143 (18%), Positives = 52/143 (36%), Gaps = 22/143 (15%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 140
           IP N  G  + +E LS   N L   +P+  +  S+  +  +   +N        +F P  
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426

Query: 141 -------QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---------D 184
                   +  ++LS N  +    +     + L+ ++L  N L+    N          +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486

Query: 185 IPKLRHLNLSYNGLKGSIPSSLQ 207
              L  ++L +N L   +    +
Sbjct: 487 TYLLTSIDLRFNKLT-KLSDDFR 508

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  106 bits (266), Expect = 3e-24
 Identities = 19/152 (12%), Positives = 49/152 (32%), Gaps = 33/152 (21%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGG-------------------LPSEITSLPSLRYLYL 125
           +    + +L  L    + ++                           +  +L  L  + +
Sbjct: 198 VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256

Query: 126 QHNNFSGKIPSSFS--PQLVVLDLSFNSFT--------GNIPQSIQNLTQLTGLSLQSNN 175
            +     K+P+     P++ +++++ N                      ++  + +  NN
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316

Query: 176 L-SGSIPN--FDIPKLRHLNLSYNGLKGSIPS 204
           L +  +      + KL  L   YN L+G +P+
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.3 bits (248), Expect = 7e-22
 Identities = 33/205 (16%), Positives = 56/205 (27%), Gaps = 25/205 (12%)

Query: 17  VSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRL 76
           V +     A+   D  AL +  DA   L   NWS      Q   G N   ++        
Sbjct: 18  VPIKLSRTAEYIKDYLALKEIWDA---LNGKNWSQQGFGTQP--GANWNFNKELDMWGAQ 72

Query: 77  PGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 136
           PG+         +L     +  LSL     +G +P  I  L  L  L L  +        
Sbjct: 73  PGV---------SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123

Query: 137 SFSPQ------LVVLDLSFNSFTGNIPQSI--QNLTQLTGLSLQSNNLSGSIPN--FDIP 186
                                +          ++ + L    + S+    SI        
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

Query: 187 KLRHLNLSYNGLKGSIPSSLQKFPN 211
           K   +    N +   +  ++ +   
Sbjct: 184 KDTQIGQLSNNI-TFVSKAVMRLTK 207

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.4 bits (217), Expect = 3e-18
 Identities = 20/110 (18%), Positives = 32/110 (29%), Gaps = 9/110 (8%)

Query: 85  IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 138
            P         L+   +R       N      P  IT  PSL  L +  N+    +    
Sbjct: 528 FPTQ-PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585

Query: 139 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKL 188
           +P + VLD+  N         +    +     L  +     I   D   +
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DIRGCDALDI 634

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 6/92 (6%)

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP------KLRHLNLS 194
           ++  L L     +G +P +I  LT+L  L+L S+    +   F                 
Sbjct: 82  RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 195 YNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 226
               + +      +   S  + + +   P  K
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (266), Expect = 2e-25
 Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 43/291 (14%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 397
            V+GKG +G  Y        +      +K L  +   +    F ++  ++  +  HPNV+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVL 85

Query: 398 PLRAYYYSKDE-KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            L       +    ++  Y   G L   +   +         +  +   L  ARG+ ++ 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLA 141

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYR------APE 508
                KF H ++ A N ++++     ++DFGL   +      +  +    R      A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
            ++T + + KSDV+SFGVLL E+LT G  P +     D+      +    R         
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGRR--------- 246

Query: 568 VELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
             L + +   + + Q M Q    C    P +RP    +V  +E++  +   
Sbjct: 247 --LPQPEYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQIVSALLG 291

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (267), Expect = 2e-25
 Identities = 65/310 (20%), Positives = 108/310 (34%), Gaps = 63/310 (20%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
           + LG G++G   +A        +    V VK LK       K     +++I+  +GQH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR---------GAGRTPLDWETRVKILL 446
           +V L          L++ +Y   G L   L                 +       +    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 505
             A+G+A + S       H ++ A NVL+       I DFGL   +         + Y  
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYIV 222

Query: 506 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 553
                      APE I    ++ +SDV+S+G+LL E+ + G  P   P         + V
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILVNSKFYKLV 280

Query: 554 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
           +   +          ++   +M+                AC A  P  RP   ++   ++
Sbjct: 281 KDGYQMAQPAFAPKNIYS--IMQ----------------ACWALEPTHRPTFQQICSFLQ 322

Query: 610 EVRQSDSENR 619
           E  Q D   R
Sbjct: 323 EQAQEDRRER 332

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  106 bits (267), Expect = 2e-25
 Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 65/308 (21%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 396
             LG+G++G  + A        ++   V VK LKE     ++DF+++ E++  + QH ++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHI 105

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR----------GAGRTPLDWETRVKILL 446
           V            L+V++Y   G L+  L  +                PL     + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR- 505
             A G+ ++  +    F H ++   N L+ Q L   I DFG++  +        +  YR 
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY------STDYYRV 216

Query: 506 -----------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV 553
                       PE I  RK + +SDV+SFGV+L E+ T GK P    +  + +D    +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC---I 273

Query: 554 QSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                         EV+   +MR                 C  + P  R ++ +V   ++
Sbjct: 274 TQGRELERPRACPPEVY--AIMR----------------GCWQREPQQRHSIKDVHARLQ 315

Query: 610 EVRQSDSE 617
            + Q+   
Sbjct: 316 ALAQAPPV 323

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (267), Expect = 2e-25
 Identities = 69/303 (22%), Positives = 135/303 (44%), Gaps = 49/303 (16%)

Query: 344 EVLGKGSYGTAYKAVL-----EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNV 396
           +V+G G +G  YK +L     ++   V +K LK       + DF  +  I+G+   H N+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 108

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           + L          +++ +Y  +G+L   L    G           V +L G A G+ ++ 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 164

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGYR------APEV 509
           +M    + H ++ A N+L+N +L   +SDFGL+  L + P     ++G +      APE 
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

Query: 510 IETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAE 564
           I  RK +  SDV+SFG+++ E++T G+ P    +  +++     +    R     +  + 
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---INDGFRLPTPMDCPSA 278

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE-VRQSDSENRPSSE 623
           ++ +              M+Q    C  +    RP   ++V ++++ +R  DS    +  
Sbjct: 279 IYQL--------------MMQ----CWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

Query: 624 ENK 626
           + +
Sbjct: 321 DPR 323

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (268), Expect = 2e-25
 Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 49/291 (16%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNVV 397
           EV+G+G +G  Y   L     +     VK L  +        F  +  I+     HPNV+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 153

Query: 398 PLRAYYYSKDEKLL-VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            L       +   L V  Y   G L   +             +  +   L  A+G+  + 
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 209

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAG-----YRAPE 508
           S    KF H ++ A N ++++     ++DFGL   M      +  +++       + A E
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 563
            ++T+K + KSDV+SFGVLL E++T G  P       D+      +    R    E    
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPD 323

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
            +++V              ML+    C     +MRP+  E+V  I  +  +
Sbjct: 324 PLYEV--------------MLK----CWHPKAEMRPSFSELVSRISAIFST 356

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (262), Expect = 3e-25
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 32/228 (14%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 399
            LGKG +G  Y A  ++S  ++ +K L +  + K   E Q+    EI   + +HPN++ L
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRL 74

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             Y++      L+ +Y   G++   L   +   +   +  T    +   A  +++ HS  
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTA-TYITELANALSYCHSKR 129

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETR 513
                H +IK  N+L+    +  I+DFG +    V A  SR      +  Y  PE+IE R
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGR 182

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 553
            H  K D++S GVL  E L GK P ++ T  +            P +V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  109 bits (274), Expect = 6e-25
 Identities = 25/154 (16%), Positives = 58/154 (37%), Gaps = 9/154 (5%)

Query: 70  RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN 129
            +    +     + PI  ++   L   + +   +N +T  +   I  L  L+ +Y  ++ 
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF-ISKAIQRLTKLQIIYFANSP 459

Query: 130 FSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPK 187
           F+    +         +  +     N   S  NL  LT + L +      +P+  +D+P+
Sbjct: 460 FTYDNIAVD---WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516

Query: 188 LRHLNLSYNGLKG--SIPSSLQKFPNSSFVGNSL 219
           L+ LN++ N       + +   +  +    G  +
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  105 bits (263), Expect = 1e-23
 Identities = 27/147 (18%), Positives = 48/147 (32%), Gaps = 18/147 (12%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG- 132
                          +   L  L  + L +      LP  +  LP L+ L +  N     
Sbjct: 472 ANSDYAKQYENEEL-SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 133 --------KIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSI 180
                   ++       P++ +  + +N+     P S  +Q + +L  L    N +   +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588

Query: 181 PNF-DIPKLRHLNLSYNGLKGSIPSSL 206
             F    KL  L L YN ++  IP   
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDF 614

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  103 bits (259), Expect = 3e-23
 Identities = 31/154 (20%), Positives = 51/154 (33%), Gaps = 18/154 (11%)

Query: 87  NNTLGKLDALEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +        L  + LR N LT  L  +   T+LP L  + + +N FS   P+      QL
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL 778

Query: 143 VVLDLSF------NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
               +        N      P  I     L  L + SN++   +     P+L  L+++ N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837

Query: 197 GLK-GSIPSSLQKFPNSSFV----GNSLLCGPPL 225
                 + S         +V        + G   
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 99.2 bits (247), Expect = 1e-21
 Identities = 23/142 (16%), Positives = 49/142 (34%), Gaps = 22/142 (15%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFSP-- 140
           IP +     D +E L    N L   +P+     S+  +  +   +N    +  +      
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

Query: 141 -----QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----------FDI 185
                    + LS+N       +     + ++ + L +N ++ SIP            + 
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727

Query: 186 PKLRHLNLSYNGLKGSIPSSLQ 207
             L  ++L +N L  S+    +
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFR 748

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 97.6 bits (243), Expect = 3e-21
 Identities = 26/144 (18%), Positives = 46/144 (31%), Gaps = 15/144 (10%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS----PQLV 143
             G    L  L L  N +   +P +       +  L   HN     IP+ F+      + 
Sbjct: 590 AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMG 647

Query: 144 VLDLSFNSFTGNIPQ-----SIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYN 196
            +D S+N                     + ++L  N +             +  + LS N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707

Query: 197 GLKGSIPSSLQKFPNSSFVGNSLL 220
            +  SIP +  K  + ++    LL
Sbjct: 708 LM-TSIPENSLKPKDGNYKNTYLL 730

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.3 bits (237), Expect = 2e-20
 Identities = 25/146 (17%), Positives = 47/146 (32%), Gaps = 21/146 (14%)

Query: 85  IPNNT-LGKLDALEVLSLRSNVLTGGLPSEITS------LPSLRYLYLQHNNFSGKIPSS 137
           IPN      +  +  +    N +       I+         +   + L +N         
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692

Query: 138 FS--PQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG---SIPNFDI 185
           F+    +  + LS N  T            + +N   LT + L+ N L+          +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTL 752

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPN 211
           P L ++++SYN    S P+       
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQ 777

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 93.0 bits (231), Expect = 9e-20
 Identities = 23/136 (16%), Positives = 44/136 (32%), Gaps = 12/136 (8%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 143
           +       +++  +  N L    P+   +  +  L  L   HN        +F    +L 
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT 598

Query: 144 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLK 199
            L L +N     IP+       Q+ GL    N L      F+      +  ++ SYN + 
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 200 GSIPSSLQKFPNSSFV 215
               +      +   +
Sbjct: 658 SEGRNISCSMDDYKGI 673

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.9 bits (215), Expect = 7e-18
 Identities = 39/250 (15%), Positives = 69/250 (27%), Gaps = 69/250 (27%)

Query: 29  SDRQALLDFADAV-------------PHLRKLNWSSTNPICQ--SWVGINCTQDRTRVFG 73
            D +AL    +A+               +  LNW+    +       G++   +  RV G
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL-DNNGRVTG 327

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS--------------------- 112
           L L G G  G +P+  +G+L  L+VLS  ++  T                          
Sbjct: 328 LSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386

Query: 113 ----EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN------IPQSIQN 162
                +     L    L  +  +         +   + L              I ++IQ 
Sbjct: 387 YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQR 446

Query: 163 LTQLTGLSLQSNNLSGSIPNFDI---------------------PKLRHLNLSYNGLKGS 201
           LT+L  +   ++  +      D                        L  + L        
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 202 IPSSLQKFPN 211
           +P  L   P 
Sbjct: 507 LPDFLYDLPE 516

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 10/100 (10%)

Query: 85  IPNNTLGKLDALEVLSLR------SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF 138
            P         L+   +R       N +    P+ IT+ PSL  L +  N+   K+    
Sbjct: 768 FPT-QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

Query: 139 SPQLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLS 177
           +PQL +LD++ N     ++      +       L  +   
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAGM-YVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 12/95 (12%)

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH---------L 191
           ++  L L+     G +P +I  LT+L  LS  +++ + S   F   +L           +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383

Query: 192 NLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLK 226
            + Y  +       L     S  + +++   P +K
Sbjct: 384 RMHYKKMFLDYDQRLNL---SDLLQDAINRNPEMK 415

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  104 bits (261), Expect = 6e-25
 Identities = 59/297 (19%), Positives = 109/297 (36%), Gaps = 62/297 (20%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVK--RLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           + LG+G +G  ++A    +     +K  RL    + +    ++++ + ++ +HP +V   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIV--- 66

Query: 401 AYYYS------------KDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
            Y+ +               K+ +Y         +L   ++G         +    + I 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIF 124

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-----------TPLMNV 494
           L  A  V  +HS       H ++K SN+    D    + DFGL           T L  +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 495 PATPSRSAG-----YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
           PA    +       Y +PE I    +SHK D++S G++L E+L    P    T+ + V  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS--TQMERVRT 236

Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                + VR      +F  +      +   +  ML          P  RP    ++ 
Sbjct: 237 ----LTDVRNLKFPPLFTQKYPCEYVM---VQDMLS-------PSPMERPEAINIIE 279

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (267), Expect = 7e-25
 Identities = 43/210 (20%), Positives = 91/210 (43%), Gaps = 27/210 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +VLG G+ GT     + ++  V VKR L E        +++++++    +HPNV+     
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCT 86

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
              +  + +  +   + +L   +   +      L+    + +L  T  G+AH+HS+    
Sbjct: 87  EKDRQFQYIAIEL-CAATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSLN--- 138

Query: 463 FTHGNIKASNVLI-----NQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEVI 510
             H ++K  N+LI     +  +   ISDFGL           +  +    + G+ APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 511 E---TRKHSHKSDVYSFGVLLLEMLTGKAP 537
                   ++  D++S G +   +++  + 
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  103 bits (260), Expect = 7e-25
 Identities = 61/303 (20%), Positives = 116/303 (38%), Gaps = 57/303 (18%)

Query: 346 LGKGSYGTAYKAVL---EESTTVVVKRLKE--VVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           LG G++G+  + V    ++   V +K LK+        +  ++ +I+ ++  +P +V L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLI 76

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                 +  +LV +    G L   L G R      +      ++L   + G+ ++     
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN- 130

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------------APE 508
             F H ++ A NVL+       ISDFGL+  +      +  + Y             APE
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKAL-----GADDSYYTARSAGKWPLKWYAPE 183

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTA 563
            I  RK S +SDV+S+GV + E L+ G+ P +     +++     ++   R     E   
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPP 240

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 623
           E++ +              M      C     + RP+   V + +     S +       
Sbjct: 241 ELYAL--------------MSD----CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282

Query: 624 ENK 626
            + 
Sbjct: 283 HHH 285

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (262), Expect = 1e-24
 Identities = 36/266 (13%), Positives = 83/266 (31%), Gaps = 54/266 (20%)

Query: 344 EVLGKGSYGTAYKAV---------------LEESTTVVVKRLKEVVVGKRDFEQ------ 382
            VLG+       +A                 E   +  +K++KE V+  R          
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 383 --------QMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 431
                       + +  Q   ++ +R            + Y     +L T      +  +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
               L    R+++ L   R +A +H  G     H  ++  +++++Q     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 492 MNVPATPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAPLQS 540
                  S S G+  PE+   R             +   D ++ G+++  +     P+  
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 541 PTRDDMV--------DLPRWVQSVVR 558
                          ++P+ V++++ 
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE 341

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  102 bits (257), Expect = 2e-24
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 36/235 (15%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM----EIVGRVGQHPNVVPL 399
            LGKG +G  Y A  +++  ++ +K L +  + K   E Q+    EI   + +HPN++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRM 79

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             Y++ +    L+ ++   G L   L   +  GR   +  +   +    A  + + H   
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEE-LADALHYCHERK 134

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 511
                H +IK  N+L+    +  I+DFG +     P+        T      Y  PE+IE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD----YLPPEMIE 185

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 558
            + H  K D++  GVL  E L G  P  SP+  +         +  P ++    +
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (255), Expect = 4e-24
 Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 67/303 (22%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPN 395
           E LG+  +G  YK  L      E++  V +K LK+   G  + +F  +  +  R  QHPN
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR-LQHPN 73

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRVKI 444
           VV L           +++ Y + G L   L                  ++ L+    V +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY 504
           +   A G+ ++ S       H ++   NVL+   L+  ISD GL   +        +  Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY------AADYY 184

Query: 505 R------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR 551
           +            APE I   K S  SD++S+GV+L E+ + G  P    +  D+V++  
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM-- 242

Query: 552 WVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
            +++       ++  A V+ +              M++    C  + P  RP   ++   
Sbjct: 243 -IRNRQVLPCPDDCPAWVYAL--------------MIE----CWNEFPSRRPRFKDIHSR 283

Query: 608 IEE 610
           +  
Sbjct: 284 LRA 286

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  105 bits (265), Expect = 5e-24
 Identities = 30/149 (20%), Positives = 46/149 (30%), Gaps = 9/149 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I N T  +L  L  L L    +         S   L  L L  N       ++ S    L
Sbjct: 48  IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKG 200
             L       +      + N   L  L L SN++S       F   KL+ L+   N +  
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

Query: 201 SIPSSLQKFPNSSFV-----GNSLLCGPP 224
                +     ++ +     GN +    P
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEP 196

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  105 bits (263), Expect = 8e-24
 Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 9/155 (5%)

Query: 81  LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS- 139
           L      +    L  L+VL+L  ++L          LP+L++L LQ N+F        + 
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 140 ----PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIPKLRHLNLS 194
                +L +L LSF   +     +  +L  +  + L  N L+ S        K  +LNL+
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLA 531

Query: 195 YNGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLK 226
            N +   +PS L        +    N L C     
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  104 bits (261), Expect = 1e-23
 Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 8/135 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS---- 139
           +   +     +L  LS++ N     L +  + +L +LR L L H++       +      
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 196
             L  L+LS+N       ++ +   QL  L L    L          ++  L+ LNLS++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 197 GLKGSIPSSLQKFPN 211
            L  S        P 
Sbjct: 436 LLDISSEQLFDGLPA 450

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (255), Expect = 8e-23
 Identities = 21/120 (17%), Positives = 33/120 (27%), Gaps = 4/120 (3%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
            E L    NVL     +  + L +L +L L           +F    +L  L L+ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
                ++     L  L      +S        +   L  L L  N +             
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  101 bits (253), Expect = 1e-22
 Identities = 30/136 (22%), Positives = 41/136 (30%), Gaps = 8/136 (5%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 140
              N  L  L  L+ L+L  N             P L  L L       K   S      
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSY 195
            L VL+LS +    +  Q    L  L  L+LQ N+              + +L  L LS+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 196 NGLKGSIPSSLQKFPN 211
             L      +      
Sbjct: 486 CDLSSIDQHAFTSLKM 501

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  100 bits (250), Expect = 3e-22
 Identities = 38/212 (17%), Positives = 65/212 (30%), Gaps = 21/212 (9%)

Query: 14  CVIVSLLPLAFADLNSDRQALLDF-----------ADAVPHLRKLNWSSTNPICQSWVGI 62
             I  L     + L       L+            A      + LN+             
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG-TQNLLVIFKG 221

Query: 63  NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSLPSL 120
                   ++      +     I       L    +E ++L+ +       +       L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280

Query: 121 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           + L L   + S ++PS       L  L LS N F      S  N   LT LS++ N    
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339

Query: 179 SIPNFDI---PKLRHLNLSYNGLKGSIPSSLQ 207
            +    +     LR L+LS++ ++ S   +LQ
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.5 bits (246), Expect = 1e-21
 Identities = 30/141 (21%), Positives = 47/141 (33%), Gaps = 5/141 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +    L    AL+ L      ++      + +  +L  LYL  N+ S           +L
Sbjct: 96  MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ-SNNLSGSIPN--FDIPKLRHLNLSYNGLK 199
            VLD   N+      + + +L Q T LSL  + N    I    FD    + LN       
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNL 215

Query: 200 GSIPSSLQKFPNSSFVGNSLL 220
             I   L+     S    +  
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFE 236

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 96.6 bits (241), Expect = 4e-21
 Identities = 28/150 (18%), Positives = 48/150 (32%), Gaps = 12/150 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I  +T      L+ L L +N L     + ++   +L++L+      S            L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-----LNLSYNG 197
             L L  N  +           +L  L  Q+N +   +   D+  L+      LNL+ N 
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGND 190

Query: 198 LKGSIPSSLQKFPNS---SFVGNSLLCGPP 224
           +   I             +F G   L    
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIF 219

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.5 bits (233), Expect = 4e-20
 Identities = 25/137 (18%), Positives = 38/137 (27%), Gaps = 9/137 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 140
           I    L     LE L L SN ++     +      L+ L  Q+N          S     
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP----NFDIPKLRHLNLSYN 196
             + L+L+ N   G I     +      L+         I     N  I  L        
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 197 GLKGSIPSSLQKFPNSS 213
             +   P+  +     S
Sbjct: 239 DDEDISPAVFEGLCEMS 255

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 22/140 (15%), Positives = 49/140 (35%), Gaps = 16/140 (11%)

Query: 87  NNTLGKLDA-------LEVLSLRSNVLTGGLPSEI--TSLPSLRYLYLQHNNFSGKIPSS 137
            N +  ++         + L+         +   +  +++ SL     +  +     P+ 
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 138 FSP----QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHL 191
           F       +  ++L  + F      +    + L  L L + +LS  +P+    +  L+ L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKL 306

Query: 192 NLSYNGLKGSIPSSLQKFPN 211
            LS N  +     S   FP+
Sbjct: 307 VLSANKFENLCQISASNFPS 326

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 12/145 (8%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QL 142
               N+L  L  LE+L L    L+       TSL  + ++ L HN  +     + S  + 
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG-- 200
           + L+L+ N  +  +P  +  L+Q   ++L+ N L  +  N  I  L     +   L+   
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN--IYFLEWYKENMQKLEDTE 583

Query: 201 ----SIPSSLQKFPNSSFVGNSLLC 221
                 P  L+          +L C
Sbjct: 584 DTLCENPPLLR---GVRLSDVTLSC 605

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 77.4 bits (191), Expect = 5e-15
 Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 3/93 (3%)

Query: 121 RYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           +    ++   + +IP +       L+ SFN        +   L  LT L L    +    
Sbjct: 15  KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 181 PNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            +      +L  L L+ N L     ++L     
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (255), Expect = 5e-24
 Identities = 65/300 (21%), Positives = 125/300 (41%), Gaps = 54/300 (18%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVVG-KRDFEQQMEIVGRVGQHPNV 396
             LG+G++G  + A        ++   V VK LK+  +  ++DF+++ E++  + QH ++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 79

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR-----------VKIL 445
           V         D  ++V++Y   G L+  L  +       +D + R           + I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT-PLMNVPATPSRSAGY 504
              A G+ ++ S     F H ++   N L+  +L   I DFG++  + +           
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 505 ---R--APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 558
              R   PE I  RK + +SDV+SFGV+L E+ T GK P    +  ++++    +     
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---ITQGRV 253

Query: 559 ----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
                    EV+D  +M                  C  + P  R N+ E+ +++  + ++
Sbjct: 254 LERPRVCPKEVYD--VML----------------GCWQREPQQRLNIKEIYKILHALGKA 295

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (256), Expect = 5e-24
 Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)

Query: 320 KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKR 378
             KL       ++F  EDL       +G+G+YG+  K V + S  ++ VKR++   V ++
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEK 62

Query: 379 DFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAG 432
           + +Q  M+  +V R    P +V    +Y    ++    +  +  +  S            
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWICMELMS-TSFDKFYKYVYSVL 118

Query: 433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM 492
              +  E   KI L T + + H+      K  H +IK SN+L+++  +  + DFG++  +
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 493 NVPATPSRSAG---YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
                 +R AG   Y APE I+          +SDV+S G+ L E+ TG+ P   P  + 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNS 234

Query: 546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 603
           + D    +  VV+ +   ++ + E   F       V        C+ K    RP   E
Sbjct: 235 VFDQ---LTQVVKGD-PPQLSNSEEREFSPSFINFVN------LCLTKDESKRPKYKE 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  102 bits (256), Expect = 5e-24
 Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 46/275 (16%)

Query: 289 GSNGVSKGKASSGGRSEKPKEEFGSGVQEP----------EKNKLVFFEGCSYNFDLEDL 338
           GS  VS G+A S     K      + +Q               + +      Y  ++  +
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60

Query: 339 LRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNV 396
                  +G+GS+G  ++    +      VK      V    F  + E+        P +
Sbjct: 61  THQ--PRVGRGSFGEVHRMKDKQTGFQCAVK-----KVRLEVFRVE-ELVACAGLSSPRI 112

Query: 397 VPLRAYY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGV 452
           VP    Y    +   + ++ +    GSL  L+   +  G  P   E R    LG    G+
Sbjct: 113 VP---LYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGL 163

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFG----LTPLMNVPATPSRSA--G-- 503
            ++H+       HG++KA NVL++ D     + DFG    L P     +  +     G  
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 504 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            + APEV+  +    K D++S   ++L ML G  P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 9e-24
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
           EV+G G+      A    +   V +KR+  +   +   ++   EI       HPN+V   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRT---PLDWETRVKILLGTARGVAH 454
           +YY  +   ++L LV    + GS+  ++      G      LD  T   IL     G+ +
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMNVPATPSRS--AG---YR 505
           +H  G     H ++KA N+L+ +D    I+DFG    L    ++     R    G   + 
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 506 APEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPL 538
           APEV+E  + +  K+D++SFG+  +E+ TG AP 
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  101 bits (253), Expect = 9e-24
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 35/211 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKR--LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E +GKGS+G  +K +   +  VV +K   L+E      D +Q++ ++ +    P V    
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVT--- 83

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            YY  Y KD KL ++ +Y   GS   LL         PLD      IL    +G+ ++HS
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 507
                  H +IKA+NVL+++  +  ++DFG      V    + +   R          AP
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFG------VAGQLTDTQIKRNTFVGTPFWMAP 188

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           EVI+   +  K+D++S G+  +E+  G+ P 
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPH 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  100 bits (252), Expect = 1e-23
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 31/213 (14%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPN 395
           E LG GS+G   +        ++ +V VK LK  V+       DF +++  +  +  H N
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 82

Query: 396 VVPLRAYYY---SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           ++ L    Y         +V +    GSL   L  ++G         T  +  +  A G+
Sbjct: 83  LIRL----YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGM 134

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR------- 505
            ++ S     F H ++ A N+L+       I DFGL   +           +R       
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           APE ++TR  SH SD + FGV L EM T G+ P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKE---VVVGKRDFEQQMEIVGRV 390
            LL    + LG G++GT  K      +   TV VK LK        K +   +  ++ ++
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
             +P +V +       +  +LV +    G L+  L  NR      +  +  ++++   + 
Sbjct: 76  -DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSM 128

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----- 505
           G+ ++       F H ++ A NVL+       ISDFGL+  +      +    Y+     
Sbjct: 129 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----RADENYYKAQTHG 180

Query: 506 -------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
                  APE I   K S KSDV+SFGVL+ E  + G+ P
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (255), Expect = 1e-23
 Identities = 39/317 (12%), Positives = 75/317 (23%), Gaps = 50/317 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-------------- 386
           E L  G     +     E      +K         R   +++                  
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 387 -----------VGRVGQHPNVVPLRAYY--YSKDEKLLVYDYFASGSLSTLLH--GNRGA 431
                         V   P    L      Y+    LL+    AS  L  L         
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TP 490
            R          +     R  A++ S G     HG+    N+ I  D    + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 491 LMNVPATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           +       S    Y   E +       +H  + +  G+ +  +     P    T      
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

Query: 549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM- 607
             R    V   +       +       + + +  ++      +      R    E +   
Sbjct: 304 WKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMETP 354

Query: 608 -IEEVRQSDSENRPSSE 623
              +++   S +  + +
Sbjct: 355 EFLQLQNEISSSLSTGQ 371

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 33/212 (15%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK-RDFEQQMEIVGRVGQHPNVVPLRA 401
            VLGKG+YG  Y    L     + +K + E      +   +++ +   + +H N+V    
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83

Query: 402 YY--YSKDEKLLVY-DYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 453
           Y   +S++  + ++ +    GSLS LL    G  +   D E  +      IL     G+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGFYTKQIL----EGLK 136

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCI--SDFG----LTPLMNVPATPSRSAGYRAP 507
           ++H        H +IK  NVLIN    G +  SDFG    L  +     T + +  Y AP
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

Query: 508 EVIE--TRKHSHKSDVYSFGVLLLEMLTGKAP 537
           E+I+   R +   +D++S G  ++EM TGK P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 2e-23
 Identities = 32/265 (12%), Positives = 77/265 (29%), Gaps = 53/265 (20%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME----------------- 385
            VLG+       +A  +E+  +  V           +  +QM+                 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 386 -----------IVGRVGQHPNVVPLRAYYYSKDEKLLVYDY-FASGSLSTLLH--GNRGA 431
                       + +  Q   ++ +R            + Y     +L T      +  +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
               L    R+++ L   R +A +H  G     H  ++  +++++Q     ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 492 MNVPATPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSP 541
               A      G+  PE                 +   D ++ G+ +  +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 542 TRDDMV--------DLPRWVQSVVR 558
                         ++P+ V++++ 
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLE 345

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 62/283 (21%), Positives = 110/283 (38%), Gaps = 58/283 (20%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 399
             LGKG +   ++    ++  V   K + + ++ K    ++M  EI + R   H +VV  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             ++   D   +V +     SL  L    +         E R   L     G  ++H   
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEP-EAR-YYLRQIVLGCQYLHRNR 135

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 511
                H ++K  N+ +N+DL+  I DFGL   +            TP+    Y APEV+ 
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 188

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 563
            + HS + DV+S G ++  +L GK P ++    +           +P+ +  V       
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 243

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                 L++         +MLQ         P  RP ++E++ 
Sbjct: 244 -----SLIQ---------KMLQ-------TDPTARPTINELLN 265

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  103 bits (257), Expect = 3e-23
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)

Query: 336 EDLLRASAEVLGKGSYGTAYKAVLE---ESTTVVVKRLKE--VVVGKRDFEQQMEIVGRV 390
            D L  +   LG G++G+  + V     +   V +K LK+        +  ++ +I+ ++
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR 450
             +P +V L       +  +LV +    G L   L G R      +      ++L   + 
Sbjct: 394 -DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSM 447

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PATPSRSAG----- 503
           G+ ++       F H N+ A NVL+       ISDFGL+  +        +RSAG     
Sbjct: 448 GMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAP 537
           + APE I  RK S +SDV+S+GV + E L+ G+ P
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 47/245 (19%), Positives = 102/245 (41%), Gaps = 28/245 (11%)

Query: 312 GSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLK 371
           GS     ++   +   G  Y  ++ DL       +G G+ G  +K    ++  V+  +  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 372 EVVVGKRDFEQ-QME--IVGRVGQHPNVVPLRAYY--YSKDEKL-LVYDYFASGSLSTLL 425
                K + ++  M+  +V +    P +V     +  +  +  + +  +   + +     
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKK 115

Query: 426 HGNRGAGRTPLDWETRV-KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS 484
              R  G  P   E  + K+ +   + + ++         H ++K SN+L+++     + 
Sbjct: 116 ---RMQGPIP---ERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLC 167

Query: 485 DFGLTPLMNVPATPSRSAG---YRAPEVIETRK-----HSHKSDVYSFGVLLLEMLTGKA 536
           DFG++  +       RSAG   Y APE I+        +  ++DV+S G+ L+E+ TG+ 
Sbjct: 168 DFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

Query: 537 PLQSP 541
           P ++ 
Sbjct: 228 PYKNC 232

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 58/283 (20%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 399
             LGKG +   ++    ++  V   K + + ++ K    ++M  EI + R   H +VV  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             ++   D   +V +     SL  L    +       + E R   L     G  ++H   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALT-EPEAR-YYLRQIVLGCQYLHRNR 161

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIE 511
                H ++K  N+ +N+DL+  I DFGL   +            TP+    Y APEV+ 
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 214

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTA 563
            + HS + DV+S G ++  +L GK P ++    +           +P+ +  V       
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----- 269

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                 L++         +MLQ         P  RP ++E++ 
Sbjct: 270 -----SLIQ---------KMLQ-------TDPTARPTINELLN 291

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 59/282 (20%), Positives = 118/282 (41%), Gaps = 59/282 (20%)

Query: 346 LGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPLRA 401
           LGKGS+   Y+A    +   V +K + +  + K    Q++  E+ +    +HP+++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLD-WETRVKILLGTARGVAHIHSMGG 460
           Y+   +   LV +   +G ++  L         P    E R   +     G+ ++HS G 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEAR-HFMHQIITGMLYLHSHG- 132

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--------TPSRSAGYRAPEVIET 512
               H ++  SN+L+ ++++  I+DFGL   + +P         TP+    Y +PE+   
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPEIATR 186

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVREEWTAE 564
             H  +SDV+S G +   +L G+ P  + T  +          ++P ++    +      
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK------ 240

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
               +L+          Q+L+       + P  R ++  V+ 
Sbjct: 241 ----DLIH---------QLLR-------RNPADRLSLSSVLD 262

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 69/313 (22%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
           + LG+G +G   KA           TTV VK LKE       RD   +  ++ +V  HP+
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPH 87

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT------- 448
           V+ L          LL+ +Y   GSL   L  +R  G   L                   
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 449 ------------ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 496
                       ++G+ ++  M   K  H ++ A N+L+ +     ISDFGL+  +    
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201

Query: 497 TPSRSAGYR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTR 543
                  Y             A E +    ++ +SDV+SFGVLL E++T G  P      
Sbjct: 202 ---EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 544 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQ-MLQIGMACVAKVPDMRPNMD 602
           + + +L   +++  R           + R  N  EEM + MLQ    C  + PD RP   
Sbjct: 259 ERLFNL---LKTGHR-----------MERPDNCSEEMYRLMLQ----CWKQEPDKRPVFA 300

Query: 603 EVVRMIEEVRQSD 615
           ++ + +E++    
Sbjct: 301 DISKDLEKMMVKR 313

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 68/323 (21%), Positives = 127/323 (39%), Gaps = 83/323 (25%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPN 395
             +G+G++G  ++A        E  T V VK LKE      + DF+++  ++     +PN
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 111

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR-------------------GAGRTPL 436
           +V L           L+++Y A G L+  L                         G  PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA 496
               ++ I    A G+A++      KF H ++   N L+ +++   I+DFGL        
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL-------- 220

Query: 497 TPSRSAG----YR------------APEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQ 539
             SR+      Y+             PE I   +++ +SDV+++GV+L E+ + G  P  
Sbjct: 221 --SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 540 SPTRDDMVDLPRWVQSVVR----EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVP 595
               ++++     V+        E    E+++  LMR                 C +K+P
Sbjct: 279 GMAHEEVIYY---VRDGNILACPENCPLELYN--LMR----------------LCWSKLP 317

Query: 596 DMRPNMDEVVRMIEEVRQSDSEN 618
             RP+   + R+++ + +     
Sbjct: 318 ADRPSFCSIHRILQRMCERAEGT 340

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.8 bits (249), Expect = 4e-22
 Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 7/134 (5%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---SP 140
              + +     +L+ L L  N +   + S    L  L +L  QH+N       S      
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 197
            L+ LD+S              L+ L  L +  N+   +     F  +  L  L+LS   
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 198 LKGSIPSSLQKFPN 211
           L+   P++     +
Sbjct: 482 LEQLSPTAFNSLSS 495

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 16/195 (8%)

Query: 42  PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSL 101
           P L  L+ S  N +             T +  L L   G++  + +N LG L+ LE L  
Sbjct: 347 PSLEFLDLSR-NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG-LEQLEHLDF 403

Query: 102 RSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP 157
           + + L   +       SL +L YL + H +        F+    L VL ++ NSF  N  
Sbjct: 404 QHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 158 QSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSS 213
             I   L  LT L L    L   +    F+ +  L+ LN++ N LK        +  +  
Sbjct: 463 PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521

Query: 214 FV---GNSLLCGPPL 225
            +    N   C  P 
Sbjct: 522 KIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 32/130 (24%), Positives = 48/130 (36%), Gaps = 8/130 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF-SGKIPSSFS--PQ 141
           +       L +L+ L      L       I  L +L+ L + HN   S K+P  FS    
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTG----LSLQSNNLSGSIPN-FDIPKLRHLNLSYN 196
           L  LDLS N         ++ L Q+      L L  N ++   P  F   +L  L L  N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

Query: 197 GLKGSIPSSL 206
               ++  + 
Sbjct: 211 FDSLNVMKTC 220

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 34/146 (23%), Positives = 49/146 (33%), Gaps = 21/146 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           I +     L  L  L L  N +   L     + L SL+ L     N +            
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 142 LVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH-------LNL 193
           L  L+++ N      +P+   NLT L  L L SN +  SI   D+  L         L+L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184

Query: 194 SYNGLKGSIPSSLQKFPNSSFVGNSL 219
           S N         +      +F    L
Sbjct: 185 SLN--------PMNFIQPGAFKEIRL 202

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 5/121 (4%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
            + L L  N L         S P L+ L L           ++     L  L L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLK-GSIPSSLQKFP 210
                +   L+ L  L     NL+         +  L+ LN+++N ++   +P       
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 211 N 211
           N
Sbjct: 150 N 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 7/109 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
             N     L +LEVL +  N        +I T L +L +L L         P++F+    
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLR 189
           L VL+++ N    ++P  I   LT L  + L +N    S P   I  L 
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP--RIDYLS 541

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.8 bits (166), Expect = 5e-12
 Identities = 29/140 (20%), Positives = 47/140 (33%), Gaps = 12/140 (8%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTG---GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 140
               + L  L  L +   R   L      +      L ++    L           S++ 
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 200
               L+L    F       +++L +LT     SN    +    D+P L  L+LS NGL  
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFSEVDLPSLEFLDLSRNGL-- 359

Query: 201 SIPSSLQKFPNSSFVGNSLL 220
               S +   + S  G + L
Sbjct: 360 ----SFKGCCSQSDFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 5/90 (5%)

Query: 125 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 182
               NF  KIP +       LDLSFN        S  +  +L  L L    +  +I +  
Sbjct: 14  CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71

Query: 183 FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           +  +  L  L L+ N ++     +     +
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSS 101

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 25/156 (16%), Positives = 42/156 (26%), Gaps = 13/156 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQ------HNNFSGKIPSS 137
           I      ++  L  L+LR+N  +  +    I  L  L    L         N      S+
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 138 FS--PQLVVLDLSFNS---FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 192
                 L + +        +  +I      LT ++  SL S  +            +HL 
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 193 LSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKAC 228
           L            L+     +F  N           
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 34/210 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
           E +G+G+ GT Y A+   +   V ++++   +  +   E    EI V R  ++PN+V   
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIV--- 80

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            Y   Y   ++L +V +Y A GSL+ ++        T +D      +     + +  +HS
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS 134

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 508
                  H +IK+ N+L+  D    ++DFG    +TP  +    +  TP     Y  APE
Sbjct: 135 NQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP-----YWMAPE 186

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           V+  + +  K D++S G++ +EM+ G+ P 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 65/288 (22%), Positives = 108/288 (37%), Gaps = 39/288 (13%)

Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QME-- 385
           S     +DL       LG+G+YG   K     S  ++ VKR++   V  ++ ++  M+  
Sbjct: 1   SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLD 57

Query: 386 IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKIL 445
           I  R    P  V      + + +  +  +   +                P D     KI 
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--KIA 115

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-- 503
           +   + + H+HS       H ++K SNVLIN      + DFG++  +         AG  
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCK 173

Query: 504 -YRAPEVIETRKH----SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR 558
            Y APE I    +    S KSD++S G+ ++E+   + P      D      + ++ VV 
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY-----DSWGTPFQQLKQVVE 228

Query: 559 EE---WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE 603
           E      A+ F  E + F +              C+ K    RP   E
Sbjct: 229 EPSPQLPADKFSAEFVDFTS-------------QCLKKNSKERPTYPE 263

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.9 bits (244), Expect = 6e-22
 Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 38/225 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           ++LG GS GT       +   V VKR L +          +++++     HPNV+     
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRYYCS 77

Query: 403 YYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +     +  +   + +L  L+                  + +L   A GVAH+HS+  
Sbjct: 78  ETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135

Query: 461 PKFTHGNIKASNVLINQDLDGC-------------ISDFGL--------TPLMNVPATPS 499
               H ++K  N+L++                   ISDFGL        +        PS
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 500 RSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAP 537
            ++G+RAPE++E        R+ +   D++S G +   +L+    
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 31/151 (20%), Positives = 52/151 (34%), Gaps = 9/151 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
           + +   G    ++ L L+ N +          S  +L +L LQ+N            +L 
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGS 201
            LDLS N     +    Q+   +T +SL++N L   I         L H +L  NG    
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 202 IPSSLQKFPN--SSFVGNSL--LCGPPLKAC 228
                        +    ++  L G   + C
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 127
           I    L     LE+L+L SNVL        L              E+   PS+  L+  +
Sbjct: 49  ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108

Query: 128 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 185
           NN S ++  S       + L+ N  T          +++  L L+ N +  ++   ++  
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166

Query: 186 --PKLRHLNLSYNGLKGSIPSSLQ 207
               L HLNL YN +   +   + 
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
              +       ++ L L  N L+    +++     L  L L  N     +       L  
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 204
           LDL+ N         +     +  L   +NN+S  +        +++ L+ N +      
Sbjct: 85  LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138

Query: 205 SLQKFPN 211
                  
Sbjct: 139 DEGCRSR 145

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 150
            +  ++  +  + L   L S   S  +++ L L  N  S    +  +   +L +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
                    +++L+ L  L L +N +   +     P +  L+ + N +   +  S 
Sbjct: 69  VLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)

Query: 109 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 166
            +     +    +   +  ++    + S       +  LDLS N  +      +   T+L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 167 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 208
             L+L SN L     +   +  LR L+L+ N ++  +    S++ 
Sbjct: 61  ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 17/108 (15%), Positives = 35/108 (32%), Gaps = 4/108 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLV 143
           +          +  +SLR+N L   +   +    +L +  L+ N F  G +   FS    
Sbjct: 206 MGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHL 191
           V  ++  +    +    +    +  L          +P     +L  L
Sbjct: 264 VQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 55/308 (17%), Positives = 111/308 (36%), Gaps = 55/308 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 398
           + +G G     ++ + E+     +K +       +    +  ++  + ++ Q  +  ++ 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 92

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L  Y  +     +V +   +  L++ L       +  +D   R          V  IH  
Sbjct: 93  LYDYEITDQYIYMVMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 459 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 510
           G     H ++K +N LI    DG   + DFG+   M    T         +  Y  PE I
Sbjct: 147 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 511 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE 559
           +             K S KSDV+S G +L  M  GK P Q    + +  L   +      
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHEI 259

Query: 560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDS 616
           E+  ++ + +L         +   L+       + P  R ++ E++    +  +    + 
Sbjct: 260 EF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPVNQ 305

Query: 617 ENRPSSEE 624
             + ++EE
Sbjct: 306 MAKGTTEE 313

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 28/207 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRAY 402
           E LG+GSYG+ YKA+ +E+  +V   +K+V V     E   EI + +    P+VV    Y
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVA--IKQVPVESDLQEIIKEISIMQQCDSPHVV---KY 89

Query: 403 Y--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
           Y  Y K+  L +V +Y  +GS+S ++          L  +    IL  T +G+ ++H M 
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR 145

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGYRAPEVIE 511
                H +IKA N+L+N +    ++DFG    LT  M     V  TP     + APEVI+
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPEVIQ 198

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPL 538
              ++  +D++S G+  +EM  GK P 
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPY 225

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 41/224 (18%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
            VLG+G++G   KA    +S    +K+++           ++ ++  +  H  VV   A 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAA 70

Query: 403 YYSKDEKL-------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +  +   +             +  +Y  +G+L  L+H      +    W    +IL    
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA-- 128

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------- 500
             +++IHS G     H ++K  N+ I++  +  I DFGL   ++      +         
Sbjct: 129 --LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 501 ---------SAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTG 534
                    +A Y A EV++   H + K D+YS G++  EM+  
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 34/217 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP---- 398
           E++G G+YG  YK    ++  +  +K +      + + +Q++ ++ +   H N+      
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 399 -LRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            ++      D++L LV ++  +GS++ L+   +G     L  E    I     RG++H+H
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 146

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------A 506
                K  H +IK  NVL+ ++ +  + DFG      V A   R+ G R          A
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFG------VSAQLDRTVGRRNTFIGTPYWMA 197

Query: 507 PEVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 538
           PEVI   ++       KSD++S G+  +EM  G  PL
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 95.3 bits (238), Expect = 2e-21
 Identities = 30/114 (26%), Positives = 55/114 (48%), Gaps = 3/114 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L  L + +N +T    S + +L +LR LYL  +N S   P +   ++  L+L  
Sbjct: 84  LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGA 141

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
           N    ++   + N+T L  L++  + +    P  ++  L  L+L+YN ++   P
Sbjct: 142 NHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP 194

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 93.0 bits (232), Expect = 9e-21
 Identities = 28/123 (22%), Positives = 56/123 (45%), Gaps = 6/123 (4%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L +L   +   N +T    + + ++  L  L + +N  +   P +   QL  L++  
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT 252

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 208
           N  + +I  ++++LT+L  L++ SN +S  I   + + +L  L L+ N L       +  
Sbjct: 253 NQIS-DIN-AVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309

Query: 209 FPN 211
             N
Sbjct: 310 LTN 312

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 92.6 bits (231), Expect = 2e-20
 Identities = 24/114 (21%), Positives = 46/114 (40%), Gaps = 3/114 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  +  L+L +N       S ++++  L YL +  +      P +    L  L L++
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNY 186

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
           N      P  + +LT L   +   N ++   P  ++ +L  L +  N +    P
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 87.2 bits (217), Expect = 8e-19
 Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 11/124 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           +  +  L  L + +N +T    S + +L  L +L +  N  S    ++     +L +L++
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP-S 204
             N  +      + NL+QL  L L +N L          +  L  L LS N +    P +
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330

Query: 205 SLQK 208
           SL K
Sbjct: 331 SLSK 334

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 87.2 bits (217), Expect = 9e-19
 Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           L  L  L  L + +N ++    + +  L  L+ L +  N  S    S  +   QL  L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 199
           + N       + I  LT LT L L  N+++   P   + K+   + +   +K
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 8/124 (6%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
               L       L+   +T         L S+  L +     +      +   L  L+L+
Sbjct: 17  PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLN 74

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 207
            N  T   P  + NL +LT L + +N ++  I     +  LR L L+ + +    P  L 
Sbjct: 75  GNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP--LA 129

Query: 208 KFPN 211
               
Sbjct: 130 NLTK 133

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 4/100 (4%)

Query: 112 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 171
                L       LQ  + +  +       +  L ++      +I   I+ LT L  L+L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73

Query: 172 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
             N ++   P  ++ KL +L +  N +  +  S+LQ   N
Sbjct: 74  NGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 34/210 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLR 400
             +G+GS G    A  + S   V   +K + + K+   +    E+ + R  QH NVV   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVA--VKMMDLRKQQRRELLFNEVVIMRDYQHFNVV--- 105

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
             Y  Y   E+L ++ ++   G+L+ ++       +  L+ E    +     + +A++H+
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA 159

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFG----LTPLMN----VPATPSRSAGY-RAPE 508
            G     H +IK+ ++L+  D    +SDFG    ++  +     +  TP     Y  APE
Sbjct: 160 QGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP-----YWMAPE 211

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           VI    ++ + D++S G++++EM+ G+ P 
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 63/309 (20%), Positives = 114/309 (36%), Gaps = 59/309 (19%)

Query: 344 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNV 396
           + LG G   T Y A   +L     V +K +      K +    FE+++    ++  H N+
Sbjct: 17  DKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNI 73

Query: 397 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           V +      +++    LV +Y    +LS  +  +      PL  +T +        G+ H
Sbjct: 74  VSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSR----SAGYRAPEV 509
            H M      H +IK  N+LI+ +    I DFG+   L     T +     +  Y +PE 
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLPRWVQSVVREE 560
            +       +D+YS G++L EML G+ P    T         +D + ++   V+  + + 
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243

Query: 561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSENR 619
                              ++      +    K    R   + E+   +  V   +  N 
Sbjct: 244 L----------------SNVI------LRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281

Query: 620 PSSEENKSK 628
              E +K K
Sbjct: 282 DVYELDKMK 290

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 94.9 bits (236), Expect = 9e-21
 Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 9/151 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
           + +   G    ++ L L+ N +          S  +L +L LQ+N            +L 
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLK 194

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLK-G 200
            LDLS N     +    Q+   +T +SL++N L   I         L H +L  NG   G
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 201 SIPSSLQKFPNSSFV---GNSLLCGPPLKAC 228
           ++     K      V       L G   + C
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 94.1 bits (234), Expect = 2e-20
 Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 6/127 (4%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
              +       ++ L L  N L+    +++     L  L L  N     +       L  
Sbjct: 25  ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRT 84

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 204
           LDL+ N         +     +  L   +NN+S  +        +++ L+ N +      
Sbjct: 85  LDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDL 138

Query: 205 SLQKFPN 211
                  
Sbjct: 139 DEGCRSR 145

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 89.9 bits (223), Expect = 4e-19
 Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 24/144 (16%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT-----GGLP------------SEITSLPSLRYLYLQH 127
           I    L     LE+L+L SNVL        L              E+   PS+  L+  +
Sbjct: 49  ISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAAN 108

Query: 128 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-- 185
           NN S ++  S       + L+ N  T          +++  L L+ N +  ++   ++  
Sbjct: 109 NNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA 166

Query: 186 --PKLRHLNLSYNGLKGSIPSSLQ 207
               L HLNL YN +   +   + 
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV 189

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 88.8 bits (220), Expect = 8e-19
 Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN 150
            +  ++  +  + L   L S   S  +++ L L  N  S    +  +   +L +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
                    +++L+ L  L L +N +   +     P +  L+ + N +   +  S 
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS-RVSCSR 118

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 81.8 bits (202), Expect = 1e-16
 Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 7/105 (6%)

Query: 109 GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQL 166
            +     +    +   +  ++    + S       +  LDLS N  +      +   T+L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 167 TGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP--SSLQK 208
             L+L SN L     +   +  LR L+L+ N ++  +    S++ 
Sbjct: 61  ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.3 bits (172), Expect = 8e-13
 Identities = 21/132 (15%), Positives = 41/132 (31%), Gaps = 3/132 (2%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFSPQLVVLDL 147
                  +  +SLR+N L   +   +    +L +  L+ N F  G +   FS    V  +
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 207
           +  +      Q+ +  T  T     +      +P     +L  L    + L     S  +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETE 326

Query: 208 KFPNSSFVGNSL 219
           +           
Sbjct: 327 RLECERENQARQ 338

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 16/158 (10%), Positives = 37/158 (23%), Gaps = 33/158 (20%)

Query: 88  NTLGKLDALEVLSLRSNVL-TGGLPSEITSLPSLRYLYLQ-------------------- 126
             L     LE   LR N    G L    +    ++ +  Q                    
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 127 -HNNFSGKIPSSFSPQLVVLDLSFNSFT-------GNIPQSIQNLTQLTGLSLQSNNLSG 178
                   +P+ F+ +L+ L    ++           +    +N  +   +         
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR- 349

Query: 179 SIPN---FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS 213
           ++ +           L      L   + +  +      
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 13/130 (10%), Positives = 27/130 (20%), Gaps = 9/130 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----- 139
           +      +     +    +             L +L+       +  G            
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334

Query: 140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 198
             +   +D     +   I Q          L  +   L   + N    +  H  L     
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN---GRRAHAELDGTLQ 391

Query: 199 KGSIPSSLQK 208
           +      LQ 
Sbjct: 392 QAVGQIELQH 401

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 54/322 (16%), Positives = 111/322 (34%), Gaps = 77/322 (23%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--VVP 398
           + +G G     ++ + E+     +K +       +    +  ++  + ++ Q  +  ++ 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 73

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L  Y  +     +V +   +  L++ L   +      +D   R          V  IH  
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIHQH 127

Query: 459 GGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPEVI 510
           G     H ++K +N LI    DG   + DFG+   M    T         +  Y  PE I
Sbjct: 128 G---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 511 E-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT-----------RDDMVD 548
           +             K S KSDV+S G +L  M  GK P Q               +  ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241

Query: 549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR-- 606
            P   +  ++          ++++           L+       + P  R ++ E++   
Sbjct: 242 FPDIPEKDLQ----------DVLK---------CCLK-------RDPKQRISIPELLAHP 275

Query: 607 -MIEEVRQSDSENRPSSEENKS 627
            +  +    +   + ++EE K 
Sbjct: 276 YVQIQTHPVNQMAKGTTEEMKY 297

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 34/258 (13%)

Query: 294 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 353
           ++     G     P       +++P+  +L F +     F            +G GS+G 
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL-------REIGHGSFGA 69

Query: 354 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQ--QMEI-VGRVGQHPNVVPLRAYY--YSKD 407
            Y A    ++ VV +K++        +  Q    E+   +  +HPN +    Y   Y ++
Sbjct: 70  VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---QYRGCYLRE 126

Query: 408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 467
               +   +  GS S LL  ++     PL       +  G  +G+A++HS       H +
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 179

Query: 468 IKASNVLINQDLDGCISDFG----LTPLMNVPATPSRSAGYRAPEVIETRKHS---HKSD 520
           +KA N+L+++     + DFG    + P  +   TP     + APEVI          K D
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY----WMAPEVILAMDEGQYDGKVD 235

Query: 521 VYSFGVLLLEMLTGKAPL 538
           V+S G+  +E+   K PL
Sbjct: 236 VWSLGITCIELAERKPPL 253

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 63/379 (16%), Positives = 131/379 (34%), Gaps = 67/379 (17%)

Query: 285 KKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEK---NKLVFFEGCSYNFDLEDLLRA 341
                 +G+ +  A+   R      + G+   +      N+ +  +G  Y+         
Sbjct: 9   GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL------- 61

Query: 342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPN--V 396
             + +G G     ++ + E+     +K +       +    +  ++  + ++ Q  +  +
Sbjct: 62  --KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKI 118

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           + L  Y  +     +V +   +  L++ L   +      +D   R          V  IH
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH 172

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR------SAGYRAPE 508
             G     H ++K +N LI    DG   + DFG+   M    T         +  Y  PE
Sbjct: 173 QHG---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 509 VIE-----------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 557
            I+             K S KSDV+S G +L  M  GK P Q    + +  L   +    
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNH 285

Query: 558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQS 614
             E+  ++ + +L         +   L+       + P  R ++ E++    +  +    
Sbjct: 286 EIEF-PDIPEKDLQDV------LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPV 331

Query: 615 DSENRPSSEENKSKDSNVQ 633
           +   + ++EE K     + 
Sbjct: 332 NQMAKGTTEEMKYVLGQLV 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 93.7 bits (233), Expect = 6e-20
 Identities = 47/227 (20%), Positives = 71/227 (31%), Gaps = 24/227 (10%)

Query: 16  IVSLLPLAFADLNSDRQALLDFAD-------AVPHLRKLNWSSTNPICQSWVGINCTQDR 68
           I  +    F  L   +   LD  D        +P +  +  S    +    + +      
Sbjct: 350 IAIIQDQTFKFLEKLQT--LDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANL-- 405

Query: 69  TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQH 127
                + L    L        L ++  L++L L  N  +     +  +  PSL  L+L  
Sbjct: 406 -----IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460

Query: 128 NNFSGKIPSSFS-------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           N       +            L VL L+ N      P    +LT L GLSL SN L+   
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS 520

Query: 181 PNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPLKA 227
            N     L  L++S N L    P             N  +C   L  
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELST 567

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 87.2 bits (216), Expect = 6e-18
 Identities = 30/137 (21%), Positives = 41/137 (29%), Gaps = 9/137 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI--PSSFS--P 140
           I       L  L +L L S+ +    P     L  L  L L     S  +     F    
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 141 QLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLS----GSIPNFDIPKLRHLNLSY 195
            L  LDLS N      +  S   L  L  +   SN +       +       L   +L+ 
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 196 NGLKGSIPSSLQKFPNS 212
           N L   +     K  N 
Sbjct: 184 NSLYSRVSVDWGKCMNP 200

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 6e-16
 Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 13/137 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           + +     L  L+VL+L  N +          L +L+ L L +N       S+F   P++
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             +DL  N       Q+ + L +L  L L+ N L+ +I     P +  + LS N      
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI--PSIPDIFLSGN------ 391

Query: 203 PSSLQKFPNSSFVGNSL 219
              L   P  +   N +
Sbjct: 392 --KLVTLPKINLTANLI 406

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 6e-16
 Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 8/127 (6%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI-PSSFS--PQLVVLDLSF 149
           L+  E L L  N +     S    L  L+ L L        I   +F   P L +LDL  
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKG-SIPS 204
           +      P + Q L  L  L L    LS ++           L  L+LS N ++   +  
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142

Query: 205 SLQKFPN 211
           S  K  +
Sbjct: 143 SFGKLNS 149

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 79.8 bits (197), Expect = 1e-15
 Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 19/160 (11%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGL--PSEITSLPSLRYLYLQHNNFSG-KIPSSFS-- 139
           +  +    L  L  L L    L+  +       +L +L  L L  N      +  SF   
Sbjct: 88  LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQ--LTGLSLQSNNLSGSIP--------NFDIPKLR 189
             L  +D S N         ++ L    L+  SL +N+L   +          F    L 
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207

Query: 190 HLNLSYNGLKGSIPS----SLQKFPNSSFVGNSLLCGPPL 225
            L++S NG    I      ++ K    S +    + G   
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.5 bits (183), Expect = 5e-14
 Identities = 34/150 (22%), Positives = 49/150 (32%), Gaps = 8/150 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
           +  +    L  L+VL L  N L    P   + L +LR L L  N  +    +     L +
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSI- 202
           LD+S N      P    +L+ L    +  N           I  L H N++  G    I 
Sbjct: 531 LDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAGPPADIY 587

Query: 203 ---PSSLQKFPNSSFVGNSLLCGPPLKACF 229
              P S       S           LK+  
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 29/147 (19%), Positives = 54/147 (36%), Gaps = 16/147 (10%)

Query: 79  IGLVGPIPNNTLGKLD------ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 132
              + P  N  L  LD       +++    SN ++      +     +       +N   
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254

Query: 133 KIPSSFSP----QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FD 184
              ++F+      +  LDLS      ++   + + L  L  L+L  N ++  I +   + 
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG 312

Query: 185 IPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           +  L+ LNLSYN L     S+    P 
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 26/152 (17%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS---- 139
            + + GKL++L+ +   SN +      E+  L   +L +  L  N+   ++   +     
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

Query: 140 ----PQLVVLDLSFNSFTGNIP------------QSIQNLTQLTGLSLQSNNLS----GS 179
                 L +LD+S N +T +I              S+     + G     +N+      +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259

Query: 180 IPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
                   +RHL+LS+  +        +   +
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 25/105 (23%), Positives = 37/105 (35%), Gaps = 13/105 (12%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
             R  + +  N + ++P         L LSFN        S   L QL  L L S     
Sbjct: 5   DGRIAFYRFCNLT-QVPQVL-NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 179 SIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
           +I    F ++P LR L+L  +         +      +F G   L
Sbjct: 63  TIDKEAFRNLPNLRILDLGSS--------KIYFLHPDAFQGLFHL 99

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.3 bits (217), Expect = 6e-20
 Identities = 24/125 (19%), Positives = 54/125 (43%), Gaps = 7/125 (5%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           +     ++ L++ +   T    + I+ L +L  L +   + +     + S    L +LD+
Sbjct: 62  IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSL 206
           S ++   +I   I  L ++  + L  N     I     +P+L+ LN+ ++G+       +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DY-RGI 177

Query: 207 QKFPN 211
           + FP 
Sbjct: 178 EDFPK 182

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.9 bits (216), Expect = 9e-20
 Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 3/109 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           +  L  LE L +    +T      ++ L SL  L + H+     I +  +  P++  +DL
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
           S+N    +I   ++ L +L  L++Q + +       D PKL  L     
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 8e-17
 Identities = 28/125 (22%), Positives = 55/125 (44%), Gaps = 5/125 (4%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           T  ++++L  ++L +  +T    + I    +++ L + + + +   P S    L  L + 
Sbjct: 39  TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIM 96

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL 206
               T +   ++  LT LT L +  +    SI      +PK+  ++LSYNG    I   L
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155

Query: 207 QKFPN 211
           +  P 
Sbjct: 156 KTLPE 160

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.0 bits (172), Expect = 6e-14
 Identities = 19/91 (20%), Positives = 40/91 (43%), Gaps = 5/91 (5%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL 147
           L  L +L +L +  +     + ++I +LP +  + L +N     I       P+L  L++
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
            F+    +  + I++  +L  L   S  + G
Sbjct: 167 QFDGVH-DY-RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 23/121 (19%), Positives = 45/121 (37%), Gaps = 7/121 (5%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
             A     L  +            + SL Y+ L + N +      ++  +  L ++    
Sbjct: 22  FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHA 78

Query: 153 TGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFP 210
           T N    I  L+ L  L +   +++   IPN   +  L  L++S++    SI + +   P
Sbjct: 79  T-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 211 N 211
            
Sbjct: 137 K 137

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.3 bits (126), Expect = 6e-08
 Identities = 10/97 (10%), Positives = 35/97 (36%), Gaps = 3/97 (3%)

Query: 115 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 174
           ++  +     L  ++ +    +  +  L  + L+  + T ++   I+    +  L++ + 
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMN-SLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76

Query: 175 NLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           + +   P   +  L  L +    +      +L    +
Sbjct: 77  HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 90.1 bits (224), Expect = 8e-20
 Identities = 34/133 (25%), Positives = 57/133 (42%), Gaps = 10/133 (7%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT-GGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQL 142
           +  +    L+ + V+ L +N L   G+ +     +  L Y+ +   N +  IP    P L
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 194

Query: 143 VVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 198
             L L  N  T  +   S++ L  L  L L  N++S ++ N    + P LR L+L+ N L
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL 252

Query: 199 KGSIPSSLQKFPN 211
              +P  L     
Sbjct: 253 V-KVPGGLADHKY 264

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 32/146 (21%), Positives = 53/146 (36%), Gaps = 18/146 (12%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 140
            I N     +  L  + +    +T  +P  +   PSL  L+L  N  + K+ + S     
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLN 216

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 198
            L  L LSFNS +     S+ N   L  L L +N L   +P    D   ++ + L  N  
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN-- 273

Query: 199 KGSIPSSLQKFPNSSFVGNSLLCGPP 224
                 ++    ++ F          
Sbjct: 274 ------NISAIGSNDFCPPGYNTKKA 293

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 25/125 (20%), Positives = 46/125 (36%), Gaps = 15/125 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +   +L  L+ L  L L  N ++      + + P LR L+L +N    K+P   +    +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 143 VVLDLSFNSFTGNIPQS-------IQNLTQLTGLSLQSNNLS-GSIPN---FDIPKLRHL 191
            V+ L  N+ +  I  +              +G+SL SN +    I       +     +
Sbjct: 266 QVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324

Query: 192 NLSYN 196
            L   
Sbjct: 325 QLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 37/154 (24%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +P +T        +L L++N +T     +  +L +L  L L +N  S   P +F+   +L
Sbjct: 50  LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 143 VVLDLSFNSFT---GNIPQSIQ------------------NLTQLTGLSLQSNNL-SGSI 180
             L LS N        +P+++Q                   L Q+  + L +N L S  I
Sbjct: 103 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 162

Query: 181 PN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            N  F  + KL ++ ++   +  +IP  L   P+
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 28/96 (29%), Positives = 37/96 (38%), Gaps = 8/96 (8%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
            LR +         K+P    P   +LDL  N  T       +NL  L  L L +N +S 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS- 89

Query: 179 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            I    F  + KL  L LS N LK  +P  +     
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 91.6 bits (228), Expect = 8e-20
 Identities = 41/120 (34%), Positives = 53/120 (44%), Gaps = 5/120 (4%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           LG L  L+ LSL  N L       + SL +L  L L +N  S   P S   +L  L L  
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 274

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 208
           N  +   P  +  LT LT L L  N L    P  ++  L +L L +N +    P SSL K
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 332

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 6/123 (4%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           +   LD +  L      +       +  L +L  +   +N  +   P     +LV + ++
Sbjct: 41  SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 98

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 208
            N      P  + NLT LTGL+L +N ++   P  ++  L  L LS N +     S+L  
Sbjct: 99  NNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSG 154

Query: 209 FPN 211
             +
Sbjct: 155 LTS 157

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.9 bits (216), Expect = 3e-18
 Identities = 38/124 (30%), Positives = 52/124 (41%), Gaps = 6/124 (4%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 147
            TL  L  L  L L +N ++    + ++ L  L  L L  N  S   P +    L  L+L
Sbjct: 237 GTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 294

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 207
           + N      P  I NL  LT L+L  NN+S   P   + KL+ L    N +     SSL 
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLA 350

Query: 208 KFPN 211
              N
Sbjct: 351 NLTN 354

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.2 bits (214), Expect = 5e-18
 Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 7/124 (5%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 147
           + L  L  L  L L SN ++    S ++ L SL+ L    N  +   P +    L  LD+
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERLDI 184

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ 207
           S N  +      +  LT L  L   +N +S   P   +  L  L+L+ N LK     +L 
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLA 240

Query: 208 KFPN 211
              N
Sbjct: 241 SLTN 244

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 9/123 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L +L+ LS  + V        + +L +L  L +  N  S     +    L  L  + 
Sbjct: 152 LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATN 208

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 208
           N  +   P  +  LT L  LSL  N L   I     +  L  L+L+ N +    P  L  
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP--LSG 263

Query: 209 FPN 211
              
Sbjct: 264 LTK 266

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 4/115 (3%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           T   L       L    +T       T L  +  L              +   L  ++ S
Sbjct: 19  TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFS 76

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
            N  T   P  ++NLT+L  + + +N ++   P  ++  L  L L  N +    P
Sbjct: 77  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.5 bits (189), Expect = 6e-15
 Identities = 20/129 (15%), Positives = 45/129 (34%), Gaps = 3/129 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           +  L  L+ L   +N ++    S + +L ++ +L   HN  S   P +   ++  L L+ 
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLND 384

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
            ++T        N++    +   +  L       D       ++++N            F
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTF 443

Query: 210 PNSSFVGNS 218
                +G  
Sbjct: 444 SQPVTIGKG 452

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 4/100 (4%)

Query: 112 SEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL 171
              T+L       L   N +  +  +   Q+  L              ++ L  LT ++ 
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75

Query: 172 QSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            +N L+   P  ++ KL  + ++ N +    P  L    N
Sbjct: 76  SNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLTN 113

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 14/79 (17%), Positives = 31/79 (39%), Gaps = 5/79 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN--FSGKIPSSFSPQL 142
            P N    +     +   +  L    P+ I+   S     +  N   ++ ++  +FS Q 
Sbjct: 390 APVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFS-QP 446

Query: 143 VVLDLSFNSFTGNIPQSIQ 161
           V +     +F+G + Q ++
Sbjct: 447 VTIGKGTTTFSGTVTQPLK 465

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 39/216 (18%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
             LG G++G  YKA  +E+  +   K ++     + + E   +EI +     HP +V   
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIV--- 79

Query: 401 AYY--YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
                Y  D KL ++ ++   G++  ++          L       +       +  +HS
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS 135

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYR----------AP 507
                  H ++KA NVL+  + D  ++DFG      V A   ++   R          AP
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFG------VSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 508 EVIETRKHS-----HKSDVYSFGVLLLEMLTGKAPL 538
           EV+           +K+D++S G+ L+EM   + P 
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 10/130 (7%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
              + +     +L+ L L  N +   + S    L  L +L  QH+N       S F    
Sbjct: 68  GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYN 196
            L+ LD+S           I   L+ L  L +  N+   +       ++  L  L+LS  
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 197 GLKGSIPSSL 206
            L+  +  + 
Sbjct: 186 QLE-QLSPTA 194

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 35/153 (22%), Positives = 55/153 (35%), Gaps = 15/153 (9%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 141
             +    L  L  L +          + I   L SL  L +  N+F        F+    
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 197
           L  LDLS       +  +   +L+ L  L++  NN   S+  F    +  L+ L+ S N 
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNH 234

Query: 198 LKGSIPSSLQKFPNS----SFVGNSLLCGPPLK 226
           +  S    LQ FP+S    +   N   C    +
Sbjct: 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 267

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 32/119 (26%), Positives = 44/119 (36%), Gaps = 11/119 (9%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVLDLSFNS 151
              L L SN L          L  L  L L  N  S K   S S      L  LDLSFN 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 152 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSSL 206
               +  +   L QL  L  Q +NL   +  F +      L +L++S+   +    + +
Sbjct: 90  VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 8/119 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
             N     L +LEVL +  N        +I T L +L +L L         P++F+    
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSYN 196
           L VL++S N+F        + L  L  L    N++  +            L  LNL+ N
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 8/98 (8%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLS 177
           S   +       +  +P+        L+L  N    ++P  +   LTQLT LSL SN LS
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 178 -GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
                +        L++L+LS+NG+  ++ S+      
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 344 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNV 396
            ++G+G  G  Y+A   V E    V +K + E +     F  +M+      GR+ Q P+V
Sbjct: 40  RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHV 96

Query: 397 VPLRAYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           VP+  + + + +    +         L+ +L       + PL     V I+      +  
Sbjct: 97  VPI--HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDA 149

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFG---------LTPLMNVPATPSRSAGYR 505
            H+ G    TH ++K  N+L++ D    + DFG         LT L N   T      Y 
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY----YM 202

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           APE       ++++D+Y+   +L E LTG  P
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPP 234

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 34/218 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 400
           ++LG+G+    ++   +++  +  +K       +   D   ++ E++ ++  H N+V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73

Query: 401 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           A       +   L+ ++   GSL T+L     A   P   E    +L     G+ H+   
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131

Query: 459 GGPKFTHGNIKASNVLINQDLDGC----ISDFGL-------TPLMNVPATPSRSAGYRAP 507
           G     H NIK  N++     DG     ++DFG           +++  T      Y  P
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE----EYLHP 184

Query: 508 EVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAP 537
           ++ E         +K+    D++S GV      TG  P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 17/128 (13%)

Query: 92  KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 149
                  L LRS  L    P +   L  L+++ +       ++P +      L  L L+ 
Sbjct: 79  TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-----------FDIPKLRHLNLSYNGL 198
           N     +P SI +L +L  LS+++      +P              +  L+ L L + G+
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 199 KGSIPSSL 206
           + S+P+S+
Sbjct: 196 R-SLPASI 202

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 16/137 (11%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------- 139
           +T+ +   LE L+L  N L   LP+ I SL  LR L ++      ++P   +        
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179

Query: 140 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 194
                L  L L +     ++P SI NL  L  L ++++ LS ++      +PKL  L+L 
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237

Query: 195 YNGLKGSIPSSLQKFPN 211
                 + P        
Sbjct: 238 GCTALRNYPPIFGGRAP 254

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 24/137 (17%), Positives = 53/137 (38%), Gaps = 17/137 (12%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
           +   +L  L+ +++ +  L   LP  +     L  L L  N     +P+S +   +L  L
Sbjct: 98  DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155

Query: 146 DLSFNSFTGNIPQSIQN---------LTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLS 194
            +        +P+ + +         L  L  L L+   +  S+P    ++  L+ L + 
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214

Query: 195 YNGLKGSIPSSLQKFPN 211
            + L  ++  ++   P 
Sbjct: 215 NSPLS-ALGPAIHHLPK 230

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 83.8 bits (208), Expect = 9e-18
 Identities = 28/128 (21%), Positives = 52/128 (40%), Gaps = 6/128 (4%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
                L  L+ L L    +   LP+ I +L +L+ L ++++  S  +  +    P+L  L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 203
           DL   +   N P        L  L L+  +   ++P     + +L  L+L        +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 204 SSLQKFPN 211
           S + + P 
Sbjct: 295 SLIAQLPA 302

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 20/134 (14%), Positives = 40/134 (29%), Gaps = 10/134 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSL--PSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
               +  ++ +     L       +     P    L L+      + P        L  +
Sbjct: 52  QANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 203
            +        +P ++Q    L  L+L  N L  ++P     + +LR L++        +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167

Query: 204 SSLQKFPNSSFVGN 217
             L     S     
Sbjct: 168 EPLASTDASGEHQG 181

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 20/96 (20%), Positives = 30/96 (31%), Gaps = 3/96 (3%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
             +  L  LE L LR        P        L+ L L+  +    +P       QL  L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 181
           DL        +P  I  L     + +   +L   + 
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 19/137 (13%), Positives = 41/137 (29%), Gaps = 28/137 (20%)

Query: 95  ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS----------------- 137
             E L  + +         ++             + + +  +S                 
Sbjct: 13  GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATA 72

Query: 138 ------FSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLR 189
                   P  V L+L         P     L+ L  +++ +  L   +P+       L 
Sbjct: 73  DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130

Query: 190 HLNLSYNGLKGSIPSSL 206
            L L+ N L+ ++P+S+
Sbjct: 131 TLTLARNPLR-ALPASI 146

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 19/120 (15%), Positives = 35/120 (29%), Gaps = 27/120 (22%)

Query: 117 LPSLRYLYLQHNNFSGKIPSSFS-------------------PQLVVLDLSFNSFTG--N 155
                 LY Q +          S                          +   +      
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70

Query: 156 IPQSIQNLTQ--LTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
               +++ TQ     L L+S  L    P+  F +  L+H+ +   GL   +P ++Q+F  
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 30/146 (20%), Positives = 50/146 (34%), Gaps = 11/146 (7%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
                 L  L  L  L +  N     +P        +R+L L        + +     L 
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLE 434

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI-PKLRHLNLSYNGLKGSI 202
           VLD+S N+   +       L +L  L +  N L  ++P+  + P L  + +S N LK   
Sbjct: 435 VLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVP 489

Query: 203 PSSLQKFPNSSFV---GNSLLCGPPL 225
                +  +   +    N   C  P 
Sbjct: 490 DGIFDRLTSLQKIWLHTNPWDCSCPR 515

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 88.6 bits (220), Expect = 1e-18
 Identities = 33/146 (22%), Positives = 57/146 (39%), Gaps = 12/146 (8%)

Query: 73  GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG 132
            L +P   L     +     L+ ++ +++ ++ +     S    L SL +L L  N    
Sbjct: 290 RLHIPQFYL-FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 133 KIPSSFS-----PQLVVLDLSFNSFT--GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI 185
           +   + +     P L  L LS N         + +  L  LT L +  N       +   
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQW 408

Query: 186 P-KLRHLNLSYNGLK---GSIPSSLQ 207
           P K+R LNLS  G++     IP +L+
Sbjct: 409 PEKMRFLNLSSTGIRVVKTCIPQTLE 434

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 87.5 bits (217), Expect = 3e-18
 Identities = 33/134 (24%), Positives = 52/134 (38%), Gaps = 8/134 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           I +  L     L+VL L+S+ +   +  +   SL SL +L L  N+ S    S F     
Sbjct: 41  IGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99

Query: 142 LVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---IPKLRHLNLSYNG 197
           L  L+L  N +    +     NLT L  L + +      I   D   +  L  L +    
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159

Query: 198 LKGSIPSSLQKFPN 211
           L+     SL+   +
Sbjct: 160 LRNYQSQSLKSIRD 173

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 10/135 (7%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSG-KIPSSFS--P 140
           I  +    L +LE L L  N L+  L S     L SL+YL L  N +    + S F    
Sbjct: 65  IEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123

Query: 141 QLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN 196
            L  L +        I       LT L  L +++ +L  +  +  +     + HL L  +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS 182

Query: 197 GLKGSIPSSLQKFPN 211
                +        +
Sbjct: 183 ESAFLLEIFADILSS 197

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 7/116 (6%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
           ++ L L  N +T     ++ +  +L+ L L+ +  +     +F     L  LDLS N  +
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSS 205
                    L+ L  L+L  N    ++    +      L+ L +        I   
Sbjct: 88  SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 17/150 (11%), Positives = 42/150 (28%), Gaps = 14/150 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I       L +L  L +++  L       + S+  + +L L  +  +  +         +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG------------SIPNFDIPKLRH 190
             L+L   +        +      + +   +   S                  ++ ++  
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258

Query: 191 LNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
            + + NGL    PS          V    +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTI 288

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 116 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 175
           S  +      +  +F+  IPS  +  +  LDLSFN  T      ++    L  L L+S+ 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 176 LSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 206
           ++ +I    F  +  L HL+LS N L  S+ SS 
Sbjct: 62  IN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 21/149 (14%), Positives = 49/149 (32%), Gaps = 22/149 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
             + +L  +  +  L+L  +     L      L S+RYL L+  N +    S      V 
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222

Query: 145 LDLSFNSFTGN---------IPQSIQNLTQLTGLSLQSNNLSG-------------SIPN 182
             +   +F G+         + + ++ + +L+ +      L+G              +  
Sbjct: 223 SPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 183 FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            +   +R L++    L   + +       
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 20/152 (13%), Positives = 50/152 (32%), Gaps = 27/152 (17%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSG--------- 132
           P         ++ L+ R +VLT      L   +  +  L  +       +G         
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274

Query: 133 ----KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 185
               ++    +  +  L +       ++      L ++  ++++++ +   +P      +
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHL 333

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN 217
             L  L+LS N +        +   NS+  G 
Sbjct: 334 KSLEFLDLSENLM------VEEYLKNSACKGA 359

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 28/152 (18%), Positives = 51/152 (33%), Gaps = 25/152 (16%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
           +P         L  LS+ +N L   +  +   +  SL+ L L  N  +  +  S  P L 
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLF 189

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
             ++S+N  +     ++     +  L    N+++  +      +L  L L +N L     
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLT-DTA 242

Query: 204 S---------------SLQKFPNSSFVGNSLL 220
                            L+K     FV    L
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 34/129 (26%), Positives = 56/129 (43%), Gaps = 13/129 (10%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
           +TL    A+E L    N +   +   +     L  L LQHNN +    +     P LV +
Sbjct: 199 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 253

Query: 146 DLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSI 202
           DLS+N     I       + +L  L + +N L  ++  +   IP L+ L+LS+N L   +
Sbjct: 254 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HV 310

Query: 203 PSSLQKFPN 211
             +  +F  
Sbjct: 311 ERNQPQFDR 319

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 24/146 (16%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 128
           I ++T     +L+ L L SN LT      +PS             +    ++  L   HN
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215

Query: 129 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DI 185
           + +  +    + +L +L L  N+ T +    + N   L  + L  N L   I       +
Sbjct: 216 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 271

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPN 211
            +L  L +S N L  ++    Q  P 
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPT 296

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)

Query: 93  LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 149
           L+  ++++ +++ +   LP+ +  S   +  L L           +F+    +  L + F
Sbjct: 44  LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 150 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 205
           N+    +P  + QN+  LT L L+ N+LS S+P     + PKL  L++S N L+  I   
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159

Query: 206 L 206
            
Sbjct: 160 T 160

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 7/125 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I  +   K+  LE L + +N L   L      +P+L+ L L HN+    +  +     +L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             L L  NS    +   +     L  L+L  N+   +        +    +        I
Sbjct: 321 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377

Query: 203 PSSLQ 207
              L+
Sbjct: 378 DYQLE 382

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.4 bits (178), Expect = 9e-14
 Identities = 19/140 (13%), Positives = 41/140 (29%), Gaps = 16/140 (11%)

Query: 87  NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 144
           ++ L        + +           E  +L + + +  +++       +      Q+ +
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73

Query: 145 LDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG 200
           L+L+       I          +  L +  N +   +P     ++P L  L L  N    
Sbjct: 74  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN---- 127

Query: 201 SIPSSLQKFPNSSFVGNSLL 220
                L   P   F     L
Sbjct: 128 ----DLSSLPRGIFHNTPKL 143

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 35/213 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  ++A L ES  V +K+   V+  KR   ++++I+ R+ +HPNVV L+A++
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKK---VLQDKRFKNRELQIM-RIVKHPNVVDLKAFF 101

Query: 404 YSKDEKL------LVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTARGVA 453
           YS  +K       LV +Y     +   ++    +    +  +     +K+ +    R +A
Sbjct: 102 YSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATP------SRSAGYRA 506
           +IHS+G     H +IK  N+L++       + DFG    + +   P      SR   YRA
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA-KILIAGEPNVSYICSRY--YRA 209

Query: 507 PEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
           PE+I    + +   D++S G ++ E++ G+ PL
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 89.4 bits (221), Expect = 1e-18
 Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 23/219 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEI-VGRVGQHPNVVPLRA 401
           E LG G +G   + + +++   V +K+ ++ +  K      +EI + +   HPNVV  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 402 YY------YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 454
                      D  LL  +Y   G L   L+            E  ++ LL   +  + +
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK---EGPIRTLLSDISSALRY 136

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSRSA----GYRAP 507
           +H        H ++K  N+++          I D G    ++              Y AP
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAP 192

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           E++E +K++   D +SFG L  E +TG  P     +   
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 57/312 (18%), Positives = 108/312 (34%), Gaps = 74/312 (23%)

Query: 344 EVLGKGSYGTAYKA---VLEESTTVVVKRLKEVVVGKRDFEQ--QME--IVGRVGQHPNV 396
           E+LG G     + A          V VK L+  +     F    + E      +  HP +
Sbjct: 18  EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAI 74

Query: 397 V----------PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           V          P     Y      +V +Y    +L  ++H        P+  +  ++++ 
Sbjct: 75  VAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 123

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 500
              + +   H  G     H ++K +N++I+      + DFG+   +              
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 501 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT---------RDDMVDLP 550
            +A Y +PE         +SDVYS G +L E+LTG+ P    +         R+D +   
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240

Query: 551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIE 609
              + +     +A++            + +V      +  +AK P+ R     E+   + 
Sbjct: 241 ARHEGL-----SADL------------DAVV------LKALAKNPENRYQTAAEMRADLV 277

Query: 610 EVRQSDSENRPS 621
            V   +    P 
Sbjct: 278 RVHNGEPPEAPK 289

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 50/241 (20%), Positives = 99/241 (41%), Gaps = 44/241 (18%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           +LG+GS+ T   A    ++    +K L K  ++ +          +++ R+  HP  V L
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKL 95

Query: 400 RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVA 453
             + +  DEKL     Y  +G L   +   R  G      ET  +     I+      + 
Sbjct: 96  Y-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD---ETCTRFYTAEIVSA----LE 144

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRS------AGYR 505
           ++H  G     H ++K  N+L+  + D    I+DFG   +++  +  +R+      A Y 
Sbjct: 145 YLHGKG---IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVV 557
           +PE++  +     SD+++ G ++ +++ G  P ++     +         D P       
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259

Query: 558 R 558
           R
Sbjct: 260 R 260

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 46/225 (20%), Positives = 79/225 (35%), Gaps = 43/225 (19%)

Query: 402 YYYSKDEKLLVY---DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
                  K+ +Y         +L   +  NR       +    + I +  A  V  +HS 
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGL-------------TPLMNVPATPSRSAG-- 503
           G     H ++K SN+    D    + DFGL                M   AT +   G  
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 504 -YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
            Y +PE I    +SHK D++S G++L E+L         T+ + V +   +  V   ++ 
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-----STQMERVRI---ITDVRNLKFP 292

Query: 563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
                     F     +   M+Q     ++  P  RP   +++  
Sbjct: 293 LL--------FTQKYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 32/212 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           +V+G GS+G  Y+A L +S  +V   +K+V+  KR   ++++I+ ++  H N+V LR ++
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKL-DHCNIVRLRYFF 116

Query: 404 YSKDEKL------LVYDYFASGSLSTLLHG---NRGAGRTPLDWETRVKILL-GTARGVA 453
           YS  EK       LV DY     +   ++    +    +  L     VK+ +    R +A
Sbjct: 117 YSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLA 170

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGL--TPLMNVPATP---SRSAGYRAP 507
           +IHS G     H +IK  N+L++ D     + DFG     +   P      SR   YRAP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAP 225

Query: 508 EVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
           E+I      +   DV+S G +L E+L G+ P+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)

Query: 339 LRASAEVLGKGSYGTAYKAVLEESTT------VVVKRLKEVVVGKRDFEQQMEIVGRVGQ 392
           L    + LG+GS+    K V  + +       ++ KR++       + ++++  +     
Sbjct: 12  LDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEA------NTQKEITALKLCEG 64

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLST--LLHGN---RGAGRTPLDWETRVKILLG 447
           HPN+V L   ++ +    LV +    G L        +     A          ++ L+ 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-------MRKLVS 117

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGL----TPLMNVPATPSR 500
               V+H+H +G     H ++K  N+L  +++ +    I DFG      P      TP  
Sbjct: 118 ---AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR 551
           +  Y APE++    +    D++S GV+L  ML+G+ P QS  R        
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 37/154 (24%), Positives = 60/154 (38%), Gaps = 17/154 (11%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 140
           +   T   L  L  L L    L   L   +   L +L+YLYLQ N     +P  +F    
Sbjct: 96  VDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            L  L L  N  + ++P+   + L  L  L L  N ++  +    F  + +L  L L  N
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFAN 211

Query: 197 GLKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 226
            L  ++P+  L       ++    N  +C    +
Sbjct: 212 NLS-ALPTEALAPLRALQYLRLNDNPWVCDCRAR 244

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 25/115 (21%), Positives = 49/115 (42%), Gaps = 8/115 (6%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
            + + L  N ++    +   +  +L  L+L  N  +    ++F+    L  LDLS N+  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 154 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPS 204
            ++  +    L +L  L L    L   +    F  +  L++L L  N L+ ++P 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 8/102 (7%)

Query: 110 LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
           +P  I    + + ++L  N  S    +SF     L +L L  N        +   L  L 
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 168 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 206
            L L  N    S+    F  + +L  L+L   GL+  +   L
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 18/86 (20%), Positives = 27/86 (31%), Gaps = 5/86 (5%)

Query: 123 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 182
                      +P         + L  N  +     S +    LT L L SN L+  I  
Sbjct: 16  TSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73

Query: 183 ---FDIPKLRHLNLSYNGLKGSIPSS 205
                +  L  L+LS N    S+  +
Sbjct: 74  AAFTGLALLEQLDLSDNAQLRSVDPA 99

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 22/216 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 399
           + LG G+YG       + +     +K +++  V         +++ ++  +  HPN++ L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKL 101

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHSM 458
             ++  K    LV + +  G L      +    R   + E    +++     GV ++H  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFN-EVDAAVIIKQVLSGVTYLHKH 155

Query: 459 GGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIET 512
                 H ++K  N+L+          I DFGL+ +            +A Y APEV+  
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR- 211

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           +K+  K DV+S GV+L  +L G  P    T  +++ 
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 54/302 (17%), Positives = 110/302 (36%), Gaps = 39/302 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 400
           ++LG+G+    ++   +++  +  +K       +   D   ++ E++ ++  H N+V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLF 73

Query: 401 AYYYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           A       +   L+ ++   GSL T+L     A   P   E    +L     G+ H+   
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHLREN 131

Query: 459 GGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVPATPSRSA----GYRAPEVI 510
           G     H NIK  N++     DG     ++DFG    +        S      Y  P++ 
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMY 187

Query: 511 ET--------RKHSHKSDVYSFGVLLLEMLTGKAP---LQSPTRDDMV-------DLPRW 552
           E         +K+    D++S GV      TG  P    + P R+  V            
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 553 VQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKV-PDMRPNMDEVVRMIEEV 611
           +  V + E     +  ++    ++   +  +L   +A + +   +     D+      ++
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 612 RQ 613
             
Sbjct: 308 LH 309

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 42/222 (18%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV--VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
           E +G GSY    + +  ++T +   VK + +    KRD  +++EI+ R GQHPN++ L+ 
Sbjct: 28  EDIGVGSYSVCKRCI-HKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETRVKILLGTARG 451
            Y       +V +    G L              LD           E    +L    + 
Sbjct: 84  VYDDGKYVYVVTELMKGGEL--------------LDKILRQKFFSEREAS-AVLFTITKT 128

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC----ISDFGLTPLMNVP----ATPSRSAG 503
           V ++H+ G     H ++K SN+L   +        I DFG    +        TP  +A 
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
           + APEV+E + +    D++S GVLL  MLTG  P  +   D 
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 87.6 bits (217), Expect = 4e-18
 Identities = 40/237 (16%), Positives = 84/237 (35%), Gaps = 42/237 (17%)

Query: 344 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRD------FEQQMEIVGRVGQHPN 395
             +  G  G  Y A+        VV+K L        D         + + +  V  HP+
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVH----SGDAEAQAMAMAERQFLAEV-VHPS 140

Query: 396 VVPLRAYYYSKDEKL-------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           +V  + + + +           +V +Y    SL              L     +  LL  
Sbjct: 141 IV--QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEI 191

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSRSAGYRAP 507
              ++++HS+G     + ++K  N+++ ++     + D G    +N       + G++AP
Sbjct: 192 LPALSYLHSIG---LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTPGFQAP 246

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQS------PTRDDMVDLPRWVQSVVR 558
           E++ T   +  +D+Y+ G  L  +               P  D ++        ++R
Sbjct: 247 EIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLR 302

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 86.7 bits (215), Expect = 4e-18
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFE---QQMEIVGRVGQHPNVVP 398
            VLGKGS+G       + +     VK + K  V  K D E   ++++++ ++  HPN++ 
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMK 90

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVAHIHS 457
           L  ++  K    LV + +  G L      +    R     E     ++     G+ ++H 
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFS-EVDAARIIRQVLSGITYMHK 144

Query: 458 MGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVIE 511
                  H ++K  N+L+          I DFGL+              +A Y APEV+ 
Sbjct: 145 NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH 201

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
              +  K DV+S GV+L  +L+G  P       D++ 
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 87.3 bits (216), Expect = 4e-18
 Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 10/130 (7%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           I          ++ L +  N +   LP  +  ++P L  L L+ N+ S  +P   F   P
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 199
           +L  L +S N+    I     Q  T L  L L SN L+  +    IP L H N+SYN L 
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205

Query: 200 G-SIPSSLQK 208
             +IP ++++
Sbjct: 206 TLAIPIAVEE 215

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.7 bits (204), Expect = 1e-16
 Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL 145
           +TL    A+E L    N +   +   +     L  L LQHNN +    +     P LV +
Sbjct: 205 STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEV 259

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP 203
           DLS+N     +      + +L  L + +N L  ++  +   IP L+ L+LS+N L   + 
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVE 317

Query: 204 SSLQKFPN 211
            +  +F  
Sbjct: 318 RNQPQFDR 325

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 82.7 bits (204), Expect = 1e-16
 Identities = 33/146 (22%), Positives = 56/146 (38%), Gaps = 24/146 (16%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT----GGLPS------------EITSLPSLRYLYLQHN 128
           I ++T     +L+ L L SN LT      +PS             +    ++  L   HN
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221

Query: 129 NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-I 185
           + +  +    + +L +L L  N+ T +    + N   L  + L  N L   I    F  +
Sbjct: 222 SIN-VVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKM 277

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPN 211
            +L  L +S N L  ++    Q  P 
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPT 302

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.8 bits (194), Expect = 2e-15
 Identities = 30/121 (24%), Positives = 57/121 (47%), Gaps = 11/121 (9%)

Query: 93  LDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF 149
           L+  ++++ +++ +   LP+ +  S   +  L L           +F+    +  L + F
Sbjct: 50  LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 150 NSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSS 205
           N+    +P  + QN+  LT L L+ N+LS S+P     + PKL  L++S N L+  I   
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165

Query: 206 L 206
            
Sbjct: 166 T 166

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 74.2 bits (182), Expect = 6e-14
 Identities = 26/126 (20%), Positives = 44/126 (34%), Gaps = 7/126 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I  +   K+  LE L + +N L   L      +P+L+ L L HN+    +  +     +L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             L L  NS    +  S      L  L+L  N+   +        +    +        I
Sbjct: 327 ENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383

Query: 203 PSSLQK 208
              L+ 
Sbjct: 384 DYQLEH 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 21/142 (14%), Positives = 42/142 (29%), Gaps = 17/142 (11%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I +N L        + +           E  +L + + +  +++       +      Q+
Sbjct: 19  IDSN-LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 143 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 198
            +L+L+       I          +  L +  N +   +P     ++P L  L L  N  
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN-- 133

Query: 199 KGSIPSSLQKFPNSSFVGNSLL 220
                  L   P   F     L
Sbjct: 134 ------DLSSLPRGIFHNTPKL 149

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 8/129 (6%)

Query: 87  NNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLD 146
           N     +  L+VL L  N L   +         L  LYL HN+    +  S    L  L 
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLT 351

Query: 147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
           LS N +  N  +++     +   ++   +    I      +L H        K  +   L
Sbjct: 352 LSHNDWDCNSLRAL--FRNVARPAVDDADQHCKID----YQLEHGLCCKESDKPYLDRLL 405

Query: 207 QKFPNSSFV 215
           Q    +S V
Sbjct: 406 QYIALTSVV 414

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 30/132 (22%), Positives = 44/132 (33%), Gaps = 9/132 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
           +P      L  +  + +  N L   G          L YL +     +  IP      L 
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLN 196

Query: 144 VLDLSFNSFTGNIPQ-SIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLK 199
            L L  N     I    +   ++L  L L  N +   I N     +P LR L+L  N L 
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254

Query: 200 GSIPSSLQKFPN 211
             +P+ L     
Sbjct: 255 -RVPAGLPDLKL 265

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 37/200 (18%), Positives = 61/200 (30%), Gaps = 43/200 (21%)

Query: 16  IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF-GL 74
           I  +    F+ L               ++  +     NP+  S             F GL
Sbjct: 135 IRKVPKGVFSGL--------------RNMNCIEMGG-NPLENSGF-------EPGAFDGL 172

Query: 75  RLPGIGLVG----PIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNN 129
           +L  + +       IP +     + L  L L  N +   +  E       L  L L HN 
Sbjct: 173 KLNYLRISEAKLTGIPKDLP---ETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228

Query: 130 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--------GS 179
                  S S  P L  L L  N  +  +P  + +L  L  + L +NN++          
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287

Query: 180 IPNFDIPKLRHLNLSYNGLK 199
                      ++L  N + 
Sbjct: 288 GFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 17/126 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           I    L +   L  L L  N +   + +   + LP+LR L+L +N  S ++P+       
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265

Query: 142 LVVLDLSFNSFTGNIPQSI-------QNLTQLTGLSLQSNNLS-GSIPN--FD-IPKLRH 190
           L V+ L  N+ T  +  +               G+SL +N +    +    F  +     
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324

Query: 191 LNLSYN 196
           +     
Sbjct: 325 IQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 43/214 (20%), Positives = 72/214 (33%), Gaps = 52/214 (24%)

Query: 30  DRQALLDFA-DAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVF--GLRLPGIGLVGP-- 84
           D +A        +P L  L   + + +C       C      V    L L  +    P  
Sbjct: 1   DEEASGAETTSGIPDLDSLP-PTYSAMCPF----GCHCHLRVVQCSDLGLKAV----PKE 51

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN--------FSG---- 132
           I  +T        +L L++N ++     +   L  L  L L +N         FS     
Sbjct: 52  ISPDT-------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 133 -----------KIPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL-SGS 179
                      +IP +    LV L +  N     +P+ +   L  +  + +  N L +  
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 180 IPN--FDIPKLRHLNLSYNGLKG---SIPSSLQK 208
                FD  KL +L +S   L G    +P +L +
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 8/96 (8%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
            LR +          +P   SP   +LDL  N  +       + L  L  L L +N +S 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS- 91

Query: 179 SIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            I    F  + KL+ L +S N L   IP +L    +
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 85.5 bits (212), Expect = 8e-18
 Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 15/148 (10%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 141
           I + +  +L  L+VL +        +        +L  L + H N +  +P  +      
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNG 197
           L  L+LS+N  +  I  S+   L +L  + L    L+  +  +    +  LR LN+S N 
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307

Query: 198 LKGSIP----SSLQKFPNSSFVGNSLLC 221
           L  ++      S+          N L C
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 82.8 bits (205), Expect = 6e-17
 Identities = 33/142 (23%), Positives = 51/142 (35%), Gaps = 16/142 (11%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           +       L  L  L LRSN L   +P  + T L +L  L +  N     +   F     
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGL 198
           L  L++  N       ++   L  L  L+L+  NL+ SIP      +  L  L L +   
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL-- 186

Query: 199 KGSIPSSLQKFPNSSFVGNSLL 220
                 ++    + SF     L
Sbjct: 187 ------NINAIRDYSFKRLYRL 202

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 16/131 (12%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
             +L L  N +      E  S P L  L L  N  S   P +F+    L  L L  N   
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 154 GNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKF 209
             IP  +   L+ LT L +  N +   + ++   D+  L+ L +  N         L   
Sbjct: 94  -LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN--------DLVYI 143

Query: 210 PNSSFVGNSLL 220
            + +F G + L
Sbjct: 144 SHRAFSGLNSL 154

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 23/106 (21%), Positives = 34/106 (32%), Gaps = 13/106 (12%)

Query: 118 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
              R +      F   +P     +  +LDL  N           +   L  L L  N +S
Sbjct: 11  AQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69

Query: 178 GSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
            ++      ++  LR L L  N         L+  P   F G S L
Sbjct: 70  -AVEPGAFNNLFNLRTLGLRSN--------RLKLIPLGVFTGLSNL 106

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 86.1 bits (213), Expect = 9e-18
 Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 12/114 (10%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
            +   VL++  + LT  LP  +     +  L +  NN +  +P+   P+L  L++S N  
Sbjct: 39  NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALP-PELRTLEVSGNQL 93

Query: 153 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
           T ++P     L +L+  S    +L           L  L +  N L  S+P   
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPALPSG-----LCKLWIFGNQLT-SLPVLP 140

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 17/126 (13%)

Query: 87  NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 142
            N L  L      L+ LS+  N L   LP+       L  L+  +N  +  +P   S  L
Sbjct: 130 GNQLTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPMLPS-GL 183

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             L +S N    ++P     L +L   + +  +L           L+ L +S N L  S+
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG-----LKELIVSGNRLT-SL 236

Query: 203 PSSLQK 208
           P    +
Sbjct: 237 PVLPSE 242

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 73.8 bits (181), Expect = 7e-14
 Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 13/119 (10%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
              L+ LS+  N L   LP+       L  L+  +N  +  +P+  S  L  L +S N  
Sbjct: 180 PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPALPS-GLKELIVSGNRL 233

Query: 153 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           T ++P     L +L    +  N L+ S+P      L  L++  N L   +P SL    +
Sbjct: 234 T-SLPVLPSELKEL---MVSGNRLT-SLPML-PSGLLSLSVYRNQLT-RLPESLIHLSS 285

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 6/87 (6%)

Query: 133 KIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 192
           K+ +  +    VL++  +  T  +P  +     +T L +  NNL+ S+P    P+LR L 
Sbjct: 33  KMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA-LPPELRTLE 87

Query: 193 LSYNGLKGSIPSSLQKFPNSSFVGNSL 219
           +S N L  S+P         S   N L
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPL 113

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 41/231 (17%)

Query: 344 EVLGKGSYGTAYKAVLEES---------------TTVVVKRLKEVVVGKRDFEQQMEIVG 388
             LG G+YG       +                         K +     +   ++ ++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGN---RGAGRTPLDWETRVK 443
            +  HPN++ L   +  K    LV +++  G L   +          A          +K
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-------MK 153

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-NQDLDGCI--SDFGLTPLM---NVPAT 497
            +L    G+ ++H        H +IK  N+L+ N++    I   DFGL+           
Sbjct: 154 QILS---GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

Query: 498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
              +A Y APEV++ +K++ K DV+S GV++  +L G  P       D++ 
Sbjct: 208 RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 36/152 (23%), Positives = 60/152 (39%), Gaps = 14/152 (9%)

Query: 85  IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFSPQ 141
           IP+    ++ +L  L L     L+  +       L +LRYL L   N   +IP+ +   +
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 198
           L  LDLS N  +   P S Q L  L  L +  + +   I      ++  L  +NL++N L
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL 267

Query: 199 KGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 226
              +P        +   +    N   C   + 
Sbjct: 268 T-LLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 22/138 (15%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           I  NT        +L+L  N +     +    L  L  L L  N+       +F+    L
Sbjct: 62  ISTNT-------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 143 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL 198
             L+L  N  T  IP      L++L  L L++N +  SIP++    IP LR L+L     
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK- 171

Query: 199 KGSIPSSLQKFPNSSFVG 216
                  L      +F G
Sbjct: 172 ------RLSYISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 6/90 (6%)

Query: 118 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
                +     N   ++P   S    +L+L  N        S ++L  L  L L  N++ 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 178 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 204
            +I       +  L  L L  N L  +IP+
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLT-TIPN 129

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 35/128 (27%), Positives = 49/128 (38%), Gaps = 15/128 (11%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSF 149
           L+VLS+           ++   P+L  L L  N   G+     +      P L VL L  
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210

Query: 150 NSFT---GNIPQSIQNLTQLTGLSLQSNNLSGSIP--NFDIP-KLRHLNLSYNGLK---G 200
                  G          QL GL L  N+L  +    + D P +L  LNLS+ GLK    
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270

Query: 201 SIPSSLQK 208
            +P+ L  
Sbjct: 271 GLPAKLSV 278

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 9/129 (6%)

Query: 79  IGLVGPIPNNTLGKLDALEVLSLRSNVLT---GGLPSEITSLPSLRYLYLQHNNFSGKIP 135
           +G  G I      K   L+VL+LR+  +    G   +   +   L+ L L HN+      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 136 SSF---SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLN 192
           +       QL  L+LSF      +P+ +    +L+ L L  N L  +    ++P++ +L+
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLS 302

Query: 193 LSYNGLKGS 201
           L  N    S
Sbjct: 303 LKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 33/181 (18%), Positives = 60/181 (33%), Gaps = 22/181 (12%)

Query: 70  RVFGLRLPGIGLVGPIPNNTLGKLDA--LEVLSLRSNVLTGGLPSEITSL--PSLRYLYL 125
            +  L +    +   I    L  L    L+ L+L +  +TG  P  +     P L  L L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 126 QHN------NFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG- 178
           ++        +  ++     P L VL ++         + ++    L+ L L  N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 179 -----SIPNFDIPKLRHLNLSYNGLK---GSIPSSLQKFPNSSFV---GNSLLCGPPLKA 227
                ++     P L+ L L   G++   G   +          +    NSL       +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 228 C 228
           C
Sbjct: 249 C 249

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 25/113 (22%), Positives = 35/113 (30%), Gaps = 3/113 (2%)

Query: 42  PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSL 101
           P L+ L   +      S V       R ++ GL L    L       +      L  L+L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260

Query: 102 RSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 154
               L   +P  +     L  L L +N           PQ+  L L  N F  
Sbjct: 261 SFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 25/145 (17%), Positives = 47/145 (32%), Gaps = 26/145 (17%)

Query: 82  VGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFSP 140
           +G       G   +LE L  R +        ++I    SL+ L ++      +I      
Sbjct: 31  LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP----NFDIPKLRHLNLSYN 196
            L                    ++ L  L+L++  ++G+ P        P L  LNL   
Sbjct: 91  VL-------------------GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 197 GLKG--SIPSSLQKFPNSSFVGNSL 219
                 +  + LQ++        S+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSI 156

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 16/153 (10%)

Query: 85  IPNNTLGKLDALEVLSL-RSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--P 140
           IP+    ++ +L  L L     L   +       L +L+YL L   N    +P+  +   
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLV 218

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNG 197
            L  L++S N F    P S   L+ L  L + ++ +S  I       +  L  LNL++N 
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277

Query: 198 LKGSIPSS-LQKFPNSSFV---GNSLLCGPPLK 226
           L  S+P            +    N   C   + 
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 13/126 (10%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
              L+L  N +          L  L  L L  N+       +F+    L  L+L  N  T
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPN--F-DIPKLRHLNLSYNGLKGSIPSSLQKFP 210
                + + L++L  L L++N +  SIP+  F  +P L  L+L            L+   
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK-------KLEYIS 188

Query: 211 NSSFVG 216
             +F G
Sbjct: 189 EGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 19/90 (21%), Positives = 30/90 (33%), Gaps = 6/90 (6%)

Query: 118 PSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
                +       S ++P         L+L  N+       + ++L  L  L L  N++ 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 178 GSIPN---FDIPKLRHLNLSYNGLKGSIPS 204
             I       +  L  L L  N L   IPS
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPS 140

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 84.3 bits (208), Expect = 4e-17
 Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 51/284 (17%)

Query: 296 GKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGT 353
            +A  G  ++ P+E+  + + + + N      G      L D   L     VLGKGS+G 
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNN------GNRDRMKLTDFNFLM----VLGKGSFGK 356

Query: 354 AYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDE 408
              +  + +  +  VK L K+VV+   D E  M    ++   G+ P +  L + + + D 
Sbjct: 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416

Query: 409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKF 463
              V +Y   G L   +      GR     E         I +G    +  + S G    
Sbjct: 417 LYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAIG----LFFLQSKG---I 463

Query: 464 THGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG---YRAPEVIETRKHSH 517
            + ++K  NV++  D +G   I+DFG+    +    T     G   Y APE+I  + +  
Sbjct: 464 IYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 553
             D ++FGVLL EML G+AP +    D++        V  P+ +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 24/227 (10%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVG 391
            + D  + S +VLG G  G   +      T     +K L +         Q+++   +  
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECF-HRRTGQKCALKLLYD----SPKARQEVDHHWQAS 79

Query: 392 QHPNVVPLRAYY----YSKDEKLLVYDYFASGSLSTLLHGNRGAGR-TPLDWETRVKILL 446
             P++V +   Y    + K   L++ +    G L + +   RG    T  +    ++ + 
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIG 138

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM--NVPATPSRS 501
                +  +HS       H ++K  N+L     +D    ++DFG       N   TP  +
Sbjct: 139 T---AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

Query: 502 AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
             Y APEV+   K+    D++S GV++  +L G  P  S T   +  
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 72/288 (25%), Positives = 113/288 (39%), Gaps = 77/288 (26%)

Query: 302 GRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEE 361
           G  E  KE  G GV    +  +  FE           +R    VLGKGS+G    A ++E
Sbjct: 1   GPKESSKEGNGIGVNSSNRLGIDNFE----------FIR----VLGKGSFGKVMLARVKE 46

Query: 362 STTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF 416
           +  +  VK L K+V++   D E  M    I+     HP +  L   + + D    V ++ 
Sbjct: 47  TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106

Query: 417 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 471
             G L   +     + R     E R +     I+      +  +H  G     + ++K  
Sbjct: 107 NGGDLMFHIQK---SRRFD---EARARFYAAEIISA----LMFLHDKG---IIYRDLKLD 153

Query: 472 NVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPEVIETR 513
           NVL+  D +G   ++DFG+                TP             Y APE+++  
Sbjct: 154 NVLL--DHEGHCKLADFGMCKEGICNGVTTATFCGTP------------DYIAPEILQEM 199

Query: 514 KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 553
            +    D ++ GVLL EML G AP ++   DD+        V  P W+
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.4 bits (202), Expect = 5e-17
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 56/248 (22%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGKRDFEQQME--IV 387
           +LL+    VLG+GS+G  +    ++ +    ++L       K  +  +     +ME  I+
Sbjct: 27  ELLK----VLGQGSFGKVFLV--KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80

Query: 388 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 443
             V  HP +V L   +Y+   + KL L+ D+   G L T L             E  VK 
Sbjct: 81  VEV-NHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFT---EEDVKF 130

Query: 444 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 497
               + L     + H+HS+G     + ++K  N+L+  D +G   ++DFGL+        
Sbjct: 131 YLAELALA----LDHLHSLG---IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK 181

Query: 498 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 546
            + S      Y APEV+  R H+  +D +SFGVL+ EMLTG  P Q   R +        
Sbjct: 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

Query: 547 -VDLPRWV 553
            + +P+++
Sbjct: 242 KLGMPQFL 249

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 83.0 bits (205), Expect = 7e-17
 Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 6/109 (5%)

Query: 92  KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 150
           ++ +L+ L +  N ++        +   SL  L +  N  +  I     P++ VLDL  N
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431

Query: 151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
               +IP+ +  L  L  L++ SN L  S+P+  FD +  L+ + L  N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 79.5 bits (196), Expect = 9e-16
 Identities = 32/133 (24%), Positives = 53/133 (39%), Gaps = 8/133 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----- 139
           +      K+     L   +N+LT  +      L  L  L LQ N    ++          
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373

Query: 140 PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 198
             L  LD+S NS + +  +        L  L++ SN L+ +I     P+++ L+L  N +
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433

Query: 199 KGSIPSSLQKFPN 211
           K SIP  + K   
Sbjct: 434 K-SIPKQVVKLEA 445

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 76.8 bits (189), Expect = 6e-15
 Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 12/135 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS-- 139
                 G L  LE L L+ N L     +    T + SL+ L +  N+ S        S  
Sbjct: 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 197
             L+ L++S N  T  I + +    ++  L L SN +  SIP     +  L+ LN++ N 
Sbjct: 399 KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455

Query: 198 LKGSIP-SSLQKFPN 211
           LK S+P     +  +
Sbjct: 456 LK-SVPDGIFDRLTS 469

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 33/129 (25%), Positives = 49/129 (37%), Gaps = 17/129 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +   T        +L++  N ++    S+I SL  LR L + HN       S F    +L
Sbjct: 19  LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 198
             LDLS N     I         L  L L  N    ++P    F  + +L+ L LS   L
Sbjct: 72  EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127

Query: 199 KGSIPSSLQ 207
           + S    + 
Sbjct: 128 EKSSVLPIA 136

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 34/197 (17%), Positives = 65/197 (32%), Gaps = 12/197 (6%)

Query: 19  LLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPG 78
           +  +   +  S   ++L      P L  L  ++      S++ I      T V+   +  
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256

Query: 79  IGLVGPIPNNTLG----KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI 134
           + L G +           L AL +  + S+V             ++       +      
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316

Query: 135 PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN----FD-IPK 187
               S     + LD S N  T  + ++  +LT+L  L LQ N L   +         +  
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375

Query: 188 LRHLNLSYNGLKGSIPS 204
           L+ L++S N +      
Sbjct: 376 LQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 6/83 (7%)

Query: 125 LQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-- 182
              N     +P   S +  +L++S N  +      I +L++L  L +  N +   +    
Sbjct: 7   RSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISV 64

Query: 183 FD-IPKLRHLNLSYNGLKGSIPS 204
           F    +L +L+LS+N L   I  
Sbjct: 65  FKFNQELEYLDLSHNKLV-KISC 86

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 7/94 (7%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV 143
                    +L  L++ SN+LT  +   +   P ++ L L  N     IP        L 
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ 447

Query: 144 VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL 176
            L+++ N    ++P  I   LT L  + L +N  
Sbjct: 448 ELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 20/138 (14%), Positives = 39/138 (28%), Gaps = 13/138 (9%)

Query: 87  NNTL-----GKLDALEVLSLRSNVLTG-GLPSEITSLPSLRYLYLQHNNFSGKIPSSF-- 138
           +N L          L+ L L  N      +  E  ++  L++L L   +           
Sbjct: 78  HNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 139 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF---DIPKLRHLNL 193
            +   V+L L         P+ +Q+    +  +   +N     I +     +  L   N+
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 194 SYNGLKGSIPSSLQKFPN 211
                       L     
Sbjct: 198 KCVLEDNKCSYFLSILAK 215

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 21/135 (15%), Positives = 39/135 (28%), Gaps = 3/135 (2%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 145
                G +  L+ L L +  L       I  L   + L +    +  K            
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 205
            L     T      I +++  T  +L+ +N+       +  K  +       L+ +   S
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKC---VLEDNKCSYFLSILAKLQTNPKLS 223

Query: 206 LQKFPNSSFVGNSLL 220
                N     NS +
Sbjct: 224 NLTLNNIETTWNSFI 238

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.5 bits (204), Expect = 9e-17
 Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 32/250 (12%)

Query: 304 SEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEEST 363
            + P +EF   +      +  + E      D     R    VLG+G +G  +   ++ + 
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR----VLGRGGFGEVFACQMKATG 210

Query: 364 TV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS 418
            +   K+L K+ +  ++ ++  M   +I+ +V     +V L   + +K +  LV      
Sbjct: 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269

Query: 419 GSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNV 473
           G +    H        P   E R       I+ G    + H+H        + ++K  NV
Sbjct: 270 GDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENV 320

Query: 474 LINQDLDG--CISDFGLT-PLMNVPATPSRSAG---YRAPEVIETRKHSHKSDVYSFGVL 527
           L+  D DG   ISD GL   L          AG   + APE++   ++    D ++ GV 
Sbjct: 321 LL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378

Query: 528 LLEMLTGKAP 537
           L EM+  + P
Sbjct: 379 LYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)

Query: 345 VLGKGSYGTAYKAVLEESTTV-VVKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPL 399
           VLGKG +G      +  +  +   K+L K+ +  ++     +   +I+ +V     VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSL 249

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAH 454
              Y +KD   LV      G L   ++     G+     E R       I  G    +  
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYH---MGQAGFP-EARAVFYAAEICCG----LED 301

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEV 509
           +H        + ++K  N+L+  D  G   ISD GL   +    T     G   Y APEV
Sbjct: 302 LHRER---IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           ++  +++   D ++ G LL EM+ G++P Q   +    +
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 30/220 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVPL 399
            +LGKGS+G   K     +     VK + +     +D     +++E++ ++  HPN++ L
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKL 86

Query: 400 RAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAH 454
                      +V + +  G L    +         A R        +K +     G+ +
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GITY 136

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPE 508
           +H        H ++K  N+L+      C   I DFGL+              +A Y APE
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           V+    +  K DV+S GV+L  +L+G  P       D++ 
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 36/130 (27%), Positives = 52/130 (40%), Gaps = 14/130 (10%)

Query: 91  GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDL 147
           G L  L  L L  N L   LP    +LP+L  L +  N  +  +P        +L  L L
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 148 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 203
             N     +P  +     +L  LSL +NNL+  +P    + +  L  L L  N L  +IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 204 SSLQKFPNSS 213
                F +  
Sbjct: 189 KGF--FGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 13/125 (10%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
           +P +T        +L L  N+L     + +     L  L L     +        P L  
Sbjct: 29  LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGS 201
           LDLS N    ++P   Q L  LT L +  N L+ S+P      + +L+ L L  N LK +
Sbjct: 82  LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-T 138

Query: 202 IPSSL 206
           +P  L
Sbjct: 139 LPPGL 143

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 37/111 (33%), Positives = 48/111 (43%), Gaps = 9/111 (8%)

Query: 92  KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS 148
            L AL VL +  N LT  LP      L  L+ LYL+ N      P   +  P+L  L L+
Sbjct: 98  TLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156

Query: 149 FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 196
            N+ T  +P  +   L  L  L LQ N+L  +IP   F    L    L  N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 4/96 (4%)

Query: 117 LPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 176
           + S   +     N +  +P        +L LS N        ++   T+LT L+L    L
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 177 SGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           +  +     +P L  L+LS+N L+ S+P   Q  P 
Sbjct: 68  T-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 8/144 (5%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
           I    +     L  L    N +T     +++    L  L    NN + K+  + + QL  
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTF 216

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS 204
           LD S N  T  I   +  LTQLT      N L+  +    + KL  L+     L     +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLEIDLT 272

Query: 205 SLQKFPNSSFVGNSLLCGPPLKAC 228
              +       G   +    +   
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHN 296

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 7/140 (5%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           +  +L  L  L   ++ +T    + I  L  L  L    NN +  +  S +  L  L   
Sbjct: 37  SEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACD 93

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 208
            N  T N+   +  LT+LT L+  +N L+  +     P L +LN + N L     S   +
Sbjct: 94  SNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLTEIDVSHNTQ 149

Query: 209 FPNSSFVGNSLLCGPPLKAC 228
                   N  +    +   
Sbjct: 150 LTELDCHLNKKITKLDVTPQ 169

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 9/120 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           + +   L  L+   N LT     +++    L  L    N    K+  +   QL  LD SF
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSF 179

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP-SSLQK 208
           N  T  +   +     L  L+  +NN++  +      +L  L+ S N L   I  + L +
Sbjct: 180 NKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EIDVTPLTQ 234

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 25/131 (19%), Positives = 44/131 (33%), Gaps = 6/131 (4%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L     L             L  ++T    L  L  Q    + ++  S +P+LV L L+ 
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNN 327

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
              T  +   + + T+L  LS  + ++        IP L +   +          +L   
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNN 384

Query: 210 PNSSFVGNSLL 220
             +  V   LL
Sbjct: 385 SLTIAVSPDLL 395

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 4/136 (2%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV 143
               N     D        +  +          L +L  L   +++ +          L 
Sbjct: 8   TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLT 67

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
            L  + N+ T  +   +   T LT L+  SN L+ ++    + KL +LN   N L     
Sbjct: 68  KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDV 123

Query: 204 SSLQKFPNSSFVGNSL 219
           S        +   N+L
Sbjct: 124 SQNPLLTYLNCARNTL 139

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 19/135 (14%), Positives = 39/135 (28%), Gaps = 10/135 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L +   L  L L +  LT  L   ++    L+ L   + +          P L     + 
Sbjct: 314 LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAE 370

Query: 150 NSFTGNIPQSIQNLTQLTG------LSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
                 +P+       LT       L    N ++    +  +       +++  L    P
Sbjct: 371 GQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

Query: 204 SSLQKFPNSSFVGNS 218
           +    F + +     
Sbjct: 430 AVTYTFTSENGAIVG 444

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 61/253 (24%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 391
            +LR     LG GS+G  +      +     +K L KE+VV  +  E       ++  V 
Sbjct: 9   QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV- 63

Query: 392 QHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----IL 445
            HP ++ +    +   +++ ++ DY   G L +LL   R + R P       K     + 
Sbjct: 64  THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVAKFYAAEVC 116

Query: 446 LGTARGVAHIHSMGGPKFTHGNI-----KASNVLINQDLDG--CISDFGLTPLMNVPA-- 496
           L     + ++HS         +I     K  N+L+  D +G   I+DFG    +      
Sbjct: 117 LA----LEYLHSK--------DIIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYT 162

Query: 497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 546
              TP     Y APEV+ T+ ++   D +SFG+L+ EML G  P                
Sbjct: 163 LCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218

Query: 547 -VDLPRWVQSVVR 558
            +  P +    V+
Sbjct: 219 ELRFPPFFNEDVK 231

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 15/130 (11%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF-SGKIPSSFS--P 140
           +       L +L+ L      L   L +     L +L+ L + HN   S K+P  FS   
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTG----LSLQSNNLSGSIPN--FDIPKLRHLNL 193
            L  LDLS N    +I  +  + L Q+      L L  N ++  I    F   +L+ L L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207

Query: 194 SYNGLKGSIP 203
             N LK S+P
Sbjct: 208 DTNQLK-SVP 216

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 28/127 (22%), Positives = 45/127 (35%), Gaps = 18/127 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 141
           +P +T       + L L  N L         S P L+ L L        I    +     
Sbjct: 26  LPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNG 197
           L  L L+ N    ++       L+ L  L     NL+ S+ N        L+ LN+++N 
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135

Query: 198 LKGSIPS 204
           ++ S   
Sbjct: 136 IQ-SFKL 141

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 16/124 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQHNNFSGKIPS-SFS-- 139
           + N  +G L  L+ L++  N++           +L +L +L L  N     I        
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172

Query: 140 PQLVV----LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDI-PKLRHLN 192
            Q+ +    LDLS N     I        +L  L+L +N L  S+P+  FD    L+ + 
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIW 230

Query: 193 LSYN 196
           L  N
Sbjct: 231 LHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 190
           IP +       LDLSFN        S  +  +L  L L    +  +I +  +  +  L  
Sbjct: 22  IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLST 80

Query: 191 LNLSYNGLKGSIPS 204
           L L+ N ++ S+  
Sbjct: 81  LILTGNPIQ-SLAL 93

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 42/225 (18%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           EVLG G++   +    +  T     +K + K         E ++ ++ ++ +H N+V L 
Sbjct: 15  EVLGSGAFSEVFLVK-QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLE 72

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILLGT 448
             Y S     LV    + G L               D           +    ++ +L  
Sbjct: 73  DIYESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLS- 117

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAG 503
              V ++H  G     H ++K  N+L     +     I+DFGL+ +    + +T   + G
Sbjct: 118 --AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG 172

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           Y APEV+  + +S   D +S GV+   +L G  P    T   + +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 32/216 (14%), Positives = 70/216 (32%), Gaps = 25/216 (11%)

Query: 345 VLGKGSYGTAYKA----------VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGR----- 389
            L +G +                  E+S     +   +    K   + + +         
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 390 -VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGN---RGAGRTPLDWETRVKIL 445
              ++   +       + DE  ++Y+Y  + S+                 +  +    I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 446 LGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAG 503
                  ++IH+       H ++K SN+L++++    +SDFG +  M          +  
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYE 215

Query: 504 YRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 537
           +  PE        +  K D++S G+ L  M     P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 63/253 (24%), Positives = 102/253 (40%), Gaps = 67/253 (26%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 391
           + L     VLGKGS+G    +  + +  +  VK L K+VV+   D E  M    ++   G
Sbjct: 23  NFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 446
           + P +  L + + + D    V +Y   G L   +      GR     E         I +
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK---EPHAVFYAAEIAI 132

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL---------------- 488
           G    +  + S G     + ++K  NV++  D +G   I+DFG+                
Sbjct: 133 G----LFFLQSKG---IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCG 183

Query: 489 TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-- 546
           TP             Y APE+I  + +    D ++FGVLL EML G+AP +    D++  
Sbjct: 184 TP------------DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

Query: 547 ------VDLPRWV 553
                 V  P+ +
Sbjct: 232 SIMEHNVAYPKSM 244

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 21/131 (16%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
             +LE +   +N+L      E+ +LP L  +Y  +N     +P    P L  L++  N  
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP-PSLEALNVRDNYL 269

Query: 153 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---------------FDIPKLRHLNLSYNG 197
           T ++P+  Q+LT L       + LS   PN                  P L  LN+S N 
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 328

Query: 198 LKGSIPSSLQK 208
           L   +P+   +
Sbjct: 329 LI-ELPALPPR 338

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 79.3 bits (196), Expect = 9e-16
 Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 9/116 (7%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
             +LE ++  +N L   LP E+ +LP L  +Y  +N+   K+P      L  +    N  
Sbjct: 172 PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPL-SLESIVAGNNIL 227

Query: 153 TGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 208
              +P  +QNL  LT +   +N L  ++P+   P L  LN+  N L   +P   Q 
Sbjct: 228 E-ELP-ELQNLPFLTTIYADNNLLK-TLPDL-PPSLEALNVRDNYLT-DLPELPQS 278

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 13/132 (9%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
           L     L+++ + +N L   LP      PSL ++   +N    ++P     P L  +   
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-ELPELQNLPFLTAIYAD 203

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 207
            NS    +P    +L  +      +N L   +P   ++P L  +    N LK ++P    
Sbjct: 204 NNSLK-KLPDLPLSLESIV---AGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDLPP 257

Query: 208 KFPNSSFVGNSL 219
                +   N L
Sbjct: 258 SLEALNVRDNYL 269

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 14/135 (10%)

Query: 91  GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN 150
               +LE L++ +N L   LP+     P L  L    N+ + ++P      L  L + +N
Sbjct: 314 DLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQ-NLKQLHVEYN 367

Query: 151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFP 210
                 P   +++       L+ N+    +P      L+ L++  N L+   P   +   
Sbjct: 368 PLR-EFPDIPESVE-----DLRMNSHLAEVPEL-PQNLKQLHVETNPLR-EFPDIPESVE 419

Query: 211 NSSFVGNSLLCGPPL 225
           +       ++     
Sbjct: 420 DLRMNSERVVDPYEF 434

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 25/154 (16%), Positives = 41/154 (26%), Gaps = 35/154 (22%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL-------------PSLRYLYLQHNNFS 131
           +P      + +        +      P                        L L +   S
Sbjct: 26  MPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 132 GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--------- 182
             +P    P L  L  S NS T  +P+  Q+L  L   +     LS   P          
Sbjct: 85  -SLPELP-PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141

Query: 183 --------FDIPKLRHLNLSYNGLKGSIPSSLQK 208
                    +   L+ +++  N LK  +P     
Sbjct: 142 QLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 27/138 (19%)

Query: 88  NTLGKLDALEVLSLRSNVLTGGLPSEITSL-----------------PSLRYLYLQHNNF 130
             L  L  L  +   +N+L   LP    SL                  SL +L +  N F
Sbjct: 231 PELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIF 289

Query: 131 SGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRH 190
           S  +     P L  L+ S N    ++     +L +L   ++ +N L   +P    P+L  
Sbjct: 290 S-GLSELP-PNLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPA-LPPRLER 341

Query: 191 LNLSYNGLKGSIPSSLQK 208
           L  S+N L   +P   Q 
Sbjct: 342 LIASFNHLA-EVPELPQN 358

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 40/160 (25%), Positives = 59/160 (36%), Gaps = 32/160 (20%)

Query: 87  NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSL-----------------PSLRYLYL 125
           NN L  L      LE L++R N LT  LP    SL                 P+L YL  
Sbjct: 246 NNLLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304

Query: 126 QHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI 185
             N     +     P L  L++S N     +P     L +L       N+L+  +P    
Sbjct: 305 SSNEIR-SLCDLP-PSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL-P 356

Query: 186 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPL 225
             L+ L++ YN L+   P   +   +   + + L   P L
Sbjct: 357 QNLKQLHVEYNPLR-EFPDIPESVEDLR-MNSHLAEVPEL 394

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.0 bits (172), Expect = 7e-13
 Identities = 23/133 (17%), Positives = 44/133 (33%), Gaps = 24/133 (18%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------------- 139
              L+     S+ LT  +P E  ++ S    Y   + +    P                 
Sbjct: 10  NTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 140 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSY 195
              Q   L+L+    + ++P+   +L     L    N+L+  +P     +  L   N + 
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 196 NGLKGSIPSSLQK 208
             L   +P  L+ 
Sbjct: 124 KALS-DLPPLLEY 135

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 14/111 (12%), Positives = 34/111 (30%), Gaps = 23/111 (20%)

Query: 87  NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSL----------------PSLRYLYLQ 126
            N L ++      L+ L +  N L    P    S+                 +L+ L+++
Sbjct: 346 FNHLAEVPELPQNLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404

Query: 127 HNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
            N    + P      +  L ++          + +   +L     + ++  
Sbjct: 405 TNPLR-EFPDIPE-SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 391
           + L+    +LGKG++G       + +     +K L KEV+V K +    +    ++    
Sbjct: 151 EYLK----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS- 205

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 446
           +HP +  L+  + + D    V +Y   G L   L       R  +  E R +     I+ 
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRARFYGAEIVS 259

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 503
                + ++HS       + ++K  N+++  D DG   I+DFGL    +   AT     G
Sbjct: 260 A----LDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCG 311

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL 549
              Y APEV+E   +    D +  GV++ EM+ G+ P  +   + + +L
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.2 bits (198), Expect = 4e-16
 Identities = 62/267 (23%), Positives = 110/267 (41%), Gaps = 45/267 (16%)

Query: 309 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 362
           +E  +     EKN L + E           +R   E      V+G+G++G      L+ +
Sbjct: 39  DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98

Query: 363 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 416
             V  +K L K  ++ + +     E   ++        +  L  Y +  D  L LV DY+
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLH-YAFQDDNNLYLVMDYY 156

Query: 417 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 471
             G L TLL  ++   R P   E   +     +++     +  +H +    + H +IK  
Sbjct: 157 VGGDLLTLL--SKFEDRLP---EEMARFYLAEMVIA----IDSVHQLH---YVHRDIKPD 204

Query: 472 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETRKHSHKS----- 519
           N+L+  D++G   ++DFG    LM      S  A G   Y +PE+++  +          
Sbjct: 205 NILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262

Query: 520 DVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           D +S GV + EML G+ P  + +  + 
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLVET 289

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 53/246 (21%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 391
            L +    +LGKGS+G  + A  +++     +K L K+VV+   D E  M    ++    
Sbjct: 20  ILHK----MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 446
           +HP +  +   + +K+    V +Y   G L   +       +      +R       I+L
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFD---LSRATFYAAEIIL 129

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA-------- 496
           G    +  +HS G     + ++K  N+L+  D DG   I+DFG+    N+          
Sbjct: 130 G----LQFLHSKG---IVYRDLKLDNILL--DKDGHIKIADFGMCKE-NMLGDAKTNTFC 179

Query: 497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------V 547
            TP     Y APE++  +K++H  D +SFGVLL EML G++P      +++         
Sbjct: 180 GTPD----YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235

Query: 548 DLPRWV 553
             PRW+
Sbjct: 236 FYPRWL 241

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.8 bits (197), Expect = 5e-16
 Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 15/129 (11%)

Query: 85  IPNNTLGKLDA--LEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS- 139
             N T   L+A  ++   L  + +   L   + +    L  L L  N  + KI   +F  
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG 321

Query: 140 -PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLS 194
              L+ L+LS N    +I   + +NL +L  L L  N++  ++ +  F  +P L+ L L 
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379

Query: 195 YNGLKGSIP 203
            N LK S+P
Sbjct: 380 TNQLK-SVP 387

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 33/146 (22%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           +   +  +L  L+ L +        + +     L SL  L L +N F  ++ +  F+   
Sbjct: 45  LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLA 103

Query: 141 QLVVLDLSFNSFTG-NIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSY 195
            L VL L+  +  G  +  +  + LT L  L L+ NN+    P   F  + +   L+L++
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163

Query: 196 NGLKGSIPSSLQKFPNSSFVGNSLLC 221
           N +K      L  F    F    L  
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 32/167 (19%), Positives = 54/167 (32%), Gaps = 28/167 (16%)

Query: 64  CTQDRTRVF--GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR 121
           C+            L     V  +P +          + L  N +     +  + L  L+
Sbjct: 8   CSVIGYNAICINRGLHQ---VPELPAHV-------NYVDLSLNSIAELNETSFSRLQDLQ 57

Query: 122 YLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNL- 176
           +L ++       I + +F     L++L L +N F   +       L  L  L+L   NL 
Sbjct: 58  FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLD 116

Query: 177 SGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
              +    F  +  L  L L  N +K  I       P S F+     
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIK-KIQ------PASFFLNMRRF 156

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 39/139 (28%), Positives = 50/139 (35%), Gaps = 17/139 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGG-LPSEI-TSLPSLRYLYLQHNNFSGKIPSSF---S 139
           +       L  LEVL+L    L G  L       L SL  L L+ NN     P+SF    
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLT--QLTGLSLQSNNL---------SGSIPNFD-IPK 187
            +  VLDL+FN       + + N      T L L S  L              N      
Sbjct: 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213

Query: 188 LRHLNLSYNGLKGSIPSSL 206
           +  L+LS NG K S+    
Sbjct: 214 ITTLDLSGNGFKESMAKRF 232

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 24/145 (16%), Positives = 45/145 (31%), Gaps = 29/145 (20%)

Query: 92  KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-----PQLVVLD 146
           +L ++ +  +    L            S+  L L  N F   +   F       ++  L 
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 147 LSFN-----SFTGNIPQSIQNLT-------QLTGLSLQSNNLSGSIPN--FD-IPKLRHL 191
           LS +     SF     +   N T        +    L  + +  ++    F     L  L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304

Query: 192 NLSYNGLKGSIPSSLQKFPNSSFVG 216
            L+ N         + K  +++F G
Sbjct: 305 TLAQN--------EINKIDDNAFWG 321

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 13/47 (27%), Positives = 24/47 (51%), Gaps = 2/47 (4%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNF 130
           + + +   L  L+ L+L +N L   +P  I   L SL+ ++L  N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.3 bits (198), Expect = 5e-16
 Identities = 51/275 (18%), Positives = 114/275 (41%), Gaps = 29/275 (10%)

Query: 284 KKKDNGSNGVSKGKASSGGRSE-KPKEEFGSGVQEPEKNKLVFFEGCSYN--FDLEDLLR 340
           +K+  G +   +GK   G  +     + +   + +    + V  +       +D+     
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH---- 162

Query: 341 ASAEVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVV 397
              E LG G++G  ++   E +T      K +       K    ++++ +  + +HP +V
Sbjct: 163 ---EELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLV 217

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L   +   +E +++Y++ + G L   +        +  +    ++ +     G+ H+H 
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK---GLCHMHE 273

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIE 511
                + H ++K  N++        +   DFGLT  ++ P    +    +A + APEV E
Sbjct: 274 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAE 329

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
            +   + +D++S GVL   +L+G +P      D+ 
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E LG G++G  ++ V E++T    V K +     + K   + ++ I+ ++  HP ++ L 
Sbjct: 57  EELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLH 114

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +  K E +L+ ++ + G L   +        +  +    ++       G+ H+H    
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACE---GLKHMHEHS- 169

Query: 461 PKFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 514
               H +IK  N++        +   DFGL   +N P    +    +A + APE+++   
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREP 226

Query: 515 HSHKSDVYSFGVLLLEMLTGKAP 537
               +D+++ GVL   +L+G +P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 38/218 (17%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKR-LKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
            + G+G++GT      + +   V +K+ +++     R+  Q M+ +  +  HPN+V L++
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVL-HHPNIVQLQS 86

Query: 402 YYYSKDEK-------LLVYDYFASGSLSTLLH---GNRGAGRTPLDWETRVKILL-GTAR 450
           Y+Y+  E+        +V +Y     +   LH    N    +        +K+ L    R
Sbjct: 87  YFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPIL-IKVFLFQLIR 140

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVPATP------SRS 501
            +  +H        H +IK  NVL+N+    L  C  DFG    +  P+ P      SR 
Sbjct: 141 SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLC--DFGSAKKL-SPSEPNVAYICSRY 196

Query: 502 AGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
             YRAPE+I   +H +   D++S G +  EM+ G+ P+
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 46/229 (20%), Positives = 93/229 (40%), Gaps = 45/229 (19%)

Query: 345 VLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPL 399
           V+G+G++       ++++  V  +K + K  ++ + +     E   ++        +  L
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQL 126

Query: 400 RAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARG 451
              +++   +  L LV +Y+  G L TLL  ++   R P       +     I++     
Sbjct: 127 ---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIP---AEMARFYLAEIVMA---- 174

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---Y 504
           +  +H +G   + H +IK  N+L+  D  G   ++DFG    L       S  A G   Y
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 505 RAPEVIETRKHSHKSDVY-------SFGVLLLEMLTGKAPLQSPTRDDM 546
            +PE+++       +  Y       + GV   EM  G+ P  + +  + 
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 65/283 (22%)

Query: 305 EKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYKAVLEES 362
            K KE+F    + P +N             L+    ++     LG GS+G       +ES
Sbjct: 20  AKAKEDFLKKWETPSQNTA----------QLDQFDRIK----TLGTGSFGRVMLVKHKES 65

Query: 363 TTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL--VYDY 415
                +K L K+ VV  +  E  +    I+  V   P +V L   +  KD   L  V +Y
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKL--EFSFKDNSNLYMVMEY 122

Query: 416 FASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKA 470
            A G + + L   R  GR     E   +     I+L       ++HS+      + ++K 
Sbjct: 123 VAGGEMFSHL---RRIGRFS---EPHARFYAAQIVLT----FEYLHSLD---LIYRDLKP 169

Query: 471 SNVLINQDLDG--CISDFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYS 523
            N+LI  D  G   ++DFG    +         TP       APE+I ++ ++   D ++
Sbjct: 170 ENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPE----ALAPEIILSKGYNKAVDWWA 223

Query: 524 FGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWVQSVVR 558
            GVL+ EM  G  P  +     +        V  P    S ++
Sbjct: 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 28/207 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
             +G+GS+G    AV + +      K++ K  V     F+Q++EI+  +  HPN++ L  
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYE 73

Query: 402 YYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIH 456
            +    +  LV +    G L    +         A R        +K +L     VA+ H
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLS---AVAYCH 123

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRAPEVI 510
            +      H ++K  N L   D       + DFGL        +  T   +  Y +P+V+
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180

Query: 511 ETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           E   +  + D +S GV++  +L G  P
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPP 206

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 43/264 (16%)

Query: 330 SYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQMEIV 387
           S++   ED+ +   +VLG+G++      +   ++    VK + K+    +    +++E++
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64

Query: 388 GRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRV 442
            +   H NV+ L  ++  +D   LV++    GS+        +     A          V
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-------V 117

Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGL----------T 489
           + +      +  +H+ G     H ++K  N+L    NQ     I DF L          +
Sbjct: 118 QDVAS---ALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 490 PLMNVP-ATPSRSAGYRAPEVIETRKHSHKS-----DVYSFGVLLLEMLTGKAPLQSPTR 543
           P+      TP  SA Y APEV+E             D++S GV+L  +L+G  P      
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231

Query: 544 DDMVDLPRWVQSVVREEWTAEVFD 567
            D      W +          +F+
Sbjct: 232 SD----CGWDRGEACPACQNMLFE 251

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 54/227 (23%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVK----------RLKEVVVGKRDFEQQMEIVGRVG 391
           E+LG+G      + +  + T     VK            +EV   +    ++++I+ +V 
Sbjct: 23  EILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR 441
            HPN++ L+  Y +     LV+D    G L               D+          ETR
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETR 127

Query: 442 --VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPA 496
             ++ LL     +  +H +      H ++K  N+L++ D++  ++DFG +  +       
Sbjct: 128 KIMRALLE---VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181

Query: 497 TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 537
               +  Y APE+IE         +  + D++S GV++  +L G  P
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 33/223 (14%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
             LG G++G  +      S    V+K +      V     E ++E++  +  HPN++ + 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIF 86

Query: 401 AYYYSKDEKLLVYDYFASGSL------STLLHGN---RGAGRTPLDWETRVKILLGTARG 451
             +       +V +    G L      +                      +K ++     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-------MKQMMN---A 136

Query: 452 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGLTPLM---NVPATPSRSAGYR 505
           +A+ HS       H ++K  N+L  +      I   DFGL  L          + +A Y 
Sbjct: 137 LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           APEV + R  + K D++S GV++  +LTG  P    + +++  
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 13/132 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSE--ITSLPSLRYLYLQHNNFSGKIPS-SF--- 138
           I  + L +L  L+ L + +  L    P    + S      L +  N +   IP  +F   
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154

Query: 139 SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 194
             + + L L  N FT ++     N T+L  + L  N     I    F         L++S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213

Query: 195 YNGLKGSIPSSL 206
              +  ++PS  
Sbjct: 214 QTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 23/130 (17%), Positives = 42/130 (32%), Gaps = 12/130 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           IP++    L  +  + +  +V    L S    +L  + ++ +++      I        P
Sbjct: 46  IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105

Query: 141 QLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLS 194
            L  L +         P    + +      L +  N    SIP   F     +   L L 
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164

Query: 195 YNGLKGSIPS 204
            NG   S+  
Sbjct: 165 NNGFT-SVQG 173

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 17/117 (14%)

Query: 112 SEITSLP-SLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 166
             I SLP S + L L   +    IPS +FS  P +  + +S +     +      NL+++
Sbjct: 24  QRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82

Query: 167 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
           T + +++      I       +P L+ L +   G        L+ FP+ + V ++ +
Sbjct: 83  THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG--------LKMFPDLTKVYSTDI 131

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 8/93 (8%)

Query: 85  IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSP-- 140
           IP N    L      L L +N  T  +     +   L  +YL  N +   I   +F    
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 141 -QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSL 171
               +LD+S  S T  +P    ++L +L   + 
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDFEQQM---EIVGRV 390
            + R    ++G+G +G  Y    +  T  +  +K L K+ +  K+     +    ++  V
Sbjct: 192 SVHR----IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246

Query: 391 --GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK----- 443
             G  P +V +   +++ D+   + D    G L   L      G      E  ++     
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS---EADMRFYAAE 300

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSR- 500
           I+LG    + H+H+       + ++K +N+L+  D  G   ISD GL    +     +  
Sbjct: 301 IILG----LEHMHNRF---VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV 351

Query: 501 -SAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD 545
            + GY APEV++    +   +D +S G +L ++L G +P +     D
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 13/127 (10%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           +P     +L  LE L +  N L   LP  +   L +L  L L  N     +P   F    
Sbjct: 76  LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           +L  L L +N    ++P+ +   LT L  L L +N L   +P   FD + +L+ L L  N
Sbjct: 134 KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191

Query: 197 GLKGSIP 203
            LK  +P
Sbjct: 192 QLK-RVP 197

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 40/127 (31%), Positives = 56/127 (44%), Gaps = 18/127 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 141
           IP +T       + L L+SN L+         L  LR LYL  N     +P+  F     
Sbjct: 35  IPADT-------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 197
           L  L ++ N     +P  +   L  L  L L  N L  S+P   FD + KL +L+L YN 
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144

Query: 198 LKGSIPS 204
           L+ S+P 
Sbjct: 145 LQ-SLPK 150

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 190
           IPS+       LDL  N  +    ++   LT+L  L L  N L  ++P   F  +  L  
Sbjct: 31  IPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET 89

Query: 191 LNLSYNGLKGSIPS 204
           L ++ N L+ ++P 
Sbjct: 90  LWVTDNKLQ-ALPI 102

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 28/94 (29%), Positives = 38/94 (40%), Gaps = 6/94 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           +P      L  L  LSL  N L   LP  +   L SL+ L L +N        +F    +
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSN 174
           L  L L  N     +P+    +L +L  L LQ N
Sbjct: 183 LKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 73/289 (25%)

Query: 290 SNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKG 349
            N   +G   SG   EK         +      L  F+          LLR    V+G+G
Sbjct: 18  ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFD----------LLR----VIGRG 63

Query: 350 SYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAY 402
           SY       L+++  +    VVK  KE+V    D +       +  +   HP +V L + 
Sbjct: 64  SYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHS 457
           + ++     V +Y   G L  + H  R   + P   E   +     I L     + ++H 
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEISLA----LNYLHE 171

Query: 458 MGGPKFTHGNIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPS 499
            G     + ++K  NVL+  D +G   ++D+G+                TP         
Sbjct: 172 RG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------- 217

Query: 500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
               Y APE++    +    D ++ GVL+ EM+ G++P       D  D
Sbjct: 218 ---NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 46/215 (21%), Positives = 95/215 (44%), Gaps = 36/215 (16%)

Query: 344 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 394
           E LG G +    K   E+ST        +  ++ +     V + + E+++ I+ +V  H 
Sbjct: 18  EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHH 75

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT-ARGVA 453
           NV+ L   Y ++ + +L+ +  + G L      +  A +  L  E      +     GV 
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLS-EEEATSFIKQILDGVN 129

Query: 454 HIHSMGGPKFTHGNIKASNVLI-NQDLDGC---ISDFGL-------TPLMNVPATPSRSA 502
           ++H+       H ++K  N+++ ++++      + DFGL           N+  TP    
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP---- 182

Query: 503 GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
            + APE++       ++D++S GV+   +L+G +P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 75/352 (21%), Positives = 122/352 (34%), Gaps = 98/352 (27%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPN 395
           + LG+G++G   +A            TV VK LKE       R    +++I+  +G H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 396 VVPLRAYYYSKDEKLLV-YDYFASGSLSTLLHGNRGA------------------GRTPL 436
           VV L          L+V  ++   G+LST L   R                    G  P+
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 437 DWETRVKILLGT----------ARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGC- 482
           D + R+  +  +           + ++ +     P+  + +      LI    Q   G  
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 483 --------------------------ISDFGLTPLMNVPATPSRSAGYR------APEVI 510
                                     I DFGL   +       R    R      APE I
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEV 565
             R ++ +SDV+SFGVLL E+ + G +P   P      +  R ++   R    +  T E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325

Query: 566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
           +                ML     C    P  RP   E+V  +  + Q++++
Sbjct: 326 YQT--------------MLD----CWHGEPSQRPTFSELVEHLGNLLQANAQ 359

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 35/294 (11%), Positives = 76/294 (25%), Gaps = 75/294 (25%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQME----IVGRVGQHPNVV 397
              G       ++A+ + +    V +  +    V   D  Q+       + R+   P V 
Sbjct: 37  IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVA 94

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            +    +++   L+V ++   GSL  +         T       ++ +   A      H 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAPEVIETRKHSH 517
            G           S V ++ D D  ++     P     A P                   
Sbjct: 148 AG---VALSIDHPSRVRVSIDGDVVLAYPATMP----DANP------------------- 181

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL-----------PRWVQSVVREEWTAEVF 566
           + D+   G  L  +L  + PL        +             P  +   +  + +A   
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA- 240

Query: 567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP 620
                                   V     +R     ++ ++++          
Sbjct: 241 ---------------------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 11/128 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---P 140
           I  ++   L +LE L L  N L+  L S     L SL +L L  N +     +S      
Sbjct: 91  IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           +L +L +        I +     LT L  L + +++L  S        I  + HL L   
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208

Query: 197 GLKGSIPS 204
                +  
Sbjct: 209 QHI-LLLE 215

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 35/225 (15%), Positives = 65/225 (28%), Gaps = 32/225 (14%)

Query: 16  IVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLR 75
           + +L    F  L                L  L     NP  ++    +     T++  LR
Sbjct: 112 LSNLSSSWFKPL--------------SSLTFL-NLLGNPY-KTLGETSLFSHLTKLQILR 155

Query: 76  LPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 135
           +  +     I       L  LE L + ++ L    P  + S+ ++ +L L        + 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215

Query: 136 SSFS--PQLVVLDLSFNSFTGNIPQSIQ--------NLTQLTGLSLQSNNLSGSIPNFD- 184
                   +  L+L            +                + +   +L   +   + 
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQ 275

Query: 185 IPKLRHLNLSYNGLKGSIPSS-LQKFPNSSFV---GNSLLCGPPL 225
           I  L  L  S N LK S+P     +  +   +    N   C  P 
Sbjct: 276 ISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 8/115 (6%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 155
             +  + S            S            + +  IPS  +  +  LDLS N  T  
Sbjct: 9   WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRIT-Y 66

Query: 156 IPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIPSSL 206
           I  S  Q    L  L L SN ++ +I    F  +  L HL+LSYN L  ++ SS 
Sbjct: 67  ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW 119

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTV----VVKRLKEVVVGKRDFEQQM---EIVGR 389
           DLLR    V+G+GSY       L+++  +    VVK  KE+V    D +       +  +
Sbjct: 12  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQTEKHVFEQ 65

Query: 390 VGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 444
              HP +V L + + ++     V +Y   G L  + H  R   + P   E   +     I
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP---EEHARFYSAEI 119

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPA------ 496
            L     + ++H  G     + ++K  NVL+  D +G   ++D+G+      P       
Sbjct: 120 SLA----LNYLHERG---IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTF 170

Query: 497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
             TP+    Y APE++    +    D ++ GVL+ EM+ G++P       D  D
Sbjct: 171 CGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 56/225 (24%)

Query: 344 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 394
           E LG G +    K   E+ST        +  ++ +     V + + E+++ I+ +V  HP
Sbjct: 18  EELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHP 75

Query: 395 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           N++ L   Y ++ + +L+ +       F       SLS                E     
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS----------------EEEATS 119

Query: 445 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 492
            +     GV ++H+       H ++K  N++ +++++      + DFGL           
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

Query: 493 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           N+  TP     + APE++       ++D++S GV+   +L+G +P
Sbjct: 177 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 50/226 (22%), Positives = 77/226 (34%), Gaps = 51/226 (22%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRD---FEQQM-------EI-VGRVGQ 392
             +  GSYG     V  E   V +KR+   V   R                EI +     
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 393 HPNVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL- 446
           HPN++ L      +      KL LV +      + T L       R  +     ++  + 
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG--- 503
               G+  +H  G     H ++   N+L+  + D  I DF L          +R      
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL----------AREDTADA 188

Query: 504 ----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
                     YRAPE++   K   K  D++S G ++ EM   K  L
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 6/117 (5%)

Query: 84  PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFSPQL 142
                    + +LE L +  N L         +   S+  L L  N  +G +     P++
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            VLDL  N    +IP+ + +L  L  L++ SN L  S+P+  FD +  L+++ L  N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 32/133 (24%), Positives = 50/133 (37%), Gaps = 8/133 (6%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP---- 140
           I         +   L+   NV T  +    ++L  L+ L LQ N                
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402

Query: 141 -QLVVLDLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 198
             L  LD+S NS       ++      +  L+L SN L+GS+     PK++ L+L  N +
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462

Query: 199 KGSIPSSLQKFPN 211
             SIP  +     
Sbjct: 463 M-SIPKDVTHLQA 474

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 33/121 (27%), Positives = 45/121 (37%), Gaps = 17/121 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +P  T       + LSL  N ++     +I+ L  LR L L HN         F     L
Sbjct: 50  LPPRT-------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FD-IPKLRHLNLSYNGL 198
             LD+S N    NI      +  L  L L  N+    +P    F  + KL  L LS    
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 199 K 199
           +
Sbjct: 159 R 159

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 11/126 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSF---S 139
                   L  L+ L L+ N L     +     ++ SL  L +  N+ +          +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNG 197
             ++VL+LS N  TG++ + +    ++  L L +N +  SIP     +  L+ LN++ N 
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484

Query: 198 LKGSIP 203
           LK S+P
Sbjct: 485 LK-SVP 489

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 29/183 (15%), Positives = 57/183 (31%), Gaps = 14/183 (7%)

Query: 42  PHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI----PNNTLGKLDALE 97
           P L  +         +  V +        V  L +  + +   I       +   L +L 
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308

Query: 98  VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNSFTG 154
           +  +++ V      +  +    +    L  ++ +  I             L+ + N FT 
Sbjct: 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTD 367

Query: 155 NIPQSIQNLTQLTGLSLQSNNLSGSIPN-FDIP----KLRHLNLSYNGLKGSIPSSLQKF 209
           ++ Q    L +L  L LQ N L  +      +      L  L++S N L          +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426

Query: 210 PNS 212
             S
Sbjct: 427 AES 429

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 6/90 (6%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
               +   + N +  +P    P+   L LS NS +      I  L++L  L L  N +  
Sbjct: 32  LESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR- 89

Query: 179 SIPN--FD-IPKLRHLNLSYNGLKGSIPSS 205
           S+    F     L +L++S+N L+ +I   
Sbjct: 90  SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC 118

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 7/83 (8%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
           + VL+L SN+LTG +   +   P ++ L L +N     IP   +    L  L+++ N   
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486

Query: 154 GNIPQSI-QNLTQLTGLSLQSNN 175
            ++P  +   LT L  + L  N 
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 394
           + +G G+ G    A        V +K+L         F+ Q        E+V  +   H 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121

Query: 395 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           N++ L   +  +       D Y     +   L       +  LD E    +L     G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 178

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 503
           H+HS G     H ++K SN+++  D    I DFGL          +R+AG          
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 225

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
              YRAPEVI    +    D++S G ++ EM+  K  L
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-IL 262

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 36/123 (29%), Positives = 48/123 (39%), Gaps = 8/123 (6%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  +  L L  N L     S I  L S++ L L     +   P +    L VL L  
Sbjct: 81  LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 208
           N  T NI   +  LT L  LS+ +  +S  +     + KL  L    N +   I S L  
Sbjct: 139 NQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DI-SPLAS 193

Query: 209 FPN 211
            PN
Sbjct: 194 LPN 196

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 24/123 (19%), Positives = 48/123 (39%), Gaps = 8/123 (6%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           +  L+ L  L L+ N +T    + + +L  +  L L  N        +    +  LDL+ 
Sbjct: 59  VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 208
              T   P  +  L+ L  L L  N ++ +I     +  L++L++    +   + + L  
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVS-DL-TPLAN 171

Query: 209 FPN 211
              
Sbjct: 172 LSK 174

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 6/123 (4%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           T   LD +  LS     +T      +  L +L  L L+ N  +   P     ++  L+LS
Sbjct: 36  TQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 208
            N    N+  +I  L  +  L L S  ++   P   +  L+ L L  N +  +I S L  
Sbjct: 94  GNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAG 149

Query: 209 FPN 211
             N
Sbjct: 150 LTN 152

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 29/123 (23%), Positives = 53/123 (43%), Gaps = 8/123 (6%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           +  L +++ L L S  +T    + +  L +L+ LYL  N  +   P +    L  L +  
Sbjct: 103 IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQK 208
              + ++   + NL++LT L    N +S  I     +P L  ++L  N +   + S L  
Sbjct: 161 AQVS-DLT-PLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DV-SPLAN 215

Query: 209 FPN 211
             N
Sbjct: 216 TSN 218

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 4/128 (3%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L+VL L  N +T    S +  L +L+YL + +   S   P +   +L  L    
Sbjct: 125 LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
           N  + +I   + +L  L  + L++N +S   P  +   L  + L+   +           
Sbjct: 183 NKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNL 240

Query: 210 PNSSFVGN 217
              + V  
Sbjct: 241 VVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 15/137 (10%)

Query: 83  GPIPNNT-------LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP 135
           G I   T          L     ++   + +T         L  +  L       +    
Sbjct: 1   GSITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEG 58

Query: 136 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLS 194
             +   L+ L+L  N  T ++   ++NLT++T L L  N L  ++     +  ++ L+L+
Sbjct: 59  VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLT 115

Query: 195 YNGLKGSIPSSLQKFPN 211
              +    P  L    N
Sbjct: 116 STQITDVTP--LAGLSN 130

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 2/107 (1%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L  L    N ++    S + SLP+L  ++L++N  S   P + +  L ++ L+ 
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
            + T        NL     +   S          D       NL++N
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 7/94 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L  + L++N ++    S + +  +L  + L +   +   P  ++  LVV ++  
Sbjct: 191 LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVK 247

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF 183
                     I   T     +  S NL+ ++ +F
Sbjct: 248 G----PSGAPIAPATISDNGTYASPNLTWNLTSF 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 41/202 (20%), Positives = 86/202 (42%), Gaps = 18/202 (8%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
           E LG+G +G  ++ V E S+  T + K +K     +   ++++ I+     H N++ L  
Sbjct: 11  EDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHE 68

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            + S +E ++++++ +   +   +           +  + V  +      +  +HS    
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE---ALQFLHSHN-- 122

Query: 462 KFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKH 515
              H +I+  N++          I +FG    +  P    R    +  Y APEV +    
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 516 SHKSDVYSFGVLLLEMLTGKAP 537
           S  +D++S G L+  +L+G  P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 72/293 (24%)

Query: 302 GRSEKPKEEFGSGVQEPE---KNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTAYK 356
           G S+  + E  +    P      ++      + +    D   L+    V+GKGS+G    
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLL 56

Query: 357 AVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVGQHPNVVPLRAYYYSKDEKLL 411
           A  +       VK L K+ ++ K++ +  M    ++ +  +HP +V L   + + D+   
Sbjct: 57  ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116

Query: 412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHG 466
           V DY   G L   L             E R +     I       + ++HS+      + 
Sbjct: 117 VLDYINGGELFYHLQR---ERCFL---EPRARFYAAEIASA----LGYLHSLN---IVYR 163

Query: 467 NIKASNVLINQDLDG--CISDFGL----------------TPLMNVPATPSRSAGYRAPE 508
           ++K  N+L+  D  G   ++DFGL                TP             Y APE
Sbjct: 164 DLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTSTFCGTP------------EYLAPE 209

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 553
           V+  + +    D +  G +L EML G  P  S    +M        + L   +
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 262

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.3 bits (186), Expect = 8e-15
 Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 44/241 (18%)

Query: 337 DLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQM---EIVGRVG 391
           D L+    +LGKG++G       + +     +K L KEV++ K +    +    ++    
Sbjct: 8   DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT- 62

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 446
           +HP +  L+  + + D    V +Y   G L    H +R         E R +     I+ 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFT---EERARFYGAEIVS 116

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPL-MNVPATPSRSAG 503
                + ++HS       + +IK  N+++  D DG   I+DFGL    ++  AT     G
Sbjct: 117 A----LEYLHSRD---VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCG 167

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRW 552
              Y APEV+E   +    D +  GV++ EM+ G+ P  +   + +        +  PR 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227

Query: 553 V 553
           +
Sbjct: 228 L 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 56/225 (24%)

Query: 344 EVLGKGSYGTAYKAVLEEST-------TVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHP 394
           E LG G +    K   E+ST        +  +R K     V + D E+++ I+  + QHP
Sbjct: 17  EELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHP 74

Query: 395 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           NV+ L   Y +K + +L+ +       F       SL+                E     
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT----------------EEEATE 118

Query: 445 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGL-------TPLM 492
            L     GV ++HS+      H ++K  N++ +++++      I DFGL           
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175

Query: 493 NVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           N+  TP     + APE++       ++D++S GV+   +L+G +P
Sbjct: 176 NIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 42/222 (18%), Positives = 91/222 (40%), Gaps = 50/222 (22%)

Query: 344 EVLGKGSYGTAYKAVLEEST-------TVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHP 394
           E LG G +    K   ++ T        +  +RL      V + + E+++ I+  + +HP
Sbjct: 11  EELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHP 68

Query: 395 NVVPLRAYYYSKDEKLLVYDY------F----ASGSLSTLLHGNRGAGRTPLDWETRVKI 444
           N++ L   + +K + +L+ +       F       SL+                E     
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT----------------EDEATQ 112

Query: 445 LLGT-ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGC---ISDFGLTPLMNVPATPS 499
            L     GV ++HS       H ++K  N++ +++++      + DFG+   +       
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168

Query: 500 R----SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           +    +  + APE++       ++D++S GV+   +L+G +P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 26/211 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQ---------MEIVGRVGQ 392
            +LGKG +GT +    L +   V +K + +  V+G                +  VG  G 
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGS-LSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           HP V+ L  ++ +++  +LV +       L   +      G       +R          
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEG-PSR-CFFGQVVAA 151

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLM--NVPATPSRSAGYRAP 507
           + H HS G     H +IK  N+LI+    GC  + DFG   L+          +  Y  P
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLR-RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPP 207

Query: 508 EVIETRK-HSHKSDVYSFGVLLLEMLTGKAP 537
           E I   + H+  + V+S G+LL +M+ G  P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 32/210 (15%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--RDFEQQMEIVGRVGQHPNVVP 398
            +LGKGS+G   K   +  T     VK + K     K      +++E++ ++  HPN++ 
Sbjct: 28  CMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMK 85

Query: 399 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 453
           L           +V + +  G L    +         A R        +K +     G+ 
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVFS---GIT 135

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMN---VPATPSRSAGYRAP 507
           ++H        H ++K  N+L+      C   I DFGL+              +A Y AP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           EV+    +  K DV+S GV+L  +L+G  P
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 64/291 (21%)

Query: 284 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLED--LLRA 341
                G+ G S      G +    K E  +        K+           +E+  LL+ 
Sbjct: 12  GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV----------GIENFELLK- 60

Query: 342 SAEVLGKGSYGTAYKAVLEESTTVVVKRL-------KEVVVGK-RDFEQQM---EIVGRV 390
              VLG G+YG  +     + +     +L       K  +V K +  E      +++  +
Sbjct: 61  ---VLGTGAYGKVFLV--RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 391 GQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---- 443
            Q P +V L   +Y+   + KL L+ DY   G L T L       R     E  V+    
Sbjct: 116 RQSPFLVTL---HYAFQTETKLHLILDYINGGELFTHL---SQRERFT---EHEVQIYVG 166

Query: 444 -ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT-PLMNVPATPS 499
            I+L     + H+H +G     + +IK  N+L+  D +G   ++DFGL+   +      +
Sbjct: 167 EIVLA----LEHLHKLG---IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERA 217

Query: 500 RS----AGYRAPEVIETRKHSHKSDV--YSFGVLLLEMLTGKAPLQSPTRD 544
                   Y AP+++      H   V  +S GVL+ E+LTG +P       
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 54/248 (21%)

Query: 337 DLLRASAEVLGKGSYGT---AYKAVLEESTTVV-VKRL-KEVVVGK-RDFEQQM---EIV 387
           +LLR    VLGKG YG      K     +  +  +K L K ++V   +D         I+
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 388 GRVGQHPNVVPLRAYYYS--KDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 443
             V +HP +V L    Y+     KL L+ +Y + G L   L      G      E     
Sbjct: 76  EEV-KHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLER---EGIFM---EDTACF 125

Query: 444 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPAT 497
               I +     + H+H  G     + ++K  N+++  +  G   ++DFGL        T
Sbjct: 126 YLAEISMA----LGHLHQKG---IIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGT 176

Query: 498 PSRS----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM------- 546
            + +      Y APE++    H+   D +S G L+ +MLTG  P     R          
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236

Query: 547 -VDLPRWV 553
            ++LP ++
Sbjct: 237 KLNLPPYL 244

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 46/258 (17%), Positives = 83/258 (32%), Gaps = 60/258 (23%)

Query: 344 EVLGKGSYGTAYKAVLEEST-------TVVVKRLKEVVVGKR-DFEQQMEIVGRVGQHPN 395
             +G+GSYG    A+ E  T        +   +++++        + ++ ++ ++  HPN
Sbjct: 32  GAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPN 89

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLL--HGNRGAGRTPLDWETRVKILLGTAR--- 450
           +  L   Y  +    LV +    G L   L    +   G+  +D                
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 451 ------------------------------GVAHIHSMGGPKFTHGNIKASNVLINQDLD 480
                                          + ++H+ G     H +IK  N L + +  
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206

Query: 481 GC--ISDFGLTPLMNVPATPSR--------SAGYRAPEVIE--TRKHSHKSDVYSFGVLL 528
               + DFGL+                   +  + APEV+      +  K D +S GVLL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 529 LEMLTGKAPLQSPTRDDM 546
             +L G  P       D 
Sbjct: 267 HLLLMGAVPFPGVNDADT 284

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 75.8 bits (186), Expect = 2e-14
 Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 17/137 (12%)

Query: 87  NNTLGKLDA----LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQL 142
            N L  L      LE L    N L+  LP       SL++L + +N  +  +P   +  L
Sbjct: 89  QNALISLPELPASLEYLDACDNRLST-LPELP---ASLKHLDVDNNQLT-MLPELPA-LL 142

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI 202
             ++   N  T  +P+   +L  L   S+++N L+  +P      L  L++S N L+ S+
Sbjct: 143 EYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPEL-PESLEALDVSTNLLE-SL 195

Query: 203 PSSLQKFPNSSFVGNSL 219
           P+   +  +S       
Sbjct: 196 PAVPVRNHHSEETEIFF 212

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 33/166 (19%), Positives = 53/166 (31%), Gaps = 14/166 (8%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 155
           LE ++  +N LT  LP   TSL     L +++N  +  +P      L  LD+S N    +
Sbjct: 142 LEYINADNNQLTM-LPELPTSL---EVLSVRNNQLT-FLPELPE-SLEALDVSTNLLE-S 194

Query: 156 IPQSIQNLTQLT----GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKF 209
           +P                  + N ++  IP     +     + L  N L   I  SL + 
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 210 PNSSFVGNSLLCGPPLKACFPVAPSPSPTYSPPPFIPRKQSSKQKL 255
                     +              P        F   KQS   ++
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 22/123 (17%), Positives = 38/123 (30%), Gaps = 7/123 (5%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVL 145
           P N    L      +  S        S               N     +      Q   L
Sbjct: 6   PINNNFSLSQNSFYNTISGTY-ADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 205
            L+  + + ++P ++    Q+T L +  N L  S+P      L +L+   N L  ++P  
Sbjct: 65  QLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS-TLPEL 118

Query: 206 LQK 208
              
Sbjct: 119 PAS 121

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 18/98 (18%), Positives = 29/98 (29%), Gaps = 5/98 (5%)

Query: 89  TLGKLDALE----VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
              +    E        R N +T  +P  I SL     + L+ N  S +I  S S Q   
Sbjct: 198 VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 182
            D        ++    QN          +     +  +
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 346 LGKGSYGTAYKAVLEESTT---VVVKRLKEVVVGKRDFEQQMEIVG-RVGQHPNVVPLR- 400
           +G+G+YG  YKA  ++        +K+++   +         EI   R  +HPNV+ L+ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 85

Query: 401 AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDW---ETRVK-ILLGTARGVAHI 455
            +    D K+ L++DY A   L  ++  +R +             VK +L     G+ ++
Sbjct: 86  VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 456 HSMGGPKFTHGNIKASNVLINQDLD--GC--ISDFGLTPLMNVPATPSRSAG-------Y 504
           H+       H ++K +N+L+  +    G   I+D G   L N P  P            Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 505 RAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           RAPE++   R ++   D+++ G +  E+LT + P+
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVK---------RLKEVVVGKRDFEQQMEIVGRVGQ 392
           + LG G+ G    A  E  T   V ++                   + E ++EI+ ++  
Sbjct: 141 KTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-N 198

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HP ++ ++ ++ ++D   +V +    G L      ++  G   L   T           V
Sbjct: 199 HPCIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NVPATPSRSAGYRA 506
            ++H  G     H ++K  NVL++   + C   I+DFG + ++   ++  T   +  Y A
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 507 PEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 537
           PEV+    T  ++   D +S GV+L   L+G  P
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 43/219 (19%), Positives = 91/219 (41%), Gaps = 26/219 (11%)

Query: 334 DLEDLLRASAEVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVG 388
           +  +    +++ LG+G +    + +  +ST        +K+ +     + +   ++ ++ 
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83

Query: 389 RVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
                P V+ L   Y +  E +L+ +Y A G + +L         +  D    +K +L  
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE- 142

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVL-INQDLDGCI--SDFGL-------TPLMNVPATP 498
             GV ++H        H ++K  N+L  +    G I   DFG+         L  +  TP
Sbjct: 143 --GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197

Query: 499 SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                Y APE++     +  +D+++ G++   +LT  +P
Sbjct: 198 ----EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 42/246 (17%)

Query: 324 VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV--VKRL-KEVVVGKRDF 380
           VF E    NFD  ++LR     +GKGS+G     V +  T  +  +K + K+  V + + 
Sbjct: 5   VFDENEDVNFDHFEILR----AIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEV 59

Query: 381 EQQM---EIVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPL 436
                  +I+  + +HP +V L  Y +  +E + +V D    G L   L   +       
Sbjct: 60  RNVFKELQIMQGL-EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK- 113

Query: 437 DWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG--CISDFGLT 489
             E  VK     +++     + ++ +       H ++K  N+L+  D  G   I+DF + 
Sbjct: 114 --EETVKLFICELVMA----LDYLQNQR---IIHRDMKPDNILL--DEHGHVHITDFNIA 162

Query: 490 PLMNVPATPSRSAG---YRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTR 543
            ++      +  AG   Y APE+  +RK   +S   D +S GV   E+L G+ P    + 
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222

Query: 544 DDMVDL 549
               ++
Sbjct: 223 TSSKEI 228

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 53/286 (18%), Positives = 104/286 (36%), Gaps = 60/286 (20%)

Query: 284 KKKDNGSNGVSKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASA 343
               + +      K +           F S   E E       +     +D +       
Sbjct: 47  DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPK------- 99

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLK---------EVVVGKRDFEQQMEIVGRVGQ 392
           +V+G+G      + V   +T     VK ++         ++   +    ++  I+ +V  
Sbjct: 100 DVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 441
           HP+++ L   Y S     LV+D    G L               D+          ETR 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRS 204

Query: 442 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPAT 497
            ++ LL     V+ +H+       H ++K  N+L++ ++   +SDFG +  +        
Sbjct: 205 IMRSLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258

Query: 498 PSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAP 537
              + GY APE+++         +  + D+++ GV+L  +L G  P
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 53/262 (20%), Positives = 101/262 (38%), Gaps = 40/262 (15%)

Query: 294 SKGKASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 353
               A     ++ P        Q   K+ L   +       + D  + +++VLG G  G 
Sbjct: 23  PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN-----AIIDDYKVTSQVLGLGINGK 77

Query: 354 AYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY----YSKDE 408
             +   + +     +K L++         +++E+  R  Q P++V +   Y      +  
Sbjct: 78  VLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 409 KLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            L+V +    G L       G+     R A          +K +      + ++HS+   
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA---IQYLHSIN-- 181

Query: 462 KFTHGNIKASNVL-INQDLDGC--ISDFGL---TPLMNVPATPSRSAGYRAPEVIETRKH 515
              H ++K  N+L  ++  +    ++DFG    T   N   TP  +  Y APEV+   K+
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240

Query: 516 SHKSDVYSFGVLLLEMLTGKAP 537
               D++S GV++  +L G  P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 17/126 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           IP  T         L L +N  T    + I   LP LR +   +N  +     +F     
Sbjct: 30  IPQYT-------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 197
           +  + L+ N    N+   + + L  L  L L+SN ++  + N  F  +  +R L+L  N 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140

Query: 198 LKGSIP 203
           +  ++ 
Sbjct: 141 IT-TVA 145

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 10/130 (7%)

Query: 74  LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSG 132
           LRL               KL  L  ++  +N +T  +          +  + L  N    
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN 95

Query: 133 KIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IP 186
                F     L  L L  N  T  +       L+ +  LSL  N ++ ++    FD + 
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153

Query: 187 KLRHLNLSYN 196
            L  LNL  N
Sbjct: 154 SLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 6/77 (7%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLR 189
           IP         L L+ N FT      I + L QL  ++  +N ++  I    F+    + 
Sbjct: 26  IPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVN 84

Query: 190 HLNLSYNGLKGSIPSSL 206
            + L+ N L+ ++   +
Sbjct: 85  EILLTSNRLE-NVQHKM 100

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 46/218 (21%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 394
           + +G G+ G    A        V +K+L         F+ Q        E+V  +   H 
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84

Query: 395 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           N++ L   +  +       D Y     +   L       +  LD E    +L     G+ 
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 141

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---------- 503
           H+HS G     H ++K SN+++  D    I DFGL          +R+AG          
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL----------ARTAGTSFMMTPYVV 188

Query: 504 ---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
              YRAPEVI    +    D++S G ++ EM+ G   L
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 25/211 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVV--------KRLKEVVVGKRDFEQQMEIVGRVGQHPN 395
           EV+GKG +    + +    T            K      +   D +++  I   +  HP+
Sbjct: 30  EVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPH 87

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSL--STLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           +V L   Y S     +V+++     L    +   + G   +       ++ +L     + 
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALR 144

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLMNVPATPSR----SAGYRA 506
           + H        H ++K   VL+    +     +  FG+   +      +     +  + A
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           PEV++   +    DV+  GV+L  +L+G  P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 38/217 (17%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM--EI-VGRVGQHPNVVP 398
           ++LG+GSYG   + +  E      VK L K+ +    + E  +  EI + R  +H NV+ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 399 LR--AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR------ 450
           L    Y   K +  +V +Y     +  +L           D     +  +  A       
Sbjct: 71  LVDVLYNEEKQKMYMVMEY-CVCGMQEML-----------DSVPEKRFPVCQAHGYFCQL 118

Query: 451 --GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSA 502
             G+ ++HS G     H +IK  N+L+       IS  G+   ++  A      T   S 
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 503 GYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAP 537
            ++ PE+          K D++S GV L  + TG  P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 71.8 bits (177), Expect = 8e-14
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 396
           E LG G+Y T YK + + +   V   LKEV   K D E+        EI + +  +H N+
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVA--LKEV---KLDSEEGTPSTAIREISLMKELKHENI 65

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLL-HGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           V L    +++++  LV+++  +  L   +     G     L+            +G+A  
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 508
           H        H ++K  N+LIN+   G   + DFGL     +P   + S+      YRAP+
Sbjct: 125 HENK---ILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPD 178

Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           V+  +R +S   D++S G +L EM+TGK    
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 32/222 (14%)

Query: 344 EVLGKGSYGTAYKAVLEESTTV-----VVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP 398
           E LGKG++    + V +          ++   K      +  E++  I   + +HPN+V 
Sbjct: 17  EELGKGAFSVVRRCV-KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVR 74

Query: 399 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 453
           L      +    L++D    G L    +         A          ++ +L     V 
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQILE---AVL 124

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR----SAGYRA 506
           H H MG     H N+K  N+L+   L G    ++DFGL   +            + GY +
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           PEV+    +    D+++ GV+L  +L G  P     +  +  
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 50/213 (23%), Positives = 94/213 (44%), Gaps = 41/213 (19%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             LG+G Y   ++A+ +  +  VVVK LK V   K+  +++++I+  +   PN++ L   
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 99

Query: 403 YYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPL-DWETRVKI--LLGTARGVAHIHS 457
                 +   LV+++  +     L           L D++ R  +  +L   + + + HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL---KALDYCHS 148

Query: 458 MGGPKFTHGNIKASNVLINQDLDGC---ISDFGL------TPLMNVPATPSRSAG--YRA 506
           MG     H ++K  NV+I+ +       + D+GL          NV     R A   ++ 
Sbjct: 149 MG---IMHRDVKPHNVMIDHE--HRKLRLIDWGLAEFYHPGQEYNV-----RVASRYFKG 198

Query: 507 PEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
           PE++   +    S D++S G +L  M+  K P 
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 61/226 (26%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 391
           E +G+G+YG  YKA   +   V +KR++         + + E  G            +  
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDE--GIPSTAIREISLLKEL 76

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 450
            HPN+V L    +S+    LV+++     L  +L  N+      L  ++++KI L    R
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQ-DSQIKIYLYQLLR 130

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 503
           GVAH H        H ++K  N+LIN   DG   ++DFGL          +R+ G     
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINS--DGALKLADFGL----------ARAFGIPVRS 175

Query: 504 ---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
                    YRAP+V+  ++K+S   D++S G +  EM+TGK    
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 26/210 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQM------EI-VGRVGQHP 394
             LG G++G  + AV  E++  VVVK + KE V+     E         EI +    +H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGS-LSTLL--HGNRGAGRTPLDWETRVKILLGTARG 451
           N++ +   + ++    LV +   SG  L   +  H         LD      I       
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYIFRQLVSA 142

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPE 508
           V ++         H +IK  N++I +D    + DFG    +          G   Y APE
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

Query: 509 VIETRK-HSHKSDVYSFGVLLLEMLTGKAP 537
           V+        + +++S GV L  ++  + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 46/152 (30%), Positives = 62/152 (40%), Gaps = 20/152 (13%)

Query: 86  PNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--PQ 141
              T  +L  L  L L  N L   + SE    +P+LRYL L  N+    +    FS    
Sbjct: 56  AEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA 113

Query: 142 LVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD----IPKLRHLNLS 194
           L VL L  N     + ++  +++ QL  L L  N +S   P         +PKL  L+LS
Sbjct: 114 LEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLS 171

Query: 195 YNGLKGSIPSSLQKFPNSSFV-----GNSLLC 221
            N LK    + LQK P           N L C
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 15/124 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPS-SFS--P 140
           I +     +  L  L L SN L   L   + + L +L  L L +N+    +   +F    
Sbjct: 79  ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136

Query: 141 QLVVLDLSFNSFTGNIP----QSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNL 193
           QL  L LS N  +   P    +    L +L  L L SN L   +P      +P      L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194

Query: 194 SYNG 197
             + 
Sbjct: 195 YLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 26/92 (28%), Positives = 38/92 (41%), Gaps = 15/92 (16%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKL 188
           +P S      +LDLS N+ +  +    +   LT L  L L  N+L+  I +  F  +P L
Sbjct: 33  VPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90

Query: 189 RHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLL 220
           R+L+LS N         L       F     L
Sbjct: 91  RYLDLSSN--------HLHTLDEFLFSDLQAL 114

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 28/100 (28%), Positives = 39/100 (39%), Gaps = 9/100 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS---- 139
           +       L ALEVL L +N +   +       +  L+ LYL  N  S            
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161

Query: 140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLT--GLSLQSNNL 176
            P+L++LDLS N         +Q L      GL L +N L
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 46/266 (17%)

Query: 309 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAE------VLGKGSYGTAYKAVLEES 362
            +         KN   F        +    LR  AE      V+G+G++G       + +
Sbjct: 34  YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93

Query: 363 TTVV-VKRL-KEVVVGKRDFEQQME---IVGRVGQHPNVVPLRAYYYSKDEKL-LVYDYF 416
             V  +K L K  ++ + D     E   I+      P VV L  Y +  D  L +V +Y 
Sbjct: 94  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLF-YAFQDDRYLYMVMEYM 151

Query: 417 ASGSLSTLLHGNRGAGRTPLDWETRVK-----ILLGTARGVAHIHSMGGPKFTHGNIKAS 471
             G L  L+         P   E   +     ++L     +  IHSMG   F H ++K  
Sbjct: 152 PGGDLVNLMS----NYDVP---EKWARFYTAEVVLA----LDAIHSMG---FIHRDVKPD 197

Query: 472 NVLINQDLDG--CISDFGL-TPLMNVPATPSRSA-G---YRAPEVIETR----KHSHKSD 520
           N+L+  D  G   ++DFG    +         +A G   Y +PEV++++     +  + D
Sbjct: 198 NMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 521 VYSFGVLLLEMLTGKAPLQSPTRDDM 546
            +S GV L EML G  P  + +    
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGT 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 53/221 (23%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 398
           E LGKG++    + V  ++T      K +    +  RDF+   ++  I  ++ QHPN+V 
Sbjct: 12  EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 69

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR--VKILL 446
           L      +    LV+D    G L               +           +    ++ +L
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQIL 115

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPA 496
                +A+ HS G     H N+K  N+L+     G    ++DFGL               
Sbjct: 116 E---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169

Query: 497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           TP    GY +PEV++   +S   D+++ GV+L  +L G  P
Sbjct: 170 TP----GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 23/223 (10%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 402
           +GKG++     A  +     V +K + +  +     ++   E+ + ++  HPN+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             ++    L+ +Y + G +   L  +   GR     E R          V + H      
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK-EAR-SKFRQIVSAVQYCHQKR--- 134

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRK-HSHK 518
             H ++KA N+L++ D++  I+DFG +    V        G   Y APE+ + +K    +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPRWV 553
            DV+S GV+L  +++G  P       ++          +P ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM 237

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 9/123 (7%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           +     L+ L L  N ++    S +  L  L  L +  N     +    S  L  L L  
Sbjct: 59  MQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 208
           N    +   S+ +L  L  LS+++N L  SI     + KL  L+L  N +  +    L +
Sbjct: 116 NELR-DT-DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT-NT-GGLTR 170

Query: 209 FPN 211
              
Sbjct: 171 LKK 173

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 26/122 (21%), Positives = 42/122 (34%), Gaps = 7/122 (5%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
              L      +L    +T         L  ++     ++N        F   L  L LS 
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSH 72

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
           N  + ++   +++LT+L  LS+  N L  ++       L  L L  N L      SL   
Sbjct: 73  NQIS-DLS-PLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL--RDTDSLIHL 127

Query: 210 PN 211
            N
Sbjct: 128 KN 129

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 2/87 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  LE+LS+R+N L       +  L  L  L L  N  +     +   ++  +DL+ 
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTG 181

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNL 176
                   +    L     +       
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW 208

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 71.7 bits (175), Expect = 3e-13
 Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
           L  L  L  L L  N +     S +  L  L+ L L+HN  S  I      PQL  L L 
Sbjct: 83  LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 139

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 207
            N  T +I   +  LT+L  LSL+ N +S  I     + KL++L LS N +   +  +L 
Sbjct: 140 NNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 194

Query: 208 KFPN 211
              N
Sbjct: 195 GLKN 198

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 10/124 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
                     +L+   +T         L S+  +   +++    +    + P +  L L+
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLN 73

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 207
            N  T +I + + NL  L  L L  N +   + +  D+ KL+ L+L +NG+   I + L 
Sbjct: 74  GNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 128

Query: 208 KFPN 211
             P 
Sbjct: 129 HLPQ 132

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.0 bits (168), Expect = 2e-12
 Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 8/123 (6%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           +  L  +  L L  N LT      +T+L +L +L+L  N            +L  L L  
Sbjct: 61  IQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEH 118

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQK 208
           N  + +I   + +L QL  L L +N ++  I     + KL  L+L  N +   I   L  
Sbjct: 119 NGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAG 173

Query: 209 FPN 211
              
Sbjct: 174 LTK 176

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 30/122 (24%), Positives = 46/122 (37%), Gaps = 4/122 (3%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L+ LSL  N ++    + +  LP L  LYL +N  +     S   +L  L L  
Sbjct: 105 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 162

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
           N  + +I   +  LT+L  L L  N++S       +  L  L L          +     
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNL 220

Query: 210 PN 211
             
Sbjct: 221 VV 222

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 2/130 (1%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L +L  L+ LSL  N ++      +  L  L+ LYL  N+ S     +    L VL+L  
Sbjct: 149 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 206

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF 209
                       NL     +     +L       D       N+ ++  + +   S   +
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 266

Query: 210 PNSSFVGNSL 219
              +      
Sbjct: 267 QPVTIGKAKA 276

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG------------- 388
             +G+G+YG  +KA   ++    V +KR++         +   E  G             
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR--------VQTGEE--GMPLSTIREVAVLR 66

Query: 389 --RVGQHPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 441
                +HPNVV L          ++ KL LV+++     L+T L      G         
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPT----ET 121

Query: 442 VKILLG-TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATP 498
           +K ++    RG+  +HS       H ++K  N+L+     G   ++DFGL  + +     
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMAL 176

Query: 499 SRSAG---YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
           +       YRAPEV+    ++   D++S G +  EM   K PL
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PL 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 25/206 (12%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E+LG G +G  +K   E +T   +  K +    +  K + + ++ ++ ++  H N++ L 
Sbjct: 95  EILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLY 152

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             + SK++ +LV +Y   G L   +  +     T LD    +K +     G+ H+H M  
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRII-DESYNLTELDTILFMKQICE---GIRHMHQMY- 207

Query: 461 PKFTHGNIKASNVL-INQDLDGC-ISDFGL-------TPLMNVPATPSRSAGYRAPEVIE 511
               H ++K  N+L +N+D     I DFGL         L     TP     + APEV+ 
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP----EFLAPEVVN 261

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAP 537
               S  +D++S GV+   +L+G +P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
             LG+G+    Y+   + +      ++ +  V K+    ++ ++ R+  HPN++ L+  +
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIF 117

Query: 404 YSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVAHIHSM 458
            +  E  LV +    G L    +  G    R A          VK +L     VA++H  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-------VKQILE---AVAYLHEN 167

Query: 459 GGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIET 512
           G     H ++K  N+L      D    I+DFGL+ ++    +  T   + GY APE++  
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG 224

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD 544
             +  + D++S G++   +L G  P      D
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 11/130 (8%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           I          LE + +  N +   + +++ ++LP L  + ++  N    I    F   P
Sbjct: 45  IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD--IPKLRHLNLSY 195
            L  L +S      ++P     +  Q   L +Q N    +I    F     +   L L+ 
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163

Query: 196 NGLKGSIPSS 205
           NG++  I +S
Sbjct: 164 NGIQ-EIHNS 172

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 28/118 (23%), Positives = 48/118 (40%), Gaps = 11/118 (9%)

Query: 85  IPNNTLGKLDA-LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--P 140
           I  N+   L     +L L  N +   + +   +   L  L L  NN   ++P+  F    
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYN 196
             V+LD+S      ++P    +NL +L   S    NL   +P  + +  L   +L+Y 
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 25/140 (17%), Positives = 46/140 (32%), Gaps = 24/140 (17%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQ 141
           +P N          L      L        +    L  + +  N+    I +  FS  P+
Sbjct: 28  LPRNA-------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 142 LVVLDLS-FNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYN 196
           L  + +   N+    I     QNL  L  L + +  +   +P+       +   L++  N
Sbjct: 81  LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138

Query: 197 GLKGSIPSSLQKFPNSSFVG 216
                   ++     +SFVG
Sbjct: 139 -------INIHTIERNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 18/123 (14%), Positives = 35/123 (28%), Gaps = 23/123 (18%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           S R    Q +  + +IPS      + L             +      L  + +  N++  
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 179 SIPN--FD-IPKLRHLNLS-YNGLKGSIPSS-----------------LQKFPNSSFVGN 217
            I    F  +PKL  + +   N L   I                    ++  P+   + +
Sbjct: 69  VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127

Query: 218 SLL 220
              
Sbjct: 128 LQK 130

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 16/125 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           +P            + L  N +    P   +    LR + L +N  S   P +F     L
Sbjct: 30  LPETI-------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 143 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGL 198
             L L  N  T  +P+S+ + L  L  L L +N ++  +    F  +  L  L+L  N L
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140

Query: 199 KGSIP 203
           + +I 
Sbjct: 141 Q-TIA 144

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 17/76 (22%), Positives = 31/76 (40%), Gaps = 5/76 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 190
           IP++    +  + L  N+     P +     +L  + L +N +S  +    F  +  L  
Sbjct: 26  IPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS 84

Query: 191 LNLSYNGLKGSIPSSL 206
           L L  N +   +P SL
Sbjct: 85  LVLYGNKIT-ELPKSL 99

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 4/93 (4%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFS--PQ 141
           +  +    L +L  L L  N +T  LP  +   L SL+ L L  N  +     +F     
Sbjct: 71  LAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129

Query: 142 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 174
           L +L L  N        +   L  +  + L  N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 69.1 bits (170), Expect = 5e-13
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG------------RVG 391
           E +G+G+YG  YKA      T  +K+++         E++ E  G            +  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDE--GIPSTTIREISILKEL 57

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TAR 450
           +H N+V L    ++K   +LV+++     L  LL    G     L+     K  L     
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLE-SVTAKSFLLQLLN 111

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG----- 503
           G+A+ H        H ++K  N+LIN+  +G   I+DFGL     +P     +       
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINR--EGELKIADFGLARAFGIP-VRKYTHEIVTLW 165

Query: 504 YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           YRAP+V+  ++K+S   D++S G +  EM+ G     
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 399
           + LG G++G             V VK L ++ +       + + EI   ++ +HP+++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 456
                +  +  +V +Y + G L   +  +   GR     E R     IL      V + H
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEM-EARRLFQQILSA----VDYCH 128

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 513
                   H ++K  NVL++  ++  I+DFGL+ +M       T   S  Y APEVI  R
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAP 537
                + D++S GV+L  +L G  P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 34/218 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI----VGRVGQ 392
             +G G+YGT YKA    S   V   LK V V                E+         +
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVA--LKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72

Query: 393 HPNVVPLR----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG 447
           HPNVV L          ++ K+ LV+++     L T L      G         +K L+ 
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA----ETIKDLMR 127

Query: 448 -TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG- 503
              RG+  +H+       H ++K  N+L+     G   ++DFGL  + +     +     
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVT 182

Query: 504 --YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
             YRAPEV+    ++   D++S G +  EM   K    
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.6 bits (171), Expect = 7e-13
 Identities = 46/229 (20%), Positives = 91/229 (39%), Gaps = 57/229 (24%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 394
            +LG+G+YG    A  + +  +V +K+++   + +   R   E    +         +H 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHE 69

Query: 395 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 444
           N++ +    R   +    ++ ++ +   +  L  ++          L  +  ++      
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLS-DDHIQYFIYQT 121

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSR 500
           L    R V  +H        H ++K SN+LIN + D  + DFGL           + P+ 
Sbjct: 122 L----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 501 SAG----------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
                        YRAPEV+ T     ++ DV+S G +L E+   + P+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 33/212 (15%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM------EI-VGRVGQHPNV 396
           + LG+G+Y T YK   + +  +V   LKE+   + + E+        E+ + +  +H N+
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVA--LKEI---RLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAHI 455
           V L    +++    LV++Y     L   L          ++    VK+ L    RG+A+ 
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIIN-MHNVKLFLFQLLRGLAYC 116

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG-----YRAPE 508
           H     K  H ++K  N+LIN+   G   ++DFGL    ++P T +         YR P+
Sbjct: 117 HR---QKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPD 170

Query: 509 VI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           ++  +  +S + D++  G +  EM TG+    
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 394
             +G G+YG+   A+ + S   V +K+L         F+ ++       E+ + +  QH 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83

Query: 395 NVVPLRAYYYSKDEKLLVYD-YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
           NV+ L   +         YD Y     + T L             E    ++    +G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK---IMGLKFSEEKIQYLVYQMLKGLK 140

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP---SRSAGYRAPEVI 510
           +IHS G     H ++K  N+ +N+D +  I DFGL    +   T    +R   YRAPEVI
Sbjct: 141 YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVI 195

Query: 511 ETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
            +  H +++ D++S G ++ EMLTGK  L
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 52/239 (21%), Positives = 88/239 (36%), Gaps = 54/239 (22%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG GS+G   +    ES       LK+V+   R   ++++I+ +V  H N++ L  Y+
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFA--LKKVLQDPRYKNRELDIM-KVLDHVNIIKLVDYF 69

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR---------------------- 441
           Y+  ++                  N                                   
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 442 -------------VKILL-GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC-ISDF 486
                        + I +    R V  IHS+G     H +IK  N+L+N   +   + DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 487 GLTPLMNVPATP------SRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
           G    + +P+ P      SR   YRAPE++      +   D++S G +  E++ GK PL
Sbjct: 187 GSAKKL-IPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PL 241

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 50/226 (22%), Positives = 97/226 (42%), Gaps = 60/226 (26%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------------MEIVGRV 390
           + LG+G + T YKA  + +  +V   +K++ +G R   +               E+    
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVA--IKKIKLGHRSEAKDGINRTALREIKLLQEL---- 69

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 449
             HPN++ L   +  K    LV+D+  +  L  ++  N       L   + +K  +  T 
Sbjct: 70  -SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLT-PSHIKAYMLMTL 122

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---- 503
           +G+ ++H        H ++K +N+L+++  +G   ++DFGL          ++S G    
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDE--NGVLKLADFGL----------AKSFGSPNR 167

Query: 504 ----------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                     YRAPE++   R +    D+++ G +L E+L    P 
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PF 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 40/124 (32%), Positives = 55/124 (44%), Gaps = 10/124 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
           L  L  L  L L  N +     S +  L  L+ L L+HN  S  I      PQL  L L 
Sbjct: 86  LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 142

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 207
            N  T +I   +  LT+L  LSL+ N +S  I     + KL++L LS N +   +  +L 
Sbjct: 143 NNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS-DL-RALA 197

Query: 208 KFPN 211
              N
Sbjct: 198 GLKN 201

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 29/124 (23%), Positives = 56/124 (45%), Gaps = 8/124 (6%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           T  +L++++ +   ++ +       I  LP++  L+L  N  +   P +    L  L L 
Sbjct: 41  TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKGSIPSSLQ 207
            N    ++  S+++L +L  LSL+ N +S  I     +P+L  L L  N +   I + L 
Sbjct: 99  ENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT-DI-TVLS 153

Query: 208 KFPN 211
           +   
Sbjct: 154 RLTK 157

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 26/124 (20%), Positives = 49/124 (39%), Gaps = 10/124 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
                     +L+   +T         L S+  +   +++    +    + P +  L L+
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLN 76

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQ 207
            N  T +I   + NL  L  L L  N +   + +  D+ KL+ L+L +NG+   I + L 
Sbjct: 77  GNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNGIS-DI-NGLV 131

Query: 208 KFPN 211
             P 
Sbjct: 132 HLPQ 135

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 30/108 (27%), Positives = 46/108 (42%), Gaps = 6/108 (5%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L+ LSL  N ++    + +  LP L  LYL +N  +     S   +L  L L  
Sbjct: 108 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYN 196
           N  + +I   +  LT+L  L L  N++S  +     +  L  L L   
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 210

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 2/107 (1%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L +L  L+ LSL  N ++      +  L  L+ LYL  N+ S     +    L VL+L  
Sbjct: 152 LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 209

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
                       NL     +     +L       D       N+ ++
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 15/88 (17%), Positives = 30/88 (34%), Gaps = 2/88 (2%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L  L  L+ L L  N ++      +  L +L  L L       K  +  S  +V   +  
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
              +   P+ I +       +++ +   
Sbjct: 232 TDGSLVTPEIISDDGDYEKPNVKWHLPE 259

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 46/221 (20%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 390
             LG+G+YG  YKA+   +   V +KR++         E + E  G            + 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEE--GVPGTAIREVSLLKE 89

Query: 391 GQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TA 449
            QH N++ L++  +      L+++Y A   L   +  N       +     +K  L    
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKN-----PDVS-MRVIKSFLYQLI 142

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGC--ISDFGLTPLMNVPATPSRSAG- 503
            GV   HS    +  H ++K  N+L++           I DFGL     +P     +   
Sbjct: 143 NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEI 198

Query: 504 ----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
               YR PE++  +R +S   D++S   +  EML       
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 67.9 bits (167), Expect = 1e-12
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 52/221 (23%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQ-------MEI-VGRVGQHPN 395
           E +G+G+YGT +KA   E+  +V   LK V   + D + +        EI + +  +H N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVA--LKRV---RLDDDDEGVPSSALREICLLKELKHKN 62

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLG-TARGVAH 454
           +V L    +S  +  LV+++     L        G     LD    VK  L    +G+  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLD-PEIVKSFLFQLLKGLGF 116

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG--------- 503
            HS       H ++K  N+LIN+  +G   +++FGL          +R+ G         
Sbjct: 117 CHSRN---VLHRDLKPQNLLINR--NGELKLANFGL----------ARAFGIPVRCYSAE 161

Query: 504 -----YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                YR P+V+   + +S   D++S G +  E+     PL
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.8 bits (170), Expect = 1e-12
 Identities = 30/106 (28%), Positives = 43/106 (40%), Gaps = 12/106 (11%)

Query: 97  EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG 154
            VL L    LT  +   +  L  + +L L HN     +P + +    L VL  S N+   
Sbjct: 444 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499

Query: 155 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 196
           N+   + NL +L  L L +N L             P+L  LNL  N
Sbjct: 500 NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 1e-10
 Identities = 26/129 (20%), Positives = 46/129 (35%), Gaps = 8/129 (6%)

Query: 88  NTLGKLDALEVL--SLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVV 144
           +TL  +D +         +               +R L+L H + +  +        +  
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTH 467

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLKG-SI 202
           LDLS N     +P ++  L  L  L    N L  ++     +P+L+ L L  N L+  + 
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAA 525

Query: 203 PSSLQKFPN 211
              L   P 
Sbjct: 526 IQPLVSCPR 534

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 13/111 (11%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLS 148
           L +L  +  L L  N L   LP  + +L  L  L    N     +   +  P+L  L L 
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLC 516

Query: 149 FNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 191
            N         Q + +  +L  L+LQ N+L              +P +  +
Sbjct: 517 NNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.1 bits (111), Expect = 1e-05
 Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 12/91 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN---NFSGKIPSSFSPQ 141
           +P   L  L  LEVL    N L   +   + +LP L+ L L +N     +   P    P+
Sbjct: 478 LPPA-LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 142 LVVLDLSFN------SFTGNIPQSIQNLTQL 166
           LV+L+L  N           + + + +++ +
Sbjct: 535 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 395
            ++G+GSYG   K   +++  +V   +K+        + +M       EI + +  +H N
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVA--IKKF---LESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +V L      K    LV+++     +   +  +       LD++   K L     G+   
Sbjct: 86  LVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 503
           HS       H +IK  N+L++Q     + DFG           +R+              
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGF----------ARTLAAPGEVYDDEVAT 187

Query: 504 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             YRAPE++    K+    DV++ G L+ EM  G+ PL
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 39/274 (14%)

Query: 298 ASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 357
               G    P  +  +    P K K          + +         +LG G +G+ Y  
Sbjct: 14  LVPRGSHMAPCNDLHATKLAPGKEKEPLES----QYQVG-------PLLGSGGFGSVYSG 62

Query: 358 V-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR--------VGQHPNVVPLRAYYYSKDE 408
           + + ++  V +K +++  +           V                V+ L  ++   D 
Sbjct: 63  IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 409 KLLVYDYFA-SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 467
            +L+ +       L   +      G    +   R          V H H+ G     H +
Sbjct: 123 FVLILERPEPVQDLFDFITER---GALQEE-LAR-SFFWQVLEAVRHCHNCG---VLHRD 174

Query: 468 IKASNVLINQDLDGC---ISDFGLTPLM--NVPATPSRSAGYRAPEVIETRK-HSHKSDV 521
           IK  N+LI  DL+     + DFG   L+   V      +  Y  PE I   + H   + V
Sbjct: 175 IKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232

Query: 522 YSFGVLLLEMLTGKAPLQSPTR--DDMVDLPRWV 553
           +S G+LL +M+ G  P +         V   + V
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFE---QQMEIVGRVGQHPNVVP 398
           E LGKG++    + V  ++T      K +    +  RDF+   ++  I  ++ QHPN+V 
Sbjct: 35  EELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVR 92

Query: 399 LRAYYYSKDEKLLVYDYFASGSL--STLLHGN---RGAGRTPLDWETRVKILLGTARGVA 453
           L      +    LV+D    G L    +         A          ++ +L     +A
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-------IQQILE---SIA 142

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGL-------TPLMNVPATPSRSAG 503
           + HS G     H N+K  N+L+     G    ++DFGL               TP    G
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----G 195

Query: 504 YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
           Y +PEV++   +S   D+++ GV+L  +L G  P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 56/230 (24%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVG------------RV 390
             +G+G++G  +KA   ++   V +K++          E + E  G            ++
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKE--GFPITALREIKILQL 72

Query: 391 GQHPNVVPLR-------AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRV 442
            +H NVV L        + Y      + LV+D+     L+ LL              + +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLS----NVLVKFT-LSEI 126

Query: 443 K-ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPS 499
           K ++     G+ +IH        H ++KA+NVLI +  DG   ++DFGL    ++    S
Sbjct: 127 KRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR--DGVLKLADFGLARAFSLAK-NS 180

Query: 500 RSAG---------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
           +            YR PE++   R +    D++  G ++ EM T    +Q
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 53/220 (24%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 394
             +G G+YG+   A   ++   V VK+L         F+  +       E+ + +  +H 
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHE 88

Query: 395 NVVPLR-----AYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           NV+ L      A    +   + LV     +  L+ ++          L  +    ++   
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQI 141

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 503
            RG+ +IHS       H ++K SN+ +N+D +  I DFGL          +R        
Sbjct: 142 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL----------ARHTADEMTG 188

Query: 504 ------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKA 536
                 YRAPE++    H +++ D++S G ++ E+LTG+ 
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 47/218 (21%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHPN 395
             +G+GSYG  +K    ++  +V   +K+        +  +       EI + +  +HPN
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVA--IKKF---LESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +V L   +  K    LV++Y         +       +  +       I   T + V   
Sbjct: 64  LVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------------ 503
           H        H ++K  N+LI +     + DFG           +R               
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGF----------ARLLTGPSDYYDDEVAT 165

Query: 504 --YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
             YR+PE++    ++    DV++ G +  E+L+G  PL
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 398
           LG+G+YG    AV       V VK     +V  +      E + +      +  H NVV 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 455
              +    + + L  +Y + G L   +  +      P   + +     ++     GV ++
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 509
           H +G    TH +IK  N+L+++  +  ISDFGL  +               +  Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 510 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 555
           ++ R+ H+   DV+S G++L  ML G+ P   P+ D   +   W + 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 65/238 (27%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIV--GRVGQH 393
           + LGKG+YG  +K++   +  VV VK++ +       F+          EI+    +  H
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68

Query: 394 PNVVPLRAYYYSKDEK--LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----ILL 446
            N+V L     + +++   LV+DY  +  L  ++  N       L+     +     ++ 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE-PVHKQYVVYQLI- 119

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----TPLMNVPATPSRSA 502
              + + ++HS G     H ++K SN+L+N +    ++DFGL      +  V      S 
Sbjct: 120 ---KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 503 G---------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
                                 YRAPE++       K  D++S G +L E+L GK P+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 54/222 (24%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EIVG-RVGQHP 394
           + +G G+YG    AV   +   V +K+L         F+ ++       E+   +  +H 
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHE 84

Query: 395 NVVPLRAYYYSKDEKL------LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           NV+ L   +   +         LV  +  +  L  L+          L  +    ++   
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQM 137

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG----- 503
            +G+ +IH+ G     H ++K  N+ +N+D +  I DFGL          +R A      
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL----------ARQADSEMTG 184

Query: 504 ------YRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPL 538
                 YRAPEVI      +   D++S G ++ EM+TGK  L
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 49/226 (21%), Positives = 91/226 (40%), Gaps = 55/226 (24%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRL-KEVVVGK--------RDFEQQMEIVGRVGQ 392
           + LG G+ G    A  E  T   V +K + K               + E ++EI+ ++  
Sbjct: 16  KTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-N 73

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDW----------ETR- 441
           HP ++ ++ ++ ++D   +V +    G L               D             + 
Sbjct: 74  HPCIIKIKNFFDAED-YYIVLELMEGGEL--------------FDKVVGNKRLKEATCKL 118

Query: 442 -VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC---ISDFGLTPLM---NV 494
               +L     V ++H  G     H ++K  NVL++   + C   I+DFG + ++   ++
Sbjct: 119 YFYQMLL---AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172

Query: 495 PATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAP 537
             T   +  Y APEV+    T  ++   D +S GV+L   L+G  P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 34/227 (14%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGR------VGQHPNVVP 398
           LG+G+YG    AV       V VK     +V  +      E + +      +  H NVV 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHI 455
              +    + + L  +Y + G L   +  +      P   + +     ++     GV ++
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP-DAQRFFHQLMA----GVVYL 121

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEV 509
           H +G    TH +IK  N+L+++  +  ISDFGL  +               +  Y APE+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 510 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS 555
           ++ R+ H+   DV+S G++L  ML G+ P   P+ D   +   W + 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEK 224

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 38/234 (16%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLRAY 402
           +G G++G A           V VK ++    G    E  Q EI   R  +HPN+V  +  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTAR--------GVAH 454
             +     ++ +Y + G L   +     AGR   D           AR        GV++
Sbjct: 85  ILTPTHLAIIMEYASGGELYERI---CNAGRFSED----------EARFFFQQLLSGVSY 131

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC--ISDFGLTPLMNVPATPSRSAG---YRAPEV 509
            HSM      H ++K  N L++        I DFG +    + + P  + G   Y APEV
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 510 IETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT 562
           +  ++     +DV+S GV L  ML G  P + P  ++  D  + +Q ++  +++
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPRDYRKTIQRILSVKYS 240

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 46/220 (20%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDF-E----QQMEIVGRVGQHP 394
             +G+G+YG    A    +   V +K++         +R   E     +        +H 
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHE 85

Query: 395 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           N++ +    RA    + + + +V D   +  L  LL          L  +     L    
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQIL 138

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
           RG+ +IHS       H ++K SN+L+N   D  I DFGL     V        G      
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA---RVADPDHDHTGFLTEYV 192

Query: 504 ----YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAPL 538
               YRAPE++   K   KS D++S G +L EML+ + P+
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 399
           E LG+GS+G    A   +    V +K + ++++       + + EI   ++ +HP+++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 456
                +  + ++V +Y A G L   +       R   D E R     I+      + + H
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEK---KRMTED-EGRRFFQQII----CAIEYCH 125

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 513
                   H ++K  N+L++ +L+  I+DFGL+ +M   N   T   S  Y APEVI  +
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182

Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAP 537
                + DV+S G++L  ML G+ P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPL 399
           + LG G++G             V VK L ++ +       + + EI   ++ +HP+++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK---ILLGTARGVAHIH 456
                +  +  +V +Y + G L   +  N   GR     E+R     IL G    V + H
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK-ESRRLFQQILSG----VDYCH 133

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM---NVPATPSRSAGYRAPEVIETR 513
                   H ++K  NVL++  ++  I+DFGL+ +M       T   S  Y APEVI  R
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 514 K-HSHKSDVYSFGVLLLEMLTGKAP 537
                + D++S GV+L  +L G  P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 16/115 (13%)

Query: 90  LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVL 145
           L  L A + L+L +N +     L    + + +LR L L  N    KI    + +  L  L
Sbjct: 44  LSTLKACKHLALSTNNIEKISSL----SGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 196
            +S+N    ++   I+ L  L  L + +N ++ +    D    + KL  L L+ N
Sbjct: 99  WISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 12/130 (9%)

Query: 88  NTLGKLDALEV-LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVV 144
            ++   +A +V L      +   + + +++L + ++L L  NN   KI SS S    L +
Sbjct: 18  KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGLK--GS 201
           L L  N     I         L  L +  N ++ S+   + +  LR L +S N +   G 
Sbjct: 75  LSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGE 132

Query: 202 IPSSLQKFPN 211
           I   L     
Sbjct: 133 I-DKLAALDK 141

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 40/209 (19%), Positives = 78/209 (37%), Gaps = 50/209 (23%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +VLG G  G   +   + +     +K L++         +++E+  R  Q P++V +   
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 79

Query: 403 Y----YSKDEKLLVYDYFASGSL--STLLHGN-----RGAGRTPLDWETRVKILLGTARG 451
           Y      +   L+V +    G L       G+     R A          +K +      
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------MKSIGEA--- 129

Query: 452 VAHIHSMGGPKFTHGNIKASNVL-INQDLDGC--ISDFGLTPLMNVPATPSRSAGYRAPE 508
           + ++HS+      H ++K  N+L  ++  +    ++DFG                  A E
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------AKE 169

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAP 537
                K+    D++S GV++  +L G  P
Sbjct: 170 TTG-EKYDKSCDMWSLGVIMYILLCGYPP 197

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 28/218 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI--------VGRVGQH 393
           +V+GKGS+G   KA   +    V +K ++     KR   Q   EI          +    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA 453
            NV+ +   +  ++   + ++   S +L  L+  N+  G   L    R K      + + 
Sbjct: 160 -NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGF-SLP-LVR-KFAHSILQCLD 214

Query: 454 HIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAPE 508
            +H     +  H ++K  N+L+ Q     I   DFG +   +        SR   YRAPE
Sbjct: 215 ALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPE 269

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM 546
           VI   ++    D++S G +L E+LTG   L      D 
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 45/228 (19%)

Query: 346 LGKGSYGTAYKAV-LEESTTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQ----------- 392
           +GKGSYG    A    ++T   +K L K+ ++ +  F ++    G               
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 393 --------------HPNVVPLRAYYY--SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPL 436
                         HPNVV L       ++D   +V++    G +  +          PL
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPL 134

Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP- 495
             +          +G+ ++H        H +IK SN+L+ +D    I+DFG++       
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 496 ATPSRSAG---YRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAP 537
           A  S + G   + APE +   +        DV++ GV L   + G+ P
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 66/247 (26%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 394
            ++G+GSYG  Y A  + +   V +K++  +      FE  +       EI +    +  
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85

Query: 395 NVVPLRAYYYSKDEKL-----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-----I 444
            ++ L       D        +V +   S  L  L           L  E  +K     +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-----FLT-EEHIKTILYNL 138

Query: 445 LLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL----------TPLMNV 494
           L     G   IH  G     H ++K +N L+NQD    + DFGL            + ++
Sbjct: 139 L----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 495 PATPSRSAG----------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 537
                                    YRAPE+I  +++  KS D++S G +  E+L     
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

Query: 538 LQSPTRD 544
             +   +
Sbjct: 252 HINDPTN 258

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.1 bits (150), Expect = 1e-10
 Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 6/93 (6%)

Query: 111 PSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
              +    +L  LY+++      +         +L  L +  +      P +     +L+
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 168 GLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGL 198
            L+L  N L  S+         L+ L LS N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 9/52 (17%), Positives = 22/52 (42%), Gaps = 4/52 (7%)

Query: 155 NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYNGLKGSIP 203
           +    +     LT L +++      +   D+    +LR+L +  +GL+  + 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 21/110 (19%), Positives = 31/110 (28%), Gaps = 12/110 (10%)

Query: 56  CQSWVGINCTQDR-----------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN 104
                G+ CT+D              +  L +     +  +    L  L  L  L++  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 105 VLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFT 153
            L    P      P L  L L  N        +     L  L LS N   
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 18/126 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 143
           IP +T       E L L+S  L     +    L  L +L L +N     + +     L  
Sbjct: 33  IPADT-------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84

Query: 144 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 197
              L L+ N    ++P  +  +LTQL  L L  N L  S+P+  FD + KL+ L L+ N 
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142

Query: 198 LKGSIP 203
           L+ SIP
Sbjct: 143 LQ-SIP 147

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 39/120 (32%), Positives = 52/120 (43%), Gaps = 12/120 (10%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           +       L  L  L L +N L   LP  +   L  L  LYL  N     +PS  F    
Sbjct: 74  LSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           +L  L L+ N    +IP      LT L  LSL +N L  S+P+  FD + KL+ + L  N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 22/74 (29%), Positives = 32/74 (43%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 190
           +PS        LDL           + + LT+LT L+L  N L  ++    FD   +L  
Sbjct: 29  VPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGT 87

Query: 191 LNLSYNGLKGSIPS 204
           L L+ N L  S+P 
Sbjct: 88  LGLANNQLA-SLPL 100

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 49/226 (21%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRL--KEVVVGKRDF-E----QQMEIVGRVGQHPN 395
           + LG G  G  + AV  +    V +K++   +    K    E    +++        H N
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDN 69

Query: 396 VVPLRAYYYSKDEKL--------------LVYDYFASGSLSTLLHGNRGAGRTPLDWETR 441
           +V +         +L              +V +Y  +  L+ +L         PL  E  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEEHA 122

Query: 442 VKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVPATPSR 500
              +    RG+ +IHS       H ++K +N+ IN +DL   I DFGL  +M+   +   
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 501 SAG-------YRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPL 538
                     YR+P ++     ++   D+++ G +  EMLTGK  L
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 50/225 (22%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQ-QMEI-------------VG 388
             LG G + T + A  +  +T V +K ++     K   E  + EI               
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 389 RVGQHPNVVPLRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK- 443
            +G + +++ L  ++  K        +V++     +L  L+      G  PL     VK 
Sbjct: 82  SMGAN-HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLI---YVKQ 135

Query: 444 ----ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC------ISDFGLTPLMN 493
               +LL    G+ ++H   G    H +IK  NVL+             I+D G     +
Sbjct: 136 ISKQLLL----GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189

Query: 494 VPATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK 535
              T    +R   YR+PEV+        +D++S   L+ E++TG 
Sbjct: 190 EHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 61/247 (24%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQM-------EI-VGRVGQHP 394
            ++G GSYG   +A    E   V +K++  V      FE  +       EI +     H 
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112

Query: 395 NVVPL----RAYYYSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTA 449
           +VV +          K ++L +V +   S     L           L       +L    
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV-----YLTELHIKTLLYNLL 166

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------ 503
            GV ++HS G     H ++K +N L+NQD    + DFGL   ++ P   +          
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 504 -------------------------YRAPEVIETRKHSHKS-DVYSFGVLLLEMLTGKAP 537
                                    YRAPE+I  +++  ++ DV+S G +  E+L     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 538 LQSPTRD 544
             +   D
Sbjct: 284 NVAYHAD 290

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 39/120 (32%), Positives = 57/120 (47%), Gaps = 13/120 (10%)

Query: 92  KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSFSPQLV---VLDL 147
           +L  L  L L  N L   LP+ +   L +L+ L L  N     +P     +L     L+L
Sbjct: 83  ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140

Query: 148 SFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 203
           + N    ++P+ +   LT LT L L  N L  S+P   FD + +L+ L L  N LK S+P
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 42/120 (35%), Positives = 58/120 (48%), Gaps = 12/120 (10%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           +PN    KL  L+ L L  N L   LP  +   L +L YL L HN     +P   F    
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLT 157

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            L  LDLS+N    ++P+ +   LTQL  L L  N L  S+P+  FD +  L+++ L  N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 15/114 (13%)

Query: 97  EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNI 156
              +L+   +T    ++   L S+  +   +++        + P +  L L  N      
Sbjct: 22  IKANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL---- 75

Query: 157 PQSI---QNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRHLNLSYNGLKGSIPS 204
              I   + LT LT L L  N L  S+PN  FD    L+ L L  N L+ S+P 
Sbjct: 76  -HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 11/67 (16%), Positives = 25/67 (37%), Gaps = 4/67 (5%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP-KLRHLN 192
            P     + +  +L   S T +   +   L  +  +   ++++  S+        +R+L 
Sbjct: 13  FPDDAFAETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQGIQYLPNVRYLA 69

Query: 193 LSYNGLK 199
           L  N L 
Sbjct: 70  LGGNKLH 76

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 34/99 (34%), Positives = 45/99 (45%), Gaps = 13/99 (13%)

Query: 115 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
             LP      +  LYL  N F+  +P   S    L ++DLS N  +    QS  N+TQL 
Sbjct: 23  KVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 168 GLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 203
            L L  N L   IP   FD +  LR L+L  N +   +P
Sbjct: 82  TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 36/118 (30%), Positives = 51/118 (43%), Gaps = 16/118 (13%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QL 142
           IP +          L L  N  T  +P E+++   L  + L +N  S     SFS   QL
Sbjct: 29  IPRDV-------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 143 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           + L LS+N     IP      L  L  LSL  N++S  +P   F+ +  L HL +  N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 41/126 (32%), Positives = 57/126 (45%), Gaps = 18/126 (14%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLV- 143
           IP  T         L L +N L          L SL  LYL  N     +P+    +L  
Sbjct: 26  IPAQT-------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 144 --VLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNG 197
              L+LS N    ++P  +   LTQL  L+L +N L  S+P+  FD + +L+ L L  N 
Sbjct: 78  LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135

Query: 198 LKGSIP 203
           LK S+P
Sbjct: 136 LK-SVP 140

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 28/74 (37%), Positives = 36/74 (48%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIP-KLRH 190
           +P+    Q   LDL  NS           LT LT L L  N L  S+PN  F+    L +
Sbjct: 22  VPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTY 80

Query: 191 LNLSYNGLKGSIPS 204
           LNLS N L+ S+P+
Sbjct: 81  LNLSTNQLQ-SLPN 93

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 21/112 (18%), Positives = 34/112 (30%), Gaps = 8/112 (7%)

Query: 90  LGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL 147
                    L LR   +     L +   +L     +    N            +L  L +
Sbjct: 15  YTNAVRDRELDLRGYKIPVIENLGA---TLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 71

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLS--GSIPNF-DIPKLRHLNLSYN 196
           + N          Q L  LT L L +N+L   G +     +  L +L +  N
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 14/108 (12%)

Query: 112 SEITSLPSLRYLYLQHNNFSGKIP--SSFSPQLVVLDLSFNSFT--GNIPQSIQNLTQLT 167
           ++ T+    R L L+       I    +   Q   +D S N        P     L +L 
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLK 67

Query: 168 GLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLK--GSIPSSLQKFPN 211
            L + +N +       D  +P L  L L+ N L   G +   L    +
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 28/109 (25%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
              L  L+ L + +N +         +LP L  L L +N+                    
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----------------EL 103

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLN 192
                     + +L  LT L +  N ++ +  +      + +P++R L+
Sbjct: 104 GDL-----DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.9 bits (136), Expect = 7e-09
 Identities = 36/236 (15%), Positives = 68/236 (28%), Gaps = 34/236 (14%)

Query: 2   KFSSAAPLFFPLCVIVSLLPLAFADLNSDRQALLDFADAVPHLRKLNWSST--NPICQSW 59
           K      L     + +        D +     +++  +   H   L W          SW
Sbjct: 99  KILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISW 158

Query: 60  VGINCTQDRTRVFG--LRLPGIGL-VGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITS 116
           +      D + V      L  + +      +        L+ L + S  L   +  +I  
Sbjct: 159 I---EQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215

Query: 117 --LPSLRYL--YLQHNNFSGK---------IPSSFSPQLVVLDLSFNSFTGNIPQSI--- 160
             LP+L  L  Y+   ++                  P L  L +        + +     
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 161 QNLTQLTGLSLQSNNLS--------GSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK 208
             L QL  + + +  L+          +       L+ +N+ YN L   +   LQK
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKI--KHLKFINMKYNYLSDEMKKELQK 329

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 7e-09
 Identities = 26/102 (25%), Positives = 39/102 (38%), Gaps = 17/102 (16%)

Query: 115 TSLPS-----LRYLYLQHNNFSGKIPSS--FS--PQLVVLDLSFNSFTGNIPQSI-QNLT 164
             +P         L L  N    +I S   F   P LV L+L  N  T  I  +  +  +
Sbjct: 21  KEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78

Query: 165 QLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYNGLKGSIP 203
            +  L L  N +   I N  F  + +L+ LNL  N +   + 
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 32/120 (26%), Positives = 45/120 (37%), Gaps = 18/120 (15%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           IP +T         L L  N L       +   LP L  L L+ N  +  I  + F    
Sbjct: 27  IPLHT-------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78

Query: 141 QLVVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            +  L L  N     I   +   L QL  L+L  N +S  +    F+ +  L  LNL+ N
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.8 bits (136), Expect = 2e-08
 Identities = 50/385 (12%), Positives = 112/385 (29%), Gaps = 100/385 (25%)

Query: 310 EFGSGVQEPEKNKL--VFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKA---------- 357
           +F +G  + +   +  VF +    NFD +D+      +L K        +          
Sbjct: 8   DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67

Query: 358 --VLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKL----- 410
              L      +V++  E V+ + +++  M  +    + P+   +   Y  + ++L     
Sbjct: 68  FWTLLSKQEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQ 124

Query: 411 LVYDYFAS---------GSLSTL-------LHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           +   Y  S          +L  L       + G  G+G+T +         L        
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV--------ALDVCLSYKV 176

Query: 455 IHSMGGPKF--THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGYRAP-EVIE 511
              M    F     N  +   ++          + + P  N  +    S+  +     I+
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLL---YQIDP--NWTSRSDHSSNIKLRIHSIQ 231

Query: 512 TRK------HSHKS------DVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVV 557
                      +++      +V +              +   TR   V   L     + +
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKA--WNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 558 REEWTAEVFD----VEL------MRFQNIEEEMVQM--LQIGMACVAKVPDM-------- 597
             +  +          L       R Q++  E++     ++ +     + D         
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIRDGLATWDNWK 348

Query: 598 RPNMDEVVRMIE---------EVRQ 613
             N D++  +IE         E R+
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRK 373

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 3e-05
 Identities = 47/289 (16%), Positives = 85/289 (29%), Gaps = 95/289 (32%)

Query: 15  VIVSLLPLAFADLNSDRQALLDFADAVPH--------LRKLNWSSTNPIC--------QS 58
           V+  L  L    ++ +  +  D +  +          LR+L  S     C         +
Sbjct: 198 VLEMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256

Query: 59  WV----GINC-----TQDRT---RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL 106
                  ++C     T+ +     +       I L     + TL   +   +L    +  
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH--SMTLTPDEVKSLLLKYLDCR 314

Query: 107 TGGLPSEITSL-P--------SLR--------YLYLQHNNFSGKIPSSF---SP------ 140
              LP E+ +  P        S+R        + ++  +  +  I SS     P      
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 141 --QLVVLDLSFNSFTGNIPQSI--------------QNLTQLTGLSL---QSNNLSGSIP 181
             +L V   S      +IP  +                + +L   SL   Q    + SIP
Sbjct: 375 FDRLSVFPPSA-----HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429

Query: 182 N--FDI-PKLR-----HLNL--SYNGLKGSIPSSLQKFPNS----SFVG 216
           +   ++  KL      H ++   YN  K      L          S +G
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 8/111 (7%)

Query: 92  KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSF 149
               ++ L L ++    G L         L +L   +   +  I +     +L  L+LS 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73

Query: 150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----IPKLRHLNLSYN 196
           N  +G +    +    LT L+L  N +   +   +    +  L+ L+L   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 32/108 (29%), Positives = 43/108 (39%), Gaps = 16/108 (14%)

Query: 111 PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT--GNIPQSIQNLTQL 166
           PS++  L     L    +N  GK+        +L  L       T   N+P     L +L
Sbjct: 16  PSDVKEL----VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKL 66

Query: 167 TGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSLQKFPN 211
             L L  N +SG +       P L HLNLS N +K  S    L+K  N
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 25/86 (29%), Positives = 34/86 (39%), Gaps = 9/86 (10%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 146
           L KL+ L+ L L  N ++GGL       P+L +L L  N     S   P      L  LD
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 147 LSFNSFTGN------IPQSIQNLTQL 166
           L     T        + + +  LT L
Sbjct: 120 LFNCEVTNLNDYRENVFKLLPQLTYL 145

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 7e-08
 Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 8/110 (7%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITS-LPSLRYLYLQHNNFSGKIPS-SFSPQLVVLDLSFN 150
             A+  L L +     G    +T+   +L +L L +      + +    P+L  L+LS N
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSEN 81

Query: 151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI----PKLRHLNLSYN 196
              G +    + L  LT L+L  N L   I   +       L+ L+L   
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 16/125 (12%)

Query: 94  DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS 151
             +++       L    P+ +  L     L    +N  GKI    +    L  L L    
Sbjct: 6   SGMDMKRRIHLELRNRTPAAVREL----VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVG 60

Query: 152 FT--GNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD--IPKLRHLNLSYNGLKG-SIPSSL 206
                N+P     L +L  L L  N + G +      +P L HLNLS N LK  S    L
Sbjct: 61  LISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116

Query: 207 QKFPN 211
           +K   
Sbjct: 117 KKLEC 121

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 28/86 (32%), Positives = 33/86 (38%), Gaps = 6/86 (6%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN---FSGKIPSSFSPQLVVLD 146
           L KL  L+ L L  N + GGL      LP+L +L L  N     S   P      L  LD
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 147 LSFNSFT---GNIPQSIQNLTQLTGL 169
           L     T          + L QLT L
Sbjct: 127 LFNCEVTNLNDYRESVFKLLPQLTYL 152

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.8 bits (129), Expect = 9e-08
 Identities = 38/287 (13%), Positives = 90/287 (31%), Gaps = 93/287 (32%)

Query: 411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK-ILLGTARGVAHIHSMGGPKFTHGNIK 469
           +V++      L   +  +      PL     VK I+    +G+ ++H+       H +IK
Sbjct: 122 MVFE-VLGHHLLKWIIKSNY-QGLPLPC---VKKIIQQVLQGLDYLHTKCR--IIHTDIK 174

Query: 470 ASNVLIN-------------------------------------------------QDLD 480
             N+L++                                                 + L 
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234

Query: 481 GCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 539
             I+D G    +        ++  YR+ EV+    ++  +D++S   +  E+ TG    +
Sbjct: 235 VKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

Query: 540 -----SPTRDD-----MVDL-----PRWVQSVVREEWTAEVFD-------VELMRFQNIE 577
                  TRD+     +++L      + +      +++ E F        +  ++   + 
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKEFFTKKGDLKHITKLKPWGLF 351

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
           E +V+  +            +         +  + +   E R ++ E
Sbjct: 352 EVLVEKYEWS----------QEEAAGFTDFLLPMLELIPEKRATAAE 388

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 23/142 (16%)

Query: 80  GLVGPIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK-- 133
            L     N        L  +    N L  G          S   L  + +  N    +  
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 134 ---IPSSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNN--------L 176
              +    +   +L VLDL  N+FT      +  ++++   L  L L            +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264

Query: 177 SGSIPNFDIPKLRHLNLSYNGL 198
             +    +   L+ L L YN +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEI 286

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 25/105 (23%), Positives = 35/105 (33%), Gaps = 17/105 (16%)

Query: 90  LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK--------IPSS 137
           L     L+VL L+ N  T      L   + S P+LR L L     S +            
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271

Query: 138 FSPQLVVLDLSFNSFTGN----IPQSIQ-NLTQLTGLSLQSNNLS 177
            +  L  L L +N    +    +   I   +  L  L L  N  S
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 22/142 (15%), Positives = 39/142 (27%), Gaps = 36/142 (25%)

Query: 90  LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------------- 131
           L K   L  + L  N         L   ++    L +LYL +N                 
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149

Query: 132 -GKIPSSFSPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNL---------- 176
                +  +P L  +    N           ++ Q+   L  + +  N +          
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209

Query: 177 SGSIPNFDIPKLRHLNLSYNGL 198
            G        +L+ L+L  N  
Sbjct: 210 EGLAYC---QELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 29/154 (18%), Positives = 51/154 (33%), Gaps = 38/154 (24%)

Query: 96  LEVLSLRSNVLT--GG-----------LPSEITSLPSLRYLYLQHNNFSGK----IPSSF 138
           LE L L +N L    G           +  +  + P LR +    N            +F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 139 S--PQLVVLDLSFNSFT-----GNIPQSIQNLTQLTGLSLQSNN--------LSGSIPNF 183
                L  + +  N          + + +    +L  L LQ N         L+ ++ ++
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 184 DIPKLRHLNLSYNGL--KG--SIPSSLQKFPNSS 213
             P LR L L+   L  +G  ++  +  K  N  
Sbjct: 244 --PNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 32/132 (24%)

Query: 96  LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVL 145
           +E  SL+ + +T      + + +    S++ + L  N    +    +  + +    L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 146 DLSFNSFTGNIP-----------QSIQNLTQLTGLSLQSNN--------LSGSIPNFDIP 186
           + S   FTG +            Q++    +L  + L  N         L   +      
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH--T 122

Query: 187 KLRHLNLSYNGL 198
            L HL L  NGL
Sbjct: 123 PLEHLYLHNNGL 134

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 41/119 (34%), Positives = 54/119 (45%), Gaps = 11/119 (9%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSS-FS--P 140
           +       L  L+ L L SN L   LP  +  SL  L  L L  N  +  +PS+ F    
Sbjct: 55  LEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLV 112

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            L  L +  N  T  +P+ I+ LT LT L+L  N L  SIP+  FD +  L H  L  N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 23/74 (31%), Positives = 33/74 (44%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 190
           +P+       +L L  N  T   P    +L  L  L L SN L  ++P   FD + +L  
Sbjct: 34  VPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTV 92

Query: 191 LNLSYNGLKGSIPS 204
           L+L  N L   +PS
Sbjct: 93  LDLGTNQLT-VLPS 105

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 28/220 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVGQ 392
            ++GKGS+G   KA    E   V +K    ++  K+ F  Q  +E+             +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           +  +V L+ ++  ++   LV++   S +L  LL          +      K        +
Sbjct: 116 Y-YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT---NFRGVSLNLTRKFAQQMCTAL 170

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCIS--DFGLTPLMNVPATP---SRSAGYRAP 507
             + +       H ++K  N+L+       I   DFG +  +         SR   YR+P
Sbjct: 171 LFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--YRSP 227

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV 547
           EV+    +    D++S G +L+EM TG+         D +
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 33/118 (27%), Positives = 47/118 (39%), Gaps = 15/118 (12%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL 142
           IP++          L L SN L          L  L  L L  N         F    +L
Sbjct: 26  IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78

Query: 143 VVLDLSFNSFTGNIPQSI-QNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
            +L L  N    ++P  +   LTQL  L+L +N L  S+P+  FD +  L+ + L  N
Sbjct: 79  TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 25/74 (33%), Positives = 35/74 (47%), Gaps = 5/74 (6%)

Query: 134 IPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FD-IPKLRH 190
           +P+        L+L  N            LTQLT LSL  N +  S+P+  FD + KL  
Sbjct: 22  VPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTI 80

Query: 191 LNLSYNGLKGSIPS 204
           L L  N L+ S+P+
Sbjct: 81  LYLHENKLQ-SLPN 93

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.3 bits (114), Expect = 4e-06
 Identities = 31/211 (14%), Positives = 60/211 (28%), Gaps = 49/211 (23%)

Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK-------RLKEVVVGKR 378
           F  C     L+       E +G+G +G  ++ + +  T V +K        L      K 
Sbjct: 13  FSHCLPTEKLQRC-----EKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKT 66

Query: 379 DFEQQMEIV----------GRVGQHPNVVPLRAYYYSKDEK----LLVYDYFAS--GSLS 422
             E   EI+              +    + L + +  +       L  +D++ S  GS +
Sbjct: 67  FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126

Query: 423 TLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFT 464
                 +                            T   IL      +A   +    +F 
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFE 184

Query: 465 HGNIKASNVLINQDLDGCISDFGLTPLMNVP 495
           H ++   NVL+ +     +          +P
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIP 215

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.3 bits (108), Expect = 5e-05
 Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 29/118 (24%)

Query: 95  ALEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 143
            L  L +    +T    G L   + +  SL+ L L  N           +       QL 
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 201
            L +   SFT        + + +    L  N             L  L +S N L+ +
Sbjct: 317 SLWVKSCSFT---AACCSHFSSV----LAQN-----------RFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.6 bits (106), Expect = 9e-05
 Identities = 23/117 (19%), Positives = 36/117 (30%), Gaps = 29/117 (24%)

Query: 96  LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 144
           LE L L    L+      L S + + P  + L + +N+ +        +       QL  
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS 201
           L L     T     + ++L       + S              LR L L  N L   
Sbjct: 204 LKLESCGVT---SDNCRDL----CGIVASK-----------ASLRELALGSNKLGDV 242

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 24/127 (18%), Positives = 44/127 (34%), Gaps = 24/127 (18%)

Query: 96  LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGK----IPSSFS--PQLVVLDLS 148
           ++ L ++   L+       +  L   + + L     +      I S+    P L  L+L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 149 FNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGS---------IPNFDIPKLRHLNLS 194
            N         +         ++  LSLQ+  L+G+               P L+ L+LS
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL---PTLQELHLS 121

Query: 195 YNGLKGS 201
            N L  +
Sbjct: 122 DNLLGDA 128

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 25/114 (21%), Positives = 44/114 (38%), Gaps = 29/114 (25%)

Query: 96  LEVLSLRSNVLT----GGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLVV 144
           ++ LSL++  LT    G L S + +LP+L+ L+L  N           +       +L  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 198
           L L + S +     S + L       L++            P  + L +S N +
Sbjct: 147 LQLEYCSLS---AASCEPL----ASVLRAK-----------PDFKELTVSNNDI 182

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.6 bits (101), Expect = 3e-04
 Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 29/115 (25%)

Query: 95  ALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSPQLV 143
            LE L ++S   T        S +     L  L + +N           +        L 
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373

Query: 144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGL 198
           VL L+    +     S  +L      +L +N             LR L+LS N L
Sbjct: 374 VLWLADCDVS---DSSCSSLAA----TLLAN-----------HSLRELDLSNNCL 410

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 34/227 (14%), Positives = 69/227 (30%), Gaps = 48/227 (21%)

Query: 344 EVLGKGSYGTAYKAV--LEESTTVVVKRLKEVVVGKRDFEQQ--MEI--------VGRVG 391
             LG+G++G   + +      + V +K    ++     + +   +EI          +  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK----IIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 392 QHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARG 451
           +    V +  ++       + ++     +    L  N      PL    R  +       
Sbjct: 81  KF-LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP-YPLP-HVR-HMAYQLCHA 135

Query: 452 VAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP------------- 498
           +  +H     + TH ++K  N+L        + +   +                      
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 499 ---------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 536
                    +R   YR PEVI     +   DV+S G +L E   G  
Sbjct: 193 HEHHTTIVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 27/109 (24%), Positives = 38/109 (34%), Gaps = 27/109 (24%)

Query: 450 RGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP----------- 498
           + V  +HS    K TH ++K  N+L  Q       +  +         P           
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 499 -----------SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 536
                      +R   YRAPEVI     S   DV+S G +L+E   G  
Sbjct: 186 YDDEHHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 41/234 (17%), Positives = 71/234 (30%), Gaps = 58/234 (24%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQ----MEIVGRVGQHP---- 394
             +G G++G       ++      VK    VV   + + +      +I+ ++        
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 395 NVVPLRAYYYSKD------EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGT 448
           N+V     +   D      E L         SL  ++  N          E      +  
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPL-------GPSLYEIITRN---NYNGFHIEDIKLYCIEI 146

Query: 449 ARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------- 500
            + + ++  M     TH ++K  N+L++                       R        
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 501 ----SAG--------------YRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA 536
                A               YRAPEVI        SD++SFG +L E+ TG  
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 22/128 (17%), Positives = 41/128 (32%), Gaps = 25/128 (19%)

Query: 96  LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---------PQL 142
           +  L+L  N L G     L     SL  L+ +YL ++                     ++
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-----------SIPNFDIPK-LRH 190
           +++D +      +    I NL +         +L             +I + +IP  LR 
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346

Query: 191 LNLSYNGL 198
              +   L
Sbjct: 347 SIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 26/130 (20%), Positives = 43/130 (33%), Gaps = 29/130 (22%)

Query: 96  LEVLSLRSN--------VLTGGLPSEITSLPSLRYLYLQHNNFS-------GKIPSSFSP 140
           +  L+LR N         L   L +   ++     L L+ NN +        K  +S   
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANV---NSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 141 QLVVLDLSFNSFTGNIPQSI-----QNLTQLTGLSLQSNNLSGSIPNF------DIPKLR 189
            +  LDLS N         +          +  L+L  N L G            +  L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 190 HLNLSYNGLK 199
            + L Y+ +K
Sbjct: 257 TVYLDYDIVK 266

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 16/114 (14%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH----NNFSGKIPSSFSPQLVVLDLSFNS 151
           L+ LSL    L+  + + +    +L  L L      + F+ +   S   +L  L+LS+  
Sbjct: 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179

Query: 152 FTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD----------IPKLRHLNLSY 195
                 + +Q        ++   NLSG   N             P L HL+LS 
Sbjct: 180 DFTE--KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 30/147 (20%), Positives = 46/147 (31%), Gaps = 16/147 (10%)

Query: 80  GLVGPIPNNTLGKLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQH-NNFSGK---I 134
           G V P           LE + L+  V+T   L     S  + + L L     FS      
Sbjct: 91  GYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150

Query: 135 PSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI--------- 185
            ++    L  LDL  +         + +       SL S N+S                 
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT-SLVSLNISCLASEVSFSALERLVTR 209

Query: 186 -PKLRHLNLSYNGLKGSIPSSLQKFPN 211
            P L+ L L+       + + LQ+ P 
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQ 236

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 35/93 (37%), Positives = 43/93 (46%), Gaps = 13/93 (13%)

Query: 115 TSLPS-----LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSI-QNLTQL 166
            S+P+      + LYL  N  +   P  F    QL  LDL  N  T  +P  +   LTQL
Sbjct: 22  ASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 167 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           T LSL  N L  SIP   FD +  L H+ L  N
Sbjct: 81  TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 39.9 bits (94), Expect = 7e-04
 Identities = 31/93 (33%), Positives = 42/93 (45%), Gaps = 13/93 (13%)

Query: 115 TSLPS-----LRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSFTGNIPQSI-QNLTQL 166
            S+P+      + L+L +N  +   P  F     L  L  + N  T  IP  +   LTQL
Sbjct: 25  ASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 167 TGLSLQSNNLSGSIPN--FD-IPKLRHLNLSYN 196
           T L L  N+L  SIP   FD +  L H+ L  N
Sbjct: 84  TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	635
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.92
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.91
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.88
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.8
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.76
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.75
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.74
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.74
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.73
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.72
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.72
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.72
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.71
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.71
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.71
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.7
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.7
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.7
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.7
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.7
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.7
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.7
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.7
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.69
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.69
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.69
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.68
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.68
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.68
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.67
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.67
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.66
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.66
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.66
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.65
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.65
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.65
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.65
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.64
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.63
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.63
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.63
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.62
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.62
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.62
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.62
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.62
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.61
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.61
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.61
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.61
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.6
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.6
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.6
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.59
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.59
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.58
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.58
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.58
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.58
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.58
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.56
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.56
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.56
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.54
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.54
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.54
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.54
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.53
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.52
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.52
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.52
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.51
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.48
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.46
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.46
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.45
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.45
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.43
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.41
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.4
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.38
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.37
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.32
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.28
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.26
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.26
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.19
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.1
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.87
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.86
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.83
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.8
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.65
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.48
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.45
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.29
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.18
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.16
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.11
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.08
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.07
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.92
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.48
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.25
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.16
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.16
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.14
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.94
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.93
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.79
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.66
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.44
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.42
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.22
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.19
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.15
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.06
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.91
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	95.82
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	95.66
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	95.26
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.91
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.56
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.47
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.13
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	88.67

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-52  Score=429.49  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=202.1

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|++.      +++.||||+++.... ..++|.+|+++++++ +|||||+++|+|.+.+..++||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey  124 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEY  124 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence            567999999999999864      367899999976532 356799999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          416 FASGSLSTLLHGNRGA----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      |++|+|.++++.....          ...+++|.+++.|+.|||.||+|||+++   ||||||||+|||+++++.+||+|
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence            9999999999765321          2346999999999999999999999988   99999999999999999999999


Q ss_pred             cCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          486 FGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       486 fGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      ||+|+.....      ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||......      .....+..
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i~~  275 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAIDCITQ  275 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHHHHHH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHHHHHc
Confidence            9999865432      23457889999999999999999999999999999999 89999864322      11222221


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .. ..          +.+......+.+++.+||+.||++||||+||+++|+.+.+..
T Consensus       276 g~-~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          276 GR-EL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             TC-CC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             CC-CC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            11 10          111123345778888999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.8e-52  Score=425.68  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|.+.      +++.||||+++....  ..++|.+|+.++.++ +|||||+++|+|.+++..++|||
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E  109 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS  109 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence            467999999999999863      467899999976533  357899999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEE
Q 006677          415 YFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                      ||++|+|.++|+.....           ....++|..++.|+.|||.||+|||+++   ||||||||+|||+++++.+||
T Consensus       110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEE
Confidence            99999999999654211           1245899999999999999999999998   999999999999999999999


Q ss_pred             eecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006677          484 SDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSV  556 (635)
Q Consensus       484 ~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~  556 (635)
                      +|||+|+.....      ....+|+.|||||++.++.|+.++|||||||++|||+| |..||.+.+..      .....+
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~~~~~i  260 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVVEMI  260 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------HHHHHH
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence            999999765322      23457889999999999999999999999999999999 89999865422      122222


Q ss_pred             hhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       557 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      . .+...          +.++.+...+.+++.+||+.||++||||+||+++|+.+.
T Consensus       261 ~-~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          261 R-NRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             H-TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             H-cCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            2 21111          111233456778889999999999999999999998653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-52  Score=420.38  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=199.4

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ..+.||+|+||+||+|+++  ..||||+++.....   .+.|.+|+++++++ +|||||++++++. ++..++|||||++
T Consensus        40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-~~~~~iVmEy~~g  115 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-KDNLAIVTQWCEG  115 (307)
T ss_dssp             EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCSS
T ss_pred             EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-CCeEEEEEEcCCC
Confidence            3578999999999999875  36999998755433   35789999999999 9999999999875 4578999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.++++...    ..++|..+..|+.|||.||+|||+++   ||||||||+|||+++++.+||+|||+|+.....   
T Consensus       116 GsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          116 SSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999997543    34999999999999999999999988   999999999999999999999999999875432   


Q ss_pred             ---CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          496 ---ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                         ....||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+..      ..+...+......    +.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~----p~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS----PD  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----CC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----CC
Confidence               23468999999999964   45899999999999999999999999754321      1222222222111    11


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...  ........+.+++.+||+.||++||||.||+++|+.++..-
T Consensus       259 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          259 LSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             STT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            000  11223346778888999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-52  Score=426.57  Aligned_cols=252  Identities=24%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|++.      ++..||||+++.... ..++|.+|+++++++ +|||||+++|+|.+++..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey   96 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY   96 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEc
Confidence            578999999999999864      367899999976532 356799999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          416 FASGSLSTLLHGNR--------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       416 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      |++|+|.++++...        ......++|..++.|+.|||.||+|||+++   ||||||||+|||+++++.+||+|||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG  173 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG  173 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence            99999999997542        122346999999999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          488 LTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       488 la~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                      +|+......      ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..      .....+....
T Consensus       174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i~~~~  247 (299)
T 4asz_A          174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECITQGR  247 (299)
T ss_dssp             CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHHTC
T ss_pred             cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC
Confidence            997543321      2247889999999999999999999999999999999 89999865422      1222222211


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ..           +.+.....++.+++.+||+.||++|||++||++.|+++....
T Consensus       248 ~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          248 VL-----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             CC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            11           111223346778888999999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-51  Score=421.64  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC----eeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|++. |+.||||++.........++.|+..+.++ +|||||+++++|..++    ..++|||||++
T Consensus         8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            568999999999999985 88999999975432222233444445566 8999999999998764    57999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      |+|.++++..      .++|..+.+++.|++.||+|||+++     .++||||||||+|||++.++.+||+|||+|+...
T Consensus        86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999999742      3999999999999999999999861     3459999999999999999999999999997653


Q ss_pred             CCC--------CCCCCCcccCcccccCC------CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--------CChhH
Q 006677          494 VPA--------TPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDLPR  551 (635)
Q Consensus       494 ~~~--------~~~~~~~y~aPE~~~~~------~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~--------~~~~~  551 (635)
                      ...        ...||+.|||||++.+.      .++.++|||||||++|||+||..||......+.        .....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            321        23589999999999764      367899999999999999999888764332211        01111


Q ss_pred             HHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       552 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .....+.+..    .++.+.......+....+.+++.+||+.||++||||.||++.|+++.+..
T Consensus       240 ~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            2222221111    11111111122355677889999999999999999999999999998653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-50  Score=416.89  Aligned_cols=240  Identities=20%  Similarity=0.344  Sum_probs=199.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... +|+.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+|||||++|+
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~  157 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA  157 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence            357999999999999975 588999999975533 456789999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++...      .+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.....    .
T Consensus       158 L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          158 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99999742      3999999999999999999999998   999999999999999999999999999866432    3


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      +..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..      .....+. ......     .   ...
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-~~~~~~-----~---~~~  293 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-DNLPPR-----L---KNL  293 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSSCCC-----C---SCG
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-cCCCCC-----C---Ccc
Confidence            457999999999999999999999999999999999999999754321      1122221 111100     1   111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||+.||++|||++|++++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1222356677789999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.1e-50  Score=412.85  Aligned_cols=246  Identities=21%  Similarity=0.242  Sum_probs=201.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .++||+|+||+||+|+.. +|+.||||+++....    ..+|+.+++++ +|||||++++++.+++..|+|||||++|+|
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            467999999999999975 478999999976432    24689999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCC-----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP-----  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~-----  495 (635)
                      .++++..     ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++ .+||+|||+|+.....     
T Consensus       138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999743     34999999999999999999999998   99999999999999998 6999999999865432     


Q ss_pred             ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                          ....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+..      ..+........      .
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~------~  277 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIR------E  277 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGG------G
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCch------h
Confidence                1235899999999999999999999999999999999999999876544321      12222111100      0


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ..+   .....+.+++.+||+.||++|||+.|++++|..+.+...
T Consensus       278 ~~~---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          278 IPP---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             SCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             cCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            111   223356677789999999999999999999988775543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-50  Score=419.66  Aligned_cols=257  Identities=26%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             hhccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLV  412 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv  412 (635)
                      ..+.||+|+||+||+|.+..      ++.||||+++....  ..+.|.+|++++.++.+|||||+++|+|..+ +..++|
T Consensus        68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV  147 (353)
T 4ase_A           68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI  147 (353)
T ss_dssp             EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred             EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence            36789999999999998653      25799999976533  2457899999999996679999999999765 568999


Q ss_pred             EEeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          413 YDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      ||||++|+|.++|+..+.           .....+++..++.++.|||.||+|||+++   ||||||||+|||+++++.+
T Consensus       148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~v  224 (353)
T 4ase_A          148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV  224 (353)
T ss_dssp             EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCE
Confidence            999999999999975432           12345899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ||+|||+|+......      ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+      .+.
T Consensus       225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~  298 (353)
T 4ase_A          225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFC  298 (353)
T ss_dssp             EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHH
T ss_pred             EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            999999998764432      2236788999999999999999999999999999998 899998654221      222


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..+.++.....          ++....++.+++.+||+.||++|||++|++++|+.+.+....
T Consensus       299 ~~i~~g~~~~~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~  351 (353)
T 4ase_A          299 RRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ  351 (353)
T ss_dssp             HHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred             HHHHcCCCCCC----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence            23322221111          112234567888899999999999999999999999876543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-49  Score=400.62  Aligned_cols=241  Identities=24%  Similarity=0.386  Sum_probs=192.8

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~  415 (635)
                      +.||+|+||+||+|... ++..||+|++......   .+.|.+|+++++++ +|||||+++++|.+    ++..|+||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy  110 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL  110 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence            56999999999999975 4788999999765443   35688999999999 99999999999875    3457999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNV  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~  494 (635)
                      |++|+|.++++..     ..+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus       111 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999743     34899999999999999999999985 56999999999999984 79999999999986543


Q ss_pred             C--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 ~--~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .  .+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..     ........ +........++.    
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~-i~~~~~~~~~~~----  253 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRR-VTSGVKPASFDK----  253 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHH-HTTTCCCGGGGG----
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHH-HHcCCCCCCCCc----
Confidence            3  24569999999999875 69999999999999999999999997432     11112222 222111111111    


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .   ...++.+++.+||+.||++|||++|++++
T Consensus       254 --~---~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          254 --V---AIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --C---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --c---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1   11246678889999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.7e-50  Score=411.00  Aligned_cols=241  Identities=18%  Similarity=0.374  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|+.. +++.||||++......   .+.+.+|+++++++ +|||||++++++.+++..|+|||||++
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~g  107 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEG  107 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            468999999999999975 5889999999765443   35688999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+++...+   ...+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+......  
T Consensus       108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99999997543   234789999999999999999999998   9999999999999999999999999998775432  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        +..||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+      .......+.......        ...
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~~--------~~~  247 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSFPP--------VSL  247 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCCC--------CCT
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCCCC--------CCc
Confidence              2358999999999999999999999999999999999999997543      223333333332211        011


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .   ...++.+++.+||+.||++|||++|++++
T Consensus       248 ~---~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          248 H---YSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             T---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1   22356677889999999999999999873

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=417.79  Aligned_cols=240  Identities=20%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+++++++ +|||||+++++|.+++..|+|||||++|+
T Consensus       156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~  234 (423)
T 4fie_A          156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA  234 (423)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence            467999999999999975 588999999976533 456789999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.++++..      .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....    .
T Consensus       235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            99999642      3899999999999999999999998   999999999999999999999999999866432    2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      +.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.      ......+. .....     .+.....+
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~-~~~~~-----~~~~~~~~  373 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIR-DNLPP-----RLKNLHKV  373 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCCC-----CCSCTTSS
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHH-cCCCC-----CCcccccC
Confidence            45689999999999999999999999999999999999999975432      11122221 11110     11111122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +   ..+.+++.+||+.||++|||++|++++
T Consensus       374 s---~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          374 S---PSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             C---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2   345677789999999999999999884

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4e-49  Score=399.74  Aligned_cols=238  Identities=18%  Similarity=0.307  Sum_probs=198.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|+.. +++.||||++.+..    ...+.+.+|+++++++ +|||||++++++.+++..|+||||++
T Consensus        37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~  115 (311)
T 4aw0_A           37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK  115 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence            578999999999999965 58899999997542    2356789999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....  
T Consensus       116 gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          116 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999743     34999999999999999999999998   999999999999999999999999999876422  


Q ss_pred             ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                          .+.+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.      ......+......   +     
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~---~-----  253 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEYD---F-----  253 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC---C-----
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC---C-----
Confidence                245699999999999999999999999999999999999999975432      2223333332211   0     


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ....+   .++.+++.+|++.||++|||++|++.+
T Consensus       254 -p~~~s---~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          254 -PEKFF---PKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -CTTCC---HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -CcccC---HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence             11122   345677789999999999999997543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-48  Score=389.24  Aligned_cols=237  Identities=23%  Similarity=0.367  Sum_probs=185.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++.+...    ..+.+.+|+++++++ +|||||++++++.+++..|+||||+ 
T Consensus        18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~-   95 (275)
T 3hyh_A           18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA-   95 (275)
T ss_dssp             EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC-
Confidence            468999999999999964 588999999976532    245789999999999 9999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....  
T Consensus        96 ~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           96 GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            67999998743     34999999999999999999999998   999999999999999999999999999876543  


Q ss_pred             -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .+..||+.|||||++.+..| +.++||||+||++|||+||+.||.+.+      .....+.+......   +      .
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~---~------p  232 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT---L------P  232 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---C------C
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC---C------C
Confidence             24568999999999998886 579999999999999999999997543      22222332222111   0      1


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...   ...+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          233 KFL---SPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCC---CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            112   2345677789999999999999999883

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-48  Score=395.96  Aligned_cols=237  Identities=26%  Similarity=0.389  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|+..    .++.||+|+++....   ....+.+|++++.++ +|||||++++++.+++..|+||||
T Consensus        29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy  107 (304)
T 3ubd_A           29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDF  107 (304)
T ss_dssp             EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECC
T ss_pred             EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEc
Confidence            578999999999999863    367899999975432   234688899999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-  494 (635)
                      +++|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.... 
T Consensus       108 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          108 LRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             CTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999743     24999999999999999999999998   99999999999999999999999999986532 


Q ss_pred             ---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          495 ---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 ---~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                         ..+..||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.      ......+......         
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~---------  244 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKLG---------  244 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC---------
Confidence               2345689999999999999999999999999999999999999986432      2222333222111         


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~  606 (635)
                      .....   ..++.+++.+||+.||++|||+     +|+++
T Consensus       245 ~p~~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 MPQFL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCTTS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCcC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            01112   2345677789999999999995     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.4e-47  Score=386.27  Aligned_cols=240  Identities=21%  Similarity=0.360  Sum_probs=182.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------------
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------------  407 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------------  407 (635)
                      .+.||+|+||+||+|+.. +++.||||+++....  ..+.+.+|+++++++ +|||||++++++.+.+            
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~   88 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKV   88 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCc
Confidence            468999999999999975 588999999975432  245688999999999 9999999999987654            


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      ..|+||||+++|+|.+++....  .....++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           89 YLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             EEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence            3689999999999999997543  1234667788999999999999999998   9999999999999999999999999


Q ss_pred             CCCCCCCCC----------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 006677          488 LTPLMNVPA----------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPR  551 (635)
Q Consensus       488 la~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~  551 (635)
                      +|+......                +..||+.|||||++.+..|+.++|||||||++|||++   ||....     +...
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~  235 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR  235 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence            998764321                2358999999999999999999999999999999996   775311     0001


Q ss_pred             HHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       552 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .........     +      .+..........+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~-----~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVRNLK-----F------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHTTC-----C------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCC-----C------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111111100     0      01112233345678889999999999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=377.70  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||+||+|... +|+.||||+++.....   .+.+.+|+++++++ +|||||++++++...      +..|+|
T Consensus        59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEE
Confidence            468999999999999975 5889999999765433   34678899999999 999999999997643      578999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ||||+ |+|.+++...     ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+..
T Consensus       138 mE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          138 LDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence            99996 6899999743     35999999999999999999999998   999999999999999999999999999865


Q ss_pred             CC--------CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc-
Q 006677          493 NV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT-  562 (635)
Q Consensus       493 ~~--------~~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  562 (635)
                      ..        ..+..||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+      ....+...... 
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~------~l~~I~~~~g~p  282 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH------QLQLIMMVLGTP  282 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH------HHHHHHHHHCCC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH------HHHHHHHhcCCC
Confidence            32        1245689999999998775 46899999999999999999999998654222      11111111000 


Q ss_pred             -cccc--------h---hhhhc-cc-Ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 -AEVF--------D---VELMR-FQ-NI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 -~~~~--------d---~~~~~-~~-~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ....        .   ..+.. .+ ..    .....++.+|+.+||+.||++|||++|++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0000        0   00000 00 00    0112356778889999999999999999984

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-44  Score=377.64  Aligned_cols=187  Identities=23%  Similarity=0.459  Sum_probs=163.8

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|+.+    .++.||+|++... .....+.+|++++..+.+|||||++++++.+++..|+||||+++
T Consensus        26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g  104 (361)
T 4f9c_A           26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH  104 (361)
T ss_dssp             EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred             EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence            468999999999999853    3578999998654 34567889999999997899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~~--  495 (635)
                      |+|.++++        .+++.++..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.....  
T Consensus       105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            99999984        2899999999999999999999998   9999999999999877 79999999999654321  


Q ss_pred             ------------------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 006677          496 ------------------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSP  541 (635)
Q Consensus       496 ------------------------------~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~  541 (635)
                                                    .+..||+.|+|||++.+. .|+.++||||+||++|||+||+.||...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                                          123589999999999775 4899999999999999999999999644

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.7e-43  Score=361.41  Aligned_cols=267  Identities=27%  Similarity=0.520  Sum_probs=225.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|...+++.||+|++..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus        44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            357999999999999988899999999876543 356788999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----  496 (635)
                      .+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......     
T Consensus       123 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          123 KRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             GGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             HHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999975432 2345899999999999999999999998   9999999999999999999999999987543221     


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+++.|+|||++.+..++.++||||||+++|||++|+.||......+......|..............+..... ..
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  277 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KI  277 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CS
T ss_pred             cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-cc
Confidence             2236788999999998899999999999999999999999999877777777777766555444444444443321 22


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ..+....+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            3567788999999999999999999999999999987643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-43  Score=387.95  Aligned_cols=241  Identities=18%  Similarity=0.250  Sum_probs=191.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHH---HHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEI---VGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~---l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .++||+|+||+||+|+.. +|+.||+|++.+..    .......+|..+   +..+ +|||||++++++.+.+..|+|||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~lylVmE  272 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILD  272 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEEEEEEe
Confidence            468999999999999975 58899999997542    223334444433   3444 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |++||+|.+++...     ..+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+....
T Consensus       273 y~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          273 LMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999743     24999999999999999999999998   99999999999999999999999999987654


Q ss_pred             C--CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          495 P--ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 ~--~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .  .+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+   .......+......         
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~~~---------  412 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAVE---------  412 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCCCC---------
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCCCC---------
Confidence            3  35679999999999964 579999999999999999999999997644332   11112222211110         


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ....++   .++.+++.+|++.||++|++     ++||++|
T Consensus       413 ~p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          413 LPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CCTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            111122   34567777999999999998     6888763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-43  Score=389.50  Aligned_cols=243  Identities=20%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... +|+.||+|++..... ..+.+.+|+++|+.+ +|||||++++++.+++..|+|||||++|+
T Consensus       162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~  240 (573)
T 3uto_A          162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE  240 (573)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence            568999999999999975 588999999976533 356788999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC--CCeEEeecCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~DfGla~~~~~~~--  496 (635)
                      |.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+......  
T Consensus       241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~  313 (573)
T 3uto_A          241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  313 (573)
T ss_dssp             HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred             HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence            999986432    34999999999999999999999998   9999999999999854  899999999998775443  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..      .....+....+...  +.   ....
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~~--~~---~~~~  382 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNMD--DS---AFSG  382 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCCC--SG---GGTT
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCCC--cc---cccC
Confidence             346899999999999999999999999999999999999999865422      22223222221110  00   1112


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ++   ..+.+|+.+||+.||++|||+.|++++
T Consensus       383 ~s---~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          383 IS---EDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             SC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22   345677789999999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.3e-43  Score=361.05  Aligned_cols=278  Identities=38%  Similarity=0.681  Sum_probs=225.6

Q ss_pred             CCChHHHHHHh-----hccccccCceEEEEEEecCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEE
Q 006677          332 NFDLEDLLRAS-----AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYY  404 (635)
Q Consensus       332 ~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~  404 (635)
                      .|+..++....     .+.||+|+||.||+|...+++.||||++.....  ....+.+|++++.++ +||||+++++++.
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~   97 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCM   97 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEEC
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEe
Confidence            45556655444     468999999999999988899999999976532  234789999999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 006677          405 SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCIS  484 (635)
Q Consensus       405 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  484 (635)
                      ..+..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+...+.|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999986543 34459999999999999999999999922239999999999999999999999


Q ss_pred             ecCCCCCCCCCC-----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC--CCCCCChhHHHHHHh
Q 006677          485 DFGLTPLMNVPA-----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT--RDDMVDLPRWVQSVV  557 (635)
Q Consensus       485 DfGla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~  557 (635)
                      |||++.......     ...+|+.|+|||++.+..++.++||||||+++|||++|+.||....  .........|+....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999997654322     2347889999999998889999999999999999999999996321  222334566666655


Q ss_pred             hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       558 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      .........+.... .....+....+.+++.+||+.||++|||+.|++++|+...
T Consensus       257 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          257 KEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            55555555444432 2334677888999999999999999999999999998644

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.9e-43  Score=361.50  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=202.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC----eeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~e~~~~  418 (635)
                      .++||+|+||+||+|+.. ++.||||++.........+++|+.++.++ +||||+++++++....    ..++||||+++
T Consensus        29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~  106 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEK  106 (322)
T ss_dssp             EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence            568999999999999976 78999999976544455666788888888 8999999999998754    36999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM----------GGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      |+|.++++..      .+++..+..++.|++.||+|||+.          +   |+||||||+|||++.++.+||+|||+
T Consensus       107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999742      389999999999999999999998          7   99999999999999999999999999


Q ss_pred             CCCCCCC------CCCCCCCcccCcccccCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-------
Q 006677          489 TPLMNVP------ATPSRSAGYRAPEVIETR-----KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-------  550 (635)
Q Consensus       489 a~~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~-------  550 (635)
                      ++.....      ....+|+.|+|||++.+.     .++.++|||||||++|||+||+.||............       
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            9654332      224578899999999863     4567889999999999999999999876544332221       


Q ss_pred             ---HHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          551 ---RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       551 ---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                         .+.......... ....    ...........+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       258 ~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          258 SLEDMQEVVVHKKKR-PVLR----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CHHHHHHHHTTSCCC-CCCC----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             chhhhhhhhhcccCC-CCcc----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               111111111111 1111    11111244566889999999999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.6e-42  Score=351.88  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|.. +++.||||++......   .+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~  119 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRG  119 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCC
Confidence            57899999999999987 4788999999765433   34688899999999 8999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....  ....+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....    
T Consensus       120 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  196 (309)
T 3p86_A          120 SLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS  196 (309)
T ss_dssp             BHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred             cHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence            9999997532  1224899999999999999999999985 55999999999999999999999999999765433    


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......      .............          ..
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~----------~~  260 (309)
T 3p86_A          197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRL----------EI  260 (309)
T ss_dssp             -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCC----------CC
T ss_pred             ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCC----------CC
Confidence            2345788999999999999999999999999999999999999754321      1111111111110          00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .......+.+++.+||+.+|++|||++|+++.|+.+.....
T Consensus       261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            11122356778889999999999999999999999987654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-41  Score=340.65  Aligned_cols=247  Identities=25%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|...+++.||+|++.......+++.+|++++.++ +||||+++++++.+++..++||||+++|+|.
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   93 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence            468999999999999998889999999988777788899999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----CC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~~  497 (635)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     ..
T Consensus        94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            9997533    34899999999999999999999998   999999999999999999999999999765432     23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |+.||......      .....+... ...  .        ..
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~-~~~--~--------~~  229 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-FRL--Y--------KP  229 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CCC--C--------CC
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC-ccC--C--------CC
Confidence            345678999999998899999999999999999999 99999754321      112221111 100  0        00


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ......+.+++.+||+.+|++|||++|++++|+++.+.
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            11223567788899999999999999999999999865

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=348.78  Aligned_cols=249  Identities=25%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .++||+|+||+||+|... ++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   93 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGT   93 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence            578999999999999975 47889999885532 2356788999999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |.++++...    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......    
T Consensus        94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999997532    34999999999999999999999998   9999999999999999999999999997653321    


Q ss_pred             --------------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC---ChhHHHHHHhhh
Q 006677          497 --------------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV---DLPRWVQSVVRE  559 (635)
Q Consensus       497 --------------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~  559 (635)
                                    ...+|+.|+|||++.+..++.++||||||+++|||++|..||.........   ..........  
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--  244 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC--  244 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC--
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC--
Confidence                          335788899999999999999999999999999999999998754332221   1111111100  


Q ss_pred             ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       560 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                                      .......+.+++.+||+.||++|||+.|+++.|+++......
T Consensus       245 ----------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          245 ----------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ----------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                            011123467788899999999999999999999999865443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-41  Score=357.17  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=204.4

Q ss_pred             hccccccCceEEEEEEec--------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||+||+|...        ++..||||+++....  ..+.+.+|++++.++.+||||+++++++...+..++|
T Consensus        86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  165 (370)
T 2psq_A           86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  165 (370)
T ss_dssp             EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence            578999999999999863        245699999976532  2356889999999997899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          413 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      |||+++|+|.+++......           ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  242 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM  242 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence            9999999999999764321           1234899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ||+|||+++......      ...+++.|+|||++.+..++.++|||||||++|||+| |..||......+   +   ..
T Consensus       243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~---~~  316 (370)
T 2psq_A          243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L---FK  316 (370)
T ss_dssp             EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---HH
T ss_pred             EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH
Confidence            999999997654322      1234678999999999999999999999999999999 999998654322   1   11


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                       .+.......          ........+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus       317 -~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          317 -LLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             -HHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -HHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence             111111110          111223457778889999999999999999999999986544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-41  Score=345.73  Aligned_cols=240  Identities=22%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|.. .+++.||+|++..... ..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+
T Consensus        25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (297)
T 3fxz_A           25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (297)
T ss_dssp             CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence            46799999999999995 4588999999875543 466788999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......    .
T Consensus       104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A          104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            99999743      3899999999999999999999998   999999999999999999999999998765432    2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.....      ..............         ....
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~---------~~~~  239 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE---------LQNP  239 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC---------CSCG
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---------CCCc
Confidence            34578899999999999999999999999999999999999975431      11111111111110         1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2223456778889999999999999999873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=350.38  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|...    .+..||||+++....  ..+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~  132 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM  132 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence            578999999999999974    344599999976432  245788999999999 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.++++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999997532    34999999999999999999999998   9999999999999999999999999997664332


Q ss_pred             C-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 ~-------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .       ..+++.|+|||++.+..++.++|||||||++|||++ |..||......      .....+... ..      
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~-~~------  272 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEG-YR------  272 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTT-CC------
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcC-CC------
Confidence            1       124567999999998899999999999999999999 99999754321      111111111 10      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCCCC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS  621 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~  621 (635)
                          .+........+.+++.+||+.||++|||+.|+++.|+.+.......+.+
T Consensus       273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~  321 (325)
T 3kul_A          273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT  321 (325)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred             ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence                0111122346778888999999999999999999999999776654443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-41  Score=338.85  Aligned_cols=248  Identities=26%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|...++..||+|+++......+++.+|++++.++ +||||+++++++...+..++||||+++++|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   91 (268)
T 3sxs_A           13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL   91 (268)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred             eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence            468999999999999998888999999988777788899999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......     .
T Consensus        92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            9997532    34899999999999999999999998   9999999999999999999999999987654332     2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......      ............   ..     .   
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~---~~-----~---  227 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHRL---YR-----P---  227 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCCC---CC-----C---
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCCC---CC-----C---
Confidence            334567999999998889999999999999999999 99999754321      111111111100   00     0   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......+.+++.+||+.+|++|||+.|++++|+.+++..
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            111235677888999999999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.7e-41  Score=339.34  Aligned_cols=248  Identities=22%  Similarity=0.347  Sum_probs=204.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|...++..||+|+++......+++.+|++++.++ +||||+++++++...+..++||||+++|+|.
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  107 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL  107 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence            468999999999999999888999999988777788899999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----CC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~~  497 (635)
                      +++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......     ..
T Consensus       108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence            9997532    24899999999999999999999998   999999999999999999999999999765432     23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+++.|+|||++.+..++.++||||||+++|||+| |+.||......      .....+... ...          ...
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~-~~~----------~~~  243 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQG-LRL----------YRP  243 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTT-CCC----------CCC
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcc-cCC----------CCC
Confidence            345678999999998899999999999999999998 99999754321      111111111 000          000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......+.+++.+||+.+|++|||++|++++|+++.+.+
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            111235677888999999999999999999999998654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.5e-40  Score=338.64  Aligned_cols=270  Identities=29%  Similarity=0.531  Sum_probs=214.4

Q ss_pred             CCChHHHHHHhh-----------ccccccCceEEEEEEecCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCc
Q 006677          332 NFDLEDLLRASA-----------EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPN  395 (635)
Q Consensus       332 ~~~~~~l~~~~~-----------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~n  395 (635)
                      .|..+++..++.           +.||+|+||.||+|.. +++.||+|++.....     ..+.+.+|++++.++ +|||
T Consensus        14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~   91 (307)
T 2nru_A           14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHEN   91 (307)
T ss_dssp             ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTT
T ss_pred             cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCC
Confidence            467777776652           6799999999999987 478999999875421     246788999999999 9999


Q ss_pred             eeceeEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       396 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      |+++++++...+..++||||+++|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            99999999999999999999999999999975432  345899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006677          476 NQDLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL  549 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~  549 (635)
                      ++++.+||+|||++......      ....+++.|+|||.+.+ .++.++||||||+++|||++|..||......+..  
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence            99999999999998765432      22357889999999865 5889999999999999999999999876544322  


Q ss_pred             hHHHHHHhhhcc-ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          550 PRWVQSVVREEW-TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       550 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      ..+......... ....++..+  ..........+.+++.+||+.+|++|||+.|++++|+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            222222221111 111112111  11234566778899999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.4e-41  Score=342.91  Aligned_cols=251  Identities=23%  Similarity=0.403  Sum_probs=194.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhh-cCCCceeceeEEEEeC----CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|.. +++.||||++...  ....+.+|.+++... .+||||+++++++...    ...++||||++
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~   89 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE   89 (301)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred             EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence            46899999999999998 5889999998653  345666777777763 2899999999997653    35789999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      +|+|.++++.      ..+++..+..++.|++.||+|||        +.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999953      24999999999999999999999        776   999999999999999999999999998


Q ss_pred             CCCCCC--------CCCCCCCcccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 006677          490 PLMNVP--------ATPSRSAGYRAPEVIETR------KHSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD  545 (635)
Q Consensus       490 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~k~Dvws~Gvvl~el~tg----------~~p~~~~~~~~  545 (635)
                      +.....        ....+|+.|+|||++.+.      .++.++|||||||++|||+||          +.||......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            654322        223688999999999876      455799999999999999999          78886543322


Q ss_pred             CCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      . .... ..............    ............+.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~-~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 P-SFED-MRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             C-CHHH-HHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             c-chhh-hhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            1 1111 12211111111111    11111234567788999999999999999999999999976

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-40  Score=343.23  Aligned_cols=239  Identities=20%  Similarity=0.305  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      +.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|
T Consensus        51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  129 (321)
T 2c30_A           51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGAL  129 (321)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred             EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence            47999999999999976 689999999976543 456788999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----CC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~~  497 (635)
                      .+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    ..
T Consensus       130 ~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          130 TDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            999863      24899999999999999999999998   999999999999999999999999998765432    23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..+|+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+.... ....     ...   .
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~-~~~~-----~~~---~  265 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRDSP-PPKL-----KNS---H  265 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSS-CCCC-----TTG---G
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-CCCc-----Ccc---c
Confidence            4578899999999999999999999999999999999999975431      11111111111 1000     001   1


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.+++.+||+.||++|||++|++++
T Consensus       266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          266 KVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122356678889999999999999999885

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.2e-40  Score=343.90  Aligned_cols=253  Identities=15%  Similarity=0.178  Sum_probs=204.0

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|++++.++.+||||+++++++...+..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL   91 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence            46899999999999996 467889999987543 34568899999999989999999999999999999999999 9999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC-----eEEeecCCCCCCCCC-
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP-  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~DfGla~~~~~~-  495 (635)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++..... 
T Consensus        92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99997542    34999999999999999999999998   999999999999998887     999999999765332 


Q ss_pred             ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          496 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       496 ----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                                ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ......+........ 
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDTKRATP-  240 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHHHHHSC-
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhhhccCC-
Confidence                      234578999999999999999999999999999999999999987643332   222222211111000 


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .+ .+  ...   .. .+.+++..||+.+|.+||+++++.+.|+++.+..
T Consensus       241 ~~-~~--~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 IE-VL--CEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HH-HH--TTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH-HH--hcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            00 00  001   11 6778888999999999999999999999988654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=350.83  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=207.6

Q ss_pred             hccccccCceEEEEEEec--------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||+||+|...        .+..||||+++.....  ...+.+|++++.++.+||||+++++++..++..++|
T Consensus        74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  153 (382)
T 3tt0_A           74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  153 (382)
T ss_dssp             EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence            578999999999999863        2356999999765332  356889999999998899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          413 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      |||+++|+|.+++......           ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  230 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  230 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence            9999999999999764321           1235899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ||+|||+++......      ...+++.|+|||++.+..++.++|||||||++|||++ |..||.....      .....
T Consensus       231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------~~~~~  304 (382)
T 3tt0_A          231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELFK  304 (382)
T ss_dssp             EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH
T ss_pred             EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence            999999998664322      2234677999999999999999999999999999999 9999975432      11222


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCCCCCc
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE  623 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~  623 (635)
                      .+. .......          .......+.+++.+||+.||++|||++|++++|+.+......++....
T Consensus       305 ~~~-~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  362 (382)
T 3tt0_A          305 LLK-EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY  362 (382)
T ss_dssp             HHH-TTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred             HHH-cCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            211 1111100          011234567788899999999999999999999999987776555443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.5e-41  Score=362.60  Aligned_cols=248  Identities=24%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|.+.++..||||+++......+.+.+|+++++++ +||||+++++++. .+..++||||+++|+|.
T Consensus       193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~  270 (454)
T 1qcf_A          193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLL  270 (454)
T ss_dssp             EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred             EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence            578999999999999998888999999987766788999999999999 9999999999986 66789999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----CC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~~  497 (635)
                      ++++...   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....     ..
T Consensus       271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~  344 (454)
T 1qcf_A          271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  344 (454)
T ss_dssp             HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred             HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence            9997532   124889999999999999999999998   999999999999999999999999999876432     22


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++....++.++|||||||++|||+| |+.||.+....      .....+. ....          .+..
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~-~~~~----------~~~~  407 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALE-RGYR----------MPRP  407 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH-HTCC----------CCCC
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCC----------CCCC
Confidence            335668999999998899999999999999999999 99999754321      1122111 1111          0111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......+.+++.+||+.||++|||++++++.|+++....
T Consensus       408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            123346778888999999999999999999999887543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-40  Score=344.14  Aligned_cols=238  Identities=20%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|.. .+++.||||++......   .+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus        20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~   98 (328)
T 3fe3_A           20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG   98 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence            46899999999999997 56899999999766443   34577899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        99 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           99 GEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            9999999643     24899999999999999999999998   999999999999999999999999999765433   


Q ss_pred             CCCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 ATPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~-~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ....+|+.|+|||++.+..+. .++||||+||++|||++|+.||.+.+      .......+.......         . 
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~---------p-  234 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYRI---------P-  234 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCC---------C-
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCC---------C-
Confidence            245689999999999888775 78999999999999999999997543      222222222221110         0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ......+.+++.+|++.||++|||++|++++
T Consensus       235 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          235 --FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              1112346678889999999999999999884

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.1e-40  Score=336.39  Aligned_cols=255  Identities=17%  Similarity=0.192  Sum_probs=204.3

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++.++.+|+|++++++++......++||||+ +++|
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   92 (298)
T 1csn_A           15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   92 (298)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence            46799999999999996 468899999986543 34568899999999988999999999999999999999999 9999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC-----eEEeecCCCCCCCCC-
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGLTPLMNVP-  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~DfGla~~~~~~-  495 (635)
                      .+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.     +||+|||++...... 
T Consensus        93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99997532    24899999999999999999999998   999999999999987776     999999999765432 


Q ss_pred             ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          496 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       496 ----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                                ....+|+.|+|||++.+..++.++||||||+++|||++|+.||..........   ....+.........
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~  242 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYERIGEKKQSTPL  242 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH---HHHHHHHHHHHSCH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH---HHHHHHhhccCccH
Confidence                      23347889999999999999999999999999999999999998754332211   11111111100000


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                        ...  .   ......+.+++.+||+.+|++||+++++++.|+++.+...
T Consensus       243 --~~~--~---~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          243 --REL--C---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             --HHH--T---TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --HHH--H---hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence              000  0   0123467788889999999999999999999999987654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-40  Score=358.28  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=202.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-eeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++.++ +||||+++++++...+ ..++||||+++|+|
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L  274 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  274 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence            578999999999999986 6799999997654 467899999999999 9999999999988765 78999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR  500 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~  500 (635)
                      .++++...   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...+
T Consensus       275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  348 (450)
T 1k9a_A          275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  348 (450)
T ss_dssp             HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred             HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence            99997542   234789999999999999999999998   9999999999999999999999999997654322 2345


Q ss_pred             CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHH
Q 006677          501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE  579 (635)
Q Consensus       501 ~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  579 (635)
                      +..|+|||++.+..++.++|||||||++|||+| |..||......+   +..   . +......          ......
T Consensus       349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~---~-i~~~~~~----------~~p~~~  411 (450)
T 1k9a_A          349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---R-VEKGYKM----------DAPDGC  411 (450)
T ss_dssp             CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH---H-HHTTCCC----------CCCTTC
T ss_pred             CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHcCCCC----------CCCCcC
Confidence            778999999999999999999999999999998 999998654332   111   1 1111111          111122


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       580 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            346778888999999999999999999999988643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.3e-40  Score=351.13  Aligned_cols=248  Identities=26%  Similarity=0.497  Sum_probs=193.0

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|+..    ++..||||+++....  ..+++.+|++++.++ +||||+++++++...+..++||||+
T Consensus        50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  128 (373)
T 2qol_A           50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYM  128 (373)
T ss_dssp             CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCC
Confidence            468999999999999865    467799999975432  245788999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.++++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999997532    34899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             C-------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          497 T-------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       497 ~-------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .       ..++..|+|||++.+..++.++|||||||++|||++ |+.||......      ..... +.....      
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~-i~~~~~------  268 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKA-VDEGYR------  268 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHH-HHTTEE------
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCC------
Confidence            1       123567999999999999999999999999999998 99999754321      11111 111111      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                          .+........+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus       269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                0111123346778888999999999999999999999997643

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-40  Score=364.76  Aligned_cols=248  Identities=26%  Similarity=0.404  Sum_probs=206.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.+.. +..||||+++......+++.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L  303 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL  303 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence            5789999999999999875 78899999987766778899999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----  496 (635)
                      .++++...   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......     
T Consensus       304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred             HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence            99997533   235899999999999999999999998   9999999999999999999999999998764322     


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ...++..|+|||++.+..++.++|||||||++|||+| |..||......+   +..    .+......          ..
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~----------~~  440 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM----------ER  440 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC----------CC
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC----------CC
Confidence            2234567999999998899999999999999999999 999998654322   111    11111111          11


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      .......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            112234567788899999999999999999999988643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-40  Score=342.47  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=197.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhh-cCCCceeceeEEEEeC----CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSK----DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++.||||++....  ...+.+|.+++... .+||||+++++++...    ...++||||++
T Consensus        42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  118 (337)
T 3mdy_A           42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE  118 (337)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred             EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence            578999999999999986 8899999986543  34455565555543 2899999999999887    67899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +|+|.++++..      .+++..+..++.|++.||+|||+.+     .+.|+||||||+|||++.++.+||+|||++...
T Consensus       119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            99999999642      3899999999999999999999980     112999999999999999999999999999655


Q ss_pred             CCCC--------CCCCCCcccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006677          493 NVPA--------TPSRSAGYRAPEVIETRKHSHK------SDVYSFGVLLLEMLTG----------KAPLQSPTRDDMVD  548 (635)
Q Consensus       493 ~~~~--------~~~~~~~y~aPE~~~~~~~~~k------~Dvws~Gvvl~el~tg----------~~p~~~~~~~~~~~  548 (635)
                      ....        ...+|+.|+|||++.+..++.+      +|||||||++|||+||          ..||......+. .
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~  271 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S  271 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-c
Confidence            3322        3357889999999988776665      9999999999999999          556654332221 1


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .. ..............+.    ...........+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus       272 ~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          272 YE-DMREIVCIKKLRPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             HH-HHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             hh-hhHHHHhhhccCcccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            11 1111111111111111    111123566778899999999999999999999999999987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-39  Score=332.81  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=201.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..||+|++......    .+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   94 (294)
T 4eqm_A           16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIE   94 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCC
Confidence            468999999999999965 5789999998654332    35688899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        95 g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           95 GPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999743     24899999999999999999999998   9999999999999999999999999998764332 


Q ss_pred             ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          497 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                          ...+|+.|+|||.+.+..++.++||||||+++|||+||+.||.....      ..............    .....
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~----~~~~~  236 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVPN----VTTDV  236 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCCC----HHHHS
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCCC----cchhc
Confidence                23478999999999999999999999999999999999999975432      11111111111110    00000


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhccCCCC
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSEN  618 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~~~~~~~~  618 (635)
                      ..   .....+.+++.+|++.||++|| +++++.+.|+.+.......
T Consensus       237 ~~---~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          237 RK---DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             CT---TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             cc---CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence            11   1234567788899999999999 8999999999887665443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-40  Score=341.21  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|...+++.||+|++......   ...+.+|++++.++ +||||+++++++.+++..++||||+++ 
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~-  103 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK-  103 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence            4679999999999999988999999999754332   35688999999999 999999999999999999999999985 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus       104 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  176 (311)
T 3niz_A          104 DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY  176 (311)
T ss_dssp             EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred             CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence            8888886533    34899999999999999999999998   999999999999999999999999999765432    


Q ss_pred             CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc---hh---
Q 006677          496 ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF---DV---  568 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d~---  568 (635)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.   .................   +.   
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchh
Confidence            23357889999999876 5689999999999999999999999986554332   11121111111000000   00   


Q ss_pred             ---hhhc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 ---ELMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ---~~~~--~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ....  ..    ..+....++.+++.+|++.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               0000  00    001122456788889999999999999999873

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.8e-41  Score=354.75  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=201.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|.+. +++.||||+++....  ..+.+.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  197 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGG  197 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence            578999999999999986 688999999875432  134688899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.++++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   
T Consensus       198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            9999997432    24899999999999999999999998   9999999999999999999999999987643321   


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                         ...++..|+|||++.+..++.++|||||||++|||+| |..||......+       ....+......         
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------  334 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRL---------  334 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCC---------
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------
Confidence               1123456999999998899999999999999999998 999997543211       11112111110         


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                       +........+.+++.+||+.||++|||++|+++.|+++...
T Consensus       335 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence             11112234567888899999999999999999999998754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.7e-40  Score=330.42  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=206.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||.||+|...+++.||+|++.......+.+.+|++++.++ +||||+++++++..++..++||||+++++|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   91 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLS   91 (267)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred             eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence            467999999999999998888999999988776778899999999999 8999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----CC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----AT  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~~  497 (635)
                      +++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++......     ..
T Consensus        92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9997543    34899999999999999999999998   999999999999999999999999998765432     23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||.....      ......+... ....       ..   
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~-~~~~-------~~---  227 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-FRLY-------KP---  227 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-CCCC-------CC---
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC-CcCC-------CC---
Confidence            345678999999998889999999999999999999 8999975431      1122222111 1000       00   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ......+.+++.+||+.+|++||++.|++++|+++.+.
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11223567788899999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-40  Score=334.62  Aligned_cols=245  Identities=25%  Similarity=0.393  Sum_probs=189.4

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++.||||+++....     ..+.+.+|++++..+ +||||+++++++..++..++||||++
T Consensus        12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFAR   89 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCT
T ss_pred             eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCC
Confidence            468999999999999976 78899999875432     246788999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC--------CCCeEEeecCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--------DLDGCISDFGLT  489 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~ki~DfGla  489 (635)
                      +++|.+++..      ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++.        ++.+||+|||++
T Consensus        90 ~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           90 GGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             TEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             CCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            9999999863      24899999999999999999999987556899999999999986        778999999999


Q ss_pred             CCCCCCC--CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          490 PLMNVPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       490 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .......  ...+++.|+|||.+.+..++.++||||||+++|||++|+.||......      ..............   
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~---  234 (271)
T 3dtc_A          164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLALP---  234 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCCCCC---
T ss_pred             cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCCCCC---
Confidence            7654432  345788999999999989999999999999999999999999754311      11111111111110   


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                             ........+.+++.+||+.+|++|||+.|++++|+++
T Consensus       235 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          235 -------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   1112234577888899999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.2e-40  Score=346.25  Aligned_cols=245  Identities=19%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|+... ++.||+|++++....    .+.+.+|..++.++.+||||+++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            5789999999999999764 678999999865332    24578899999888789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus       137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            99999999743     24899999999999999999999998   99999999999999999999999999976322   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhccccccchhhhh
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--VDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  .....+....+.....        .
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~  280 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R  280 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------C
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------C
Confidence             2345689999999999999999999999999999999999999975432221  1111222211111110        0


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~  606 (635)
                      ..   ......+.+++.+||+.||++||++      +|+++
T Consensus       281 ~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          281 IP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             CC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             CC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            01   1122356677889999999999996      56665

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-39  Score=342.21  Aligned_cols=241  Identities=21%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|... +++.||+|+++....       ..+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e   95 (361)
T 2yab_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILE   95 (361)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEE
Confidence            468999999999999976 578999999976532       246789999999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC----CeEEeecCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP  490 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla~  490 (635)
                      |+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||++.
T Consensus        96 ~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             CCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999642     35899999999999999999999998   99999999999998877    79999999997


Q ss_pred             CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          491 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       491 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .....   ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..      .....+....+.   ++
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~~~---~~  238 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVSYD---FD  238 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCC---CC
T ss_pred             EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC---CC
Confidence            76543   2345899999999999999999999999999999999999999764321      122222221111   11


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ...  ...   ....+.+++.+|+..||++|||+.|+++
T Consensus       239 ~~~--~~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          239 EEF--FSQ---TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHH--HTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chh--ccC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110  111   1234667788999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=334.68  Aligned_cols=264  Identities=17%  Similarity=0.253  Sum_probs=206.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|.... ++.||||++....  ...+.+.+|++++.++ +||||+++++++...+  ..++||||++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCC
Confidence            4689999999999999764 7899999997543  3456788999999999 8999999999998765  6799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE----cCCCCeEEeecCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~DfGla~~~~  493 (635)
                      +|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++...
T Consensus        93 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             TCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            9999999976432  234899999999999999999999998   9999999999999    788889999999997765


Q ss_pred             CCC---CCCCCCcccCccccc--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          494 VPA---TPSRSAGYRAPEVIE--------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       494 ~~~---~~~~~~~y~aPE~~~--------~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ...   ...+++.|+|||++.        +..++.++|||||||++|||++|+.||........  .......+......
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~  245 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS  245 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCT
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCCCc
Confidence            433   345788999999986        56789999999999999999999999975432221  12223333322211


Q ss_pred             cc---c---------chhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          563 AE---V---------FDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       563 ~~---~---------~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ..   .         +..... ...........+.+++.+||+.||++|||++|++++..+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            00   0         000000 1122345566788899999999999999999999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-40  Score=357.74  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|.+.++..||||+++......+++.+|+++++++ +||||+++++++.. +..++||||+++|+|.
T Consensus       189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~  266 (452)
T 1fmk_A          189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL  266 (452)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred             eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence            568999999999999998888899999987666778899999999999 99999999999865 6789999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      ++++...   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++......     .
T Consensus       267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  340 (452)
T 1fmk_A          267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  340 (452)
T ss_dssp             HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence            9997432   134899999999999999999999998   9999999999999999999999999998764322     2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++|||||||++|||+| |+.||.+....      .....+ ......          +..
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i-~~~~~~----------~~~  403 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV-ERGYRM----------PCP  403 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH-HTTCCC----------CCC
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcCCCC----------CCC
Confidence            234667999999998899999999999999999999 99999754321      111111 111110          111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......+.+++.+||+.+|++|||++++++.|+++....
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            123346778888999999999999999999999987554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-40  Score=340.82  Aligned_cols=243  Identities=20%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... ++..||+|.+.........+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L   88 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI   88 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence            467999999999999976 467899999876544556788999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC--CCCeEEeecCCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~DfGla~~~~~~~---  496 (635)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||++.......   
T Consensus        89 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  161 (321)
T 1tki_A           89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence            99997432    34899999999999999999999998   999999999999987  7899999999998765433   


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|..||.....      ......+.......   +..  ...  
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~---~~~--~~~--  228 (321)
T 1tki_A          162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF---DEE--AFK--  228 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC---CHH--HHT--
T ss_pred             cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCC---Chh--hhc--
Confidence            23478899999999998899999999999999999999999975432      12222222222110   000  011  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .....+.+++.+|+..||++|||+.|++++
T Consensus       229 -~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          229 -EISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             123456778889999999999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-39  Score=336.68  Aligned_cols=238  Identities=21%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||+|++++..    .....+.+|+.++..+ +||||+++++++...+..++||||++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~   88 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            468999999999999976 58899999997642    2356788899999998 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        89 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999998743     24899999999999999999999998   999999999999999999999999999764322  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+......         ..
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~p  225 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR---------FP  225 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC---------CC
Confidence              234578999999999999999999999999999999999999975431      1222222222110         00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                      .   .....+.+++.+||+.||++||     +++|++++
T Consensus       226 ~---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          226 R---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             T---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1   1223566777899999999999     89999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.6e-41  Score=350.66  Aligned_cols=254  Identities=27%  Similarity=0.374  Sum_probs=202.2

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-eEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-KLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~  413 (635)
                      .+.||+|+||.||+|.+.      +++.||||+++....  ..+.+.+|++++.++.+||||+++++++...+. .++||
T Consensus        27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~  106 (359)
T 3vhe_A           27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  106 (359)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence            578999999999999842      357899999976433  235689999999999889999999999987654 89999


Q ss_pred             EeccCCChhhhccCCCCCC-------------------------------------------------------------
Q 006677          414 DYFASGSLSTLLHGNRGAG-------------------------------------------------------------  432 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~-------------------------------------------------------------  432 (635)
                      ||+++|+|.++++......                                                             
T Consensus       107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3vhe_A          107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY  186 (359)
T ss_dssp             ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred             EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence            9999999999997653210                                                             


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC------CCCCCCcccC
Q 006677          433 RTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA------TPSRSAGYRA  506 (635)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~a  506 (635)
                      ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......      ...+|+.|+|
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  263 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  263 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence            122899999999999999999999998   9999999999999999999999999998654322      2235678999


Q ss_pred             cccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHH
Q 006677          507 PEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQ  585 (635)
Q Consensus       507 PE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  585 (635)
                      ||++.+..++.++|||||||++|||+| |..||......+      ..............          .......+.+
T Consensus       264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~l~~  327 (359)
T 3vhe_A          264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA----------PDYTTPEMYQ  327 (359)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC----------CTTCCHHHHH
T ss_pred             hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC----------CCCCCHHHHH
Confidence            999999999999999999999999999 999997654321      11111111111110          0112235677


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          586 IGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       586 l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ++.+||+.||++|||++|++++|+++.+..
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            888999999999999999999999988643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-40  Score=339.37  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=196.9

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e  414 (635)
                      .+.||+|+||+||+|++     .+++.||||++..... ..+.+.+|++++.++ +||||+++++++...  ...++|||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e   93 (295)
T 3ugc_A           15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME   93 (295)
T ss_dssp             EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred             hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEE
Confidence            46899999999999984     2578899999875432 245788999999999 899999999998654  45899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999997543    24899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC--------CCC-ChhHHHHHHhh
Q 006677          495 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMV-DLPRWVQSVVR  558 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~--------~~~-~~~~~~~~~~~  558 (635)
                      ..       ...++..|+|||++.+..++.++||||||+++|||+||..|+......        ... ...........
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            32       123455699999999999999999999999999999999998643110        000 00001111111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...          ..+........+.+++.+||+.||++|||++|+++.|+++.+.-
T Consensus       247 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          247 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            110          11111223356778888999999999999999999999998653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.8e-40  Score=340.49  Aligned_cols=247  Identities=21%  Similarity=0.351  Sum_probs=180.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... +++.||||++...  ....+.+|+.++.++.+||||+++++++.++...++||||+++|+|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            467999999999999975 5788999999754  3567888999999996699999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP---  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla~~~~~~---  495 (635)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++   .+||+|||+++.....   
T Consensus        94 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           94 FERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             HHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999753     34999999999999999999999998   99999999999998765   8999999999765433   


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM-VDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+........  ..     
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~-----  238 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE--GE-----  238 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC--SH-----
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC--cc-----
Confidence             234568899999999999999999999999999999999999986543322 222222222222211100  00     


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ........+.+++.+|++.||++|||++|++++
T Consensus       239 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          239 -AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             001223456778889999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=340.00  Aligned_cols=243  Identities=23%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||+|... ++..||+|++.....       ..+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~   93 (326)
T 2y0a_A           15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILIL   93 (326)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred             eceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEE
Confidence            3578999999999999976 578999999976532       356789999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC----CeEEeecCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLT  489 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla  489 (635)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++    .+||+|||++
T Consensus        94 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           94 ELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             ECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999642     34899999999999999999999998   99999999999999887    8999999999


Q ss_pred             CCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          490 PLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       490 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ......   ....+|+.|+|||++.+..++.++|||||||++|||++|..||......      .....+......   +
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~---~  236 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE---F  236 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTCCC---C
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcCCC---c
Confidence            766432   2345889999999999999999999999999999999999999754321      111111111110   0


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....  ..   .....+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~--~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 EDEY--FS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CHHH--HT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Cccc--cc---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000  01   112356678889999999999999999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-40  Score=345.82  Aligned_cols=246  Identities=22%  Similarity=0.377  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEecC-CCe----EEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|.+.. ++.    ||+|.+....  ...+.+.+|++++.++ +||||+++++++... ..++|+||
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~v~e~   97 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL   97 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-SEEEEEEC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-CeEEEEEe
Confidence            4689999999999999643 333    5788775443  3457899999999999 999999999999875 47899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999997543    34899999999999999999999998   999999999999999999999999998765432


Q ss_pred             C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .      ...+++.|+|||++.+..++.++|||||||++|||+| |+.||......+.   .    ..+.....      
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~------  237 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGER------  237 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCC------
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---H----HHHHcCCC------
Confidence            2      1234668999999999999999999999999999999 9999986543221   1    11111110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                          ..........+.+++.+||+.+|++||++.|++++|+.+...
T Consensus       238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                011112334677888899999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.1e-40  Score=340.69  Aligned_cols=241  Identities=22%  Similarity=0.363  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++|
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence            468999999999999976 688899999865432  246688999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        91 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999743     34899999999999999999999998   999999999999999999999999999754321    


Q ss_pred             --CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 --ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                        ....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|.    .....          
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~----------  227 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY----------  227 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTT----------
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccccc----------
Confidence              24468899999999987775 7789999999999999999999975442211 111111    01000          


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00011122345678889999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-39  Score=346.53  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=190.4

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~  418 (635)
                      ++||+|+||+||+|... +++.||||++..    ...+.+|++++.++.+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999975 478899999864    35678899988777799999999999876    5578999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~~  495 (635)
                      |+|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.....
T Consensus       144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999997532   235899999999999999999999998   999999999999998   789999999999765432


Q ss_pred             ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                         ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...........  ....+....+...  ..   .
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~~~~~--~~---~  290 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFP--NP---E  290 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTCCCCC--TT---T
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCcccCC--Cc---c
Confidence               244578999999999999999999999999999999999999986554332110  1111111111000  00   0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      .   ......+.+++.+||+.||++|||+.|++++-
T Consensus       291 ~---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          291 W---SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             T---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             c---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            1   11234567788899999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=344.23  Aligned_cols=238  Identities=24%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|+.. +++.||+|+++...    ...+.+.+|.+++..+.+||||+++++++.+.+..|+||||++
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999976 47889999997642    2345677899999988789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       108 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          108 GGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            99999999743     24899999999999999999999998   999999999999999999999999999864322  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+.......         .
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~~~~---------p  244 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEVVY---------P  244 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC---------C
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCCC---------C
Confidence              2345899999999999989999999999999999999999999754322      2222222221110         0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~  606 (635)
                         ......+.+++.+|++.||++||++      +|+++
T Consensus       245 ---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          245 ---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence               1122346677889999999999998      77776

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.8e-40  Score=340.67  Aligned_cols=237  Identities=22%  Similarity=0.325  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.. .+++.||+|++....    .....+.+|+++++.+ +||||+++++++...+..++||||+ 
T Consensus        14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~-   91 (336)
T 3h4j_B           14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA-   91 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECC-
Confidence            46899999999999997 467899999987542    2345788999999999 8999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......  
T Consensus        92 ~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           92 GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            68999988643     24899999999999999999999998   999999999999999999999999999876543  


Q ss_pred             -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       ....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||......+....               +.....   
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~~~---  225 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSCVY---  225 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSSCC---
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcCCC---
Confidence             34568899999999988776 6899999999999999999999986543332210               000000   


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .........+.+++.+|++.||.+|||++|++++
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0011122346678889999999999999999984

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=348.40  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|.+.      ++..||||+++....  ....+.+|+.++.++ +||||+++++++......++|||
T Consensus        76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e  154 (367)
T 3l9p_A           76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLE  154 (367)
T ss_dssp             EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEE
Confidence            568999999999999953      356799999975432  245688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRG--AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla  489 (635)
                      |+++|+|.+++...+.  .....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|||++
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a  231 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA  231 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence            9999999999975432  12235899999999999999999999998   99999999999999555   5999999998


Q ss_pred             CCCC------CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMN------VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      +...      ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......      .....+......
T Consensus       232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i~~~~~~  305 (367)
T 3l9p_A          232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRM  305 (367)
T ss_dssp             HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCC
T ss_pred             cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence            6431      1222346788999999999999999999999999999998 99999754321      112222111110


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                                 .........+.+++.+||+.+|++|||+.|++++|+.+.+..
T Consensus       306 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          306 -----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                       001122335678888999999999999999999999988654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.7e-40  Score=344.16  Aligned_cols=256  Identities=17%  Similarity=0.214  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccCChHHHHHHHHHHHhhc--------------CCCceeceeEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVVGKRDFEQQMEIVGRVG--------------QHPNVVPLRAY  402 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------------~h~niv~l~~~  402 (635)
                      .+.||+|+||+||+|.+..      ++.||||++....   ..+.+|++++.++.              +|+||++++++
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            4689999999999999765      3679999986542   23444444444332              69999999999


Q ss_pred             EEeC----CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc--
Q 006677          403 YYSK----DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--  476 (635)
Q Consensus       403 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--  476 (635)
                      +...    ...++||||+ +++|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence            9875    4479999999 999999997532    34999999999999999999999998   99999999999999  


Q ss_pred             CCCCeEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 006677          477 QDLDGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD  545 (635)
Q Consensus       477 ~~~~~ki~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~  545 (635)
                      .++.+||+|||+++.....           ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999654321           12338889999999999999999999999999999999999998543221


Q ss_pred             CCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                        ....+....... ......+..+.. .   .....+.+++..||+.+|++||++.++++.|+++.....
T Consensus       269 --~~~~~~~~~~~~-~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          269 --KYVRDSKIRYRE-NIASLMDKCFPA-A---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             --HHHHHHHHHHHH-CHHHHHHHHSCT-T---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --HHHHHHHHHhhh-hHHHHHHHhccc-c---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence              111111111111 111112211110 1   113456778889999999999999999999999886543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-39  Score=342.83  Aligned_cols=244  Identities=20%  Similarity=0.307  Sum_probs=191.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||++... +++.||+|++.......+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|
T Consensus        25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L  103 (361)
T 3uc3_A           25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL  103 (361)
T ss_dssp             EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence            467999999999999976 678899999987666667899999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC--eEEeecCCCCCCCC---CC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV---PA  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~DfGla~~~~~---~~  496 (635)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.  +||+|||+++....   ..
T Consensus       104 ~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~  175 (361)
T 3uc3_A          104 YERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  175 (361)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence            9998642     24899999999999999999999998   999999999999987765  99999999875432   23


Q ss_pred             CCCCCCcccCcccccCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHK-SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k-~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ...+|+.|+|||++.+..++.+ +|||||||++|||++|+.||.......  ........+........       ....
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~-------~~~~  246 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSIP-------DDIR  246 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCCC-------TTSC
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCCC-------CcCC
Confidence            4458899999999988887665 899999999999999999998654322  23333333332221100       0001


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ....+.+++.+||+.||++|||+.|++++
T Consensus       247 ---~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          247 ---ISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence               12356678889999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.5e-40  Score=344.33  Aligned_cols=246  Identities=23%  Similarity=0.358  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecC-CCe----EEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|.+.. +..    |++|.+....  .....+.+|+.++.++ +||||+++++++. ++..++||||
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~   95 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQY   95 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEe
Confidence            4689999999999999653 443    7777775442  2245678899999999 9999999999886 5678999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++...+    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999997542    34889999999999999999999998   999999999999999999999999999876433


Q ss_pred             C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .      ...++..|+|||++.+..++.++|||||||++|||+| |..||......+.   .   .. +.......    
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~-~~~~~~~~----  237 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---P---DL-LEKGERLA----  237 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---H---HH-HHTTCBCC----
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---H---HH-HHcCCCCC----
Confidence            2      2235668999999998999999999999999999999 9999986543221   1   11 11111000    


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                            ........+.+++.+||+.||++||++.|++++|+.+...
T Consensus       238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          238 ------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  0011122456788899999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-40  Score=343.01  Aligned_cols=253  Identities=23%  Similarity=0.395  Sum_probs=201.5

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...+      ++.||+|+++....  ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e  130 (343)
T 1luf_A           52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE  130 (343)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEe
Confidence            4689999999999999753      37899999976432  245788999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          415 YFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      |+++|+|.+++......                   ....+++..++.++.||+.||+|||+.+   |+||||||+||++
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~  207 (343)
T 1luf_A          131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV  207 (343)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEE
Confidence            99999999999764311                   1246899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCC------CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNV------PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD  548 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~  548 (635)
                      +.++.+||+|||+++....      .....+++.|+|||++.+..++.++||||||+++|||+| |..||.....     
T Consensus       208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----  282 (343)
T 1luf_A          208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-----  282 (343)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred             CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-----
Confidence            9999999999999865422      223346778999999998899999999999999999999 9999975432     


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                       ......+...... .          ........+.+++.+||+.||++||++.|++++|+++.+...
T Consensus       283 -~~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          283 -EEVIYYVRDGNIL-A----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             -HHHHHHHHTTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             -HHHHHHHhCCCcC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence             1112222111110 0          011223457778889999999999999999999999986543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=334.02  Aligned_cols=239  Identities=21%  Similarity=0.319  Sum_probs=187.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---------------------------ChHHHHHHHHHHHhhcCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------------------------GKRDFEQQMEIVGRVGQHP  394 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~~h~  394 (635)
                      .+.||+|+||.||+|... +++.||+|++.....                           ..+.+.+|++++.++ +||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~   96 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHP   96 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-CCT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-CCC
Confidence            467999999999999965 578899999875431                           124688999999999 999


Q ss_pred             ceeceeEEEEe--CCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 006677          395 NVVPLRAYYYS--KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASN  472 (635)
Q Consensus       395 niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  472 (635)
                      ||+++++++..  .+..++||||+++|+|.+++..      ..+++..+..++.||+.||+|||+.+   |+||||||+|
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N  167 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN  167 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence            99999999987  5678999999999999887642      34999999999999999999999998   9999999999


Q ss_pred             eEEcCCCCeEEeecCCCCCCCCC----CCCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 006677          473 VLINQDLDGCISDFGLTPLMNVP----ATPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD  545 (635)
Q Consensus       473 Ill~~~~~~ki~DfGla~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~  545 (635)
                      |+++.++.+||+|||++......    ....+|+.|+|||++.+..   ++.++|||||||++|||++|+.||....   
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---  244 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER---  244 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence            99999999999999999765433    2346789999999997765   3778999999999999999999997532   


Q ss_pred             CCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ...+...+.......       ....   .....+.+++.+||+.||++|||+.|++++
T Consensus       245 ---~~~~~~~~~~~~~~~-------~~~~---~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 ---IMCLHSKIKSQALEF-------PDQP---DIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             ---HHHHHHHHHHCCCCC-------CSSS---CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ---HHHHHHHHhcccCCC-------CCcc---ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence               112222221111100       0011   122356778889999999999999999763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-39  Score=337.78  Aligned_cols=245  Identities=19%  Similarity=0.293  Sum_probs=194.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|+.. +++.||+|+++.....    .+.+.+|..++.++.+||||+++++++.+.+..++||||++
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999976 4788999999865432    23477888999888789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus        94 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           94 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            99999999743     24899999999999999999999998   99999999999999999999999999976432   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHHhhhccccccchhhhh
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV--DLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+..  .........+......        
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------  237 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------  237 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--------
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--------
Confidence             22446899999999999999999999999999999999999999754322111  1111111111111100        


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNM------DEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~  606 (635)
                      ..   ......+.+++.+||+.||++||++      +|+++
T Consensus       238 ~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          238 IP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            01   1122356677889999999999996      56665

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-39  Score=330.05  Aligned_cols=247  Identities=22%  Similarity=0.434  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||+||+|... +++.||+|++......        .+.+.+|++++.++ +||||+++++++.+..  ++||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~  100 (287)
T 4f0f_A           24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVM  100 (287)
T ss_dssp             EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEE
T ss_pred             hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEE
Confidence            467999999999999974 6888999998654321        16788999999999 8999999999986544  7999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC-----eEEeecCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-----GCISDFGL  488 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~DfGl  488 (635)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.     +||+|||+
T Consensus       101 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A          101 EFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             ECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             EecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            9999999999886432    35999999999999999999999985 45999999999999988776     99999999


Q ss_pred             CCCCCCCC-CCCCCCcccCccccc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          489 TPLMNVPA-TPSRSAGYRAPEVIE--TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       489 a~~~~~~~-~~~~~~~y~aPE~~~--~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                      ++...... ...+++.|+|||++.  ...++.++|||||||++|||++|+.||......+    ................
T Consensus       176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~  251 (287)
T 4f0f_A          176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPTI  251 (287)
T ss_dssp             CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCCC
T ss_pred             cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCCC
Confidence            97654432 356789999999984  4557899999999999999999999997544322    1112222222211111


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                                .......+.+++.+||+.||++|||++|+++.|+++
T Consensus       252 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          252 ----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                      112234567888899999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-40  Score=343.25  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             hhccccccCceEEEEEEec------CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||+|...      ++..||+|++....  ...+.+.+|+.++.++.+||||+++++++...+..++||
T Consensus        49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  128 (344)
T 1rjb_A           49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF  128 (344)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence            3578999999999999962      34579999997542  235678999999999988999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          414 DYFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      ||+++|+|.+++......                  ....+++..+..++.||+.||+|||+.+   |+||||||+||++
T Consensus       129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll  205 (344)
T 1rjb_A          129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLV  205 (344)
T ss_dssp             ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEE
T ss_pred             ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEE
Confidence            999999999999764321                  0134899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD  548 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~  548 (635)
                      +.++.+||+|||++........      ..+++.|+|||++.+..++.++||||||+++|||+| |..||......+   
T Consensus       206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---  282 (344)
T 1rjb_A          206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---  282 (344)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---
T ss_pred             cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH---
Confidence            9999999999999976543321      224667999999998899999999999999999998 999997654221   


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENR  619 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~  619 (635)
                         .............          ........+.+++.+||+.||++|||+.|++++|+.+.....+..
T Consensus       283 ---~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  340 (344)
T 1rjb_A          283 ---NFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM  340 (344)
T ss_dssp             ---HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred             ---HHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence               1122222211110          011123456778889999999999999999999999988766544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=331.75  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|... ++.||+|++... ...+.+.+|++++.++ +||||+++++++.  +..++||||+++|+|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~   87 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLVMEYAEGGSLY   87 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence            468999999999999986 688999998643 2356789999999999 9999999999876  4589999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC-eEEeecCCCCCCCCC-CCCCC
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD-GCISDFGLTPLMNVP-ATPSR  500 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~ki~DfGla~~~~~~-~~~~~  500 (635)
                      ++++....  ...+++..++.++.|+++||+|||+.+...|+||||||+||+++.++. +||+|||++...... ....+
T Consensus        88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~g  165 (307)
T 2eva_A           88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG  165 (307)
T ss_dssp             HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------C
T ss_pred             HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCC
Confidence            99975431  234789999999999999999999932223999999999999998887 799999999765433 23457


Q ss_pred             CCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHH
Q 006677          501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM  580 (635)
Q Consensus       501 ~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  580 (635)
                      ++.|+|||++.+..++.++||||||+++|||++|+.||.......    ......... .....          ......
T Consensus       166 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~----------~~~~~~  230 (307)
T 2eva_A          166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTRPP----------LIKNLP  230 (307)
T ss_dssp             CTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCCCC----------CBTTCC
T ss_pred             CCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCCCC----------cccccC
Confidence            899999999999999999999999999999999999997543211    111111111 11000          011122


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          581 VQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       581 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..+.+++.+||+.||++|||++|++++|+.+.+....
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            3567788899999999999999999999999876654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-39  Score=338.59  Aligned_cols=242  Identities=21%  Similarity=0.331  Sum_probs=196.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||+|++......   .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g  112 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG  112 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            578999999999999975 5789999999765443   34678899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla~~~~~~  495 (635)
                      |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|||++......
T Consensus       113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999998642     34899999999999999999999998   99999999999998654   5999999999876543


Q ss_pred             C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .   ...+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+........  ..   .
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~~~--~~---~  253 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDYP--SP---E  253 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--TT---G
T ss_pred             cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCCC--cc---c
Confidence            3   34688999999999999999999999999999999999999975432      122222222111100  00   0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .   ......+.+++.+||+.||++|||+.|++++
T Consensus       254 ~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          254 W---DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             G---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1   1122356678889999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-39  Score=340.33  Aligned_cols=245  Identities=16%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeeccc------CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      ..+.||+|+||+||+|... +++.||+|++....      ...+.+.+|++++.++ +||||+++++++..++..++|||
T Consensus        28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e  106 (351)
T 3c0i_A           28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFE  106 (351)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEe
Confidence            3578999999999999975 57899999986431      2357799999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC---eEEeecCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPL  491 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~DfGla~~  491 (635)
                      |+++|+|.+++..... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++..
T Consensus       107 ~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          107 FMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             CCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            9999999888754321 1234899999999999999999999998   999999999999987655   99999999976


Q ss_pred             CCCCC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          492 MNVPA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       492 ~~~~~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .....    ...+|+.|+|||++.+..++.++|||||||++|||++|+.||....       ......+.......   .
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~~---~  252 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYKM---N  252 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCCC---C
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCCC---C
Confidence            65432    3458899999999999999999999999999999999999997532       11122222111110   0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..  ...   .....+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~--~~~---~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          253 PR--QWS---HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HH--HHT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cc--ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00  001   11245677888999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.6e-40  Score=336.91  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=205.3

Q ss_pred             hccccccCceEEEEEEe------cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|..      .+++.||+|+++....  ..+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  107 (313)
T 1t46_A           28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (313)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence            57899999999999985      2457899999975532  246788999999999889999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          415 YFASGSLSTLLHGNRGA-------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      |+++|+|.+++......             ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  184 (313)
T 1t46_A          108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (313)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence            99999999999754321             1234899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ||+|||++........      ..+++.|+|||++.+..++.++||||||+++|||+| |..||......+      ...
T Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~  258 (313)
T 1t46_A          185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY  258 (313)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred             EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHH
Confidence            9999999987654332      224567999999999899999999999999999999 999997654221      111


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ..........          ........+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       259 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHhccCCCCC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            2222211110          011123456778889999999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-39  Score=336.53  Aligned_cols=240  Identities=19%  Similarity=0.323  Sum_probs=190.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-----------
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----------  408 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----------  408 (635)
                      .+.||+|+||.||+|... +++.||||+++....  ..+.+.+|+++++++ +||||+++++++.+...           
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~   89 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIW   89 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence            568999999999999976 688999999975432  346789999999999 89999999999866442           


Q ss_pred             ----------------------------------------------eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHH
Q 006677          409 ----------------------------------------------KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRV  442 (635)
Q Consensus       409 ----------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~  442 (635)
                                                                    .++||||+++|+|.+++....  .....++..+.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~  167 (332)
T 3qd2_B           90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCL  167 (332)
T ss_dssp             ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHH
T ss_pred             hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHH
Confidence                                                          789999999999999998643  23446778899


Q ss_pred             HHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----------------CCCCCCCcccC
Q 006677          443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----------------ATPSRSAGYRA  506 (635)
Q Consensus       443 ~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----------------~~~~~~~~y~a  506 (635)
                      .++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....                ....+|+.|+|
T Consensus       168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            99999999999999998   999999999999999999999999999765433                22357889999


Q ss_pred             cccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHH
Q 006677          507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQI  586 (635)
Q Consensus       507 PE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l  586 (635)
                      ||++.+..++.++|||||||++|||++|..|+...        ........ ....          ..........+.++
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~-~~~~----------~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDVR-NLKF----------PLLFTQKYPQEHMM  305 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHH-TTCC----------CHHHHHHCHHHHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhh-ccCC----------CcccccCChhHHHH
Confidence            99999999999999999999999999987765310        00011100 0000          00112333456788


Q ss_pred             HHHcccCCCCCCCCHHHHHHH
Q 006677          587 GMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       587 ~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +.+||+.||++|||++|++++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            899999999999999999873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=333.93  Aligned_cols=238  Identities=19%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|+.. +++.||+|+++...    ...+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCC
Confidence            468999999999999975 58899999997642    2346678899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-C
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-~  496 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus        90 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           90 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            99999999743     24899999999999999999999998   999999999999999999999999999766443 3


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+......         .... 
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~---------~p~~-  225 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR---------FPPF-  225 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC---------CCTT-
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---------CCCC-
Confidence            45689999999999999999999999999999999999999975431      2222233222110         0111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                        ....+.+++.+|++.||++||     +++|++++
T Consensus       226 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          226 --FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              123566777899999999999     89999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.3e-40  Score=360.80  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=205.6

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ..+.||+|+||.||+|.+.++..||||+++......++|.+|+++++++ +|+||+++++++.. +..++||||+++|+|
T Consensus       271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL  348 (535)
T 2h8h_A          271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  348 (535)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred             hheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence            3578999999999999998888899999987766778899999999999 99999999999865 678999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-----C
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-----A  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-----~  496 (635)
                      .++++...   ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....     .
T Consensus       349 ~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          349 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred             HHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence            99997432   124899999999999999999999998   999999999999999999999999999876432     2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||......      ..... +......          ..
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~-i~~~~~~----------~~  485 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQ-VERGYRM----------PC  485 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHH-HHTTCCC----------CC
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCCC----------CC
Confidence            2335678999999998899999999999999999999 99999754321      11111 1111111          01


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .......+.+++.+||+.||++|||++++++.|+++....
T Consensus       486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            1122345778888999999999999999999999887544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-39  Score=328.10  Aligned_cols=249  Identities=26%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|...++..||+|++.......+.+.+|++++.++ +||||+++++++. .+..++||||+++++|.
T Consensus        18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   95 (279)
T 1qpc_A           18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV   95 (279)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred             eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence            468999999999999998888999999987766778899999999999 9999999999976 45689999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......     .
T Consensus        96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  169 (279)
T 1qpc_A           96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (279)
T ss_dssp             HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence            9997432   124899999999999999999999998   9999999999999999999999999997654322     2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||......      .....+. ......       ..   
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~-~~~~~~-------~~---  232 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLE-RGYRMV-------RP---  232 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH-TTCCCC-------CC---
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHh-cccCCC-------Cc---
Confidence            335678999999998889999999999999999999 99999754321      1122211 111100       01   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ......+.+++.+|++.+|++|||+.++++.|+++.....
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            1122456778889999999999999999999999986644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.7e-40  Score=346.40  Aligned_cols=193  Identities=21%  Similarity=0.337  Sum_probs=169.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhc----CCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----QHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|... +++.||||+++........+..|++++..+.    .||||+++++++...+..++||||+ 
T Consensus        40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-  118 (360)
T 3llt_A           40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-  118 (360)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred             EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence            468999999999999974 5788999999765444567788999999984    4999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC--------------------
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--------------------  477 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--------------------  477 (635)
                      +++|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.                    
T Consensus       119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence            889999997543   234899999999999999999999998   999999999999975                    


Q ss_pred             -----CCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          478 -----DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       478 -----~~~~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                           ++.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                 789999999999765443 34567899999999999999999999999999999999999997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=347.06  Aligned_cols=242  Identities=20%  Similarity=0.311  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.+|+|++......   .+.+.+|+++++++ +||||+++++++.+++..++||||+++
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   94 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG   94 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence            578999999999999864 5788999998765432   35688999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc---CCCCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~DfGla~~~~~~  495 (635)
                      |+|.+.+...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++   +++.+||+|||++......
T Consensus        95 g~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           95 GELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999998743     34899999999999999999999998   99999999999998   4678999999999776543


Q ss_pred             C----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 A----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .    ...||+.|+|||++.+..++.++||||+||++|||++|..||.....      ......+.......     ...
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~-----~~~  235 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAYDF-----PSP  235 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCCC-----CTT
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCCCC-----Ccc
Confidence            2    34689999999999999999999999999999999999999975432      11222222221110     000


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....   ....+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~---~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          236 EWDT---VTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccc---CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1111   22356677789999999999999999983

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-38  Score=325.08  Aligned_cols=255  Identities=17%  Similarity=0.168  Sum_probs=199.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeE-EEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA-YYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|++++.++ +|++++..+. +....+..++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEEEec-CCC
Confidence            46799999999999996 568899999986543 345789999999999 5655444444 446677889999999 899


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~--  495 (635)
                      |.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++   ++++.+||+|||++......  
T Consensus        91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999997432    34999999999999999999999998   9999999999999   48899999999998765432  


Q ss_pred             ---------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ---------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ---------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                               ....+++.|+|||++.+..++.++|||||||++|||++|+.||......+.......+.........    
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  239 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence                     2335788999999999999999999999999999999999999876544433322221111100000    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      . ..  ..   .....+.+++.+||+.||++|||++|+++.|+++......
T Consensus       240 ~-~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          240 E-VL--CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             H-HH--TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             H-HH--Hh---hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            0 00  01   1124577788899999999999999999999999876643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.8e-39  Score=325.26  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=199.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... ++.||+|+++.....   .+.+.+|+.++.++ +||||+++++++...  ...++||||++
T Consensus        15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccC
Confidence            468999999999999986 788999999865433   35688899999998 899999999999877  67899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +|+|.++++...   ...+++..+..++.|++.||+|||+.+ ++++||||||+||+++.++.++|+|||++..... ..
T Consensus        93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~  167 (271)
T 3kmu_A           93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PG  167 (271)
T ss_dssp             TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TT
T ss_pred             CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-cC
Confidence            999999998543   235899999999999999999999975 5699999999999999999999999988765432 34


Q ss_pred             CCCCCcccCcccccCCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIETRKHSH---KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~---k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..+|+.|+|||++.+..++.   ++||||||+++|||++|+.||.....      ................         
T Consensus       168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~---------  232 (271)
T 3kmu_A          168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPTI---------  232 (271)
T ss_dssp             CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCC---------
T ss_pred             ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCCC---------
Confidence            45788999999998766554   79999999999999999999975432      1122222222211111         


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                       .......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       233 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          233 -PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             01123356778889999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.1e-40  Score=332.81  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=196.0

Q ss_pred             hccccccCceEEEEEEecC-C-------CeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-S-------TTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||+||+|.... +       ..||+|++.... ...+.+.+|++++.++ +||||+++++++..++..++||
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEE
Confidence            4689999999999998654 2       469999986553 3356789999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC--------eEEee
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--------GCISD  485 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~ki~D  485 (635)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.        +||+|
T Consensus        92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999997532    33899999999999999999999998   999999999999998887        99999


Q ss_pred             cCCCCCCCCCCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006677          486 FGLTPLMNVPATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE  564 (635)
Q Consensus       486 fGla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  564 (635)
                      ||++..........+++.|+|||++.+ ..++.++||||||+++|||++|..|+....     +............... 
T Consensus       165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~-  238 (289)
T 4fvq_A          165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQFYEDRHQLP-  238 (289)
T ss_dssp             CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCC-
T ss_pred             CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHHHhhccCCCC-
Confidence            999977654444457888999999987 678999999999999999999655543221     1111111111100000 


Q ss_pred             cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       565 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                               .   .....+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       239 ---------~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          239 ---------A---PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             ---------C---CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             ---------C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                     0   012246678889999999999999999999999886543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.6e-40  Score=338.68  Aligned_cols=255  Identities=23%  Similarity=0.392  Sum_probs=190.8

Q ss_pred             hccccccCceEEEEEEecCCC----eEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCee------
Q 006677          343 AEVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------  409 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------  409 (635)
                      .+.||+|+||+||+|....+.    .||||+++....   ..+.+.+|+++++++ +||||+++++++...+..      
T Consensus        28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~  106 (323)
T 3qup_A           28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIP  106 (323)
T ss_dssp             EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CE
T ss_pred             eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCcc
Confidence            578999999999999976433    799999976532   246788999999999 999999999999877655      


Q ss_pred             EEEEEeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYFASGSLSTLLHGNRG-AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus       107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~  183 (323)
T 3qup_A          107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL  183 (323)
T ss_dssp             EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence            999999999999999864331 12235899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      ++......      ...+++.|+|||.+.+..++.++|||||||++|||++ |..||......+      ..........
T Consensus       184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~  257 (323)
T 3qup_A          184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGNR  257 (323)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC
T ss_pred             cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHHhcCCC
Confidence            97654322      2234667999999999999999999999999999999 999998654322      1111111111


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN  618 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~  618 (635)
                      .           .........+.+++.+||+.||++|||+.|+++.|+++.......
T Consensus       258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            0           011122345778888999999999999999999999999877543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=333.75  Aligned_cols=237  Identities=22%  Similarity=0.323  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCCh---HHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .++||+|+||+||+|... +++.||||++.......   ..+..|+..+.++.+|+||+++++++.+.+..++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            568999999999999976 68899999987654332   344556666666668999999999999999999999999 6


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      ++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus       141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            69988886532    34999999999999999999999998   999999999999999999999999998766433   


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+|+.|+|||++.+ .++.++|||||||++|||++|..|+....        .| .. +....    ......    
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~-~~-~~~~~----~~~~~~----  274 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GW-QQ-LRQGY----LPPEFT----  274 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HH-HH-HTTTC----CCHHHH----
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HH-HH-HhccC----CCcccc----
Confidence            23457899999999876 78999999999999999999977765321        11 11 11111    111110    


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ......+.+++.+||+.||++|||++|++++
T Consensus       275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          275 -AGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence             1123457788889999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-39  Score=339.41  Aligned_cols=238  Identities=22%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|+.+ +++.||+|+++...    .....+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999976 47889999997642    2345677888898887799999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....   
T Consensus       102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A          102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            99999999743     24899999999999999999999998   99999999999999999999999999976432   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+......   +      .
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~~---~------p  238 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNPF---Y------P  238 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---C------C
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCCC---C------C
Confidence             23446899999999999999999999999999999999999999754321      122222211110   0      0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  606 (635)
                      .   .....+.+++.+|++.||++||++. |+++
T Consensus       239 ~---~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          239 R---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             T---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             c---ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            1   1123566778899999999999998 6654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-39  Score=330.47  Aligned_cols=246  Identities=22%  Similarity=0.373  Sum_probs=189.7

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|....    +..||+|+++....  ..+.+.+|+.++.++ +||||+++++++ .++..++||||+
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~   97 (281)
T 1mp8_A           20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-TENPVWIIMELC   97 (281)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred             EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE-ccCccEEEEecC
Confidence            5789999999999999753    34689998865432  245688999999999 899999999997 456789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999997532    34899999999999999999999998   9999999999999999999999999997764432


Q ss_pred             -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 -----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                           ...+++.|+|||++.+..++.++||||||+++|||++ |..||......+   .   ...+......        
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~---~~~i~~~~~~--------  236 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V---IGRIENGERL--------  236 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHHHTTCCC--------
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---H---HHHHHcCCCC--------
Confidence                 1234668999999998899999999999999999997 999998654322   1   1111111110        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                         .........+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               00112234567788899999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.1e-39  Score=336.52  Aligned_cols=242  Identities=24%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|.. .+++.||||++......    .+.+.+|++++.++ +||||+++++++..++..++||||+.
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence            46799999999999996 46888999999754322    24688999999999 99999999999999999999999997


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                       |+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~  209 (348)
T 1u5q_A          138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS  209 (348)
T ss_dssp             -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred             -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence             68888875432    34899999999999999999999998   99999999999999999999999999988776667


Q ss_pred             CCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..+|+.|+|||++.   ...++.++|||||||++|||++|+.||.....      ......+...... ...      ..
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~-~~~------~~  276 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-ALQ------SG  276 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCC------CT
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-CCC------CC
Confidence            78999999999984   56789999999999999999999999975431      1222222221111 000      01


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                         .....+.+++.+||+.||++|||++|++++-.
T Consensus       277 ---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          277 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             ---CCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence               11234667888999999999999999987543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.7e-39  Score=335.26  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             hhccccccCceEEEEEEec--------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE--------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      ..+.||+|+||+||+|...        ++..||+|+++....  ..+.+.+|++++.++.+||||+++++++...+..++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  118 (334)
T 2pvf_A           39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  118 (334)
T ss_dssp             EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred             EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence            3578999999999999863        467899999976432  235688999999999889999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD  480 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  480 (635)
                      ||||+++|+|.+++......           ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  195 (334)
T 2pvf_A          119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNV  195 (334)
T ss_dssp             EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCC
Confidence            99999999999999765421           1234899999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 006677          481 GCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWV  553 (635)
Q Consensus       481 ~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~  553 (635)
                      +||+|||++.......      ...+++.|+|||++.+..++.++||||||+++|||++ |..||......      ...
T Consensus       196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~  269 (334)
T 2pvf_A          196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELF  269 (334)
T ss_dssp             EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred             EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH------HHH
Confidence            9999999997654321      2235678999999998889999999999999999999 99999754321      111


Q ss_pred             HHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 006677          554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENR  619 (635)
Q Consensus       554 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~  619 (635)
                      ..+. ......          ........+.+++.+||+.+|++|||+.|+++.|+.+........
T Consensus       270 ~~~~-~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~  324 (334)
T 2pvf_A          270 KLLK-EGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE  324 (334)
T ss_dssp             HHHH-HTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             HHHh-cCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence            1111 111100          011223456778889999999999999999999999987665433

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=341.16  Aligned_cols=240  Identities=20%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.... ++.||+|++....    ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~   98 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLL   98 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            5789999999999999764 7789999987542    2346788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999743     34899999999999999999999998   999999999999999999999999999865433  


Q ss_pred             -CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 -ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       ....||+.|+|||++..   ..++.++|||||||++|||++|+.||.......   .............          
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~~----------  237 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETTVV----------  237 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHCCC----------
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhccc----------
Confidence             34568999999999964   458999999999999999999999997544322   1111221111110          


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~  606 (635)
                        .........+.+++.+||+.||++||+ ++++.+
T Consensus       238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              001112345677888999999999999 677665

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-39  Score=335.32  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=202.4

Q ss_pred             hhccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||+|...      ++..||+|++.....  ..+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~  105 (314)
T 2ivs_A           27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIV  105 (314)
T ss_dssp             EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEE
Confidence            3578999999999999862      347899999975432  235688899999999 9999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeE
Q 006677          414 DYFASGSLSTLLHGNRGA-------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVL  474 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIl  474 (635)
                      ||+++|+|.+++......                   ....+++..+..++.||+.||+|||+.+   |+||||||+||+
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIl  182 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNIL  182 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEE
Confidence            999999999999764321                   1234899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 006677          475 INQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMV  547 (635)
Q Consensus       475 l~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~  547 (635)
                      ++.++.+||+|||++.......      ...+++.|+|||++.+..++.++||||||+++|||++ |..||......+  
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  260 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--  260 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            9999999999999997654322      2235677999999998889999999999999999999 999997654322  


Q ss_pred             ChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          548 DLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                       +.    ..+.......          ........+.+++.+||+.||++||++.|++++|+++...
T Consensus       261 -~~----~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          261 -LF----NLLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             -HH----HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -HH----HHhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence             11    1111111100          0112234567788899999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.1e-40  Score=333.79  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|...+++.||+|++.....   ..+.+.+|+++++++ +||||+++++++...+..++||||+++ 
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-   84 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ-   84 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence            467999999999999998899999999865432   246788999999999 899999999999999999999999986 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    
T Consensus        85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           85 DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            9999887533    34899999999999999999999998   999999999999999999999999998654322    


Q ss_pred             CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----cccc----ccc
Q 006677          496 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTA----EVF  566 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~  566 (635)
                      ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +.. .......    .|..    ..+
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHHCCCChhhchhhhccccc
Confidence            233578899999999764 589999999999999999999999975432110  111 1111100    0000    000


Q ss_pred             hhhhhcc------cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRF------QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +......      .........+.+++.+|++.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1110000      0001123456778889999999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-39  Score=345.65  Aligned_cols=241  Identities=22%  Similarity=0.309  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|+... ++.||+|++++..    .....+.+|+.++..+ +||||+++++++.+.+..|+||||++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~  152 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP  152 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            4689999999999999764 7889999997532    2345588899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.++++..      .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            99999999642      3899999999999999999999998   999999999999999999999999999766543  


Q ss_pred             ---CCCCCCCcccCcccccCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 ---ATPSRSAGYRAPEVIETRK----HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~----~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                         .+..||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.      ......+.......     
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~-----  292 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL-----  292 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHC-----
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhccccc-----
Confidence               2556899999999997665    78999999999999999999999975432      22222222211000     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  607 (635)
                      ........   ...+.+++.+|++.+|++  ||+++|++++
T Consensus       293 ~~p~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFPDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCTTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCCCcccc---cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00011112   234566777999999988  9999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-39  Score=331.53  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|.... +..||+|++.......+.+.+|+++++++ +||||+++++++..++..++||||+++|+|
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   96 (288)
T 3kfa_A           18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL   96 (288)
T ss_dssp             EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred             EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence            4689999999999999765 77899999987665667899999999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........    
T Consensus        97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            99997543   345899999999999999999999998   99999999999999999999999999987654321    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ..+++.|+|||++.+..++.++||||||+++|||++ |..||......+   ...    ........          ..
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~~~----------~~  233 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM----------ER  233 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC----------CC
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccCCC----------CC
Confidence             224667999999998899999999999999999999 999997654222   111    11111110          00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .......+.+++.+|++.||++|||++|+++.|+.+.+..
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            1122345678888999999999999999999999987653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-40  Score=344.34  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=193.5

Q ss_pred             hccccccCceEEEEEEecC--C--CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|...+  +  ..||+|.++....  ..+.+.+|+.+++++ +||||+++++++.. ++..++||||
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEEC
Confidence            4689999999999998642  2  3588998865432  246788999999999 89999999999764 4578999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999997532    34889999999999999999999998   999999999999999999999999999765332


Q ss_pred             C--------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 A--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ~--------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .        ...+++.|+|||++.+..++.++|||||||++|||+| |..||......+   ....   .......    
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~~~~~----  315 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRRL----  315 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHTTCCC----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHcCCCC----
Confidence            1        2234667999999999999999999999999999999 677787544322   1111   1111100    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP  620 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~  620 (635)
                             .........+.+++.+||+.+|++|||+.|+++.|+++......+.+
T Consensus       316 -------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~  362 (373)
T 3c1x_A          316 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  362 (373)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence                   00111234577888899999999999999999999999977665443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=342.06  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            357999999999999964 58899999997653 2356789999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE--cCCCCeEEeecCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI--NQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++......  
T Consensus       173 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          173 LFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             EHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999886432    34899999999999999999999998   9999999999999  567889999999998765432  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....+...  ..   ....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~--~~---~~~~  314 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDLE--DE---EFQD  314 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCSC--SG---GGTT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCCC--hh---hhcc
Confidence             34588999999999998999999999999999999999999975432      222333333322111  00   1111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHh
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEV  611 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~  611 (635)
                         ....+.+++.+|++.||++|||+.|+++  .+.+.
T Consensus       315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          315 ---ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ---CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence               2235667788999999999999999998  44433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=361.04  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=199.7

Q ss_pred             cccccCceEEEEEEec---CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .||+|+||.||+|.+.   ++..||||+++...  ...+++.+|++++.++ +||||+++++++.. +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            6999999999999864   45679999997653  2467899999999999 99999999999976 5689999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT--  497 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~--  497 (635)
                      +|.+++...    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  
T Consensus       421 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          421 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             BHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999999743    234999999999999999999999998   99999999999999999999999999987643221  


Q ss_pred             -----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          498 -----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       498 -----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                           ..+++.|+|||++.+..++.++|||||||++|||++ |+.||......+      ....+ ......        
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i-~~~~~~--------  558 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFI-EQGKRM--------  558 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHH-HTTCCC--------
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHH-HcCCCC--------
Confidence                 123568999999999999999999999999999998 999998654322      11111 111111        


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                        .........+.+++.+||+.+|++||++.++++.|+.+......
T Consensus       559 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          559 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             --CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence              11112335677888899999999999999999999998765543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9e-39  Score=326.04  Aligned_cols=254  Identities=17%  Similarity=0.183  Sum_probs=197.5

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceec-eeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP-LRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~-l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|.. .+++.||+|++.... ....+.+|++++.++ +|++++. +..++...+..++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHh-cCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence            56899999999999996 467889999876543 235688899999999 5555554 445556777889999999 999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~--  495 (635)
                      |.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++.....  
T Consensus        91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999997432    24999999999999999999999998   9999999999999   78999999999999765432  


Q ss_pred             ---------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ---------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ---------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                               ....+++.|+|||++.+..++.++|||||||++|||++|+.||........................    
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  239 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----
Confidence                     2335788999999999999999999999999999999999999876554443332221111100000    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ..   ...   .....+.+++.+||+.+|++|||++|+++.|+++.+...
T Consensus       240 ~~---~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          240 EV---LCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HH---HTT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hh---hhc---cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            00   000   112457788889999999999999999999999987654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=337.22  Aligned_cols=267  Identities=23%  Similarity=0.344  Sum_probs=193.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHH--hhcCCCceeceeEEEEeC-----CeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVG--RVGQHPNVVPLRAYYYSK-----DEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~--~l~~h~niv~l~~~~~~~-----~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|.. +++.||||++....  ...+..|.++..  .+ +||||+++++.+...     ...++||||
T Consensus        18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   93 (336)
T 3g2f_A           18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYLLVMEY   93 (336)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred             eeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEEEEEec
Confidence            46899999999999987 47899999997543  344555555443  35 899999999876532     256899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM---------GGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +++|+|.+++...      ..++..+..++.||+.||+|||+.         +   |+||||||+|||++.++.+||+||
T Consensus        94 ~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           94 YPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred             CCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence            9999999999643      268999999999999999999998         6   999999999999999999999999


Q ss_pred             CCCCCCCCC------------CCCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-CCC
Q 006677          487 GLTPLMNVP------------ATPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR-DDM  546 (635)
Q Consensus       487 Gla~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~-~~~  546 (635)
                      |+++.....            ....+|+.|+|||++.+       ..++.++|||||||++|||++|..||..... .+.
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            999765321            12347889999999986       4567789999999999999999777643322 221


Q ss_pred             CCh----------hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          547 VDL----------PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       547 ~~~----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ...          ................+..   ...........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            111          0111111111111111111   111122355678889999999999999999999999999998887


Q ss_pred             CCCCCCccC
Q 006677          617 ENRPSSEEN  625 (635)
Q Consensus       617 ~~~~~~~~~  625 (635)
                      .+...+..+
T Consensus       322 ~~~~~~~~~  330 (336)
T 3g2f_A          322 RNKSVSPTA  330 (336)
T ss_dssp             C--------
T ss_pred             hcccCCCcc
Confidence            765554433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-39  Score=332.30  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||.||+|.+     .+++.||+|++....  ...+.+.+|++++.++ +||||+++++++...  ...++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~  104 (302)
T 4e5w_A           26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIM  104 (302)
T ss_dssp             EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEE
T ss_pred             hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEE
Confidence            46899999999999984     357889999997543  2357789999999999 899999999999876  6689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999996433    34899999999999999999999998   9999999999999999999999999997664


Q ss_pred             CCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------CCCCChhHHHHHHhh
Q 006677          494 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVDLPRWVQSVVR  558 (635)
Q Consensus       494 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~  558 (635)
                      ...       ...++..|+|||++.+..++.++||||||+++|||+||..|+.....        ...............
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            332       23466779999999998999999999999999999999998753210        000000000111111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                      ...          ...........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       258 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            110          01111122346778888999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-39  Score=328.73  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=198.6

Q ss_pred             hccccccCceEEEEEEecCC-C---eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCee-EEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES-T---TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK-LLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~-~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~-~lv~e~  415 (635)
                      .++||+|+||+||+|.+.++ .   .||+|++.....  ..+.+.+|+++++++ +||||+++++++...+.. ++||||
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEec
Confidence            47899999999999986432 2   689999875433  235688999999999 999999999999876665 999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +.+|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       105 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             ccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999997532    34899999999999999999999998   999999999999999999999999999755321


Q ss_pred             --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 --------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                              ....+++.|+|||.+.+..++.++||||||+++|||++|..|+......  .++..   ... .....    
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~---~~~-~~~~~----  247 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTH---FLA-QGRRL----  247 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHH---HHH-TTCCC----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHH---Hhh-cCCCC----
Confidence                    2234567899999999999999999999999999999966655422111  11111   111 11100    


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENR  619 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~  619 (635)
                            .........+.+++.+||+.||++|||++|+++.|+++........
T Consensus       248 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          248 ------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             ------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence                  0011122356778889999999999999999999999987765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=335.89  Aligned_cols=242  Identities=21%  Similarity=0.321  Sum_probs=182.4

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|.... ++.||||+++... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus        58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  135 (349)
T 2w4o_A           58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGEL  135 (349)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence            4679999999999999864 6789999997643 356788899999999 899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~~---  495 (635)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+++.....   
T Consensus       136 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  207 (349)
T 2w4o_A          136 FDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM  207 (349)
T ss_dssp             HHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence            9999742     34899999999999999999999998   999999999999975   899999999999866443   


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+     .....+.......  ..+      .
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~~~--~~~------~  274 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEYYF--ISP------W  274 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCCCC--CTT------T
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCCcc--CCc------h
Confidence            23457899999999999999999999999999999999999997543211     1122222211110  000      0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+|++.||++|||+.|++++
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01223456778889999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-39  Score=334.36  Aligned_cols=249  Identities=25%  Similarity=0.471  Sum_probs=195.9

Q ss_pred             hccccccCceEEEEEEecCC-----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|.....     ..||+|+++....  ....+.+|++++.++ +||||+++++++...+..++||||
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeC
Confidence            46899999999999986532     3599999875432  245688999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       128 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          128 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999997532    34899999999999999999999998   999999999999999999999999999776432


Q ss_pred             C-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .       ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......      .....+. .....    
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~-~~~~~----  269 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAIN-DGFRL----  269 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-TTCCC----
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHH-CCCcC----
Confidence            2       1124567999999999999999999999999999999 99999754321      1111111 11100    


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                            +........+.+++.+||+.+|++||++.|++++|+++.....
T Consensus       270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                  0111223456778889999999999999999999999886543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-39  Score=335.59  Aligned_cols=258  Identities=22%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             hccccccCceEEEEEEec-----CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-----ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~  413 (635)
                      .+.||+|+||+||++.+.     +++.||||+++....  ..+.+.+|+++++++ +||||+++++++.+.  ...++||
T Consensus        36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~  114 (318)
T 3lxp_A           36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVM  114 (318)
T ss_dssp             EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEE
T ss_pred             hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEE
Confidence            468999999999998753     578899999976532  245688999999999 899999999999884  5779999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999743      3899999999999999999999998   9999999999999999999999999997765


Q ss_pred             CCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCC-----CCC-h--hHHHHHHhh
Q 006677          494 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDD-----MVD-L--PRWVQSVVR  558 (635)
Q Consensus       494 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~-----~~~-~--~~~~~~~~~  558 (635)
                      ...       ...++..|+|||++.+..++.++||||||+++|||+||..||.......     ... .  .........
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            432       2345677999999999889999999999999999999999987432100     000 0  000001111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCCCC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRP  620 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~  620 (635)
                      ...          ...........+.+++.+||+.||++|||+.|+++.|+.+.+......|
T Consensus       266 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          266 RGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             ccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            100          1111122335677888899999999999999999999999876654443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1e-38  Score=339.19  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=197.2

Q ss_pred             hcccccc--CceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKG--SYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .++||+|  +||+||+|... +++.||||++......   .+.+.+|+++++++ +||||+++++++..++..++||||+
T Consensus        30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  108 (389)
T 3gni_B           30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM  108 (389)
T ss_dssp             EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEcc
Confidence            4689999  99999999976 5889999999866443   34677899999999 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC---
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN---  493 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~---  493 (635)
                      ++|+|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||.+....   
T Consensus       109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            9999999997543   234899999999999999999999998   9999999999999999999999999874331   


Q ss_pred             --------CCCCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-----
Q 006677          494 --------VPATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-----  558 (635)
Q Consensus       494 --------~~~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----  558 (635)
                              ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||......+..  .........     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  260 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT  260 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-----------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccc
Confidence                    1223357888999999987  67999999999999999999999999865433211  000000000     


Q ss_pred             -----hcc------------ccccch--------hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 006677          559 -----EEW------------TAEVFD--------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV  611 (635)
Q Consensus       559 -----~~~------------~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~  611 (635)
                           +..            ......        ......+........+.+++.+||+.||++|||++|++++  ++.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                 000            000000        0000000111223457888899999999999999999975  5554


Q ss_pred             h
Q 006677          612 R  612 (635)
Q Consensus       612 ~  612 (635)
                      .
T Consensus       341 ~  341 (389)
T 3gni_B          341 K  341 (389)
T ss_dssp             -
T ss_pred             h
Confidence            4

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-39  Score=326.97  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=200.6

Q ss_pred             ccccccCceEEEEEEec---CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      +.||+|+||.||+|.+.   ++..||+|+++....  ..+.+.+|++++.++ +||||+++++++ ..+..++||||+++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            47999999999999854   567799999976432  345688999999999 999999999999 55678999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        94 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           94 GPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            9999999643    234899999999999999999999998   9999999999999999999999999997654321  


Q ss_pred             -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 -----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                           ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+      ....+..... .       
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~-~-------  232 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKR-M-------  232 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCC-C-------
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCc-C-------
Confidence                 2234678999999988889999999999999999999 999997543211      1111111110 0       


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                         .........+.+++.+||+.+|++||++.|++++|+++......
T Consensus       233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               00112234677788899999999999999999999999866543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=338.98  Aligned_cols=256  Identities=16%  Similarity=0.222  Sum_probs=189.5

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeecccC------------ChHHHHHHHHHHHhhcCCCceeceeEEEEe-
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVVV------------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-  405 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-  405 (635)
                      .+.||+|+||+||+|...    .+..+|+|++.....            ....+.+|+..+..+ +||||+++++++.. 
T Consensus        42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~  120 (345)
T 2v62_A           42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTE  120 (345)
T ss_dssp             EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEE
T ss_pred             EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccc
Confidence            468999999999999975    467899999875422            122355666777777 99999999999988 


Q ss_pred             ---CCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC--C
Q 006677          406 ---KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL--D  480 (635)
Q Consensus       406 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~--~  480 (635)
                         ....++||||+ +++|.+++....     .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++  .
T Consensus       121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred             cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence               67889999999 999999997532     5999999999999999999999998   99999999999999887  9


Q ss_pred             eEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006677          481 GCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL  549 (635)
Q Consensus       481 ~ki~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~  549 (635)
                      +||+|||+++.....           ....+++.|+|||++.+..++.++|||||||++|||++|+.||........  .
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~  269 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A  269 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence            999999999765321           233578899999999999999999999999999999999999964321110  0


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .............     ...............+.+++.+||+.||++||+++|+++.|+++....
T Consensus       270 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          270 VQTAKTNLLDELP-----QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             HHHHHHHHHHTTT-----HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             HHHHHHhhccccc-----HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence            1111111111110     000000000012346777888999999999999999999999876533

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.2e-39  Score=330.23  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      ++||+|+||+||+|... +++.||||++..... ....+.+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            57999999999999954 688999999976533 3677899999999976899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC---eEEeecCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP---  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~DfGla~~~~~~---  495 (635)
                      .+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.   +||+|||++......   
T Consensus        99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            9999753     24899999999999999999999998   999999999999998776   999999998765321   


Q ss_pred             --------CCCCCCCcccCcccccC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHH
Q 006677          496 --------ATPSRSAGYRAPEVIET-----RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL---------PRWV  553 (635)
Q Consensus       496 --------~~~~~~~~y~aPE~~~~-----~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~---------~~~~  553 (635)
                              ....+|+.|+|||++..     ..++.++|||||||++|||++|+.||......+....         ....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                    12347889999999875     5588999999999999999999999987654331100         0001


Q ss_pred             HHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       554 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+.....  ......   ..   .....+.+++.+||+.||++|||++|++++
T Consensus       251 ~~i~~~~~--~~~~~~---~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          251 ESIQEGKY--EFPDKD---WA---HISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHCCC--CCCHHH---HT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhccCc--ccCchh---cc---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11111100  000000   00   122456788889999999999999999884

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.3e-39  Score=335.65  Aligned_cols=256  Identities=23%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhh-cCCCceeceeEEEEeCC----eeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRV-GQHPNVVPLRAYYYSKD----EKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... ++.||+|++...  ....+.+|.+++..+ .+||||+++++++....    ..++||||++
T Consensus        47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~  123 (342)
T 1b6c_B           47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE  123 (342)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred             EeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence            578999999999999985 889999998653  356678888888873 28999999999998876    7899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--------SMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      +|+|.+++...      .+++..+..++.|++.||+|||        +.+   |+||||||+||+++.++.+||+|||++
T Consensus       124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            99999999642      3899999999999999999999        666   999999999999999999999999998


Q ss_pred             CCCCCC--------CCCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CCCCCCCCCCC
Q 006677          490 PLMNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTG----------KAPLQSPTRDD  545 (635)
Q Consensus       490 ~~~~~~--------~~~~~~~~y~aPE~~~~~~------~~~k~Dvws~Gvvl~el~tg----------~~p~~~~~~~~  545 (635)
                      ......        ....+++.|+|||++.+..      ++.++|||||||++|||+||          ..||......+
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            655432        2335788999999997753      34689999999999999999          77876543322


Q ss_pred             CCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          546 MVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                       .....+............. ...    ....+....+.+++.+||+.||++|||+.|++++|+++.+...
T Consensus       275 -~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          275 -PSVEEMRKVVCEQKLRPNI-PNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             -CCHHHHHHHHTTSCCCCCC-CGG----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             -ccHHHHHHHHHHHHhCCCC-ccc----ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence             1222333322222211111 110    1123556678899999999999999999999999999987653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.6e-39  Score=327.44  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|...  ..||+|+++.....   .+.+.+|+++++++ +||||+++++++ .....++||||++++
T Consensus        29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~  104 (289)
T 3og7_A           29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGS  104 (289)
T ss_dssp             EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred             eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCC
Confidence            468999999999999865  45999998765433   35688999999999 899999999965 556789999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    
T Consensus       105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            9999996432    34899999999999999999999998   999999999999999999999999998765421    


Q ss_pred             --CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          496 --ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                        ....+++.|+|||++.   +..++.++||||||+++|||++|+.||......+      ................   
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~---  248 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLS---  248 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTT---
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchh---
Confidence              1234788999999986   5668889999999999999999999997543211      1111121111110000   


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                       .  ........+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus       249 -~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 -K--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -S--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -h--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence             0  001223467788889999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=338.00  Aligned_cols=248  Identities=14%  Similarity=0.207  Sum_probs=199.0

Q ss_pred             hccccccCceEEEEEE------ecCCCeEEEEEeecccCChHHHHHHHHHHHhhc--CCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAV------LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|.      ...++.||+|++...  ...++.+|++++.++.  .|+||+.+++++...+..++|||
T Consensus        70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e  147 (365)
T 3e7e_A           70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE  147 (365)
T ss_dssp             EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred             EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence            4679999999999994      456889999998653  4667888888888883  28999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-----------CCCeEE
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----------DLDGCI  483 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----------~~~~ki  483 (635)
                      |+++|+|.++++.........+++..+..++.||+.||+|||+.+   |+||||||+|||++.           ++.+||
T Consensus       148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEE
Confidence            999999999997543333456999999999999999999999998   999999999999998           899999


Q ss_pred             eecCCCCCCC---C---CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006677          484 SDFGLTPLMN---V---PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV  557 (635)
Q Consensus       484 ~DfGla~~~~---~---~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  557 (635)
                      +|||+++...   .   .....||+.|+|||++.+..++.++|||||||++|||+||+.||........           
T Consensus       225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----------  293 (365)
T 3e7e_A          225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----------  293 (365)
T ss_dssp             CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----------
T ss_pred             eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----------
Confidence            9999996542   1   1234589999999999999999999999999999999999999964322110           


Q ss_pred             hhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhhccCCC
Q 006677          558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMR-PNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       558 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~~~~~~~~  617 (635)
                          .   ......... ..+   .+.+++..|++.+|.+| |+++++.+.|+++.+....
T Consensus       294 ----~---~~~~~~~~~-~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~  343 (365)
T 3e7e_A          294 ----K---PEGLFRRLP-HLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT  343 (365)
T ss_dssp             ----E---ECSCCTTCS-SHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred             ----e---echhccccC-cHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence                0   001111111 122   34456679999999998 6788999999998876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-39  Score=336.55  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.... ++.||+|+++...    ...+.+..|..++..+.+||||+++++++.+.+..|+||||++
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  104 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  104 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence            4689999999999999865 6789999997642    2345677888888887789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus       105 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          105 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            99999999743     24899999999999999999999998   99999999999999999999999999976432   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+......   +      .
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---~------p  241 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA---Y------P  241 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---C------C
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---C------C
Confidence             2345689999999999999999999999999999999999999975432      2222333322111   0      0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                         ......+.+++.+|++.||++||+     ++|++++
T Consensus       242 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          242 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               112235667788999999999995     5777764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-39  Score=347.52  Aligned_cols=244  Identities=18%  Similarity=0.300  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|+... ++.||+|++++..    .....+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCC
Confidence            4689999999999999865 6789999997532    2234588899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            999999997532    34999999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ----CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 ----TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                          ...||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..      .....+........ +.
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~-~p  303 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ-FP  303 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCC-CC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhhcccccc-CC
Confidence                246899999999997     567899999999999999999999999854322      22222221110000 00


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDM--RPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  607 (635)
                      .   .....   ...+.+++.+|++.+|++  ||+++|++++
T Consensus       304 ~---~~~~~---s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          304 T---QVTDV---SENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             S---SCCCS---CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             c---ccccC---CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            0   00112   234566777999888888  9999999884

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=330.55  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC------ChHHHHHHHHHHHhhc--CCCceeceeEEEEeCC-----e
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV------GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKD-----E  408 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~-----~  408 (635)
                      .+.||+|+||+||+|.. .+++.||+|++.....      ....+.+|+++++++.  +||||+++++++....     .
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~   93 (308)
T 3g33_A           14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK   93 (308)
T ss_dssp             EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence            46799999999999996 4578999999874432      2356778888888774  4999999999998765     4


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .++||||+. |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            789999997 59999997543   234899999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCCC---CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------
Q 006677          489 TPLMNVPAT---PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------  558 (635)
Q Consensus       489 a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  558 (635)
                      ++.......   ..+|+.|+|||++.+..++.++|||||||++|||++|+.||......+      ....+..       
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~  240 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD------QLGKIFDLIGLPPE  240 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH------HHHHHHHHHCCCCT
T ss_pred             ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCh
Confidence            987654332   347889999999999999999999999999999999999997643221      1111111       


Q ss_pred             hccccccch--hhhh-c-ccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVFD--VELM-R-FQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~d--~~~~-~-~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..|......  .... . ...    ..+....+.+++.+|++.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            111110000  0000 0 000    01122456778889999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=340.50  Aligned_cols=265  Identities=16%  Similarity=0.248  Sum_probs=207.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|.... ++.||||++....  ...+.+.+|++++.++ +||||+++++++...+  ..++||||++
T Consensus        14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~   92 (396)
T 4eut_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred             EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence            4689999999999999764 8899999997643  3456788999999999 8999999999998765  6799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE----cCCCCeEEeecCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~DfGla~~~~  493 (635)
                      +|+|.+++.....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++...
T Consensus        93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            9999999975432  233899999999999999999999998   9999999999999    778889999999997765


Q ss_pred             CCC---CCCCCCcccCcccccC--------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          494 VPA---TPSRSAGYRAPEVIET--------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       494 ~~~---~~~~~~~y~aPE~~~~--------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ...   ...+++.|+|||++.+        ..++.++|||||||++|||++|+.||........  .......+......
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~  245 (396)
T 4eut_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS  245 (396)
T ss_dssp             CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCT
T ss_pred             CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCc
Confidence            432   3457899999999865        5678899999999999999999999975432221  12223333322211


Q ss_pred             ccc------------chhhhh-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          563 AEV------------FDVELM-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       563 ~~~------------~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...            +..... ...........+.+++.+||+.||++||+++|+++.++++.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            100            000000 11122456667788999999999999999999999999988653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.4e-39  Score=331.91  Aligned_cols=238  Identities=22%  Similarity=0.340  Sum_probs=187.6

Q ss_pred             hccccccCceEEEEEEe----cCCCeEEEEEeecccC-----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV-----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||.||+++.    .+++.||+|+++....     ....+.+|++++.++ +||||+++++++...+..++||
T Consensus        22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~  100 (327)
T 3a62_A           22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLIL  100 (327)
T ss_dssp             EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred             EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEE
Confidence            46899999999999997    4688999999976432     234577899999999 8999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A          101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            999999999999743     24889999999999999999999998   9999999999999999999999999987643


Q ss_pred             CC----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          494 VP----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       494 ~~----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                      ..    ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+......       
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~-------  239 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKLN-------  239 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCC-------
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC-------
Confidence            22    234578999999999999999999999999999999999999975432      1222222221110       


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                        ...   .....+.+++.+||+.||++||     ++.|++++
T Consensus       240 --~p~---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          240 --LPP---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             --CCT---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             --CCC---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence              001   1223566778899999999999     77888773

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-39  Score=339.15  Aligned_cols=243  Identities=21%  Similarity=0.383  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|... +++.||+|++..... ....+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus        56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~  134 (387)
T 1kob_A           56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE  134 (387)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence            468999999999999975 578899999875432 345788999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC--CCCeEEeecCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~DfGla~~~~~~~--  496 (635)
                      |.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++......  
T Consensus       135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  207 (387)
T 1kob_A          135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  207 (387)
T ss_dssp             HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence            999997432    34899999999999999999999998   999999999999974  4789999999998765432  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+|+.|+|||++.+..++.++|||||||++|||++|..||.....      ......+....+..   +..  ..  
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~~---~~~--~~--  274 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWEF---DED--AF--  274 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCCC---CSS--TT--
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---Ccc--cc--
Confidence             23578999999999999999999999999999999999999975431      12222222222111   000  01  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ......+.+++.+||+.||++|||+.|++++
T Consensus       275 -~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 -SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             1122356678889999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.2e-39  Score=335.78  Aligned_cols=238  Identities=18%  Similarity=0.215  Sum_probs=197.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|++....    ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            468999999999999975 58899999997542    2346788899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-C
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-~  496 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus       125 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~  196 (350)
T 1rdq_E          125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence            99999999743     24899999999999999999999998   999999999999999999999999999866443 2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+......   +      .   
T Consensus       197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---~------p---  258 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKVR---F------P---  258 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---C------C---
T ss_pred             cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCCC---C------C---
Confidence            44689999999999999999999999999999999999999975431      2222222222110   0      0   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ......+.+++.+||+.||++||+     ++|++++
T Consensus       259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            112235677888999999999998     8888773

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-38  Score=330.38  Aligned_cols=255  Identities=23%  Similarity=0.406  Sum_probs=201.6

Q ss_pred             hccccccCceEEEEEEecC-CCe--EEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STT--VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~--vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.... +..  +++|+++...  ...+.+.+|++++.++.+||||+++++++...+..++||||++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  109 (327)
T 1fvr_A           30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP  109 (327)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence            5789999999999999654 443  4899887542  2346788999999999889999999999999999999999999


Q ss_pred             CCChhhhccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          418 SGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       418 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +|+|.+++....           ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df  186 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  186 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence            999999997543           012345899999999999999999999998   999999999999999999999999


Q ss_pred             CCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          487 GLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       487 Gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      |+++.....   ....+++.|+|||++.+..++.++||||||+++|||+| |+.||.....      ......+. ....
T Consensus       187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~-~~~~  259 (327)
T 1fvr_A          187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLP-QGYR  259 (327)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHGG-GTCC
T ss_pred             CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHHhh-cCCC
Confidence            998754322   22335778999999998889999999999999999998 9999975432      11122211 1111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..       ..   ......+.+++.+||+.+|++|||++|++++|+.+.+....
T Consensus       260 ~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          260 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             CC-------CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CC-------CC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            00       01   11224567788899999999999999999999999977654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-38  Score=324.86  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.||+|++......   ...+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            467999999999999975 4788999999765432   35688899999999 899999999999999999999999986


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                       ++.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   
T Consensus        86 -~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           86 -DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             -EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence             5655554322    34999999999999999999999998   999999999999999999999999999765432   


Q ss_pred             -CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h----ccccccc
Q 006677          496 -ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---E----EWTAEVF  566 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~  566 (635)
                       ....+|+.|+|||++.+.. ++.++|||||||++|||++|..||....     +.......+..   .    .|.....
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----CHHHHHHHHHHHhCCCChhhhhhhcc
Confidence             2345788899999997766 7999999999999999999998864322     11111222111   0    0000000


Q ss_pred             --h--------hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 --D--------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 --d--------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        +        ...............+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              0        0000000011223456678889999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=335.20  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCe----EEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTT----VVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|... +++.    |++|.+....  ...+.+.+|+.++.++ +||||+++++++.... .++|+||
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v~~~   97 (327)
T 3lzb_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEEECC
T ss_pred             EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEEEEe
Confidence            468999999999999964 3444    4677665432  2467899999999999 8999999999998754 7899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +.+|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            99999999997543    34899999999999999999999998   999999999999999999999999999876432


Q ss_pred             C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .      ...+++.|+|||++.+..++.++|||||||++|||++ |..||......+.   .    ..+.....      
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~----~~~~~~~~------  237 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGER------  237 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCC------
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCCC------
Confidence            2      1234667999999999999999999999999999999 9999986543321   1    11111110      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                          ..........+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       238 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 ----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                001112233567788899999999999999999999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-39  Score=329.13  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=195.6

Q ss_pred             hccccccCceEEEEEEecCC----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|...++    ..+|+|.+.....  ..+.+.+|+++++++ +||||+++++++.. ++..++||||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~  108 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY  108 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeC
Confidence            47899999999999986432    2578888875432  235688999999999 89999999999654 5578999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus       109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999997532    34899999999999999999999998   999999999999999999999999999765432


Q ss_pred             --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 --------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                              ....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+   ..   .........    
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~~~~----  251 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQGRRL----  251 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTTCCC----
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcCCCC----
Confidence                    12335677999999999999999999999999999999 555665443222   11   111111100    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                             .........+.+++.+||+.+|++|||+.|+++.|+++......
T Consensus       252 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          252 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                   00011223577788899999999999999999999999876544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-38  Score=336.37  Aligned_cols=240  Identities=20%  Similarity=0.315  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcC-CCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|...+++.||||++......   .+.+.+|++++.++.+ ||||+++++++..++..++||| +.+
T Consensus        61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~  139 (390)
T 2zmd_A           61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  139 (390)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred             EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence            4689999999999999888999999999765433   3568899999999953 6999999999999999999999 668


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      ++|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++ ++.+||+|||+++.....   
T Consensus       140 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          140 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            8999999753     24889999999999999999999998   99999999999995 589999999999876432   


Q ss_pred             ---CCCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          496 ---ATPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~-----------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                         ....+|+.|+|||++.+           ..++.++|||||||++|||++|+.||....     +.......+.....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH  285 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTS
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccc
Confidence               23458999999999865           368899999999999999999999997432     11222222222211


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....       ...   ....+.+++.+||+.||++|||+.|++++
T Consensus       286 ~~~~-------~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          286 EIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCC-------Ccc---chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1100       001   12356778889999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.4e-39  Score=350.85  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||+|... +++.||+|++....    .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~  267 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN  267 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence            468999999999999975 58899999997542    2356688999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       268 gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          268 GGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             SCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            999999997543   234899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........+.... . . +      . 
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~~~-~-~-~------p-  409 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVP-E-E-Y------S-  409 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHHCC-C-C-C------C-
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhccc-c-c-C------C-
Confidence              3468999999999999899999999999999999999999998654322  1111111111110 0 0 0      0 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                        ......+.+++.+|++.||++||     +++|++++
T Consensus       410 --~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          410 --ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              11223566777899999999999     78898874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.2e-39  Score=331.83  Aligned_cols=255  Identities=27%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             hccccccCceEEEEEEe------cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~  413 (635)
                      .+.||+|+||+||+|..      .+++.||+|+++....  ..+.+.+|++++.++.+||||+++++++...+ ..++||
T Consensus        32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~  111 (316)
T 2xir_A           32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  111 (316)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence            57899999999999984      2457899999976533  23568899999999988999999999988765 489999


Q ss_pred             EeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          414 DYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      ||+++|+|.+++......           ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k  188 (316)
T 2xir_A          112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  188 (316)
T ss_dssp             ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence            999999999999764421           0223889999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006677          483 ISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS  555 (635)
Q Consensus       483 i~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~  555 (635)
                      |+|||+++.......      ..+++.|+|||++.+..++.++||||||+++|||+| |..||......+      ....
T Consensus       189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~  262 (316)
T 2xir_A          189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR  262 (316)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred             ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence            999999986643322      234678999999999999999999999999999998 999997643221      1111


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ..........          .......+.+++.+||+.||++|||+.|++++|+++.+...
T Consensus       263 ~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          263 RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HhccCccCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            1111111000          01122356778889999999999999999999999987654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-39  Score=337.57  Aligned_cols=243  Identities=24%  Similarity=0.373  Sum_probs=193.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|... +++.||+|++....   ....+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            578999999999999976 47889999997653   23457888898887899999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC----CCeEEeecCCCCCCCCC--
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD----LDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~DfGla~~~~~~--  495 (635)
                      .+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.....  
T Consensus       104 ~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          104 LDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             HHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            9999743     34899999999999999999999998   9999999999998543    35999999999765432  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+|+.|+|||++.+..++.++|||||||++|||++|..||......   ........+........  .   ...
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~~~~~--~---~~~  247 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSGKFSLS--G---GYW  247 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHCCCCCC--S---TTT
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccCCcccC--c---ccc
Confidence              2446789999999998888999999999999999999999999753221   22222232222221100  0   001


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .   .....+.+++.+||+.||++||++.|++++
T Consensus       248 ~---~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          248 N---SVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             T---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             c---cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1   122356677789999999999999999984

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=330.73  Aligned_cols=241  Identities=21%  Similarity=0.323  Sum_probs=189.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCC-CceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++...+++.||||++......   .+.+.+|++++.++.+| +||+++++++..++..++||| +.+
T Consensus        14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~   92 (343)
T 3dbq_A           14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN   92 (343)
T ss_dssp             EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence            4689999999999999988999999999765443   35688999999999433 999999999999999999999 567


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++ ++.+||+|||+++......  
T Consensus        93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            8999999753     34899999999999999999999998   99999999999997 6789999999998764332  


Q ss_pred             ----CCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          497 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~-----------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                          ...+|+.|+|||++.+           ..++.++|||||||++|||++|+.||....     +.............
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH  238 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTS
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCc
Confidence                3458999999999864           678899999999999999999999997432     11122222222111


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ....       .   ......+.+++.+||+.||++|||+.|++++-
T Consensus       239 ~~~~-------~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          239 EIEF-------P---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CCCC-------C---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccCC-------c---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            1110       0   01123567788899999999999999999853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-38  Score=336.36  Aligned_cols=190  Identities=26%  Similarity=0.433  Sum_probs=154.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~  416 (635)
                      .+.||+|+||.||+|... +++.||||++......   ...+.+|+.++.++.+||||+++++++...+  ..|+||||+
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            468999999999999964 5789999998755332   3457789999999956999999999998654  689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC--
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~--  494 (635)
                      + |+|.+++...      .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....  
T Consensus        94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            7 5999998742      4899999999999999999999998   99999999999999999999999999975432  


Q ss_pred             -----------------------CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          495 -----------------------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       495 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                                             .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                                   112357888999999976 678999999999999999999999998653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=325.07  Aligned_cols=239  Identities=22%  Similarity=0.421  Sum_probs=176.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.. .+++.||+|++....    ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCC
Confidence            46899999999999997 468899999997542    1246788999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999997532    35899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...+++.|+|||.+.+..++.++||||||+++|||++|+.||......+...      .......       .  ..
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-------~--~~  232 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLADY-------E--MP  232 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSCC-------C--CC
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhccc-------C--Cc
Confidence               3457889999999999889999999999999999999999998654332211      1110000       0  00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ......+.+++.+||+.||++|||++|++++
T Consensus       233 ---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          233 ---SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence               1122356678889999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=336.06  Aligned_cols=279  Identities=18%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|++......  ...+.+|++++.++ +||||+++++++...+..++||||++ |
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K   84 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence            467999999999999976 5788999998754322  22455789999999 89999999999999999999999997 5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   
T Consensus        85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           85 DLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            9998887532    34899999999999999999999998   9999999999999999999999999987654322   


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----ccccccchhhh
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----EWTAEVFDVEL  570 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~d~~~  570 (635)
                       ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+   ....+......    .|.........
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhh
Confidence             2346889999999876 568999999999999999999999998654222   11111111111    01000000000


Q ss_pred             hc-------cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhccCCCCCCCCccCCCCCCCCC
Q 006677          571 MR-------FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSDSENRPSSEENKSKDSNVQ  633 (635)
Q Consensus       571 ~~-------~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~~  633 (635)
                      ..       ..    ........+.+++.+|++.||++|||++|+++  .+..+.+..............++-+.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q  310 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQ  310 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCC
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhh
Confidence            00       00    00111235678888999999999999999998  566665544433333333333444444

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.4e-39  Score=330.55  Aligned_cols=256  Identities=21%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCee----EEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK----LLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~----~lv~  413 (635)
                      .+.||+|+||+||+|.. .+++.||+|++......    ...+.+|++++.++ +||||+++++++......    ++||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~   95 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM   95 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEE
Confidence            46899999999999996 46788999999765332    24577888888888 899999999998876543    9999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.++++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        96 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           96 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            999999999999743     24899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VPA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ...       ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ..............   
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~---  238 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP---  238 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC---
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC---
Confidence            321       23478899999999999999999999999999999999999975432      11122222111110   


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHHhhccCCCCCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV-RMIEEVRQSDSENRPS  621 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl-~~L~~~~~~~~~~~~~  621 (635)
                       ... ...   .....+.+++.+||+.||++||++.+++ ..+..+........+.
T Consensus       239 -~~~-~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          239 -PSA-RHE---GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             -HHH-HST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             -ccc-ccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence             000 011   1224567788899999999999766555 5666666554444333

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=334.38  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=184.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEe--------CCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~lv  412 (635)
                      .++||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++.++.+||||+++++++..        ....++|
T Consensus        33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv  112 (337)
T 3ll6_A           33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL  112 (337)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred             EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence            578999999999999965 578999999865432 345688999999999669999999999953        3347899


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+. |+|.+++.....  ...+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||++...
T Consensus       113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  188 (337)
T 3ll6_A          113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTI  188 (337)
T ss_dssp             EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred             EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceec
Confidence            99996 699998864321  235999999999999999999999975 46999999999999999999999999999776


Q ss_pred             CCCC----------------CCCCCCcccCcccc---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 006677          493 NVPA----------------TPSRSAGYRAPEVI---ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV  553 (635)
Q Consensus       493 ~~~~----------------~~~~~~~y~aPE~~---~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  553 (635)
                      ....                ...+++.|+|||++   .+..++.++|||||||++|||++|+.||.........      
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------  262 (337)
T 3ll6_A          189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------  262 (337)
T ss_dssp             SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------
Confidence            4322                22378889999998   5667889999999999999999999999754322110      


Q ss_pred             HHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006677          554 QSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN  618 (635)
Q Consensus       554 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~  618 (635)
                          .......       ..   ......+.+++.+||+.||++|||+.|++++|+.+.......
T Consensus       263 ----~~~~~~~-------~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          263 ----NGKYSIP-------PH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             -------CCCC-------TT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             ----cCcccCC-------cc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence                0000000       00   011123567888999999999999999999999998766543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-39  Score=326.53  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=196.1

Q ss_pred             hccccccCceEEEEEEecCC----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|...+.    ..||+|++.....  ..+.+.+|++++.++ +||||+++++++.+ +..++||||+
T Consensus        17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~   94 (281)
T 3cc6_A           17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPTWIIMELY   94 (281)
T ss_dssp             EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCCEEEEecC
Confidence            56899999999999986532    3599999876432  346788999999999 99999999999764 5678999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            9999999997532    34899999999999999999999998   9999999999999999999999999987664332


Q ss_pred             -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 -----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                           ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+   ..   .........        
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~---~~~~~~~~~--------  233 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI---GVLEKGDRL--------  233 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH---HHHHHTCCC--------
T ss_pred             ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH---HHHhcCCCC--------
Confidence                 2335678999999998899999999999999999998 999997543322   11   111111100        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                         .........+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence               00011224567788899999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-39  Score=333.38  Aligned_cols=257  Identities=22%  Similarity=0.354  Sum_probs=187.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|+++....  ..+.+.+|++++.++ +||||+++++++..++..++||||++ |
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~   87 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMD-N   87 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecC-C
Confidence            467999999999999965 578899999975432  346788999999999 89999999999999999999999998 5


Q ss_pred             ChhhhccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          420 SLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       420 ~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      +|.+++.... ......+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   
T Consensus        88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  164 (317)
T 2pmi_A           88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT  164 (317)
T ss_dssp             BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred             CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence            9999886432 112235899999999999999999999998   999999999999999999999999999765432   


Q ss_pred             -CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---ccccc-----
Q 006677          496 -ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEV-----  565 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  565 (635)
                       ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.   ...+.......   .....     
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhhhhh
Confidence             23457889999999976 4689999999999999999999999976432211   11111111000   00000     


Q ss_pred             chhhhh-----------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          566 FDVELM-----------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +.....           ...........+.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000000           000000122357788889999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.7e-39  Score=359.93  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             ccccccCceEEEEEEec---CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||+||+|.+.   .++.||||+++.....   .+++.+|++++.++ +|||||++++++. .+..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEEEEccC
Confidence            47999999999999753   3568999999865432   46799999999999 8999999999986 456889999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.++++..     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999999743     34899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          497 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       497 ------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                            ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+       +...+.......     
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~-----  592 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG-----  592 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence                  1224567999999999999999999999999999998 999997654221       111111111110     


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                           ........+.+++.+||+.||++||+++++++.|+++..
T Consensus       593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 111223467788889999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-39  Score=336.62  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|.+     .++..||||++..... ..+.+.+|++++.++ +||||+++++++..  ....++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e  106 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVME  106 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEe
Confidence            56899999999999984     3578899999876532 245689999999999 99999999999874  456889999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999997532    24899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC--------CCCChhHHHHHHhhh
Q 006677          495 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD--------DMVDLPRWVQSVVRE  559 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~  559 (635)
                      ..       ...++..|+|||++.+..++.++||||||+++|||++|..||......        ...............
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            22       234667799999999888999999999999999999999998643210        000000111111111


Q ss_pred             ccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006677          560 EWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN  618 (635)
Q Consensus       560 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~  618 (635)
                      ..          ...........+.+++.+||+.||++|||++|++++|+.+.......
T Consensus       260 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          260 GQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             cc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            10          01111223345778888999999999999999999999998766543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.7e-39  Score=329.62  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=192.6

Q ss_pred             hhccccccCceEEEEEEecC----CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-----e
Q 006677          342 SAEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----K  409 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~  409 (635)
                      ..+.||+|+||.||+|....    +..||+|+++.....   .+.+.+|+.++.++ +||||+++++++...+.     .
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~  116 (313)
T 3brb_A           38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKP  116 (313)
T ss_dssp             EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CE
T ss_pred             eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCccc
Confidence            35789999999999998643    347999998765433   35688899999999 89999999999987653     4


Q ss_pred             EEEEEeccCCChhhhccCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          410 LLVYDYFASGSLSTLLHGNR-GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ++||||+++|+|.+++.... ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus       117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~  193 (313)
T 3brb_A          117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGL  193 (313)
T ss_dssp             EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred             EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCc
Confidence            99999999999999985332 122345999999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      +.......      ...+++.|+|||.+.+..++.++||||||+++|||++ |..||......+      ..........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~  267 (313)
T 3brb_A          194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHGHR  267 (313)
T ss_dssp             C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCC
T ss_pred             ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHHcCCC
Confidence            97654322      2235678999999999999999999999999999999 889997644322      1111111110


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      .           .........+.+++.+||+.+|++|||+.|++++|+++.+..+
T Consensus       268 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          268 L-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             C-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             C-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            0           0111223457788889999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6e-39  Score=325.28  Aligned_cols=243  Identities=21%  Similarity=0.383  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----------------
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----------------  405 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----------------  405 (635)
                      .+.||+|+||.||+|... +++.||+|++...   ...+.+|++++.++ +||||+++++++..                
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   91 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSK   91 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECC---SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccC
Confidence            578999999999999976 6889999998754   35678899999999 99999999999864                


Q ss_pred             CCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          406 KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       406 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      ....++||||+++|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred             cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECc
Confidence            345789999999999999997543   234899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          486 FGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       486 fGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ||++......   ....+++.|+|||++.+..++.++||||||+++|||++|..|+...        ....... .....
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~~-~~~~~  236 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTDL-RDGII  236 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHHH-HTTCC
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHHh-hcccc
Confidence            9998765443   2345788999999999999999999999999999999999887421        1111111 11111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      ..          .   ....+.+++.+||+.||++|||+.|++++|+.+......
T Consensus       237 ~~----------~---~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          237 SD----------I---FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             CT----------T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             cc----------c---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            10          1   123456788899999999999999999999999866543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=330.76  Aligned_cols=253  Identities=20%  Similarity=0.318  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|.... ++.||+|++......   .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCC
Confidence            4689999999999999764 889999998765433   35677899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        87 ~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           87 TVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             chHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            9999988643     34899999999999999999999998   9999999999999999999999999997665322  


Q ss_pred             --CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hcc
Q 006677          497 --TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------------EEW  561 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~  561 (635)
                        ...+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+..   ........            ..+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccccccccccccc
Confidence              3357888999999976 56899999999999999999999999765422211   11111110            000


Q ss_pred             ccccchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.......    .......+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000000000    01223456788889999999999999999974

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-38  Score=343.30  Aligned_cols=254  Identities=19%  Similarity=0.234  Sum_probs=201.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .++||+|+||.||+|.. .+++.||||++.... ...++.+|++++..+.+|+++..+..++...+..++||||+ +++|
T Consensus        12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            46799999999999996 458899999876543 34568899999999966678888888888888999999999 8999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCCC--
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      .+++....    ..+++..++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++......  
T Consensus        90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            99997432    24999999999999999999999998   9999999999999   688999999999997654322  


Q ss_pred             ---------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          497 ---------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       497 ---------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                               ...+|+.|+|||++.+..++.++|||||||++|||++|+.||...........   ...+...... ....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~i~~~~~~-~~~~  238 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEKISEKKVA-TSIE  238 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHHHHHHHHH-SCHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHHHhhcccc-ccHH
Confidence                     34578899999999999999999999999999999999999987554332111   1111111110 0000


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...      .....++.+++..||+.+|++||++.+|++.|+++....
T Consensus       239 ~l~------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          239 ALC------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHh------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000      011246778888999999999999999999999997644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=343.44  Aligned_cols=242  Identities=17%  Similarity=0.270  Sum_probs=192.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|+.. +++.||+|++.+...    ..+.+.+|..++..+ +||||+++++++.+.+..|+||||++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~  144 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence            468999999999999975 588999999975321    234578899999998 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            999999997432    24899999999999999999999998   9999999999999999999999999997664432 


Q ss_pred             ----CCCCCCcccCccccc-------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          497 ----TPSRSAGYRAPEVIE-------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~-------~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                          ...||+.|+|||++.       ...++.++|||||||++|||++|+.||...+..      .....+.......  
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~--  289 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKIVHYKEHL--  289 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHC--
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhcccCc--
Confidence                346899999999997       456899999999999999999999999754321      1222222111000  


Q ss_pred             chhhhhcccC-hHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 006677          566 FDVELMRFQN-IEEEMVQMLQIGMACVAKVPDMR---PNMDEVVRM  607 (635)
Q Consensus       566 ~d~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~~  607 (635)
                            ..+. .......+.+++.+|++ +|++|   |+++|++++
T Consensus       290 ------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          290 ------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                  0000 01122356677779999 99998   589999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.8e-38  Score=324.91  Aligned_cols=256  Identities=20%  Similarity=0.363  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.. .+++.||+|++.....    ....+.+|++++.++ +||||+++++++...+..++||||++
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~  115 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD  115 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCC
Confidence            46899999999999996 4688999999975322    235688899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++..... ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus       116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~  191 (310)
T 2wqm_A          116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  191 (310)
T ss_dssp             SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred             CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence            9999999864321 1335899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....    ................ ..      .
T Consensus       192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~-~~------~  260 (310)
T 2wqm_A          192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDYPP-LP------S  260 (310)
T ss_dssp             -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCSCC-CC------T
T ss_pred             cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccCCC-Cc------c
Confidence               23478889999999999999999999999999999999999975321    2222222222211110 00      0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                         ......+.+++.+||+.||++|||+.|+++.|+++......
T Consensus       261 ---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          261 ---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence               11223567788899999999999999999999999876644

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-38  Score=320.55  Aligned_cols=238  Identities=25%  Similarity=0.379  Sum_probs=193.1

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|.... +..||+|++....    .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCC
Confidence            4689999999999998764 6689999986542    2356788899999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        93 ~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           93 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            99999998743     24899999999999999999999998   999999999999999999999999988665433  


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|..||.....      ......+......            .
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------------~  226 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEFT------------F  226 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC------------C
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhCCCC------------C
Confidence            234578899999999999999999999999999999999999975431      1111111111110            0


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+||+.||++|||++|++++
T Consensus       227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            01122356678889999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.1e-38  Score=324.77  Aligned_cols=243  Identities=21%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||.||+|... +++.||+|++.....       ..+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   94 (321)
T 2a2a_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLIL   94 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEE
Confidence            3578999999999999976 578899999976532       256789999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC----CeEEeecCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLT  489 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla  489 (635)
                      ||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++
T Consensus        95 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           95 ELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             CCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999742     34899999999999999999999998   99999999999999888    7999999999


Q ss_pred             CCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          490 PLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       490 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .......   ...+++.|+|||++.+..++.++||||||+++|||++|..||.....      ......+......   +
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~---~  237 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSYD---F  237 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC---C
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcccc---c
Confidence            7665432   34578899999999999999999999999999999999999975432      1112222111110   0


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +...  ..   .....+.+++.+|++.||++|||+.|++++
T Consensus       238 ~~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          238 DEEF--FS---HTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CHHH--HT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Chhh--hc---ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110  01   112356778889999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-38  Score=320.61  Aligned_cols=244  Identities=22%  Similarity=0.325  Sum_probs=191.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||++... ++..||+|++.....  ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~  105 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGG  105 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCC
Confidence            578999999999999975 578899999876543  457899999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCC-
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~-  495 (635)
                      +|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++...... 
T Consensus       106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            99998854321 1235899999999999999999999998   9999999999999   45688999999999765433 


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++. ..++.++||||||+++|||++|+.||......      ...............      ..
T Consensus       182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~------~~  248 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYAV------EC  248 (285)
T ss_dssp             -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCC--------
T ss_pred             cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccccc------cc
Confidence              2345788999999986 46889999999999999999999999754311      111111111111000      00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   ....+.+++.+|++.||++|||++|++++
T Consensus       249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             Cc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   12356678889999999999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-38  Score=323.64  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.++.++ +||||+++++++..++..++||||++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLIN  117 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecC
Confidence            468999999999999975 5788999998765332    35688899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus       118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999999743     24899999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          497 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                          ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....       .............    .. ..
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~----~~-~~  257 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPR----PS-TV  257 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCC----GG-GT
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCC----cc-cc
Confidence                33578889999999999999999999999999999999999975321       1112212111110    00 00


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhhccCCC
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~~~~~~~  617 (635)
                      .   ......+.+++.+||+.||++|| +++++++.|+++......
T Consensus       258 ~---~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          258 R---PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             S---TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             C---CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            1   11223566788899999999999 999999999988766644

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-38  Score=344.38  Aligned_cols=238  Identities=23%  Similarity=0.360  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||||++....    .....+.+|+++++.+ +||||+++++++...+..++||||++
T Consensus        21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~   99 (476)
T 2y94_A           21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVS   99 (476)
T ss_dssp             EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            468999999999999976 68899999997542    2345788999999998 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......  
T Consensus       100 gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A          100 GGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             SEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999742     34899999999999999999999998   999999999999999999999999999876443  


Q ss_pred             -CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 -ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       ....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.....      ......+......         ..
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p  236 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIFY---------TP  236 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCCC---------CC
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCcC---------CC
Confidence             24568999999999988776 6899999999999999999999975432      1222222221110         01


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   ....+.+++.+||+.||++|||++|++++
T Consensus       237 ~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          237 QY---LNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             cc---CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            11   12346678889999999999999999983

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.1e-38  Score=327.25  Aligned_cols=245  Identities=17%  Similarity=0.281  Sum_probs=196.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||+|+++....   ....+.+|+.++.++.+||||+++++++...+..++||||+++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~  113 (327)
T 3lm5_A           34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG  113 (327)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence            378999999999999976 588999999976533   3567889999999997889999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~~  495 (635)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+++.....
T Consensus       114 ~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          114 GEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            99999986432   235899999999999999999999998   999999999999998   789999999999776543


Q ss_pred             C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .   ...+++.|+|||++.+..++.++||||||+++|||++|+.||......+      ....+......  ..      
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~--~~------  253 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQVNVD--YS------  253 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC--CC------
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhcccc--cC------
Confidence            2   3457899999999999999999999999999999999999997543211      11111111100  00      


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00011223456778889999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=330.63  Aligned_cols=256  Identities=20%  Similarity=0.359  Sum_probs=197.1

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~  416 (635)
                      .+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++.++ +||||+++++++..    ....++||||+
T Consensus        34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  112 (317)
T 2buj_A           34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFF  112 (317)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred             EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence            47899999999999997 568899999986542 2356788999999999 99999999999873    34678999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  188 (317)
T 2buj_A          113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV  188 (317)
T ss_dssp             TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred             CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence            99999999975322 2345899999999999999999999998   9999999999999999999999999987653211


Q ss_pred             -------------CCCCCCcccCcccccCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006677          497 -------------TPSRSAGYRAPEVIETRK---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE  560 (635)
Q Consensus       497 -------------~~~~~~~y~aPE~~~~~~---~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  560 (635)
                                   ...+++.|+|||++.+..   ++.++||||||+++|||++|+.||....... .......    ...
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~~  263 (317)
T 2buj_A          189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAV----QNQ  263 (317)
T ss_dssp             ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHH----HCC
T ss_pred             ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHh----hcc
Confidence                         112588899999997654   6899999999999999999999996321111 0111100    010


Q ss_pred             cccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCCC
Q 006677          561 WTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN  618 (635)
Q Consensus       561 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~  618 (635)
                      .          ..+........+.+++.+||+.||++|||++|++++|+.+....+.+
T Consensus       264 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          264 L----------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             C----------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence            0          00011122345777888999999999999999999999988655543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=331.62  Aligned_cols=256  Identities=14%  Similarity=0.161  Sum_probs=199.2

Q ss_pred             hccccccCceEEEEEEecC---------CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceec---------------
Q 006677          343 AEVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVP---------------  398 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~---------------  398 (635)
                      .+.||+|+||.||+|....         ++.||+|++...    +.+.+|++++.++ +||||++               
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhccCCccCccc
Confidence            4679999999999999764         788999998753    5688999999999 8999887               


Q ss_pred             eeEEEEe-CCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC
Q 006677          399 LRAYYYS-KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       399 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  477 (635)
                      +++++.. ++..++||||+ +++|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP  194 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEET
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcC
Confidence            6778876 67889999999 999999997542   235999999999999999999999998   999999999999999


Q ss_pred             CC--CeEEeecCCCCCCCCC-----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 006677          478 DL--DGCISDFGLTPLMNVP-----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRD  544 (635)
Q Consensus       478 ~~--~~ki~DfGla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~  544 (635)
                      ++  .+||+|||+++.....           ....+++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            98  9999999999765422           2235788999999999999999999999999999999999999854321


Q ss_pred             CCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          545 DMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                      . ..+......... . .....+... .....   ...+.+++.+||+.||++|||++|+++.|+++.+....
T Consensus       275 ~-~~~~~~~~~~~~-~-~~~~~~~~~-~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          275 T-EDIMKQKQKFVD-K-PGPFVGPCG-HWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             H-HHHHHHHHHHHH-S-CCCEECTTS-CEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             H-HHHHHHHHhccC-C-hhhhhhhcc-ccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            1 111111111111 1 111111000 00111   24567777899999999999999999999999877643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.2e-39  Score=324.52  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... ++.||+|+++... ..+.+.+|++++.++ +||||+++++++... +..++||||+++|+|
T Consensus        26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L  102 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  102 (278)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence            578999999999999875 7899999987543 456789999999999 899999999997654 478999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSR  500 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~  500 (635)
                      .+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... ...+
T Consensus       103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  176 (278)
T 1byg_A          103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL  176 (278)
T ss_dssp             HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred             HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence            99996432   123789999999999999999999998   9999999999999999999999999987654432 3346


Q ss_pred             CCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHH
Q 006677          501 SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEE  579 (635)
Q Consensus       501 ~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  579 (635)
                      ++.|+|||++.+..++.++||||||+++|||+| |..||......+      ...... ......          .....
T Consensus       177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~-~~~~~~----------~~~~~  239 (278)
T 1byg_A          177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVE-KGYKMD----------APDGC  239 (278)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHT-TTCCCC----------CCTTC
T ss_pred             cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHh-cCCCCC----------CcccC
Confidence            778999999998899999999999999999998 999997543221      111111 111100          01122


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          580 MVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       580 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ...+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            345677888999999999999999999999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.4e-38  Score=344.70  Aligned_cols=244  Identities=20%  Similarity=0.297  Sum_probs=197.7

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      ++||+|+||.||+|+.. +++.||+|++....    .....+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence            56999999999999975 58899999997542    2346788899999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |+|.+++..... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  
T Consensus       270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            999999875432 2345999999999999999999999998   9999999999999999999999999997654332  


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.+......         ...
T Consensus       346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~~---------~p~  414 (543)
T 3c4z_A          346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAVT---------YPD  414 (543)
T ss_dssp             BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCCC---------CCT
T ss_pred             cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcccC---------CCc
Confidence              2468999999999999999999999999999999999999998653221  222222222221110         011


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~  606 (635)
                         .....+.+++.+||+.||++||++     +|+++
T Consensus       415 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          415 ---KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               122355677789999999999975     66665

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=338.65  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|....      ...||+|++.....  ..+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus        51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  130 (333)
T 2i1m_A           51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE  130 (333)
T ss_dssp             EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence            5789999999999999653      23699999876532  245688999999999789999999999999999999999


Q ss_pred             eccCCChhhhccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          415 YFASGSLSTLLHGNRG---------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                      |+++|+|.+++.....         .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  207 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD  207 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence            9999999999864321         01234899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          486 FGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       486 fGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      ||++.......      ...+++.|+|||++.+..++.++||||||+++|||+| |..||......+      .......
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~  281 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYKLVK  281 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHHHHH
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHHHHh
Confidence            99997653322      2234667999999998899999999999999999999 999997543221      1122222


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......          ........+.+++.+||+.||.+|||+.|++++|+++....
T Consensus       282 ~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          282 DGYQMA----------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCC----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            221110          00111245677888999999999999999999999987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.6e-38  Score=322.15  Aligned_cols=245  Identities=23%  Similarity=0.339  Sum_probs=195.6

Q ss_pred             ccccccCceEEEEEEec---CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||+||+|.+.   .++.||||+++.....   .+.+.+|++++.++ +||||+++++++ ..+..++||||++
T Consensus        23 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~  100 (291)
T 1xbb_A           23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAE  100 (291)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCT
T ss_pred             CccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCC
Confidence            37999999999999643   3578999999765332   46788999999999 899999999999 5677899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus       101 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A          101 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            99999999753     24899999999999999999999998   99999999999999999999999999976543321


Q ss_pred             -------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          498 -------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       498 -------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                             ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+      .. ..+.......     
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~~-----  240 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VT-AMLEKGERMG-----  240 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HH-HHHHTTCCCC-----
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCCCCC-----
Confidence                   234577999999998889999999999999999999 999997543211      11 1111111100     


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                           ........+.+++.+||+.||++||++.|+++.|+++....
T Consensus       241 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          241 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                 01122345777888999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-38  Score=336.95  Aligned_cols=258  Identities=17%  Similarity=0.255  Sum_probs=197.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhc-------CCCceeceeEEEE----eCCeeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG-------QHPNVVPLRAYYY----SKDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-------~h~niv~l~~~~~----~~~~~~  410 (635)
                      .++||+|+||+||+|... +++.||+|+++......+.+.+|++++.++.       .|+||+++++++.    .....+
T Consensus        42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  121 (397)
T 1wak_A           42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC  121 (397)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred             EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence            568999999999999864 5778999999765444567889999999884       2888999999987    455789


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCC----------
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDL----------  479 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~----------  479 (635)
                      +||||+ +++|.+++....   ...+++..+..++.||+.||+|||++ +   |+||||||+|||++.++          
T Consensus       122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence            999999 556666654332   23489999999999999999999998 7   99999999999999775          


Q ss_pred             ---------------------------------------CeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCcc
Q 006677          480 ---------------------------------------DGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKS  519 (635)
Q Consensus       480 ---------------------------------------~~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~  519 (635)
                                                             .+||+|||++...... ....+|+.|+|||++.+..++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  274 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA  274 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence                                                   8999999999766443 334678999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h---------ccccccch------------------hh
Q 006677          520 DVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---E---------EWTAEVFD------------------VE  569 (635)
Q Consensus       520 Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d------------------~~  569 (635)
                      |||||||++|||+||+.||......+..........+..   .         .+....+.                  ..
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL  354 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence            999999999999999999987655443322111111110   0         00000000                  00


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .............+.+++.+||+.||++|||++|++++
T Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            01112235666788999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.3e-38  Score=317.02  Aligned_cols=241  Identities=22%  Similarity=0.361  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... +++.||+|++.....  ..+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG   90 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence            568999999999999976 588999999875533  246788999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----  494 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-----  494 (635)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....     
T Consensus        91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            999999642     34899999999999999999999998   99999999999999999999999999875432     


Q ss_pred             -CCCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                       .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|.    .....   .      
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~---~------  228 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---L------  228 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTT---S------
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccc---c------
Confidence             223457889999999987765 7789999999999999999999976543211 111111    11000   0      


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .........+.+++.+|++.||++|||++|++++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             0001122356678889999999999999999763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.6e-38  Score=316.44  Aligned_cols=250  Identities=20%  Similarity=0.373  Sum_probs=200.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... +++.||+|+++....       ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   88 (283)
T 3bhy_A           10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILE   88 (283)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEe
Confidence            568999999999999976 588999999876532       356789999999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC----CeEEeecCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP  490 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla~  490 (635)
                      |+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++    .+||+|||++.
T Consensus        89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999642     34899999999999999999999998   99999999999998877    89999999997


Q ss_pred             CCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          491 LMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       491 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      ......   ...+++.|+|||++.+..++.++||||||+++|||++|..||......      .....+......   ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---~~  231 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNYD---FD  231 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCCC---CC
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcccC---Cc
Confidence            654332   335788999999999999999999999999999999999999754321      111111111100   00


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhhccC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVRQSD  615 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~~~~  615 (635)
                      ...  .   ......+.+++.+||+.||++|||+.|+++  .++.+....
T Consensus       232 ~~~--~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          232 EEY--F---SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHH--H---TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             chh--c---ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            000  0   111235677888999999999999999998  577776554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.4e-38  Score=317.94  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||+|++......   .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~   89 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG   89 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence            467999999999999975 4789999999766543   34677899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC---eEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~DfGla~~~~~~  495 (635)
                      |+|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++......
T Consensus        90 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           90 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999888643     34899999999999999999999998   999999999999987665   999999999766543


Q ss_pred             C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .   ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ...............  .   ..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~--~---~~  230 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDYP--S---PE  230 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--T---TT
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhccccCC--c---hh
Confidence            3   34578899999999999999999999999999999999999975432      111222221111100  0   00


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   .....+.+++.+|++.||++|||++|++++
T Consensus       231 ~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          231 WD---TVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TT---TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hc---ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11   122356678889999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.6e-38  Score=316.26  Aligned_cols=240  Identities=21%  Similarity=0.325  Sum_probs=194.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|.... +..||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE   92 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence            5789999999999999764 5689999987653 3467899999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~--  495 (635)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++......  
T Consensus        93 L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           93 LFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             HHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            99988643     24899999999999999999999998   9999999999999   78899999999999765433  


Q ss_pred             -CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          496 -ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                       ....+++.|+|||++.+. ++.++||||||+++|||++|+.||......      .....+.......  ....   ..
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~--~~~~---~~  232 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF--PEKD---WL  232 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC--CHHH---HT
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC--Cchh---hh
Confidence             234578899999998764 899999999999999999999999754321      1111211111100  0000   00


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                         .....+.+++.+|++.||++|||+.|+++
T Consensus       233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 ---NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               12345677888999999999999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=329.72  Aligned_cols=232  Identities=22%  Similarity=0.314  Sum_probs=192.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||+||+|... +++.||||++.....         ....+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEE
Confidence            578999999999999964 578899999976532         234577899999999 999999999999999999999


Q ss_pred             EEeccCC-ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          413 YDYFASG-SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       413 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      |||+.+| +|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       108 ~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            9999777 999999743     24899999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCC---CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          492 MNVPA---TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       492 ~~~~~---~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .....   ...+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.......                     .
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------------~  238 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------------E  238 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------------T
T ss_pred             CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------------h
Confidence            65433   2347899999999988876 789999999999999999999997422100                     0


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........   ....+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 AAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000111   12346778889999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-38  Score=330.12  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=193.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc------CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||+||+|... ++..||+|++....      ...+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus        31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~  109 (345)
T 3hko_A           31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMEL  109 (345)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeC
Confidence            578999999999999975 57789999987542      2246788999999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006677          416 FASGSLSTLLHGNRGA-----------------------------------GRTPLDWETRVKILLGTARGVAHIHSMGG  460 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  460 (635)
                      +++|+|.+++......                                   ....+++..+..++.||+.||+|||+.+ 
T Consensus       110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-  188 (345)
T 3hko_A          110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-  188 (345)
T ss_dssp             CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence            9999999998521100                                   0112467788899999999999999998 


Q ss_pred             CCceecCCCCCCeEEcCCC--CeEEeecCCCCCCCC--------CCCCCCCCcccCcccccC--CCCCCccchhhHHHHH
Q 006677          461 PKFTHGNIKASNVLINQDL--DGCISDFGLTPLMNV--------PATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLL  528 (635)
Q Consensus       461 ~~ivH~Dlk~~NIll~~~~--~~ki~DfGla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl  528 (635)
                        |+||||||+||+++.++  .+||+|||++.....        .....+++.|+|||++.+  ..++.++|||||||++
T Consensus       189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il  266 (345)
T 3hko_A          189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL  266 (345)
T ss_dssp             --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred             --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence              99999999999998776  899999999975422        123457889999999975  6789999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--
Q 006677          529 LEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--  606 (635)
Q Consensus       529 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--  606 (635)
                      |||++|+.||......      ..............  .      +........+.+++.+||+.+|++||++.|+++  
T Consensus       267 ~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          267 HLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--N------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--S------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred             HHHHHCCCCCCCCChH------HHHHHHHhcccccC--C------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence            9999999999754321      11222222111100  0      001112345677888999999999999999998  


Q ss_pred             HHHHh
Q 006677          607 MIEEV  611 (635)
Q Consensus       607 ~L~~~  611 (635)
                      .++++
T Consensus       333 ~~~~~  337 (345)
T 3hko_A          333 WISQF  337 (345)
T ss_dssp             HHHTT
T ss_pred             hhccC
Confidence            44443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-38  Score=344.43  Aligned_cols=237  Identities=20%  Similarity=0.266  Sum_probs=187.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||+|... +++.||+|+++...    .....+.+|+.+++++ +||||+++++++...+..++||||++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~  231 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYAN  231 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence            578999999999999965 57899999997542    1234567788888888 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-  495 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       232 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          232 GGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             SCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999643     248999999999999999999998 77   999999999999999999999999999764322 


Q ss_pred             ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                         ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+......         .
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~  368 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR---------F  368 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------C
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC---------C
Confidence               234588999999999999999999999999999999999999975432      1222222221110         0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR  606 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  606 (635)
                      .   ......+.+++.+||+.||++||     +++|+++
T Consensus       369 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          369 P---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             C---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            0   11223566788899999999999     9999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-38  Score=342.94  Aligned_cols=193  Identities=23%  Similarity=0.319  Sum_probs=168.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhc-----CCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVG-----QHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .++||+|+||+||+|.... ++.||||++.........+.+|++++..+.     +|+||+++++++...+..++||||+
T Consensus       102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  181 (429)
T 3kvw_A          102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL  181 (429)
T ss_dssp             EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence            4689999999999998654 788999999765444567788888888774     5779999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC--eEEeecCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD--GCISDFGLTPLMNV  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~DfGla~~~~~  494 (635)
                      . ++|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||++.....
T Consensus       182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            6 59999987543   234899999999999999999999998   999999999999999987  99999999976544


Q ss_pred             C-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          495 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       495 ~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      . ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            3 34568899999999999999999999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=333.27  Aligned_cols=244  Identities=21%  Similarity=0.341  Sum_probs=195.0

Q ss_pred             hccccccCceEEEEEEe----cCCCeEEEEEeeccc-----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||+||+|+.    .+++.||||+++...     ...+.+.+|++++.++.+||||+++++++...+..++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            57899999999999997    368899999987532     234667789999999977999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999743     24899999999999999999999998   9999999999999999999999999987653


Q ss_pred             CC-----CCCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VP-----ATPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~-----~~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..     ....+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.......  ..............     
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~-----  283 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP-----  283 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCCC-----
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccCC-----
Confidence            22     12357899999999985  347899999999999999999999997544322  22222222221110     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRMI  608 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  608 (635)
                             .........+.+++.+||+.||++||     +++|++++.
T Consensus       284 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   00111223566788899999999999     999998854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.6e-38  Score=319.99  Aligned_cols=241  Identities=21%  Similarity=0.347  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.||+|++.....   ....+.+|+..+.++.+||||+++++++.+++..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            578999999999999976 688999999986532   2456778888888887899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-------------------CC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-------------------DL  479 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------------------~~  479 (635)
                      |+|.+++..... ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.                   ..
T Consensus        96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred             CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            999999975321 1134899999999999999999999998   999999999999984                   44


Q ss_pred             CeEEeecCCCCCCCCCCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006677          480 DGCISDFGLTPLMNVPATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR  558 (635)
Q Consensus       480 ~~ki~DfGla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  558 (635)
                      .+||+|||.+..........+++.|+|||++.+. .++.++|||||||++|||++|..|+....        .+ ..+. 
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~-~~~~-  241 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------QW-HEIR-  241 (289)
T ss_dssp             CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------HH-HHHH-
T ss_pred             EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------HH-HHHH-
Confidence            7999999999888777777789999999999776 56689999999999999999998764321        11 1111 


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......       ..   .....+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~-------~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          242 QGRLPRI-------PQ---VLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             TTCCCCC-------SS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cCCCCCC-------Cc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111000       01   122356778889999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-39  Score=341.80  Aligned_cols=247  Identities=13%  Similarity=0.032  Sum_probs=177.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhc-CCCceecee-------EEEEeC---
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG-QHPNVVPLR-------AYYYSK---  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-~h~niv~l~-------~~~~~~---  406 (635)
                      .+.||+|+||+||+|... +++.||+|++.....    ..+.+.+|++++..+. +||||++++       +++...   
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence            468999999999999965 678899999987543    2345677877677664 499987754       455433   


Q ss_pred             --------------CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCceec
Q 006677          407 --------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETR------VKILLGTARGVAHIHSMGGPKFTHG  466 (635)
Q Consensus       407 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ivH~  466 (635)
                                    ...++||||++ |+|.+++.....    .+.+..+      ..++.||+.||+|||+++   |+||
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr  218 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG  218 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence                          23799999999 899999975321    2444555      778899999999999998   9999


Q ss_pred             CCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 006677          467 NIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR  543 (635)
Q Consensus       467 Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~  543 (635)
                      ||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            999999999999999999999998765544 4456789999999987  6799999999999999999999999987643


Q ss_pred             CCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          544 DDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .......        ............ ..+........+.+++.+||+.||++|||+.|+++
T Consensus       299 ~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          299 GIKGSWK--------RPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TCTTCCC--------BCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccccchh--------hhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3211100        000000000000 01111122345677788999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-38  Score=335.21  Aligned_cols=235  Identities=21%  Similarity=0.278  Sum_probs=182.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|+... +..||+|++++....    ...+.+|..++.+..+||||+++++++.+.+..|+||||++
T Consensus        43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  122 (373)
T 2r5t_A           43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN  122 (373)
T ss_dssp             EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence            4689999999999999764 678999999765432    23445555553333389999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....   
T Consensus       123 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          123 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            99999999743     24889999999999999999999998   99999999999999999999999999975322   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.      ......+......         ..
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~~  259 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPLQ---------LK  259 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCCC---------CC
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcccC---------CC
Confidence             2244689999999999999999999999999999999999999975432      2222222222110         01


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDE  603 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  603 (635)
                      ...   ...+.+++.+|++.||++||++.+
T Consensus       260 ~~~---~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          260 PNI---TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             SSS---CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCC---CHHHHHHHHHHcccCHHhCCCCCC
Confidence            112   234567778999999999999853

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.2e-38  Score=342.15  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=186.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||+||+|... +++.||||++......   .+.+.+|+.+++.+ +||||+++++++...      ...|+|
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEE
Confidence            468999999999999865 4788999999765332   45678899999999 999999999999654      356999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++ +|.+.+..       .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            999976 56666642       2889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH---------------
Q 006677          493 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ---------------  554 (635)
Q Consensus       493 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~---------------  554 (635)
                      ...   ....+|+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+.  +.....               
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHHHcch
Confidence            543   234689999999999999999999999999999999999999986432111  000000               


Q ss_pred             ---HHhhhccc-ccc-chhhhh----c--ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          555 ---SVVREEWT-AEV-FDVELM----R--FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       555 ---~~~~~~~~-~~~-~d~~~~----~--~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ........ ... +.....    .  ..........+.+++.+||+.||++|||++|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000000 000 000000    0  00011224567889999999999999999999984

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.6e-40  Score=346.76  Aligned_cols=243  Identities=13%  Similarity=0.167  Sum_probs=185.2

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC----ChHHHHHHHHHHHhhc--CCCceecee-------EEEEeCCe
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVG--QHPNVVPLR-------AYYYSKDE  408 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~-------~~~~~~~~  408 (635)
                      .+.||+|+||+||+|.. .+++.||||++.....    ..+.+.+|++++..+.  +||||++++       +++...+.
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            46899999999999996 4589999999974421    2467889995554443  799999998       77665532


Q ss_pred             -----------------eEEEEEeccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006677          409 -----------------KLLVYDYFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIK  469 (635)
Q Consensus       409 -----------------~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  469 (635)
                                       .++||||+ +|+|.+++......  ....+++..+..++.||+.||+|||+.+   |+|||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik  233 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR  233 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence                             78999999 68999999753211  1123556888899999999999999998   9999999


Q ss_pred             CCCeEEcCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCCC
Q 006677          470 ASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVIETR-----------KHSHKSDVYSFGVLLLEMLTGKAP  537 (635)
Q Consensus       470 ~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~~~~y~aPE~~~~~-----------~~~~k~Dvws~Gvvl~el~tg~~p  537 (635)
                      |+|||++.++.+||+|||+++...... ...+ +.|+|||++.+.           .++.++|||||||++|||++|+.|
T Consensus       234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P  312 (377)
T 3byv_A          234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP  312 (377)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred             HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence            999999999999999999998654432 3345 899999999887           899999999999999999999999


Q ss_pred             CCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 006677          538 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR  612 (635)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~  612 (635)
                      |......+....               +    .......   ...+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       313 f~~~~~~~~~~~---------------~----~~~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          313 ITKDAALGGSEW---------------I----FRSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             C------CCSGG---------------G----GSSCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             Ccccccccchhh---------------h----hhhccCC---CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            976543332110               0    0001111   235667888999999999999999997  455544

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=336.25  Aligned_cols=203  Identities=23%  Similarity=0.414  Sum_probs=156.4

Q ss_pred             hHHHHHHhhccccccCceEEEEEEec---CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe--CCee
Q 006677          335 LEDLLRASAEVLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEK  409 (635)
Q Consensus       335 ~~~l~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~  409 (635)
                      +.+.....+++||+|+||+||+|...   ++..||+|++..... ...+.+|++++.++ +||||+++++++..  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeE
Confidence            33333333568999999999999965   467899999975433 45788999999999 89999999999965  5678


Q ss_pred             EEEEEeccCCChhhhccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE----cCCCCe
Q 006677          410 LLVYDYFASGSLSTLLHGNR----GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI----NQDLDG  481 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~  481 (635)
                      ++||||+.+ +|.+++....    ......+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999975 8888775322    111234899999999999999999999998   9999999999999    778999


Q ss_pred             EEeecCCCCCCCCC-------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 006677          482 CISDFGLTPLMNVP-------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTR  543 (635)
Q Consensus       482 ki~DfGla~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~  543 (635)
                      ||+|||+++.....       ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            99999999876432       234578899999999874 589999999999999999999999976543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.5e-38  Score=334.93  Aligned_cols=242  Identities=21%  Similarity=0.335  Sum_probs=184.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||+||+|... +++.||+|++.....         ....+.+|+++++++ +||||+++++++. .+..++|
T Consensus       140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv  217 (419)
T 3i6u_A          140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIV  217 (419)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEE
T ss_pred             EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEE
Confidence            578999999999999965 478999999975421         123578999999999 9999999999975 4568999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEeecCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~DfGla  489 (635)
                      |||+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||++
T Consensus       218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccc
Confidence            9999999999998743     34899999999999999999999998   99999999999997544   5999999999


Q ss_pred             CCCCCCC---CCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          490 PLMNVPA---TPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       490 ~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      +......   ...+|+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  .+....    ......
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i----~~~~~~  363 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYN  363 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH----HTTCCC
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH----hcCCCC
Confidence            8765432   3457899999999853   567889999999999999999999997543222  111111    111000


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       .....   .   ......+.+++.+||+.||++|||++|++++
T Consensus       364 -~~~~~---~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          364 -FIPEV---W---AEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -CCHHH---H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCchh---h---cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00000   0   1123456778889999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-38  Score=328.68  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=201.0

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...      .++.||+|++.....  ....+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  108 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME  108 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEE
Confidence            578999999999999864      367899999975433  234688899999999 89999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla  489 (635)
                      |+++|+|.+++.....     .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~  185 (322)
T 1p4o_A          109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT  185 (322)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccc
Confidence            9999999999975321     11234789999999999999999999998   999999999999999999999999998


Q ss_pred             CCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      .......      ...+++.|+|||++.+..++.++||||||+++|||++ |..||.....      .............
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~  259 (322)
T 1p4o_A          186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGLL  259 (322)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHHTTCCC
T ss_pred             cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHHHHHHHcCCcC
Confidence            7653321      2234678999999998899999999999999999999 8999975432      1122222211110


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .           ........+.+++.+||+.||++|||+.|++++|+++....
T Consensus       260 ~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          260 D-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             C-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            0           01122345677888999999999999999999999886543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8e-38  Score=324.75  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|.... ++.||+|++......   .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCc
Confidence            4689999999999999764 788999998765443   34577899999999 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus       109 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          109 TILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             chHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            9998887532     24899999999999999999999998   999999999999999999999999999765432   


Q ss_pred             -CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH----------HHhh-hccc
Q 006677          496 -ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ----------SVVR-EEWT  562 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~----------~~~~-~~~~  562 (635)
                       ....+++.|+|||++.+. .++.++|||||||++|||++|+.||......+.  +.....          .... ....
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcccc
Confidence             234578899999999875 689999999999999999999999976432211  000000          0000 0000


Q ss_pred             cccchhhhhcccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 AEVFDVELMRFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ~~~~d~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....+.......    .......+.+++.+||+.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000000    01123467788889999999999999999873

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.6e-38  Score=325.10  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|.. .+++.||+|+++..  ..+.+.+|++++.++.+||||+++++++..  ....++||||++++
T Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~  118 (330)
T 3nsz_A           41 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  118 (330)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence            46899999999999986 46789999998743  367899999999999669999999999988  56789999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~~--  496 (635)
                      +|.+++..        +++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++......  
T Consensus       119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence            99999852        889999999999999999999998   99999999999999777 89999999997654332  


Q ss_pred             -CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc-------ch
Q 006677          497 -TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV-------FD  567 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~d  567 (635)
                       ...++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+...... .......+.       .+
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~-~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKV-LGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHH-HCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHh-cCCchhhhHHHHhccccc
Confidence             3457888999999977 67899999999999999999999999643211 0011111100 000000000       00


Q ss_pred             hh---------------hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VE---------------LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~---------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      +.               .............+.+++.+||+.||++|||++|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00               00000111123567788889999999999999999873

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-37  Score=316.04  Aligned_cols=238  Identities=22%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... ++..||+|++....    .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   97 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAP   97 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence            568999999999999976 46789999986542    2346788999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        98 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           98 RGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            99999999743     24899999999999999999999998   999999999999999999999999998655432  


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+++.|+|||++.+..++.++||||||+++|||++|..||.....      ......+......         ... 
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~---------~~~-  233 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDLK---------FPP-  233 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC---------CCT-
T ss_pred             ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhccccC---------CCC-
Confidence            234578899999999999999999999999999999999999975431      1111222111110         001 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .....+.+++.+|++.||++||+++|++++
T Consensus       234 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          234 --FLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence              122356678889999999999999999983

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-37  Score=314.66  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=191.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|... ++..||+|++......   .+.+.+|++++.++ +||||+++++++..    ....++|||
T Consensus        31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEE
Confidence            457999999999999975 4678999998765443   35688899999999 99999999999876    345789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMN  493 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla~~~~  493 (635)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ +++.+||+|||++....
T Consensus       110 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          110 LMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             ecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999743     34899999999999999999999975 4599999999999998 78999999999997654


Q ss_pred             CCC--CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          494 VPA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       494 ~~~--~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      ...  ...+++.|+|||++.+ .++.++||||||+++|||++|+.||....     ........... ......++.   
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~-~~~~~~~~~---  253 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTS-GVKPASFDK---  253 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTT-TCCCGGGGG---
T ss_pred             ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhc-cCCccccCC---
Confidence            432  3457889999998874 58999999999999999999999997532     11122222111 111111110   


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            .....+.+++.+||+.||++|||++|++++
T Consensus       254 ------~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          254 ------VAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ------CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                  111356788889999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-37  Score=326.31  Aligned_cols=243  Identities=19%  Similarity=0.362  Sum_probs=194.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||.||+|... +|+.||||++......         .+.+.+|+.++.++.+||||+++++++......++|
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            378999999999999985 6899999998754321         345778999999987899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       179 ~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             ECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            9999999999999742     34899999999999999999999998   999999999999999999999999998766


Q ss_pred             CCC---CCCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          493 NVP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       493 ~~~---~~~~~~~~y~aPE~~~~------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      ...   ....+|+.|+|||++.+      ..++.++|||||||++|||++|..||.....      ......+.......
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIMEGQYQF  324 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC
Confidence            433   23457899999999863      3588999999999999999999999975321      11111111111110


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..+.   ..   .....+.+++.+|++.||++|||+.|++++
T Consensus       325 --~~~~---~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          325 --SSPE---WD---DRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             --CHHH---HS---SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCcc---cc---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0000   01   112356778889999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=327.87  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=198.1

Q ss_pred             hccccccCceEEEEEEe-----cCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC--eeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL-----EESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD--EKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e  414 (635)
                      .+.||+|+||.||+|.+     .+++.||+|++..... ..+.+.+|++++.++ +||||+++++++...+  ..++|||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e  124 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME  124 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEEC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEE
Confidence            57899999999999984     3578899999876432 245788999999999 8999999999987654  6799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999997543    34899999999999999999999998   99999999999999999999999999976643


Q ss_pred             CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------CCCCC-hhHHHHHHhh
Q 006677          495 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTR--------DDMVD-LPRWVQSVVR  558 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~--------~~~~~-~~~~~~~~~~  558 (635)
                      ..       ...++..|+|||.+.+..++.++||||||+++|||+||..||.....        ..... ........+.
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            32       22356679999999988899999999999999999999999863210        00000 0000111111


Q ss_pred             hccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       559 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ...          ..+........+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus       278 ~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          278 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            110          0111122334677888899999999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=334.43  Aligned_cols=251  Identities=20%  Similarity=0.337  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||||++......   .+.+.+|+++++++ +||||+++++++...+      ..++|
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv  108 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV  108 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEE
Confidence            467999999999999974 5889999999654333   35678899999999 8999999999997653      45999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+ +++|.+++..      ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          109 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            9999 7899999874      23899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------cccc
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE------WTAE  564 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~  564 (635)
                      .... ...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..      .....+....      ....
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHT
T ss_pred             ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHH
Confidence            5433 3467889999999877 67999999999999999999999999864321      1111111100      0000


Q ss_pred             c---------------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          565 V---------------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       565 ~---------------~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      +               ....+.  .........+.+++.+|++.||++|||++|++++  ++.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0               000000  0001123456778889999999999999999983  55443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.2e-38  Score=329.65  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=190.9

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeC--------CeeE
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--------DEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~  410 (635)
                      .+.||+|+||+||+|.. .+++.||+|++.....   ....+.+|++++.++ +||||+++++++...        +..+
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~  100 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY  100 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEE
Confidence            46899999999999997 4688999999865432   245788999999999 899999999999874        4689


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||+++ +|.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A          101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            99999985 7777776432    34899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCC--------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---
Q 006677          491 LMNVP--------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---  558 (635)
Q Consensus       491 ~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  558 (635)
                      .....        ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.   ...+.....   
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~  249 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSIT  249 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            65321        22346888999999876 4589999999999999999999999986432211   111111111   


Q ss_pred             hccccccchhhh--------hcccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVFDVEL--------MRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~d~~~--------~~~~~~~~~------~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ............        .........      ...+.+++.+|++.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000000000000        000111111      2347788999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.4e-38  Score=327.96  Aligned_cols=254  Identities=19%  Similarity=0.295  Sum_probs=196.5

Q ss_pred             hccccccCceEEEEEEe--cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC------ceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVL--EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP------NVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~------niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|..  .+++.||+|+++......+.+.+|++++..+ +|+      +++++++++...+..++|||
T Consensus        19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   97 (339)
T 1z57_A           19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHGHICIVFE   97 (339)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCCcEEEEEc
Confidence            46799999999999986  3578899999976544456788899998888 444      59999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-----------------
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----------------  477 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----------------  477 (635)
                      |+ +++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.                 
T Consensus        98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99 889999997543   235899999999999999999999998   999999999999987                 


Q ss_pred             --CCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          478 --DLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       478 --~~~~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                        ++.+||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|..||...+..+..   ....
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~  247 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL---AMME  247 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH---HHHH
T ss_pred             ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH
Confidence              678999999999765543 3446789999999999999999999999999999999999999864422211   1111


Q ss_pred             HHhhhc---c-----ccccc---------------------hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006677          555 SVVREE---W-----TAEVF---------------------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV  605 (635)
Q Consensus       555 ~~~~~~---~-----~~~~~---------------------d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl  605 (635)
                      ......   +     ....+                     ................+.+++.+||+.||++|||++|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence            111000   0     00000                     000000111234456788999999999999999999998


Q ss_pred             HH
Q 006677          606 RM  607 (635)
Q Consensus       606 ~~  607 (635)
                      ++
T Consensus       328 ~h  329 (339)
T 1z57_A          328 KH  329 (339)
T ss_dssp             TS
T ss_pred             cC
Confidence            74

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-37  Score=338.80  Aligned_cols=241  Identities=21%  Similarity=0.335  Sum_probs=195.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecc---cCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEV---VVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .++||+|+||+||+|... +++.||||++...   ......+.+|+++++++ +||||+++++++......++||||+++
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  105 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG  105 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence            578999999999999975 5789999998654   23467789999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc---CCCCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~DfGla~~~~~~  495 (635)
                      |+|.+.+...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++   .++.+||+|||+++.....
T Consensus       106 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999988643     24899999999999999999999998   99999999999995   4567999999999866543


Q ss_pred             C---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 A---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .   ...+|+.|+|||++.+ .++.++||||+||++|||++|+.||.+...      ......+....+....     ..
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~-----~~  245 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFDL-----PQ  245 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCS-----GG
T ss_pred             CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCC-----cc
Confidence            2   3458899999999976 589999999999999999999999975432      1222222222211110     01


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   .....+.+++.+||+.||++|||+.|++++
T Consensus       246 ~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GG---GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             cC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11   122356678889999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=322.23  Aligned_cols=243  Identities=23%  Similarity=0.385  Sum_probs=191.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe------CCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.||+|++.........+.+|+.++.++.+||||+++++++..      .+..++||||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~  108 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF  108 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence            468999999999999974 688999999987666678899999999999789999999999987      4678999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  182 (326)
T ss_dssp             CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred             CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence            99999999997543   235899999999999999999999998   999999999999999999999999998765432


Q ss_pred             ----CCCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 ----ATPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                          ....+++.|+|||++.     +..++.++|||||||++|||++|..||......      .......... .....
T Consensus       183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~  255 (326)
T 2x7f_A          183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRNP-APRLK  255 (326)
T ss_dssp             --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCS
T ss_pred             ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCc-cccCC
Confidence                2345788999999987     567899999999999999999999999753311      1111111111 10000


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                            ...   ....+.+++.+||..||++||+++|++++
T Consensus       256 ------~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          256 ------SKK---WSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------CSC---SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------ccc---cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  011   12356778889999999999999999883

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-37  Score=318.45  Aligned_cols=242  Identities=20%  Similarity=0.332  Sum_probs=194.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||++... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE   92 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence            578999999999999975 588999999976532 345688999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCCCC-
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++....... 
T Consensus        93 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  164 (304)
T 2jam_A           93 LFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM  164 (304)
T ss_dssp             HHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence            99998643     24899999999999999999999998   9999999999999   788999999999987654332 


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+.......   ..     ..
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~---~~-----~~  230 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEGYYEF---ES-----PF  230 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHCCCCC---CT-----TT
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC---Cc-----cc
Confidence             12378899999999999999999999999999999999999975432      11122222111100   00     00


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......+.+++.+|++.||++|||++|++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            01123456778889999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-37  Score=327.96  Aligned_cols=258  Identities=19%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhc----------CCCceeceeEEEEeCC----
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSKD----  407 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~~----  407 (635)
                      .+.||+|+||+||+|.. .+++.||||++.......+.+.+|++++.++.          .|+||+++++++...+    
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  103 (373)
T 1q8y_A           24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV  103 (373)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence            46899999999999996 45788999999765445667888999988873          2899999999998654    


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEc------CCCC
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLIN------QDLD  480 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~------~~~~  480 (635)
                      ..++||||+ +++|.+++.....   ..+++..+..++.||+.||+|||++ +   |+||||||+|||++      ..+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A          104 HVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence            678999999 8899999975432   3489999999999999999999998 8   99999999999994      4457


Q ss_pred             eEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006677          481 GCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE  559 (635)
Q Consensus       481 ~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  559 (635)
                      +||+|||++...... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.................+...
T Consensus       177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (373)
T 1q8y_A          177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  256 (373)
T ss_dssp             EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence            999999999766543 3446789999999999999999999999999999999999999865433322211111111110


Q ss_pred             --cc----------c----------ccc--------chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          560 --EW----------T----------AEV--------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       560 --~~----------~----------~~~--------~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ..          .          ..+        .+...............+.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence              00          0          000        000001112334566788899999999999999999999983

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.9e-38  Score=329.69  Aligned_cols=191  Identities=21%  Similarity=0.373  Sum_probs=167.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... ++..||+|++.....  ..+.+.+|++++.++ +||||+++++++..++..++||||+++|
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~  116 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG  116 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence            467999999999999976 578899999876532  245688999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC--CC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PA  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~--~~  496 (635)
                      +|.+++...     ..+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||++.....  ..
T Consensus       117 ~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  188 (360)
T 3eqc_A          117 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  188 (360)
T ss_dssp             BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence            999999743     2489999999999999999999996 7   99999999999999999999999999864422  23


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3468899999999999999999999999999999999999997543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-38  Score=323.41  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEecC--CC--eEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE--ST--TVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|.+..  ++  .||+|+++....    ..+.+.+|++++.++ +||||+++++++.... .++|+|
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e  100 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTE  100 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEE
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEe
Confidence            4689999999999998642  33  589999875432    245788999999999 8999999999987654 889999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A          101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999997532    34899999999999999999999998   99999999999999999999999999876643


Q ss_pred             CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          495 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..       ...++..|+|||++.+..++.++||||||+++|||++ |..||.....      ......+.......   
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~---  244 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL---  244 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC---
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC---
Confidence            22       2235667999999998889999999999999999999 9999975432      12222222211110   


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                             .........+.+++.+||+.+|++|||+.|++++|+++......
T Consensus       245 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          245 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             -------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence                   01112234577888899999999999999999999998865543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=320.77  Aligned_cols=240  Identities=25%  Similarity=0.402  Sum_probs=191.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV  111 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence            468999999999999976 48899999997643 456789999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----CC
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----AT  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~~  497 (635)
                      .+++...    ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......    ..
T Consensus       112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence            9998632    234899999999999999999999998   999999999999999999999999998665432    23


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ........ .......        ....
T Consensus       185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~--------~~~~  249 (314)
T 3com_A          185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIP-TNPPPTF--------RKPE  249 (314)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCCCCC--------SSGG
T ss_pred             cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHh-cCCCccc--------CCcc
Confidence            4578889999999999999999999999999999999999975321      11111111 1110000        0111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            12345678888999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-38  Score=339.74  Aligned_cols=181  Identities=28%  Similarity=0.440  Sum_probs=146.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~  413 (635)
                      .++||+|+||+||+|... +++.||||++......   .+.+.+|++++.++ +||||+++++++...     ...|+||
T Consensus        58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEE
Confidence            468999999999999865 5789999999765333   35688999999999 999999999998543     4689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+ +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       137 e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          137 EIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             ecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            998 46999998742     34999999999999999999999998   9999999999999999999999999998754


Q ss_pred             CC-------------------------------CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHh
Q 006677          494 VP-------------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLT  533 (635)
Q Consensus       494 ~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~k~Dvws~Gvvl~el~t  533 (635)
                      ..                               ....+|+.|+|||++ ....++.++|||||||++|||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            22                               123468889999986 56679999999999999999999

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.2e-38  Score=318.56  Aligned_cols=238  Identities=21%  Similarity=0.348  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|...+ ++.||+|++.....    ..+.+.+|+.+++++ +||||+++++++...+..++||||++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCC
Confidence            4689999999999999764 67899999876532    245678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus        99 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           99 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999988642     24899999999999999999999998   999999999999999999999999998765422  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||.+.+..++.++||||||+++|||++|+.||.....      .............         ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---------~~  235 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEYS---------IP  235 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC---------CC
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhccCC---------Cc
Confidence              234578899999999998999999999999999999999999975431      1111111111110         00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ......+.+++.+||+.||++|||++|++++
T Consensus       236 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          236 ---KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1112356678889999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7e-38  Score=354.02  Aligned_cols=238  Identities=24%  Similarity=0.307  Sum_probs=195.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||+|... +++.||||+++...    ...+.+..|..++..+.+||||+.+++++.+.+..|+||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            468999999999999976 46789999997542    2345677888899888789999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC---
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV---  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~---  494 (635)
                      +|+|.++++..     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   
T Consensus       426 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          426 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            99999999753     24899999999999999999999998   99999999999999999999999999975322   


Q ss_pred             -CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          495 -PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                       .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.      ......+......         ..
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p  562 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA---------YP  562 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCCC---------CC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---------CC
Confidence             2245689999999999999999999999999999999999999986432      2223333322111         01


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNM-----DEVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~  606 (635)
                         .....++.+++.+||+.||++||++     +||++
T Consensus       563 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          563 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               1122356677789999999999998     67765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.3e-38  Score=325.53  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|...      ++..||||++.....  ...++.+|+.++.++ +||||+++++++...+..++|||
T Consensus        35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  113 (327)
T 2yfx_A           35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILME  113 (327)
T ss_dssp             EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEe
Confidence            468999999999999842      467899999965432  245688899999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCC
Q 006677          415 YFASGSLSTLLHGNRGA--GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLT  489 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla  489 (635)
                      |+++|+|.+++......  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.   +..+||+|||++
T Consensus       114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~  190 (327)
T 2yfx_A          114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA  190 (327)
T ss_dssp             CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccc
Confidence            99999999999765321  1245899999999999999999999998   999999999999984   456999999988


Q ss_pred             CCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          490 PLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       490 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ......      ....+++.|+|||++.+..++.++||||||+++|||+| |..||......      .....+......
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~  264 (327)
T 2yfx_A          191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRM  264 (327)
T ss_dssp             HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCC
T ss_pred             cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHhcCCCC
Confidence            643221      22345778999999998899999999999999999998 99999754311      111111111110


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                       .          ........+.+++.+||+.||++||++.|++++|+.+....
T Consensus       265 -~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          265 -D----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -C----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence             0          00112245677888999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2e-37  Score=317.48  Aligned_cols=240  Identities=24%  Similarity=0.374  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~  105 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG  105 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence            467999999999999864 57889999997653  2357789999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    
T Consensus       106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          106 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            99999963      24899999999999999999999998   999999999999999999999999998765432    


Q ss_pred             CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          496 ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                      ....+++.|+|||++.+..++.++||||||+++|||++|+.||......      ..... ........ .      .. 
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~-~------~~-  241 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFL-IPKNNPPT-L------EG-  241 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCC-C------CS-
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHH-hhcCCCCC-C------cc-
Confidence            2345788899999999999999999999999999999999999754211      11111 11111100 0      01 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE  609 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  609 (635)
                        .....+.+++.+||+.||++|||+.|++++..
T Consensus       242 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          242 --NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             --SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             --ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence              11234677888999999999999999998643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=325.15  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=191.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.||+|++......      .+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~   93 (346)
T 1ua2_A           15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF   93 (346)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEc
Confidence            568999999999999975 4789999998754221      24678899999999 899999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++ +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            986 8988886432    34888999999999999999999998   999999999999999999999999999876432


Q ss_pred             C----CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------hcccc
Q 006677          496 A----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------EEWTA  563 (635)
Q Consensus       496 ~----~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~  563 (635)
                      .    ...+|+.|+|||++.+. .++.++|||||||++|||++|..||.+....      .....+..       +.|..
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~------~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL------DQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCTTTSSS
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHcCCCChhhhhh
Confidence            2    34578899999999754 5889999999999999999999999754321      11111111       01110


Q ss_pred             ccchhhh---hcccC------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 EVFDVEL---MRFQN------IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ~~~d~~~---~~~~~------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .......   ...+.      .......+.+++.+|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000000   00000      01122467788889999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.5e-38  Score=319.14  Aligned_cols=243  Identities=24%  Similarity=0.300  Sum_probs=191.9

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++..+ +||||+++++++...+..++||||+++++|
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence            47999999999999964 578899999876533 356788999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCCCCCC----C
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~~~~~----~  496 (635)
                      .+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||++......    .
T Consensus       107 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          107 SALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             HHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             HHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            999975432  234778999999999999999999998   999999999999987 899999999999765432    2


Q ss_pred             CCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 TPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~--~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ...+++.|+|||++.+..  ++.++||||||+++|||++|+.||......+     ..............          
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~----------  246 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFKVHPE----------  246 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHCCCCC----------
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccccccc----------
Confidence            345788999999997643  7899999999999999999999996432111     00000000000000          


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........+.+++.+||+.||++||++.|++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            011123456678889999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.7e-37  Score=318.48  Aligned_cols=241  Identities=23%  Similarity=0.357  Sum_probs=187.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||||++.....         ....+.+|++++.++ +||||+++++++..++ .++|
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv   92 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIV   92 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEE
Confidence            578999999999999975 468899999865421         123588999999999 9999999999987654 8999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC---eEEeecCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~DfGla  489 (635)
                      |||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.   +||+|||++
T Consensus        93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            9999999999998643     34899999999999999999999998   999999999999987664   999999999


Q ss_pred             CCCCCCC---CCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006677          490 PLMNVPA---TPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA  563 (635)
Q Consensus       490 ~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  563 (635)
                      .......   ...+++.|+|||++.   ...++.++|||||||++|||++|..||.......  .+...+.    .....
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~  238 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SGKYN  238 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----HTCCC
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----hCccc
Confidence            8765432   224788999999973   5678999999999999999999999997544322  2211111    11000


Q ss_pred             ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       . .+..  .   ......+.+++.+||+.||++||+++|+++
T Consensus       239 -~-~~~~--~---~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          239 -F-IPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -C-CHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -c-Cchh--h---hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             0 0000  0   112345678888999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-37  Score=339.11  Aligned_cols=241  Identities=21%  Similarity=0.342  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc--------------CChHHHHHHHHHHHhhcCCCceeceeEEEEeCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--------------VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD  407 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~  407 (635)
                      .++||+|+||+||+|... +++.||+|++....              ...+.+.+|++++.++ +||||+++++++.+..
T Consensus        41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  119 (504)
T 3q5i_A           41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKK  119 (504)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCC
Confidence            468999999999999976 46889999997643              2245788999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC---CeEEe
Q 006677          408 EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL---DGCIS  484 (635)
Q Consensus       408 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~  484 (635)
                      ..++||||+++|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999998643     24899999999999999999999998   99999999999998776   69999


Q ss_pred             ecCCCCCCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          485 DFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       485 DfGla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      |||++......   ....+|+.|+|||++.+ .++.++||||+||++|+|++|..||.+....      .....+.....
T Consensus       192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~  264 (504)
T 3q5i_A          192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIKKVEKGKY  264 (504)
T ss_dssp             CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC
T ss_pred             ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCC
Confidence            99999766543   24468999999999874 6999999999999999999999999864321      22222222211


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   +  ......   ....+.+++.+|++.||.+|||++|++++
T Consensus       265 ~~---~--~~~~~~---~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          265 YF---D--FNDWKN---ISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CC---C--HHHHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CC---C--ccccCC---CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10   0  001111   12356778889999999999999999984

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.8e-38  Score=341.29  Aligned_cols=241  Identities=23%  Similarity=0.379  Sum_probs=196.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|... +++.||||++....    .....+.+|++++.++ +||||+++++++...+..++||||+.
T Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            578999999999999976 68899999997542    2456789999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE---cCCCCeEEeecCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI---NQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~DfGla~~~~~  494 (635)
                      +|+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++....
T Consensus       110 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          110 GGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             SCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            99999998743     34899999999999999999999998   9999999999999   5678999999999876654


Q ss_pred             CC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          495 PA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 ~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      ..   ...+|+.|+|||++.+ .++.++||||+||++|||++|..||......      .....+....+...     ..
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~-----~~  249 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYTFE-----LP  249 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC-----SG
T ss_pred             ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCC-----Cc
Confidence            33   2357899999999876 6999999999999999999999999864321      12222222221111     00


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...   .....+.+++.+||+.+|++|||+.|++++
T Consensus       250 ~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          250 QWK---KVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            111   122356677889999999999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-37  Score=311.20  Aligned_cols=238  Identities=21%  Similarity=0.337  Sum_probs=188.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|... +++.||+|++....    ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVS   94 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccC
Confidence            468999999999999976 68899999987542    2345788999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        95 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           95 GGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             CCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999643     24899999999999999999999998   9999999999999999999999999987765432 


Q ss_pred             --CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 --TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ...+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....      .......+......           
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-----------  229 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRGGVFY-----------  229 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC-----------
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCccc-----------
Confidence              3357888999999988765 689999999999999999999997532      11112221111100           


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ........+.+++.+|++.||++|||++|++++
T Consensus       230 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 -IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             001112356778889999999999999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.6e-37  Score=330.70  Aligned_cols=187  Identities=26%  Similarity=0.398  Sum_probs=159.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~  413 (635)
                      .+.||+|+||.||+|... +++.||||++......   .+.+.+|+++++++ +||||+++++++...     ...|+||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~  109 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVL  109 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEE
Confidence            468999999999999975 4678999999765332   45788999999999 899999999999776     5689999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||++ |+|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       110 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          110 EIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             ECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             ecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            9986 5999999743     34899999999999999999999998   9999999999999999999999999997654


Q ss_pred             CC--------------------------CCCCCCCcccCcccc-cCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 006677          494 VP--------------------------ATPSRSAGYRAPEVI-ETRKHSHKSDVYSFGVLLLEMLTGKAPLQ  539 (635)
Q Consensus       494 ~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~k~Dvws~Gvvl~el~tg~~p~~  539 (635)
                      ..                          ....+|+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            32                          234578899999986 56679999999999999999998655554

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.7e-37  Score=324.89  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC------------hHHHHHHHHHHHhhcCCCceeceeEEEEeCC---
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG------------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD---  407 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~---  407 (635)
                      .+.||+|+||.||+|...++..||||++......            .+.+.+|++++.++ +||||+++++++...+   
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTT
T ss_pred             eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccCCC
Confidence            4689999999999999888999999998654321            26788999999999 8999999999986533   


Q ss_pred             --eeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEee
Q 006677          408 --EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISD  485 (635)
Q Consensus       408 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  485 (635)
                        ..++||||++ |+|.+++...    ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence              5799999998 5888888743    235899999999999999999999998   99999999999999999999999


Q ss_pred             cCCCCCCCCCC---CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          486 FGLTPLMNVPA---TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       486 fGla~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      ||++.......   ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+      ....+.....
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~  251 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN------QLNKIVEVVG  251 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHC
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHcC
Confidence            99997544322   3357888999999877 678999999999999999999999997643211      1111111000


Q ss_pred             ccc--------------cchhhhhccc------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          562 TAE--------------VFDVELMRFQ------NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       562 ~~~--------------~~d~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...              ..........      ........+.+++.+|++.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            000              0000000000      001112457788889999999999999999983

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-37  Score=323.96  Aligned_cols=238  Identities=21%  Similarity=0.348  Sum_probs=194.9

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||++...+ ++.||+|++.....    ..+.+.+|+.+++++ +|+||+++++++.+.+..++||||++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCC
Confidence            4689999999999999764 67899999876532    245678899999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......  
T Consensus       125 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          125 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999998642     24899999999999999999999998   999999999999999999999999999765422  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+......         ..
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~---------~~  261 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEYS---------IP  261 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---------CC
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCCCC---------CC
Confidence              234578899999999998999999999999999999999999975331      1111111111110         00


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .   .....+.+++.+||+.||++|||++|++++
T Consensus       262 ~---~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          262 K---HINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             T---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             c---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1   112346678889999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-37  Score=328.86  Aligned_cols=195  Identities=22%  Similarity=0.299  Sum_probs=165.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-----ceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-----NVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|... +++.||||+++.......++..|+.++..+.+|+     +|+++++++...+..++||||+
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  138 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML  138 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence            468999999999999976 4678999999765444567778888888885566     4999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc--CCCCeEEeecCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~DfGla~~~~~  494 (635)
                      + |+|.+++....   ...+++..+..++.|++.||+|||.+. ..|+||||||+|||++  .++.+||+|||+++....
T Consensus       139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            6 59999997543   234899999999999999999999521 2399999999999995  478899999999977654


Q ss_pred             C-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          495 P-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       495 ~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      . ....+|+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus       214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            3 34567899999999999999999999999999999999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-37  Score=338.03  Aligned_cols=245  Identities=21%  Similarity=0.351  Sum_probs=192.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc---CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV---VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... ++..||+|++....   .....+.+|+++++++ +||||+++++++.+....++||||+++
T Consensus        42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~  120 (494)
T 3lij_A           42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG  120 (494)
T ss_dssp             EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            578999999999999976 57889999997653   2356788999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC---CCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~DfGla~~~~~~  495 (635)
                      |+|.+.+...     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.+   +.+||+|||++......
T Consensus       121 g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          121 GELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999988643     34899999999999999999999998   9999999999999764   55999999999765433


Q ss_pred             ---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                         ....+|+.|+|||++. ..++.++||||+||++|||++|..||.....      ......+........  .+   .
T Consensus       193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~--~~---~  260 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKYTFD--SP---E  260 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--SG---G
T ss_pred             ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCC--ch---h
Confidence               2345899999999986 4699999999999999999999999976432      122222222221110  00   1


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEV  611 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~  611 (635)
                      ...   ....+.+++.+||+.||++|||+.|++++  +.++
T Consensus       261 ~~~---~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          261 WKN---VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             GTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ccc---CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            111   22346677889999999999999999973  5544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-37  Score=316.28  Aligned_cols=241  Identities=21%  Similarity=0.330  Sum_probs=189.5

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||.||+|.... +..||+|++.... ...+.+.+|++++.++ +||||+++++++..++..++||||+++++
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (302)
T 2j7t_A           24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGA  102 (302)
T ss_dssp             EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred             cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence            4679999999999999864 7889999987553 3457889999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC----CCC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN----VPA  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~----~~~  496 (635)
                      |.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....    ...
T Consensus       103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A          103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence            999886432    34899999999999999999999998   9999999999999999999999999864321    123


Q ss_pred             CCCCCCcccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 TPSRSAGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 ~~~~~~~y~aPE~~-----~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      ...+++.|+|||++     ....++.++||||||+++|||++|+.||.....      ................      
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~------  243 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPTLL------  243 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCCCS------
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCcccC------
Confidence            34578899999998     466789999999999999999999999975431      1122222211111000      


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                         ........+.+++.+||+.||++|||+.|+++
T Consensus       244 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 ---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               01112345677888999999999999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-37  Score=315.74  Aligned_cols=244  Identities=22%  Similarity=0.320  Sum_probs=176.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|+++.....  ..+...|...+.+..+||||+++++++...+..++||||+++ 
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-   90 (290)
T 3fme_A           12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-   90 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred             HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence            468999999999999974 6788999999765332  223333444433434999999999999999999999999974 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +|.+++..... ....+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||++.......  
T Consensus        91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  166 (290)
T 3fme_A           91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK  166 (290)
T ss_dssp             EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence            88877754221 124599999999999999999999998 8   9999999999999999999999999997664432  


Q ss_pred             -CCCCCCcccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 -~~~~~~~y~aPE~~----~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       ...+++.|+|||++    .+..++.++||||||+++|||++|+.||.....     ................ .     
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~-~-----  235 (290)
T 3fme_A          167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQL-P-----  235 (290)
T ss_dssp             ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCCC-C-----
T ss_pred             cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCCc-c-----
Confidence             23578899999996    566789999999999999999999999974321     1111122221111100 0     


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                          .......+.+++.+|++.||++|||++|+++
T Consensus       236 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 ----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                0112345677888999999999999999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-37  Score=323.43  Aligned_cols=245  Identities=19%  Similarity=0.279  Sum_probs=168.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|... +++.||+|++...    ....+|+..+.+..+||||+++++++..    ....++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            457999999999999976 5889999998653    3344455554445599999999999976    445799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~  494 (635)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||++.....
T Consensus       110 gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          110 GGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             TEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999997543   235999999999999999999999998   999999999999986   45599999999976543


Q ss_pred             C--CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 P--ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 ~--~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      .  ....+++.|+|||++.+..++.++||||||+++|||++|+.||...........  ..........     ..   .
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~-----~~---~  253 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLGQY-----GF---P  253 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC---C
T ss_pred             cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcccc-----cc---C
Confidence            3  234578899999999888899999999999999999999999976543322100  0000000000     00   0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00011223456778889999999999999999983

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.3e-38  Score=324.36  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=184.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.||+|+++.....   .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCC
Confidence            468999999999999865 5788999999754332   34577899999999 999999999999999999999999985


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-----CCCCeEEeecCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-----QDLDGCISDFGLTPLMN  493 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-----~~~~~ki~DfGla~~~~  493 (635)
                       +|.+++....     .+++..+..++.||+.||+|||+.+   |+||||||+|||++     .++.+||+|||++....
T Consensus       118 -~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          118 -DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             -EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             -CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence             9999997532     4899999999999999999999998   99999999999994     45569999999986554


Q ss_pred             CC----CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------cc
Q 006677          494 VP----ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE-------EW  561 (635)
Q Consensus       494 ~~----~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~  561 (635)
                      ..    ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+      ....+...       .+
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID------QLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCCCCTTTS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH------HHHHHHHHhCCCchhhh
Confidence            22    233468899999999875 48999999999999999999999997543211      11111110       00


Q ss_pred             cccc----chhhhh--cccChHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          562 TAEV----FDVELM--RFQNIEE-----EMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       562 ~~~~----~d~~~~--~~~~~~~-----~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ....    ......  .......     ....+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000    000000  0000000     1245678888999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.8e-38  Score=315.70  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|... +++.||+|++......   .+.+.+|++++.++ +||||+++++++..  ....++||||+
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~   89 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC   89 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCC
Confidence            467999999999999975 5788999999765432   35688899999999 89999999998865  56789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      ++|+|.+++..... ....+++..+..++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~  168 (279)
T 2w5a_A           90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  168 (279)
T ss_dssp             TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred             CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence            99999999975332 2344899999999999999999999976  23499999999999999999999999999876543


Q ss_pred             CC----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          495 PA----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       495 ~~----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      ..    ...+++.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+.... ....     
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~-~~~~-----  236 (279)
T 2w5a_A          169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGK-FRRI-----  236 (279)
T ss_dssp             -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-CCCC-----
T ss_pred             ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHhhcc-cccC-----
Confidence            32    12468889999999998999999999999999999999999975431      11112211111 1100     


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                           .......+.+++.+||+.||++||++.|+++++..
T Consensus       237 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          237 -----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                 01122456778889999999999999999987653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.2e-37  Score=323.76  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=184.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||||++......   .+.+.+|+.+++.+ +||||+++++++...+      ..++|
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv  108 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV  108 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEE
Confidence            467999999999999865 5788999999765333   35678899999999 9999999999997665      67999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+++ +|.+++..       .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       109 ~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          109 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             EEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            999975 78888752       3889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----------
Q 006677          493 NVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE----------  559 (635)
Q Consensus       493 ~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  559 (635)
                      ...   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+      ....+...          
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID------QWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHC-CCCCCHHHHT
T ss_pred             ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHHH
Confidence            543   23457889999999999999999999999999999999999998643211      11111100          


Q ss_pred             ------------c--cccccchhhhhc--cc----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          560 ------------E--WTAEVFDVELMR--FQ----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       560 ------------~--~~~~~~d~~~~~--~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                                  .  +....+......  .+    ........+.+++.+|++.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                        0  000000000000  00    012234568889999999999999999999983

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-37  Score=335.13  Aligned_cols=245  Identities=23%  Similarity=0.363  Sum_probs=184.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .++||+|+||+||.+...+|+.||||++....  .+.+.+|++++.++.+||||+++++++.+++..++||||++ |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            46799999999987777779999999986532  45678899999887789999999999999999999999996 6999


Q ss_pred             hhccCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-------------CCeEEeecC
Q 006677          423 TLLHGNRGAGR--TPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-------------LDGCISDFG  487 (635)
Q Consensus       423 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~ki~DfG  487 (635)
                      +++........  ...++..+..++.||+.||+|||+.+   |+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            99975432111  11133456789999999999999998   9999999999999754             489999999


Q ss_pred             CCCCCCCCC--------CCCCCCcccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 006677          488 LTPLMNVPA--------TPSRSAGYRAPEVIET-------RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPR  551 (635)
Q Consensus       488 la~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~  551 (635)
                      +++......        ...+|+.|+|||++.+       ..++.++|||||||++|||+| |..||......+      
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------  247 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------  247 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence            998765422        2357899999999975       568999999999999999999 999997432111      


Q ss_pred             HHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          552 WVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       552 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                        ..+..........     ...........+.+++.+||+.||++|||+.|+++
T Consensus       248 --~~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 --SNIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --HHHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence              1111111110000     01112344567788889999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.3e-37  Score=312.88  Aligned_cols=242  Identities=19%  Similarity=0.354  Sum_probs=194.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      .+.||+|+||.||+|... +++.||+|++.....          ..+.+.+|++++.++.+||||+++++++...+..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            467999999999999975 578899999875431          134577899999999669999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus       102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A          102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999742     34899999999999999999999998   99999999999999999999999999876


Q ss_pred             CCCCC---CCCCCCcccCccccc------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          492 MNVPA---TPSRSAGYRAPEVIE------TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       492 ~~~~~---~~~~~~~y~aPE~~~------~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      .....   ...+++.|+|||++.      ...++.++||||||+++|||++|..||.....      ......+......
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~  247 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ  247 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCcc
Confidence            54332   345788999999985      45688999999999999999999999975431      1122222222111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..  .      +........+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~--~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          248 FG--S------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC--T------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cC--c------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00  0      001122345778888999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-37  Score=323.83  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=174.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||||++......   .+.+.+|+++++.+ +||||+++++++...      ...++|
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv  112 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV  112 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEE
Confidence            468999999999999864 5788999999764332   45678899999999 899999999998754      567999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      +||+ +++|.+++..      ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            9999 6799998863      24999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCC-CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---cccccch
Q 006677          493 NVP-ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE---WTAEVFD  567 (635)
Q Consensus       493 ~~~-~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d  567 (635)
                      ... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+   ....+.......   ....+..
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHTTCCC
T ss_pred             cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhh
Confidence            543 23467899999999877 678999999999999999999999997643211   111111111000   0000000


Q ss_pred             h-------hhhc--ccChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 V-------ELMR--FQNIE----EEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~-------~~~~--~~~~~----~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .       .+..  .....    .....+.+++.+|++.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0       0000  00000    112356788889999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-37  Score=323.26  Aligned_cols=252  Identities=16%  Similarity=0.253  Sum_probs=196.2

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCCh------------------HHHHHHHHHHHhhcCCCceeceeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGK------------------RDFEQQMEIVGRVGQHPNVVPLRAYYY  404 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~~~e~~~l~~l~~h~niv~l~~~~~  404 (635)
                      .+.||+|+||.||+|.. +++.||+|++.......                  +.+.+|++++.++ +||||+++++++.
T Consensus        36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~  113 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCCSEEEE
T ss_pred             EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence            46799999999999999 79999999997543211                  7899999999999 8999999999999


Q ss_pred             eCCeeEEEEEeccCCChhhh------ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcC
Q 006677          405 SKDEKLLVYDYFASGSLSTL------LHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQ  477 (635)
Q Consensus       405 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~  477 (635)
                      ..+..++||||+++|+|.++      +...   ....+++..+..++.|++.||+|||+ .+   |+||||||+||+++.
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK  187 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence            99999999999999999999      5432   13459999999999999999999999 87   999999999999999


Q ss_pred             CCCeEEeecCCCCCCCCC--CCCCCCCcccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 006677          478 DLDGCISDFGLTPLMNVP--ATPSRSAGYRAPEVIETR-KHSH-KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWV  553 (635)
Q Consensus       478 ~~~~ki~DfGla~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  553 (635)
                      ++.+||+|||++......  ....++..|+|||++.+. .++. ++||||||+++|||++|..||......     ....
T Consensus       188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~  262 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELF  262 (348)
T ss_dssp             TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHH
T ss_pred             CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHH
Confidence            999999999999765332  344578899999999887 5666 999999999999999999999854321     1122


Q ss_pred             HHHhhhcccccc----chhhhhc---ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          554 QSVVREEWTAEV----FDVELMR---FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       554 ~~~~~~~~~~~~----~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..+.........    +......   ..........+.+++.+||+.||++|||++|++++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            222211110000    0000000   00001223456788889999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.6e-38  Score=322.54  Aligned_cols=247  Identities=19%  Similarity=0.322  Sum_probs=189.4

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|...+  .+|+|+++....   ..+.+.+|+.++.++ +||||+++++++...+..++||||++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~  114 (319)
T 2y4i_B           38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGR  114 (319)
T ss_dssp             CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred             eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCC
Confidence            4689999999999999763  599999875432   235677899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ ++.+||+|||++......    
T Consensus       115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            9999997532    34899999999999999999999998   99999999999998 689999999998654321    


Q ss_pred             -----CCCCCCCcccCcccccC---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          496 -----ATPSRSAGYRAPEVIET---------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       496 -----~~~~~~~~y~aPE~~~~---------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                           ....+++.|+|||++.+         ..++.++||||||+++|||++|+.||......      ....... ...
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~  259 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQMG-TGM  259 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHHH-TTC
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHhc-cCC
Confidence                 12236778999999864         35788999999999999999999999754321      1111111 111


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ......      .   .....+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus       260 ~~~~~~------~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          260 KPNLSQ------I---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             CCCCCC------S---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             CCCCCc------C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            111100      0   112346678889999999999999999999999886643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-37  Score=328.39  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=188.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe------eEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv~e~~  416 (635)
                      .++||+|+||+||+|...++..||+|++....   ....+|+++++.+ +||||+++++++.....      .++||||+
T Consensus        45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~  120 (394)
T 4e7w_A           45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV  120 (394)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred             eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence            46899999999999999888889999886542   2234689999999 99999999999976543      78999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla~~~~~~  495 (635)
                      +++.+....+...  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++ .++.+||+|||+++.....
T Consensus       121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            8754433322111  1235899999999999999999999998   99999999999999 7999999999999765432


Q ss_pred             ---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH----------hhhcc
Q 006677          496 ---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV----------VREEW  561 (635)
Q Consensus       496 ---~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~  561 (635)
                         ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.  +.......          ....+
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhh
Confidence               234578889999998765 589999999999999999999999986532211  11111100          00000


Q ss_pred             ccccchhhhhcccCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhc
Q 006677          562 TAEVFDVELMRFQNI-----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ  613 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~  613 (635)
                      ....+.. . .....     ......+.+++.+||+.||++|||+.|++++  ++++..
T Consensus       274 ~~~~~~~-~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          274 MEHKFPQ-I-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             SSSCCCC-C-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhcccc-c-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            0000000 0 00000     1122467788889999999999999999984  555543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.6e-37  Score=347.16  Aligned_cols=246  Identities=22%  Similarity=0.354  Sum_probs=196.9

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|.+..    +..||+|+++....  ..+.+.+|+.++.++ +||||+++++++. ++..++||||+
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~E~~  472 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC  472 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEEEcC
Confidence            5789999999999999743    34689998865432  236788999999999 9999999999984 56789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.++++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            9999999997432    34899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             C-----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 T-----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 ~-----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      .     ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+....      .....+......        
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~~--------  611 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL--------  611 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCCC--------
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCCC--------
Confidence            1     234568999999998899999999999999999997 99999754321      112222111110        


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                         .........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence               01112234567788899999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.3e-37  Score=320.38  Aligned_cols=263  Identities=21%  Similarity=0.298  Sum_probs=182.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-------eEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-------KLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-------~~lv~e  414 (635)
                      .+.||+|+||+||+|... +++.||||++.........+.++++.+..+ +||||+++++++.....       .++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e  106 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVME  106 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEee
Confidence            467999999999999975 578999999876655556677788888888 99999999999976543       789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCceecCCCCCCeEEcC-CCCeEEeecCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH--SMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPL  491 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~Dlk~~NIll~~-~~~~ki~DfGla~~  491 (635)
                      |+++ +|.+.+..... ....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+||+|||+++.
T Consensus       107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~  181 (360)
T 3e3p_A          107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKK  181 (360)
T ss_dssp             CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred             cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence            9987 54444332111 2335889999999999999999999  877   999999999999997 89999999999987


Q ss_pred             CCCCC---CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH-----------H
Q 006677          492 MNVPA---TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQS-----------V  556 (635)
Q Consensus       492 ~~~~~---~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~  556 (635)
                      .....   ...+|+.|+|||++.+.. ++.++|||||||++|||++|+.||......+.  +....+.           .
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH
T ss_pred             cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhc
Confidence            65433   345788899999986654 89999999999999999999999986432211  1111110           0


Q ss_pred             hhhccccccchhh---h--hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhc
Q 006677          557 VREEWTAEVFDVE---L--MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQ  613 (635)
Q Consensus       557 ~~~~~~~~~~d~~---~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~  613 (635)
                      ..........+..   +  ............+.+++.+||+.||++|||+.|++++  ++++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            0000000000000   0  0000001134567888889999999999999999984  555543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.4e-38  Score=321.39  Aligned_cols=253  Identities=24%  Similarity=0.383  Sum_probs=178.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... +++.||+|++....  ...+++.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   98 (303)
T 2vwi_A           20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGG   98 (303)
T ss_dssp             EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred             hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCC
Confidence            468999999999999864 57899999986542  2345678899998888 8999999999999999999999999999


Q ss_pred             ChhhhccCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-
Q 006677          420 SLSTLLHGNR---GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       420 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-  495 (635)
                      +|.+++....   ......+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  175 (303)
T 2vwi_A           99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG  175 (303)
T ss_dssp             BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred             chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence            9999986421   112345899999999999999999999998   999999999999999999999999988654321 


Q ss_pred             --------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 --------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 --------~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                              ....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+      ........... .. 
T Consensus       176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-~~-  247 (303)
T 2vwi_A          176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQNDPP-SL-  247 (303)
T ss_dssp             ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSSCC-CT-
T ss_pred             CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccCCC-cc-
Confidence                    12357888999999875 568999999999999999999999997643221      11111111100 00 


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ................+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00000000001122356778889999999999999999873

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-37  Score=323.54  Aligned_cols=253  Identities=17%  Similarity=0.286  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEecC-C-CeEEEEEeecccCChHHHHHHHHHHHhhcCCCc------eeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE-S-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN------VVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n------iv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|.... + ..||+|+++......+.+.+|++++.++ +|++      ++.+.+++...+..++|||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~lv~e  102 (355)
T 2eu9_A           24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHGHMCIAFE  102 (355)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred             EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence            4679999999999999753 3 5899999976544456788899999988 5544      9999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE-------------------
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI-------------------  475 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll-------------------  475 (635)
                      |+ ++++.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+                   
T Consensus       103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A          103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence            99 567777765432   235899999999999999999999998   9999999999999                   


Q ss_pred             cCCCCeEEeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006677          476 NQDLDGCISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~  554 (635)
                      +.++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .....
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~  252 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---LVMME  252 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred             cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            67889999999999765443 344688999999999999999999999999999999999999986432211   11111


Q ss_pred             HHhhhc--------------------cccccchhh---------hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006677          555 SVVREE--------------------WTAEVFDVE---------LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV  605 (635)
Q Consensus       555 ~~~~~~--------------------~~~~~~d~~---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl  605 (635)
                      ......                    |.....+..         .............+.+++.+||+.||++|||++|++
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            111000                    000000000         000011123345788899999999999999999998


Q ss_pred             H
Q 006677          606 R  606 (635)
Q Consensus       606 ~  606 (635)
                      +
T Consensus       333 ~  333 (355)
T 2eu9_A          333 L  333 (355)
T ss_dssp             T
T ss_pred             c
Confidence            6

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-37  Score=325.49  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=190.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... ++..||+|++.....  ..+.+.+|++++.++ +||||+++++++...     ...++|||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e  110 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQD  110 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEc
Confidence            468999999999999965 577899999975432  235688999999999 899999999999765     36799999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+. |+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            997 5999998642      3899999999999999999999998   99999999999999999999999999976543


Q ss_pred             C-------CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---c
Q 006677          495 P-------ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---A  563 (635)
Q Consensus       495 ~-------~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  563 (635)
                      .       ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.   .............   .
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLN  257 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHH
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHH
Confidence            2       23467889999998754 4589999999999999999999999986543321   1111111100000   0


Q ss_pred             ccchh-------hhh--cccC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          564 EVFDV-------ELM--RFQN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       564 ~~~d~-------~~~--~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...+.       ...  ....    .......+.+++.+|++.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000       000  0000    01112456788889999999999999999983

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-37  Score=326.73  Aligned_cols=258  Identities=23%  Similarity=0.338  Sum_probs=189.1

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeC---------------
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK---------------  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~---------------  406 (635)
                      .+.||+|+||+||+|.. .+++.||+|++....   ....+|+++++.+ +||||+++++++...               
T Consensus        12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~   87 (383)
T 3eb0_A           12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN   87 (383)
T ss_dssp             EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence            46899999999999986 468899999986542   2334789999999 999999999998543               


Q ss_pred             -----------------------CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 006677          407 -----------------------DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF  463 (635)
Q Consensus       407 -----------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  463 (635)
                                             ...++||||++ |+|.+.+..... ....+++..+..++.||+.||+|||+.+   |
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i  162 (383)
T 3eb0_A           88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---I  162 (383)
T ss_dssp             ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred             cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence                                   23789999998 488777753221 1235999999999999999999999998   9


Q ss_pred             eecCCCCCCeEEc-CCCCeEEeecCCCCCCCCC---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCC
Q 006677          464 THGNIKASNVLIN-QDLDGCISDFGLTPLMNVP---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPL  538 (635)
Q Consensus       464 vH~Dlk~~NIll~-~~~~~ki~DfGla~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~  538 (635)
                      +||||||+||+++ .++.+||+|||+++.....   ....+++.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            9999999999998 6899999999999765433   234578889999998765 4899999999999999999999999


Q ss_pred             CCCCCCCCCChhHHHHHHhhhc-----------cccccc----hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006677          539 QSPTRDDMVDLPRWVQSVVREE-----------WTAEVF----DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDE  603 (635)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~----d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  603 (635)
                      .+....+.  +...+. .....           +....+    ...+. ..........+.+++.+||+.||++|||+.|
T Consensus       243 ~~~~~~~~--~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          243 SGETSIDQ--LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-KILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             CCSSHHHH--HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHH-HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCChHHH--HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHH-hhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            86432211  111111 00000           000000    00000 0000112345778888999999999999999


Q ss_pred             HHH--HHHHhhc
Q 006677          604 VVR--MIEEVRQ  613 (635)
Q Consensus       604 vl~--~L~~~~~  613 (635)
                      +++  .++++..
T Consensus       319 ~l~hp~f~~~~~  330 (383)
T 3eb0_A          319 AMAHPFFDHLRN  330 (383)
T ss_dssp             HHTSGGGHHHHH
T ss_pred             HhcCHHHHHHHh
Confidence            997  4666554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.5e-37  Score=318.17  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=192.3

Q ss_pred             hccccccCceEEEEEEe--cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhc--CCCceeceeEEEE-----eCCeeE
Q 006677          343 AEVLGKGSYGTAYKAVL--EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYY-----SKDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~-----~~~~~~  410 (635)
                      .+.||+|+||.||+|..  .+++.||+|++.....   ....+.+|+.+++.+.  +||||+++++++.     .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            46899999999999997  3578899999875432   2346778888877764  7999999999987     456789


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||++ |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            9999998 69999987543   234899999999999999999999998   9999999999999999999999999997


Q ss_pred             CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------hc
Q 006677          491 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR-------EE  560 (635)
Q Consensus       491 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~  560 (635)
                      .....   ....+++.|+|||++.+..++.++||||||+++|||++|+.||......      .....+..       ..
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCGGG
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHcCCCCccc
Confidence            76432   2345788999999999999999999999999999999999999854321      11111111       11


Q ss_pred             cccccchhh--hh------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          561 WTAEVFDVE--LM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       561 ~~~~~~d~~--~~------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      |........  ..      ...........+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111000000  00      000001123456678889999999999999999963

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-37  Score=329.58  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=187.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~e~  415 (635)
                      .+.||+|+||.||+|... +++.||||++....   ....+|+++++++ +||||+++++++....      ..++||||
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            468999999999999985 48899999986542   3345799999999 9999999999986432      25789999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPLMNV  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~~~~  494 (635)
                      +++ ++.+.+..... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.+ +.+||+|||+++....
T Consensus       135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            986 66665542211 1345999999999999999999999998   9999999999999965 5689999999976543


Q ss_pred             C---CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hcc---ccc
Q 006677          495 P---ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEW---TAE  564 (635)
Q Consensus       495 ~---~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~~  564 (635)
                      .   ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+  .+...+.....   +.+   ...
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChh
Confidence            2   234578899999998764 78999999999999999999999998643211  11111111000   000   000


Q ss_pred             cchhhhhcc--c-----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 006677          565 VFDVELMRF--Q-----NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR  612 (635)
Q Consensus       565 ~~d~~~~~~--~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~  612 (635)
                      ..+..+...  .     ........+.+|+.+||+.||++|||+.|+++  .++++.
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            000000000  0     00111245778888999999999999999997  455544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.3e-36  Score=318.85  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=190.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCee------EEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEK------LLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------~lv  412 (635)
                      .+.||+|+||+||+|... +++.||+|++......   .+.+.+|+.++.++ +||||+++++++...+..      ++|
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv  125 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV  125 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEE
Confidence            467999999999999965 5788999999765433   35678899999999 899999999999877654      999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+. ++|.+++..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            99997 588888742       3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE  564 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~  564 (635)
                      .... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....      .....+...      .+...
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCHHHHTT
T ss_pred             ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCcHHHHHH
Confidence            5433 3467899999999987 67899999999999999999999999764321      111111110      00000


Q ss_pred             cch-------hhhhc--ccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          565 VFD-------VELMR--FQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       565 ~~d-------~~~~~--~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      ..+       .....  ....    ......+.+++.+|++.||++|||++|++++  ++.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            000       00000  0000    1123467788889999999999999999984  44443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-36  Score=310.79  Aligned_cols=241  Identities=20%  Similarity=0.306  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---hHHHHHHHHHHHhhcC-CCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||++...+++.||+|++......   .+.+.+|++++.++.+ |+||+++++++...+..++||| +.+
T Consensus        33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~  111 (313)
T 3cek_A           33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  111 (313)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence            4689999999999999888999999999765433   3568889999999953 7999999999999999999999 668


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++ +.+||+|||++.......  
T Consensus       112 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          112 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            8999999743     34899999999999999999999998   999999999999964 899999999998764322  


Q ss_pred             ----CCCCCCcccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          497 ----TPSRSAGYRAPEVIET-----------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~-----------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                          ...+++.|+|||++.+           ..++.++||||||+++|||++|+.||....     ..............
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~~~~~~  257 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH  257 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTS
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----HHHHHHHHHHhccc
Confidence                2347889999999875           468889999999999999999999997432     11122222222111


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI  608 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  608 (635)
                      ....       ...   ....+.+++.+||+.||++||++.|++++-
T Consensus       258 ~~~~-------~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          258 EIEF-------PDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CCCC-------CCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccCC-------ccc---chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            1100       011   123567788899999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.8e-37  Score=320.24  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=190.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe------eEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE------KLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv  412 (635)
                      .+.||+|+||.||+|... +++.||||++......   .+.+.+|+.++.++ +||||+++++++...+.      .++|
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEE
Confidence            467999999999999975 5789999999765433   35678899999999 89999999999987654      4999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+. |+|.+++..       .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       108 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          108 MPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             EECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             ecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            99997 588888742       3899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC-CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 006677          493 NVPA-TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE------EWTAE  564 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~  564 (635)
                      .... ...+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..      .....+...      .+...
T Consensus       177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHHH
Confidence            5432 3457889999999877 67899999999999999999999999764321      111111110      00000


Q ss_pred             cchh-------hhh-----c-ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          565 VFDV-------ELM-----R-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       565 ~~d~-------~~~-----~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      +.+.       .+.     . ..........+.+++.+|++.||++|||++|++++  ++.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            0000       000     0 00011223467778889999999999999999973  44443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=308.70  Aligned_cols=239  Identities=21%  Similarity=0.342  Sum_probs=187.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc-----CChHHHHHHHHHHHhhcCCCceeceeEEEE--eCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYY--SKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... +++.||+|++....     .....+.+|++++.++ +||||+++++++.  ..+..++|||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e   88 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVME   88 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEE
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEeh
Confidence            467999999999999975 57889999997542     2346788999999999 8999999999985  3457899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |++++ |.+++....   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99876 777765433   235899999999999999999999998   99999999999999999999999999876542


Q ss_pred             C------CCCCCCCcccCcccccCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          495 P------ATPSRSAGYRAPEVIETRK--HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       495 ~------~~~~~~~~y~aPE~~~~~~--~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .      ....+++.|+|||++.+..  ++.++||||||+++|||++|+.||....      .......+......    
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~~----  231 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGSYA----  231 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC----
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCCCC----
Confidence            1      2345788999999997644  3779999999999999999999997532      12222222211110    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                           ..   ......+.+++.+||+.||++|||++|++++
T Consensus       232 -----~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          232 -----IP---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----CC---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----CC---CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00   1122356678889999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-36  Score=317.93  Aligned_cols=256  Identities=20%  Similarity=0.280  Sum_probs=190.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e  414 (635)
                      .+.||+|+||.||+|... +++.||||++.....  ....+.+|++++.++ +||||+++++++...     ...++|||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e   94 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQE   94 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEe
Confidence            467999999999999976 578899999964332  235677899999999 899999999998764     57899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+. |+|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           95 LMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            997 599999864      24899999999999999999999998   99999999999999999999999999976542


Q ss_pred             CC--------------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006677          495 PA--------------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVRE  559 (635)
Q Consensus       495 ~~--------------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  559 (635)
                      ..              ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.   ..........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~  241 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFGIIGT  241 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCC
Confidence            11              2346888999998754 6789999999999999999999999986432110   0001111100


Q ss_pred             cc----ccccchh-------hhhcc--cC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 006677          560 EW----TAEVFDV-------ELMRF--QN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR  612 (635)
Q Consensus       560 ~~----~~~~~d~-------~~~~~--~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~  612 (635)
                      ..    .......       .+...  ..    .......+.+++.+||+.||++|||++|+++  .++.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            00    0000000       00000  00    0112345678888999999999999999998  344433

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-36  Score=308.41  Aligned_cols=241  Identities=21%  Similarity=0.357  Sum_probs=184.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe-------------CCe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-------------KDE  408 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-------------~~~  408 (635)
                      .+.||+|+||.||+|... +++.||+|++.......+.+.+|++++.++ +||||+++++++..             .+.
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKST   89 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence            468999999999999974 688999999976544456788999999999 89999999999865             346


Q ss_pred             eEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          409 KLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       409 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      .++||||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcc
Confidence            789999999999999997432    34788999999999999999999998   99999999999999999999999999


Q ss_pred             CCCCCCC------------------CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006677          489 TPLMNVP------------------ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDL  549 (635)
Q Consensus       489 a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~  549 (635)
                      +......                  ....+++.|+|||++.+. .++.++|||||||++|||++   ||....     +.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~  234 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ER  234 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hH
Confidence            8765421                  123467889999999764 68999999999999999998   553210     11


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ............   .+...     ........+.+++.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 VNILKKLRSVSI---EFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHSTTC---CCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhcccccc---ccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111111111100   00000     011223456778889999999999999999873

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-36  Score=305.96  Aligned_cols=241  Identities=21%  Similarity=0.333  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|... +++.||+|++.....   ..+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  105 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG  105 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCC
Confidence            578999999999999976 588999999875532   456788999999999 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC---CCeEEeecCCCCCCCCC
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD---LDGCISDFGLTPLMNVP  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~DfGla~~~~~~  495 (635)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.+   +.+||+|||++......
T Consensus       106 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            9999988643     24899999999999999999999998   9999999999999764   47999999998766543


Q ss_pred             CCC---CCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 ATP---SRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 ~~~---~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      ...   .+++.|+|||.+.+ .++.++||||||+++|||++|..||.....      ......+........     ...
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~-----~~~  245 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFD-----LPQ  245 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC-----SGG
T ss_pred             CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCCC-----chh
Confidence            322   25677999999876 489999999999999999999999975432      122222222111110     001


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   .....+.+++.+|++.||++|||+.|++++
T Consensus       246 ~~---~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             GT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hh---hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            11   122356778889999999999999999983

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=326.86  Aligned_cols=239  Identities=21%  Similarity=0.350  Sum_probs=180.7

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .++||+|+||+||.....+++.||||++....  ...+.+|+++++++.+||||+++++++.+.+..++||||+. |+|.
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~  105 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ  105 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence            46899999999766556678999999986532  23467899999998789999999999999999999999996 5999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-----CCCeEEeecCCCCCCCCC--
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~DfGla~~~~~~--  495 (635)
                      +++.....    ...+..+..++.||+.||+|||+.+   |+||||||+|||++.     ...+||+|||+++.....  
T Consensus       106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            99975432    2444456789999999999999998   999999999999953     346889999999766432  


Q ss_pred             -----CCCCCCCcccCccccc---CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          496 -----ATPSRSAGYRAPEVIE---TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 -----~~~~~~~~y~aPE~~~---~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                           ....+|+.|+|||++.   ...++.++|||||||++|||++ |..||......       ....... .......
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~-~~~~~~~  250 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLG-ACSLDCL  250 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTT-CCCCTTS
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhc-cCCcccc
Confidence                 2345899999999997   4567889999999999999999 99999643211       1111111 1111000


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                             .........+.+++.+||+.||++|||++|+++
T Consensus       251 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          251 -------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                   011123344677888999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-36  Score=314.11  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=170.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||.||+|... +++.||||++......  ..++..|+..+.+..+||||+++++++...+..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            467999999999999975 5788999999765322  334556666444444999999999999999999999999985 


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      +|.+++..........+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++......  
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  182 (327)
T 3aln_A          106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK  182 (327)
T ss_dssp             EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred             ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence            887777532211234589999999999999999999998 8   9999999999999999999999999997764432  


Q ss_pred             -CCCCCCcccCcccc----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 -TPSRSAGYRAPEVI----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 -~~~~~~~y~aPE~~----~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                       ...+++.|+|||++    .+..++.++||||||+++|||++|+.||........     ......... ..     .+.
T Consensus       183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~~-----~~~  251 (327)
T 3aln_A          183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKGD-PP-----QLS  251 (327)
T ss_dssp             -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-CC-----CCC
T ss_pred             ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcCC-CC-----CCC
Confidence             23578889999998    456789999999999999999999999975431100     000000000 00     000


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                       ..........+.+++.+||+.||++|||+.|+++
T Consensus       252 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 -NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             0000112345677888999999999999999988

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=310.34  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=182.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEE--------------eC
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYY--------------SK  406 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------------~~  406 (635)
                      .+.||+|+||.||+|.... ++.||+|++..... ..+.+.+|++++.++ +||||+++++++.              ..
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~   94 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTEL   94 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccccccc
Confidence            4679999999999999765 78899999875432 246788999999999 9999999999873              34


Q ss_pred             CeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEee
Q 006677          407 DEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISD  485 (635)
Q Consensus       407 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~D  485 (635)
                      ...++||||++ |+|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++.+||+|
T Consensus        95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECC
T ss_pred             CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEcc
Confidence            67799999998 699999863      24899999999999999999999998   99999999999997 567999999


Q ss_pred             cCCCCCCCCCC-------CCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006677          486 FGLTPLMNVPA-------TPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV  557 (635)
Q Consensus       486 fGla~~~~~~~-------~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  557 (635)
                      ||+++......       ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......      .....+.
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~  238 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQLIL  238 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence            99998764321       1235778999998865 67899999999999999999999999864321      1111111


Q ss_pred             hhcccc-------------ccchhhhhcc-cC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          558 REEWTA-------------EVFDVELMRF-QN----IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       558 ~~~~~~-------------~~~d~~~~~~-~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......             .......... ..    .......+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            110000             0000000000 00    01123457788889999999999999999883

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=313.32  Aligned_cols=241  Identities=18%  Similarity=0.304  Sum_probs=170.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCCh--HHHHHHHH-HHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGK--RDFEQQME-IVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||.||+|... +++.||||++.......  .++..|.. ++..+ +||||+++++++...+..++||||+ +
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~-~  107 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELM-G  107 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecc-C
Confidence            568999999999999975 58899999997654322  23333443 45555 9999999999999999999999999 4


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +.+..+....    ...+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||++....... 
T Consensus       108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            4555555422    23489999999999999999999995 7   9999999999999999999999999987654322 


Q ss_pred             --CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          497 --TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                        ...+++.|+|||++.     ...++.++||||||+++|||++|+.||.....     ...............      
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~------  249 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEPPL------  249 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCCCC------
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCCCC------
Confidence              335788999999994     45688999999999999999999999975321     112222222221110      


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ......   ....+.+++.+||+.||.+||+++|+++
T Consensus       250 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          250 LPGHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            000111   1235667788999999999999999988

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9e-37  Score=315.28  Aligned_cols=233  Identities=21%  Similarity=0.382  Sum_probs=189.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC-------hHHHHHHHHHHHhhc-CCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||.||+|... +++.||||++......       ...+.+|++++.++. .|+||+++++++...+..++|+
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~  127 (320)
T 3a99_A           48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL  127 (320)
T ss_dssp             EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence            468999999999999864 5788999999765322       255778999999995 3799999999999999999999


Q ss_pred             EeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCCCC
Q 006677          414 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPL  491 (635)
Q Consensus       414 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla~~  491 (635)
                      ||+.+ ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++.+||+|||++..
T Consensus       128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            99986 8999998742     34899999999999999999999998   99999999999999 789999999999976


Q ss_pred             CCCCC--CCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          492 MNVPA--TPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       492 ~~~~~--~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .....  ...+++.|+|||++.+..+ +.++||||||+++|||++|+.||....            .......   .+  
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~---~~--  262 (320)
T 3a99_A          200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FF--  262 (320)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CC--
T ss_pred             cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc---cc--
Confidence            65432  3457889999999987665 678999999999999999999996421            0111100   00  


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ...   ....+.+++.+||+.||++|||++|++++
T Consensus       263 ----~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          263 ----RQR---VSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ----SSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----ccc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                011   12356678889999999999999999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=311.40  Aligned_cols=233  Identities=23%  Similarity=0.381  Sum_probs=183.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhc---CCCceeceeEEEEeCCeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVG---QHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~---~h~niv~l~~~~~~~~~~~l  411 (635)
                      .+.||+|+||.||+|... +++.||+|++.....       ....+.+|+.++.++.   +|+||+++++++...+..++
T Consensus        36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~  115 (312)
T 2iwi_A           36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML  115 (312)
T ss_dssp             EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred             eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence            568999999999999864 578899999975432       2234567888888875   79999999999999999999


Q ss_pred             EEEe-ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCC
Q 006677          412 VYDY-FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLT  489 (635)
Q Consensus       412 v~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla  489 (635)
                      |+|| +.+++|.+++...     ..+++..+..++.||+.||+|||+.+   |+||||||+||+++ .++.+||+|||++
T Consensus       116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            9999 7899999999742     24899999999999999999999998   99999999999999 8899999999998


Q ss_pred             CCCCCCC--CCCCCCcccCcccccCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          490 PLMNVPA--TPSRSAGYRAPEVIETRKHS-HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       490 ~~~~~~~--~~~~~~~y~aPE~~~~~~~~-~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .......  ...++..|+|||++.+..+. .++||||||+++|||++|+.||....            .......     
T Consensus       188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~-----  250 (312)
T 2iwi_A          188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL-----  250 (312)
T ss_dssp             EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----
T ss_pred             hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----
Confidence            7664432  34578899999999876664 58999999999999999999996321            0111100     


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ...   ......+.+++.+||+.+|++|||++|++++
T Consensus       251 ----~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          251 ----HFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ----CCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000   1122356678889999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.4e-35  Score=296.78  Aligned_cols=229  Identities=12%  Similarity=0.117  Sum_probs=178.0

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCCh----HHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||.||+|.... ++.||+|++.......    +.+.+|+.++.++ +||||+++++++..++..|+||||++
T Consensus        36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~  114 (286)
T 3uqc_A           36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIR  114 (286)
T ss_dssp             EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecC
Confidence            3679999999999999764 7899999998654432    6788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +++|.++++..       ....++..++.|++.||+|||+++   |+||||||+|||++.++.+||+++|          
T Consensus       115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999531       345578899999999999999998   9999999999999999999998553          


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                            |++       .++.++|||||||++|||+||+.||...+..+.....       ............ .....  
T Consensus       175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~--  231 (286)
T 3uqc_A          175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPA-DIDRD--  231 (286)
T ss_dssp             ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHH-HHCTT--
T ss_pred             ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChh-hcccC--
Confidence                  333       3688999999999999999999999876543321000       000000000000 00111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCCC
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE  617 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~~  617 (635)
                       ....+.+++.+||+.||++| |+.|+++.|+++......
T Consensus       232 -~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~  269 (286)
T 3uqc_A          232 -IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADR  269 (286)
T ss_dssp             -SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC----
T ss_pred             -CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCc
Confidence             22346778889999999999 999999999999876653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-35  Score=301.62  Aligned_cols=227  Identities=18%  Similarity=0.289  Sum_probs=175.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~  417 (635)
                      .++||+|+||.||+|... +++.||+|+++.    ...+.+|++++.++.+||||+++++++..    ....++||||++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            367999999999999974 578999999864    35678899988777799999999999987    667899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~  494 (635)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||++.... 
T Consensus        99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            999999997543   235899999999999999999999998   999999999999998   7899999999986542 


Q ss_pred             CCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          495 PATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       495 ~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                                       +..++.++|||||||++|||++|+.||......+....       ................. 
T Consensus       172 -----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-  226 (299)
T 3m2w_A          172 -----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNPEW-  226 (299)
T ss_dssp             -----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSCTTCCSSCHHHH-
T ss_pred             -----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHhhccccCCchhc-
Confidence                             24577899999999999999999999975432221000       00000000000000000 


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ......+.+++.+||+.||++|||+.|++++
T Consensus       227 --~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          227 --SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              1123456778889999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-35  Score=336.48  Aligned_cols=233  Identities=18%  Similarity=0.266  Sum_probs=188.1

Q ss_pred             hccccccCceEEEEEEec--CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCe-----eEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE--ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE-----KLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~  413 (635)
                      .+.||+|+||+||+|...  +++.||||++.....  ....+.+|++++.++ +||||+++++++...+.     .|+||
T Consensus        85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~  163 (681)
T 2pzi_A           85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVM  163 (681)
T ss_dssp             EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEE
Confidence            467999999999999975  578899999865422  235678899999999 89999999999988765     69999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++++|.+++..       .+++..++.++.||+.||+|||+++   |+||||||+|||++.+ .+||+|||+++...
T Consensus       164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            99999999987752       4899999999999999999999998   9999999999999986 89999999998877


Q ss_pred             CCCCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          494 VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       494 ~~~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                      ......+|+.|+|||++.+. ++.++|||||||++|||++|..||..........                        .
T Consensus       233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~------------------------~  287 (681)
T 2pzi_A          233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------------------D  287 (681)
T ss_dssp             CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT------------------------T
T ss_pred             cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc------------------------c
Confidence            66667799999999998765 4889999999999999999999887532211100                        0


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHhh
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPN-MDEVVRMIEEVR  612 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~~~~  612 (635)
                      .........+.+++.+||+.||++||+ ++++...|..+.
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            000112245678888999999999996 666666666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.8e-36  Score=330.82  Aligned_cols=263  Identities=19%  Similarity=0.283  Sum_probs=197.3

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEe------CCeeEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS------KDEKLLV  412 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv  412 (635)
                      ..+.||+|+||+||+|... +++.||||++.....  ..+.+.+|++++.++ +||||+++++++..      .+..++|
T Consensus        18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LV   96 (676)
T 3qa8_A           18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLA   96 (676)
T ss_dssp             CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEE
Confidence            3578999999999999974 588899999875422  245688999999999 99999999999765      5677999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCC---eEEeecCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLD---GCISDFGLT  489 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~DfGla  489 (635)
                      |||+++|+|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++
T Consensus        97 mEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           97 MEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             EECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            999999999999986432  234888999999999999999999998   999999999999997765   999999999


Q ss_pred             CCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh--------
Q 006677          490 PLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--------  558 (635)
Q Consensus       490 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  558 (635)
                      .......   ...+++.|+|||++.+..++.++|||||||++|||++|..||.....     ...|......        
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCS
T ss_pred             cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhh
Confidence            8765432   34578899999999999999999999999999999999999965311     0001000000        


Q ss_pred             -hccccc-cchhhhhc-ccChHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHhhccC
Q 006677          559 -EEWTAE-VFDVELMR-FQNIEEEMVQMLQIGMACVAKVPDMRPNMDE-----VVRMIEEVRQSD  615 (635)
Q Consensus       559 -~~~~~~-~~d~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e-----vl~~L~~~~~~~  615 (635)
                       +..... .+...... ..........+.+++.+|++.||++|||++|     ..+.++.+....
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence             000000 00000000 0011234456778888999999999999988     566777777554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-34  Score=309.85  Aligned_cols=236  Identities=13%  Similarity=0.127  Sum_probs=172.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC----ChHHHHHHHHHHHhhcCC-Ccee---------c---------
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQH-PNVV---------P---------  398 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h-~niv---------~---------  398 (635)
                      .++||+|+||+||+|... +++.||||++.....    ..+.+.+|+.++..+ +| +|..         .         
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhcccCC
Confidence            468999999999999954 688999999873322    246788999888887 44 3211         1         


Q ss_pred             ---eeEEEEe-----CCeeEEEEEeccCCChhhhccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 006677          399 ---LRAYYYS-----KDEKLLVYDYFASGSLSTLLHGNR--GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNI  468 (635)
Q Consensus       399 ---l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl  468 (635)
                         ++.++..     ....+++|+++ +++|.++++...  ......+++..+..++.||+.||+|||+++   |+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence               1111111     12346666654 679998884210  012335888999999999999999999998   999999


Q ss_pred             CCCCeEEcCCCCeEEeecCCCCCCCCCC-CCCCCCcccCcccc----------cCCCCCCccchhhHHHHHHHHHhCCCC
Q 006677          469 KASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVI----------ETRKHSHKSDVYSFGVLLLEMLTGKAP  537 (635)
Q Consensus       469 k~~NIll~~~~~~ki~DfGla~~~~~~~-~~~~~~~y~aPE~~----------~~~~~~~k~Dvws~Gvvl~el~tg~~p  537 (635)
                      ||+|||++.++.+||+|||+++...... ...+ +.|+|||++          .+..++.++|||||||++|||++|+.|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999987655432 3456 899999999          556688999999999999999999999


Q ss_pred             CCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          538 LQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      |......+...                   ..+......+   ..+.+++.+||+.||++||++.|+++
T Consensus       317 f~~~~~~~~~~-------------------~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          317 NTDDAALGGSE-------------------WIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             CCTTGGGSCSG-------------------GGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCcchhhhHH-------------------HHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            97654322211                   0111111122   45677888999999999999777754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-33  Score=293.64  Aligned_cols=238  Identities=13%  Similarity=0.173  Sum_probs=180.9

Q ss_pred             HhhccccccCceEEEEEEecCCCeEEEEEeecccC---------ChHHHHHHHHHHHhhc--------CCCceeceeEEE
Q 006677          341 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---------GKRDFEQQMEIVGRVG--------QHPNVVPLRAYY  403 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~--------~h~niv~l~~~~  403 (635)
                      ...+.||+|+||+||+|+. +++.||||++.....         ..+.+.+|+.+++++.        +||||+++.+.+
T Consensus        23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~  101 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH  101 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred             hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence            4468899999999999998 579999999976532         2377899999999885        488888887775


Q ss_pred             E------------------------------eCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 006677          404 Y------------------------------SKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVA  453 (635)
Q Consensus       404 ~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~  453 (635)
                      .                              ..+..++||||+++|++.+.+.+      ..+++..+..++.||+.||+
T Consensus       102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A          102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence            3                              26788999999999977776642      24899999999999999999


Q ss_pred             HHH-hcCCCCceecCCCCCCeEEcCCC--------------------CeEEeecCCCCCCCCCCCCCCCCcccCcccccC
Q 006677          454 HIH-SMGGPKFTHGNIKASNVLINQDL--------------------DGCISDFGLTPLMNVPATPSRSAGYRAPEVIET  512 (635)
Q Consensus       454 ~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~y~aPE~~~~  512 (635)
                      ||| +.+   |+||||||+|||++.++                    .+||+|||+|+..... ...+|+.|+|||++.+
T Consensus       176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred             HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence            999 888   99999999999999887                    8999999999876533 3468899999999987


Q ss_pred             CCCCCccchhhHHHH-HHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcc
Q 006677          513 RKHSHKSDVYSFGVL-LLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACV  591 (635)
Q Consensus       513 ~~~~~k~Dvws~Gvv-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl  591 (635)
                      .. +.++||||+|++ .+++++|..||..         ..|.......-......... ............+.+++.+||
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTK-CNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSC-CCSHHHHHHHHHHHHHHHHGG
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcc-cchhhhhhcCHHHHHHHHHHh
Confidence            66 889999998777 7889999999852         11221111110000000000 001112345567888889999


Q ss_pred             cCCCCCCCCHHHHH
Q 006677          592 AKVPDMRPNMDEVV  605 (635)
Q Consensus       592 ~~~P~~RPs~~evl  605 (635)
                      +.|     |++|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     999988

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.95  E-value=1.5e-28  Score=252.72  Aligned_cols=188  Identities=36%  Similarity=0.675  Sum_probs=170.0

Q ss_pred             CCChhHHHHHHHHHHhCCCCC-CCCCCCCCCCCCC--cceeEecCCC--CeEEEEEeCCCCccC--cCCcccccCCCCCc
Q 006677           25 ADLNSDRQALLDFADAVPHLR-KLNWSSTNPICQS--WVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALE   97 (635)
Q Consensus        25 ~~~~~~~~al~~~~~~~~~~~-~~~w~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~l~~~~l~~l~~L~   97 (635)
                      .|.+.|++||++||+++.+.. ..+|+.+.+|| .  |.||.|+...  ++|+.|+|++++++|  .+|+ .|+++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence            478899999999999996543 44898776666 5  9999998654  799999999999999  8998 899999999


Q ss_pred             EEEeec-CCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCC
Q 006677           98 VLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN  174 (635)
Q Consensus        98 ~L~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  174 (635)
                      +|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|.  ++|++|+|++|+|++.+|..|.++++|++|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 999999999999999999999999999999999887  89999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCC-CCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          175 NLSGSIPNF--DIP-KLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       175 ~l~~~~p~~--~l~-~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|+|.+|..  .++ +|+.|+|++|+++|.+|..+..++ |..+
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L  202 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV  202 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence            999988875  676 999999999999999999888776 5554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.3e-29  Score=278.44  Aligned_cols=181  Identities=17%  Similarity=0.105  Sum_probs=127.7

Q ss_pred             cccccCceEEEEEE-ecCCCeEEEEEeecccC-----------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          345 VLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV-----------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      -.+.|++|.+..++ .--|+.+++|++.....           ..++|.+|+++|+++..|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777666654 23478899999975421           2356899999999998999999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||++|++|.+++...     .+++..   +|+.||+.||+|+|++|   ||||||||+|||+++++.+||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999743     246654   58899999999999999   999999999999999999999999999876


Q ss_pred             CCCCC----CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006677          493 NVPAT----PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP  537 (635)
Q Consensus       493 ~~~~~----~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p  537 (635)
                      .....    ..||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       390 ~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            54432    237889999999976 467789999999998887665444

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.93  E-value=3.6e-26  Score=263.48  Aligned_cols=189  Identities=24%  Similarity=0.350  Sum_probs=157.7

Q ss_pred             ccCCChhHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCcceeEecCCCCeEEEEEeCCCCccCc---CCc-----------
Q 006677           23 AFADLNSDRQALLDFADAVPHL-RKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGP---IPN-----------   87 (635)
Q Consensus        23 ~~~~~~~~~~al~~~~~~~~~~-~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~---l~~-----------   87 (635)
                      +.++.++|++||++||+++.++ ...+|+.+++|| +|.||+|+  .++|+.|+|+++++.|.   +|+           
T Consensus         6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l   82 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL   82 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred             cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence            3445678999999999999544 345998666655 89999998  58999999999999987   543           


Q ss_pred             -----------ccccCCCCCcEEEeecCCCCCCCCC--CCCCCCcccEEeeccCccCCcCCCCcc---CCcceeeccCcc
Q 006677           88 -----------NTLGKLDALEVLSLRSNVLTGGLPS--EITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLDLSFNS  151 (635)
Q Consensus        88 -----------~~l~~l~~L~~L~L~~n~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~ls~N~  151 (635)
                                 ..++++++|++|||++|.++|.+|.  .+++|++|++|+|++|.+++.+|..+.   ++|++|+|++|+
T Consensus        83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  162 (768)
T 3rgz_A           83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS  162 (768)
T ss_dssp             ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred             CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence                       3688899999999999999999998  999999999999999999999998763   789999999999


Q ss_pred             CcccCCch---hhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          152 FTGNIPQS---IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       152 l~g~~p~~---~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +++..|..   +.++++|++|+|++|.+++.+|...+++|++|+|++|++++.+|. ++++++|+.+
T Consensus       163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L  228 (768)
T 3rgz_A          163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHL  228 (768)
T ss_dssp             CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEE
T ss_pred             cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEE
Confidence            99888877   788888888888888888877777788888888888888877776 7777766654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=5.1e-26  Score=250.29  Aligned_cols=177  Identities=16%  Similarity=0.210  Sum_probs=144.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .++||+|+||+||+|... +..+++|+.......         .+.+.+|++++.++ +||||+++..++...+..++||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEE
Confidence            568999999999999544 678888886543221         23478999999999 9999997777777888899999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.++++.             +..++.|++.||+|||+++   |+||||||+|||+++  .+||+|||+++...
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            99999999999963             4579999999999999998   999999999999999  99999999998876


Q ss_pred             CCC-----------CCCCCCcccCcccccC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 006677          494 VPA-----------TPSRSAGYRAPEVIET--RKHSHKSDVYSFGVLLLEMLTGKAPLQ  539 (635)
Q Consensus       494 ~~~-----------~~~~~~~y~aPE~~~~--~~~~~k~Dvws~Gvvl~el~tg~~p~~  539 (635)
                      ...           ...+|+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            532           2347889999999987  568888999999999999888887774

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.92  E-value=6.4e-26  Score=255.65  Aligned_cols=185  Identities=26%  Similarity=0.456  Sum_probs=162.0

Q ss_pred             ChhHHHHHHHHHHhCCCCCC----------CCCCCCCCCCCCc---ceeEecCCCCeEEEEEeCCCCccCcCCcccccCC
Q 006677           27 LNSDRQALLDFADAVPHLRK----------LNWSSTNPICQSW---VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKL   93 (635)
Q Consensus        27 ~~~~~~al~~~~~~~~~~~~----------~~w~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l   93 (635)
                      ...|+.||.++++++....+          .+|+.+.++| .|   .||+|+.. +||+.|+|++++++|.+|+ .|++|
T Consensus        28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L  104 (636)
T 4eco_A           28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQL  104 (636)
T ss_dssp             HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGC
T ss_pred             HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcC
Confidence            34699999999999854322          2798776665 89   99999865 8999999999999999998 89999


Q ss_pred             CCCcEEEeecCC--------------------------------------------------------------------
Q 006677           94 DALEVLSLRSNV--------------------------------------------------------------------  105 (635)
Q Consensus        94 ~~L~~L~L~~n~--------------------------------------------------------------------  105 (635)
                      ++|++|+|++|+                                                                    
T Consensus       105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~  184 (636)
T 4eco_A          105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK  184 (636)
T ss_dssp             TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred             ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence            999999999984                                                                    


Q ss_pred             ----------CCCCCCCCCCCCCcccEEeeccCccCCc-----------------CCCCcc----CCcceeeccCccCcc
Q 006677          106 ----------LTGGLPSEITSLPSLRYLYLQHNNFSGK-----------------IPSSFS----PQLVVLDLSFNSFTG  154 (635)
Q Consensus       106 ----------l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~----~~L~~L~ls~N~l~g  154 (635)
                                |+| ||.+|++|++|++|+|++|+|+|.                 +|..++    ++|++|+|++|++.|
T Consensus       185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~  263 (636)
T 4eco_A          185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT  263 (636)
T ss_dssp             TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred             hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence                      445 899999999999999999999986                 999877    789999999999999


Q ss_pred             cCCchhhccccCCcEEcCCCc-ccc-cCCCC--CC------CCCcEEEeecccCcCCCCc--ccCCCCCCCccC
Q 006677          155 NIPQSIQNLTQLTGLSLQSNN-LSG-SIPNF--DI------PKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG  216 (635)
Q Consensus       155 ~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~--~l------~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~  216 (635)
                      .+|..|+++++|++|+|++|+ ++| .+|..  .+      ++|+.|+|++|+++ .+|.  .++++++|..++
T Consensus       264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~  336 (636)
T 4eco_A          264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE  336 (636)
T ss_dssp             SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred             cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence            999999999999999999998 998 77763  43      89999999999999 8998  888888887664

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.91  E-value=9.5e-26  Score=259.37  Aligned_cols=185  Identities=26%  Similarity=0.470  Sum_probs=162.5

Q ss_pred             CChhHHHHHHHHHHhCCCCCCCCCCCCC-----CC-CCCc------------ceeEecCCCCeEEEEEeCCCCccCcCCc
Q 006677           26 DLNSDRQALLDFADAVPHLRKLNWSSTN-----PI-CQSW------------VGINCTQDRTRVFGLRLPGIGLVGPIPN   87 (635)
Q Consensus        26 ~~~~~~~al~~~~~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~l~~   87 (635)
                      +...|+.||++||+++...   +|+.++     ++ ||+|            .||.|+. .+||+.|+|++++|.|.+|+
T Consensus       266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~  341 (876)
T 4ecn_A          266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD  341 (876)
T ss_dssp             HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred             cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence            3457999999999999654   787554     44 2599            9999986 58999999999999999998


Q ss_pred             ccccCCCCCcEEEe-ecCCCCCC---------------------------------------------------------
Q 006677           88 NTLGKLDALEVLSL-RSNVLTGG---------------------------------------------------------  109 (635)
Q Consensus        88 ~~l~~l~~L~~L~L-~~n~l~g~---------------------------------------------------------  109 (635)
                       .|++|++|++|+| ++|.++|.                                                         
T Consensus       342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence             8999999999999 77766554                                                         


Q ss_pred             -------------------CCCCCCCCCcccEEeeccCccCC-----------------cCCCCcc----CCcceeeccC
Q 006677          110 -------------------LPSEITSLPSLRYLYLQHNNFSG-----------------KIPSSFS----PQLVVLDLSF  149 (635)
Q Consensus       110 -------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~----~~L~~L~ls~  149 (635)
                                         ||..|++|++|++|+|++|+|+|                 .+|..++    ++|++|+|++
T Consensus       421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~  500 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN  500 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred             cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence                               88899999999999999999998                 4999875    7899999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCc-ccc-cCCCC---------CCCCCcEEEeecccCcCCCCc--ccCCCCCCCccC
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNN-LSG-SIPNF---------DIPKLRHLNLSYNGLKGSIPS--SLQKFPNSSFVG  216 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~---------~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~  216 (635)
                      |++.|.+|..|++|++|+.|+|++|+ |+| .+|..         .+++|+.|+|++|+++ .+|.  .|.++++|..++
T Consensus       501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~  579 (876)
T 4ecn_A          501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD  579 (876)
T ss_dssp             CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred             CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence            99999999999999999999999998 998 77742         4569999999999999 8998  898888887664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.88  E-value=3e-23  Score=214.42  Aligned_cols=186  Identities=18%  Similarity=0.324  Sum_probs=152.6

Q ss_pred             cCCChhHHHHHHHHHHhCC-CC-C-CCCCC----CCCCCCCCcceeEecC--------CCCeEEEEEeCCCCccCcCCcc
Q 006677           24 FADLNSDRQALLDFADAVP-HL-R-KLNWS----STNPICQSWVGINCTQ--------DRTRVFGLRLPGIGLVGPIPNN   88 (635)
Q Consensus        24 ~~~~~~~~~al~~~~~~~~-~~-~-~~~w~----~~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~g~l~~~   88 (635)
                      .++...|++||++||.++. +. . ..+|.    ...++| .|.|+.|..        ...+|+.|+|++|+++ .+|+ 
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~-   98 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-   98 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-
Confidence            4566789999999999772 22 2 23783    334445 899999952        3468999999999998 8998 


Q ss_pred             cccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhc----
Q 006677           89 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN----  162 (635)
Q Consensus        89 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~----  162 (635)
                      .++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..+.  ++|++|+|++|++.+.+|..++.    
T Consensus        99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~  176 (328)
T 4fcg_A           99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS  176 (328)
T ss_dssp             CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred             hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence            6888999999999999999 89999999999999999999999 7888877  78999999999988899887765    


Q ss_pred             -----cccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          163 -----LTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       163 -----l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                           +++|++|+|++|+|+ .+|..  .+++|+.|+|++|++++ +|..+.++++|..++
T Consensus       177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~  235 (328)
T 4fcg_A          177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD  235 (328)
T ss_dssp             CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred             hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence                 899999999999998 66653  78889999999999984 666788777776653

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.87  E-value=5.3e-23  Score=237.01  Aligned_cols=160  Identities=36%  Similarity=0.635  Sum_probs=126.0

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCC------------------------------------
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE------------------------------------  113 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~------------------------------------  113 (635)
                      ++..|+|++|.++|.+|. .++++++|+.|+|++|.++|.+|..                                    
T Consensus       515 ~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (768)
T 3rgz_A          515 NLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL  593 (768)
T ss_dssp             TCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred             CCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence            456667777777766666 5777777777777777776666543                                    


Q ss_pred             ----------------------------------CCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCC
Q 006677          114 ----------------------------------ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP  157 (635)
Q Consensus       114 ----------------------------------~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p  157 (635)
                                                        ++++++|++|||++|+++|.+|..++  ++|+.|+|++|+|+|.+|
T Consensus       594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip  673 (768)
T 3rgz_A          594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP  673 (768)
T ss_dssp             EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred             cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence                                              33356677788888888888887777  778888888888888888


Q ss_pred             chhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcc--cCCCCCCCccCCCCCCCCCCCCCCC
Q 006677          158 QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKACFP  230 (635)
Q Consensus       158 ~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~l~~~~l~~c~~  230 (635)
                      ..|+++++|+.|||++|+++|.+|..  .+++|++|||++|+|+|.||..  +..++.++|.||+.+||.|+..|.+
T Consensus       674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~  750 (768)
T 3rgz_A          674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP  750 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred             hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence            88888888888888888888888875  7888999999999999999864  6678888899999999999888853

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=3e-22  Score=202.01  Aligned_cols=151  Identities=19%  Similarity=0.248  Sum_probs=119.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC-------------------ChHHHHHHHHHHHhhcCCCceeceeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-------------------GKRDFEQQMEIVGRVGQHPNVVPLRAYY  403 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~  403 (635)
                      .+.||+|+||.||+|...+++.||+|+++....                   ....+.+|++++.++ +  | +++.+++
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v~~~~  170 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSSCCEE
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCcCeEE
Confidence            378999999999999997789999999964321                   134588999999999 4  4 5666655


Q ss_pred             EeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEE
Q 006677          404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCI  483 (635)
Q Consensus       404 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki  483 (635)
                      .. +..++||||+++|+|.+ +..           .....++.|++.||+|||+.+   |+||||||+|||++ ++.+||
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEE
T ss_pred             ec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEE
Confidence            43 56699999999999998 531           124469999999999999998   99999999999999 999999


Q ss_pred             eecCCCCCCCCCCCCCCCCcccCcccccC----------CCCCCccchhh
Q 006677          484 SDFGLTPLMNVPATPSRSAGYRAPEVIET----------RKHSHKSDVYS  523 (635)
Q Consensus       484 ~DfGla~~~~~~~~~~~~~~y~aPE~~~~----------~~~~~k~Dvws  523 (635)
                      +|||+++..         ..|+|||++..          ..+...+|+|.
T Consensus       234 ~DFG~a~~~---------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          234 IDFPQSVEV---------GEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             CCCTTCEET---------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EECCCCeEC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999998643         34789998854          34555666664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.84  E-value=1.2e-20  Score=187.10  Aligned_cols=145  Identities=24%  Similarity=0.223  Sum_probs=120.5

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .++.|+|++|++++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.  ++|++|+|
T Consensus        36 ~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDA-TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TCCEEECTTSCCCCCCTT-TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEccCCCcCccCHh-HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            477889999999865544 789999999999999999987788889999999999999999976666665  78999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ++|+|++..+..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|++++..|..+.++++|..+
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  184 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI  184 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence            999999777777888999999999999999766643  78899999999999997777777777766554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=7.3e-20  Score=178.87  Aligned_cols=149  Identities=27%  Similarity=0.266  Sum_probs=86.7

Q ss_pred             CCCCCCCCCCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCc
Q 006677           49 WSSTNPICQSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPS  119 (635)
Q Consensus        49 w~~~~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~  119 (635)
                      |......| +|.+|.|+...         ..++.|+|++|.+++..|. .|.++++|++|+|++|+|++..+..|.++++
T Consensus        12 ~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~   89 (229)
T 3e6j_A           12 ACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQ   89 (229)
T ss_dssp             CCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             cCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence            44455556 89999997531         2455566666666643343 5666666666666666665333344556666


Q ss_pred             ccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeec
Q 006677          120 LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY  195 (635)
Q Consensus       120 L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~  195 (635)
                      |++|+|++|+|++..+..|.  ++|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..  .+++|+.|+|++
T Consensus        90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  168 (229)
T 3e6j_A           90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG  168 (229)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence            66666666666644444333  55666666666666 55666666666666666666666444332  455666666666


Q ss_pred             ccCcC
Q 006677          196 NGLKG  200 (635)
Q Consensus       196 N~l~g  200 (635)
                      |.+++
T Consensus       169 N~~~c  173 (229)
T 3e6j_A          169 NPWDC  173 (229)
T ss_dssp             SCBCT
T ss_pred             CCccC
Confidence            66554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.82  E-value=4.9e-21  Score=196.55  Aligned_cols=141  Identities=23%  Similarity=0.395  Sum_probs=101.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCC-cccEEeeccCccCCcCCCCcc-CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFS-PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~-~~L~~L~  146 (635)
                      .+++.|+|++|.++|.+|. .++.+++|++|+|++|.++|.+|..+++++ +|++|+|++|+++|.+|..+. ..|++|+
T Consensus       125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~  203 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD  203 (313)
T ss_dssp             TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred             CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence            4688899999999988887 789999999999999999988998999988 899999999999888887776 3477777


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFP  210 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~  210 (635)
                      |++|++++.+|..|.++++|+.|+|++|++++.+|.. .+++|++|+|++|+++|.+|..+.+++
T Consensus       204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  268 (313)
T 1ogq_A          204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK  268 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred             CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCc
Confidence            7777777666666666666666666666665544432 344444444444444444444443333

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.80  E-value=3.2e-19  Score=171.56  Aligned_cols=146  Identities=26%  Similarity=0.282  Sum_probs=116.7

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|.+|.|+...         .+++.|+|++|+++ .+++..++.+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus         7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A            7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            489999997532         35888999999988 45555788899999999999999865556678899999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      |++++..+..|.  ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|.+.+..|
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  165 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  165 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence            999866555554  78999999999998777777888999999999999998766643  68888889988887776443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.79  E-value=4e-19  Score=178.24  Aligned_cols=145  Identities=25%  Similarity=0.291  Sum_probs=97.8

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .++.|+|++|+++ .+++..|+++++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|.  ++|++|+|
T Consensus        38 ~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  116 (270)
T 2o6q_A           38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL  116 (270)
T ss_dssp             TCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred             CCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence            3566777777776 34444677777777777777777744344456777777777777777754444444  67777777


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ++|++++..|..|.++++|++|+|++|+|++..+..  .+++|+.|+|++|++++..+..|.++++|..+
T Consensus       117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  186 (270)
T 2o6q_A          117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL  186 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEE
Confidence            777777666666777777777777777777554432  66777777777777776555566666666554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=1.8e-19  Score=174.92  Aligned_cols=136  Identities=20%  Similarity=0.232  Sum_probs=69.3

Q ss_pred             EEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCc
Q 006677           74 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN  150 (635)
Q Consensus        74 l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N  150 (635)
                      +++++++++ .+|. .+.  ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..|..|.  ++|++|+|++|
T Consensus        16 l~~s~n~l~-~iP~-~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           16 VDCSNQKLN-KIPE-HIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             eEeCCCCcc-cCcc-CCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            444444544 3444 221  234555555555554433 2345555555555555555544444444  45555555555


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      +|++..|..|.++++|++|+|++|+|++..|..  .+++|+.|+|++|+|++..|..|..+++|.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  156 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLS  156 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCC
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCC
Confidence            555544445555555555555555555544432  455555555555555555555555444443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=5.5e-19  Score=171.49  Aligned_cols=133  Identities=24%  Similarity=0.275  Sum_probs=74.4

Q ss_pred             CCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcc
Q 006677           77 PGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG  154 (635)
Q Consensus        77 ~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g  154 (635)
                      ++++++ .+|. .+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.  ++|++|+|++|+|++
T Consensus        19 ~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~   94 (220)
T 2v9t_B           19 RGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE   94 (220)
T ss_dssp             TTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCc
Confidence            334444 4554 222  4566666666666644444566666666666666666655555554  556666666666664


Q ss_pred             cCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          155 NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       155 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      ..+..|.++++|+.|+|++|+|++..|..  .+++|+.|+|++|+|++..+..|..+++|.
T Consensus        95 l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  155 (220)
T 2v9t_B           95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ  155 (220)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCC
Confidence            44444556666666666666666554443  556666666666666655554455444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=2.5e-18  Score=166.84  Aligned_cols=147  Identities=20%  Similarity=0.193  Sum_probs=131.4

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|..+.|++..         ..++.|+|++|++++..|.+.|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            479999997532         25778999999999776766799999999999999999987778999999999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      |++++..|..|.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..  .+++|+.|+|++|.+++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            999987777776  89999999999999999999999999999999999999987764  79999999999999987544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=3.6e-18  Score=165.70  Aligned_cols=143  Identities=22%  Similarity=0.229  Sum_probs=126.6

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|..|.|.+..         ..++.|+|++|++++ +++..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            479999997532         368999999999995 5555899999999999999999988899999999999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      |+|++..+..|.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|.+..
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            999954444454  89999999999999999999999999999999999999877753  78999999999999874

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.76  E-value=5.2e-18  Score=170.30  Aligned_cols=150  Identities=26%  Similarity=0.311  Sum_probs=131.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ ++  .++.+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.  ++|++|+
T Consensus        63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  139 (272)
T 3rfs_A           63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN  139 (272)
T ss_dssp             TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence            468999999999986 44  699999999999999999987777899999999999999999977776665  7999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc---CCCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLC  221 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~---~n~~l~  221 (635)
                      |++|+|++..|..++++++|+.|+|++|+|++..+..  .+++|+.|+|++|++++..|..+.++++|..+   +|+..|
T Consensus       140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            9999999888888899999999999999999877754  78999999999999998888778888777655   454444

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.3e-18  Score=173.20  Aligned_cols=132  Identities=14%  Similarity=0.160  Sum_probs=102.0

Q ss_pred             hccccccCceEEEEEEe-cCCCe--EEEEEeecccCC-------------------------hHHHHHHHHHHHhhcCCC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTT--VVVKRLKEVVVG-------------------------KRDFEQQMEIVGRVGQHP  394 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h~  394 (635)
                      .+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+.++.++ +|+
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~  130 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-KEA  130 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-HHT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-HhC
Confidence            46799999999999998 67888  999987543211                         12578899999999 676


Q ss_pred             ce--eceeEEEEeCCeeEEEEEeccC-C----ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceec
Q 006677          395 NV--VPLRAYYYSKDEKLLVYDYFAS-G----SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH-SMGGPKFTHG  466 (635)
Q Consensus       395 ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~  466 (635)
                      ++  +..+.+    +..++||||+.+ |    +|.++...        .++..+..++.|++.||.||| +.+   |+||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            54  333332    367899999942 4    56655431        224467789999999999999 888   9999


Q ss_pred             CCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          467 NIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       467 Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.76  E-value=8.8e-19  Score=180.89  Aligned_cols=144  Identities=26%  Similarity=0.393  Sum_probs=126.5

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc----------
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF----------  138 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~----------  138 (635)
                      .+++.|+|++|+++ .+|. .++++++|++|+|++|+++ .+|..|++|++|++|+|++|++.+.+|..+          
T Consensus       104 ~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~  180 (328)
T 4fcg_A          104 SHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ  180 (328)
T ss_dssp             TTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred             CCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence            46888999999999 8887 7899999999999999999 889999999999999999999999999887          


Q ss_pred             -cCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          139 -SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       139 -~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                       .++|++|+|++|+|+ .+|..++++++|++|+|++|++++.++.. .+++|+.|+|++|++.+.+|..+.++++|..++
T Consensus       181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~  259 (328)
T 4fcg_A          181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI  259 (328)
T ss_dssp             ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred             cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence             378999999999999 88888999999999999999999755544 788999999999999999998888888877664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.75  E-value=1.1e-17  Score=167.64  Aligned_cols=153  Identities=24%  Similarity=0.286  Sum_probs=131.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .++..|+|++|.++ .+|+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.  ++|++|+
T Consensus        61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            47899999999998 67776789999999999999999976667789999999999999999987777765  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCc---cCCCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLC  221 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~---~~n~~l~  221 (635)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..  .+++|+.|+|++|++++..+..+..+++|..   .+|+..|
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            9999999777777999999999999999999876653  7899999999999999766666777776654   4565555


Q ss_pred             C
Q 006677          222 G  222 (635)
Q Consensus       222 ~  222 (635)
                      .
T Consensus       220 ~  220 (270)
T 2o6q_A          220 T  220 (270)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.74  E-value=1.4e-17  Score=162.50  Aligned_cols=153  Identities=25%  Similarity=0.338  Sum_probs=127.8

Q ss_pred             cceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc
Q 006677           59 WVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF  138 (635)
Q Consensus        59 w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~  138 (635)
                      |..-.|+.     +.++.++++++ .+|. .+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus        14 ~~~~~Cs~-----~~v~c~~~~l~-~ip~-~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~   84 (229)
T 3e6j_A           14 PSQCSCSG-----TTVDCRSKRHA-SVPA-GIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF   84 (229)
T ss_dssp             CTTCEEET-----TEEECTTSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             CCCCEEeC-----CEeEccCCCcC-ccCC-CCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence            44556753     35889999988 7887 343  899999999999999889999999999999999999985555555


Q ss_pred             c--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCc
Q 006677          139 S--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF  214 (635)
Q Consensus       139 ~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~  214 (635)
                      .  ++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..  .+++|+.|+|++|+|++..+..|.++++|..
T Consensus        85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  163 (229)
T 3e6j_A           85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH  163 (229)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence            5  89999999999999877778899999999999999999 56654  8999999999999999776677887777665


Q ss_pred             c---CCCCCC
Q 006677          215 V---GNSLLC  221 (635)
Q Consensus       215 ~---~n~~l~  221 (635)
                      +   +|+.-|
T Consensus       164 L~l~~N~~~c  173 (229)
T 3e6j_A          164 AYLFGNPWDC  173 (229)
T ss_dssp             EECTTSCBCT
T ss_pred             EEeeCCCccC
Confidence            4   555444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.74  E-value=1.7e-18  Score=181.35  Aligned_cols=166  Identities=28%  Similarity=0.275  Sum_probs=138.9

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCccccc-CCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeec
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLG-KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQ  126 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~-~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~  126 (635)
                      |.|..|.|....         ..++.|+|++|+|++ +++..+. ++++|+.|+|++|+|++..|..|.++++|++|+|+
T Consensus        18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            478889997531         347789999999995 5554777 99999999999999997777889999999999999


Q ss_pred             cCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-----CCCCCcEEEeecccCc
Q 006677          127 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       127 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l~~N~l~  199 (635)
                      +|+|++..+..|.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..     .+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            9999976666665  89999999999999888999999999999999999999754432     5899999999999999


Q ss_pred             CCCCcccCCCC-----CCCccCCCCCCCC
Q 006677          200 GSIPSSLQKFP-----NSSFVGNSLLCGP  223 (635)
Q Consensus       200 g~~p~~~~~l~-----~l~~~~n~~l~~~  223 (635)
                      +..+..+..++     .|...+|+..|.+
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence            65556666665     3567788877764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.73  E-value=9.9e-18  Score=169.41  Aligned_cols=146  Identities=23%  Similarity=0.198  Sum_probs=107.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCC-CCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~-l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .+++.|+|++|.+++..|. .|+++++|++|+|++|. ++...|..+.++++|++|+|++|.+++..|..+.  ++|++|
T Consensus        56 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  134 (285)
T 1ozn_A           56 RNLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL  134 (285)
T ss_dssp             TTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence            4677788888877754454 67788888888888886 6655577777888888888888888776666665  678888


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++|++++..+..|+++++|++|+|++|+|++..+..  .+++|+.|+|++|++++..|..|.++++|..+
T Consensus       135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  206 (285)
T 1ozn_A          135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL  206 (285)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe
Confidence            88888887666666777788888888888777655532  67777778888877777777777776666654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.73  E-value=4.5e-18  Score=173.77  Aligned_cols=156  Identities=24%  Similarity=0.298  Sum_probs=94.5

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCC--CCCCCCCCCCcccEEee
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYL  125 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g--~~p~~~~~l~~L~~L~l  125 (635)
                      |.|.+|.|+...         .+++.|+|++|+++ .+|+..|+++++|++|+|++|.++.  .+|..+.++++|++|+|
T Consensus         7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L   85 (306)
T 2z66_A            7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL   85 (306)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred             eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence            589999998532         46899999999998 7887678999999999999999872  23445555666666666


Q ss_pred             ccCccCCcCCCCcc--CCcceeeccCccCcccCC-chhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          126 QHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       126 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      ++|.++ .+|..+.  ++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..|..  .+++|+.|+|++|.+++
T Consensus        86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  164 (306)
T 2z66_A           86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE  164 (306)
T ss_dssp             CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence            666655 3343333  445555555555553332 34455555555555555555444432  44455555555555543


Q ss_pred             -CCCcccCCCCCCCc
Q 006677          201 -SIPSSLQKFPNSSF  214 (635)
Q Consensus       201 -~~p~~~~~l~~l~~  214 (635)
                       .+|..+.++++|..
T Consensus       165 ~~~~~~~~~l~~L~~  179 (306)
T 2z66_A          165 NFLPDIFTELRNLTF  179 (306)
T ss_dssp             GEECSCCTTCTTCCE
T ss_pred             ccchhHHhhCcCCCE
Confidence             34444444444433

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=3e-18  Score=162.56  Aligned_cols=127  Identities=27%  Similarity=0.318  Sum_probs=110.6

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCC-CCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccC
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF  149 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~  149 (635)
                      .+++++++++ .+|. .+..  +|++|+|++|+|++..|. .|+++++|++|+|++|+|++..|..|.  ++|++|+|++
T Consensus        12 ~l~~s~~~l~-~ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           12 TVDCTGRGLK-EIPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EEECTTSCCS-SCCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EEEcCCCCcC-cCcc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            4666777885 7887 4443  899999999999965554 489999999999999999998898887  7999999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      |+|++..|..|.++++|++|+|++|+|++.+|..  .+++|++|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            9999988888999999999999999999988864  78999999999999998765

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.72  E-value=3.5e-17  Score=165.80  Aligned_cols=143  Identities=31%  Similarity=0.329  Sum_probs=96.5

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      ..++.|+|++|.+++..+. .|.++++|++|+|++|+|++ +|.. +.+++|++|+|++|+++ .+|..+.  ++|++|+
T Consensus        31 ~~l~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~  106 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLA-TLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD  106 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGG-GGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred             CCCCEEEcCCCcCCccCHH-HhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence            3577788888887754443 67777777777777777774 4432 67777777777777776 5666554  6677777


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |++|+|++..|..|.++++|++|+|++|+|++..+..  .+++|+.|+|++|+|++..+..|.++++|..+
T Consensus       107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L  177 (290)
T 1p9a_G          107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL  177 (290)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEE
Confidence            7777777666666777777777777777777555443  56777777777777775444455556655544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.72  E-value=2.5e-17  Score=166.38  Aligned_cols=147  Identities=24%  Similarity=0.233  Sum_probs=129.5

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCc-cCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~--~~L~~L  145 (635)
                      ..++.|+|++|++++ +++..|+++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..+.  ++|++|
T Consensus        32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L  110 (285)
T 1ozn_A           32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (285)
T ss_dssp             TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence            468999999999995 555589999999999999999998889999999999999999998 7766577776  799999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      +|++|++++..|..|.++++|++|+|++|++++..+..  .+++|+.|+|++|++++..+..+.++++|..++
T Consensus       111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  183 (285)
T 1ozn_A          111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (285)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence            99999999888999999999999999999999776653  799999999999999976666788888777653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.72  E-value=3.4e-18  Score=189.34  Aligned_cols=157  Identities=23%  Similarity=0.248  Sum_probs=136.7

Q ss_pred             CCCcceeEecCC-----------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEe
Q 006677           56 CQSWVGINCTQD-----------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLY  124 (635)
Q Consensus        56 c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~  124 (635)
                      | .|.|+ |+..           ..+++.|+|++|++++..|. .|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus         4 C-~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            4 C-DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             E-CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             C-CCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            5 79998 8632           13699999999999966565 799999999999999999988889999999999999


Q ss_pred             eccCccCCcCCCCcc--CCcceeeccCccCcc-cCCchhhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccC
Q 006677          125 LQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGL  198 (635)
Q Consensus       125 l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l  198 (635)
                      |++|++++..|..|.  ++|++|+|++|++++ .+|..++++++|++|+|++|++.+.+|..   .+++|++|+|++|++
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            999999987776676  799999999999997 46789999999999999999966666642   789999999999999


Q ss_pred             cCCCCcccCCCCCCCcc
Q 006677          199 KGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       199 ~g~~p~~~~~l~~l~~~  215 (635)
                      ++.+|..+.++++|..+
T Consensus       161 ~~~~~~~l~~l~~L~~L  177 (549)
T 2z81_A          161 RNYQSQSLKSIRDIHHL  177 (549)
T ss_dssp             CEECTTTTTTCSEEEEE
T ss_pred             cccChhhhhccccCceE
Confidence            99999999888776554

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.71  E-value=5.9e-18  Score=190.44  Aligned_cols=153  Identities=20%  Similarity=0.215  Sum_probs=130.3

Q ss_pred             ceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCcc
Q 006677           60 VGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF  130 (635)
Q Consensus        60 ~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l  130 (635)
                      ..|.|...         ...++.|+|++|.|+ .||+..|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|
T Consensus        34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l  112 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI  112 (635)
T ss_dssp             TEEECTTSCCSSCCSSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CEEECCCCCcCccCCCCCcCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence            35778642         146899999999999 57766899999999999999999976677899999999999999999


Q ss_pred             CCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCccccc-CCCC--CCCCCcEEEeecccCcCCCCcc
Q 006677          131 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSS  205 (635)
Q Consensus       131 ~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~l~l~~N~l~g~~p~~  205 (635)
                      ++..|..|.  ++|++|+|++|+|++..+..|++|++|++|+|++|+|++. +|..  .+++|++|+|++|++++..|..
T Consensus       113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence            966666666  7999999999999987777899999999999999999863 4543  7899999999999999888888


Q ss_pred             cCCCCCCC
Q 006677          206 LQKFPNSS  213 (635)
Q Consensus       206 ~~~l~~l~  213 (635)
                      +..+.++.
T Consensus       193 l~~L~~l~  200 (635)
T 4g8a_A          193 LRVLHQMP  200 (635)
T ss_dssp             GHHHHTCT
T ss_pred             ccchhhhh
Confidence            87665544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=2.9e-17  Score=155.68  Aligned_cols=126  Identities=26%  Similarity=0.278  Sum_probs=112.1

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|..+.|++..         ..++.|+|++|.+++..+.+.++.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus         8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A            8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            479999997532         37889999999998655544599999999999999999998899999999999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCC
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN  182 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~  182 (635)
                      |+|++..|..|.  ++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            999988887776  8999999999999999999999999999999999999987653

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.71  E-value=7e-17  Score=159.99  Aligned_cols=154  Identities=24%  Similarity=0.316  Sum_probs=135.4

Q ss_pred             CCCcceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCC
Q 006677           56 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIP  135 (635)
Q Consensus        56 c~~w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p  135 (635)
                      |+.|.|+.|..   ....+++++++++ .+|. .+.  ++|+.|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus         4 Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            4 CETVTGCTCNE---GKKEVDCQGKSLD-SVPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             CHHHHSSEEEG---GGTEEECTTCCCS-SCCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             CCCCCceEcCC---CCeEEecCCCCcc-ccCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            55899999964   2346899999999 7887 454  689999999999998888899999999999999999998888


Q ss_pred             CCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCC
Q 006677          136 SSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPN  211 (635)
Q Consensus       136 ~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~  211 (635)
                      ..|.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..  .+++|+.|+|++|+|++..|..|.++++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  156 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN  156 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence            7776  89999999999999888888999999999999999999776653  7999999999999999777778888888


Q ss_pred             CCccC
Q 006677          212 SSFVG  216 (635)
Q Consensus       212 l~~~~  216 (635)
                      |..++
T Consensus       157 L~~L~  161 (251)
T 3m19_A          157 LQTLS  161 (251)
T ss_dssp             CCEEE
T ss_pred             CCEEE
Confidence            87664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.71  E-value=5.5e-18  Score=176.87  Aligned_cols=164  Identities=25%  Similarity=0.267  Sum_probs=128.7

Q ss_pred             CCCCCCCCCCcceeEecCC-----------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCC
Q 006677           49 WSSTNPICQSWVGINCTQD-----------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSL  117 (635)
Q Consensus        49 w~~~~~~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l  117 (635)
                      |......| .|.|+ |+..           ..+++.|+|++|++++ +|+..++++++|++|+|++|++++..|..|+++
T Consensus        23 ~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (353)
T 2z80_A           23 SNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL   99 (353)
T ss_dssp             ----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             CCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence            44344445 79988 6521           1368899999999985 555579999999999999999998778889999


Q ss_pred             CcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCc--hhhccccCCcEEcCCCc-ccccCCCC--CCCCCcE
Q 006677          118 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNN-LSGSIPNF--DIPKLRH  190 (635)
Q Consensus       118 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~--~l~~L~~  190 (635)
                      ++|++|+|++|++++..+..|.  ++|++|+|++|++++ +|.  .+.++++|++|++++|+ +.+..+..  .+++|+.
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~  178 (353)
T 2z80_A          100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE  178 (353)
T ss_dssp             TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred             CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence            9999999999999954443354  789999999999994 554  78899999999999994 66554443  7889999


Q ss_pred             EEeecccCcCCCCcccCCCCCCCccC
Q 006677          191 LNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       191 l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++++|++++..|..+.++++|+.++
T Consensus       179 L~l~~n~l~~~~~~~l~~l~~L~~L~  204 (353)
T 2z80_A          179 LEIDASDLQSYEPKSLKSIQNVSHLI  204 (353)
T ss_dssp             EEEEETTCCEECTTTTTTCSEEEEEE
T ss_pred             EECCCCCcCccCHHHHhccccCCeec
Confidence            99999999988898888888776653

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.71  E-value=1.5e-17  Score=186.03  Aligned_cols=171  Identities=19%  Similarity=0.160  Sum_probs=137.2

Q ss_pred             CCCCCCCCCCCCC---cceeEecCC----------------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCC
Q 006677           46 KLNWSSTNPICQS---WVGINCTQD----------------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVL  106 (635)
Q Consensus        46 ~~~w~~~~~~c~~---w~gv~C~~~----------------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l  106 (635)
                      ..+|.++.+||..   |.++.|+..                -..+..+++.++.+. .+|+..++++++|++|+|++|.+
T Consensus         9 l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l   87 (597)
T 3oja_B            9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI   87 (597)
T ss_dssp             --CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCC
T ss_pred             ccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCC
Confidence            3478877777654   655555410                024567888888887 68877789999999999999999


Q ss_pred             CCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-
Q 006677          107 TGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-  183 (635)
Q Consensus       107 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-  183 (635)
                      ++..|..|+++++|++|+|++|.+++..|..|+  ++|++|+|++|+|++..+..|+++++|++|+|++|.|++.+|.. 
T Consensus        88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  167 (597)
T 3oja_B           88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF  167 (597)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred             CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence            988888999999999999999999988887776  89999999999999666666799999999999999999888764 


Q ss_pred             -CCCCCcEEEeecccCcCCCCcccCCCCCCCccCC
Q 006677          184 -DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN  217 (635)
Q Consensus       184 -~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  217 (635)
                       .+++|+.|+|++|.+++..+..+.++..|...+|
T Consensus       168 ~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n  202 (597)
T 3oja_B          168 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN  202 (597)
T ss_dssp             TTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred             hcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence             8999999999999999765555555555444444

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.70  E-value=1.8e-16  Score=152.20  Aligned_cols=152  Identities=24%  Similarity=0.326  Sum_probs=125.4

Q ss_pred             eeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc-
Q 006677           61 GINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-  139 (635)
Q Consensus        61 gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-  139 (635)
                      +..|..     +.++..+++++ .+|.. +  .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|. 
T Consensus         4 ~C~C~~-----~~v~c~~~~l~-~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~   74 (208)
T 2o6s_A            4 RCSCSG-----TTVECYSQGRT-SVPTG-I--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK   74 (208)
T ss_dssp             TCEEET-----TEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred             CCEECC-----CEEEecCCCcc-CCCCC-C--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC
Confidence            455643     46888999988 67763 3  56899999999999976667789999999999999999966555555 


Q ss_pred             -CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc-
Q 006677          140 -PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV-  215 (635)
Q Consensus       140 -~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~-  215 (635)
                       ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..  .+++|+.|+|++|++++..+..+.++++|..+ 
T Consensus        75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  154 (208)
T 2o6s_A           75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW  154 (208)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred             CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence             89999999999999777777899999999999999999877753  78999999999999997777667777776654 


Q ss_pred             --CCCCCC
Q 006677          216 --GNSLLC  221 (635)
Q Consensus       216 --~n~~l~  221 (635)
                        +|+..|
T Consensus       155 l~~N~~~~  162 (208)
T 2o6s_A          155 LHDNPWDC  162 (208)
T ss_dssp             CCSCCBCC
T ss_pred             ecCCCeec
Confidence              555444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.70  E-value=6.3e-17  Score=151.20  Aligned_cols=131  Identities=26%  Similarity=0.307  Sum_probs=109.8

Q ss_pred             CCcceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCC
Q 006677           57 QSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS  136 (635)
Q Consensus        57 ~~w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~  136 (635)
                      |+|.+|.|+.            ++++ .+|.. +  .++|+.|+|++|++++..+..|.++++|++|+|++|++++..+.
T Consensus         7 C~~~~l~~~~------------~~l~-~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (177)
T 2o6r_A            7 CSGTEIRCNS------------KGLT-SVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG   70 (177)
T ss_dssp             EETTEEECCS------------SCCS-SCCTT-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             eCCCEEEecC------------CCCc-cCCCC-C--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence            3788777764            4555 56652 3  37899999999999976667789999999999999999976665


Q ss_pred             Ccc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          137 SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       137 ~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      .|.  ++|++|+|++|+|++..+..+.++++|++|+|++|+|++..+..  .+++|+.|+|++|++++..|
T Consensus        71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            555  79999999999999877778899999999999999999766653  68999999999999998665

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.70  E-value=1.8e-17  Score=175.47  Aligned_cols=170  Identities=20%  Similarity=0.178  Sum_probs=130.5

Q ss_pred             CCCCCCCCCCCCcceeEecCC-------------------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCC
Q 006677           47 LNWSSTNPICQSWVGINCTQD-------------------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT  107 (635)
Q Consensus        47 ~~w~~~~~~c~~w~gv~C~~~-------------------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~  107 (635)
                      .+|....+||+.|.++.|...                   -.++..|++.++.+. .+|+..+..+++|++|+|++|.++
T Consensus         4 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~   82 (390)
T 3o6n_A            4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE   82 (390)
T ss_dssp             ---CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred             CCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCccc
Confidence            368877777776555555310                   135677899999887 688867899999999999999999


Q ss_pred             CCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--
Q 006677          108 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--  183 (635)
Q Consensus       108 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--  183 (635)
                      +..|..|.++++|++|+|++|++++..|..|.  ++|++|+|++|+|+...+..|.++++|++|+|++|++++..|..  
T Consensus        83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (390)
T 3o6n_A           83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ  162 (390)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred             ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence            77777999999999999999999988787776  78999999999999544445799999999999999999877753  


Q ss_pred             CCCCCcEEEeecccCcCCCCcccCCCCCCCccCC
Q 006677          184 DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGN  217 (635)
Q Consensus       184 ~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  217 (635)
                      .+++|+.|+|++|++++.-...+.++..+...+|
T Consensus       163 ~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n  196 (390)
T 3o6n_A          163 ATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN  196 (390)
T ss_dssp             SCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred             CCCCCCEEECCCCcCCccccccccccceeecccc
Confidence            7899999999999999754444444444444443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.70  E-value=9.8e-17  Score=160.94  Aligned_cols=135  Identities=30%  Similarity=0.345  Sum_probs=120.6

Q ss_pred             CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           68 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        68 ~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      -.+++.|+|++|.+++ +++..++++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+.  ++|++|
T Consensus        84 l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  162 (272)
T 3rfs_A           84 LTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL  162 (272)
T ss_dssp             CTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence            3579999999999995 5554799999999999999999987777899999999999999999977776665  899999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      +|++|+|++..+..|+++++|+.|+|++|+|++.+|..  .+++|+.|+|++|.+.+..|
T Consensus       163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            99999999888888899999999999999999887763  79999999999999987655

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.70  E-value=2.9e-17  Score=167.78  Aligned_cols=145  Identities=25%  Similarity=0.266  Sum_probs=90.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .++..|+|++|.+. .+|. .+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+++..|..+.  ++|++|
T Consensus        78 ~~L~~L~Ls~n~i~-~l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           78 TSLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             SCCCEEECCSCSEE-EEEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             cccCEEECCCCccc-cChh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            35666777777666 4555 46666666666666666664333 4566666666666666666665555554  566666


Q ss_pred             eccCccCcc-cCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++|++++ .+|..+..+++|++|+|++|+|++..|..  .+++|+.|+|++|++++..+..+.++++|..+
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  228 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  228 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence            666666665 45666666666666666666666555543  56666666666666665555455555555443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.70  E-value=2.3e-17  Score=178.27  Aligned_cols=151  Identities=23%  Similarity=0.314  Sum_probs=133.0

Q ss_pred             Ccce--eEecCCC--------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeec
Q 006677           58 SWVG--INCTQDR--------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQ  126 (635)
Q Consensus        58 ~w~g--v~C~~~~--------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~  126 (635)
                      .|.+  |.|+...        .+++.|+|++|.+++..|. .|+++++|++|+|++|.+.+.+| ..|.++++|++|+|+
T Consensus         9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A            9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            4554  8887542        4689999999999976565 89999999999999999987774 679999999999999


Q ss_pred             cCccCCcCCCCcc--CCcceeeccCccCcccCCch--hhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCc
Q 006677          127 HNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       127 ~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~  199 (635)
                      +|++++..|..|.  ++|++|+|++|++++.+|..  |+++++|++|+|++|++++..|..   .+++|++|+|++|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            9999988898887  89999999999999876665  999999999999999999887763   7999999999999999


Q ss_pred             CCCCcccCCC
Q 006677          200 GSIPSSLQKF  209 (635)
Q Consensus       200 g~~p~~~~~l  209 (635)
                      +..|..+.++
T Consensus       168 ~~~~~~l~~l  177 (455)
T 3v47_A          168 SICEEDLLNF  177 (455)
T ss_dssp             CCCTTTSGGG
T ss_pred             ccChhhhhcc
Confidence            9989888766

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.70  E-value=4e-17  Score=177.55  Aligned_cols=157  Identities=21%  Similarity=0.199  Sum_probs=136.4

Q ss_pred             CcceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC
Q 006677           58 SWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN  128 (635)
Q Consensus        58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N  128 (635)
                      .|..|.|...         ...++.|+|++|++++..+. .|.++++|++|+|++|.+++..|..|.+|++|++|+|++|
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            5788999753         23688999999999965554 8999999999999999999888999999999999999999


Q ss_pred             ccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCc
Q 006677          129 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS  204 (635)
Q Consensus       129 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~  204 (635)
                      ++++..+..|.  ++|++|+|++|++++..|..|.++++|+.|+|++|.+++..|..  .+++|+.|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            99965555555  89999999999999999999999999999999999999877754  889999999999999976666


Q ss_pred             ccCCCCCCCcc
Q 006677          205 SLQKFPNSSFV  215 (635)
Q Consensus       205 ~~~~l~~l~~~  215 (635)
                      .+.++++|..+
T Consensus       171 ~l~~l~~L~~L  181 (477)
T 2id5_A          171 ALSHLHGLIVL  181 (477)
T ss_dssp             HHTTCTTCCEE
T ss_pred             HhcccCCCcEE
Confidence            77777777655

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.70  E-value=6.9e-18  Score=192.22  Aligned_cols=178  Identities=20%  Similarity=0.260  Sum_probs=112.1

Q ss_pred             CChhHHHHHHHHHHhCC---CCCCCCCCCCCCCCCCcceeEecCCCCeEEEEEeCCCCcc------------------C-
Q 006677           26 DLNSDRQALLDFADAVP---HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLV------------------G-   83 (635)
Q Consensus        26 ~~~~~~~al~~~~~~~~---~~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~------------------g-   83 (635)
                      ....++++|+++..++.   ......|......+.+|.++.++.  .+++.|+|.++++.                  + 
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~  206 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDED  206 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence            34678899999987762   223336765555556899988875  45666666544332                  2 


Q ss_pred             -------cCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcc
Q 006677           84 -------PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTG  154 (635)
Q Consensus        84 -------~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g  154 (635)
                             .++++.+..+.+|+.|+|++|.+. .+|..+.+|++|++|+|++|.|+ .+|..|.  ++|++|+|++|+|+ 
T Consensus       207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-  283 (727)
T 4b8c_D          207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred             cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence                   134446888899999999999998 78888889999999999999999 8888876  78999999999999 


Q ss_pred             cCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCC
Q 006677          155 NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKF  209 (635)
Q Consensus       155 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l  209 (635)
                      .+|..|++|++|++|+|++|.|+ .+|..  .+++|+.|+|++|.|+|.+|..+..+
T Consensus       284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  339 (727)
T 4b8c_D          284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK  339 (727)
T ss_dssp             SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred             ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence            88999999999999999999997 55653  78899999999999998888777543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.70  E-value=4.6e-17  Score=175.79  Aligned_cols=157  Identities=22%  Similarity=0.168  Sum_probs=115.2

Q ss_pred             CcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC
Q 006677           58 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN  128 (635)
Q Consensus        58 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N  128 (635)
                      .|..|.|.+..         .+++.|+|++|++++..|. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQAD-TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHH-HcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            46788887532         4689999999999965555 8999999999999999999888899999999999999999


Q ss_pred             ccCCcCCCCcc--CCcceeeccCccCcccCCchhhc-------------------------cccCCcEEcCCCcccccCC
Q 006677          129 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQN-------------------------LTQLTGLSLQSNNLSGSIP  181 (635)
Q Consensus       129 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~-------------------------l~~L~~L~l~~N~l~~~~p  181 (635)
                      ++++..+..|.  ++|++|+|++|+|++..+..|.+                         +++|++|+|++|+|++...
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~  213 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN  213 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccccc
Confidence            99966555565  78999999999888655545544                         4455555555555553321


Q ss_pred             CCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          182 NFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       182 ~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ...+++|+.|+|++|++++..|..|.++++|..+
T Consensus       214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  247 (452)
T 3zyi_A          214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL  247 (452)
T ss_dssp             CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred             ccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence            1255666666666666666666666666665544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.69  E-value=5.8e-17  Score=164.11  Aligned_cols=149  Identities=29%  Similarity=0.326  Sum_probs=109.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ ++.  .+.+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.  ++|++|+
T Consensus        55 ~~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~  130 (290)
T 1p9a_G           55 TRLTQLNLDRAELTK-LQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY  130 (290)
T ss_dssp             TTCCEEECTTSCCCE-EEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCc-ccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence            467788888888774 554  367888888888888887 6777788888888888888888866666665  6788888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCc---cCCCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLC  221 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~---~~n~~l~  221 (635)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..  .+++|+.|+|++|+|+ .+|..+..+.+|..   .+|+..|
T Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            8888888666666778888888888888888554443  5778888888888887 67766665555443   3555554


Q ss_pred             C
Q 006677          222 G  222 (635)
Q Consensus       222 ~  222 (635)
                      .
T Consensus       210 ~  210 (290)
T 1p9a_G          210 N  210 (290)
T ss_dssp             S
T ss_pred             c
Confidence            3

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.69  E-value=8.2e-18  Score=189.40  Aligned_cols=132  Identities=17%  Similarity=0.314  Sum_probs=117.8

Q ss_pred             CccCcCCcccccCCCCCcEEEeecCCCCCC-----------------CCCCCC--CCCcccEEeeccCccCCcCCCCcc-
Q 006677           80 GLVGPIPNNTLGKLDALEVLSLRSNVLTGG-----------------LPSEIT--SLPSLRYLYLQHNNFSGKIPSSFS-  139 (635)
Q Consensus        80 ~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p~~~~-  139 (635)
                      +++| ||+ .++++++|++|+|++|.|+|.                 +|..++  +|++|++|+|++|++.|.+|..|+ 
T Consensus       194 ~l~~-ip~-~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~  271 (636)
T 4eco_A          194 NITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA  271 (636)
T ss_dssp             EEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred             CCcc-CCH-HHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence            4556 887 799999999999999999986                 999999  999999999999999999999887 


Q ss_pred             -CCcceeeccCcc-Ccc-cCCchhhcc------ccCCcEEcCCCcccccCCC--C--CCCCCcEEEeecccCcCCCCccc
Q 006677          140 -PQLVVLDLSFNS-FTG-NIPQSIQNL------TQLTGLSLQSNNLSGSIPN--F--DIPKLRHLNLSYNGLKGSIPSSL  206 (635)
Q Consensus       140 -~~L~~L~ls~N~-l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~--~l~~L~~l~l~~N~l~g~~p~~~  206 (635)
                       ++|++|+|++|+ |+| .+|..++++      ++|++|+|++|+++ .+|.  .  .+++|+.|+|++|+++|.+| .+
T Consensus       272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~  349 (636)
T 4eco_A          272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF  349 (636)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred             CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence             799999999998 998 899999887      99999999999999 7776  3  88999999999999999999 88


Q ss_pred             CCCCCCCcc
Q 006677          207 QKFPNSSFV  215 (635)
Q Consensus       207 ~~l~~l~~~  215 (635)
                      .++++|..+
T Consensus       350 ~~l~~L~~L  358 (636)
T 4eco_A          350 GSEIKLASL  358 (636)
T ss_dssp             EEEEEESEE
T ss_pred             CCCCCCCEE
Confidence            777766655

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.69  E-value=1.2e-16  Score=160.56  Aligned_cols=152  Identities=22%  Similarity=0.271  Sum_probs=84.4

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      +++.|+|++|.+++ +++..++++++|++|+|++|.+++..|..|.++++|++|++++|++++..+..+.  ++|++|+|
T Consensus        53 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  131 (276)
T 2z62_A           53 ELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (276)
T ss_dssp             TCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred             CCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence            45566666666653 3333556666666666666666655555566666666666666666544443443  45556666


Q ss_pred             cCccCccc-CCchhhccccCCcEEcCCCcccccC----------------------------CCC-CCCCCcEEEeeccc
Q 006677          148 SFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSGSI----------------------------PNF-DIPKLRHLNLSYNG  197 (635)
Q Consensus       148 s~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~----------------------------p~~-~l~~L~~l~l~~N~  197 (635)
                      ++|++++. +|..|.++++|+.|+|++|++++..                            +.. ...+|+.|+|++|+
T Consensus       132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~  211 (276)
T 2z62_A          132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ  211 (276)
T ss_dssp             CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSC
T ss_pred             cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCc
Confidence            66655542 4555555555555555555555432                            222 33467777777777


Q ss_pred             CcCCCCcccCCCCCCC---ccCCCCCCC
Q 006677          198 LKGSIPSSLQKFPNSS---FVGNSLLCG  222 (635)
Q Consensus       198 l~g~~p~~~~~l~~l~---~~~n~~l~~  222 (635)
                      +++..+..+.++++|.   ..+|+..|.
T Consensus       212 l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          212 LKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             CSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             eeecCHhHhcccccccEEEccCCccccc
Confidence            7755555555555544   334544443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.68  E-value=9e-17  Score=166.14  Aligned_cols=157  Identities=21%  Similarity=0.284  Sum_probs=127.0

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|..+.|+...         .+++.|+|++|++++ +++..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            479999997532         368999999999995 4444899999999999999999988899999999999999999


Q ss_pred             CccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccc--cCCCC--CCCCCcEEEeecccCcCCCC
Q 006677          128 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       128 N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~l~l~~N~l~g~~p  203 (635)
                      |+++ .+|..+.++|++|+|++|++++..+..|.++++|+.|++++|.++.  ..|..  .+ +|+.|++++|++++ +|
T Consensus       112 n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~  188 (332)
T 2ft3_A          112 NHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP  188 (332)
T ss_dssp             SCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred             CcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence            9999 7888888999999999999997777789999999999999999963  44432  33 77777777777774 44


Q ss_pred             ccc-CCCCCCCccCC
Q 006677          204 SSL-QKFPNSSFVGN  217 (635)
Q Consensus       204 ~~~-~~l~~l~~~~n  217 (635)
                      ..+ .++..|...+|
T Consensus       189 ~~~~~~L~~L~l~~n  203 (332)
T 2ft3_A          189 KDLPETLNELHLDHN  203 (332)
T ss_dssp             SSSCSSCSCCBCCSS
T ss_pred             ccccCCCCEEECCCC
Confidence            433 34444444444

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.68  E-value=5e-17  Score=163.40  Aligned_cols=143  Identities=21%  Similarity=0.212  Sum_probs=125.4

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .++.|+|++|++++ +++..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.  ++|++|++
T Consensus        29 ~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            58999999999995 4444799999999999999999977777899999999999999999987777776  79999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCccccc-CCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      ++|++++..+..++++++|++|+|++|++++. +|..  .+++|+.|+|++|++++..+..+..++++.
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  176 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP  176 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence            99999987777899999999999999999873 4654  789999999999999987777776665554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.68  E-value=1.6e-16  Score=164.15  Aligned_cols=142  Identities=20%  Similarity=0.249  Sum_probs=117.8

Q ss_pred             CCcceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|+.+.|++.         ...++.|+|++|++++ +++..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            47999999742         2468889999999995 5555799999999999999999988899999999999999999


Q ss_pred             CccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccc--cCCCC--CCCCCcEEEeecccCcC
Q 006677          128 NNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG--SIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       128 N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      |+++ .+|..+.++|++|++++|++++..+..|.++++|+.|+|++|.++.  ..+..  .+++|+.|++++|+++.
T Consensus       110 n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          110 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            9999 7888888899999999999997777778888888888888888863  33332  56677777777776663

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.68  E-value=5.6e-17  Score=175.15  Aligned_cols=129  Identities=22%  Similarity=0.264  Sum_probs=113.3

Q ss_pred             CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEc
Q 006677           94 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSL  171 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  171 (635)
                      ++|+.|+|++|++++.+|..|+++++|++|+|++|++++..|..|.  ++|++|+|++|++++..|..|.++++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            6899999999999988999999999999999999999988888887  79999999999999888999999999999999


Q ss_pred             CCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc---CCCCCCC
Q 006677          172 QSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCG  222 (635)
Q Consensus       172 ~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~---~n~~l~~  222 (635)
                      ++|++++..|..  .+++|++|+|++|++++..+..+.++++|..+   +|+.-|.
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  410 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  410 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence            999999887764  89999999999999997666667777776654   5555444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.68  E-value=4.9e-17  Score=182.27  Aligned_cols=152  Identities=20%  Similarity=0.229  Sum_probs=133.3

Q ss_pred             ceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCcc
Q 006677           60 VGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF  130 (635)
Q Consensus        60 ~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l  130 (635)
                      ..|.|.+.         ..+++.|+|++|.+++..+. .|+++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus        14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSY-SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChh-hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            35777642         25789999999999965554 799999999999999999988888999999999999999999


Q ss_pred             CCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccc-cCCCC--CCCCCcEEEeecccCcCCCCcc
Q 006677          131 SGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLKGSIPSS  205 (635)
Q Consensus       131 ~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~--~l~~L~~l~l~~N~l~g~~p~~  205 (635)
                      ++..|..|.  ++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..  .+++|++|+|++|++++..|..
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~  172 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND  172 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence            988899887  899999999999998887899999999999999999986 56764  8999999999999999888887


Q ss_pred             cCCCCCC
Q 006677          206 LQKFPNS  212 (635)
Q Consensus       206 ~~~l~~l  212 (635)
                      ++.++++
T Consensus       173 ~~~l~~L  179 (606)
T 3vq2_A          173 LQFLREN  179 (606)
T ss_dssp             THHHHHC
T ss_pred             hhhhhcc
Confidence            7766544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=6.1e-17  Score=149.89  Aligned_cols=132  Identities=25%  Similarity=0.229  Sum_probs=109.6

Q ss_pred             CeEEEEEeCCCCcc-CcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~-g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .+++.|+|++|+++ |.+|. .+..+++|++|+|++|.+++.  ..+.++++|++|+|++|++++.+|..+.  ++|++|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            46888999999998 78887 688999999999999999865  7889999999999999999987777664  789999


Q ss_pred             eccCccCcccC-CchhhccccCCcEEcCCCcccccCC----C-CCCCCCcEEEeecccCcCCCCc
Q 006677          146 DLSFNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIP----N-FDIPKLRHLNLSYNGLKGSIPS  204 (635)
Q Consensus       146 ~ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~p----~-~~l~~L~~l~l~~N~l~g~~p~  204 (635)
                      +|++|+|++.. +..+..+++|+.|+|++|.+++..+    . ..+++|++|++++|.+. .+|.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99999998542 2788899999999999999987665    1 27889999999999887 4554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.67  E-value=7.4e-17  Score=180.86  Aligned_cols=154  Identities=19%  Similarity=0.108  Sum_probs=137.1

Q ss_pred             cceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCc
Q 006677           59 WVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN  129 (635)
Q Consensus        59 w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~  129 (635)
                      +..|.|.+.         ...++.|+|++|.+++..|. .|+++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            566888643         24689999999999965554 89999999999999999998889999999999999999999


Q ss_pred             cCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCccccc-CCCC-CCCCCcEEEeecccCcCCCCcc
Q 006677          130 FSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS-IPNF-DIPKLRHLNLSYNGLKGSIPSS  205 (635)
Q Consensus       130 l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~-~l~~L~~l~l~~N~l~g~~p~~  205 (635)
                      +++..|..|.  ++|++|+|++|++++..|..++++++|++|+|++|++++. +|.. .+++|+.|+|++|++++..|..
T Consensus        93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred             ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence            9988898887  8999999999999987788999999999999999999974 4544 7999999999999999888888


Q ss_pred             cCCCCCCC
Q 006677          206 LQKFPNSS  213 (635)
Q Consensus       206 ~~~l~~l~  213 (635)
                      +.++++|.
T Consensus       173 ~~~l~~L~  180 (606)
T 3t6q_A          173 MSSLQQAT  180 (606)
T ss_dssp             HHTTTTCC
T ss_pred             hhhhcccc
Confidence            88888776

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.67  E-value=9e-17  Score=176.78  Aligned_cols=145  Identities=26%  Similarity=0.370  Sum_probs=122.2

Q ss_pred             CCCCCCCCCC----Cccee-EecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccE
Q 006677           48 NWSSTNPICQ----SWVGI-NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY  122 (635)
Q Consensus        48 ~w~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~  122 (635)
                      +|..+..+|.    .|.|+ .|..  .+++.|+|++|+|++ ||.. +  +++|++|+|++|+|+ .+|   ..+++|++
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~  104 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEY  104 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence            5766666663    49999 7864  479999999999996 8873 5  389999999999999 788   56899999


Q ss_pred             EeeccCccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCC
Q 006677          123 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSI  202 (635)
Q Consensus       123 L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~  202 (635)
                      |+|++|+|++ +|. +..+|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +
T Consensus       105 L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          105 LDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             EECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-C
T ss_pred             EEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-c
Confidence            9999999997 888 77899999999999997 777   68999999999999997 665 78899999999999997 7


Q ss_pred             CcccCCCCCCCc
Q 006677          203 PSSLQKFPNSSF  214 (635)
Q Consensus       203 p~~~~~l~~l~~  214 (635)
                      |. |.  ++|.+
T Consensus       176 p~-l~--~~L~~  184 (571)
T 3cvr_A          176 PE-LP--ESLEA  184 (571)
T ss_dssp             CC-CC--TTCCE
T ss_pred             ch-hh--CCCCE
Confidence            77 54  44443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.67  E-value=7.2e-17  Score=180.94  Aligned_cols=144  Identities=24%  Similarity=0.211  Sum_probs=83.3

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      ++..|+|++|.+++ +|. .+..+++|+.|+|++|++++..| ..+.++++|++|+|++|.+++.+|..+.  ++|++|+
T Consensus       377 ~L~~L~L~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  454 (606)
T 3vq2_A          377 SLRHLDLSFNGAII-MSA-NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK  454 (606)
T ss_dssp             CCCEEECCSCSEEE-ECC-CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred             cccEeECCCCcccc-chh-hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEE
Confidence            45666666666653 443 46666666666666666665555 4556666666666666666655555554  5566666


Q ss_pred             ccCccCcc-cCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          147 LSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       147 ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |++|++++ .+|..|+++++|+.|+|++|++++.+|..  .+++|+.|+|++|++++.+|..+.++++|..+
T Consensus       455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  526 (606)
T 3vq2_A          455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL  526 (606)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred             CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence            66666655 25555566666666666666665555442  55556666666666655555555555554443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.67  E-value=1.1e-16  Score=186.32  Aligned_cols=136  Identities=28%  Similarity=0.303  Sum_probs=118.2

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCC-CCCCCCcccEEeeccCccCC-----cCCCCcc--CCcceeeccCccCcccCCchhh
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRYLYLQHNNFSG-----KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ  161 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~-~~~~l~~L~~L~l~~N~l~g-----~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~  161 (635)
                      ++++++|+.|+|++|++++..+. .+..+++|+.|+|++|.+++     ..|..|.  ++|++|+|++|+|++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            55889999999999999965443 46778999999999999983     3344454  7899999999999999999999


Q ss_pred             ccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccCCCCCCCCCC
Q 006677          162 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPPL  225 (635)
Q Consensus       162 ~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~l~~~~l  225 (635)
                      ++++|+.|+|++|+|++.+|....++|+.|+|++|+|++.+|..+.++..+.+.+|+..|.+++
T Consensus       502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred             chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence            9999999999999999877766558999999999999999999999999999999999986653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.66  E-value=1.9e-16  Score=150.11  Aligned_cols=123  Identities=30%  Similarity=0.379  Sum_probs=108.7

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCc
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN  150 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N  150 (635)
                      .+++++++++ .+|.+ +  .++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.  ++|++|+|++|
T Consensus        14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            4667778887 78873 4  368999999999999 8999999999999999999999987777776  89999999999


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      +|++..|..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|.+..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            999888889999999999999999999766643  78999999999999874

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.66  E-value=6.5e-17  Score=158.93  Aligned_cols=141  Identities=16%  Similarity=0.196  Sum_probs=112.7

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCC-CCCCCCCCCCCCCcccEEeecc-CccCCcCCCCcc--CCcce
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVV  144 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~-l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~  144 (635)
                      ..++.|+|++|+++ .+|+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.  ++|++
T Consensus        31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            46889999999998 4565579999999999999997 8855556899999999999998 999966556665  78999


Q ss_pred             eeccCccCcccCCchhhccccCC---cEEcCCC-cccccCCCC--CCCCCc-EEEeecccCcCCCCcccCCCCCCC
Q 006677          145 LDLSFNSFTGNIPQSIQNLTQLT---GLSLQSN-NLSGSIPNF--DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       145 L~ls~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~--~l~~L~-~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      |+|++|++++ +|. |.++++|+   .|++++| ++++..+..  .+++|+ .|+|++|+++ .+|......++|.
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~  182 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD  182 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEE
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCC
Confidence            9999999986 776 88888888   9999999 888666543  788899 9999999988 5665433224443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.66  E-value=4.3e-17  Score=167.05  Aligned_cols=133  Identities=23%  Similarity=0.288  Sum_probs=70.0

Q ss_pred             eEEEEEeCCCCccCcCCcccc-cCCCCCcEEEeecCCCCCCCCCCCCCC-----CcccEEeeccCccCCcCCCCcc--CC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTL-GKLDALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS--PQ  141 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l-~~l~~L~~L~L~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~--~~  141 (635)
                      +++.|+|++|+++|.+|...+ +.+++|++|+|++|++++. |..++++     ++|++|+|++|++++..|..|.  ++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            455555555555555555221 5555555566655555544 5555554     5555555555555555545554  45


Q ss_pred             cceeeccCccCccc--CCchh--hccccCCcEEcCCCccccc--CCCC---CCCCCcEEEeecccCcCCCC
Q 006677          142 LVVLDLSFNSFTGN--IPQSI--QNLTQLTGLSLQSNNLSGS--IPNF---DIPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       142 L~~L~ls~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~~~--~p~~---~l~~L~~l~l~~N~l~g~~p  203 (635)
                      |++|+|++|++.|.  +|..+  +++++|++|+|++|+|++.  ++..   .+++|+.|+|++|++++.+|
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence            55555555555544  22233  5555555555555555521  1111   44555566666665555443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.65  E-value=4.6e-17  Score=187.34  Aligned_cols=144  Identities=22%  Similarity=0.372  Sum_probs=131.7

Q ss_pred             CeEEEEEeCCCCccC-----------------cCCccccc--CCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCc
Q 006677           69 TRVFGLRLPGIGLVG-----------------PIPNNTLG--KLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN  129 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g-----------------~l~~~~l~--~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~  129 (635)
                      .+++.|+|++|.++|                 .+|+ .++  ++++|++|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence            578999999999998                 4998 677  99999999999999999999999999999999999998


Q ss_pred             -cCC-cCCCCcc---------CCcceeeccCccCcccCCc--hhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeec
Q 006677          130 -FSG-KIPSSFS---------PQLVVLDLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSY  195 (635)
Q Consensus       130 -l~g-~~p~~~~---------~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~  195 (635)
                       |+| .+|..++         ++|++|+|++|+|+ .+|.  .|+++++|+.|+|++|+|+ .+|.. .+++|+.|+|++
T Consensus       527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~  604 (876)
T 4ecn_A          527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY  604 (876)
T ss_dssp             TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred             CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence             998 8998765         38999999999999 8999  9999999999999999999 78755 889999999999


Q ss_pred             ccCcCCCCcccCCCCC-CCccC
Q 006677          196 NGLKGSIPSSLQKFPN-SSFVG  216 (635)
Q Consensus       196 N~l~g~~p~~~~~l~~-l~~~~  216 (635)
                      |+++ .+|..+.++++ |..++
T Consensus       605 N~l~-~lp~~l~~l~~~L~~L~  625 (876)
T 4ecn_A          605 NQIE-EIPEDFCAFTDQVEGLG  625 (876)
T ss_dssp             SCCS-CCCTTSCEECTTCCEEE
T ss_pred             Cccc-cchHHHhhccccCCEEE
Confidence            9999 89998988877 76553

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.65  E-value=1.6e-16  Score=184.95  Aligned_cols=149  Identities=20%  Similarity=0.207  Sum_probs=130.4

Q ss_pred             CcceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCC-CCCCCCCCcccEEeeccCccCCcCCC
Q 006677           58 SWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPS  136 (635)
Q Consensus        58 ~w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~  136 (635)
                      +|+.|-+  ...+++.|+|++|.+++..|. .|+++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|.+++..|.
T Consensus        15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            5777766  346799999999999966565 7999999999999999887777 78899999999999999999988899


Q ss_pred             Ccc--CCcceeeccCccCcccCCch--hhccccCCcEEcCCCcccccCCC---CCCCCCcEEEeecccCcCCCCcccCCC
Q 006677          137 SFS--PQLVVLDLSFNSFTGNIPQS--IQNLTQLTGLSLQSNNLSGSIPN---FDIPKLRHLNLSYNGLKGSIPSSLQKF  209 (635)
Q Consensus       137 ~~~--~~L~~L~ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~~~~p~---~~l~~L~~l~l~~N~l~g~~p~~~~~l  209 (635)
                      .|.  ++|++|+|++|++++.+|..  |+++++|++|+|++|.+++..+.   ..+++|+.|+|++|.+++..|..+..+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            887  79999999999999877776  99999999999999999987654   289999999999999998888877654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.65  E-value=4.4e-16  Score=167.48  Aligned_cols=154  Identities=27%  Similarity=0.271  Sum_probs=112.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCC-------------------------CCcccEE
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITS-------------------------LPSLRYL  123 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~-------------------------l~~L~~L  123 (635)
                      .++..|+|++|+++ .+|+..|..+++|++|+|++|.|++..+..|.+                         +++|++|
T Consensus       112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  190 (440)
T 3zyj_A          112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL  190 (440)
T ss_dssp             SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred             ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence            56888899998888 566557888888888888888887444434444                         5555555


Q ss_pred             eeccCccCCcCCCCcc-CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          124 YLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       124 ~l~~N~l~g~~p~~~~-~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      +|++|+++ .+|.-.. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|+|++
T Consensus       191 ~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  269 (440)
T 3zyj_A          191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL  269 (440)
T ss_dssp             ECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred             cCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence            55555555 3332111 57888888888888888888888999999999999988776654  78899999999999997


Q ss_pred             CCCcccCCCCCCC---ccCCCCCCCCC
Q 006677          201 SIPSSLQKFPNSS---FVGNSLLCGPP  224 (635)
Q Consensus       201 ~~p~~~~~l~~l~---~~~n~~l~~~~  224 (635)
                      ..+..|.++++|.   ..+|+..|.+.
T Consensus       270 ~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          270 LPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             cChhHhccccCCCEEEcCCCCccCCCC
Confidence            7776677666654   45777777654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.65  E-value=2.3e-16  Score=150.15  Aligned_cols=139  Identities=19%  Similarity=0.364  Sum_probs=119.4

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|+++ .+|  .+..+++|++|+|++|.++  .++.+.++++|++|+|++|++++..|..+.  ++|++|+
T Consensus        44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            35888999999998 777  3999999999999999776  334899999999999999999987888887  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCc-ccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNN-LSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |++|++++..|..+.++++|++|+|++|. ++ .+|.. .+++|+.|++++|++++ ++ .+.++++|..+
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L  186 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL  186 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence            99999999899999999999999999998 55 45544 88999999999999996 44 66677766654

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.64  E-value=6.3e-17  Score=176.10  Aligned_cols=147  Identities=20%  Similarity=0.188  Sum_probs=94.4

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc---CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L  145 (635)
                      ..+..|+|++|.+++..+.    .+++|+.|+|++|.|++..|..++++++|++|+|++|.+++.+|..+.   ++|++|
T Consensus        99 ~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L  174 (487)
T 3oja_A           99 PSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (487)
T ss_dssp             TTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence            3456667777776643322    346677777777777766666777777777777777777776666654   567777


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCC---ccCCCCCC
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS---FVGNSLLC  221 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~---~~~n~~l~  221 (635)
                      +|++|+|++..+  +..+++|+.|+|++|.|++.+|.. .+++|+.|+|++|.|++ +|..+..+++|.   +.+|+..|
T Consensus       175 ~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c  251 (487)
T 3oja_A          175 NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (487)
T ss_dssp             ECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred             ecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence            777777775522  334677777777777777655554 56777777777777774 565565555443   33555544


Q ss_pred             C
Q 006677          222 G  222 (635)
Q Consensus       222 ~  222 (635)
                      +
T Consensus       252 ~  252 (487)
T 3oja_A          252 G  252 (487)
T ss_dssp             H
T ss_pred             c
Confidence            3

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.64  E-value=7.8e-16  Score=166.12  Aligned_cols=154  Identities=25%  Similarity=0.233  Sum_probs=117.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCC-------------------------CCCCCcccEE
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-------------------------ITSLPSLRYL  123 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~-------------------------~~~l~~L~~L  123 (635)
                      .++..|+|++|.++ .+|+..|.++++|++|+|++|+|++..+..                         |.++++|++|
T Consensus       123 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L  201 (452)
T 3zyi_A          123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL  201 (452)
T ss_dssp             TTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred             ccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence            46888999999988 566657888889999999888887443334                         4455566666


Q ss_pred             eeccCccCCcCCCCcc-CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          124 YLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       124 ~l~~N~l~g~~p~~~~-~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      +|++|++++ +|.-.. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..  .+++|+.|+|++|+|++
T Consensus       202 ~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  280 (452)
T 3zyi_A          202 NLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS  280 (452)
T ss_dssp             ECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             ECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence            666666663 332111 67889999999999888999999999999999999999877764  78999999999999997


Q ss_pred             CCCcccCCCCCCC---ccCCCCCCCCC
Q 006677          201 SIPSSLQKFPNSS---FVGNSLLCGPP  224 (635)
Q Consensus       201 ~~p~~~~~l~~l~---~~~n~~l~~~~  224 (635)
                      ..+..+..+++|.   ..+|+..|.+.
T Consensus       281 ~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          281 LPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             cChHHhccccCCCEEEccCCCcCCCCC
Confidence            7777777666654   55787777654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=1.2e-16  Score=144.86  Aligned_cols=123  Identities=26%  Similarity=0.283  Sum_probs=78.7

Q ss_pred             CeEEEEEeCCCCcc-CcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~-g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .+++.|++++|+++ |.+|. .++.+++|++|+|++|.+++.  ..++++++|++|+|++|.+++.+|..+.  ++|++|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            34666777777776 66665 566777777777777777644  5666777777777777777665555543  566777


Q ss_pred             eccCccCccc-CCchhhccccCCcEEcCCCcccccCC---C-C-CCCCCcEEEee
Q 006677          146 DLSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSGSIP---N-F-DIPKLRHLNLS  194 (635)
Q Consensus       146 ~ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~-~-~l~~L~~l~l~  194 (635)
                      +|++|++++. .|..+.++++|++|++++|.+++..+   . . .+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            7777766642 33566666666666666666665444   1 1 56666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.63  E-value=1.4e-16  Score=163.01  Aligned_cols=147  Identities=22%  Similarity=0.229  Sum_probs=109.1

Q ss_pred             CeEEEEEeCCCCccCcCCc---ccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCc--CCCCc--c--
Q 006677           69 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IPSSF--S--  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~---~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--~--  139 (635)
                      .++..|+|++|.+++..+.   ..+..+++|++|+|++|++++..|..|+++++|++|+|++|++.+.  ++...  .  
T Consensus       117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l  196 (310)
T 4glp_A          117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF  196 (310)
T ss_dssp             BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred             CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence            4688899999999876552   2456788999999999999888888899999999999999988752  22221  2  


Q ss_pred             CCcceeeccCccCcccCCc----hhhccccCCcEEcCCCcccccCCCC--C---CCCCcEEEeecccCcCCCCcccC-CC
Q 006677          140 PQLVVLDLSFNSFTGNIPQ----SIQNLTQLTGLSLQSNNLSGSIPNF--D---IPKLRHLNLSYNGLKGSIPSSLQ-KF  209 (635)
Q Consensus       140 ~~L~~L~ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~--~---l~~L~~l~l~~N~l~g~~p~~~~-~l  209 (635)
                      ++|++|+|++|+|+ .+|.    .++++++|++|+|++|+|++..|..  .   +++|++|+|++|+|+ .+|..+. ++
T Consensus       197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L  274 (310)
T 4glp_A          197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKL  274 (310)
T ss_dssp             CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCC
T ss_pred             CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCC
Confidence            68899999999987 3333    2577888999999999998876642  3   368999999999988 6676653 34


Q ss_pred             CCCCccCC
Q 006677          210 PNSSFVGN  217 (635)
Q Consensus       210 ~~l~~~~n  217 (635)
                      ..|...+|
T Consensus       275 ~~L~Ls~N  282 (310)
T 4glp_A          275 RVLDLSSN  282 (310)
T ss_dssp             SCEECCSC
T ss_pred             CEEECCCC
Confidence            44444344

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.63  E-value=2e-16  Score=172.18  Aligned_cols=97  Identities=21%  Similarity=0.216  Sum_probs=60.2

Q ss_pred             CcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhh-ccccCCcEEcCCCcccccCCCCCCCCCcEEEee
Q 006677          118 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS  194 (635)
Q Consensus       118 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~  194 (635)
                      ++|+.|+|++|.+++..|..+.  ++|++|+|++|+|++.+|..+. ++++|+.|+|++|.|++..+...+++|+.|+|+
T Consensus       120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls  199 (487)
T 3oja_A          120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLS  199 (487)
T ss_dssp             SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECC
T ss_pred             CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECC
Confidence            3444555555555554455544  5666777777777766666665 567777777777777665444567777777777


Q ss_pred             cccCcCCCCcccCCCCCCCcc
Q 006677          195 YNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       195 ~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|+|++ +|..+..+++|..+
T Consensus       200 ~N~l~~-~~~~~~~l~~L~~L  219 (487)
T 3oja_A          200 SNKLAF-MGPEFQSAAGVTWI  219 (487)
T ss_dssp             SSCCCE-ECGGGGGGTTCSEE
T ss_pred             CCCCCC-CCHhHcCCCCccEE
Confidence            777775 34446666665554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.63  E-value=2.5e-16  Score=176.48  Aligned_cols=145  Identities=23%  Similarity=0.241  Sum_probs=118.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCC-CCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE-ITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .++..|+|++|.+.+..|. .++.+++|+.|+|++|.+++..|.. +.++++|++|+|++|.+++..|..+.  ++|++|
T Consensus       376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  454 (606)
T 3t6q_A          376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL  454 (606)
T ss_dssp             TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence            4688899999988866665 7888899999999999988776654 88889999999999998888887775  788888


Q ss_pred             eccCccCccc---CCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFTGN---IPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~g~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++|++++.   .+..+..+++|++|+|++|++++.+|..  .+++|+.|+|++|++++..|..+.+++.| ++
T Consensus       455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L  528 (606)
T 3t6q_A          455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL  528 (606)
T ss_dssp             ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred             ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence            8888888863   3356888888888888888888877664  78888888888888888888888888777 44

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.63  E-value=7.7e-16  Score=158.93  Aligned_cols=144  Identities=25%  Similarity=0.357  Sum_probs=122.3

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCC--CCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l  147 (635)
                      .+..|+|++|.+++ +++..+.++++|++|+|++|.++  +..|..+.++++|++|++++|.++ .+|..+.++|++|+|
T Consensus       122 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l  199 (330)
T 1xku_A          122 TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL  199 (330)
T ss_dssp             TCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEEC
T ss_pred             cccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEEC
Confidence            45566666666663 44446888999999999999886  367788999999999999999998 578887799999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      ++|++++..|..|.++++|+.|+|++|++++..+..  .+++|+.|+|++|+++ .+|..+..+++|..++
T Consensus       200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~  269 (330)
T 1xku_A          200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  269 (330)
T ss_dssp             TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence            999999988999999999999999999999877753  7899999999999999 8898888888877653

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.62  E-value=8.6e-16  Score=170.56  Aligned_cols=150  Identities=23%  Similarity=0.339  Sum_probs=122.2

Q ss_pred             CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCC--CCCCCCCCCCcccEEeeccCccCCcCCCCcc---CCc
Q 006677           68 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQL  142 (635)
Q Consensus        68 ~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L  142 (635)
                      ..+++.|+|++|.+++.+|. .++++++|++|+|++|++++  .+|..++++++|++|+|++|++++.+|....   ++|
T Consensus       352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L  430 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI  430 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred             CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence            45788999999999987887 78999999999999999996  3456789999999999999999987776533   789


Q ss_pred             ceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcc-cCCCCCCCcc---C
Q 006677          143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSSFV---G  216 (635)
Q Consensus       143 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~~---~  216 (635)
                      ++|+|++|+|++.+|..+.  ++|+.|+|++|+|+ .+|..  .+++|+.|+|++|+|+ .+|.. +..+++|..+   +
T Consensus       431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCS
T ss_pred             CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecC
Confidence            9999999999988877665  78999999999998 45543  7899999999999999 56665 7777766544   5


Q ss_pred             CCCCCC
Q 006677          217 NSLLCG  222 (635)
Q Consensus       217 n~~l~~  222 (635)
                      |+..|.
T Consensus       507 N~~~c~  512 (562)
T 3a79_B          507 NPWDCT  512 (562)
T ss_dssp             CCBCCC
T ss_pred             CCcCCC
Confidence            655553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.62  E-value=4.9e-16  Score=176.64  Aligned_cols=148  Identities=26%  Similarity=0.289  Sum_probs=125.6

Q ss_pred             CcceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC
Q 006677           58 SWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN  128 (635)
Q Consensus        58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N  128 (635)
                      .+..|.|+..         ..+++.|+|++|++++ +++..|+++++|++|+|++|.+++..|..|++|++|++|+|++|
T Consensus         5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             ECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            4556677532         2478999999999995 55557999999999999999999888999999999999999999


Q ss_pred             ccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCc
Q 006677          129 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPS  204 (635)
Q Consensus       129 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~  204 (635)
                      ++++..+..|.  ++|++|+|++|++++..|..|+++++|++|+|++|.+++.+|..  .+++|++|+|++|.+++..|.
T Consensus        84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            99965554566  78999999999999877789999999999999999999887764  789999999999999987776


Q ss_pred             cc
Q 006677          205 SL  206 (635)
Q Consensus       205 ~~  206 (635)
                      .+
T Consensus       164 ~~  165 (680)
T 1ziw_A          164 EL  165 (680)
T ss_dssp             HH
T ss_pred             Hh
Confidence            54

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.62  E-value=1.5e-16  Score=162.96  Aligned_cols=146  Identities=27%  Similarity=0.291  Sum_probs=119.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCC-----CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCc--CCCCc--c
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKL-----DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGK--IPSSF--S  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l-----~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--~  139 (635)
                      .+++.|+|++|.+++. |. .++.+     ++|++|+|++|++++..|..|+++++|++|+|++|++.|.  +|..+  .
T Consensus       121 ~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  198 (312)
T 1wwl_A          121 PDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL  198 (312)
T ss_dssp             CCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred             CCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence            5789999999999976 65 78877     9999999999999988889999999999999999999875  33333  2


Q ss_pred             --CCcceeeccCccCcc--cCC-chhhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCcCCCCcccC-CCC
Q 006677          140 --PQLVVLDLSFNSFTG--NIP-QSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQ-KFP  210 (635)
Q Consensus       140 --~~L~~L~ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g~~p~~~~-~l~  210 (635)
                        ++|++|+|++|+|++  .++ ..+.++++|+.|+|++|+|++.+|..   .+++|+.|+|++|+|+ .+|..+. ++.
T Consensus       199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~  277 (312)
T 1wwl_A          199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLS  277 (312)
T ss_dssp             SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEE
T ss_pred             cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCce
Confidence              799999999999993  233 34468899999999999999977532   5789999999999999 7888776 333


Q ss_pred             CCCccCC
Q 006677          211 NSSFVGN  217 (635)
Q Consensus       211 ~l~~~~n  217 (635)
                      .|...+|
T Consensus       278 ~L~Ls~N  284 (312)
T 1wwl_A          278 VLDLSYN  284 (312)
T ss_dssp             EEECCSS
T ss_pred             EEECCCC
Confidence            3433344

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.62  E-value=1.2e-15  Score=164.04  Aligned_cols=156  Identities=25%  Similarity=0.248  Sum_probs=103.9

Q ss_pred             CcceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC
Q 006677           58 SWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN  128 (635)
Q Consensus        58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N  128 (635)
                      .|..|.|.+.         ...++.|+|++|++++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            4678888753         1357788999999885444 47888888888888888888666678888888888888888


Q ss_pred             ccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCC-------------------------CcccccCC
Q 006677          129 NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS-------------------------NNLSGSIP  181 (635)
Q Consensus       129 ~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~-------------------------N~l~~~~p  181 (635)
                      +|++..+..|.  ++|++|+|++|+|++..+..|.++++|+.|+|++                         |+|+. +|
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~  201 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP  201 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence            88855555555  6788888888887755554555555555555555                         44442 22


Q ss_pred             CC-CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          182 NF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       182 ~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      .. .+++|+.|+|++|++++..|..|.++++|..+
T Consensus       202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  236 (440)
T 3zyj_A          202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL  236 (440)
T ss_dssp             CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccCCCcccCEEECCCCccCccChhhhccCccCCEE
Confidence            22 44555555555555555555555555554433

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.62  E-value=8.6e-16  Score=171.78  Aligned_cols=109  Identities=24%  Similarity=0.261  Sum_probs=89.6

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .++..|+|++|.+++..|. .|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.  ++|++|+
T Consensus        75 ~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTY-AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCSEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCCCChH-HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            3678889999988865444 788899999999999999887777888899999999999998854444444  7889999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      |++|+|++..|..|+++++|+.|+|++|.|++
T Consensus       154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             eeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence            99999988888888888888888888888875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=9.4e-16  Score=158.71  Aligned_cols=133  Identities=12%  Similarity=0.121  Sum_probs=96.0

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCC---------------hHH--------HHHHHHHHHhhcCCCceece
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG---------------KRD--------FEQQMEIVGRVGQHPNVVPL  399 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------~~~--------~~~e~~~l~~l~~h~niv~l  399 (635)
                      .+.||+|+||.||+|...+|+.||||+++.....               ...        ..+|...+.++ .+.++...
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~gv~vp  178 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEGFPVP  178 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTTCSCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcCCCCC
Confidence            5689999999999999989999999987532110               111        23455666666 33333221


Q ss_pred             eEEEEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC
Q 006677          400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL  479 (635)
Q Consensus       400 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  479 (635)
                      .-+..  ...++||||++++.|.++...           .....++.|++.+|.|||+.|   ||||||||.|||+++++
T Consensus       179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            11111  234799999999888766431           123568899999999999998   99999999999998877


Q ss_pred             C----------eEEeecCCCCCC
Q 006677          480 D----------GCISDFGLTPLM  492 (635)
Q Consensus       480 ~----------~ki~DfGla~~~  492 (635)
                      .          +.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence            3          889999976543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.62  E-value=9.1e-16  Score=158.54  Aligned_cols=143  Identities=23%  Similarity=0.359  Sum_probs=107.0

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCC--CCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT--GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~l  147 (635)
                      .++.|+|++|.++ .+|+..++++++|+.|+|++|.++  +..|..+..+ +|+.|++++|++++ +|..+.++|++|+|
T Consensus       124 ~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l  200 (332)
T 2ft3_A          124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHL  200 (332)
T ss_dssp             TCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBC
T ss_pred             cCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEEC
Confidence            3455555555555 344435666666666666666664  3556666666 67777777777663 66666678999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      ++|++++..|..|.++++|+.|+|++|++++..+..  .+++|+.|+|++|+++ .+|..+.++++|..++
T Consensus       201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~  270 (332)
T 2ft3_A          201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY  270 (332)
T ss_dssp             CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred             CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence            999999888889999999999999999999877643  7899999999999999 7888888888877653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=3.1e-16  Score=142.02  Aligned_cols=123  Identities=17%  Similarity=0.258  Sum_probs=108.1

Q ss_pred             CCCCCcEEEeecCCCC-CCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCc
Q 006677           92 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG  168 (635)
Q Consensus        92 ~l~~L~~L~L~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~  168 (635)
                      ..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..+.  ++|++|+|++|++++.+|..+.++++|++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            3478999999999998 89999999999999999999999976  5554  79999999999999889999999999999


Q ss_pred             EEcCCCcccccC--CCC-CCCCCcEEEeecccCcCCCC---cccCCCCCCCccC
Q 006677          169 LSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVG  216 (635)
Q Consensus       169 L~l~~N~l~~~~--p~~-~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l~~~~  216 (635)
                      |+|++|++++..  +.. .+++|+.|++++|++++..+   ..+..+++|.+++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~  146 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD  146 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEET
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccccc
Confidence            999999999742  222 89999999999999997665   4788888887765

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=8.7e-16  Score=142.09  Aligned_cols=123  Identities=22%  Similarity=0.291  Sum_probs=108.0

Q ss_pred             CCCCCcEEEeecCCCC-CCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCc
Q 006677           92 KLDALEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG  168 (635)
Q Consensus        92 ~l~~L~~L~L~~n~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~  168 (635)
                      ..++|+.|+|++|+++ +.+|..+.++++|++|+|++|.+++.  ..+.  ++|++|+|++|++++.+|..+.++++|++
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            4578999999999998 89999999999999999999999976  5555  79999999999999889999999999999


Q ss_pred             EEcCCCcccccC--CCC-CCCCCcEEEeecccCcCCCC---cccCCCCCCCccC
Q 006677          169 LSLQSNNLSGSI--PNF-DIPKLRHLNLSYNGLKGSIP---SSLQKFPNSSFVG  216 (635)
Q Consensus       169 L~l~~N~l~~~~--p~~-~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l~~~~  216 (635)
                      |+|++|+|++..  +.. .+++|+.|+|++|.+++..+   ..+..+++|.+++
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~  153 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD  153 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence            999999999743  233 89999999999999996655   4788888888775

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.62  E-value=6.8e-16  Score=167.77  Aligned_cols=147  Identities=20%  Similarity=0.155  Sum_probs=130.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++..|. .|+++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.  ++|++|+
T Consensus        56 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  134 (477)
T 2id5_A           56 PHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE  134 (477)
T ss_dssp             TTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence            5789999999999976665 899999999999999999965556789999999999999999988888887  7999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCC--CCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++|++++..|..|.++++|+.|+|++|++++..+.  ..+++|+.|+|++|.+++..+..|.++++|..++
T Consensus       135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~  206 (477)
T 2id5_A          135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE  206 (477)
T ss_dssp             ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEE
T ss_pred             CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceee
Confidence            999999999999999999999999999999975554  2889999999999999988888888888877653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.61  E-value=1.6e-15  Score=151.28  Aligned_cols=137  Identities=20%  Similarity=0.242  Sum_probs=115.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .+++.|+|++|+++ .+|  .++.+++|+.|+|++|+|++..|  +.++++|++|+|++|++++ +|....++|++|+|+
T Consensus        41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~  114 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLD  114 (263)
T ss_dssp             TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECC
T ss_pred             CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccccCcccEEEcc
Confidence            46888999999998 677  48999999999999999996444  9999999999999999996 444333899999999


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|+|++ +| .+.++++|+.|+|++|+|++..+-..+++|+.|+|++|++++.  ..+.++++|..+
T Consensus       115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L  177 (263)
T 1xeu_A          115 NNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWI  177 (263)
T ss_dssp             SSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEE
T ss_pred             CCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEE
Confidence            999996 43 6999999999999999999764333889999999999999976  667777777654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.61  E-value=2.8e-15  Score=156.71  Aligned_cols=147  Identities=25%  Similarity=0.246  Sum_probs=122.2

Q ss_pred             ceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCC-CCCcccEEeeccCccCCcCCCCc
Q 006677           60 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHNNFSGKIPSSF  138 (635)
Q Consensus        60 ~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~  138 (635)
                      .+..|..     ..+++++++|+ .+|. .+.  ..|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|
T Consensus        14 ~~C~C~~-----~~l~c~~~~l~-~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~   84 (361)
T 2xot_A           14 ANCLCAS-----NILSCSKQQLP-NVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF   84 (361)
T ss_dssp             TTCEEET-----TEEECCSSCCS-SCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT
T ss_pred             CCCEECC-----CEEEeCCCCcC-ccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc
Confidence            5677764     25899999998 6887 343  4689999999999977777787 99999999999999997777777


Q ss_pred             c--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCccc---CCCCC
Q 006677          139 S--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL---QKFPN  211 (635)
Q Consensus       139 ~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~---~~l~~  211 (635)
                      .  ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..  .+++|+.|+|++|+|++..+..|   .++++
T Consensus        85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~  164 (361)
T 2xot_A           85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK  164 (361)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTT
T ss_pred             cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc
Confidence            6  79999999999999888888999999999999999999877764  89999999999999996444444   45666


Q ss_pred             CCcc
Q 006677          212 SSFV  215 (635)
Q Consensus       212 l~~~  215 (635)
                      |..+
T Consensus       165 L~~L  168 (361)
T 2xot_A          165 LMLL  168 (361)
T ss_dssp             CCEE
T ss_pred             CCEE
Confidence            6654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.61  E-value=9.2e-16  Score=168.64  Aligned_cols=141  Identities=27%  Similarity=0.365  Sum_probs=91.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCC--CCCCCCCCCCcccEEeeccCccCCcCCCC-cc--CCcc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLV  143 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~  143 (635)
                      ..++.|+|++|.+++.+|. .++++++|++|+|++|++++  .+|..++++++|++|+|++|.+++.+|.. +.  ++|+
T Consensus       324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            3566677777777766665 56777777777777777765  45556667777777777777777655554 22  5677


Q ss_pred             eeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcc-cCCCCCCCc
Q 006677          144 VLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS-LQKFPNSSF  214 (635)
Q Consensus       144 ~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~-~~~l~~l~~  214 (635)
                      +|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..  .+++|+.|+|++|+|+ .+|.. +.++++|..
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~  472 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK  472 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccE
Confidence            777777777666665553  56777777777776 44442  6677777777777777 45543 555555443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.61  E-value=1e-15  Score=170.15  Aligned_cols=145  Identities=26%  Similarity=0.300  Sum_probs=102.7

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .++..|+|++|.+.+ +++ .++.+++|+.|+|++|.+++..| ..+.++++|++|+|++|.+++.+|..+.  ++|++|
T Consensus       373 ~~L~~L~l~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  450 (570)
T 2z63_A          373 TSLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  450 (570)
T ss_dssp             SCCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred             CccCEEECCCCcccc-ccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence            345666666666663 444 37777777777777777776555 4577777777777777777777776665  677788


Q ss_pred             eccCccCc-ccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFT-GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++|+++ +.+|..+..+++|++|+|++|++++..|..  .+++|+.|+|++|++++..|..+.++++|..+
T Consensus       451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  523 (570)
T 2z63_A          451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI  523 (570)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence            88888776 567777777778888888888777766653  67778888888888877666667666665543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=1.9e-15  Score=143.24  Aligned_cols=120  Identities=21%  Similarity=0.268  Sum_probs=108.0

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|..|.|++..         ..++.|+|++|.++ .+|. .|.++++|+.|+|++|+|++..|..|.+|++|++|+|++
T Consensus        10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            478899997531         36899999999998 8986 899999999999999999988888899999999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccc
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      |+|++..|..|.  ++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            999988777777  899999999999997666789999999999999999974

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.61  E-value=7.5e-16  Score=146.56  Aligned_cols=128  Identities=23%  Similarity=0.339  Sum_probs=109.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.++ .+ + .+..+++|++|+|++|++++..|..|++|++|++|+|++|++++..|..+.  ++|++|+
T Consensus        66 ~~L~~L~l~~n~~~-~~-~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~  142 (197)
T 4ezg_A           66 HNIKDLTINNIHAT-NY-N-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID  142 (197)
T ss_dssp             TTCSEEEEESCCCS-CC-G-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred             CCCCEEEccCCCCC-cc-h-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence            46889999999765 33 3 699999999999999999988899999999999999999999987787776  7999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g  200 (635)
                      |++|++.+.+| .+.++++|+.|+|++|++++..+-..+++|+.|++++|++.+
T Consensus       143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred             ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence            99999444676 799999999999999999975433489999999999999874

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.60  E-value=1.4e-15  Score=170.88  Aligned_cols=156  Identities=22%  Similarity=0.235  Sum_probs=134.7

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccC-CcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS-GKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~--~~L~~L  145 (635)
                      ..+..+++.+++..+..+...+..+.+|+.++++.|.+++..|..+..+++|+.|+|++|.+. +.+|..|.  ++|++|
T Consensus       420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L  499 (635)
T 4g8a_A          420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  499 (635)
T ss_dssp             TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence            346677788888877777777899999999999999999999999999999999999999855 45677776  799999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCC-CCCC---ccCCCC
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKF-PNSS---FVGNSL  219 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l-~~l~---~~~n~~  219 (635)
                      +|++|+|++..|..|.++++|++|+|++|+|++..|..  .+++|+.|+|++|+|++..|..+.++ ++|+   ..+|+.
T Consensus       500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~  579 (635)
T 4g8a_A          500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF  579 (635)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred             ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence            99999999999999999999999999999999877764  89999999999999999999988776 3454   557888


Q ss_pred             CCCCC
Q 006677          220 LCGPP  224 (635)
Q Consensus       220 l~~~~  224 (635)
                      .|.+.
T Consensus       580 ~C~C~  584 (635)
T 4g8a_A          580 ACTCE  584 (635)
T ss_dssp             CCSGG
T ss_pred             cccCC
Confidence            77643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.60  E-value=1.3e-15  Score=168.46  Aligned_cols=146  Identities=22%  Similarity=0.284  Sum_probs=111.3

Q ss_pred             CeEEEEEeCCCCccCcCCc--ccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPN--NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~--~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~  146 (635)
                      .+++.|+|++|.+++ +++  ..++.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|..+.++|++|+
T Consensus       361 ~~L~~L~Ls~N~l~~-~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~  437 (549)
T 2z81_A          361 PSLQTLVLSQNHLRS-MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLD  437 (549)
T ss_dssp             TTCCEEECTTSCCCC-HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEE
T ss_pred             ccCcEEEccCCcccc-cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEE
Confidence            356667777776663 221  24777888888888888888 67878888888888888888887 56666667888888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCc---cCCCCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF---VGNSLLCG  222 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~---~~n~~l~~  222 (635)
                      |++|+|++.+    .++++|++|+|++|+|+ .+|.. .+++|+.|+|++|++++.+|..+.++++|..   .+|+..|.
T Consensus       438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CCCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            8888888643    57889999999999998 56654 7899999999999999888887877776654   45665554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.60  E-value=3.9e-16  Score=159.71  Aligned_cols=145  Identities=21%  Similarity=0.227  Sum_probs=120.2

Q ss_pred             eEEEEEeCCCCccCcCCcccc--cCCCCCcEEEeecCCCCCCCC----CCCCCCCcccEEeeccCccCCcCCCCcc--CC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTL--GKLDALEVLSLRSNVLTGGLP----SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQ  141 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l--~~l~~L~~L~L~~n~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~  141 (635)
                      +++.|+|++|++++.+|. .+  +.+++|++|+|++|.+++..|    ..+..+++|++|+|++|++++..|..|.  ++
T Consensus        92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            488999999999998888 56  999999999999999998766    3456899999999999999988888876  79


Q ss_pred             cceeeccCccCccc--C--CchhhccccCCcEEcCCCcccccCCC-----CCCCCCcEEEeecccCcCCCCcccCCC---
Q 006677          142 LVVLDLSFNSFTGN--I--PQSIQNLTQLTGLSLQSNNLSGSIPN-----FDIPKLRHLNLSYNGLKGSIPSSLQKF---  209 (635)
Q Consensus       142 L~~L~ls~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~-----~~l~~L~~l~l~~N~l~g~~p~~~~~l---  209 (635)
                      |++|+|++|++.+.  +  +..++++++|++|+|++|+|+...+.     ..+++|++|+|++|++++.+|..+..+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            99999999998763  3  23357899999999999999743221     167999999999999999888887766   


Q ss_pred             CCCCcc
Q 006677          210 PNSSFV  215 (635)
Q Consensus       210 ~~l~~~  215 (635)
                      ++|..+
T Consensus       251 ~~L~~L  256 (310)
T 4glp_A          251 SALNSL  256 (310)
T ss_dssp             TTCCCE
T ss_pred             CcCCEE
Confidence            455554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.59  E-value=1e-15  Score=150.37  Aligned_cols=144  Identities=19%  Similarity=0.235  Sum_probs=122.7

Q ss_pred             CeEEEEEeCCCC-ccCcCCcccccCCCCCcEEEeec-CCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcc-
Q 006677           69 TRVFGLRLPGIG-LVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLV-  143 (635)
Q Consensus        69 ~~v~~l~l~~~~-l~g~l~~~~l~~l~~L~~L~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~-  143 (635)
                      .+++.|+|++|. ++ .+++..|.++++|++|+|++ |++++..|..|.++++|++|+|++|++++ +|. +.  ++|+ 
T Consensus        55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~  131 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI  131 (239)
T ss_dssp             TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred             CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence            578999999997 66 67766899999999999999 99996666789999999999999999996 776 54  6677 


Q ss_pred             --eeeccCc-cCcccCCchhhccccCC-cEEcCCCcccccCCCC--CCCCCcEEEeeccc-CcCCCCcccCCC-CCCCcc
Q 006677          144 --VLDLSFN-SFTGNIPQSIQNLTQLT-GLSLQSNNLSGSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKF-PNSSFV  215 (635)
Q Consensus       144 --~L~ls~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~-l~g~~p~~~~~l-~~l~~~  215 (635)
                        +|+|++| ++++..+..|.++++|+ .|+|++|+++ .+|..  ..++|+.|+|++|+ +++..+..|.++ ++|..+
T Consensus       132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L  210 (239)
T 2xwt_C          132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL  210 (239)
T ss_dssp             EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred             ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence              9999999 99977777899999999 9999999999 55543  44789999999995 996667778888 777765


Q ss_pred             C
Q 006677          216 G  216 (635)
Q Consensus       216 ~  216 (635)
                      +
T Consensus       211 ~  211 (239)
T 2xwt_C          211 D  211 (239)
T ss_dssp             E
T ss_pred             E
Confidence            3

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.59  E-value=1.4e-15  Score=169.08  Aligned_cols=143  Identities=21%  Similarity=0.193  Sum_probs=125.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|++++..+ ..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.  ++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCCEECT-TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccCccCh-hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            468899999999996444 4799999999999999999977788899999999999999999987777776  7999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccc-cCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG-SIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS  212 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l  212 (635)
                      |++|++++..+..|+++++|++|+|++|.+++ .+|..  .+++|+.|++++|++++..|..+.++++|
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  175 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM  175 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence            99999997666679999999999999999997 45654  79999999999999998888878777666

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.58  E-value=2.5e-15  Score=166.84  Aligned_cols=125  Identities=26%  Similarity=0.326  Sum_probs=103.1

Q ss_pred             cCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCC--cCCCCcc--CCcceeeccCccCcccCCc-hhhcccc
Q 006677           91 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQ-SIQNLTQ  165 (635)
Q Consensus        91 ~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~-~~~~l~~  165 (635)
                      +.+++|++|+|++|++++.+|..++++++|++|+|++|++++  .+|..+.  ++|++|+|++|++++.+|. .+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            678889999999999998888899999999999999999986  3345555  7899999999999985665 4788899


Q ss_pred             CCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          166 LTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       166 L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |+.|+|++|+|++.+|..-.++|+.|+|++|+++ .+|..+.++++|..++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~  479 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELN  479 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred             CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence            9999999999988777653378999999999998 7888777888777653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.58  E-value=4.7e-15  Score=168.51  Aligned_cols=152  Identities=23%  Similarity=0.261  Sum_probs=97.5

Q ss_pred             EEEEeCCCCcc--CcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCC--------Ccc--
Q 006677           72 FGLRLPGIGLV--GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS--------SFS--  139 (635)
Q Consensus        72 ~~l~l~~~~l~--g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--------~~~--  139 (635)
                      ..|+|.+|.+.  +.+|. .++++++|++|+|++|++++..|..|.++++|++|+|++|++++..+.        .|.  
T Consensus       457 ~~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l  535 (680)
T 1ziw_A          457 QRLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL  535 (680)
T ss_dssp             CEEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTC
T ss_pred             ccchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCC
Confidence            33444444333  34454 567777777777777777765556677777777777777777643211        122  


Q ss_pred             CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCccc----CCCCCCC
Q 006677          140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSL----QKFPNSS  213 (635)
Q Consensus       140 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~----~~l~~l~  213 (635)
                      ++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..+..  .+++|+.|+|++|++++..|..+    .++..+.
T Consensus       536 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~  615 (680)
T 1ziw_A          536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD  615 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEE
Confidence            56777777777777433345777788888888888887555443  67778888888888877666533    4555556


Q ss_pred             ccCCCCCCCCC
Q 006677          214 FVGNSLLCGPP  224 (635)
Q Consensus       214 ~~~n~~l~~~~  224 (635)
                      ..+|+..|.++
T Consensus       616 l~~N~~~c~c~  626 (680)
T 1ziw_A          616 MRFNPFDCTCE  626 (680)
T ss_dssp             CTTCCCCBCCC
T ss_pred             ccCCCcccCCc
Confidence            66777777643

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.58  E-value=4.6e-15  Score=156.81  Aligned_cols=108  Identities=26%  Similarity=0.348  Sum_probs=78.6

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCC-cc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~~L  145 (635)
                      .+++.|+|++|.+++ +++..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. |.  ++|++|
T Consensus        69 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L  146 (390)
T 3o6n_A           69 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL  146 (390)
T ss_dssp             CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             ccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence            357777888877774 44346777888888888888887666677777888888888888777 44443 33  677888


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      +|++|++++..|..|.++++|++|+|++|++++
T Consensus       147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             ECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence            888888777667777777777777777777764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.58  E-value=3.5e-15  Score=155.34  Aligned_cols=95  Identities=21%  Similarity=0.241  Sum_probs=61.5

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCC-CCCCCCcccE-Eee
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EITSLPSLRY-LYL  125 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~-~~~~l~~L~~-L~l  125 (635)
                      |+|..|.|++..         ..++.|+|++|+|+ .||++.|.+|++|++|+|++|++.+.+|. .|.+|++|.. +++
T Consensus         9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X            9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            489999997531         36889999999998 78887899999999999999998766653 3444444332 333


Q ss_pred             ccCccCCcCCCCcc--CCcceeeccCccC
Q 006677          126 QHNNFSGKIPSSFS--PQLVVLDLSFNSF  152 (635)
Q Consensus       126 ~~N~l~g~~p~~~~--~~L~~L~ls~N~l  152 (635)
                      +.|++++..|..|.  ++|++|++++|+|
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l  116 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGI  116 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred             cCCcccccCchhhhhcccccccccccccc
Confidence            34444433333332  3344444433333

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.58  E-value=1.2e-15  Score=167.68  Aligned_cols=125  Identities=27%  Similarity=0.314  Sum_probs=86.6

Q ss_pred             cCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCC--cCCCCcc--CCcceeeccCccCcccCCch-hhcccc
Q 006677           91 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQS-IQNLTQ  165 (635)
Q Consensus        91 ~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~~-~~~l~~  165 (635)
                      ..+++|++|+|++|++++.+|..++++++|++|+|++|++++  .+|..+.  ++|++|+|++|++++.+|.. +..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            566777777777777777677777777777777777777775  4444444  67777777777777655543 667777


Q ss_pred             CCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          166 LTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       166 L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |+.|+|++|++++.+|..-.++|+.|+|++|+++ .+|..+.++++|..++
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~  450 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELN  450 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEE
T ss_pred             CCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEE
Confidence            7777777777776666543367777777777777 6777666666666553

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.56  E-value=1e-15  Score=157.09  Aligned_cols=143  Identities=22%  Similarity=0.208  Sum_probs=93.1

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCC-C---------------CCCCCcccEEeeccCccCC
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-E---------------ITSLPSLRYLYLQHNNFSG  132 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~-~---------------~~~l~~L~~L~l~~N~l~g  132 (635)
                      .+++.|+|++|.+++..+   ++.+++|++|+|++|++++..+. .               ...+++|+.|+|++|++++
T Consensus        58 ~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~  134 (317)
T 3o53_A           58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM  134 (317)
T ss_dssp             TTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred             CcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence            467788888888875432   77788888888888877632110 0               1123455666666666665


Q ss_pred             cCCCCcc--CCcceeeccCccCcccCCchhh-ccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCC
Q 006677          133 KIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ-NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKF  209 (635)
Q Consensus       133 ~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l  209 (635)
                      ..|..+.  ++|++|+|++|++++..|..+. .+++|++|+|++|+|++..+...+++|+.|+|++|++++ +|..+..+
T Consensus       135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l  213 (317)
T 3o53_A          135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSA  213 (317)
T ss_dssp             GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGG
T ss_pred             ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhccc
Confidence            5555554  5677777777777766666653 677777777777777765444467778888888888874 44456666


Q ss_pred             CCCCcc
Q 006677          210 PNSSFV  215 (635)
Q Consensus       210 ~~l~~~  215 (635)
                      ++|..+
T Consensus       214 ~~L~~L  219 (317)
T 3o53_A          214 AGVTWI  219 (317)
T ss_dssp             TTCSEE
T ss_pred             CcccEE
Confidence            666554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=1.8e-17  Score=157.98  Aligned_cols=143  Identities=25%  Similarity=0.331  Sum_probs=120.9

Q ss_pred             eEEEEEeCCCCccCcCCc-----ccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCc
Q 006677           70 RVFGLRLPGIGLVGPIPN-----NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL  142 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~-----~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L  142 (635)
                      +|+.++|+++.++|.+|.     ..++.+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+.  ++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            456666777777777664     258999999999999999996 88 8999999999999999999 6787665  789


Q ss_pred             ceeeccCccCcccCCchhhccccCCcEEcCCCcccccCC--C-CCCCCCcEEEeecccCcCCCCcc----------cCCC
Q 006677          143 VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKF  209 (635)
Q Consensus       143 ~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~~----------~~~l  209 (635)
                      ++|+|++|+|++ +| .+.++++|+.|+|++|+|++..+  . ..+++|++|++++|.+++.+|..          +.++
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l  173 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL  173 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence            999999999996 55 79999999999999999996433  2 38999999999999999877753          7888


Q ss_pred             CCCCccCC
Q 006677          210 PNSSFVGN  217 (635)
Q Consensus       210 ~~l~~~~n  217 (635)
                      ++|..++.
T Consensus       174 ~~L~~Ld~  181 (198)
T 1ds9_A          174 PNLKKLDG  181 (198)
T ss_dssp             SSCSEECC
T ss_pred             CCcEEECC
Confidence            88888763

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.56  E-value=8.5e-15  Score=148.25  Aligned_cols=136  Identities=32%  Similarity=0.400  Sum_probs=103.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ +++  ++++++|++|+|++|.+++ +| .+.++++|++|+|++|++++. + .+.  ++|++|+
T Consensus        68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~-~l~~l~~L~~L~  140 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY  140 (291)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G-GGGGCTTCCEEE
T ss_pred             CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-h-hhcCCCCCCEEE
Confidence            467788888888874 443  7888888888888888884 44 488888888888888888853 3 333  7788888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |++|++++.  ..+.++++|+.|+|++|+|++..|-..+++|+.|+|++|++++ +| .+.++++|..+
T Consensus       141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L  205 (291)
T 1h6t_A          141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVL  205 (291)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEE
T ss_pred             ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            888888854  5788888888888888888876664578888888888888885 44 36666666654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.56  E-value=3.5e-16  Score=178.15  Aligned_cols=137  Identities=27%  Similarity=0.308  Sum_probs=119.3

Q ss_pred             CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           68 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        68 ~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      ...+..|+|++|.+. .||+ .+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|+  ++|++|
T Consensus       223 l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L  298 (727)
T 4b8c_D          223 DQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF  298 (727)
T ss_dssp             CCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred             CCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence            357889999999998 8998 5779999999999999999 89999999999999999999999 8899987  799999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CC-CCCcEEEeecccCcCCCCcccCCC
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DI-PKLRHLNLSYNGLKGSIPSSLQKF  209 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l-~~L~~l~l~~N~l~g~~p~~~~~l  209 (635)
                      +|++|+|+ .+|..|++|++|+.|+|++|.|+|.+|..  .+ ..+..|+|++|.++|.+|..+..+
T Consensus       299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l  364 (727)
T 4b8c_D          299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI  364 (727)
T ss_dssp             ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred             ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence            99999998 88999999999999999999999988864  11 122357899999999999876654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.56  E-value=6.8e-16  Score=158.43  Aligned_cols=138  Identities=19%  Similarity=0.142  Sum_probs=87.2

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc---CCcceee
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---PQLVVLD  146 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---~~L~~L~  146 (635)
                      .+..|+|++|.+++..+    ..+++|+.|+|++|++++..|..++++++|++|+|++|.+++..|..+.   ++|++|+
T Consensus       100 ~L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  175 (317)
T 3o53_A          100 SIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (317)
T ss_dssp             TCCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             CcCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence            34455555555553222    2356677777777777766666677777777777777777766565553   5677777


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF  214 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~  214 (635)
                      |++|+|++. | ....+++|++|+|++|+|++..+.. .+++|+.|+|++|+++ .+|..+..+++|..
T Consensus       176 L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~  241 (317)
T 3o53_A          176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH  241 (317)
T ss_dssp             CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE
T ss_pred             CCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE
Confidence            777777644 2 2234677777777777777554443 5667777777777777 45666655555543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.54  E-value=7.9e-15  Score=161.99  Aligned_cols=117  Identities=25%  Similarity=0.263  Sum_probs=84.6

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeecc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLS  148 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls  148 (635)
                      +..|+|++|+|++ +|.  ++++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++  ++|++|+|+
T Consensus       443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             ceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            5567777777774 663  777777777777777777 677777777777777777777775 56 454  677777777


Q ss_pred             CccCcccC-CchhhccccCCcEEcCCCcccccCCCC-----CCCCCcEEEe
Q 006677          149 FNSFTGNI-PQSIQNLTQLTGLSLQSNNLSGSIPNF-----DIPKLRHLNL  193 (635)
Q Consensus       149 ~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~l~~L~~l~l  193 (635)
                      +|+|++.+ |..|++|++|+.|+|++|+|++.+|..     .+++|+.|+|
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            77777665 777777777777777777777766643     3667777654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.54  E-value=1.2e-14  Score=147.03  Aligned_cols=136  Identities=22%  Similarity=0.321  Sum_probs=116.6

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|++++|++. .++  .++.+++|++|+|++|++++..|  +.++++|++|+|++|.+++ +|. +.  ++|++|+
T Consensus        46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~  118 (291)
T 1h6t_A           46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLS  118 (291)
T ss_dssp             HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEE
T ss_pred             CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEE
Confidence            45889999999998 465  38999999999999999996544  9999999999999999996 443 44  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++|++++.  ..+.++++|+.|+|++|++++. +.. .+++|+.|+|++|++++..|  +.++++|..++
T Consensus       119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~  184 (291)
T 1h6t_A          119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY  184 (291)
T ss_dssp             CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence            999999963  5799999999999999999976 443 89999999999999997655  88888877654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.54  E-value=1.4e-14  Score=147.85  Aligned_cols=136  Identities=27%  Similarity=0.380  Sum_probs=101.1

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ +++  +..+++|++|+|++|.+++ +| .+.++++|++|+|++|++++. |. +.  ++|++|+
T Consensus        63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~  135 (308)
T 1h6u_A           63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLY  135 (308)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred             CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEE
Confidence            467888888888874 554  7888888888888888884 44 688888888888888888864 32 33  7788888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |++|++++..+  +.++++|+.|+|++|++++..+-..+++|+.|+|++|++++..+  +.++++|..+
T Consensus       136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  200 (308)
T 1h6u_A          136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEV  200 (308)
T ss_dssp             CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             CCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEE
Confidence            88888885443  77888888888888888865554477888888888888875433  5666666554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.54  E-value=1.8e-14  Score=150.19  Aligned_cols=149  Identities=23%  Similarity=0.250  Sum_probs=123.7

Q ss_pred             ceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc
Q 006677           60 VGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS  139 (635)
Q Consensus        60 ~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  139 (635)
                      ..+.|...  .+  .++++++++ .+|. .+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.
T Consensus        26 ~~~~C~~~--~~--c~~~~~~l~-~iP~-~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (353)
T 2z80_A           26 ASLSCDRN--GI--CKGSSGSLN-SIPS-GLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS   97 (353)
T ss_dssp             -CCEECTT--SE--EECCSTTCS-SCCT-TCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             cCCCCCCC--eE--eeCCCCCcc-cccc-ccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence            46777653  23  789999999 7887 343  5899999999999966566899999999999999999988788787


Q ss_pred             --CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCC-C-C-CCCCCcEEEeeccc-CcCCCCcccCCCCCCC
Q 006677          140 --PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-N-F-DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSS  213 (635)
Q Consensus       140 --~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~-~-~l~~L~~l~l~~N~-l~g~~p~~~~~l~~l~  213 (635)
                        ++|++|+|++|+|++..+..|+++++|++|+|++|++++..+ . . .+++|+.|++++|+ +++..|..+.++++|.
T Consensus        98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  177 (353)
T 2z80_A           98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE  177 (353)
T ss_dssp             TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred             CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence              899999999999996555569999999999999999996544 1 2 79999999999995 7766677888888877


Q ss_pred             ccC
Q 006677          214 FVG  216 (635)
Q Consensus       214 ~~~  216 (635)
                      .++
T Consensus       178 ~L~  180 (353)
T 2z80_A          178 ELE  180 (353)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.53  E-value=1.3e-14  Score=148.15  Aligned_cols=137  Identities=26%  Similarity=0.404  Sum_probs=117.8

Q ss_pred             CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           68 RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        68 ~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      -.++..|+|++|.+++ ++  .++.+++|++|+|++|++++ +|. +.++++|++|+|++|++++..+  +.  ++|++|
T Consensus        84 l~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  156 (308)
T 1h6u_A           84 LTKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL  156 (308)
T ss_dssp             CCSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             CCCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence            3579999999999985 54  59999999999999999996 553 9999999999999999997655  44  899999


Q ss_pred             eccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       146 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++|++++. +. +.++++|+.|+|++|++++..+-..+++|+.|+|++|++++..|  +.++++|..+
T Consensus       157 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  222 (308)
T 1h6u_A          157 SIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV  222 (308)
T ss_dssp             ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             EccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEE
Confidence            9999999964 44 99999999999999999976665589999999999999996553  7777777655

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.52  E-value=2.5e-14  Score=158.99  Aligned_cols=137  Identities=32%  Similarity=0.382  Sum_probs=117.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .++..|+|++|.+++ +++  ++.+++|+.|+|++|.|++ +| .+.+|++|+.|+|++|+|++. | .+.  ++|+.|+
T Consensus        65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~  137 (605)
T 1m9s_A           65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY  137 (605)
T ss_dssp             TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-G-GGGGCTTCSEEE
T ss_pred             CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-c-cccCCCccCEEE
Confidence            568999999999995 554  8999999999999999995 55 799999999999999999963 3 343  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++|+|++.  ..|..|++|+.|+|++|+|++.+|...+++|+.|+|++|+|++. | .+.++++|..++
T Consensus       138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~  203 (605)
T 1m9s_A          138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLE  203 (605)
T ss_dssp             CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEE
T ss_pred             CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEE
Confidence            999999965  68999999999999999999888856899999999999999964 4 577777776653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.52  E-value=2.8e-14  Score=133.13  Aligned_cols=112  Identities=27%  Similarity=0.313  Sum_probs=98.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      ..++.|+|++|++++ +|+..++.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+.  ++|++|+
T Consensus        28 ~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           28 SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             TTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            468999999999994 6655789999999999999999976667789999999999999999977666665  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP  181 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p  181 (635)
                      |++|+|++..+..+.++++|+.|+|++|.+++..|
T Consensus       107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99999997666667899999999999999998665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.52  E-value=3.1e-14  Score=156.63  Aligned_cols=118  Identities=28%  Similarity=0.424  Sum_probs=80.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .+++.|+|++|+|+ .||    +.+++|++|+|++|+|++ +|. +.+  +|++|+|++|+|++ +|. ..++|++|+|+
T Consensus        80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls  148 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINAD  148 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECC
T ss_pred             CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCC
Confidence            35777888888877 676    346777888888888875 776 655  77777777777776 565 44677777777


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPS  204 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~  204 (635)
                      +|+|++ +|.   .+++|+.|+|++|+|++ +|... ++|+.|+|++|+|+ .+|.
T Consensus       149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~-~lp~  197 (571)
T 3cvr_A          149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE-SLPA  197 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS-SCCC
T ss_pred             CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC-chhh
Confidence            777774 554   45677777777777775 44433 66677777777666 5555

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=5.6e-14  Score=130.16  Aligned_cols=104  Identities=25%  Similarity=0.273  Sum_probs=80.1

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCc
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN  150 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N  150 (635)
                      .|++++|+|+ .+|. .+  .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.  ++|++|+|++|
T Consensus        13 ~l~~s~n~l~-~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           13 TVDCSGKSLA-SVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             EEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            5677778887 5886 34  38899999999999988888899999999999999999865555553  67777777777


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccC
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSI  180 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~  180 (635)
                      +|++..+..|.++++|+.|+|++|.++...
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            777655556777777777777777776543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=6.8e-14  Score=130.07  Aligned_cols=104  Identities=25%  Similarity=0.284  Sum_probs=81.3

Q ss_pred             EEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccC
Q 006677           72 FGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSF  149 (635)
Q Consensus        72 ~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~  149 (635)
                      +.+++++++++ .+|. .+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.  ++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            46888999986 7887 453  8999999999999988888999999999999999999965444443  6778888888


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCccccc
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGS  179 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~  179 (635)
                      |+|++..+..|.++++|+.|+|++|.+...
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            888755555577777777777777777643

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=5.3e-14  Score=130.34  Aligned_cols=104  Identities=29%  Similarity=0.334  Sum_probs=93.2

Q ss_pred             CcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCC
Q 006677           96 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS  173 (635)
Q Consensus        96 L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  173 (635)
                      .+.|++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|.  ++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            478999999999 6898774  8999999999999988888887  7999999999999977777889999999999999


Q ss_pred             CcccccCCCC--CCCCCcEEEeecccCcCCC
Q 006677          174 NNLSGSIPNF--DIPKLRHLNLSYNGLKGSI  202 (635)
Q Consensus       174 N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~  202 (635)
                      |+|++..+..  .+++|+.|+|++|.++...
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            9999877753  8999999999999998653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.51  E-value=1.4e-14  Score=135.04  Aligned_cols=123  Identities=24%  Similarity=0.337  Sum_probs=90.1

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCC-CCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc-c--CCccee
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLD-ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-S--PQLVVL  145 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~-~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~--~~L~~L  145 (635)
                      .++.|+|++|+++ .+|.  +..+. +|++|+|++|.|++.  ..|+++++|++|+|++|++++ +|..+ .  ++|++|
T Consensus        20 ~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L   93 (176)
T 1a9n_A           20 RDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL   93 (176)
T ss_dssp             SCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred             CceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEE
Confidence            5778888888887 4553  44444 888888888888854  578888888888888888884 44433 3  778888


Q ss_pred             eccCccCcccCCc--hhhccccCCcEEcCCCcccccCCC----C-CCCCCcEEEeecccCc
Q 006677          146 DLSFNSFTGNIPQ--SIQNLTQLTGLSLQSNNLSGSIPN----F-DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       146 ~ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~~~~p~----~-~l~~L~~l~l~~N~l~  199 (635)
                      +|++|+|+ .+|.  .+.++++|+.|+|++|.++...+.    . .+++|+.||+++|.+.
T Consensus        94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            88888886 5665  778888888888888888743331    2 6778888888888664

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.50  E-value=5e-15  Score=159.57  Aligned_cols=135  Identities=22%  Similarity=0.251  Sum_probs=77.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcc-------------cEEeeccCccCCcCC
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSL-------------RYLYLQHNNFSGKIP  135 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L-------------~~L~l~~N~l~g~~p  135 (635)
                      .++..|++++|++ |.+|+ .+++|++|++|+|++|.++|.+|.+++++++|             ++|++++|.+++ +|
T Consensus        11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp   87 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP   87 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred             ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence            5688899999999 79998 69999999999999999999999999998875             888888888885 44


Q ss_pred             CCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          136 SSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       136 ~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      . +.++|++|+|++|++++ +|..   +++|+.|++++|++++ +|.. .++|++|+|++|++++ +| .++++++|+++
T Consensus        88 ~-~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~-~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L  158 (454)
T 1jl5_A           88 E-LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL-PPLLEYLGVSNNQLEK-LP-ELQNSSFLKII  158 (454)
T ss_dssp             S-CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred             C-CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC-CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEE
Confidence            4 34677888888888775 6643   2556666666666664 2221 1456666666666664 55 35555555443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=1.1e-13  Score=128.65  Aligned_cols=101  Identities=26%  Similarity=0.348  Sum_probs=89.8

Q ss_pred             cEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCC
Q 006677           97 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN  174 (635)
Q Consensus        97 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  174 (635)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|.  ++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            68999999997 8898775  8999999999999988888886  79999999999999766667899999999999999


Q ss_pred             cccccCCC-C-CCCCCcEEEeecccCcC
Q 006677          175 NLSGSIPN-F-DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       175 ~l~~~~p~-~-~l~~L~~l~l~~N~l~g  200 (635)
                      +|++..+. + .+++|++|+|++|.+..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccc
Confidence            99977665 3 78999999999999984

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.48  E-value=4.7e-14  Score=156.76  Aligned_cols=136  Identities=24%  Similarity=0.344  Sum_probs=116.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .++..|+|+++++. .+|  .++.|++|+.|+|++|+|++..|  +.+|++|+.|+|++|.|++ +| .+.  ++|+.|+
T Consensus        43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~  115 (605)
T 1m9s_A           43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS  115 (605)
T ss_dssp             TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred             CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence            45778999999998 566  49999999999999999996555  9999999999999999996 44 454  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++|+|++ + +.+.+|++|+.|+|++|+|++. +.. .+++|+.|+|++|+|++..|  +..+++|..++
T Consensus       116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~  181 (605)
T 1m9s_A          116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY  181 (605)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             ecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence            99999996 3 5699999999999999999976 433 89999999999999998766  88888777653

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.48  E-value=7.2e-14  Score=151.29  Aligned_cols=138  Identities=33%  Similarity=0.356  Sum_probs=101.1

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .++..|+|++|.+++ ++  .+..+++|+.|+|++|.+++..|  +.++++|+.|+|++|.+++..|-.-.++|++|+|+
T Consensus       221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~  295 (466)
T 1o6v_A          221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN  295 (466)
T ss_dssp             TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcC
Confidence            457788888888874 43  47788888888888888886554  78888888888888888865542222678888888


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++++..|  +..+++|+.|+|++|++++..|...+++|+.|++++|++++.  ..+.++++|..+
T Consensus       296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  358 (466)
T 1o6v_A          296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL  358 (466)
T ss_dssp             SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred             CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence            888876544  777888888888888888776655777788888888877764  356666666554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.47  E-value=4.8e-14  Score=131.38  Aligned_cols=123  Identities=17%  Similarity=0.149  Sum_probs=103.4

Q ss_pred             cccCCCCCcEEEeecCCCCCCCCCCCCCCC-cccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhcccc
Q 006677           89 TLGKLDALEVLSLRSNVLTGGLPSEITSLP-SLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ  165 (635)
Q Consensus        89 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~  165 (635)
                      .+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|.+++.  ..+.  ++|++|+|++|+|++..|..+..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            4778999999999999999 5664 66666 999999999999965  4555  79999999999999665566699999


Q ss_pred             CCcEEcCCCcccccCCC---C-CCCCCcEEEeecccCcCCCCcc----cCCCCCCCccCC
Q 006677          166 LTGLSLQSNNLSGSIPN---F-DIPKLRHLNLSYNGLKGSIPSS----LQKFPNSSFVGN  217 (635)
Q Consensus       166 L~~L~l~~N~l~~~~p~---~-~l~~L~~l~l~~N~l~g~~p~~----~~~l~~l~~~~n  217 (635)
                      |++|+|++|+|+. +|.   . .+++|+.|+|++|.++ .+|..    +..+++|.+++-
T Consensus        90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~  147 (176)
T 1a9n_A           90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF  147 (176)
T ss_dssp             CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred             CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCC
Confidence            9999999999974 443   2 7899999999999998 56764    888888887763

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.46  E-value=2.4e-13  Score=146.33  Aligned_cols=132  Identities=25%  Similarity=0.381  Sum_probs=100.9

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF  149 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~  149 (635)
                      .++.|+|++|.+++ +|.  +  .++|++|+|++|++++ +| +|+++++|++|++++|++++ +|..+ .+|++|+|++
T Consensus       112 ~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-~~L~~L~L~~  182 (454)
T 1jl5_A          112 SLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-PSLEFIAAGN  182 (454)
T ss_dssp             TCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCS
T ss_pred             CCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-ccccEEECcC
Confidence            45555555555552 332  1  1688899999999985 88 69999999999999999986 66554 5899999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      |++++ +| .++++++|+.|++++|++++ +|.. .++|+.|++++|+++ .+|. +.++++|..++
T Consensus       183 n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~  243 (454)
T 1jl5_A          183 NQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE-LQNLPFLTTIY  243 (454)
T ss_dssp             SCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred             CcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc-cCCCCCCCEEE
Confidence            99996 66 68999999999999999986 4432 368999999999998 6774 77777776653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.46  E-value=5.3e-14  Score=155.36  Aligned_cols=116  Identities=29%  Similarity=0.323  Sum_probs=90.2

Q ss_pred             CCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcC
Q 006677           95 ALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ  172 (635)
Q Consensus        95 ~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  172 (635)
                      .|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..++  ++|+.|+|++|+|++ +| .|++|++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            46778888888885 776 888888888888888888 7788777  788888888888885 66 78888888888888


Q ss_pred             CCcccccC-CCC--CCCCCcEEEeecccCcCCCCcc---cCCCCCCCcc
Q 006677          173 SNNLSGSI-PNF--DIPKLRHLNLSYNGLKGSIPSS---LQKFPNSSFV  215 (635)
Q Consensus       173 ~N~l~~~~-p~~--~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~  215 (635)
                      +|+|++.+ |..  .+++|+.|+|++|+|++.+|..   +..+++|.++
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L  565 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  565 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCcc
Confidence            88888775 553  7888888888888888665522   2235565544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.45  E-value=1.3e-13  Score=148.62  Aligned_cols=124  Identities=23%  Similarity=0.153  Sum_probs=81.4

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .++..|+|++|...|.++   ++.+++|+.|+|++|++++ +|  ++++++|+.|++++|++++. +-.-.++|++|+|+
T Consensus       148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls  220 (457)
T 3bz5_A          148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCS  220 (457)
T ss_dssp             TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECC
T ss_pred             CcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECc
Confidence            356777787776666662   6677788888888888775 55  77777777777777777754 31112677777777


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCC----------CCcEEEeecccCcCCCC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP----------KLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~----------~L~~l~l~~N~l~g~~p  203 (635)
                      +|+|++ +|  ++.+++|+.|++++|+|++..+ ..++          +|+.|++++|.+.|.+|
T Consensus       221 ~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~-~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          221 SNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV-STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             SSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC-TTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred             CCcccc-cC--ccccCCCCEEEeeCCcCCCcCH-HHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence            777775 55  6777777777777777776433 2233          33444455555555554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.45  E-value=6.1e-14  Score=156.11  Aligned_cols=151  Identities=25%  Similarity=0.345  Sum_probs=106.4

Q ss_pred             CCCCCCCCCCCcceeEec------CCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCccc
Q 006677           48 NWSSTNPICQSWVGINCT------QDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLR  121 (635)
Q Consensus        48 ~w~~~~~~c~~w~gv~C~------~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~  121 (635)
                      .|....++| .|.|..|.      .....++.|++++++|+ .+|. .+.  ++|++|+|++|+|+ .+|.   .+++|+
T Consensus        14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~   84 (622)
T 3g06_A           14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELR   84 (622)
T ss_dssp             HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred             HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence            577665555 78664221      11134788999999998 8887 454  78999999999998 6776   578899


Q ss_pred             EEeeccCccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCC
Q 006677          122 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS  201 (635)
Q Consensus       122 ~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~  201 (635)
                      +|+|++|+|+ .+|. ..++|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|. .+++|++|+|++|++++ 
T Consensus        85 ~L~Ls~N~l~-~lp~-~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~-  155 (622)
T 3g06_A           85 TLEVSGNQLT-SLPV-LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS-  155 (622)
T ss_dssp             EEEECSCCCS-CCCC-CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-
T ss_pred             EEEcCCCcCC-cCCC-CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC-
Confidence            9999999988 4666 34788888888888884 554   56778888888888775 443 35777777777777774 


Q ss_pred             CCcccCCCCCCCccC
Q 006677          202 IPSSLQKFPNSSFVG  216 (635)
Q Consensus       202 ~p~~~~~l~~l~~~~  216 (635)
                      +|..+.++..|...+
T Consensus       156 l~~~~~~L~~L~L~~  170 (622)
T 3g06_A          156 LPALPSELCKLWAYN  170 (622)
T ss_dssp             CCCCCTTCCEEECCS
T ss_pred             cCCccCCCCEEECCC
Confidence            455555554443333

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.45  E-value=2.4e-13  Score=135.36  Aligned_cols=123  Identities=24%  Similarity=0.292  Sum_probs=105.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ +++  ++++++|+.|+|++|++++ +|. +.. ++|+.|+|++|++++. | .+.  ++|++|+
T Consensus        63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~  134 (263)
T 1xeu_A           63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILS  134 (263)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEE
T ss_pred             CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEE
Confidence            579999999999995 665  9999999999999999995 664 334 9999999999999963 4 344  8999999


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGS  201 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~  201 (635)
                      |++|+|++. | .+..+++|+.|+|++|+|++...-..+++|+.|+|++|.+++.
T Consensus       135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCCcCCCC-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence            999999964 4 7999999999999999999873333899999999999999965

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.43  E-value=2.4e-13  Score=147.22  Aligned_cols=138  Identities=29%  Similarity=0.358  Sum_probs=108.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .++..|+|++|.+.+..|   ++.+++|+.|+|++|++++ ++ .+..+++|+.|+|++|.+++..|-.-.++|++|+|+
T Consensus       199 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~  273 (466)
T 1o6v_A          199 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG  273 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             CCCCEEEecCCccccccc---ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCccccchhhhcCCCCCEEECC
Confidence            468888999998886433   7778899999999999885 43 688889999999999999876662223789999999


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++++..|  +..+++|+.|+|++|++++..+...+++|+.|+|++|++++..|  +..+++|..+
T Consensus       274 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          274 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             SSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             CCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            999986544  88889999999999999876665588889999999999987665  5556655543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.42  E-value=7.4e-13  Score=142.69  Aligned_cols=133  Identities=23%  Similarity=0.221  Sum_probs=103.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .++..|+|++|.+++ +|   ++++++|++|+|++|++++ +|  ++++++|++|++++|++.+.++-.-.++|++|+|+
T Consensus       106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls  178 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS  178 (457)
T ss_dssp             TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECC
T ss_pred             CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECC
Confidence            468899999999986 54   8899999999999999996 44  88888888888888877767653333788888888


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|+|++ +|  ++.+++|+.|++++|+|++. +-..+++|+.|+|++|++++ +|  +..+++|..+
T Consensus       179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L  238 (457)
T 3bz5_A          179 FNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYF  238 (457)
T ss_dssp             SSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEE
T ss_pred             CCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC--ccccCCCCEE
Confidence            888886 55  77888888888888888864 44477888888888888886 55  6666666544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.42  E-value=2.7e-13  Score=140.66  Aligned_cols=139  Identities=23%  Similarity=0.315  Sum_probs=94.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .++..|++++|.+.+ +++  +..+++|+.|++++|.+++..+  +..+++|+.|+|++|++++..+-.-.++|++|+|+
T Consensus       177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~  251 (347)
T 4fmz_A          177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIG  251 (347)
T ss_dssp             TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECC
T ss_pred             CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECC
Confidence            457788888888773 443  6777777777777777775433  77777777777777777754441112677777777


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++++ + ..+..+++|+.|++++|++++. +.. .+++|+.|+|++|++++..|..+.++++|..+
T Consensus       252 ~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  316 (347)
T 4fmz_A          252 TNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL  316 (347)
T ss_dssp             SSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred             CCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence            777774 3 4567777777777777777754 332 66777777777777776666666666665544

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.41  E-value=2.6e-13  Score=140.91  Aligned_cols=106  Identities=26%  Similarity=0.360  Sum_probs=81.3

Q ss_pred             CCcceeEecCCCCeEEEEEeCCC-CccCcCCcccccCCCCCcEEEeec-CCCCCCCCCCCCCCCcccEEeeccCccCCcC
Q 006677           57 QSWVGINCTQDRTRVFGLRLPGI-GLVGPIPNNTLGKLDALEVLSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKI  134 (635)
Q Consensus        57 ~~w~gv~C~~~~~~v~~l~l~~~-~l~g~l~~~~l~~l~~L~~L~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  134 (635)
                      |.|.+|.|++            + +|+ .||.  |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..
T Consensus         8 C~~~~v~~~~------------~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~   72 (347)
T 2ifg_A            8 HGSSGLRCTR------------DGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA   72 (347)
T ss_dssp             SSSSCEECCS------------SCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred             ccCCEEEcCC------------CCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC
Confidence            3787777754            3 676 5886  89999999999996 9999777788999999999999999998877


Q ss_pred             CCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccc
Q 006677          135 PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       135 p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      |..|.  ++|++|+|++|+|++..+..|..++ |+.|+|++|.|..
T Consensus        73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            76665  6778888888888755444555554 7777777777763

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.40  E-value=5e-15  Score=153.07  Aligned_cols=126  Identities=20%  Similarity=0.244  Sum_probs=74.2

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCC-CCCCCCCCCcccEEeeccCccCCcCCCCcc--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L  145 (635)
                      .+++.|++++|.+.+..+.  +..+++|++|+|++|.+++. +|..+.++++|++|+|++|.+++.+|..+.  ++|++|
T Consensus        70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L  147 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL  147 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred             ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence            3466666777766655443  45566666666666666644 555666666666666666666655554444  566666


Q ss_pred             eccCc-cCccc-CCchhhccccCCcEEcCCC-ccccc-CCCC--CCC-CCcEEEeecc
Q 006677          146 DLSFN-SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGS-IPNF--DIP-KLRHLNLSYN  196 (635)
Q Consensus       146 ~ls~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~--~l~-~L~~l~l~~N  196 (635)
                      +|++| .+++. +|..+.++++|++|+|++| .+++. ++..  .++ +|++|+|++|
T Consensus       148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY  205 (336)
T ss_dssp             ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred             ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence            66666 45542 5555566666666666666 55542 2221  444 5555555555

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.38  E-value=4e-13  Score=139.42  Aligned_cols=138  Identities=26%  Similarity=0.317  Sum_probs=107.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      ..+..|+++++.+.+ +++  ++.+++|+.|+|++|.+++ ++. +..+++|+.|++++|.+++..+-.-.++|++|+|+
T Consensus       155 ~~L~~L~l~~~~~~~-~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~  229 (347)
T 4fmz_A          155 TGLNYLTVTESKVKD-VTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIG  229 (347)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECC
T ss_pred             CCCcEEEecCCCcCC-chh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCchhhcCCcCCEEEcc
Confidence            468889999998874 443  8889999999999999984 443 88899999999999999866552223789999999


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +|++++..+  +..+++|+.|++++|.+++......+++|+.|++++|++++.  ..+..+++|..+
T Consensus       230 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L  292 (347)
T 4fmz_A          230 NNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL  292 (347)
T ss_dssp             SSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             CCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEE
Confidence            999985443  888999999999999988642223788999999999998864  346666666554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.37  E-value=9.3e-15  Score=151.02  Aligned_cols=147  Identities=23%  Similarity=0.295  Sum_probs=99.7

Q ss_pred             CeEEEEEeCCCCccCc-CCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC-ccCCc-CCCCcc--CCcc
Q 006677           69 TRVFGLRLPGIGLVGP-IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGK-IPSSFS--PQLV  143 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~-l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~--~~L~  143 (635)
                      .+++.|+|++|.+++. ++. .+..+++|++|+|++|.+++.+|..++++++|++|+|++| .+++. +|..+.  ++|+
T Consensus        93 ~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           93 FRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             BCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            4577777777777655 555 5777777777777777777667777777777777777777 56642 443333  6777


Q ss_pred             eeeccCc-cCccc-CCchhhccc-cCCcEEcCCC--ccc-ccCCCC--CCCCCcEEEeeccc-CcCCCCcccCCCCCCCc
Q 006677          144 VLDLSFN-SFTGN-IPQSIQNLT-QLTGLSLQSN--NLS-GSIPNF--DIPKLRHLNLSYNG-LKGSIPSSLQKFPNSSF  214 (635)
Q Consensus       144 ~L~ls~N-~l~g~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~--~l~~L~~l~l~~N~-l~g~~p~~~~~l~~l~~  214 (635)
                      +|+|++| ++++. ++..+.+++ +|++|+|++|  .++ +.+|..  .+++|+.|+|++|. +++..+..+.++++|..
T Consensus       172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~  251 (336)
T 2ast_B          172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH  251 (336)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence            7777777 77754 566677777 7777777777  344 333332  56777777777777 66666666666666665


Q ss_pred             cC
Q 006677          215 VG  216 (635)
Q Consensus       215 ~~  216 (635)
                      ++
T Consensus       252 L~  253 (336)
T 2ast_B          252 LS  253 (336)
T ss_dssp             EE
T ss_pred             ee
Confidence            53

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.35  E-value=2.1e-14  Score=151.52  Aligned_cols=148  Identities=20%  Similarity=0.300  Sum_probs=105.4

Q ss_pred             CeEEEEEeCCC---CccCcCCccc------ccCCCCCcEEEeecCCCCC----CCCCCCCCCCcccEEeeccCccCCcCC
Q 006677           69 TRVFGLRLPGI---GLVGPIPNNT------LGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIP  135 (635)
Q Consensus        69 ~~v~~l~l~~~---~l~g~l~~~~------l~~l~~L~~L~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p  135 (635)
                      .+++.|+|++|   .++|.+|.+.      +..+++|++|+|++|.+++    .+|..+.++++|++|+|++|.+++..+
T Consensus        60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~  139 (386)
T 2ca6_A           60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG  139 (386)
T ss_dssp             TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred             CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence            45777888874   5556666521      3678888888888888886    467777888888888888888864433


Q ss_pred             CCcc---------------CCcceeeccCccCc-ccCC---chhhccccCCcEEcCCCccc--c---cCC-CC-CCCCCc
Q 006677          136 SSFS---------------PQLVVLDLSFNSFT-GNIP---QSIQNLTQLTGLSLQSNNLS--G---SIP-NF-DIPKLR  189 (635)
Q Consensus       136 ~~~~---------------~~L~~L~ls~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p-~~-~l~~L~  189 (635)
                      ..+.               ++|++|+|++|+|+ +.+|   ..+.++++|+.|+|++|+|+  |   .+| .. .+++|+
T Consensus       140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~  219 (386)
T 2ca6_A          140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK  219 (386)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred             HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence            3332               47888888888887 4555   46777888888888888887  3   333 22 677888


Q ss_pred             EEEeecccCc----CCCCcccCCCCCCCccC
Q 006677          190 HLNLSYNGLK----GSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       190 ~l~l~~N~l~----g~~p~~~~~l~~l~~~~  216 (635)
                      .|+|++|.++    +.+|..+.++++|..++
T Consensus       220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          220 VLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             EEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             EEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            8888888885    56777777777666553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.34  E-value=2.9e-12  Score=142.54  Aligned_cols=132  Identities=27%  Similarity=0.346  Sum_probs=74.9

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCC---CCCC--------------CcccEEeeccCccCC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSE---ITSL--------------PSLRYLYLQHNNFSG  132 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~---~~~l--------------~~L~~L~l~~N~l~g  132 (635)
                      .+..|+|++|+++ .+|. .   +++|++|+|++|++++ +|..   +..|              ++|+.|+|++|+|++
T Consensus       122 ~L~~L~L~~N~l~-~lp~-~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~  195 (622)
T 3g06_A          122 GLCKLWIFGNQLT-SLPV-L---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS  195 (622)
T ss_dssp             TCCEEECCSSCCS-CCCC-C---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC
T ss_pred             CcCEEECCCCCCC-cCCC-C---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC
Confidence            4556666666666 3554 1   3667777777777663 3332   2222              667777777777774


Q ss_pred             cCCCCc-------------------cCCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEe
Q 006677          133 KIPSSF-------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNL  193 (635)
Q Consensus       133 ~~p~~~-------------------~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l  193 (635)
                       +|..+                   .++|++|+|++|+|++ +|   ..+++|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus       196 -l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~-~~~~L~~L~L  268 (622)
T 3g06_A          196 -LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM-LPSGLLSLSV  268 (622)
T ss_dssp             -CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEEC
T ss_pred             -CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc-ccccCcEEeC
Confidence             33322                   1345555555555553 44   334556666666666663 333 5566666666


Q ss_pred             ecccCcCCCCcccCCCCCCCcc
Q 006677          194 SYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       194 ~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      ++|+|+ .+|..|.++++|..+
T Consensus       269 s~N~L~-~lp~~l~~l~~L~~L  289 (622)
T 3g06_A          269 YRNQLT-RLPESLIHLSSETTV  289 (622)
T ss_dssp             CSSCCC-SCCGGGGGSCTTCEE
T ss_pred             CCCCCC-cCCHHHhhccccCEE
Confidence            666666 556666666655544

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.32  E-value=2.4e-12  Score=133.66  Aligned_cols=102  Identities=20%  Similarity=0.168  Sum_probs=90.3

Q ss_pred             cEEEeecC-CCCCCCCCCCCCCCcccEEeecc-CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcC
Q 006677           97 EVLSLRSN-VLTGGLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ  172 (635)
Q Consensus        97 ~~L~L~~n-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  172 (635)
                      ..+++++| +|+ .||. |..+++|+.|+|++ |+|++..|..|.  ++|++|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35789998 899 6998 99999999999996 999987777776  899999999999999999999999999999999


Q ss_pred             CCcccccCCCC-CCCCCcEEEeecccCcC
Q 006677          173 SNNLSGSIPNF-DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       173 ~N~l~~~~p~~-~l~~L~~l~l~~N~l~g  200 (635)
                      +|+|++.++.. ...+|+.|+|++|.|..
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccC
Confidence            99999766654 33349999999999984

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.28  E-value=1e-13  Score=146.25  Aligned_cols=148  Identities=20%  Similarity=0.270  Sum_probs=115.7

Q ss_pred             CeEEEEEeCCCCccCcCCc---ccccCCCCCcEEEeecC---CCCCCCCCCC-------CCCCcccEEeeccCccCC---
Q 006677           69 TRVFGLRLPGIGLVGPIPN---NTLGKLDALEVLSLRSN---VLTGGLPSEI-------TSLPSLRYLYLQHNNFSG---  132 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~---~~l~~l~~L~~L~L~~n---~l~g~~p~~~-------~~l~~L~~L~l~~N~l~g---  132 (635)
                      .+++.|+|++|++++..+.   ..+..+++|++|+|++|   ++++.+|..+       .++++|++|+|++|.+++   
T Consensus        32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~  111 (386)
T 2ca6_A           32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  111 (386)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence            4689999999999865332   14778999999999995   5566777665       789999999999999997   


Q ss_pred             -cCCCCcc--CCcceeeccCccCcccCCchh----hcc---------ccCCcEEcCCCccc-ccCCCC-----CCCCCcE
Q 006677          133 -KIPSSFS--PQLVVLDLSFNSFTGNIPQSI----QNL---------TQLTGLSLQSNNLS-GSIPNF-----DIPKLRH  190 (635)
Q Consensus       133 -~~p~~~~--~~L~~L~ls~N~l~g~~p~~~----~~l---------~~L~~L~l~~N~l~-~~~p~~-----~l~~L~~  190 (635)
                       .+|..+.  ++|++|+|++|+|++..+..+    ..+         ++|++|+|++|+|+ +.+|..     .+++|+.
T Consensus       112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~  191 (386)
T 2ca6_A          112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT  191 (386)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred             HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence             4666665  799999999999986544444    444         89999999999998 455531     6789999


Q ss_pred             EEeecccCc--C---CCCcccCCCCCCCccC
Q 006677          191 LNLSYNGLK--G---SIPSSLQKFPNSSFVG  216 (635)
Q Consensus       191 l~l~~N~l~--g---~~p~~~~~l~~l~~~~  216 (635)
                      |+|++|+++  |   .+|..+.++++|..++
T Consensus       192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~  222 (386)
T 2ca6_A          192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLD  222 (386)
T ss_dssp             EECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred             EECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence            999999998  3   3454677777776654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.28  E-value=1.5e-13  Score=143.55  Aligned_cols=135  Identities=24%  Similarity=0.280  Sum_probs=76.8

Q ss_pred             eEEEEEeCCCCccCcCCc---ccccCCC-CCcEEEeecCCCCCCCCCCCCCC-----CcccEEeeccCccCCcCCCCcc-
Q 006677           70 RVFGLRLPGIGLVGPIPN---NTLGKLD-ALEVLSLRSNVLTGGLPSEITSL-----PSLRYLYLQHNNFSGKIPSSFS-  139 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~---~~l~~l~-~L~~L~L~~n~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~-  139 (635)
                      .++.|+|++|.+++.-+.   ..+..++ +|++|+|++|++++..+..+..+     ++|++|+|++|.+++..+..+. 
T Consensus        23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            366666666666632220   2455666 66666666666665555555554     6666666666666654444322 


Q ss_pred             ------CCcceeeccCccCcccCCchhhc-----cccCCcEEcCCCcccccCCC----C--CCC-CCcEEEeecccCcCC
Q 006677          140 ------PQLVVLDLSFNSFTGNIPQSIQN-----LTQLTGLSLQSNNLSGSIPN----F--DIP-KLRHLNLSYNGLKGS  201 (635)
Q Consensus       140 ------~~L~~L~ls~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~~~~p~----~--~l~-~L~~l~l~~N~l~g~  201 (635)
                            ++|++|+|++|+|++..+..+..     .++|++|+|++|+|++..+.    .  .++ +|+.|+|++|++++.
T Consensus       103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~  182 (362)
T 3goz_A          103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK  182 (362)
T ss_dssp             HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence                  35666666666666555444433     24666666666666642221    1  232 666666666666655


Q ss_pred             CCc
Q 006677          202 IPS  204 (635)
Q Consensus       202 ~p~  204 (635)
                      .+.
T Consensus       183 ~~~  185 (362)
T 3goz_A          183 NCA  185 (362)
T ss_dssp             CHH
T ss_pred             hHH
Confidence            443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=2.4e-11  Score=120.76  Aligned_cols=136  Identities=17%  Similarity=0.113  Sum_probs=107.5

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      ..++.|+++.||++... ++.+++|+..... .....+.+|++++..+.++..+.++++++...+..|+||||++|.+|.
T Consensus        20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            45677788999999855 6889999987532 234578999999999966788889999999888999999999999998


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-------------------------------------------  459 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------  459 (635)
                      +.+..          ......++.+++++++.||+..                                           
T Consensus        99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            76421          1123468889999999999811                                           


Q ss_pred             -------------CCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          460 -------------GPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       460 -------------~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                                   .+.++|+|+++.||+++++..+.|+||+.+.
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                         1338999999999999876666799998764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.26  E-value=3e-14  Score=135.55  Aligned_cols=123  Identities=20%  Similarity=0.231  Sum_probs=105.6

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCC------CCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhh
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPS------EITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ  161 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~------~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~  161 (635)
                      +.....++.++|+.|.++|.+|.      .+.++++|++|+|++|++++ +| .+.  ++|++|+|++|+|+ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            55677889999999999999987      89999999999999999997 77 665  89999999999999 7899999


Q ss_pred             ccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCC-cccCCCCCCCccC
Q 006677          162 NLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIP-SSLQKFPNSSFVG  216 (635)
Q Consensus       162 ~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~  216 (635)
                      .+++|+.|+|++|+|++ +|.. .+++|+.|+|++|++++..+ ..+.++++|..++
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~  146 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred             cCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence            99999999999999997 4443 78899999999999995322 4677777776653

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.26  E-value=5e-13  Score=139.64  Aligned_cols=130  Identities=20%  Similarity=0.145  Sum_probs=108.9

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC----CCCCCCC-cccEEeeccCccCCcCCCCcc-------C
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP----SEITSLP-SLRYLYLQHNNFSGKIPSSFS-------P  140 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~-------~  140 (635)
                      ..+|++++++|.+|. .+...++|++|||++|.+++..+    ..+.+++ +|++|+|++|++++..+..+.       +
T Consensus         2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            367899999998887 77777889999999999996655    6788898 999999999999987666553       5


Q ss_pred             CcceeeccCccCcccCCchhhcc-----ccCCcEEcCCCcccccCCCC------C-CCCCcEEEeecccCcCCCC
Q 006677          141 QLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGSIPNF------D-IPKLRHLNLSYNGLKGSIP  203 (635)
Q Consensus       141 ~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~------~-l~~L~~l~l~~N~l~g~~p  203 (635)
                      +|++|+|++|+|++..+..+...     ++|++|+|++|+|++..+..      . .++|++|+|++|+++..-+
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  155 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS  155 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence            79999999999998887766654     89999999999998765532      2 3699999999999996444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.19  E-value=4e-11  Score=124.58  Aligned_cols=139  Identities=15%  Similarity=0.144  Sum_probs=106.5

Q ss_pred             eEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccEEeeccCccCCcCCCCcc-
Q 006677           62 INCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRYLYLQHNNFSGKIPSSFS-  139 (635)
Q Consensus        62 v~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~-  139 (635)
                      ..|+.   +  .++.++++|+ .||.+ +  .++|++|+|++|+|+ .|| ..|.+|++|++|+|++|++.+.+|.... 
T Consensus         7 C~C~~---~--~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~   76 (350)
T 4ay9_X            7 CHCSN---R--VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS   76 (350)
T ss_dssp             SEEET---T--EEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBC
T ss_pred             cEeeC---C--EEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhh
Confidence            46764   2  3677899999 89873 4  478999999999999 565 5799999999999999999888887543 


Q ss_pred             --CCc-ceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeec-ccCcCCCCcccCCCC
Q 006677          140 --PQL-VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSY-NGLKGSIPSSLQKFP  210 (635)
Q Consensus       140 --~~L-~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~-N~l~g~~p~~~~~l~  210 (635)
                        ++| +.+++++|+|++..|..|.++++|++|++++|+|++..+..  ...++..|++++ |++....+..|..+.
T Consensus        77 ~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~  153 (350)
T 4ay9_X           77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  153 (350)
T ss_dssp             SCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             cchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence              444 45788899999888899999999999999999999765543  445666777765 455533334454443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.14  E-value=2e-13  Score=134.66  Aligned_cols=159  Identities=19%  Similarity=0.192  Sum_probs=118.4

Q ss_pred             CcceeEecCCCCeEEEEEeCC---CCccCcCCcccccCCCCCcEEEeecCCCCCCCC-CCCCCCCcccE--EeeccCccC
Q 006677           58 SWVGINCTQDRTRVFGLRLPG---IGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLP-SEITSLPSLRY--LYLQHNNFS  131 (635)
Q Consensus        58 ~w~gv~C~~~~~~v~~l~l~~---~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p-~~~~~l~~L~~--L~l~~N~l~  131 (635)
                      +|.|+.|+.+..+|+.+...+   ..+.|.++++.+..|..  .|...+|..++.++ +.+...+.|..  ++++.|+..
T Consensus        79 ~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~  156 (267)
T 3rw6_A           79 AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS  156 (267)
T ss_dssp             HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred             hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence            799999998767887777766   56777787666655554  45566676666665 23666777777  788888544


Q ss_pred             CcCCCCc------cCCcceeeccCccCcc--cCCchhhccccCCcEEcCCCcccccCCCCCCC--CCcEEEeecccCcCC
Q 006677          132 GKIPSSF------SPQLVVLDLSFNSFTG--NIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIP--KLRHLNLSYNGLKGS  201 (635)
Q Consensus       132 g~~p~~~------~~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~--~L~~l~l~~N~l~g~  201 (635)
                       .++..+      .++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++.-.-..+.  +|+.|+|++|.+++.
T Consensus       157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~  235 (267)
T 3rw6_A          157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDT  235 (267)
T ss_dssp             -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGG
T ss_pred             -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccc
Confidence             333322      1689999999999998  66788899999999999999999752212233  999999999999988


Q ss_pred             CCc-------ccCCCCCCCccCCCC
Q 006677          202 IPS-------SLQKFPNSSFVGNSL  219 (635)
Q Consensus       202 ~p~-------~~~~l~~l~~~~n~~  219 (635)
                      +|.       .+..+++|..++...
T Consensus       236 ~~~~~~y~~~il~~~P~L~~LDg~~  260 (267)
T 3rw6_A          236 FRDQSTYISAIRERFPKLLRLDGHE  260 (267)
T ss_dssp             CSSHHHHHHHHHHHCTTCCEESSCB
T ss_pred             cCcchhHHHHHHHHCcccCeECCcC
Confidence            873       367889998887543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.12  E-value=7e-13  Score=143.14  Aligned_cols=147  Identities=20%  Similarity=0.092  Sum_probs=116.0

Q ss_pred             CeEEEEEeCCCCccCc----CCcccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc-
Q 006677           69 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS-  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~----l~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-  139 (635)
                      .+++.|+|++|.+++.    +.+..+..+++|++|+|++|++++.    +|..+.++++|++|+|++|.+++..+..+. 
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            4688999999988753    2232345689999999999999854    677788899999999999998754443332 


Q ss_pred             ------CCcceeeccCccCccc----CCchhhccccCCcEEcCCCcccccCCCC-------CCCCCcEEEeecccCcC--
Q 006677          140 ------PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIPNF-------DIPKLRHLNLSYNGLKG--  200 (635)
Q Consensus       140 ------~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------~l~~L~~l~l~~N~l~g--  200 (635)
                            ++|++|+|++|++++.    ++..+..+++|+.|+|++|++++..+..       ..++|+.|+|++|++++  
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~  386 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS  386 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence                  4899999999999876    6777888899999999999998654321       26799999999999986  


Q ss_pred             --CCCcccCCCCCCCcc
Q 006677          201 --SIPSSLQKFPNSSFV  215 (635)
Q Consensus       201 --~~p~~~~~l~~l~~~  215 (635)
                        .+|..+.++++|..+
T Consensus       387 ~~~l~~~l~~~~~L~~L  403 (461)
T 1z7x_W          387 CSSLAATLLANHSLREL  403 (461)
T ss_dssp             HHHHHHHHHHCCCCCEE
T ss_pred             HHHHHHHHHhCCCccEE
Confidence              778777767766655

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=3.3e-10  Score=112.00  Aligned_cols=130  Identities=11%  Similarity=0.089  Sum_probs=98.3

Q ss_pred             cc-ccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCc-eeceeEEEEeCCeeEEEEEeccCCChhh
Q 006677          346 LG-KGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN-VVPLRAYYYSKDEKLLVYDYFASGSLST  423 (635)
Q Consensus       346 lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~L~~  423 (635)
                      ++ .|..+.||++...+|..+++|+....  ....+.+|+++++.+.+|.- +.+++++....+..++||||++|.+|. 
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            44 55569999998777788999997653  33568899999999855522 566888888777889999999998884 


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006677          424 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------------  459 (635)
Q Consensus       424 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  459 (635)
                       ...        .+   ...++.+++..++.||+..                                            
T Consensus       104 -~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          104 -SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             -TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             -cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence             211        11   2356778888888888743                                            


Q ss_pred             -----------CCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          460 -----------GPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       460 -----------~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                                 .+.++|+|++|.||+++++..+.|+|||.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       1129999999999999887667799999864

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.10  E-value=5.2e-13  Score=144.15  Aligned_cols=137  Identities=20%  Similarity=0.222  Sum_probs=108.5

Q ss_pred             CeEEEEEeCCCCccCc----CCcccccCCCCCcEEEeecCCCCCCC-----CCCCCCCCcccEEeeccCccCCc----CC
Q 006677           69 TRVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTGGL-----PSEITSLPSLRYLYLQHNNFSGK----IP  135 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~----l~~~~l~~l~~L~~L~L~~n~l~g~~-----p~~~~~l~~L~~L~l~~N~l~g~----~p  135 (635)
                      .+++.|+|++|++++.    ++. .+..+++|++|+|++|.+++.-     +..+..+++|++|+|++|.+++.    ++
T Consensus       199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  277 (461)
T 1z7x_W          199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC  277 (461)
T ss_dssp             CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence            4789999999999863    565 6888999999999999987532     33344689999999999999864    55


Q ss_pred             CCcc--CCcceeeccCccCcccCCchhhcc-----ccCCcEEcCCCccccc----CCCC--CCCCCcEEEeecccCcCCC
Q 006677          136 SSFS--PQLVVLDLSFNSFTGNIPQSIQNL-----TQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLKGSI  202 (635)
Q Consensus       136 ~~~~--~~L~~L~ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~~~----~p~~--~l~~L~~l~l~~N~l~g~~  202 (635)
                      ..+.  ++|++|+|++|++++..+..+...     ++|+.|+|++|.+++.    ++..  .+++|+.|+|++|++++..
T Consensus       278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  357 (461)
T 1z7x_W          278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG  357 (461)
T ss_dssp             HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence            5554  789999999999987666666554     6999999999999865    2322  6789999999999998654


Q ss_pred             Cccc
Q 006677          203 PSSL  206 (635)
Q Consensus       203 p~~~  206 (635)
                      +..+
T Consensus       358 ~~~l  361 (461)
T 1z7x_W          358 VREL  361 (461)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            4433

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=1.6e-09  Score=112.74  Aligned_cols=140  Identities=15%  Similarity=0.223  Sum_probs=105.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEee--ccc--CChHHHHHHHHHHHhhcC-CCceeceeEEEEeC---CeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLK--EVV--VGKRDFEQQMEIVGRVGQ-HPNVVPLRAYYYSK---DEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~---~~~~lv~e~  415 (635)
                      +.|+.|.++.||+....+ ..+++|+..  ...  .....+.+|..+++.+.. +..++++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            468899999999998764 678888776  322  234578899999999853 45588888888766   347999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG------------------------------------  459 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------  459 (635)
                      ++|..+.+..       ...++...+..++.++++.|+.||+..                                    
T Consensus       123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9998775422       123778888999999999999999731                                    


Q ss_pred             -------------------CCCceecCCCCCCeEEcCCCC--eEEeecCCCCC
Q 006677          460 -------------------GPKFTHGNIKASNVLINQDLD--GCISDFGLTPL  491 (635)
Q Consensus       460 -------------------~~~ivH~Dlk~~NIll~~~~~--~ki~DfGla~~  491 (635)
                                         .+.++|+|+++.||++++++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               235899999999999998754  68999998754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.87  E-value=3.2e-11  Score=126.00  Aligned_cols=129  Identities=24%  Similarity=0.233  Sum_probs=61.7

Q ss_pred             eEEEEEeCCCCccCcCCccccc-----CCCCCcEEEeecCCCCCCCCCCC-CCCCcccEEeeccCccCCcCCCCc-----
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLG-----KLDALEVLSLRSNVLTGGLPSEI-TSLPSLRYLYLQHNNFSGKIPSSF-----  138 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~-----~l~~L~~L~L~~n~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~~~-----  138 (635)
                      .+..|+|++|.++..-.. .+.     ...+|+.|+|++|.|+..-...+ ..+++|+.|+|++|.|+......+     
T Consensus        73 ~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           73 SLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            355666666665431111 111     12456666666666543211122 234556666666666553222222     


Q ss_pred             --cCCcceeeccCccCcc----cCCchhhccccCCcEEcCCCcccccC----CC--CCCCCCcEEEeecccCc
Q 006677          139 --SPQLVVLDLSFNSFTG----NIPQSIQNLTQLTGLSLQSNNLSGSI----PN--FDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       139 --~~~L~~L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~~~~----p~--~~l~~L~~l~l~~N~l~  199 (635)
                        .++|++|+|++|+|+.    .++..+..+++|++|+|++|.|+..-    +.  ...++|+.|+|++|.++
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence              1346666666666653    23334455556666666666655311    11  13345666666666654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.87  E-value=1e-09  Score=111.50  Aligned_cols=183  Identities=17%  Similarity=0.203  Sum_probs=120.2

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCc--eeceeEEEEeCC---eeEEEEEeccC
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPN--VVPLRAYYYSKD---EKLLVYDYFAS  418 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n--iv~l~~~~~~~~---~~~lv~e~~~~  418 (635)
                      +.++.|.+..||+..    ..+++|+.... .....+.+|.+++..+..+..  +.+.+......+   ..|+|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            357889999999873    56888875432 234678899999988854433  344444433332   34789999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG---------------------------------------  459 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------  459 (635)
                      ..+.+...       ..++..++..++.+++..++.||+..                                       
T Consensus       101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            88865332       12677788888899999998888621                                       


Q ss_pred             ----------------CCCceecCCCCCCeEEcC--CCCeEEeecCCCCCCCCCCCCCCCCcc---cCcccccC-----C
Q 006677          460 ----------------GPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPATPSRSAGY---RAPEVIET-----R  513 (635)
Q Consensus       460 ----------------~~~ivH~Dlk~~NIll~~--~~~~ki~DfGla~~~~~~~~~~~~~~y---~aPE~~~~-----~  513 (635)
                                      .+.++|+|+++.||++++  ...+.|+||+.+..............+   ..|+....     +
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134799999999999998  456789999987653221000000000   12221100     0


Q ss_pred             ---------CCCCccchhhHHHHHHHHHhCCCCC
Q 006677          514 ---------KHSHKSDVYSFGVLLLEMLTGKAPL  538 (635)
Q Consensus       514 ---------~~~~k~Dvws~Gvvl~el~tg~~p~  538 (635)
                               +.....+.|+++.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     0112358999999999999998776

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.86  E-value=4.3e-09  Score=108.14  Aligned_cols=142  Identities=18%  Similarity=0.196  Sum_probs=88.4

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCcc----CCcCCCCc------
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF----SGKIPSSF------  138 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l----~g~~p~~~------  138 (635)
                      ..++.|+|++ +++ .|++..|.++++|+.|+|++|.+...-+..|.++.+|..|.++.+..    ...-+..|      
T Consensus       101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            3477788887 776 67777888888888888888887644445566665555555444211    00000000      


Q ss_pred             ----------------------------------------------cCCcceeeccCccCcccCCchhhccccCCcEEcC
Q 006677          139 ----------------------------------------------SPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ  172 (635)
Q Consensus       139 ----------------------------------------------~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  172 (635)
                                                                    .++|+.|+|++|+++...+.+|.+|++|+.|+|.
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~  258 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP  258 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence                                                          2467777777777775555567777777777777


Q ss_pred             CCcccccCCCC---CCCCCc-EEEeecccCcCCCCcccCCCCCCCcc
Q 006677          173 SNNLSGSIPNF---DIPKLR-HLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       173 ~N~l~~~~p~~---~l~~L~-~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      +| ++ .++..   ++.+|+ .++|.+ +++..-+..|.+|++|+.+
T Consensus       259 ~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          259 HN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             TT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            77 55 34432   667777 777776 5654445667777666554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.83  E-value=1.1e-11  Score=129.51  Aligned_cols=138  Identities=17%  Similarity=0.171  Sum_probs=102.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCC-----CCCCcccEEeeccCccCCc----CCCCcc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEI-----TSLPSLRYLYLQHNNFSGK----IPSSFS  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~-----~~l~~L~~L~l~~N~l~g~----~p~~~~  139 (635)
                      ..++.|+|++|+++..-.......+.+|+.|+|++|+|+..-...+     ...++|+.|+|++|.|+..    ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4799999999998753332233456789999999999985433333     3468899999999999742    222222


Q ss_pred             --CCcceeeccCccCccc----CCchhhccccCCcEEcCCCcccccCC----CC--CCCCCcEEEeecccCcCCCCccc
Q 006677          140 --PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSIP----NF--DIPKLRHLNLSYNGLKGSIPSSL  206 (635)
Q Consensus       140 --~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~--~l~~L~~l~l~~N~l~g~~p~~~  206 (635)
                        ++|++|+|++|+|+..    ++..+..+++|+.|+|++|.|+..-.    ..  ..++|+.|+|++|.|+..-...+
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence              6899999999999853    45677888999999999999985321    11  46889999999999975433333

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.80  E-value=3.9e-09  Score=108.40  Aligned_cols=129  Identities=16%  Similarity=0.261  Sum_probs=93.1

Q ss_pred             cCCcccccC--------CCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccC--CcceeeccCccC-
Q 006677           84 PIPNNTLGK--------LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSF-  152 (635)
Q Consensus        84 ~l~~~~l~~--------l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~--~L~~L~ls~N~l-  152 (635)
                      .||+..|.+        +++|+.|+|.+ +++..-+..|.+|++|+.|+|++|.+....+..|..  ++..+.++.+.. 
T Consensus        83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~  161 (329)
T 3sb4_A           83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY  161 (329)
T ss_dssp             EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH
T ss_pred             ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh
Confidence            567777888        99999999999 888444567999999999999999998555555553  455555444211 


Q ss_pred             ------c-------------------ccCCch---------------------------h-hccccCCcEEcCCCccccc
Q 006677          153 ------T-------------------GNIPQS---------------------------I-QNLTQLTGLSLQSNNLSGS  179 (635)
Q Consensus       153 ------~-------------------g~~p~~---------------------------~-~~l~~L~~L~l~~N~l~~~  179 (635)
                            .                   +.++..                           + ..+++|+.|+|++|+++ .
T Consensus       162 ~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~  240 (329)
T 3sb4_A          162 RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-T  240 (329)
T ss_dssp             HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-E
T ss_pred             hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-e
Confidence                  0                   001100                           0 13789999999999999 4


Q ss_pred             CCCC---CCCCCcEEEeecccCcCCCCcccCCCCCCC-cc
Q 006677          180 IPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS-FV  215 (635)
Q Consensus       180 ~p~~---~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~-~~  215 (635)
                      +|..   .+.+|+.|+|.+| ++..-+..|.++++|+ .+
T Consensus       241 I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l  279 (329)
T 3sb4_A          241 IPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL  279 (329)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred             ecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence            5543   8999999999998 7755557789998887 44

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.65  E-value=6.6e-10  Score=123.76  Aligned_cols=60  Identities=17%  Similarity=0.192  Sum_probs=27.6

Q ss_pred             CCcceeeccCccCcc-cCCchhhccccCCcEEcCCCccccc-CCCC--CCCCCcEEEeecccCc
Q 006677          140 PQLVVLDLSFNSFTG-NIPQSIQNLTQLTGLSLQSNNLSGS-IPNF--DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       140 ~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~l~~L~~l~l~~N~l~  199 (635)
                      ++|++|+|++|++++ .++..+.++++|++|+|++|.|++. ++..  .+++|++|+|++|+++
T Consensus       463 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             TTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred             ccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence            345555555555543 2333334455555555555554432 1111  3445555555555544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.51  E-value=2.5e-09  Score=100.04  Aligned_cols=111  Identities=14%  Similarity=0.175  Sum_probs=79.4

Q ss_pred             cccCCCCCcEEEeecC-CCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc------CCcceeeccCccCccc--
Q 006677           89 TLGKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN--  155 (635)
Q Consensus        89 ~l~~l~~L~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~--  155 (635)
                      .+...++|++|+|++| .+...    +...+...++|++|+|++|.+...-...+.      +.|++|+|++|+|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            5677888888999888 87632    344566678888999999888742222222      5789999999988754  


Q ss_pred             --CCchhhccccCCcEEc--CCCcccccCCC----C--CCCCCcEEEeecccCc
Q 006677          156 --IPQSIQNLTQLTGLSL--QSNNLSGSIPN----F--DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       156 --~p~~~~~l~~L~~L~l--~~N~l~~~~p~----~--~l~~L~~l~l~~N~l~  199 (635)
                        +...+...++|++|+|  ++|.|...-..    .  ..++|++|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              4566777788999999  78888743211    1  4577999999998875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.50  E-value=4.4e-08  Score=96.43  Aligned_cols=101  Identities=25%  Similarity=0.340  Sum_probs=59.0

Q ss_pred             ccCCCCCcE--EEeecCCCC---CCCCCCCCCCCcccEEeeccCccCC--cCCCCcc--CCcceeeccCccCcccCCchh
Q 006677           90 LGKLDALEV--LSLRSNVLT---GGLPSEITSLPSLRYLYLQHNNFSG--KIPSSFS--PQLVVLDLSFNSFTGNIPQSI  160 (635)
Q Consensus        90 l~~l~~L~~--L~L~~n~l~---g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~--~~L~~L~ls~N~l~g~~p~~~  160 (635)
                      |...+.|..  ++++.|...   +.++-...++++|+.|+|++|+|++  .+|..+.  ++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            444455554  556666332   1111112356667777777777776  3444332  6677777777777654  334


Q ss_pred             hccc--cCCcEEcCCCcccccCCCC---------CCCCCcEEE
Q 006677          161 QNLT--QLTGLSLQSNNLSGSIPNF---------DIPKLRHLN  192 (635)
Q Consensus       161 ~~l~--~L~~L~l~~N~l~~~~p~~---------~l~~L~~l~  192 (635)
                      ..+.  +|++|+|++|.+++.+|..         .+++|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            4454  7777788888777766631         567777765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.48  E-value=8.4e-07  Score=88.01  Aligned_cols=135  Identities=16%  Similarity=0.178  Sum_probs=98.0

Q ss_pred             ccccCce-EEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhh
Q 006677          346 LGKGSYG-TAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLST  423 (635)
Q Consensus       346 lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  423 (635)
                      +..|..| .||+.... ++..+++|+-...  ...++.+|...+..+..+--+.++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445554 68988754 4567888886543  245788899999988666567889999999999999999999988776


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 006677          424 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------------  459 (635)
Q Consensus       424 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  459 (635)
                      .....         ......++.+++..|+.||+..                                            
T Consensus       110 ~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          110 VLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            54321         1223445666666667666420                                            


Q ss_pred             -----------CCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          460 -----------GPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       460 -----------~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                                 .+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11278999999999999887778999987643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.45  E-value=1.3e-08  Score=113.33  Aligned_cols=143  Identities=15%  Similarity=0.072  Sum_probs=78.9

Q ss_pred             eEEEEEeCCCCccCc----CCcccccCCCCCcEEEeecCCCCC----CCCCCCCCCCcccEEeeccCccCCcCCC-----
Q 006677           70 RVFGLRLPGIGLVGP----IPNNTLGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPS-----  136 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~----l~~~~l~~l~~L~~L~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~p~-----  136 (635)
                      +++.|+|++|.+++.    ++. .+.++++|++|+|++|.+++    .++..+.++++|+.|+|++|.+.+ +|.     
T Consensus       165 ~L~~L~L~~~~~~~~~~~~l~~-~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~  242 (592)
T 3ogk_B          165 KIKTLLMEESSFSEKDGKWLHE-LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA  242 (592)
T ss_dssp             TCSEEECTTCEEECCCSHHHHH-HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred             CCCEEECccccccCcchhHHHH-HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence            455566666655443    222 34455566666666666552    233334455566666666655543 222     


Q ss_pred             ----------------------Ccc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCC---CCCCCCc
Q 006677          137 ----------------------SFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN---FDIPKLR  189 (635)
Q Consensus       137 ----------------------~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~---~~l~~L~  189 (635)
                                            .+.  ++|+.|+++++.. +.+|..+..+++|++|+|++|.+++....   ..+++|+
T Consensus       243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~  321 (592)
T 3ogk_B          243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE  321 (592)
T ss_dssp             TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred             hHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence                                  121  4566666666433 36677777888888888888887654332   3678888


Q ss_pred             EEEeecccCcCCCCcccCCCCCCCcc
Q 006677          190 HLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       190 ~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      .|+|++|-..+.++..+..+++|+.+
T Consensus       322 ~L~L~~~~~~~~l~~~~~~~~~L~~L  347 (592)
T 3ogk_B          322 VLETRNVIGDRGLEVLAQYCKQLKRL  347 (592)
T ss_dssp             EEEEEGGGHHHHHHHHHHHCTTCCEE
T ss_pred             EEeccCccCHHHHHHHHHhCCCCCEE
Confidence            88888443333333333444555444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.31  E-value=1.4e-08  Score=112.94  Aligned_cols=121  Identities=21%  Similarity=0.253  Sum_probs=55.4

Q ss_pred             CCCCCcEEEeecCCCCCCCCCCCC-CCCcccEEeeccC-ccCCc-CCCCc--cCCcceeeccCccCcccCCchhh----c
Q 006677           92 KLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQHN-NFSGK-IPSSF--SPQLVVLDLSFNSFTGNIPQSIQ----N  162 (635)
Q Consensus        92 ~l~~L~~L~L~~n~l~g~~p~~~~-~l~~L~~L~l~~N-~l~g~-~p~~~--~~~L~~L~ls~N~l~g~~p~~~~----~  162 (635)
                      .+++|++|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+  .++|++|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            445555555555555544444443 4555555555555 33221 11111  14555555555555543333332    3


Q ss_pred             cccCCcEEcCCCcccccCCCC-------CCCCCcEEEeecc-cCcCCCCcccCCCCCCCcc
Q 006677          163 LTQLTGLSLQSNNLSGSIPNF-------DIPKLRHLNLSYN-GLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       163 l~~L~~L~l~~N~l~~~~p~~-------~l~~L~~l~l~~N-~l~g~~p~~~~~l~~l~~~  215 (635)
                      +++|+.|+|++|.  +.++..       .+++|+.|+|++| .+++ +|..+.++++|..+
T Consensus       183 ~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L  240 (594)
T 2p1m_B          183 YTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEEL  240 (594)
T ss_dssp             CCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEE
T ss_pred             CCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEc
Confidence            4455555555554  111110       2455555555555 2222 44444444444433

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.31  E-value=4e-06  Score=84.85  Aligned_cols=136  Identities=18%  Similarity=0.208  Sum_probs=94.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-C-ceeceeEEEE-eCCeeEEEEEeccCCC
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-P-NVVPLRAYYY-SKDEKLLVYDYFASGS  420 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~-niv~l~~~~~-~~~~~~lv~e~~~~g~  420 (635)
                      +.++.|....||+.    +..+++|+-.. ......+.+|.+++..+.+| + .+.+.+.++. ..+..++||||++|..
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899988    56788887432 12245788999999999544 2 3566666664 3445789999999988


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----------------------------------------  459 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------------  459 (635)
                      +.+..-.       .++......++.++++.|+.||+..                                         
T Consensus       100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8663211       1445555666666666666666432                                         


Q ss_pred             ----------------CCCceecCCCCCCeEEcC---CCC-eEEeecCCCCC
Q 006677          460 ----------------GPKFTHGNIKASNVLINQ---DLD-GCISDFGLTPL  491 (635)
Q Consensus       460 ----------------~~~ivH~Dlk~~NIll~~---~~~-~ki~DfGla~~  491 (635)
                                      .+.++|+|+++.||++++   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            224699999999999997   455 48999997654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=1.7e-06  Score=89.52  Aligned_cols=80  Identities=14%  Similarity=0.139  Sum_probs=57.2

Q ss_pred             ccc-cccCceEEEEEEec-------CCCeEEEEEeeccc---C-ChHHHHHHHHHHHhhcCC--CceeceeEEEEeC---
Q 006677          344 EVL-GKGSYGTAYKAVLE-------ESTTVVVKRLKEVV---V-GKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSK---  406 (635)
Q Consensus       344 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~---  406 (635)
                      +.| +.|....+|+....       ++..+++|+.....   . ....+.+|..++..+..+  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999998764       25678888765432   1 235688899999888655  3567788877654   


Q ss_pred             CeeEEEEEeccCCChhh
Q 006677          407 DEKLLVYDYFASGSLST  423 (635)
Q Consensus       407 ~~~~lv~e~~~~g~L~~  423 (635)
                      ...++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.28  E-value=2.4e-08  Score=111.11  Aligned_cols=107  Identities=18%  Similarity=0.108  Sum_probs=62.5

Q ss_pred             CCCCCcEEEeecCCCCCCCCCCCC-CCCcccEEeec--c----CccCCcCCC--C----cc--CCcceeeccCccCcccC
Q 006677           92 KLDALEVLSLRSNVLTGGLPSEIT-SLPSLRYLYLQ--H----NNFSGKIPS--S----FS--PQLVVLDLSFNSFTGNI  156 (635)
Q Consensus        92 ~l~~L~~L~L~~n~l~g~~p~~~~-~l~~L~~L~l~--~----N~l~g~~p~--~----~~--~~L~~L~ls~N~l~g~~  156 (635)
                      .+++|+.|+++.|++++..+..+. ++++|+.|+|+  +    |.+++ .|.  .    +.  ++|+.|+|++ .+++..
T Consensus       370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~  447 (594)
T 2p1m_B          370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV  447 (594)
T ss_dssp             HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred             hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence            367777777777777655444444 46777777777  3    44442 111  1    11  5677777765 555555


Q ss_pred             Cchhhc-cccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCcC
Q 006677          157 PQSIQN-LTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       157 p~~~~~-l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g  200 (635)
                      +..++. +++|+.|+|++|.+++.....   .+++|+.|+|++|.+++
T Consensus       448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            555554 666777777777765432221   46667777777777643

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.18  E-value=6.4e-08  Score=90.38  Aligned_cols=108  Identities=15%  Similarity=0.186  Sum_probs=83.2

Q ss_pred             CeEEEEEeCCC-CccC----cCCcccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCc----CC
Q 006677           69 TRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGK----IP  135 (635)
Q Consensus        69 ~~v~~l~l~~~-~l~g----~l~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p  135 (635)
                      ..++.|+|++| ++..    .+.. .+...++|++|+|++|.|...    +...+...++|++|+|++|.|+..    +.
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~  114 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV  114 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence            56889999999 7763    2333 577789999999999999742    344456668999999999999853    23


Q ss_pred             CCcc--CCcceeec--cCccCccc----CCchhhccccCCcEEcCCCccc
Q 006677          136 SSFS--PQLVVLDL--SFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       136 ~~~~--~~L~~L~l--s~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                      ..+.  ++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            3333  68999999  88999854    4455667799999999999986

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.16  E-value=4.6e-07  Score=93.78  Aligned_cols=38  Identities=16%  Similarity=0.240  Sum_probs=16.1

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCcc
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF  130 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l  130 (635)
                      +..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.+
T Consensus       168 l~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l  205 (362)
T 2ra8_A          168 LDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGL  205 (362)
T ss_dssp             HHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBC
T ss_pred             HhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCC
Confidence            344455555555544211 1222 2 244555555544444

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.11  E-value=8.6e-06  Score=85.60  Aligned_cols=136  Identities=15%  Similarity=0.121  Sum_probs=73.1

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc-CCcceeecc
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLS  148 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~~L~~L~ls  148 (635)
                      +++.+.|+++ ++ .|+..+|.+ .+|+.++|.+ +++..-+..|.+|++|+.++|++|+++..-...|. .+|+.+.|.
T Consensus       136 ~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp  211 (401)
T 4fdw_A          136 QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLP  211 (401)
T ss_dssp             CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECC
T ss_pred             CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeC
Confidence            3556666554 44 566556666 3577777764 55533345667777777777777776632222332 566667666


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      +| ++..-..+|.++++|+.++|.+| ++ .++..  .-.+|+.++| .|.++..-+..|.++++|.
T Consensus       212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~  274 (401)
T 4fdw_A          212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELA  274 (401)
T ss_dssp             TT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCC
T ss_pred             Cc-hheehhhHhhCCCCCCEEecCCC-cc-CccccccccCCccEEEe-CCCccEEChhHhhCCCCCC
Confidence            33 55444556666667777776654 22 22221  1145555555 2334322234455554444

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.08  E-value=2.5e-07  Score=95.75  Aligned_cols=127  Identities=21%  Similarity=0.284  Sum_probs=81.7

Q ss_pred             CeEEEEEeCCCC-ccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCC--CCCcccEEeecc--CccCCc---------C
Q 006677           69 TRVFGLRLPGIG-LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT--SLPSLRYLYLQH--NNFSGK---------I  134 (635)
Q Consensus        69 ~~v~~l~l~~~~-l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~---------~  134 (635)
                      .++..|+|.++. +  .+++  +. +++|+.|+|..|.++...-..+.  ++++|+.|+|+.  |...|.         +
T Consensus       172 P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l  246 (362)
T 2ra8_A          172 PLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF  246 (362)
T ss_dssp             TTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred             CCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence            467888887762 2  3443  33 78888888888877633222333  678888888863  222211         1


Q ss_pred             CCCccCCcceeeccCccCcccCCchhh---ccccCCcEEcCCCccccc----CCCC--CCCCCcEEEeecccCcC
Q 006677          135 PSSFSPQLVVLDLSFNSFTGNIPQSIQ---NLTQLTGLSLQSNNLSGS----IPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       135 p~~~~~~L~~L~ls~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~~~----~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      ...-.++|++|+|++|.+++..+..+.   .+++|+.|+|+.|.|++.    ++..  .+++|+.|+|++|.++.
T Consensus       247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            111126888888888888765544444   477888888888888753    2222  56788888888887763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.07  E-value=6.6e-06  Score=86.48  Aligned_cols=122  Identities=16%  Similarity=0.206  Sum_probs=73.3

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .++.+.|++ ++. .|+...|.++.+|+.++|++|+++ .||......++|+.+.|.+| ++..-...|.  ++|+.++|
T Consensus       158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l  233 (401)
T 4fdw_A          158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI  233 (401)
T ss_dssp             CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred             CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence            477788875 565 677778888888888888888887 55544444677777777744 5523333333  46777777


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCC-C--CCCCCcEEEeecccCc
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN-F--DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~--~l~~L~~l~l~~N~l~  199 (635)
                      ..| ++..-..+|.+ .+|+.+.| .|.++ .++. .  .+++|+.+++.+|.+.
T Consensus       234 ~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          234 PEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             CTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCC
T ss_pred             CCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCcccc
Confidence            654 44333344544 55666666 33343 2222 1  5566666666665543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.92  E-value=6.7e-05  Score=75.75  Aligned_cols=140  Identities=17%  Similarity=0.154  Sum_probs=91.9

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC--CceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      +.|+.|.+..+|+.... +..+++|+....  ....+..|.+.++.+..+  ..+++.++++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            35788999999999864 678888887543  256788999999888543  6688889888888889999999998764


Q ss_pred             hh-----------hccCCCC-C----------------CCCCCCHHHHH---HHHH----------------HHHHH-HH
Q 006677          422 ST-----------LLHGNRG-A----------------GRTPLDWETRV---KILL----------------GTARG-VA  453 (635)
Q Consensus       422 ~~-----------~l~~~~~-~----------------~~~~l~~~~~~---~i~~----------------~ia~~-l~  453 (635)
                      ..           .+|.... .                ....-+|....   ++..                .+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            21           2232211 0                00012454321   1111                11111 12


Q ss_pred             HHHh-cCCCCceecCCCCCCeEEcCCCCeEEeecC
Q 006677          454 HIHS-MGGPKFTHGNIKASNVLINQDLDGCISDFG  487 (635)
Q Consensus       454 ~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~DfG  487 (635)
                      .|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 2246699999999999999887 8899973

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=4.2e-05  Score=78.26  Aligned_cols=143  Identities=14%  Similarity=0.212  Sum_probs=80.2

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-CceeceeE------EEEeCCeeEEEEEec
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRA------YYYSKDEKLLVYDYF  416 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~------~~~~~~~~~lv~e~~  416 (635)
                      +.|+.|..+.||+....++ .+++|+...   ...+...|.+++..+.++ -.+.+++.      +....+..++||+|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3466677889999987654 588888865   234455566666655321 12333332      123456788999999


Q ss_pred             cCCChh--------------hhccCCCC----C-C----CCCCCHHHH-------------------------------H
Q 006677          417 ASGSLS--------------TLLHGNRG----A-G----RTPLDWETR-------------------------------V  442 (635)
Q Consensus       417 ~~g~L~--------------~~l~~~~~----~-~----~~~l~~~~~-------------------------------~  442 (635)
                      +|..+.              ..+|....    . .    ...-.|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11121100    0 0    001123211                               0


Q ss_pred             HHHHHHHHHHHHHHh--------c--CCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          443 KILLGTARGVAHIHS--------M--GGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       443 ~i~~~ia~~l~~LH~--------~--~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      .+...+..++++|++        .  ..+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111123345666653        1  23459999999999999888899999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.89  E-value=6.8e-05  Score=78.69  Aligned_cols=74  Identities=12%  Similarity=0.194  Sum_probs=49.5

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeeccc--------CChHHHHHHHHHHHhhcCC-Cc-eeceeEEEEeCCeeEEE
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV--------VGKRDFEQQMEIVGRVGQH-PN-VVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h-~n-iv~l~~~~~~~~~~~lv  412 (635)
                      +.||.|.++.||++... +++.+++|......        .....+..|.+++..+..+ +. +.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999754 46789999764321        1234567888888887443 33 3445543  45567899


Q ss_pred             EEeccCC
Q 006677          413 YDYFASG  419 (635)
Q Consensus       413 ~e~~~~g  419 (635)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.66  E-value=0.00034  Score=69.81  Aligned_cols=74  Identities=15%  Similarity=0.185  Sum_probs=54.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCC--ceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHP--NVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~--niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      +.+|.|..+.||+....+|+.+++|+-..... ....|+.|.+.|+.+.+..  .+.+.+++  .  ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence            45899999999999999999999998764432 2456889999999885432  24444443  2  3478999998764


Q ss_pred             h
Q 006677          421 L  421 (635)
Q Consensus       421 L  421 (635)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.54  E-value=0.00011  Score=63.85  Aligned_cols=57  Identities=19%  Similarity=0.251  Sum_probs=43.9

Q ss_pred             cEEeeccCccC-CcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCCCccc
Q 006677          121 RYLYLQHNNFS-GKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       121 ~~L~l~~N~l~-g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                      ..++.+++.|+ ..+|..+.++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            36777777776 4677777778888888888888655566788888888888888764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00042  Score=73.17  Aligned_cols=73  Identities=12%  Similarity=0.084  Sum_probs=45.8

Q ss_pred             CCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCC---CC--CCcccCcccccCCC---CCCccchhhHHHHHHHHH
Q 006677          461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATP---SR--SAGYRAPEVIETRK---HSHKSDVYSFGVLLLEML  532 (635)
Q Consensus       461 ~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~---~~--~~~y~aPE~~~~~~---~~~k~Dvws~Gvvl~el~  532 (635)
                      +.++|+|+++.|||+++++ ++|+||+.+.........   ..  ...|.+|+......   .....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4599999999999999876 999999987653211000   00  12256665543211   112345567788888887


Q ss_pred             hC
Q 006677          533 TG  534 (635)
Q Consensus       533 tg  534 (635)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.48  E-value=0.00087  Score=68.01  Aligned_cols=144  Identities=15%  Similarity=0.106  Sum_probs=83.3

Q ss_pred             cccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-ceeceeEE-----EEeCCeeEEEEEeccC
Q 006677          345 VLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY-----YYSKDEKLLVYDYFAS  418 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~-----~~~~~~~~lv~e~~~~  418 (635)
                      .++ |....||+....+|+.+++|+..........+..|..++..+..+. .+++++..     ....+..+++|+|++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            355 7778999988777778999998754445667788888888775332 24444432     1234556789999987


Q ss_pred             CChhh--------------hccCC----CCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc---
Q 006677          419 GSLST--------------LLHGN----RGAGRTPLDWETR----VKI---------------LLGTARGVAHIHSM---  458 (635)
Q Consensus       419 g~L~~--------------~l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~~---  458 (635)
                      ..+..              .+|..    ........++...    ..+               ...+...++.+...   
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            54321              01110    0000111222211    001               01111223333221   


Q ss_pred             -CCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          459 -GGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       459 -~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                       ..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             223479999999999999 4 899999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00062  Score=68.34  Aligned_cols=71  Identities=6%  Similarity=-0.011  Sum_probs=44.7

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec-cCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF-ASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~-~~g~L  421 (635)
                      +.|+.|....+|+.     ..+++|+........-+..+|..++..+..+.-..+++++  +.+.-++|+||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            46888999999999     5688888764322222346688777777544333455544  344467899999 55444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.33  E-value=4.3e-05  Score=69.70  Aligned_cols=81  Identities=7%  Similarity=0.055  Sum_probs=47.6

Q ss_pred             CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCc-cCCcCCCCc------cCCcceeeccCcc-CcccCCchhhcccc
Q 006677           94 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNN-FSGKIPSSF------SPQLVVLDLSFNS-FTGNIPQSIQNLTQ  165 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~------~~~L~~L~ls~N~-l~g~~p~~~~~l~~  165 (635)
                      -+|+.|||+++.++..=-..+.++++|+.|+|+++. ++..-=..+      .++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            367888888877764322346777888888888774 442111111      1257777777763 65433344556666


Q ss_pred             CCcEEcCCC
Q 006677          166 LTGLSLQSN  174 (635)
Q Consensus       166 L~~L~l~~N  174 (635)
                      |+.|+|+++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            666666655

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.25  E-value=0.002  Score=65.04  Aligned_cols=145  Identities=10%  Similarity=0.096  Sum_probs=80.1

Q ss_pred             ccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-ceeceeEE------EEeCCeeEEEEEec
Q 006677          344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAY------YYSKDEKLLVYDYF  416 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~------~~~~~~~~lv~e~~  416 (635)
                      +.|+.|....+|+....++ .+++|+.... ....++..|..++..+..+. .+.+++..      ....+..+++++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            3467788889999987655 6788887652 23356677888887775431 12333321      12345678999999


Q ss_pred             cCCChhh--------------hccCCC-C--CCC-CC---CCHHHHHH------------HHHHHHHHHHHHHhc----C
Q 006677          417 ASGSLST--------------LLHGNR-G--AGR-TP---LDWETRVK------------ILLGTARGVAHIHSM----G  459 (635)
Q Consensus       417 ~~g~L~~--------------~l~~~~-~--~~~-~~---l~~~~~~~------------i~~~ia~~l~~LH~~----~  459 (635)
                      +|..+..              .+|... .  ... ..   ..|.....            +...+...++++++.    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865421              112110 0  000 00   12322110            011134455555532    1


Q ss_pred             CCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          460 GPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       460 ~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      .+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2348999999999999987666899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.0011  Score=68.68  Aligned_cols=142  Identities=15%  Similarity=0.214  Sum_probs=83.6

Q ss_pred             cccccCceEEEEEEecC--------CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          345 VLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .|..|....+|+....+        ++.+++|+............+|..+++.+..+.-..++++++.+    .+||||+
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i  132 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI  132 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence            46667778899988642        46788888644333456677899999888666555667766532    3999999


Q ss_pred             cCCChhhh-----------------ccCCCC-CCCCCC-CHHHHHHHHHHHHH-------------------HHHHH---
Q 006677          417 ASGSLSTL-----------------LHGNRG-AGRTPL-DWETRVKILLGTAR-------------------GVAHI---  455 (635)
Q Consensus       417 ~~g~L~~~-----------------l~~~~~-~~~~~l-~~~~~~~i~~~ia~-------------------~l~~L---  455 (635)
                      +|..|..-                 +|...- ..+.+. -|.++.++..++..                   .+..|   
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            98655311                 121111 111111 24444544443321                   23333   


Q ss_pred             -HhcC-CCCceecCCCCCCeEEcCC----CCeEEeecCCCC
Q 006677          456 -HSMG-GPKFTHGNIKASNVLINQD----LDGCISDFGLTP  490 (635)
Q Consensus       456 -H~~~-~~~ivH~Dlk~~NIll~~~----~~~ki~DfGla~  490 (635)
                       .... ...++|+|+.+.||+++++    +.+.++||..+.
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             2222 2248999999999999877    789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.16  E-value=0.00079  Score=71.22  Aligned_cols=73  Identities=12%  Similarity=0.102  Sum_probs=50.2

Q ss_pred             ccccccCceEEEEEEecC--------CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      +.|+.|....+|++...+        +..+++|+.... .....+.+|..++..+..+.-..++++.+.  +  .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence            457778889999998753        467888887432 122566689888888865554566776543  2  389999


Q ss_pred             ccCCCh
Q 006677          416 FASGSL  421 (635)
Q Consensus       416 ~~~g~L  421 (635)
                      +++-.+
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.16  E-value=0.0017  Score=69.02  Aligned_cols=74  Identities=7%  Similarity=0.059  Sum_probs=48.2

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      +.|+.|-...+|+....+ +..+++|+........-+..+|..++..+..+.-..++++.+  .+  .+||||+++-.|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence            457778889999998765 467888876432211223368888999886555456777766  22  359999987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.14  E-value=0.001  Score=67.73  Aligned_cols=143  Identities=15%  Similarity=0.104  Sum_probs=72.7

Q ss_pred             cccccCceE-EEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-ceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          345 VLGKGSYGT-AYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       345 ~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .|+.|+... +|+....++..+++|......  ..++..|+.++..+..+. .+.+++.+.  .+.-+++||++.+..+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcchH
Confidence            455554444 667765446677776544321  144566777777775442 355566653  23337899999776665


Q ss_pred             hhccCC---------------------CCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHH---hc
Q 006677          423 TLLHGN---------------------RGAGRTPLDWETRV-------K-------------ILLGTARGVAHIH---SM  458 (635)
Q Consensus       423 ~~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~~l~~LH---~~  458 (635)
                      +++...                     .......++.....       .             ....+...++.+.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            443211                     00001112211100       0             0001112222331   11


Q ss_pred             CCCCceecCCCCCCeEEcCC----CCeEEeecCCCCC
Q 006677          459 GGPKFTHGNIKASNVLINQD----LDGCISDFGLTPL  491 (635)
Q Consensus       459 ~~~~ivH~Dlk~~NIll~~~----~~~ki~DfGla~~  491 (635)
                      ..+.++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            22358999999999999875    6789999998754

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.94  E-value=6.5e-05  Score=69.84  Aligned_cols=110  Identities=13%  Similarity=0.156  Sum_probs=64.8

Q ss_pred             cccCCCCCcEEEeecC-CCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc------CCcceeeccCccCccc--
Q 006677           89 TLGKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN--  155 (635)
Q Consensus        89 ~l~~l~~L~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~--  155 (635)
                      .+.+-+.|+.|+|++| +|...    +-..+..=+.|+.|+|++|.+...--..+.      +.|++|+|++|+|+..  
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3455677888888875 66521    233445557788888888888743333333      5688888888888743  


Q ss_pred             --CCchhhccccCCcEEcCCCc---cccc----CCCC--CCCCCcEEEeecccC
Q 006677          156 --IPQSIQNLTQLTGLSLQSNN---LSGS----IPNF--DIPKLRHLNLSYNGL  198 (635)
Q Consensus       156 --~p~~~~~l~~L~~L~l~~N~---l~~~----~p~~--~l~~L~~l~l~~N~l  198 (635)
                        +-..+..-+.|+.|+|++|.   +...    +...  .-+.|+.|+|+.|.+
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence              22344445567888887553   2211    1000  234577777766543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.93  E-value=0.0019  Score=66.82  Aligned_cols=74  Identities=12%  Similarity=0.112  Sum_probs=44.7

Q ss_pred             ccccccCceEEEEEEecC---------CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          344 EVLGKGSYGTAYKAVLEE---------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      +.|+.|....+|+....+         +..+++|+.........+...|.+++..+..+.-+.++++..  .  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            357778888999998754         267888876543211123467888888875554345666543  2  378999


Q ss_pred             eccCCCh
Q 006677          415 YFASGSL  421 (635)
Q Consensus       415 ~~~~g~L  421 (635)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.79  E-value=0.00044  Score=62.94  Aligned_cols=80  Identities=10%  Similarity=0.035  Sum_probs=56.7

Q ss_pred             CcccEEeeccCccCCcCCCCcc--CCcceeeccCcc-CcccCCchhhcc----ccCCcEEcCCCc-ccc--cCCCCCCCC
Q 006677          118 PSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNS-FTGNIPQSIQNL----TQLTGLSLQSNN-LSG--SIPNFDIPK  187 (635)
Q Consensus       118 ~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~~--~~p~~~l~~  187 (635)
                      -+|+.|||+++.++..--..+.  ++|++|+|+++. ++..--..+..+    ++|+.|+|+++. |+.  ...-..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            4799999999998743222232  789999999995 775433445553    479999999874 663  111126899


Q ss_pred             CcEEEeeccc
Q 006677          188 LRHLNLSYNG  197 (635)
Q Consensus       188 L~~l~l~~N~  197 (635)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            9999999875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.66  E-value=0.008  Score=61.26  Aligned_cols=69  Identities=16%  Similarity=0.140  Sum_probs=43.9

Q ss_pred             cccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC--CceeceeEE------EEeCCeeEEEEEeccC
Q 006677          347 GKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH--PNVVPLRAY------YYSKDEKLLVYDYFAS  418 (635)
Q Consensus       347 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~------~~~~~~~~lv~e~~~~  418 (635)
                      |.|....||+....++ .+++|+......     ..|+.++..+.++  +++++.+..      ....+..++||+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444679999987766 889998765432     3556666655332  224444432      2334667899999998


Q ss_pred             CCh
Q 006677          419 GSL  421 (635)
Q Consensus       419 g~L  421 (635)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.44  E-value=0.00021  Score=66.33  Aligned_cols=108  Identities=14%  Similarity=0.217  Sum_probs=75.0

Q ss_pred             CeEEEEEeCCC-CccC----cCCcccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc
Q 006677           69 TRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS  139 (635)
Q Consensus        69 ~~v~~l~l~~~-~l~g----~l~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  139 (635)
                      ..++.|+|+++ ++..    .|-. .+..=+.|+.|+|++|+|...    |-..+..=+.|+.|+|++|.|...--..+.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala  119 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL  119 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence            56888999885 5542    1233 466778999999999999732    223333457899999999999843222221


Q ss_pred             ------CCcceeeccCc---cCcc----cCCchhhccccCCcEEcCCCccc
Q 006677          140 ------PQLVVLDLSFN---SFTG----NIPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       140 ------~~L~~L~ls~N---~l~g----~~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                            ..|++|+|++|   .+..    .+-..+..-+.|+.|+++.|.+.
T Consensus       120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence                  57999999876   3442    24456667788999999988764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.42  E-value=0.0088  Score=62.33  Aligned_cols=56  Identities=16%  Similarity=0.129  Sum_probs=28.7

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN  128 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N  128 (635)
                      .+..+.++.. ++ .|....+.+...|+.+.+..|..+ .-...+.++..|+.+.+..+
T Consensus       231 ~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~  286 (394)
T 4fs7_A          231 GVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV  286 (394)
T ss_dssp             CCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred             CCceEEECCC-ce-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence            3455555433 22 344445666677777777665443 22344555555555544443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.33  E-value=0.0053  Score=52.98  Aligned_cols=56  Identities=27%  Similarity=0.291  Sum_probs=39.9

Q ss_pred             EEEeCCCCcc-CcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccC
Q 006677           73 GLRLPGIGLV-GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFS  131 (635)
Q Consensus        73 ~l~l~~~~l~-g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~  131 (635)
                      .++.++++|+ ..+|.+ +  -.+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677778876 456652 2  246888999999998444456777888888888888765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.22  E-value=0.032  Score=52.11  Aligned_cols=102  Identities=12%  Similarity=0.066  Sum_probs=66.7

Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCCCC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS  499 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~~~  499 (635)
                      +|.++|...    ..++++++++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+...+ +.+.        .
T Consensus        34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~   98 (229)
T 2yle_A           34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------A   98 (229)
T ss_dssp             EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------c
Confidence            788888753    3569999999999999998877632111 1 1233446899999999998764 1111        1


Q ss_pred             CCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCC
Q 006677          500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAP  537 (635)
Q Consensus       500 ~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p  537 (635)
                      ....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            223467888764 3456788999999999999875554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.19  E-value=0.0065  Score=63.78  Aligned_cols=74  Identities=7%  Similarity=0.075  Sum_probs=49.1

Q ss_pred             ccccccCceEEEEEEecC--------CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      +.+..|-...+|+....+        +..+++++........-+..+|..++..+..+.-..++++.+  .  -++||||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            346667778999998763        577888886443222234567888888886555456666533  2  3789999


Q ss_pred             ccCCCh
Q 006677          416 FASGSL  421 (635)
Q Consensus       416 ~~~g~L  421 (635)
                      ++|..|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.15  E-value=0.0078  Score=62.74  Aligned_cols=110  Identities=15%  Similarity=0.277  Sum_probs=77.8

Q ss_pred             cCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCC-Ccc--CCcceeeccCccCcccCCchh
Q 006677           84 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFS--PQLVVLDLSFNSFTGNIPQSI  160 (635)
Q Consensus        84 ~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~--~~L~~L~ls~N~l~g~~p~~~  160 (635)
                      .+....|.+..+|+.+.+.++..+ .-...|.++++|+.+.+. +.++ .|+. .|.  .+|+.++|..| ++..-..+|
T Consensus       255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF  330 (394)
T 4gt6_A          255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAF  330 (394)
T ss_dssp             EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred             EcccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence            344457888889999988766544 334678888999999886 4455 3443 343  68999998765 664556788


Q ss_pred             hccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCc
Q 006677          161 QNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       161 ~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~  199 (635)
                      .+|.+|+.+.|..+ ++ .|...   ++.+|+.+++.+|...
T Consensus       331 ~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          331 AGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             TTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             hCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence            89999999998655 54 34432   7888999999887543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.06  E-value=0.011  Score=61.47  Aligned_cols=100  Identities=12%  Similarity=0.145  Sum_probs=64.9

Q ss_pred             CCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC---CC
Q 006677          111 PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DI  185 (635)
Q Consensus       111 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l  185 (635)
                      ...|.++++|+.+.+.++..+ .-...|.  ..|+.+.+. +.++..-..+|.++.+|+.++|..| ++ .|...   ++
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C  333 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGC  333 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTC
T ss_pred             cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCC
Confidence            356788888888888765443 2223333  678888885 4566455567888888888888765 44 33332   67


Q ss_pred             CCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          186 PKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       186 ~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      .+|+.+.|..+ ++..-...|.++++|+.+
T Consensus       334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i  362 (394)
T 4gt6_A          334 EQLERIAIPSS-VTKIPESAFSNCTALNNI  362 (394)
T ss_dssp             TTCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred             CCCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence            88888888654 553334567777776544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=95.82  E-value=0.022  Score=58.78  Aligned_cols=123  Identities=13%  Similarity=0.085  Sum_probs=78.5

Q ss_pred             ccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhcccc
Q 006677           88 NTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQ  165 (635)
Q Consensus        88 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~  165 (635)
                      ..+....+|+.+.+..+ +...-...+.++.+|+.+.+..+ ++..-...|.  .+|+.+.+..+ +...-...|.++++
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            35667778888887655 33233456778888888888765 4422223332  56888887644 55344567788888


Q ss_pred             CCcEEcCCCcccccCCCC---CCCCCcEEEeecccCcCCCCcccCCCCCCCcc
Q 006677          166 LTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       166 L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~  215 (635)
                      |+.+.+.+|.++ .++..   ++.+|+.++|..| ++..-...|.++++|+.+
T Consensus       288 L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i  338 (379)
T 4h09_A          288 LTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI  338 (379)
T ss_dssp             CCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred             cccccccccccc-eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence            888888888777 33332   6788888888654 542223567776666544

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=95.66  E-value=0.038  Score=57.43  Aligned_cols=16  Identities=19%  Similarity=0.222  Sum_probs=7.7

Q ss_pred             CCCCCCcccEEeeccC
Q 006677          113 EITSLPSLRYLYLQHN  128 (635)
Q Consensus       113 ~~~~l~~L~~L~l~~N  128 (635)
                      .+.++.+|+.+.+..|
T Consensus       248 ~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          248 VFYGCTDLESISIQNN  263 (394)
T ss_dssp             TTTTCSSCCEEEECCT
T ss_pred             cccccccceeEEcCCC
Confidence            3444455555554444

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=95.26  E-value=0.071  Score=54.90  Aligned_cols=82  Identities=15%  Similarity=0.210  Sum_probs=36.7

Q ss_pred             cccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCC-cc--CCcceeeccCccCcccCCchhhcccc
Q 006677           89 TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDLSFNSFTGNIPQSIQNLTQ  165 (635)
Q Consensus        89 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~~L~ls~N~l~g~~p~~~~~l~~  165 (635)
                      .+.+...|+.+.+..+ ++..-...+.++.+|+.+.+..+ +. .++.. |.  .+|+.+++.+|.++..-..+|.+|.+
T Consensus       235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~  311 (379)
T 4h09_A          235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK  311 (379)
T ss_dssp             TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred             cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCC
Confidence            4445555555555443 33122234455555555555432 22 22221 21  44555555555554333344555555


Q ss_pred             CCcEEcCC
Q 006677          166 LTGLSLQS  173 (635)
Q Consensus       166 L~~L~l~~  173 (635)
                      |+.+.|.+
T Consensus       312 L~~i~lp~  319 (379)
T 4h09_A          312 LSSVTLPT  319 (379)
T ss_dssp             CCEEECCT
T ss_pred             CCEEEcCc
Confidence            55555543

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.91  E-value=0.051  Score=36.39  Aligned_cols=30  Identities=30%  Similarity=0.287  Sum_probs=16.7

Q ss_pred             ceeeeeehhhHHHHHHHHHHHhhhhccccC
Q 006677          258 GAIIAIAVGGSAVLLLVALVILCYCLKKKD  287 (635)
Q Consensus       258 ~~ii~ivvg~~~~~llv~~~i~~~~~~r~~  287 (635)
                      ..|++.++++++++++++++++++.++|+.
T Consensus        11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            445666666666655555555555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.56  E-value=0.046  Score=36.51  Aligned_cols=32  Identities=28%  Similarity=0.387  Sum_probs=18.2

Q ss_pred             cceeeeeehhhHHHHHHHHHHHhhhhccccCC
Q 006677          257 LGAIIAIAVGGSAVLLLVALVILCYCLKKKDN  288 (635)
Q Consensus       257 ~~~ii~ivvg~~~~~llv~~~i~~~~~~r~~~  288 (635)
                      ...|++.+++++++++++++.+++++++|+.+
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            34566666666666555555555555555443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.47  E-value=0.035  Score=36.02  Aligned_cols=31  Identities=19%  Similarity=0.163  Sum_probs=21.0

Q ss_pred             ccCcceeeeeehhhHHHHHHHHHHHhhhhcc
Q 006677          254 KLGLGAIIAIAVGGSAVLLLVALVILCYCLK  284 (635)
Q Consensus       254 ~~~~~~ii~ivvg~~~~~llv~~~i~~~~~~  284 (635)
                      ..+.++|.+++++.++.+.+++.+++++++|
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            3456778888888877766666666555544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.13  E-value=0.45  Score=49.39  Aligned_cols=29  Identities=21%  Similarity=0.462  Sum_probs=24.2

Q ss_pred             ceecCCCCCCeEE------cCCCCeEEeecCCCCC
Q 006677          463 FTHGNIKASNVLI------NQDLDGCISDFGLTPL  491 (635)
Q Consensus       463 ivH~Dlk~~NIll------~~~~~~ki~DfGla~~  491 (635)
                      ++|+|+.+.|||+      +++..++++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999987643

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=88.67  E-value=0.15  Score=33.91  Aligned_cols=29  Identities=17%  Similarity=0.348  Sum_probs=14.1

Q ss_pred             ceeeeeehhhHHHHHHHHHHHhhhhccccC
Q 006677          258 GAIIAIAVGGSAVLLLVALVILCYCLKKKD  287 (635)
Q Consensus       258 ~~ii~ivvg~~~~~llv~~~i~~~~~~r~~  287 (635)
                      ..|+++++| +++++++++.++++.+||+.
T Consensus        12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           12 TSIISAVVG-ILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred             cchHHHHHH-HHHHHHHHHHHHhheehhhh
Confidence            345556666 44444444444444444443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	635
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-55
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-45
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-12
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	9e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.004

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 7e-55
 Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E LG G +G  +       T V VK LK+  +    F  +  ++ ++ QH  +V L A  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYA-V 76

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            +++   ++ +Y  +GSL   L    G     L     + +    A G+A I       +
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---Y 130

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 518
            H +++A+N+L++  L   I+DFGL  L+      +R        + APE I     + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
           SDV+SFG+LL E++T             +  P  +Q++ R           ++R  N  E
Sbjct: 191 SDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLER--------GYRMVRPDNCPE 237

Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
           E+ Q++     C  + P+ RP  D +  ++E+   +
Sbjct: 238 ELYQLM---RLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-54
 Identities = 64/283 (22%), Positives = 127/283 (44%), Gaps = 35/283 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLR 400
           + +G GS+GT YK        V VK L          + F+ ++ ++ +  +H N++   
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 70

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            Y  +  +  +V  +    SL   LH          +    + I   TA+G+ ++H+   
Sbjct: 71  GYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS- 124

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
               H ++K++N+ +++DL   I DFGL  + +  +   +      S  + APEVI  + 
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 515 ---HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 571
              +S +SDVY+FG++L E++TG+ P  +      ++    +  +V   + +        
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMVGRGYLSPDLS---K 233

Query: 572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
              N  + M +++     C+ K  D RP   +++  IE + +S
Sbjct: 234 VRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARS 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-53
 Identities = 62/277 (22%), Positives = 120/277 (43%), Gaps = 31/277 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +G G +G  +         V +K ++E  + + DF ++ E++ ++  HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +    LV+++   G LS  L   R         ET + + L    G+A++        
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---V 122

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 518
            H ++ A N L+ ++    +SDFG+T  +      S         + +PEV    ++S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SDV+SFGVL+ E+ + GK P ++ +  ++V+       + +    +              
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
                + QI   C  + P+ RP    ++R + E+ +S
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-53
 Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 35/300 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           E +GKG +G  ++        V VK            E ++     + +H N++   A  
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 66

Query: 404 YSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-- 457
              +       LV DY   GSL   L+      R  +  E  +K+ L TA G+AH+H   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 458 ---MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA--------GYRA 506
               G P   H ++K+ N+L+ ++   CI+D GL    +        A         Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 507 PEVIETRKH------SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM----VDLPRWVQSV 556
           PEV++   +        ++D+Y+ G++  E+    +         +    +         
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           +R+    +     +       E +  M +I   C       R     + + + ++ Q + 
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 9e-52
 Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 27/272 (9%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + +GKG +G            V VK +K      + F  +  ++ ++ +H N+V L    
Sbjct: 13  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 69

Query: 404 YSKDEKL-LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             +   L +V +Y A GSL   L      GR+ L  +  +K  L     + ++       
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMN-VPATPSRSAGYRAPEVIETRKHSHKSDV 521
           F H ++ A NVL+++D    +SDFGLT   +    T      + APE +  +K S KSDV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183

Query: 522 YSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEMV 581
           +SFG+LL E+ +         R  + D+   V+   + +                   + 
Sbjct: 184 WSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMD-----------APDGCPPAVY 230

Query: 582 QMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
           +++     C      MRP+  ++   +E ++ 
Sbjct: 231 EVM---KNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-51
 Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
           + LG G +G            V +K +KE  + + +F ++ +++  +  H  +V L    
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
             +    ++ +Y A+G L   L   R         +  +++       + ++ S     F
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---F 121

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-----SAGYRAPEVIETRKHSHK 518
            H ++ A N L+N      +SDFGL+  +      S         +  PEV+   K S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 519 SDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           SD+++FGVL+ E+ + GK P +  T  +  +       + R    +E             
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
               ++  I  +C  +  D RP    ++  I +V
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-50
 Identities = 64/302 (21%), Positives = 117/302 (38%), Gaps = 46/302 (15%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLK--EVVVGKRDFEQQMEIVGRVGQHPN 395
           + LG G++G   +A        + + TV VK LK    +  +     +++++  +G H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA-------------GRTPLDWETRV 442
           +V L          L++ +Y   G L   L   R +                 LD E  +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 501
                 A+G+A + S       H ++ A N+L+       I DFGL   +   +      
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 502 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV 556
                  + APE I    ++ +SDV+S+G+ L E+ +  +          + +      +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKM 260

Query: 557 VREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           ++E +          R  + E    +M  I   C    P  RP   ++V++IE+   S+S
Sbjct: 261 IKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI-SES 309

Query: 617 EN 618
            N
Sbjct: 310 TN 311

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-49
 Identities = 48/291 (16%), Positives = 114/291 (39%), Gaps = 18/291 (6%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 400
             LG G+ G  +K   + S   +  K +   +    +    ++++++      P +V   
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFY 70

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +YS  E  +  ++   GSL  +L          +  +   K+ +   +G+ ++     
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIETRKHSHK 518
               H ++K SN+L+N   +  + DFG++  +  ++  +   +  Y +PE ++   +S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV--FDVELMRFQNI 576
           SD++S G+ L+EM  G+ P+  P   ++  +          E           L  +   
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 577 EEEMVQMLQIGMACVAKVPDMRPNM---DEVVRMIEEVRQSDSENRPSSEE 624
               + + ++    V + P   P+     E    + +    +   R   ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-49
 Identities = 59/310 (19%), Positives = 127/310 (40%), Gaps = 38/310 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVP 398
           +V+G+G++G   KA +++        +KR+KE       RDF  ++E++ ++G HPN++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGN-----------RGAGRTPLDWETRVKILLG 447
           L      +    L  +Y   G+L   L  +             +  + L  +  +     
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 448 TARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---Y 504
            ARG+ ++       F H ++ A N+L+ ++    I+DFGL+    V    +       +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
            A E +    ++  SDV+S+GVLL E+++       P            + + +      
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGM--TCAELYEKLPQ------ 241

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
                L +  N ++E+  ++     C  + P  RP+  +++  +  + +       ++  
Sbjct: 242 --GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296

Query: 625 NKSKDSNVQT 634
            K   + +  
Sbjct: 297 EKFTYAGIDC 306

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-48
 Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYY 403
             LG+G +G  +      +T V +K LK   +    F Q+ +++ ++ +H  +V L A  
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYA-V 80

Query: 404 YSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKF 463
            S++   +V +Y + GSL   L G  G     L     V +    A G+A++  M    +
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---Y 134

Query: 464 THGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-----GYRAPEVIETRKHSHK 518
            H +++A+N+L+ ++L   ++DFGL  L+      +R        + APE     + + K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
           SDV+SFG+LL E+ T              ++   V+   R     E  +           
Sbjct: 195 SDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE----------- 241

Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS-DSENRPSSE 623
               +  +   C  K P+ RP  + +   +E+   S + + +P   
Sbjct: 242 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 1e-48
 Identities = 65/290 (22%), Positives = 129/290 (44%), Gaps = 41/290 (14%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVV 397
           +V+G G +G      L    +    V +K LK       +RDF  +  I+G+   HPNV+
Sbjct: 32  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVI 90

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L          +++ ++  +GSL + L  N G           V +L G A G+ ++  
Sbjct: 91  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD 146

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR---------SAGYRAPE 508
           M    + H ++ A N+L+N +L   +SDFGL+  +    +               + APE
Sbjct: 147 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
            I+ RK +  SDV+S+G+++ E+++ G+ P    T  D+++        + +++      
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-------IEQDY------ 250

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSE 617
               R     +    + Q+ + C  K  + RP   ++V  ++++ ++ + 
Sbjct: 251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-47
 Identities = 65/329 (19%), Positives = 116/329 (35%), Gaps = 56/329 (17%)

Query: 318 PEKNKLVFFEGCSYNFDLEDLLRAS----AEVLGKGSYGTAYKAVLEES------TTVVV 367
              N+  + +   Y +DL+           +VLG G++G    A             V V
Sbjct: 13  SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72

Query: 368 KRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLL 425
           K LKE      +     +++++ ++G H N+V L           L+++Y   G L   L
Sbjct: 73  KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132

Query: 426 HGNRG------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGN 467
              R                        L +E  +      A+G+  +         H +
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189

Query: 468 IKASNVLINQDLDGCISDFGLTPLMN------VPATPSRSAGYRAPEVIETRKHSHKSDV 521
           + A NVL+       I DFGL   +       V         + APE +    ++ KSDV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249

Query: 522 YSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEEEM 580
           +S+G+LL E+ + G  P   P      +  + +Q+  + +                 EE+
Sbjct: 250 WSYGILLWEIFSLGVNPY--PGIPVDANFYKLIQNGFKMDQP-----------FYATEEI 296

Query: 581 VQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
             ++Q   +C A     RP+   +   + 
Sbjct: 297 YIIMQ---SCWAFDSRKRPSFPNLTSFLG 322

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (419), Expect = 3e-47
 Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 29/279 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             LG G YG  Y+ V ++   TV VK LKE  +   +F ++  ++  + +HPN+V L   
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 81

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
              +    ++ ++   G+L   L       R  +     + +    +  + ++       
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN--- 135

Query: 463 FTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEVIETRKHSH 517
           F H ++ A N L+ ++    ++DFGL+ LM      + +       + APE +   K S 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           KSDV++FGVLL E+ T             +DL +  + + ++            R +  E
Sbjct: 196 KSDVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEKD-----------YRMERPE 239

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
               ++ ++  AC    P  RP+  E+ +  E + Q  S
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 4e-47
 Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 39/286 (13%)

Query: 344 EVLGKGSYGTAYKAVLEESTT----VVVKRLKEV--VVGKRDFEQQMEIVGRVGQHPNVV 397
           EV+G+G +G  Y   L ++        VK L  +  +     F  +  I+     HPNV+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 91

Query: 398 PLRAYYYSKDEK-LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
            L       +   L+V  Y   G L   +             +  +   L  A+G+  + 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 147

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 508
           S     F H ++ A N ++++     ++DFGL   M      S            + A E
Sbjct: 148 SKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
            ++T+K + KSDV+SFGVLL E++T  AP   P  D   +       +++          
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDV--NTFDITVYLLQGR-------- 251

Query: 569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
            L++ +   + +    ++ + C     +MRP+  E+V  I  +  +
Sbjct: 252 RLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (420), Expect = 4e-47
 Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 55/304 (18%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 395
             +G+G++G  ++A        E  T V VK LKE      + DF+++  ++     +PN
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 77

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRG-------------------AGRTPL 436
           +V L           L+++Y A G L+  L                         G  PL
Sbjct: 78  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 437 DWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN--- 493
               ++ I    A G+A++       F H ++   N L+ +++   I+DFGL+  +    
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194

Query: 494 ---VPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDL 549
                   +    +  PE I   +++ +SDV+++GV+L E+ + G  P      ++++  
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254

Query: 550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIE 609
                          V D  ++     E   +++  +   C +K+P  RP+   + R+++
Sbjct: 255 ---------------VRDGNILAC--PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

Query: 610 EVRQ 613
            + +
Sbjct: 298 RMCE 301

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-47
 Identities = 62/294 (21%), Positives = 126/294 (42%), Gaps = 38/294 (12%)

Query: 344 EVLGKGSYGTAYKAVLEEST-----TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNV 396
           +V+G G +G  YK +L+ S+      V +K LK       + DF  +  I+G+   H N+
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 71

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           + L          +++ +Y  +G+L   L    G           V +L G A G+ ++ 
Sbjct: 72  IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 127

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-------GYRAPEV 509
           +M    + H ++ A N+L+N +L   +SDFGL+ ++      + +         + APE 
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
           I  RK +  SDV+SFG+++ E++T              ++ + +    R           
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAINDGFRLPT-------- 234

Query: 570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSE 623
                   +    + Q+ M C  +    RP   ++V +++++ ++    +  ++
Sbjct: 235 ------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-46
 Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 45/300 (15%)

Query: 332 NFDLEDLLRASAEVLGKGSYGTAYKAVL---EESTTVVVKRLKEVV--VGKRDFEQQMEI 386
           N  + D+       LG G++G+  + V    ++   V +K LK+        +  ++ +I
Sbjct: 9   NLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 387 VGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILL 446
           + ++  +P +V L     + +  +LV +    G L   L G R      +      ++L 
Sbjct: 63  MHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLH 116

Query: 447 GTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------ 500
             + G+ ++       F H ++ A NVL+       ISDFGL+  +    +         
Sbjct: 117 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 501 -SAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVR 558
               + APE I  RK S +SDV+S+GV + E L+ G+ P +     +++    +++   R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR 230

Query: 559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSEN 618
            E   E                 ++  +   C     + RP+   V + +     S +  
Sbjct: 231 MECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-46
 Identities = 51/276 (18%), Positives = 114/276 (41%), Gaps = 33/276 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPL 399
             +G GSYG   K   +     +V K L    +    K+    ++ ++  + +HPN+V  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 68

Query: 400 RAYYYSKDEKLL--VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
                 +    L  V +Y   G L++++       R  LD E  ++++      +   H 
Sbjct: 69  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHR 127

Query: 458 MG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE 511
               G    H ++K +NV ++   +  + DFGL  ++N   + +++      Y +PE + 
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 571
              ++ KSD++S G LL E+     P  + ++ ++                 ++ + +  
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIREGKFR 232

Query: 572 RF-QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           R      +E+ +++      +      RP+++E++ 
Sbjct: 233 RIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 40/298 (13%)

Query: 317 EPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVV 375
           +P+  +L F +     F            +G GS+G  Y A  +  S  V +K++     
Sbjct: 1   DPDVAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53

Query: 376 GK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGA 431
                 +D  +++  + ++ +HPN +  R  Y  +    LV +Y    +   L    +  
Sbjct: 54  QSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-- 110

Query: 432 GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL 491
              PL       +  G  +G+A++HS       H ++KA N+L+++     + DFG   +
Sbjct: 111 ---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Query: 492 MNVPATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD 548
           M    +   +  + APEVI      ++  K DV+S G+  +E+   K PL +        
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-- 222

Query: 549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
               +  + + E  A       ++  +  E     +    +C+ K+P  RP  + +++
Sbjct: 223 ----LYHIAQNESPA-------LQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (402), Expect = 5e-45
 Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 32/269 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQM--EI-VGRVGQHPNVVPL 399
             LGKG +G  Y A  ++S   + +K L +  + K   E Q+  E+ +    +HPN++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
             Y++      L+ +Y   G++   L           D +     +   A  +++ HS  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR 126

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--SAGYRAPEVIETRKHSH 517
                H +IK  N+L+    +  I+DFG +         +   +  Y  PE+IE R H  
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           K D++S GVL  E L GK P ++ T  +       V+    +  T    D+         
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL--------- 234

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
             + ++L+         P  RP + EV+ 
Sbjct: 235 --ISRLLK-------HNPSQRPMLREVLE 254

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (407), Expect = 1e-44
 Identities = 55/297 (18%), Positives = 121/297 (40%), Gaps = 32/297 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
           E LG G++G  ++     +      K +       K    ++++ +  + +HP +V L  
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 90

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            +   +E +++Y++ + G L   +          +  +  V+ +    +G+ H+H     
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN-- 144

Query: 462 KFTHGNIKASNVLINQDLDGCI--SDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHS 516
            + H ++K  N++        +   DFGLT  ++        + +A + APEV E +   
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
           + +D++S GVL   +L+G +P      D+       +++V   +W      ++   F  I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN-----MDDSAFSGI 252

Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDS 630
            E+    ++     +   P+ R  + + +    +            PSS   K +DS
Sbjct: 253 SEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVV-VKRLKEVVVGKRD---FEQQMEIVGRVGQHPNVVPL 399
             +G+GS+ T YK +  E+T  V    L++  + K +   F+++ E++  + QHPN+V  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 73

Query: 400 RAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
              + S    K   +LV +   SG+L T L   +      +  +          +G+  +
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIET 512
           H+   P   H ++K  N+ I        I D GL  L       +   +  + APE+ E 
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
            K+    DVY+FG+ +LEM T + P       +   + R V S V+     +V   E+  
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                            C+ +  D R ++ +++ 
Sbjct: 245 I-------------IEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-44
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 41/280 (14%)

Query: 345 VLGKGSYGTAYKAVLEESTT---VVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVP 398
            LG G++GT  K   +       V VK LK        K +   +  ++ ++  +P +V 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           +       +  +LV +    G L+  L  NR      +  +  ++++   + G+ ++   
Sbjct: 73  MIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPEVIE 511
               F H ++ A NVL+       ISDFGL+  +       +          + APE I 
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 512 TRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 570
             K S KSDV+SFGVL+ E  + G+ P +     ++  +   ++   R            
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEKGERMGCP-------- 232

Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE 610
                   EM  ++     C     + RP    V   +  
Sbjct: 233 ---AGCPREMYDLM---NLCWTYDVENRPGFAAVELRLRN 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-44
 Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 41/285 (14%)

Query: 344 EVLGKGSYGTAYKAVLEEST----TVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPN 395
           E LG GS+G   +   +  +    +V VK LK  V+ +     DF +++  +  +  H N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 72

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           ++ L     +   K+ V +    GSL   L  ++G         T  +  +  A G+ ++
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 127

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAPE 508
            S     F H ++ A N+L+       I DFGL   +                  + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
            ++TR  SH SD + FGV L EM T G+ P        ++        + +E        
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGE------ 232

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR 612
               R    E+    +  + + C A  P+ RP    +   + E +
Sbjct: 233 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-44
 Identities = 58/292 (19%), Positives = 119/292 (40%), Gaps = 35/292 (11%)

Query: 326 FEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV-VKRL-KEVVVGKRDFEQQ 383
           +E  + + + ED        LG G++G  YKA  +E++ +   K +  +      D+  +
Sbjct: 1   YEHVTRDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59

Query: 384 MEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVK 443
           ++I+     HPN+V L   +Y ++   ++ ++ A G++  ++         PL       
Sbjct: 60  IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQV 114

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-- 501
           +   T   + ++H        H ++KA N+L   D D  ++DFG++           S  
Sbjct: 115 VCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 502 --AGYRAPEVI-----ETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQ 554
               + APEV+     + R + +K+DV+S G+ L+EM   + P        +      + 
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LL 225

Query: 555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
            + + E         L +           L+    C+ K  D R    ++++
Sbjct: 226 KIAKSEP------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 48/296 (16%)

Query: 344 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQH 393
           + LG+G++G    A             T V VK LK     K   D   +ME++  +G+H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 394 PNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----------RTPLDWETRV 442
            N++ L           ++ +Y + G+L   L   R  G              L  +  V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 443 KILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS- 501
                 ARG+ ++ S       H ++ A NVL+ +D    I+DFGL   ++      ++ 
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 502 -----AGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQS 555
                  + APE +  R ++H+SDV+SFGVLL E+ T G +P      +++    + ++ 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLKE 252

Query: 556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
             R +  +   +              ++  +   C   VP  RP   ++V  ++ +
Sbjct: 253 GHRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 70/299 (23%), Positives = 117/299 (39%), Gaps = 44/299 (14%)

Query: 344 EVLGKGSYGTAYKAVLEES------TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 395
           + LG+G++G   +A            TV VK LKE       R    +++I+  +G H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 396 VVPLRAYYYSKDEKL-LVYDYFASGSLSTLLHGNRG-----------AGRTPLDWETRVK 443
           VV L          L ++ ++   G+LST L   R              +  L  E  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 444 ILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA- 502
                A+G+  + S       H ++ A N+L+++     I DFGL   +       R   
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 503 -----GYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV 557
                 + APE I  R ++ +SDV+SFGVLL E+ +  A          V +       +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRL 250

Query: 558 REEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS 616
           +E            R +  +    +M Q  + C    P  RP   E+V  +  + Q+++
Sbjct: 251 KEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-42
 Identities = 53/269 (19%), Positives = 111/269 (41%), Gaps = 31/269 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
           E +G+G+ GT Y A+   +   V ++++  +    K     ++ ++    ++PN+V    
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            Y   DE  +V +Y A GSL+ ++        T +D      +     + +  +HS    
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 462 KFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRKHSH 517
              H +IK+ N+L+  D    ++DFG    +    +       +  + APEV+  + +  
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
           K D++S G++ +EM+ G+ P  +      + L      +            EL   + + 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------PELQNPEKLS 243

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                 L     C+    + R +  E+++
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 6e-42
 Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 38/284 (13%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVV 397
             +G+G +G  ++ +       +  V +K  K       +  F Q+   + +   HP++V
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 71

Query: 398 PLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS 457
            L     +++   ++ +    G L + L   +      LD  + +      +  +A++ S
Sbjct: 72  KLIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 126

Query: 458 MGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG-----YRAPEVIET 512
                F H +I A NVL++ +    + DFGL+  M        S G     + APE I  
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 513 RKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM 571
           R+ +  SDV+ FGV + E+L  G  P Q    +D++     +++  R             
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPM---------- 230

Query: 572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD 615
              N    +  ++     C A  P  RP   E+   +  + + +
Sbjct: 231 -PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  152 bits (386), Expect = 7e-42
 Identities = 57/296 (19%), Positives = 119/296 (40%), Gaps = 31/296 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRDFEQQMEIVGRVGQHPNVVPLRA 401
           E LG G++G  ++ V + +    V K +     + K   + ++ I+ ++  HP ++ L  
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 93

Query: 402 YYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGP 461
            +  K E +L+ ++ + G L   +          +     +  +     G+ H+H     
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS-- 147

Query: 462 KFTHGNIKASNVLINQDLDG--CISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHS 516
              H +IK  N++          I DFGL   +N       +     + APE+++     
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206

Query: 517 HKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI 576
             +D+++ GVL   +L+G +P       +       +Q+V R +W    FD +   F ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---FDEDA--FSSV 255

Query: 577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENRPSSEENKSKDS 630
             E    ++     + K P  R  + + +    ++    + +   PSS  NK +  
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-41
 Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 34/273 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL--KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           + LG+G+YG    AV   +   V VK +  K  V    + ++++ I   +  H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFY 69

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
            +    + + L  +Y + G L   +  + G     +      +       GV ++H +G 
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG- 123

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGYRAPEVIETRK 514
              TH +IK  N+L+++  +  ISDFGL  +               +  Y APE+++ R+
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 515 -HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 573
            H+   DV+S G++L  ML G+ P   P+ D   +   W +                  +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLN-----------PW 229

Query: 574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           + I+   + +L      + + P  R  + ++ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 51/301 (16%), Positives = 124/301 (41%), Gaps = 31/301 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           E LG+G +G  ++ V   S  T + K +K     +   ++++ I+    +H N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
           + S +E ++++++ +   +   ++ +       L+    V  +      +  +HS     
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN--- 122

Query: 463 FTHGNIKASNVLINQDLDG--CISDFGLTPLMNVP---ATPSRSAGYRAPEVIETRKHSH 517
             H +I+  N++          I +FG    +           +  Y APEV +    S 
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
            +D++S G L+  +L+G  P  + T   +      +++++  E+T   FD E   F+ I 
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT---FDEEA--FKEIS 231

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR---MIEEVRQSDSENRPSSEENKSKDSNVQT 634
            E +  +      + K    R    E ++   + +++ +  ++   + +  +   + ++ 
Sbjct: 232 IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

Query: 635 P 635
            
Sbjct: 289 D 289

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 41/298 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVGK--RDFEQQMEIVGRVGQHPNV 396
           +VLG G++GT YK +           V +K L+E    K  ++   +  ++  V  +P+V
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 73

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
             L           L+      G L   +  ++      +  +  +   +  A+G+ ++ 
Sbjct: 74  CRLL-GICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLE 128

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG------YRAPEVI 510
                   H ++ A NVL+       I+DFGL  L+        + G      + A E I
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 511 ETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
             R ++H+SDV+S+GV + E++T G  P       ++  +    +               
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------------- 230

Query: 570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEENKS 627
             R        + +  I + C     D RP   E++    ++ + D +     + ++ 
Sbjct: 231 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-DPQRYLVIQGDER 285

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 9e-40
 Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 41/303 (13%)

Query: 344 EVLGKGSYGTAYKAVL------EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPN 395
             LG+GS+G  Y+ V       E  T V +K + E      + +F  +  ++       +
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 84

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAG-----RTPLDWETRVKILLGTAR 450
           VV L          L++ +    G L + L   R A        P      +++    A 
Sbjct: 85  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 451 GVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR------SAGY 504
           G+A++++     F H ++ A N ++ +D    I DFG+T  +       +         +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201

Query: 505 RAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAE 564
            +PE ++    +  SDV+SFGV+L E+ T               + R+V      +    
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLDKPDN 259

Query: 565 VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPS--S 622
             D               + ++   C    P MRP+  E++  I+E  +          S
Sbjct: 260 CPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305

Query: 623 EEN 625
           EEN
Sbjct: 306 EEN 308

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 57/306 (18%), Positives = 120/306 (39%), Gaps = 36/306 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +VLG G  G   +   + +     +K L++         +++E+  R  Q P++V +   
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDV 73

Query: 403 YYSKDEK----LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           Y +        L+V +    G L + +      G          +I+      + ++HS+
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 459 GGPKFTHGNIKASNVLINQDLDG---CISDFG---LTPLMNVPATPSRSAGYRAPEVIET 512
                 H ++K  N+L           ++DFG    T   N   TP  +  Y APEV+  
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
            K+    D++S GV++  +L G  P  S   +  + +   +++ +R       ++     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRIRMGQ----YEFPNPE 240

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV-----VRMIEEVRQSDSENRPSSEENKS 627
           +  + EE+  +++     +   P  R  + E      +    +V Q+        +E+K 
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297

Query: 628 KDSNVQ 633
           +  +V+
Sbjct: 298 RWEDVK 303

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 51/281 (18%), Positives = 107/281 (38%), Gaps = 42/281 (14%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLK----------EVVVGKRDFEQQMEIVGRVGQ 392
           E+LG+G      + + + +     VK +           EV   +    ++++I+ +V  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           HPN++ L+  Y +     LV+D    G L   L          L  +   KI+      +
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 509
             +H +      H ++K  N+L++ D++  ++DFG +  ++         G   Y APE+
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 510 IET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA 563
           IE         +  + D++S GV++  +L G  P     +  M+               +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----------RMIMS 229

Query: 564 EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
             +      + +  + +  ++      +   P  R   +E 
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 44/272 (16%), Positives = 106/272 (38%), Gaps = 38/272 (13%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 398
           ++LG+GS+ T   A  L  S    +K L++  + K +      ++ +++ R+  HP  V 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVK 72

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L   +   ++      Y  +G L   +           D              + ++H  
Sbjct: 73  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG- 126

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS------AGYRAPEVIET 512
                 H ++K  N+L+N+D+   I+DFG   +++  +  +R+      A Y +PE++  
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
           +     SD+++ G ++ +++ G  P ++     +                 ++  +E   
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---------------KIIKLEYDF 229

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
            +    +   +++     +      R   +E+
Sbjct: 230 PEKFFPKARDLVE---KLLVLDATKRLGCEEM 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 6e-37
 Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 35/272 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 398
           ++LGKGS+G  + A  +++     +K LK+ VV   D       +  ++    +HP +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           +   + +K+    V +Y   G L   +           D             G+  +HS 
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 514
           G     + ++K  N+L+++D    I+DFG+     +    +     +  Y APE++  +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           ++H  D +SFGVLL EML G++P      +++    R            E  D+      
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL------ 233

Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                +V++         + P+ R  +   +R
Sbjct: 234 -----LVKLFV-------REPEKRLGVRGDIR 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (347), Expect = 6e-37
 Identities = 51/269 (18%), Positives = 110/269 (40%), Gaps = 26/269 (9%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRL-KEVVVGKRD-FEQQMEIVGRVGQHPNVVPLR 400
           +VLG G++     A  + +   V +K + K+ + GK    E ++ ++ ++ +HPN+V L 
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALD 73

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             Y S     L+    + G L   +                 +++      V ++H +G 
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 517
                         +++D    ISDFGL+ + +  +  S + G   Y APEV+  + +S 
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE 577
             D +S GV+   +L G  P        +       + +++ E     ++ +   + +I 
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAE-----YEFDSPYWDDIS 237

Query: 578 EEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
           +     ++     + K P+ R   ++ ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 40/286 (13%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVP 398
           E+LG G     + A  L     V VK L+  +         F ++ +    +  HP +V 
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVA 71

Query: 399 LRAYYYSKDEKL----LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
           +     ++        +V +Y    +L  ++H        P+  +  ++++    + +  
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR-------SAGYRAP 507
            H  G     H ++K +N++I+      + DFG+   +               +A Y +P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 508 EVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
           E         +SDVYS G +L E+LTG+ P    +   +          VRE+       
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---- 233

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR 612
               R + +  ++  ++   +  +AK P+ R     E+   +  V 
Sbjct: 234 -PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVH 275

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 43/288 (14%), Positives = 80/288 (27%), Gaps = 36/288 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             +G+GS+G  ++   L  +  V +K              +      +     +  +  +
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
                  +LV D         L    R         +T           V  IH      
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS--- 121

Query: 463 FTHGNIKASNVLINQDLDG-----CISDFGLTPLMNVPATPSR-----------SAGYRA 506
             + +IK  N LI +          + DFG+      P T              +A Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 507 PEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF 566
                 R+ S + D+ + G + +  L G  P Q             +    +     E+ 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
                      EE  + +           D  P+ D +  +  +V + 
Sbjct: 242 A-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER 279

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-35
 Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 38/287 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
           +V+G GS+G  Y+A L +S   V +K++ +    KR   ++++I+ ++  H N+V LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKL-DHCNIVRLRYF 81

Query: 403 YYSKDEK------LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           +YS  EK       LV DY          H +R   +  L        +    R +A+IH
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLM---NVPATPSRSAGYRAP-EVIE 511
           S G     H +IK  N+L++ D     + DFG    +       +   S  YRAP  +  
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 512 TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV------ 565
              ++   DV+S G +L E+L G+      +  D +     V      E   E+      
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 566 --------FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
                        +       E + +       +   P  R    E 
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 8e-35
 Identities = 45/283 (15%), Positives = 86/283 (30%), Gaps = 34/283 (12%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             +G GS+G  Y    +     V +K    V         + +I   + Q    +P   +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMM-QGGVGIPTIRW 70

Query: 403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPK 462
             ++ +  ++       SL  L +            +T + +       + +IHS     
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN--- 123

Query: 463 FTHGNIKASNVLINQDLDG---CISDFGLTPLMNVPATPSR-----------SAGYRAPE 508
           F H ++K  N L+     G    I DFGL        T              +A Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
                + S + D+ S G +L+    G  P Q                        ++   
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------YERISEKKMSTP 236

Query: 569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV 611
             +  +    E    L     C +   D +P+   + ++   +
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  129 bits (324), Expect = 4e-34
 Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 34/285 (11%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRL---KEVVVGKRDFEQQMEIVGRVGQHPNVVPLR 400
           E +G+G+YG  YKA      T  +K++   KE         +++ I+  + +H N+V L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
              ++K   +LV+++        L           L+  T    LL    G+A+ H    
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRR- 120

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVIE-TRKH 515
               H ++K  N+LIN++ +  I+DFGL     +P            YRAP+V+  ++K+
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR--- 572
           S   D++S G +  EM+ G       +  D +     +      +    V ++       
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 573 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
                       + ++E  + +L      +   P+ R    + + 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  131 bits (330), Expect = 4e-34
 Identities = 50/281 (17%), Positives = 106/281 (37%), Gaps = 37/281 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQ-------MEIVGRVGQHPN 395
            ++G+G +G  Y     ++     +K L +  +  +  E         + +V   G  P 
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV-STGDCPF 68

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           +V +   +++ D+   + D    G L   L  +                      G+ H+
Sbjct: 69  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHM 123

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM--NVPATPSRSAGYRAPEVIET- 512
           H+       + ++K +N+L+++     ISD GL        P     + GY APEV++  
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
             +   +D +S G +L ++L G +P +     D  ++ R   ++  E             
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----------- 229

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
             +   E+  +L+     + +  + R       R  +EV++
Sbjct: 230 -DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVKE 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 58/278 (20%), Positives = 109/278 (39%), Gaps = 38/278 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLK-------EVVVGKRDFEQQMEIVGRVGQHPN 395
           E LG G +    K   + +      K +K          V + D E+++ I+  + QHPN
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 74

Query: 396 VVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHI 455
           V+ L   Y +K + +L+ +  A G L   L          L  E   + L     GV ++
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYL 129

Query: 456 HSMGGPKFTHGNIKASNVLINQDLDG----CISDFGLTPLMNVPATPSRSAG---YRAPE 508
           HS+   +  H ++K  N+++           I DFGL   ++         G   + APE
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 509 VIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
           ++       ++D++S GV+   +L+G +P    T+ + +     V     +E+       
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239

Query: 569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
               F N        ++     + K P  R  + + ++
Sbjct: 240 ----FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 3e-33
 Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 32/300 (10%)

Query: 344 EVLGKGSYGTAYKAVLEEST--TVVVKRLKEVVVGKRDFEQQMEIVG-----RVGQHPNV 396
             +G+G+YG  +KA   ++    V +KR++     +      +  V         +HPNV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 397 VPLRAYYYS----KDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
           V L          ++ KL +        L+T L      G   +  ET   ++    RG+
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV 509
             +HS       H ++K  N+L+       ++DFGL  + +     +       YRAPEV
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 510 IETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE 569
           +    ++   D++S G +  EM   K   +  +  D +     V  +  EE       + 
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 570 LMRFQNIEEEMVQMLQIGMA---------CVAKVPDMRPNMDEVVRM--IEEVRQSDSEN 618
              F +   + ++     +          C+   P  R +    +     +++ +   EN
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC-KEN 305

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 54/321 (16%), Positives = 116/321 (36%), Gaps = 46/321 (14%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLR 400
             +G+G+YG    A    +   V +K++         +   ++++I+ R  +H N++ + 
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGIN 72

Query: 401 AYYYSKD----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
               +      + + +  +     L  LL          L  +     L    RG+ +IH
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH 126

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGL-------TPLMNVPATPSRSAGYRAPEV 509
           S       H ++K SN+L+N   D  I DFGL                   +  YRAPE+
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 510 IET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
           +   + ++   D++S G +L EML+ +         D ++    +     +E    + ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 569 ELMR----------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEE 610
           +                   F N + + + +L      +   P  R  +++ +    +E+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 611 VRQSDSENRPSSEENKSKDSN 631
                 E    +      + +
Sbjct: 301 YYDPSDEPIAEAPFKFDMELD 321

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-32
 Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 44/276 (15%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLK-------EVVVGKRDFEQQMEIVGRV-GQHP 394
            +LG G +G+ Y  + + ++  V +K ++         +        ++ ++ +V     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
            V+ L  ++   D  +L+ +              RG     L  E            V H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGC-ISDFGLTPLMNVPATPSR--SAGYRAPEVIE 511
            H+ G     H +IK  N+LI+ +     + DFG   L+          +  Y  PE I 
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182

Query: 512 TRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL 570
             + H   + V+S G+LL +M+ G  P +                        E+   ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQV 221

Query: 571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR 606
              Q +  E   +++    C+A  P  RP  +E+  
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 5e-31
 Identities = 51/289 (17%), Positives = 113/289 (39%), Gaps = 37/289 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK------RDFEQQMEIVGRVGQHPNV 396
           + LG+G + T YKA  + +   V +K++K     +      R   ++++++  +  HPN+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 397 VPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
           + L   +  K    LV+D+  +     +   +       L        +L T +G+ ++H
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 117

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIET 512
                   H ++K +N+L++++    ++DFGL      P         +  YRAPE++  
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 513 RK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMV-------------DLPRWVQSVVR 558
            + +    D+++ G +L E+L     L   +  D +               P        
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 559 EEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM 607
             + +         F    ++++ ++Q         P  R    + ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 5e-31
 Identities = 54/284 (19%), Positives = 110/284 (38%), Gaps = 34/284 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 399
           E +G+G+YG  YKA  + +   V +K+++     +       +++ ++  +  HPN+V L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKL 66

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
               +++++  LV+++        +           +        L    +G+A  HS  
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH- 121

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS----AGYRAPEVI-ETRK 514
             +  H ++K  N+LIN +    ++DFGL     VP            YRAPE++   + 
Sbjct: 122 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR-- 572
           +S   D++S G +  EM+T +A     +  D +           E     V  +   +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 573 ------------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEV 604
                          ++E+   +L      +   P+ R +    
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (303), Expect = 6e-31
 Identities = 51/275 (18%), Positives = 106/275 (38%), Gaps = 33/275 (12%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQQME---IVGRVGQHPNVVPL 399
             LG GS+G  +      +     +K LK+ +V +    +      ++  +  HP ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              +    +  ++ DY   G L +LL  ++                      + ++HS  
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHK 518
                + ++K  N+L++++    I+DFG    + +V  T   +  Y APEV+ T+ ++  
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 519 SDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE 578
            D +SFG+L+ EML G  P          +               ++ + EL       E
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYE---------------KILNAELRFPPFFNE 226

Query: 579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
           ++  +L      + +    R    +     E+V+ 
Sbjct: 227 DVKDLLS---RLITRDLSQRLGNLQ--NGTEDVKN 256

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-30
 Identities = 62/316 (19%), Positives = 120/316 (37%), Gaps = 35/316 (11%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 399
           + +G G+YG    AV   +   V +K+L      +   +   +++ ++  + +H NV+ L
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 82

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
              +   +      D++          G        L  +    ++    +G+ +IH+ G
Sbjct: 83  LDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSA-GYRAPEVI-ETRKHSH 517
                H ++K  N+ +N+D +  I DFGL    +   T       YRAPEVI    +++ 
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR----- 572
             D++S G ++ EM+TGK   +     D +     V      E+   +   E        
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258

Query: 573 -----------FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQSDSENR 619
                        N     V +L+     +    + R    E +     E +   D+E+ 
Sbjct: 259 PELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLH--DTEDE 313

Query: 620 PSSEE-NKSKDSNVQT 634
           P  ++ + S D   +T
Sbjct: 314 PQVQKYDDSFDDVDRT 329

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  116 bits (291), Expect = 5e-29
 Identities = 53/278 (19%), Positives = 104/278 (37%), Gaps = 19/278 (6%)

Query: 297 KASSGGRSEKPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYK 356
            A+  G  ++  +EF +  +E    K       +   D  D ++     LG GS+G    
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVML 59

Query: 357 AVLEES-TTVVVKRLKEVVVGK----RDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL 411
              +ES     +K L +  V K         +  I+  V   P +V L   +       +
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118

Query: 412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKAS 471
           V +Y A G + + L                            ++HS+      + ++K  
Sbjct: 119 VMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170

Query: 472 NVLINQDLDGCISDFGL-TPLMNVPATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLE 530
           N+LI+Q     ++DFG    +     T   +    APE+I ++ ++   D ++ GVL+ E
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 531 MLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV 568
           M  G  P  +     + +     +      +++++ D+
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (289), Expect = 5e-29
 Identities = 50/289 (17%), Positives = 117/289 (40%), Gaps = 22/289 (7%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAY 402
             LG+G Y   ++A+ +  +  VVVK LK V   K+  +++++I+  +   PN++ L   
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 98

Query: 403 YYSKDEKL--LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
                 +   LV+++  +     L           L        +    + + + HSMG 
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 461 PKFTHGNIKASNVLI-NQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEV-IETRKH 515
               H ++K  NV+I ++     + D+GL    +     +       ++ PE+ ++ + +
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 516 SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN 575
            +  D++S G +L  M+  K P      D+   L R  + +  E+    +    +     
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPF-FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
             + + +  +          +      E +  ++++ + D ++R ++ E
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 7e-28
 Identities = 52/279 (18%), Positives = 104/279 (37%), Gaps = 38/279 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRD----FEQQMEIVGRVGQHPNVVP 398
           ++LGKG++G       + +     +K L++ V+  +D       +  ++    +HP +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTA 69

Query: 399 LRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM 458
           L+  + + D    V +Y   G L   L   R         E            + ++HS 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR 124

Query: 459 GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR----SAGYRAPEVIETRK 514
                 + +IK  N+++++D    I+DFGL           +    +  Y APEV+E   
Sbjct: 125 D---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ 574
           +    D +  GV++ EM+ G+ P  +   + + +L    +       + E   +      
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL------ 235

Query: 575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
                +  +L+       K P  R          +EV +
Sbjct: 236 -----LAGLLK-------KDPKQRLGGGP--SDAKEVME 260

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 56/284 (19%), Positives = 112/284 (39%), Gaps = 30/284 (10%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGK---RDFEQQMEIVGRVGQHPNVVPL 399
           E +G+G+YGT +KA   E+   V +KR++     +       +++ ++  + +H N+V L
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRL 66

Query: 400 RAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG 459
               +S  +  LV+++            N       LD E     L    +G+   HS  
Sbjct: 67  HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 460 GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPS----RSAGYRAPEVIETRK- 514
                H ++K  N+LIN++ +  +++FGL     +P         +  YR P+V+   K 
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 515 HSHKSDVYSFGVLLLEMLTGKAPL-QSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF 573
           +S   D++S G +  E+     PL      DD +     +     EE    +  +   + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 574 QNIEEEMVQMLQIG-----------MACVAKVPDMRPNMDEVVR 606
             +      ++ +               +   P  R + +E ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 1e-26
 Identities = 56/286 (19%), Positives = 108/286 (37%), Gaps = 40/286 (13%)

Query: 344 EVLGKGSYGTAYKAVL----EESTTVVVKRLKEVVVGKRD-----FEQQMEIVGRVGQHP 394
           +VLG G+YG  +        +      +K LK+  + ++         + +++  + Q P
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 395 NVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
            +V L   + ++ +  L+ DY   G L T L       R           +      + H
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRS-----AGYRAPEV 509
           +H +G     + +IK  N+L++ +    ++DFGL+       T           Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 510 IET--RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
           +      H    D +S GVL+ E+LTG +P       +            + E +  +  
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILK 250

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ 613
            E    Q +      ++Q     + K P  R       R  +E+++
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIKE 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 2e-26
 Identities = 54/297 (18%), Positives = 112/297 (37%), Gaps = 27/297 (9%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 399
             +G+G++G  +KA   ++   V +K++    E         ++++I+  + +H NVV L
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 74

Query: 400 RAYYYSKDEKLLVYD---YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIH 456
                +K           Y         L G               +++     G+ +IH
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 457 SMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSR--------SAGYRAPE 508
                   H ++KA+NVLI +D    ++DFGL    ++              +  YR PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 509 VIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD 567
           ++   + +    D++  G ++ EM T    +Q  T    + L   +   +  E    V +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDSENRPSSEE 624
            EL     + +   + ++  +    + P      D + +++      D   R  S++
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYAL---DLIDKLL----VLDPAQRIDSDD 301

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 7e-26
 Identities = 53/293 (18%), Positives = 119/293 (40%), Gaps = 31/293 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLK---EVVVGKRDFEQQMEIVGRVGQHPNVVPL 399
             +G G+YG+   A   +    V VK+L    + ++  +   +++ ++  + +H NV+ L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL 82

Query: 400 RAYYYSKD-----EKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAH 454
              +           + +  +     L+ ++   +      L  +    ++    RG+ +
Sbjct: 83  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKY 136

Query: 455 IHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPSRSAGYRAPEVI-ET 512
           IHS       H ++K SN+ +N+D +  I DFGL    +        +  YRAPE++   
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193

Query: 513 RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR 572
             ++   D++S G ++ E+LTG+         D + L   +               EL++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG---------TPGAELLK 244

Query: 573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVRMIEEVRQSDSENRPSSEE 624
             + E     +  +         ++    +   V ++E++   DS+ R ++ +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 9e-24
 Identities = 55/323 (17%), Positives = 108/323 (33%), Gaps = 44/323 (13%)

Query: 344 EVLGKGSYGTAYKAVLEES-TTVVVKRLKEVVVGKRDFEQ-QMEI-VGRVGQHPNVVPLR 400
           + +G G+ G    A        V +K+L      +   ++   E+ + +   H N++ L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 401 AYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGG 460
             +  +       D +    L  +        +  LD E    +L     G+ H+HS   
Sbjct: 83  NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-- 138

Query: 461 PKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAG---YRAPEVIETRKHSH 517
               H ++K SN+++  D    I DFGL          +       YRAPEVI    +  
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197

Query: 518 KSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD---------------------------LP 550
             D++S G ++ EM+  K         D  +                            P
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 551 RWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR---M 607
           ++      + +   +F  +    +    +   +L      +   P  R ++D+ ++   +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQHPYI 314

Query: 608 IEEVRQSDSENRPSSEENKSKDS 630
                 ++ E  P    +K  D 
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDE 337

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.7 bits (247), Expect = 2e-23
 Identities = 51/310 (16%), Positives = 98/310 (31%), Gaps = 33/310 (10%)

Query: 344 EVLGKGSYGTAYKAV-LEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQ---------- 392
             LG G + T + A  +  +T V +K ++   V     E +++++ RV            
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
             +++ L  ++  K    +            LL   +      +      +I      G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQ-DLDGCISDFGLTPLMNVPATPSRSA------GYR 505
            ++H   G    H +IK  NVL+   D    +    +  L N                YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 506 APEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD-----------LPRWVQ 554
           +PEV+        +D++S   L+ E++TG    +                    L     
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS 614
            ++R       F       +NI +     L+  +    K         E+   +  + Q 
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA--KEISDFLSPMLQL 314

Query: 615 DSENRPSSEE 624
           D   R  +  
Sbjct: 315 DPRKRADAGG 324

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.1 bits (209), Expect = 2e-18
 Identities = 41/180 (22%), Positives = 62/180 (34%), Gaps = 25/180 (13%)

Query: 37  FADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDAL 96
            +D  P     N    +        I      T +  L L    +    P   L  L  L
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP---LSGLTKL 265

Query: 97  EVLSLRSNVLTGGLP--------------------SEITSLPSLRYLYLQHNNFSGKIPS 136
             L L +N ++   P                    S I++L +L YL L  NN S   P 
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV 325

Query: 137 SFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
           S   +L  L  + N  +     S+ NLT +  LS   N +S   P  ++ ++  L L+  
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.5 bits (192), Expect = 3e-16
 Identities = 42/156 (26%), Positives = 58/156 (37%), Gaps = 27/156 (17%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 155
           L+ LSL  N L       + SL +L  L L +N  S   P S   +L  L L  N  +  
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNI 278

Query: 156 IP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSY 195
            P                      I NL  LT L+L  NN+S   P   + KL+ L  + 
Sbjct: 279 SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFAN 338

Query: 196 NGLKGSIPSSLQKFPNSSFV---GNSLLCGPPLKAC 228
           N +     SSL    N +++    N +    PL   
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANL 372

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.5 bits (153), Expect = 2e-11
 Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 2/88 (2%)

Query: 116 SLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNN 175
            L +L  L   +N  S   P      L  L L+ N        ++ +LT LT L L +N 
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252

Query: 176 LSGSIPNFDIPKLRHLNLSYNGLKGSIP 203
           +S   P   + KL  L L  N +    P
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 1e-06
 Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 2/82 (2%)

Query: 115 TSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN 174
           T+L       L   N +  +  +   Q+  L         +I   ++ L  LT ++  +N
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76

Query: 175 NLSGSIPNFDIPKLRHLNLSYN 196
            L+   P  ++ KL  + ++ N
Sbjct: 77  QLTDITPLKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 2/111 (1%)

Query: 114 ITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS 173
           + +L +L  L +  N  S     +    L  L  + N  +   P  I   T L  LSL  
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNG 228

Query: 174 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 224
           N L        +  L  L+L+ N +    P S         +G + +    
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS 279

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 5/70 (7%)

Query: 162 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNS 218
            L +     L   N++ ++   D+ ++  L     G+K SI   ++   N + +    N 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 219 LLCGPPLKAC 228
           L    PLK  
Sbjct: 78  LTDITPLKNL 87

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.6 bits (192), Expect = 2e-16
 Identities = 27/83 (32%), Positives = 35/83 (42%), Gaps = 20/83 (24%)

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 205
           DL  N   G +PQ +  L  L  L++  NNL G IP                       +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--------------------GN 289

Query: 206 LQKFPNSSFVGNSLLCGPPLKAC 228
           LQ+F  S++  N  LCG PL AC
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.9 bits (172), Expect = 6e-14
 Identities = 59/162 (36%), Positives = 82/162 (50%), Gaps = 8/162 (4%)

Query: 29  SDRQALLDFADAVPHLRKL-NWSSTNPICQ-SWVGINCTQD--RTRVFGLRLPGIGLVGP 84
            D+QALL     + +   L +W  T   C  +W+G+ C  D    RV  L L G+ L  P
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 85  IP-NNTLGKLDALEVLSLRSNV-LTGGLPSEITSLPSLRYLYLQHNNFSGKIP--SSFSP 140
            P  ++L  L  L  L +     L G +P  I  L  L YLY+ H N SG IP   S   
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN 182
            LV LD S+N+ +G +P SI +L  L G++   N +SG+IP+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 6e-11
 Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 1/58 (1%)

Query: 101 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGNIP 157
           LR+N + G LP  +T L  L  L +  NN  G+IP   +  +  V   + N      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.1 bits (118), Expect = 3e-07
 Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 2/88 (2%)

Query: 48  NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 107
                         +        + GL L    + G +P   L +L  L  L++  N L 
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLC 281

Query: 108 GGLPSEITSLPSLRYLYLQHNNFSGKIP 135
           G +P +  +L         +N      P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.8 bits (156), Expect = 4e-12
 Identities = 35/168 (20%), Positives = 60/168 (35%), Gaps = 4/168 (2%)

Query: 43  HLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLR 102
            L +L+    +      +G    +    +  L L    L   +P++T   L  L  L L 
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLH 161

Query: 103 SNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP--QLVVLDLSFNSFTGNIPQSI 160
            N ++         L SL  L L  N  +   P +F    +L+ L L  N+ +    +++
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221

Query: 161 QNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQ 207
             L  L  L L  N          +   L+    S + +  S+P  L 
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.5 bits (137), Expect = 1e-09
 Identities = 43/220 (19%), Positives = 67/220 (30%), Gaps = 36/220 (16%)

Query: 38  ADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALE 97
           A +    R L     +    + +          +  L L     +  +   T   L  L 
Sbjct: 49  AASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108

Query: 98  VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGN 155
            L L    L    P     L +L+YLYLQ N        +F     L  L L  N  +  
Sbjct: 109 TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168

Query: 156 IPQSIQNLTQLTGLSLQSNNLSGSIPNF--------------------------DIPKLR 189
             ++ + L  L  L L  N ++   P+                            +  L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228

Query: 190 HLNLSYNGLKGSIP-----SSLQKFPNSSFVGNSLLCGPP 224
           +L L+ N            + LQKF  SS   + + C  P
Sbjct: 229 YLRLNDNPWVCDCRARPLWAWLQKFRGSS---SEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 1e-04
 Identities = 27/156 (17%), Positives = 47/156 (30%), Gaps = 36/156 (23%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKI---------- 134
           IP  +       + + L  N ++    +   +  +L  L+L  N  +             
Sbjct: 30  IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 135 ---------------PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
                          P++F    +L  L L         P   + L  L  L LQ N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 178 GSIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
               +   D+  L HL L  N +      + +   +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 9e-04
 Identities = 6/45 (13%), Positives = 10/45 (22%), Gaps = 1/45 (2%)

Query: 123 LYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
                      +P         + L  N  +     S +    LT
Sbjct: 16  TSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLT 59

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 65.2 bits (157), Expect = 5e-12
 Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 8/94 (8%)

Query: 101 LRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSI 160
              N  +  + S     PSL  L + +N    ++P+   P+L  L  SFN     +P+  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP-PRLERLIASFNHLA-EVPELP 323

Query: 161 QNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLS 194
           QNL Q   L ++ N L    P+     +  L ++
Sbjct: 324 QNLKQ---LHVEYNPLR-EFPDI-PESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.1 bits (141), Expect = 5e-10
 Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 8/89 (8%)

Query: 122 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 181
             YL  ++   +      P L  L++S N     +P     L +   L    N+L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320

Query: 182 NFDIPKLRHLNLSYNGLKG--SIPSSLQK 208
                 L+ L++ YN L+    IP S++ 
Sbjct: 321 EL-PQNLKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 3e-09
 Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 8/73 (10%)

Query: 93  LDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSF 152
             +LE L++ +N L   LP+     P L  L    N+ + ++P      L  L + +N  
Sbjct: 283 PPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELP-QNLKQLHVEYNPL 336

Query: 153 TG--NIPQSIQNL 163
               +IP+S+++L
Sbjct: 337 REFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.9 bits (112), Expect = 2e-06
 Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 3/79 (3%)

Query: 147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL 206
              N+ +  I         L  L++ +N L   +P    P+L  L  S+N L   +P   
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL-PPRLERLIASFNHLA-EVPELP 323

Query: 207 QKFPNSSFVGNSLLCGPPL 225
           Q         N L   P +
Sbjct: 324 QNLKQLHVEYNPLREFPDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 7e-05
 Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 6/60 (10%)

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKG 200
           Q   L+L+    + ++P+   +L  L       N+L+  +P      L+ L +  N LK 
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 1e-04
 Identities = 17/56 (30%), Positives = 22/56 (39%), Gaps = 3/56 (5%)

Query: 164 TQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL 219
            Q   L L +  LS S+P    P L  L  S N L   +P   Q   +     N+L
Sbjct: 38  RQAHELELNNLGLS-SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 5e-04
 Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 6/59 (10%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTG 154
              L L +  L+  LP      P L  L    N+ + ++P      L  L +  N+   
Sbjct: 40  AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQ-SLKSLLVDNNNLKA 92

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 62.1 bits (150), Expect = 1e-11
 Identities = 34/203 (16%), Positives = 62/203 (30%), Gaps = 33/203 (16%)

Query: 344 EVLGKGSYGTAYKAVLEESTTVVVKRLK-----------EVVVGKRDFEQQMEIVGRVGQ 392
           +++G+G     +    E+    VVK  K           +   G   F        R  +
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN-E 64

Query: 393 HPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGV 452
              +  L+     K      Y +  +  L  L+           + +   ++L      V
Sbjct: 65  FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEV 116

Query: 453 AHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPATPSRSAGY--RAPEVI 510
           A  +        HG++   NVL+  +    I DF  +    V            R    I
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQS----VEVGEEGWREILERDVRNI 168

Query: 511 ET---RKHSHKSDVYSFGVLLLE 530
            T   R +  + D+ S    +L+
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.1 bits (152), Expect = 2e-11
 Identities = 29/106 (27%), Positives = 40/106 (37%), Gaps = 4/106 (3%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
            LR +         K+P    P   +LDL  N  T       +NL  L  L L +N +S 
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 179 SIPN--FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCG 222
             P     + KL  L LS N LK  +P  + K      V  + +  
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 61.6 bits (148), Expect = 7e-11
 Identities = 49/239 (20%), Positives = 83/239 (34%), Gaps = 19/239 (7%)

Query: 9   LFFPLCVIVSLLPLAFADLNS------DRQALLDFADAVPHLRKLNWSSTNPICQSWVGI 62
           L      I  + P AFA L         +  L +  + +P   +      N I +    +
Sbjct: 60  LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119

Query: 63  NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRY 122
               ++  V  L    +   G         +  L  + +    +T  +P  +   PSL  
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENG-AFQGMKKLSYIRIADTNITT-IPQGL--PPSLTE 175

Query: 123 LYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSI 180
           L+L  N  +    +S      L  L LSFNS +     S+ N   L  L L +N L    
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235

Query: 181 PN-FDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL----LCGPPLKACFPVAPS 234
               D   ++ + L  N +  +I S+    P  +    S     L   P++  + + PS
Sbjct: 236 GGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPS 292

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.2 bits (134), Expect = 3e-09
 Identities = 24/119 (20%), Positives = 45/119 (37%), Gaps = 3/119 (2%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFT 153
             +L L++N +T     +  +L +L  L L +N  S   P +F+   +L  L LS N   
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 154 GNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
               +  + L +L     +   +  S+ N  +   +  L  +     G    + Q    
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.9 bits (148), Expect = 1e-10
 Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 7/108 (6%)

Query: 96  LEVLSLRSNVLT-GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLS 148
           ++ L ++   L+       +  L   + + L     +       S      P L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYN 196
            N         +    Q     +Q  +L           +    L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTL 111

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 1e-08
 Identities = 21/93 (22%), Positives = 29/93 (31%), Gaps = 15/93 (16%)

Query: 118 PSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGNIPQSI-----QNLTQL 166
             LR L+L   + S    SS +        L  LDLS N         +     Q    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 167 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK 199
             L L     S  + +     L+ L      L+
Sbjct: 429 EQLVLYDIYWSEEMEDR----LQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 2e-08
 Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 14/93 (15%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSP---QLVVLDLSFNSFTG----NIPQSIQNLTQLTGLSL 171
            ++ L +Q    S    +   P   Q  V+ L     T     +I  +++    L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 172 QSNNLSGSIPNF-------DIPKLRHLNLSYNG 197
           +SN L     +           K++ L+L    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (129), Expect = 2e-08
 Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 15/90 (16%)

Query: 96  LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-------PQLVV 144
           L VL L    ++      L + + +  SLR L L +N                    L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 145 LDLSFNSFTGNIPQSIQNL----TQLTGLS 170
           L L    ++  +   +Q L      L  +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 2e-07
 Identities = 15/77 (19%), Positives = 25/77 (32%), Gaps = 7/77 (9%)

Query: 139 SPQLVVLDLSFNSFTGN-IPQSIQNLTQLTGLSLQSNNLSG----SIPNF--DIPKLRHL 191
           S  +  LD+     +     + +  L Q   + L    L+      I +     P L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 192 NLSYNGLKGSIPSSLQK 208
           NL  N L       + +
Sbjct: 61  NLRSNELGDVGVHCVLQ 77

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.5 bits (133), Expect = 4e-10
 Identities = 28/120 (23%), Positives = 43/120 (35%), Gaps = 9/120 (7%)

Query: 98  VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIP 157
           VL L    LT      +  L  + +L L HN      P+  +    +  L  +       
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 158 QSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRHLNLSYN---GLKGSIPSSLQKFPN 211
             + NL +L  L L +N L  S     +   P+L  LNL  N     +G      +  P+
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.6 bits (123), Expect = 1e-08
 Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 9/109 (8%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF 149
           L +L  +  L L  N L    P+ + +L  L  L    N        +  P+L  L L  
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74

Query: 150 NSFTG-NIPQSIQNLTQLTGLSLQSNNLSGSIPNFD------IPKLRHL 191
           N        Q + +  +L  L+LQ N+L              +P +  +
Sbjct: 75  NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 3e-07
 Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 6/94 (6%)

Query: 121 RYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           R L+L H + +  +         +  LDLS N      P ++  L  L  L    N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 179 SIPNFDIPKLRHLNLSYNGLKG-SIPSSLQKFPN 211
                ++P+L+ L L  N L+  +    L   P 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.002
 Identities = 19/126 (15%), Positives = 37/126 (29%), Gaps = 13/126 (10%)

Query: 26  DLNSDRQALLDFADAVPHLRKLNWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPI 85
            L      +L   + +  +  L+ S  N +      +   +    +         + G  
Sbjct: 4   HLAHKDLTVLCHLEQLLLVTHLDLSH-NRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 86  PNNTLGKLDALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSGKIP-----SSFS 139
               L +L       L +N L        + S P L  L LQ N+   +       +   
Sbjct: 63  NLPRLQELL------LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 140 PQLVVL 145
           P +  +
Sbjct: 117 PSVSSI 122

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 1e-08
 Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 1/78 (1%)

Query: 113 EITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 172
           E++ + S   +     N +  +P        +L LS N        ++   T+LT L+L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 173 SNNLSGSIPNFDIPKLRH 190
              L+    +  +P L  
Sbjct: 64  RAELTKLQVDGTLPVLGT 81

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 9e-05
 Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 3/54 (5%)

Query: 159 SIQNLTQLTGLSLQSNNLSGSIPNFDIPK-LRHLNLSYNGLKGSIPSSLQKFPN 211
            +  +     ++    NL+ ++P  D+PK    L+LS N L     ++L  +  
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTR 56

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 5e-04
 Identities = 15/51 (29%), Positives = 20/51 (39%), Gaps = 3/51 (5%)

Query: 148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--FDIPKLRHLNLSYN 196
           + N+ T      +  L  L  L LQ N+L  +IP   F    L    L  N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 5e-04
 Identities = 12/46 (26%), Positives = 20/46 (43%), Gaps = 1/46 (2%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNF 130
           +P   L  L+ L+ L L+ N L   +P        L + +L  N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 17/87 (19%), Positives = 28/87 (32%), Gaps = 6/87 (6%)

Query: 104 NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS-PQLVVLDLSFNSFTGN-----IP 157
           N LT      +  L +L  L LQ N+        F    L    L  N +  N       
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFR 217

Query: 158 QSIQNLTQLTGLSLQSNNLSGSIPNFD 184
           + +Q+  +   +  Q  ++     N  
Sbjct: 218 RWLQDNAENVYVWKQGVDVKAMTSNVA 244

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (85), Expect = 0.003
 Identities = 33/178 (18%), Positives = 44/178 (24%), Gaps = 53/178 (29%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDL-------- 147
             +L L  N+L     + +     L  L L     +        P L  LDL        
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92

Query: 148 ---------------------------------------SFNSFTGNIPQSIQNLTQLTG 168
                                                    N      P  +    +L  
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152

Query: 169 LSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLC 221
           LSL +NNL+         +  L  L L  N L  +IP          F    GN  LC
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (127), Expect = 2e-08
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 5/98 (5%)

Query: 99  LSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP-QLVVLDLSFNSFTGN-I 156
           L L    L   +   + S   +       +     +   FSP ++  +DLS +    + +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 157 PQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLN 192
              +   ++L  LSL+   LS  I N       L  LN
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 6e-05
 Identities = 8/69 (11%), Positives = 30/69 (43%), Gaps = 3/69 (4%)

Query: 145 LDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP-NFDIPKLRHLNLSYNGLKG-SI 202
           LDL+  +   ++   + +   +       + +   +  +F   +++H++LS + ++  ++
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 203 PSSLQKFPN 211
              L +   
Sbjct: 64  HGILSQCSK 72

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 3e-07
 Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 14/116 (12%)

Query: 90  LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS----PQLVVL 145
           L   +   VL+ RS++    L     ++P L  L L +N        S      P L +L
Sbjct: 38  LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD---------IPKLRHLN 192
           +LS N              +L  L L  N+LS +  +            PKL  L+
Sbjct: 97  NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (83), Expect = 0.003
 Identities = 26/127 (20%), Positives = 42/127 (33%), Gaps = 8/127 (6%)

Query: 110 LPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 169
           L   ++         L         P   +  + V+    +S    +    +N+ +L  L
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR-SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSL 70

Query: 170 SLQSNNLSGSIPNFDI----PKLRHLNLSYNGLKGSIPSSLQKFPNS---SFVGNSLLCG 222
           +L +N L        I    P L+ LNLS N LK        K          GNSL   
Sbjct: 71  NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130

Query: 223 PPLKACF 229
              ++ +
Sbjct: 131 FRDQSTY 137

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 8e-07
 Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 2/64 (3%)

Query: 85  IPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVV 144
                L  L  L  L    N ++    S + SLP+L  ++L++N  S   P + +  L +
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFI 221

Query: 145 LDLS 148
           + L+
Sbjct: 222 VTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 16/73 (21%), Positives = 30/73 (41%), Gaps = 2/73 (2%)

Query: 122 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 181
           YL + +   S   P +   +L  L    N  +   P  + +L  L  + L++N +S   P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

Query: 182 NFDIPKLRHLNLS 194
             +   L  + L+
Sbjct: 213 LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 15/64 (23%), Positives = 27/64 (42%), Gaps = 3/64 (4%)

Query: 111 PSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLS 170
            + + +L  L  L    N  S   P +  P L+ + L  N  +   P  + N + L  ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 171 LQSN 174
           L +N
Sbjct: 224 L-TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 11/59 (18%), Positives = 24/59 (40%), Gaps = 4/59 (6%)

Query: 141 QLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 198
             + +    ++ T  + Q+  +L  +T LS     ++ +I     +  L  L L  N +
Sbjct: 20  NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 8/50 (16%), Positives = 21/50 (42%), Gaps = 2/50 (4%)

Query: 162 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            L     ++   +N++ ++   D+  +  L+    G+  +I   +Q   N
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNN 64

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 9e-04
 Identities = 15/52 (28%), Positives = 23/52 (44%), Gaps = 2/52 (3%)

Query: 160 IQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
           + NL++LT L    N +S   P   +P L  ++L  N +    P  L    N
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSN 218

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 6e-06
 Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 11/98 (11%)

Query: 108 GGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLT 167
           G L SE  ++P+        + F+         + +  +L   S T  + Q+   L  + 
Sbjct: 1   GPLGSETITVPTPIKQIFSDDAFA---------ETIKDNLKKKSVTDAVTQN--ELNSID 49

Query: 168 GLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSS 205
            +   ++++        +P +  L L+ N L    P +
Sbjct: 50  QIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLA 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 4e-04
 Identities = 14/79 (17%), Positives = 27/79 (34%), Gaps = 5/79 (6%)

Query: 84  PIPNNTLGKLDALE---VLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSP 140
           P P   +   DA       +L+   +T         L S+  +   +++        + P
Sbjct: 11  PTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYLP 68

Query: 141 QLVVLDLSFNSFTGNIPQS 159
            +  L L+ N  T   P +
Sbjct: 69  NVTKLFLNGNKLTDIKPLA 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 30/165 (18%), Positives = 54/165 (32%), Gaps = 46/165 (27%)

Query: 89  TLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS 148
           T  +L++++ +   ++ +       I  LP++  L+L  N  +   P +    L  L L 
Sbjct: 41  TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98

Query: 149 FNSFTGN------------------------------------------IPQSIQNLTQL 166
            N                                                   +  LT+L
Sbjct: 99  ENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL 158

Query: 167 TGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
             LSL+ N +S  +P   + KL++L LS N +      +L    N
Sbjct: 159 DTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKN 201

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 13/83 (15%), Positives = 27/83 (32%), Gaps = 15/83 (18%)

Query: 122 YLYLQHNNFSGKIPSSFS--------PQLVVLDLSFNSFTGNIPQSI-----QNLTQLTG 168
            L L     S +  ++            L  L L +N    +  +++     + +  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 169 LSLQSNNLSGSIPNFDIPKLRHL 191
           L L  N  S       + ++R +
Sbjct: 307 LELNGNRFSEEDDV--VDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 3e-05
 Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 9/64 (14%)

Query: 116 SLPSLRYLYLQHNNFSGKIPSSFS-------PQLVVLDLSFNSFT--GNIPQSIQNLTQL 166
               L+ L LQ+N        +         P L+ L+L+ N F+   ++   I+ +   
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330

Query: 167 TGLS 170
            G  
Sbjct: 331 RGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 13/89 (14%), Positives = 26/89 (29%), Gaps = 5/89 (5%)

Query: 48  NWSSTNPICQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLT 107
                +      +          +    L   G    +   +  +   L+ L L+ N + 
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286

Query: 108 GGLPSEITS-----LPSLRYLYLQHNNFS 131
                 + +     +P L +L L  N FS
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 10/91 (10%)

Query: 96  LEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVL 145
           +E  SL+ + +T      + + +    S++ + L  N    +     S        L + 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 146 DLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL 176
           + S         +  + L  L    L+   L
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.3 bits (100), Expect = 2e-05
 Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 3/106 (2%)

Query: 122 YLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGS 179
            L L  N         F    QL  L+L  N  +  +P S ++L  LT L+L SN  + +
Sbjct: 82  ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141

Query: 180 IPNFDIPKL-RHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 224
                  +  R  +L+    +   PS ++         +   C   
Sbjct: 142 CHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 4e-05
 Identities = 21/122 (17%), Positives = 33/122 (27%), Gaps = 7/122 (5%)

Query: 96  LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGN 155
              L LR   +   + +   +L     +    N            +L  L ++ N     
Sbjct: 20  DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRI 78

Query: 156 IPQSIQNLTQLTGLSL---QSNNLSGSIPNFDIPKLRHLNLS---YNGLKGSIPSSLQKF 209
                Q L  LT L L       L    P   +  L +L +        K      + K 
Sbjct: 79  GEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKV 138

Query: 210 PN 211
           P 
Sbjct: 139 PQ 140

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 1e-04
 Identities = 17/115 (14%), Positives = 31/115 (26%), Gaps = 5/115 (4%)

Query: 112 SEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGL 169
           ++ T+    R L L+       I +  +   Q   +D S N            L +L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 170 SLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSLLCGPP 224
            + +N +       D        L            L    +   +    +   P
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 5e-05
 Identities = 10/65 (15%), Positives = 19/65 (29%), Gaps = 1/65 (1%)

Query: 119 SLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSG 178
           S R    Q +  + +IPS      + L             +      L  + +  N++  
Sbjct: 9   SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 179 SIPNF 183
            I   
Sbjct: 68  VIEAD 72

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 1e-04
 Identities = 14/67 (20%), Positives = 22/67 (32%), Gaps = 5/67 (7%)

Query: 120 LRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLS 177
                  +NN        F      V+LD+S           ++NL +L   S    NL 
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

Query: 178 GSIPNFD 184
             +P  +
Sbjct: 237 -KLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 4e-04
 Identities = 8/54 (14%), Positives = 18/54 (33%), Gaps = 3/54 (5%)

Query: 83  GPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS 136
             +PN+         +L +    +       + +L  LR     +     K+P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 6e-04
 Identities = 11/84 (13%), Positives = 26/84 (30%), Gaps = 3/84 (3%)

Query: 122 YLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP 181
           +L             + +    +     N+            +    L +    +  S+P
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 217

Query: 182 NFDIPKLRHLN-LSYNGLKGSIPS 204
           ++ +  L+ L   S   LK  +P+
Sbjct: 218 SYGLENLKKLRARSTYNLK-KLPT 240

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 9e-05
 Identities = 10/50 (20%), Positives = 21/50 (42%), Gaps = 2/50 (4%)

Query: 162 NLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPN 211
            L +     L   N++ ++   D+ ++  L     G+K SI   ++   N
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNN 63

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 4/62 (6%)

Query: 140 PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFD-IPKLRHLNLSYNGL 198
            + +   L   + T  + Q+  +L Q+T L      +  SI   + +  L  +N S N L
Sbjct: 18  AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 74

Query: 199 KG 200
             
Sbjct: 75  TD 76

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (92), Expect = 2e-04
 Identities = 32/164 (19%), Positives = 52/164 (31%), Gaps = 21/164 (12%)

Query: 56  CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEIT 115
                G+ CT+D                   ++ L   + L  L + +      L     
Sbjct: 7   PHGSSGLRCTRDGAL-------------DSLHH-LPGAENLTELYIENQQHLQHLELRDL 52

Query: 116 S-LPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQ 172
             L  LR L +  +      P +F   P+L  L+LSFN+   ++         L  L L 
Sbjct: 53  RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111

Query: 173 SNNLSGSIPNFDIPKL---RHLNLSYNGLKGSIPSSLQKFPNSS 213
            N L  S     + +        +    L+      L   PN+S
Sbjct: 112 GNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 16/88 (18%), Positives = 33/88 (37%), Gaps = 5/88 (5%)

Query: 135 PSSFSPQ-LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDI---PKLRH 190
           P +  P     L  + +    +    +     LT L +++      +   D+    +LR+
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 191 LNLSYNGLKGSIPSSLQKFPNSSFVGNS 218
           L +  +GL+   P +    P  S +  S
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLS 88

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 36.6 bits (83), Expect = 0.004
 Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 8/59 (13%)

Query: 141 QLVVLDLSFNSFTGNIP------QSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLN 192
            +V  +       G IP       ++  L     L+L +NN+   I +   +  LR L+
Sbjct: 19  SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS 76

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	635
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.69
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.68
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.65
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.62
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.61
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.6
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.5
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.49
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.45
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.39
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.36
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.35
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.34
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.31
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.29
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.24
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.23
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.23
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.09
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.95
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.95
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.87
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.68
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.45
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.44
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.26
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.23
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.05
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.97
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.96
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.54
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.46
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.21
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.5
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.85
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.3

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=403.38  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=198.9

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|.+.+++.||||+++......++|.+|+++++++ +|||||+++|+|..++..++||||+++|+|.
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~   88 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   88 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHH
Confidence            467999999999999998888999999988777788999999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....    ..+++..+..++.|||.||+|||+.+   |+||||||+|||+++++.+||+|||+++......     .
T Consensus        89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9987533    34899999999999999999999998   9999999999999999999999999998764332     2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+|+.|+|||++.+..++.++|||||||++|||+|+ ..||....      .......+.. .....          .+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~-~~~~~----------~p  224 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDIST-GFRLY----------KP  224 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHH-TCCCC----------CC
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHh-cCCCC----------Cc
Confidence            3467889999999999999999999999999999995 45554322      1222222221 11100          01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      .....++.+++.+||+.||++||||+|++++|++++++
T Consensus       225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            11234567888899999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=398.37  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=197.3

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|+++  ..||||+++....   ..+.|.+|++++.++ +|||||++++++. ++..++||||+++|
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~~g   88 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIVTQWCEGS   88 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred             EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence            468999999999999865  4699999975433   246788999999999 9999999999875 45689999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      +|.++++...    ..+++..+..++.||++||+|||+++   ||||||||+|||++.++.+||+|||+|+.....    
T Consensus        89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999997543    34999999999999999999999998   999999999999999999999999999776432    


Q ss_pred             --CCCCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          496 --ATPSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                        ....+|+.|||||++.+   ..|+.++|||||||++|||+||+.||.+....      ..+..............   
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~p~~~---  232 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLSPDLS---  232 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCCCCGG---
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCCcch---
Confidence              23357899999999864   35889999999999999999999999754321      11222222222111100   


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                       .  ........+.+++.+||+.||++|||++|++++|+.+.+.-
T Consensus       233 -~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         233 -K--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             -G--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -h--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence             0  01122345677888999999999999999999999998654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=396.50  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|.+++++.||||+++......+.|.+|++++.++ +|||||++++++. ++..++||||+++|+|.
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~   95 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV   95 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred             eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence            567999999999999998888999999987777788999999999999 9999999999875 46779999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....   ...+++..++.|+.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+......     .
T Consensus        96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~  169 (272)
T d1qpca_          96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (272)
T ss_dssp             HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence            9886433   234899999999999999999999998   9999999999999999999999999998764322     3


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChH
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIE  577 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  577 (635)
                      ..+++.|+|||++.+..++.++|||||||++|||+||..|+....     ......+.+. ......          ...
T Consensus       170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~-~~~~~~----------~p~  233 (272)
T d1qpca_         170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE-RGYRMV----------RPD  233 (272)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHH-TTCCCC----------CCT
T ss_pred             cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH-hcCCCC----------Ccc
Confidence            457788999999999999999999999999999999766554221     1111122221 111100          011


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          578 EEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       578 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                      .....+.+++.+||+.||++||||+||++.|+++..
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            223456778889999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=389.63  Aligned_cols=244  Identities=22%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChh
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLS  422 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  422 (635)
                      .+.||+|+||+||+|++++++.||||+++.....+++|.+|+++++++ +||||++++|+|.+++..++||||+++|+|.
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            467999999999999998888999999998777888999999999999 9999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-----C
Q 006677          423 TLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-----T  497 (635)
Q Consensus       423 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-----~  497 (635)
                      +++....    ..+++..+.+++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......     .
T Consensus        88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            9976543    34899999999999999999999998   9999999999999999999999999997654322     2


Q ss_pred             CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ..+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+      ....+ .......          .+
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i-~~~~~~~----------~p  223 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHI-AQGLRLY----------RP  223 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHH-HTTCCCC----------CC
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHH-HhCCCCC----------Cc
Confidence            346788999999999999999999999999999998 899997654222      12222 2211110          11


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                      ......+.+++.+||+.||++|||++|++++|.++
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            12224677888899999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-49  Score=399.85  Aligned_cols=247  Identities=25%  Similarity=0.481  Sum_probs=194.0

Q ss_pred             hccccccCceEEEEEEecC-C---CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE-S---TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .++||+|+||+||+|.+.. +   ..||||++.....  ..++|.+|+++++++ +|||||++++++..++..++||||+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~  109 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM  109 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence            4689999999999999753 2   2488888765433  245799999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++....    ..+++.++..++.|||.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus       110 ~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         110 ENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             TTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999887543    34999999999999999999999998   9999999999999999999999999998764322


Q ss_pred             C---------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          497 T---------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       497 ~---------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      .         ..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....      .....+... ..    
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~-~~----  251 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQD-YR----  251 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-CC----
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC-CC----
Confidence            1         235778999999999999999999999999999998 89999764322      122222211 11    


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                            .+........+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                  111122334577888899999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-49  Score=397.58  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             hccccccCceEEEEEEecC-CCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLEE-STTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|.+.+ ++.||||+++......++|.+|+++++++ +|||||+++++|.+++..++||||+++|+|
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l  100 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL  100 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcch
Confidence            5689999999999999764 77899999987777788899999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC----
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT----  497 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~----  497 (635)
                      .+++....   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.......    
T Consensus       101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_         101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            99997533   345999999999999999999999998   99999999999999999999999999987654322    


Q ss_pred             -CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          498 -PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       498 -~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                       ..+++.|+|||++.+..|+.++|||||||++|||++|..||....     +... +...+.......       ..   
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~-~~~~i~~~~~~~-------~~---  238 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ-VYELLEKDYRME-------RP---  238 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHH-HHHHHHTTCCCC-------CC---
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHH-HHHHHhcCCCCC-------CC---
Confidence             225678999999999999999999999999999999877764322     1111 112222221111       11   


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ......+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus       239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            12234567888899999999999999999999988654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=393.58  Aligned_cols=240  Identities=22%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~  103 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence            367999999999999964 58899999997654 3467799999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----C
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----A  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----~  496 (635)
                      |.+++...      .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....    .
T Consensus       104 L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1         104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             HHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            99988642      3899999999999999999999998   999999999999999999999999999865432    2


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.      ..............         ....
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~---------~~~~  239 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE---------LQNP  239 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC---------CSSG
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC---------CCCc
Confidence            44589999999999999999999999999999999999999975432      12222222222111         0111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ......+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1223456677889999999999999999863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=389.53  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=192.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||||++.....  ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg   88 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG   88 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCC
Confidence            468999999999999975 588999999875532  345789999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-----  494 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-----  494 (635)
                      +|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+....     
T Consensus        89 ~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          89 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999742     35999999999999999999999998   99999999999999999999999999986532     


Q ss_pred             -CCCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 -PATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 -~~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                       .....||+.|||||++.+..+ +.++||||+||++|||+||+.||........    . ............       .
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----~-~~~~~~~~~~~~-------~  228 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----E-YSDWKEKKTYLN-------P  228 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH----H-HHHHHTTCTTST-------T
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH----H-HHHHhcCCCCCC-------c
Confidence             234568999999999988876 5789999999999999999999975432211    1 111111110000       0


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ....   ...+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 WKKI---DSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGGS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111   234567778999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=386.28  Aligned_cols=238  Identities=26%  Similarity=0.382  Sum_probs=198.5

Q ss_pred             hhccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          342 SAEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      ..+.||+|+||+||+|... +++.||+|++....    ...+.+.+|+++++++ +|||||++++++.+++..++||||+
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~   88 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYA   88 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeec
Confidence            3578999999999999975 57889999987432    2356788999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        89 ~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          89 PLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             CCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999999743     34999999999999999999999998   9999999999999999999999999998765432


Q ss_pred             --CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          497 --TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                        ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.      ......+......         ...
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~p~  225 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEFT---------FPD  225 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC---------CCT
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC---------CCc
Confidence              34588999999999999999999999999999999999999975432      1222222222111         011


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..   ...+.+++.+||+.||++|||++|+++
T Consensus       226 ~~---s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         226 FV---TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            12   235567778999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=390.52  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             cccccCceEEEEEEec---CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          345 VLGKGSYGTAYKAVLE---ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       345 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .||+|+||+||+|.+.   ++..||||+++....  ..++|.+|++++.++ +|||||++++++.. +..++||||+++|
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g   93 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG   93 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence            4999999999999864   344799999975432  246789999999999 99999999999864 5689999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~---  496 (635)
                      +|.+++...+    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......   
T Consensus        94 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          94 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             cHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            9999986433    35999999999999999999999998   9999999999999999999999999998664322   


Q ss_pred             ----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 ----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                          ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+      .... +..+....       
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~-i~~~~~~~-------  232 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAF-IEQGKRME-------  232 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHH-HHTTCCCC-------
T ss_pred             ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCCC-------
Confidence                2346788999999999999999999999999999998 899998654221      1122 22221111       


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                         .++.....+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus       233 ---~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               1112234567888899999999999999999999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=389.48  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             HhhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          341 ASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       341 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      ...+.||+|+||+||+|.+++++.||||+++......+.|.+|+.+++++ +|||||++++++. ++..++||||+++|+
T Consensus        20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGS   97 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence            34678999999999999999888999999987777788999999999999 9999999999984 567899999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC----
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA----  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~----  496 (635)
                      |..++....   ...++|.+++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++......    
T Consensus        98 l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          98 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             hhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            999987532   234999999999999999999999998   9999999999999999999999999998764322    


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+|+.|+|||++..+.++.++|||||||++|||+||..|+....     ........+... ....          .
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~-~~~~----------~  235 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERG-YRMP----------C  235 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTT-CCCC----------C
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhc-CCCC----------C
Confidence             2347888999999999999999999999999999999776665322     111222222211 1111          1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ......++.+++.+||+.||++||++++|+++|+......
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            1122345677888999999999999999999999877544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-48  Score=387.60  Aligned_cols=248  Identities=24%  Similarity=0.434  Sum_probs=195.3

Q ss_pred             hccccccCceEEEEEEecCC-----CeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES-----TTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|.++.+     ..||||++......  ..+|.+|++++.++ +|||||+++|++.+.+..++||||
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEe
Confidence            46899999999999997643     36999998654332  35688999999999 999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +.+|++.+++....    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          91 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999886533    34999999999999999999999998   999999999999999999999999999876432


Q ss_pred             C-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .       ...+|+.|+|||++.+..++.++|||||||++|||++|..|+....     ....... .+......     
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~-~i~~~~~~-----  232 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMK-AINDGFRL-----  232 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH-HHHTTCCC-----
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHH-HHhccCCC-----
Confidence            1       1246788999999999999999999999999999999766654321     1111111 12222111     


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                           +........+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus       233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                 11122334677888999999999999999999999998864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=391.07  Aligned_cols=242  Identities=21%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... ++..||||++..... ..+.+.+|+++++++ +|||||++++++.+++..++||||+++|+
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~   95 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGA   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence            467999999999999975 578899999976533 346789999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC----CC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV----PA  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~----~~  496 (635)
                      |.+++....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....    ..
T Consensus        96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            999976432    34999999999999999999999998   99999999999999999999999999976532    23


Q ss_pred             CCCCCCcccCccccc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          497 TPSRSAGYRAPEVIE-----TRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~-----~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      +..||+.|+|||++.     ...|+.++|||||||++|||+||+.||.+.+..+      ....+.......        
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~~--------  234 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPT--------  234 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCCC--------
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCCC--------
Confidence            567899999999984     4568999999999999999999999998654322      122222222110        


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ..........+.+++.+||+.||++|||++|++++
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             01111223456778889999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=387.09  Aligned_cols=242  Identities=24%  Similarity=0.354  Sum_probs=194.1

Q ss_pred             ccccccCceEEEEEEecC---CCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          344 EVLGKGSYGTAYKAVLEE---STTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      +.||+|+||+||+|.+++   ++.||||+++.....   .+++.+|+++++++ +|||||+++++|.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence            469999999999998653   357999999754332   45789999999999 99999999999864 56789999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.++++..     ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        91 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          91 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            99999999743     34999999999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhh
Q 006677          497 ------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVE  569 (635)
Q Consensus       497 ------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  569 (635)
                            ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+       +...+..+....     
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~-----  230 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG-----  230 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC-----
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCC-----
Confidence                  2347788999999999999999999999999999998 899998643211       111222211111     


Q ss_pred             hhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhh
Q 006677          570 LMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVR  612 (635)
Q Consensus       570 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~  612 (635)
                           ........+.+++.+||+.||++|||++||++.|+...
T Consensus       231 -----~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         231 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -----CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence                 11122345677888999999999999999999888754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=379.61  Aligned_cols=241  Identities=24%  Similarity=0.389  Sum_probs=192.0

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~  415 (635)
                      +.||+|+||+||+|... ++..||+|++......   .+.+.+|+++++++ +|||||++++++.+    +...++||||
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~   93 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL   93 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence            46999999999999975 4778999999866443   35688999999999 89999999999875    3457899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc-CCCCeEEeecCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN-QDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~DfGla~~~~~  494 (635)
                      +++|+|.+++...     ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus        94 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          94 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999743     34899999999999999999999975 5699999999999996 578999999999986544


Q ss_pred             CC--CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          495 PA--TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       495 ~~--~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                      ..  ...||+.|+|||++.+ .++.++|||||||++|||++|+.||....     +.....+.+. .......++     
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~-~~~~~~~~~-----  235 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVT-SGVKPASFD-----  235 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHT-TTCCCGGGG-----
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHH-cCCCCcccC-----
Confidence            32  3468999999999875 59999999999999999999999997432     1111122222 111111111     


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ..   ...++.+++.+||+.||++|||++|++++
T Consensus       236 -~~---~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 -KV---AIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -GC---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -cc---CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             11   12246678889999999999999999863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=398.11  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=199.7

Q ss_pred             hhccccccCceEEEEEEecCC------CeEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEES------TTVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..++||+|+||+||+|++...      ..||+|++....  .....+.+|+.++.++.+|||||++++++.+.+..++||
T Consensus        41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (325)
T d1rjba_          41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF  120 (325)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence            367899999999999996532      258999886543  234678899999999988999999999999999999999


Q ss_pred             EeccCCChhhhccCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          414 DYFASGSLSTLLHGNRGA------------------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      ||+++|+|.++++..+..                  ....+++..++.++.||+.||+|||+++   ||||||||+|||+
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill  197 (325)
T d1rjba_         121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLV  197 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEE
T ss_pred             EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhcccc
Confidence            999999999999765421                  1235899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVD  548 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~  548 (635)
                      +.++.+||+|||+|+......      +..+|+.|||||++.+..++.++|||||||++|||+| |+.||.+....+   
T Consensus       198 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---  274 (325)
T d1rjba_         198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---  274 (325)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---
T ss_pred             ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH---
Confidence            999999999999998765433      2235888999999999999999999999999999998 899998654322   


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEE  610 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  610 (635)
                         -+..++.......          ........+.+++.+||+.||++|||++||+++|.+
T Consensus       275 ---~~~~~~~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         275 ---NFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             ---HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHHhcCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence               1222222222111          111223457788889999999999999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=385.38  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=187.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEe--CCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYS--KDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|+.. +|+.||+|++......   .+.+.+|+++++++ +|||||++++++.+  ++..|+||||+
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~   87 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC   87 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence            468999999999999975 5789999999766443   34588899999999 99999999999865  45679999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG--GPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      ++|+|.+++..... ....+++..++.++.||+.||+|||+++  ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus        88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  166 (269)
T d2java1          88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  166 (269)
T ss_dssp             TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred             CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence            99999999864321 1345999999999999999999999875  23599999999999999999999999999976543


Q ss_pred             C----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          495 P----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       495 ~----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                      .    ....+|+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..      .....+...... .+     
T Consensus       167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~~~~-~~-----  234 (269)
T d2java1         167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGKFR-RI-----  234 (269)
T ss_dssp             ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-CC-----
T ss_pred             CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC-CC-----
Confidence            2    2346899999999999999999999999999999999999999754321      122222222111 10     


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        ...   ...++.+++.+||+.||++|||++|++++
T Consensus       235 --~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         235 --PYR---YSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --Ccc---cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              011   22356677889999999999999999763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=395.32  Aligned_cols=191  Identities=21%  Similarity=0.378  Sum_probs=169.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||+|+++.....  .+.+.+|+.+++++ +|||||+++++|.+++..++||||+++|
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            467999999999999975 5788999999765322  46788999999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC--CC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSM-GGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV--PA  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~--~~  496 (635)
                      +|.+++.+.     ..+++..+..++.|++.||+|||++ +   |+||||||+|||+++++.+||+|||+|+....  ..
T Consensus        90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            999999743     2489999999999999999999974 7   99999999999999999999999999976532  33


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPT  542 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~  542 (635)
                      +..||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            5579999999999999999999999999999999999999998654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=387.35  Aligned_cols=239  Identities=23%  Similarity=0.355  Sum_probs=197.0

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||||++......    .+.+.+|+++++++ +|||||++++++.+++..|+||||++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~   98 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL   98 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecC
Confidence            467999999999999965 5778999999765432    24688999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPAT  497 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~~  497 (635)
                      +|+|..++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.......
T Consensus        99 ~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (309)
T d1u5ra_          99 GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS  170 (309)
T ss_dssp             EEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred             CCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence            9999776653     235999999999999999999999998   99999999999999999999999999998877777


Q ss_pred             CCCCCcccCcccccC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhccc
Q 006677          498 PSRSAGYRAPEVIET---RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQ  574 (635)
Q Consensus       498 ~~~~~~y~aPE~~~~---~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  574 (635)
                      ..||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+...      ......+...... ...      ..
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~~-~~~------~~  237 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-ALQ------SG  237 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCS------CT
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC-CCC------CC
Confidence            889999999999864   4589999999999999999999999975431      1112222222111 010      11


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          575 NIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       575 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      .   ....+.+++.+||+.||++|||++|+++
T Consensus       238 ~---~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         238 H---WSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             T---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1   1235667778999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=380.46  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=194.3

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe-CCeeEEEEEeccCCC
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS-KDEKLLVYDYFASGS  420 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~~~g~  420 (635)
                      ..+.||+|+||.||+|.++ |+.||||+++.. ...+++.+|+++++++ +||||++++|++.+ ++..++||||+++|+
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            3578999999999999986 778999999764 3457899999999999 99999999999865 456899999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-CCC
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-TPS  499 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-~~~  499 (635)
                      |.++++...   ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++...... ...
T Consensus        88 L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~  161 (262)
T d1byga_          88 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK  161 (262)
T ss_dssp             HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCcccc
Confidence            999996432   234899999999999999999999988   9999999999999999999999999998765433 345


Q ss_pred             CCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccChHH
Q 006677          500 RSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNIEE  578 (635)
Q Consensus       500 ~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  578 (635)
                      ++..|+|||++.+..++.++|||||||++|||+| |+.||......+   +..++    ..+...+.          +..
T Consensus       162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~~~~~----------~~~  224 (262)
T d1byga_         162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMDA----------PDG  224 (262)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTCCCCC----------CTT
T ss_pred             ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCCCCC----------Ccc
Confidence            6788999999999999999999999999999998 688876543322   22222    11111111          112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          579 EMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       579 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ....+.+++.+||+.||++||||.|++++|+.++..
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            224567788899999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-46  Score=382.64  Aligned_cols=242  Identities=21%  Similarity=0.374  Sum_probs=183.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|... +++.||||++.....  ....+.+|+++++++ +|||||++++++.+++..|+||||+++|
T Consensus        14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg   92 (307)
T d1a06a_          14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGG   92 (307)
T ss_dssp             EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            468999999999999975 578899999976532  245678899999999 9999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc---CCCCeEEeecCCCCCCCCCC
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~DfGla~~~~~~~  496 (635)
                      +|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+......
T Consensus        93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999999742     34999999999999999999999998   99999999999995   57899999999998765432


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         +..||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....      .....+........     ....
T Consensus       165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-----~~~~  233 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYEFD-----SPYW  233 (307)
T ss_dssp             --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCCCC-----TTTT
T ss_pred             eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCCC-----Cccc
Confidence               346899999999999999999999999999999999999999754321      11222222221100     0011


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..   ....+.+++.+||+.||++|||++|++++
T Consensus       234 ~~---~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         234 DD---ISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TT---SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cC---CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11   22356677889999999999999999884

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=381.05  Aligned_cols=238  Identities=18%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||||++....    ...+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~   91 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK   91 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence            578999999999999975 58899999997532    2346789999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.....  
T Consensus        92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999998743     34999999999999999999999998   999999999999999999999999999876432  


Q ss_pred             ----CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          496 ----ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       496 ----~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                          ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+.      ......+......   +     
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~---~-----  229 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLEYD---F-----  229 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCCC---C-----
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCCCC---C-----
Confidence                234589999999999999999999999999999999999999985432      1122222222211   0     


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                       ....   ...+.+++.+||+.||++|||++|++++
T Consensus       230 -p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         230 -PEKF---FPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -CTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -CccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             1111   2346677889999999999999998664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=384.94  Aligned_cols=259  Identities=23%  Similarity=0.326  Sum_probs=196.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHH--HhhcCCCceeceeEEEEeCC----eeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIV--GRVGQHPNVVPLRAYYYSKD----EKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l--~~l~~h~niv~l~~~~~~~~----~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|++. |+.||||+++...  .+++.+|.+++  ..+ +|||||++++++..++    ..++||||+
T Consensus         8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~   83 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence            467999999999999974 7899999986543  34444555544  455 8999999999998764    578999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMG-----GPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ++|+|.++++..      .++|..+..++.|+|.||+|+|+..     .++|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999743      3999999999999999999999741     23499999999999999999999999999876


Q ss_pred             CCCC--------CCCCCCCcccCcccccCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCCCC--------CCh
Q 006677          492 MNVP--------ATPSRSAGYRAPEVIETRK------HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDM--------VDL  549 (635)
Q Consensus       492 ~~~~--------~~~~~~~~y~aPE~~~~~~------~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~--------~~~  549 (635)
                      ....        ....||+.|+|||++.+..      ++.++|||||||++|||+||..||......+.        ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            5322        2345899999999987643      57789999999999999999988754332211        011


Q ss_pred             hHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          550 PRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       550 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      ..........+..    ++.........+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus       238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            2222222222111    1111111122345677889999999999999999999999999998654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-46  Score=385.13  Aligned_cols=243  Identities=19%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... +|+.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~  109 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE  109 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence            568999999999999975 578999999976533 346688999999999 89999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC--CCCeEEeecCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ--DLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~DfGla~~~~~~~--  496 (635)
                      |.+++....    ..+++..+..++.||+.||+|||+++   ||||||||+|||++.  ++.+||+|||+|+......  
T Consensus       110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            999986432    34999999999999999999999998   999999999999964  5789999999998765433  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.      ......+....+....  .   ... 
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~--~---~~~-  250 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMDD--S---AFS-  250 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCC--G---GGG-
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCc--c---ccc-
Confidence             34689999999999999999999999999999999999999975432      2223333332221110  0   011 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .....+.+++.+||+.||++|||++|++++
T Consensus       251 --~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         251 --GISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              112356677889999999999999999885

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=380.18  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=193.4

Q ss_pred             hccccccCceEEEEEEecC------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC-eeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD-EKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~  413 (635)
                      .+.||+|+||+||+|.+..      ++.||||+++....  ..+.+.+|.+++.++.+|+||+.+++++..++ ..++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            5789999999999999642      35799999875432  24567888889999888999999999987654 679999


Q ss_pred             EeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          414 DYFASGSLSTLLHGNRG-----------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      ||+++|+|.++++..+.           .....+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence            99999999999975431           11345899999999999999999999998   99999999999999999999


Q ss_pred             EeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHH
Q 006677          483 ISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQS  555 (635)
Q Consensus       483 i~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~  555 (635)
                      |+|||+|+......      ...||+.|+|||++.+..++.++|||||||++|||+||. .||......      ..+..
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------~~~~~  248 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR  248 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------HHHHH
T ss_pred             EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence            99999997654322      234788999999999999999999999999999999975 577644322      12223


Q ss_pred             HhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          556 VVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       556 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      .+..+.....          .......+.+++.+||+.||++|||++|++++|+++.+..
T Consensus       249 ~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         249 RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            3333222111          1122345778888999999999999999999999998653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=378.30  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             hccccccCceEEEEEEecCC-C--eEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLEES-T--TVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|.++++ .  .||||+++....  ..+++.+|++++.++.+|||||++++++.+++..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            57899999999999997643 3  477888764432  356799999999998779999999999999999999999999


Q ss_pred             CCChhhhccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeec
Q 006677          418 SGSLSTLLHGNR-----------GAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDF  486 (635)
Q Consensus       418 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  486 (635)
                      +|+|.++++...           ......+++..+..++.|||.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence            999999997542           122345999999999999999999999998   999999999999999999999999


Q ss_pred             CCCCCCCCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCC-CCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          487 GLTPLMNVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKA-PLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       487 Gla~~~~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      |+++......   ...+|..|+|||.+.+..++.++|||||||++|||++|.. ||...+      .......+. .+..
T Consensus       172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~i~-~~~~  244 (309)
T d1fvra_         172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLP-QGYR  244 (309)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGG-GTCC
T ss_pred             cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHHHH-hcCC
Confidence            9997654332   3347889999999999999999999999999999999764 665433      222222222 2111


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                      ..       ..   .....++.+++.+||+.||++||||+||+++|+.+.+...
T Consensus       245 ~~-------~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         245 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             CC-------CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CC-------CC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            11       11   1122456677889999999999999999999999987554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=377.74  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=198.4

Q ss_pred             hccccccCceEEEEEEecCC----CeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeC-CeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEES----TTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-DEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~  415 (635)
                      .++||+|+||+||+|.+.++    ..||||+++....  ..++|.+|++++.++ +||||++++|++... ...++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence            46899999999999997542    2589999875332  236799999999999 899999999998764 578999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.++++...    ...++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            99999999987533    34788999999999999999999998   999999999999999999999999999875432


Q ss_pred             C--------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          496 A--------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       496 ~--------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .        ...+|+.|+|||.+.+..++.++||||||+++|||+||+.||......  .++..   .+......     
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~g~~~-----  253 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQGRRL-----  253 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTTCCC-----
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHcCCCC-----
Confidence            2        123678899999999999999999999999999999988887643211  12222   21111111     


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccCC
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSDS  616 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~~  616 (635)
                            ..+......+.+++.+||+.||++||+|.||+++|+.+...-.
T Consensus       254 ------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         254 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence                  0111122456788889999999999999999999999986543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=375.68  Aligned_cols=246  Identities=22%  Similarity=0.369  Sum_probs=190.8

Q ss_pred             hccccccCceEEEEEEecC----CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          343 AEVLGKGSYGTAYKAVLEE----STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      .+.||+|+||+||+|.+..    +..||||+++....  ..+.+.+|+++++++ +|||||++++++. ++..++||||+
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~   89 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC   89 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEec
Confidence            5789999999999998653    34588888865433  245689999999999 9999999999985 56789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      ++|+|.+++....    ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+......
T Consensus        90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999876433    34899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             -----CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhh
Q 006677          497 -----TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVEL  570 (635)
Q Consensus       497 -----~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  570 (635)
                           ...+|+.|+|||++.+..++.++|||||||++|||+| |..||......+.      ...+.... ...      
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------~~~i~~~~-~~~------  229 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGE-RLP------  229 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTC-CCC------
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC-CCC------
Confidence                 2346788999999999999999999999999999998 8999986543321      11111111 111      


Q ss_pred             hcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          571 MRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       571 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                       ..   ......+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus       230 -~~---~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 -MP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CC---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             11   12234567788899999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-46  Score=380.95  Aligned_cols=245  Identities=22%  Similarity=0.375  Sum_probs=196.0

Q ss_pred             hccccccCceEEEEEEecC-CC----eEEEEEeeccc--CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLEE-ST----TVVVKRLKEVV--VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|.+.. |+    .||+|+++...  ...+++.+|++++.++ +|||||+++++|.++ ..++++||
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~~v~e~   91 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL   91 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CeeEEEEe
Confidence            4689999999999999753 33    58889886543  2467899999999999 999999999999764 56788999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +.+|+|.+++...    ...+++..++.++.|||.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        92 ~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          92 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             CTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             ccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            9999999988753    335999999999999999999999998   999999999999999999999999999765432


Q ss_pred             C------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          496 A------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       496 ~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      .      ...+|+.|+|||++.++.++.++|||||||++|||+| |..||.+....+   +..    .+..+..      
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~------  231 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER------  231 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCC------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC------
Confidence            2      1246889999999999999999999999999999999 788987654332   111    1111111      


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                          .+..+.....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                11111223456788889999999999999999999998864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-46  Score=375.13  Aligned_cols=242  Identities=23%  Similarity=0.380  Sum_probs=197.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-------ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-------GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|... +|+.||||+++....       ..+.+.+|+++++++ +|||||++++++.+++..|+|||
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E   93 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE   93 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999975 588999999975422       246799999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC----CeEEeecCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL----DGCISDFGLTP  490 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~DfGla~  490 (635)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+|++|||+|.
T Consensus        94 ~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          94 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             cCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999743     24999999999999999999999998   99999999999998776    49999999997


Q ss_pred             CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccch
Q 006677          491 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFD  567 (635)
Q Consensus       491 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  567 (635)
                      .....   .+..+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+      ....+......   +.
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~---~~  236 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYE---FE  236 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCC---CC
T ss_pred             hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCC---CC
Confidence            76443   24467889999999999999999999999999999999999998643221      12222211111   00


Q ss_pred             hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..  ...   .....+.+++.+||+.||++|||++|++++
T Consensus       237 ~~--~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         237 DE--YFS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HH--HHT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ch--hcC---CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00  001   122356678889999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-46  Score=377.57  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=200.6

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|+++      +++.||||+++.....  .++|.+|+++++++ +||||++++++|...+..++|||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e   96 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE   96 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEE
Confidence            567999999999999964      3467999998754332  45799999999999 99999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEE
Q 006677          415 YFASGSLSTLLHGNRG-------------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLI  475 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  475 (635)
                      |+++|+|.++++....                   .....+++..++.++.|++.||+|||+++   ||||||||+|||+
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILl  173 (301)
T d1lufa_          97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV  173 (301)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEE
Confidence            9999999999964321                   12234899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeecCCCCCCCCC------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 006677          476 NQDLDGCISDFGLTPLMNVP------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVD  548 (635)
Q Consensus       476 ~~~~~~ki~DfGla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~-~p~~~~~~~~~~~  548 (635)
                      +.++.+||+|||+|+.....      .+..+++.|+|||.+.+..|+.++|||||||++|||++|. .||......    
T Consensus       174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~----  249 (301)
T d1lufa_         174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE----  249 (301)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----
T ss_pred             CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH----
Confidence            99999999999998654321      2345678899999999999999999999999999999996 567654322    


Q ss_pred             hhHHHHHHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhc
Q 006677          549 LPRWVQSVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQ  613 (635)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~  613 (635)
                        .....+.... ....          ......++.+|+.+||+.+|++||||.||+++|++|.+
T Consensus       250 --e~~~~v~~~~-~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         250 --EVIYYVRDGN-ILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --HHHHHHHTTC-CCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --HHHHHHHcCC-CCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              2222222221 1111          11223457788889999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-45  Score=382.43  Aligned_cols=243  Identities=21%  Similarity=0.375  Sum_probs=198.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC-ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV-GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGS  420 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  420 (635)
                      .+.||+|+||+||+|... +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||+++|+
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~  112 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE  112 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence            468999999999999974 588999999876532 345688999999999 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc--CCCCeEEeecCCCCCCCCCC--
Q 006677          421 LSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN--QDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       421 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~DfGla~~~~~~~--  496 (635)
                      |.+++...    ...+++..+..++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|+......  
T Consensus       113 L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         113 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            99887643    234999999999999999999999998   99999999999998  67899999999998775443  


Q ss_pred             -CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccC
Q 006677          497 -TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQN  575 (635)
Q Consensus       497 -~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  575 (635)
                       ...+|+.|+|||++.+..++.++||||+||++|||+||+.||.+.+..      .....+.......   ..  .... 
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~---~~--~~~~-  253 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWEF---DE--DAFS-  253 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCCC---CS--STTT-
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC---Cc--cccc-
Confidence             245889999999999999999999999999999999999999754321      2222222221110   00  0011 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          576 IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       576 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .....+.+++.+||+.||++|||++|++++
T Consensus       254 --~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         254 --SVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              122356677889999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=378.61  Aligned_cols=245  Identities=19%  Similarity=0.305  Sum_probs=193.4

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEe----CCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYS----KDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~  417 (635)
                      .++||+|+||+||+|.. .+++.||||+++.    ...+.+|++++.++.+|||||++++++.+    +...|+|||||+
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~   92 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   92 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence            35799999999999996 4588999999865    35678899998877689999999999876    356899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC---CCCeEEeecCCCCCCCC
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ---DLDGCISDFGLTPLMNV  494 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~DfGla~~~~~  494 (635)
                      +|+|.+++....   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|+....
T Consensus        93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccC
Confidence            999999997532   235999999999999999999999998   999999999999985   56799999999976543


Q ss_pred             C---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhh
Q 006677          495 P---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELM  571 (635)
Q Consensus       495 ~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  571 (635)
                      .   ....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+....+...   ....    ......++.   
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~----~i~~~~~~~---  236 (335)
T d2ozaa1         167 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKT----RIRMGQYEF---  236 (335)
T ss_dssp             CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSC---
T ss_pred             CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHH----HHhcCCCCC---
Confidence            3   34568999999999999999999999999999999999999997654332211   0000    000000000   


Q ss_pred             cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          572 RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       572 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...........+.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            000112233467788889999999999999999884

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=371.74  Aligned_cols=238  Identities=22%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|+.. +++.||+|++++..    ...+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~   88 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccC
Confidence            468999999999999974 68899999997542    2356788999999999 89999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...... 
T Consensus        89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999997533     4899999999999999999999998   9999999999999999999999999998754322 


Q ss_pred             ---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          497 ---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       497 ---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                         ...||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..      .....+......         ..
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~~~---------~p  225 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEIR---------FP  225 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---------CC
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCCCC---------CC
Confidence               345899999999999999999999999999999999999999865422      122222222110         01


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ...+   .++.+++.+||+.||++||+     ++|++++
T Consensus       226 ~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         226 RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1122   34567778999999999995     8888874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-46  Score=373.08  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=188.6

Q ss_pred             hccccccCceEEEEEEecC--C--CeEEEEEeecccC----ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE--S--TTVVVKRLKEVVV----GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .+.||+|+||+||+|++..  +  ..||||+++....    ..++|.+|+++++++ +||||++++|++.+ ...++|||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e   90 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTE   90 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeee
Confidence            4679999999999998643  2  3689999875432    135789999999999 99999999999965 56789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC
Q 006677          415 YFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV  494 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~  494 (635)
                      |+++|++.+++....    ..+++..++.++.|||.||+|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999998886533    34999999999999999999999998   99999999999999999999999999987644


Q ss_pred             CC-------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          495 PA-------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       495 ~~-------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..       ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..      .....+......... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~~-  236 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLPR-  236 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCCC-
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCCC-
Confidence            32       2235678999999999999999999999999999998 89999754322      222333333221111 


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEV  611 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~  611 (635)
                               .......+.+++.+||+.||++||||+||++.|+++
T Consensus       237 ---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     112224567888899999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-45  Score=372.94  Aligned_cols=238  Identities=19%  Similarity=0.291  Sum_probs=198.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|+.. +|+.||||+++...    ...+.+.+|+.+++++ +|||||++++++.+++..|+||||++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~   87 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE   87 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecC
Confidence            478999999999999975 58899999997542    2356788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC-
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA-  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~-  496 (635)
                      +|+|..++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...... 
T Consensus        88 gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~  159 (316)
T d1fota_          88 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  159 (316)
T ss_dssp             SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             Ccccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence            99999998743     34888999999999999999999998   9999999999999999999999999998765443 


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      +..||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+.      ......+......         .....
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p~~~  224 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR---------FPPFF  224 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC---------CCTTS
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC---------CCCCC
Confidence            45689999999999999999999999999999999999999975432      2222233222211         01111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  607 (635)
                         ...+.+++.+|+..||++|+     |++|++++
T Consensus       225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               23466777899999999996     89999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=372.99  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=198.4

Q ss_pred             hccccccCceEEEEEEecC--------CCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLEE--------STTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv  412 (635)
                      .+.||+|+||.||+|+...        +..||||+++....  ...++.+|...+.++.+|||||+++++|.+++..++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            5789999999999998643        24699999976543  2467888999999998899999999999999999999


Q ss_pred             EEeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          413 YDYFASGSLSTLLHGNRGA-----------GRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      |||+++|+|.+++...+..           ....+++..++.++.||+.||+|||+.+   ||||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence            9999999999999755321           1245899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLT-GKAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~  554 (635)
                      ||+|||+++......      ...+++.|+|||.+.++.|+.++|||||||++|||++ |..||......+       +.
T Consensus       175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-------~~  247 (299)
T d1fgka_         175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF  247 (299)
T ss_dssp             EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HH
T ss_pred             EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-------HH
Confidence            999999998664322      2346778999999999999999999999999999998 688887543211       11


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ..+..+.....       ..   .....+.+++.+||+.||++|||+.||++.|+++...
T Consensus       248 ~~i~~~~~~~~-------p~---~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         248 KLLKEGHRMDK-------PS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHHTTCCCCC-------CS---SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCC-------Cc---cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            22222211111       11   1223577888899999999999999999999998753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=372.66  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=202.4

Q ss_pred             hccccccCceEEEEEEec------CCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYD  414 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e  414 (635)
                      .++||+|+||.||+|++.      .++.||||+++....  ....+.+|+.++.++.+|||||++++++.+.+..++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            578999999999999863      356799999976533  345688999999999789999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCe
Q 006677          415 YFASGSLSTLLHGNRG-------------AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDG  481 (635)
Q Consensus       415 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  481 (635)
                      |+++|+|.++++....             .....+++..+..++.||+.||+|||+++   ++||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence            9999999999975432             12335899999999999999999999998   9999999999999999999


Q ss_pred             EEeecCCCCCCCCCCC------CCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHH
Q 006677          482 CISDFGLTPLMNVPAT------PSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTG-KAPLQSPTRDDMVDLPRWVQ  554 (635)
Q Consensus       482 ki~DfGla~~~~~~~~------~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~  554 (635)
                      |++|||+++.......      ..+|+.|+|||++.+..++.++|||||||++|||+|+ .+||......+      .+.
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~------~~~  258 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY  258 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence            9999999987654322      2367889999999999999999999999999999995 55554433221      122


Q ss_pred             HHhhhccccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          555 SVVREEWTAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       555 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ..+..+....          ..+.....+.+|+.+||+.||++||||+|++++|+++...
T Consensus       259 ~~i~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2222221111          1112234577888899999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-44  Score=360.74  Aligned_cols=243  Identities=20%  Similarity=0.364  Sum_probs=195.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLL  411 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l  411 (635)
                      .+.||+|+||+||+|+.. +++.||||++......          .+.+.+|+.+++++..||||+++++++.+++..|+
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            578999999999999974 5789999999765321          23577899999999669999999999999999999


Q ss_pred             EEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCC
Q 006677          412 VYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPL  491 (635)
Q Consensus       412 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~  491 (635)
                      ||||+++|+|.++++..     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999743     24999999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCC---CCCCCCCcccCcccccC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006677          492 MNVP---ATPSRSAGYRAPEVIET------RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT  562 (635)
Q Consensus       492 ~~~~---~~~~~~~~y~aPE~~~~------~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  562 (635)
                      ....   ....||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+..      ...+.+......
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~~~  233 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGNYQ  233 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCCCC
Confidence            6543   23457899999999853      34788999999999999999999999864321      112222222211


Q ss_pred             cccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          563 AEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       563 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ..     ....   .....++.+++.+||+.||++|||++|++++
T Consensus       234 ~~-----~~~~---~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         234 FG-----SPEW---DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CC-----TTTG---GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CC-----Cccc---ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00     0011   1222356677789999999999999999764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-45  Score=371.13  Aligned_cols=243  Identities=20%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... +++.||||+++........+.+|+++++++ +|||||++++++.+++..|+||||+++|+|
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L   88 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI   88 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence            468999999999999976 577899999987655556788999999999 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC--CCeEEeecCCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD--LDGCISDFGLTPLMNVPA---  496 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~DfGla~~~~~~~---  496 (635)
                      .+++....    ..+++.++..++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++......   
T Consensus        89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            99997532    24899999999999999999999998   9999999999999854  589999999998765433   


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...+++.|+|||.+.+..|+.++||||+||++|||++|+.||...+..      .....+....+..   +..  .....
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~---~~~--~~~~~  230 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTF---DEE--AFKEI  230 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCC---CHH--HHTTS
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC---Chh--hccCC
Confidence            234788999999999999999999999999999999999999865322      2222332222110   100  01111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                         ...+.+++.+|+..||++|||++|++++
T Consensus       231 ---s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         231 ---SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               2345677889999999999999999983

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.2e-44  Score=361.68  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC----hHHHHHHHHHHHhhcCCCceeceeEEEEeCCe----eEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG----KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDE----KLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lv~  413 (635)
                      .+.||+|+||+||+|... +++.||||+++.....    ...+.+|+++++++ +||||+++++++..++.    .|+||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEE
Confidence            468999999999999964 6889999999765332    34688999999998 99999999999987653    78999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++..+|+|||.+....
T Consensus        91 E~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             ECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence            999999999988643     34999999999999999999999998   9999999999999999999999999876543


Q ss_pred             CC-------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VP-------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~-------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..       ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.      ...............  
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP--  234 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCG--
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCC--
Confidence            22       234579999999999999999999999999999999999999975432      222223332221110  


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhh
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-NMDEVVRMIEEVR  612 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~~~  612 (635)
                        . ......   ...+.+++.+|++.||++|| |++|+++.|..+.
T Consensus       235 --~-~~~~~~---s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 --S-ARHEGL---SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --G-GTSSSC---CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --c-hhccCC---CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              0 011122   23566777899999999999 8999999988775

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=370.27  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=190.6

Q ss_pred             ccccccCceEEEEEEec-CCCeEEEEEeecccCC------hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEec
Q 006677          344 EVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG------KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYF  416 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~  416 (635)
                      ++||+|+||+||+|... +++.||||+++.....      .+.+.+|+++++++ +|||||++++++..++..++||||+
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhh
Confidence            67999999999999975 5889999998654321      24688999999999 9999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC
Q 006677          417 ASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA  496 (635)
Q Consensus       417 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~  496 (635)
                      .++++..+...     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            99887777653     234888999999999999999999998   9999999999999999999999999997765432


Q ss_pred             ----CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccccc-
Q 006677          497 ----TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR----EEWTAEVF-  566 (635)
Q Consensus       497 ----~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-  566 (635)
                          ...+|+.|+|||++... .|+.++|||||||++|||+||+.||.+.+..+.   ...+.....    +.+..... 
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence                34578999999998654 579999999999999999999999976442211   111111110    00000000 


Q ss_pred             --hhhhhcccC------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 --DVELMRFQN------IEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 --d~~~~~~~~------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                        .......+.      .......+.+++.+|++.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              000000000      01112457788889999999999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-44  Score=372.31  Aligned_cols=237  Identities=18%  Similarity=0.201  Sum_probs=197.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +|+.||||++....    ...+.+.+|+++++++ +|||||++++++...+..++||||+.
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~  124 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence            468999999999999975 58899999987432    2346788999999999 99999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC-C
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP-A  496 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~-~  496 (635)
                      +|+|.+++...     ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+..... .
T Consensus       125 ~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~  196 (350)
T d1rdqe_         125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             ccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence            99999999743     24899999999999999999999998   999999999999999999999999999876543 3


Q ss_pred             CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcccCh
Q 006677          497 TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRFQNI  576 (635)
Q Consensus       497 ~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  576 (635)
                      ...||+.|||||++.+..++.++|||||||++|||+||+.||.+.+      .......+......         ...  
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p~--  259 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKVR---------FPS--  259 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CCT--
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCCC---------CCc--
Confidence            4568999999999999999999999999999999999999997543      12222222222111         011  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006677          577 EEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR  606 (635)
Q Consensus       577 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  606 (635)
                       .....+.+++.+||+.||++|+     |++|+++
T Consensus       260 -~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         260 -HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             1223566778899999999994     8999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.2e-44  Score=372.39  Aligned_cols=242  Identities=18%  Similarity=0.252  Sum_probs=190.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhc--CCCceeceeEEEEeCCeeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVG--QHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      .++||+|+||+||+|+.. +|+.||||++....    .....+.+|..++..+.  +|||||++++++.+++..|+||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            468999999999999975 58899999986542    23344555544444332  799999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP  495 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~  495 (635)
                      +++|+|.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999743     34889999999999999999999998   999999999999999999999999999866543


Q ss_pred             --CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhc
Q 006677          496 --ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMR  572 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  572 (635)
                        ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+   .....+.......         ..
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~~~---------~~  228 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAV---------EL  228 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSSCCC---------CC
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccCCC---------CC
Confidence              34568999999999975 568999999999999999999999998654332   1111111111110         01


Q ss_pred             ccChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006677          573 FQNIEEEMVQMLQIGMACVAKVPDMRPN-----MDEVVRM  607 (635)
Q Consensus       573 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  607 (635)
                      ....+   ..+.+++.+||+.||++|||     ++|++++
T Consensus       229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         229 PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            11122   34667778999999999999     6888763

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=367.87  Aligned_cols=238  Identities=22%  Similarity=0.355  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeeccc----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEecc
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVV----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFA  417 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~  417 (635)
                      .+.||+|+||+||+|... +++.||||++++..    ...+.+..|..++.+..+|||||++++++.+++..|+||||++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~   86 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN   86 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence            468999999999999975 57889999997532    2345677787777654499999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC--
Q 006677          418 SGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP--  495 (635)
Q Consensus       418 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~--  495 (635)
                      +|+|.++++...     .+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....  
T Consensus        87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            999999997432     4899999999999999999999998   999999999999999999999999999765432  


Q ss_pred             --CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchhhhhcc
Q 006677          496 --ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDVELMRF  573 (635)
Q Consensus       496 --~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  573 (635)
                        ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+      ....+......         ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~---------~p  223 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPF---------YP  223 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC---------CC
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC---------CC
Confidence              23458899999999999999999999999999999999999998643221      11222111110         01


Q ss_pred             cChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006677          574 QNIEEEMVQMLQIGMACVAKVPDMRPNMD-EVVR  606 (635)
Q Consensus       574 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  606 (635)
                      ...   ...+.+++.+||+.||++||++. |+++
T Consensus       224 ~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            112   23466778899999999999995 7764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=368.58  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             hhccccccCceEEEEEEec------CCCeEEEEEeecccCC--hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          342 SAEVLGKGSYGTAYKAVLE------ESTTVVVKRLKEVVVG--KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      ..+.||+|+||+||+|.+.      +++.||||+++.....  ...|.+|+++++++ +||||+++++++..++..++||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEE
Confidence            4678999999999999864      2568999999754322  34588999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCC
Q 006677          414 DYFASGSLSTLLHGNRG-----AGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGL  488 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGl  488 (635)
                      ||+++|+|.++++..+.     .....+++..+.+++.|+|+||.|||+++   |+||||||+|||+++++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeeccc
Confidence            99999999999864321     12234789999999999999999999987   99999999999999999999999999


Q ss_pred             CCCCCCCC------CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhcc
Q 006677          489 TPLMNVPA------TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGK-APLQSPTRDDMVDLPRWVQSVVREEW  561 (635)
Q Consensus       489 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  561 (635)
                      |+......      ...+++.|+|||.+.+..++.++||||||+++|||+||. .||.+.+      ...+...+.....
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~~i~~~~~  253 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVMEGGL  253 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHHTTCC
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhCCC
Confidence            98664322      234678899999999999999999999999999999985 6775432      2233333332221


Q ss_pred             ccccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          562 TAEVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       562 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      . ..       .   ......+.+++.+||+.+|++|||++||+++|++..+..
T Consensus       254 ~-~~-------p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         254 L-DK-------P---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             C-CC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C-CC-------c---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            1 11       1   112245778888999999999999999999998876644

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=361.23  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=189.3

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|.. .+++.||||+++....   ..+.+.+|+++++++ +|||||++++++.+++..|+||||+.+
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~   85 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQ   85 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCC
Confidence            36799999999999997 4588999999965432   356788999999999 999999999999999999999999976


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC---
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~---  495 (635)
                      +.+ +++....   ...+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.....   
T Consensus        86 ~~~-~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          86 DLK-KFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EHH-HHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             chh-hhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            544 4443222   234999999999999999999999998   999999999999999999999999998665432   


Q ss_pred             -CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh--hccccccc-----
Q 006677          496 -ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR--EEWTAEVF-----  566 (635)
Q Consensus       496 -~~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----  566 (635)
                       ....+|+.|+|||.+.... ++.++||||+||++|||++|+.||.+.+..+.  +.........  +.......     
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccccccc
Confidence             2345889999999987665 57899999999999999999999975432110  1111110000  00000000     


Q ss_pred             hhhhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          567 DVELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       567 d~~~~--~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      .....  .....    ......+.+++.+|++.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000  00000    1112456778889999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-44  Score=355.85  Aligned_cols=233  Identities=21%  Similarity=0.389  Sum_probs=188.4

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC-------hHHHHHHHHHHHhhc-CCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG-------KRDFEQQMEIVGRVG-QHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .++||+|+||+||+|... +++.||||++......       ...+.+|+++++++. .|||||++++++.+++..++||
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~   88 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL   88 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence            468999999999999975 5889999999754321       234678999999984 3999999999999999999999


Q ss_pred             EeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCC-CCeEEeecCCCCC
Q 006677          414 DYFAS-GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQD-LDGCISDFGLTPL  491 (635)
Q Consensus       414 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~DfGla~~  491 (635)
                      ||+.+ +++.+++...     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence            99976 5788887642     34999999999999999999999998   9999999999999854 7999999999976


Q ss_pred             CCCC--CCCCCCCcccCcccccCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccchh
Q 006677          492 MNVP--ATPSRSAGYRAPEVIETRKH-SHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVFDV  568 (635)
Q Consensus       492 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  568 (635)
                      ....  .+..||+.|+|||++.+..+ +.++||||+||++|||+||+.||....            .+......   +  
T Consensus       161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~---~--  223 (273)
T d1xwsa_         161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF---F--  223 (273)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC---C--
T ss_pred             cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC---C--
Confidence            5443  34568999999999987765 567899999999999999999997421            11111100   0  


Q ss_pred             hhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          569 ELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       569 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                          ....+   .++.+++.+||+.||++|||++|++++
T Consensus       224 ----~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         224 ----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                11122   345677789999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-43  Score=356.38  Aligned_cols=254  Identities=23%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             hccccccCceEEEEEEecCCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g  419 (635)
                      .+.||+|+||+||+|+.++++.||||+++....   ..+.+.+|+.+++++ +|||||++++++..++..++++||+.++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~   85 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQD   85 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhh
Confidence            467999999999999999999999999965432   256789999999999 8999999999999999999999999887


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCC----
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVP----  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~----  495 (635)
                      .+..+...     ...+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+|++|||.+......    
T Consensus        86 ~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          86 LKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             HHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             hHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence            77777653     234999999999999999999999998   999999999999999999999999998665432    


Q ss_pred             CCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccccc----cch
Q 006677          496 ATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---EEWTAE----VFD  567 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~d  567 (635)
                      ....+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..+.  +.........   ..+...    ..+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhhhcc
Confidence            233578889999998754 468999999999999999999999976432111  1110100000   000000    000


Q ss_pred             hhhh------cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          568 VELM------RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       568 ~~~~------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....      ...........+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000      000011122456788889999999999999999863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-43  Score=356.96  Aligned_cols=256  Identities=20%  Similarity=0.291  Sum_probs=189.4

Q ss_pred             hccccccCceEEEEEEec-C-CCeEEEEEeecccC---ChHHHHHHHHHHHhhc--CCCceeceeEEEEe-----CCeeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-E-STTVVVKRLKEVVV---GKRDFEQQMEIVGRVG--QHPNVVPLRAYYYS-----KDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~  410 (635)
                      .+.||+|+||+||+|... + ++.||||+++....   ....+.+|+.+++.+.  +||||+++++++..     ....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            467999999999999974 3 45689999875432   2345778888877764  79999999999863     23678


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      ++|||++++++.......    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence            999999988776554432    234899999999999999999999998   9999999999999999999999999987


Q ss_pred             CCCCC---CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccccc
Q 006677          491 LMNVP---ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---REEWTAE  564 (635)
Q Consensus       491 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  564 (635)
                      .....   ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+..+.  +........   ...+...
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCchhccccc
Confidence            65432   355689999999999999999999999999999999999999986542211  111111000   0111100


Q ss_pred             cchh--hh-----h-cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 VFDV--EL-----M-RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 ~~d~--~~-----~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ....  ..     . ...........+.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000  00     0 000011122345677889999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-41  Score=346.34  Aligned_cols=252  Identities=17%  Similarity=0.164  Sum_probs=190.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... +++.||||++.... ...++.+|+++++++.+|++|+.+.+++...+..++||||+. |++
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l   89 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSL   89 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBH
T ss_pred             eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cch
Confidence            468999999999999964 57899999887543 345688999999999555556666677778888999999995 566


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEc---CCCCeEEeecCCCCCCCCC---
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLIN---QDLDGCISDFGLTPLMNVP---  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~DfGla~~~~~~---  495 (635)
                      .+.+...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.....   
T Consensus        90 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          90 EDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             hhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            6665432    234999999999999999999999998   99999999999985   4567999999999765432   


Q ss_pred             --------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChh-HHHHHHhhhccccccc
Q 006677          496 --------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLP-RWVQSVVREEWTAEVF  566 (635)
Q Consensus       496 --------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  566 (635)
                              ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+..... .+........      
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------  236 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------  236 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC------
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC------
Confidence                    2335899999999999999999999999999999999999999876544332211 1111111000      


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhcc
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQS  614 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~  614 (635)
                      ...  ...   ....++.+++.+||+.+|++||+++++.+.|+.+...
T Consensus       237 ~~~--~~~---~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 IEV--LCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHH--HTT---TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhH--hcc---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            000  001   1224567788899999999999999999999887543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-41  Score=341.48  Aligned_cols=254  Identities=17%  Similarity=0.195  Sum_probs=200.5

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCCh
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSL  421 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  421 (635)
                      .+.||+|+||+||+|... +++.||||++.... ....+.+|++++..+.+|+|++.+++++..+...++||||+ +++|
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l   87 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   87 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence            468999999999999965 57889999886543 34567889999999977799999999999999999999998 6799


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcC-----CCCeEEeecCCCCCCCCC-
Q 006677          422 STLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQ-----DLDGCISDFGLTPLMNVP-  495 (635)
Q Consensus       422 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~DfGla~~~~~~-  495 (635)
                      .++++...    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+..... 
T Consensus        88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99886533    34899999999999999999999998   999999999999974     578999999999765321 


Q ss_pred             ----------CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006677          496 ----------ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEV  565 (635)
Q Consensus       496 ----------~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  565 (635)
                                ....||+.|||||++.+..++.++|||||||++|||+||+.||.+........   ....+........ 
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~---~~~~i~~~~~~~~-  236 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYERIGEKKQSTP-  236 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH---HHHHHHHHHHHSC-
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH---HHHHHHhccCCCC-
Confidence                      23358999999999999999999999999999999999999998654433211   1111111110000 


Q ss_pred             chhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhhccC
Q 006677          566 FDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMIEEVRQSD  615 (635)
Q Consensus       566 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~~~~~~  615 (635)
                      . ..+  ....   ..++.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus       237 ~-~~l--~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         237 L-REL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             H-HHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             h-HHh--cCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0 000  0111   235677778999999999999999999999887544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=353.24  Aligned_cols=260  Identities=25%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~e~  415 (635)
                      .++||+|+||+||+|+.. +++.||||+++...   ....+|+++++++ +||||+++++++....      ..++||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            367999999999999975 58899999997643   2335799999999 9999999999986532      46899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCC
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNV  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~  494 (635)
                      ++++.+..+.+...  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_         101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             cCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            98764444332111  2345999999999999999999999998   99999999999999775 899999999976643


Q ss_pred             C---CCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH----------hhhc
Q 006677          495 P---ATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSV----------VREE  560 (635)
Q Consensus       495 ~---~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~  560 (635)
                      .   .+..+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.  +.......          ....
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         176 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCC-
T ss_pred             CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhhccc
Confidence            3   34467889999998765 5689999999999999999999999975542211  11111000          0000


Q ss_pred             cccccch----hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhcc
Q 006677          561 WTAEVFD----VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS  614 (635)
Q Consensus       561 ~~~~~~d----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~  614 (635)
                      .....+.    ..... .........+.+++.+|++.||++|||++|++++  ++++.+.
T Consensus       254 ~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             --CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            0000000    00000 0001122356778889999999999999999974  6666543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=347.57  Aligned_cols=253  Identities=20%  Similarity=0.249  Sum_probs=186.9

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccC---ChHHHHHHHHHHHhhcCCCceeceeEEEEe--------CCeeE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVV---GKRDFEQQMEIVGRVGQHPNVVPLRAYYYS--------KDEKL  410 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~  410 (635)
                      .+.||+|+||+||+|... +|+.||||++.....   ...++.+|+++++++ +||||+++++++..        +...+
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~   93 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY   93 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEE
Confidence            468999999999999974 688999999865432   346788999999999 99999999999865        34578


Q ss_pred             EEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          411 LVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       411 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      +||||+.++.+......     ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        94 iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          94 LVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             EEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence            99999988777665542     234889999999999999999999998   9999999999999999999999999996


Q ss_pred             CCCC--------CCCCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---
Q 006677          491 LMNV--------PATPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR---  558 (635)
Q Consensus       491 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  558 (635)
                      ....        .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+...   .......   
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~  242 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQLCGSIT  242 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH---HHHHhcCCCC
Confidence            5432        1234578999999998765 68999999999999999999999997543211110   0111110   


Q ss_pred             hccccccc--------hhhhhcccChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          559 EEWTAEVF--------DVELMRFQNIEEE------MVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       559 ~~~~~~~~--------d~~~~~~~~~~~~------~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ........        ...........+.      ...+++++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00000000        0000001111111      2346788999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=350.26  Aligned_cols=257  Identities=20%  Similarity=0.291  Sum_probs=187.6

Q ss_pred             hccccccCceEEEEEEe-cCCCeEEEEEeecccC--ChHHHHHHHHHHHhhcCCCceeceeEEEEeCC----eeEEEEEe
Q 006677          343 AEVLGKGSYGTAYKAVL-EESTTVVVKRLKEVVV--GKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD----EKLLVYDY  415 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~e~  415 (635)
                      .+.||+|+||+||+|.. .+++.||||++.....  ..+.+.+|+++++++ +||||+++++++....    ..+++++|
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~   91 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTH   91 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEe
Confidence            46899999999999986 4689999999975432  235688999999999 9999999999997653    23556667


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCC-
Q 006677          416 FASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNV-  494 (635)
Q Consensus       416 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~-  494 (635)
                      +.+|+|.+++...      .+++..++.++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+++.... 
T Consensus        92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            7899999999642      3899999999999999999999998   99999999999999999999999999875432 


Q ss_pred             ------CCCCCCCCcccCcccccC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc---c
Q 006677          495 ------PATPSRSAGYRAPEVIET-RKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTA---E  564 (635)
Q Consensus       495 ------~~~~~~~~~y~aPE~~~~-~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~  564 (635)
                            .....+++.|+|||++.. ..++.++||||+||++|||++|+.||......+..   .............   .
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHT
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhhh
Confidence                  223457889999999854 56789999999999999999999999765422111   0000000000000   0


Q ss_pred             cch-------hhhh--cccCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhh
Q 006677          565 VFD-------VELM--RFQNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVR  612 (635)
Q Consensus       565 ~~d-------~~~~--~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~  612 (635)
                      ...       ....  .....    ......+.+++.+|++.||++|||++|++++  ++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence            000       0000  00000    0111356788889999999999999999985  55443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-41  Score=347.54  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=187.8

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCC------eeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKD------EKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv  412 (635)
                      .+.||+|+||+||+|... +++.||||+++.....   .+.+.+|+++++.+ +|||||+++++|...+      ..++|
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv  101 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV  101 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEE
Confidence            467999999999999965 5889999999765433   34678899999999 9999999999997654      46999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+ +++|..+.+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+|+..
T Consensus       102 ~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_         102 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             Eecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence            9999 5678887753      23999999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCC-CCCCCCcccCcccccCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------hcccc-
Q 006677          493 NVPA-TPSRSAGYRAPEVIETR-KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVR------EEWTA-  563 (635)
Q Consensus       493 ~~~~-~~~~~~~y~aPE~~~~~-~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~-  563 (635)
                      .... ...+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.  +.........      ..... 
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHHhhhcch
Confidence            6543 35688999999998764 568999999999999999999999976532211  0000000000      00000 


Q ss_pred             ----------ccchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhhcc
Q 006677          564 ----------EVFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IEEVRQS  614 (635)
Q Consensus       564 ----------~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~~~~~  614 (635)
                                ......+.  .........+.+++.+|+..||++|||++|++++  ++++.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                      00000000  0001112345678889999999999999999985  7666533

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-40  Score=341.94  Aligned_cols=249  Identities=20%  Similarity=0.297  Sum_probs=189.1

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeC--CeeEEEEEeccCC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSK--DEKLLVYDYFASG  419 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~~g  419 (635)
                      .++||+|+||+||+|+.. +++.||||+++..  ..+.+.+|++++..+..||||+++++++...  ...++||||+.+|
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~  117 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  117 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence            578999999999999974 5788999998653  3577899999999996799999999999854  4689999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCC-CeEEeecCCCCCCCCC---
Q 006677          420 SLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDL-DGCISDFGLTPLMNVP---  495 (635)
Q Consensus       420 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~DfGla~~~~~~---  495 (635)
                      +|..+.+        .+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.....   
T Consensus       118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            9987653        3899999999999999999999998   99999999999998665 5899999999766543   


Q ss_pred             CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc----------cc-c
Q 006677          496 ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREE----------WT-A  563 (635)
Q Consensus       496 ~~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~-~  563 (635)
                      ....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......  +............          .. .
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccC
Confidence            2345788999999987654 7999999999999999999999997543211  0000011110000          00 0


Q ss_pred             ccch-----------hhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006677          564 EVFD-----------VELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVR  606 (635)
Q Consensus       564 ~~~d-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  606 (635)
                      ..+.           ..............++.+++.+|++.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000           000001111122345678888999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-41  Score=343.00  Aligned_cols=242  Identities=21%  Similarity=0.333  Sum_probs=192.4

Q ss_pred             hccccccCceEEEEEEec----CCCeEEEEEeeccc-----CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE----ESTTVVVKRLKEVV-----VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~  413 (635)
                      .+.||+|+||+||+|...    +|+.||||+++...     ...+.+.+|++++.++.+||||+++++++.+....++||
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            568999999999999852    47889999986532     235678899999999955589999999999999999999


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      ||+.+|+|.+++....     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999997543     3778899999999999999999998   9999999999999999999999999987654


Q ss_pred             CC-----CCCCCCCcccCcccccCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006677          494 VP-----ATPSRSAGYRAPEVIETR--KHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWTAEVF  566 (635)
Q Consensus       494 ~~-----~~~~~~~~y~aPE~~~~~--~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  566 (635)
                      ..     ....+++.|+|||.+.+.  .++.++||||+||++|||+||+.||......+..  ...........      
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~~------  252 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE------  252 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccCC------
Confidence            32     234578899999999754  4688999999999999999999999876544321  11111111111      


Q ss_pred             hhhhhcccChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006677          567 DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRP-----NMDEVVR  606 (635)
Q Consensus       567 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  606 (635)
                            ..........+.+++.+||+.||++||     |++|+++
T Consensus       253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  001112334667778899999999999     4788886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=334.59  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=193.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccC
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFAS  418 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~  418 (635)
                      .+.||+|+||+||+|+.. +++.||||+++.....   ...+.+|+.+++.+ +||||+++++++.+.+..++|+|++.+
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~   85 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccc
Confidence            367999999999999974 5788999999755432   46788999999998 999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCCCCC--
Q 006677          419 GSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMNVPA--  496 (635)
Q Consensus       419 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~~~~--  496 (635)
                      ++|..++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......  
T Consensus        86 ~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          86 DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             cccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            9998888643     34889999999999999999999998   9999999999999999999999999998765433  


Q ss_pred             --CCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---cc------
Q 006677          497 --TPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT---AE------  564 (635)
Q Consensus       497 --~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~------  564 (635)
                        ...+++.|+|||++.... ++.++||||+||++|||++|+.||....     +.......+......   ..      
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-----CHHHHHHHHHhhcCCCChhhhhhhhh
Confidence              223567799999987665 6899999999999999999999975322     122222222110000   00      


Q ss_pred             --------cchhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          565 --------VFDVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       565 --------~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                              ..................+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0000000000111222456778889999999999999999873

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=342.42  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=183.2

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC------CeeEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK------DEKLLV  412 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv  412 (635)
                      .++||+|+||+||+|... +|+.||||++......   ...+.+|+.+++++ +||||+++++++...      ...|+|
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv  100 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV  100 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEE
Confidence            368999999999999976 5899999999866443   24578999999999 899999999999643      578999


Q ss_pred             EEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCC
Q 006677          413 YDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLM  492 (635)
Q Consensus       413 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~  492 (635)
                      |||+.++.+ +.++       ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+++..
T Consensus       101 ~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1         101 MELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence            999976544 4443       13899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCC---CCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC----------------hhHHH
Q 006677          493 NVPA---TPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVD----------------LPRWV  553 (635)
Q Consensus       493 ~~~~---~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~----------------~~~~~  553 (635)
                      ....   ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+......                .....
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            4432   3457889999999999999999999999999999999999997543211000                00000


Q ss_pred             HHHhhhccccc------cchhhhh--cccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006677          554 QSVVREEWTAE------VFDVELM--RFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM  607 (635)
Q Consensus       554 ~~~~~~~~~~~------~~d~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  607 (635)
                      ...........      .+.....  ...........+.+++.+|++.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11111100000      0000000  000122345567889999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=345.61  Aligned_cols=254  Identities=20%  Similarity=0.296  Sum_probs=188.3

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCC---hHHHHHHHHHHHhhcCCCceeceeEEEEeC-----CeeEEEE
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVG---KRDFEQQMEIVGRVGQHPNVVPLRAYYYSK-----DEKLLVY  413 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~  413 (635)
                      .+.||+|+||+||+|... +++.||||+++....+   .+.+.+|+++++++ +|||+|++++++...     ...++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~  101 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV  101 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEE
Confidence            468999999999999964 6889999999765443   34678899999999 999999999998643     3446778


Q ss_pred             EeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeEEeecCCCCCCC
Q 006677          414 DYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGCISDFGLTPLMN  493 (635)
Q Consensus       414 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~~~~  493 (635)
                      +|+.+|+|.++++..      .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++....
T Consensus       102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence            888999999999632      3999999999999999999999998   9999999999999999999999999987664


Q ss_pred             CC-CCCCCCCcccCcccccCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc--ccc----
Q 006677          494 VP-ATPSRSAGYRAPEVIETRK-HSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVVREEWT--AEV----  565 (635)
Q Consensus       494 ~~-~~~~~~~~y~aPE~~~~~~-~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----  565 (635)
                      .. .+..+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.+.+....      ...+......  .+.    
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~------~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ------LKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCCCCHHHHTTC
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCChHHhhhc
Confidence            43 2445678899999876654 68899999999999999999999976432111      1111100000  000    


Q ss_pred             ch-------hhhhcc--cCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhh
Q 006677          566 FD-------VELMRF--QNI----EEEMVQMLQIGMACVAKVPDMRPNMDEVVR--MIEEVR  612 (635)
Q Consensus       566 ~d-------~~~~~~--~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~~~  612 (635)
                      ..       ......  ...    ......+.+++.+|++.||++|||++|+++  .+.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            00       000000  000    011234677888999999999999999998  455443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-36  Score=314.89  Aligned_cols=271  Identities=18%  Similarity=0.234  Sum_probs=191.7

Q ss_pred             hccccccCceEEEEEEec-CCCeEEEEEeecccCChHHHHHHHHHHHhhc----------CCCceeceeEEEEeC--Cee
Q 006677          343 AEVLGKGSYGTAYKAVLE-ESTTVVVKRLKEVVVGKRDFEQQMEIVGRVG----------QHPNVVPLRAYYYSK--DEK  409 (635)
Q Consensus       343 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~--~~~  409 (635)
                      .++||+|+||+||+|+.. +|+.||||+++......+.+.+|+.+++++.          .|+||+++++++...  ...
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~   97 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV   97 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence            578999999999999974 6889999999866544567788988888773          368899999888653  456


Q ss_pred             EEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeEEcCCCC------eE
Q 006677          410 LLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS-MGGPKFTHGNIKASNVLINQDLD------GC  482 (635)
Q Consensus       410 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~------~k  482 (635)
                      +++++++..+..........  ....+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.      ++
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence            67777765554333222111  23458899999999999999999998 66   999999999999987654      89


Q ss_pred             EeecCCCCCCCCC-CCCCCCCcccCcccccCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---h
Q 006677          483 ISDFGLTPLMNVP-ATPSRSAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPTRDDMVDLPRWVQSVV---R  558 (635)
Q Consensus       483 i~DfGla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~k~Dvws~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~  558 (635)
                      ++|||.+...... ....+|+.|+|||++....++.++||||+||+++||++|+.||...................   .
T Consensus       173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg  252 (362)
T d1q8ya_         173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  252 (362)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence            9999998765443 34568899999999999999999999999999999999999997654332222111111110   0


Q ss_pred             h---c------cccccc------------------hhhhhcccChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HH
Q 006677          559 E---E------WTAEVF------------------DVELMRFQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRM--IE  609 (635)
Q Consensus       559 ~---~------~~~~~~------------------d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~  609 (635)
                      .   .      .....+                  +...............+.+++.+|++.||++|||++|++++  ++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~  332 (362)
T d1q8ya_         253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK  332 (362)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred             CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccC
Confidence            0   0      000000                  00001222345667788999999999999999999999984  66


Q ss_pred             HhhccCCCC
Q 006677          610 EVRQSDSEN  618 (635)
Q Consensus       610 ~~~~~~~~~  618 (635)
                      +.....+..
T Consensus       333 ~~~~~~~~~  341 (362)
T d1q8ya_         333 DTLGMEEIR  341 (362)
T ss_dssp             TCTTCTTCC
T ss_pred             CCCCcccCC
Confidence            554444433

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.4e-32  Score=280.53  Aligned_cols=203  Identities=38%  Similarity=0.689  Sum_probs=150.0

Q ss_pred             CCChhHHHHHHHHHHhCCCCC-CCCCCCCCCCCC-CcceeEecCCC--CeEEEEEeCCCCccC--cCCcccccCCCCCcE
Q 006677           25 ADLNSDRQALLDFADAVPHLR-KLNWSSTNPICQ-SWVGINCTQDR--TRVFGLRLPGIGLVG--PIPNNTLGKLDALEV   98 (635)
Q Consensus        25 ~~~~~~~~al~~~~~~~~~~~-~~~w~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~g--~l~~~~l~~l~~L~~   98 (635)
                      .|.++|++||++||+++.+.. ..+|..+++||. +|.||+|+..+  .||+.|+|++++++|  .||+ .+++|++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~   80 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence            378999999999999996554 448988888774 69999998643  489999999999998  5787 7999999999


Q ss_pred             EEeec-CCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--------------------------CCcceeeccCcc
Q 006677           99 LSLRS-NVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--------------------------PQLVVLDLSFNS  151 (635)
Q Consensus        99 L~L~~-n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--------------------------~~L~~L~ls~N~  151 (635)
                      |+|++ |+++|.+|.+|++|++|++|+|++|+|.+..|..+.                          +.|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99997 899999999999999999999999999875554322                          233334444443


Q ss_pred             CcccCCc-----------------------------------------------------------------------hh
Q 006677          152 FTGNIPQ-----------------------------------------------------------------------SI  160 (635)
Q Consensus       152 l~g~~p~-----------------------------------------------------------------------~~  160 (635)
                      ++|.+|.                                                                       .+
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~  240 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV  240 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3333222                                                                       23


Q ss_pred             hccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcc--cCCCCCCCccCCCCCCCCCCCCC
Q 006677          161 QNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSS--LQKFPNSSFVGNSLLCGPPLKAC  228 (635)
Q Consensus       161 ~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~l~~~~l~~c  228 (635)
                      +.+++|+.|+|++|+|+|.+|..  .+++|++|+|++|+|+|.+|..  +.++..+.+.+|+.+||.|++.|
T Consensus       241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c  312 (313)
T d1ogqa_         241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred             ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence            33555666666667776666654  6677777777777777777742  33444455667777888777666

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=8.1e-23  Score=191.72  Aligned_cols=161  Identities=17%  Similarity=0.160  Sum_probs=117.5

Q ss_pred             hhccccccCceEEEEEEecCCCeEEEEEeecccCC-------------------hHHHHHHHHHHHhhcCCCceeceeEE
Q 006677          342 SAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVVVG-------------------KRDFEQQMEIVGRVGQHPNVVPLRAY  402 (635)
Q Consensus       342 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~~h~niv~l~~~  402 (635)
                      .+++||+|+||+||+|...+|+.||||+++.....                   ......|...+.++ .|.+++..+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~   82 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEe
Confidence            35789999999999999888999999987532110                   12244577788888 89999887765


Q ss_pred             EEeCCeeEEEEEeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeEEcCCCCeE
Q 006677          403 YYSKDEKLLVYDYFASGSLSTLLHGNRGAGRTPLDWETRVKILLGTARGVAHIHSMGGPKFTHGNIKASNVLINQDLDGC  482 (635)
Q Consensus       403 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  482 (635)
                      .    ..+++|||+++..+.++            +......++.|++.+++|||+.+   |+||||||+|||+++++ ++
T Consensus        83 ~----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~  142 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IW  142 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EE
T ss_pred             c----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EE
Confidence            3    34799999988655432            23345679999999999999998   99999999999999654 89


Q ss_pred             EeecCCCCCCCCCCCCCCCCcccCc------ccccCCCCCCccchhhHHHHH
Q 006677          483 ISDFGLTPLMNVPATPSRSAGYRAP------EVIETRKHSHKSDVYSFGVLL  528 (635)
Q Consensus       483 i~DfGla~~~~~~~~~~~~~~y~aP------E~~~~~~~~~k~Dvws~Gvvl  528 (635)
                      |+|||.|.....+..    ..|...      |. ..+.|+.++|+||..--+
T Consensus       143 liDFG~a~~~~~~~~----~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGW----REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTH----HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCc----HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999999876543221    112111      11 135678899999976544

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=5.3e-19  Score=165.49  Aligned_cols=124  Identities=27%  Similarity=0.332  Sum_probs=90.1

Q ss_pred             EEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCC-CCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCc
Q 006677           74 LRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL-PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN  150 (635)
Q Consensus        74 l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N  150 (635)
                      ++.++++|+ +||.+ +.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|.  ++|++|+|++|
T Consensus        13 v~Cs~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          13 VDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEeCCCcC-ccCCC-CC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            445556676 67763 32  57778888888887544 35567788888888888888877666665  67888888888


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCC
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGS  201 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~  201 (635)
                      +|++..|..|.++++|++|+|++|+|++..|..  .+++|++|+|++|.+...
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            888766777788888888888888888666653  677788888888877643

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.69  E-value=7.2e-17  Score=150.70  Aligned_cols=166  Identities=23%  Similarity=0.252  Sum_probs=137.1

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |+|..|.|++..         ..++.|+|++|.|++.++...|+++++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus         8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_           8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            379999997532         46899999999999888887899999999999999999988899999999999999999


Q ss_pred             CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCc
Q 006677          128 NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPS  204 (635)
Q Consensus       128 N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~  204 (635)
                      |+|++..|..|.  ++|++|+|++|+|++..|..|..+++|++|+|++|.+....+.. ....|+.+.+..|.++...|.
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence            999977777776  89999999999999888889999999999999999998654432 223466677888888888887


Q ss_pred             ccCCCCCCCccCCCCCCC
Q 006677          205 SLQKFPNSSFVGNSLLCG  222 (635)
Q Consensus       205 ~~~~l~~l~~~~n~~l~~  222 (635)
                      .+.++.-+....|..-|.
T Consensus       168 ~l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         168 KVRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             TTTTSBGGGSCTTTCCCC
T ss_pred             hhcCCEeeecCHhhCcCC
Confidence            776655334344444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=1.1e-16  Score=157.60  Aligned_cols=149  Identities=30%  Similarity=0.278  Sum_probs=98.8

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCc----
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQL----  142 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L----  142 (635)
                      ..++.|+|++|.|+ .+|++.|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|++++. |..+.  ++|    
T Consensus        31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~  106 (266)
T d1p9ag_          31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLD  106 (266)
T ss_dssp             TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEE
T ss_pred             cCCCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccccc-cccccccccccccc
Confidence            35788899999888 466667888888999999888888 565 367888888888888888743 33332  344    


Q ss_pred             --------------------ceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          143 --------------------VVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       143 --------------------~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                                          ++|++++|.+++..+..+..+++|+.|++++|+|++..+..  .+++|++|+|++|+|+ 
T Consensus       107 l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-  185 (266)
T d1p9ag_         107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-  185 (266)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred             ccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-
Confidence                                45555555555444455556666666666666666555442  5667777777777776 


Q ss_pred             CCCcccCCCCCCCc---cCCCCCCC
Q 006677          201 SIPSSLQKFPNSSF---VGNSLLCG  222 (635)
Q Consensus       201 ~~p~~~~~l~~l~~---~~n~~l~~  222 (635)
                      .+|+.+..+++|++   .+|+..|.
T Consensus       186 ~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         186 TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ccChhHCCCCCCCEEEecCCCCCCC
Confidence            66666655555443   35555543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=2.4e-16  Score=155.15  Aligned_cols=144  Identities=24%  Similarity=0.253  Sum_probs=107.8

Q ss_pred             EecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCC-CccCC
Q 006677           63 NCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPS-SFSPQ  141 (635)
Q Consensus        63 ~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~  141 (635)
                      .|.... ...+++.++++|+ .||+ .+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +|. ...++
T Consensus         5 ~~~~~~-~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~   78 (266)
T d1p9ag_           5 EVSKVA-SHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPV   78 (266)
T ss_dssp             EEECST-TCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTT
T ss_pred             EEcccC-CCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccc
Confidence            455432 3445688899999 6887 353  689999999999996556789999999999999999994 443 33489


Q ss_pred             cceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          142 LVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       142 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      |++|+|++|+|+ .++..+.++++|+.|++++|.+.+..+..  .+.+|+.|++++|.+++..+..+..++++.
T Consensus        79 L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~  151 (266)
T d1p9ag_          79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE  151 (266)
T ss_dssp             CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccch
Confidence            999999999999 56778899999999999999888654432  556666666666666644444444444444

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.62  E-value=1.1e-15  Score=153.46  Aligned_cols=157  Identities=25%  Similarity=0.335  Sum_probs=125.4

Q ss_pred             CCcceeEecCC---------CCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeecc
Q 006677           57 QSWVGINCTQD---------RTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQH  127 (635)
Q Consensus        57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~  127 (635)
                      |.|.+|.|++.         ...++.|+|++|+++ .+|+..|.++++|++|++++|.++...|..|.++++|+.|+|++
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            47999999753         245889999999998 78876899999999999999999977788999999999999999


Q ss_pred             CccCCcCCCCcc--------------------------------------------------------------------
Q 006677          128 NNFSGKIPSSFS--------------------------------------------------------------------  139 (635)
Q Consensus       128 N~l~g~~p~~~~--------------------------------------------------------------------  139 (635)
                      |+++ .+|..+.                                                                    
T Consensus        89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~  167 (305)
T d1xkua_          89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ  167 (305)
T ss_dssp             SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred             CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence            9987 3332210                                                                    


Q ss_pred             ---CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCc
Q 006677          140 ---PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSF  214 (635)
Q Consensus       140 ---~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~  214 (635)
                         ++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..  .+++|+.|+|++|+|+ .+|..|.++++|+.
T Consensus       168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~  246 (305)
T d1xkua_         168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV  246 (305)
T ss_dssp             SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCE
T ss_pred             ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCE
Confidence               23566677777777777777888888888888888888766654  6788888888888888 67878888887776


Q ss_pred             cC
Q 006677          215 VG  216 (635)
Q Consensus       215 ~~  216 (635)
                      ++
T Consensus       247 L~  248 (305)
T d1xkua_         247 VY  248 (305)
T ss_dssp             EE
T ss_pred             EE
Confidence            53

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.2e-15  Score=151.61  Aligned_cols=158  Identities=23%  Similarity=0.242  Sum_probs=117.6

Q ss_pred             CcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCC------------------
Q 006677           58 SWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGL------------------  110 (635)
Q Consensus        58 ~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~------------------  110 (635)
                      .|.-|.|++..         ..++.|+|++|+|+ .+|+..|.++++|++|++++|++.+..                  
T Consensus        12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             CCeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            35567886521         24678999999998 788778999999999999999886432                  


Q ss_pred             -------CCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCC
Q 006677          111 -------PSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIP  181 (635)
Q Consensus       111 -------p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p  181 (635)
                             |..|.++++|++|+|++|.+.+..+..+.  .+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence                   44566777888888888887755555554  677888888888876666777778888888888888876555


Q ss_pred             CC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          182 NF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       182 ~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      ..  .+++|+.+++++|++++..|..|.+++++..++
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence            43  677888888888888877777777777766553

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=1.7e-15  Score=150.53  Aligned_cols=153  Identities=24%  Similarity=0.294  Sum_probs=128.8

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .+..+....++....+++..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|.  ++|++|+|
T Consensus        81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l  160 (284)
T d1ozna_          81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (284)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence            3444444433333366666899999999999999999977778899999999999999999976666675  78999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCcc---CCCCCCC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFV---GNSLLCG  222 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~---~n~~l~~  222 (635)
                      ++|+|++..+..|.++++|+.|++++|++++..|..  .+++|++|++++|++++..|..|.++++|+++   +|+.-|.
T Consensus       161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            999999888899999999999999999999888865  88999999999999998888888887777655   6666554

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.55  E-value=1.7e-15  Score=152.60  Aligned_cols=119  Identities=30%  Similarity=0.544  Sum_probs=111.8

Q ss_pred             CCCcEEEeecCCCCC--CCCCCCCCCCcccEEeecc-CccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCc
Q 006677           94 DALEVLSLRSNVLTG--GLPSEITSLPSLRYLYLQH-NNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTG  168 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g--~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~  168 (635)
                      .+++.|||++|+++|  .+|++|++|++|++|+|++ |+++|.+|..|+  ++|++|+|++|+|++..|..+.++.+|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            468999999999998  5899999999999999997 899999999998  79999999999999999999999999999


Q ss_pred             EEcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCC
Q 006677          169 LSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNS  212 (635)
Q Consensus       169 L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l  212 (635)
                      +++++|.+.+.+|..  .+++|+.+++++|.++|.+|..+.++..+
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l  175 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL  175 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred             cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence            999999999999875  89999999999999999999999888775

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=2.1e-14  Score=123.22  Aligned_cols=100  Identities=27%  Similarity=0.318  Sum_probs=67.1

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCc
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFN  150 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N  150 (635)
                      .|+|++|+++ .++.  ++++++|++|+|++|+|+ .+|+.++.+++|+.|++++|.|++ +|. +.  ++|++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCC
Confidence            3677777776 5553  677777777777777777 567677777777777777777773 342 33  56777777777


Q ss_pred             cCcccC-CchhhccccCCcEEcCCCcccc
Q 006677          151 SFTGNI-PQSIQNLTQLTGLSLQSNNLSG  178 (635)
Q Consensus       151 ~l~g~~-p~~~~~l~~L~~L~l~~N~l~~  178 (635)
                      +|+... ...+..+++|+.|++++|.++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            776332 1456666777777777777663

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=8.8e-15  Score=125.59  Aligned_cols=99  Identities=32%  Similarity=0.368  Sum_probs=86.7

Q ss_pred             cEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCC
Q 006677           97 EVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSN  174 (635)
Q Consensus        97 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  174 (635)
                      ++|||++|+++ .+| .+.++++|++|+|++|+|+ .+|..+.  ++|+.|++++|+|++ +| .+.++++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            58999999999 666 5999999999999999999 6787776  899999999999994 55 5999999999999999


Q ss_pred             cccccCCC---CCCCCCcEEEeecccCcC
Q 006677          175 NLSGSIPN---FDIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       175 ~l~~~~p~---~~l~~L~~l~l~~N~l~g  200 (635)
                      +|+.....   ..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            99954332   278999999999999984

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1e-14  Score=131.56  Aligned_cols=124  Identities=19%  Similarity=0.127  Sum_probs=91.6

Q ss_pred             ccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCC
Q 006677           90 LGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT  167 (635)
Q Consensus        90 l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~  167 (635)
                      +.+..+|+.|||++|+|+ .||..+..+++|+.|||++|+++ .++. |.  ++|++|+|++|+|+...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCccccccccccc
Confidence            667778888888888888 56766677888888888888887 4432 33  7888888888888865555567788888


Q ss_pred             cEEcCCCcccccCC--C-CCCCCCcEEEeecccCcCCCCc----ccCCCCCCCccCC
Q 006677          168 GLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPS----SLQKFPNSSFVGN  217 (635)
Q Consensus       168 ~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~~~n  217 (635)
                      .|+|++|+|+....  . ..+++|++|++++|.++ ..|.    .+..+++|.+++.
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence            88888888874221  1 26788888888888887 3443    4677788877763

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.50  E-value=3.2e-14  Score=134.35  Aligned_cols=137  Identities=33%  Similarity=0.411  Sum_probs=105.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .+++.|+|++|.+++ +++  ++++++|++|+|++|+++ .+| .+.++++|+.|++++|.+.. ++. +.  +.|+.++
T Consensus        68 ~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~~-l~~l~~l~~l~  140 (210)
T d1h6ta2          68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-ING-LVHLPQLESLY  140 (210)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEE
T ss_pred             CCCCEEeCCCccccC-ccc--cccCcccccccccccccc-ccc-cccccccccccccccccccc-ccc-ccccccccccc
Confidence            357888888888874 553  678888888888888888 455 58888888888888888773 332 22  6788888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      +++|++++  +..+.++++|+.+++++|++++..+-..+++|+.|+|++|+++ .+| .|.++++|++++
T Consensus       141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~  206 (210)
T d1h6ta2         141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE  206 (210)
T ss_dssp             CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred             cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence            88888874  3457788889999999999886555458888999999999887 455 578888877654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.49  E-value=4.8e-14  Score=131.92  Aligned_cols=122  Identities=24%  Similarity=0.333  Sum_probs=56.3

Q ss_pred             EEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCc
Q 006677           71 VFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFN  150 (635)
Q Consensus        71 v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N  150 (635)
                      ++.|+|++|.+++ +++  ++++++|+.|++++|.+. .+| .+.++++|+.|++++|.+....+-.-.++|+.|++++|
T Consensus        64 L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n  138 (199)
T d2omxa2          64 LTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN  138 (199)
T ss_dssp             CCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred             cCcCccccccccC-ccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhhhh
Confidence            4445555554442 222  444555555555555444 232 24444555555555444443222111144555555555


Q ss_pred             cCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCc
Q 006677          151 SFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       151 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~  199 (635)
                      ++. .+| .+..+++|+.|++++|++++..+-..+++|+.|+|++|+++
T Consensus       139 ~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         139 TIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             hhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC
Confidence            554 222 34555555555555555554333234555555555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.45  E-value=1.3e-13  Score=128.81  Aligned_cols=139  Identities=24%  Similarity=0.307  Sum_probs=113.1

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .+++.|++++++++ .++  .+..+++|++|+|++|++++..|  +++|++|++|++++|.+....+-.-.+.|+.|+++
T Consensus        40 ~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~  114 (199)
T d2omxa2          40 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF  114 (199)
T ss_dssp             TTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             cCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccccccccccccccccccc
Confidence            36789999999998 565  38999999999999999996433  99999999999999999843322222899999999


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      +|.+...  ..+..+++|+.|++++|++....+-..+++|+.|++++|++++. + .+.++++|..++
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~  178 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLD  178 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEEE
Confidence            9999853  35889999999999999998543334889999999999999964 3 377777776654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=7e-14  Score=125.96  Aligned_cols=118  Identities=25%  Similarity=0.378  Sum_probs=99.6

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc-c--CCccee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-S--PQLVVL  145 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~--~~L~~L  145 (635)
                      .++..|+|++|+++ .|+. .+..+++|++|||++|+|+ .++ .|..+++|++|+|++|+++. +|..+ .  ++|++|
T Consensus        18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL   92 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred             CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC-CCccccccccccccc
Confidence            35788999999998 6775 6788999999999999999 665 59999999999999999995 55443 2  799999


Q ss_pred             eccCccCcccCC--chhhccccCCcEEcCCCcccccCCC------CCCCCCcEEEe
Q 006677          146 DLSFNSFTGNIP--QSIQNLTQLTGLSLQSNNLSGSIPN------FDIPKLRHLNL  193 (635)
Q Consensus       146 ~ls~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~~~~p~------~~l~~L~~l~l  193 (635)
                      +|++|+|+. ++  ..+..+++|++|++++|.++. .|.      ..+++|++||-
T Consensus        93 ~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          93 ILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             ECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred             eeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence            999999984 44  468899999999999999984 443      16899999873

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.39  E-value=4.7e-13  Score=126.17  Aligned_cols=136  Identities=22%  Similarity=0.311  Sum_probs=113.5

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeec
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDL  147 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~l  147 (635)
                      .++.|++++++++ .++.  +..+++|++|+|++|+|++ ++ .+++|++|++|++++|++++ +|. +.  ++|+.|++
T Consensus        47 ~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~-l~~l~~L~~L~l  119 (210)
T d1h6ta2          47 SIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSL  119 (210)
T ss_dssp             TCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEEC
T ss_pred             CccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccc-cccccccccccc
Confidence            5788999999998 4553  8899999999999999996 44 47899999999999999995 453 33  89999999


Q ss_pred             cCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCCccC
Q 006677          148 SFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVG  216 (635)
Q Consensus       148 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~  216 (635)
                      ++|.+. .+ ..+.++++|+.+++++|.+++..+...+++|+.+++++|++++ ++ .+.++++|..++
T Consensus       120 ~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~  184 (210)
T d1h6ta2         120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY  184 (210)
T ss_dssp             TTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred             cccccc-cc-ccccccccccccccccccccccccccccccccccccccccccc-cc-cccCCCCCCEEE
Confidence            999997 33 4689999999999999999975555589999999999999996 44 377777776543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=8.3e-13  Score=127.27  Aligned_cols=161  Identities=19%  Similarity=0.156  Sum_probs=102.8

Q ss_pred             CCcceeEecCCC---------CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCC-CC------------
Q 006677           57 QSWVGINCTQDR---------TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPS-EI------------  114 (635)
Q Consensus        57 ~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~-~~------------  114 (635)
                      |.+..|.|.+..         ..++.|+|++|.++ .+|+..|.++++|++|+|++|.+...+|. .|            
T Consensus         8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1           8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            378889997421         36889999999998 68877899999999999999988755442 23            


Q ss_pred             -------------CCCCcccEEeeccCccCCcCCCCcc----------------------------CCcceeeccCccCc
Q 006677          115 -------------TSLPSLRYLYLQHNNFSGKIPSSFS----------------------------PQLVVLDLSFNSFT  153 (635)
Q Consensus       115 -------------~~l~~L~~L~l~~N~l~g~~p~~~~----------------------------~~L~~L~ls~N~l~  153 (635)
                                   .++++|+.|++++|.+....+..+.                            ..++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence                         4456666666666666532221110                            13555666666666


Q ss_pred             ccCCchhhccccCCcE-EcCCCcccccCCCC--CCCCCcEEEeecccCcCCCCcccCCCCCCCccCCCC
Q 006677          154 GNIPQSIQNLTQLTGL-SLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKGSIPSSLQKFPNSSFVGNSL  219 (635)
Q Consensus       154 g~~p~~~~~l~~L~~L-~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~  219 (635)
                      . ++....+..+++.+ ++++|+|+...+..  .+++|+.|+|++|+|+...+..|.++++|+.+++..
T Consensus       167 ~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         167 E-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             E-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             c-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            3 33333344444333 45666666433322  678888888888888844445677777777766543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.36  E-value=4.5e-15  Score=138.69  Aligned_cols=129  Identities=24%  Similarity=0.316  Sum_probs=104.7

Q ss_pred             cCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceeeccCccCcccCCchhh
Q 006677           84 PIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQ  161 (635)
Q Consensus        84 ~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~  161 (635)
                      .+|. .++.|++|++|+|++|+|+ .++ .|.+|++|+.|+|++|.++ .+|..+.  ++|++|++++|+|+. + +.+.
T Consensus        39 ~l~~-sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~  112 (198)
T d1m9la_          39 KMDA-TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIE  112 (198)
T ss_dssp             CCHH-HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHH
T ss_pred             hhhh-HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccc
Confidence            3444 6899999999999999999 566 5999999999999999998 5665443  689999999999994 4 4589


Q ss_pred             ccccCCcEEcCCCcccccCC--C-CCCCCCcEEEeecccCcCCCCcc----------cCCCCCCCccCCC
Q 006677          162 NLTQLTGLSLQSNNLSGSIP--N-FDIPKLRHLNLSYNGLKGSIPSS----------LQKFPNSSFVGNS  218 (635)
Q Consensus       162 ~l~~L~~L~l~~N~l~~~~p--~-~~l~~L~~l~l~~N~l~g~~p~~----------~~~l~~l~~~~n~  218 (635)
                      ++++|+.|+|++|+|+....  . ..+++|+.|+|++|+++...+..          +.++++|..++..
T Consensus       113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD~~  182 (198)
T d1m9la_         113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGM  182 (198)
T ss_dssp             HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEESSG
T ss_pred             ccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeCCc
Confidence            99999999999999985322  2 37999999999999987544432          5678888877643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.35  E-value=9.4e-13  Score=125.68  Aligned_cols=138  Identities=23%  Similarity=0.332  Sum_probs=87.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc---------
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---------  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---------  139 (635)
                      .++..|+|++|.+++ +++  +..+++|++|++++|.++ .++ .+.++++|+.|++++|...+..+-...         
T Consensus        63 ~~L~~L~ls~n~i~~-~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~  137 (227)
T d1h6ua2          63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD  137 (227)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred             CCCcEeecCCceeec-ccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence            467788888888774 433  778888888888888877 454 577888888888888887754332211         


Q ss_pred             -------------CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCccc
Q 006677          140 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSL  206 (635)
Q Consensus       140 -------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~  206 (635)
                                   ++|++|++++|++++..  .++++++|+.|+|++|++++..+-..+++|++|+|++|++++ +| .+
T Consensus       138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~-i~-~l  213 (227)
T d1h6ua2         138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-VS-PL  213 (227)
T ss_dssp             SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB-CG-GG
T ss_pred             hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCC-Cc-cc
Confidence                         34666666666665322  256666666666666666643222356666666666666663 33 25


Q ss_pred             CCCCCCCcc
Q 006677          207 QKFPNSSFV  215 (635)
Q Consensus       207 ~~l~~l~~~  215 (635)
                      .++++|.++
T Consensus       214 ~~l~~L~~L  222 (227)
T d1h6ua2         214 ANTSNLFIV  222 (227)
T ss_dssp             TTCTTCCEE
T ss_pred             ccCCCCCEE
Confidence            555555443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.34  E-value=1.4e-12  Score=130.42  Aligned_cols=125  Identities=24%  Similarity=0.294  Sum_probs=89.1

Q ss_pred             EEEEEeCCCC--ccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           71 VFGLRLPGIG--LVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        71 v~~l~l~~~~--l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      ...++...+.  ..+..+ ..+..+++|+.+++++|+++ .+|..+  +++|+.|++++|..++..+..|.  +.+++|+
T Consensus       126 ~~~l~~~~n~~~~~~~~~-~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~  201 (305)
T d1xkua_         126 MIVVELGTNPLKSSGIEN-GAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG  201 (305)
T ss_dssp             CCEEECCSSCCCGGGBCT-TGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred             ccccccccccccccCCCc-cccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccc
Confidence            4445555543  222233 35777888888888888877 566543  57788888888888877776665  6778888


Q ss_pred             ccCccCcccCCchhhccccCCcEEcCCCcccccCCCC--CCCCCcEEEeecccCcC
Q 006677          147 LSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF--DIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       147 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~l~~L~~l~l~~N~l~g  200 (635)
                      +++|++++..+..+.++++|++|+|++|+|+. +|..  .+++|++|+|++|+|+.
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCC
T ss_pred             cccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCc
Confidence            88888887777778888888888888888874 4432  67888888888888874

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.31  E-value=1.8e-12  Score=133.52  Aligned_cols=137  Identities=26%  Similarity=0.345  Sum_probs=94.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc---------
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS---------  139 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~---------  139 (635)
                      .++..|++++|.++. ++  .+..+++|+.|++++|.+++..|  ++.+++|+.|++++|++++..|-.-.         
T Consensus       219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~  293 (384)
T d2omza2         219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN  293 (384)
T ss_dssp             TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccc
Confidence            467889999998884 44  58889999999999999986543  88899999999999998865432211         


Q ss_pred             -------------CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCCC-CCCCCcEEEeecccCcCCCCcc
Q 006677          140 -------------PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLKGSIPSS  205 (635)
Q Consensus       140 -------------~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~g~~p~~  205 (635)
                                   ++++.|++++|+|++..  .+..+++|++|+|++|+|++ ++.. .+++|++|+|++|++++..|  
T Consensus       294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--  368 (384)
T d2omza2         294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--  368 (384)
T ss_dssp             SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--
T ss_pred             ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--
Confidence                         45666667777666432  26666777777777776664 3322 56667777777777765443  


Q ss_pred             cCCCCCCCcc
Q 006677          206 LQKFPNSSFV  215 (635)
Q Consensus       206 ~~~l~~l~~~  215 (635)
                      +.++++|+.+
T Consensus       369 l~~l~~L~~L  378 (384)
T d2omza2         369 LANLTRITQL  378 (384)
T ss_dssp             GTTCTTCSEE
T ss_pred             hccCCCCCEe
Confidence            5555555443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=2.9e-12  Score=114.35  Aligned_cols=106  Identities=25%  Similarity=0.318  Sum_probs=61.4

Q ss_pred             CCCcceeEecCCCCeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecC-CCCCCCCCCCCCCCcccEEeeccCccCCcC
Q 006677           56 CQSWVGINCTQDRTRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSN-VLTGGLPSEITSLPSLRYLYLQHNNFSGKI  134 (635)
Q Consensus        56 c~~w~gv~C~~~~~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  134 (635)
                      |+.+.+|+|..            +++. .+|. .+..+++|+.|+|++| .|+..-+..|.+|++|+.|+|++|+|+...
T Consensus         7 c~~~~~l~c~~------------~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~   72 (156)
T d2ifga3           7 PHGSSGLRCTR------------DGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA   72 (156)
T ss_dssp             CSSSSCEECCS------------SCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred             cCCCCeEEecC------------CCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcc
Confidence            33566666653            3444 4555 5777888888888765 477433456888888888888877777443


Q ss_pred             CCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcc
Q 006677          135 PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNL  176 (635)
Q Consensus       135 p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  176 (635)
                      |..|.  ++|++|+|++|+|+ .+|.......+|+.|+|++|.+
T Consensus        73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             TTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred             cccccccccccceeccCCCCc-ccChhhhccccccccccCCCcc
Confidence            44343  45555555555555 3333222222344444444444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.24  E-value=1.3e-11  Score=110.02  Aligned_cols=108  Identities=17%  Similarity=0.087  Sum_probs=89.9

Q ss_pred             cCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC-ccCCcCCCCcc--CCcceeeccCccCcccCCchhhccccCC
Q 006677           91 GKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGKIPSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLT  167 (635)
Q Consensus        91 ~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~  167 (635)
                      +.....+.++.+++++. .+|..+.++++|+.|+|++| .++..-+..|.  ++|+.|+|++|+|+...|.+|..+++|+
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            34445567999999998 78889999999999999876 47754445565  7999999999999988888999999999


Q ss_pred             cEEcCCCcccccCCCC-CCCCCcEEEeecccCc
Q 006677          168 GLSLQSNNLSGSIPNF-DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       168 ~L~l~~N~l~~~~p~~-~l~~L~~l~l~~N~l~  199 (635)
                      +|+|++|+|+...+.. ...+|+.|+|++|.|.
T Consensus        84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ceeccCCCCcccChhhhccccccccccCCCccc
Confidence            9999999999544443 5558999999999885

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.23  E-value=8e-12  Score=128.58  Aligned_cols=141  Identities=30%  Similarity=0.355  Sum_probs=106.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeecc
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLS  148 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls  148 (635)
                      .....++++++.+++. ++  +...++|+.|++++|.++. +| .+..+++|+.|++++|.+++..|-...++|++|+++
T Consensus       197 ~~~~~l~l~~n~i~~~-~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~  271 (384)
T d2omza2         197 TNLESLIATNNQISDI-TP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG  271 (384)
T ss_dssp             TTCSEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred             cccceeeccCCccCCC-Cc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCcccccccCCEeecc
Confidence            3567899999999964 43  5678899999999999994 44 689999999999999999987665555899999999


Q ss_pred             CccCcccCC--------------------chhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccCC
Q 006677          149 FNSFTGNIP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQK  208 (635)
Q Consensus       149 ~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~  208 (635)
                      +|++++..+                    ..+..+++|+.|++++|+|++..+-..+++|+.|+|++|++++ +| .+.+
T Consensus       272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~  349 (384)
T d2omza2         272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLAN  349 (384)
T ss_dssp             SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred             CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence            999886432                    2355566777777777777765443467777888888877774 44 5677


Q ss_pred             CCCCCccC
Q 006677          209 FPNSSFVG  216 (635)
Q Consensus       209 l~~l~~~~  216 (635)
                      +++|++++
T Consensus       350 l~~L~~L~  357 (384)
T d2omza2         350 LTNINWLS  357 (384)
T ss_dssp             CTTCCEEE
T ss_pred             CCCCCEEE
Confidence            77766553

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.23  E-value=1.4e-11  Score=117.25  Aligned_cols=140  Identities=26%  Similarity=0.323  Sum_probs=111.0

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc-cCCcceeec
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF-SPQLVVLDL  147 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~~L~~L~l  147 (635)
                      ..++.|++.+++++ .++  .+.++++|++|+|++|++++..|  +.++++|++|++++|.++ .++.-. .++|+.|++
T Consensus        41 ~~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l  114 (227)
T d1h6ua2          41 DGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDL  114 (227)
T ss_dssp             HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCCC-cch--hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cccccccccccccccc
Confidence            35889999999998 575  39999999999999999996544  999999999999999998 444321 278999999


Q ss_pred             cCccCcccCC--------------------chhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCcCCCCcccC
Q 006677          148 SFNSFTGNIP--------------------QSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQ  207 (635)
Q Consensus       148 s~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~  207 (635)
                      ++|+..+..+                    ..+.++++|+.|++++|.+++..+-..+++|+.|+|++|++++ +| .+.
T Consensus       115 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~  192 (227)
T d1h6ua2         115 TSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-IS-PLA  192 (227)
T ss_dssp             TTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGG
T ss_pred             ccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchhhcccccceecccCCCccCC-Ch-hhc
Confidence            9988764322                    2366778899999999988865555588999999999999985 44 367


Q ss_pred             CCCCCCccC
Q 006677          208 KFPNSSFVG  216 (635)
Q Consensus       208 ~l~~l~~~~  216 (635)
                      ++++|..++
T Consensus       193 ~l~~L~~L~  201 (227)
T d1h6ua2         193 SLPNLIEVH  201 (227)
T ss_dssp             GCTTCCEEE
T ss_pred             CCCCCCEEE
Confidence            777776654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.09  E-value=5.1e-13  Score=124.50  Aligned_cols=123  Identities=22%  Similarity=0.278  Sum_probs=100.4

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCcc--CCcceee
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFS--PQLVVLD  146 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~--~~L~~L~  146 (635)
                      .++..|+|++|+++ .++.  |..+++|++|+|++|.|+ .+|..+..+++|+.|++++|+++. ++. +.  ++|++|+
T Consensus        48 ~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~  121 (198)
T d1m9la_          48 KACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLY  121 (198)
T ss_dssp             TTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHH-HHHHHHSSEEE
T ss_pred             cccceeECcccCCC-Cccc--ccCCccccChhhcccccc-cccccccccccccccccccccccc-ccc-ccccccccccc
Confidence            46889999999998 6763  999999999999999998 678666677899999999999995 332 33  7899999


Q ss_pred             ccCccCcccCC-chhhccccCCcEEcCCCcccccCCCC------------CCCCCcEEEeecccCc
Q 006677          147 LSFNSFTGNIP-QSIQNLTQLTGLSLQSNNLSGSIPNF------------DIPKLRHLNLSYNGLK  199 (635)
Q Consensus       147 ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~------------~l~~L~~l~l~~N~l~  199 (635)
                      |++|+|+.... ..+..+++|+.|+|++|.+....+..            .+++|+.||  +..++
T Consensus       122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            99999984322 46899999999999999998655542            478899886  44443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.95  E-value=8.5e-10  Score=105.59  Aligned_cols=134  Identities=16%  Similarity=0.123  Sum_probs=101.6

Q ss_pred             EEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCC-cc--CCcceeecc-
Q 006677           73 GLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSS-FS--PQLVVLDLS-  148 (635)
Q Consensus        73 ~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~--~~L~~L~ls-  148 (635)
                      .++.++.+++ .+|++ +  .+++++|+|++|+|+...+..|.++++|++|+|++|.+...+|.. |.  +.+++|++. 
T Consensus        12 ~i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             EEEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             EEEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            4667788888 89874 4  258999999999999444457999999999999999998777654 33  678888876 


Q ss_pred             CccCcccCCchhhccccCCcEEcCCCcccccCCCC---CCCCCcEEEeecccCcCCCCcccCCCC
Q 006677          149 FNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNF---DIPKLRHLNLSYNGLKGSIPSSLQKFP  210 (635)
Q Consensus       149 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~l~~L~~l~l~~N~l~g~~p~~~~~l~  210 (635)
                      .|++....+..|.++++|+.|++++|++....+..   .+..|..+..+++.+...-+..+.+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~  152 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  152 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence            57888888888999999999999999998544433   345555556667777644445554443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.95  E-value=2.1e-09  Score=108.47  Aligned_cols=115  Identities=29%  Similarity=0.411  Sum_probs=92.1

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccC
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSF  149 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~  149 (635)
                      +++.|+|++++|+ .+|+ .   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++. +.+.|++|+|++
T Consensus        39 ~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp~~L~~L~L~~  107 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LPPLLEYLGVSN  107 (353)
T ss_dssp             TCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CCTTCCEEECCS
T ss_pred             CCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hccccccccccc
Confidence            4678999999998 6886 3   578999999999999 889764   57889999999998 5553 557899999999


Q ss_pred             ccCcccCCchhhccccCCcEEcCCCcccccCCCCCCCCCcEEEeecccCc
Q 006677          150 NSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPNFDIPKLRHLNLSYNGLK  199 (635)
Q Consensus       150 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~L~~l~l~~N~l~  199 (635)
                      |+++ .+|. ++++++|+.|++++|.+......  ...+..+.+.++...
T Consensus       108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred             cccc-cccc-hhhhccceeeccccccccccccc--cccccchhhcccccc
Confidence            9999 6664 68899999999999999854432  445666666665544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.87  E-value=4.9e-09  Score=105.62  Aligned_cols=109  Identities=20%  Similarity=0.215  Sum_probs=86.9

Q ss_pred             CCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCccCCcceeeccCccCcccCCchhhccccCCcEEcCC
Q 006677           94 DALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSFSPQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQS  173 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  173 (635)
                      .+|++|||++|+++ .+|+.   +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.-   .+.|++|+|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN  107 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence            46899999999999 78964   578999999999999 788765 68999999999998 55532   24699999999


Q ss_pred             CcccccCCCCCCCCCcEEEeecccCcCCCCcccCCCCCCC
Q 006677          174 NNLSGSIPNFDIPKLRHLNLSYNGLKGSIPSSLQKFPNSS  213 (635)
Q Consensus       174 N~l~~~~p~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~  213 (635)
                      |.|........+++|+.|++++|.++ ..|..+..+..+.
T Consensus       108 n~l~~lp~~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~  146 (353)
T d1jl5a_         108 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA  146 (353)
T ss_dssp             SCCSSCCCCTTCTTCCEEECCSSCCS-CCCCCCTTCCEEE
T ss_pred             cccccccchhhhccceeecccccccc-ccccccccccchh
Confidence            99995433348999999999999998 4455555554443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.68  E-value=4.1e-10  Score=110.78  Aligned_cols=148  Identities=23%  Similarity=0.262  Sum_probs=89.9

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCCCCCCCCCCCCcccEEeeccC-ccCCcCCCCc---cCCcce
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHN-NFSGKIPSSF---SPQLVV  144 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~---~~~L~~  144 (635)
                      .++..|+|+++.+++......+.++++|++|+|++|.+++..+..++++++|++|+|+++ .++...-..+   .++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            467888888887765433336788888999999988888777778888888999998884 5542100011   167888


Q ss_pred             eeccCc-cCcc-cCCchhhc-cccCCcEEcCCC--ccccc-CCCC--CCCCCcEEEeecc-cCcCCCCcccCCCCCCCcc
Q 006677          145 LDLSFN-SFTG-NIPQSIQN-LTQLTGLSLQSN--NLSGS-IPNF--DIPKLRHLNLSYN-GLKGSIPSSLQKFPNSSFV  215 (635)
Q Consensus       145 L~ls~N-~l~g-~~p~~~~~-l~~L~~L~l~~N--~l~~~-~p~~--~l~~L~~l~l~~N-~l~g~~p~~~~~l~~l~~~  215 (635)
                      |+|+++ +++. .+...+.. .++|+.|++++.  .++.. +...  .+++|++|+|++| .+++.....+.++++|+++
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence            888774 4432 12223333 356677776643  23211 1111  4566677777664 3555555556666665554


Q ss_pred             C
Q 006677          216 G  216 (635)
Q Consensus       216 ~  216 (635)
                      +
T Consensus       206 ~  206 (284)
T d2astb2         206 S  206 (284)
T ss_dssp             E
T ss_pred             E
Confidence            3

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=5.7e-09  Score=93.09  Aligned_cols=119  Identities=19%  Similarity=0.162  Sum_probs=69.6

Q ss_pred             CcEEEeecCCCCCCCCCCCCCCCcccEEeeccCccCCcCCCCc--cCCcceeeccCccCccc--CCchhhccccCCcEEc
Q 006677           96 LEVLSLRSNVLTGGLPSEITSLPSLRYLYLQHNNFSGKIPSSF--SPQLVVLDLSFNSFTGN--IPQSIQNLTQLTGLSL  171 (635)
Q Consensus        96 L~~L~L~~n~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~--~~~L~~L~ls~N~l~g~--~p~~~~~l~~L~~L~l  171 (635)
                      .+.||++++...    ..+..+..+..|++.+|... .++..+  .+.|++|+|++|+|+..  ++..+..+++|+.|+|
T Consensus        24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L   98 (162)
T d1koha1          24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL   98 (162)
T ss_dssp             SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred             hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence            344555544322    23444455555555544433 222111  15677777777777743  3455677888888888


Q ss_pred             CCCcccccCCC--CCCCCCcEEEeecccCcCCCCc-------ccCCCCCCCccCCCC
Q 006677          172 QSNNLSGSIPN--FDIPKLRHLNLSYNGLKGSIPS-------SLQKFPNSSFVGNSL  219 (635)
Q Consensus       172 ~~N~l~~~~p~--~~l~~L~~l~l~~N~l~g~~p~-------~~~~l~~l~~~~n~~  219 (635)
                      ++|.|+...+.  ....+|+.|+|++|.++.....       .+..+|+|..+++..
T Consensus        99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LDg~~  155 (162)
T d1koha1          99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE  155 (162)
T ss_dssp             TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEETTEE
T ss_pred             ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEECcCC
Confidence            88888743221  1445678888888888765543       255677887776543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=1.2e-08  Score=99.98  Aligned_cols=147  Identities=24%  Similarity=0.284  Sum_probs=103.3

Q ss_pred             CeEEEEEeCCCCccCcCCcccccCCCCCcEEEeec-CCCCCC-CCCCCCCCCcccEEeeccC-ccCCc-CCC---CccCC
Q 006677           69 TRVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRS-NVLTGG-LPSEITSLPSLRYLYLQHN-NFSGK-IPS---SFSPQ  141 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~-n~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~-~p~---~~~~~  141 (635)
                      .+++.|+|+++.+++..+. .++.+++|++|+|++ +.++.. +..-+.++++|++|+|+++ .++.. +..   ...+.
T Consensus        71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~  149 (284)
T d2astb2          71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET  149 (284)
T ss_dssp             CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred             CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence            4688999999998876666 689999999999999 466621 2222457899999999985 44421 111   11267


Q ss_pred             cceeeccCc--cCccc-CCchhhccccCCcEEcCCC-cccccCCCC--CCCCCcEEEeec-ccCcCCCCcccCCCCCCCc
Q 006677          142 LVVLDLSFN--SFTGN-IPQSIQNLTQLTGLSLQSN-NLSGSIPNF--DIPKLRHLNLSY-NGLKGSIPSSLQKFPNSSF  214 (635)
Q Consensus       142 L~~L~ls~N--~l~g~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~--~l~~L~~l~l~~-N~l~g~~p~~~~~l~~l~~  214 (635)
                      |+.|+++++  .++.. +..-+.++++|++|+|++| .+++.....  .+++|++|+|++ +.++......++++++|..
T Consensus       150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~  229 (284)
T d2astb2         150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT  229 (284)
T ss_dssp             CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence            999999864  45432 3334567889999999875 466443332  788999999998 4677666667777888777


Q ss_pred             cC
Q 006677          215 VG  216 (635)
Q Consensus       215 ~~  216 (635)
                      ++
T Consensus       230 L~  231 (284)
T d2astb2         230 LQ  231 (284)
T ss_dssp             EE
T ss_pred             Ee
Confidence            65

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.29  E-value=2.5e-06  Score=81.69  Aligned_cols=129  Identities=17%  Similarity=0.140  Sum_probs=91.6

Q ss_pred             ceEEEEEEecCCCeEEEEEeeccc-CChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEeccCCChhhhccCCC
Q 006677          351 YGTAYKAVLEESTTVVVKRLKEVV-VGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYFASGSLSTLLHGNR  429 (635)
Q Consensus       351 fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  429 (635)
                      .+.||+... +++.+++|+..... .....+.+|...+..+..+--+.+++++...++..++||+++++..+.+..... 
T Consensus        27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-  104 (263)
T d1j7la_          27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-  104 (263)
T ss_dssp             SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred             CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence            468999874 45667888876543 234567889999888866655778888888888999999999998886654211 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 006677          430 GAGRTPLDWETRVKILLGTARGVAHIHSMG--------------------------------------------------  459 (635)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------------  459 (635)
                            .   ....++.++++.++.||+..                                                  
T Consensus       105 ------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (263)
T d1j7la_         105 ------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             ------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred             ------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence                  1   12334555556666666420                                                  


Q ss_pred             ------CCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          460 ------GPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       460 ------~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                            .+.++|+|+.+.||++++++.+.|+||+.+.
T Consensus       176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                  1127899999999999987777799998764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.26  E-value=1.8e-08  Score=89.79  Aligned_cols=78  Identities=28%  Similarity=0.321  Sum_probs=41.6

Q ss_pred             CCCCcccEEeeccCccCCcC--CCCcc--CCcceeeccCccCcccCCchhhccccCCcEEcCCCcccccCCC--------
Q 006677          115 TSLPSLRYLYLQHNNFSGKI--PSSFS--PQLVVLDLSFNSFTGNIPQSIQNLTQLTGLSLQSNNLSGSIPN--------  182 (635)
Q Consensus       115 ~~l~~L~~L~l~~N~l~g~~--p~~~~--~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~--------  182 (635)
                      .++++|++|+|++|+++..-  +..+.  ++|+.|+|++|+|+..-+-.+....+|+.|+|++|.++.....        
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence            44556666666666665321  11111  5566666666666632222333344567777777777655442        


Q ss_pred             -CCCCCCcEEE
Q 006677          183 -FDIPKLRHLN  192 (635)
Q Consensus       183 -~~l~~L~~l~  192 (635)
                       ..+++|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
Confidence             1466777665

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=3e-08  Score=103.36  Aligned_cols=108  Identities=22%  Similarity=0.262  Sum_probs=63.4

Q ss_pred             eEEEEEeCCCCccCcCCcccccCCCCCcEEEeecCCCCC----CCCCCCCCCCcccEEeeccCccCC----cCCCCcc--
Q 006677           70 RVFGLRLPGIGLVGPIPNNTLGKLDALEVLSLRSNVLTG----GLPSEITSLPSLRYLYLQHNNFSG----KIPSSFS--  139 (635)
Q Consensus        70 ~v~~l~l~~~~l~g~l~~~~l~~l~~L~~L~L~~n~l~g----~~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~--  139 (635)
                      +++.||++++++++.-=...+..+++|++|+|++|+++.    .+...+..+++|+.|||++|.++.    .+...+.  
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            567777777777642111135556777777777777662    234445667777777777777642    1122221  


Q ss_pred             -CCcceeeccCccCccc----CCchhhccccCCcEEcCCCccc
Q 006677          140 -PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       140 -~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                       .+|++|+|++|+++..    ++..+..+++|++|+|++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence             3567777777776533    3445555666666666666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.20  E-value=2.6e-08  Score=100.45  Aligned_cols=132  Identities=23%  Similarity=0.258  Sum_probs=81.2

Q ss_pred             CeEEEEEeCCCCcc--------CcCCc----ccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCC
Q 006677           69 TRVFGLRLPGIGLV--------GPIPN----NTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSG  132 (635)
Q Consensus        69 ~~v~~l~l~~~~l~--------g~l~~----~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g  132 (635)
                      .+++.|+|++|.+.        ..+..    ........|+.|++++|.++..    +...+..+++|+.|+|++|+++.
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  200 (344)
T d2ca6a1         121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  200 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence            35777888887642        00100    0123566788888888877622    22334556778888888887763


Q ss_pred             c-----CCCCcc--CCcceeeccCccCccc----CCchhhccccCCcEEcCCCcccccC--------CCCCCCCCcEEEe
Q 006677          133 K-----IPSSFS--PQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGSI--------PNFDIPKLRHLNL  193 (635)
Q Consensus       133 ~-----~p~~~~--~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--------p~~~l~~L~~l~l  193 (635)
                      .     +...+.  ++|+.|+|++|.|+..    +...+..+++|++|+|++|.|++.-        .......|+.|+|
T Consensus       201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l  280 (344)
T d2ca6a1         201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  280 (344)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence            1     122222  6788888888887633    4455667778888888888876421        1113456888888


Q ss_pred             ecccCcC
Q 006677          194 SYNGLKG  200 (635)
Q Consensus       194 ~~N~l~g  200 (635)
                      ++|+++.
T Consensus       281 s~N~i~~  287 (344)
T d2ca6a1         281 QYNEIEL  287 (344)
T ss_dssp             CSSCCBH
T ss_pred             CCCcCCh
Confidence            8887753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.05  E-value=9e-06  Score=77.26  Aligned_cols=130  Identities=11%  Similarity=0.079  Sum_probs=86.1

Q ss_pred             ccccCc-eEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCC-CceeceeEEEEeCCeeEEEEEeccCCChhh
Q 006677          346 LGKGSY-GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQH-PNVVPLRAYYYSKDEKLLVYDYFASGSLST  423 (635)
Q Consensus       346 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  423 (635)
                      +..|.. +.||+....++..+++|......  ..++..|.+.++.+..+ -.+.+++++..+++..++||+|+++.++.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            445543 68999998878888888765432  34577888888777433 236677888888888899999998866543


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006677          424 LLHGNRGAGRTPLDWETRVKILLGTARGVAHIHS----------------------------------------------  457 (635)
Q Consensus       424 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~----------------------------------------------  457 (635)
                      ..          ...   ...+.+++..|+-||+                                              
T Consensus        96 ~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          96 SH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             SC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            21          111   1112233333333332                                              


Q ss_pred             -----cC----CCCceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          458 -----MG----GPKFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       458 -----~~----~~~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                           ..    .+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 11    1227999999999999988777899998764

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.97  E-value=1.5e-07  Score=94.72  Aligned_cols=147  Identities=18%  Similarity=0.206  Sum_probs=92.8

Q ss_pred             CeEEEEEeCCCCccCc---CCc------ccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcCC
Q 006677           69 TRVFGLRLPGIGLVGP---IPN------NTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIP  135 (635)
Q Consensus        69 ~~v~~l~l~~~~l~g~---l~~------~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p  135 (635)
                      .++..|++.++.....   .+.      ..+...++|+.|+|++|.++..    +...+..+++|+.|+|++|.+...-.
T Consensus        59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~  138 (344)
T d2ca6a1          59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG  138 (344)
T ss_dssp             TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred             CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence            4677788877654311   111      1356678889999998888753    33344567888999998888752111


Q ss_pred             CCc---------------cCCcceeeccCccCccc----CCchhhccccCCcEEcCCCccccc-----CCCC--CCCCCc
Q 006677          136 SSF---------------SPQLVVLDLSFNSFTGN----IPQSIQNLTQLTGLSLQSNNLSGS-----IPNF--DIPKLR  189 (635)
Q Consensus       136 ~~~---------------~~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~--~l~~L~  189 (635)
                      ..+               .+.|+.|++++|+++..    +...+..++.|+.|+|++|+|+..     +...  ..++|+
T Consensus       139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~  218 (344)
T d2ca6a1         139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK  218 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred             ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence            111               14688888888887632    334466778888888888887632     1111  567788


Q ss_pred             EEEeecccCcCC----CCcccCCCCCCCcc
Q 006677          190 HLNLSYNGLKGS----IPSSLQKFPNSSFV  215 (635)
Q Consensus       190 ~l~l~~N~l~g~----~p~~~~~l~~l~~~  215 (635)
                      .|+|++|.++..    +...+..+++|+.+
T Consensus       219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L  248 (344)
T d2ca6a1         219 VLDLQDNTFTHLGSSALAIALKSWPNLREL  248 (344)
T ss_dssp             EEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred             ccccccccccccccccccccccccccchhh
Confidence            888888887532    33445556666544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.96  E-value=1.2e-07  Score=98.53  Aligned_cols=107  Identities=24%  Similarity=0.347  Sum_probs=78.1

Q ss_pred             CCCcEEEeecCCCCCC-CCCCCCCCCcccEEeeccCccCC----cCCCCcc--CCcceeeccCccCccc----CCchhh-
Q 006677           94 DALEVLSLRSNVLTGG-LPSEITSLPSLRYLYLQHNNFSG----KIPSSFS--PQLVVLDLSFNSFTGN----IPQSIQ-  161 (635)
Q Consensus        94 ~~L~~L~L~~n~l~g~-~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~--~~L~~L~ls~N~l~g~----~p~~~~-  161 (635)
                      .+|+.||++.|++++. +..-+..+++|++|+|++|.++-    .++..+.  ++|++|||++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999853 13346678999999999999872    2222222  7899999999999732    222222 


Q ss_pred             ccccCCcEEcCCCccccc----CCC--CCCCCCcEEEeecccCcC
Q 006677          162 NLTQLTGLSLQSNNLSGS----IPN--FDIPKLRHLNLSYNGLKG  200 (635)
Q Consensus       162 ~l~~L~~L~l~~N~l~~~----~p~--~~l~~L~~l~l~~N~l~g  200 (635)
                      ...+|++|+|++|+++..    ++.  ..+++|++|+|++|.++.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            235799999999999753    222  267899999999999873

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.54  E-value=5.2e-06  Score=73.64  Aligned_cols=107  Identities=13%  Similarity=0.115  Sum_probs=59.8

Q ss_pred             cCCCCCcEEEeecC-CCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc------CCcceeeccCccCccc----
Q 006677           91 GKLDALEVLSLRSN-VLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN----  155 (635)
Q Consensus        91 ~~l~~L~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~----  155 (635)
                      .+.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.+...-...+.      +.|++|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            34566777777753 45421    222355566777777777776632222222      5677777777777643    


Q ss_pred             CCchhhccccCCcEEcCCCcccccCC-------CC--CCCCCcEEEeeccc
Q 006677          156 IPQSIQNLTQLTGLSLQSNNLSGSIP-------NF--DIPKLRHLNLSYNG  197 (635)
Q Consensus       156 ~p~~~~~l~~L~~L~l~~N~l~~~~p-------~~--~l~~L~~l~l~~N~  197 (635)
                      +-..+...++|++|+|++|.+...-.       ..  .-++|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            22344555667777777776542110       00  24566777766553

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.46  E-value=0.00025  Score=71.71  Aligned_cols=75  Identities=12%  Similarity=0.140  Sum_probs=48.4

Q ss_pred             ccccccCceEEEEEEecC-CCeEEEEEeecc--------cCChHHHHHHHHHHHhhcCC--CceeceeEEEEeCCeeEEE
Q 006677          344 EVLGKGSYGTAYKAVLEE-STTVVVKRLKEV--------VVGKRDFEQQMEIVGRVGQH--PNVVPLRAYYYSKDEKLLV  412 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--------~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lv  412 (635)
                      +.||.|....||+....+ ++.++||.-...        .....+...|.+.+..+..+  ..+++++.  .+.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence            458999999999998654 567888864321        11223456688888877544  23444544  356677899


Q ss_pred             EEeccCCC
Q 006677          413 YDYFASGS  420 (635)
Q Consensus       413 ~e~~~~g~  420 (635)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.21  E-value=1.4e-05  Score=70.69  Aligned_cols=108  Identities=14%  Similarity=0.183  Sum_probs=74.8

Q ss_pred             CeEEEEEeCCCC-ccCc----CCcccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc
Q 006677           69 TRVFGLRLPGIG-LVGP----IPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS  139 (635)
Q Consensus        69 ~~v~~l~l~~~~-l~g~----l~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  139 (635)
                      ..++.|+|++++ +...    +-. .+...++|+.|+|++|.+...    +-..+...+.|+.|+|++|.++..--..+.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            568889998743 4321    222 467778899999999998732    223345568899999999998843222222


Q ss_pred             ------CCcceeeccCccCccc-------CCchhhccccCCcEEcCCCccc
Q 006677          140 ------PQLVVLDLSFNSFTGN-------IPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       140 ------~~L~~L~ls~N~l~g~-------~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                            ++|++|+|++|++...       +...+...++|+.|+++.+...
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence                  6799999999976521       4455667889999999877643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.08  E-value=0.0022  Score=62.68  Aligned_cols=68  Identities=10%  Similarity=0.044  Sum_probs=48.4

Q ss_pred             eEEEEEEecCCCeEEEEEeecccCChHHHHHHHHHHHhhcCCC-ceecee-----EEEEeCCeeEEEEEeccCC
Q 006677          352 GTAYKAVLEESTTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHP-NVVPLR-----AYYYSKDEKLLVYDYFASG  419 (635)
Q Consensus       352 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~-----~~~~~~~~~~lv~e~~~~g  419 (635)
                      -.||++..++|+.+++|+......+.+++..|...+..|..+. -++..+     .........+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            4799999999999999998776667788899999888875331 111111     1223456678899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.002  Score=64.81  Aligned_cols=73  Identities=12%  Similarity=0.076  Sum_probs=50.4

Q ss_pred             ccccccCceEEEEEEecCC--------CeEEEEEeecccCChHHHHHHHHHHHhhcCCCceeceeEEEEeCCeeEEEEEe
Q 006677          344 EVLGKGSYGTAYKAVLEES--------TTVVVKRLKEVVVGKRDFEQQMEIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY  415 (635)
Q Consensus       344 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~  415 (635)
                      +.|+-|-.-.+|++...++        ..|++++.- .....-+..+|..+++.+..+.-..++++++.    -.+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence            4577788889999987543        345555544 33345567788999988876765667777763    2689999


Q ss_pred             ccCCCh
Q 006677          416 FASGSL  421 (635)
Q Consensus       416 ~~~g~L  421 (635)
                      +++-.+
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.50  E-value=6.6e-05  Score=66.13  Aligned_cols=107  Identities=16%  Similarity=0.222  Sum_probs=54.1

Q ss_pred             cCCCCCcEEEeec-CCCCCC----CCCCCCCCCcccEEeeccCccCCcCCCCcc------CCcceeeccCccCccc----
Q 006677           91 GKLDALEVLSLRS-NVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPSSFS------PQLVVLDLSFNSFTGN----  155 (635)
Q Consensus        91 ~~l~~L~~L~L~~-n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~------~~L~~L~ls~N~l~g~----  155 (635)
                      .+.++|+.|+|++ |.++..    +-..+...++|+.|+|++|.++...-..+.      +.|+.|++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            3456666666665 345411    122344556666666666666532222221      4566677776666532    


Q ss_pred             CCchhhccccCCcEEc--CCCccccc----CCCC--CCCCCcEEEeeccc
Q 006677          156 IPQSIQNLTQLTGLSL--QSNNLSGS----IPNF--DIPKLRHLNLSYNG  197 (635)
Q Consensus       156 ~p~~~~~l~~L~~L~l--~~N~l~~~----~p~~--~l~~L~~l~l~~N~  197 (635)
                      +-..+...++|+.++|  ++|.+...    +...  ..++|+.|+++.|.
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            2234555666665444  34555321    1110  34566777666554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.85  E-value=0.0002  Score=62.88  Aligned_cols=108  Identities=14%  Similarity=0.139  Sum_probs=74.1

Q ss_pred             CeEEEEEeCCC-CccC----cCCcccccCCCCCcEEEeecCCCCCC----CCCCCCCCCcccEEeeccCccCCcCCC---
Q 006677           69 TRVFGLRLPGI-GLVG----PIPNNTLGKLDALEVLSLRSNVLTGG----LPSEITSLPSLRYLYLQHNNFSGKIPS---  136 (635)
Q Consensus        69 ~~v~~l~l~~~-~l~g----~l~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~---  136 (635)
                      ..++.|+|+++ .++.    .+-. .+...++|+.|+|++|.++..    +-..+...++|+.|++++|.++...-.   
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~   95 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV   95 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence            46788888874 4431    1222 466789999999999998743    223355678999999999998743221   


Q ss_pred             -Ccc--CCcce--eeccCccCcc----cCCchhhccccCCcEEcCCCccc
Q 006677          137 -SFS--PQLVV--LDLSFNSFTG----NIPQSIQNLTQLTGLSLQSNNLS  177 (635)
Q Consensus       137 -~~~--~~L~~--L~ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~  177 (635)
                       .+.  ++|+.  |++++|++..    .+...+...++|+.|+++.|...
T Consensus        96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence             222  56776  4556778864    35566778999999999887654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.30  E-value=0.073  Score=50.84  Aligned_cols=29  Identities=21%  Similarity=0.204  Sum_probs=26.0

Q ss_pred             CceecCCCCCCeEEcCCCCeEEeecCCCC
Q 006677          462 KFTHGNIKASNVLINQDLDGCISDFGLTP  490 (635)
Q Consensus       462 ~ivH~Dlk~~NIll~~~~~~ki~DfGla~  490 (635)
                      .+||+|+.+.||+++.+...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            38999999999999998878899999764